PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tan, LD; Sarkis, PTN; Wang, T; Tian, CJ; Yu, XF				Tan, Lindi; Sarkis, Phuong Thi Nguyen; Wang, Tao; Tian, Chunjuan; Yu, Xiao-Fang			Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1	FASEB JOURNAL			English	Article						Vif; L1; virus; antiviral; evolution; G to A hypermutation	VIRUS TYPE-1 VIF; E3 UBIQUITIN LIGASE; ANTIRETROVIRAL FACTOR; FAMILY PROTEINS; URACIL-DNA; L1 RETROTRANSPOSITION; ADAPTIVE EVOLUTION; AID/APOBEC FAMILY; POTENT INHIBITOR; ENZYME APOBEC3G	Human cytidine deaminase apolipoprotein B mRNA-editing catalytic polypeptide-like 3 (APOBEC3) proteins have been classified as either Z1- or Z2-type cytidine deaminases on the basis of phylogenetic analysis of their catalytic domains. Despite the identification of a number of Z1-type domain-containing cytidine deaminases, only one copy of Z2-type cytidine deaminase has been detected in each of the mammalian species evaluated thus far. Z1-type human APOBEC3 proteins are known to exhibit broad activities against diverse retroelements. However, the potential role of the only human Z2-type cytidine deaminase, APOBEC3H (A3H), in the restriction of retroelements has not yet been fully characterized. Here, we demonstrate that human A3H is a potent inhibitor of non-LTR LINE-1 transposition. Interestingly, it was also as efficient as A3G in inhibiting Alu retrotransposition, despite its poor association with Alu RNA. We have further demonstrated, for the first time, that human APOBEC3DE is also a potent inhibitor of Alu retrotransposition. Variants of A3H have divergent antiviral activities against HIV-1-Vif-deficient viruses. Unlike the anti-HIV-1 cytidine deaminases A3G and A3F, A3H is moderately regulated by interferons. These observations suggest that human Z2-type cytidine deaminase A3H variants have varying intrinsic abilities to restrict retroelements and that various APOBEC3 proteins may have evolved distinct inhibitory mechanisms against retroelements.-Tan, L., Sarkis, P. T. N., Wang, T., Tian, C., Yu, X.-F. Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1. FASEB J. 23, 279-287 (2009)	[Tan, Lindi; Sarkis, Phuong Thi Nguyen; Wang, Tao; Tian, Chunjuan; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Yu, Xiao-Fang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Zhejiang University	Yu, XF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	xfyu@jhsph.edu			NIAID NIH HHS [R01 AI062644-05, R21 AI071769, R56 AI062644, AI071769, R01 AI062644, AI062644] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071769, R56AI062644, R01AI062644] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*APPL BIOS, 1997, ABI PRISM 7700 SEQ D, V2, P11; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Kremer M, 2005, VIROLOGY, V337, P175, DOI 10.1016/j.virol.2005.04.006; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Navarro F, 2004, CURR OPIN IMMUNOL, V16, P477, DOI 10.1016/j.coi.2004.05.006; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Rose KM, 2004, J BIOL CHEM, V279, P41744, DOI 10.1074/jbc.M406760200; Rosler C, 2004, SCIENCE, V305, p1403A, DOI 10.1126/science.1100464; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Shirakawa K, 2006, VIROLOGY, V344, P263, DOI 10.1016/j.virol.2005.10.028; Simon B, 2005, SURVEILL SOC, V3, P1; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Turelli P, 2004, J BIOL CHEM, V279, P43371, DOI 10.1074/jbc.C400334200; Turelli P, 2004, SCIENCE, V305, p1403B; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xiao ZX, 2007, FASEB J, V21, P217, DOI 10.1096/fj.06-6773com; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Ying SC, 2007, ACTA BIOCH BIOPH SIN, V39, P297, DOI 10.1111/j.1745-7270.2007.00275.x; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	85	65	66	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					279	287		10.1096/fj.07-088781	http://dx.doi.org/10.1096/fj.07-088781			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18827027	Green Published			2022-12-25	WOS:000262095500030
J	Downie, BR; Sanchez, A; Knotgen, H; Contreras-Jurado, C; Gymnopoulos, M; Weber, C; Stuhmer, W; Pardo, LA				Downie, Bryan R.; Sanchez, Araceli; Knoetgen, Hendrik; Contreras-Jurado, Constanza; Gymnopoulos, Marco; Weber, Claudia; Stuehmer, Walter; Pardo, Luis A.			Eag1 Expression Interferes with Hypoxia Homeostasis and Induces Angiogenesis in Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-GO-GO; GATED POTASSIUM CHANNELS; HIF-ALPHA; ETHER; CANCER; PROLIFERATION; CELLS	Ether-a-go-go-1 (Eag1) is a CNS-localized voltage-gated potassium channel that is found ectopically expressed in a majority of extracranial solid tumors. While circumstantial evidence linking Eag1 to tumor biology has been well established, the mechanisms by which the channel contributes to tumor progression remain elusive. In this study, we have used in vivo and in vitro techniques to identify a candidate mechanism. A mutation that eliminates ion permeation fails to completely abolish xenograft tumor formation by transfected cells, indicating that Eag1 contributes to tumor progression independently of its primary function as an ion channel. Our data suggest that Eag1 interferes with the cellular mechanism for maintaining oxygen homeostasis, increasing HIF-1 activity, and thereby VEGF secretion and tumor vascularization.	[Downie, Bryan R.; Sanchez, Araceli; Contreras-Jurado, Constanza; Weber, Claudia; Stuehmer, Walter; Pardo, Luis A.] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Knoetgen, Hendrik; Gymnopoulos, Marco; Pardo, Luis A.] IOnGen AG, D-37077 Gottingen, Germany	Max Planck Society	Pardo, LA (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.		Contreras-Jurado, Constanza/K-9028-2014; Pardo, Luis/C-5066-2013; Stuehmer, Walter/A-2176-2009	Contreras-Jurado, Constanza/0000-0002-4578-801X; Pardo, Luis/0000-0003-1375-4349; Stuehmer, Walter/0000-0002-0642-7764; Downie, Bryan/0000-0001-8278-722X				Arcangeli A, 2005, NOVART FDN SYMP, V266, P232, DOI [10.100210470021r12X.ch 17, DOI 10.1002/0470021R12X.CH]; Arcangeli Annarosa, 2005, V266, P225; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Conti DJ, 2004, AM J TRANSPLANT, V4, P166; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; Dubois JM, 2004, EUR BIOPHYS J BIOPHY, V33, P227, DOI 10.1007/s00249-003-0364-1; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hegle AP, 2006, P NATL ACAD SCI USA, V103, P2886, DOI 10.1073/pnas.0505909103; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Masi A, 2005, BRIT J CANCER, V93, P781, DOI 10.1038/sj.bjc.6602775; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Meyer R, 1999, J MEMBRANE BIOL, V171, P107, DOI 10.1007/s002329900563; Meyer R, 1998, J PHYSIOL-LONDON, V508, P49, DOI 10.1111/j.1469-7793.1998.049br.x; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Murata H, 2002, CANCER RES, V62, P7004; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2005, J MEMBRANE BIOL, V205, P115, DOI 10.1007/s00232-005-0776-1; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; ROUZAIREDUBOIS B, 2002, ION CHANNELS PHYSIOP, P187; Schafer WF, 2006, ANNU REV GENET, V40, P487, DOI 10.1146/annurev.genet.40.110405.090527; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; Stuhmer W, 2006, FEBS LETT, V580, P2850, DOI 10.1016/j.febslet.2006.03.062; Tomlinson VAL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-113; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135	40	123	125	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36234	36240		10.1074/jbc.M801830200	http://dx.doi.org/10.1074/jbc.M801830200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18927085	hybrid, Green Published			2022-12-25	WOS:000261840500018
J	Clausen, JD; McIntosh, DB; Woolley, DG; Andersen, JP				Clausen, Johannes D.; McIntosh, David B.; Woolley, David G.; Andersen, Jens Peter			Critical Interaction of Actuator Domain Residues Arginine 174, Isoleucine 188, and Lysine 205 with Modulatory Nucleotide in Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED PHOSPHORYLATION LOOP; CA2+-DEPENDENT ATP HYDROLYSIS; ALKALI-METAL SALTS; CALCIUM-PUMP; FUNCTIONAL CONSEQUENCES; REACTION-MECHANISM; CRYSTAL-STRUCTURE; CATALYTIC SITE; PHOSPHOENZYME INTERMEDIATE; ADENOSINE-TRIPHOSPHATASE	ATP plays dual roles in the reaction cycle of the sarcoplasmic reticulum Ca2+-ATPase by acting as the phosphorylating substrate as well as in nonphosphorylating (modulatory) modes accelerating conformational transitions of the enzyme cycle. Here we have examined the involvement of actuator domain residues Arg(174), Ile(188), Lys(204), and Lys(205) by mutagenesis. Alanine mutations to these residues had little effect on the interaction of the Ca(2)E1 state with nucleotide or on the H(n)E2 to Ca(2)E1 transition of the dephosphoenzyme. The phosphoenzyme processing steps, Ca(2)E1P to E2P and E2P dephosphorylation, and their stimulation by MgATP/ATP were markedly affected by mutations to Arg(174), Ile(188), and Lys(205). Replacement of Ile(188) with alanine abolished nucleotide modulation of dephosphorylation but not the modulation of the Ca(2)E1P to E2P transition. Mutation to Arg(174) interfered with nucleotide modulation of either of the phosphoenzyme processing steps, indicating a significant overlap between the modulatory nucleotide-binding sites involved. Mutation to Lys(205) enhanced the rates of the phosphoenzyme processing steps in the absence of nucleotide and disrupted the nucleotide modulation of the Ca(2)E1P to E2P transition. Remarkably, the mutants with alterations to Lys(205) showed an anomalous inhibition by ATP of the dephosphorylation, and in the alanine mutant the affinity for the inhibition by ATP was indistinguishable from that for stimulation by ATP of the wild type. Hence, the actuator domain is an important player in the function of ATP as modulator of phosphoenzyme processing, with Arg(174), Ile(188), and Lys(205) all being critically involved, although in different ways. The data support a variable site model for the modulatory effects with the nucleotide binding somewhat differently in each of the conformational states occurring during the transport cycle.	[Clausen, Johannes D.; Andersen, Jens Peter] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [McIntosh, David B.; Woolley, David G.] Univ Cape Town, Fac Hlth Sci, Div Chem Pathol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	Aarhus University; University of Cape Town	Andersen, JP (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ole Worms Alle 1185, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council; Danish National Research Foundation (PUMPKIN Centre); Novo Nordisk Foundation, Denmark; Lundbeck Foundation, Denmark; Research Foundation of Aarhus University; National Research Foundation of South Africa	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond); Novo Nordisk Foundation, Denmark(Novo Nordisk Foundation); Lundbeck Foundation, Denmark(Lundbeckfonden); Research Foundation of Aarhus University; National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported in part by grants from the Danish Medical Research Council, the Danish National Research Foundation (PUMPKIN Centre), the Novo Nordisk Foundation, Denmark, the Lundbeck Foundation, Denmark, the Research Foundation of Aarhus University (to J.P.A.), and the National Research Foundation of South Africa (to D.B.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; ARAV R, 1983, J BIOL CHEM, V258, P433; ARIKI M, 1980, BIOCHEMISTRY-US, V19, P2001, DOI 10.1021/bi00550a042; ASKARI A, 1982, BIOCHEM BIOPH RES CO, V104, P1447, DOI 10.1016/0006-291X(82)91412-7; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BISHOP JE, 1987, J BIOL CHEM, V262, P4658; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; CABLE MB, 1985, BIOCHEMISTRY-US, V24, P5612, DOI 10.1021/bi00341a049; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; Clarke RJ, 2007, BIOCHEMISTRY-US, V46, P7034, DOI 10.1021/bi700619s; Clausen JD, 2006, J BIOL CHEM, V281, P9471, DOI 10.1074/jbc.M512371200; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Clausen JD, 2001, J BIOL CHEM, V276, P35741, DOI 10.1074/jbc.M105434200; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; COLL RJ, 1991, BIOCHEMISTRY-US, V30, P1456, DOI 10.1021/bi00220a002; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DUPONT Y, 1977, EUR J BIOCHEM, V72, P185, DOI 10.1111/j.1432-1033.1977.tb11238.x; FORGE V, 1993, J BIOL CHEM, V268, P10961; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LACAPERE JJ, 1990, J BIOL CHEM, V265, P348; LACAPERE JJ, 1993, EUR J BIOCHEM, V211, P117, DOI 10.1111/j.1432-1033.1993.tb19877.x; Mahmmoud YA, 2008, P NATL ACAD SCI USA, V105, P1757, DOI 10.1073/pnas.0711838105; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh DB, 2008, BIOCHEMISTRY-US, V47, P6386, DOI 10.1021/bi800290q; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McIntosh DB, 2004, J BIOL CHEM, V279, P32515, DOI 10.1074/jbc.M403242200; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P5553, DOI 10.1021/bi00415a025; PICK U, 1982, J BIOL CHEM, V257, P6111; Reenstra WW, 2007, BIOCHEMISTRY-US, V46, P10145, DOI 10.1021/bi700991n; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1458; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; SUZUKI H, 1990, BIOCHEMISTRY-US, V29, P7040, DOI 10.1021/bi00482a013; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P7309, DOI 10.1021/bi00483a022; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762	62	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35703	35714		10.1074/jbc.M806795200	http://dx.doi.org/10.1074/jbc.M806795200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18930923	hybrid, Green Published			2022-12-25	WOS:000261687900044
J	Ishima, Y; Akaike, T; Kragh-Hansen, U; Hiroyama, S; Sawa, T; Suenaga, A; Maruyama, T; Kai, T; Otagiri, M				Ishima, Yu; Akaike, Takaaki; Kragh-Hansen, Ulrich; Hiroyama, Shuichi; Sawa, Tomohiro; Suenaga, Ayaka; Maruyama, Toru; Kai, Toshiya; Otagiri, Masaki			S-Nitrosylated Human Serum Albumin-mediated Cytoprotective Activity Is Enhanced by Fatty Acid Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; PHARMACOKINETIC ANALYSIS; LIGAND-BINDING; ISCHEMIA; PROTEINS; INJURY; NITROSOTHIOLS; REPERFUSION; CYSTEINE-34; PLASMA	Binding of oleate to S-nitrosylated human serum albumin (SNO-HSA) enhances its cytoprotective effect on liver cells in a rat ischemia/reperfusion model. It enhances the antiapoptotic effect of SNO-HSA on HepG2 cells exposed to anti-Fas antibody. To identify some of the reasons for the increased cytoprotective effects, additional experiments were performed with glutathione and HepG2 cells. As indicated by 5,5'-dithiobis-2-nitrobenzoic acid binding, the addition of oleate increased the accessibility of the single thiol group of albumin. Binding of increasing amounts of oleate resulted in increasing and more rapid S-transnitrosation of glutathione. Likewise, binding of oleate, or of a mixture of endogenous fatty acids, improved S-denitrosation of SNO-HSA by HepG2 cells. Oleate also enhanced S-transnitrosation by HepG2 cells, as detected by intracellular fluorescence of diaminofluorescein-FM. All of the S-transnitrosation caused by oleate binding was blocked by filipin III. Oleate also increased, in a dose-dependent manner, the binding of SNO-HSA labeled with fluorescein isothiocyanate to the surface of the hepatocytes. A model in two parts was worked out for S-transnitrosation, which does not involve low molecular weight thiols. Fatty acid binding facilitates S-denitrosation of SNO-HSA, increases its binding to HepG2 cells and greatly increases S-transnitrosation by hepatocytes in a way that is sensitive to filipin III. A small nitric oxide transfer takes place in a slow system, which is unaffected by fatty acid binding to SNO-HSA and not influenced by filipin III. Thus, fatty acids could be a novel type of mediator for S-transnitrosation.	[Ishima, Yu; Hiroyama, Shuichi; Suenaga, Ayaka; Maruyama, Toru; Kai, Toshiya; Otagiri, Masaki] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Akaike, Takaaki; Sawa, Tomohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Kragh-Hansen, Ulrich] Univ Aarhus, Dept Med Biochem, DK-8000 Aarhus C, Denmark; [Kai, Toshiya] Nipro Corp, Pharmaceut Res Ctr, Shiga, Japan	Kumamoto University; Kumamoto University; Aarhus University; Nipro Corporation	Otagiri, M (corresponding author), 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	otagirim@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology, Japan [18390051]; Fonden af 1870	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fonden af 1870	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (JSPS), a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (18390051), Japan, and by Fonden af 1870. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akaike T, 1997, J BIOCHEM-TOKYO, V122, P459; CHEN RF, 1967, J BIOL CHEM, V242, P173; Crane MS, 2002, J BIOL CHEM, V277, P46858, DOI 10.1074/jbc.M208608200; DASGUPTA A, 1990, CLIN PHYSIOL BIOCH, V8, P238; Dworschak M, 2004, PHARMACOLOGY, V72, P106, DOI 10.1159/000079139; Gryzunov YA, 2003, ARCH BIOCHEM BIOPHYS, V413, P53, DOI 10.1016/S0003-9861(03)00091-2; Hallstrom S, 2008, CARDIOVASC RES, V77, P506, DOI 10.1093/cvr/cvm052; Hallstrom S, 2002, CIRCULATION, V105, P3032, DOI 10.1161/01.CIR.0000018745.11739.9B; HNATOWICH DJ, 1982, INT J APPL RADIAT IS, V33, P327, DOI 10.1016/0020-708X(82)90144-2; Ikebe N, 2000, J PHARMACOL EXP THER, V295, P904; Ishima Y, 2007, BIOCHEM BIOPH RES CO, V364, P790, DOI 10.1016/j.bbrc.2007.10.094; Ishima Y, 2007, J PHARMACOL EXP THER, V320, P969, DOI 10.1124/jpet.106.114959; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; MAEDA H, 1969, J BIOCHEM-TOKYO, V65, P777, DOI 10.1093/oxfordjournals.jbchem.a129077; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Narazaki R, 1997, BBA-PROTEIN STRUCT M, V1338, P275, DOI 10.1016/S0167-4838(96)00221-X; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Pohl J, 2002, J LIPID RES, V43, P1390, DOI 10.1194/jlr.M100404-JLR200; Pohl R, 2004, P NUTR SOC, V63, P259, DOI 10.1079/PNS2004341; Ristic V, 2006, RENAL FAILURE, V28, P211, DOI 10.1080/08860220600574897; Shah CM, 2007, NITRIC OXIDE-BIOL CH, V16, P135, DOI 10.1016/j.niox.2006.08.001; SIMON DI, 1993, ARTERIOSCLER THROMB, V13, P791, DOI 10.1161/01.ATV.13.6.791; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stremmel W, 2001, LIPIDS, V36, P981, DOI 10.1007/s11745-001-0809-2; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Watanabe H, 2001, PHARMACEUT RES, V18, P1775, DOI 10.1023/A:1013391001141; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Yamasaki Y, 2002, J PHARMACOL EXP THER, V301, P467, DOI 10.1124/jpet.301.2.467	30	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34966	34975		10.1074/jbc.M807009200	http://dx.doi.org/10.1074/jbc.M807009200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940810	Green Published, hybrid			2022-12-25	WOS:000261469100053
J	Mahul-Mellier, AL; Strappazzon, F; Petiot, A; Chatellard-Causse, C; Torch, S; Blot, B; Freeman, K; Kuhn, L; Garin, J; Verna, JM; Fraboulet, S; Sadoul, R				Mahul-Mellier, Anne-Laure; Strappazzon, Flavie; Petiot, Anne; Chatellard-Causse, Christine; Torch, Sakina; Blot, Beatrice; Freeman, Kimberley; Kuhn, Loriane; Garin, Jerome; Verna, Jean-Marc; Fraboulet, Sandrine; Sadoul, Remy			Alix and ALG-2 Are Involved in Tumor Necrosis Factor Receptor 1-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA; CALCIUM CONCENTRATIONS; ENDOPLASMIC-RETICULUM; PROTEIN ALG-2; APOPTOSIS; TNF-RECEPTOR-1; INTRANUCLEAR; TRAFFICKING; ACTIVATION; AIP1/ALIX	Alix/AIP1 regulates cell death in a way involving interactions with the calcium-binding protein ALG-2 and with proteins of ESCRT((e) under bar ndosomal (s) under bar orting (c) under bar omplex (r) under bar equired for (t) under bar ransport). Using mass spectrometry we identified caspase-8 among proteins co-immunoprecipitating with Alix in dying neurons. We next demonstrated that Alix and ALG-2 interact with pro-caspase-8 and that Alix forms a complex with the TNF alpha receptor-1 (TNF-R1), depending on its capacity to bind ESCRT proteins. Thus, Alix and ALG-2 may allow the recruitment of pro-caspase-8 onto endosomes containing TNF-R1, a step thought to be necessary for activation of the apical caspase. In line with this, expression of Alix deleted of its ALG-2-binding site (Alix Delta ALG-2) significantly reduced TNF-R1-induced cell death, without affecting endocytosis of the receptor. In a more physiological setting, we found that programmed cell death of motoneurons, which can be inhibited by Alix Delta ALG-2, is regulated by TNF-R1. Taken together, these results highlight Alix and ALG-2 as new actors of the TNF-R1 pathway.	[Mahul-Mellier, Anne-Laure; Strappazzon, Flavie; Petiot, Anne; Chatellard-Causse, Christine; Torch, Sakina; Blot, Beatrice; Freeman, Kimberley; Verna, Jean-Marc; Fraboulet, Sandrine; Sadoul, Remy] INSERM, U836, Equipe 2, F-38042 Grenoble, France; [Kuhn, Loriane; Garin, Jerome] Commissariat Energie Atom, Dept Sci Vivant Lab Etud Dynam Proteomes, F-38054 Grenoble, France; [Kuhn, Loriane; Garin, Jerome] INSERM, U880, F-38054 Grenoble, France; [Mahul-Mellier, Anne-Laure; Strappazzon, Flavie; Petiot, Anne; Chatellard-Causse, Christine; Torch, Sakina; Blot, Beatrice; Freeman, Kimberley; Kuhn, Loriane; Verna, Jean-Marc; Fraboulet, Sandrine; Sadoul, Remy] Univ Grenoble 1, Grenoble Inst Neurosci, F-38042 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fraboulet, S (corresponding author), Univ Oxford, MRC Funct Genet Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England.	sandrine.fraboulet@dpag.ox.ac.uk; remy.sadoul@ujf-grenoble.fr	TORCH, sakina/N-7717-2013; FRABOULET, Sandrine/D-5046-2019; Strappazzon, Flavie/ABB-6775-2020; TORCH, SAKINA/AAC-2994-2019; Strappazzon, Flavie/K-6035-2016; FRABOULET, sandrine/H-5677-2012	FRABOULET, Sandrine/0000-0002-2651-9084; Strappazzon, Flavie/0000-0003-0285-7449; TORCH, Sakina/0000-0003-3691-4376; SADOUL, Remy/0000-0002-4763-0320; Kuhn, Lauriane/0000-0002-2637-1024; PETIOT, Anne/0000-0001-8038-470X	INSERM; University Joseph Fourier; Association Francaise contre les Myopathies; Association pour la Recherche sur la Sclerose Laterale Amyotrophique; Association pour la Recherche contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Joseph Fourier; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur la Sclerose Laterale Amyotrophique; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by INSERM, the University Joseph Fourier, and grants from the Association Francaise contre les Myopathies, the Association pour la Recherche sur la Sclerose Laterale Amyotrophique, and the Association pour la Recherche contre le Cancer. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a fellowship from the Association Francaise contre les Myopathies. Present address: Imperial College London, Experimental Medicine&Toxicology, London W120NN, UK.	Barker PA, 2002, TRENDS NEUROSCI, V25, P379, DOI 10.1016/S0166-2236(02)02199-9; BELLOMO G, 1992, CANCER RES, V52, P1342; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Draper DW, 2004, J IMMUNOL, V172, P2416, DOI 10.4049/jimmunol.172.4.2416; Ferro M, 2000, ELECTROPHORESIS, V21, P3517; Fraboulet S, 2003, GENE EXPR PATTERNS, V3, P139, DOI 10.1016/S1567-133X(03)00025-5; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; HASEGAWA Y, 1989, J IMMUNOL, V142, P2670; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kong SK, 1997, ONCOLOGY-BASEL, V54, P55; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McFarlane SM, 2000, MOL CELL BIOCHEM, V211, P19, DOI 10.1023/A:1007189911897; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; MORITA E, 2007, EMBO J, V13, P13; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Narita T, 2005, EXP CELL RES, V304, P256, DOI 10.1016/j.yexcr.2004.11.005; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Raoul C, 2000, CURR OPIN NEUROBIOL, V10, P111, DOI 10.1016/S0959-4388(99)00055-0; Sadoul R, 2006, BIOL CELL, V98, P69, DOI 10.1042/BC20050007; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sedel F, 2004, J NEUROSCI, V24, P2236, DOI 10.1523/JNEUROSCI.4464-03.2004; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Todd I, 2004, IMMUNOLOGY, V113, P65, DOI 10.1111/j.1365-2567.2004.01942.x; Trioulier Y, 2004, J BIOL CHEM, V279, P2046, DOI 10.1074/jbc.M309243200; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035	42	53	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34954	34965		10.1074/jbc.M803140200	http://dx.doi.org/10.1074/jbc.M803140200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936101	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000261469100052
J	Lin, ZH; Gao, C; Ning, YH; He, X; Wu, W; Chen, YG				Lin, Zhenghong; Gao, Chan; Ning, Yuanheng; He, Xi; Wu, Wei; Chen, Ye-Guang			The Pseudoreceptor BMP and Activin Membrane-bound Inhibitor Positively Modulates Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; BETA-CATENIN; TGF-BETA; TRANSCRIPTIONAL REGULATION; NEGATIVE REGULATOR; COLORECTAL-CANCER; CYCLIN D1; AXIN; BAMBI; EXPRESSION	The canonical Wnt/beta-catenin pathway plays a pivotal role in regulating embryogenesis and tumorigenesis by promoting cell proliferation. BAMBI (BMP and activin membrane-bound inhibitor) has previously been shown to negatively regulate the signaling activity of transforming growth factor-beta, activin, and BMP and was identified as a target of beta-catenin in colorectal and hepatocellular tumor cells. In this study, we provide evidence that BAMBI can promote the transcriptional activity of Wnt/beta-catenin signaling. Overexpression of BAMBI enhances the expression of Wnt-responsive reporters, whereas knockdown of endogenous BAMBI attenuates them. Accordingly, BAMBI also promotes the nuclear translocation of beta-catenin. BAMBI interacts with Wnt receptor Frizzled5, coreceptor LRP6, and Dishevelled2 and increases the interaction between Frizzled5 and Dishevelled2. Finally we show that BAMBI promotes the expression of c-myc and cyclin D1 and increases Wnt-promoted cell cycle progression. Altogether, our data indicate that BAMBI can function as a positive regulator of the Wnt/beta-catenin pathway to promote cell proliferation.	[Lin, Zhenghong; Gao, Chan; Ning, Yuanheng; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Lin, Zhenghong; Gao, Chan; Ning, Yuanheng; Wu, Wei; Chen, Ye-Guang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [He, Xi] Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA	Tsinghua University; Tsinghua University; Harvard University; Boston Children's Hospital; Harvard Medical School	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Gao, Chan/D-7964-2013; Chen, Ye-Guang/L-6998-2019	Lin, Zhenghong/0000-0002-6354-0042	National Natural Science Foundation of China [30430360, 30671033, 90713045]; 973 Program [2004CB720002, 2006CB943401, 2006CB910102]; 863 Program [2006AA02Z172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (Grants 30430360, 30671033, and 90713045), the 973 Program (Grants 2004CB720002, 2006CB943401, and 2006CB910102), and the 863 Program (Grant 2006AA02Z172). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Degen WGJ, 1996, INT J CANCER, V65, P460, DOI 10.1002/(SICI)1097-0215(19960208)65:4<460::AID-IJC12>3.3.CO;2-B; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Higashihori N, 2008, DEV DYNAM, V237, P1500, DOI 10.1002/dvdy.21529; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loveland KL, 2003, ENDOCRINOLOGY, V144, P4180, DOI 10.1210/en.2002-0124; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sasaki T, 2004, ONCOL REP, V11, P1219; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tsang M, 2000, GENESIS, V28, P47, DOI 10.1002/1526-968X(200010)28:2<47::AID-GENE20>3.0.CO;2-S; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603	40	46	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33053	33058		10.1074/jbc.M804039200	http://dx.doi.org/10.1074/jbc.M804039200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838381	Green Published, hybrid			2022-12-25	WOS:000261183700005
J	Baptista, MS; de Carvalho, JX; Hussein, MS				Baptista, Murilo S.; de Carvalho, Josue X.; Hussein, Mahir S.			Finding Quasi-Optimal Network Topologies for Information Transmission in Active Networks	PLOS ONE			English	Article							SMALL-WORLD; SYNCHRONIZATION; ENTROPIES	This work clarifies the relation between network circuit (topology) and behaviour (information transmission and synchronization) in active networks, e.g. neural networks. As an application, we show how one can find network topologies that are able to transmit a large amount of information, possess a large number of communication channels, and are robust under large variations of the network coupling configuration. This theoretical approach is general and does not depend on the particular dynamic of the elements forming the network, since the network topology can be determined by finding a Laplacian matrix (the matrix that describes the connections and the coupling strengths among the elements) whose eigenvalues satisfy some special conditions. To illustrate our ideas and theoretical approaches, we use neural networks of electrically connected chaotic Hindmarsh-Rose neurons.	[Baptista, Murilo S.; de Carvalho, Josue X.; Hussein, Mahir S.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Baptista, Murilo S.] Univ Porto, Ctr Mat, Porto, Portugal; [Hussein, Mahir S.] Univ Sao Paulo, Inst Phys, BR-05508 Sao Paulo, Brazil	Max Planck Society; Universidade do Porto; Universidade de Sao Paulo	Baptista, MS (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.	murilo.baptista@fc.up.pt	baptista, murilo s/B-7277-2008; Huseein, Mahir/M-4506-2019		Max Planck Institute for the Physics of Complex Systems; FCT; FAPESP; CNPq; Martin Gutzwiller prize	Max Planck Institute for the Physics of Complex Systems(Foundation CELLEX); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Martin Gutzwiller prize	This study was financed by the Max Planck Institute for the Physics of Complex Systems, FCT, FAPESP, CNPq, and the Martin Gutzwiller prize 2007/2008 (MSH).	Baptista MS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026205; Baptista MS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.045202; BAPTISTA MS, EUROPHYSICS IN PRESS; BAPTISTA MS, BOUNDS KOLMOGO UNPUB; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Chavez M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066107; Chavez M, 2006, CHAOS, V16, DOI 10.1063/1.2180467; Corron NJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.024101; DERMALSBURG CV, 1985, BER BUNSEN PHYS CHEM, V89, P703; DJURFELDT M, 2006, PROJECT REPORT BLUE; Eggermont JJ, 1998, NEUROSCI BIOBEHAV R, V22, P355, DOI 10.1016/S0149-7634(97)00021-3; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; HEAGY JF, 1995, PHYS REV LETT, V74, P4185, DOI 10.1103/PhysRevLett.74.4185; HEAGY JF, 1994, PHYS REV E, V50, P1874, DOI 10.1103/PhysRevE.50.1874; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Ipsen M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046109; Jirsa VK, 2004, NEUROINFORMATICS, V2, P183, DOI 10.1385/NI:2:2:183; Mendes RV, 1998, PHYS LETT A, V248, P167, DOI 10.1016/S0375-9601(98)00604-5; PALUS M, 2001, SYNCHRONIZATION INFO, P65; Pareti G, 2004, NEUROL SCI, V25, P41, DOI 10.1007/s10072-004-0235-2; Pecora LM, 1998, PHYS REV LETT, V80, P2109, DOI 10.1103/PhysRevLett.80.2109; Pecora LM, 1998, PHYS REV E, V58, P347, DOI 10.1103/PhysRevE.58.347; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Pesin YB., 1977, RUSS MATH SURV, V32, P55, DOI [10.1070/RM1977v032n04ABEH001639, DOI 10.1070/RM1977V032N04ABEH001639]; Rosenblum M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041904; SANLIANG X, 2005, PHYS REV LETT, V95; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Smith VA, 2006, PLOS COMPUT BIOL, V2, P1436, DOI 10.1371/journal.pcbi.0020161; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Wagner C, 2007, INT J BIFURCAT CHAOS, V17, P3409, DOI 10.1142/S0218127407019135; Zhou CS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.034101; Zochowski M, 2004, J PHYS A-MATH GEN, V37, P3823, DOI 10.1088/0305-4470/37/12/007	37	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3479	10.1371/journal.pone.0003479	http://dx.doi.org/10.1371/journal.pone.0003479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941516	Green Submitted, Green Published, gold			2022-12-25	WOS:000265126100010
J	Gomez-Baena, G; Lopez-Lozano, A; Gil-Martinez, J; Lucena, JM; Diez, J; Candau, P; Garcia-Fernandez, JM				Gomez-Baena, Guadalupe; Lopez-Lozano, Antonio; Gil-Martinez, Jorge; Manuel Lucena, Jose; Diez, Jesus; Candau, Pedro; Manuel Garcia-Fernandez, Jose			Glucose Uptake and Its Effect on Gene Expression in Prochlorococcus	PLOS ONE			English	Article							AMINO-ACID-UPTAKE; SP STRAIN PCC-6803; SURFACE WATERS; BACTERIAL PRODUCTION; ADAPTIVE-MECHANISMS; NITROGEN CONTROL; CYANOBACTERIA; METABOLISM; GENOME; CARBON	The marine cyanobacteria Prochlorococcus have been considered photoautotrophic microorganisms, although the utilization of exogenous sugars has never been specifically addressed in them. We studied glucose uptake in different high irradiance-and low irradiance-adapted Prochlorococcus strains, as well as the effect of glucose addition on the expression of several glucose-related genes. Glucose uptake was measured by adding radiolabelled glucose to Prochlorococcus cultures, followed by flow cytometry coupled with cell sorting in order to separate Prochlorococcus cells from bacterial contaminants. Sorted cells were recovered by filtration and their radioactivity measured. The expression, after glucose addition, of several genes (involved in glucose metabolism, and in nitrogen assimilation and its regulation) was determined in the low irradiance-adapted Prochlorococcus SS120 strain by semi-quantitative real time RT-PCR, using the rnpB gene as internal control. Our results demonstrate for the first time that the Prochlorococcus strains studied in this work take up glucose at significant rates even at concentrations close to those found in the oceans, and also exclude the possibility of this uptake being carried out by eventual bacterial contaminants, since only Prochlorococcus cells were used for radioactivity measurements. Besides, we show that the expression of a number of genes involved in glucose utilization (namely zwf, gnd and dld, encoding glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase and lactate dehydrogenase, respectively) is strongly increased upon glucose addition to cultures of the SS120 strain. This fact, taken together with the magnitude of the glucose uptake, clearly indicates the physiological importance of the phenomenon. Given the significant contribution of Prochlorococcus to the global primary production, these findings have strong implications for the understanding of the phytoplankton role in the carbon cycle in nature. Besides, the ability of assimilating carbon molecules could provide additional hints to comprehend the ecological success of Prochlorococcus.	[Gomez-Baena, Guadalupe; Lopez-Lozano, Antonio; Diez, Jesus; Manuel Garcia-Fernandez, Jose] Univ Cordoba, Dept Bioquim & Biol Mol, Cordoba, Spain; [Gil-Martinez, Jorge; Manuel Lucena, Jose; Candau, Pedro] Univ Seville, CSIC, Inst Bioquim Vegetal Fotosintesis, Seville, Spain	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Gomez-Baena, G (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa,Campus Rabanales, Cordoba, Spain.	bb1gafej@uco.es	Gómez-Baena, Guadalupe/N-2368-2013; Diez, Jesús/R-3500-2019; García Fernández, José Manuel/M-2431-2014; Lopez-Lozano, Antonio/F-1295-2016	Gómez-Baena, Guadalupe/0000-0003-3796-3874; Diez, Jesús/0000-0002-1346-3528; García Fernández, José Manuel/0000-0003-2983-1214; Lopez-Lozano, Antonio/0000-0003-1136-9762	Spanish Ministerio de Educacion y Ciencia [BMC2003-09218-CO2-01, BMC2003-09218-CO2-02, BFU2006-10011/BMC]; Universidad de Cordoba; Junta de Andalucia [fellowships]; MEC [fellowships]; Spanish Consejo Superior de Investigaciones Cientificas	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Universidad de Cordoba; Junta de Andalucia(Junta de Andalucia); MEC(European Commission); Spanish Consejo Superior de Investigaciones Cientificas	This work was supported by grants BMC2003-09218-CO2-01, BMC2003-09218-CO2-02 and BFU2006-10011/BMC from Spanish Ministerio de Educacion y Ciencia (MEC, co-funded by the European Social Fund from the European Union), Universidad de Cordoba and Junta de Andalucia (JA). G.G.-B., A.L.-L. and J.G.-M. were recipients of fellowships from JA and MEC and Spanish Consejo Superior de Investigaciones Cientificas.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON SL, 1991, J BACTERIOL, V173, P2761, DOI 10.1128/JB.173.9.2761-2767.1991; AZAM F, 1981, MAR ECOL PROG SER, V6, P213, DOI 10.3354/meps006213; AZAM F, 1977, LIMNOL OCEANOGR, V22, P492, DOI 10.4319/lo.1977.22.3.0492; CARON DA, 2000, MICROBIAL ECOLOGY OC; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; de Marsac NT, 2001, J APPL PHYCOL, V13, P287; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Eiler A, 2006, APPL ENVIRON MICROB, V72, P7431, DOI 10.1128/AEM.01559-06; El Alaoui S, 2001, APPL ENVIRON MICROB, V67, P2202, DOI 10.1128/AEM.67.5.2202-2207.2001; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; Flores E., 1994, MOL BIOL CYANOBACTER, VVol 1, P487; Fuller NJ, 2005, LIMNOL OCEANOGR, V50, P363, DOI 10.4319/lo.2005.50.1.0363; Garcia-Fernandez JM, 2004, MICROBIOL MOL BIOL R, V68, P630, DOI 10.1128/MMBR.68.4.630-638.2004; Garcia-Fernandez JM, 1998, ARCH BIOCHEM BIOPHYS, V359, P17, DOI 10.1006/abbi.1998.0862; Garcia-Fernandez JM, 2004, RES MICROBIOL, V155, P795, DOI 10.1016/j.resmic.2004.06.009; Goericke R, 2000, DEEP-SEA RES PT I, V47, P1183, DOI 10.1016/S0967-0637(99)00108-9; JANNASCH HW, 1974, LIMNOL OCEANOGR, V19, P716, DOI 10.4319/lo.1974.19.4.0716; Johnson Z, 1999, DEEP-SEA RES PT II, V46, P1719, DOI 10.1016/S0967-0645(99)00041-7; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kirchman DL, 2000, MICROBIAL ECOLOGY OC; Lee S, 2007, PLANT PHYSIOL, V145, P1018, DOI 10.1104/pp.107.105023; Lopez-Lozano A, 2002, FEMS MICROBIOL ECOL, V41, P151, DOI 10.1111/j.1574-6941.2002.tb00976.x; LUQUE I, 1994, EMBO J, V13, P2862, DOI 10.1002/j.1460-2075.1994.tb06580.x; Luque I, 2008, CYANOBACTERIA MOL BI; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Marie D, 1999, CURRENT PROTOCOLS CY; MARIE D, 2005, ALGAL CULTURAL TECHN; Mary I, 2008, FEMS MICROBIOL ECOL, V63, P36, DOI 10.1111/j.1574-6941.2007.00414.x; Michelou VK, 2007, APPL ENVIRON MICROB, V73, P5539, DOI 10.1128/AEM.00212-07; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Navarro F, 2000, ARCH BIOCHEM BIOPHYS, V379, P267, DOI 10.1006/abbi.2000.1894; PARSONS TR, 1961, DEEP-SEA RES, V8, P211, DOI 10.1016/0146-6313(61)90022-3; Partensky F, 2003, ADV PHOTO RESPIRAT, V14, P29; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; PEARCE J, 1969, J GEN MICROBIOL, V55, P371, DOI 10.1099/00221287-55-3-371; PELROY RA, 1972, ARCH MIKROBIOL, V87, P303, DOI 10.1007/BF00409131; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRIVALLE LS, 1984, J BACTERIOL, V160, P794, DOI 10.1128/JB.160.2.794-796.1984; Rich J, 1997, DEEP-SEA RES PT II, V44, P1645, DOI 10.1016/S0967-0645(97)00058-1; Rich JH, 1996, LIMNOL OCEANOGR, V41, P595, DOI 10.4319/lo.1996.41.4.0595; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; RIPPKA R, 1972, ARCH MIKROBIOL, V87, P93, DOI 10.1007/BF00424781; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; RUBIN PM, 1977, PLANT PHYSIOL, V60, P407, DOI 10.1104/pp.60.3.407; SANCHEZ JJ, 1975, ARCH MICROBIOL, V104, P57, DOI 10.1007/BF00447300; Singh AK, 2005, J BACTERIOL, V187, P2368, DOI 10.1128/JB.187.7.2368-2376.2005; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1111/j.1574-6976.1997.tb00350.x; VACCARO RF, 1968, LIMNOL OCEANOGR, V13, P356, DOI 10.4319/lo.1968.13.2.0356; VAULOT D, 1989, CYTOMETRY, V10, P629, DOI 10.1002/cyto.990100519; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043; Zubkov MV, 2008, J PLANKTON RES, V30, P211, DOI 10.1093/plankt/fbm091; Zubkov MV, 2004, FEMS MICROBIOL ECOL, V50, P153, DOI 10.1016/j.femsec.2004.06.009; Zubkov MV, 2005, AQUAT MICROB ECOL, V40, P241, DOI 10.3354/ame040241; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003	56	44	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3416	10.1371/journal.pone.0003416	http://dx.doi.org/10.1371/journal.pone.0003416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941506	gold, Green Published			2022-12-25	WOS:000265125600001
J	Ke, XS; Qu, Y; Goldfinger, N; Rostad, K; Hovland, R; Akslen, LA; Rotter, V; Oyan, AM; Kalland, KH				Ke, Xi-Song; Qu, Yi; Goldfinger, Naomi; Rostad, Kari; Hovland, Randi; Akslen, Lars A.; Rotter, Varda; Oyan, Anne Margrete; Kalland, Karl-Henning			Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation	PLOS ONE			English	Article								Background: Epithelial to mesenchymal transition (EMT) has been connected with cancer progression in vivo and the generation of more aggressive cancer cell lines in vitro. EMT has been induced in prostate cancer cell lines, but has previously not been shown in primary prostate cells. The role of EMT in malignant transformation has not been clarified. Methodology/Principal Findings: In a transformation experiment when selecting for cells with loss of contact inhibition, the immortalized prostate primary epithelial cell line, EP156T, was observed to undergo EMT accompanied by loss of contact inhibition after about 12 weeks in continuous culture. The changed new cells were named EPT1. EMT of EPT1 was characterized by striking morphological changes and increased invasion and migration compared with the original EP156T cells. Gene expression profiling showed extensively decreased epithelial markers and increased mesenchymal markers in EPT1 cells, as well as pronounced switches of gene expression modules involved in cell adhesion and attachment. Transformation assays showed that EPT1 cells were sensitive to serum or growth factor withdrawal. Most importantly, EPT1 cells were not able to grow in an anchorage-independent way in soft agar, which is considered a critical feature of malignant transformation. Conclusions/Significance: This work for the first time established an EMT model from primary prostate cells. The results show that EMT can be activated as a coordinated gene expression program in association with early steps of transformation. The model allows a clearer identification of the molecular mechanisms of EMT and its potential role in malignant transformation.	[Ke, Xi-Song; Qu, Yi; Rostad, Kari; Akslen, Lars A.; Oyan, Anne Margrete; Kalland, Karl-Henning] Univ Bergen, Gade Inst, Bergen, Norway; [Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Hovland, Randi] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway; [Akslen, Lars A.] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Oyan, Anne Margrete; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol & Immunol, Bergen, Norway	University of Bergen; Weizmann Institute of Science; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Ke, XS (corresponding author), Univ Bergen, Gade Inst, Bergen, Norway.	Kalland@gades.uib.no	Kalland, Karl-Henning/B-9445-2017; Akslen, Lars A./AAG-6097-2021; Akslen, Lars A/C-1202-2017	Kalland, Karl-Henning/0000-0003-4486-2334; Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543	Helse Vest [911005, 911227, 911401]; Research Council of Norway [154942/310, 163920/V50, 185676/V40]; Norwegian Cancer Society [HS01-2006-0446, HS01-2006-0468]; University of Bergen	Helse Vest; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); University of Bergen	This study was funded by the following grants: Helse Vest (Grants 911005, 911227 and 911401), The Research Council of Norway (Grants 154942/310, 163920/V50, 185676/V40, The Norwegian Cancer Society (grants HS01-2006-0446 and HS01-2006-0468) and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beheshti B, 2000, MOL DIAGN, V5, P23, DOI 10.2165/00066982-200005010-00008; Beitzinger M, 2008, EMBO J, V27, P792, DOI 10.1038/emboj.2008.13; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Billottet C, 2008, J CELL BIOCHEM, V104, P826, DOI 10.1002/jcb.21667; BOREK C, 1966, P NATL ACAD SCI USA, V56, P1705, DOI 10.1073/pnas.56.6.1705; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Geiger T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001574; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P60, DOI 10.1016/S0966-842X(99)01689-3; Gotoh N, 2007, INVEST OPHTH VIS SCI, V48, P4679, DOI 10.1167/iovs.07-0091; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gu XS, 2007, CANCER RES, V67, P4219, DOI 10.1158/0008-5472.CAN-06-3689; Gu YP, 2006, EXP CELL RES, V312, P831, DOI 10.1016/j.yexcr.2005.11.029; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Jarrard DF, 1997, CLIN CANCER RES, V3, P2121; Jiang M, 2008, PROSTATE, V68, P1496, DOI 10.1002/pros.20756; KAIGHN ME, 1989, CANCER RES, V49, P3050; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kiemer AK, 2001, ONCOGENE, V20, P6679, DOI 10.1038/sj.onc.1204872; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kuettel MR, 1996, CANCER RES, V56, P5; Laffin B, 2008, MOL CELL BIOL, V28, P1936, DOI 10.1128/MCB.01701-07; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Luo Y, 2006, CHINESE MED J-PEKING, V119, P713, DOI 10.1097/00029330-200605010-00002; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Miki J, 2008, PROSTATE CANCER P D, V11, P32, DOI 10.1038/sj.pcan.4501018; Mimeault M, 2007, ANN ONCOL, V18, P1605, DOI 10.1093/annonc/mdm070; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Petersen K, 2007, ANAL BIOCHEM, V366, P46, DOI 10.1016/j.ab.2007.03.013; Rhim JS, 1997, CANCER RES, V57, P576; Rubin H, 2005, P NATL ACAD SCI USA, V102, P9276, DOI 10.1073/pnas.0503688102; Rubin H, 2008, P NATL ACAD SCI USA, V105, P6215, DOI 10.1073/pnas.0800747105; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Spaderna S, 2007, Verh Dtsch Ges Pathol, V91, P21; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Strefford JC, 2001, CANCER GENET CYTOGEN, V124, P112, DOI 10.1016/S0165-4608(00)00339-3; SZILVAY AM, 1995, J VIROL, V69, P3315, DOI 10.1128/JVI.69.6.3315-3323.1995; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tran NL, 1999, AM J PATHOL, V155, P787, DOI 10.1016/S0002-9440(10)65177-2; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Vincan E, 2007, CELLS TISSUES ORGANS, V185, P20, DOI 10.1159/000101299; Wolter H, 2002, EUR UROL, V41, P328, DOI 10.1016/S0302-2838(02)00035-0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Yang Z, 2007, BIOCHEM BIOPH RES CO, V358, P925, DOI 10.1016/j.bbrc.2007.05.023; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140	75	48	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3368	10.1371/journal.pone.0003368	http://dx.doi.org/10.1371/journal.pone.0003368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852876	Green Published, gold, Green Submitted			2022-12-25	WOS:000265121600001
J	Simhadri, VR; Reiners, KS; Hansen, HP; Topolar, D; Simhadri, VL; Nohroudi, K; Kufer, TA; Engert, A; von Strandmann, EP				Simhadri, Venkateswara Rao; Reiners, Katrin S.; Hansen, Hinrich P.; Topolar, Daniela; Simhadri, Vijaya Lakshmi; Nohroudi, Klaus; Kufer, Thomas A.; Engert, Andreas; von Strandmann, Elke Pogge			Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function	PLOS ONE			English	Article								NKp30, a natural cytotoxicity receptor expressed on NK cells is critically involved in direct cytotoxicity against various tumor cells and directs both maturation and selective killing of dendritic cells. Recently the intracellular protein BAT3, which is involved in DNA damage induced apoptosis, was identified as a ligand for NKp30. However, the mechanisms underlying the exposure of the intracellular ligand BAT3 to surface NKp30 and its role in NK-DC cross talk remained elusive. Electron microscopy and flow cytometry demonstrate that exosomes released from 293T cells and iDCs express BAT3 on the surface and are recognized by NKp30-Ig. Overexpression and depletion of BAT3 in 293T cells directly correlates with the exosomal expression level and the activation of NK cell-mediated cytokine release. Furthermore, the NKp30-mediated NK/DC cross talk resulting either in iDC killing or maturation was BAT3-dependent. Taken together this puts forward a new model for the activation of NK cells through intracellular signals that are released via exosomes from accessory cells. The manipulation of the exosomal regulation may offer a novel strategy to induce tumor immunity or inhibit autoimmune diseases caused by NK cell-activation.	[Simhadri, Venkateswara Rao; Reiners, Katrin S.; Hansen, Hinrich P.; Topolar, Daniela; Simhadri, Vijaya Lakshmi; Engert, Andreas; von Strandmann, Elke Pogge] Univ Cologne, Dept Internal Med 1, Lab Immune Therapy, Ctr Integrated Oncol Koeln Bonn, Cologne, Germany; [Nohroudi, Klaus] Univ Hosp Cologne, Inst Anat I, Cologne, Germany; [Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol, Immunol & Hyg, D-5000 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Simhadri, VR (corresponding author), Univ Cologne, Dept Internal Med 1, Lab Immune Therapy, Ctr Integrated Oncol Koeln Bonn, Cologne, Germany.	venkatsimhadri@googlemail.com; elke.pogge@uk-koeln.de	Kufer, Thomas A/I-5146-2015	Kufer, Thomas A/0000-0003-4563-0412; Reiners, Katrin/0000-0002-5908-8823	Deutsche Forschungsgemeinschaft (DFG) [STR 530/5-1]; Deutsche Krebshilfe [107276]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	Research was supported by Deutsche Forschungsgemeinschaft (DFG) (STR 530/5-1) and Deutsche Krebshilfe (107276).	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Augugliaro R, 2003, EUR J IMMUNOL, V33, P1235, DOI 10.1002/eji.200323896; BIENZ M, 1987, ADV GENET, V24, P31, DOI 10.1016/S0065-2660(08)60006-1; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Byrd A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001339; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; DESMOTS F, 2007, J BIOL CHEM; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Hershkovitz O, 2008, GLYCOBIOLOGY, V18, P28, DOI 10.1093/glycob/cwm125; Hollins Susan, 2005, Nurs Manag (Harrow), V12, P22; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; LESPAGNOL A, 2008, CELL DEATH DIFFER; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; North J, 2007, J IMMUNOL, V178, P85, DOI 10.4049/jimmunol.178.1.85; Nowbakht P, 2005, BLOOD, V105, P3615, DOI 10.1182/blood-2004-07-2585; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Warren HS, 2005, J IMMUNOL, V175, P207, DOI 10.4049/jimmunol.175.1.207; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	40	176	185	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3377	10.1371/journal.pone.0003377	http://dx.doi.org/10.1371/journal.pone.0003377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852879	Green Published, Green Submitted, gold			2022-12-25	WOS:000265121600003
J	Ching, OY; Smith, DD; Krontiris, TG				Ching Ouyang; Smith, David D.; Krontiris, Theodore G.			Evolutionary Signatures of Common Human Cis-Regulatory Haplotypes	PLOS ONE			English	Article								Variation in gene expression may give rise to a significant fraction of inter-individual phenotypic variation. Studies searching for the underlying genetic controls for such variation have been conducted in model organisms and humans in recent years. In our previous effort of assessing conserved underlying haplotype patterns across ethnic populations, we constructed common haplotypes using SNPs having conserved linkage disequilibrium (LD) across ethnic populations. These common haplotypes cluster into a simple evolutionary structure based on their frequencies, defining only up to three conserved clusters termed 'haplotype frameworks'. One intriguing preliminary finding was that a significant portion of reported variants strongly associated with cis-regulation tags these globally conserved haplotype frameworks. Here we expand the investigation by collecting genes showing stringently determined cis-association between genotypes and expression phenotypes from major studies. We conducted phylogenetic analysis of current major haplotypes along with the corresponding haplotypes derived from chimpanzee reference sequences. Our analysis reveals that, for the vast majority of such cis-regulatory genes, the tagging SNPs showing the strongest association also tag the haplotype lineages directly separated from ancestry, inferred from either chimpanzee reference sequences or the allele frequency-derived haplotype frameworks, suggesting that the differentially expressed phenotypes were evolved relatively early in human history. Such evolutionary signatures provide keys for a more effective identification of globally-conserved candidate regulatory haplotypes across human genes in future epidemiologic and pharmacogenetic studies.	[Ching Ouyang; Krontiris, Theodore G.] Beckman Res Inst City Hope, Div Mol Med, Duarte, CA USA; [Smith, David D.] Beckman Res Inst City of Hope, Div Informat Sci, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Ching, OY (corresponding author), Beckman Res Inst City Hope, Div Mol Med, Duarte, CA USA.	tkrontir@coh.org	Smith, David/A-4115-2017	Smith, David/0000-0001-9644-2353	Beckman Research Institute of the City of Hope	Beckman Research Institute of the City of Hope	This work was supported by funds from the Beckman Research Institute of the City of Hope.	Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ouyang C, 2006, PHARMACOGENET GENOM, V16, P667, DOI 10.1097/01.fpc.0000220569.82842.9b; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Spielman RS, 2007, NAT GENET, V39, P808, DOI 10.1038/ng0707-808; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Williams RBH, 2006, NAT GENET, V38, P855, DOI 10.1038/ng0806-855; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	40	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3362	10.1371/journal.pone.0003362	http://dx.doi.org/10.1371/journal.pone.0003362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846218	Green Published, gold, Green Submitted			2022-12-25	WOS:000265114500004
J	Alter, MD; Rubin, DB; Ramsey, K; Halpern, R; Stephan, DA; Abbott, LF; Hen, R				Alter, Mark D.; Rubin, Daniel B.; Ramsey, Keri; Halpern, Rebecca; Stephan, Dietrich A.; Abbott, L. F.; Hen, Rene			Variation in the Large-Scale Organization of Gene Expression Levels in the Hippocampus Relates to Stable Epigenetic Variability in Behavior	PLOS ONE			English	Article								Background: Despite sharing the same genes, identical twins demonstrate substantial variability in behavioral traits and in their risk for disease. Epigenetic factors-DNA and chromatin modifications that affect levels of gene expression without affecting the DNA sequence-are thought to be important in establishing this variability. Epigenetically-mediated differences in the levels of gene expression that are associated with individual variability traditionally are thought to occur only in a gene-specific manner. We challenge this idea by exploring the large-scale organizational patterns of gene expression in an epigenetic model of behavioral variability. Methodology/Findings: To study the effects of epigenetic influences on behavioral variability, we examine gene expression in genetically identical mice. Using a novel approach to microarray analysis, we show that variability in the large-scale organization of gene expression levels, rather than differences in the expression levels of specific genes, is associated with individual differences in behavior. Specifically, increased activity in the open field is associated with increased variance of log-transformed measures of gene expression in the hippocampus, a brain region involved in open field activity. Early life experience that increases adult activity in the open field also similarly modifies the variance of gene expression levels. The same association of the variance of gene expression levels with behavioral variability is found with levels of gene expression in the hippocampus of genetically heterogeneous outbred populations of mice, suggesting that variation in the large-scale organization of gene expression levels may also be relevant to phenotypic differences in outbred populations such as humans. We find that the increased variance in gene expression levels is attributable to an increasing separation of several large, log-normally distributed families of gene expression levels. We also show that the presence of these multiple log-normal distributions of gene expression levels is a universal characteristic of gene expression in eurkaryotes. We use data from the MicroArray Quality Control Project (MAQC) to demonstrate that our method is robust and that it reliably detects biological differences in the large-scale organization of gene expression levels. Conclusions: Our results contrast with the traditional belief that epigenetic effects on gene expression occur only at the level of specific genes and suggest instead that the large-scale organization of gene expression levels provides important insights into the relationship of gene expression with behavioral variability. Understanding the epigenetic, genetic, and environmental factors that regulate the large-scale organization of gene expression levels, and how changes in this large-scale organization influences brain development and behavior will be a major future challenge in the field of behavioral genomics.	[Alter, Mark D.; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Alter, Mark D.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Rubin, Daniel B.; Abbott, L. F.] Columbia Univ, Dept Neurosci, Div Theoret Neurosci, New York, NY 10027 USA; [Ramsey, Keri; Halpern, Rebecca; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA	Columbia University; Columbia University; Columbia University; Translational Genomics Research Institute	Alter, MD (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	alterm@childpsych.columbia.edu; rh95@columbia.edu		Rubin, Daniel/0000-0001-6982-9587	NARSAD Young Investigator Award [R01 MH068542-6]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068542] Funding Source: NIH RePORTER	NARSAD Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NARSAD Young Investigator Award, R01 MH068542-6	AXEL R, 1976, CELL, V7, P247, DOI 10.1016/0092-8674(76)90024-6; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Kazlauckas V, 2005, BEHAV BRAIN RES, V162, P272, DOI 10.1016/j.bbr.2005.03.021; Kendall K., 2007, PSYCHOL MED, P1; Kuznetsov VA, 2002, GENETICS, V161, P1321; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; MEANEY MJ, 1991, PSYCHONEUROENDOCRINO, V16, P85, DOI 10.1016/0306-4530(91)90072-2; MEANEY MJ, 1985, BEHAV NEUROSCI, V99, P765, DOI 10.1037/0735-7044.99.4.765; Mortazavi A, 2008, NAT METHODS; MULERONAVARRO S, 2008, CRIT REV ONCOL HEMAT; PETRONIS A, 2006, TRENDS GENET; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Ponder CA, 2008, BEHAV GENET, V38, P277, DOI 10.1007/s10519-008-9203-6; Ray J, 2005, DEV PSYCHOBIOL, V47, P136, DOI 10.1002/dev.20080; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Weaver ICG, 2002, ENDOCR RES, V28, P699, DOI 10.1081/ERC-120016989; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, ANN NY ACAD SCI, V1024, P182, DOI 10.1196/annals.1321.099; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weaver ICG, 2001, MOL CELL ENDOCRINOL, V185, P205, DOI 10.1016/S0303-7207(01)00635-9; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	37	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3344	10.1371/journal.pone.0003344	http://dx.doi.org/10.1371/journal.pone.0003344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836535	gold, Green Published, Green Submitted			2022-12-25	WOS:000265113500008
J	Galvan, I; Alonso-Alvarez, C				Galvan, Ismael; Alonso-Alvarez, Carlos			An Intracellular Antioxidant Determines the Expression of a Melanin-Based Signal in a Bird	PLOS ONE			English	Article							MALE HOUSE SPARROWS; OXIDATIVE STRESS; GLUTATHIONE METABOLISM; BUTHIONINE SULFOXIMINE; PLUMAGE COLORATION; SEXUAL SIGNALS; GREAT TITS; TESTOSTERONE; TYROSINASE; EVOLUTION	To understand how traits used in animal communication evolved and are maintained as honest signals, we need to understand the mechanisms that prevent cheating. It has been proposed that honest signaling is guaranteed by the costs associated with the signal expression. However, the nature of these costs is still under debate. Melanin-based signals are intriguing because their expression seems to be tightly controlled by genes and the resource involved (i.e. melanin) seems to be not limited. However, in vertebrates, low levels of a key intracellular antioxidant (i.e. glutathione) are needed to promote melanogenesis. We propose that melanin- based ornaments can signal the ability to cope with oxidative stress because those individuals with low enough levels of glutathione, such as those required for melanin production, should manage well the whole of the antioxidant machinery in order to maintain a certain oxidative status. We analysed the expression of a melanin- based signal: the well-known black stripe of the great tit (Parus major). Great tit nestlings were injected with a specific inhibitor of glutathione production (DL-buthionine- S, R-sulfoximine; BSO) throughout their development. BSO effectively decreased intracellular glutathione levels without apparent side effects on growth or body condition. Instead, treated nestlings developed black breast stripes 70-100% larger than controls. Moreover, treated nestlings also compensated the decrease in glutathione levels by increasing the levels of circulating antioxidants. Results indicate that melanin- based signals can be at least partially permeable to environmental influences such as those associated to oxidative stress. They also reveal a potential handicap associated to the expression of this kind of signals. Finally, although other contributing factors could have been present, our findings emphasize the role of oxidative stress in shaping the evolution of animal signals in general and, in particular, those produced by pigments.	[Galvan, Ismael] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain; [Alonso-Alvarez, Carlos] IREC CSIC UCLM JCCM, Inst Investigac Recursos Cineget, Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Galvan, I (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain.	galvan@mncn.csic.es; carlos.alonso@uclm.es	Alonso-Alvarez, Carlos/M-6804-2014; Galvan, Ismael/H-8602-2015	Alonso-Alvarez, Carlos/0000-0002-4765-551X; Galvan, Ismael/0000-0002-6523-8592	Ministerio de Educacion y Ciencia (Spanish Government) [CGL2006-10357-C02-02, CGL2007-61395BOS]; FPI; Ramon y Cajal fellowship; Ministerio de Educacion y Ciencia	Ministerio de Educacion y Ciencia (Spanish Government)(Spanish Government); FPI(Spanish Government); Ramon y Cajal fellowship(Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government)	Financial support was obtained from the CGL2006-10357-C02-02 and CGL2007-61395BOS projects from Ministerio de Educacion y Ciencia (Spanish Government). I.G. benefited from a FPI grant, whereas C.A.-A. from a Ramon y Cajal fellowship, both from Ministerio de Educacion y Ciencia.	AHN DU, 1993, POULTRY SCI, V72, P1972, DOI 10.3382/ps.0721972; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; [Anonymous], 2006, SAS MIXED MODELS; [Anonymous], [No title captured]; Badyaev AV, 2000, BIOL J LINN SOC, V69, P153, DOI 10.1111/j.1095-8312.2000.tb01196.x; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; BENEDETTO JP, 1981, J INVEST DERMATOL, V77, P402, DOI 10.1111/1523-1747.ep12494592; Bize P, 2006, EVOLUTION, V60, P2370; Borgia G., 1979, SEXUAL SELECTION REP, P19; Buchanan KL, 2003, BEHAV ECOL SOCIOBIOL, V55, P50, DOI 10.1007/s00265-003-0682-4; Carrascal LM, 1998, AUK, V115, P727, DOI 10.2307/4089420; CHO ES, 1981, J NUTR, V111, P914, DOI 10.1093/jn/111.5.914; DELMARMOL V, 1993, J INVEST DERMATOL, V101, P871, DOI 10.1111/1523-1747.ep12371709; Evans MR, 2000, BEHAV ECOL SOCIOBIOL, V47, P156, DOI 10.1007/s002650050006; Fargallo JA, 2007, J ANIM ECOL, V76, P201, DOI 10.1111/j.1365-2656.2006.01193.x; Fargallo JA, 2007, EVOL ECOL, V21, P157, DOI 10.1007/s10682-006-0020-1; Figuerola J, 2000, IBIS, V142, P482, DOI 10.1111/j.1474-919X.2000.tb04445.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fitze PS, 2002, BEHAV ECOL, V13, P401, DOI 10.1093/beheco/13.3.401; Galvan I, 2006, IBIS, V148, P687, DOI 10.1111/j.1474-919X.2006.00576.x; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Gosler A, 1993, GREAT TIT; Grether GF, 2004, BIOL REV, V79, P583, DOI 10.1017/S1464793103006390; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HALPRIN KM, 1966, ARCH DERMATOL, V94, P355, DOI 10.1001/archderm.94.3.355; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; Hasson O, 1997, J THEOR BIOL, V185, P139, DOI 10.1006/jtbi.1996.0258; Iwata S, 2002, CLIN EXP MED, V2, P99, DOI 10.1007/s102380200013; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; JARVI T, 1984, ANIM BEHAV, V32, P590, DOI 10.1016/S0003-3472(84)80296-1; JARVI T, 1987, ETHOLOGY, V76, P334; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; KARG E, 1993, J INVEST DERMATOL, V100, pS209, DOI 10.1111/1523-1747.ep12465218; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Marchionatti A, 2001, COMP BIOCHEM PHYS C, V129, P85, DOI 10.1016/S1532-0456(01)00185-5; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2007, BEHAV ECOL, V18, P137, DOI 10.1093/beheco/arl059; McGraw KJ., 2006, BIRD COLORATION, P243; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; Moreno Juan, 2006, Acta Zoologica Sinica, V52, P202; Niecke M, 2003, OECOLOGIA, V137, P153, DOI 10.1007/s00442-003-1307-3; NORRIS KJ, 1990, BEHAV ECOL SOCIOBIOL, V27, P275; OHTSUKA Y, 1994, EUR J APPL PHYSIOL O, V68, P87, DOI 10.1007/BF00599247; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Poston JP, 2005, ANIM BEHAV, V70, P1171, DOI 10.1016/j.anbehav.2005.02.015; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Quesada J, 2007, ETHOLOGY, V113, P640, DOI 10.1111/j.1439-0310.2007.01364.x; Rajasekaran NS, 2005, BBA-MOL BASIS DIS, V1741, P103, DOI 10.1016/j.bbadis.2004.11.025; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Sarna T., 2006, PIGMENTARY SYSTEM PH, P311, DOI DOI 10.1002/9780470987100.CH16; Senar JC, 2006, BEHAVIOUR, V143, P589, DOI 10.1163/156853906776759484; Silverin B, 1996, GEN COMP ENDOCR, V103, P150, DOI 10.1006/gcen.1996.0106; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; West-Eberhard Mary Jane, 2003, pi; WILSON JD, 1992, ANIM BEHAV, V43, P999, DOI 10.1016/0003-3472(92)90013-Y; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	70	125	128	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3335	10.1371/journal.pone.0003335	http://dx.doi.org/10.1371/journal.pone.0003335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RW	18833330	Green Submitted, gold, Green Published			2022-12-25	WOS:000264797400007
J	Hatterer, E; Touret, M; Belin, MF; Honnorat, J; Nataf, S				Hatterer, Eric; Touret, Monique; Belin, Marie-Francoise; Honnorat, Jerome; Nataf, Serge			Cerebrospinal Fluid Dendritic Cells Infiltrate the Brain Parenchyma and Target the Cervical Lymph Nodes under Neuroinflammatory Conditions	PLOS ONE			English	Article								Background: In many neuroinflammatory diseases, dendritic cells (DCs) accumulate in several compartments of the central nervous system (CNS), including the cerebrospinal fluid (CSF). Myeloid DCs invading the inflamed CNS are thus thought to play a major role in the initiation and perpetuation of CNS-targeted autoimmune responses. We previously reported that, in normal rats, DCs injected intra-CSF migrated outside the CNS and reached the B-cell zone of cervical lymph nodes. However, there is yet no information on the migratory behavior of CSF-circulating DCs under neuroinflammatory conditions. Methodology/Principal Findings: To address this issue, we performed in vivo transfer experiments in rats suffering from experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. EAE or control rats were injected intra-CSF with bone marrow-derived myeloid DCs labeled with the fluorescent marker carboxyfluorescein diacetate succinimidyl ester (CFSE). In parallel experiments, fluorescent microspheres were injected intra-CSF to EAE rats in order to track endogenous antigen-presenting cells (APCs). Animals were then sacrificed on day 1 or 8 post-injection and their brain and peripheral lymph nodes were assessed for the presence of microspheres(+) APCs or CFSE(+) DCs by immunohistology and/or FACS analysis. Data showed that in EAE rats, DCs injected intra-CSF substantially infiltrated several compartments of the inflamed CNS, including the periventricular demyelinating lesions. We also found that in EAE rats, as compared to controls, a larger number of intra-CSF injected DCs reached the cervical lymph nodes. This migratory behavior was accompanied by an accentuation of EAE clinical signs and an increased systemic antibody response against myelin oligodendrocyte glycoprotein, a major immunogenic myelin antigen. Conclusions/Significance: Altogether, these results indicate that CSF-circulating DCs are able to both survey the inflamed brain and to reach the cervical lymph nodes. In EAE and maybe multiple sclerosis, CSF-circulating DCs may thus support the immune responses that develop within and outside the inflamed CNS.	[Hatterer, Eric; Touret, Monique; Belin, Marie-Francoise; Honnorat, Jerome; Nataf, Serge] INSERM, U842, Lyon, France; [Hatterer, Eric; Touret, Monique; Belin, Marie-Francoise; Honnorat, Jerome; Nataf, Serge] Univ Lyon, UMR S842, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Hatterer, E (corresponding author), INSERM, U842, Lyon, France.	nataf@lyon.inserm.fr	Honnorat, jerome/G-6394-2017	Honnorat, jerome/0000-0002-4721-5952	INSERM; ARSEP; MRT	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ARSEP; MRT	This work was supported by grants from INSERM and ARSEP (to S. Nataf) and by a fellowship from MRT to E. Hatterer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIGUET P, 1992, J NEUROCHEM, V58, P1676, DOI 10.1111/j.1471-4159.1992.tb10040.x; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Carson MJ, 1999, AM J PATHOL, V154, P481, DOI 10.1016/S0002-9440(10)65294-7; Christodoulides M, 2002, INFECT IMMUN, V70, P4035, DOI 10.1128/IAI.70.8.4035-4044.2002; Dubois B, 1999, J IMMUNOL, V162, P3428; Fernandez M, 2004, P NATL ACAD SCI USA, V101, P16363, DOI 10.1073/pnas.0407262101; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; Hatterer E, 2006, BLOOD, V107, P806, DOI 10.1182/blood-2005-01-0154; Jagessar SA, 2008, J NEUROPATH EXP NEUR, V67, P326, DOI 10.1097/NEN.0b013e31816a6851; Karman J, 2004, J IMMUNOL, V173, P2353, DOI 10.4049/jimmunol.173.4.2353; Kostulas N, 2002, STROKE, V33, P1129, DOI 10.1161/hs0402.105379; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LININGTON C, 1988, AM J PATHOL, V130, P443; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Marta CB, 2005, P NATL ACAD SCI USA, V102, P13992, DOI 10.1073/pnas.0504979102; Matsuno K, 1996, J EXP MED, V183, P1865, DOI 10.1084/jem.183.4.1865; Mitra R, 2004, FASEB J, V18, P1764, DOI 10.1096/fj.04-1855fje; NEWCOMBE J, 1991, BRAIN, V114, P1013, DOI 10.1093/brain/114.2.1013; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; Pashenkov M, 2002, J NEUROIMMUNOL, V122, P106, DOI 10.1016/S0165-5728(01)00451-9; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Schley D, 2006, J THEOR BIOL, V238, P962, DOI 10.1016/j.jtbi.2005.07.005; Serafini B, 2006, J NEUROPATH EXP NEUR, V65, P124, DOI 10.1097/01.jnen.0000199572.96472.1c; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; SHIN TY, 1995, J NEUROIMMUNOL, V56, P171, DOI 10.1016/0165-5728(94)00144-D; Weller RO, 1998, J NEUROPATH EXP NEUR, V57, P885, DOI 10.1097/00005072-199810000-00001	31	57	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3321	10.1371/journal.pone.0003321	http://dx.doi.org/10.1371/journal.pone.0003321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830405	Green Published, Green Submitted, gold			2022-12-25	WOS:000264797300009
J	Mottet, D; Pirotte, S; Lamour, V; Hagedorn, M; Javerzat, S; Bikfalvi, A; Bellahcene, A; Verdin, E; Castronovo, V				Mottet, D.; Pirotte, S.; Lamour, V.; Hagedorn, M.; Javerzat, S.; Bikfalvi, A.; Bellahcene, A.; Verdin, E.; Castronovo, V.			HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism	ONCOGENE			English	Article						histone deacetylase; p21(WAF1/Cip1); Sp1; siRNA; cancer	HISTONE DEACETYLASE INHIBITORS; TUMOR-SUPPRESSOR PROTEIN; WAF1/CIP1 GENE PROMOTER; IN-VIVO; DNA-BINDING; SP1 SITES; P53; TRANSCRIPTION; ACETYLATION; COLON	Cancer cells have complex, unique characteristics that distinguish them from normal cells, such as increased growth rates and evasion of anti-proliferative signals. Global inhibition of class I and II histone deacetylases (HDACs) stops cancer cell proliferation in vitro and has proven effective against cancer in clinical trials, at least in part, through transcriptionalreac tivation of the p21(WAF1/Cip1) gene. The HDACs that regulate p21(WAF1/Cip1) are not fully identified. Using small interfering RNAs, we found that HDAC4 participates in the repression of p21(WAF1/Cip1) through Sp1/Sp3-, but not p53-binding sites. HDAC4 interacts with Sp1, binds and reduces histone H3 acetylation at the Sp1/Sp3 binding site-rich p21(WAF1/Cip1) proximal promoter, suggesting a key role for Sp1 in HDAC4-mediated repression of p21(WAF1/Cip1). Induction of p21(WAF1/Cip1) mediated by silencing of HDAC4 arrested cancer cell growth in vitro and inhibited tumor growth in an in vivo human glioblastoma model. Thus, HDAC4 could be a useful target for new anti-cancer therapies based on selective inhibition of specific HDACs.	[Mottet, D.; Pirotte, S.; Lamour, V.; Bellahcene, A.; Castronovo, V.] Univ Liege, Metastasis Res Lab, GIGA Canc Ctr Expt Canc Res, B-4000 Liege, Belgium; [Mottet, D.; Verdin, E.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Javerzat, S.; Bikfalvi, A.] Univ Bordeaux 1, INSERM, U920, European Lab Angiogenesis & Translat Res,Ex E0113, F-33405 Talence, France	University of Liege; University of California System; University of California San Francisco; The J David Gladstone Institutes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Castronovo, V (corresponding author), Univ Liege, Metastasis Res Lab, GIGA Canc Ctr Expt Canc Res, B23, B-4000 Liege, Belgium.	everdin@gladstone.ucsf.edu; vcastronovo@ulg.ac.be	Verdin, Eric/AAB-7999-2019	Hagedorn, Martin/0000-0002-0960-5116; Verdin, Eric/0000-0003-3703-3183	European FP6 (STROMA and METABRE); National Fund for Scientific Research (Belgium); Centre Anti-Cancereux pres de l'Universite de Liege; Fonds Leon Fredericq; TELEVIE and Interuniversity Attraction Pole Program-Belgian Science Policy [IAP 5/31]	European FP6 (STROMA and METABRE)(European Commission); National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); Centre Anti-Cancereux pres de l'Universite de Liege; Fonds Leon Fredericq; TELEVIE and Interuniversity Attraction Pole Program-Belgian Science Policy	This work was supported by grants from European FP6 (STROMA and METABRE), the National Fund for Scientific Research (Belgium), the Centre Anti-Cancereux pres de l'Universite de Liege, the Fonds Leon Fredericq, TELEVIE and Interuniversity Attraction Pole Program-Belgian Science Policy (IAP 5/31). DM and AB are Research Associates at the National Fund for Scientific Research (Belgium). VL and SP are NFSR National Fund for Scientific Research fellows.	Acharya MR, 2005, MOL PHARMACOL, V68, P917, DOI 10.1124/mol.105.014167; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Duvic M, 2007, DRUG TODAY, V43, P585, DOI 10.1358/dot.2007.43.9.1112980; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; Enya K, 2008, J LEUKOCYTE BIOL, V83, P190, DOI 10.1189/jlb.0106008; Fang JY, 2002, WORLD J GASTROENTERO, V8, P400, DOI 10.3748/wjg.v8.i3.400; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Geng L, 2006, CANCER RES, V66, P11298, DOI 10.1158/0008-5472.CAN-06-0049; Glenisson W, 2007, BBA-MOL CELL RES, V1773, P1572, DOI 10.1016/j.bbamcr.2007.05.016; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Halkidou K, 2004, EUR UROL, V45, P382, DOI 10.1016/j.eururo.2003.10.005; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Han JW, 2000, CANCER RES, V60, P6068; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Huang EY, 2000, GENE DEV, V14, P45; Huang LL, 2000, MOL MED, V6, P849, DOI 10.1007/BF03401823; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Kang JE, 2005, CELL PHYSIOL BIOCHEM, V16, P23, DOI 10.1159/000087728; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Kao HY, 2000, GENE DEV, V14, P55; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kim YB, 1999, ONCOGENE, V18, P2461, DOI 10.1038/sj.onc.1202564; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Lleonart ME, 2006, ONCOL REP, V16, P603; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Marks Paul A, 2004, Novartis Found Symp, V259, P269; Martin-Caballero J, 2001, CANCER RES, V61, P6234; McLaughlin F, 2004, BIOCHEM PHARMACOL, V68, P1139, DOI 10.1016/j.bcp.2004.05.034; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mottet D, 2007, CIRC RES, V101, P1237, DOI 10.1161/CIRCRESAHA.107.149377; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Rasheed WK, 2007, EXPERT OPIN INV DRUG, V16, P659, DOI 10.1517/13543784.16.5.659; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rocchi P, 2005, ONCOL REP, V13, P1139; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Sawa H, 2004, ACTA NEUROPATHOL, V107, P523, DOI 10.1007/s00401-004-0841-3; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Sowa Y, 1999, CANCER RES, V59, P4266; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Spurling CC, 2008, MOL CARCINOGEN, V47, P137, DOI 10.1002/mc.20373; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Tang H, 1998, J BIOL CHEM, V273, P29156, DOI 10.1074/jbc.273.44.29156; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Urban G, 2003, J BIOL CHEM, V278, P9747, DOI 10.1074/jbc.M210993200; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; WILSON AJ, 2008, MOL BIOL CELL; Wouters BG, 1997, CANCER RES, V57, P4703; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	73	119	127	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					243	256		10.1038/onc.2008.371	http://dx.doi.org/10.1038/onc.2008.371			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18850004				2022-12-25	WOS:000262501100008
J	Bateman, RL; Rauh, D; Tavshanjian, B; Shokat, KM				Bateman, Raynard L.; Rauh, Daniel; Tavshanjian, Brandon; Shokat, Kevan M.			Human Carbonyl Reductase 1 Is an S-Nitrosoglutathione Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE-ADENINE DINUCLEOTIDE; FORMYLGLUTATHIONE HYDROLASE; REDOX STATE; RAT LIVER; DEHYDROGENASE; NITROSOTHIOLS; GLUTATHIONE; CRYSTALLOGRAPHY; DECOMPOSITION; FORMALDEHYDE	Human carbonyl reductase 1 (hCBR1) is an NADPH-dependent short chain dehydrogenase/reductase with broad substrate specificity and is thought to be responsible for the in vivo reduction of quinones, prostaglandins, and other carbonyl-containing compounds including xenobiotics. In addition, hCBR1 possesses a glutathione binding site that allows for increased affinity toward GSH-conjugated molecules. It has been suggested that the GSH-binding site is near the active site; however, no structures with GSH or GSH conjugates have been reported. We have solved the x-ray crystal structures of hCBR1 and a substrate mimic in complex with GSH and the catalytically inert GSH conjugate hydroxymethylglutathione (HMGSH). The structures reveal the GSH-binding site and provide insight into the affinity determinants for GSH-conjugated substrates. We further demonstrate that the structural isostere of HMGSH, S-nitrosoglutathione, is an ideal hCBR1 substrate (K-m = 30 mu M, k(cat) = 450 min(-1)) with kinetic constants comparable with the best known hCBR1 substrates. Furthermore, we demonstrate that hCBR1 dependent GSNO reduction occurs in A549 lung adenocarcinoma cell lysates and suggest that hCBR1 may be involved in regulation of tissue levels of GSNO.	[Bateman, Raynard L.; Rauh, Daniel; Tavshanjian, Brandon; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Bateman, Raynard L.; Tavshanjian, Brandon] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94143 USA.	shokat@cmp.ucsf.edu	Rauh, Daniel/G-1595-2013	Rauh, Daniel/0000-0002-1970-7642	National Institutes of Health [RO1 AI44009]; Sandler Program for Asthma Research; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program for Asthma Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI44009 (to K.M.S.). This work was also supported by an award from the Sandler Program for Asthma Research (to K.M.S.) and by funds from the Deutsche Forschungsgemeinschaft (to D.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Bateman R, 2007, ORG BIOMOL CHEM, V5, P3363, DOI 10.1039/b707602a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Doorn JA, 2004, BIOCHEMISTRY-US, V43, P13106, DOI 10.1021/bi049136q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang KH, 2000, AM J PHYSIOL-LUNG C, V279, pL716, DOI 10.1152/ajplung.2000.279.4.L716; Forrest GL, 2000, CHEM-BIOL INTERACT, V129, P21, DOI 10.1016/S0009-2797(00)00196-4; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hedberg JJ, 2003, EUR J BIOCHEM, V270, P1249, DOI 10.1046/j.1432-1033.2003.03486.x; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; Hou YC, 1996, BIOCHEM BIOPH RES CO, V228, P88, DOI 10.1006/bbrc.1996.1620; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; KOIVUSALO M, 1995, ADV EXP MED BIOL, V372, P427; LASKOWSKI ER, 1993, MAYO CLIN PROC, V68, P1029, DOI 10.1016/S0025-6196(12)62282-4; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; REISS PD, 1984, ANAL BIOCHEM, V140, P162, DOI 10.1016/0003-2697(84)90148-9; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Tinguely JN, 1999, EUR J BIOCHEM, V260, P9, DOI 10.1046/j.1432-1327.1999.00089.x; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Uotila L, 1997, ADV EXP MED BIOL, V414, P365; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	31	106	110	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35756	35762		10.1074/jbc.M807125200	http://dx.doi.org/10.1074/jbc.M807125200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18826943	hybrid, Green Published			2022-12-25	WOS:000261687900049
J	Elias, EV; Quiroga, R; Gottig, N; Nakanishi, H; Nash, TE; Neiman, A; Lujan, HD				Elias, Eliana V.; Quiroga, Rodrigo; Gottig, Natalia; Nakanishi, Hideki; Nash, Theodore E.; Neiman, Aaron; Lujan, Hugo D.			Characterization of SNAREs Determines the Absence of a Typical Golgi Apparatus in the Ancient Eukaryote Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYST WALL; PRIMITIVE EUKARYOTE; ENDOPLASMIC-RETICULUM; PERIPHERAL VACUOLES; SECRETORY PATHWAY; PROTEIN-STRUCTURE; SURFACE-PROTEINS; SYNTAXIN GENES; BREFELDIN-A; IDENTIFICATION	Giardia is a eukaryotic protozoal parasite with unusual characteristics, such as the absence of a morphologically evident Golgi apparatus. Although both constitutive and regulated pathways for protein secretion are evident in Giardia, little is known about the mechanisms involved in vesicular docking and fusion. In higher eukaryotes, soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) of the vesicle-associated membrane protein and syntaxin families play essential roles in these processes. In this work we identified and characterized genes for 17 SNAREs in Giardia to define the minimal set of subcellular organelles present during growth and encystation, in particular the presence or not of a Golgi apparatus. Expression and localization of all Giardia SNAREs demonstrate their presence in distinct subcellular compartments, which may represent the extent of the endomembrane system in eukaryotes. Remarkably, Giardia SNAREs, homologous to Golgi SNAREs from other organisms, do not allow the detection of a typical Golgi apparatus in either proliferating or differentiating trophozoites. However, some features of the Golgi, such as the packaging and sorting function, seem to be performed by the endoplasmic reticulum and/or the nuclear envelope. Moreover, depletion of individual genes demonstrated that several SNAREs are essential for viability, whereas others are dispensable. Thus, Giardia requires a smaller number of SNAREs compared with other eukaryotes to accomplish all of the vesicle trafficking events that are critical for the growth and differentiation of this important human pathogen.	[Elias, Eliana V.; Quiroga, Rodrigo; Gottig, Natalia; Lujan, Hugo D.] Catholic Univ Cordoba, Sch Med, Natl Council Sci & Technol, Biochem & Mol Biol Lab, Cordoba, Argentina; [Nakanishi, Hideki; Neiman, Aaron] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Nash, Theodore E.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Catholic University of Cordoba; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lujan, HD (corresponding author), Univ Catolica Cordoba, Fac Med, Lab Bioquim & Biol Mol, Jacinto Rios 571,CP X5004ASK, Cordoba, Argentina.	hlujan@ucc.edu.ar	Quiroga, Rodrigo/GLT-7145-2022; Elias, Eliana Vanina/AAF-1997-2021	Quiroga, Rodrigo/0000-0001-5015-0531; Neiman, Aaron/0000-0002-6600-6996	National Institutes of Health NIAID Intramural Research Program; Agencia Nacional para la Promocion de la Ciencia y la Tecnologia (FONCYT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Howard Hughes Medical Institute (HHMI); Universidad Catolica de Cordoba; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000161, ZIAAI000161] Funding Source: NIH RePORTER	National Institutes of Health NIAID Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agencia Nacional para la Promocion de la Ciencia y la Tecnologia (FONCYT)(FONCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Universidad Catolica de Cordoba; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health NIAID Intramural Research Program. This work was also supported by the Agencia Nacional para la Promocion de la Ciencia y la Tecnologia (FONCYT), the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Howard Hughes Medical Institute (HHMI), and the Universidad Catolica de Cordoba. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Ayong L, 2007, MOL BIOCHEM PARASIT, V152, P113, DOI 10.1016/j.molbiopara.2006.12.007; Besteiro S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-250; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BOUCHER SEM, 1990, INFECT IMMUN, V58, P3516, DOI 10.1128/IAI.58.11.3516-3522.1990; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Chaturvedi S, 1999, J BIOL CHEM, V274, P2424, DOI 10.1074/jbc.274.4.2424; Cole L, 2000, FUNGAL GENET BIOL, V29, P95, DOI 10.1006/fgbi.2000.1190; Dacks JB, 2004, MOL BIOCHEM PARASIT, V136, P123, DOI 10.1016/j.molbiopara.2004.02.014; Dacks JB, 2002, J CELL SCI, V115, P1635; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; Gottig N, 2006, J BIOL CHEM, V281, P18156, DOI 10.1074/jbc.M602081200; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hay JC, 1996, J BIOL CHEM, V271, P5671, DOI 10.1074/jbc.271.10.5671; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jarroll EL, 2001, J EUKARYOT MICROBIOL, V48, P22, DOI 10.1111/j.1550-7408.2001.tb00412.x; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Karr CD, 2004, MICROBIOL-SGM, V150, P1237, DOI 10.1099/mic.0.26922-0; Kissmehl R, 2007, TRAFFIC, V8, P523, DOI 10.1111/j.1600-0854.2007.00544.x; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Knodler LA, 1999, J BIOL CHEM, V274, P29805, DOI 10.1074/jbc.274.42.29805; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Kuratsu M, 2007, FUNGAL GENET BIOL, V44, P1310, DOI 10.1016/j.fgb.2007.04.012; Lanfredi-Rangel A, 1998, J STRUCT BIOL, V123, P225, DOI 10.1006/jsbi.1998.4035; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Lujan HD, 1996, BIOL CELL, V86, P11, DOI 10.1016/0248-4900(96)89519-0; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Lujan HD, 1998, PARASITOL TODAY, V14, P446, DOI 10.1016/S0169-4758(98)01333-7; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Marti M, 2003, J BIOL CHEM, V278, P24837, DOI 10.1074/jbc.M302082200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; MOWATT MR, 1994, INFECT IMMUN, V62, P1213, DOI 10.1128/IAI.62.4.1213-1218.1994; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; NASH TE, 1993, P NATL ACAD SCI USA, V90, P5489, DOI 10.1073/pnas.90.12.5489; NASH TE, 1988, J IMMUNOL, V141, P636; Regoes A, 2005, BIOTECHNIQUES, V39, P809, DOI 10.2144/000112054; REINER DS, 1990, EUR J CELL BIOL, V53, P142; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tamaki H, 2002, J HISTOCHEM CYTOCHEM, V50, P1611, DOI 10.1177/002215540205001205; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teng FYH, 2001, GENOME BIOL, V2; Touz MC, 2004, MOL BIOL CELL, V15, P3053, DOI 10.1091/mbc.E03-10-0744; Touz MC, 2003, J BIOL CHEM, V278, P6420, DOI 10.1074/jbc.M208354200; Touz MC, 2002, J BIOL CHEM, V277, P50557, DOI 10.1074/jbc.M202558200; Touz MC, 2002, J BIOL CHEM, V277, P8474, DOI 10.1074/jbc.M110250200; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Weiland MEL, 2003, INT J PARASITOL, V33, P1341, DOI 10.1016/S0020-7519(03)00201-7; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; YEE J, 1995, P NATL ACAD SCI USA, V92, P5615, DOI 10.1073/pnas.92.12.5615; YEE J, 1992, J BIOL CHEM, V267, P7539; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	76	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35996	36010		10.1074/jbc.M806545200	http://dx.doi.org/10.1074/jbc.M806545200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18930915	Green Published, hybrid			2022-12-25	WOS:000261687900074
J	Navadgi-Patil, VM; Burgers, PM				Navadgi-Patil, Vasundhara M.; Burgers, Peter M.			Yeast DNA Replication Protein Dpb11 Activates the Mec1/ATR Checkpoint Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; POLYMERASE-EPSILON; DAMAGE; PHOSPHORYLATION; CLAMP; ATR; TOPBP1; ALPHA; RAD9	The Saccharomyces cerevisiae Mec1-Ddc2 protein kinase (human ATR-ATRIP) initiates a signal transduction pathway in response to DNA damage and replication stress to mediate cell cycle arrest. The yeast DNA damage checkpoint clamp Ddc1-Mec3- Rad17 (human Rad9-Hus1-Rad1:9-1-1) is loaded around effector DNA and thereby activates Mec1 kinase. Dpb11 (Schizosaccharomyces pombe Cut5/Rad4 or human TopBP1) is an essential protein required for the initiation of DNA replication and has a role in checkpoint activation. In this study, we demonstrate that Dpb11 directly activates the Mec1 kinase in phosphorylating the downstream effector kinase Rad53 (human Chk1/2) and DNA bound RPA. However, DNA was not required for Dpb11 to function as an activator. Dpb11 and yeast 9-1-1 independently activate Mec1, but substantial synergism in activation was observed when both activators were present. Our studies suggest that Dpb11 and 9-1-1 may partially compensate for each other during yeast checkpoint function.	[Navadgi-Patil, Vasundhara M.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM32431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431, R01GM083970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32431. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartrand AJ, 2004, J BIOL CHEM, V279, P26762, DOI 10.1074/jbc.M312353200; Brush GS, 2000, NUCLEIC ACIDS RES, V28, P3725, DOI 10.1093/nar/28.19.3725; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; DUrso G, 1997, P NATL ACAD SCI USA, V94, P12491, DOI 10.1073/pnas.94.23.12491; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Frei C, 2000, GENE DEV, V14, P81; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim HS, 2003, DNA REPAIR, V2, P1321, DOI 10.1016/j.dnarep.2003.07.004; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lawrence JC, 2003, CURR TOP MICROBIOL, V279, P199; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Longhese MP, 2003, MUTAT RES-FUND MOL M, V532, P41, DOI 10.1016/j.mrfmmm.2003.08.009; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Majka J, 2007, CELL CYCLE, V6, P1157, DOI 10.4161/cc.6.10.4221; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Parrilla-Castellar E, 2003, J BIOL CHEM, V278, P45507, DOI 10.1074/jbc.C300418200; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Puddu F, 2008, MOL CELL BIOL, V28, P4782, DOI 10.1128/MCB.00330-08; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; SAKA Y, 1994, EMBO J, V13, P5319, DOI 10.1002/j.1460-2075.1994.tb06866.x; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Wang H, 2002, GENETICS, V160, P1295; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	46	93	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35853	35859		10.1074/jbc.M807435200	http://dx.doi.org/10.1074/jbc.M807435200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18922789	Green Published, hybrid			2022-12-25	WOS:000261687900060
J	Takasawa, A; Kato, I; Takasawa, K; Ishii, Y; Yoshida, T; Shehata, MH; Kawaguchi, H; Mohafez, OMM; Sasahara, M; Hiraga, K				Takasawa, Akira; Kato, Ichiro; Takasawa, Kumi; Ishii, Yoko; Yoshida, Toshiko; Shehata, Mohammad H.; Kawaguchi, Hiroshi; Mohafez, Omar M. M.; Sasahara, Masakiyo; Hiraga, Koichi			Mutation-, Aging-, and Gene Dosage-dependent Accumulation of Neuroserpin (G392E) in Endoplasmic Reticula and Lysosomes of Neurons in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; SERINE-PROTEASE INHIBITOR; INCLUSION-BODIES; FAMILIAL ENCEPHALOPATHY; FORMS POLYMERS; INTRACELLULAR ACCUMULATION; ANTITHROMBIN DEFICIENCY; PROTEINASE-INHIBITOR; DEMENTIA FENIB; EXPRESSION	Mutations in human neuroserpin gene cause an autosomal dementia, familial encephalopathy with neuroserpin inclusion bodies (FENIB). We generated and analyzed transgenic mice expressing high levels of either FENIB-type (G392E) or wildtype human neuroserpin in neurons of the central nervous system. G392E neuroserpin accumulated age-dependently in neurons of the neocortex, thalamus, amygdala, pons, and spinal cord of homozygous transgenic mice. Such accumulations were not observed in hemizygous transgenic mice nor in transgenic mice for wild-type neuroserpin. In differential centrifugation of brain homogenates, G392E neuroserpin recovered in the nucleus-rich fraction dramatically increased along with aging, suggesting that the aggregations gradually increase their densities presumably by their conversion into heavier and more compact configurations. In immunoelectron microscopical analyses, immunopositivities for G392E neuroserpin were found not only in endoplasmic reticulum but also in lysosomes. G392E neuroserpin transgenic mice were much more susceptible to seizures induced by kainate administration than nontransgenic mice. Overall, G392E neuroserpin accumulated in the central nervous system neurons of transgenic mice in mutation-, aging-, and gene dosage- dependent manners. The established transgenic mice will be valuable to elucidate not only mechanisms for the formation of G392E neuroserpin aggregations but also pathways for the degradation and/or clearance of the already formed aggregations in neurons.	[Takasawa, Akira; Kato, Ichiro; Takasawa, Kumi; Shehata, Mohammad H.; Kawaguchi, Hiroshi; Mohafez, Omar M. M.; Hiraga, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, Toyama 9300194, Japan; [Ishii, Yoko; Sasahara, Masakiyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pathol, Toyama 9300194, Japan; [Yoshida, Toshiko] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 9300194, Japan; [Takasawa, Akira] Hokkaido Univ, Grad Sch Med, Dept Surg Pathol, Kita Ku, Sapporo, Hokkaido 0608648, Japan	University of Toyama; University of Toyama; University of Toyama; Hokkaido University	Kato, I (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, 2630 Sugitani, Toyama 9300194, Japan.	ichikato@med.u-toyama.ac.jp	Mohafez, Omar/AAA-4883-2022	Mohafez, Omar/0000-0001-5352-8210	Ministry of Education, Culture, Sports, Science and Technology of Japan [18590285]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research 18590285 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Belorgey D, 2004, EUR J BIOCHEM, V271, P3360, DOI 10.1111/j.1432-1033.2004.04270.x; Belorgey D, 2002, J BIOL CHEM, V277, P17367, DOI 10.1074/jbc.M200680200; Briand C, 2001, FEBS LETT, V505, P18, DOI 10.1016/S0014-5793(01)02764-8; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Cuadrado A, 2002, NUCLEIC ACIDS RES, V30, P2202, DOI 10.1093/nar/30.10.2202; Davis RL, 1999, AM J PATHOL, V155, P1901, DOI 10.1016/S0002-9440(10)65510-1; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; Galliciotti G, 2007, AM J PATHOL, V170, P1305, DOI 10.2353/ajpath.2007.060910; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hansen TWR, 2001, PEDIATR RES, V49, P203, DOI 10.1203/00006450-200102000-00012; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Hasumi H, 2005, INT J CANCER, V115, P911, DOI 10.1002/ijc.20967; JOCHMANS K, 1994, BLOOD, V83, P146; KATO I, 1995, J BIOL CHEM, V270, P30045, DOI 10.1074/jbc.270.50.30045; KELLEY KA, 1994, MOL BRAIN RES, V24, P261, DOI 10.1016/0169-328X(94)90139-2; Krueger SR, 1997, J NEUROSCI, V17, P8984; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Madani R, 2003, MOL CELL NEUROSCI, V23, P473, DOI 10.1016/S1044-7431(03)00077-0; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Onda M, 2005, J BIOL CHEM, V280, P13735, DOI 10.1074/jbc.M413282200; Osterwalder T, 1998, J BIOL CHEM, V273, P2312, DOI 10.1074/jbc.273.4.2312; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Parmar PK, 2002, J NEUROCHEM, V82, P1406, DOI 10.1046/j.1471-4159.2002.01100.x; Schauwecker PE, 2004, J COMP NEUROL, V477, P96, DOI 10.1002/cne.20245; SEYAMA K, 1991, J BIOL CHEM, V266, P12627; STEINBERGER D, 1995, HUM GENET, V96, P113, DOI 10.1007/BF00214198; Takao M, 2000, J NEUROPATH EXP NEUR, V59, P1070, DOI 10.1093/jnen/59.12.1070; Tanaka Y, 2002, J BIOL CHEM, V277, P51058, DOI 10.1074/jbc.M210231200; Umemura K, 2007, STROKE, V38, P1063, DOI 10.1161/01.STR.0000257981.09329.d2; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Yepes M, 2000, BLOOD, V96, P569	35	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35606	35613		10.1074/jbc.M804125200	http://dx.doi.org/10.1074/jbc.M804125200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18940798	hybrid			2022-12-25	WOS:000261687900033
J	Liu, LN; Aartsma, TJ; Thomas, JC; Lamers, GEM; Zhou, BC; Zhang, YZ				Liu, Lu-Ning; Aartsma, Thijs J.; Thomas, Jean-Claude; Lamers, Gerda E. M.; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Watching the Native Supramolecular Architecture of Photosynthetic Membrane in Red Algae TOPOGRAPHY OF PHYCOBILISOMES AND THEIR CROWDING, DIVERSE DISTRIBUTION PATTERNS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; PORPHYRIDIUM-CRUENTUM; THYLAKOID MEMBRANES; CRYSTAL-STRUCTURE; SYNECHOCOCCUS-ELONGATUS; 3-DIMENSIONAL STRUCTURE; EXCITATION-ENERGY; CORE COMPLEX; ATOMIC-FORCE; ORGANIZATION	The architecture of the entire photosynthetic membrane network determines, at the supramolecular level, the physiological roles of the photosynthetic protein complexes involved. So far, a precise picture of the native configuration of red algal thylakoids is still lacking. In this work, we investigated the supramolecular architectures of phycobilisomes (PBsomes) and native thylakoid membranes from the unicellular red alga Porphyridium cruentum using atomic force microscopy (AFM) and transmission electron microscopy. The topography of single PBsomes was characterized by AFM imaging on both isolated and membrane-combined PBsomes complexes. The native organization of thylakoid membranes presented variable arrangements of PBsomes on the membrane surface. It indicates that different light illuminations during growth allow diverse distribution of PBsomes upon the isolated photosynthetic membranes from P. cruentum, random arrangement or rather ordered arrays, to be observed. Furthermore, the distributions of PBsomes on the membrane surfaces are mostly crowded. This is the first investigation using AFM to visualize the native architecture of PBsomes and their crowding distribution on the thylakoid membrane from P. cruentum. Various distribution patterns of PBsomes under different light conditions indicate the photoadaptation of thylakoid membranes, probably promoting the energy-harvesting efficiency. These results provide important clues on the supramolecular architecture of red algal PBsomes and the diverse organizations of thylakoid membranes in vivo.	[Liu, Lu-Ning; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Liu, Lu-Ning; Aartsma, Thijs J.] Leiden Univ, Dept Biophys, Huygens Lab, NL-2300 RA Leiden, Netherlands; [Thomas, Jean-Claude] CNRS, UMR 8186, F-75230 Paris, France; [Thomas, Jean-Claude] Ecole Normale Super, F-75230 Paris, France; [Lamers, Gerda E. M.] Leiden Univ, Inst Biol, NL-2333 AL Leiden, Netherlands	Shandong University; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Leiden University; Leiden University - Excl LUMC	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Liu, Lu-Ning/B-1460-2009	Liu, Lu-Ning/0000-0002-8884-4819	National Natural Science Foundation of China [40676078]; Hi-Tech Research and Development program of China [2008AA09Z404]; Key International S&T Cooperation Project of China [2008DFA30440]; Netherlands Organization for Scientific Research and the Foundation for Earth and Life Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); Key International S&T Cooperation Project of China; Netherlands Organization for Scientific Research and the Foundation for Earth and Life Sciences	The work was supported by the National Natural Science Foundation of China (Grant 40676078), by the Hi-Tech Research and Development program of China (Grant 2008AA09Z404), and by the Key International S&T Cooperation Project of China (Grant 2008DFA30440). This project is part of the research programme "From Molecule to Cell" funded by the Netherlands Organization for Scientific Research and the Foundation for Earth and Life Sciences. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Arteni AA, 2008, PHOTOSYNTH RES, V95, P169, DOI 10.1007/s11120-007-9264-z; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; Barber J, 2003, PHOTOCH PHOTOBIO SCI, V2, P536, DOI 10.1039/b300063j; Betz M, 1997, BIOL CHEM, V378, P167; BRIMBLE S, 1989, BIOCHIM BIOPHYS ACTA, V973, P315, DOI 10.1016/S0005-2728(89)80438-4; Bumba L, 2004, EUR J BIOCHEM, V271, P2967, DOI 10.1111/j.1432-1033.2004.04226.x; CUNNINGHAM FX, 1990, PLANT PHYSIOL, V93, P888, DOI 10.1104/pp.93.3.888; DILWORTH MF, 1981, PLANT PHYSIOL, V67, P608, DOI 10.1104/pp.67.4.608; Ducret A, 1998, J MOL BIOL, V278, P369, DOI 10.1006/jmbi.1998.1678; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; Frese RN, 2008, BIOPHYS J, V94, P640, DOI 10.1529/biophysj.107.116913; GANTT E, 1966, J CELL BIOL, V29, P423, DOI 10.1083/jcb.29.3.423; GANTT E, 1976, BIOCHIM BIOPHYS ACTA, V430, P375, DOI 10.1016/0005-2728(76)90093-1; Gantt E., 1994, MOL BIOL CYANOBACTER, P119; GANTT E, 1986, PHOTOSYNTHESIS, V3, P260; Gantt E., 1980, INT REV CYTOL, V66, P45, DOI 10.1016/S0074-7696(08)61971-3; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; Gardian Z, 2007, BBA-BIOENERGETICS, V1767, P725, DOI 10.1016/j.bbabio.2007.01.021; GIDDINGS TH, 1983, PLANT PHYSIOL, V71, P409, DOI 10.1104/pp.71.2.409; GINDT YM, 1994, BBA-BIOENERGETICS, V1186, P153, DOI 10.1016/0005-2728(94)90174-0; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47; GLAZER AN, 1985, SCIENCE, V230, P1051, DOI 10.1126/science.230.4729.1051; Goncalves RP, 2005, J STRUCT BIOL, V152, P221, DOI 10.1016/j.jsb.2005.10.002; Gradinaru CC, 2004, ULTRAMICROSCOPY, V99, P235, DOI 10.1016/j.ultramic.2003.12.009; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; HOUMARD J, 1990, P NATL ACAD SCI USA, V87, P2152, DOI 10.1073/pnas.87.6.2152; JONES RF, 1963, PHYSIOL PLANTARUM, V16, P636, DOI 10.1111/j.1399-3054.1963.tb08342.x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Joshua S, 2005, PLANT PHYSIOL, V138, P1577, DOI 10.1104/pp.105.061168; Joshua S, 2004, PLANT PHYSIOL, V135, P2112, DOI 10.1104/pp.104.046110; Kaftan D, 2002, EMBO J, V21, P6146, DOI 10.1093/emboj/cdf624; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; LEFORTTRAN M, 1973, J ULTRA MOL STRUCT R, V44, P199, DOI 10.1016/S0022-5320(73)80056-5; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Liu LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003134; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; McConnell MD, 2002, PLANT PHYSIOL, V130, P1201, DOI 10.1104/pp.009845; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Mullineaux CW, 1997, NATURE, V390, P421, DOI 10.1038/37157; Mullineaux CW, 1999, AUST J PLANT PHYSIOL, V26, P671, DOI 10.1071/PP99027; MULLINEAUX CW, 2008, PHOTOCHEM P IN PRESS; MUSTARDY L, 1992, P NATL ACAD SCI USA, V89, P10021, DOI 10.1073/pnas.89.21.10021; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nield J, 2000, J BIOL CHEM, V275, P27940; OHKI K, 1985, PLANT PHYSIOL, V79, P943, DOI 10.1104/pp.79.4.943; REDECKER D, 1993, EUR J CELL BIOL, V62, P442; REDLINGER T, 1981, PLANT PHYSIOL, V68, P1375, DOI 10.1104/pp.68.6.1375; REDLINGER T, 1982, P NATL ACAD SCI-BIOL, V79, P5542, DOI 10.1073/pnas.79.18.5542; Ritz M, 1998, J PHYCOL, V34, P835, DOI 10.1046/j.1529-8817.1998.340835.x; Sarcina M, 2001, J BIOL CHEM, V276, P46830, DOI 10.1074/jbc.M107111200; Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085; Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879; Scheuring S, 2004, P NATL ACAD SCI USA, V101, P11293, DOI 10.1073/pnas.0404350101; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Shimoni E, 2005, PLANT CELL, V17, P2580, DOI 10.1105/tpc.105.035030; Sidler W.A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Tsekos I, 2004, PHYCOLOGIA, V43, P543, DOI 10.2216/i0031-8884-43-5-543.1; Tsekos I, 1996, NEW PHYTOL, V133, P543, DOI 10.1111/j.1469-8137.1996.tb01923.x; WANNER G, 1980, PROTOPLASMA, V102, P97, DOI 10.1007/BF01276950; Yi ZW, 2005, FEBS LETT, V579, P3569, DOI 10.1016/j.febslet.2005.05.033; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	65	31	33	2	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34946	34953		10.1074/jbc.M805114200	http://dx.doi.org/10.1074/jbc.M805114200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930925	Green Published, hybrid			2022-12-25	WOS:000261469100051
J	Atsawasuwan, P; Mochida, Y; Katafuchi, M; Kaku, M; Fong, KSK; Csiszar, K; Yamauchi, M				Atsawasuwan, Phimon; Mochida, Yoshiyuki; Katafuchi, Michitsuna; Kaku, Masaru; Fong, Keith S. K.; Csiszar, Katalin; Yamauchi, Mitsuo			Lysyl Oxidase Binds Transforming Growth Factor-beta and Regulates Its Signaling via Amine Oxidase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; TGF-BETA; EXTRACELLULAR-MATRIX; OSTEOBLAST DIFFERENTIATION; COLLAGEN FIBRILLOGENESIS; SMALL PROTEOGLYCANS; DECORIN EXPRESSION; DEMINERALIZED BONE; ENZYME-ACTIVITY; UP-REGULATION	Lysyl oxidase (LOX), an amine oxidase critical for the initiation of collagen and elastin cross-linking, has recently been shown to regulate cellular activities possibly by modulating the functions of growth factors. In this study, we investigated the interaction between LOX and transforming growth factor-beta 1 (TGF-beta 1), a potent growth factor abundant in bone, the effect of LOX on TGF-beta 1 signaling, and its potential mechanism. The specific binding between mature LOX and mature TGF-beta 1 was demonstrated by immunoprecipitation and glutathione S-transferase pulldown assay in vitro. Both proteins were colocalized in the extracellular matrix in an osteoblastic cell culture system, and the binding complex was identified in the mineral-associated fraction of bone matrix. Furthermore, LOX suppressed TGF-beta 1-induced Smad3 phosphorylation likely through its amine oxidase activity. The data indicate that LOX binds to mature TGF-beta 1 and enzymatically regulates its signaling in bone and thus may play an important role in bone maintenance and remodeling.	[Atsawasuwan, Phimon; Mochida, Yoshiyuki; Katafuchi, Michitsuna; Kaku, Masaru; Yamauchi, Mitsuo] Univ N Carolina, Dent Res Ctr, Chapel Hill, NC 27599 USA; [Fong, Keith S. K.; Csiszar, Katalin] Univ Hawaii, John A Burns Sch Med, Cardiovasc Res Ctr, Honolulu, HI 96822 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Hawaii System	Yamauchi, M (corresponding author), Univ N Carolina, Dent Res Ctr, CB 7455, Chapel Hill, NC 27599 USA.	Mitsuo_Yamauchi@dentistry.unc.edu	Kaku, Masaru/K-5041-2019; Ariel, Pablo/AGJ-4118-2022; Kaku, Masaru/S-7309-2017	Kaku, Masaru/0000-0002-7988-6435; Kaku, Masaru/0000-0002-7988-6435; Atsawasuwan, Phimon/0000-0002-2576-060X; Fong, Keith/0000-0001-6845-1754; Mochida, Yoshiyuki/0000-0002-2115-4303	National Institutes of Health [R01 DE10489, R21 AR052824]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR052824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE10489 (to M. Y.) and R21 AR052824 (to M. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Beekman B, 1997, EXP CELL RES, V237, P135, DOI 10.1006/excr.1997.3771; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; BOAK AM, 1994, AM J RESP CELL MOL, V11, P751, DOI 10.1165/ajrcmb.11.6.7946403; BONAR LC, 1970, J ULTRA MOL STRUCT R, V32, P545, DOI 10.1016/S0022-5320(70)80027-2; Bonewald L. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P239; Bonewald L.F., 2002, PRINCIPLES BONE BIOL, Vsecond, P903; Bose KK, 2000, J OCCUP ENVIRON MED, V42, P582, DOI 10.1097/00043764-200006000-00005; BREUER B, 1990, BIOCHEM J, V269, P551, DOI 10.1042/bj2690551; Cheng H, 1999, CONNECT TISSUE RES, V40, P37, DOI 10.3109/03008209909005276; CRONLUND AL, 1985, CONNECT TISSUE RES, V14, P109, DOI 10.3109/03008208509015017; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Domenicucci C, 1997, CONNECT TISSUE RES, V36, P151, DOI 10.3109/03008209709160217; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Ekholm EC, 2000, BONE, V27, P551, DOI 10.1016/S8756-3282(00)00359-8; Feres EJ, 1995, J BIOL CHEM, V270, P30797, DOI 10.1074/jbc.270.51.30797; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Fox SW, 2005, MOL CELL ENDOCRINOL, V243, P19, DOI 10.1016/j.mce.2005.09.008; Fromigue O, 2004, CURR PHARM DESIGN, V10, P2593, DOI 10.2174/1381612043383773; Gacheru SN, 1997, J CELL BIOCHEM, V65, P395, DOI 10.1002/(SICI)1097-4644(19970601)65:3<395::AID-JCB9>3.0.CO;2-N; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Giampuzzi M, 2003, BBA-PROTEINS PROTEOM, V1647, P245, DOI 10.1016/S1570-9639(03)00059-1; Goto Y, 2005, VIRCHOWS ARCH, V447, P859, DOI 10.1007/s00428-005-0001-8; HAUSSER H, 1994, FEBS LETT, V353, P243, DOI 10.1016/0014-5793(94)01044-7; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Hong HH, 1999, LAB INVEST, V79, P1655; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; KAGAN HM, 1995, METHOD ENZYMOL, V258, P122; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; KAGAN HM, 1983, BIOCHEM BIOPH RES CO, V115, P186, DOI 10.1016/0006-291X(83)90987-7; Kahai S, 2004, MATRIX BIOL, V23, P445, DOI 10.1016/j.matbio.2004.09.004; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; LEVENE CI, 1959, J EXP MED, V110, P771, DOI 10.1084/jem.110.5.771; Li PA, 2004, MOL BRAIN RES, V120, P115, DOI 10.1016/j.molbrainres.2003.10.013; Li WD, 2003, J CELL BIOCHEM, V88, P152, DOI 10.1002/jcb.10304; LINDE A, 1980, J BIOL CHEM, V255, P5931; Luppen CA, 2003, J BIOL CHEM, V278, P44995, DOI 10.1074/jbc.M306730200; MACHWATE M, 1995, MOL ENDOCRINOL, V9, P187, DOI 10.1210/me.9.2.187; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Markmann A, 2000, MATRIX BIOL, V19, P631, DOI 10.1016/S0945-053X(00)00097-4; Mochida Y, 2006, ADV EXP MED BIOL, V585, P101; Mochida Y, 2006, J BIOL CHEM, V281, P36044, DOI 10.1074/jbc.M604787200; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; Oleggini R, 2007, MATRIX BIOL, V26, P494, DOI 10.1016/j.matbio.2007.02.003; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; PFEILSCHIFTER J, 1990, BIOCHEM J, V270, P269, DOI 10.1042/bj2700269; PIRCHER R, 1986, BIOCHEM BIOPH RES CO, V136, P30, DOI 10.1016/0006-291X(86)90872-7; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 1998, KIDNEY INT, V54, P1529, DOI 10.1046/j.1523-1755.1998.00149.x; Schaefer L, 2001, FASEB J, V15, P559; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; Shanley CJ, 1997, J VASC SURG, V25, P446, DOI 10.1016/S0741-5214(97)70254-4; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X; TERMINE JD, 1981, J BIOL CHEM, V256, P403; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Wong M, 2002, TISSUE ENG, V8, P979, DOI 10.1089/107632702320934074; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Yamane K, 2005, J CELL PHYSIOL, V202, P822, DOI 10.1002/jcp.20205; Yamauchi M, 1988, COLLAGEN, P157; YEAGER V L, 1985, Journal of Experimental Pathology (New York), V2, P1; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	75	90	96	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34229	34240		10.1074/jbc.M803142200	http://dx.doi.org/10.1074/jbc.M803142200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835815	Green Published, hybrid			2022-12-25	WOS:000261277700051
J	Antenos, M; Zhu, J; Jetly, NM; Woodruff, TK				Antenos, Monica; Zhu, Jie; Jetly, Niti M.; Woodruff, Teresa K.			An Activin/Furin Regulatory Loop Modulates the Processing and Secretion of Inhibin alpha- and beta(B)-Subunit Dimers in Pituitary Gonadotrope Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE FOLLICULAR-FLUID; PROPROTEIN CONVERTASES; GENE-EXPRESSION; FURIN; RAT; HORMONE; PROLIFERATION; EMBRYOGENESIS; ENDOPROTEASE; SUPPRESSION	Of all ligands of the transforming growth factor beta superfamily, inhibins and activins are a physiologically relevant pair that are functional antagonists of each other. Activin stimulates whereas inhibin blocks follicle-stimulating hormone biosynthesis and secretion from pituitary gonadotrope cells, and together, inhibin and activin control the pituitary gonadal axis essential for normal reproductive function. Sharing a similar beta-subunit, the secretion of inhibin heterodimers (alpha/beta) or activin homodimers (beta/beta) as mature bioactive ligands depends, in part, on the proteolytic processing of precursor proteins. A short loop regulatory pathway controlling precursor processing and dimer secretion was discovered. Activin stimulates endogenous inhibin alpha- and beta(B)-subunit mRNA, protein, and proteolytic processing. Simultaneously, activin stimulated the proconvertase furin through a Smad2/3-dependent process. The data provide a mechanism where the regulation of furin and inhibin subunits cooperates in an important positive short feedback loop. This regulatory loop augments the secretion of bioactive mature activin B, as well as inhibin B dimers, necessary for local follicle-stimulating hormone beta regulation.	[Antenos, Monica; Zhu, Jie; Woodruff, Teresa K.] Northwestern Univ, Feinburg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Antenos, Monica; Zhu, Jie; Jetly, Niti M.; Woodruff, Teresa K.] Northwestern Univ, Ctr Reprod Sci, Evanston, IL 60208 USA; [Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Woodruff, TK (corresponding author), Northwestern Univ, Feinburg Sch Med, Dept Obstet & Gynecol, Lurie 10-250,303 E Super St, Chicago, IL 60611 USA.	tkw@northwestern.edu	Antenos, Monica/J-8985-2017	Antenos, Monica/0000-0001-6350-2911; Woodruff, Teresa/0000-0002-1197-3399	National Institutes of Health [R01 HD37096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD37096. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Blanchette F, 1997, J CLIN INVEST, V99, P1974, DOI 10.1172/JCI119365; Blanchette F, 2001, J CELL PHYSIOL, V188, P264, DOI 10.1002/jcp.1116; Constam DB, 2000, DEVELOPMENT, V127, P245; Constam DB, 2000, GENE DEV, V14, P1146; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; DEKRETSER DM, 1989, BIOL REPROD, V40, P33, DOI 10.1095/biolreprod40.1.33; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; LING N, 1985, P NATL ACAD SCI USA, V82, P7217, DOI 10.1073/pnas.82.21.7217; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZEN JR, 1981, AM J PHYSIOL, V240, pE209, DOI 10.1152/ajpendo.1981.240.2.E209; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; MATHER JP, 1990, ENDOCRINOLOGY, V127, P3206, DOI 10.1210/endo-127-6-3206; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Nachtigal MW, 1996, P NATL ACAD SCI USA, V93, P7711, DOI 10.1073/pnas.93.15.7711; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nicol L, 2008, J ENDOCRINOL, V196, P497, DOI 10.1677/jOE-07-0542; Pangas SA, 2002, J ENDOCRINOL, V172, P199, DOI 10.1677/joe.0.1720199; Rivier C, 1990, Recent Prog Horm Res, V46, P231; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SCHWARTZ NB, 1977, P NATL ACAD SCI USA, V74, P5721, DOI 10.1073/pnas.74.12.5721; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Suszko MI, 2006, J MOL ENDOCRINOL, V36, P591, DOI 10.1677/jme.1.01936; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; Zhang H, 2006, MOL ENDOCRINOL, V20, P2909, DOI 10.1210/me.2006-0109	32	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33059	33068		10.1074/jbc.M804190200	http://dx.doi.org/10.1074/jbc.M804190200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826955	Green Published, hybrid			2022-12-25	WOS:000261183700006
J	Garcia-Elias, A; Lorenzo, IM; Vicente, R; Valverde, MA				Garcia-Elias, Anna; Lorenzo, Ivan M.; Vicente, Ruben; Valverde, Miguel A.			IP3 Receptor Binds to and Sensitizes TRPV4 Channel to Osmotic Stimuli via a Calmodulin-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; CATION CHANNEL; ION-CHANNEL; HYPERALGESIA; MODULATION; EXPRESSION; DOMAINS; COMPLEX; ENTRY	Activation of the non-selective cation channel TRPV4 by mechanical and osmotic stimuli requires the involvement of phospholipase A(2) and the subsequent production of the arachidonic acid metabolites, epoxieicosatrienoic acids (EET). Previous studies have shown that inositol trisphosphate (IP3) sensitizes TRPV4 to mechanical, osmotic, and direct EET stimulation. We now search for the IP3 receptor-binding site on TRPV4 and its relevance to IP3-mediated sensitization. Three putative sites involved in protein-protein interactions were evaluated: a proline-rich domain (PRD), a calmodulin (CaM)-binding site, and the last four amino acids (DAPL) that show a PDZ-binding motif-like. TRPV4-Delta CaM-(Delta 812-831) channels preserved activation by hypotonicity, 4 alpha-phorbol 12,13-didecanoate, and EET but lost their physical interaction with IP3 receptor 3 and IP3-mediated sensitization. Deletion of a PDZ-binding motif-like (TRPV4-Delta DAPL) did not affect channel activity or IP3-mediated sensitization, whereas TRPV4-Delta PRD-(Delta 132-144) resulted in loss of channel function despite correct trafficking. We conclude that IP3-mediated sensitization requires IP3 receptor binding to a TRPV4 C-terminal domain that overlaps with a previously described calmodulin-binding site.	[Garcia-Elias, Anna; Lorenzo, Ivan M.; Vicente, Ruben; Valverde, Miguel A.] Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Barcelona 08003, Spain	Pompeu Fabra University	Valverde, MA (corresponding author), Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Parc Recerca Biomed Barcelona,C Dr Aiguader 88, Barcelona 08003, Spain.	miguel.valverde@upf.edu	Garcia-Elias Heras, Anna/K-4367-2014; García, Rubén Vicente/L-1097-2014	Garcia-Elias Heras, Anna/0000-0002-6609-6119; García, Rubén Vicente/0000-0003-0401-4808; Valverde, Miguel A./0000-0002-6961-3361	Spanish Ministries of Education and Science [SAF2006-04973, SAF2006-13893-C02-02]; Spanish Ministries of Health; Generalitat de Catalunya [SGR05-266]; Fundacio la Marato de TV3 [061331]	Spanish Ministries of Education and Science(Spanish Government); Spanish Ministries of Health(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio la Marato de TV3	This work was supported by grants from the Spanish Ministries of Education and Science (Grant SAF2006-04973 and SAF2006-13893-C02-02), Spanish Ministries of Health (Fondo de Investigacion Sanitaria, Red HERACLES RD06/0009), Generalitat de Catalunya (SGR05-266), and Fundacio la Marato de TV3 (061331). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Cohen DM, 2007, CURR OPIN NEPHROL HY, V16, P451, DOI 10.1097/MNH.0b013e32821f6060; Cohen DM, 2005, PFLUG ARCH EUR J PHY, V451, P168, DOI 10.1007/s00424-005-1456-9; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3; Fu Y, 2006, AM J PHYSIOL-RENAL, V290, pF1305, DOI 10.1152/ajprenal.00391.2005; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Guler AD, 2002, J NEUROSCI, V22, P6408; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Plant T. D., 2007, V179, P189; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	35	61	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31284	31288		10.1074/jbc.C800184200	http://dx.doi.org/10.1074/jbc.C800184200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18826956	hybrid			2022-12-25	WOS:000260760800004
J	Bray, DP; Bennett, M; Stockley, P; Hurst, JL; Kipar, A				Bray, Daniel P.; Bennett, Malcolm; Stockley, Paula; Hurst, Jane L.; Kipar, Anja			Composition and Function of Haemolymphatic Tissues in the European Common Shrew	PLOS ONE			English	Article								Background: Studies of wild animals responding to their native parasites are essential if we are to understand how the immune system functions in the natural environment. While immune defence may bring increased survival, this may come at a resource cost to other physiological traits, including reproduction. Here, we tested the hypothesis that wild common shrews (Sorex araneus), which produce large numbers of offspring during the one breeding season of their short life span, forgo investment in immunity and immune system maintenance, as increased longevity is unlikely to bring further opportunities for mating. In particular, we predicted that adult shrews, with shorter expected lifespans, would not respond as effectively as young animals to infection. Methodology/Principal Findings: We examined haemolymphatic tissues from wild-caught common shrews using light and transmission electron microscopy, applied in conjunction with immunohistology. We compared composition and function of these tissues in shrews of different ages, and the extent and type of inflammatory reactions observed in response to natural parasitic infections. All ages seemed able to mount systemic, specific immune responses, but adult shrews showed some signs of lymphatic tissue exhaustion: lymphatic follicles in adults (n = 21) were both smaller than those in sub-adults (n= 18; Wald = 11.1, p < 0.05) and exhibited greater levels of depletion (Wald = 13.3, p < 0.05). Conclusions/Significance: Contrary to our expectations, shrews respond effectively to their natural parasites, and show little indication of immunosenescence as adults. The pancreas of Aselli, a unique lymphoid organ, may aid in providing efficient immune responses through the storage of large numbers of plasma cells. This may allow older animals to react effectively to previously encountered parasites, but infection by novel agents, and eventual depletion of plasma cell reserves, could both still be factors in the near-synchronous mortality of adult shrews observed shortly after breeding.	[Bray, Daniel P.; Stockley, Paula; Hurst, Jane L.] Univ Liverpool, Fac Vet Sci, Mammalian Behav & Evolut Grp, Neston, Cheshire, England; [Bennett, Malcolm; Kipar, Anja] Univ Liverpool, Fac Vet Sci, Dept Vet Pathol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Bray, DP (corresponding author), Univ Liverpool, Fac Vet Sci, Mammalian Behav & Evolut Grp, Neston, Cheshire, England.	akipar@liverpool.ac.uk	Bray, Daniel/H-4890-2012; Hurst, Jane L/G-8793-2015; Kipar, Anja/L-7214-2014; Bennett, Malcolm/G-4004-2010	Hurst, Jane L/0000-0002-3728-9624; Kipar, Anja/0000-0001-7289-3459; Bennett, Malcolm/0000-0002-5490-2910; Bennett, Malcolm/0000-0003-0475-390X	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work formed part of a PhD thesis submitted by DPB, funded by the Biotechnology and Biological Sciences Research Council.	ADAMS LE, 1910, MANCHESTER MEM, V54, P1; Brambell FWR, 1935, PHILOS T ROY SOC B, V225, P1, DOI 10.1098/rstb.1935.0005; Bray DP, 2007, PARASITOLOGY, V134, P819, DOI 10.1017/S0031182007002302; BUCKNER CH, 1969, J MAMMAL, V50, P326, DOI 10.2307/1378350; BUTCHER EC, 1982, ADV EXP MED BIOL, V149, P765; Chu PG, 2001, APPL IMMUNOHISTO M M, V9, P97, DOI 10.1097/00022744-200106000-00001; CHURCHFIELD S, 1981, J ZOOL, V194, P165; CHURCHFIELD S, 1980, ACTA THERIOL, V25, P415, DOI 10.4098/AT.arch.80-38; Churchfield S., 1990, NATURAL HIST SHREWS; CROWCROFT WP, 1957, LIFE SHREW; EWALD JA, 1991, J PARASITOL, V77, P485, DOI 10.2307/3283141; Fernandez-Gutierrez B, 1999, EXP GERONTOL, V34, P217, DOI 10.1016/S0531-5565(98)00068-0; FUKUTA K, 1982, J ANAT, V134, P129; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENOUD M, 1990, J ZOOL, V220, P41, DOI 10.1111/j.1469-7998.1990.tb04293.x; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; Holmberg M, 2003, EPIDEMIOL INFECT, V130, P149, DOI 10.1017/S0950268802008075; HOLMES RL, 1965, J ANAT, V99, P445; HOYTE HMD, 1956, PARASITOLOGY, V46, P224, DOI 10.1017/S0031182000026469; Kipar A, 1998, VET IMMUNOL IMMUNOP, V65, P243, DOI 10.1016/S0165-2427(98)00158-5; Kipar A, 1998, VET PATHOL, V35, P43, DOI 10.1177/030098589803500104; Kipar A, 2001, J COMP PATHOL, V125, P182, DOI 10.1053/jcpa.2001.0501; Kohler K., 2000, European Journal of Veterinary Pathology, V6, P107; Laakkonen J, 1998, J PARASITOL, V84, P1300, DOI 10.2307/3284698; Laakkonen J, 2000, ANN ZOOL FENN, V37, P37; Laakkonen J, 1995, MAMMALIA, V59, P623, DOI 10.1515/mamm.1995.59.4.623; Liz JS, 2000, J CLIN MICROBIOL, V38, P1002, DOI 10.1128/JCM.38.3.1002-1007.2000; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lustig A, 2007, CELL IMMUNOL, V245, P42, DOI 10.1016/j.cellimm.2007.03.008; MCCORMICK D, 1992, HISTOPATHOLOGY, V21, P591, DOI 10.1111/j.1365-2559.1992.tb00454.x; MICHIELSEN NORA CROIN, 1966, ARCH NEER ZOOL, V17, P73; MIDDLETON AD, 1931, J ZOOL LOND, P133; Milner RJ, 1996, ONDERSTEPOORT J VET, V63, P309; NAGEL A, 1994, ADV BIOL SHREWS, P421; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; PERNETTA JC, 1977, ACTA THERIOL, V22, P279, DOI 10.4098/AT.arch.77-25; RANDOLPH SE, 1975, J ANIM ECOL, V44, P425, DOI 10.2307/3605; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Roots C. D., 1992, THESIS U LONDON; ROOTS CD, 1994, J HELMINTHOL, V68, P247, DOI 10.1017/S0022149X00014425; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SHILLITO JOY F., 1963, PROC ZOOL SOC LONDON, V140, P99; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Smit FGAM, 1957, HDB IDENTIFICATION B; SNOOK T, 1950, AM J ANAT, V87, P31, DOI 10.1002/aja.1000870103; STOCKLEY P, 1993, P ROY SOC B-BIOL SCI, V254, P173, DOI 10.1098/rspb.1993.0143; Stockley P, 1998, OIKOS, V83, P560, DOI 10.2307/3546682; Stockley P, 1996, BEHAV ECOL, V7, P334, DOI 10.1093/beheco/7.3.334; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tsiperson VP, 1997, CELL BIOL INT, V21, P359, DOI 10.1006/cbir.1997.0135; TWIGG GI, 1970, J ZOOL, V162, P541; WOLK E, 1981, ACTA THERIOL, V26, P219; Wunschmann A, 2000, VET IMMUNOL IMMUNOP, V73, P83, DOI 10.1016/S0165-2427(99)00156-7; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3413	10.1371/journal.pone.0003413	http://dx.doi.org/10.1371/journal.pone.0003413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923707	Green Published, gold, Green Submitted			2022-12-25	WOS:000265121800011
J	Haeberle, HA; Duerrstein, C; Rosenberger, P; Hosakote, YM; Kuhlicke, J; Kempf, VAJ; Garofalo, RP; Eltzschig, HK				Haeberle, Helene A.; Duerrstein, Carin; Rosenberger, Peter; Hosakote, Yashoda M.; Kuhlicke, Johannes; Kempf, Volkhard A. J.; Garofalo, Roberto P.; Eltzschig, Holger K.			Oxygen-Independent Stabilization of Hypoxia Inducible Factor (HIF)-1 during RSV Infection	PLOS ONE			English	Article								Background: Hypoxia-inducible factor 1 (HIF)-1 alpha is a transcription factor that functions as master regulator of mammalian oxygen homeostasis. In addition, recent studies identified a role for HIF-1 alpha as transcriptional regulator during inflammation or infection. Based on studies showing that respiratory syncytial virus (RSV) is among the most potent biological stimuli to induce an inflammatory milieu, we hypothesized a role of HIF-1 alpha as transcriptional regulator during infections with RSV. Methodology, Principal Findings: We gained first insight from immunohistocemical studies of RSV-infected human pulmonary epithelia that were stained for HIF-1 alpha. These studies revealed that RSV-positive cells also stained for HIF-1 alpha, suggesting concomitant HIF-activation during RSV infection. Similarly, Western blot analysis confirmed an approximately 8-fold increase in HIF-1 alpha protein 24 h after RSV infection. In contrast, HIF-1 alpha activation was abolished utilizing UV-treated RSV. Moreover, HIF-alpha-regulated genes (VEGF, CD73, FN-1, COX-2) were induced with RSV infection of wild-type cells. In contrast, HIF-1 alpha dependent gene induction was abolished in pulmonary epithelia following siRNA mediated repression of HIF-1 alpha. Measurements of the partial pressure of oxygen in the supernatants of RSV infected epithelia or controls revealed no differences in oxygen content, suggesting that HIF-1 alpha activation is not caused by RSV associated hypoxia. Finally, studies of RSV pneumonitis in mice confirmed HIF-alpha-activation in a murine in vivo model. Conclusions/Significance: Taking together, these studies suggest hypoxia-independent activation of HIF-1 alpha during infection with RSV in vitro and in vivo.	[Haeberle, Helene A.; Duerrstein, Carin; Rosenberger, Peter; Kuhlicke, Johannes; Eltzschig, Holger K.] Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Kempf, Volkhard A. J.] Univ Tubingen, Med Microbiol & Hyg Dept, D-72074 Tubingen, Germany; [Hosakote, Yashoda M.; Garofalo, Roberto P.] Univ Texas, Med Branch, Dept Pediat, Galveston, TX USA; [Eltzschig, Holger K.] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol & Perioperat Med, Mucosal Inflammat Program, Denver, CO USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Texas System; University of Texas Medical Branch Galveston; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Haeberle, HA (corresponding author), Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	holger.eltzschig@uchsc.edu	Garofalo, Roberto P./AAF-7385-2022; Hosakote, Yashoda/AAP-6845-2020; Garofalo, Roberto P./ABL-2322-2022		Foundation for Anesthesia Education and Research (FAER)	Foundation for Anesthesia Education and Research (FAER)	This manuscript was supported in part by a Foundation for Anesthesia Education and Research (FAER) Grant to HKE.	Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Bunn HF, 1998, J EXP BIOL, V201, P1197; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carroll PA, 2006, J VIROL, V80, P10802, DOI 10.1128/JVI.00673-06; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; de Avalos SV, 2002, J BIOL CHEM, V277, P639, DOI 10.1074/jbc.M109037200; ECKLE T, 2007, BLOOD; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Garofalo RP, 2000, AM J RESP CELL MOL, V23, P581, DOI 10.1165/ajrcmb.23.5.f204; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Guido B, 2008, FRONT BIOSCI-LANDMRK, V13, P2588, DOI 10.2741/2868; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Haeberle HA, 2006, J CLIN ANESTH, V18, P96, DOI 10.1016/j.jclinane.2005.06.010; Haeberle HA, 2004, J VIROL, V78, P2232, DOI 10.1128/JVI.78.5.2232-2241.2004; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Haeberle HA, 2002, AM J RESP CRIT CARE, V165, P1433, DOI 10.1164/rccm.2109077; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Han HK, 2007, BIOCHEM BIOPH RES CO, V357, P567, DOI 10.1016/j.bbrc.2007.04.012; HARTMANN H, 2007, GASTROENTER IN PRESS; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Karhausen J, 2005, CELL CYCLE, V4, P256; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kilani MM, 2004, INFLAMMATION, V28, P245, DOI 10.1007/s10753-004-6047-y; KISCH AL, 1963, P SOC EXP BIOL MED, V112, P583, DOI 10.3181/00379727-112-28111; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kong TQ, 2004, P NATL ACAD SCI USA, V101, P10440, DOI 10.1073/pnas.0401339101; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kvietikova I, 1997, KIDNEY INT, V51, P564, DOI 10.1038/ki.1997.80; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; MOROTEGARCIA JC, 2008, BLOOD; Moskowitz DW, 2006, NEW ENGL J MED, V354, P975; Nasimuzzaman M, 2007, J VIROL, V81, P10249, DOI 10.1128/JVI.00763-07; Olszewska-Pazdrak B, 1998, J VIROL, V72, P4756, DOI 10.1128/JVI.72.6.4756-4764.1998; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; RIUS J, 2008, NATURE; SEMENZA GL, 1994, HEMATOL ONCOL CLIN N, V8, P863, DOI 10.1016/S0889-8588(18)30134-5; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Semenza GL, 2008, CELL, V133, P206, DOI 10.1016/j.cell.2008.04.004; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Spear W, 2006, CELL MICROBIOL, V8, P339, DOI 10.1111/j.1462-5822.2005.00628.x; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; van der Flier M, 2001, J INFECT DIS, V183, P149, DOI 10.1086/317643; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wotzlaw C, 2007, FASEB J, V21, P700, DOI 10.1096/fj.06-6280com; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	71	60	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2008	3	10							e3352	10.1371/journal.pone.0003352	http://dx.doi.org/10.1371/journal.pone.0003352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DM	18839041	Green Submitted, gold, Green Published			2022-12-25	WOS:000265113700002
J	Wang, Y; Meriin, AB; Zaarur, N; Romanova, NV; Chernoff, YO; Costello, CE; Sherman, MY				Wang, Yan; Meriin, Anatoli B.; Zaarur, Nava; Romanova, Nina V.; Chernoff, Yury O.; Costello, Catherine E.; Sherman, Michael Y.			Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery	FASEB JOURNAL			English	Article						polyglutamine; aggregation; VCP; 14-3-3 protein; neurodegeneration; misfolding	ENDOPLASMIC-RETICULUM MEMBRANE; NEURODEGENERATIVE DISEASES; POLYGLUTAMINE AGGREGATION; HUNTINGTONS-DISEASE; MISFOLDED PROTEINS; ALPHA-SYNUCLEIN; BODY FORMATION; MALLORY BODY; DEGRADATION; UBIQUITIN	In mammalian cells, abnormal proteins that escape proteasome-dependent degradation form small aggregates that can be transported into a centrosome-associated structure, called an aggresome. Here we demonstrate that in yeast a single aggregate formed by the huntingtin exon 1 with an expanded polyglutamine domain (103QP) represents a bona fide aggresome that colocalizes with the spindle pole body (the yeast centrosome) in a microtubule-dependent fashion. Since a polypeptide lacking the proline-rich region (P-region) of huntingtin (103Q) cannot form aggresomes, this domain serves as an aggresome-targeting signal. Coexpression of 103Q with 25QP, a soluble polypeptide that also carries the P-region, led to the recruitment of 103Q to the aggresome via formation of hetero-oligomers, indicating the aggresome targeting in trans. To identify additional factors involved in aggresome formation and targeting, we purified 103QP aggresomes and 103Q aggregates and identified the associated proteins using mass spectrometry. Among the aggresome-associated proteins we identified, Cdc48 (VCP/p97) and its cofactors, Ufd1 and Nlp4, were shown genetically to be essential for aggresome formation. The 14-3-3 protein, Bmh1, was also found to be critical for aggresome targeting. Its interaction with the huntingtin fragment and its role in aggresome formation required the huntingtin N-terminal N17 domain, adjacent to the polyQ domain. Accordingly, the huntingtin N17 domain, along with the P-region, plays a role in aggresome targeting. We also present direct genetic evidence for the protective role of aggresomes by demonstrating genetically that aggresome targeting of polyglutamine polypeptides relieves their toxicity. - Wang, Y., Meriin, A. B., Zaarur, N., Romanova, N. V., Chernoff, Y. O., Costello, C. E., Sherman, M. Y. Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J. 23, 451-463 (2009)	[Wang, Yan; Meriin, Anatoli B.; Zaarur, Nava; Costello, Catherine E.; Sherman, Michael Y.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Romanova, Nina V.; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Romanova, Nina V.; Chernoff, Yury O.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Boston University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sherman, MY (corresponding author), 715 Albany St,K323, Boston, MA 02118 USA.	sherma1@bu.edu	Romanova, Nina V/F-9852-2014; Chernoff, Yury O/J-2833-2014	Romanova, Nina V/0000-0003-4177-2712; Costello, Catherine/0000-0003-1594-5122; Meriin, Anatoli/0000-0003-0087-814X; Sherman, Michael/0000-0003-3345-073X; Chernoff, Yury/0000-0002-8934-9051	U.S. National Institutes of Health [R01 NS047705, P41 RR10888, S10 RR15942, R01GM58763]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015942, P41RR010888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047705] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health grants R01 NS047705 (to M.Y.S.), P41 RR10888 and S10 RR15942 (to C.E.C.), and R01GM58763 (to Y.O.C.). We are grateful to Dr. Martin Duennwald (Boston Biomedical Research Institute, Boston, MA, USA) for very helpful suggestions and insights.	Ardley HC, 2004, J NEUROCHEM, V90, P379, DOI 10.1111/j.1471-4159.2004.02485.x; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bardag-Gorce F, 2004, EXP MOL PATHOL, V76, P9, DOI 10.1016/j.yexmp.2003.08.006; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Cheeseman IM, 2004, CURR BIOL, V14, pR70, DOI 10.1016/j.cub.2003.12.048; Corboy Michael J., 2005, V301, P305; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Fortun J, 2003, J NEUROSCI, V23, P10672; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Meriin AB, 2001, J CELL BIOL, V153, P851, DOI 10.1083/jcb.153.4.851; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; MOENS PB, 1971, J CELL BIOL, V50, P344, DOI 10.1083/jcb.50.2.344; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nowis D, 2006, EXP CELL RES, V312, P2921, DOI 10.1016/j.yexcr.2006.05.013; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Preisinger E, 1999, PHILOS T ROY SOC B, V354, P1029, DOI 10.1098/rstb.1999.0455; Riley NE, 2002, EXP MOL PATHOL, V72, P17, DOI 10.1006/exmp.2001.2413; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shirakashi Y, 2006, ACTA NEUROPATHOL, V112, P681, DOI 10.1007/s00401-006-0132-2; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Weissmann C, 2002, ACTA NEUROBIOL EXP, V62, P153; Wigley WC, 1999, J CELL BIOL, V145, P481; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Yang H, 2005, NEUROREPORT, V16, P1117, DOI 10.1097/00001756-200507130-00017; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zubarev R, 2007, MOL CELL PROTEOMICS, V6, P377, DOI 10.1074/mcp.M600380-MCP200	60	109	111	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					451	463		10.1096/fj.08-117614	http://dx.doi.org/10.1096/fj.08-117614			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18854435	Green Published			2022-12-25	WOS:000262892900017
J	Prabhakar, V; Capila, I; Soundararajan, V; Raman, R; Sasisekharan, R				Prabhakar, Vikas; Capila, Ishan; Soundararajan, Venkataramanan; Raman, Rahul; Sasisekharan, Ram			Recombinant Expression, Purification, and Biochemical Characterization of Chondroitinase ABC II from Proteus vulgaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; AC LYASE; FLAVOBACTERIUM-HEPARINUM; ESCHERICHIA-COLI; CLONING; COMPLEX	Chondroitin lyases (or chondroitinases) are a family of enzymes that depolymerize chondroitin sulfate (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology. Two distinct chondroitinase ABC enzymes, cABCI and cABCII, were identified in Proteus vulgaris. Recently, cABCI was cloned, recombinantly expressed, and extensively characterized structurally and biochemically. This study focuses on recombinant expression, purification, biochemical characterization, and understanding the structure-function relationship of cABCII. The biochemical parameters for optimal activity and kinetic parameters associated with processing of various CS and DS substrates were determined. The profile of products formed by action of cABCII on different substrates was compared with product profile of cABCI. A homology-based structural model of cABCII and its complexes with CS oligosaccharides was constructed. This structural model provided molecular insights into the experimentally observed differences in the product profile of cABCII as compared with that of cABCI. The critical active site residues involved in the catalytic activity of cABCII identified based on the structural model were validated using site-directed mutagenesis and kinetic characterization of the mutants. The development of such a contaminant-free cABCII enzyme provides additional tools to decode the biologically important structure-function relationship of CS and DS galactosaminoglycans and offers novel therapeutic strategies for recovery after central nervous system injury.	[Sasisekharan, Ram] Harvard Univ, MIT, Div Hlth Sci & Technol, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), 77 Massachusetts Ave,Rm 16-561, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [GM57073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008334, R01GM057073, R37GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57073. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Guda C, 2001, Pac Symp Biocomput, P275; Hamai A, 1997, J BIOL CHEM, V272, P9123; Hartmann U, 2001, MATRIX BIOL, V20, P23, DOI 10.1016/S0945-053X(00)00137-2; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; HUIGE CJM, 1995, J COMPUT CHEM, V16, P56, DOI 10.1002/jcc.540160106; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; Pojasek K, 2002, J BIOL CHEM, V277, P31179, DOI 10.1074/jbc.M201552200; Pojasek K, 2001, BIOCHEM BIOPH RES CO, V286, P343, DOI 10.1006/bbrc.2001.5380; Prabhakar V, 2005, BIOCHEM J, V390, P395, DOI 10.1042/BJ20050532; Prabhakar V, 2005, BIOCHEM J, V386, P103, DOI 10.1042/BJ20041222; Prabhakar V, 2006, BIOCHEMISTRY-US, V45, P11130, DOI 10.1021/bi0605484; RYAN MJ, 1994, Patent No. 9425567; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; SATO N, 1994, APPL MICROBIOL BIOT, V41, P39, DOI 10.1007/s002530050104; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523	24	36	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					974	982		10.1074/jbc.M806630200	http://dx.doi.org/10.1074/jbc.M806630200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18849565	Green Published, hybrid			2022-12-25	WOS:000262122900033
J	Brenet, F; Socci, ND; Sonenberg, N; Holland, EC				Brenet, F.; Socci, N. D.; Sonenberg, N.; Holland, E. C.			Akt phosphorylation of La regulates specific mRNA translation in glial progenitors	ONCOGENE			English	Article						Ras/Akt pathway; La autoantigen; translation; ribonomics; polysomes	GLIOBLASTOMA FORMATION; ENHANCES TRANSLATION; NEURAL PROGENITORS; POLIOVIRUS RNA; AUTOANTIGEN LA; SS-B; PROTEIN; BINDING; OVEREXPRESSION; LOCALIZATION	The Akt signaling pathway activity increases as normal tissue progresses to malignant transformation, and regulates the translation of specific messenger RNAs (mRNAs) through multiple mechanisms. We have identified one such mechanism of Akt-dependent translation control as involving the lupus autoantigen La. La is an RNA-associated protein that contains multiple trafficking elements to support the interaction with RNAs in different subcellular locations. We show here that the La protein is a direct target of the serine/threonine protein kinase Akt on threonine 301, and La nuclear export in mouse glial progenitors, as well as its association with polysomes is modulated by Akt activity. Using a functional approach to determine the network of genes affected by La in the cytoplasm by microarray analysis of polysome-bound mRNAs, we found that La binds 34% of the polysome bound mRNAs and regulates the expression of a specific pool of mRNAs under KRas/Akt activation. Therefore, La appears to be an important contributor to Akt-mediated translational regulation of these transcripts in murine glial cells.	[Brenet, F.; Holland, E. C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Socci, N. D.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Sonenberg, N.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Holland, E. C.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Holland, E. C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Holland, E. C.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Holland, E. C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; McGill University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Brenet, F (corresponding author), Cornell Univ, Dept Med, Weill Med Coll, 1300 York Ave,Room A635, New York, NY 10021 USA.	fab2008@med.cornell.edu	Brenet, Fabienne/R-1881-2016	Brenet, Fabienne/0000-0003-4098-1096	National Institutes of Health [UO1CA04002]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr Agnes Viale and the members of the Genomic Core Facility (MSKCC) for generation of Affymetrix data, Yelena Lyustikman for reading of the manuscript and Gloria Curto- Gonzalez, Elena Fomchenko and Hiro Momota for discussion and technical suggestions. We also thank Keryx Biopharmaceuticals for generously providing us with perifosine. This work was supported by a National Institutes of Health Grant (UO1CA04002).	Alfano C, 2004, NAT STRUCT MOL BIOL, V11, P323, DOI 10.1038/nsmb747; BABOONIAN C, 1989, CLIN EXP IMMUNOL, V78, P454; BACHMANN M, 1990, EXP CELL RES, V191, P171, DOI 10.1016/0014-4827(90)90002-R; Bayfield MA, 2007, MOL CELL BIOL, V27, P3303, DOI 10.1128/MCB.00026-07; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Brenet F, 2005, MOL CELL BIOL, V25, P7505, DOI 10.1128/MCB.25.17.7505-7521.2005; Broekhuis CHD, 2000, BIOCHEMISTRY-US, V39, P3023, DOI 10.1021/bi992308c; Cardinali B, 2003, J BIOL CHEM, V278, P35145, DOI 10.1074/jbc.M300722200; CHANG YN, 1994, J VIROL, V68, P7008, DOI 10.1128/JVI.68.11.7008-7020.1994; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Crul M, 2002, EUR J CANCER, V38, P1615, DOI 10.1016/S0959-8049(02)00127-2; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Dong G, 2004, EMBO J, V23, P1000, DOI 10.1038/sj.emboj.7600115; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Fan H, 1998, MOL CELL BIOL, V18, P3201, DOI 10.1128/MCB.18.6.3201; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gouble A, 2002, CANCER RES, V62, P1489; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3644, DOI 10.1101/gad.12.23.3644; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Kim YK, 2001, NUCLEIC ACIDS RES, V29, P5009, DOI 10.1093/nar/29.24.5009; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li XQ, 2006, J BIOL CHEM, V281, P13837, DOI 10.1074/jbc.M602060200; MANNING BD, 2002, SCI STKE, V162, pPE49; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Momota H, 2005, CANCER RES, V65, P7429, DOI 10.1158/0008-5472.CAN-05-1042; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Rajasekhar VK, 2004, ONCOGENE, V23, P3248, DOI 10.1038/sj.onc.1207546; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2	43	40	43	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					128	139		10.1038/onc.2008.376	http://dx.doi.org/10.1038/onc.2008.376			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18836485				2022-12-25	WOS:000262294100013
J	Fogarty, S; Hardie, DG				Fogarty, Sarah; Hardie, D. Grahame			C-terminal Phosphorylation of LKB1 Is Not Required for Regulation of AMP-activated Protein Kinase, BRSK1, BRSK2, or Cell Cycle Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; SKELETAL-MUSCLE; UPSTREAM KINASE; SUBSTRATE; ENERGY; IDENTIFICATION; POLARIZATION; CONTRACTION; DEFICIENCY; LKB1/STK11	The tumor suppressor protein kinase LKB1 exerts its effects by phosphorylating and activating AMP-activated protein kinase (AMPK) and members of the AMPK-related kinase family, such as the brain-specific kinases BRSK1/BRSK2 (SAD-B/SAD-A). LKB1 contains a conserved serine residue near the C terminus (Ser-431 in mouse LKB1) that is phosphorylated by cyclic AMP-dependent protein kinase and p90-RSK. Although some studies suggest that LKB1 is constitutively active and is not rate-limiting for activation of AMPK, others have suggested that phosphorylation of Ser-431 is necessary to allow LKB1 to phosphorylate and activate AMPK and other downstream kinases. Prompted by our discovery of an LKB1 splice variant (LKB1(S)) that lacks Ser-431, we have reinvestigated this question. In HeLa cells (which lack endogenous LKB1), co-expression with STRAD alpha and MO25 alpha of wild type LKB1, the S431A or S431E mutants of LKB1, or LKB1S gave equal levels of activation of endogenous AMPK. Similarly, recombinant STRAD alpha center dot MO25 alpha complexes containing these LKB1 variants were equally effective at phosphorylating and activating AMPK, BRSK1, and BRSK2 in cell-free assays. Finally, all four LKB1 variants and a truncated LKB1 lacking the C-terminal region altogether were equally effective at causing cell cycle arrest when co-expressed with STRAD alpha and MO25 alpha in the G361 melanoma cell line. Our results do not support the idea that phosphorylation of Ser-431 increases the ability of LKB1 to phosphorylate downstream targets.	[Fogarty, Sarah; Hardie, D. Grahame] Univ Dundee, Div Mol Physiol, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Hardie, DG (corresponding author), Univ Dundee, Div Mol Physiol, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	d.g.hardie@dundee.ac.uk	Hardie, David/Z-1979-2019	Hardie, Grahame/0000-0002-8373-7379	Wellcome Trus; European Commission [LSHM-CT-2004-005272]; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck Co. Inc; Merck KgaA; Pfizer	Wellcome Trus(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck Co. Inc(Merck & Company); Merck KgaA; Pfizer(Pfizer)	This work was also supported by a Wellcome Trust Programme Grant, by EXGENESIS Integrated Project Grant LSHM-CT-2004-005272 of the European Commission, and by the pharmaceutical companies supporting the Division of Signal Transduction Therapy at Dundee (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck & Co. Inc, Merck KgaA and Pfizer). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2000, METH MOL B, V99, P63; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2002, BIOCHEM J, V368, P507, DOI 10.1042/BJ20021284; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490	36	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					77	84		10.1074/jbc.M806152200	http://dx.doi.org/10.1074/jbc.M806152200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18854318	Green Published, hybrid			2022-12-25	WOS:000261974800009
J	Liu, XB; Yamada, N; Maruyama, W; Osawa, T				Liu, Xuebo; Yamada, Naruomi; Maruyama, Wakako; Osawa, Toshihiko			Formation of Dopamine Adducts Derived from Brain Polyunsaturated Fatty Acids MECHANISM FOR PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; DOCOSAHEXAENOIC ACID; LIPID HYDROPEROXIDE; INDUCED NEUROTOXICITY; SUBSTANTIA-NIGRA; PROTEIN ADDUCTS; NEURONAL DEATH; LYSINE ADDUCT; IN-VIVO; MITOCHONDRIA	Oxidative stress appears to be directly involved in the pathogenesis of the neurodegeneration of dopaminergic systems in Parkinson disease. In this study, we formed four dopamine modification adducts derived from docosahexaenoic acid (C22:6/omega-3) and arachidonic acid (C18:4/omega-6), which are known as the major polyunsaturated fatty acids in the brain. Upon incubation of dopamine with fatty acid hydroperoxides and an in vivo experiment using rat brain tissue, all four dopamine adducts were detected. Furthermore, hexanoyl dopamine (HED), an arachidonic acid-derived adduct, caused severe cytotoxicity in human dopaminergic neuroblastoma SH-SY5Y cells, whereas the other adducts were only slightly affected. The HED-induced cell death was found to include apoptosis, which also seems to be mediated by reactive oxygen species generation and mitochondrial abnormality. Additionally, the experiments using monoamine transporter inhibitor and mouse embryonic fibroblast NIH-3T3 cells that lack the monoamine transporter indicate that the HED-induced cytotoxicity might specially occur in the neuronal cells. These data suggest that the formation of the docosahexaenoic acid- and arachidonic acid-derived dopamine adducts in vitro and in vivo, and HED, the arachidonic acid- derived dopamine modification adduct, which caused selective cytotoxicity of neuronal cells, may indicate a novel mechanism responsible for the pathogenesis in Parkinson disease.	[Liu, Xuebo; Yamada, Naruomi; Osawa, Toshihiko] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; [Maruyama, Wakako] Natl Inst Longev Sci, Dept Basic Gerontol, Obu 4748522, Japan	Nagoya University	Osawa, T (corresponding author), Furo Cho,Chikusa Ku, Nagoya, Aichi 4648601, Japan.	osawat@agr.nagoya-u.ac.jp						Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bazan NG, 2002, MOL NEUROBIOL, V26, P283, DOI 10.1385/MN:26:2-3:283; Beermann C, 2005, LIPIDS, V40, P211, DOI 10.1007/s11745-005-1377-1; Berman SB, 1999, J NEUROCHEM, V73, P1127, DOI 10.1046/j.1471-4159.1999.0731127.x; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; Buhmann C, 2004, NEUROBIOL DIS, V15, P160, DOI 10.1016/j.nbd.2003.10.003; Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; DIEZ E, 1994, BIOCHEM J, V301, P721, DOI 10.1042/bj3010721; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; Galvan A, 2008, CLIN NEUROPHYSIOL, V119, P1459, DOI 10.1016/j.clinph.2008.03.017; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Gorman AM, 2000, DEV NEUROSCI-BASEL, V22, P348, DOI 10.1159/000017460; GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8; Graumann R, 2002, POL J PHARMACOL, V54, P573; Hadders-Algra M, 2008, J PERINAT MED, V36, P101, DOI 10.1515/JPM.2008.029; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Izumi Y, 2005, J NEUROSCI RES, V79, P849, DOI 10.1002/jnr.20382; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jia ZQ, 2008, BRAIN RES, V1197, P159, DOI 10.1016/j.brainres.2007.12.044; Kato Y, 1999, J BIOL CHEM, V274, P20406, DOI 10.1074/jbc.274.29.20406; Kato Y, 1997, J LIPID RES, V38, P1334; Kato Y, 1998, ARCH BIOCHEM BIOPHYS, V351, P106, DOI 10.1006/abbi.1997.0519; Kawai Y, 2004, BIOCHEM BIOPH RES CO, V313, P271, DOI 10.1016/j.bbrc.2003.11.123; Kawai Y, 2003, J LIPID RES, V44, P1124, DOI 10.1194/jlr.M200442-JLR200; Kawai Y, 2006, J LIPID RES, V47, P1386, DOI 10.1194/jlr.M600091-JLR200; Kita T, 2003, J PHARMACOL SCI, V92, P178; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; LaVoie MJ, 1999, J NEUROCHEM, V73, P2546, DOI 10.1046/j.1471-4159.1999.0732546.x; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu Hai-Yan, 2008, Chinese Journal of Zoology, V43, P26; Long EK, 2008, J NEUROCHEM, V105, P714, DOI 10.1111/j.1471-4159.2007.05175.x; Ma QL, 2007, J NEUROSCI, V27, P14299, DOI 10.1523/JNEUROSCI.3593-07.2007; Maharaj H, 2005, BRAIN RES, V1063, P180, DOI 10.1016/j.brainres.2005.09.041; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Maruyama Wakako, 2002, Journal of Neurology, V249, P6; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Pezzella A, 1997, J MED CHEM, V40, P2211, DOI 10.1021/jm970099t; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Qu Y, 2003, BRAIN RES PROTOC, V12, P16, DOI 10.1016/S1385-299X(03)00057-6; Rapoport SI, 1999, NEUROCHEM RES, V24, P1403, DOI 10.1023/A:1022584707352; Rosenberger TA, 2004, J NEUROCHEM, V88, P1168, DOI 10.1046/j.1471-4159.2003.02246.x; SANER A, 1971, MOL PHARMACOL, V7, P147; Schapira AHV, 2001, ADV NEUROL, V86, P155; Shamoto-Nagai M, 2003, J NEUROSCI RES, V74, P589, DOI 10.1002/jnr.10777; Shibata T, 2006, J BIOL CHEM, V281, P1196, DOI 10.1074/jbc.M509065200; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Wakamatsu K, 2003, J NEUROCHEM, V86, P1015, DOI 10.1046/j.1471-4159.2003.01917.x; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	62	57	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34887	34895		10.1074/jbc.M805682200	http://dx.doi.org/10.1074/jbc.M805682200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922792	Green Published, hybrid			2022-12-25	WOS:000261469100045
J	Sharlow, ER; Giridhar, KV; Lavalle, CR; Chen, J; Leimgruber, S; Barrett, R; Bravo-Altamirano, K; Wipf, P; Lazo, JS; Wang, QJ				Sharlow, Elizabeth R.; Giridhar, Karthik V.; Lavalle, Courtney R.; Chen, Jun; Leimgruber, Stephanie; Barrett, Rebecca; Bravo-Altamirano, Karla; Wipf, Peter; Lazo, John S.; Wang, Q. Jane			Potent and Selective Disruption of Protein Kinase D Functionality by a Benzoxoloazepinolone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MU; D ACTIVATION; MOLECULAR-CLONING; PROSTATE-CANCER; DNA-SYNTHESIS; PKC-MU; PATHWAY; INHIBITORS; TRANSPORT; FAMILY	Protein kinase D (PKD) is a novel family of serine/threonine kinases targeted by the second messenger diacylglycerol. It has been implicated in many important cellular processes and pathological conditions. However, further analysis of PKD in these processes is severely hampered by the lack of a PKD-specific inhibitor that can be readily applied to cells and in animal models. We now report the discovery of the first potent and selective cell-active small molecule inhibitor for PKD, benzoxoloazepinolone (CID755673). This inhibitor was identified from the National Institutes of Health small molecule repository library of 196,173 compounds using a human PKD1 (PKC mu)-based fluorescence polarization high throughput screening assay. CID755673 suppressed half of the PKD1 enzyme activity at 182 nM and exhibited selective PKD1 inhibition when compared with AKT, polo-like kinase 1 (PLK1), CDK activating kinase (CAK), CAMKII alpha, and three different PKC isoforms. Moreover, it was not competitive with ATP for enzyme inhibition. In cell-based assays, CID755673 blocked phorbol ester-induced endogenous PKD1 activation in LNCaP cells in a concentration-dependent manner. Functionally, CID755673 inhibited the known biological actions of PKD1 including phorbol ester-induced class IIa histone deacetylase 5 nuclear exclusion, vesicular stomatitis virus glycoprotein transport from the Golgi to the plasma membrane, and the ilimaquinone-induced Golgi fragmentation. Moreover, CID755673 inhibited prostate cancer cell proliferation, cell migration, and invasion. In summary, our findings indicate that CID755673 is a potent and selective PKD1 inhibitor with valuable pharmacological and cell biological potential.	[Sharlow, Elizabeth R.; Giridhar, Karthik V.; Lavalle, Courtney R.; Chen, Jun; Lazo, John S.; Wang, Q. Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Sharlow, Elizabeth R.; Leimgruber, Stephanie; Barrett, Rebecca; Wipf, Peter; Lazo, John S.] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15261 USA; [Bravo-Altamirano, Karla; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, QJ (corresponding author), E1354 BST, Pittsburgh, PA 15261 USA.	qjw1@pitt.edu	Wang, Qiming Jane/B-6064-2012; Wipf, Peter/AAG-1771-2021	Wang, Qiming Jane/0000-0002-9502-4851; Wipf, Peter/0000-0001-7693-5863; Giridhar, Karthik/0000-0003-4640-9197	National Institutes of Health [R03 MH082038-01, R01 DK066168-01, 1U54MH074411, GM067082]; NATIONAL CANCER INSTITUTE [R01CA129127, R01CA142580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R03 MH082038-01, R01 DK066168-01, 1U54MH074411, and GM067082. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gschwendt M, 1997, J BIOL CHEM, V272, P20742, DOI 10.1074/jbc.272.33.20742; Guha S, 2002, CANCER RES, V62, P1632; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jaggi M, 2005, CANCER RES, V65, P483; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; JOHANNES FJ, 1995, EUR J BIOCHEM, V227, P303, DOI 10.1111/j.1432-1033.1995.tb20389.x; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lu GW, 2007, CELL SIGNAL, V19, P867, DOI 10.1016/j.cellsig.2006.10.012; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sharlow ER, 2008, NAT PROTOC, V3, P1350, DOI 10.1038/nprot.2008.111; Sharlow ER, 2007, ASSAY DRUG DEV TECHN, V5, P723, DOI 10.1089/adt.2007.102; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sonoda H, 2007, J BIOL CHEM, V282, P34085, DOI 10.1074/jbc.M705593200; Stewart JR, 2000, BIOCHEM PHARMACOL, V60, P1355, DOI 10.1016/S0006-2952(00)00450-0; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	37	105	108	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33516	33526		10.1074/jbc.M805358200	http://dx.doi.org/10.1074/jbc.M805358200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829454	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000261183700056
J	Lai, SL; Chan, TH; Lin, MJ; Huang, WP; Lou, SW; Lee, SJ				Lai, Shih-Lei; Chan, Tun-Hao; Lin, Meng-Ju; Huang, Wei-Pang; Lou, Show-Wan; Lee, Shyh-Jye			Diaphanous-Related Formin 2 and Profilin I Are Required for Gastrulation Cell Movements	PLOS ONE			English	Article								Intensive cellular movements occur during gastrulation. These cellular movements rely heavily on dynamic actin assembly. Rho with its associated proteins, including the Rho-activated formin, Diaphanous, are key regulators of actin assembly in cellular protrusion and migration. However, the function of Diaphanous in gastrulation cell movements remains unclear. To study the role of Diaphanous in gastrulation, we isolated a partial zebrafish diaphanous-related formin 2 (zdia2) clone with its N-terminal regulatory domains. The GTPase binding domain of zDia2 is highly conserved compared to its mammalian homologues. Using a yeast two-hybrid assay, we showed that zDia2 interacts with constitutively-active RhoA and Cdc42. The zdia2 mRNAs were ubiquitously expressed during early embryonic development in zebrafish as determined by RT-PCR and whole-mount in situ hybridization analyses. Knockdown of zdia2 by antisense morpholino oligonucleotides (MOs) blocked epiboly formation and convergent extension in a dose-dependent manner, whereas ectopic expression of a human mdia gene partially rescued these defects. Time-lapse recording further showed that bleb-like cellular processes of blastoderm marginal deep marginal cells and pseudopod-/filopod-like processes of prechordal plate cells and lateral cells were abolished in the zdia2 morphants. Furthermore, zDia2 acts cell-autonomously since transplanted zdia2-knockdown cells exhibited low protrusive activity with aberrant migration in wild type host embryos. Lastly, co-injection of antisense MOs of zdia2 and zebrafish profilin I (zpfn 1), but not zebrafish profilin II, resulted in a synergistic inhibition of gastrulation cell movements. These results suggest that zDia2 in conjunction with zPfn 1 are required for gastrulation cell movements in zebrafish.	[Lai, Shih-Lei; Chan, Tun-Hao; Lin, Meng-Ju; Huang, Wei-Pang; Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Huang, Wei-Pang; Lou, Show-Wan; Lee, Shyh-Jye] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Lou, Show-Wan] Natl Taiwan Univ, Inst Fisheries Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University	Lee, SJ (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	jefflee@ntu.edu.tw	Lai, Ben/AAD-1628-2019; Lee, Shyh-Jye/C-6092-2008; Lai, Shih-Lei/O-1562-2018	Lee, Shyh-Jye/0000-0001-8452-9152; Lai, Shih-Lei/0000-0002-1409-4701; HUANG, WEI-PANG/0000-0001-8410-6555; Lin, Meng-Ju/0000-0001-7971-3668	National Science Council of Taiwan, R.O.C. [NSC94-2311-B-002-019]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (NSC94-2311-B-002-019) from the National Science Council of Taiwan, R.O.C.	Afshar K, 2000, DEVELOPMENT, V127, P1887; Alberts AS, 2002, CURR BIOL, V12, pR796, DOI 10.1016/S0960-9822(02)01309-X; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Crawford JM, 1998, DEV BIOL, V204, P151, DOI 10.1006/dbio.1998.9061; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; FINK RD, 1988, DEV BIOL, V129, P179, DOI 10.1016/0012-1606(88)90172-8; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; Goto H, 2000, MICROSC RES TECHNIQ, V49, P173, DOI 10.1002/(SICI)1097-0029(20000415)49:2<173::AID-JEMT10>3.0.CO;2-A; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HOGAN JC, 1977, J EMBRYOL EXP MORPH, V40, P125; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Kane DA, 1996, DEVELOPMENT, V123, P47; Karakesisoglou I, 1996, CELL MOTIL CYTOSKEL, V34, P36; Kato T, 2001, J CELL SCI, V114, P775; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lai SL, 2005, MOL REPROD DEV, V71, P186, DOI 10.1002/mrd.20290; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Martin P, 2002, CURR OPIN CELL BIOL, V14, P569, DOI 10.1016/S0955-0674(02)00369-1; Matsumura F, 2001, CELL STRUCT FUNCT, V26, P639, DOI 10.1247/csf.26.639; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schluter K, 1998, J CELL SCI, V111, P3261; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; THISSE C, 1993, STRUCTURE ZEBRAFISH, P1203; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Trinkaus J P, 1980, Prog Clin Biol Res, V41, P887; TRINKAUS JP, 1992, J EXP ZOOL, V261, P40, DOI 10.1002/jez.1402610107; TRINKAUS JP, 1992, DEVELOPMENT, P75; Trinkaus JP, 1996, DEV BIOL, V177, P356, DOI 10.1006/dbio.1996.0169; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WilliamsMasson EM, 1997, DEVELOPMENT, V124, P2889; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	82	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3439	10.1371/journal.pone.0003439	http://dx.doi.org/10.1371/journal.pone.0003439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941507	Green Submitted, gold, Green Published			2022-12-25	WOS:000265125900002
J	Shea, KF; Wells, CM; Garner, AP; Jones, GE				Shea, Kerry F.; Wells, Claire M.; Garner, Andrew P.; Jones, Gareth E.			ROCK1 and LIMK2 Interact in Spread but Not Blebbing Cancer Cells	PLOS ONE			English	Article								Cancer cells migrating within a 3D microenvironment are able to adopt either a mesenchymal or amoeboid mode of migration. Amoeboid migration is characterised by membrane blebbing that is dependent on the Rho effectors, ROCK1/2. We identify LIMK2 as the preferred substrate for ROCK1 but find that LIMK2 did not induce membrane blebbing, suggesting that a LIMK2 pathway is not involved in amoeboid-mode migration. In support of this hypothesis, novel FRET data demonstrate a direct interaction between ROCK1 and LIMK2 in polarised but not blebbing cells. Our results point to a specific role for the ROCK1: LIMK2 pathway in mesenchymal-mode migration.	[Shea, Kerry F.; Wells, Claire M.; Jones, Gareth E.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Shea, Kerry F.; Garner, Andrew P.] AstraZeneca, Canc & Infect Res Area, Macclesfield, Cheshire, England; [Wells, Claire M.] Kings Coll London, Div Canc Stud, London, England	University of London; King's College London; AstraZeneca; University of London; King's College London	Shea, KF (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	gareth.jones@kcl.ac.uk	Jones, Gareth E/H-2282-2012	Jones, Gareth E/0000-0001-5879-3048	Medical Research Council (MRC); BBSRC/AstraZeneca plc. [CASE studentship]	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC/AstraZeneca plc.(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)AstraZeneca)	This work was supported by the Medical Research Council (MRC), and the award of a CASE studentship from BBSRC/AstraZeneca plc.	AHMED T, 2008, CELLULAR SIGNALLING; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Honma M, 2006, MOL BIOL CELL, V17, P1888, DOI 10.1091/mbc.E05-12-1173; Hopkins AM, 2007, AM J PHYSIOL-GASTR L, V292, pG806, DOI 10.1152/ajpgi.00333.2006; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2002, BJU INT, V89, P449, DOI 10.1046/j.1464-4096.2001.01920.x; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lawler S, 1999, CURR BIOL, V9, pR800, DOI 10.1016/S0960-9822(99)80493-X; Lin T, 2003, CIRC RES, V92, P1296, DOI 10.1161/01.RES.0000078780.65824.8B; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Pandey D, 2006, BLOOD, V107, P575, DOI 10.1182/blood-2004-11-4377; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Torgerson RR, 1998, J CELL SCI, V111, P2911; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Zhou J, 2003, WORLD J GASTROENTERO, V9, P9, DOI 10.3748/wjg.v9.i1.9	35	17	17	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3398	10.1371/journal.pone.0003398	http://dx.doi.org/10.1371/journal.pone.0003398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852895	Green Submitted, Green Published, gold			2022-12-25	WOS:000265121700006
J	Begliomini, C; Nelini, C; Caria, A; Grodd, W; Castiello, U				Begliomini, Chiara; Nelini, Cristian; Caria, Andrea; Grodd, Wolfgang; Castiello, Umberto			Cortical Activations in Humans Grasp-Related Areas Depend on Hand Used and Handedness	PLOS ONE			English	Article							REACH-TO-GRASP; DORSAL PREMOTOR CORTEX; PRIMARY MOTOR CORTEX; PARIETAL CORTEX; ONLINE ADJUSTMENTS; CEREBELLAR; PRECISION; MOVEMENTS; FMRI; FORCE	Background: In non-human primates grasp-related sensorimotor transformations are accomplished in a circuit involving the anterior intraparietal sulcus (area AIP) and both the ventral and the dorsal sectors of the premotor cortex (vPMC and dPMC, respectively). Although a human homologue of such a circuit has been identified whether activity within this circuit varies depending on handedness has yet to be investigated. Methodology/Principal Findings: We used functional magnetic resonance imaging (fMRI) to explicitly test how handedness modulates activity within human grasping-related brain areas. Right-and left-handers subjects were requested to reach towards and grasp an object with either the right or the left hand using a precision grip while scanned. A kinematic study was conducted with similar procedures as a behavioral counterpart for the fMRI experiment. Results from a factorial design revealed significant activity within the right dPMC, the right cerebellum and AIP bilaterally. The pattern of activity within these areas mirrored the results found for the behavioral study. Conclusion/Significance: Data are discussed in terms of an handedness-independent role for the right dPMC in monitoring hand shaping, the need for bilateral AIP activity for the performance of precision grip movements which varies depending on handedness and the involvement of the cerebellum in terms of its connections with AIP. These results provide the first compelling evidence of specific grasping related neural activity depending on handedness.	[Begliomini, Chiara; Nelini, Cristian; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy; [Caria, Andrea; Grodd, Wolfgang] Univ Tubingen Hosp, Dept Neuroradiol, D-72074 Tubingen, Germany	University of Padua; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Begliomini, C (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	BEGLIOMINI, CHIARA/D-1516-2014	BEGLIOMINI, CHIARA/0000-0001-7433-0414; Castiello, Umberto/0000-0003-0629-1286; Caria, Andrea/0000-0003-2017-7084	Italian Ministry of Research and University	Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Italian Ministry of Research and University (MUR) to UC.	Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; ANNETT M, 1992, BRIT J PSYCHOL, V83, P493, DOI 10.1111/j.2044-8295.1992.tb02455.x; Begliomini C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001108; Begliomini C, 2007, EUR J NEUROSCI, V25, P1245, DOI 10.1111/j.1460-9568.2007.05365.x; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Brochier T, 2007, CURR OPIN NEUROBIOL, V17, P637, DOI 10.1016/j.conb.2007.12.002; CASTIELLO U, 1993, BEHAV BRAIN RES, V56, P43, DOI 10.1016/0166-4328(93)90021-H; Castiello U, 1997, BRAIN, V120, P593, DOI 10.1093/brain/120.4.593; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 2008, NEUROSCIENTIST, V14, P157, DOI 10.1177/1073858407312080; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Chapman H, 2002, EUR J NEUROSCI, V15, P2037, DOI 10.1046/j.1460-9568.2002.02021.x; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; Clower DM, 2005, CEREB CORTEX, V15, P913, DOI 10.1093/cercor/bhh190; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; COREN S, 1992, CAUSES CONSEQUENCES; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; CULHAM JC, 2004, FUNCTIONAL NEUROIMAG, V20, P1706; CULHAM JC, 2001, SOC NEUR SAN DIEG CA; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Farne A, 2003, NEUROPSYCHOLOGIA, V41, P739, DOI 10.1016/S0028-3932(02)00177-X; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S., 2004, ADV ANAT EMBRYOL CEL, V174, P1, DOI [DOI 10.1007/978-3-642-18910-4_1, 10.1007/978-3-642-18910-4_1]; GIBSON AR, 1994, INSIGHTS REACH GRASP, P129; Glaser DE, 2001, NEUROIMAGE, V13, pS127; Glover S, 2005, J COGNITIVE NEUROSCI, V17, P124, DOI 10.1162/0898929052880066; Gomez JE, 2000, EUR J NEUROSCI, V12, P3748, DOI 10.1046/j.1460-9568.2000.00232.x; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grosskopf A, 2006, EXP BRAIN RES, V168, P230, DOI 10.1007/s00221-005-0083-1; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; HAGGARD P, 1994, NEUROPSYCHOLOGIA, V32, P827, DOI 10.1016/0028-3932(94)90021-3; HEALEY JM, 1986, CORTEX, V22, P33, DOI 10.1016/S0010-9452(86)80031-4; Hermsdorfer J, 1999, EXP BRAIN RES, V128, P41, DOI 10.1007/s002210050815; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Lang CE, 1999, J NEUROPHYSIOL, V82, P2108, DOI 10.1152/jn.1999.82.5.2108; Mason CR, 2006, J NEUROPHYSIOL, V95, P144, DOI 10.1152/jn.00492.2005; Mason CR, 1998, J NEUROPHYSIOL, V79, P537, DOI 10.1152/jn.1998.79.2.537; Rand MK, 2000, EXP BRAIN RES, V135, P179, DOI 10.1007/s002210000528; Raos V, 2004, J NEUROPHYSIOL, V92, P1990, DOI 10.1152/jn.00154.2004; Raos V, 2003, J NEUROPHYSIOL, V89, P1503, DOI 10.1152/jn.00661.2002; Rice NJ, 2007, BRAIN RES, V1175, P76, DOI 10.1016/j.brainres.2007.08.009; Rice NJ, 2006, J NEUROSCI, V26, P8176, DOI 10.1523/JNEUROSCI.1641-06.2006; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Sainburg RL, 2004, J NEUROPHYSIOL, V92, P1374, DOI 10.1152/jn.00181.2004; Smeets JBJ, 2001, EXP BRAIN RES, V139, P92, DOI 10.1007/s002210100748; Smith Allan M., 1993, Canadian Journal of Neurological Sciences, V20, pS53; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Timmann D, 1999, J NEUROPHYSIOL, V82, P103, DOI 10.1152/jn.1999.82.1.103; Timmann D, 2001, J NEUROPHYSIOL, V86, P2690, DOI 10.1152/jn.2001.86.6.2690; Tretriluxana J, 2008, EXP BRAIN RES, V188, P305, DOI 10.1007/s00221-008-1364-2; Tunik E, 2005, NAT NEUROSCI, V8, P505, DOI 10.1038/nn1430; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Umilta MA, 2007, J NEUROPHYSIOL, V98, P488, DOI 10.1152/jn.01094.2006; VANKAN PLE, 1994, J PHYSIOL-LONDON, V480, P171, DOI 10.1113/jphysiol.1994.sp020351; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zackowski KM, 2002, EXP BRAIN RES, V146, P511, DOI 10.1007/s00221-002-1191-9	72	59	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3388	10.1371/journal.pone.0003388	http://dx.doi.org/10.1371/journal.pone.0003388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846222	Green Published, gold, Green Submitted			2022-12-25	WOS:000265114500011
J	Tsang, LH; Cassat, JE; Shaw, LN; Beenken, KE; Smeltzer, MS				Tsang, Laura H.; Cassat, James E.; Shaw, Lindsey N.; Beenken, Karen E.; Smeltzer, Mark S.			Factors Contributing to the Biofilm-Deficient Phenotype of Staphylococcus aureus sarA Mutants	PLOS ONE			English	Article								Mutation of sarA in Staphylococcus aureus results in a reduced capacity to form a biofilm, but the mechanistic basis for this remains unknown. Previous transcriptional profiling experiments identified a number of genes that are differentially expressed both in a biofilm and in a sarA mutant. This included genes involved in acid tolerance and the production of nucleolytic and proteolytic exoenzymes. Based on this we generated mutations in alsSD, nuc and sspA in the S. aureus clinical isolate UAMS-1 and its isogenic sarA mutant and assessed the impact on biofilm formation. Because expression of alsSD was increased in a biofilm but decreased in a sarA mutant, we also generated a plasmid construct that allowed expression of alsSD in a sarA mutant. Mutation of alsSD limited biofilm formation, but not to the degree observed with the corresponding sarA mutant, and restoration of alsSD expression did not restore the ability to form a biofilm. In contrast, concomitant mutation of sarA and nuc significantly enhanced biofilm formation by comparison to the sarA mutant. Although mutation of sspA had no significant impact on the ability of a sarA mutant to form a biofilm, a combination of protease inhibitors (E-64, 1-10-phenanthroline, and dichloroisocoumarin) that was shown to inhibit the production of multiple extracellular proteases without inhibiting growth was also shown to enhance the ability of a sarA mutant to form a biofilm. This effect was evident only when all three inhibitors were used concurrently. This suggests that the reduced capacity of a sarA mutant to form a biofilm involves extracellular proteases of all three classes (serine, cysteine and metalloproteases). Inclusion of protease inhibitors also enhanced biofilm formation in a sarA/nuc mutant, with the combined effect of mutating nuc and adding protease inhibitors resulting in a level of biofilm formation with the sarA mutant that approached that of the UAMS-1 parent strain. These results demonstrate that the inability of a sarA mutant to repress production of extracellular nuclease and multiple proteases have independent but cumulative effects that make a significant contribution to the biofilm-deficient phenotype of an S. aureus sarA mutant.	[Tsang, Laura H.; Cassat, James E.; Beenken, Karen E.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Shaw, Lindsey N.] Univ S Florida, Dept Biol, Tampa, FL USA	University of Arkansas System; University of Arkansas Medical Sciences; State University System of Florida; University of South Florida	Tsang, LH (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	smeltzermarks@uams.edu	Shaw, Lindsey/AAI-1741-2020; Smeltzer, Mark/M-2009-2018	Shaw, Lindsey/0000-0002-0629-8990; Smeltzer, Mark/0000-0002-0878-0692	National Institute of Allergy and Infectious Diseases (NIAID) [R01-AI43356]; American Heart Association [Predoctoral Fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043356] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) grant R01-AI43356 to MS. Further support was provided by an American Heart Association Predoctoral Fellowship to JC.	Angeles Tormo M, 2007, MICROBIOL-SGM, V153, P1702, DOI 10.1099/mic.0.2006/005744-0; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Balaban N, 2007, ANTIMICROB AGENTS CH, V51, P2226, DOI 10.1128/AAC.01097-06; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Cirioni O, 2007, ANTIMICROB AGENTS CH, V51, P4518, DOI 10.1128/AAC.00808-07; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; DeLeo FR, 2008, J EXP MED, V205, P271, DOI 10.1084/jem.20080167; Dubin G, 2008, J MOL BIOL, V379, P343, DOI 10.1016/j.jmb.2008.03.059; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Giacometti A, 2003, ANTIMICROB AGENTS CH, V47, P1979, DOI 10.1128/AAC.47.6.1979-1983.2003; Gillaspy AF, 1998, INFECT IMMUN, V66, P3170, DOI 10.1128/IAI.66.7.3170-3178.1998; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004; Karlsson A, 2002, INFECT IMMUN, V70, P4239, DOI 10.1128/IAI.70.8.4239-4246.2002; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kim JH, 2008, J MICROBIOL BIOTECHN, V18, P28; Kiran MD, 2008, MOL PHARMACOL, V73, P1578, DOI 10.1124/mol.107.044164; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x; LEE CY, 1986, J BACTERIOL, V166, P385, DOI 10.1128/jb.166.2.385-391.1986; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; MILLER JR, 1987, J BACTERIOL, V169, P3508, DOI 10.1128/jb.169.8.3508-3514.1987; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Popowicz GM, 2006, J MOL BIOL, V358, P270, DOI 10.1016/j.jmb.2006.01.098; Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Tsang LH, 2007, INFECT IMMUN, V75, P4528, DOI 10.1128/IAI.00603-07; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Vautor E, 2008, VET MICROBIOL, V127, P407, DOI 10.1016/j.vetmic.2007.08.018; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Welin-Neilands J, 2007, APPL ENVIRON MICROB, V73, P5633, DOI 10.1128/AEM.01049-07; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	56	90	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3361	10.1371/journal.pone.0003361	http://dx.doi.org/10.1371/journal.pone.0003361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846215	Green Submitted, Green Published, gold			2022-12-25	WOS:000265114500003
J	Rezaval, C; Berni, J; Gorostiza, EA; Werbajh, S; Fagilde, MM; Fernandez, MP; Beckwith, EJ; Aranovich, EJ; Garcia, CASY; Ceriani, MF				Rezaval, Carolina; Berni, Jimena; Axel Gorostiza, Ezequiel; Werbajh, Santiago; Marta Fagilde, Maria; Paz Fernandez, Maria; Beckwith, Esteban J.; Aranovich, Ezequiel J.; Sabio y Garcia, Carmen A.; Fernanda Ceriani, Maria			A Functional Misexpression Screen Uncovers a Role for Enabled in Progressive Neurodegeneration	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; AXONAL-TRANSPORT; LOCOMOTOR-ACTIVITY; ACTIN CYTOSKELETON; BRAIN DEGENERATION; ENA/VASP PROTEINS; TYROSINE KINASE; DROSOPHILA; MODEL; MUTATIONS	Drosophila is a well-established model to study the molecular basis of neurodegenerative diseases. We carried out a misexpression screen to identify genes involved in neurodegeneration examining locomotor behavior in young and aged flies. We hypothesized that a progressive loss of rhythmic activity could reveal novel genes involved in neurodegenerative mechanisms. One of the interesting candidates showing progressive arrhythmicity has reduced enabled (ena) levels. ena down-regulation gave rise to progressive vacuolization in specific regions of the adult brain. Abnormal staining of presynaptic markers such as cystein string protein (CSP) suggest that axonal transport could underlie the neurodegeneration observed in the mutant. Reduced ena levels correlated with increased apoptosis, which could be rescued in the presence of p35, a general Caspase inhibitor. Thus, this mutant recapitulates two important features of human neurodegenerative diseases, i.e., vulnerability of certain neuronal populations and progressive degeneration, offering a unique scenario in which to unravel the specific mechanisms in an easily tractable organism.	[Rezaval, Carolina; Berni, Jimena; Axel Gorostiza, Ezequiel; Werbajh, Santiago; Marta Fagilde, Maria; Paz Fernandez, Maria; Beckwith, Esteban J.; Aranovich, Ezequiel J.; Sabio y Garcia, Carmen A.; Fernanda Ceriani, Maria] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Genet Comportamiento, RA-1405 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Rezaval, C (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Genet Comportamiento, RA-1405 Buenos Aires, DF, Argentina.	fceriani@leloir.org.ar	Gorostiza, E. Axel/S-8675-2019; de la Paz Fernandez, Maria/ABC-5366-2020	de la Paz Fernandez, Maria/0000-0002-9261-6114; Gorostiza, E. Axel/0000-0002-0185-971X; Ceriani, Maria/0000-0001-8945-3070; Berni, Jimena/0000-0002-5068-1372; Rezaval, Carolina/0000-0002-1410-5589	Argentine Research Council (CONICET) [graduate fellowships]; Agencia Nacional para la Promocion de Ciencia y Tecnologia (ANPCyT); HHMI International Research Program	Argentine Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional para la Promocion de Ciencia y Tecnologia (ANPCyT)(ANPCyT); HHMI International Research Program	MFC is a member of the Argentine Research Council (CONICET). CR, JB, EAG, MPF and EJB are/were supported by graduate fellowships from CONICET. This work was supported by a grant from the Agencia Nacional para la Promocion de Ciencia y Tecnologia (ANPCyT) and by the HHMI International Research Program to MFC. Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly M, 2004, DEV CELL, V7, P462, DOI 10.1016/j.devcel.2004.09.008; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bowman AB, 1999, J CELL BIOL, V146, P165; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; Chan HYE, 2002, HUM MOL GENET, V11, P2895, DOI 10.1093/hmg/11.23.2895; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Fernandez MD, 2007, P NATL ACAD SCI USA, V104, P5650, DOI 10.1073/pnas.0608260104; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gnerer JP, 2006, P NATL ACAD SCI USA, V103, P14987, DOI 10.1073/pnas.0606887103; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; HAY BA, 1994, DEVELOPMENT, V120, P2121; Helfrich-Forster C, 2003, MICROSC RES TECHNIQ, V62, P94, DOI 10.1002/jemt.10357; Hurd DD, 1996, GENETICS, V144, P1075; Joshi D, 1999, CHRONOBIOL INT, V16, P751, DOI 10.3109/07420529909016942; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kraemer BC, 2007, HUM MOL GENET, V16, P1959, DOI 10.1093/hmg/ddm143; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Martin M, 2005, MOL BIOL CELL, V16, P4225, DOI 10.1091/mbc.E05-02-0116; Min KT, 1997, CURR BIOL, V7, P885, DOI 10.1016/S0960-9822(06)00378-2; Minois N, 2001, EXP GERONTOL, V36, P1137, DOI 10.1016/S0531-5565(00)00263-1; Myers KA, 2006, NEUROSCIENTIST, V12, P107, DOI 10.1177/1073858405283428; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Palladino MJ, 2002, GENETICS, V161, P1197; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; ROBERTSON HM, 1988, GENETICS, V118, P461; Rohn TT, 2008, J NEUROSCI, V28, P3051, DOI 10.1523/JNEUROSCI.5620-07.2008; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rusu P, 2007, EUR J NEUROSCI, V25, P1079, DOI 10.1111/j.1460-9568.2007.05341.x; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Shulman JM, 2003, GENETICS, V165, P1233; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Vloeberghs E, 2004, EUR J NEUROSCI, V20, P2757, DOI 10.1111/j.1460-9568.2004.03755.x; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532	59	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3332	10.1371/journal.pone.0003332	http://dx.doi.org/10.1371/journal.pone.0003332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841196	gold, Green Published, Green Submitted			2022-12-25	WOS:000265113900002
J	Brunner, S; Winogradow, J; Huber, BC; Zaruba, MM; Fischer, R; David, R; Assmann, G; Herbach, N; Wanke, R; Mueller-Hoecker, J; Franz, WM				Brunner, Stefan; Winogradow, Janina; Huber, Bruno C.; Zaruba, Marc-Michael; Fischer, Rebekka; David, Robert; Assmann, Gerald; Herbach, Nadja; Wanke, Ruediger; Mueller-Hoecker, Josef; Franz, Wolfgang-Michael			Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis	FASEB JOURNAL			English	Article						EPO; cytokines; stem cell mobilization and homing	COLONY-STIMULATING FACTOR; IMPROVES CARDIAC-FUNCTION; ENDOTHELIAL GROWTH-FACTOR; HEMATOPOIETIC STEM-CELLS; REPERFUSION INJURY; HEART; NEOVASCULARIZATION; MOBILIZATION; REGENERATION; EXPRESSION	Mobilization of bone marrow-derived stem cells (BMCs) was shown to have protective effects after myocardial infarction (MI). However, the classical mobilizing agent, granulocyte-colony stimulating factor (G-CSF) relapsed after revealing an impaired homing capacity. In the search for superior cytokines, erythropoietin (EPO) appears to be a promising agent. Therefore, we analyzed in a murine model of surgically induced MI the influence of EPO treatment on survival and functional parameters as well as BMC mobilization, homing, and effect on resident cardiac stem cells (CSCs). Human EPO was injected intraperitoneally after ligation of the left anterior descendens (LAD) for 3 days with a total dose of 5000 IU/kg 6 and 30 days after MI, and pressure volume relationships were investigated in vivo. Cardiac tissues were analyzed by histology. To show the effect on BMCs and CSCs, FACS analyses were performed. Homing factors were analyzed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and ELISA. EPO-treated animals showed a significant improvement of survival post-MI (62 vs. 36%). At days 6 and 30, all hemodynamic parameters associated with attenuated remodeling, enhanced neovascularization, and diminished apoptotic cells in the peri-infarct area were improved. BMC subpopulations (CD31(+), c-kit(+), and Sca-1(+) cells) were mobilized, and homing of Sca-1(+) and CXCR4(+) BMCs toward an SDF-1 gradient into the ischemic myocardium was enhanced. However, there was no beneficial effect on CSCs. We have shown that EPO application after MI shows cardioprotective effects. This may be explained by mobilization of BMCs, which are homing via the CXCR-4/SDF-1 axis. However, EPO has no beneficial effects on resident CSCs. Therefore, new treatment regimes using EPO together with other agents may combine complementary beneficial effects preventing ischemic cardiomyopathy. - Brunner, S., Winogradow, J., Huber, B. C., Zaruba, M.-M., Fischer, R., David, R., Assmann, G., Herbach, N., Wanke, R., Mueller-Hoecker, J., Franz, W.-M. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. FASEB J. 23, 351-361 (2009)	[Brunner, Stefan; Winogradow, Janina; Huber, Bruno C.; Zaruba, Marc-Michael; Fischer, Rebekka; David, Robert; Franz, Wolfgang-Michael] Univ Munich, Klinikum Grosshadern, Dept Med 1, Med Klin & Poliklin 1, D-81377 Munich, Germany; [Assmann, Gerald; Mueller-Hoecker, Josef] Univ Munich, Inst Pathol, D-81377 Munich, Germany; [Herbach, Nadja; Wanke, Ruediger] Univ Munich, Inst Vet Pathol, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich	Franz, WM (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Med 1, Med Klin & Poliklin 1, Marchioninistr 15, D-81377 Munich, Germany.	wolfgang.franz@med.uni-muenchen.de	Zaruba, Marc-Michael/AAI-8571-2020	Zaruba, Marc-Michael/0000-0003-1074-5463; Wanke, Rudiger/0000-0002-0153-224X; Herbach, Nadja/0000-0001-5893-0356	Ludwig-Maximilians-University (Munich, Germany); Dr. Helmut Legerlotz-Stiftung (Munich, Germany)	Ludwig-Maximilians-University (Munich, Germany); Dr. Helmut Legerlotz-Stiftung (Munich, Germany)	We thank Judith Arcifa and Barbara Markieton for excellent technical assistance. Fritz-Bender-Stiftung provided funding to R. F. and B. M. Additional financial support was provided by the FoFoLe program of the Ludwig-Maximilians-University (Munich, Germany) and by the Dr. Helmut Legerlotz-Stiftung (Munich, Germany).	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Brunner S, 2008, EXP HEMATOL, V36, P695, DOI 10.1016/j.exphem.2008.01.011; Bullard AJ, 2005, BASIC RES CARDIOL, V100, P397, DOI 10.1007/s00395-005-0537-4; Cai ZQ, 2004, CIRCULATION, V109, P2050, DOI 10.1161/01.CIR.0000127954.98131.23; Deindl E, 2006, FASEB J, V20, P956, DOI 10.1096/fj.05-4763fje; Engelmann MG, 2006, J AM COLL CARDIOL, V48, P1712, DOI 10.1016/j.jacc.2006.07.044; Engelmann MG, 2006, CURR OPIN MOL THER, V8, P396; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Freedman A, 1997, BLOOD, V90, P4996, DOI 10.1182/blood.V90.12.4996.4996_4996_5001; Hanlon PR, 2005, FASEB J, V19, P1323, DOI 10.1096/fj.04-3545fje; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Ho QT, 2007, INT J BIOCHEM CELL B, V39, P1349, DOI 10.1016/j.biocel.2007.04.010; Honold J, 2006, ARTERIOSCL THROM VAS, V26, P2238, DOI 10.1161/01.ATV.0000240248.55172.dd; Jaquet K, 2002, MICROVASC RES, V64, P326, DOI 10.1006/mvre.2002.2426; Lips DJ, 2004, BASIC RES CARDIOL, V99, P351, DOI 10.1007/s00395-004-0476-5; Lipsic E, 2006, CARDIOVASC DRUG THER, V20, P135, DOI 10.1007/s10557-006-7680-5; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Parsa CJ, 2004, J BIOL CHEM, V279, P20655, DOI 10.1074/jbc.M314099200; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schuster MD, 2004, AM J PHYSIOL-HEART C, V287, pH525, DOI 10.1152/ajpheart.00058.2004; Shi Y, 2004, BASIC RES CARDIOL, V99, P173, DOI 10.1007/s00395-004-0455-x; Tramontano AF, 2003, BIOCHEM BIOPH RES CO, V308, P990, DOI 10.1016/S0006-291X(03)01503-1; van der Meer P, 2005, J AM COLL CARDIOL, V46, P125, DOI 10.1016/j.jacc.2005.03.044; van Os R, 1998, BLOOD, V92, P1950, DOI 10.1182/blood.V92.6.1950.418k21_1950_1956; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Westenbrink BD, 2007, EUR HEART J, V28, P2018, DOI 10.1093/eurheartj/ehm177; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; Zaruba MM, 2008, CARDIOVASC RES, V77, P722, DOI 10.1093/cvr/cvm080; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003	45	70	82	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					351	361		10.1096/fj.08-109462	http://dx.doi.org/10.1096/fj.08-109462			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18827024				2022-12-25	WOS:000262892900007
J	Segditsas, S; Rowan, AJ; Howarth, K; Jones, A; Leedham, S; Wright, NA; Gorman, P; Chambers, W; Domingo, E; Roylance, RR; Sawyer, EJ; Sieber, OM; Tomlinson, IPM				Segditsas, S.; Rowan, A. J.; Howarth, K.; Jones, A.; Leedham, S.; Wright, N. A.; Gorman, P.; Chambers, W.; Domingo, E.; Roylance, R. R.; Sawyer, E. J.; Sieber, O. M.; Tomlinson, I. P. M.			APC and the three-hit hypothesis	ONCOGENE			English	Article						two hits; tumour suppressor; APC; Wnt; copy number change; 'just right'	FAMILIAL ADENOMATOUS POLYPOSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CHROMOSOMAL INSTABILITY; COLORECTAL ADENOMAS; SOMATIC MUTATIONS; GERMLINE MUTATION; BETA-CATENIN; CANCERS; ALLELES; MODEL	The seminal 'two-hit hypothesis' implicitly assumes that bi-allelic tumour suppressor gene (TSG) mutations cause loss of protein function. All subsequent events in that tumour therefore take place on an essentially null background for that TSG protein. We have shown that the two-hit model requires modi. cation for the APC TSG, because mutant APC proteins probably retain some function and the two hits are co-selected to produce an optimal level of Wnt activation. We wondered whether the optimal Wnt level might change during tumour progression, leading to selection for more than two hits at the APC locus. Comprehensive screening of a panel of colorectal cancer (CRC) cell lines and primary CRCs showed that some had indeed acquired third hits at APC. These third hits were mostly copy number gains or deletions, but could be protein-truncating mutations. Third hits were significantly less common when the second hit at APC had arisen by copy-neutral loss of heterozygosity. Both polyploid and near-diploid CRCs had third hits, and the third hits did not simply arise as a result of acquiring a polyploid karyotype. The third hits affected mRNA and protein levels, with potential functional consequences for Wnt signalling and tumour growth. Although some third hits were probably secondary to genomic instability, others did appear specifically to target APC. Whilst it is generally believed that tumours develop and progress through stepwise accumulation of mutations in different functional pathways, it also seems that repeated targeting of the same pathway and/or gene is selected in some cancers.	[Segditsas, S.; Rowan, A. J.; Howarth, K.; Jones, A.; Gorman, P.; Chambers, W.; Domingo, E.; Roylance, R. R.; Sawyer, E. J.; Sieber, O. M.; Tomlinson, I. P. M.] Canc Res UK, London Res Inst, Mol & Populat Genet Lab, London, England; [Leedham, S.; Wright, N. A.] Canc Res UK, London Res Inst, Histopathol Lab, London, England; [Chambers, W.] Oxford Radcliffe Hosp, Dept Colorectal Surg & Genet Knowledge Pk, Oxford, England	Cancer Research UK; Cancer Research UK; University of Oxford	Tomlinson, IPM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	iant@well.ox.ac.uk	Domingo, Enric/A-9099-2018; Sieber, Oliver/ABA-9211-2021; Wright, Nicholas/HHY-7227-2022; Sieber, Oliver/M-9473-2015	Domingo, Enric/0000-0003-4390-8767; Sieber, Oliver/0000-0001-9480-0786; Sieber, Oliver/0000-0001-9480-0786; Wright, Nicholas/0000-0002-5525-3457	MRC [G84/6549] Funding Source: UKRI; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; Medical Research Council [G84/6549] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jones AM, 2007, J PATHOL, V213, P249, DOI 10.1002/path.2234; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Leslie A, 2006, GENE CHROMOSOME CANC, V45, P126, DOI 10.1002/gcc.20271; Michor F, 2005, SEMIN CANCER BIOL, V15, P43, DOI 10.1016/j.semcancer.2004.09.007; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Sieber OM, 2006, GUT, V55, P1440, DOI 10.1136/gut.2005.087106; Sieber OM, 2005, NAT REV CANCER, V5, P649, DOI 10.1038/nrc1674; Sieber OM, 2002, P NATL ACAD SCI USA, V99, P16910, DOI 10.1073/pnas.012679099; Spirio LN, 1998, NAT GENET, V20, P385, DOI 10.1038/3865; Su LK, 2000, AM J HUM GENET, V67, P582, DOI 10.1086/303058; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	17	45	45	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					146	155		10.1038/onc.2008.361	http://dx.doi.org/10.1038/onc.2008.361			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18836487				2022-12-25	WOS:000262294100015
J	Zhang, JH; Cao, RH; Zhang, Y; Jia, TH; Cao, YH; Wahlberg, E				Zhang, Junhang; Cao, Renhai; Zhang, Yun; Jia, Tanghong; Cao, Yihai; Wahlberg, Eric			Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability	FASEB JOURNAL			English	Article						neovascularization; ischemia; growth factor; receptor	ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC ANGIOGENESIS; MACULAR DEGENERATION; RANIBIZUMAB; ISCHEMIA; PROTEIN; CANCER; GENE	Preclinical and clinical evaluations of individual proangiogenic/arteriogenic factors for the treatment of ischemic myocardium and skeletal muscle have produced unfulfilled promises. The establishment of functional and stable arterial vascular networks may require combinations of different angiogenic and arteriogenic factors. Using in vivo angiogenesis and ischemic hind-limb animal models, we have compared the angiogenic and therapeutic activities of fibroblast growth factor 2 (FGF-2) in combinations with PDGF-AA and PDGF-AB, two members of the platelet-derived growth factor (PDGF) family, with distinct receptor binding patterns. We show that both PDGF-AA/FGF-2 and PDGF-AB/FGF-2 in combinations synergistically induce angiogenesis in the mouse cornea. FGF-2 upregulates PDGFR-alpha and -beta expression levels in the newly formed blood vessels. Interestingly, PDGF-AB/FGF-2, but not PDGF-AA/ FGF-2, is able to stabilize the newly formed vasculature by recruiting pericytes, and an anti-PDGFR-beta neutralizing antibody significantly blocks PDGF-AB/FGF-2-induced vessel stability. These findings demonstrate that PDGFR-beta receptor is essential for vascular stability. Similarly, PDGF-AB/FGF-2 significantly induces stable collateral growth in the rat ischemic hind limb. The high number of collaterals induced by PDGF-AB/FGF-2 leads to dramatic improvement of the paw's skin perfusion. Immunohistochemical analysis of the treated skeletal muscles confirms that a combination of PDGF-AB and FGF-2 significantly induces arteriogenesis in the ischemic tissue. A combination of PDGF-AB and FGF-2 would be optimal proangiogenic agents for the treatment of ischemic diseases.-Zhang, J., Cao, R., Zhang, Y., Jia, T., Cao, Y., Wahlberg, E. Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. FASEB J. 23, 153-163 (2009)	[Cao, Renhai; Cao, Yihai] Karolinska Inst, Lab Angiogenesis Res, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Zhang, Junhang; Wahlberg, Eric] Karolinska Inst, Div Vasc Surg, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Zhang, Yun] Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Jia, Tanghong] Shandong Univ, Clin Med Coll, Jinan 250100, Shandong, Peoples R China; [Zhang, Junhang] China Med Univ, Dept Dev Biol, Liaoning Canc Hosp & Inst, Shenyang, Peoples R China	Karolinska Institutet; Karolinska Institutet; Shandong University; Shandong University; China Medical University	Cao, YH (corresponding author), Karolinska Inst, Lab Angiogenesis Res Microbiol Tumor & Cell Biol, Nobels Vag 16, SE-17177 Stockholm, Sweden.	yihai.cao@ki.se; eric.wahlberg@ki.se			China State Scholarship (Beijing, China); National Basic Research Program of China [2006CB503803]; National Natural Science Foundation of China [30428005]; Swedish Heart and Lung Foundation (Stockholm, Sweden); EU [STRP 013811]; Angiotargeting [504743]; Soderberg Foundation (Stockholm, Sweden); Swedish Medical Research Council (Stockholm, Sweden)	China State Scholarship (Beijing, China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish Heart and Lung Foundation (Stockholm, Sweden)(Swedish Heart-Lung Foundation); EU(European Commission); Angiotargeting; Soderberg Foundation (Stockholm, Sweden); Swedish Medical Research Council (Stockholm, Sweden)(Swedish Medical Research Council (SMRC))	We thank Dr. Ebba Brakenhielm for performing the in situ hybridization studies. This study was supported by grants from China State Scholarship (Beijing, China), the National Basic Research Program of China (2006CB503803), the National Natural Science Foundation of China (30428005), the Swedish Heart and Lung Foundation (Stockholm, Sweden), the EU integrated project of VascuPlug (contract STRP 013811) and Angiotargeting (contract 504743), the Soderberg Foundation (Stockholm, Sweden), and the Swedish Medical Research Council (Stockholm, Sweden).	ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; Arbiser JL, 2007, J CLIN INVEST, V117, P2762, DOI 10.1172/JCI33190; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; Carmeliet P, 2000, CIRC RES, V87, P176, DOI 10.1161/01.RES.87.3.176; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Crosby JR, 1998, NAT GENET, V18, P385, DOI 10.1038/ng0498-385; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; KITAMI Y, 1995, J CLIN INVEST, V96, P558, DOI 10.1172/JCI118068; KUMAR S, 1983, LANCET, V2, P364; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226; Stone EM, 2006, NEW ENGL J MED, V355, P1493, DOI 10.1056/NEJMe068191; Toyota E, 2005, CIRCULATION, V112, P2108, DOI 10.1161/CIRCULATIONAHA.104.526954; Vale PR, 2000, CIRCULATION, V102, P965, DOI 10.1161/01.CIR.102.9.965; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	21	119	122	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					153	163		10.1096/fj.08-113860	http://dx.doi.org/10.1096/fj.08-113860			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18827023				2022-12-25	WOS:000262095500018
J	Leboeuf, AC; Levy, SF; Gaylord, M; Bhattacharya, A; Singh, AK; Jordan, MA; Wilson, L; Feinstein, SC				Leboeuf, Adria C.; Levy, Sasha F.; Gaylord, Michelle; Bhattacharya, Arnab; Singh, Ambuj K.; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.			FTDP-17 Mutations in Tau Alter the Regulation of Microtubule Dynamics AN "ALTERNATIVE CORE" MODEL FOR NORMAL AND PATHOLOGICAL TAU ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY-PROMOTING FACTORS; NEURITE OUTGROWTH; PROTEIN-TAU; NEURODEGENERATIVE DISORDERS; NEUROFIBRILLARY PATHOLOGY; INDIVIDUAL MICROTUBULES; KINETIC STABILIZATION; ALZHEIMERS-DISEASE; MISSENSE MUTATIONS; DEMENTIA FTDP-17	Mutations affecting either the structure or regulation of the microtubule-associated protein Tau cause neuronal cell death and dementia. However, the molecular mechanisms mediating these deleterious effects remain unclear. Among the most characterized activities of Tau is the ability to regulate microtubule dynamics, known to be essential for proper cell function and viability. Here we have tested the hypothesis that Tau mutations causing neurodegeneration also alter the ability of Tau to regulate the dynamic instability behaviors of microtubules. Using in vitro microtubule dynamics assays to assess average microtubule growth rates, microtubule growth rate distributions, and catastrophe frequencies, we found that all tested mutants possessing amino acid substitutions or deletions mapping to either the repeat or interrepeat regions of Tau do indeed compromise its ability to regulate microtubule dynamics. Further mutational analyses suggest a novel mechanism of Tau regulatory action based on an "alternative core" of microtubule binding and regulatory activities composed of two repeats and the interrepeat between them. In this model, the interrepeat serves as the primary regulator of microtubule dynamics, whereas the flanking repeats serve as tethers to properly position the interrepeat on the microtubule. Importantly, since there are multiple interrepeats on each Tau molecule, there are also multiple cores on each Tau molecule, each with distinct mechanistic capabilities, thereby providing significant regulatory potential. Taken together, the data are consistent with a microtubule misregulation mechanism for Tau-mediated neuronal cell death and provide a novel mechanistic model for normal and pathological Tau action.	[Leboeuf, Adria C.; Levy, Sasha F.; Gaylord, Michelle; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Leboeuf, Adria C.; Levy, Sasha F.; Gaylord, Michelle; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Dept Mol & Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Bhattacharya, Arnab; Singh, Ambuj K.] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Leboeuf, Adria C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Leboeuf, Adria C.] Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; [Levy, Sasha F.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Bhattacharya, Arnab] Indian Inst Technol, Dept Comp Sci & Engn, Kanpur 208016, Uttar Pradesh, India	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; New York University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Feinstein, SC (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	feinstei@lifesci.ucsb.edu	LeBoeuf, Adria C/F-1837-2017	LeBoeuf, Adria C/0000-0002-2931-1510; Bhattacharya, Arnab/0000-0001-7331-0788; Levy, Sasha/0000-0002-0923-1636	National Institutes of Health [NS-35010, NS-13560, CA-57291]; National Science Foundation [ITR-0331697]; IIT Kanpur; NATIONAL CANCER INSTITUTE [R01CA057291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013560, R01NS035010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); IIT Kanpur; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-35010 (to S. C. F.), NS-13560 (to L. W.), and CA-57291 (to M. A. J.). This work was also supported by a National Science Foundation predoctoral fellowship (to S. F. L.), an initiation grant from IIT Kanpur (to A. B.), and National Science Foundation Grant ITR-0331697 (to A. K. S., S. C. F., and L. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Arrasate M, 1999, FEBS LETT, V446, P199, DOI 10.1016/S0014-5793(99)00210-0; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Bhattacharya A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-339; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Delobel P, 2002, J BIOL CHEM, V277, P9199, DOI 10.1074/jbc.M107716200; DeTure M, 2000, BRAIN RES, V853, P5, DOI 10.1016/S0006-8993(99)02124-1; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Duff K, 2005, NAT MED, V11, P826, DOI 10.1038/nm0805-826; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; FELLOUS A, 1977, EUR J BIOCHEM, V78, P167, DOI 10.1111/j.1432-1033.1977.tb11726.x; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P15009, DOI 10.1021/bi035722s; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan Mary Ann, 2008, P47, DOI 10.1007/978-1-59745-336-3_3; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; LEVY SF, 2005, J BIOL CHEM; Liu CWA, 1999, CELL MOTIL CYTOSKEL, V43, P232, DOI 10.1002/(SICI)1097-0169(1999)43:3<232::AID-CM6>3.0.CO;2-7; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Rizzini C, 2000, J NEUROPATH EXP NEUR, V59, P990, DOI 10.1093/jnen/59.11.990; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WERMAN M, 1985, COMPUT VISION GRAPH, V32, P328, DOI 10.1016/0734-189X(85)90055-6; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yen SH, 1999, BRAIN PATHOL, V9, P695; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	65	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36406	36415		10.1074/jbc.M803519200	http://dx.doi.org/10.1074/jbc.M803519200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940799	Green Published, hybrid			2022-12-25	WOS:000261840500038
J	Shawgo, ME; Shelton, SN; Robertson, JD				Shawgo, Mary E.; Shelton, Shary N.; Robertson, John D.			Caspase-mediated Bak Activation and Cytochrome c Release during Intrinsic Apoptotic Cell Death in Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBERS; SERINE-PROTEASE; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL EVENTS; CLEAVAGE; PROTEINS; REQUIREMENT; XIAP; MECHANISMS; APOPTOSOME	Mitochondrial outer membrane permeabilization and the release of intermembrane space proteins, such as cytochrome c, are early events during intrinsic (mitochondria-mediated) apoptotic signaling. Although this process is generally accepted to require the activation of Bak or Bax, the underlying mechanism responsible for their activation during true intrinsic apoptosis is not well understood. In the current study, we investigated the molecular requirements necessary for Bak activation using distinct clones of Bax-deficient Jurkat T-lymphocytes in which the intrinsic pathway had been inhibited. Cells stably overexpressing Bcl-2/Bcl-xL or stably depleted of Apaf-1 were equally resistant to apoptosis induced by the DNA-damaging anticancer drug etoposide as determined by phosphatidylserine externalization and caspase activation. Strikingly, characterization of mitochondrial apoptotic events in all three drug-resistant cell lines revealed that, without exception, resistance to apoptosis was associated with an absence of Bak activation, cytochrome c release, and mitochondrial membrane depolarization. Furthermore, we found that etoposide-induced apoptosis and mitochondrial events were inhibited in cells stably overexpressing either full-length X-linked inhibitor of apoptosis protein (XIAP) or the BIR1/BIR2 domains of XIAP. Combined, our findings suggest that caspase-mediated positive amplification of initial mitochondrial changes can determine the threshold for irreversible activation of the intrinsic apoptotic pathway.	[Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Robertson, JD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jrobertson3@kumc.edu			National Institutes of Health [K22 ES011647]; IDeA Networks of Biomedical Research Excellence Program of the NCRR [P20 RR016475]; National Center for Research Resources [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDeA Networks of Biomedical Research Excellence Program of the NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 ES011647 ( to J. D. R.) and P20 RR016475 from the IDeA Networks of Biomedical Research Excellence Program of the NCRR. The Flow Cytometry Core is supported in part by National Institutes of Health Grant P20 RR016443 from the National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Berger AB, 2006, CELL RES, V16, P961, DOI 10.1038/sj.cr.7310112; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Petak I, 2000, CANCER RES, V60, P2643; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	49	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35532	35538		10.1074/jbc.M807656200	http://dx.doi.org/10.1074/jbc.M807656200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18927073	hybrid, Green Published			2022-12-25	WOS:000261687900025
J	Brandt, S; von Stetten, D; Gunther, M; Hildebrandt, P; Frankenberg-Dinkel, N				Brandt, Sonja; von Stetten, David; Guenther, Mina; Hildebrandt, Peter; Frankenberg-Dinkel, Nicole			The Fungal Phytochrome FphA from Aspergillus nidulans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGROBACTERIUM-TUMEFACIENS; HISTIDINE KINASES; LIGHT; CHROMOPHORE; BACTERIOPHYTOCHROMES; REVEALS; TRANSCRIPTION; NEUROSPORA; ATTACHMENT; SENSORS	The red light-sensing photoreceptor FphA from Aspergillus nidulans is involved in the regulation of developmental processes in response to light. Here we present extended biochemical and spectroscopic characterization of recombinant FphA using a synthetic gene with host-adapted codon usage. The recombinant photosensory domain FphAN753 was shown to display all features of a bona fide phytochrome. It covalently binds biliverdin as chromophore and undergoes red/far-red light-inducible photoconversion with both parent states being protonated. The large N-terminal variable extension of FphA exerts a stabilizing effect on the active Pfr state. Upon substitution of the highly conserved histidine 504, involved in the hydrogen-bonding network of the protein moiety and the chromophore, chromophore attachment and photoreversibility were completely impaired. FphA is a functional sensor histidine kinase with a strong red-light-dependent autophosphorylation activity. Furthermore, intermolecular trans-phosphorylation to the response regulator domain of a second monomer could be demonstrated. Interestingly, co-incubation of FphA and FphA variants led to enhanced autophosphorylation, including the "inactive" Pr form. The latter observed phenomenon might suggest that auto- and trans-phosphorylation activity is modulated by additional interaction partners leading to variable phosphorylation events that trigger a specific output response.	[Brandt, Sonja; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, D-44780 Bochum, Germany; [von Stetten, David; Guenther, Mina; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, Sekretariat PC14, D-10623 Berlin, Germany	Ruhr University Bochum; Technical University of Berlin	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44780 Bochum, Germany.	nicole.frankenberg@rub.de	Hildebrandt, Peter/J-5658-2014; Frankenberg-Dinkel, Nicole/C-1058-2011	Hildebrandt, Peter/0000-0003-1030-5900; Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; von Stetten, David/0000-0001-7906-9788	Volkswagen Foundation; Deutsche Forschungsgemeinschaft [SFB 498]	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Volkswagen Foundation (to N.F.D.) and funds from the Deutsche Forschungsgemeinschaft (Grant SFB 498 to P. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Azuma N, 2007, BIOSCI BIOTECH BIOCH, V71, P2493, DOI 10.1271/bbb.70292; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Bhoo SH, 1997, J AM CHEM SOC, V119, P11717, DOI 10.1021/ja972875s; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; CHERRY JR, 1992, P NATL ACAD SCI USA, V89, P5039, DOI 10.1073/pnas.89.11.5039; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Eichenberg K, 2000, FEBS LETT, V470, P107, DOI 10.1016/S0014-5793(00)01301-6; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Hubschmann T, 2001, EUR J BIOCHEM, V268, P2055, DOI 10.1046/j.1432-1327.2001.02083.x; Jorissen HJMM, 2002, EUR J BIOCHEM, V269, P2662, DOI 10.1046/j.1432-1033.2002.02928.x; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kim D, 2006, BIOCHEMISTRY-US, V45, P14772, DOI 10.1021/bi061429r; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; Lamparter T, 2005, BIOCHEMISTRY-US, V44, P8461, DOI 10.1021/bi047510g; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; LI LM, 1992, J BIOL CHEM, V267, P19204; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; MOONEY JL, 1990, GENE DEV, V4, P1473, DOI 10.1101/gad.4.9.1473; Pao GM, 1997, J MOL EVOL, V44, P605, DOI 10.1007/PL00006183; Pendrak ML, 2004, J BIOL CHEM, V279, P3426, DOI 10.1074/jbc.M311550200; PURSCHWITZ J, 2008, MOL GEN GEN IN PRESS; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Purschwitz J, 2006, CURR OPIN MICROBIOL, V9, P566, DOI 10.1016/j.mib.2006.10.011; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; VIERSTRA RD, 1982, P NATL ACAD SCI-BIOL, V79, P5272, DOI 10.1073/pnas.79.17.5272; Von Stetten D., 2008, THESIS TU BERLIN; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	42	63	66	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34605	34614		10.1074/jbc.M805506200	http://dx.doi.org/10.1074/jbc.M805506200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18931394	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000261469100015
J	Rickert, KW; Kelley, P; Byrne, NJ; Diehl, RE; Hall, DL; Montalvo, AM; Reid, JC; Shipman, JM; Thomas, BW; Munshi, SK; Darke, PL; Su, HP				Rickert, Keith W.; Kelley, Paul; Byrne, Noel J.; Diehl, Ronald E.; Hall, Dawn L.; Montalvo, Allison M.; Reid, John C.; Shipman, Jennifer M.; Thomas, Bradley W.; Munshi, Sanjeev K.; Darke, Paul L.; Su, Hua-Poo			Structure of Human Prostasin, a Target for the Regulation of Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNELS; CRYSTAL-STRUCTURE; NA+ CHANNELS; ACTIVATION; EXPRESSION; THROMBIN; PROTEIN; CRYSTALLIZATION; LOCALIZATION; SUBSTRATE	Prostasin (also called channel activating protease-1 (CAP1)) is an extracellular serine protease implicated in the modulation of fluid and electrolyte regulation via proteolysis of the epithelial sodium channel. Several disease states, particularly hypertension, can be affected by modulation of epithelial sodium channel activity. Thus, understanding the biochemical function of prostasin and developing specific agents to inhibit its activity could have a significant impact on a widespread disease. We report the expression of the prostasin proenzyme in Escherichia coli as insoluble inclusion bodies, refolding and activating via proteolytic removal of the N-terminal propeptide. The refolded and activated enzyme was shown to be pure and monomeric, with kinetic characteristics very similar to prostasin expressed from eukaryotic systems. Active prostasin was crystallized, and the structure was determined to 1.45 angstrom resolution. These apoprotein crystals were soaked with nafamostat, allowing the structure of the inhibited acyl-enzyme intermediate structure to be determined to 2.0 angstrom resolution. Comparison of the inhibited and apoprotein forms of prostasin suggest a mechanism of regulation through stabilization of a loop which interferes with substrate recognition.	[Rickert, Keith W.; Kelley, Paul; Byrne, Noel J.; Diehl, Ronald E.; Hall, Dawn L.; Montalvo, Allison M.; Reid, John C.; Shipman, Jennifer M.; Thomas, Bradley W.; Munshi, Sanjeev K.; Darke, Paul L.; Su, Hua-Poo] Merck Res Labs, Dept Global Struct Biol, West Point, PA 19486 USA	Merck & Company	Rickert, KW (corresponding author), WP26-354,POB 4, West Point, PA 19486 USA.	keith_rickert@merck.com; hua-poo_su@merck.com		Su, Hua-Poo/0000-0003-3808-7837				Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; ALOBEIDI AM, 1988, J BIOL CHEM, V263, P8642; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7; CORRAN PH, 1989, HPLC MACROMOLECULES, P127; Czapinska H, 2004, J MOL BIOL, V344, P1005, DOI 10.1016/j.jmb.2004.09.088; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHLHAMMER H, 1975, J MOL BIOL, V98, P683, DOI 10.1016/S0022-2836(75)80004-0; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Greig ER, 2004, J PATHOL, V204, P84, DOI 10.1002/path.1613; HEARN MTW, 2002, HPLC BIOL MACROMOLEC, P99; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Hink-Schauer C, 2002, J BIOL CHEM, V277, P50923, DOI 10.1074/jbc.M207962200; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEYER E, 1988, ACTA CRYSTALLOGR B, V44, P26, DOI 10.1107/S0108768187007559; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Ramjee MK, 2000, THROMB RES, V98, P559, DOI 10.1016/S0049-3848(00)00206-1; Rohr KB, 2006, J MOL BIOL, V357, P195, DOI 10.1016/j.jmb.2005.12.037; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Tong ZY, 2004, AM J PHYSIOL-LUNG C, V287, pL928, DOI 10.1152/ajplung.00160.2004; TSUKADA H, 1985, J MOL BIOL, V184, P703, DOI 10.1016/0022-2836(85)90314-6; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Williams SP, 2005, CURR OPIN CHEM BIOL, V9, P371, DOI 10.1016/j.cbpa.2005.06.007; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; YU JX, 1994, J BIOL CHEM, V269, P18843	47	26	26	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34864	34872		10.1074/jbc.M805262200	http://dx.doi.org/10.1074/jbc.M805262200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922802	Green Published, hybrid			2022-12-25	WOS:000261469100042
J	Lin, G; Tsu, C; Dick, L; Zhou, XK; Nathan, C				Lin, Gang; Tsu, Christopher; Dick, Lawrence; Zhou, Xi K.; Nathan, Carl			Distinct Specificities of Mycobacterium tuberculosis and Mammalian Proteasomes for N-Acetyl Tripeptide Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; MICROBIAL PERSISTENCE; TUBERCLE BACILLI; INHIBITORS; RESISTANCE; LIBRARIES; ACTIVATOR; POTENT; ACIDS; PA28	The proteasome of Mycobacterium tuberculosis (Mtb) is a validated and drug-treatable target for therapeutics. To lay groundwork for developing peptide-based inhibitors with a useful degree of selectivity for the Mtb proteasome over those of the host, we used a library of 5,920 N-acetyl tripeptide-aminomethylcoumarins to contrast the substrate preferences of the recombinant Mtb proteasome wild type and open gate mutant, the Rhodococcus erythropolis proteasome, and the bovine proteasome with activator PA28. The Mtb proteasome was distinctive in strictly preferring P1 = tryptophan, particularly in combination with P3 = glycine, proline, lysine or arginine. Screening results were validated with Michalis-Menten kinetic analyses of 21 oligopeptide aminomethyl-coumarin substrates. Bortezomib, a proteasome inhibitor in clinical use, and 17 analogs varying only at P1 were used to examine the differential impact of inhibitors on human and Mtb proteasomes. The results with the inhibitor panel confirmed those with the substrate panel in demonstrating differential preferences of Mtb and mammalian proteasomes at the P1 amino acid. Changing P1 in bortezomib from Leu to m-CF3-Phe led to a 220-fold increase in IC50 against the human proteasome, whereas changing a P1 Ala to m-FPhe decreased the IC50 400-fold against the Mtb proteasome. The change of a P1 Ala tom-Cl-Phe led to an 8000-fold shift in inhibitory potency in favor of the Mtb proteasome, resulting in 8-fold selectivity. Combinations of preferred amino acids at different sites may thus improve the species selectivity of peptide-based inhibitors that target the Mtb proteasome.	[Lin, Gang; Nathan, Carl] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Tsu, Christopher; Dick, Lawrence] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; [Zhou, Xi K.] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10065 USA	Cornell University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Cornell University	Lin, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	gal2005@med.cornell.edu; cnathan@med.cornell.edu	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405	National Institutes of Health [PO1-AI06293]; Milstein Program in Chemical Biology of Infectious Diseases; National Institutes of Health Clinical and Translational Science Award [UL1-RR024996]; William Randolph Hearst Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milstein Program in Chemical Biology of Infectious Diseases; National Institutes of Health Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Randolph Hearst Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1-AI06293. This work was also supported by the Milstein Program in Chemical Biology of Infectious Diseases, in part by National Institutes of Health Clinical and Translational Science Award UL1-RR024996. The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Goldberg AL, 1995, COLD SPRING HARB SYM, V60, P479, DOI 10.1101/SQB.1995.060.01.052; Groll M, 2002, CHEM BIOL, V9, P655, DOI 10.1016/S1074-5521(02)00144-8; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Harris JL, 2001, CHEM BIOL, V8, P1131, DOI 10.1016/S1074-5521(01)00080-1; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Kropff M, 2007, BRIT J HAEMATOL, V138, P330, DOI 10.1111/j.1365-2141.2007.06656.x; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; McCUNE ROBERT M., 1966, J EXP MED, V123, P469, DOI 10.1084/jem.123.3.469; MCGUIRE MJ, 1989, BIOCHEM BIOPH RES CO, V160, P911, DOI 10.1016/0006-291X(89)92521-7; Nazif T, 2001, P NATL ACAD SCI USA, V98, P2967, DOI 10.1073/pnas.061028898; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Sheppeck JE, 2000, BIOORG MED CHEM LETT, V10, P2639, DOI 10.1016/S0960-894X(00)00545-X; Song XL, 1996, J BIOL CHEM, V271, P26410, DOI 10.1074/jbc.271.42.26410; Song XL, 1997, J BIOL CHEM, V272, P27994, DOI 10.1074/jbc.272.44.27994; Spigelman MK, 2007, J INFECT DIS, V196, pS28, DOI 10.1086/518663; Stein RL, 1996, BIOCHEMISTRY-US, V35, P3899, DOI 10.1021/bi952262x; Wang CC, 2003, J BIOL CHEM, V278, P15800, DOI 10.1074/jbc.M300195200; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05	31	41	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34423	34431		10.1074/jbc.M805324200	http://dx.doi.org/10.1074/jbc.M805324200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18829465	hybrid, Green Published			2022-12-25	WOS:000261277700070
J	Bennett, RP; Salter, JD; Liu, X; Wedekind, JE; Smith, HC				Bennett, Ryan P.; Salter, Jason D.; Liu, Xiang; Wedekind, Joseph E.; Smith, Harold C.			APOBEC3G Subunits Self-associate via the C-terminal Deaminase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 VIF; B MESSENGER-RNA; ACTIVATION-INDUCED DEAMINASE; RETRACTED ARTICLE. SEE; CYTIDINE DEAMINASE; CRYSTAL-STRUCTURE; HIV-1 INFECTION; VIRAL-RNA; IDENTIFICATION; MODEL	Human APOBEC3G (hA3G) is a cytidine deaminase active on HIV single-stranded DNA. Small angle x-ray scattering and molecular envelope restorations predicted a C-terminal dimeric model for RNA-depleted hA3G in solution. Each subunit was elongated, suggesting that individual domains of hA3G are solvent-exposed and therefore may interact with other macromolecules even as isolated substructures. In this study, co-immunoprecipitation and in-cell quenched fluorescence resonance energy transfer assays reveal that hA3G forms RNA-independent oligomers through interactions within its C terminus. Residues 209-336 were necessary and sufficient for homoligomerization. N-terminal domains of hA3G were unable to multimerize but remained functional for Gag and viral infectivity factor (Vif) interactions when expressed apart from the C terminus. These findings corroborate the small angle x-ray scattering structural model and are instructive for development of high throughput screens that target specific domains and their functions to identify HIV/AIDS therapeutics.	[Bennett, Ryan P.; Salter, Jason D.; Wedekind, Joseph E.; Smith, Harold C.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Liu, Xiang] Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Wedekind, JE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	joseph.wedekind@rochester.edu; harold.smith@rochester.edu		Smith, Harold/0000-0001-6257-6791	National Institutes of Health [AI058789, AI076085, T32 AI49815]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076085, R33AI076085, T32AI049815, R21AI058789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health from the NIAID Grants AI058789 (to H. C. S.) and AI076085 (to J. E. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health HIV Training Grant T32 AI49815 to S. Dewhurst.; We thank Dr. Jay Reeder for use of a fluorescence microscope and for helpful discussions on quantification of data and software manipulations and Dr. Baek Kim for providing the HIV viral DNA constructs. The following reagents were obtained from the National Institutes of Health AIDS Research and Reference Reagent Program, Division of AIDS, NIAID: HIV-1 p24 monoclonal antibody (183-H12-5C) from Dr. B. Chesebro and K. Wehrly and HIV-1 Vif monoclonal antibody (antibody number 319) from Dr. M. H. Malim.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Brar SS, 2008, DNA REPAIR, V7, P77, DOI 10.1016/j.dnarep.2007.08.002; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kuratani M, 2005, J BIOL CHEM, V280, P16002, DOI 10.1074/jbc.M414541200; LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; MACELREVEY C, 2008, RNA DNA EDITING MOL, P369; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Oka K, 1997, J BIOL CHEM, V272, P1456, DOI 10.1074/jbc.272.39.24387; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith HC, 2007, METHOD ENZYMOL, V424, P389, DOI 10.1016/S0076-6879(07)24018-2; Smith HC, 1998, METHODS, V15, P27, DOI 10.1006/meth.1998.0603; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wang JS, 2006, J BIOL CHEM, V281, P19115, DOI 10.1074/jbc.M601645200; Wang XJ, 2007, J BIOL CHEM, V282, P1585, DOI 10.1074/jbc.M610150200; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378	65	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33329	33336		10.1074/jbc.M803726200	http://dx.doi.org/10.1074/jbc.M803726200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18842592	hybrid, Green Published			2022-12-25	WOS:000261183700037
J	Eisenhauer, N; Milcu, A; Sabais, ACW; Scheu, S				Eisenhauer, Nico; Milcu, Alexandru; Sabais, Alexander C. W.; Scheu, Stefan			Animal Ecosystem Engineers Modulate the Diversity-Invasibility Relationship	PLOS ONE			English	Article							PLANT DIVERSITY; SEED BANKS; EARTHWORMS; DYNAMICS; GROWTH; SOIL	Background: Invasions of natural communities by non-indigenous species are currently rated as one of the most important global-scale threats to biodiversity. Biodiversity itself is known to reduce invasions and increase stability. Disturbances by ecosystem engineers affect the distribution, establishment, and abundance of species but this has been ignored in studies on diversity-invasibility relationships. Methodology/Principal Findings: We determined natural plant invasion into 46 plots varying in the number of plant species (1, 4, and 16) and plant functional groups (1, 2, 3, and 4) for three years beginning two years after the establishment of the Jena Experiment. We sampled subplots where earthworms were artificially added and others where earthworm abundance was reduced. We also performed a seed-dummy experiment to investigate the role of earthworms as secondary seed dispersers along a plant diversity gradient. Horizontal dispersal and burial of seed dummies were significantly reduced in subplots where earthworms were reduced in abundance. Seed dispersal by earthworms decreased with increasing plant species richness and presence of grasses but increased in presence of small herbs. These results suggest that dense vegetation inhibits the surface activity of earthworms. Further, there was a positive relationship between the number of earthworms and the number and diversity of invasive plants. Hence, earthworms decreased the stability of grassland communities against plant invasion. Conclusions/Significance: Invasibility decreased and stability increased with increasing plant diversity and, most remarkably, earthworms modulated the diversity-invasibility relationship. While the impacts of earthworms were unimportant in low diverse (low earthworm densities) and high diverse (high floral structural complexity) plant communities, earthworms decreased the stability of intermediate diverse plant communities against plant invasion. Overall, the results document that fundamental processes in plant communities like plant seed burial and invader establishment are modulated by soil fauna calling for closer cooperation between soil animal and plant ecologists.	[Eisenhauer, Nico; Sabais, Alexander C. W.; Scheu, Stefan] Tech Univ Darmstadt, Inst Zool, Darmstadt, Germany; [Milcu, Alexandru] Imperial Coll London, Div Biol, NERC Ctr Populat Biol, Silwood Pk Campus, Ascot, Berks, England	Technical University of Darmstadt; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Eisenhauer, N (corresponding author), Tech Univ Darmstadt, Inst Zool, Darmstadt, Germany.	eisenhauer@bio.tu-darmstadt.de	Scheu, Stefan/H-7049-2015; Eisenhauer, Nico/I-5932-2012; Eisenhauer, Nico/I-3191-2019; Milcu, Alexandru/X-6267-2018	Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; Milcu, Alexandru/0000-0002-2889-1234	German Science Foundation [FOR 456]	German Science Foundation(German Research Foundation (DFG))	The present study was funded by the German Science Foundation (FOR 456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2001, J ARID ENVIRON, V49, P343, DOI 10.1006/jare.2000.0781; Ayanlaja SA, 2001, HORTSCIENCE, V36, P143, DOI 10.21273/HORTSCI.36.1.143; Burnham K. P., 1998, MODEL SELECTION INTE; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Crawley MJ, 1992, SEEDS ECOLOGY REGENE, P157; Decaens T, 2003, ACTA OECOL, V24, P175, DOI 10.1016/S1146-609X(03)00083-3; DECAENS T, 2001, NATURES PLOW SOIL MA, P174; Dukes JS, 2002, ECOL APPL, V12, P602, DOI 10.1890/1051-0761(2002)012[0602:SCADAG]2.0.CO;2; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO, V3rd; EISENHAUER N, 2008, INVASIBILITY EXPT GR, P1026; Eisenhauer N, 2008, APPL SOIL ECOL, V38, P79, DOI 10.1016/j.apsoil.2007.07.002; Eisenhauer N, 2009, PEDOBIOLOGIA, V52, P151, DOI 10.1016/j.pedobi.2008.07.002; ELASHOFF JD, 1986, 83 BMDP; Elton C., 1958; FAO UNESCO, 1997, SOIL MAP WORLD; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; FOX JF, 1979, SCIENCE, V204, P1344, DOI 10.1126/science.204.4399.1344; Grant J.D., 1983, P107; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; King TJ, 2007, PLANT ECOL, V193, P233, DOI 10.1007/s11258-006-9261-x; KLUGE G, 2000, KLIMA AUSGEWAHLTER O; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; MCRILL M, 1973, NATURE, V244, P482, DOI 10.1038/243482a0; Meyer AH, 1999, J ECOL, V87, P17, DOI 10.1046/j.1365-2745.1999.00315.x; Milcu A, 2006, FUNCT ECOL, V20, P261, DOI 10.1111/j.1365-2435.2006.01098.x; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Scheiner SM, 2001, DESIGN ANAL ECOLOGIC; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Schulze E, 1994, BIODIVERSITY ECOSYST; Shumway DL, 1994, APPL SOIL ECOL, V1, P11, DOI 10.1016/0929-1393(94)90019-1; THIELEMANN U, 1986, PEDOBIOLOGIA, V29, P296; Thompson K, 2001, SEED SCI RES, V11, P345; Thompson K, 1992, SEEDS ECOLOGY REGENE, P231; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Vitousek PM, 1996, AM SCI, V84, P468; WILLEMS JH, 1994, ECOGRAPHY, V17, P124, DOI 10.1111/j.1600-0587.1994.tb00084.x; Wright JP, 2004, OIKOS, V105, P336, DOI 10.1111/j.0030-1299.2004.12654.x; Zaller JG, 1999, SOIL BIOL BIOCHEM, V31, P517, DOI 10.1016/S0038-0717(98)00126-6; Zaller JG, 2007, EUR J SOIL BIOL, V43, pS86, DOI 10.1016/j.ejsobi.2007.08.010	47	39	40	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3489	10.1371/journal.pone.0003489	http://dx.doi.org/10.1371/journal.pone.0003489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941521	Green Published, gold, Green Submitted			2022-12-25	WOS:000265126100020
J	Wang, S; Raven, JF; Durbin, JE; Koromilas, AE				Wang, Shuo; Raven, Jennifer F.; Durbin, Joan E.; Koromilas, Antonis E.			Stat1 Phosphorylation Determines Ras Oncogenicity by Regulating p27(Kip1)	PLOS ONE			English	Article								Inactivation of p27(Kip1) is implicated in tumorigenesis and has both prognostic and treatment-predictive values for many types of human cancer. The transcription factor Stat1 is essential for innate immunity and tumor immunosurveillance through its ability to act downstream of interferons. Herein, we demonstrate that Stat1 functions as a suppressor of Ras transformation independently of an interferon response. Inhibition of Ras transformation and tumorigenesis requires the phosphorylation of Stat1 at tyrosine 701 but is independent of Stat1 phosphorylation at serine 727. Stat1 induces p27(Kip1) expression in Ras transformed cells at the transcriptional level through mechanisms that depend on Stat1 phosphorylation at tyrosine 701 and activation of Stat3. The tumor suppressor properties of Stat1 in Ras transformation are reversed by the inactivation of p27(Kip1). Our work reveals a novel functional link between Stat1 and p27(Kip1), which act in coordination to suppress the oncogenic properties of activated Ras. It also supports the notion that evaluation of Stat1 phosphorylation in human tumors may prove a reliable prognostic factor for patient outcome and a predictor of treatment response to anticancer therapies aimed at activating Stat1 and its downstream effectors.	[Wang, Shuo; Raven, Jennifer F.; Koromilas, Antonis E.] McGill Univ, Fac Med, Dept Oncol, Montreal, PQ, Canada; [Wang, Shuo; Raven, Jennifer F.; Koromilas, Antonis E.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Durbin, Joan E.] Columbus Childrens Res Inst, Columbus, OH USA; [Durbin, Joan E.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	McGill University; Lady Davis Institute; McGill University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wang, S (corresponding author), McGill Univ, Fac Med, Dept Oncol, Montreal, PQ, Canada.	antonis.koromilas@mcgill.ca			Canadian Breast Cancer Research Alliance (CBCRA); Canadian Institutes of Health Research (CIHR); U.S. Army Pre-doctoral Traineeship Award	Canadian Breast Cancer Research Alliance (CBCRA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); U.S. Army Pre-doctoral Traineeship Award	The work was funded with a grant from the Canadian Breast Cancer Research Alliance (CBCRA) awarded through the Canadian Institutes of Health Research (CIHR) to AEK. JFR is the recipient of a U.S. Army Pre-doctoral Traineeship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2000, MOL CELL BIOL, V20, P4580, DOI 10.1128/MCB.20.13.4580-4590.2000; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; de Koning JP, 2000, ONCOGENE, V19, P3290, DOI 10.1038/sj.onc.1203627; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dimberg A, 2003, BLOOD, V102, P254, DOI 10.1182/blood-2002-10-3149; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; Evdonin A. L., 1998, Molekulyarnaya Biologiya (Moscow), V32, P712; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fryknas M, 2007, INT J CANCER, V120, P189, DOI 10.1002/ijc.22291; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Horio Y, 1996, MOL CARCINOGEN, V17, P217, DOI 10.1002/(SICI)1098-2744(199612)17:4<217::AID-MC5>3.0.CO;2-A; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Jiang H, 2007, NUCLEIC ACIDS RES, V35, P4767, DOI 10.1093/nar/gkm512; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Kerkhoff E, 1998, ONCOGENE, V17, P1457, DOI 10.1038/sj.onc.1202185; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; Kortylewski M, 1999, ONCOGENE, V18, P3742, DOI 10.1038/sj.onc.1202708; Kovacic B, 2006, CANCER CELL, V10, P77, DOI 10.1016/j.ccr.2006.05.025; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kwon TK, 1996, GENE, V180, P113, DOI 10.1016/S0378-1119(96)00416-7; Laimer K, 2007, CANCER, V110, P326, DOI 10.1002/cncr.22813; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Liu Y, 1996, CANCER RES, V56, P31; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; Miskimins WK, 2001, MOL CELL BIOL, V21, P4960, DOI 10.1128/MCB.21.15.4960-4967.2001; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Paris M, 2006, MOL CELL BIOL, V26, P8826, DOI 10.1128/MCB.00575-06; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; Song JH, 2002, MOL CELLS, V13, P322; Terui K, 2004, BIOCHEM J, V380, P203, DOI 10.1042/BJ20031891; Thomas M, 2004, CANCER RES, V64, P8357, DOI 10.1158/0008-5472.CAN-04-1864; Timofeeva OA, 2006, ONCOGENE; Townsend PA, 2005, J CELL SCI, V118, P1629, DOI 10.1242/jcs.01728; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; Wei Q, 2003, MOL CELL BIOL, V23, P4035, DOI 10.1128/MCB.23.12.4035-4045.2003; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Widschwendter A, 2002, CLIN CANCER RES, V8, P3065; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Wong AHT, 2001, J BIOL CHEM, V276, P13727, DOI 10.1074/jbc.M011240200; Xie B, 2001, J BIOL CHEM, V276, P19512, DOI 10.1074/jbc.M009063200; Youlyouz-Marfak I, 2008, CELL DEATH DIFFER, V15, P376, DOI 10.1038/sj.cdd.4402270; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	71	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3476	10.1371/journal.pone.0003476	http://dx.doi.org/10.1371/journal.pone.0003476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941537	Green Published, Green Submitted, gold			2022-12-25	WOS:000265126100007
J	DaSilva, AF; Becerra, L; Pendse, G; Chizh, B; Tully, S; Borsook, D				DaSilva, Alexandre F.; Becerra, Lino; Pendse, Gautam; Chizh, Boris; Tully, Shannon; Borsook, David			Colocalized Structural and Functional Changes in the Cortex of Patients with Trigeminal Neuropathic Pain	PLOS ONE			English	Article								Background: Recent data suggests that in chronic pain there are changes in gray matter consistent with decreased brain volume, indicating that the disease process may produce morphological changes in the brains of those affected. However, no study has evaluated cortical thickness in relation to specific functional changes in evoked pain. In this study we sought to investigate structural (gray matter thickness) and functional (blood oxygenation dependent level - BOLD) changes in cortical regions of precisely matched patients with chronic trigeminal neuropathic pain (TNP) affecting the right maxillary (V2) division of the trigeminal nerve. The model has a number of advantages including the evaluation of specific changes that can be mapped to known somatotopic anatomy. Methodology/Principal Findings: Cortical regions were chosen based on sensory (Somatosensory cortex (SI and SII), motor (MI) and posterior insula), or emotional (DLPFC, Frontal, Anterior Insula, Cingulate) processing of pain. Both structural and functional (to brush-induced allodynia) scans were obtained and averaged from two different imaging sessions separated by 2-6 months in all patients. Age and gender-matched healthy controls were also scanned twice for cortical thickness measurement. Changes in cortical thickness of TNP patients were frequently colocalized and correlated with functional allodynic activations, and included both cortical thickening and thinning in sensorimotor regions, and predominantly thinning in emotional regions. Conclusions: Overall, such patterns of cortical thickness suggest a dynamic functionally-driven plasticity of the brain. These structural changes, which correlated with the pain duration, age-at-onset, pain intensity and cortical activity, may be specific targets for evaluating therapeutic interventions.	[DaSilva, Alexandre F.; Becerra, Lino; Pendse, Gautam; Tully, Shannon; Borsook, David] Harvard Univ, Med Sch, Mclean Hosp, Brain Imag Ctr, PAIN Grp, Boston, MA USA; [Becerra, Lino; Borsook, David] Harvard Univ, Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Chizh, Boris] GSK Addenbrooks Hosp, Cambridge, England	Harvard University; Harvard Medical School; McLean Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	DaSilva, AF (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	adasilva@umich.edu			NINDS [R01 NS042721, 1K24NS064050]; GSK; NIDCR [K12-DE014528]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K12DE014528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050, R01NS042721] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); GSK(GlaxoSmithKline); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was primarily supported by NINDS R01 NS042721 and 1K24NS064050 (DB), as well as in part from an investigator initiated grant from GSK (DB). Additional support was provided by NIDCR K12-DE014528 (AFMD).	Anderson BJ, 2002, LEARN MEMORY, V9, P1, DOI 10.1101/lm.43402; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Becerra L, 2006, J NEUROSCI, V26, P10646, DOI 10.1523/JNEUROSCI.2305-06.2006; Brooks JCW, 2007, PAIN, V128, P1, DOI 10.1016/j.pain.2006.12.025; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Caclin A, 2006, EUR J NEUROSCI, V23, P2531, DOI 10.1111/j.1460-9568.2006.04773.x; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; Cesa R, 2007, J NEUROSCI, V27, P4603, DOI 10.1523/JNEUROSCI.5617-06.2007; Clarey JC, 1996, CEREB CORTEX, V6, P196, DOI 10.1093/cercor/6.2.196; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DASILVA AF, 2007, THICKENING SOMATOSEN; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Derbyshire SWG, 1999, EUR J PAIN, V3, P103, DOI 10.1053/eujp.1998.0102; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Farina S, 2001, NEUROSCI LETT, V314, P97, DOI 10.1016/S0304-3940(01)02297-2; FELDMAN ML, 1975, ANAT EMBRYOL, V148, P279, DOI 10.1007/BF00319848; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fitzgerald PB, 2006, PSYCHIAT RES-NEUROIM, V148, P33, DOI 10.1016/j.pscychresns.2006.04.006; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Fukuda M, 2008, BRAIN, V131, P1793, DOI 10.1093/brain/awn100; Goldstein RZ, 2007, NEUROSCIENCE, V144, P1153, DOI 10.1016/j.neuroscience.2006.11.024; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Grachev ID, 2003, J NEURAL TRANSM, V110, P287, DOI 10.1007/s00702-002-0781-9; Grachev ID, 2002, J NEURAL TRANSM, V109, P1309, DOI 10.1007/s00702-002-0722-7; Grachev ID, 2000, PAIN, V89, P7, DOI 10.1016/S0304-3959(00)00340-7; GUSTORFF B, 2007, ACTA ANAESTHESIOL SC; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hickmott PW, 2002, J NEUROPHYSIOL, V88, P1288, DOI 10.1152/jn.00994.2001; Hickmott PW, 2006, NEUROSCIENTIST, V12, P16, DOI 10.1177/1073858405282417; Hickmott PW, 2005, NAT NEUROSCI, V8, P140, DOI 10.1038/nn1384; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Hsieh JC, 1996, PAIN, V67, P59, DOI 10.1016/0304-3959(96)03066-7; Ito U, 2006, STROKE, V37, P2134, DOI 10.1161/01.STR.0000231875.96714.b1; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Kaas J, 2003, HUMAN NERVOUS SYSTEM, P1061; Kaas JH, 2000, PROG BRAIN RES, V128, P173; KNIGHT RT, 1995, ADV NEUROL, V66, P21; Kobayashi E, 2006, HUM BRAIN MAPP, V27, P488, DOI 10.1002/hbm.20193; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kwan CL, 2005, NEUROLOGY, V65, P1268, DOI 10.1212/01.wnl.0000180971.95473.cc; LaBuda CJ, 2005, NEUROSCIENCE, V136, P311, DOI 10.1016/j.neuroscience.2005.07.010; LaGraize SC, 2004, EXP NEUROL, V188, P139, DOI 10.1016/j.expneurol.2004.04.003; Li YF, 2007, NEUROSCI LETT, V418, P227, DOI 10.1016/j.neulet.2007.03.023; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Maihofner C, 2006, NEUROLOGY, V66, P711, DOI 10.1212/01.wnl.0000200961.49114.39; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Ostrowsky K, 2000, EPILEPSIA, V41, P681, DOI 10.1111/j.1528-1157.2000.tb00228.x; PENDSE G, 2006, SOC NEUR ABSTR, V32, P4925; PENFIELD W, 1950, SECONDARY SENSORY MO, P109; Perlstein WM, 2002, P NATL ACAD SCI USA, V99, P1736, DOI 10.1073/pnas.241650598; PETRIDES M, 2003, HUMAN NERVOUS SYSTEM, P950; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Povedano M, 2007, J PAIN SYMPTOM MANAG, V33, P78, DOI 10.1016/j.jpainsymman.2006.07.012; Romaniello A, 2000, BRAIN RES, V882, P120, DOI 10.1016/S0006-8993(00)02856-0; Schaechter JD, 2006, BRAIN, V129, P2722, DOI 10.1093/brain/awl214; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Schweinhardt P, 2006, NEUROIMAGE, V32, P256, DOI 10.1016/j.neuroimage.2006.03.024; SESSLE BJ, 1982, J PHYSIOL-LONDON, V323, P245, DOI 10.1113/jphysiol.1982.sp014071; Skoglund TS, 2004, NEUROSCI RES, V50, P189, DOI 10.1016/j.neures.2004.06.017; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Steen PA, 2007, J COMP NEUROL, V500, P634, DOI 10.1002/cne.21199; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Vees AM, 1998, J COMP NEUROL, V400, P110; Viswanathan V, 2006, NEUROREPORT, V17, P1669, DOI 10.1097/01.wnr.0000239953.60695.08; VOGT B, 2003, HUMAN NERVOUS SYSTEM, P916; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Witting N, 2001, NEUROLOGY, V57, P1817, DOI 10.1212/WNL.57.10.1817; YAMAGUCHI S, 1990, BRAIN RES, V521, P281, DOI 10.1016/0006-8993(90)91553-S; Zilles K, 2003, HUMAN NERVOUS SYSTEM, P997	86	100	104	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3396	10.1371/journal.pone.0003396	http://dx.doi.org/10.1371/journal.pone.0003396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923647	Green Submitted, gold, Green Published			2022-12-25	WOS:000265122200001
J	Zhang, XB; Jiang, P; Gong, N; Hu, XL; Fei, D; Xiong, ZQ; Xu, L; Xu, TL				Zhang, Xiao-Bing; Jiang, Peng; Gong, Neng; Hu, Xiao-Ling; Fei, Da; Xiong, Zhi-Qi; Xu, Lin; Xu, Tian-Le			A-Type GABA Receptor as a Central Target of TRPM8 Agonist Menthol	PLOS ONE			English	Article								Menthol is a widely-used cooling and flavoring agent derived from mint leaves. In the peripheral nervous system, menthol regulates sensory transduction by activating TRPM8 channels residing specifically in primary sensory neurons. Although behavioral studies have implicated menthol actions in the brain, no direct central target of menthol has been identified. Here we show that menthol reduces the excitation of rat hippocampal neurons in culture and suppresses the epileptic activity induced by pentylenetetrazole injection and electrical kindling in vivo. We found menthol not only enhanced the currents induced by low concentrations of GABA but also directly activated GABA(A) receptor (GABA(A)R) in hippocampal neurons in culture. Furthermore, in the CA1 region of rat hippocampal slices, menthol enhanced tonic GABAergic inhibition although phasic GABAergic inhibition was unaffected. Finally, the structure-effect relationship of menthol indicated that hydroxyl plays a critical role in menthol enhancement of tonic GABA(A)R. Our results thus reveal a novel cellular mechanism that may underlie the ambivalent perception and psychophysical effects of menthol and underscore the importance of tonic inhibition by GABA(A)Rs in regulating neuronal activity.	[Zhang, Xiao-Bing; Jiang, Peng; Gong, Neng; Hu, Xiao-Ling; Fei, Da; Xiong, Zhi-Qi; Xu, Tian-Le] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Lab Learning & Memory, Kunming, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, XB (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.	tlxu@ion.ac.cn	ZHANG, XIAOBING/J-4076-2015	ZHANG, XIAOBING/0000-0002-5707-193X; Jiang, Peng/0000-0002-2650-3082; Xu, Lin/0000-0002-2710-3507	National Natural Science Foundation of China [30621062]; National Basic Research Program of China [2006CB500803]; Knowledge Innovation Project from the Chinese Academy of Sciences [KSCX2-YW-R-35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Knowledge Innovation Project from the Chinese Academy of Sciences	This study was supported by the National Natural Science Foundation of China (No. 30621062), the National Basic Research Program of China (No. 2006CB500803) and the Knowledge Innovation Project from the Chinese Academy of Sciences (KSCX2-YW-R-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Croteau RB, 2005, NATURWISSENSCHAFTEN, V92, P562, DOI 10.1007/s00114-005-0055-0; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Hall AC, 2004, EUR J PHARMACOL, V506, P9, DOI 10.1016/j.ejphar.2004.10.026; Houser CR, 2003, HIPPOCAMPUS, V13, P633, DOI 10.1002/hipo.10108; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; LIU QY, 1995, J MEMBRANE BIOL, V145, P279; Majkowski J, 1999, Adv Neurol, V81, P105; Mangan PS, 2004, J NEUROPHYSIOL, V91, P946, DOI 10.1152/jn.00547.2003; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Mtchedlishvili Z, 2006, MOL PHARMACOL, V69, P564, DOI 10.1124/mol.105.016683; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; OKADA R, 1989, BRAIN RES, V480, P383, DOI 10.1016/0006-8993(89)90212-6; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706, DOI 10.1152/jn.1995.73.4.1706; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsunashima K, 1997, NEUROSCIENCE, V80, P1019, DOI 10.1016/S0306-4522(97)00144-9; Tsuzuki K, 2004, J NEUROSCI, V24, P762, DOI 10.1523/JNEUROSCI.4658-03.2004; Umezu T, 2001, PHARMACOL BIOCHEM BE, V69, P383, DOI 10.1016/S0091-3057(01)00543-3; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Watt EE, 2008, EUR J PHARMACOL, V590, P120, DOI 10.1016/j.ejphar.2008.06.003; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; White H. Steve, 1995, P99; Yeh JH, 2005, BIOCHEM BIOPH RES CO, V338, P1417, DOI 10.1016/j.bbrc.2005.10.103; Yeung JYT, 2003, MOL PHARMACOL, V63, P2, DOI 10.1124/mol.63.1.2; Zuker CS, 2002, NATURE, V416, P27, DOI 10.1038/416027a	41	65	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3386	10.1371/journal.pone.0003386	http://dx.doi.org/10.1371/journal.pone.0003386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852885	Green Published, gold, Green Submitted			2022-12-25	WOS:000265121600010
J	Brumm, J; Conibear, E; Wasserman, WW; Bryan, J				Brumm, Jochen; Conibear, Elizabeth; Wasserman, Wyeth W.; Bryan, Jennifer			Discovery and Expansion of Gene Modules by Seeking Isolated Groups in a Random Graph Process	PLOS ONE			English	Article								Background: A central problem in systems biology research is the identification and extension of biological modules groups of genes or proteins participating in a common cellular process or physical complex. As a result, there is a persistent need for practical, principled methods to infer the modular organization of genes from genome-scale data. Results: We introduce a novel approach for the identification of modules based on the persistence of isolated gene groups within an evolving graph process. First, the underlying genomic data is summarized in the form of ranked gene-gene relationships, thereby accommodating studies that quantify the relevant biological relationship directly or indirectly. Then, the observed gene-gene relationship ranks are viewed as the outcome of a random graph process and candidate modules are given by the identifiable subgraphs that arise during this process. An isolation index is computed for each module, which quantifies the statistical significance of its survival time. Conclusions: The Miso (module isolation) method predicts gene modules from genomic data and the associated isolation index provides a module-specific measure of confidence. Improving on existing alternative, such as graph clustering and the global pruning of dendrograms, this index offers two intuitively appealing features: (1) the score is module-specific; and (2) different choices of threshold correlate logically with the resulting performance, i.e. a stringent cutoff yields high quality predictions, but low sensitivity. Through the analysis of yeast phenotype data, the Miso method is shown to outperform existing alternatives, in terms of the specificity and sensitivity of its predictions.	[Brumm, Jochen; Bryan, Jennifer] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Brumm, Jochen; Conibear, Elizabeth; Wasserman, Wyeth W.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Conibear, Elizabeth; Wasserman, Wyeth W.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; [Bryan, Jennifer] Univ British Columbia, Michael Smith Lab, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia	Brumm, J (corresponding author), Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada.	jenny@stat.ubc.ca	Wasserman, Wyeth/I-4866-2015; Conibear, Elizabeth/G-5297-2010	Brumm, Jochen/0000-0001-9518-038X; Wasserman, Wyeth/0000-0001-6098-6412; Bryan, Jennifer/0000-0002-6983-2759; Conibear, Elizabeth/0000-0001-5129-0499	Canadian Institutes of Health Research; National Sciences and Engineering Research Council; Canada Foundation for Innovation; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by funding from the Canadian Institutes of Health Research (EC, WWW, JOB), the National Sciences and Engineering Research Council (JEB), the Canada Foundation for Innovation (WWW) and IBM (WWW). Additional support was provided by the Michael Smith Foundation for Health Research (Career Investigator awards to JEB, EC, and WWW) and CIHR (New Investigator awards to EC and WWW). The funders did not play any role in the design or conduct of the study.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Duda R.O., 2000, PATTERN CLASSIFICATI; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hartuv E, 2000, GENOMICS, V66, P249, DOI 10.1006/geno.2000.6187; Huber W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S8; Kiemer L, 2007, PROTEOMICS, V7, P932, DOI 10.1002/pmic.200600448; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; LING RF, 1973, J AM STAT ASSOC, V68, P159, DOI 10.2307/2284161; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; R Core Team, 2022, R LANG ENV STAT COMP; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Schluter C, 2008, MOL BIOL CELL, V19, P1282, DOI 10.1091/mbc.E07-07-0659; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stuetzle W, 2003, J CLASSIF, V20, P25, DOI 10.1007/s00357-003-0004-6; STUETZLE W, 2007, 514 U WASH DEP STAT; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; van Dongen S. M., 2000, GRAPH CLUSTERING FLO; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WONG MA, 1983, J ROY STAT SOC B MET, V45, P362	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3358	10.1371/journal.pone.0003358	http://dx.doi.org/10.1371/journal.pone.0003358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18843375	Green Published, Green Submitted, gold			2022-12-25	WOS:000265114100004
J	Sanford, JR; Coutinho, P; Hackett, JA; Wang, X; Ranahan, W; Caceres, JF				Sanford, Jeremy R.; Coutinho, Pedro; Hackett, Jamie A.; Wang, Xin; Ranahan, William; Caceres, Javier F.			Identification of Nuclear and Cytoplasmic mRNA Targets for the Shuttling Protein SF2/ASF	PLOS ONE			English	Article								The serine and arginine-rich protein family (SR proteins) are highly conserved regulators of pre-mRNA splicing. SF2/ASF, a prototype member of the SR protein family, is a multifunctional RNA binding protein with roles in pre-mRNA splicing, mRNA export and mRNA translation. These observations suggest the intriguing hypothesis that SF2/ASF may couple splicing and translation of specific mRNA targets in vivo. Unfortunately the paucity of endogenous mRNA targets for SF2/ASF has hindered testing of this hypothesis. Here, we identify endogenous mRNAs directly cross-linked to SF2/ASF in different subcellular compartments. Cross-Linking Immunoprecipitation (CLIP) captures the in situ specificity of protein-RNA interaction and allows for the simultaneous identification of endogenous RNA targets as well as the locations of binding sites within the RNA transcript. Using the CLIP method we identified 326 binding sites for SF2/ASF in RNA transcripts from 180 protein coding genes. A purine-rich consensus motif was identified in binding sites located within exon sequences but not introns. Furthermore, 72 binding sites were occupied by SF2/ASF in different sub-cellular fractions suggesting that these binding sites may influence the splicing or translational control of endogenous mRNA targets. We demonstrate that ectopic expression of SF2/ASF regulates the splicing and polysome association of transcripts derived from the SFRS1, PABC1, NETO2 and ENSA genes. Taken together the data presented here indicate that SF2/ASF has the capacity to co-regulate the nuclear and cytoplasmic processing of specific mRNAs and provide further evidence that the nuclear history of an mRNA may influence its cytoplasmic fate.	[Sanford, Jeremy R.; Coutinho, Pedro; Hackett, Jamie A.; Caceres, Javier F.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Sanford, Jeremy R.; Wang, Xin; Ranahan, William] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	University of Edinburgh; Indiana University System; Indiana University-Purdue University Indianapolis	Sanford, JR (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	sanford@biology.ucsc.edu; Javier.Caceres@hgu.mrc.ac.uk	Caceres, Javier F/D-5260-2013; Wang, Xin/A-1130-2012	Caceres, Javier F/0000-0001-8025-6169; Wang, Xin/0000-0002-5122-2418; Hackett, Jamie/0000-0002-6237-3684	Medical Research Council; EURASNET; Caledonian Research Foundation [postdoctoral fellowship]; American Heart Association [0830206N]; Medical Research Council [MC_U127584479] Funding Source: researchfish; MRC [MC_U127584479] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EURASNET; Caledonian Research Foundation; American Heart Association(American Heart Association); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Medical Research Council (J.F.C., P.C. and J.A.H) plus additional funds from EURASNET (European Alternative splicing Network) to J.F.C.. J.R.S. was initially supported by a postdoctoral fellowship from the Caledonian Research Foundation and is currently funded by American Heart Association Scientist Development Grant #0830206N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; Cazalla D, 2005, PROTEIN EXPRES PURIF, V42, P54, DOI 10.1016/j.pep.2005.03.035; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; Drummond-Barbosa D, 2004, DEV BIOL, V266, P310, DOI 10.1016/j.ydbio.2003.10.028; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Nagalakshmi U, 2008, SCIENCE; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Ram O, 2007, TRENDS GENET, V23, P5, DOI 10.1016/j.tig.2006.10.002; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; THIERRYMIEG D, 2006, GENOME BIOL S1, V7, pS1211; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Ule J., 2006, NATURE; Wang H, 2004, MOL GENET METAB, V81, P9, DOI 10.1016/j.ymgme.2003.08.003; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhang ZDD, 2007, GENOME RES, V17, P787, DOI 10.1101/gr.5573107	42	91	93	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3369	10.1371/journal.pone.0003369	http://dx.doi.org/10.1371/journal.pone.0003369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841201	Green Published, gold, Green Submitted			2022-12-25	WOS:000265113900006
J	Luo, S; Levine, RL				Luo, Shen; Levine, Rodney L.			Methionine in proteins defends against oxidative stress	FASEB JOURNAL			English	Article						norleucine; elongation factor Tu; hypochlorous acid	SULFOXIDE-REDUCTASE-A; PERFORMANCE LIQUID-CHROMATOGRAPHY; WERNER SYNDROME PROTEIN; ESCHERICHIA-COLI-CELLS; SACCHAROMYCES-CEREVISIAE; GLUTAMINE-SYNTHETASE; ANTIOXIDANT DEFENSE; CELLULAR-REGULATION; OXIDIZED PROTEINS; CRYSTAL-STRUCTURE	A variety of reactive oxygen species react readily with methionine residues in proteins to form methionine sulfoxide, thus scavenging the reactive species. Most cells contain methionine sulfoxide reductases, which catalyze a thioredoxin-dependent reduction of methionine sulfoxide back to methionine. Thus, methionine residues may act as catalytic antioxidants, protecting both the protein where they are located and other macromolecules. To test this hypothesis directly, we replaced 40% of the methionine residues in Escherichia coli with norleucine, the carbon-containing analog, in which the sulfur of methionine is substituted by a methylene group (-CH2-). The intracellular free methionine and S-adenosylmethionine pools were not altered, nor was the specific activity of the key enzyme, glutamine synthetase. When unstressed, both control and norleucine-substituted cells survived equally well at stationary phase for at least 32 h. However, oxidative stress was more damaging to the norleucine-substituted cells. They died more rapidly than control cells when challenged by hypochlorite, hydrogen peroxide, or ionizing radiation. One of the most abundant proteins in the cell, elongation factor Tu, was found to be more oxidatively modified in norleucine-substituted cells, consistent with loss of the antioxidant defense provided by methionine residues. The results of these studies support the hypothesis that methionine in protein acts as an endogenous antioxidant in cells. - Luo, S., Levine, R. L. Methionine in proteins defends against oxidative stress. FASEB J. 23, 464-472 (2009)	[Luo, Shen; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, RL (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 50,Rm 2351, Bethesda, MD 20892 USA.	rlevine@nih.gov	Levine, Rodney L/D-9885-2011	Luo, Shen/0000-0002-1912-6741	Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000225, ZIAHL000225] Funding Source: NIH RePORTER	Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Elena K. Gaidamakova and Alexander Vasilenko for performing the irradiation of the E. coli. This research was supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health.	ANFINSEN CB, 1969, J BIOL CHEM, V244, P5149; BARKER DG, 1979, J MOL BIOL, V133, P217, DOI 10.1016/0022-2836(79)90531-X; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Cabreiro F, 2007, BIOCHIMIE, V89, P1388, DOI 10.1016/j.biochi.2007.05.005; Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; COWIE DB, 1959, BIOCHIM BIOPHYS ACTA, V34, P39, DOI 10.1016/0006-3002(59)90230-6; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; FARBER JM, 1986, J BIOL CHEM, V261, P4574; GILLES AM, 1988, J BIOL CHEM, V263, P8204; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; IIDA H, 1988, MOL CELL BIOL, V8, P5555, DOI 10.1128/MCB.8.12.5555; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; KITZLER JW, 1990, J BACTERIOL, V172, P686, DOI 10.1128/jb.172.2.686-690.1990; Kohen R, 1985, Free Radic Res Commun, V1, P79, DOI 10.3109/10715768509056540; KOPOLDOVA J, 1967, RADIAT RES, V30, P261, DOI 10.2307/3572051; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; Levine RL, 2000, METH MOL B, V99, P15; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MINAKAMI H, 1990, FREE RADICAL BIO MED, V8, P387, DOI 10.1016/0891-5849(90)90105-R; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; NAIDER F, 1972, BIOCHEMISTRY-US, V11, P3202, DOI 10.1021/bi00767a010; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nystrom Thomas, 2006, Methods Biochem Anal, V49, P89; OLIVER CN, 1987, J BIOL CHEM, V262, P5488; RANDHAWA ZI, 1994, BIOCHEMISTRY-US, V33, P4352, DOI 10.1021/bi00180a032; REDDY VY, 1994, J BIOL CHEM, V269, P4683; REDDY VY, 1989, J BIOL CHEM, V264, P13801; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; STADTMAN ER, 1979, ANAL BIOCHEM, V95, P275, DOI 10.1016/0003-2697(79)90217-3; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Taggart C, 2000, J BIOL CHEM, V275, P27258; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Wang Y, 2001, FREE RADICAL BIO MED, V31, P1448, DOI 10.1016/S0891-5849(01)00728-6; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101	61	306	313	1	45	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					464	472		10.1096/fj.08-118414	http://dx.doi.org/10.1096/fj.08-118414			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18845767	Green Published			2022-12-25	WOS:000262892900018
J	Hurtel-Lemaire, AS; Mentaverri, R; Caudrillier, A; Cournarie, F; Wattel, A; Kamel, S; Terwilliger, EF; Brown, EM; Brazier, M				Hurtel-Lemaire, Anne S.; Mentaverri, Romuald; Caudrillier, Axelle; Cournarie, Fabienne; Wattel, Alice; Kamel, Said; Terwilliger, Ernest F.; Brown, Edward M.; Brazier, Michel			The Calcium-sensing Receptor Is Involved in Strontium Ranelate-induced Osteoclast Apoptosis NEW INSIGHTS INTO THE ASSOCIATED SIGNALING PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAINTAINING BONE-FORMATION; RESORPTION IN-VITRO; EXTRACELLULAR CALCIUM; POSTMENOPAUSAL OSTEOPOROSIS; CA2+-SENSING RECEPTOR; VERTEBRAL FRACTURE; KAPPA-B; RATS; DIFFERENTIATION; WOMEN	Strontium ranelate exerts both an anti-catabolic and an anabolic effect on bone cells. To further investigate the molecular mechanism whereby strontium ranelate inhibits bone resorption, we focused our attention on the effects of strontium ranelate on osteoclast apoptosis and on the underlying mechanism(s). Using primary mature rabbit osteoclasts, we demonstrated that strontium (Sr-o(2+)) dose-dependently stimulates the apoptosis of mature osteoclasts. As shown previously for calcium (Ca-o(2+)), the Sr-o(2+)-induced effect on mature osteoclasts is mediated by the Ca-o(2+)-sensing receptor, CaR, which in turn stimulates a phospholipase C-dependent signaling pathway and nuclear translocation of NF-kappa B. Unlike Ca-o(2+), however, Sr-o(2+)-induced osteoclast apoptosis was shown to depend on PKC beta II activation and to be independent of inositol 1,4,5-trisphosphate action. As a consequence of these differences in their intracellular signaling pathways, Sr-o(2+) and Ca-o(2+) in combination were shown to exert a greater effect on mature osteoclast apoptosis than did either divalent cation by itself. Altogether, our results show that Sr-o(2+) acts through the CaR and induces osteoclast apoptosis through a signaling pathway similar to but different in certain respects from that of Ca-o(2+). This difference in the respective signaling cascades enables Sr-o(2+) to potentiate Ca-o(2)+ induced osteoclast apoptosis and vice versa. In this manner, it is conceivable that Sr-o(2+) and Ca-o(2+) act together to inhibit bone resorption in strontium ranelate-treated patients.	[Hurtel-Lemaire, Anne S.; Mentaverri, Romuald; Caudrillier, Axelle; Wattel, Alice; Kamel, Said; Brazier, Michel] Univ Picardie Jules Verne, INSERM, ERI 12, F-80037 Amiens, France; [Cournarie, Fabienne] Inst Rech Int Servier, F-92415 Courbevoie, France; [Terwilliger, Ernest F.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Mentaverri, Romuald; Brown, Edward M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Servier; Institut de Recherches Internationales Servier; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Brazier, M (corresponding author), Univ Picardie Jules Verne, INSERM, ERI 12, 1 Rue Louvels, F-80037 Amiens, France.	michel.brazier@sa.u-picardie.fr	Kamel, Said/HGA-7781-2022		Institut de Recherches Internationales Servier	Institut de Recherches Internationales Servier(Servier)	This work was supported by research grants from the Institut de Recherches Internationales Servier. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ammann P, 2004, J BONE MINER RES, V19, P2012, DOI 10.1359/JBMR.040906; AMMANN P, 2006, SUPPL NY S1, V38, pS15; Bai M, 1997, J CLIN INVEST, V99, P88, DOI 10.1172/JCI119137; Bai M, 2004, CELL CALCIUM, V35, P197, DOI 10.1016/j.ceca.2003.10.018; Baron R, 2002, EUR J PHARMACOL, V450, P11, DOI 10.1016/S0014-2999(02)02040-X; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Breitwieser GE, 2004, CELL CALCIUM, V35, P209, DOI 10.1016/j.ceca.2003.10.013; Brown EM, 2003, OSTEOPOROSIS INT, V14, pS25, DOI 10.1007/s00198-002-1343-6; Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7; Butters RR, 1997, J BONE MINER RES, V12, P568, DOI 10.1359/jbmr.1997.12.4.568; Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4; Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P65; Coulombe J, 2004, BIOCHEM BIOPH RES CO, V323, P1184, DOI 10.1016/j.bbrc.2004.08.209; Delannoy P, 2002, METABOLISM, V51, P906, DOI 10.1053/meta.2002.33360; Delmas PD, 2005, OSTEOPOROSIS INT, V16, P1, DOI 10.1007/s00198-004-1813-0; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Foged NT, 1996, J BONE MINER RES, V11, P226; Hott M, 2003, BONE, V33, P115, DOI 10.1016/S8756-3282(03)00115-7; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; KAMEDA T, 1995, BIOCHEM BIOPH RES CO, V207, P753, DOI 10.1006/bbrc.1995.1251; Korcok J, 2004, J BONE MINER RES, V19, P642, DOI 10.1359/JBMR.040108; Lee SW, 2003, BONE, V32, P217, DOI 10.1016/S8756-3282(02)00976-6; Lorget F, 2000, BIOCHEM BIOPH RES CO, V268, P899, DOI 10.1006/bbrc.2000.2229; Marie PJ, 2006, CURR OPIN RHEUMATOL, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b; MARIE PJ, 1993, J BONE MINER RES, V8, P607; Marie PJ, 2003, OSTEOPOROSIS INT, V14, pS9, DOI 10.1007/s00198-002-1344-5; Marin Maria Susana, 2006, Revista de la Facultad de Ciencias Agrarias Universidad Nacional de Cuyo, V38, P1; Mentaverri R, 2006, FASEB J, V20, P2562, DOI 10.1096/fj.06-6304fje; Mentaverri R, 2003, J CELL BIOCHEM, V88, P1145, DOI 10.1002/jcb.10463; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Moonga BS, 1996, CALCIFIED TISSUE INT, V59, P105, DOI 10.1007/s002239900095; Reginster Jean-Yves, 2005, Curr Osteoporos Rep, V3, P30; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Rizzoli R, 2005, J Endocrinol Invest, V28, P50; Roux C, 2006, J BONE MINER RES, V21, P536, DOI 10.1359/JBMR.060101; Tai YH, 2008, NEUROSCIENCE, V153, P823, DOI 10.1016/j.neuroscience.2008.02.055; Takahashi N, 2003, J BONE MINER RES, V18, P1082, DOI 10.1359/jbmr.2003.18.6.1082; TETI A, 1995, J BONE NY, V17, P175; Tfelt-Hansen J, 2003, AM J PHYSIOL-ENDOC M, V285, pE329, DOI 10.1152/ajpendo.00489.2002; Vaananen K, 2005, ADV DRUG DELIVER REV, V57, P959, DOI 10.1016/j.addr.2004.12.018; Ward BK, 2004, J CLIN ENDOCR METAB, V89, P3721, DOI 10.1210/jc.2003-031653; Zhang ZX, 2001, J BIOL CHEM, V276, P5316, DOI 10.1074/jbc.M005958200	43	178	194	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					575	584		10.1074/jbc.M801668200	http://dx.doi.org/10.1074/jbc.M801668200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18927086	hybrid			2022-12-25	WOS:000261974800063
J	Miyoshi, T; Nomura, T; Uchiumi, T				Miyoshi, Tomohiro; Nomura, Takaomi; Uchiumi, Toshio			Engineering and Characterization of the Ribosomal L10.L12 Stalk Complex A STRUCTURAL ELEMENT RESPONSIBLE FOR HIGH TURNOVER OF THE ELONGATION FACTOR G-DEPENDENT GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; ESCHERICHIA-COLI RIBOSOMES; NUCLEAR-MAGNETIC-RESONANCE; PROTEIN L7/L12; EF-G; TRANSLATION ELONGATION; ANGSTROM RESOLUTION; FACTOR-BINDING; FACTORS TU; SUBUNIT	The ribosomal stalk protein L12 is essential for events dependent on the GTP-binding translation factors. It has been recently shown that ribosomes from Thermus thermophilus contain a heptameric complex L10.(L12)(2).(L12)(2).(L12)(2), rather than the conventional pentameric complex L10(L12)(2).( L12)(2). Here we describe the reconstitution of the heptameric complex from purified L10 and L12 and the characterization of its role in elongation factor G-dependent GTPase activity using a hybrid system with Escherichia coli ribosomes. The T. thermophilus heptameric complex resulted in a 2.5-fold higher activity than the E. coli pentameric complex. The structural element of the T. thermophilus complex responsible for the higher activity was investigated using a chimeric L10 protein ( Ec-Tt-L10), in which the C-terminal L12-binding site in E. coli L10 was replaced with the same region from T. thermophilus, and two chimeric L12 proteins: Ec-Tt-L12, in which the E. coli N-terminal domain was fused with the T. thermophilus C-terminal domain, and Tt.Ec-L12, in which the T. thermophilus N-terminal domain was fused with the E. coli C-terminal domain. High GTPase turnover was observed with the pentameric chimeric complex formed from E. coli L10 and Ec-Tt-L12 but not with the heptameric complex formed from Ec-Tt-L10 and Tt.c-L12. This suggested that the C-terminal region of T. thermophilus L12, rather than the heptameric nature of the complex, was responsible for the high GTPase turnover. Further analyses with other chimeric L12 proteins identified helix alpha 6 as the region most likely to contain the responsible element.	[Miyoshi, Tomohiro; Uchiumi, Toshio] Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan; [Nomura, Takaomi] Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 3868567, Japan	Niigata University; Shinshu University	Uchiumi, T (corresponding author), Niigata Univ, Fac Sci, Dept Biol, Ikarashi 2-8050, Niigata 9502181, Japan.	uchiumi@bio.sc.niigata-u.ac.jp			Uchida Energy Science Promotion Foundation [14035222]; Naito Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Uchida Energy Science Promotion Foundation(Uchida Energy Science Promotion Foundation); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research 14035222 (to T. U.), grants from the Uchida Energy Science Promotion Foundation (to T. U.) and the Naito Foundation (to T. U.), and a Grant-in-Aid for Global COE Program (to T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARAI KI, 1972, J BIOL CHEM, V247, P7029; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bocharov EV, 1996, FEBS LETT, V379, P291, DOI 10.1016/0014-5793(95)01531-0; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; BUSHUEV VN, 1989, J BIOL CHEM, V264, P4498; Christodoulou J, 2004, P NATL ACAD SCI USA, V101, P10949, DOI 10.1073/pnas.0400928101; COWGILL CA, 1984, J BIOL CHEM, V259, P5257; DABBS ER, 1979, J BACTERIOL, V140, P734, DOI 10.1128/JB.140.2.734-737.1979; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Griaznova O, 2000, BIOCHEMISTRY-US, V39, P4075, DOI 10.1021/bi992621e; Gudkov AT, 1997, FEBS LETT, V407, P253, DOI 10.1016/S0014-5793(97)00361-X; GUDKOV AT, 1978, EUR J BIOCHEM, V90, P313, DOI 10.1111/j.1432-1033.1978.tb12606.x; GUDKOV AT, 1982, FEBS LETT, V138, P229, DOI 10.1016/0014-5793(82)80448-1; HAMEL E, 1972, J BIOL CHEM, V247, P805; Hamman BD, 1996, BIOCHEMISTRY-US, V35, P16680, DOI 10.1021/bi9624189; HARDY SJS, 1975, MOL GEN GENET, V140, P253, DOI 10.1007/BF00334270; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; KOTELIANSKY VE, 1977, FEBS LETT, V73, P6, DOI 10.1016/0014-5793(77)80003-3; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; LEIJONMARCK M, 1987, J MOL BIOL, V195, P555, DOI 10.1016/0022-2836(87)90183-5; LILJAS A, 1987, BIOCHIMIE, V69, P1043, DOI 10.1016/0300-9084(87)90004-6; MAKAROV EM, 1993, BIOCHIMIE, V75, P963, DOI 10.1016/0300-9084(93)90146-J; Maki Y, 2007, J BIOL CHEM, V282, P32827, DOI 10.1074/jbc.M705412200; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; Nomura T, 2003, BIOCHEMISTRY-US, V42, P4691, DOI 10.1021/bi027087g; Nomura T, 2008, J BIOCHEM, V144, P665, DOI 10.1093/jb/mvn113; Nomura T, 2006, BIOCHEM J, V396, P565, DOI 10.1042/BJ20060038; OLSON HM, 1986, J BIOL CHEM, V261, P6924; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANDER G, 1975, BIOCHEMISTRY-US, V14, P1805, DOI 10.1021/bi00680a001; SANDER G, 1972, BIOCHEM BIOPH RES CO, V47, P866, DOI 10.1016/0006-291X(72)90573-6; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shcherbakov D, 2006, NUCLEIC ACIDS RES, V34, P5800, DOI 10.1093/nar/gkl751; SUBRAMANIAN AR, 1975, J MOL BIOL, V95, P1, DOI 10.1016/0022-2836(75)90330-7; TOKIMATSU H, 1981, J MOL BIOL, V152, P397, DOI 10.1016/0022-2836(81)90250-3; Uchiumi T, 1999, J BIOL CHEM, V274, P27578, DOI 10.1074/jbc.274.39.27578; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174	47	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					85	92		10.1074/jbc.M806024200	http://dx.doi.org/10.1074/jbc.M806024200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18936095	hybrid			2022-12-25	WOS:000261974800010
J	Crane, CA; Panner, A; Murray, JC; Wilson, SP; Xu, H; Chen, L; Simko, JP; Waldman, FM; Pieper, RO; Parsa, AT				Crane, C. A.; Panner, A.; Murray, J. C.; Wilson, S. P.; Xu, H.; Chen, L.; Simko, J. P.; Waldman, F. M.; Pieper, R. O.; Parsa, A. T.			PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer	ONCOGENE			English	Article						PI(3) kinase; B7-H1; immunoresistance; breast cancer; prostate cancer; T cell	CELL CARCINOMA PATIENTS; MHC CLASS-II; B7-H1 EXPRESSION; POTENTIAL MECHANISM; MOLECULE B7-H1; TUMOR; MELANOMA; TRANSLATION; PHOSPHATASE; PROGNOSIS	Immune escape describes a critical event whereby tumor cells adopt an immunoresistant phenotype to escape adaptive surveillance. We show that expression of a pivotal negative regulator of T-cell function, B7-H1, correlates with PI(3) kinase activation in breast and prostate cancer patients. B7-H1-mediated immunoresistance can be attenuated by inhibitors of the PI(3) kinase pathway, and is dependent on S6K1-mediated translational regulation of B7-H1 protein. Breast and prostate carcinoma cells with activated PI(3) kinase lose the immunoresistant phenotype after treatment with B7-H1 siRNA. Conversely, breast and prostate carcinoma cells with minimal PI(3) kinase activation adopt an immunoresistant phenotype when engineered to overexpress B7-H1 protein. These observations describe a mechanism for immune escape from tumor dormancy in humans that relates to oncogenesis.	[Crane, C. A.; Panner, A.; Murray, J. C.; Wilson, S. P.; Pieper, R. O.; Parsa, A. T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Xu, H.; Chen, L.] Johns Hopkins Univ, Sch Med, Dept Dermatol & Oncol, Baltimore, MD USA; [Simko, J. P.] Univ Calif San Francisco, Dept Pathol & Urol, San Francisco, CA 94143 USA; [Waldman, F. M.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Parsa, AT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,M-779, San Francisco, CA 94143 USA.	parsaa@neurosurg.ucsf.edu	Murray, Joseph C/J-8916-2014	Murray, Joseph C/0000-0001-6159-7814; Wilson, Sean/0000-0001-8667-6236	National Institute of Neurological Disorder and Stroke; National Cancer Institute; Seibrandt Vaccine Fund; Khatib Foundation; NATIONAL CANCER INSTITUTE [P50CA097257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS046671] Funding Source: NIH RePORTER	National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Seibrandt Vaccine Fund; Khatib Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Pramod Srivastava and C David James for critical review of the manuscript, as well as the UCSF cancer center for providing tissue with known PI3K activation status. ATP was supported in part by a K08 grant from the National Institute of Neurological Disorder and Stroke, a career development award from Brain Specialized Programs of Research Excellence (SPORE) of the National Cancer Institute, the Seibrandt Vaccine Fund and the Khatib Foundation.	Baleeiro RB, 2008, MOL IMMUNOL, V45, P3502, DOI 10.1016/j.molimm.2008.04.005; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; Chang YC, 2008, BLOOD, V111, P5054, DOI 10.1182/blood-2007-12-130609; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Geng L, 2008, J CANCER RES CLIN, V134, P1021, DOI 10.1007/s00432-008-0364-8; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Johnson LE, 2007, CANCER IMMUNOL IMMUN, V56, P885, DOI 10.1007/s00262-006-0241-8; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kozikowski AP, 2003, J AM CHEM SOC, V125, P1144, DOI 10.1021/ja0285159; Krambeck AE, 2007, CLIN CANCER RES, V13, P1749, DOI 10.1158/1078-0432.CCR-06-2129; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Loos M, 2008, CANCER LETT, V268, P98, DOI 10.1016/j.canlet.2008.03.056; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Mazanet MM, 2002, J IMMUNOL, V169, P3581, DOI 10.4049/jimmunol.169.7.3581; Meyer RG, 2007, LUNG CANCER, V58, P88, DOI 10.1016/j.lungcan.2007.05.003; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Mittenclorf EA, 2007, CANCER-AM CANCER SOC, V110, P1677, DOI 10.1002/cncr.22978; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Penn I, 1996, TRANSPLANTATION, V61, P274, DOI 10.1097/00007890-199601270-00019; Powell DJ, 2006, J IMMUNOL, V177, P6527, DOI 10.4049/jimmunol.177.9.6527; Roth TJ, 2007, CANCER RES, V67, P7893, DOI 10.1158/0008-5472.CAN-07-1068; Routh JC, 2008, J UROLOGY, V179, P1954, DOI 10.1016/j.juro.2008.01.056; Schartner JM, 2005, GLIA, V51, P279, DOI 10.1002/glia.20201; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Siva A, 2008, CANCER IMMUNOL IMMUN, V57, P987, DOI 10.1007/s00262-007-0429-6; Slingluff CL, 2007, CLIN CANCER RES, V13, P6386, DOI 10.1158/1078-0432.CCR-07-0486; Slovin SF, 2008, CANCER J, V14, P26, DOI 10.1097/PPO.0b013e318161bffa; Small EJ, 2007, CLIN CANCER RES, V13, P1810, DOI 10.1158/1078-0432.CCR-06-2318; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thompson RH, 2007, CLIN CANCER RES, V13, p709S, DOI 10.1158/1078-0432.CCR-06-1868; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wintterle S, 2003, CANCER RES, V63, P7462; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104	37	134	146	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					306	312		10.1038/onc.2008.384	http://dx.doi.org/10.1038/onc.2008.384			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18850006	Green Accepted			2022-12-25	WOS:000262501100014
J	Moller, A; House, CM; Wong, CSF; Scanlon, DB; Liu, MCP; Ronai, Z; Bowtell, DDL				Moller, A.; House, C. M.; Wong, C. S. F.; Scanlon, D. B.; Liu, M. C. P.; Ronai, Z.; Bowtell, D. D. L.			Inhibition of Siah ubiquitin ligase function	ONCOGENE			English	Article						ubiquitin; degradation; hypoxia	HYPOXIA-INDUCIBLE FACTOR; FACTOR 1-ALPHA; TRANSCRIPTIONAL REPRESSOR; PROTEASOME PATHWAY; O-2 HOMEOSTASIS; DEGRADATION; HOMOLOGS; PROTEIN; SINA; HIF	Tumor hypoxia induces the upregulation of hypoxiainducible factor 1 alpha (Hif-1 alpha), which in turn induces the expression of genes including VEGF to recruit new blood vessel outgrowth, enabling tumor growth and metastasis. Interference with the Hif-1 pathway and neoangiogenesis is an attractive antitumor target. The hydroxylation of Hif-1 alpha by prolyl-hydroxylase (PHD) proteins during normoxia serves as a recognition motif for its proteasomal degradation. However, under hypoxic conditions, hydroxylation is inhibited and furthermore, PHD proteins are themselves polyubiquitylated and degraded by Siah ubiquitin ligases. Our data demonstrate for the first time that inhibition of the interaction between Siah and PHD proteins using a fragment derived from a Drosophila protein ( phyllopod) interferes with the PHD degradation. Furthermore, cells stably expressing the phyllopod fragment display reduced upregulation of Hif-1 alpha protein levels and Hif-1-mediated gene expression under hypoxia. In a syngeneic mouse model of breast cancer, the phyllopod fragment reduced tumor growth and neoangiogenesis and prolonged survival of the mice. In addition, levels of Hif-1 alpha and its target Glut-1 are reduced in tumors expressing the phyllopod fragment. These data show, in a proof-of-principle study, that Siah protein, the most upstream component of the hypoxia pathway yet identified, is a viable drug target for antitumor therapies.	[Moller, A.; House, C. M.; Wong, C. S. F.; Liu, M. C. P.; Bowtell, D. D. L.] Peter MacCallum Canc Ctr, Canc Genom & Biochem Lab, Melbourne, Vic 3002, Australia; [Moller, A.; Scanlon, D. B.; Bowtell, D. D. L.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Ronai, Z.] Burnham Inst Med Res, Signal Transduct Program, La Jolla, CA USA	Peter Maccallum Cancer Center; University of Melbourne; Sanford Burnham Prebys Medical Discovery Institute	Bowtell, DDL (corresponding author), Peter MacCallum Canc Ctr, Canc Genom & Biochem Lab, St Andrews Pl, Melbourne, Vic 3002, Australia.	d.bowtell@petermac.org	Bowtell, David/H-1007-2016; Wong, Christina SF/G-9972-2017; Möller, Andreas/O-1063-2015	Bowtell, David/0000-0001-9089-7525; Möller, Andreas/0000-0002-8618-6998; RONAI, ZEEV/0000-0002-3859-0400	Australian National Health and Medical Research Council (NHMRC) [400321, 509331]; NATIONAL CANCER INSTITUTE [R01CA111515] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The EO771 cells were a kind gift from Dr Robin Anderson, Peter MacCallum Cancer Centre. The expression plasmid for FLAG-TIEG-1 was provided by Steven Johnsen and Thomas Spelsburg ( Mayo Clinic and Foundation, Rochester, NY, USA). The expression plasmid for Myc-FIH-1 was a kind gift from Daniel Peet ( School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia). This study was funded by grants of the Australian National Health and Medical Research Council (NHMRC) to AM, CH and DB ( no. 400321 and no. 509331).	Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; CASEY AE, 1951, P SOC EXP BIOL MED, V77, P358; Chene P, 2000, J MOL BIOL, V299, P245, DOI 10.1006/jmbi.2000.3738; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Depaux A, 2006, BIOCHEM BIOPH RES CO, V348, P857, DOI 10.1016/j.bbrc.2006.07.092; Dickins RA, 2002, MOL CELL BIOL, V22, P2294, DOI 10.1128/MCB.22.7.2294-2303.2002; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Frew IJ, 2003, MOL CELL BIOL, V23, P9150, DOI 10.1128/MCB.23.24.9150-9161.2003; Fukuba H, 2007, BIOCHEM BIOPH RES CO, V353, P324, DOI 10.1016/j.bbrc.2006.12.051; Germani A, 2003, ONCOGENE, V22, P8845, DOI 10.1038/sj.onc.1206994; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Wang JL, 2000, CANCER RES, V60, P1498; Wasylyk C, 1999, ONCOGENE, V18, P1921, DOI 10.1038/sj.onc.1202528; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775	39	66	73	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					289	296		10.1038/onc.2008.382	http://dx.doi.org/10.1038/onc.2008.382			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18850011	Green Accepted			2022-12-25	WOS:000262501100012
J	Foucaud, M; Marco, E; Escrieut, C; Low, C; Kalindjian, B; Fourmy, D				Foucaud, Magali; Marco, Esther; Escrieut, Chantal; Low, Caroline; Kalindjian, Barret; Fourmy, Daniel			Linking Non-peptide Ligand Binding Mode to Activity at the Human Cholecystokinin-2 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CRYSTAL-STRUCTURE; GASTRIN RECEPTOR; ANTAGONISTS; ACTIVATION; RHODOPSIN; EXPRESSION; MECHANISM; AGONISTS; SITE	Given the importance of G-protein-coupled receptors as pharmacological targets in medicine, efforts directed at the understanding the molecular mechanism by which pharmacological compounds regulate their activity is of paramount importance. Here, we investigated at an atomic level the mechanism of inverse agonism and partial agonism of two high affinity, high selectivity very similar non-peptide ligands of the cholecystokinin-2 receptor (CCK2R) which differ by the absence or presence of a methyl group on their indole moiety. Using in silico, site-directed mutagenesis and pharmacological experiments, we demonstrated that these functionally different activities are due to differing anchoring modes of the two compounds to a residue of helix II (Thr-2.61) in the inactive state of the CCK2R. The binding mode of the inverse agonist allows the ligand to interact through its phenyl moiety with a key amino acid for CCK2R activation (Trp-6.48), preventing rotation of helix VI and, thus, CCK2R activation, whereas the partial agonist binds deeper into the binding pocket and closer to helix V, so that CCK2R activation is favored. This study on the molecular mechanism of ligand action opens the possibility of target-based optimization of G protein-coupled receptor non-peptide ligands.	[Fourmy, Daniel] INSERM, I2MR Equipe 13, U858, F-31432 Toulouse 4, France; [Foucaud, Magali; Marco, Esther; Escrieut, Chantal; Fourmy, Daniel] Univ Toulouse 3, F-31062 Toulouse, France; [Low, Caroline; Kalindjian, Barret] James Black Fdn, London SE24 9JE, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Fourmy, D (corresponding author), INSERM, I2MR Equipe 13, U858, 1 Ave Jean Poulhes,BP 84225, F-31432 Toulouse 4, France.	fourmyd@inserm.fr	Fourmy, Daniel/AAE-3703-2019	Fourmy, Daniel/0000-0001-9910-4827				Bayly CI, 1999, BIOORG MED CHEM LETT, V9, P307, DOI 10.1016/S0960-894X(98)00717-3; Becker OM, 2004, P NATL ACAD SCI USA, V101, P11304, DOI 10.1073/pnas.0401862101; Black JW, 2002, PHARMACOL TOXICOL, V91, P275, DOI 10.1034/j.1600-0773.2002.910602.x; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Foucaud M, 2006, MOL PHARMACOL, V69, P680, DOI 10.1124/mol.105.019992; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gales C, 2003, ONCOGENE, V22, P6081, DOI 10.1038/sj.onc.1206823; Gales C, 2003, MOL PHARMACOL, V63, P973, DOI 10.1124/mol.63.5.973; Herranz R, 2003, MED RES REV, V23, P559, DOI 10.1002/med.10042; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kalindjian SB, 1996, J MED CHEM, V39, P1806, DOI 10.1021/jm9508907; Kalindjian SB, 2001, J MED CHEM, V44, P1125, DOI 10.1021/jm0010668; KALINDJIAN SB, 1994, J MED CHEM, V37, P3671, DOI 10.1021/jm00048a001; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; Langer I, 2005, J BIOL CHEM, V280, P22198, DOI 10.1074/jbc.M501786200; Lu XP, 2004, MOL PHARMACOL, V66, P1192, DOI 10.1124/mol.104.000349; Marco E, 2007, J BIOL CHEM, V282, P28779, DOI 10.1074/jbc.M700349200; Noble F, 1999, PHARMACOL REV, V51, P745; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; POPLE JA, 2001, GAUSSIAN 98 REVISION; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; SADOWSKI J, 2008, CORINA 3 1; Silvente-Poirot S, 1999, J BIOL CHEM, V274, P23191, DOI 10.1074/jbc.274.33.23191; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	28	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35860	35868		10.1074/jbc.M805513200	http://dx.doi.org/10.1074/jbc.M805513200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18936102	hybrid			2022-12-25	WOS:000261687900061
J	Liu, JM; Gurpur, PB; Kaufman, SJ				Liu, Jianming; Gurpur, Praveen B.; Kaufman, Stephen J.			Genetically Determined Proteolytic Cleavage Modulates alpha 7 beta 1 Integrin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE REGENERATION; UROKINASE PLASMINOGEN-ACTIVATOR; ALPHA 7 INTEGRIN; IN-VIVO; MUSCULAR-DYSTROPHY; SATELLITE CELLS; DIFFERENTIAL EXPRESSION; EXTRACELLULAR SEGMENT; CYTOPLASMIC DOMAINS; TUMOR PROGRESSION	The dystrophin-glycoprotein complex and the alpha 7 beta 1 integrin are trans-sarcolemmal linkage systems that connect and transduce contractile forces between muscle fibers and the extracellular matrix. alpha 7 beta 1 is the major laminin binding integrin in skeletal muscle. Different functional variants of this integrin are generated by alternative splicing and post-translational modifications such as glycosylation and ADP-ribosylation. Here we report a species-specific difference in alpha 7 chains that results from an intra-peptide proteolytic cleavage, by a serine protease, at the (603)RRQ(605) site. Site-directed mutagenesis of RRQ to GRQ prevents this cleavage. This RRQ sequence in the alpha 7 integrin chain is highly conserved among vertebrates but it is absent in mice. Protein structure modeling indicates this cleavage site is located in an open region between the alpha-propeller and thigh domains of the alpha 7 chain. Compared with the non-cleavable alpha 7 chain, the cleaved form enhances cell adhesion and spreading on laminin. Cleavage of the alpha 7 chain is elevated upon myogenic differentiation, and this cleavage may be mediated by urokinase-type plasminogen activator. These results suggest proteolytic cleavage is a novel mechanism that regulates alpha 7 integrin functions in skeletal muscle, and that the generation of such cleavage sites is another evolutionary mechanism for expanding and modifying protein functions.	[Liu, Jianming; Gurpur, Praveen B.; Kaufman, Stephen J.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kaufman, SJ (corresponding author), B107 Chem & Life Sci Lab, 601 S Goodwin Ave, Urbana, IL 61801 USA.	stephenk@illinois.edu			National Institutes of Health [AG14632]; Muscular Dystrophy Association; NATIONAL INSTITUTE ON AGING [R01AG014632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health NIA Grant AG14632. This work was also supported by the Muscular Dystrophy Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Blanco-Bose WE, 2001, DEV BIOL, V233, P148, DOI 10.1006/dbio.2001.0177; Bonavaud S, 1997, J CELL SCI, V110, P1083; Boppart MD, 2006, AM J PHYSIOL-CELL PH, V290, pC1660, DOI 10.1152/ajpcell.00317.2005; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; BUCK CA, 1987, J CELL SCI, P231; Burkin DJ, 2005, AM J PATHOL, V166, P253, DOI 10.1016/S0002-9440(10)62249-3; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chernousov MA, 2007, GLIA, V55, P1134, DOI 10.1002/glia.20536; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; COLLO G, 1993, J BIOL CHEM, V268, P19019; Crawley S, 1997, EXP CELL RES, V235, P274, DOI 10.1006/excr.1997.3671; Davis TL, 2002, CELL GROWTH DIFFER, V13, P107; Davis TL, 2001, J BIOL CHEM, V276, P26099, DOI 10.1074/jbc.M102811200; Demetriou MC, 2004, EXP CELL RES, V294, P550, DOI 10.1016/j.yexcr.2003.11.023; Demetriou MC, 2004, J CELL BIOCHEM, V91, P26, DOI 10.1002/jcb.10675; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; FESTOFF BW, 1994, J CELL PHYSIOL, V159, P11, DOI 10.1002/jcp.1041590103; FESTOFF BW, 1990, J CELL PHYSIOL, V144, P262, DOI 10.1002/jcp.1041440212; Fibbi G, 2002, BIOL CHEM, V383, P127, DOI 10.1515/BC.2002.013; Fibbi G, 2001, LAB INVEST, V81, P27, DOI 10.1038/labinvest.3780209; FOSTER RF, 1987, DEV BIOL, V122, P11, DOI 10.1016/0012-1606(87)90327-7; Ge Y, 2004, ELECTROPHORESIS, V25, P2576, DOI 10.1002/elps.200406013; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Harbeck N, 2004, THROMB HAEMOSTASIS, V91, P450, DOI 10.1160/TH03-12-0798; HEMLER ME, 1990, IMMUNOL REV, V114, P45, DOI 10.1111/j.1600-065X.1990.tb00561.x; HEMLER ME, 1987, J BIOL CHEM, V262, P11478; Hodges BL, 1997, J CELL SCI, V110, P2873; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; HUMPHRIES MJ, 1990, J CELL SCI, V97, P585; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jethanandani P, 2005, J BIOL CHEM, V280, P36037, DOI 10.1074/jbc.M508698200; Kaariainen M, 2002, AM J PATHOL, V161, P1023, DOI 10.1016/S0002-9440(10)64263-0; KASSNER PD, 1992, ADV EXP MED BIOL, V323, P163; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Kugler MC, 2003, CURR PHARM DESIGN, V9, P1565, DOI 10.2174/1381612033454658; Laufs S, 2006, CELL CYCLE, V5, P1760; Le Moigne A, 1990, Int J Dev Biol, V34, P171; Lluis F, 2001, BLOOD, V97, P1703, DOI 10.1182/blood.V97.6.1703; Lopez-Alemany R, 2005, FRONT BIOSCI-LANDMRK, V10, P30, DOI 10.2741/1503; LOWREY AA, 1989, EXP CELL RES, V183, P1, DOI 10.1016/0014-4827(89)90414-X; Magdolen V, 2003, RECENT RESULTS CANC, V162, P43; Malik RK, 1997, J PEDIAT HEMATOL ONC, V19, P541, DOI 10.1097/00043426-199711000-00013; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; Miralles F, 1999, THROMB HAEMOSTASIS, V81, P767, DOI 10.1055/s-0037-1614569; Nozaki S, 2006, ANTI-CANCER DRUG, V17, P1109, DOI 10.1097/01.cad.0000231483.09439.3a; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; PARKER CM, 1993, J BIOL CHEM, V268, P7028; Pawar SC, 2007, EXP CELL RES, V313, P1080, DOI 10.1016/j.yexcr.2007.01.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pillay V, 2007, TRENDS BIOTECHNOL, V25, P33, DOI 10.1016/j.tibtech.2006.10.011; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; QUAX PHA, 1992, DEV BIOL, V151, P166, DOI 10.1016/0012-1606(92)90224-5; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Ren BG, 2007, J NATL CANCER I, V99, P868, DOI 10.1093/jnci/djk199; RONNE E, 1994, J IMMUNOL METHODS, V167, P91, DOI 10.1016/0022-1759(94)90078-7; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; SANADA Y, 1978, J BIOCHEM, V83, P27, DOI 10.1093/oxfordjournals.jbchem.a131901; SCHMALBRUCH H, 1986, BIBL ANAT, V29, P126; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Snider L, 2003, CELL, V113, P811, DOI 10.1016/S0092-8674(03)00474-4; SONG WK, 1993, J CELL SCI, V106, P1139; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; Suelves M, 2005, FRONT BIOSCI-LANDMRK, V10, P2978, DOI 10.2741/1754; Suelves M, 2002, BLOOD, V99, P2835, DOI 10.1182/blood.V99.8.2835; Suelves M, 2007, J CELL BIOL, V178, P1039, DOI 10.1083/jcb.200705127; Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200; TEIXIDO J, 1992, J BIOL CHEM, V267, P1786; Tomatis D, 1999, EXP CELL RES, V246, P421, DOI 10.1006/excr.1998.4315; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; Wells JM, 1997, J CELL PHYSIOL, V171, P217, DOI 10.1002/(SICI)1097-4652(199705)171:2<217::AID-JCP13>3.0.CO;2-A; Xiao JQ, 2003, J BIOL CHEM, V278, P49780, DOI 10.1074/jbc.M308542200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598; Yeh MG, 2003, MOL BIOL CELL, V14, P3507, DOI 10.1091/mbc.E02-12-0824; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200; Zhao ZF, 2005, BIOCHEM J, V385, P309, DOI 10.1042/BJ20040590; Ziober BL, 1997, MOL BIOL CELL, V8, P1723, DOI 10.1091/mbc.8.9.1723; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773; Zolkiewska A, 1997, ADV EXP MED BIOL, V419, P297	94	9	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35668	35678		10.1074/jbc.M804661200	http://dx.doi.org/10.1074/jbc.M804661200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18940796	Green Published, hybrid			2022-12-25	WOS:000261687900041
J	Zhou, JL; Blue, EK; Hu, GQ; Herring, BP				Zhou, Jiliang; Blue, Emily K.; Hu, Guoqing; Herring, B. Paul			Thymine DNA Glycosylase Represses Myocardin-induced Smooth Muscle Cell Differentiation by Competing with Serum Response Factor for Myocardin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; EXCISION-REPAIR; TRANSCRIPTION; PROMOTER; ALPHA; ACTIVATION; PROGRAMS; FAMILY	Myocardin is a serum response factor (SRF) co-activator that regulates transcription of many smooth muscle-specific genes and is essential for development of vascular smooth muscle. We used a yeast two-hybrid screen, with myocardin as bait in a search for factors that regulate myocardin transcriptional activity. From this screen, thymine DNA glycosylase (TDG) was identified as a myocardin-associated protein. TDG was originally identified as an enzyme involved in base excision repair of T: G mismatches caused by spontaneous deamination of methylated cytosines. However, TDG has also been shown to act as a transcriptional co-activator or co-repressor. The interaction between TDG and myocardin was confirmed in vitro by glutathione S-transferase pull down and in vivo by co-immunoprecipitation assays. We found that TDG abrogates myocardin induced expression of smooth muscle-specific genes and represses the trans-activation of the promoters of myocardin of these genes. Overexpression of TDG in SMCs down-regulated smooth muscle marker expression. Conversely, depletion of endogenous TDG in SMCs increased smooth muscle-specific myosin heavy chain (SM MHC) and Telokin gene expression. Glutathione S-transferase pull-down assays demonstrated that TDG binds to a region of myocardin that includes the SRF binding domain. Furthermore, TDG was found to compete with SRF for binding to myocardin in vitro and in vivo, suggesting that TDG can inhibit expression of smooth muscle-specific genes, at least in part, through disrupting SRF/myocardin interactions. Finally, we demonstrated that the glycosylase activity of TDG is not required for its inhibitory effects on myocardin function. This study reveals a previously unsuspected role for the repair enzyme TDG as a repressor of smooth	[Zhou, Jiliang; Hu, Guoqing] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Blue, Emily K.; Herring, B. Paul] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Albany Medical College; Indiana University System; Indiana University-Purdue University Indianapolis	Zhou, JL (corresponding author), 47 New Scotland Ave, Albany, NY 12208 USA.	zhouj1@mail.amc.edu		Blue, Emily/0000-0001-8290-4473	National Institutes of Health [DK61130, DK65644]; American Heart Association postdoctoral fellowship and Scientist Development; Indiana University Diabetes and Obesity Training [DK064466]; American Heart Association predoctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064466, R01DK061130, R01DK065644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship and Scientist Development(American Heart Association); Indiana University Diabetes and Obesity Training; American Heart Association predoctoral fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61130 and DK65644 ( to B. P. H.). This work was also supported by an American Heart Association postdoctoral fellowship and Scientist Development grant ( to J. Z.), Indiana University Diabetes and Obesity Training Grant DK064466, and an American Heart Association predoctoral fellowship ( to E. K. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Herring BP, 1996, AM J PHYSIOL-CELL PH, V270, pC1656, DOI 10.1152/ajpcell.1996.270.6.C1656; Hoggatt AM, 2002, CIRC RES, V91, P1151, DOI 10.1161/01.RES.0000047508.30800.4F; JOST JP, 1993, P NATL ACAD SCI USA, V90, P4684, DOI 10.1073/pnas.90.10.4684; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lucey MJ, 2005, NUCLEIC ACIDS RES, V33, P6393, DOI 10.1093/nar/gki940; Mack CP, 1999, CIRC RES, V84, P852; Madsen CS, 1998, CIRC RES, V82, P908; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; Niederreither K, 1998, ONCOGENE, V17, P1577, DOI 10.1038/sj.onc.1202072; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Schmutte C, 1997, CANCER RES, V57, P3010; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	36	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35383	35392		10.1074/jbc.M805489200	http://dx.doi.org/10.1074/jbc.M805489200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945672	Green Published, hybrid			2022-12-25	WOS:000261687900009
J	Gundimeda, U; Schiffman, JE; Chhabra, D; Wong, J; Wu, A; Gopalakrishna, R				Gundimeda, Usha; Schiffman, Jason Eric; Chhabra, Divya; Wong, Jourdan; Wu, Adela; Gopalakrishna, Rayudu			Locally Generated Methylseleninic Acid Induces Specific Inactivation of Protein Kinase C Isoenzymes RELEVANCE TO SELENIUM-INDUCED APOPTOSIS IN PROSTATE CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN REDUCTASE; MALIGNANT MESOTHELIOMA CELLS; REGULATED GENE-EXPRESSION; PHORBOL ESTER BINDING; CHEMOPREVENTIVE AGENTS; SELENOCOMPOUNDS INDUCE; LIPID OXIDATION; DELTA-PKC; IN-VITRO; INHIBITION	In this study, we show that methylselenol, a selenometabolite implicated in cancer prevention, did not directly inactivate protein kinase C (PKC). Nonetheless, its oxidation product, methylseleninic acid (MSA), inactivated PKC at low micromolar concentrations through a redox modification of vicinal cysteine sulfhydryls in the catalytic domain of PKC. This modification of PKC that occurred in both isolated form and in intact cells was reversed by a reductase system involving thioredoxin reductase, a selenoprotein. PKC isoenzymes exhibited variable sensitivity to MSA with Ca2+-dependent PKC isoenzymes (alpha, beta, and gamma) being the most susceptible, followed by isoenzymes delta and epsilon. Other enzymes tested were inactivated only with severalfold higher concentrations of MSA than those required for PKC inactivation. This specificity for PKC was further enhanced when MSA was generated within close proximity to PKC through a reaction of methylselenol with PKC-bound lipid peroxides in the membrane. The MSA-methylselenol redox cycle resulted in the catalytic oxidation of sulfhydryls even with nanomolar concentrations of selenium. MSA inhibited cell growth and induced apoptosis in DU145 prostate cancer cells at a concentration that was higher than that needed to inhibit purified PKC alpha but in a range comparable with that required for the inhibition of PKC epsilon. This MSA-induced growth inhibition and apoptosis decreased with a conditional overexpression of PKC epsilon and increased with its knock-out by small interfering RNA. Conceivably, when MSA is generated within the vicinity of PKC, it specifically inactivates PKC isoenzymes, particularly the promitogenic and prosurvival epsilon isoenzyme, and this inactivation causes growth inhibition and apoptosis.	[Gundimeda, Usha; Schiffman, Jason Eric; Chhabra, Divya; Wong, Jourdan; Wu, Adela; Gopalakrishna, Rayudu] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA	University of Southern California	Gopalakrishna, R (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, BMT 403,1333 San Pablo St, Los Angeles, CA 90089 USA.	rgopalak@usc.edu		Wu, Adela/0000-0003-4543-9300				Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Berggren M, 1996, ANTICANCER RES, V16, P3459; Bjornstedt M, 1996, BIOCHEMISTRY-US, V35, P8511, DOI 10.1021/bi9528762; BLUMBERG PM, 1991, MOL CARCINOGEN, V4, P339, DOI 10.1002/mc.2940040502; BONI LT, 1985, J BIOL CHEM, V260, P819; BOREK C, 1986, P NATL ACAD SCI USA, V83, P1490, DOI 10.1073/pnas.83.5.1490; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; CACACE AM, 1993, ONCOGENE, V8, P2095; CHEN SJ, 1993, BIOCHEMISTRY-US, V32, P1032, DOI 10.1021/bi00055a006; Christensen MJ, 2007, NUTR CANCER, V58, P197, DOI 10.1080/01635580701328701; Chu F, 2004, CARCINOGENESIS, V25, P585, DOI 10.1093/carcin/bgh041; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; CLARK LC, 1985, FED PROC, V44, P2584; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; COTGREAVE IA, 1992, CHEM-BIOL INTERACT, V84, P69, DOI 10.1016/0009-2797(92)90121-Z; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Drake EN, 2006, MED HYPOTHESES, V67, P318, DOI 10.1016/j.mehy.2006.01.058; El-Bayoumy K, 2001, NUTR CANCER, V40, P18, DOI 10.1207/S15327914NC401_6; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fleshner N, 1999, J UROLOGY, V161, P1651, DOI 10.1016/S0022-5347(05)68998-7; FORMAN HJ, 1989, ARCH BIOCHEM BIOPHYS, V274, P443, DOI 10.1016/0003-9861(89)90457-8; FROSCIO M, 1989, BIOCHEM PHARMACOL, V38, P2087, DOI 10.1016/0006-2952(89)90061-0; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; Ghosh J, 2004, BIOCHEM BIOPH RES CO, V315, P624, DOI 10.1016/j.bbrc.2004.01.100; Ghosh J, 1997, BIOCHEM BIOPH RES CO, V235, P418, DOI 10.1006/bbrc.1997.6799; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; GOPALAKRISHNA R, 1993, ANAL BIOCHEM, V212, P296, DOI 10.1006/abio.1993.1331; Gopalakrishna R, 2002, J NUTR, V132, p3819S, DOI 10.1093/jn/132.12.3819S; Gopalakrishna R, 2001, NUTR CANCER, V40, P55, DOI 10.1207/S15327914NC401_11; Gopalakrishna R, 1997, ARCH BIOCHEM BIOPHYS, V348, P37, DOI 10.1006/abbi.1997.0335; Gopalakrishna R, 1997, ARCH BIOCHEM BIOPHYS, V348, P25, DOI 10.1006/abbi.1997.0334; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; GOPALAKRISHNA R, 1992, ANAL BIOCHEM, V206, P24, DOI 10.1016/S0003-2697(05)80006-5; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; GREEDER GA, 1980, SCIENCE, V209, P825, DOI 10.1126/science.7406957; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Gromer S, 2002, J BIOL CHEM, V277, P9701, DOI 10.1074/jbc.M109234200; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Holmgren A, 2006, FREE RADICAL BIO MED, V41, P862, DOI 10.1016/j.freeradbiomed.2006.05.024; IP C, 1990, CANCER RES, V50, P1206; Ip C, 2000, CANCER RES, V60, P2882; Jiang C, 2001, CANCER RES, V61, P3062; Kahlos K, 2003, MOL CELL BIOCHEM, V254, P47, DOI 10.1023/A:1027380828645; Karp JE, 1996, CANCER RES, V56, P5547; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; KILLILEA SD, 1979, ARCH BIOCHEM BIOPHYS, V193, P130, DOI 10.1016/0003-9861(79)90016-X; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; KOSAKA Y, 1988, BIOCHEM BIOPH RES CO, V151, P973, DOI 10.1016/S0006-291X(88)80461-3; Kumar S, 1999, CARCINOGENESIS, V20, P1761, DOI 10.1093/carcin/20.9.1761; Lamm MLG, 1997, ENDOCRINOLOGY, V138, P4657, DOI 10.1210/en.138.11.4657; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Moak MA, 2001, BIOL TRACE ELEM RES, V79, P257, DOI 10.1385/BTER:79:3:257; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murriel CL, 2003, ARCH BIOCHEM BIOPHYS, V420, P246, DOI 10.1016/j.abb.2003.08.038; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Nilsonne G, 2006, FREE RADICAL BIO MED, V41, P874, DOI 10.1016/j.freeradbiomed.2006.04.031; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OBRIAN CA, 1988, BIOCHEM BIOPH RES CO, V155, P1374, DOI 10.1016/S0006-291X(88)81293-2; OGITA K, 1992, P NATL ACAD SCI USA, V89, P1592, DOI 10.1073/pnas.89.5.1592; OLAH Z, 1994, ANAL BIOCHEM, V221, P94, DOI 10.1006/abio.1994.1384; Orlandi L, 2003, PROSTATE, V54, P133, DOI 10.1002/pros.10181; Park HS, 2000, J BIOL CHEM, V275, P2527, DOI 10.1074/jbc.275.4.2527; Parker TL, 2007, J NUTR BIOCHEM, V18, P746, DOI 10.1016/j.jnutbio.2006.12.013; SAIDO TC, 1992, BIOCHEMISTRY-US, V31, P482, DOI 10.1021/bi00117a026; SALGO MG, 1993, ARCH BIOCHEM BIOPHYS, V304, P123, DOI 10.1006/abbi.1993.1330; Seo YR, 2002, P NATL ACAD SCI USA, V99, P14548, DOI 10.1073/pnas.212319799; SHARMA S, 1994, CANCER RES, V54, P5848; Sies H, 1997, Adv Pharmacol, V38, P229; Sinha R, 2001, BIOCHEM PHARMACOL, V61, P311, DOI 10.1016/S0006-2952(00)00545-1; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; SPYROU G, 1995, FEBS LETT, V368, P59, DOI 10.1016/0014-5793(95)00599-5; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; SWEETMAN LL, 1995, ARCH BIOCHEM BIOPHYS, V323, P97, DOI 10.1006/abbi.1995.0014; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; THANNHAUSER TW, 1987, METHOD ENZYMOL, V143, P115; Thompson IM, 1997, PROSTATE, V33, P217, DOI 10.1002/(SICI)1097-0045(19971101)33:3<217::AID-PROS11>3.0.CO;2-N; Watson JA, 1999, BIOCHEM J, V343, P301, DOI 10.1042/0264-6021:3430301; WEBBER MM, 1985, BIOCHEM BIOPH RES CO, V130, P603, DOI 10.1016/0006-291X(85)90459-0; WENDEL A, 1984, BIOCHEM PHARMACOL, V33, P3241, DOI 10.1016/0006-2952(84)90084-4; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902; Wu DQ, 2002, CANCER RES, V62, P2423; Wycherly BJ, 2004, NUTR CANCER, V48, P78, DOI 10.1207/s15327914nc4801_11	88	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34519	34531		10.1074/jbc.M807007200	http://dx.doi.org/10.1074/jbc.M807007200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922790	hybrid, Green Published			2022-12-25	WOS:000261469100006
J	Mitsi, M; Forsten-Williams, K; Gopalakrishnan, M; Nugent, MA				Mitsi, Maria; Forsten-Williams, Kimberly; Gopalakrishnan, Manoj; Nugent, Matthew A.			A Catalytic Role of Heparin within the Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR BINDING; LIGAND DISSOCIATION KINETICS; MAST-CELLS; PLASMA FIBRONECTIN; GRANULE PROTEASES; IONIC-STRENGTH; BREAST-CANCER; MECHANISM; INTEGRIN; ANTITHROMBIN	We investigated the mechanism by which heparin enhances the binding of vascular endothelial growth factor ( VEGF) to the extracellular matrix protein fibronectin. In contrast to other systems, where heparin acts as a protein scaffold, we found that heparin functions catalytically to modulate VEGF binding site availability on fibronectin. By measuring the binding of VEGF and heparin to surface-immobilized fibronectin, we show that substoichiometric amounts of heparin exposed cryptic VEGF binding sites within fibronectin that remain available after heparin removal. Measurement of association and dissociation kinetics for heparin binding to fibronectin indicated that the interaction is rapid and transient. We localized the heparin-responsive element to the C-terminal 40-kDa Hep2 domain of fibronectin. A mathematical model of this catalytic process was constructed that supports a mechanism whereby the heparin-induced conformational change in fibronectin is accompanied by release of heparin. Experiments with endothelial extracellular matrix suggest that this process may also occur within biological matrices. These results indicate a novel mechanism whereby heparin catalyzes the conversion of fibronectin to an open conformation by transiently interacting with fibronectin and progressively hopping from molecule to molecule. Catalytic activation of the extracellular matrix might be an important mechanism for heparin to regulate function during normal and disease states.	[Mitsi, Maria; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Nugent, Matthew A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Nugent, Matthew A.] Boston Univ, Dept Biomed Engn, Boston, MA 02118 USA; [Forsten-Williams, Kimberly] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA; [Gopalakrishnan, Manoj] Harish Chandra Res Inst, Allahabad 211019, Uttar Pradesh, India	Boston University; Boston University; Boston University; Virginia Polytechnic Institute & State University; Harish Chandra Research Institute	Nugent, MA (corresponding author), Boston Univ, Sch Med, Dept Biochem, Rm K225,715 Albany St, Boston, MA 02118 USA.	mnugent@bu.edu	Gopalakrishnan, Manoj/D-3359-2014; Mitsi, Maria/S-2519-2017	Gopalakrishnan, Manoj/0000-0002-7931-5042; Mitsi, Maria/0000-0001-8983-1983; Nugent, Matthew/0000-0002-8630-4712	National Institutes of Health [HL56200, HL088572]; Massachusetts Lions Eye Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088572, R01HL056200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56200 and HL088572. This work was also supported by a departmental grant from the Massachusetts Lions Eye Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AZIZKHAN RG, 1980, J EXP MED, V152, P931, DOI 10.1084/jem.152.4.931; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Borsig L, 2003, PATHOPHYSIOL HAEMO T, V33, P64, DOI 10.1159/000073298; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; CLARK RAF, 1982, J INVEST DERMATOL, V79, P269, DOI 10.1111/1523-1747.ep12500076; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Della Rovere F, 2007, ANTICANCER RES, V27, P2465; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; ERICKSON J, 1987, BIOPHYS J, V52, P657, DOI 10.1016/S0006-3495(87)83258-7; ERICKSON JW, 1991, BIOCHEMISTRY-US, V30, P2357, DOI 10.1021/bi00223a009; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; EVINGTON JRN, 1986, BIOCHIM BIOPHYS ACTA, V870, P92, DOI 10.1016/0167-4838(86)90012-9; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Goerges AL, 2004, J BIOL CHEM, V279, P2307, DOI 10.1074/jbc.M308482200; GOLDSTEIN B, 1989, BIOPHYS J, V56, P955, DOI 10.1016/S0006-3495(89)82741-9; Gopalakrishnan M, 2005, BIOPHYS J, V89, P3686, DOI 10.1529/biophysj.105.065300; Gopalakrishnan M, 2005, EUR BIOPHYS J BIOPHY, V34, P943, DOI 10.1007/s00249-005-0471-2; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Humphries DE, 1999, J HISTOCHEM CYTOCHEM, V47, P1645; INGHAM KC, 1993, BIOCHEMISTRY-US, V32, P12548, DOI 10.1021/bi00097a035; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Lagerholm BC, 1998, BIOPHYS J, V74, P1215, DOI 10.1016/S0006-3495(98)77836-1; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; MACHOVICH R, 1981, BIOCHEM J, V199, P521, DOI 10.1042/bj1990521; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miralem T, 2001, ONCOGENE, V20, P5511, DOI 10.1038/sj.onc.1204753; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.3.CO;2-R; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Nader HB, 2004, CURR PHARM DESIGN, V10, P951, DOI 10.2174/1381612043452758; NESHEIM ME, 1983, J BIOL CHEM, V258, P4708; Nienartowicz A, 2006, MED SCI MONITOR, V12, pRA53; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; OSTERLUND E, 1985, BIOCHEMISTRY-US, V24, P2661, DOI 10.1021/bi00332a011; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; POMERANTZ MW, 1978, BIOCHIM BIOPHYS ACTA, V535, P66, DOI 10.1016/0005-2795(78)90033-8; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; RICHTER H, 1985, BIOL CHEM H-S, V366, P509, DOI 10.1515/bchm3.1985.366.1.509; ROCCO M, 1983, J BIOL CHEM, V258, P4545; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Samoszuk M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-121; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Stringer SE, 1997, INT J BIOCHEM CELL B, V29, P709, DOI 10.1016/S1357-2725(96)00170-7; Tsou R, 2001, MOL CELL BIOCHEM, V224, P81, DOI 10.1023/A:1011947301849; VUILLARD L, 1994, INT J BIOL MACROMOL, V16, P21, DOI 10.1016/0141-8130(94)90006-X; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973; Zacharski LR, 1998, THROMB HAEMOSTASIS, V80, P10; Zacharski LR, 2002, CANCER LETT, V186, P1, DOI 10.1016/S0304-3835(02)00258-6	62	59	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34796	34807		10.1074/jbc.M806692200	http://dx.doi.org/10.1074/jbc.M806692200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845539	Green Published, hybrid			2022-12-25	WOS:000261469100036
J	Stevens, HC; Malone, L; Nichols, JW				Stevens, Haley C.; Malone, Lynn; Nichols, J. Wylie			The Putative Aminophospholipid Translocases, DNF1 and DNF2, Are Not Required for 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-phosphatidylserine Flip across the Plasma Membrane of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; FLUORESCENCE-LABELED PHOSPHOLIPIDS; ASYMMETRIC DISTRIBUTION; TRANSPORT PATHWAYS; YEAST; ENDOCYTOSIS; PROTEIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; DRS2P	The regulation of phosphatidylserine (PS) distribution across the plasma membrane of eukaryotic cells has been implicated in numerous cell functions (e.g. apoptosis and coagulation). In a recent study, fluorescent phospholipids labeled in the acyl chain with 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) were used to identify two members of the P4 subfamily of P-type ATPases, Dnf1p and Dnf2p, that are necessary for the inward-directed transport of phospholipids across the plasma membrane (flip) of yeast (Pomorski, T., Lombardi, R., Riezman, H., Devaux, P. F., Van Meer, G., and Holthuis, J.C. (2003) Mol. Biol. Cell 14, 1240 1254). Herein, we present evidence that the flip of NBD-labeled PS (NBD-PS) across the plasma membrane does not require the expression of Dnf1p or Dnf2p. In strains in which DNF1 and DNF2 are both deleted, the flip of NBD-PS is increased similar to 2-fold over that of the isogenic parent strain, whereas the flip of NBD-labeled phosphatidylcholine and NBD-labeled phosphatidylethanolamine are reduced to similar to 20 and similar to 50%, respectively. The mechanism responsible for NBD-PS flip is similar to that for NBD-labeled phosphatidylcholine and NBD-labeled phosphatidylethanolamine in its dependence on cellular ATP and the plasma membrane proton electrochemical gradient, as well as its regulation by the transcription factors Pdr1p and Pdr3p. Based on the observation that deletion or inactivation of all four members of the DRS2/DNF essential subfamily of P-type ATPases does not affect NBD-PS flip, we conclude that the activity reflected by NBD-PS internalization is not the essential function of the DRS2/DNF subfamily of P-type ATPases.	[Stevens, Haley C.; Malone, Lynn; Nichols, J. Wylie] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Nichols, JW (corresponding author), Emory Univ, Sch Med, Dept Physiol, 615 Michael St,605G Whitehead, Atlanta, GA 30322 USA.	wylie.nichols@emory.edu			Institute of General Medicine [GM64770]; University Research Committee of Emory University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064770] Funding Source: NIH RePORTER	Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Research Committee of Emory University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grant GM64770 from the Institute of General Medicine and by a grant from the University Research Committee of Emory University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Elvington SM, 2005, J BIOL CHEM, V280, P40957, DOI 10.1074/jbc.M507926200; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Grant AM, 2001, TRAFFIC, V2, P37, DOI 10.1034/j.1600-0854.2001.020106.x; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Hanson PK, 2001, J BIOL CHEM, V276, P9861, DOI 10.1074/jbc.M009065200; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Ikeda M, 2006, BIOL PHARM BULL, V29, P1542, DOI 10.1248/bpb.29.1542; Karpova TS, 2000, MOL BIOL CELL, V11, P1727, DOI 10.1091/mbc.11.5.1727; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; KEAN LS, 1993, J CELL BIOL, V123, P1403, DOI 10.1083/jcb.123.6.1403; Kean LS, 1997, J CELL BIOL, V138, P255, DOI 10.1083/jcb.138.2.255; Marx U, 1999, EUR J BIOCHEM, V263, P254, DOI 10.1046/j.1432-1327.1999.00497.x; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Nichols JW, 2002, SEMIN CELL DEV BIOL, V13, P179, DOI 10.1016/S1084-9521(02)00046-0; PAGANO RE, 1985, SCIENCE, V229, P1051, DOI 10.1126/science.4035344; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Prezant TR, 1996, MICROBIOL-SGM, V142, P3407, DOI 10.1099/13500872-142-12-3407; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; RIEZMAN H, 1986, TRENDS BIOCHEM SCI, V11, P325, DOI 10.1016/0968-0004(86)90290-2; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Sherman F., 1986, METHODS YEAST GENETI; Siegmund A, 1998, J BIOL CHEM, V273, P34399, DOI 10.1074/jbc.273.51.34399; Stevens HC, 2007, J BIOL CHEM, V282, P17563, DOI 10.1074/jbc.M700454200; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Yamaji-Hasegawa A, 2006, BIOL PHARM BULL, V29, P1547, DOI 10.1248/bpb.29.1547	40	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35060	35069		10.1074/jbc.M802379200	http://dx.doi.org/10.1074/jbc.M802379200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18931395	Green Published, hybrid			2022-12-25	WOS:000261469100063
J	Zhang, P; Samuel, CE				Zhang, Ping; Samuel, Charles E.			Induction of Protein Kinase PKR-dependent Activation of Interferon Regulatory Factor 3 by Vaccinia Virus Occurs through Adapter IPS-1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; ANTIVIRAL RESPONSE; I-INTERFERON; HUMAN-CELLS; TRANSCRIPTION FACTORS; ADENOSINE-DEAMINASE; IRF-3 ACTIVATION; INFECTED CELLS; PHOSPHORYLATION	Interferon regulatory factor 3 (IRF-3) undergoes phosphorylation-induced activation in virus-infected cells and plays an important role in the antiviral innate immune response. The E3L protein encoded by vaccinia virus is known to impair phosphorylation and activation of IRF-3. Kinases in addition to I kappa B kinase-related kinases are implicated in the IRF-3-dependent antiviral response. To test in human cells the role of the protein kinase regulated by RNA (PKR) in IRF-3 activation, HeLa cells made stably deficient in PKR using an RNA interference strategy were compared with PKR-sufficient cells. Rapid phosphorylation and nuclear accumulation of IRF-3 were detected in PKR-sufficient cells following infection with E3L deletion mutant (Delta E3L) virus. By contrast, the full IRF-3 activation response was largely abolished in PKR-deficient cells. The Delta E3L virus-induced IRF-3 activation seen in PKR-sufficient cells was diminished by treatment with cytosine beta-D-arabinofuranoside. Furthermore, the vaccinia mutant ts23, which displays increased viral double-stranded RNA production at 39 C, induced PKR-dependent IRF-3 phosphorylation at 39 C but not at 31 C. Both IRF-3 phosphorylation and cell apoptosis induced by infection with Delta E3L virus were dependent upon RIG-I-like receptor signal transduction components, including the adapter IPS-1. These data suggest that PKR facilitates the host innate immune response and apoptosis in virus-infected cells by mediating IRF-3 activation through the mitochondrial IPS-1 signal transduction pathway.	[Zhang, Ping; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			National Institutes of Health [AI-12520, AI-20611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020611, R01AI012520, R37AI012520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-12520 and AI-20611 (NIAID research grants from USPHS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Arsenio J, 2008, VIROLOGY, V377, P124, DOI 10.1016/j.virol.2008.04.014; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; BAYLISS CD, 1993, VIROLOGY, V194, P254, DOI 10.1006/viro.1993.1256; BEATTIE E, 1995, VIROLOGY, V210, P254, DOI 10.1006/viro.1995.1342; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bouxsein NF, 2007, BIOCHEMISTRY-US, V46, P4785, DOI 10.1021/bi062138l; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; COLBY C, 1971, J VIROL, V7, P71, DOI 10.1128/JVI.7.1.71-76.1971; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gil J, 2000, ONCOGENE, V19, P3665, DOI 10.1038/sj.onc.1203710; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Ho CK, 1996, J VIROL, V70, P2611, DOI 10.1128/JVI.70.4.2611-2614.1996; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Iordanov MS, 2005, APOPTOSIS, V10, P153, DOI 10.1007/s10495-005-6070-y; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson J, 2007, J BIOL CHEM, V282, P15022, DOI 10.1074/jbc.M700421200; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; Moss B, 2001, FIELDS VIROLOGY, P2849; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Onomoto K, 2007, CURR TOP MICROBIOL, V316, P193; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Uno T, 2005, MOL CANCER THER, V4, P799, DOI 10.1158/1535-7163.MCT-04-0317; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07	62	58	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34580	34587		10.1074/jbc.M807029200	http://dx.doi.org/10.1074/jbc.M807029200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18927075	Green Published, hybrid			2022-12-25	WOS:000261469100012
J	Lee, YM; Lee, JO; Jung, JH; Kim, JH; Park, SH; Park, JM; Kim, EK; Suh, PG; Kim, HS				Lee, Yun Mi; Lee, Jung Ok; Jung, Jin-Hee; Kim, Ji Hae; Park, Sun-Hwa; Park, Ji Man; Kim, Eung-Kyun; Suh, Pann-Ghill; Kim, Hyeon Soo			Retinoic Acid Leads to Cytoskeletal Rearrangement through AMPK-Rac1 and Stimulates Glucose Uptake through AMPK-p38 MAPK in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-INHIBITION; CANCER CELLS; FATTY-ACID; ACTIN; EXPRESSION; MOTILITY; DIFFERENTIATION; PATHWAY; CA2+	Retinoic acid (RA) is one of the major components of vitamin A. In the present study, we found that retinoic acid activated AMP-activated protein kinase (AMPK). RA induced Rac1-GTP formation and phosphorylation of its downstream target, p21-activated kinase (PAK), whereas the inhibition of AMPK blocked RA-induced Rac1 activation. Moreover, cofilin, an actin polymerization regulator, was activated when incubated with RA. We then showed that inhibition of AMPK by compound C, a selective inhibitor of AMPK, or small interfering RNA of AMPK alpha 1 blocked RA-induced cofilin phosphorylation. Additionally, we found that retinoic acid-stimulated glucose uptake in differentiated C2C12 myoblast cells and activated p38 mitogen-activated protein kinase (MAPK). Finally, the inhibition of AMPK and p38 MAPK blocked retinoic acid-induced glucose uptake. In summary, our results suggest that retinoic acid may have cytoskeletal roles in skeletal muscle cells via stimulation of the AMPK-Rac1-PAK-cofillin pathway and may also have beneficial roles in glucose metabolism via stimulation of the AMPK-p38 MAPK pathway.	[Lee, Yun Mi; Lee, Jung Ok; Jung, Jin-Hee; Kim, Ji Hae; Park, Sun-Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea; [Park, Ji Man; Kim, Eung-Kyun; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 770784, South Korea	Korea University; Korea University Medicine (KU Medicine); Pohang University of Science & Technology (POSTECH)	Kim, HS (corresponding author), 126-1,5 Ga Anam Dong, Seoul 136701, South Korea.	anatomykim@korea.ac.kr	Suh, Pann-Ghill/F-3610-2010		Korea University College of Medicine; Korea Science and Engineering Foundation [R01-2008-000-11180-0]	Korea University College of Medicine; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported Korea University College of Medicine and Korea Science and Engineering Foundation Grant KOSEF, R01-2008-000-11180-0. The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must therefore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1291, DOI 10.1152/ajpendo.00167.2001; Blutt SE, 1997, ENDOCRINOLOGY, V138, P1491, DOI 10.1210/en.138.4.1491; Carlier MF, 2003, BIOESSAYS, V25, P336, DOI 10.1002/bies.10257; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Fitzgerald P, 1997, CANCER RES, V57, P2642; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Hong SE, 2004, J MED FOOD, V7, P320, DOI 10.1089/1096620041938696; HONG WK, 1994, LEUKEMIA, V8, pS33; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Makinde AO, 1997, CIRC RES, V80, P482, DOI 10.1161/01.RES.80.4.482; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Montessuit C, 2008, ENDOCRINOLOGY, V149, P1064, DOI 10.1210/en.2007-0656; Nicholson-Dykstra S, 2005, CURR BIOL, V15, pR346, DOI 10.1016/j.cub.2005.04.029; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; ODWYER PJ, 1987, J SURG RES, V43, P550, DOI 10.1016/0022-4804(87)90130-2; OREFFO ROC, 1988, J BONE MINER RES, V3, P203; PANG J, 2005, J NEUOROCHEM, V93, P571; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; SHEIKH MS, 1994, J BIOL CHEM, V269, P21440; Shyu RY, 2003, J BIOMED SCI, V10, P313, DOI 10.1159/000070096; VARANI J, 1995, AM J PATHOL, V147, P718; Zhang WK, 2007, AM J PHYSIOL-RENAL, V292, pF1054, DOI 10.1152/ajprenal.00286.2006; Zitterbart K, 2001, NEOPLASMA, V48, P456; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	32	67	71	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33969	33974		10.1074/jbc.M804469200	http://dx.doi.org/10.1074/jbc.M804469200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18927084	Green Published, hybrid			2022-12-25	WOS:000261277700023
J	Ponticelli, S; Marasco, D; Tarallo, V; Albuquerque, RJC; Mitola, S; Takeda, A; Stassen, JM; Presta, M; Ambati, J; Ruvo, M; De Falco, S				Ponticelli, Salvatore; Marasco, Daniela; Tarallo, Valeria; Albuquerque, Romulo J. C.; Mitola, Stefania; Takeda, Atsunobu; Stassen, Jean-Marie; Presta, Marco; Ambati, Jayakrishna; Ruvo, Menotti; De Falco, Sandro			Modulation of Angiogenesis by a Tetrameric Tripeptide That Antagonizes Vascular Endothelial Growth Factor Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC PEPTIDE LIBRARY; CRYSTAL-STRUCTURE; TUMOR ANGIOGENESIS; VEGF RECEPTOR-1; FLT-1 RECEPTOR; AMINO-ACIDS; FACTOR-B; BINDING; ACTIVATION; CELLS	Vascular endothelial growth factor receptor-1 (VEGFR-1, also known as Flt-1) is involved in complex biological processes often associated to severe pathological conditions like cancer, inflammation, and metastasis formation. Consequently, the search for antagonists of Flt-1 has recently gained a growing interest. Here we report the identification of a tetrameric tripeptide from a combinatorial peptide library built using non-natural amino acids, which binds Flt-1 and inhibits in vitro its interaction with placental growth factor (PlGF) and vascular endothelial growth factor (VEGF) A and B (IC50 similar to 10 mu M). The peptide is stable in serum for 7 days and prevents both Flt-1 phosphorylation and the capillary-like tube formation of human primary endothelial cells stimulated by PlGF or VEGF-A. Conversely, the identified peptide does not interfere in VEGF-induced VEGFR-2 activation. In vivo, this peptide inhibits VEGF-A- and PlGF-induced neoangiogenesis in the chicken embryo chorioallantoic membrane assay. In contrast, in the cornea, where avascularity is maintained by high levels of expression of the soluble form of Flt-1 receptor (sFlt-1) that prevents the VEGF-A activity, the peptide is able to stimulate corneal mouse neovascularization in physiological condition, as reported previously for others neutralizing anti-Flt-1 molecules. This tetrameric tripeptide represents a new, promising compound for therapeutic approaches in pathologies where Flt-1 activation plays a crucial role.	[Ponticelli, Salvatore; Tarallo, Valeria; De Falco, Sandro] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Stem Cell Fate Lab, I-80131 Naples, Italy; [Ponticelli, Salvatore; Tarallo, Valeria; De Falco, Sandro] CNR, Angiogenesis Lab, I-80131 Naples, Italy; [Marasco, Daniela; Ruvo, Menotti] CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy; [Albuquerque, Romulo J. C.; Takeda, Atsunobu; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA; [Mitola, Stefania; Presta, Marco] Univ Brescia, Dept Biomed Sci & Biotechnol, Unit Gen Pathol & Immunol, I-25123 Brescia, Italy; [Stassen, Jean-Marie] Thrombogenics, B-3000 Louvain, Belgium	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Kentucky; University of Brescia	De Falco, S (corresponding author), CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Stem Cell Fate Lab, Via Pietro Castellino 111, I-80131 Naples, Italy.	defalco@igb.cnr.it	De Falco, Sandro/P-6724-2015; Presta, Marco/B-4345-2010; Marasco, Daniela/H-4848-2015	Marasco, Daniela/0000-0002-6618-2949; Tarallo, Valeria/0000-0002-6920-4402; PRESTA, Marco/0000-0002-4398-8376; De Falco, Sandro/0000-0002-6501-1697; MITOLA, Stefania/0000-0002-5557-738X	AIRC [4840]; Telethon-Italy [GGP08062]; FIRB [RBNE03PX83_005]; National Institutes of Health (NEI) [EY015422, EY018350, EY018836]; NATIONAL EYE INSTITUTE [R01EY018350, R01EY018836, R01EY015422] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); National Institutes of Health (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by AIRC (Associazione Italiana Ricerca sul Cancro, Grant 4840) and Telethon-Italy (Grant GGP08062) (to S. D. F.) and only in part by FIRB (Grant RBNE03PX83_005) (to M. R.) and National Institutes of Health (NEI) Grants EY015422, EY018350, and EY018836 (to J. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bae DG, 2005, CLIN CANCER RES, V11, P2651, DOI 10.1158/1078-0432.CCR-04-1564; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; CUNNINGHAM SA, 1995, J BIOL CHEM, V270, P20254, DOI 10.1074/jbc.270.35.20254; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; De Falco S, 2001, J BIOL CHEM, V276, P36613, DOI 10.1074/jbc.M102377200; El-Mousawi M, 2003, J BIOL CHEM, V278, P46681, DOI 10.1074/jbc.M308681200; Errico M, 2004, J BIOL CHEM, V279, P43929, DOI 10.1074/jbc.M401418200; FASSINA G, 1992, J CHROMATOGR, V591, P99, DOI 10.1016/0021-9673(92)80226-K; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; FURKA A, 1991, INT J PEPT PROT RES, V37, P487, DOI 10.1111/j.1399-3011.1991.tb00765.x; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Iyer S, 2001, J BIOL CHEM, V276, P12153, DOI 10.1074/jbc.M008055200; Iyer S, 2006, J MOL BIOL, V359, P76, DOI 10.1016/j.jmb.2006.03.002; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Luttun A, 2002, ANN NY ACAD SCI, V979, P80, DOI 10.1111/j.1749-6632.2002.tb04870.x; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Marino M, 2000, NAT BIOTECHNOL, V18, P735, DOI 10.1038/77296; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; Nishi JI, 2008, CIRC RES, V103, P261, DOI 10.1161/CIRCRESAHA.108.174128; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Taylor AP, 2007, MOL CANCER THER, V6, P524, DOI 10.1158/1535-7163.MCT-06-0461; Verdoliva A, 2005, CHEMBIOCHEM, V6, P1242, DOI 10.1002/cbic.200400368; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	48	35	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34250	34259		10.1074/jbc.M806607200	http://dx.doi.org/10.1074/jbc.M806607200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922791	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000261277700053
J	Wu, SF; Fadoju, D; Rezvani, G; De Luca, F				Wu, Shufang; Fadoju, Doris; Rezvani, Geoffrey; De Luca, Francesco			Stimulatory Effects of Insulin-like Growth Factor-I on Growth Plate Chondrogenesis Are Mediated by Nuclear Factor-kappa B p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGITUDINAL BONE-GROWTH; DISTINCT SIGNALING PATHWAYS; CELL-LINE; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIAPOPTOTIC ACTIONS; HUMAN CHONDROCYTES; GENE-EXPRESSION; IGF-I; ACTIVATION; KINASE	Insulin-like growth factor-I (IGF-I) is an important regulator of endochondral ossification. However, little is known about the signaling pathways activated by IGF-I in growth plate chondrocytes. We have previously shown that NF-kappa B-p65 facilitates growth plate chondrogenesis. In this study, we first cultured rat metatarsal bones with IGF-I and/or pyrrolidine dithiocarbamate (PDTC), a known NF-kappa B inhibitor. The IGF-I-mediated stimulation of metatarsal growth and growth plate chondrogenesis was neutralized by PDTC. In rat growth plate chondrocytes, IGF-I induced NF-kappa B-p65 nuclear translocation. The inhibition of NF-kappa B-p65 expression and activity (by p65 short interfering RNA and PDTC, respectively) in chondrocytes reversed the IGF-I-mediated induction of cell proliferation and differentiation and the IGF-I-mediated prevention of cell apoptosis. Moreover, the inhibition of the phosphatidylinositol 3-kinase and Akt abolished the effects of IGF-I on NF-kappa B activation. In conclusion, our findings indicate that IGF-I stimulates growth plate chondrogenesis by activating NF-kappa B-p65 in chondrocytes.	[Wu, Shufang; Fadoju, Doris; Rezvani, Geoffrey; De Luca, Francesco] Drexel Univ, St Christophers Hosp Children, Sect Endocrinol & Diabet, Dept Pediat,Coll Med, Philadelphia, PA 19134 USA	Drexel University	De Luca, F (corresponding author), Drexel Univ, St Christophers Hosp Children, Sect Endocrinol & Diabet, Dept Pediat,Coll Med, Erie Ave,Front St, Philadelphia, PA 19134 USA.	francesco.deluca@drexelmed.edu						Abbaspour A, 2008, BONE, V42, P98, DOI 10.1016/j.bone.2007.08.031; AHARINEJAD S, 1995, ANAT REC, V242, P111, DOI 10.1002/ar.1092420115; BAGI C, 1989, CALCIFIED TISSUE INT, V45, P342, DOI 10.1007/BF02556004; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baixeras E, 2001, ENDOCRINOLOGY, V142, P2968, DOI 10.1210/en.142.7.2968; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cherng YG, 2008, J ORTHOP RES, V26, P1018, DOI 10.1002/jor.20578; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; Ciarmatori S, 2007, J MOL ENDOCRINOL, V38, P493, DOI 10.1677/jme.1.02179; Cruickshank J, 2005, J ENDOCRINOL, V184, P543, DOI 10.1677/joe.1.05947; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; de Moissac D, 1999, J BIOL CHEM, V274, P29505, DOI 10.1074/jbc.274.41.29505; Del Rio MJ, 2006, GROWTH FACTORS, V24, P67, DOI 10.1080/08977190500361788; Eshet R, 2004, J ENDOCRINOL, V182, P165, DOI 10.1677/joe.0.1820165; FARNUM CE, 1987, MICROSCOP RES TECH, V28, P505; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Grey A, 2003, ENDOCRINOLOGY, V144, P4886, DOI 10.1210/en.2003-0350; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Heck S, 1999, J BIOL CHEM, V274, P9828, DOI 10.1074/jbc.274.14.9828; Hoshi K, 2004, J BONE MINER RES, V19, P214, DOI 10.1359/JBMR.0301221; HUNZIKER EB, 1994, J CLIN INVEST, V93, P1078, DOI 10.1172/JCI117058; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kiepe D, 2005, ENDOCRINOLOGY, V146, P3096, DOI 10.1210/en.2005-0324; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu WL, 2001, ENDOCRINOLOGY, V142, P1710, DOI 10.1210/en.142.5.1710; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mushtaq T, 2004, ENDOCRINOLOGY, V145, P2478, DOI 10.1210/en.2003-1435; Parrizas M, 1997, J BIOL CHEM, V272, P154; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Phornphutkul C, 2004, J ENDOCRINOL, V183, P477, DOI 10.1677/joe.1.05873; Pons S, 2000, J BIOL CHEM, V275, P38620, DOI 10.1074/jbc.M004531200; SCHEVEN BAA, 1991, ACTA ENDOCRINOL-COP, V124, P602, DOI 10.1530/acta.0.1240602; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Sugimori K, 2005, J BONE MINER METAB, V23, P411, DOI 10.1007/s00774-005-0622-7; Tsakiridis T, 2001, BIOCHEM BIOPH RES CO, V288, P205, DOI 10.1006/bbrc.2001.5762; Vallee S, 2003, BIOCHEM BIOPH RES CO, V305, P831, DOI 10.1016/S0006-291X(03)00866-0; Wang J, 2004, J ENDOCRINOL, V180, P247, DOI 10.1677/joe.0.1800247; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Wu GJ, 2007, J CELL BIOCHEM, V101, P1520, DOI 10.1002/jcb.21268; Wu SF, 2004, J BIOL CHEM, V279, P4642, DOI 10.1074/jbc.M305518200; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Zhang LH, 2001, J BIOL CHEM, V276, P43534, DOI 10.1074/jbc.M104257200	45	36	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34037	34044		10.1074/jbc.M803754200	http://dx.doi.org/10.1074/jbc.M803754200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922796	Green Published, hybrid			2022-12-25	WOS:000261277700031
J	Chamberlain, KL; Marshall, RS; Jolliffe, NA; Frigerio, L; Ceriotti, A; Lord, JM; Roberts, LM				Chamberlain, Kerry L.; Marshall, Richard S.; Jolliffe, Nicholas A.; Frigerio, Lorenzo; Ceriotti, Aldo; Lord, J. Michael; Roberts, Lynne M.			Ricin B Chain Targeted to the Endoplasmic Reticulum of Tobacco Protoplasts Is Degraded by a CDC48-and Vacuole-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; PLANT-CELLS; A-CHAIN; ASIALOGLYCOPROTEIN RECEPTOR; PROTEASOMAL DEGRADATION; RETRO-TRANSLOCATION; MOVEMENT PROTEIN; MOSAIC-VIRUS; ER; TRANSPORT	The B chain of ricin was expressed and delivered to the endoplasmic reticulum of tobacco protoplasts where it disappeared with time in a manner consistent with degradation. This turnover did not occur in the vacuoles or upon secretion. Indeed, several lines of evidence indicate that, in contrast to the turnover of endoplasmic reticulum-targeted ricin A chain in the cytosol, the bulk of expressed ricin B chain was degraded in the secretory pathway.	[Chamberlain, Kerry L.; Marshall, Richard S.; Jolliffe, Nicholas A.; Frigerio, Lorenzo; Lord, J. Michael; Roberts, Lynne M.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Ceriotti, Aldo] CNR, Ist Biol & Biotecnol Agr, I-20133 Milan, Italy	University of Warwick; Consiglio Nazionale delle Ricerche (CNR)	Roberts, LM (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	lynne.roberts@warwick.ac.uk	Frigerio, Lorenzo/D-2685-2009; Frigerio, Lorenzo/M-6013-2019; Ceriotti, Aldo/A-1448-2016	Frigerio, Lorenzo/0000-0003-4100-6022; Frigerio, Lorenzo/0000-0003-4100-6022; Ceriotti, Aldo/0000-0002-8230-8863	Wellcome Trust [080566/Z/06/Z]; UK Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Wellcome Trust Programme Grant 080566/Z/06/Z (to L. M. R. and J. M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a Wellcome Trust Prize Studentship.; Supported by a studentship from the UK Biotechnology and Biological Sciences Research Council.	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; BARLOWE C, 1993, J BIOL CHEM, V268, P873; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; BENATTI L, 1989, EUR J BIOCHEM, V183, P465, DOI 10.1111/j.1432-1033.1989.tb14951.x; Blanchard N, 2008, CURR OPIN IMMUNOL, V20, P82, DOI 10.1016/j.coi.2007.12.004; Brandizzi F, 2003, PLANT J, V34, P269, DOI 10.1046/j.1365-313X.2003.01728.x; Brauer D, 1997, PLANT PHYSIOL, V113, P809, DOI 10.1104/pp.113.3.809; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; DENFERT C, 1991, MOL CELL BIOL, V11, P5727, DOI 10.1128/MCB.11.11.5727; DENFERT C, 1991, J CELL BIOL, V114, P663, DOI 10.1083/jcb.114.4.663; Di Cola A, 2005, PLANT PHYSIOL, V137, P287, DOI 10.1104/pp.104.055434; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; Donoso G, 2005, BIOCHEM J, V387, P897, DOI 10.1042/BJ20041312; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ENDO Y, 1987, J BIOL CHEM, V262, P8128; FEILER HS, 1995, EMBO J, V14, P5626, DOI 10.1002/j.1460-2075.1995.tb00250.x; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FERRINI JB, 1995, EUR J BIOCHEM, V233, P772, DOI 10.1111/j.1432-1033.1995.772_3.x; Frigerio L, 1998, J BIOL CHEM, V273, P14194, DOI 10.1074/jbc.273.23.14194; Frigerio L, 2001, PLANT CELL, V13, P1109, DOI 10.1105/tpc.13.5.1109; Frigerio L, 1998, PLANT CELL, V10, P1031, DOI 10.1105/tpc.10.6.1031; Frigerio L, 2001, PLANT PHYSIOL, V126, P167, DOI 10.1104/pp.126.1.167; Frigerio L, 1998, J EXP BOT, V49, P1473, DOI 10.1093/jexbot/49.326.1473; Gillespie T, 2002, PLANT CELL, V14, P1207, DOI 10.1105/tpc.002303; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jolliffe NA, 2003, PLANT MOL BIOL, V51, P631, DOI 10.1023/A:1022553424859; Jolliffe NA, 2006, J BIOL CHEM, V281, P23377, DOI 10.1074/jbc.M602678200; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; LORD JM, 1985, EUR J BIOCHEM, V146, P411, DOI 10.1111/j.1432-1033.1985.tb08667.x; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; MA JKC, 1994, EUR J IMMUNOL, V24, P131, DOI 10.1002/eji.1830240120; MALIGA P, 1973, NATURE-NEW BIOL, V244, P29, DOI 10.1038/newbio244029a0; Marshall RS, 2008, J BIOL CHEM, V283, P15869, DOI 10.1074/jbc.M709316200; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Muller J, 2005, PLANT CELL, V17, P149, DOI 10.1105/tpc.104.026625; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nuttall J, 2003, PLANT MOL BIOL, V51, P885, DOI 10.1023/A:1023041901029; Nuttall J, 2002, EUR J BIOCHEM, V269, P6042, DOI 10.1046/j.1432-1033.2002.03302.x; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Pedrazzini E, 1997, PLANT CELL, V9, P1869, DOI 10.1105/tpc.9.10.1869; Phillipson BA, 2001, PLANT CELL, V13, P2005, DOI 10.1105/tpc.13.9.2005; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; Rancour DM, 2002, PLANT PHYSIOL, V130, P1241, DOI 10.1104/pp.011742; Reichel C, 2000, J VIROL, V74, P3330, DOI 10.1128/JVI.74.7.3330-3337.2000; Roberts LM, 2004, MINI-REV MED CHEM, V4, P505, DOI 10.2174/1389557043403846; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Saint-Jore-Dupas C, 2007, TRENDS BIOTECHNOL, V25, P317, DOI 10.1016/j.tibtech.2007.04.008; Schmitz A, 2004, EUR J CELL BIOL, V83, P501, DOI 10.1078/0171-9335-00412; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; Sheng XY, 2006, PLANT PHYSIOL, V141, P1578, DOI 10.1104/pp.106.081703; Smith DC, 2002, J IMMUNOL, V169, P99, DOI 10.4049/jimmunol.169.1.99; Speranza A, 2001, PLANT PHYSIOL, V126, P1150, DOI 10.1104/pp.126.3.1150; TABE LM, 1995, J ANIM SCI, V73, P2752; TAIZ L, 1992, J EXP BIOL, V172, P113; Tamura K, 2004, PLANT J, V39, P393, DOI 10.1111/j.1365-313X.2004.02141.x; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Tormakangas K, 2001, PLANT CELL, V13, P2021, DOI 10.1105/tpc.13.9.2021; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; VITALE A, 1989, PLANT PHYSIOL, V89, P1079, DOI 10.1104/pp.89.4.1079; WALES R, 1991, J BIOL CHEM, V266, P19172; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; YUK MH, 1993, J CELL BIOL, V123, P1735, DOI 10.1083/jcb.123.6.1735	74	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33276	33286		10.1074/jbc.M805222200	http://dx.doi.org/10.1074/jbc.M805222200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832379	Green Published, hybrid			2022-12-25	WOS:000261183700031
J	Greeson, NT; Sengupta, R; Arida, AR; Jenuwein, T; Sanders, SL				Greeson, Nikole T.; Sengupta, Roopsha; Arida, Ahmad R.; Jenuwein, Thomas; Sanders, Steven L.			Di-methyl H4 Lysine 20 Targets the Checkpoint Protein Crb2 to Sites of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; S-PHASE; HISTONE-H4 LYSINE-20; FISSION YEAST; TUDOR DOMAIN; METHYLATION; CHROMATIN; GENOME; REPAIR; 53BP1	Histone lysine methylation is an important chromatin modification that can be catalyzed to a mono-, di-, or tri-methyl state. An ongoing challenge is to decipher how these different methyllysine histone marks can mediate distinct aspects of chromatin function. The fission yeast checkpoint protein Crb2 is rapidly targeted to sites of DNA damage after genomic insult, and this recruitment requires methylation of histone H4 lysine 20 (H4K20). Here we show that the tandem tudor domains of Crb2 preferentially bind the di- methylated H4K20 residue. Loss of this interaction by disrupting either the tudor-binding motif or the H4K20 methylating enzyme Set9/Kmt5 ablates Crb2 localization to double-strand breaks and impairs checkpoint function. Further we show that dimethylation, but not tri-methylation, of H4K20 is required for Crb2 localization, checkpoint function, and cell survival after DNA damage. These results argue that the di- methyl H4K20 modification serves as a binding target that directs Crb2 to sites of genomic lesions and defines an important genome integrity pathway mediated by a specific methyl-lysine histone mark.	[Greeson, Nikole T.; Arida, Ahmad R.; Sanders, Steven L.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Greeson, Nikole T.; Arida, Ahmad R.; Sanders, Steven L.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Sengupta, Roopsha; Jenuwein, Thomas] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	Case Western Reserve University; Case Western Reserve University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Sanders, SL (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	steven.sanders@case.edu			International Human Frontier Science Program Organization [0017/2006-C]; Case Comprehensive Cancer Center and Radiation Resource Core Facility [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); Case Comprehensive Cancer Center and Radiation Resource Core Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Career Development Award 0017/2006-C from the International Human Frontier Science Program Organization and Grant P30 CA43703 from the Case Comprehensive Cancer Center and Radiation Resource Core Facility. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Grenon M, 2007, YEAST, V24, P105, DOI 10.1002/yea.1441; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lancelot N, 2007, NUCLEIC ACIDS RES, V35, P5898, DOI 10.1093/nar/gkm607; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nakamura TM, 2005, MOL CELL BIOL, V25, P10721, DOI 10.1128/MCB.25.24.10721-10730.2005; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200	38	52	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33168	33174		10.1074/jbc.M806857200	http://dx.doi.org/10.1074/jbc.M806857200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826944	Green Published, hybrid			2022-12-25	WOS:000261183700019
J	Park, KM; Yule, DI; Bowers, WJ				Park, Keigan M.; Yule, David I.; Bowers, William J.			Tumor Necrosis Factor-alpha Potentiates Intraneuronal Ca2+ Signaling via Regulation of the Inositol 1,4,5-Trisphosphate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; N-TERMINAL KINASE; TRISPHOSPHATE RECEPTOR; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; GENE-EXPRESSION; CALCIUM-RELEASE; RAT; INHIBITION; MICROGLIA	Inflammatory events have long been implicated in initiating and/or propagating the pathophysiology associated with a number of neurological diseases. In addition, defects in Ca2+-handling processes, which shape membrane potential, influence gene transcription, and affect neuronal spiking patterns, have also been implicated in disease progression and cognitive decline. The mechanisms underlying the purported interplay that exists between neuroinflammation and Ca2+ homeostasis have yet to be defined. Herein, we describe a novel neuron-intrinsic pathway in which the expression of the type-1 inositol 1,4,5-trisphosphate receptor is regulated by the potent pro-inflammatory cytokine tumor necrosis factor-alpha. Exposure of primary murine neurons to tumor necrosis factor-alpha resulted in significant enhancement of Ca2+ signals downstream of muscarinic and purinergic stimulation. An increase in type-1 inositol 1,4,5-trisphosphate receptor mRNA and protein steady-state levels following cytokine exposure positively correlated with this alteration in Ca2+ homeostasis. Modulation of Ca2+ responses arising from this receptor subtype and its downstream effectors may exact significant consequences on neuronal function and could underlie the compromise in neuronal activity observed in the setting of chronic neuroinflammation, such as that associated with Parkinson disease and Alzheimer disease.	[Park, Keigan M.; Bowers, William J.] Univ Rochester, Med Ctr, Sch Med & Dent, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Yule, David I.; Bowers, William J.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Park, Keigan M.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Bowers, WJ (corresponding author), 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	william_bowers@urmc.rochester.edu			National Institutes of Health [F31-NS056731]; Oral Biology Training [T32-DE07202]; NIH [R01-DK54588, R01-DE14756, R01-AG023593, R01AG026328]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK054588, R43DK054588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026328, R01AG023593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral Biology Training; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant F31-NS056731. This work was also supported by the Oral Biology Training Grant NIH T32-DE07202 (to K.M.P.), NIH Grants R01-DK54588 and R01-DE14756 (to D.I.Y.), and NIH Grants R01-AG023593 and NIH R01AG026328 (to W.J.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Bokkala S, 1999, ALCOHOL CLIN EXP RES, V23, P1875, DOI 10.1097/00000374-199912000-00004; Bruce JIE, 2004, J BIOL CHEM, V279, P12909, DOI 10.1074/jbc.M309070200; Camandola S, 2005, J BIOL CHEM, V280, P22287, DOI 10.1074/jbc.M410923200; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Deelman LE, 1998, GENE, V207, P219, DOI 10.1016/S0378-1119(97)00630-6; Detrait ER, 2002, MOL THER, V5, P723, DOI 10.1006/mthe.2002.0609; DieckmannSchuppert A, 1997, CELL TISSUE RES, V288, P119, DOI 10.1007/s004410050799; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; EDWARDS DR, 1985, EXP CELL RES, V157, P127, DOI 10.1016/0014-4827(85)90157-0; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GOEGER DE, 1988, BIOCHEM PHARMACOL, V37, P978, DOI 10.1016/0006-2952(88)90195-5; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Jara JH, 2007, J NEUROCHEM, V100, P1407, DOI 10.1111/j.1471-4159.2006.04330.x; JOSEPH SK, 1989, MOL PHARMACOL, V35, P355; JOSEPH SK, 1993, J BIOL CHEM, V268, P23059; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; LANSMAN JB, 1990, J GEN PHYSIOL, V95, P679, DOI 10.1085/jgp.95.4.679; LASTER SM, 1988, J IMMUNOL, V141, P2629; LU B, 1995, HUM GENE THER, V6, P419, DOI 10.1089/hum.1995.6.4-419; MATTSON MP, 1987, J NEUROSCI, V7, P4034; McGeer EG, 2005, NEUROBIOL AGING, V26, pS94, DOI 10.1016/j.neurobiolaging.2005.08.008; McGowan TA, 2000, KIDNEY INT, V58, pS99, DOI 10.1046/j.1523-1755.2000.07716.x; Muschol M, 1999, BIOPHYS J, V77, P577, DOI 10.1016/S0006-3495(99)76914-6; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; ORTALDO JR, 1986, NATURE, V321, P700, DOI 10.1038/321700a0; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; SICA A, 1990, J IMMUNOL, V144, P3034; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; TOKUYAMA Y, 1995, BIOCHEM BIOPH RES CO, V211, P211, DOI 10.1006/bbrc.1995.1798; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; WEISS GB, 1974, ANNU REV PHARMACOL, V14, P343, DOI 10.1146/annurev.pa.14.040174.002015; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	41	37	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33069	33079		10.1074/jbc.M802209200	http://dx.doi.org/10.1074/jbc.M802209200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838384	Green Published, hybrid			2022-12-25	WOS:000261183700007
J	Mohamood, AS; Bargatze, D; Xiao, ZX; Jie, CF; Yagita, H; Ruben, D; Watson, J; Chakravarti, S; Schneck, JP; Hamad, ARA				Mohamood, Abdiaziz S.; Bargatze, Dylan; Xiao, Zuoxiang; Jie, Chunfa; Yagita, Hideo; Ruben, Dawn; Watson, Julie; Chakravarti, Shukti; Schneck, Jonathan P.; Hamad, Abdel Rahim A.			Fas-Mediated Apoptosis Regulates the Composition of Peripheral alpha beta T Cell Repertoire by Constitutively Purging Out Double Negative T Cells	PLOS ONE			English	Article								Background: The Fas pathway is a major regulator of T cell homeostasis, however, the T cell population that is controlled by the Fas pathway in vivo is poorly defined. Although CD4 and CD8 single positive (SP) T cells are the two major T cell subsets in the periphery of wild type mice, the repertoire of mice bearing loss-of-function mutation in either Fas (lpr mice) or Fas ligand (gld mice) is predominated by CD4(-) CD8(-) double negative alpha beta T cells that also express B220 and generally referred to as B220(+) DN T cells. Despite extensive analysis, the basis of B220(+) DN T cell lymphoproliferation remains poorly understood. In this study we re-examined the issue of why T cell lymphoproliferation caused by gld mutation is predominated by B220(+) DN T cells. Methodology and Principal Findings: We combined the following approaches to study this question: Gene transcript profiling, BrdU labeling, and apoptosis assays. Our results show that B220(+) DN T cells are proliferating and dying at exceptionally high rates than SP T cells in the steady state. The high proliferation rate is restricted to B220(+) DN T cells found in the gut epithelium whereas the high apoptosis rate occurred both in the gut epithelium and periphery. However, only in the periphery, apoptosis of B220(+) DN T cell is Fas-dependent. When the Fas pathway is genetically impaired, apoptosis of peripheral B220(+) DN T cells was reduced to a baseline level similar to that of SP T cells. Under these conditions of normalized apoptosis, B220(+) DN T cells progressively accumulate in the periphery, eventually resulting in B220(+) DN T cell lymphoproliferation. Conclusions/Significance: The Fas pathway plays a critical role in regulating the tissue distribution of DN T cells through targeting and elimination of DN T cells from the periphery in the steady state. The results provide new insight into pathogenesis of DN T cell lymphoproliferation.	[Mohamood, Abdiaziz S.; Bargatze, Dylan; Xiao, Zuoxiang; Schneck, Jonathan P.; Hamad, Abdel Rahim A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Jie, Chunfa] Johns Hopkins Univ, Sch Med, Inst Genet Med, Baltimore, MD 21218 USA; [Ruben, Dawn; Watson, Julie] Johns Hopkins Univ, Sch Med, Dept Mol & Comparative Pathobiol, Baltimore, MD 21218 USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo, Japan; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Juntendo University; Johns Hopkins University	Mohamood, AS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	ahamad@jhmi.edu			NIH [DK069279, DK 066039]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK066039, R21DK069279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH DK069279 and NIH DK 066039	ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Borrmann CM, 2000, ANN NY ACAD SCI, V915, P144; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Clark LB, 1999, J IMMUNOL, V162, P2546; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; DAVIES MDJ, 1981, GUT, V22, P481, DOI 10.1136/gut.22.6.481; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; GIESE T, 1994, J IMMUNOL, V152, P2000; GIESE T, 1993, J IMMUNOL, V151, P597; GIESE T, 1995, INT IMMUNOL, V7, P1213, DOI 10.1093/intimm/7.8.1213; GILLETTEFERGUSON I, 1994, EUR J IMMUNOL, V24, P1181, DOI 10.1002/eji.1830240526; GONZALO JA, 1994, CLIN IMMUNOL IMMUNOP, V71, P176, DOI 10.1006/clin.1994.1069; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hughes RC, 2001, BIOCHIMIE, V83, P667; Inagaki-Ohara K, 2005, BIOCHEM BIOPH RES CO, V331, P977, DOI 10.1016/j.bbrc.2005.04.025; Inki P, 1996, ANN MED, V28, P63, DOI 10.3109/07853899608999076; Johansson M, 2003, J IMMUNOL, V170, P1659, DOI 10.4049/jimmunol.170.4.1659; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kayagaki N, 1997, P NATL ACAD SCI USA, V94, P3914, DOI 10.1073/pnas.94.8.3914; KOTZIN BL, 1988, J EXP MED, V168, P2221, DOI 10.1084/jem.168.6.2221; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; LANDOLFI MMT, 1993, J IMMUNOL, V151, P1086; Lohman BL, 1996, J VIROL, V70, P8199, DOI 10.1128/JVI.70.11.8199-8203.1996; MALDONADO MA, 1995, J EXP MED, V181, P641, DOI 10.1084/jem.181.2.641; Miethke T, 1996, EUR J IMMUNOL, V26, P1459, DOI 10.1002/eji.1830260709; MOGIL RJ, 1995, INT IMMUNOL, V7, P1451, DOI 10.1093/intimm/7.9.1451; Mohamood AS, 2007, AM J PATHOL, V171, P97, DOI 10.2353/ajpath.2007.070148; Mohamood AS, 2006, INT IMMUNOL, V18, P1265, DOI 10.1093/intimm/dxl057; MOUNTZ JD, 1990, J IMMUNOL, V144, P2159; Nochi T, 2004, CLIN IMMUNOL, V113, P326, DOI 10.1016/j.clim.2004.08.013; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; PRASAD VS, 1991, J IMMUNOL, V147, P4200; Rao VK, 2005, BRIT J HAEMATOL, V129, P534, DOI 10.1111/j.1365-2141.2005.05496.x; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; ROTHGEB CL, 1984, BEHAV SOC SCI LIBR, V3, P1, DOI 10.1300/J103v03n04_01; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; SCHMIDT A, 1994, EUR J CELL BIOL, V65, P229; SINGER PA, 1989, J EXP MED, V170, P1869, DOI 10.1084/jem.170.6.1869; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Tan KH, 2003, EXP CELL RES, V284, P283, DOI 10.1016/S0014-4827(02)00056-3; Teachey DT, 2008, BLOOD, V111, P705, DOI 10.1182/blood-2007-05-087353; ten Bosch JV, 2002, BRIT J HAEMATOL, V117, P176, DOI 10.1046/j.1365-2141.2002.03357.x; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; WATANABE Y, 1994, SCAND J IMMUNOL, V39, P419, DOI 10.1111/j.1365-3083.1994.tb03395.x; Worth A, 2006, BRIT J HAEMATOL, V133, P124, DOI 10.1111/j.1365-2141.2006.05993.x; Xiao S, 2004, INT IMMUNOL, V16, P759, DOI 10.1093/intimm/dxh078; Yamagiwa S, 1998, J IMMUNOL, V160, P2665; ZHOU T, 1992, J EXP MED, V176, P1063, DOI 10.1084/jem.176.4.1063	58	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3465	10.1371/journal.pone.0003465	http://dx.doi.org/10.1371/journal.pone.0003465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941614	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125900009
J	Vali, B; Yue, FY; Jones, RB; Sheth, PM; Kaul, R; Betts, MR; Wong, D; Kovacs, C; Loutfy, M; Common, A; Halpenny, R; Ostrowski, MA				Vali, Bahareh; Yue, Feng Yun; Jones, R. Brad; Sheth, Prameet M.; Kaul, Rupert; Betts, Michael R.; Wong, David; Kovacs, Colin; Loutfy, Mona; Common, Andrew; Halpenny, Roberta; Ostrowski, Mario A.			HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection	PLOS ONE			English	Article								Background and Aims: Hepatitis C Virus (HCV)-related liver disease progresses more rapidly in individuals co-infected with Human Immunodeficiency Virus-1 (HIV), although the underlying immunologic mechanisms are unknown. We examined whether HIV-specific T-cells are identified in the liver of HCV/HIV co-infected individuals and promote liver inflammation through bystander immune responses. Methods: Ex-vivo intra-hepatic lymphocytes from HCV mono-infected and HCV/HIV co-infected individuals were assessed for immune responses to HIV and HCV antigens by polychromatic flow cytometry. Results: HCV/HIV liver biopsies had similar frequencies of lymphocytes but lower percentages of CD4(+) T-cells compared to HCV biopsies. In co-infection, intra-hepatic HIV-specific CD8(+) and CD4(+) T-cells producing IFN-gamma and TNF-alpha were detected and were comparable in frequency to those that were HCV-specific. In co-infected individuals, viral-specific CD8(+) T-cells produced more of the fibrogenic cytokine, TNF-alpha. In both mono-and co-infected individuals, intra-hepatic HCV-specific T-cells were poorly functional compared to HIV-specific T-cells. In co-infection, HAART was not associated with a reconstitution of intra-hepatic CD4(+) T-cells and was associated with reduction in both HIV and HCV-specific intra-hepatic cytokine responses. Conclusion: The accumulation of functional HIV-specific T-cells in the liver during HCV/HIV co-infection may represent a bystander role for HIV in inducing faster progression of liver disease.	[Vali, Bahareh; Sheth, Prameet M.; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Inst Med Sci, Dept Med, Toronto, ON M5S 1A1, Canada; [Yue, Feng Yun; Jones, R. Brad; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Betts, Michael R.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Wong, David] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Kovacs, Colin; Loutfy, Mona; Halpenny, Roberta] Canadian Immunodeficiency Res Collaborat, Toronto, ON, Canada; [Common, Andrew; Ostrowski, Mario A.] St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Pennsylvania; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Vali, B (corresponding author), Univ Toronto, Inst Med Sci, Dept Med, Toronto, ON M5S 1A1, Canada.	bahareh.vali@utoronto.ca		Kaul, Rupert/0000-0002-1586-4093; Wong, David/0000-0002-3310-3538	CANFAR (Canadian Foundation for AIDS Research)	CANFAR (Canadian Foundation for AIDS Research)	Financial support for this study was obtained from CANFAR (Canadian Foundation for AIDS Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatrakchi N, 2005, J INFECT DIS, V191, P702, DOI 10.1086/427778; Banner BF, 1997, VIRCHOWS ARCH, V431, P181, DOI 10.1007/s004280050086; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; CAO YZ, 1992, AIDS, V6, P65, DOI 10.1097/00002030-199201000-00008; Chan HLY, 2005, WORLD J GASTROENTERO, V11, P2148, DOI 10.3748/wjg.v11.i14.2148; Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dutoit V, 2005, EUR J IMMUNOL, V35, P3493, DOI 10.1002/eji.200535035; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Graham CS, 2004, HEPATOLOGY, V40, P125, DOI 10.1002/hep.20258; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; KHATIB R, 1993, INFECTION, V21, P112, DOI 10.1007/BF01710744; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Kitamura K, 2002, LAB INVEST, V82, P571, DOI 10.1038/labinvest.3780452; Lauer GM, 2002, J VIROL, V76, P2817, DOI 10.1128/JVI.76.6.2817-2826.2002; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3; Polakos NK, 2006, AM J PATHOL, V168, P1169, DOI 10.2353/ajpath.2006.050875; Sheth PM, 2005, J IMMUNOL, V175, P4789, DOI 10.4049/jimmunol.175.7.4789; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Spangenberg HC, 2005, HEPATOLOGY, V42, P828, DOI 10.1002/hep.20856; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thomas DL, 1996, J INFECT DIS, V174, P690, DOI 10.1093/infdis/174.4.690; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Valdez H, 2002, AIDS, V16, P1113, DOI 10.1097/00002030-200205240-00004; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Zhang LQ, 2002, J VIROL, V76, P5271, DOI 10.1128/JVI.76.10.5271-5273.2002	30	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3454	10.1371/journal.pone.0003454	http://dx.doi.org/10.1371/journal.pone.0003454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941622	Green Published, gold			2022-12-25	WOS:000265125600013
J	Herrera, FE; Chesi, A; Paleologou, KE; Schmid, A; Munoz, A; Vendruscolo, M; Gustincich, S; Lashuel, HA; Carloni, P				Herrera, Fernando E.; Chesi, Alessandra; Paleologou, Katerina E.; Schmid, Adrian; Munoz, Adriana; Vendruscolo, Michele; Gustincich, Stefano; Lashuel, Hilal A.; Carloni, Paolo			Inhibition of alpha-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region	PLOS ONE			English	Article								The interplay between dopamine and alpha-synuclein (AS) plays a central role in Parkinson's disease (PD). PD results primarily from a severe and selective devastation of dopaminergic neurons in substantia nigra pars compacta. The neuropathological hallmark of the disease is the presence of intraneuronal proteinaceous inclusions known as Lewy bodies within the surviving neurons, enriched in filamentous AS. In vitro, dopamine inhibits AS fibril formation, but the molecular determinants of this inhibition remain obscure. Here we use molecular dynamic (MD) simulations to investigate the binding of dopamine and several of its derivatives onto conformers representative of an NMR ensemble of AS structures in aqueous solution. Within the limitations inherent to MD simulations of unstructured proteins, our calculations suggest that the ligands bind to the (YEMPS129)-Y-125 region, consistent with experimental findings. The ligands are further stabilized by long-range electrostatic interactions with glutamate 83 (E83) in the NAC region. These results suggest that by forming these interactions with AS, dopamine may affect AS aggregation and fibrillization properties. To test this hypothesis, we investigated in vitro the effects of dopamine on the aggregation of mutants designed to alter or abolish these interactions. We found that point mutations in the (YEMPS129)-Y-125 region do not affect AS aggregation, which is consistent with the fact that dopamine interacts non-specifically with this region. In contrast, and consistent with our modeling studies, the replacement of glutamate by alanine at position 83 (E83A) abolishes the ability of dopamine to inhibit AS fibrillization.	[Herrera, Fernando E.; Munoz, Adriana; Carloni, Paolo] INFM DEMOCRITOS, Int Sch Adv Studies SISSA, Trieste, Italy; [Herrera, Fernando E.; Chesi, Alessandra; Munoz, Adriana; Gustincich, Stefano; Carloni, Paolo] Italian Inst Technol, SISSA Unit, Trieste, Italy; [Chesi, Alessandra; Munoz, Adriana; Gustincich, Stefano] Int Sch Advanced Stud SISSA, Sector Neurobiol, Trieste, Italy; [Chesi, Alessandra; Munoz, Adriana; Gustincich, Stefano] Int Sch Advanced Stud SISSA, Sector Neurobiol, Giovanni Armenise Harvard Fdn Lab, Trieste, Italy; [Paleologou, Katerina E.; Schmid, Adrian; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne EPFL, Brain Mind Inst, Lab Mol Neurobiol & Neuroproteom, Lausanne, Switzerland; [Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1TN, England	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Cambridge	Herrera, FE (corresponding author), INFM DEMOCRITOS, Int Sch Adv Studies SISSA, Trieste, Italy.	gustinci@sissa.it; carloni@sissa.it	Lashuel, Hilal/M-3500-2017; Vendruscolo, Michele/F-5901-2012; Carloni, Paolo/H-8736-2013; Chesi, Alessandra/AAT-8248-2020; Chesi, Alessandra/N-7693-2017	Vendruscolo, Michele/0000-0002-3616-1610; Gustincich, Stefano/0000-0002-2749-2514; Herrera, Fernando E./0000-0002-8595-3382; Chesi, Alessandra/0000-0002-0954-7446; Schmid, Adrien W./0000-0001-6671-7950	Telethon [GGP06268]; IIT; GRAND; MURST FIRB; The Giovanni Armenise-Harvard Foundation; Swiss National Science Foundation [310000-110027]	Telethon(Fondazione Telethon); IIT(Istituto Italiano di Tecnologia - IIT); GRAND; MURST FIRB; The Giovanni Armenise-Harvard Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Telethon grant# GGP06268, IIT, GRAND, MURST FIRB and the "The Giovanni Armenise-Harvard Foundation" for financial support. This work was also supported by the Swiss National Science Foundation (HLA, 310000-110027).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Allen M. P., 1987, COMPUTER SIMULATIONS; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barcelo-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cole NB, 2005, J BIOL CHEM, V280, P9678, DOI 10.1074/jbc.M409946200; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Corona-Avendano S, 2007, J PHYS CHEM B, V111, P1640, DOI 10.1021/jp0637227; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125; FRISCH MJ, 2001, GAUSSIAN 98; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Green Mario, 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P280; Guidoni L, 2000, FEBS LETT, V477, P37, DOI 10.1016/S0014-5793(00)01712-9; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ischiropoulos H, 2003, ANN NY ACAD SCI, V991, P93; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; MCLACHLAN AD, 1979, J MOL BIOL, V128, P49, DOI 10.1016/0022-2836(79)90308-5; Micheletti C, 2000, PROTEINS, V40, P662, DOI 10.1002/1097-0134(20000901)40:4<662::AID-PROT90>3.0.CO;2-F; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; *OPENEYE SCI SOFTW, 2005, EON; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Rivers RC, 2008, PROTEIN SCI, V17, P887, DOI 10.1110/ps.073181508; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Slutzki M, 2006, J MOL BIOL, V360, P1019, DOI 10.1016/j.jmb.2006.05.069; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Takeda A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/19365; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	69	89	92	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3394	10.1371/journal.pone.0003394	http://dx.doi.org/10.1371/journal.pone.0003394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852892	Green Submitted, Green Published, gold			2022-12-25	WOS:000265121700003
J	Imamura, S; Uchiyama, J; Koshimizu, E; Hanai, JI; Raftopoulou, C; Murphey, RD; Bayliss, PE; Imai, Y; Burns, CE; Masutomi, K; Gagos, S; Zon, LI; Roberts, TM; Kishi, S				Imamura, Shintaro; Uchiyama, Junzo; Koshimizu, Eriko; Hanai, Jun-ichi; Raftopoulou, Christina; Murphey, Ryan D.; Bayliss, Peter E.; Imai, Yoichi; Burns, Caroline Erter; Masutomi, Kenkichi; Gagos, Sarantis; Zon, Leonard I.; Roberts, Thomas M.; Kishi, Shuji			A Non-Canonical Function of Zebrafish Telomerase Reverse Transcriptase Is Required for Developmental Hematopoiesis	PLOS ONE			English	Article								Although it is clear that telomerase expression is crucial for the maintenance of telomere homeostasis, there is increasing evidence that the TERT protein can have physiological roles that are independent of this central function. To further examine the role of telomerase during vertebrate development, the zebrafish telomerase reverse transcriptase (zTERT) was functionally characterized. Upon zTERT knockdown, zebrafish embryos show reduced telomerase activity and are viable, but develop pancytopenia resulting from aberrant hematopoiesis. The blood cell counts in TERT-depleted zebrafish embryos are markedly decreased and hematopoietic cell differentiation is impaired, whereas other somatic lineages remain morphologically unaffected. Although both primitive and definitive hematopoiesis is disrupted by zTERT knockdown, the telomere lengths are not significantly altered throughout early development. Induced p53 deficiency, as well as overexpression of the anti-apoptotic proteins Bcl-2 and E1B-19K, significantly relieves the decreased blood cells numbers caused by zTERT knockdown, but not the impaired blood cell differentiation. Surprisingly, only the reverse transcriptase motifs of zTERT are crucial, but the telomerase RNA-binding domain of zTERT is not required, for rescuing complete hematopoiesis. This is therefore the first demonstration of a non-canonical catalytic activity of TERT, which is different from 'authentic'' telomerase activity, is required for during vertebrate hematopoiesis. On the other hand, zTERT deficiency induced a defect in hematopoiesis through a potent and specific effect on the gene expression of key regulators in the absence of telomere dysfunction. These results suggest that TERT non-canonically functions in hematopoietic cell differentiation and survival in vertebrates, independently of its role in telomere homeostasis. The data also provide insights into a non-canonical pathway by which TERT functions to modulate specification of hematopoietic stem/progenitor cells during vertebrate development. (276 words)	[Imamura, Shintaro; Koshimizu, Eriko; Kishi, Shuji] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA; [Uchiyama, Junzo; Bayliss, Peter E.; Roberts, Thomas M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA USA; [Hanai, Jun-ichi] Beth Israel Deaconess Med Ctr, Dept Med, Renal Div, Boston, MA USA; [Murphey, Ryan D.; Burns, Caroline Erter; Zon, Leonard I.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp Boston,Div Hematol Oncol, Boston, MA USA; [Raftopoulou, Christina; Gagos, Sarantis] Biomed Res Fdn Acad Athens Greece, Lab Genet, Athens, Greece; [Imai, Yoichi] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA USA; [Masutomi, Kenkichi] Natl Canc Ctr, Canc Stem Cell Project, Tokyo, Japan	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Academy of Athens; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; National Cancer Center - Japan	Imamura, S (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA.	s.kishi@mac.com		Bayliss, Peter/0000-0003-4807-6365; Raftopoulou, Christina/0000-0002-5132-2822; GAGOS, SARANTIS/0000-0003-4907-7706; Imai, Yoichi/0000-0002-2938-6133	A-T Childrens Project; Ellison Medical Foundation; NIA/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067179] Funding Source: NIH RePORTER	A-T Childrens Project; Ellison Medical Foundation(Lawrence Ellison Foundation); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by research grants from the A-T Childrens Project, the Ellison Medical Foundation and NIA/NIH to S.K..	ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Armstrong L, 2005, STEM CELLS, V23, P516, DOI 10.1634/stemcells.2004-0269; Artandi SE, 2002, TRENDS MOL MED, V8, P44, DOI 10.1016/S1471-4914(01)02222-5; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Bachand F, 2001, MOL CELL BIOL, V21, P1888, DOI 10.1128/MCB.21.5.1888-1897.2001; Beattie TL, 2000, MOL BIOL CELL, V11, P3329, DOI 10.1091/mbc.11.10.3329; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598; Blasco MA, 1996, NAT GENET, V12, P200, DOI 10.1038/ng0296-200; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bousman S, 2003, J EXP ZOOL PART B, V295B, P82, DOI 10.1002/jez.b.00007; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Calado RT, 2006, BIOESSAYS, V28, P109, DOI 10.1002/bies.20365; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004; CHIOU SK, 1994, MOL CELL BIOL, V14, P2556, DOI 10.1128/MCB.14.4.2556; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DEJONG JL, 2005, ANN REV GENET; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; GESERICK C, 2006, ONCOGENE; GESERICK C, 2006, MECH AGEING DEV; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Harrington L, 2004, ONCOGENE, V23, P7283, DOI 10.1038/sj.onc.1207948; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hiyama E, 2002, ONCOGENE, V21, P643, DOI 10.1038/sj.onc.1205070; Hsia N, 2005, EXP HEMATOL, V33, P1007, DOI 10.1016/j.exphem.2005.06.013; Jagadeesh S, 2006, BIOCHEM BIOPH RES CO, V347, P774, DOI 10.1016/j.bbrc.2006.06.172; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; KRAEMER K, 2006, INT J CANC; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lansdorp PM, 2005, ANN NY ACAD SCI, V1044, P220, DOI 10.1196/annals.1349.027; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Liu Y, 2002, P NATL ACAD SCI USA, V99, P3597, DOI 10.1073/pnas.062549199; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Long QM, 1997, DEVELOPMENT, V124, P4105; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Lue NF, 2005, P NATL ACAD SCI USA, V102, P9778, DOI 10.1073/pnas.0502252102; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 1997, ANNU REV GENET, V31, P33, DOI 10.1146/annurev.genet.31.1.33; Peng Y, 2001, MOL CELL, V7, P1201, DOI 10.1016/S1097-2765(01)00268-4; Poon SSS, 2001, METHOD CELL BIOL, V64, P69; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Shafizadeh E, 2004, CURR OPIN HEMATOL, V11, P255, DOI 10.1097/01.moh.0000138686.15806.71; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Sun CF, 2008, GENE, V420, P90, DOI 10.1016/j.gene.2008.05.013; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x; Veitonmaki N, 2003, FASEB J, V17, P764, DOI 10.1096/fj.02-0599-fje; Venkatesan RN, 1998, P NATL ACAD SCI USA, V95, P14763, DOI 10.1073/pnas.95.25.14763; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xia JQ, 2000, MOL CELL BIOL, V20, P5196, DOI 10.1128/MCB.20.14.5196-5207.2000; Xiang H, 2002, ONCOGENE, V21, P3784, DOI 10.1038/sj.onc.1205455; Xie MY, 2008, J BIOL CHEM, V283, P2049, DOI 10.1074/jbc.M708032200; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Young JI, 2003, J BIOL CHEM, V278, P19904, DOI 10.1074/jbc.M301685200; Yu RM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-27; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423; Zimmermann S, 2004, STEM CELLS, V22, P741, DOI 10.1634/stemcells.22-5-741	110	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3364	10.1371/journal.pone.0003364	http://dx.doi.org/10.1371/journal.pone.0003364			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846223	gold, Green Submitted, Green Published			2022-12-25	WOS:000265114500005
J	Hiramatsu, C; Melin, AD; Aureli, F; Schaffner, CM; Vorobyev, M; Matsumoto, Y; Kawamura, S				Hiramatsu, Chihiro; Melin, Amanda D.; Aureli, Filippo; Schaffner, Colleen M.; Vorobyev, Misha; Matsumoto, Yoshifumi; Kawamura, Shoji			Importance of Achromatic Contrast in Short-Range Fruit Foraging of Primates	PLOS ONE			English	Article								Trichromatic primates have a 'red-green' chromatic channel in addition to luminance and 'blue-yellow' channels. It has been argued that the red-green channel evolved in primates as an adaptation for detecting reddish or yellowish objects, such as ripe fruits, against a background of foliage. However, foraging advantages to trichromatic primates remain unverified by behavioral observation of primates in their natural habitats. New World monkeys (platyrrhines) are an excellent model for this evaluation because of the highly polymorphic nature of their color vision due to allelic variation of the L-M opsin gene on the X chromosome. In this study we carried out field observations of a group of wild, frugivorous black-handed spider monkeys (Ateles geoffroyi frontatus, Gray 1842, Platyrrhini), consisting of both dichromats (n = 12) and trichromats (n = 9) in Santa Rosa National Park, Costa Rica. We determined the color vision types of individuals in this group by genotyping their L-M opsin and measured foraging efficiency of each individual for fruits located at a grasping distance. Contrary to the predicted advantage for trichromats, there was no significant difference between dichromats and trichromats in foraging efficiency and we found that the luminance contrast was the main determinant of the variation of foraging efficiency among red-green, blue-yellow and luminance contrasts. Our results suggest that luminance contrast can serve as an important cue in short-range foraging attempts despite other sensory cues that could be available. Additionally, the advantage of red-green color vision in primates may not be as salient as previously thought and needs to be evaluated in further field observations.	[Hiramatsu, Chihiro; Matsumoto, Yoshifumi; Kawamura, Shoji] Univ Tokyo, Gradu Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Melin, Amanda D.] Univ Calgary, Dept Anthropol, Calgary, AB T2N 1N4, Canada; [Aureli, Filippo] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolut Anthropol & Palaeoecol, Liverpool, Merseyside, England; [Schaffner, Colleen M.] Univ Chester, Dept Pyschol, Chester, Cheshire, England; [Vorobyev, Misha] Univ Auckland, Dept Optomet & Vision Sci, Auckland, New Zealand	University of Tokyo; University of Calgary; Liverpool John Moores University; University of Chester; University of Auckland	Hiramatsu, C (corresponding author), Natl Inst Physiol Sci, Div Sensory & Cognit Informat, Okazaki, Aichi 444, Japan.	Kawamura@k.u-tokyo.ac.jp		Melin, Amanda/0000-0002-0612-2514; Aureli, Filippo/0000-0002-0671-013X	Japan Society for the Promotion of Science (JSPS) [15-11926, 16405015, 19207018]; Alberta Ingenuity Fund; National Sciences and Engineering Research Council of Canada; Leakey Foundation; North of England Zoological Society; The British Academy	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alberta Ingenuity Fund; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leakey Foundation; North of England Zoological Society; The British Academy	This study was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows (15-11926) to C.H., grants from the Alberta Ingenuity Fund and National Sciences and Engineering Research Council of Canada to A.D.M., the Leakey Foundation and the North of England Zoological Society to F.A., The British Academy to C.M.S., and Grants-in-Aid for Scientific Research (B) (16405015) and (A) (19207018) from JSPS to S.K..	Allen G., 1879, COLOR SENSE ITS ORIG; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Asensio N, 2008, BEHAVIOUR, V145, P983, DOI 10.1163/156853908784089234; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; Boinski S., 2000, MOVE WHY ANIMALS TRA; Brown H., 1999, APPL MIXED MODELS ME; Caine NG, 2002, EAT OR BE EATEN, P58, DOI 10.1017/CBO9780511610233.005; Caine NG, 2003, INT J PRIMATOL, V24, P1163, DOI 10.1023/B:IJOP.0000005985.18112.25; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; Campbell CJ, 2005, INT J PRIMATOL, V26, P1039, DOI 10.1007/s10764-005-6457-1; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; CHAPMAN C, 1988, PRIMATES, V29, P177, DOI 10.1007/BF02381121; CHAPMAN CA, 1989, OECOLOGIA, V79, P506, DOI 10.1007/BF00378668; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; De Araujo MFP, 2006, AM J PRIMATOL, V68, P1129, DOI 10.1002/ajp.20312; Di Fiore A, 2004, MOL ECOL NOTES, V4, P246, DOI 10.1111/j.1471-8286.2004.00631.x; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Dominy NJ, 2004, AM J PRIMATOL, V62, P189, DOI 10.1002/ajp.20015; Dominy NJ, 2003, ANIM BEHAV, V66, P829, DOI 10.1006/anbe.2003.2288; Dominy NJ, 2003, J HUM EVOL, V44, P25, DOI 10.1016/S0047-2484(02)00167-7; Fernandez AA, 2007, AM NAT, V170, P10, DOI 10.1086/518566; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hiramatsu C, 2005, AM J PRIMATOL, V67, P447, DOI 10.1002/ajp.20199; Hiramatsu C, 2004, VISION RES, V44, P2225, DOI 10.1016/j.visres.2004.04.008; Jacobs GH, 2007, INT J PRIMATOL, V28, P729, DOI 10.1007/s10764-007-9168-y; Jacobs GH, 2005, J OPT SOC AM A, V22, P2072, DOI 10.1364/JOSAA.22.002072; Jacobs GH, 1996, NATURE, V382, P156, DOI 10.1038/382156a0; Jacobs GH, 1998, VISION RES, V38, P3307, DOI 10.1016/S0042-6989(97)00405-7; Jacobs GH, 2001, P ROY SOC B-BIOL SCI, V268, P695, DOI 10.1098/rspb.2000.1421; JACOBS GH, 1993, VISION RES, V33, P1773, DOI 10.1016/0042-6989(93)90168-V; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; Janzen D.H., 1986, GUANACASTE NATL PARK; Kawamura S, 2001, GENE, V269, P45, DOI 10.1016/S0378-1119(01)00454-1; Kinzey WG., 1997, NEW WORLD PRIMATES E; KOLB H, 1991, J COMP NEUROL, V303, P617, DOI 10.1002/cne.903030408; Levenson DH, 2007, AM J PRIMATOL, V69, P757, DOI 10.1002/ajp.20402; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LU C, 1972, INVEST OPHTH VISUAL, V11, P482; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; Lucas PW, 1998, FOLIA PRIMATOL, V69, P139, DOI 10.1159/000021576; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Melin AD, 2008, BEHAV ECOL SOCIOBIOL, V62, P659, DOI 10.1007/s00265-007-0490-3; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; MULLEN KT, 1985, J PHYSIOL-LONDON, V359, P381, DOI 10.1113/jphysiol.1985.sp015591; Nunes A, 1995, FOLIA PRIMATOL, V65, P85, DOI 10.1159/000156873; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; Pinheiro J, 2001, MIXED EFFECTS MODELS; Regan BC, 1998, VISION RES, V38, P3321, DOI 10.1016/S0042-6989(97)00462-8; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Riba-Hernandez P, 2005, AM J PRIMATOL, V67, P411, DOI 10.1002/ajp.20196; Riba-Hernandez P, 2004, J EXP BIOL, V207, P2465, DOI 10.1242/jeb.01046; Rowe MP, 2007, VISUAL NEUROSCI, V24, P17, DOI 10.1017/S0952523807230159; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Silveira LCL, 1999, VISUAL NEUROSCI, V16, P333, DOI 10.1017/S0952523899162138; Smith AC, 2005, INT J PRIMATOL, V26, P337, DOI 10.1007/s10764-005-2928-7; Smith AC, 2003, AM J PRIMATOL, V61, P145, DOI 10.1002/ajp.10117; Smith AC, 2003, J EXP BIOL, V206, P3159, DOI 10.1242/jeb.00536; Stoner KE, 2005, AM J PRIMATOL, V67, P399, DOI 10.1002/ajp.20195; Sumner P, 2000, J EXP BIOL, V203, P1987; Sumner P, 2000, J EXP BIOL, V203, P1963; Sumner P, 2003, AM J PRIMATOL, V59, P67, DOI 10.1002/ajp.10066; Surridge AK, 2002, AM J PRIMATOL, V56, P185, DOI 10.1002/ajp.1073; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Talebi MG, 2006, MOL ECOL, V15, P551, DOI 10.1111/j.1365-294X.2005.02822.x; VANROOSMALEN MGM, 1985, ACTA AMAZON, V15, P3; Vogel ER, 2007, BEHAV ECOL, V18, P292, DOI 10.1093/beheco/arl082; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1; Vorobyev Misha, 2004, Clin Exp Optom, V87, P230; WYZECKI G, 1982, COLOR SCI CONCEPTS M; Yamada ES, 1996, VISUAL NEUROSCI, V13, P1011, DOI 10.1017/S0952523800007677; Yokoyama S, 2001, GENETICS, V158, P1697	75	74	75	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3356	10.1371/journal.pone.0003356	http://dx.doi.org/10.1371/journal.pone.0003356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836576	Green Published, Green Submitted, gold			2022-12-25	WOS:000265113500011
J	Moussion, C; Ortega, N; Girard, JP				Moussion, Christine; Ortega, Nathalie; Girard, Jean-Philippe			The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?	PLOS ONE			English	Article								Background: Interleukin-33 (IL-33) is an IL-1-like cytokine ligand for the IL-1 receptor-related protein ST2, that activates mast cells and Th2 lymphocytes, and induces production of Th2-associated cytokines in vivo. We initially discovered IL-33 as a nuclear factor (NF-HEV) abundantly expressed in high endothelial venules from lymphoid organs, that associates with chromatin and exhibits transcriptional regulatory properties. This suggested that, similarly to IL-1 alpha and chromatin-associated cytokine HMGB1, IL-33 may act as both a cytokine and a nuclear factor. Although the activity of recombinant IL-33 has been well characterized, little is known yet about the expression pattern of endogenous IL-33 in vivo. Methodology/Principal Findings: Here, we show that IL-33 is constitutively and abundantly expressed in normal human tissues. Using a combination of human tissue microarrays and IL-33 monoclonal and polyclonal antibodies, we found that IL-33 is a novel nuclear marker of the endothelium widely expressed along the vascular tree. We observed abundant nuclear expression of IL-33 in endothelial cells from both large and small blood vessels in most normal human tissues, as well as in human tumors. In addition to endothelium, we also found constitutive nuclear expression of IL-33 in fibroblastic reticular cells of lymphoid tissues, and epithelial cells of tissues exposed to the environment, including skin keratinocytes and epithelial cells of the stomach, tonsillar crypts and salivary glands. Conclusions/Significance: Together, our results indicate that, unlike inducible cytokines, IL-33 is constitutively expressed in normal human tissues. In addition, they reveal that endothelial cells and epithelial cells constitute major sources of IL-33 in vivo. Based on these findings, we speculate that IL-33 may function, similarly to the prototype 'alarmin' HMGB1, as an endogenous 'danger' signal to alert the immune system after endothelial or epithelial cell damage during trauma or infection.	[Moussion, Christine; Ortega, Nathalie; Girard, Jean-Philippe] CNRS, IPBS Inst Pharmacol & Struct Biol, Toulouse, France; [Moussion, Christine; Ortega, Nathalie; Girard, Jean-Philippe] Univ Toulouse, UPS, IPBS, F-31042 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Moussion, C (corresponding author), CNRS, IPBS Inst Pharmacol & Struct Biol, Toulouse, France.	Jean-Philippe.Girard@ipbs.fr	GIRARD, Jean-Philippe/F-5229-2010; Ortega, Nathalie/C-3382-2019	GIRARD, Jean-Philippe/0000-0002-9154-1691; 	Ligue Nationale contre le Cancer (Equipe labellisee); ANR-programme blanc "Cuboidale"; egion Midi-Pyrenees and MAIN European Network of Excellence [FP6-502935]	Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); ANR-programme blanc "Cuboidale"(French National Research Agency (ANR)); egion Midi-Pyrenees and MAIN European Network of Excellence	This work was supported by grants from Ligue Nationale contre le Cancer (Equipe labellisee), ANR-programme blanc "Cuboidale", Region Midi-Pyrenees and MAIN European Network of Excellence (FP6-502935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Brunner M, 2004, INTENS CARE MED, V30, P1468, DOI 10.1007/s00134-004-2184-x; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; GADINA M, 2007, SCI STKE, pPE31; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; HAUSER C, 1986, J IMMUNOL, V136, P3317; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Kuroiwa K, 2001, BIOCHEM BIOPH RES CO, V284, P1104, DOI 10.1006/bbrc.2001.5090; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; MIZUTANI H, 1991, J CLIN INVEST, V87, P1066, DOI 10.1172/JCI115067; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Onda H, 1999, J CEREBR BLOOD F MET, V19, P1279, DOI 10.1097/00004647-199911000-00013; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; ROUSSEL L, 2008, EMBO REP; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tajima S, 2003, CHEST, V124, P1206, DOI 10.1378/chest.124.4.1206; TOCCANIERPELTE MF, 1987, AM J PATHOL, V129, P109; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101	42	863	901	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3331	10.1371/journal.pone.0003331	http://dx.doi.org/10.1371/journal.pone.0003331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836528	Green Published, gold			2022-12-25	WOS:000265113500002
J	Van Gammeren, D; Damrauer, JS; Jackman, RW; Kandarian, SC				Van Gammeren, Darin; Damrauer, Jeffrey S.; Jackman, Robert W.; Kandarian, Susan C.			The I kappa B kinases IKK alpha and IKK beta are necessary and sufficient for skeletal muscle atrophy	FASEB JOURNAL			English	Article						muscle wasting; inhibitor of kappa B kinase; IKK complex; NF-kappa B signaling	GENE-TRANSFER; ACTIVATION; PATHWAYS; PHOSPHORYLATION; ELECTROPORATION; TRANSCRIPTION; DEREPRESSION; EXPRESSION	Nuclear factor-kappa B (NF-kappa B) signaling is necessary for many types of muscle atrophy, yet only some of the required components have been identified. Gene transfer of a dominant negative (d.n.) IKK beta into rat soleus muscles showed complete inhibition of 7-day disuse-induced activation of a kappa B reporter gene, while overexpression of wild-type (w.t.) IKK beta did not. Overexpression of a d.n. IKK beta-EGFP fusion protein showed that atrophy was inhibited by 50%, indicating that IKK beta is required for the atrophy process. Overexpression of constitutively active (c.a.) IKK beta-EGFP showed a marked increase in NF-kappa B activity and a decrease in fiber size of weight-bearing soleus muscles, while muscles overexpressing w.t. IKK beta-HA had no effect. The same results were found for IKK alpha; overexpression of a d.n. form of the protein decreased unloading-induced NF-kappa B activation and inhibited atrophy by 50%, while overexpression of the w.t. protein had no effect. Overexpression of a c. a. IKK alpha-EGFP fusion protein showed that IKK alpha was sufficient to activate NF-kappa B activity and induce fiber atrophy in muscle. Overexpression of d.n. IKK beta plus d.n. IKK alpha showed an additive effect on the inhibition of disuse atrophy (70%), suggesting that both kinases of the IKK complex are required for muscle atrophy. These data show that both IKK alpha and IKK beta are necessary and sufficient for physiological muscle atrophy. - Van Gammeren, D., Damrauer, J.S., Jackman, R. W., Kandarian, S. C. The I kappa B kinases IKK alpha and IKK beta are necessary and sufficient for skeletal muscle atrophy. FASEB J. 23, 362-370 (2009)	[Kandarian, Susan C.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Kandarian, SC (corresponding author), Boston Univ, Dept Hlth Sci, 635 Commonwealth Ave,Rm 443, Boston, MA 02215 USA.	skandar@bu.edu	Damrauer, Jeffrey/AAW-3845-2020	Damrauer, Jeffrey/0000-0001-8148-0285	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [F32 AR054265, AR41705]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR054265, R01AR041705] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Ruth L. Kirschstein National Research Service Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to D. V. G. (F32 AR054265) and an R01 award from NIAMS to S. K. (AR41705). We thank Mary Rhoads and Angie Cornwell for technical assistance.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Alzghoul MB, 2004, FASEB J, V18, P221, DOI 10.1096/fj.03-0293fje; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Bar-Shai M, 2008, FREE RADICAL BIO MED, V44, P202, DOI 10.1016/j.freeradbiomed.2007.03.019; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1081, DOI 10.1016/j.bcp.2006.06.017; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hasselgren PO, 2005, INT J BIOCHEM CELL B, V37, P2156, DOI 10.1016/j.biocel.2005.01.017; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Huynh QK, 2000, J BIOL CHEM, V275, P25883, DOI 10.1074/jbc.M000296200; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Mitchell-Felton H, 1999, AM J PHYSIOL-CELL PH, V277, pC1269, DOI 10.1152/ajpcell.1999.277.6.C1269; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peter I, 1999, Twin Res, V2, P1, DOI 10.1375/twin.2.1.1; Polkinghorne E, 2008, AM J PHYSIOL-ENDOC M, V294, pE316, DOI 10.1152/ajpendo.00537.2007; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Rossini K, 2002, BASIC APPL MYOL, V12, P97; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schertzer JD, 2006, MOL THER, V13, P795, DOI 10.1016/j.ymthe.2005.09.019; Taylor J, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-11; VANGAMMEREN D, 2006, FRONTIERS MYOGENESIS, P28; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	40	79	80	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					362	370		10.1096/fj.08-114249	http://dx.doi.org/10.1096/fj.08-114249			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18827022	Green Published			2022-12-25	WOS:000262892900008
J	Saito, Y; Sano, Y; Vassar, R; Gandy, S; Nakaya, T; Yamamoto, T; Suzuki, T				Saito, Yuhki; Sano, Yoshitake; Vassar, Robert; Gandy, Sam; Nakaya, Tadashi; Yamamoto, Tohru; Suzuki, Toshiharu			X11 Proteins Regulate the Translocation of Amyloid beta-Protein Precursor (APP) into Detergent-resistant Membrane and Suppress the Amyloidogenic Cleavage of APP by beta-Site-cleaving Enzyme in Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE65-DEPENDENT GENE TRANSACTIVATION; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; LIPID RAFTS; TRANSGENIC MICE; MOUSE-BRAIN; KNOCKOUT MICE; RAT-BRAIN; METABOLISM; PHOSPHORYLATION	X11 and X11-like proteins (X11L) are neuronal adaptor proteins whose association to the cytoplasmic domain of amyloid beta-protein precursor (APP) suppresses the generation of amyloid beta-protein (A beta) implicated in Alzheimer disease pathogenesis. The amyloidogenic, but not amyloidolytic, metabolism of APP was selectively increased in the brain of mutant mice lacking X11L (Sano, Y., Syuzo-Takabatake, A., Nakaya, T., Saito, Y., Tomita, S., Itohara, S., and Suzuki, T. (2006) J. Biol. Chem. 281, 37853-37860). To reveal the actual role of X11 proteins (X11s) in suppressing amyloidogenic cleavage of APP in vivo, we generated X11 and X11L double knock-out mice and analyzed the metabolism of APP. The mutant mice showed enhanced beta-site cleavage of APP along with increased accumulation of A beta in brain and increased colocalization of APP with beta-site APP-cleaving enzyme (BACE). In the brains of mice deficient in both X11 and X11L, the apparent relative subcellular distributions of both mature APP and its beta-C-terminal fragment were shifted toward the detergent-resistant membrane (DRM) fraction, an organelle in which BACE is active and both X11s are not nearly found. These results indicate that X11s associate primarily with APP molecules that are outside of DRM, that the dissociation of APP-X11/X11L complexes leads to entry of APP into DRM, and that cleavage of uncomplexed APP by BACE within DRM is enhanced by X11s deficiency. Present results lead to an idea that the dysfunction of X11L in the interaction with APP may recruit more APP into DRM and increase the generation of A beta even if BACE activity did not increase in brain.	[Saito, Yuhki; Sano, Yoshitake; Nakaya, Tadashi; Yamamoto, Tohru; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Sano, Yoshitake] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3150198, Japan; [Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Gandy, Sam] Mt Sinai Sch Med, New York, NY 10029 USA	Hokkaido University; RIKEN; Northwestern University; Feinberg School of Medicine; Icahn School of Medicine at Mount Sinai	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Kita12 Nishi6, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Yamamoto, Tohru/A-3801-2012; Suzuki, Toshiharu/B-5342-2013	Yamamoto, Tohru/0000-0002-1652-0233; Sano, Yoshitake/0000-0001-5188-3104	National Institutes of Health [P01 AG10491]; MEXT Japan [207900049, 20390018, 20023001]; NATIONAL INSTITUTE ON AGING [P01AG010491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AG10491 (to S.G.). This work was also supported by Grants-in-aid for Scientific Research 207900049 (to T.N.) and 20390018 (to T.S.) and 20023001 (to T.S.) from MEXT Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Mori A, 2002, NEUROSCI RES, V43, P251, DOI 10.1016/S0168-0102(02)00041-X; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; OUIMET CC, 1994, J COMP NEUROL, V348, P244, DOI 10.1002/cne.903480207; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Sawamura N, 2000, J BIOL CHEM, V275, P27901; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	41	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35763	35771		10.1074/jbc.M801353200	http://dx.doi.org/10.1074/jbc.M801353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18845544	Green Published, hybrid			2022-12-25	WOS:000261687900050
J	Wang, SF; Shen, Y; Yuan, XH; Chen, K; Guo, XY; Chen, YC; Niu, YY; Li, J; Xu, RH; Yan, XY; Zhou, Q; Ji, WZ				Wang, Shufen; Shen, Yi; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang; Niu, Yuyu; Li, Jian; Xu, Ren-He; Yan, Xiyun; Zhou, Qi; Ji, Weizhi			Dissecting Signaling Pathways That Govern Self-renewal of Rabbit Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; MAINTAIN PLURIPOTENCY; FUNCTIONAL-ANALYSIS; FEEDER LAYERS; KINASE DOMAIN; DIFFERENTIATION; MAINTENANCE; ACTIVATION; RECEPTOR; LINES	The pluripotency and self-renewal of embryonic stem cells (ESC) are regulated by a variety of cytokines/growth factors with some species differences. We reported previously that rabbit ESC (rESC) are more similar to primate ESC than to mouse ESC. However, the signaling pathways that regulate rESC self-renewal had not been identified. Here we show that inhibition of the transforming growth factor beta(TGF beta), fibroblast growth factor (FGF), and canonical Wnt/beta-catenin (Wnt) pathways results in enhanced differentiation of rESC accompanied by down- regulation of Smad2/3 phosphorylation and beta-catenin expression and up-regulation of phosphorylation of Smad1 and beta-catenin. These results imply that the TGF beta, FGF, and Wnt pathways are required for rESC self-renewal. Inhibition of the MAPK/ERK and PI3K/AKT pathways, which lie downstream of the FGF pathway, led to differentiation of rESC accompanied by down-regulation of phosphorylation of ERK1/2 or AKT, respectively. Long-term self-renewal of rESC could be achieved by adding a mixture of TGF beta ligands (activin A, Nodal, or TGF beta 1) plus basic FGF( bFGF) and Noggin in the absence of serum and feeder cells. Our findings also suggest that there is a regulatory network consisting of the FGF, Wnt, and TGF beta pathways that controls rESC pluripotency and self-renewal. We conclude that bFGF controls the stem cell properties of rESC both directly and indirectly through TGF beta or other pathways, whereas the effect of Wnt on rESC might be mediated by the TGF beta pathway.	[Zhou, Qi] Chinese Acad Sci, Inst Zool, Beijing 100108, Peoples R China; [Wang, Shufen; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang; Niu, Yuyu; Li, Jian; Ji, Weizhi] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming 650223, Yunnan, Peoples R China; [Wang, Shufen; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang; Niu, Yuyu; Li, Jian; Ji, Weizhi] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Wang, Shufen; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang; Niu, Yuyu; Ji, Weizhi] Yunnan Key Lab Anim Reprod Biol, Kunming 650223, Yunnan, Peoples R China; [Shen, Yi; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Shen, Yi; Yan, Xiyun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Xu, Ren-He] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Xu, Ren-He] Univ Connecticut, Hlth Ctr Regenerat Biol, Farmington, CT 06030 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Connecticut; University of Connecticut	Yan, XY (corresponding author), Chinese Acad Sci, Inst Zool, Beijing 100108, Peoples R China.	yanxy@sun5.ibp.ac.cn; qizhou@ioz.ac.cn; wji@mail.kiz.ac.cn	Xu, Ren-He/M-3125-2016; Xu, Ren-He/AAK-7392-2021	Ji, Weizhi/0000-0003-2550-4224	Chinese Major State Research Development Program [2005AA219010]; Chinese National Basic Research Program [2007CB947701, 2006CB701505]; Chinese Academy of Sciences [KSCX2-YWR-47]; Chinese National Science Foundation [30370166, 30700425]	Chinese Major State Research Development Program; Chinese National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Chinese Major State Research Development Program (2005AA219010), the Chinese National Basic Research Program (2007CB947701 and 2006CB701505), The Chinese Academy of Sciences (KSCX2-YWR-47), and the Chinese National Science Foundation (30370166 and 30700425). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Hayes H, 2002, CYTOGENET GENOME RES, V98, P199, DOI 10.1159/000069807; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JAMES D, 2005, DEVELOPMENT, V132, P1273, DOI DOI 10.1242/DEV.01706; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nakayama K, 2003, J BONE MINER RES, V18, P827, DOI 10.1359/jbmr.2003.18.5.827; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Roman-Roman S, 2004, J BIOL CHEM, V279, P5725, DOI 10.1074/jbc.M309233200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sumi T, 2004, STEM CELLS, V22, P861, DOI 10.1634/stemcells.22-5-861; Thomson JA, 1996, BIOL REPROD, V55, P254, DOI 10.1095/biolreprod55.2.254; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang GW, 2005, BIOCHEM BIOPH RES CO, V330, P934, DOI 10.1016/j.bbrc.2005.03.058; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	53	41	49	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35929	35940		10.1074/jbc.M804091200	http://dx.doi.org/10.1074/jbc.M804091200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18940811	hybrid			2022-12-25	WOS:000261687900068
J	Chen, YY; Chu, HM; Pan, KT; Teng, CH; Wang, DL; Wang, AHJ; Khoo, KH; Meng, TC				Chen, Yi-Yun; Chu, Hsing-Mao; Pan, Kuan-Ting; Teng, Chun-Hung; Wang, Danny-Ling; Wang, Andrew H. -J.; Khoo, Kay-Hooi; Meng, Tzu-Ching			Cysteine S-Nitrosylation Protects Protein-tyrosine Phosphatase 1B against Oxidation-induced Permanent Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVE-SITE CYSTEINE; NF-KAPPA-B; REDOX REGULATION; IN-VIVO; REACTIVE OXYGEN; REVERSIBLE INACTIVATION; ISCHEMIA-REPERFUSION; SIGNAL-TRANSDUCTION; HUMAN ERYTHROCYTES	Protein S-nitrosylation mediated by cellular nitric oxide (NO) plays a primary role in executing biological functions in cGMP-independent NO signaling. Although S-nitrosylation appears similar to Cys oxidation induced by reactive oxygen species, the molecular mechanism and biological consequence remain unclear. We investigated the structural process of S-nitrosylation of protein-tyrosine phosphatase 1B (PTP1B). We treated PTP1B with various NO donors, including S-nitrosothiol reagents and compound-releasing NO radicals, to produce site-specific Cys S-nitrosylation identified using advanced mass spectrometry (MS) techniques. Quantitative MS showed that the active site Cys-215 was the primary residue susceptible to S-nitrosylation. The crystal structure of NO donor-reacted PTP1B at 2.6 angstrom resolution revealed that the S-NO state at Cys-215 had no discernible irreversibly oxidized forms, whereas other Cys residues remained in their free thiol states. We further demonstrated that S-nitrosylation of the Cys-215 residue protected PTP1B from subsequent H2O2-induced irreversible oxidation. Increasing the level of cellular NO by pretreating cells with an NO donor or by activating ectopically expressed NO synthase inhibited reactive oxygen species-induced irreversible oxidation of endogenous PTP1B. These findings suggest that S-nitrosylation might prevent PTPs from permanent inactivation caused by oxidative stress.	[Chen, Yi-Yun; Chu, Hsing-Mao; Teng, Chun-Hung; Wang, Andrew H. -J.; Khoo, Kay-Hooi; Meng, Tzu-Ching] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Chen, Yi-Yun; Pan, Kuan-Ting; Wang, Andrew H. -J.; Khoo, Kay-Hooi] Acad Sinica, Natl Core Facil Proteom Res, Taipei 11529, Taiwan; [Wang, Danny-Ling] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chen, Yi-Yun; Chu, Hsing-Mao; Wang, Andrew H. -J.; Khoo, Kay-Hooi; Meng, Tzu-Ching] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Khoo, KH (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	kkhoo@gate.sinica.edu.tw; tcmeng@gate.sinica.edu.tw	Meng, Tzu-Ching/G-5426-2019; Khoo, Kay-Hooi/E-1989-2019	Meng, Tzu-Ching/0000-0001-7693-2021; Khoo, Kay-Hooi/0000-0003-2906-406X; Pan, Kuan-Ting/0000-0001-6974-5324	Taiwan National Science Council [NSC95-3112-B-002-028, NSC-96-3112-B-002-018, NSC-94-3112-B009-Y, NSC-95-3112-B-001-014]; Academia Sinica	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Taiwan National Science Council Grants NSC95-3112-B-002-028, NSC-96-3112-B-002-018 ( to T. C.M.), NSC-94-3112-B009-Y, and NSC-95-3112-B-001-014 ( to the National Proteomic Core Facility). This work was also supported by Academia Sinica ( to T. C. M., K. H. K., D. L. W., and A. H. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barbul A, 1999, FEBS LETT, V455, P87, DOI 10.1016/S0014-5793(99)00822-4; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Bell RM, 2003, CARDIOVASC RES, V57, P405, DOI 10.1016/S0008-6363(02)00675-2; Chen YY, 2007, METHODS, V42, P243, DOI 10.1016/j.ymeth.2007.03.002; Ciana A, 2004, BIOELECTROCHEMISTRY, V62, P169, DOI 10.1016/j.bioelechem.2003.07.004; Cohen MV, 2006, CARDIOVASC RES, V70, P231, DOI 10.1016/j.cardiores.2005.10.021; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Datta B, 2004, CIRCULATION, V109, P1339, DOI 10.1161/01.CIR.0000124450.07016.1D; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones SP, 2006, J MOL CELL CARDIOL, V40, P16, DOI 10.1016/j.yjmcc.2005.09.011; Kaneko R, 2003, J MASS SPECTROM, V38, P526, DOI 10.1002/jms.466; Kanno S, 2000, CIRCULATION, V101, P2742, DOI 10.1161/01.CIR.101.23.2742; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kobayashi N, 2003, HYPERTENSION, V42, P1004, DOI 10.1161/01.HYP.0000097547.35570.70; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li S, 2005, J BIOL CHEM, V280, P20102, DOI 10.1074/jbc.M413164200; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; McCord J M, 1985, Adv Myocardiol, V5, P183; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Monteiro HP, 2000, FREE RADICAL BIO MED, V28, P174, DOI 10.1016/S0891-5849(99)00233-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Persson C, 2005, METHODS, V35, P37, DOI 10.1016/j.ymeth.2004.07.006; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wang QP, 2004, BIOCHEMISTRY-US, V43, P4294, DOI 10.1021/bi035986e; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Xu JW, 2004, HYPERTENSION, V44, P217, DOI 10.1161/01.HYP.0000135868.38343.c6; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504; Zhang YY, 1996, J BIOL CHEM, V271, P14271, DOI 10.1074/jbc.271.24.14271; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; Zipser Y, 2002, BIOCHEM J, V368, P137, DOI 10.1042/BJ20020359; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3	58	128	131	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35265	35272		10.1074/jbc.M805287200	http://dx.doi.org/10.1074/jbc.M805287200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18840608	Green Published, hybrid			2022-12-25	WOS:000261469100082
J	Nitta, RT; Chu, AH; Wong, AJ				Nitta, Ryan T.; Chu, Albert H.; Wong, Albert J.			Constitutive Activity of JNK2 alpha 2 Is Dependent on a Unique Mechanism of MAPK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; PROTEIN-KINASE; GLIOBLASTOMA CELLS; CRYSTAL-STRUCTURE; FACTOR-I; JNK2; AUTOPHOSPHORYLATION; APOPTOSIS; PATHWAYS; PROMOTES	c-Jun N-terminal kinases (JNKs) are part of the mitogen-activated protein kinase ( MAPK) family and are important regulators of cell growth, proliferation, and apoptosis. Typically, a sequential series of events are necessary for MAPK activation: phosphorylation, dimerization, and then subsequent translocation to the nucleus. Interestingly, a constitutively active JNK isoform, JNK2 alpha 2, possesses the ability to autophosphorylate and has been implicated in several human tumors, including glioblastoma multiforme. Because overexpression of JNK2 alpha 2 enhances several tumorigenic phenotypes, including cell growth and tumor formation in mice, we studied the mechanisms of JNK2 alpha 2 autophosphorylation and autoactivation. We find that JNK2 alpha 2 dimerization in vitro and in vivo occurs independently of its autophosphorylation but is dependent on nine amino acids, known as the alpha-region. Alanine scanning mutagenesis of the alpha-region reveals that five specific mutants (L218A, K220A, G221A, I224A, and F225A) prevent JNK2 alpha 2 dimerization rendering JNK2 alpha 2 inactive and incapable of stimulating tumor formation. Previous studies coupled with additional mutagenesis of neighboring isoleucines and leucines (I208A, I214A, I231A, and I238A) suggest that a leucine zipper may play an important role in JNK2 alpha 2 homodimerization. We also show that a kinase-inactive JNK2 alpha 2 mutant can interact with and inhibit wild type JNK2 alpha 2 autophosphorylation, suggesting that JNK2 alpha 2 undergoes trans-autophosphorylation. Together, our results demonstrate that JNK2 alpha 2 differs from other MAPK proteins in two major ways; its autoactivation/autophosphorylation is dependent on dimerization, and dimerization most likely precedes autophosphorylation. In addition, we show that dimerization is essential for JNK2 alpha 2 activity and that prevention of dimerization may decrease JNK2 alpha 2 induced tumorigenic phenotypes.	[Nitta, Ryan T.; Chu, Albert H.; Wong, Albert J.] Stanford Univ, Med Ctr, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Wong, Albert J.] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Wong, AJ (corresponding author), Stanford Univ, Med Ctr, Sch Med, Dept Neurosurg, 300 Pasteur Dr,Edwards Bldg 221, Stanford, CA 94305 USA.	ajwong@stanford.edu			National Institutes of Health [CA69495, CA124832]; National Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA069495, R01CA124832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA69495, CA96539 and CA124832 ( to A. J. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Mark Linder/American Brain Tumor Association fellowship.; Supported by a research grant from the National Brain Tumor Foundation.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Arbour N, 2002, J EXP MED, V195, P801, DOI 10.1084/jem.20011481; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Chen NY, 2001, CANCER RES, V61, P3908; Cheng HL, 1998, J BIOL CHEM, V273, P14560, DOI 10.1074/jbc.273.23.14560; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Ishii M, 2004, J IMMUNOL, V172, P2569, DOI 10.4049/jimmunol.172.4.2569; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kyriakis John M, 2004, Methods Mol Biol, V250, P61; Lively TN, 2004, J BIOL CHEM, V279, P26257, DOI 10.1074/jbc.M400892200; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Nitta RT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000963; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Pimienta G, 2007, CELL CYCLE, V6, P1762, DOI 10.4161/cc.6.14.4434; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; ROBBINS DJ, 1993, J AM SOC NEPHROL, V4, P1104; Shaw D, 2008, J MOL BIOL, V383, P885, DOI 10.1016/j.jmb.2008.08.086; Tsuiki H, 2003, CANCER RES, V63, P250; Wilsbacher JL, 2006, BIOCHEMISTRY-US, V45, P13175, DOI 10.1021/bi061041w; Wilson DJ, 1996, EUR J IMMUNOL, V26, P989, DOI 10.1002/eji.1830260505; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2	30	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34935	34945		10.1074/jbc.M804970200	http://dx.doi.org/10.1074/jbc.M804970200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940813	Green Published, hybrid			2022-12-25	WOS:000261469100050
J	He, PJ; Zhang, HC; Yun, CC				He, Peijian; Zhang, Huanchun; Yun, C. Chris			IRBIT, Inositol 1,4,5-Triphosphate (IP3) Receptor-binding Protein Released with IP3, Binds Na+/H+ Exchanger NHE3 and Activates NHE3 Activity in Response to Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; C-TERMINAL DOMAINS; BRUSH-BORDER; 1,4,5-TRISPHOSPHATE RECEPTOR; PROXIMAL TUBULE; KINASE-C; INHIBITION; REQUIRES; E3KARP; SGK1	Calcium (Ca2+) is a highly versatile second messenger that regulates various cellular processes. Previous studies showed that elevation of intracellular Ca2+ regulates the activity of Na+/H+ exchanger 3 ( NHE3). However, the effect of Ca2+-dependent signaling on NHE3 activity varies depending on cell types. In this study, we report the identification of IP3 receptor-binding protein released with IP3 (IRBIT) as a NHE3 interacting protein and its role in regulation of NHE3 activity. IRBIT bound to the carboxyl-terminal domain of NHE3, which is necessary for acute regulation of NHE3. Ectopic expression of IRBIT resulted in Ca2+-dependent activation of NHE3 activity, whereas silencing of endogenous IRBIT resulted in inhibition of NHE3 activity. Ca2+-dependent stimulation of NHE3 activity was dependent on the binding of IRBIT to NHE3. Previously Ca2+-dependent inhibition of NHE3 was demonstrated in the presence of NHERF2. Co-expression of IRBIT was able to reverse the NHERF2-dependent inhibition of NHE3. We also showed that IRBIT-dependent activation of NHE3 involves exocytic trafficking of NHE3 to the plasma membrane and this activation was blocked by inhibition of calmodulin (CaM) or CaM-dependent kinase II. These results suggest that the overall effect of Ca2+ on NHE3 activity is balanced by IRBIT-dependent activation and NHERF2-dependent inhibition.	[He, Peijian; Zhang, Huanchun; Yun, C. Chris] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Yun, CC (corresponding author), Whitehead Bldg,Rm 201,615 Michael St, Atlanta, GA 30322 USA.	ccyun@emory.edu	He, Peijian/F-4790-2011	He, Peijian/0000-0002-9526-8004	National Institutes of Health [DK061418]; Emory Digestive Disease Research Development Center [DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK061418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Digestive Disease Research Development Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK061418. This work was also supported by Emory Digestive Disease Research Development Center Grant DK064399. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Choi JW, 2004, BBA-MOL CELL BIOL L, V1683, P59, DOI 10.1016/j.bbalip.2004.04.005; Chu TS, 1996, J CLIN INVEST, V97, P1454, DOI 10.1172/JCI118567; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; COHEN ME, 1990, P NATL ACAD SCI USA, V87, P8990, DOI 10.1073/pnas.87.22.8990; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; Cooper BJ, 2006, J BIOL CHEM, V281, P22471, DOI 10.1074/jbc.M602520200; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Dekker JW, 2002, IMMUNOGENETICS, V53, P993, DOI 10.1007/s00251-001-0402-z; Devogelaere B, 2006, BIOCHEM BIOPH RES CO, V343, P49, DOI 10.1016/j.bbrc.2006.02.119; Devogelaere B, 2007, BIOCHEM J, V407, P303, DOI 10.1042/BJ20070361; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; DONOWITZ M, 1989, J CLIN INVEST, V83, P1953, DOI 10.1172/JCI114104; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Kloor D, 2004, TRENDS PHARMACOL SCI, V25, P294, DOI 10.1016/j.tips.2004.04.004; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Wang T, 1999, AM J PHYSIOL-RENAL, V277, pF298, DOI 10.1152/ajprenal.1999.277.2.F298; Yun CC, 2003, CELL PHYSIOL BIOCHEM, V13, P29, DOI 10.1159/000070247; Yun CC, 2002, J AM SOC NEPHROL, V13, P2823, DOI 10.1097/01.ASN.0000035085.54451.81; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; YUN CHC, 1995, P NATL ACAD SCI USA, V92, P10723, DOI 10.1073/pnas.92.23.10723; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	41	49	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33544	33553		10.1074/jbc.M805534200	http://dx.doi.org/10.1074/jbc.M805534200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829453	hybrid, Green Published			2022-12-25	WOS:000261183700059
J	Kim, SY; Jo, HY; Kim, MH; Cha, YY; Choi, SW; Shim, JH; Kim, TJ; Lee, KY				Kim, So Yong; Jo, Hee-Yeon; Kim, Mi Hye; Cha, Yun-Yi; Choi, Sung Won; Shim, Jae-Hyuck; Kim, Tae Jin; Lee, Ki-Young			H2O2-dependent Hyperoxidation of Peroxiredoxin 6 (Prdx6) Plays a Role in Cellular Toxicity via Up-regulation of iPLA2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; INDEPENDENT PHOSPHOLIPASE A(2); OXIDATIVE STRESS; SITE CYSTEINE; 1-CYS PEROXIREDOXIN; G2/M ARREST; IN-VIVO; CELLS; OVEROXIDATION; INACTIVATION	Peroxiredoxin 6 (Prdx6) is a bifunctional enzyme with peroxidase activity and Ca2+-independent phospholipase A2 (iPLA2) activity. Here, we report that H2O2-induced cellular toxicity acts through Prdx6 hyperoxidation. Under high concentrations of H2O2 (> 100 mu M), Prdx6, and 2-Cys Prdxs were hyperoxidized. Contrary to hyperoxidation of 2-Cys Prdxs, hyperoxidation of Prdx6 was irreversible in vivo. Surprisingly, H2O2-induced cell cycle arrest at the G2/M transition correlated with hyperoxidation and increased iPLA2 activity of Prdx6. This arrest was also associated with up-regulation of p53 and p21 and with down-regulation of cyclin B1. Furthermore, the H2O2-mediated increase in iPLA2 activity was dramatically abolished in a hyperoxidation mutant (C47A), an iPLA2 mutant (S32A), and a double mutant (C47A/S32A) of Prdx6, demonstrating the essential requirement of Prdx6 C47 hyperoxidation for its iPLA2 activity. Together, our results demonstrate that H2O2-mediated hyperoxidation of Prdx6 induces cell cycle arrest at the G2/M transition through up-regulation of iPLA2 activity.	[Kim, So Yong; Jo, Hee-Yeon; Kim, Mi Hye; Cha, Yun-Yi; Kim, Tae Jin; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea; [Choi, Sung Won] Cornell Univ, Sch Arts & Sci, Dept Mol Biol, New York, NY 10021 USA; [Shim, Jae-Hyuck] Harvard Univ, Sch Med, Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Sungkyunkwan University (SKKU); Cornell University; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health	Lee, KY (corresponding author), 300 Cheoncheon Dong, Suwon 440746, Gyeonggi Do, South Korea.	thylee@med.skku.ac.kr	; Kim, Tae Jin/D-6544-2011	Shim, Jae-Hyuck/0000-0002-4947-3293; Kim, Tae Jin/0000-0001-9802-0568	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A080250]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A080250). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Dona F, 2008, INT J ONCOL, V33, P613, DOI 10.3892/ijo_00000047; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lee SM, 2008, PHYTOTHER RES, V22, P752, DOI 10.1002/ptr.2355; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Saigusa K, 2007, ONCOGENE, V26, P1110, DOI 10.1038/sj.onc.1210148; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wang Y, 2006, AM J RESP CELL MOL, V34, P481, DOI 10.1165/rcmb.2005-0333OC; Wang Y, 2004, AM J PHYSIOL-LUNG C, V286, pL1188, DOI 10.1152/ajplung.00288.2003; Wang Y, 2008, J CELL BIOCHEM, V104, P1274, DOI 10.1002/jcb.21703; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	24	84	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33563	33568		10.1074/jbc.M806578200	http://dx.doi.org/10.1074/jbc.M806578200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826942	hybrid, Green Published			2022-12-25	WOS:000261183700061
J	Qin, DJ; Gan, Y; Shao, KF; Wang, H; Li, W; Wang, T; He, WZ; Xu, JY; Zhang, Y; Kou, ZH; Zeng, LW; Sheng, GQ; Esteban, MA; Gao, SR; Pei, DQ				Qin, Dajiang; Gan, Yi; Shao, Kaifeng; Wang, Hao; Li, Wen; Wang, Tao; He, Wenzhi; Xu, Jianyong; Zhang, Yu; Kou, Zhaohui; Zeng, Lingwen; Sheng, Guoqing; Esteban, Miguel A.; Gao, Shaorong; Pei, Duanqing			Mouse Meningiocytes Express Sox2 and Yield High Efficiency of Chimeras after Nuclear Reprogramming with Exogenous Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; FIBROBLASTS; ADULT; INDUCTION	Induced pluripotent stem cell technology, also termed iPS, is an emerging approach to reprogram cells into an embryonic stem cell-like state by viral transduction with defined combinations of factors. iPS cells share most characteristics of embryonic stem cells, counting pluripotency and self-renewal, and have so far been obtained from mouse and humans, including patients with genetic diseases. Remarkably, autologous transplantation of cell lineages derived from iPS cells will eliminate the possibility of immunological rejection, as well as current ethical issues surrounding human embryonic stem cell research. However, before iPS can be used for clinical purposes, technical problems must be overcome. Among other considerations, full and homogeneous iPS reprogramming is an important prerequisite. However, despite the fact that cells from several mouse tissues can be successfully induced to iPS, the overall efficiency of chimera formation of these clones remains low even if selection for Oct4 or Nanog expression is applied. In this report, we demonstrate that cells from the mouse meningeal membranes express elevated levels of the embryonic master regulator Sox2 and are highly amenable to iPS. Meningeal iPS clones, generated without selection, are fully and homogeneously reprogrammed based on DNA methylation analysis and 100% chimera competent. Our results define a population of somatic cells that are ready to undergo iPS, thus highlighting a very attractive cell type for iPS research and application.	[Qin, Dajiang; Gan, Yi; Shao, Kaifeng; Wang, Hao; Li, Wen; Wang, Tao; He, Wenzhi; Xu, Jianyong; Zeng, Lingwen; Sheng, Guoqing; Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Stem Cell & Canc Biol Grp, Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Guangdong, Peoples R China; [Zhang, Yu; Kou, Zhaohui; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Chinese Academy of Sciences; National Institute of Biological Sciences, Beijing	Pei, DQ (corresponding author), Chinese Acad Sci, Stem Cell & Canc Biol Grp, Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Shao, Kaifeng/T-3547-2018; zhou, xingru/G-4442-2012	Shao, Kaifeng/0000-0003-2066-9054; 	National Natural Science Foundation of China [30725012, 30630039]; Chinese Academy of Sciences [KSCX2-YW-R-48]; Guangzhou Science and Technology [2006A50104002]; Ministry of Science and Technology 973 [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804]; National High Technology [2005AA210930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Guangzhou Science and Technology; Ministry of Science and Technology 973(National Basic Research Program of China); National High Technology(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30725012 and 30630039; Chinese Academy of Sciences Grant KSCX2-YW-R-48; Guangzhou Science and Technology Grant 2006A50104002; Ministry of Science and Technology 973 Grants 2006CB701504, 2006CB943600, 2007CB948002, and 2007CB947804; and National High Technology Project 863 Grant 2005AA210930. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gagan Jeffrey R., 2007, Birth Defects Research, V81, P297, DOI 10.1002/bdrc.20104; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qin DJ, 2007, CELL RES, V17, P959, DOI 10.1038/cr.2007.92; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	22	42	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33730	33735		10.1074/jbc.M806788200	http://dx.doi.org/10.1074/jbc.M806788200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826945	Green Published, hybrid			2022-12-25	WOS:000261183700079
J	Busuttil, RA; Munoz, DP; Garcia, AM; Rodier, F; Kim, WH; Suh, Y; Hasty, P; Campisi, J; Vijg, J				Busuttil, Rita A.; Munoz, Denise P.; Garcia, Ana Maria; Rodier, Francis; Kim, Woo Ho; Suh, Yousin; Hasty, Paul; Campisi, Judith; Vijg, Jan			Effect of Ku80 Deficiency on Mutation Frequencies and Spectra at a LacZ Reporter Locus in Mouse Tissues and Cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; STEM-CELLS; DNA; ACCUMULATION; SENESCENCE; CANCER; CAPACITY; DELETION; BRAIN; LIVER	Non-homologous end joining (NHEJ) is thought to be an important mechanism for preventing the adverse effects of DNA double strand breaks (DSBs) and its absence has been associated with premature aging. To investigate the effect of inactivated NHEJ on spontaneous mutation frequencies and spectra in vivo and in cultured cells, we crossed a Ku80-deficient mouse with mice harboring a lacZ-plasmid-based mutation reporter. We analyzed various organs and tissues, as well as cultured embryonic fibroblasts, for mutations at the lacZ locus. When comparing mutant with wild-type mice, we observed a significantly higher number of genome rearrangements in liver and spleen and a significantly lower number of point mutations in liver and brain. The reduced point mutation frequency was not due to a decrease in small deletion mutations thought to be a hallmark of NHEJ, but could be a consequence of increased cellular responses to unrepaired DSBs. Indeed, we found a substantial increase in persistent 53BP1 and gamma H2AX DNA damage foci in Ku80(-/-) as compared to wild-type liver. Treatment of cultured Ku80-deficient or wild-type embryonic fibroblasts, either proliferating or quiescent, with hydrogen peroxide or bleomycin showed no differences in the number or type of induced genome rearrangements. However, after such treatment, Ku80-deficient cells did show an increased number of persistent DNA damage foci. These results indicate that Ku80-dependent repair of DNA damage is predominantly error-free with the effect of alternative more error-prone pathways creating genome rearrangements only detectable after extended periods of time, i.e., in young adult animals. The observed premature aging likely results from a combination of increased cellular senescence and an increased load of stable, genome rearrangements.	[Busuttil, Rita A.; Munoz, Denise P.; Campisi, Judith; Vijg, Jan] Buck Inst Age Res, Novato, CA USA; [Garcia, Ana Maria] Univ Texas, Dept Biol, San Antonio, TX USA; [Rodier, Francis; Campisi, Judith] Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA USA; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Suh, Yousin] Albert Einstein Coll Med, Dept Med, Bronx, NY USA; [Hasty, Paul] Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX USA	Buck Institute for Research on Aging; University of Texas System; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Seoul National University (SNU); Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Health San Antonio	Busuttil, RA (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.	jvijg@aecom.yu.edu	Kim, Wooho/G-3703-2011	Hasty, Paul/0000-0003-3046-0131; Rodier, Francis/0000-0003-2523-309X	NIH [AG17242]; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH program project grant AG17242.	Andressoo JO, 2006, CELL CYCLE, V5, P2886, DOI 10.4161/cc.5.24.3565; Bau DT, 2004, CANCER RES, V64, P5013, DOI 10.1158/0008-5472.CAN-04-0403; BISHOP JM, 1995, GENE DEV, V9, P1309, DOI 10.1101/gad.9.11.1309; BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Busuttil RA, 2006, DNA REPAIR, V5, P52, DOI 10.1016/j.dnarep.2005.07.006; Busuttil RA, 2005, CANCER RES, V65, P11271, DOI 10.1158/0008-5472.CAN-05-2980; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Dolle MET, 2002, GENOME RES, V12, P1732, DOI 10.1101/gr.125502; Dolle MET, 2002, NUCLEIC ACIDS RES, V30, P545, DOI 10.1093/nar/30.2.545; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Garcia Ana Maria, 2007, Methods Mol Biol, V371, P267; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3; Suh YS, 2000, CANCER RES, V60, P5067; Vijg J, 2005, AGING CELL, V4, P331, DOI 10.1111/j.1474-9726.2005.00179.x; Vijg J., 2007, AGING GENOME; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3458	10.1371/journal.pone.0003458	http://dx.doi.org/10.1371/journal.pone.0003458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941635	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125600016
J	Puiu, D; Salzberg, SL				Puiu, Daniela; Salzberg, Steven L.			Re-Assembly of the Genome of Francisella tularensis Subsp holarctica OSU18	PLOS ONE			English	Article								Francisella tularensis is a highly infectious human intracellular pathogen that is the causative agent of tularemia. It occurs in several major subtypes, including the live vaccine strain holarctica (type B). F. tularensis is classified as category A biodefense agent in part because a relatively small number of organisms can cause severe illness. Three complete genomes of subspecies holarctica have been sequenced and deposited in public archives, of which OSU18 was the first and the only strain for which a scientific publication has appeared [1]. We re-assembled the OSU18 strain using both de novo and comparative assembly techniques, and found that the published sequence has two large inversion mis-assemblies. We generated a corrected assembly of the entire genome along with detailed information on the placement of individual reads within the assembly. This assembly will provide a more accurate basis for future comparative studies of this pathogen.	[Puiu, Daniela; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Puiu, D (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	salzberg@umd.edu	Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432	US Department of Homeland Security Science and Technology Directorate [W81XWH-05-2-0051, NBCH2070002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	US Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the US Department of Homeland Security Science and Technology Directorate under awards W81XWH-05-2-0051 and NBCH2070002.	Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Enserink M, 2008, SCIENCE, V321, P898, DOI 10.1126/science.321.5891.898; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Phillippy AM, 2007, PLOS COMPUT BIOL, V3, P887, DOI 10.1371/journal.pcbi.0030098; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Salzberg SL, 2004, PLOS BIOL, V2, P1273, DOI 10.1371/journal.pbio.0020285; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; White JR, 2008, BIOINFORMATICS, V24, P462, DOI 10.1093/bioinformatics/btm632	16	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3427	10.1371/journal.pone.0003427	http://dx.doi.org/10.1371/journal.pone.0003427			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927608	Green Published, gold, Green Submitted			2022-12-25	WOS:000265122400003
J	Palmeira, VF; Kneipp, LF; Rozental, S; Alviano, CS; Santos, ALS				Palmeira, Vanila F.; Kneipp, Lucimar F.; Rozental, Sonia; Alviano, Celuta S.; Santos, Andre L. S.			Beneficial Effects of HIV Peptidase Inhibitors on Fonsecaea pedrosoi: Promising Compounds to Arrest Key Fungal Biological Processes and Virulence	PLOS ONE			English	Article							SECRETED ASPARTYL PROTEINASES; CANDIDA-ALBICANS; ANTIRETROVIRAL THERAPY; IN-VITRO; PROTEASE INHIBITORS; CHROMOBLASTOMYCOSIS; COMBINATION; INDINAVIR; PATHOGEN; CRYPTOSPORIDIUM	Background: Fonsecaea pedrosoi is the principal etiologic agent of chromoblastomycosis, a fungal disease whose pathogenic events are poorly understood. Current therapy for chromoblastomycosis is suboptimal due to toxicity of the available therapeutic agents and the emergence of drug resistance. Compounding these problems is the fact that endemic countries and regions are economically poor. Purpose and Principal Findings: In the present work, we have investigated the effect of human immunodeficiency virus (HIV) peptidase inhibitors (PIs) on the F. pedrosoi conidial secreted peptidase, growth, ultrastructure and interaction with different mammalian cells. All the PIs impaired the acidic conidial-derived peptidase activity in a dose-dependent fashion, in which nelfinavir produced the best inhibitory effect. F. pedrosoi growth was also significantly reduced upon exposure to PIs, especially nelfinavir and saquinavir. PIs treatment caused profound changes in the conidial ultrastructure as shown by transmission electron microscopy, including invaginations in the cytoplasmic membrane, disorder and detachment of the cell wall, enlargement of fungi cytoplasmic vacuoles, and abnormal cell division. The synergistic action on growth ability between nelfinavir and amphotericin B, when both were used at sub-inhibitory concentrations, was also observed. PIs reduced the adhesion and endocytic indexes during the interaction between conidia and epithelial cells (CHO), fibroblasts or macrophages, in a cell type-dependent manner. Moreover, PIs interfered with the conidia into mycelia transformation when in contact with CHO and with the susceptibility killing by macrophage cells. Conclusions/Significance: Overall, by providing the first evidence that HIV PIs directly affects F. pedrosoi development and virulence, these data add new insights on the wide-spectrum efficacy of HIV PIs, further arguing for the potential chemotherapeutic targets for aspartyl-type peptidase produced by this human pathogen.	[Palmeira, Vanila F.; Santos, Andre L. S.] Univ Fed Rio de Janeiro, CCS, Lab Estudos Integrados Bioquim Microbiana, Dept Microbiol Geral,IMPPG, Rio De Janeiro, Brazil; [Palmeira, Vanila F.; Alviano, Celuta S.] Univ Fed Rio de Janeiro, CCS, Dept Microbiol Geral, Lab Estrutura Microrganismos, Rio De Janeiro, Brazil; [Kneipp, Lucimar F.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Taxonom, Bioquim Bioprospeccao Fungos, Rio De Janeiro, Brazil; [Rozental, Sonia] Univ Fed Rio de Janeiro, CCS, IBCCF, Lab Biol Celular Fungos, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Palmeira, VF (corresponding author), Univ Fed Rio de Janeiro, CCS, Lab Estudos Integrados Bioquim Microbiana, Dept Microbiol Geral,IMPPG, Rio De Janeiro, Brazil.	andre@micro.ufrj.br	Alviano, Celuta/V-3878-2019; Santos, André/Z-5853-2019; Rozental, Sonia/A-8537-2013; KNEIPP, LUCIMAR/AAK-5141-2020	Alviano, Celuta/0000-0002-0806-6712; Santos, André/0000-0003-0821-8592; Rozental, Sonia/0000-0002-3659-5945; 	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); FUJB (Fundacao Universitaria Jose Bonifacio); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FUJB (Fundacao Universitaria Jose Bonifacio); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Brazilian agencies: MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro), FUJB (Fundacao Universitaria Jose Bonifacio) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior).	Alviano CS, 1999, GLYCOCONJUGATE J, V16, P545, DOI 10.1023/A:1007078106280; Alviano DS, 2004, ARCH MICROBIOL, V181, P278, DOI 10.1007/s00203-004-0653-9; Andrade TS, 2004, MYCOSES, V47, P216, DOI 10.1111/j.1439-0507.2004.00984.x; Andrews L, 2000, INFECT DIS CLIN N AM, V14, P901, DOI 10.1016/S0891-5520(05)70139-2; Atzori C, 2003, J ANTIMICROB CHEMOTH, V52, P276, DOI 10.1093/jac/dkg314; Blasi E, 2004, FEMS IMMUNOL MED MIC, V42, P187, DOI 10.1016/j.femsim.2004.05.001; Bobin S, 1998, PATHOL BIOL, V46, P418; Bonifaz A, 1997, INT J DERMATOL, V36, P542, DOI 10.1046/j.1365-4362.1997.00085.x; BUROKERKILGORE M, 1993, ANAL BIOCHEM, V208, P387, DOI 10.1006/abio.1993.1066; Casolari C, 2004, PHARMACOL RES, V50, P605, DOI 10.1016/j.phrs.2004.06.008; Cassone A, 1999, J INFECT DIS, V180, P448, DOI 10.1086/314871; Dash C, 2003, CRIT REV BIOCHEM MOL, V38, P89, DOI 10.1080/713609213; De Hoog GS, 2000, MED MYCOL, V38, P243, DOI 10.1080/mmy.38.s1.243.250; Esterre F, 2000, CLIN DIAGN LAB IMMUN, V7, P497, DOI 10.1128/CDLI.7.3.497-500.2000; Esterre P, 1996, AM J TROP MED HYG, V55, P45, DOI 10.4269/ajtmh.1996.55.45; FARBIARZ SR, 1990, J MED VET MYCOL, V28, P373; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Gallagher JC, 2003, EXPERT OPIN PHARMACO, V4, P147, DOI 10.1517/eoph.4.2.147.21077; Gruber A, 1999, IMMUNOBIOLOGY, V201, P133, DOI 10.1016/S0171-2985(99)80052-7; Gruber A, 1999, IMMUNOPHARMACOLOGY, V41, P227, DOI 10.1016/S0162-3109(99)00035-1; Gupta AK, 2002, MED MYCOL, V40, P529; Hommer V, 2003, J ANTIMICROB CHEMOTH, V52, P359, DOI 10.1093/jac/dkg357; Kneipp LF, 2004, MICROBIOL-SGM, V150, P3355, DOI 10.1099/mic.0.27405-0; Korting HC, 1999, ANTIMICROB AGENTS CH, V43, P2038, DOI 10.1128/AAC.43.8.2038; Kwon-Chung KJ, 1992, CHROMOBLASTOMYCOSIS, P337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Limongi CL, 1997, MYCOPATHOLOGIA, V138, P127, DOI 10.1023/A:1006841529438; Limongi CL, 2001, MED MYCOL, V39, P429, DOI 10.1080/714031051; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; Manfredi R, 2003, INT J ANTIMICROB AG, V22, P449, DOI 10.1016/S0924-8579(03)00113-4; Marques SA, 2000, MED MYCOL, V38, P269, DOI 10.1080/mmy.38.s1.269.279; Martinez RL, 2007, CLIN DERMATOL, V25, P188, DOI 10.1016/j.clindermatol.2006.05.007; Mastroianni CM, 1999, AIDS, V13, P883, DOI 10.1097/00002030-199905280-00003; Mezzaroma I, 1999, AIDS, V13, P1187, DOI 10.1097/00002030-199907090-00006; Monari C, 2005, J INFECT DIS, V191, P307, DOI 10.1086/426828; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; OLIVEIRA LG, 1983, REV SOC BRAS MED TRO, V7, P7; Palmeira VF, 2006, RES MICROBIOL, V157, P819, DOI 10.1016/j.resmic.2006.07.003; Palmeira VF, 2006, FEMS IMMUNOL MED MIC, V46, P21, DOI 10.1111/j.1574-695X.2005.00003.x; Pernerstorfer-Schoen H, 2001, AIDS, V15, P725, DOI 10.1097/00002030-200104130-00008; Poirriez J, 2000, AM J TROP MED HYG, V63, P61, DOI 10.4269/ajtmh.2000.63.61; Porter S R, 1998, Oral Dis, V4, P159; Powderly WG, 1998, JAMA-J AM MED ASSOC, V280, P72, DOI 10.1001/jama.280.1.72; Rippon JW., 1988, MED MYCOLOGY PATHOGE, P276; ROZENTAL S, 1994, MYCOPATHOLOGIA, V126, P85, DOI 10.1007/BF01146200; RUCHEL R, 1990, ZBL BAKT-INT J MED M, V273, P391; Saag MS, 1998, CURR CLIN TOPICS INF, V18, P154; Santos ALS, 2007, FEMS MICROBIOL REV, V31, P570, DOI 10.1111/j.1574-6976.2007.00077.x; Savoia D, 2005, INT J ANTIMICROB AG, V26, P92, DOI 10.1016/j.ijantimicag.2005.04.003	51	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3382	10.1371/journal.pone.0003382	http://dx.doi.org/10.1371/journal.pone.0003382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852883	Green Published, Green Submitted, gold			2022-12-25	WOS:000265121600007
J	Chen, JN; Kinter, M; Shank, S; Cotton, C; Kelley, TJ; Ziady, AG				Chen, Junnan; Kinter, Michael; Shank, Samuel; Cotton, Calvin; Kelley, Thomas J.; Ziady, Assem G.			Dysfunction of Nrf-2 in CF Epithelia Leads to Excess Intracellular H2O2 and Inflammatory Cytokine Production	PLOS ONE			English	Article								Cystic fibrosis is characterized by recurring pulmonary exacerbations that lead to the deterioration of lung function and eventual lung failure. Excessive inflammatory responses by airway epithelia have been linked to the overproduction of the inflammatory cytokine IL-6 and IL-8. The mechanism by which this occurs is not fully understood, but normal IL-1 beta mediated activation of the production of these cytokines occurs via H2O2 dependent signaling. Therefore, we speculated that CFTR dysfunction causes alterations in the regulation of steady state H2O2. We found significantly elevated levels of H2O2 in three cultured epithelial cell models of CF, one primary and two immortalized. Increases in H2O2 heavily contributed to the excessive IL-6 and IL-8 production in CF epithelia. Proteomic analysis of three in vitro and two in vivo models revealed a decrease in antioxidant proteins that regulate H2O2 processing, by >= 2 fold in CF vs. matched normal controls. When cells are stimulated, differential expression in CF versus normal is enhanced; corresponding to an increase in H2O2 mediated production of IL-6 and IL-8. The cause of this redox imbalance is a decrease by similar to 70% in CF cells versus normal in the expression and activity of the transcription factor Nrf-2. Inhibition of CFTR function in normal cells produced this phenotype, while N-acetyl cysteine, selenium, an activator of Nrf-2, and the overexpression of Nrf-2 all normalized H2O2 processing and decreased IL-6 and IL-8 to normal levels, in CF cells. We conclude that a paradoxical decrease in Nrf-2 driven antioxidant responses in CF epithelia results in an increase in steady state H2O2, which in turn contributes to the overproduction of the pro-inflammatory cytokines IL-6 and IL-8. Treatment with antioxidants can ameliorate exaggerated cytokine production without affecting normal responses.	[Chen, Junnan; Shank, Samuel; Cotton, Calvin; Kelley, Thomas J.; Ziady, Assem G.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Kinter, Michael] Oklahoma Med Res Fdn, Free Radical Biol & Aging Res Program, Oklahoma City, OK USA	Case Western Reserve University; Oklahoma Medical Research Foundation	Ziady, AG (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	agz2@case.edu		Kinter, Michael/0000-0001-7409-8918	Cystic Fibrosis Foundation Therapeutic Inc. [ZIADY-Y03FGO]	Cystic Fibrosis Foundation Therapeutic Inc.	This work was supported by a grant from the Cystic Fibrosis Foundation Therapeutic Inc. (ZIADY-Y03FGO).	ARMITAGE P, 2002, STAT METHODS MED RES, P307; Beyer TA, 2007, CELL DEATH DIFFER, V14, P1250, DOI 10.1038/sj.cdd.4402133; Blackwell TS, 2001, AM J PHYSIOL-LUNG C, V281, pL69, DOI 10.1152/ajplung.2001.281.1.L69; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; Ionescu AA, 2002, AM J RESP CRIT CARE, V165, P495, DOI 10.1164/ajrccm.165.4.2104065; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jones KL, 2000, PEDIATR PULM, V30, P79, DOI 10.1002/1099-0496(200008)30:2<79::AID-PPUL1>3.0.CO;2-1; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Kraynack NC, 2002, AM J PHYSIOL-LUNG C, V283, pL604, DOI 10.1152/ajplung.00459.2001; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Li Q, 2006, J BIOL CHEM, V281, P1495, DOI 10.1074/jbc.M511153200; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Musial J, 2001, INT J CARDIOL, V77, P247, DOI 10.1016/S0167-5273(00)00439-3; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Oermann CM, 1999, CHEST, V115, P1053, DOI 10.1378/chest.115.4.1053; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Pervaiz S, 2002, BIOCHEM BIOPH RES CO, V290, P1145, DOI 10.1006/bbrc.2001.6274; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Pollard HB, 2006, MOL CELL PROTEOMICS, V5, P1628, DOI 10.1074/mcp.M600091-MCP200; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Rowinsky EK, 1999, J CLIN ONCOL, V17, P3631, DOI 10.1200/JCO.1999.17.11.3631; Roxo-Rosa M, 2006, PROTEOMICS, V6, P2314, DOI 10.1002/pmic.200500273; Sakoda K, 2006, J DENT RES, V85, P520, DOI 10.1177/154405910608500608; Schwarzer C, 2007, FREE RADICAL BIO MED, V43, P300, DOI 10.1016/j.freeradbiomed.2007.04.015; SHAPIRO BL, 1989, LIFE SCI, V44, P1327, DOI 10.1016/0024-3205(89)90389-5; Sigal N, 2003, J BIOL CHEM, V278, P4854, DOI 10.1074/jbc.M211011200; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; White NM, 2007, AM J PHYSIOL-LUNG C, V292, pL476, DOI 10.1152/ajplung.00262.2006; Wright Jeffrey G, 2003, Am J Respir Med, V2, P211; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	47	80	82	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3367	10.1371/journal.pone.0003367	http://dx.doi.org/10.1371/journal.pone.0003367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846238	Green Published, gold, Green Submitted			2022-12-25	WOS:000265114500007
J	Meulle, A; Salles, B; Daviaud, D; Valet, P; Muller, C				Meulle, Aline; Salles, Bernard; Daviaud, Daniele; Valet, Philippe; Muller, Catherine			Positive Regulation of DNA Double Strand Break Repair Activity during Differentiation of Long Life Span Cells: The Example of Adipogenesis	PLOS ONE			English	Article								Little information is available on the ability of terminally differentiated cells to efficiently repair DNA double strand breaks (DSBs), and one might reasonably speculate that efficient DNA repair of these threatening DNA lesions, is needed in cells of long life span with no or limited regeneration from precursor. Few tissues are available besides neurons that allow the study of DNA DSBs repair activity in very long-lived cells. Adipocytes represent a suitable model since it is generally admitted that there is a very slow turnover of adipocytes in adult. Using both Pulse Field Gel Electrophoresis (PFGE) and the disappearance of the phosphorylated form of the histone variant H2AX, we demonstrated that the ability to repair DSBs is increased during adipocyte differentiation using the murine pre-adipocyte cell line, 3T3F442A. In mammalian cells, DSBs are mainly repaired by the non-homologous end-joining pathway (NHEJ) that relies on the DNA dependent protein kinase (DNA-PK) activity. During the first 24 h following the commitment into adipogenesis, we show an increase in the expression and activity of the catalytic sub-unit of the DNA-PK complex, DNA-PKcs. The increased in DNA DSBs repair activity observed in adipocytes was due to the increase in DNA-PK activity as shown by the use of DNA-PK inhibitor or sub-clones of 3T3F442A deficient in DNA-PKcs using long term RNA interference. Interestingly, the up-regulation of DNA-PK does not regulate the differentiation program itself. Finally, similar positive regulation of DNA-PKcs expression and activity was observed during differentiation of primary culture of pre-adipocytes isolated from human sub-cutaneous adipose tissue. Our results show that DNA DSBs repair activity is up regulated during the early commitment into adipogenesis due to an up-regulation of DNA-PK expression and activity. In opposition to the general view that DNA DSBs repair is decreased during differentiation, our results demonstrate that an up-regulation of this process might be observed in post-mitotic long-lived cells.	[Meulle, Aline; Salles, Bernard; Daviaud, Daniele; Valet, Philippe; Muller, Catherine] Univ Toulouse, Toulouse, France; [Meulle, Aline; Salles, Bernard; Muller, Catherine] Inst Pharmacol & Structural Biol, CNRS, UMR 5089, Toulouse, France; [Daviaud, Daniele; Valet, Philippe] INSERM, U858 Equipe 3, Toulouse, France	Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Meulle, A (corresponding author), Univ Toulouse, Toulouse, France.	salles@ipbs.fr; muller@ipbs.fr	Valet, Philippe/N-7472-2017; Meulle, Aline/M-6370-2014; MULLER, Catherine/E-2060-2011; MULLER, Catherine/M-2185-2018	Valet, Philippe/0000-0001-6520-7393; 	Canceropole Grand Sud-Ouest; Institut National du Cancer [PL2006_035]; Electricite de France; Ligue Nationale contre le Cancer	Canceropole Grand Sud-Ouest; Institut National du Cancer(Institut National du Cancer (INCA) France); Electricite de France; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Canceropole Grand Sud-Ouest, the Institut National du Cancer (INCA grants PL2006_035), the Electricite de France and the Ligue Nationale contre le Cancer (Equipe Labelisee) (AM, BS and CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Ader I, 2002, ONCOGENE, V21, P6471, DOI 10.1038/sj.onc.1205838; AJMANI AK, 1995, J EXP MED, V181, P2049, DOI 10.1084/jem.181.6.2049; Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Biard DSF, 2005, MOL CANCER RES, V3, P519, DOI 10.1158/1541-7786.MCR-05-0044; Boulton S, 1996, CARCINOGENESIS, V17, P2285, DOI 10.1093/carcin/17.11.2285; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Bour S, 2007, BIOCHIMIE, V89, P916, DOI 10.1016/j.biochi.2007.02.013; Bracker TU, 2006, STEM CELLS, V24, P722, DOI 10.1634/stemcells.2005-0227; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; CEDERVALL B, 1995, RADIAT RES, V143, P8, DOI 10.2307/3578920; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Engeli S, 2004, J LIPID RES, V45, P1640, DOI 10.1194/jlr.M300322-JLR200; FARMER SR, 2006, P NATL ACAD SCI USA, V99, P15345; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Friedberg EC, 2004, CURR OPIN GENET DEV, V14, P5, DOI 10.1016/j.gde.2003.11.001; Gobbel GT, 2003, BRAIN RES, V980, P221, DOI 10.1016/S0006-8993(03)02977-9; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Kubota N, 1998, CANCER LETT, V133, P161, DOI 10.1016/S0304-3835(98)00221-3; Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004; Lee SE, 1997, MOL CELL BIOL, V17, P1425, DOI 10.1128/MCB.17.3.1425; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; MERLO D, 2005, CELL, V72, P131; Muller C, 1998, NUCLEIC ACIDS RES, V26, P1382, DOI 10.1093/nar/26.6.1382; Muller C, 2001, ONCOGENE, V20, P4373, DOI 10.1038/sj.onc.1204571; MURRAY D, 1987, RADIAT RES, V109, P153, DOI 10.2307/3576876; Nawrocki AR, 2005, DRUG DISCOV TODAY, V10, P1219, DOI 10.1016/S1359-6446(05)03569-5; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Nouspikel T, 2007, NEUROSCIENCE, V145, P1213, DOI 10.1016/j.neuroscience.2006.07.006; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nowak E, 2006, RADIAT RES, V165, P155, DOI 10.1667/RR3496.1; Okayasu R, 1998, RADIAT RES, V149, P440, DOI 10.2307/3579783; Price BD, 1996, CANCER RES, V56, P246; Ren KQ, 2002, J NEUROCHEM, V80, P949, DOI 10.1046/j.0022-3042.2002.00776.x; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Sjakste N, 2007, EUR J HISTOCHEM, V51, P81; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; Tabocchini MA, 2000, MUTAT RES-DNA REPAIR, V461, P71, DOI 10.1016/S0921-8777(00)00041-0; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WETERINGS E, 2004, J CELL BIOL; WETERINGS E, 2007, J CELL BIOL; Wyman C, 2004, CURR BIOL, V14, pR629, DOI 10.1016/j.cub.2004.07.049; Xu WM, 2000, NAT CELL BIOL, V2, P339, DOI 10.1038/35014028; ZHANG WW, 1992, BIOCHEM BIOPH RES CO, V186, P574, DOI 10.1016/S0006-291X(05)80847-2	58	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3345	10.1371/journal.pone.0003345	http://dx.doi.org/10.1371/journal.pone.0003345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846213	Green Published, Green Submitted, gold			2022-12-25	WOS:000265114500002
J	Camacho, CJ				Camacho, Carlos J.			Quantitative Modeling of Currents from a Voltage Gated Ion Channel Undergoing Fast Inactivation	PLOS ONE			English	Article								Ion channels play a central role in setting gradients of ion concentration and electrostatic potentials, which in turn regulate sensory systems and other functions. Based on the structure of the open configuration of the Kv1.2 channel and the suggestion that the two ends of the N-terminal inactivating peptide form a bivalent complex that simultaneously blocks the channel pore and binds to the cytoplasmic T1 domain, we propose a six state kinetic model that for the first time reproduces the kinetics of recovery of the Drosophila Shaker over the full range of time scales and hyperpolarization potentials, including tail currents. The model is motivated by a normal mode analysis of the inactivated channel that suggests that a displacement consistent with models of the closed state propagates to the T1 domain via the S1-T1 linker. This motion stretches the bound (inactivating) peptide, hastening the unblocking of the pore. This pulling force is incorporated into the rates of the open to blocked states, capturing the fast recovery phase of the current for repolarization events shorter than 1 ms. If the membrane potential is hyperpolarized, essential dynamics further suggests that the T1 domain returns to a configuration where the peptide is unstretched and the S1-T1 linker is extended. Coupling this novel hyperpolarized substate to the closed, open and blocked pore states is enough to quantitatively estimate the number of open channels as a function of time and membrane potential. A straightforward prediction of the model is that a slow ramping of the potential leads to very small currents.	[Camacho, Carlos J.] Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Camacho, CJ (corresponding author), Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15260 USA.	ccamacho@pitt.edu			National Science Foundation [MCB-0444291/0744077]; Direct For Biological Sciences [0744077] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation MCB-0444291/0744077. NSF played no role in this research.	ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Camacho CJ, 2005, BIOINFORMATICS, V21, P2534, DOI 10.1093/bioinformatics/bti322; Camacho CJ, 2001, P NATL ACAD SCI USA, V98, P10636, DOI 10.1073/pnas.181147798; CHEN CF, 1990, J GEN PHYSIOL, V96, P603, DOI 10.1085/jgp.96.3.603; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P473, DOI 10.1113/jphysiol.1952.sp004718; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Johnstone DB, 1997, NEURON, V19, P151, DOI 10.1016/S0896-6273(00)80355-4; Kuo CC, 1997, J NEUROSCI, V17, P3436; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Rodriguez BM, 1996, NEUROPHARMACOLOGY, V35, P775, DOI 10.1016/0028-3908(96)00111-6; Roux MJ, 1998, J GEN PHYSIOL, V111, P625, DOI 10.1085/jgp.111.5.625; Shrivastava IH, 2006, BIOPHYS J, V90, P3929, DOI 10.1529/biophysj.105.080093; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Valadie H, 2003, J MOL BIOL, V332, P657, DOI 10.1016/S0022-2836(03)00851-9; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3342	10.1371/journal.pone.0003342	http://dx.doi.org/10.1371/journal.pone.0003342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833322	gold, Green Accepted, Green Published			2022-12-25	WOS:000264797400010
J	van Raalten, TR; Ramsey, NF; Duyn, J; Jansma, JM				van Raalten, Tamar R.; Ramsey, Nick F.; Duyn, Jeff; Jansma, Johan M.			Practice Induces Function-Specific Changes in Brain Activity	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; DUAL-TASK INTERFERENCE; EVENT-RELATED FMRI; SHORT-TERM-MEMORY; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; CORTICAL ACTIVITY; COGNITIVE TASK; MRI; PERFORMANCE	Background: Practice can have a profound effect on performance and brain activity, especially if a task can be automated. Tasks that allow for automatization typically involve repeated encoding of information that is paired with a constant response. Much remains unknown about the effects of practice on encoding and response selection in an automated task. Methodology: To investigate function-specific effects of automatization we employed a variant of a Sternberg task with optimized separation of activity associated with encoding and response selection by means of m-sequences. This optimized randomized event-related design allows for model free measurement of BOLD signals over the course of practice. Brain activity was measured at six consecutive runs of practice and compared to brain activity in a novel task. Principal Findings: Prompt reductions were found in the entire cortical network involved in encoding after a single run of practice. Changes in the network associated with response selection were less robust and were present only after the third run of practice. Conclusions/Significance: This study shows that automatization causes heterogeneous decreases in brain activity across functional regions that do not strictly track performance improvement. This suggests that cognitive performance is supported by a dynamic allocation of multiple resources in a distributed network. Our findings may bear importance in understanding the role of automatization in complex cognitive performance, as increased encoding efficiency in early stages of practice possibly increases the capacity to otherwise interfering information.	[van Raalten, Tamar R.; Ramsey, Nick F.] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [van Raalten, Tamar R.] Univ Med Ctr Utrecht, Dept Child & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Duyn, Jeff] NIH, NINDS, Lab Mol Funct Imag, Bethesda, MD USA; [Jansma, Johan M.] NIH, NIMH, Sect Neuroimag Mood & Anxiety Disorders, Bethesda, MD USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	van Raalten, TR (corresponding author), Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	t.vanraalten@umcutrecht.nl	Duyn, Jozef H/F-2483-2010	Lauwereyns, Jan/0000-0003-0551-2550; ramsey, nick/0000-0002-7136-259X	Netherlands Organisation for Scientific Research; Utrecht University [016.036.401]; Organisation for Scientific Research [R-95-405]; Foundation de Drie Lichten in the Netherlands; NIH, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003027, ZIANS003027] Funding Source: NIH RePORTER	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Utrecht University; Organisation for Scientific Research; Foundation de Drie Lichten in the Netherlands(Netherlands Government); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was sponsored by Netherlands Organisation for Scientific Research and Utrecht University, Grant 016.036.401, Netherlands, Organisation for Scientific Research Travel Grant R-95-405 and by Foundation de Drie Lichten in the Netherlands. This research was supported (in part) by the Intramural Research Program of the NIH, NINDS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura M, 2007, PSYCHIAT RES-NEUROIM, V154, P103, DOI 10.1016/j.pscychresns.2006.08.002; Bedwell JS, 2005, INT J NEUROSCI, V115, P1017, DOI 10.1080/00207450590901530; BODURKA J, 2004, SCALABLE MULTICHANNE; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bor D, 2007, CEREB CORTEX, V17, P778, DOI 10.1093/cercor/bhk035; BRUDER H, 1992, MAGNET RESON MED, V23, P311, DOI 10.1002/mrm.1910230211; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Chen SHA, 2005, NEUROPSYCHOLOGIA, V43, P1227, DOI 10.1016/j.neuropsychologia.2004.12.015; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; de Zwart JA, 2002, MAGNET RESON MED, V47, P1218, DOI 10.1002/mrm.10169; DEZWART J, 2004, SIGNAL NOISE RATIO P; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.3.CO;2-A; Habeck C, 2005, COGNITIVE BRAIN RES, V23, P207, DOI 10.1016/j.cogbrainres.2004.10.010; Jansma JM, 2007, HUM BRAIN MAPP, V28, P431, DOI 10.1002/hbm.20297; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Jonides J, 2004, NAT NEUROSCI, V7, P10, DOI 10.1038/nn0104-10; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kassubek J, 2001, COGNITIVE BRAIN RES, V10, P207, DOI 10.1016/S0926-6410(00)00037-9; Kellman P, 2003, NEUROIMAGE, V19, P190, DOI 10.1016/S1053-8119(03)00056-9; Kelly AMC, 2006, NEUROIMAGE, V31, P866, DOI 10.1016/j.neuroimage.2006.01.008; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; Koch K, 2006, BRAIN RES, V1107, P140, DOI 10.1016/j.brainres.2006.06.003; Landau SM, 2004, NEUROIMAGE, V22, P211, DOI 10.1016/j.neuroimage.2004.01.003; Manoach DS, 2003, NEUROIMAGE, V20, P1670, DOI 10.1016/j.neuroimage.2003.08.002; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Poldrack RA, 1998, CEREB CORTEX, V8, P1, DOI 10.1093/cercor/8.1.1; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Ramsey NF, 2004, BRAIN, V127, P517, DOI 10.1093/brain/awh060; Ruthruff E, 2006, PSYCHOL RES-PSYCH FO, V70, P125, DOI 10.1007/s00426-004-0192-7; Ruthruff E, 2001, J EXP PSYCHOL HUMAN, V27, P3, DOI 10.1037/0096-1523.27.1.3; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 2006, NEUROSCIENCE, V139, P223, DOI 10.1016/j.neuroscience.2005.07.062; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Woodward TS, 2006, NEUROSCIENCE, V139, P317, DOI 10.1016/j.neuroscience.2005.05.043	49	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3270	10.1371/journal.pone.0003270	http://dx.doi.org/10.1371/journal.pone.0003270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RU	18827897	Green Submitted, Green Published, gold			2022-12-25	WOS:000264797200001
J	Talotta, F; Cimmino, A; Matarazzo, MR; Casalino, L; De Vita, G; D'Esposito, M; Di Lauro, R; Verde, P				Talotta, F.; Cimmino, A.; Matarazzo, M. R.; Casalino, L.; De Vita, G.; D'Esposito, M.; Di Lauro, R.; Verde, P.			An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation	ONCOGENE			English	Article						miR-21; AP-1; PDCD4; PTEN; RAS; thyroid tumorigenesis	TUMOR-SUPPRESSOR PDCD4; GENE-EXPRESSION; C-JUN; MICRORNA-21 TARGETS; CELLS; TRANSLATION; INVASION; SURVIVAL; PROTEIN; PHOSPHORYLATION	The transcription factor AP-1 plays key roles in tumorigenesis, by regulating a variety of protein-coding genes, implicated in multiple hallmarks of cancer. Among non-coding genes, no AP-1 target has been described yet in tumorigenesis. MicroRNAs (miRNAs) are negative post-transcriptional regulators of protein-coding genes. miRNA expression signatures are highly relevant in cancer and several tumor-associated miRNAs (oncomirs) play critical roles in oncogenesis. Here, we show that the miRNA miR-21, which represents the most frequently upregulated oncomir in solid tumors, is induced by AP-1 in response to RAS. By analyzing validated miR-21 targets, we have found that the tumor suppressors PTEN and PDCD4 are downregulated by RAS in an AP-1- and miR-21-dependent fashion. We further show that, given the role of PDCD4 as negative regulator of AP-1, the miR-21-mediated downregulation of PDCD4 is essential for the maximal induction of AP-1 activity in response to RAS. Our data reveal a novel mechanism of positive autoregulation of the AP-1 complex in RAS transformation and disclose the function of oncomirs as critical targets and regulators of AP-1 in tumorigenesis.	[Verde, P.] CNR, Inst Genet & Biophys A Buzzati Traverso, Inst Genet & Biophys, I-80131 Naples, Italy; [Cimmino, A.] Univ Naples 2, Dept Biochem & Biophys, Sch Med, Naples, Italy; [De Vita, G.; Di Lauro, R.] Univ Naples Federico II, Dept Mol & Cellular Biol & Pathol, Sch Med, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Universita della Campania Vanvitelli; University of Naples Federico II	Verde, P (corresponding author), CNR, Inst Genet & Biophys A Buzzati Traverso, Inst Genet & Biophys, Via P Castellino 111, I-80131 Naples, Italy.	verde@igb.cnr.it	D'Esposito, Maurizio/J-9205-2016; De Vita, Gabriella/H-4422-2011; Casalino, Laura/C-1506-2015; D'Esposito, Maurizio/AAY-6376-2020; Di Lauro, Roberto/A-2746-2012	De Vita, Gabriella/0000-0002-7302-1174; Casalino, Laura/0000-0002-2557-0443; Di Lauro, Roberto/0000-0001-9493-3036; Cimmino, Amelia/0000-0002-0004-9299	AIRC (Associazione Italiana per la Ricerca sul Cancro); AICR (Association for International Cancer Research, UK); AIRC and EU-Project-SIROCCO [LSHG-CT2006037900]	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); AICR (Association for International Cancer Research, UK); AIRC and EU-Project-SIROCCO(Fondazione AIRC per la ricerca sul cancro)	We thank Robert Hennigan (University of Cincinnati, USA), Nancy Colburn (NCI, NIH, USA), Anders Lund (University of Copenhagen, Denmark) and Hideo Iba (University of Tokyo, Japan) for expression and reporter constructs. We also thank Floriana Della Ragione and Ingram Iaccarino (IGB) for technical help and critical reading of the paper. This work was supported by grants from AIRC (Associazione Italiana per la Ricerca sul Cancro) and AICR (Association for International Cancer Research, UK) to PV and AIRC and EU-Project-SIROCCO (Grant LSHG-CT2006037900) to RDL.	Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bahassi EM, 2004, CLIN EXP METASTAS, V21, P293, DOI 10.1023/B:CLIN.0000046132.46946.dd; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Vallone D, 1997, EMBO J, V16, P5310, DOI 10.1093/emboj/16.17.5310; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	53	200	215	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					73	84		10.1038/onc.2008.370	http://dx.doi.org/10.1038/onc.2008.370			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18850008				2022-12-25	WOS:000262294100008
J	Sekiyama, N; Ikegami, T; Yamane, T; Ikeguchi, M; Uchimura, Y; Baba, D; Ariyoshi, M; Tochio, H; Saitoh, H; Shirakawa, M				Sekiyama, Naotaka; Ikegami, Takahisa; Yamane, Tsutomu; Ikeguchi, Mitsunori; Uchimura, Yasuhiro; Baba, Daichi; Ariyoshi, Mariko; Tochio, Hidehito; Saitoh, Hisato; Shirakawa, Masahiro			Structure of the Small Ubiquitin-like Modifier (SUMO)-interacting Motif of MBD1-containing Chromatin-associated Factor 1 Bound to SUMO-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-DNA GLYCOSYLASE; PROTEIN MODIFICATION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TOPOISOMERASE-II; NMR; INSIGHTS; SYSTEM; NUCLEAR; DOMAIN	Post-translational modification by small ubiquitin-like modifier (SUMO) proteins has been implicated in the regulation of a variety of cellular events. The functions of sumoylation are often mediated by downstream effector proteins harboring SUMO interacting motifs (SIMs) that are composed of a hydrophobic core and a stretch of acidic residues. MBD1-containing chromatin-associated factor 1 (MCAF1), a transcription repressor, interacts with SUMO-2/3 and SUMO-1, with a preference for SUMO-2/3. We used NMR spectroscopy to solve the solution structure of the SIM of MCAF1 bound to SUMO-3. The hydrophobic core of the SIM forms a parallel beta-sheet pairing with strand beta 2 of SUMO-3, whereas its C-terminal acidic stretch seems to mediate electrostatic interactions with a surface area formed by basic residues of SUMO-3. The significance of these electrostatic interactions was shown by mutations of both SUMO- 3 and MCAF1. The present structural and biochemical data suggest that the acidic stretch of the SIM of MCAF1 plays an important role in the binding to SUMO-3.	[Sekiyama, Naotaka; Baba, Daichi; Ariyoshi, Mariko; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Yamane, Tsutomu; Ikeguchi, Mitsunori] Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan; [Uchimura, Yasuhiro] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Saitoh, Hisato] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Shirakawa, Masahiro] Japan Sci & Technol Corp, CREST, Saitama 3320012, Japan; [Shirakawa, Masahiro] RIKEN, Genome Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Kyoto University; Osaka University; Yokohama City University; Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST); RIKEN	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan.	shirakawa@moleng.kyoto-u.ac.jp	Ikegami, Takahisa/I-9626-2017; Tochio, Hidehito/F-6109-2011; Tochio, Hidehito/GWV-0429-2022	Ikegami, Takahisa/0000-0002-1429-1844; Tochio, Hidehito/0000-0003-3843-3330; Sekiyama, Naotaka/0000-0003-4537-6565; Ariyoshi, Mariko/0000-0002-1361-2642	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency; Global COE Program; MEXT of Japan [B-09]; Japan Society for the Promotion of Science; Global COE Program [B-09]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants (to M. S.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the Japan Science and Technology Agency; by the Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" (No. B-09) of MEXT of Japan, administrated by the Japan Society for the Promotion of Science; and by the Global COE Program "Integrated Materials Science" (# B-09). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Chupreta S, 2007, J BIOL CHEM, V282, P36155, DOI 10.1074/jbc.M708130200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Goddard T. D. and Kneller D. G ., 2002, SPARKY; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huang WC, 2004, EUR J BIOCHEM, V271, P4114, DOI 10.1111/j.1432-1033.2004.04349.x; Ikegami T, 1999, J BIOCHEM, V125, P495, DOI 10.1093/oxfordjournals.jbchem.a022313; Ikeguchi M, 2004, J COMPUT CHEM, V25, P529, DOI 10.1002/jcc.10402; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kurepa J, 2003, J BIOL CHEM, V278, P6862, DOI 10.1074/jbc.M209694200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Sternsdorf T, 1999, MOL CELL BIOL, V19, P5170; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Yamane T, 2008, PROTEINS, V71, P1970, DOI 10.1002/prot.21874	35	62	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35966	35975		10.1074/jbc.M802528200	http://dx.doi.org/10.1074/jbc.M802528200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18842587	hybrid			2022-12-25	WOS:000261687900071
J	Koh, YK; Lee, MY; Kim, JW; Kim, M; Moon, JS; Lee, YJ; Ahn, YH; Kim, KS				Koh, Yoo-Kyung; Lee, Min-Young; Kim, Jae-Woo; Kim, Minji; Moon, Jong-Seok; Lee, Yoo-Jung; Ahn, Yong-Ho; Kim, Kyung-Sup			Lipin1 Is a Key Factor for the Maturation and Maintenance of Adipocytes in the Regulatory Network with CCAAT/Enhancer-binding Protein alpha and Peroxisome Proliferator-activated Receptor gamma(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; C/EBP-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; DISEASE BURDEN; PPAR-GAMMA; EXPRESSION; OBESITY; ADIPOGENESIS; MUTATION	Lipin1 expression was induced at a late stage of differentiation of 3T3-L1 preadipocytes and maintained at high levels in mature adipocytes. Knockdown of expression of lipin1 by small interfering RNA in 3T3-L1 preadipocytes almost completely inhibited differentiation into adipocytes, whereas overexpression of lipin1 accelerated adipocyte differentiation, demonstrating that lipin1 is required for adipocyte differentiation. In mature adipocytes, transfection of lipin1-small interfering RNA decreased the expression of adipocyte functional genes, indicating the involvement of lipin1 in the maintenance of adipocyte function. Lipin1 increases the transcription-activating function of peroxisome proliferator-activated receptor gamma(2) (PPAR gamma(2)) via direct physical interaction, whereas lipin1 did not affect the function of other adipocyte-related transcription factors such as C/EBP alpha, liver X-activated receptor alpha, or sterol regulatory element binding protein 1c. In mature adipocytes, lipin1 was specifically recruited to the PPAR gamma-response elements of the phosphoenolpyruvate carboxykinase gene, an adipocyte-specific gene. C/EBP alpha up-regulates lipin1 transcription by directly binding to the lipin1 promoter. Based on the existence of a positive feedback loop between C/EBP alpha and PPAR gamma(2), we propose that lipin1 functions as an amplifier of the network between these factors, resulting in the maintenance of high levels of the specific gene expression that are required for adipogenesis and mature adipocyte functions.	[Koh, Yoo-Kyung; Lee, Min-Young; Kim, Jae-Woo; Kim, Minji; Moon, Jong-Seok; Lee, Yoo-Jung; Ahn, Yong-Ho; Kim, Kyung-Sup] Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res,Inst Genet Sci, Dept Biochem & Mol Biol,Brain Korea Project Med S, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System	Kim, KS (corresponding author), 134 Shinchon Dong, Seoul 120752, South Korea.	kyungsup59@yuhs.ac	AHN, Yong Ho/H-6712-2017	AHN, Yong Ho/0000-0002-4133-0757; Kim, Jae-woo/0000-0001-5456-9495; Kim, Kyung-sup/0000-0001-8483-8537	Korea Science and Engineering Foundation [R13-2002-054-03001-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation Grant R13-2002-054-03001-0. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Beale EG, 2003, BIOCHIMIE, V85, P1207, DOI 10.1016/j.biochi.2003.10.012; Bogacka I, 2004, DIABETES CARE, V27, P1660, DOI 10.2337/diacare.27.7.1660; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Duplus E, 2003, BIOCHIMIE, V85, P1257, DOI 10.1016/j.biochi.2003.10.016; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hegele RA, 2003, TRENDS ENDOCRIN MET, V14, P371, DOI 10.1016/S1043-2760(03)00142-5; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kress AA, 2005, PREV MED, V41, P63, DOI 10.1016/j.ypmed.2004.10.012; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LEE MY, 2008, BIOCH J IN PRESS; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nowicki EM, 2003, MIL MED, V168, P252, DOI 10.1093/milmed/168.3.252; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Pedersen TA, 2007, EMBO J, V26, P1081, DOI 10.1038/sj.emboj.7601563; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Reitman ML, 2000, TRENDS ENDOCRIN MET, V11, P410, DOI 10.1016/S1043-2760(00)00309-X; Reue K, 2000, Curr Atheroscler Rep, V2, P390, DOI 10.1007/s11883-000-0077-1; Reue K, 2000, J LIPID RES, V41, P1067; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Scavello GS, 2005, MOL VIS, V11, P97; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Schott M, 2004, NEW ENGL J MED, V351, P103; Scott CL, 2003, AM J CARDIOL, V92, p35I, DOI 10.1016/S0002-9149(03)00507-1; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Tange Y, 2002, J CELL SCI, V115, P4375, DOI 10.1242/jcs.00135; van Harmelen V, 2007, J LIPID RES, V48, P201, DOI 10.1194/jlr.M600272-JLR200; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yubero P, 2004, ENDOCRINOLOGY, V145, P4268, DOI 10.1210/en.2004-0099	41	101	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34896	34906		10.1074/jbc.M804007200	http://dx.doi.org/10.1074/jbc.M804007200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930917	Green Published, hybrid			2022-12-25	WOS:000261469100046
J	Shankaranarayanan, A; Thal, DM; Tesmer, VM; Roman, DL; Neubig, RR; Kozasa, T; Tesmer, JJG				Shankaranarayanan, Aruna; Thal, David M.; Tesmer, Valerie M.; Roman, David L.; Neubig, Richard R.; Kozasa, Tohru; Tesmer, John J. G.			Assembly of High Order G alpha(q)-Effector Complexes with RGS Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; COUPLED RECEPTOR KINASE-2; G-ALPHA SUBUNITS; HETEROTRIMERIC G-PROTEINS; SIGNALING IN-VIVO; PHOSPHOLIPASE-C; GQ-ALPHA; ADENYLYL-CYCLASE; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURE	Transmembrane signaling through G alpha(q)-coupled receptors is linked to physiological processes such as cardiovascular development and smooth muscle function. Recent crystallographic studies have shown how G alpha(q) interacts with two activation-dependent targets, p63RhoGEF and G protein-coupled receptor kinase 2 (GRK2). These proteins bind to the effector-binding site of G alpha(q) in a manner that does not appear to physically overlap with the site on G alpha(q) bound by regulator of G-protein signaling (RGS) proteins, which function as GTPase-activating proteins ( GAPs). Herein we confirm the formation of RGS-G alpha(q)-GRK2/p63RhoGEF ternary complexes using flow cytometry protein interaction and GAP assays. RGS2 and, to a lesser extent, RGS4 are negative allosteric modulators of G alpha(q) binding to either p63RhoGEF or GRK2. Conversely, GRK2 enhances the GAP activity of RGS4 but has little effect on that of RGS2. Similar but smaller magnitude responses are induced by p63RhoGEF. The fact that GRK2 and p63RhoGEF respond similarly to these RGS proteins supports the hypothesis that GRK2 is a bona fide G alpha(q) effector. The results also suggest that signal transduction pathways initiated by GRK2, such as the phosphorylation of G protein-coupled receptors, and by p63RhoGEF, such as the activation of gene transcription, can be regulated by RGS proteins via both allosteric and GAP mechanisms.	[Shankaranarayanan, Aruna; Thal, David M.; Tesmer, Valerie M.; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Shankaranarayanan, Aruna] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Thal, David M.; Tesmer, John J. G.] Univ Michigan, Chem Biol Program, Ann Arbor, MI 48109 USA; [Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Roman, David L.; Neubig, Richard R.; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	johntesmer@umich.edu	Roman, David/G-2637-2010; Thal, David/GXH-4911-2022	Roman, David/0000-0002-8250-0337; Tesmer, John/0000-0003-1125-3727; Thal, David/0000-0002-0325-2524; Neubig, Richard/0000-0003-0501-0008	National Institutes of Health [HL086865, HL071818, GM61454]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086865, R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076821, R01GM061454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL086865 and HL071818 ( to J. J. G. T.), GM61454 ( to T. K.), DA23252 ( to R. R. N.), and GM076821 ( to D. L. R.). This work was also supported by an American Heart Association Greater Midwest Affiliate grant-in-aid ( to T. K.) and a predoctoral fellowship from the Midwest Affiliate of the American Heart Association ( to A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen CH, 1999, J BIOL CHEM, V274, P19799, DOI 10.1074/jbc.274.28.19799; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Cook B, 2000, NAT CELL BIOL, V2, P296, DOI 10.1038/35010571; Day PW, 2003, BIOCHEMISTRY-US, V42, P9176, DOI 10.1021/bi034442+; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gu S, 2007, J BIOL CHEM, V282, P33064, DOI 10.1074/jbc.M702685200; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; Harris DM, 2007, AM J PHYSIOL-HEART C, V293, pH3072, DOI 10.1152/ajpheart.00880.2007; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2004, METHOD ENZYMOL, V390, P65; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Ingi T, 1998, J NEUROSCI, V18, P7178; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Karakoula A, 2008, EUR J PHARMACOL, V587, P16, DOI 10.1016/j.ejphar.2008.03.047; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kristelly R, 2003, ACTA CRYSTALLOGR D, V59, P1859, DOI 10.1107/S0907444903018067; Lodowski DT, 2003, ACTA CRYSTALLOGR D, V59, P936, DOI 10.1107/S0907444903002622; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; McEntaffer RL, 1999, BIOCHEMISTRY-US, V38, P4931, DOI 10.1021/bi982636x; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Natochin M, 1998, J BIOL CHEM, V273, P6731, DOI 10.1074/jbc.273.12.6731; Natochin M, 1997, J BIOL CHEM, V272, P17444, DOI 10.1074/jbc.272.28.17444; Nekrasova ER, 1997, BIOCHEMISTRY-US, V36, P7638, DOI 10.1021/bi970427r; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Offermanns S, 1998, ONCOGENE, V17, P1375, DOI 10.1038/sj.onc.1202173; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Schoeber JP, 2006, J BIOL CHEM, V281, P29669, DOI 10.1074/jbc.M606233200; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Theilade J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P139, DOI 10.2174/1568008013341352; Usui I, 2005, MOL ENDOCRINOL, V19, P2760, DOI 10.1210/me.2004-0429; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wieland T, 1997, J BIOL CHEM, V272, P8853; Willets JM, 2004, J NEUROSCI, V24, P4157, DOI 10.1523/JNEUROSCI.5506-03.2004; Willets JM, 2005, J BIOL CHEM, V280, P18950, DOI 10.1074/jbc.M412682200; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	77	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34923	34934		10.1074/jbc.M805860200	http://dx.doi.org/10.1074/jbc.M805860200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936096	Green Published, hybrid			2022-12-25	WOS:000261469100049
J	Shemesh, R; Toporik, A; Levine, Z; Hecht, I; Rotman, G; Wool, A; Dahary, D; Gofer, E; Kliger, Y; Soffer, MA; Rosenberg, A; Eshel, D; Cohen, Y				Shemesh, Ronen; Toporik, Amir; Levine, Zurit; Hecht, Iris; Rotman, Galit; Wool, Assaf; Dahary, Dvir; Gofer, Eyal; Kliger, Yossef; Soffer, Michal Ayalon; Rosenberg, Avi; Eshel, Dani; Cohen, Yossi			Discovery and Validation of Novel Peptide Agonists for G-protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREDICTING LIGANDS; TARGETS; BIOLOGY; FAMILY	G-protein-coupled receptors (GPCRs) represent an important group of targets for pharmaceutical therapeutics. The completion of the human genome revealed a large number of putative GPCRs. However, the identification of their natural ligands, and especially peptides, suffers from low discovery rates, thus impeding development of therapeutics based on these potential drug targets. We describe the discovery of novel GPCR ligands encrypted in the human proteome. Hundreds of potential peptide ligands were predicted by machine learning algorithms. In vitro screening of selected 33 peptides on a set of 152 GPCRs, including a group of designated orphan receptors, was conducted by intracellular calcium measurements and cAMP assays. The screening revealed eight novel peptides as potential agonists that specifically activated six different receptors in a dose-dependent manner. Most of the peptides showed distinct stimulatory patterns targeted at designated and orphan GPCRs. Further analysis demonstrated a significant in vivo effect for one of the peptides in a mouse inflammation model.	[Shemesh, Ronen; Toporik, Amir; Levine, Zurit; Hecht, Iris; Rotman, Galit; Wool, Assaf; Dahary, Dvir; Gofer, Eyal; Kliger, Yossef; Soffer, Michal Ayalon; Rosenberg, Avi; Eshel, Dani; Cohen, Yossi] Compugen Ltd, IL-69512 Tel Aviv, Israel		Shemesh, R (corresponding author), Compugen Ltd, 72 Pinchas Rosen St, IL-69512 Tel Aviv, Israel.	ronens@compugen.co.il	Dahary, Dvir/AAR-4534-2020; Eshel, Dani/AAH-8174-2020					Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bock JR, 2005, J CHEM INF MODEL, V45, P1402, DOI 10.1021/ci050006d; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Eglen RM, 2005, COMB CHEM HIGH T SCR, V8, P311, DOI 10.2174/1386207054020813; Halls ML, 2006, MOL PHARMACOL, V70, P214, DOI 10.1124/mol.105.021691; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Huang ES, 2005, DRUG DISCOV TODAY, V10, P69, DOI 10.1016/S1359-6446(04)03349-5; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Iribarren P, 2005, IMMUNOL RES, V31, P165, DOI 10.1385/IR:31:3:165; Jiang ZR, 2006, CURR PROTEIN PEPT SC, V7, P459, DOI 10.2174/138920306778559359; Joost P, 2002, GENOME BIOL, V3; Katugampola S, 2003, TRENDS PHARMACOL SCI, V24, P30, DOI 10.1016/S0165-6147(02)00007-X; Kliger Y, 2008, BIOINFORMATICS, V24, P1049, DOI 10.1093/bioinformatics/btn084; Kutzleb C, 2005, CURR PROTEIN PEPT SC, V6, P265, DOI 10.2174/1389203054065419; Leifert WR, 2005, J BIOMOL SCREEN, V10, P765, DOI 10.1177/1087057105280517; Lin SH, 2004, ANN MED, V36, P204, DOI 10.1080/07853890310024668; Liu AMF, 2003, J BIOMOL SCREEN, V8, P39, DOI 10.1177/1087057102239665; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Perretti Mauro, 2006, Inflammation & Allergy Drug Targets, V5, P107, DOI 10.2174/187152806776383170; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Wollemann M, 2004, LIFE SCI, V75, P257, DOI 10.1016/j.lfs.2003.12.005	27	60	63	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34643	34649		10.1074/jbc.M805181200	http://dx.doi.org/10.1074/jbc.M805181200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18854305	Green Published, hybrid			2022-12-25	WOS:000261469100019
J	Stuart, HC; Jia, ZJ; Messenberg, A; Joshi, B; Underhill, TM; Moukhles, H; Nabi, IR				Stuart, Heather C.; Jia, Zongjian; Messenberg, Anat; Joshi, Bharat; Underhill, T. Michael; Moukhles, Hakima; Nabi, Ivan R.			Localized Rho GTPase Activation Regulates RNA Dynamics and Compartmentalization in Tumor Cell Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN MESSENGER-RNA; FOCAL ADHESION DYNAMICS; M-RAS; TRANSLATION INITIATION; SPATIAL REGULATION; KINASE; MIGRATION; EXPRESSION; MEMBRANE; GROWTH	mRNA trafficking and local protein translation are associated with protrusive cellular domains, such as neuronal growth cones, and deregulated control of protein translation is associated with tumor malignancy. We show here that activated RhoA, but not Rac1, is enriched in pseudopodia of MSV-MDCK-INV tumor cells and that Rho, Rho kinase ( ROCK), and myosin II regulate the microtubule-independent targeting of RNA to these tumor cell domains. ROCK inhibition does not affect pseudopodial actin turnover but significantly reduces the dynamics of pseudopodial RNA turnover. Gene array analysis shows that 7.3% of the total genes analyzed exhibited a greater than 1.6-fold difference between the pseudopod and cell body fractions. Of these, only 13.2% ( 261 genes) are enriched in pseudopodia, suggesting that only a limited number of total cellular mRNAs are enriched in tumor cell protrusions. Comparison of the tumor pseudopod mRNA cohort and a cohort of mRNAs enriched in neuronal processes identified tumor pseudopod-specific signaling networks that were defined by expression of M-Ras and the Shp2 protein phosphatase. Pseudopod expression of M-Ras and Shp2 mRNA were diminished by ROCK inhibition linking pseudopodial Rho/ROCK activation to the localized expression of specific mRNAs. Pseudopodial enrichment for mRNAs involved in protein translation and signaling suggests that local mRNA translation regulates pseudopodial expression of less stable signaling molecules as well as the cellular machinery to translate these mRNAs. Pseudopodial Rho/ROCK activation may impact on tumor cell migration and metastasis by stimulating the pseudopodial translocation of mRNAs and thereby regulating the expression of local signaling cascades.	[Stuart, Heather C.; Jia, Zongjian; Messenberg, Anat; Joshi, Bharat; Underhill, T. Michael; Moukhles, Hakima; Nabi, Ivan R.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Nabi, IR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	irnabi@interchange.ubc.ca	Nabi, Ivan/GWZ-5144-2022; Nabi, Ivan R/C-5493-2009	Nabi, Ivan/0000-0002-0670-0513; 	Metastatic Cancer from the Cancer Research Society Inc	Metastatic Cancer from the Cancer Research Society Inc	This work was supported by a Strategic Research Grant on Genomics and Proteomics of Metastatic Cancer from the Cancer Research Society Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; BASSELL GJ, 1994, NEURON, V12, P571, DOI 10.1016/0896-6273(94)90213-5; Cardone RA, 2005, MOL BIOL CELL, V16, P3117, DOI 10.1091/mbc.e04-10-0945; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Duan HF, 2006, CELL SIGNAL, V18, P2049, DOI 10.1016/j.cellsig.2006.04.002; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jia ZJ, 2005, J BIOL CHEM, V280, P30564, DOI 10.1074/jbc.M501754200; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Le PU, 1998, CANCER RES, V58, P1631; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Matsumoto K, 1997, ONCOGENE, V15, P2409, DOI 10.1038/sj.onc.1201416; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Muschler J, 2002, CANCER RES, V62, P7102; Nabi IR, 1999, J CELL SCI, V112, P1803; Nguyen TN, 2000, EXP CELL RES, V258, P171, DOI 10.1006/excr.2000.4929; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Shestakova EA, 1999, CANCER RES, V59, P1202; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Vadnais J, 2002, J BIOL CHEM, V277, P48342, DOI 10.1074/jbc.M209481200; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang YC, 2006, J PROTEOME RES, V5, P907, DOI 10.1021/pr050390u; Wang YC, 2007, P NATL ACAD SCI USA, V104, P8328, DOI 10.1073/pnas.0701103104; Ward KR, 2004, ONCOGENE, V23, P1187, DOI 10.1038/sj.onc.1207226; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhang KX, 2004, MOL CANCER RES, V2, P242; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	58	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34785	34795		10.1074/jbc.M804014200	http://dx.doi.org/10.1074/jbc.M804014200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845542	Green Published, hybrid			2022-12-25	WOS:000261469100035
J	Von Lohneysen, K; Noack, D; Jesaitis, AJ; Dinauer, MC; Knaus, UG				Von Loehneysen, Katharina; Noack, Deborah; Jesaitis, Algirdas J.; Dinauer, Mary C.; Knaus, Ulla G.			Mutational Analysis Reveals Distinct Features of the Nox4-p22(phox) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; GENE-ENCODING P22(PHOX); NADPH OXIDASE ACTIVITY; MONOCLONAL-ANTIBODIES; FLAVOCYTOCHROME-B; NOX FAMILY; SUPEROXIDE; MATURATION; SUBUNIT; CELLS	The integral membrane protein p22(phox) forms a heterodimeric enzyme complex with NADPH oxidases (Noxs) and is required for their catalytic activity. Nox4, a Nox linked to cardiovascular disease, angiogenesis, and insulin signaling, is unique in its ability to produce hydrogen peroxide constitutively. To date, p22phox constitutes the only identified regulatory component for Nox4 function. To delineate structural elements in p22phox essential for formation and localization of the Nox4-p22(phox) complex and its enzymatic function, truncation and point mutagenesis was used. Human lung carcinoma cells served as a heterologous expression system, since this cell type is p22(phox)-deficient and promotes cell surface expression of the Nox4-p22(phox) heterodimer. Expression of p22(phox) truncation mutants indicates that the dual tryptophan motif contained in the N-terminal amino acids 6-11 is essential, whereas the C terminus (amino acids 130-195) is dispensable for Nox4 activity. Introduction of charged residues in domains predicted to be extracellular by topology modeling was mostly tolerated, whereas the exchange of amino acids in predicted membrane-spanning domains caused loss of function or showed distinct differences in p22phox interaction with various Noxs. For example, the substitution of tyrosine 121 with histidine in p22(phox), which abolished Nox2 and Nox3 function in vivo, preserved Nox4 activity when expressed in lung cancer cells. Many of the examined p22(phox) mutations inhibiting Nox1 to -3 maturation did not alter Nox4-p22(phox) association, further accenting the differences between Noxs. These studies highlight the distinct interaction of the key regulatory p22(phox) subunit with Nox4, a feature which could provide the basis for selective inhibitor development.	[Von Loehneysen, Katharina; Noack, Deborah; Knaus, Ulla G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Jesaitis, Algirdas J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Dinauer, Mary C.] James Whitcomb Riley Hosp Children, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Scripps Research Institute; Montana State University System; Montana State University Bozeman; James Whitcomb Riley Hospital Children	Knaus, UG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	uknaus@scripps.edu		Jesaitis, Algirdas/0000-0001-9001-5617	National Institutes of Health [R01 AI024838, P01 CI000095, R01 AI026711, R01 HL045635]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [P01CI000095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024838, R01AI026711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI024838 and P01 CI000095 ( to U. G. K.), R01 AI026711 ( to A. J. J.), and R01 HL045635 ( to M. C. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Burritt JB, 1998, J BIOL CHEM, V273, P24847, DOI 10.1074/jbc.273.38.24847; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Dahan I, 2002, J BIOL CHEM, V277, P8421, DOI 10.1074/jbc.M109778200; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kuroda J, 2007, EUR J NEUROL, V14, P1091, DOI 10.1111/j.1468-1331.2007.01904.x; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Nakano Y, 2008, J CLIN INVEST, V118, P1176, DOI 10.1172/JCI33835; Nakano Y, 2007, BIOCHEM J, V403, P97, DOI 10.1042/BJ20060819; Rae J, 2000, BLOOD, V96, P1106, DOI 10.1182/blood.V96.3.1106.015k44_1106_1112; Roos D, 1996, BLOOD, V87, P1663; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; Werner Erica, 2003, Sci STKE, V2003, pPL3, DOI 10.1126/stke.2003.168.pl3; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	29	79	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35273	35282		10.1074/jbc.M804200200	http://dx.doi.org/10.1074/jbc.M804200200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18849343	hybrid, Green Published			2022-12-25	WOS:000261469100083
J	Gazi, AD; Bastaki, M; Charova, SN; Gkougkoulia, EA; Kapellios, EA; Panopoulos, NJ; Kokkinidis, M				Gazi, Anastasia D.; Bastaki, Marina; Charova, Spyridoula N.; Gkougkoulia, Eirini A.; Kapellios, Efthymios A.; Panopoulos, Nicholas J.; Kokkinidis, Michael			Evidence for a Coiled-coil Interaction Mode of Disordered Proteins from Bacterial Type III Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; CIRCULAR-DICHROISM SPECTROSCOPY; 4-ALPHA-HELIX BUNDLE; INTRINSIC DISORDER; MOLECULAR-BASIS; LEUCINE-ZIPPER; EXPORT; MECHANISM; BINDING; ATPASE	Gene clusters encoding various type III secretion system (T3SS) injectisomes, frequently code downstream of the conserved atpase gene for small hydrophilic proteins whose amino acid sequences display a propensity for intrinsic disorder and coiled-coil formation. These properties were confirmed experimentally for a member of this class, the HrpO protein from the T3SS of Pseudomonas syringae pv phaseolicola: HrpO exhibits high alpha-helical content with coiled-coil characteristics, strikingly low melting temperature, structural properties that are typical for disordered proteins, and a pronounced self-association propensity, most likely via coiled-coil interactions, resulting in heterogeneous populations of quaternary complexes. HrpO interacts in vivo with HrpE, a T3SS protein for which coiled-coil formation is also strongly predicted. Evidence from HrpO analogues from all T3SS families and the flagellum suggests that the extreme flexibility and propensity for coiled-coil interactions of this diverse class of small, intrinsically disordered proteins, whose structures may alter as they bind to their cognate folded protein targets, might be important elements in the establishment of protein-protein interaction networks required for T3SS function.	[Gazi, Anastasia D.; Bastaki, Marina; Panopoulos, Nicholas J.; Kokkinidis, Michael] Univ Crete, Inst Mol Biol & Biotechnol, Fdn Res & Technol, GR-71409 Iraklion, Crete, Greece; [Gazi, Anastasia D.; Bastaki, Marina; Charova, Spyridoula N.; Gkougkoulia, Eirini A.; Kapellios, Efthymios A.; Panopoulos, Nicholas J.; Kokkinidis, Michael] Univ Crete, Dept Biol, GR-71409 Iraklion, Crete, Greece	University of Crete; University of Crete	Kokkinidis, M (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Crete, Greece.	kokkinid@imbb.forth.gr	Gazi, Anastasia/ABD-8988-2021; Gkougkoulia, Eirini/AAY-9789-2020	Gazi, Anastasia/0000-0002-2922-3625; Gkougkoulia, Eirini/0000-0003-0112-5449	PENED; PYTHAGORAS; PEP; GSRT; EPEAEK-Plant Molecular Biology and Biotechnology graduate program; EMBL/Hamburg Outstation; EU [RII3/CT/2004/5060008]	PENED(Greek Ministry of Development-GSRT); PYTHAGORAS; PEP; GSRT(Greek Ministry of Development-GSRT); EPEAEK-Plant Molecular Biology and Biotechnology graduate program; EMBL/Hamburg Outstation; EU(European Commission)	This work was supported by PENED, PYTHAGORAS, and PEP (KP-15) Grants from the Greek Ministry of Education, GSRT, and the EPEAEK-Plant Molecular Biology and Biotechnology graduate program. This work was also supported by the EMBL/Hamburg Outstation and the EU through the EU-I3 access grant from the EU Research Infrastructure Action under the FP6 "Structuring the European Research Area Programme,"Contract Number RII3/CT/2004/5060008. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; DUNKER AK, 2002, PROTEIN-STRUCT FUNCT, V41, P6573; Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103; Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101; FISCHETTI VA, 1993, INFORM PROCESS LETT, V45, P11, DOI 10.1016/0020-0190(93)90245-5; Fraser GM, 2003, J BACTERIOL, V185, P5546, DOI 10.1128/JB.185.18.5546-5554.2003; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guinier A, 1955, SMALL ANGLE XRAY SCA; Hagihara Y, 1998, FOLD DES, V3, P195, DOI 10.1016/S1359-0278(98)00027-3; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Holtzer ME, 2000, BIOPHYS J, V78, P2037, DOI 10.1016/S0006-3495(00)76751-8; HOLTZER ME, 1995, BIOPOLYMERS, V36, P365, DOI 10.1002/bip.360360310; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; ISHIMURO Y, 1979, J POLYM SCI POL CHEM, V17, P1811, DOI 10.1002/pol.1979.170170623; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lane MC, 2006, J BIOL CHEM, V281, P508, DOI 10.1074/jbc.M507238200; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Matsuo K, 2004, J BIOCHEM, V135, P405, DOI 10.1093/jb/mvh048; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Muskotal A, 2006, FEBS LETT, V580, P3916, DOI 10.1016/j.febslet.2006.06.024; PALIAKASIS CD, 1992, PROTEIN ENG, V5, P739, DOI 10.1093/protein/5.8.739; Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Perez J, 2001, J MOL BIOL, V308, P721, DOI 10.1006/jmbi.2001.4611; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ramos AR, 2007, J BACTERIOL, V189, P5773, DOI 10.1128/JB.00435-07; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 1999, PROTEIN SCI, V8, P161; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; VLASSI M, 1994, NAT STRUCT BIOL, V1, P706, DOI 10.1038/nsb1094-706; Wall MichaelE., 2003, SINGULAR VALUE DECOM; YOSHIDA K, 1993, BIOCHEMISTRY-US, V32, P2162, DOI 10.1021/bi00060a006; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	57	34	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34062	34068		10.1074/jbc.M803408200	http://dx.doi.org/10.1074/jbc.M803408200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18836182	Green Published, hybrid			2022-12-25	WOS:000261277700034
J	Zhang, LP; Zhang, Y; Ten Hagen, KG				Zhang, Liping; Zhang, Ying; Ten Hagen, Kelly G.			A Mucin-type O-Glycosyltransferase Modulates Cell Adhesion during Drosophila Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; UDP-GALNAC; GENETIC-ANALYSIS; PS2 INTEGRIN; NOTCH; EXPRESSION; PROTEIN; FAMILY; LIGAND; GLYCOSYLATION	Cell-cell and cell-matrix adhesion are crucial during many stages of eukaryotic development. Here, we provide the first example that mucin-type O-linked glycosylation is involved in a developmentally regulated cell adhesion event in Drosophila melanogaster. Mutations in one member of the evolutionarily conserved family of enzymes that initiates O-linked glycosylation alter epithelial cell adhesion in the Drosophila wing blade. A transposon insertion mutation in pgant3 or RNA interference to pgant3 resulted in blistered wings, a phenotype characteristic of genes involved in integrin-mediated cell interactions. Expression of wild type pgant3 in the mutant background rescued the wing blistering phenotype, whereas expression of another family member (pgant35A) did not, revealing a unique requirement for pgant3. pgant3 mutants displayed reduced O-glycosylation along the basal surface of larval wing imaginal discs, which was restored with wild type pgant3 expression, suggesting that reduced glycosylation of basal proteins is responsible for disruption of adhesion in the adult wing blade. Glycosylation reactions demonstrated that PGANT3 glycosylates certain extracellular matrix (ECM) proteins. Immunoprecipitation experiments revealed that PGANT3 glycosylates tiggrin, an ECM protein known to bind integrin. We propose that this glycosyltransferase is uniquely responsible for glycosylating tiggrin in the wing disc, thus modulating proper cell adhesion through integrin-ECM interactions. This study provides the first evidence for the role of O-glycosylation in a developmentally regulated, integrin-mediated, cell adhesion event and reveals a novel player in wing blade formation during Drosophila development.	[Zhang, Liping; Zhang, Ying; Ten Hagen, Kelly G.] NIH, Dev Glycobiol Unit, NIDCR, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by the National Institutes of Health (the Intramural Research Program of the NIDCR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; Araujo H, 2003, DEVELOPMENT, V130, P3851, DOI 10.1242/dev.00613; Avichezer D, 1997, INT J CANCER, V72, P119, DOI 10.1002/(SICI)1097-0215(19970703)72:1<119::AID-IJC17>3.3.CO;2-5; Bloor JW, 1998, GENETICS, V148, P1127; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWER DL, 1995, DEVELOPMENT, V121, P1311; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Bunch TA, 1998, DEVELOPMENT, V125, P1679; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FOGERTY FJ, 1994, DEVELOPMENT, V120, P1747; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; Graner MW, 1998, J BIOL CHEM, V273, P18235, DOI 10.1074/jbc.273.29.18235; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Prout M, 1997, GENETICS, V146, P275; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Subramanian A, 2007, DEVELOPMENT, V134, P1269, DOI 10.1242/dev.000406; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Walsh EP, 1998, GENETICS, V150, P791; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112	49	40	42	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34076	34086		10.1074/jbc.M804267200	http://dx.doi.org/10.1074/jbc.M804267200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835818	Green Published, hybrid			2022-12-25	WOS:000261277700036
J	Biddick, RK; Law, GL; Chin, KKB; Young, ET				Biddick, Rhiannon K.; Law, G. Lynn; Chin, Kevin Khaw Beng; Young, Elton T.			The Transcriptional Coactivators SAGA, SWI/SNF, and Mediator Make Distinct Contributions to Activation of Glucose-repressed Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; PROMOTERS IN-VIVO; SACCHAROMYCES-CEREVISIAE; PHO5 PROMOTER; HISTONE ACETYLATION; ADH2 EXPRESSION; SWI-SNF; CHROMATIN; YEAST	The paradigm of activation via ordered recruitment has evolved into a complicated picture as the influence of coactivators and chromatin structures on gene regulation becomes understood. We present here a comprehensive study of many elements of activation of ADH2 and FBP1, two glucose-regulated genes. We identify SWI/SNF as the major chromatin-remodeling complex at these genes, whereas SAGA (Spt-Ada-Gcn5-acetyltransferase complex) is required for stable recruitment of other coactivators. Mediator plays a crucial role in expression of both genes but does not affect chromatin remodeling. We found that Adr1 bound unaided by coactivators to ADH2, but Cat8 binding depended on coactivators at FBP1. Taken together, our results suggest that commonly regulated genes share many aspects of activation, but that gene-specific regulators or elements of promoter architecture may account for small differences in the mechanism of activation. Finally, we found that activator overexpression can compensate for the loss of SWI/SNF but not for the loss of SAGA.	[Biddick, Rhiannon K.; Law, G. Lynn; Chin, Kevin Khaw Beng; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98105 USA.	ety@u.washington.edu			National Institutes of Health [GM26079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM026079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM26079 (to E.T.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Agricola E, 2004, BIOCHEMISTRY-US, V43, P8878, DOI 10.1021/bi049577+; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Burns LG, 1997, MOL CELL BIOL, V17, P4811, DOI 10.1128/MCB.17.8.4811; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; DELOLMO ML, 1993, YEAST, V9, P1229, DOI 10.1002/yea.320091110; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; IRANI M, 1987, MOL CELL BIOL, V7, P1233, DOI 10.1128/MCB.7.3.1233; Kim SJ, 2005, MOL CELL BIOL, V25, P11171, DOI 10.1128/MCB.25.24.11171-11183.2005; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Lemieux K, 2004, EMBO J, V23, P4040, DOI 10.1038/sj.emboj.7600416; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; Mitra D, 2006, MOL CELL BIOL, V26, P4095, DOI 10.1128/MCB.01849-05; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reinke H, 2001, MOL CELL, V7, P529, DOI 10.1016/S1097-2765(01)00200-3; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; Verdone L, 1997, J BIOL CHEM, V272, P30828, DOI 10.1074/jbc.272.49.30828; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Young ET, 2008, MOL CELL BIOL, V28, P2509, DOI 10.1128/MCB.00658-07; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000; Zaragoza O, 2001, BIOCHEM J, V359, P193, DOI 10.1042/0264-6021:3590193	48	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33101	33109		10.1074/jbc.M805258200	http://dx.doi.org/10.1074/jbc.M805258200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826948	Green Published, hybrid			2022-12-25	WOS:000261183700011
J	Codutti, L; van Ingen, H; Vascotto, C; Fogolari, F; Corazza, A; Tell, G; Quadrifoglio, F; Viglino, P; Boelens, R; Esposito, G				Codutti, Luca; van Ingen, Hugo; Vascotto, Carlo; Fogolari, Federico; Corazza, Alessandra; Tell, Gianluca; Quadrifoglio, Franco; Viglino, Paolo; Boelens, Rolf; Esposito, Gennaro			The Solution Structure of DNA-free Pax-8 Paired Box Domain Accounts for Redox Regulation of Transcriptional Activity in the Pax Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE H-1-N-15 CORRELATIONS; ISOTOPICALLY ENRICHED PROTEINS; CONGENITAL HYPOTHYROIDISM; CHEMICAL-SHIFTS; BINDING ACTIVITY; C-13-ENRICHED PROTEINS; THYROID HYPOPLASIA; C-13 MAGNETIZATION; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE	Pax-8 is a transcription factor belonging to the PAX genes superfamily and its crucial role has been proven both in embryo and in the adult organism. Pax-8 activity is regulated via a redox-based mechanism centered on the glutathionylation of specific cysteines in the N-terminal region (Cys(45) and Cys(57)). These residues belong to a highly evolutionary conserved DNA binding site: the Paired Box (Prd) domain. Crystallographic protein-DNA complexes of the homologues Pax-6 and Pax-5 showed a bipartite Prd domain consisting of two helix-turn-helix (HTH) motifs separated by an extended linker region. Here, by means of nuclear magnetic resonance, we show for the first time that the HTH motifs are largely defined in the unbound Pax-8 Prd domain. Our findings contrast with previous induced fit models, in which Pax-8 is supposed to largely fold upon DNA binding. Importantly, our data provide the structural basis for the enhanced chemical reactivity of residues Cys45 and Cys57 and explain clinical missense mutations that are not obviously related to the DNA binding interface of the paired box domain. Finally, sequence conservation suggests that our findings could be a general feature of the Pax family transcription factors.	[Codutti, Luca; Vascotto, Carlo; Fogolari, Federico; Corazza, Alessandra; Tell, Gianluca; Quadrifoglio, Franco; Viglino, Paolo; Esposito, Gennaro] Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy; [van Ingen, Hugo; Boelens, Rolf] Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Fogolari, Federico; Corazza, Alessandra; Viglino, Paolo; Esposito, Gennaro] INBB, I-00100 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Esposito, G (corresponding author), Univ Udine, Dipartimento Sci & Tecnol Biomed, P Le Kolbe 4, I-33100 Udine, Italy.	gesposito@mail.dstb.uniud.it	Corazza, Alessandra/AGB-1457-2022; Boelens, Rolf/B-4702-2009; van Ingen, Hugo/Q-2883-2016	Corazza, Alessandra/0000-0003-2272-1928; Boelens, Rolf/0000-0002-6939-8913; van Ingen, Hugo/0000-0002-0808-3811; Fogolari, Federico/0000-0001-9862-250X; vascotto, carlo/0000-0003-4431-029X; Tell, Gianluca/0000-0001-8845-6448	Italian Ministry for University and Research Grants [COFIN 2006058958, FIRB RBNE03PX83, FIRB RBNE03B8KK]; European Union [LSHM-CT-2005-037525, 026145]	Italian Ministry for University and Research Grants; European Union(European Commission)	This work was supported by Italian Ministry for University and Research Grants COFIN 2006058958, FIRB RBNE03PX83, and FIRB RBNE03B8KK, European Union Grant LSHM-CT-2005-037525, and European Union project "EU-NMR-European Network of Research Infrastructures for Providing Access & Technological Advancement in Bio-NMR" FP-2005-RII3 Contract 026145. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Apuzzo S, 2006, BIOCHEMISTRY-US, V45, P7154, DOI 10.1021/bi060009z; Balczarek KA, 1997, MOL BIOL EVOL, V14, P829, DOI 10.1093/oxfordjournals.molbev.a025824; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Cao X, 2005, J BIOL CHEM, V280, P25901, DOI 10.1074/jbc.M411443200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Congdon T, 2001, J CLIN ENDOCR METAB, V86, P3962, DOI 10.1210/jc.86.8.3962; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAMANTE G, 1994, BBA-GENE STRUCT EXPR, V1218, P255, DOI 10.1016/0167-4781(94)90176-7; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Espinoza CR, 2001, J MOL ENDOCRINOL, V27, P59, DOI 10.1677/jme.0.0270059; Fogolari F, 2000, PROTEINS, V39, P317, DOI 10.1002/(SICI)1097-0134(20000601)39:4<317::AID-PROT50>3.0.CO;2-W; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Grasberger H, 2005, MOL ENDOCRINOL, V19, P1779, DOI 10.1210/me.2004-0426; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; IKURA M, 1991, J BIOMOL NMR, V1, P99; ISRAELACHVILI J, 1982, NATURE, V300, P341, DOI 10.1038/300341a0; Jun S, 1996, DEVELOPMENT, V122, P2639; Kambe F, 1996, MOL ENDOCRINOL, V10, P801, DOI 10.1210/me.10.7.801; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KAY MD, 1988, J AM CHEM SOC, V111, P1515; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Meeus L, 2004, J CLIN ENDOCR METAB, V89, P4285, DOI 10.1210/jc.2004-0166; Ohno M, 1999, MOL CELL BIOL, V19, P2051; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Pellizzari L, 1999, BIOCHEM J, V337, P253, DOI 10.1042/0264-6021:3370253; POLEEV A, 1992, DEVELOPMENT, V116, P611; Santisteban P, 2005, REV ENDOCR METAB DIS, V6, P217, DOI 10.1007/s11154-005-3053-9; Schubert M, 1999, J MAGN RESON, V141, P34, DOI 10.1006/jmre.1999.1881; Schubert M, 2001, J MAGN RESON, V148, P61, DOI 10.1006/jmre.2000.2222; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Tell G, 1998, BIOCHEM BIOPH RES CO, V252, P178, DOI 10.1006/bbrc.1998.9548; Tell G, 1998, J BIOL CHEM, V273, P25062, DOI 10.1074/jbc.273.39.25062; Tell G, 1999, BIOCHEM J, V341, P89, DOI 10.1042/0264-6021:3410089; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilain C, 2001, J CLIN ENDOCR METAB, V86, P234, DOI 10.1210/jc.86.1.234; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Wang YJ, 2002, J AM CHEM SOC, V124, P14075, DOI 10.1021/ja026811f; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230	68	19	21	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33321	33328		10.1074/jbc.M805717200	http://dx.doi.org/10.1074/jbc.M805717200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829450	Green Published, hybrid			2022-12-25	WOS:000261183700036
J	Fukui, K; Nakagawa, N; Kitamura, Y; Nishida, Y; Masui, R; Kuramitsu, S				Fukui, Kenji; Nakagawa, Noriko; Kitamura, Yoshiaki; Nishida, Yuya; Masui, Ryoji; Kuramitsu, Seiki			Crystal Structure of MutS2 Endonuclease Domain and the Mechanism of Homologous Recombination Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS MUTS2; MISMATCH REPAIR; HOLLIDAY JUNCTION; CATALYTIC DOMAIN; PROTEIN; BACTERIAL; MUTATIONS; MARKER; TOOLS; GENE	DNA recombination events need to be strictly regulated, because an increase in the recombinational frequency causes unfavorable alteration of genetic information. Recent studies revealed the existence of a novel anti-recombination enzyme, MutS2. However, the mechanism by which MutS2 inhibits homologous recombination has been unknown. Previously, we found that Thermus thermophilus MutS2 (ttMutS2) harbors an endonuclease activity and that this activity is confined to the C-terminal domain, whose amino acid sequence is widely conserved in a variety of proteins with unknown function from almost all organisms ranging from bacteria to man. In this study, we determined the crystal structure of the ttMutS2 endonuclease domain at 1.7-angstrom resolution, which resembles the structure of the DNase I-like catalytic domain of Escherichia coli RNase E, a sequence-nonspecific endonuclease. The N-terminal domain of ttMutS2, however, recognized branched DNA structures, including the Holliday junction and D-loop structure, a primary intermediate in homologous recombination. The full-length of ttMutS2 digested the branched DNA structures at the junction. These results indicate that ttMutS2 suppresses homologous recombination through a novel mechanism involving resolution of early intermediates.	[Fukui, Kenji; Nakagawa, Noriko; Kitamura, Yoshiaki; Nishida, Yuya; Masui, Ryoji; Kuramitsu, Seiki] RIKEN, Ctr SPring 8, Harima Inst, Sayo, Hyogo 6795148, Japan; [Nakagawa, Noriko; Masui, Ryoji; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan	RIKEN; Osaka University	Kuramitsu, S (corresponding author), RIKEN, Ctr SPring 8, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	kuramitu@spring8.or.jp		Fukui, Kenji/0000-0003-2463-7578; nishida, yuya/0000-0002-1994-0807	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20870042, 20570131]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (Grant 20870042 to K. F. and Grant 20570131 to R. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berthiau AS, 2006, EMBO J, V25, P846, DOI 10.1038/sj.emboj.7600975; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fukui K, 2004, J BIOCHEM, V135, P375, DOI 10.1093/jb/mvh045; Fukui K, 2007, NUCLEIC ACIDS RES, V35, P850, DOI 10.1093/nar/gkl735; Fukui K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm575; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3; Guan C, 2005, NUCLEIC ACIDS RES, V33, P6225, DOI 10.1093/nar/gki921; Hadden JM, 2007, NATURE, V449, P621, DOI 10.1038/nature06158; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Ishino Y, 2006, CHEM REV, V106, P324, DOI 10.1021/cr0404803; Jiricny J, 1998, MUTAT RES-DNA REPAIR, V409, P107, DOI 10.1016/S0921-8777(98)00056-1; Kang J, 2005, J BACTERIOL, V187, P3528, DOI 10.1128/JB.187.10.3528-3537.2005; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kitazono AA, 2002, YEAST, V19, P141, DOI 10.1002/yea.806; Kumarathasan P, 2005, ANAL BIOCHEM, V346, P85, DOI 10.1016/j.ab.2005.06.004; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lilley DMJ, 2000, P NATL ACAD SCI USA, V97, P9351, DOI 10.1073/pnas.97.17.9351; Malik HS, 2000, TRENDS BIOCHEM SCI, V25, P414, DOI 10.1016/S0968-0004(00)01623-6; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Moreira D, 1999, TRENDS BIOCHEM SCI, V24, P298, DOI 10.1016/S0968-0004(99)01419-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pinto AV, 2005, MOL CELL, V17, P113, DOI 10.1016/j.molcel.2004.11.035; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SHINOHARA A, 1995, TRENDS BIOCHEM SCI, V20, P387, DOI 10.1016/S0968-0004(00)89085-4; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; SOLARO PC, 1993, J MOL BIOL, V230, P868, DOI 10.1006/jmbi.1993.1207; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Takamatsu S, 1996, NUCLEIC ACIDS RES, V24, P640, DOI 10.1093/nar/24.4.640; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Watanabe N, 2003, J BIOL CHEM, V278, P26102, DOI 10.1074/jbc.M303518200; WEAVER DT, 1995, TRENDS GENET, V11, P388, DOI 10.1016/S0168-9525(00)89121-0; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238	55	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33417	33427		10.1074/jbc.M806755200	http://dx.doi.org/10.1074/jbc.M806755200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838375	Green Published, hybrid			2022-12-25	WOS:000261183700046
J	Jakob, S; Schroeder, P; Lukosz, M; Buchner, N; Spyridopoulos, I; Altschmied, J; Haendeler, J				Jakob, Sascha; Schroeder, Peter; Lukosz, Margarete; Buechner, Nicole; Spyridopoulos, Ioakim; Altschmied, Joachim; Haendeler, Judith			Nuclear Protein Tyrosine Phosphatase Shp-2 Is One Important Negative Regulator of Nuclear Export of Telomerase Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; TUMOR-CELLS; KINASE; APOPTOSIS; GENE; EXPRESSION; PHOSPHORYLATION; ACTIVATION	Aging is one major risk factor for numerous diseases. The enzyme telomerase reverse transcriptase ( TERT) plays an important role for aging and apoptosis. Previously, we demonstrated that inhibition of oxidative stress-induced Src kinase family-dependent nuclear export of TERT results in delayed replicative senescence and reduced apoptosis sensitivity. Therefore, the aim of this study was to investigate mechanisms inhibiting nuclear export of TERT. First, we demonstrated that H2O2 induced nuclear export of TERT was abolished in Src, Fyn, and Yes-deficient embryonic fibroblasts. Next, we wanted to identify one potential negative regulator of this export process. One candidate is the protein tyrosine phosphatase Shp-2 (Shp-2), which can counteract activities of the Src kinase family. Indeed, Shp-2 was evenly distributed between the nucleus and cytosol. Nuclear Shp-2 associates with TERT in endothelial cells and dissociates from TERT prior to its nuclear export. Overexpression of Shp-2 wt inhibited H2O2-induced export of TERT. Overexpression of the catalytically inactive, dominant negative Shp-2 mutant (Shp2(C459S)) reduced endogenous as well as overexpressed nuclear TERT protein and telomerase activity, whereas it had no influence on TERT(Y707F). Binding of TERT( Y707F) to Shp-2 is reduced compared with TERTwt. Ablation of Shp-2 expression led only to an increased tyrosine phosphorylation of TERTwt, but not of TERT( Y707F). Moreover, reduced Shp-2 expression decreased nuclear telomerase activity, whereas nuclear telomerase activity was increased in Shp-2-overexpressing endothelial cells. Inconclusion, Shp-2 retains TERT in the nucleus by regulating tyrosine 707 phosphorylation.	[Jakob, Sascha; Schroeder, Peter; Lukosz, Margarete; Buechner, Nicole; Altschmied, Joachim; Haendeler, Judith] Univ Duesseldorf gGmbH, IUF, Dept Mol Cell & Aging Res, D-40225 Dusseldorf, Germany; [Spyridopoulos, Ioakim] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Newcastle University - UK	Altschmied, J (corresponding author), Univ Duesseldorf gGmbH, IUF, Dept Mol Cell & Aging Res, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.	joalt001@uni-duesseldorf.de; juhae001@uni-duesseldorf.de		Spyridopoulos, Ioakim/0000-0002-2750-2444; Haendeler, Judith/0000-0001-8507-4540	Deutsche Forschungsgemeinschaft [SFB728/B5, HA2868/2-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (SFB728/B5 and HA2868/2-3, to J.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chughtai N, 2002, J BIOL CHEM, V277, P31107, DOI 10.1074/jbc.M200156200; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; de Lange T, 1998, NATURE, V392, P753, DOI 10.1038/33790; Dimmeler S, 1996, FEBS LETT, V399, P71, DOI 10.1016/S0014-5793(96)01289-6; Geserick C, 2006, MECH AGEING DEV, V127, P579, DOI 10.1016/j.mad.2006.01.017; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Haendeler J, 2003, FEBS LETT, V536, P180, DOI 10.1016/S0014-5793(03)00058-9; Haendeler J, 1997, NITRIC OXIDE-BIOL CH, V1, P282, DOI 10.1006/niox.1997.0134; Haendeler J, 2000, CIRC RES, V86, P729, DOI 10.1161/01.RES.86.7.729; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Huang QH, 2002, J BIOL CHEM, V277, P29330, DOI 10.1074/jbc.M112450200; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Kharbanda S, 2000, CURR BIOL, V10, P568, DOI 10.1016/S0960-9822(00)00483-8; Li H, 1998, J BIOL CHEM, V273, P33436, DOI 10.1074/jbc.273.50.33436; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; Mattson MP, 2001, J NEUROSCI RES, V63, P1; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Osawa M, 2004, J BIOL CHEM, V279, P29691, DOI 10.1074/jbc.M309371200; Qu CK, 2002, BBA-MOL CELL RES, V1592, P297, DOI 10.1016/S0167-4889(02)00322-1; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Seimiya H, 1999, BIOCHEM BIOPH RES CO, V260, P365, DOI 10.1006/bbrc.1999.0910; Tran KT, 2003, EXP CELL RES, V289, P359, DOI 10.1016/S0014-4827(03)00287-8; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; Wang JF, 2004, J BIOL CHEM, V279, P27088, DOI 10.1074/jbc.M314015200; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664, DOI 10.1073/pnas.92.3.664; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	39	67	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33155	33161		10.1074/jbc.M805138200	http://dx.doi.org/10.1074/jbc.M805138200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829466	hybrid, Green Published			2022-12-25	WOS:000261183700017
J	Cao, F; Wagner, RA; Wilson, KD; Xie, XY; Fu, JD; Drukker, M; Lee, A; Li, RA; Gambhir, SS; Weissman, IL; Robbins, RC; Wu, JC				Cao, Feng; Wagner, Roger A.; Wilson, Kitchener D.; Xie, Xiaoyan; Fu, Ji-Dong; Drukker, Micha; Lee, Andrew; Li, Ronald A.; Gambhir, Sanjiv S.; Weissman, Irving L.; Robbins, Robert C.; Wu, Joseph C.			Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							DIFFERENTIATION; EXPRESSION; NETWORKS; HEART; PROTECTION; SURVIVAL; MYOCYTES; DEVELOP; REPAIR; NANOG	Human embryonic stemcells (hESCs) can serve as a potentially limitless source of cells that may enable regeneration of diseased tissue and organs. Here we investigate the use of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in promoting recovery from cardiac ischemia reperfusion injury in a mouse model. Using microarrays, we have described the hESC-CM transcriptome within the spectrum of changes that occur between undifferentiated hESCs and fetal heart cells. The hESC-CMs expressed cardiomyocyte genes at levels similar to those found in 20-week fetal heart cells, making this population a good source of potential replacement cells in vivo. Echocardiographic studies showed significant improvement in heart function by 8 weeks after transplantation. Finally, we demonstrate long-term engraftment of hESC-CMs by using molecular imaging to track cellular localization, survival, and proliferation in vivo. Taken together, global gene expression profiling of hESC differentiation enables a systems-based analysis of the biological processes, networks, and genes that drive hESC fate decisions, and studies such as this will serve as the foundation for future clinical applications of stem cell therapies.	[Cao, Feng; Wilson, Kitchener D.; Xie, Xiaoyan; Lee, Andrew; Gambhir, Sanjiv S.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Wagner, Roger A.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Wilson, Kitchener D.; Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Drukker, Micha; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Robbins, Robert C.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Fu, Ji-Dong; Li, Ronald A.] Univ Calif Davis, Dept Cell Biol & Human Anat, Stem Cell Program, Davis, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California Davis	Cao, F (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	joewu@stanford.edu	Fu, Jidong/E-8173-2012; Lee, Andrew/GVU-2817-2022; Wilson, Kitchener/A-7146-2016; Li, Ronald/E-9833-2010; Wu, Joseph/H-1067-2013	Drukker, Micha/0000-0002-4279-1125; Fu, Jidong/0000-0003-2797-5193; Wu, Joseph/0000-0002-6068-8041	BWF CAMS; Stanford Cardiovascular Institute; NIH [HL089027, CA114747, HL076445, HL72857]; CIRM [RS1-00322]; NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072857, K08HL076445, R21HL089027, R33HL089027] Funding Source: NIH RePORTER	BWF CAMS; Stanford Cardiovascular Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the BWF CAMS, Stanford Cardiovascular Institute, NIH HL089027, and CIRM RS1-00322 (JCW). This work was also supported in part by NIH CA114747 (SSG), NIH HL076445 (RAW), and NIH HL72857 (RAL).	Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Collins KA, 2003, PHYSIOL GENOMICS, V13, P227, DOI 10.1152/physiolgenomics.00005.2003; CROTTI L, 2007, HUM GENET, V120, P912; Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d; Gambhir SS, 1999, NUCL MED BIOL, V26, P481, DOI 10.1016/S0969-8051(99)00021-9; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hentschke M, 2006, J BIOL CHEM, V281, P33497, DOI 10.1074/jbc.M606975200; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; LEOR J, 2007, HEART, V12, P12; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Luo XB, 2007, J CELL PHYSIOL, V212, P358, DOI 10.1002/jcp.21030; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; McMartin GA, 2003, J ANAT, V203, P369, DOI 10.1046/j.1469-7580.2003.00228.x; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Michele DE, 2002, CIRC RES, V91, P255, DOI 10.1161/01.RES.0000027530.58419.82; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; MURAGAKI Y, 1991, EUR J BIOCHEM, V197, P615, DOI 10.1111/j.1432-1033.1991.tb15951.x; Newton-Cheh C, 2007, CIRCULATION, V116, P1128, DOI 10.1161/CIRCULATIONAHA.107.710780; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; PFEFFER MA, 1995, ANNU REV MED, V46, P455, DOI 10.1146/annurev.med.46.1.455; Plaisier E, 2007, NEW ENGL J MED, V357, P2687, DOI 10.1056/NEJMoa071906; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Schulz WA, 2007, EPIGENETICS-US, V2, P37, DOI 10.4161/epi.2.1.4067; Synnergren J, 2008, STEM CELLS, V26, P1831, DOI 10.1634/stemcells.2007-1033; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; VANAMERONGEN MJ, 2008, J CELLULAR IN PRESS; Wagner RA, 2005, DEV BIOL, V288, P595, DOI 10.1016/j.ydbio.2005.09.036; WEBB GC, 1993, GENOMICS, V18, P464, DOI 10.1006/geno.1993.1505; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894	46	170	175	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3474	10.1371/journal.pone.0003474	http://dx.doi.org/10.1371/journal.pone.0003474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941512	Green Published, gold, Green Submitted			2022-12-25	WOS:000265126100005
J	Tirino, V; Desiderio, V; d'Aquino, R; De Francesco, F; Pirozzi, G; Galderisi, U; Cavaliere, C; De Rosa, A; Papaccio, G				Tirino, Virginia; Desiderio, Vincenzo; d'Aquino, Riccardo; De Francesco, Francesco; Pirozzi, Giuseppe; Galderisi, Umberto; Cavaliere, Carlo; De Rosa, Alfredo; Papaccio, Gianpaolo			Detection and Characterization of CD133(+) Cancer Stem Cells in Human Solid Tumours	PLOS ONE			English	Article								Background: Osteosarcoma is the most common primary tumour of bone. Solid tumours are made of heterogeneous cell populations, which display different goals and roles in tumour economy. A rather small cell subset can hold or acquire stem potentials, gaining aggressiveness and increasing expectancy of recurrence. The CD133 antigen is a pentaspan membrane glycoprotein, which has been proposed as a cancer stem cell marker, since it has been previously demonstrated to be capable of identifying a cancer initiating subpopulation in brain, colon, melanoma and other solid tumours. Therefore, our aim was to observe the possible presence of cells expressing the CD133 antigen within solid tumour cell lines of osteosarcoma and, then, understand their biological characteristics and performances. Methodology and Principal Findings: In this study, using SAOS2, MG63 and U2OS, three human sarcoma cell lines isolated from young Caucasian subjects, we were able to identify and characterize, among them, CD133(+) cells showing the following features: high proliferation rate, cell cycle detection in a G2\M phase, positivity for Ki-67, and expression of ABCG2 transporters. In addition, at the FACS, we were able to observe the CD133(+) cell fraction showing side population profile and forming sphere-clusters in serum-free medium with a high clonogenic efficiency. Conclusions: Taken together, our findings lead to the thought that we can assume that we have identified, for the first time, CD133(+) cells within osteosarcoma cell lines, showing many features of cancer stem cells. This can be of rather interest in order to design new therapies against the bone cancer.	[Tirino, Virginia; Desiderio, Vincenzo; d'Aquino, Riccardo; De Francesco, Francesco; Papaccio, Gianpaolo] Univ Naples 2, Sez Istol & Embriol, Dipartimento Med Sperimentale, Naples, Italy; [Pirozzi, Giuseppe] INT, Dipartimento Oncol Sperimentale, Naples, Italy; [Galderisi, Umberto] Univ Naples 2, Sez Biotecnol, Dipartimento Med Sperimentale, Naples, Italy; [Cavaliere, Carlo] Univ Naples 2, Sez Anatom Umana, Dipartimento Med Pubbl Prevent, Naples, Italy; [De Rosa, Alfredo] Ateneo Napoli 2, Dipartimento Sci Odontostomatol Ortodont Chirurg, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Tirino, V (corresponding author), Univ Naples 2, Sez Istol & Embriol, Dipartimento Med Sperimentale, Naples, Italy.	gianpaolo.papaccio@unina2.it	Cavaliere, Carlo/K-6544-2016; desiderio, vincenzo/K-4244-2018; De Francesco, Francesco/D-8080-2016; Papaccio, Gianpaolo/B-7150-2014	Cavaliere, Carlo/0000-0002-3297-2213; De Francesco, Francesco/0000-0003-2977-7828; Papaccio, Gianpaolo/0000-0002-4014-5306; desiderio, vincenzo/0000-0003-1819-6083; GALDERISI, Umberto/0000-0003-0909-7403; Tirino, Virginia/0000-0003-2731-5718	MURST (Italy); 2nd University of Naples	MURST (Italy)(Ministry of Education, Universities and Research (MIUR)); 2nd University of Naples	MURST (Italy), 2nd University of Naples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Costea DE, 2006, ORAL DIS, V12, P443, DOI 10.1111/j.1601-0825.2006.01264.x; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Fargeas CA, 2003, STEM CELLS, V21, P506, DOI 10.1634/stemcells.21-4-506; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hirschmann-Jax C, 2005, CELL CYCLE, V4, P203; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Pascal Laura E, 2007, BMC Urol, V7, P6, DOI 10.1186/1471-2490-7-6; Pautke C, 2004, ANTICANCER RES, V24, P3743; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; RAILE K, 1994, J CELL PHYSIOL, V159, P531, DOI 10.1002/jcp.1041590317; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; TAKEUCHI Y, 1995, J CELL PHYSIOL, V162, P315, DOI 10.1002/jcp.1041620303; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Xu Z, 2006, CANCER RES, V66, P6657, DOI 10.1158/0008-5472.CAN-05-3624; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	32	218	235	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3469	10.1371/journal.pone.0003469	http://dx.doi.org/10.1371/journal.pone.0003469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941626	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125900012
J	Tilquin, M; Paris, M; Reynaud, S; Despres, L; Ravanel, P; Geremia, RA; Gury, J				Tilquin, Mathieu; Paris, Margot; Reynaud, Stephane; Despres, Laurence; Ravanel, Patrick; Geremia, Roberto A.; Gury, Jerome			Long Lasting Persistence of Bacillus thuringiensis Subsp israelensis (Bti) in Mosquito Natural Habitats	PLOS ONE			English	Article								Background: The detrimental effects of chemical insecticides on the environment and human health have lead to the call for biological alternatives. Today, one of the most promising solutions is the use of spray formulations based on Bacillus thuringiensis subsp. israelensis (Bti) in insect control programs. As a result, the amounts of Bti spread in the environment are expected to increase worldwide, whilst the common belief that commercial Bti is easily cleared from the ecosystem has not yet been clearly established. Methodology/Main Findings: In this study, we aimed to determine the nature and origin of the high toxicity toward mosquito larvae found in decaying leaf litter collected in several natural mosquito breeding sites in the Rhone-Alpes region. From the toxic fraction of the leaf litter, we isolated B. cereus-like bacteria that were further characterized as B. thuringiensis subsp. israelensis using PCR amplification of specific toxin genes. Immunological analysis of these Bti strains showed that they belong to the H14 group. We finally used amplified length polymorphism (AFLP) markers to show that the strains isolated from the leaf litter were closely related to those present in the commercial insecticide used for field application, and differed from natural worldwide genotypes. Conclusions/Significance: Our results raise the issue of the persistence, potential proliferation and environmental accumulation of human-spread Bti in natural mosquito habitats. Such Bti environmental persistence may lengthen the exposure time of insects to this bio-insecticide, thereby increasing the risk of resistance acquisition in target insects, and of a negative impact on non-target insects.	[Tilquin, Mathieu] Floralis UJF Filiale, Gieres, France; [Tilquin, Mathieu; Paris, Margot; Reynaud, Stephane; Despres, Laurence; Ravanel, Patrick; Geremia, Roberto A.; Gury, Jerome] Univ Joseph Fourier, CNRS, UMR 5553, Lab Ecol Alpine LECA, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Tilquin, M (corresponding author), Floralis UJF Filiale, Gieres, France.	roberto.geremia@ujf-grenoble.fr	Paris, Margot/AAD-1971-2020; Reynaud, Stephane/H-5493-2013; Geremia, Roberto A/A-7972-2010; Paris, Margot/C-8076-2012; Despres, Laurence/AAC-9518-2021	Paris, Margot/0000-0001-7328-3820; Reynaud, Stephane/0000-0003-0248-0602; Despres, Laurence/0000-0002-0660-6260	Floralis [0501545401]; UJF filiale [0501545401]; Region Rhone-Alps [0501545401]; Demoustication Rhone-Alps; TOXNUC	Floralis; UJF filiale; Region Rhone-Alps(Region Auvergne-Rhone-Alpes); Demoustication Rhone-Alps(Region Auvergne-Rhone-Alpes); TOXNUC	This work was supported financially by Floralis, UJF filiale, Region Rhone-Alps (grant 0501545401 to L.D.) and Demoustication Rhone-Alps (Collaborative research grant to M.P. and L.D.). Mathieu Tilquin was supported by the Grant 0501545401 from Floralis, UJF Filiale, Rhone Alpes region. Jerome Gury was supported by the TOXNUC program. The agency Demoustication Rhone Alpes provided financial support but also data (date, sites and times) on Bti spraying.	ADDISON JA, 1993, CAN J FOREST RES, V23, P2329, DOI 10.1139/x93-287; AKIBA Y, 1991, JPN J APPL ENTOMOL Z, V26, P477; BACKER N, 1993, BACILLUS THURINGIENS, P147; BenDov E, 1997, APPL ENVIRON MICROB, V63, P4883, DOI 10.1128/AEM.63.12.4883-4890.1997; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Blanco MGM, 2002, J AM MOSQUITO CONTR, V18, P352; Boisvert M, 2000, BIOCONTROL SCI TECHN, V10, P517, DOI 10.1080/095831500750016361; Bonin A, 2005, METHOD ENZYMOL, V395, P145, DOI 10.1016/S0076-6879(05)95010-6; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Boyer S, 2007, ENVIRON TOXICOL CHEM, V26, P157, DOI 10.1897/06-205R.1; Bravo A, 1998, APPL ENVIRON MICROB, V64, P4965; Burke SA, 2004, APPL ENVIRON MICROB, V70, P2786, DOI 10.1128/AEM.70.5.2786-2790.2004; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; Damgaard PH, 1997, J APPL MICROBIOL, V82, P253, DOI 10.1111/j.1365-2672.1997.tb02859.x; David JP, 2000, J CHEM ECOL, V26, P901, DOI 10.1023/A:1005456124756; David JP, 2003, MED VET ENTOMOL, V17, P151, DOI 10.1046/j.1365-2915.2003.00432.x; David JP, 2003, MOL ECOL, V12, P1951, DOI 10.1046/j.1365-294X.2003.01870.x; David JP, 2000, J INVERTEBR PATHOL, V75, P9, DOI 10.1006/jipa.1999.4886; De Respinis S, 2006, LETT APPL MICROBIOL, V43, P495, DOI 10.1111/j.1472-765x.2006.01999.x; DELUCCA AJ, 1981, CAN J MICROBIOL, V27, P865, DOI 10.1139/m81-137; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Georghiou GP, 1997, APPL ENVIRON MICROB, V63, P1095, DOI 10.1128/AEM.63.3.1095-1101.1997; GILL SS, 1987, INFECT IMMUN, V55, P1300, DOI 10.1128/IAI.55.5.1300-1308.1987; Hajaij M, 2005, MICROB ECOL, V50, P475, DOI 10.1007/s00248-005-0247-3; Hendriksen NB, 2002, CAN J MICROBIOL, V48, P256, DOI [10.1139/w02-009, 10.1139/W02-009]; Hernandez CS, 2005, J INVERTEBR PATHOL, V88, P8, DOI 10.1016/j.jip.2004.10.006; Hill KK, 2004, APPL ENVIRON MICROB, V70, P1068, DOI 10.1128/AEM.70.2.1068-1080.2004; Ibarra JE, 2003, APPL ENVIRON MICROB, V69, P5269, DOI 10.1128/AEM.69.9.5269-5274.2003; Janssen P, 1996, MICROBIOL-UK, V142, P1881, DOI 10.1099/13500872-142-7-1881; Keto-Timonen R, 2006, J CLIN MICROBIOL, V44, P4057, DOI 10.1128/JCM.01275-06; Kokotovic B, 2007, J CLIN MICROBIOL, V45, P3921, DOI 10.1128/JCM.00906-07; Maduell P, 2008, MICROB ECOL, V55, P212, DOI 10.1007/s00248-007-9268-4; MARTIN WF, 1989, BACILLUS THURINGIENS; NAAVON A, 2000, ENTOMOPATHOGENIC BAC, P355; Nester E., 2002, 100 YEARS BACILLUS T; Nguyen TTH, 1999, J VECTOR ECOL, V24, P138; Pattanayak D, 2000, WORLD J MICROB BIOT, V16, P667, DOI 10.1023/A:1008936127319; PEARSON D, 1987, BIOTECHNOL LETT, V9, P771, DOI 10.1007/BF01028282; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Porcar M, 2000, J APPL MICROBIOL, V89, P309, DOI 10.1046/j.1365-2672.2000.01115.x; Raymond M., 1993, PROBIT CNRS UMII; Regis L, 2001, TRENDS PARASITOL, V17, P377, DOI 10.1016/S1471-4922(01)01953-5; Ryu C, 2005, APPL ENVIRON MICROB, V71, P4664, DOI 10.1128/AEM.71.8.4664-4671.2005; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Smits PH, 1997, BCPC SYMP SER, P21; THOMAS WE, 1983, FEBS LETT, V154, P362, DOI 10.1016/0014-5793(83)80183-5; Tilquin M, 2002, J CHEM ECOL, V28, P1497, DOI 10.1023/A:1019920310315; Tilquin M, 2002, J AGR FOOD CHEM, V50, P6378, DOI 10.1021/jf0205155; TILQUIN M, 2002, ACTIVE INSECTICIDE M; Van der Zwet WC, 2000, J CLIN MICROBIOL, V38, P4131, DOI 10.1128/JCM.38.11.4131-4136.2000; van Rossem MC, 2007, J HOSP INFECT, V67, P142, DOI 10.1016/j.jhin.2007.07.018; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Whatmore AM, 2005, J CLIN MICROBIOL, V43, P761, DOI 10.1128/JCM.43.2.761-769.2005; *WHO, 1985, TDRBCVSPHAERICUS853; *WHO, 1999, 114 WHO, P217; WHO (World Health Organization), 2020, 22 WHO; Wirth MC, 2005, APPL ENVIRON MICROB, V71, P185, DOI 10.1128/AEM.71.1.185-189.2005	58	50	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3432	10.1371/journal.pone.0003432	http://dx.doi.org/10.1371/journal.pone.0003432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941501	gold, Green Published, Green Submitted			2022-12-25	WOS:000265125600002
J	Derikx, JPM; Matthijsen, RA; de Bruine, AP; van Bijnen, AA; Heineman, E; van Dam, RM; Dejong, CHC; Buurman, WA				Derikx, Joep P. M.; Matthijsen, Robert A.; de Bruine, Adriaan P.; van Bijnen, Annemarie A.; Heineman, Erik; van Dam, Ronald M.; Dejong, Cornelis H. C.; Buurman, Wim A.			Rapid Reversal of Human Intestinal Ischemia-Reperfusion Induced Damage by Shedding of Injured Enterocytes and Reepithelialisation	PLOS ONE			English	Article								Intestinal ischemia-reperfusion (IR) is a phenomenon related to physiological conditions (e.g. exercise, stress) and to pathophysiological events (e.g. acute mesenteric ischemia, aortic surgery). Although intestinal IR has been studied extensively in animals, results remain inconclusive and data on human intestinal IR are scarce. Therefore, an experimental harmless model for human intestinal IR was developed, enabling us to clarify the sequelae of human intestinal IR for the first time. Methods and Findings: In 30 patients undergoing pancreatico-duodenectomy we took advantage of the fact that in this procedure a variable length of jejunum is removed. Isolated jejunum (5 cm) was subjected to 30 minutes ischemia followed by reperfusion. Intestinal Fatty Acid Binding Protein (I-FABP) arteriovenous concentration differences across the bowel segment were measured before and after ischemia to assess epithelial cell damage. Tissue sections were collected after ischemia and at 25, 60 and 120 minutes reperfusion and stained with H&E, and for I-FABP and the apoptosis marker M30. Bonferroni's test was used to compare I-FABP differences. Mean (SEM) arteriovenous concentration gradients of I-FABP across the jejunum revealed rapidly developing epithelial cell damage. I-FABP release significantly increased from 290 (46) pg/ml before ischemia towards 3,997 (554) pg/ml immediately after ischemia (p<0.001) and declined gradually to 1,143 (237) pg/ml within 1 hour reperfusion (p<0.001). Directly after ischemia the intestinal epithelial lining was microscopically normal, while subepithelial spaces appeared at the villus tip. However, after 25 minutes reperfusion, enterocyte M30 immunostaining was observed at the villus tip accompanied by shedding of mature enterocytes into the lumen and loss of I-FABP staining. Interestingly, within 60 minutes reperfusion the epithelial barrier resealed, while debris of apoptotic, shedded epithelial cells was observed in the lumen. At the same time, M30 immunoreactivity was absent in intact epithelial lining. Conclusions: This is the first human study to clarify intestinal IR induced cell damage and repair and its direct consequences. It reveals a unique, endogenous clearing mechanism for injured enterocytes: rapid detachment of damaged apoptotic enterocytes into the lumen. This process is followed by repair of the epithelial continuity within an hour, resulting in a normal epithelial lining.	[Derikx, Joep P. M.; Matthijsen, Robert A.; van Bijnen, Annemarie A.; Heineman, Erik; van Dam, Ronald M.; Dejong, Cornelis H. C.; Buurman, Wim A.] Maastricht Univ, Med Ctr, Sch Nutr & Metab NUTRIM, Dept Surg, Maastricht, Netherlands; [de Bruine, Adriaan P.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst CARIM, Dept Pathol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Derikx, JPM (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Metab NUTRIM, Dept Surg, Maastricht, Netherlands.	w.buurman@ah.unimaas.nl	Heineman, Erik/ABG-9592-2021	derikx, joep/0000-0003-0694-7679	Netherlands Organisation for Health Research and Development [912-03-013, 920-03-438]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was financially supported by the Netherlands Organisation for Health Research and Development (ZonMw Grant 912-03-013, to WA Buurman) and the Netherlands Organisation for Health Research and Development (AGIKO-stipendium 920-03-438, to JPM Derikx).	[Anonymous], 2000, Gastroenterology, V118, P951; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Blikslager AT, 2008, GASTROENTEROLOGY, V134, P346, DOI 10.1053/j.gastro.2007.11.049; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Daemen MARC, 2002, TRANSPLANTATION, V73, P1693; Dufour G, 2004, J BIOL CHEM, V279, P44113, DOI 10.1074/jbc.M405323200; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukatsu K, 2006, CRIT CARE MED, V34, P182, DOI 10.1097/01.CCM.0000196207.86570.16; Gassler N, 2007, GASTROENTEROLOGY, V133, P587, DOI 10.1053/j.gastro.2007.06.005; HAGLUND U, 1975, GUT, V16, P979, DOI 10.1136/gut.16.12.979; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jeukendrup AE, 2000, CLIN SCI, V98, P47, DOI 10.1042/CS19990258; Kerstens HMJ, 2000, J HISTOCHEM CYTOCHEM, V48, P709, DOI 10.1177/002215540004800515; KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; MOORE R, 1989, LAB INVEST, V60, P237; MOORE R, 1992, GASTROENTEROLOGY, V102, P119, DOI 10.1016/0016-5085(92)91791-2; Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; Panes J, 1998, GASTROENTEROLOGY, V114, P1066, DOI 10.1016/S0016-5085(98)70328-2; PARK PO, 1992, CRIT CARE MED, V20, P135, DOI 10.1097/00003246-199201000-00026; PARK PO, 1990, SURGERY, V107, P574; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Perko MJ, 1998, J PHYSIOL-LONDON, V513, P907, DOI 10.1111/j.1469-7793.1998.907ba.x; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Rokyta R, 2002, PFLUG ARCH EUR J PHY, V443, P852, DOI 10.1007/s00424-001-0761-1; Semenza GL, 2000, J CLIN INVEST, V106, P613, DOI 10.1172/JCI10913; Vachon PH, 2002, GASTROENTEROLOGY, V123, P1980, DOI 10.1053/gast.2002.37072; Veenstra RP, 2007, DIGESTION, V75, P205, DOI 10.1159/000109373; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	43	80	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3428	10.1371/journal.pone.0003428	http://dx.doi.org/10.1371/journal.pone.0003428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927609	gold, Green Published			2022-12-25	WOS:000265122400004
J	Catania, KC				Catania, Kenneth C.			Worm Grunting, Fiddling, and Charming-Humans Unknowingly Mimic a Predator to Harvest Bait	PLOS ONE			English	Article							ANCIENT ESCAPE CIRCUIT; AVIAN PREDATOR; EASTERN MOLE; PREY; EXPLOITATION; SENSITIVITY; EARTHWORMS; BEHAVIOR	Background: For generations many families in and around Florida's Apalachicola National Forest have supported themselves by collecting the large endemic earthworms (Diplocardia mississippiensis). This is accomplished by vibrating a wooden stake driven into the soil, a practice called "worm grunting''. In response to the vibrations, worms emerge to the surface where thousands can be gathered in a few hours. Why do these earthworms suddenly exit their burrows in response to vibrations, exposing themselves to predation? Principal Findings: Here it is shown that a population of eastern American moles (Scalopus aquaticus) inhabits the area where worms are collected and that earthworms have a pronounced escape response from moles consisting of rapidly exiting their burrows to flee across the soil surface. Recordings of vibrations generated by bait collectors and moles suggest that "worm grunters'' unknowingly mimic digging moles. An alternative possibility, that worms interpret vibrations as rain and surface to avoid drowning is not supported. Conclusions: Previous investigations have revealed that both wood turtles and herring gulls vibrate the ground to elicit earthworm escapes, indicating that a range of predators may exploit the predator-prey relationship between earthworms and moles. In addition to revealing a novel escape response that may be widespread among soil fauna, the results show that humans have played the role of "rare predators'' in exploiting the consequences of a sensory arms race.	[Catania, Kenneth C.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	ken.catania@vanderbilt.edu			National Science Foundation Career Award [0238364]; MacArthur Award	National Science Foundation Career Award(National Science Foundation (NSF)); MacArthur Award	National Science Foundation Career Award # 0238364, MacArthur Award	Arlton A. V., 1936, Journal of Mammalogy, V17, P349, DOI 10.2307/1374401; BROWER K, 1999, ATLANTIC MONTHLY, V283, P91; BULLOCK TH, 1945, J NEUROPHYSIOL, V8, P55, DOI 10.1152/jn.1945.8.1.55; Catania KC, 1997, J COMP NEUROL, V378, P337, DOI 10.1002/(SICI)1096-9861(19970217)378:3<337::AID-CNE3>3.0.CO;2-4; Chuang SC, 2008, INVERTEBR BIOL, V127, P80, DOI 10.1111/j.1744-7410.2007.00117.x; Darwin C., 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; DAVENPORT J, 1994, REV FISH BIOL FISHER, V4, P184, DOI 10.1007/BF00044128; Dawkins R., 1982, pi; DREW MC, 1983, PLANT SOIL, V75, P179, DOI 10.1007/BF02375564; Drewes C.D., 1984, P43; DYCHE LL, 1903, T KANSAS ACAD SCI, V18, P183; Godfrey GK, 1960, LIFE MOLE; Gorman M.L, 1990, NATURAL HIST MOLES; Hartman GD, 2000, AM MIDL NAT, V144, P342, DOI 10.1674/0003-0031(2000)144[0342:DOTMSA]2.0.CO;2; HARVEY MJ, 1976, AM MIDL NAT, V95, P436, DOI 10.2307/2424406; Hendrix PF, 2006, BIOL INVASIONS, V8, P1201, DOI 10.1007/s10530-006-9048-y; Hendrix Paul F., 1994, Megadrilogica, V5, P73; HICKMAN J. C., 1984, MADRONO, V31, P249; HOY RR, 1989, ANNU REV NEUROSCI, V12, P355, DOI 10.1146/annurev.ne.12.030189.002035; Jablonski PG, 2005, ETHOLOGY, V111, P381, DOI 10.1111/j.1439-0310.2004.01059.x; Jablonski PG, 2001, BRAIN BEHAV EVOLUT, V58, P218, DOI 10.1159/000057565; Jablonski PG, 2001, P ROY SOC B-BIOL SCI, V268, P1017, DOI 10.1098/rspb.2001.1623; Jablonski PG, 1999, BEHAV ECOL, V10, P7, DOI 10.1093/beheco/10.1.7; Jablonski PG, 2000, BRAIN BEHAV EVOLUT, V56, P94, DOI 10.1159/000006680; James Samuel W., 2004, P75; Kaufmann J.H., 1989, Bulletin of the Chicago Herpetological Society, V24, P125; KAUFMANN JH, 1986, COPEIA, P1001, DOI 10.2307/1445299; KAUFMANN JH, 1989, NAT HIST, P8; Kuralt Charles, 1985, ROAD C KURALT; Roeder K.D., 1963, NERVE CELLS INSECT B; SCHEFFER TH, 1914, USDA FARMERS B, V583, P3; TINBERGEN N., 1953, HERRING GULLS WORLD; TOBIN TC, 2002, ST PETERSBURG T 0414; WHITAKER J O JR, 1974, Proceedings of the Indiana Academy of Science, V83, P478; Wickler W., 1968, MIMICRY PLANTS ANIMA; Yates T.L., 1982, P37; ZEILER D, 1969, INT TURT TORT SOC J, V3, P30; Zeiller D., 1969, Int. Turtle Tortoise Soc. J., V3, P6	38	28	30	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3472	10.1371/journal.pone.0003472	http://dx.doi.org/10.1371/journal.pone.0003472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852902	gold, Green Published, Green Submitted			2022-12-25	WOS:000265121700013
J	Li, WZ; Wooley, JC; Godzik, A				Li, Weizhong; Wooley, John C.; Godzik, Adam			Probing Metagenomics by Rapid Cluster Analysis of Very Large Datasets	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; PROTEIN SEQUENCES; REDUNDANCY; STRATEGIES; ALGORITHM; UNIPROT; SETS	Background: The scale and diversity of metagenomic sequencing projects challenge both our technical and conceptual approaches in gene and genome annotations. The recent Sorcerer II Global Ocean Sampling (GOS) expedition yielded millions of predicted protein sequences, which significantly altered the landscape of known protein space by more than doubling its size and adding thousands of new families (Yooseph et al., 2007 PLoS Biol 5, e16). Such datasets, not only by their sheer size, but also by many other features, defy conventional analysis and annotation methods. Methodology/Principal Findings: In this study, we describe an approach for rapid analysis of the sequence diversity and the internal structure of such very large datasets by advanced clustering strategies using the newly modified CD-HIT algorithm. We performed a hierarchical clustering analysis on the 17.4 million Open Reading Frames (ORFs) identified from the GOS study and found over 33 thousand large predicted protein clusters comprising nearly 6 million sequences. Twenty percent of these clusters did not match known protein families by sequence similarity search and might represent novel protein families. Distributions of the large clusters were illustrated on organism composition, functional class, and sample locations. Conclusion/Significance: Our clustering took about two orders of magnitude less computational effort than the similar protein family analysis of original GOS study. This approach will help to analyze other large metagenomic datasets in the future. A Web server with our clustering results and annotations of predicted protein clusters is available online at http://tools.camera.calit2.net/gos under the CAMERA project.	[Li, Weizhong] Univ Calif San Diego, Calif Inst Telecommun & Informat Technol, La Jolla, CA 92093 USA; [Wooley, John C.; Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Godzik, Adam] Burnham Inst Med Res, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Li, WZ (corresponding author), Univ Calif San Diego, Calif Inst Telecommun & Informat Technol, La Jolla, CA 92093 USA.	adam@burnham.org	WU, TAKLON/A-2827-2010; Godzik, Adam/AAW-1467-2020; Li, Weizhong/A-9735-2008; Godzik, Adam/A-7279-2009	Godzik, Adam/0000-0002-2425-852X; Li, Weizhong/0000-0003-1804-9403; Godzik, Adam/0000-0002-2425-852X	Gordon and Betty Moore Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was partly supported by the CAMERA project (http://camera.calit2.net) which is funded by the Gordon and Betty Moore Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Holm L, 1998, BIOINFORMATICS, V14, P423, DOI 10.1093/bioinformatics/14.5.423; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2002, PROTEIN ENG, V15, P643, DOI 10.1093/protein/15.8.643; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Park J, 2000, BIOINFORMATICS, V16, P458, DOI 10.1093/bioinformatics/16.5.458; Pipenbacher P, 2002, BIOINFORMATICS, V18, pS182, DOI 10.1093/bioinformatics/18.suppl_2.S182; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasson Ori, 2002, Bioinformatics, V18 Suppl 1, pS14; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tress ML, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-213; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yona G, 1999, PROTEINS, V37, P360, DOI 10.1002/(SICI)1097-0134(19991115)37:3<360::AID-PROT5>3.0.CO;2-Z; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	40	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3375	10.1371/journal.pone.0003375	http://dx.doi.org/10.1371/journal.pone.0003375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846219	Green Published, gold			2022-12-25	WOS:000265114500008
J	Alves, S; Nascimento-Ferreira, I; Auregan, G; Hassig, R; Dufour, N; Brouillet, E; de Lima, MCP; Hantraye, P; de Almeida, LP; Deglon, N				Alves, Sandro; Nascimento-Ferreira, Isabel; Auregan, Gwennaelle; Hassig, Raymonde; Dufour, Noelle; Brouillet, Emmanuel; de Lima, Maria C. Pedroso; Hantraye, Philippe; de Almeida, Luis Pereira; Deglon, Nicole			Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease	PLOS ONE			English	Article								Recent studies have demonstrated that RNAi is a promising approach for treating autosomal dominant disorders. However, discrimination between wild-type and mutant transcripts is essential, to preserve wild-type expression and function. A single nucleotide polymorphism (SNP) is present in more than 70% of patients with Machado-Joseph disease (MJD). We investigated whether this SNP could be used to inactivate mutant ataxin-3 selectively. Lentiviral-mediated silencing of mutant human ataxin-3 was demonstrated in vitro and in a rat model of MJD in vivo. The allele-specific silencing of ataxin-3 significantly decreased the severity of the neuropathological abnormalities associated with MJD. These data demonstrate that RNAi has potential for use in MJD treatment and constitute the first proof-of-principle for allele-specific silencing in the central nervous system.	[Alves, Sandro; Nascimento-Ferreira, Isabel; de Lima, Maria C. Pedroso; de Almeida, Luis Pereira] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Alves, Sandro; Nascimento-Ferreira, Isabel; de Almeida, Luis Pereira] Univ Coimbra, Fac Pharm, P-3000 Coimbra, Portugal; [de Lima, Maria C. Pedroso] Univ Coimbra, Fac Sci, P-3000 Coimbra, Portugal; [Alves, Sandro; Auregan, Gwennaelle; Hassig, Raymonde; Dufour, Noelle; Brouillet, Emmanuel; Hantraye, Philippe; Deglon, Nicole] Inst Mol Imag I2BM, Mol Imag Res Ctr MIRCen, CEA, Orsay, France; [Auregan, Gwennaelle; Hassig, Raymonde; Dufour, Noelle; Brouillet, Emmanuel; Hantraye, Philippe; Deglon, Nicole] CNRS, URA 2210, Orsay, France	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; CEA; Centre National de la Recherche Scientifique (CNRS)	Alves, S (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	luispa@cnc.uc.pt	Brouillet, Emmanuel/B-4784-2014; Deglon, Nicole/A-2265-2012; de Lima, Maria da Conceição Monteiro/AAS-5602-2021; de Almeida, Luis Pereira/O-8196-2019; de Almeida, Luis Pereira/A-4605-2009	Brouillet, Emmanuel/0000-0001-6322-7403; Deglon, Nicole/0000-0003-4475-9476; de Lima, Maria da Conceição Monteiro/0000-0003-1844-5027; de Almeida, Luis Pereira/0000-0001-5831-3307; de Almeida, Luis Pereira/0000-0001-5831-3307; Alves, Sandro/0000-0002-1396-7523	Commissariat a L'Energie Atomique (CEA); National Ataxia Foundation (NAF); Portuguese Foundation for Science and Technology [POCI/SAU-MMO/56055/2004, PTDC/SAU-FCF/70384/2006, SFRH/BD/12675/2003, SFRH/BD/29479/2006]	Commissariat a L'Energie Atomique (CEA)(French Atomic Energy Commission); National Ataxia Foundation (NAF); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the Commissariat a L'Energie Atomique (CEA), the National Ataxia Foundation (NAF) and the Portuguese Foundation for Science and Technology (POCI/SAU-MMO/56055/2004 and PTDC/SAU-FCF/70384/2006). Sandro Alves and Isabel Nascimento-Ferreira were supported by the Portuguese Foundation for Science and Technology (Fellowships SFRH/BD/12675/2003 and SFRH/BD/29479/2006, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVES S, 2008, HUM MOL GENET; Arango M, 2006, J NEUROSCI, V26, P4649, DOI 10.1523/JNEUROSCI.5409-05.2006; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; CANCEL G, 1995, AM J HUM GENET, V57, P809; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; CLARKE PGH, 1992, TRENDS NEUROSCI, V15, P211, DOI 10.1016/0166-2236(92)90036-8; de Almeida LP, 2002, J NEUROSCI, V22, P3473; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Gaspar C, 1996, HUM GENET, V98, P620, DOI 10.1007/s004390050270; Gaspar C, 2001, AM J HUM GENET, V68, P523, DOI 10.1086/318184; Gonzalez-Alegre P, 2003, ANN NEUROL, V53, P781, DOI 10.1002/ana.10548; Gwinn-Hardy K, 2001, ARCH NEUROL-CHICAGO, V58, P296, DOI 10.1001/archneur.58.2.296; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; LANG AE, 1994, ANN NEUROL, V36, P443, DOI 10.1002/ana.410360318; LI LB, 2008, NATURE; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACEDORIBEIRO S, 2007, INTERACTIONS NEURONS; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; Matsumura R, 1996, HUM GENET, V98, P643, DOI 10.1007/s004390050276; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Palfi S, 2007, MOL THER, V15, P1444, DOI 10.1038/sj.mt.6300185; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; RANUM LPW, 1995, AM J HUM GENET, V57, P603; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Regulier E, 2003, HUM MOL GENET, V12, P2827, DOI 10.1093/hmg/ddg305; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rodrigues AJ, 2007, FASEB J, V21, P1126, DOI 10.1096/fj.06-7002com; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Sobue G, 1996, J NEUROL NEUROSUR PS, V60, P354, DOI 10.1136/jnnp.60.3.354-a; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; SUDARSKY L, 1995, CLIN NEUROSCI, V3, P17; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Wullner U, 2005, ARCH NEUROL-CHICAGO, V62, P1280, DOI 10.1001/archneur.62.8.1280; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019	41	116	130	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3341	10.1371/journal.pone.0003341	http://dx.doi.org/10.1371/journal.pone.0003341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841197	Green Submitted, gold, Green Published			2022-12-25	WOS:000265113900004
J	Sereno, PC; Martinez, RN; Wilson, JA; Varricchio, DJ; Alcober, OA; Larsson, HCE				Sereno, Paul C.; Martinez, Ricardo N.; Wilson, Jeffrey A.; Varricchio, David J.; Alcober, Oscar A.; Larsson, Hans C. E.			Evidence for Avian Intrathoracic Air Sacs in a New Predatory Dinosaur from Argentina	PLOS ONE			English	Article								Background: Living birds possess a unique heterogeneous pulmonary system composed of a rigid, dorsally-anchored lung and several compliant air sacs that operate as bellows, driving inspired air through the lung. Evidence from the fossil record for the origin and evolution of this system is extremely limited, because lungs do not fossilize and because the bellow-like air sacs in living birds only rarely penetrate (pneumatize) skeletal bone and thus leave a record of their presence. Methodology/Principal Findings: We describe a new predatory dinosaur from Upper Cretaceous rocks in Argentina, Aerosteon riocoloradensis gen. et sp. nov., that exhibits extreme pneumatization of skeletal bone, including pneumatic hollowing of the furcula and ilium. In living birds, these two bones are pneumatized by diverticulae of air sacs ( clavicular, abdominal) that are involved in pulmonary ventilation. We also describe several pneumatized gastralia ("stomach ribs''), which suggest that diverticulae of the air sac system were present in surface tissues of the thorax. Conclusions/Significance: We present a four-phase model for the evolution of avian air sacs and costosternal-driven lung ventilation based on the known fossil record of theropod dinosaurs and osteological correlates in extant birds: (1) Phase I-Elaboration of paraxial cervical air sacs in basal theropods no later than the earliest Late Triassic. (2) Phase II-Differentiation of avian ventilatory air sacs, including both cranial ( clavicular air sac) and caudal (abdominal air sac) divisions, in basal tetanurans during the Jurassic. A heterogeneous respiratory tract with compliant air sacs, in turn, suggests the presence of rigid, dorsally attached lungs with flow-through ventilation. (3) Phase III-Evolution of a primitive costosternal pump in maniraptoriform theropods before the close of the Jurassic. (4) Phase IV-Evolution of an advanced costosternal pump in maniraptoran theropods before the close of the Jurassic. In addition, we conclude: (5) The advent of avian unidirectional lung ventilation is not possible to pinpoint, as osteological correlates have yet to be identified for uni- or bidirectional lung ventilation. (6) The origin and evolution of avian air sacs may have been driven by one or more of the following three factors: flow-through lung ventilation, locomotory balance, and/or thermal regulation.	[Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Martinez, Ricardo N.; Alcober, Oscar A.] Museo Ciencias Nat, San Juan, PR USA; [Wilson, Jeffrey A.] Univ Michigan, Dept Geol Sci, Museum Paleontol, Ann Arbor, MI 48109 USA; [Varricchio, David J.] Montana State Univ, Dept Earth Sci, Bozeman, MT USA; [Larsson, Hans C. E.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2T5, Canada	University of Chicago; University of Michigan System; University of Michigan; Montana State University System; Montana State University Bozeman; McGill University	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu	Wilson, Jeffrey/C-2737-2008; Larsson, Hans/AAD-4579-2019	Larsson, Hans/0000-0002-6377-4770	National Geographic Society; The David and Lucile Packard Foundation; Pritzker Foundation	National Geographic Society(National Geographic Society); The David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Pritzker Foundation	Fieldwork and lab work was funded by National Geographic Society, The David and Lucile Packard Foundation, and the Pritzker Foundation (to PCS).	Alcober O., 1998, Journal of Vertebrate Paleontology, V18, p23A; BERNSTEIN MH, 1976, RESP PHYSIOL, V26, P371, DOI 10.1016/0034-5687(76)90007-4; Bezuidenhout AJ, 1999, ONDERSTEPOORT J VET, V66, P317; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P325; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; Brainerd EL, 2006, RESP PHYSIOL NEUROBI, V154, P73, DOI 10.1016/j.resp.2006.06.003; Britt BB, 1998, NATURE, V395, P374, DOI 10.1038/26469; BRITT BB, 1993, THESIS U CALGARY CAL; Brochu C., 2002, J VERTEBRATE PALEO S, V7, P1, DOI DOI 10.1671/0272-4634(2002)022[0001:ARAOPA]2.0.CO;2; BROWN RE, 1995, J EXP BIOL, V198, P2349; Burnham DA, 2004, LIFE O PAST, P67; CARRIER DR, 1987, PALEOBIOLOGY, V13, P326; Carrier DR, 2000, AM ZOOL, V40, P87, DOI 10.1668/0003-1569(2000)040[0087:TIOVAL]2.0.CO;2; Carrier DR, 2001, J EXP BIOL, V204, P3917; Carrier DR, 2000, PALEOBIOLOGY, V26, P271, DOI 10.1666/0094-8373(2000)026<0271:TEOPAI>2.0.CO;2; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Christiansen P, 2000, P ROY SOC B-BIOL SCI, V267, P2501, DOI 10.1098/rspb.2000.1311; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; Codd JR, 2008, P ROY SOC B-BIOL SCI, V275, P157, DOI 10.1098/rspb.2007.1233; Codd JR, 2005, J EXP BIOL, V208, P849, DOI 10.1242/jeb.01489; Coria R., 2000, GAIA, V102, P89; Coria RA, 2006, GEODIVERSITAS, V28, P71; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie Philip J., 2000, Geodiversitas, V22, P207; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Duncker H.-R., 1978, P2; DUNCKER HR, 1972, RESP PHYSIOL, V14, P44, DOI 10.1016/0034-5687(72)90016-3; DUNCKER HR, 1989, LIFE SCI R, V45, P147; DUNCKER HR, 1971, ERGEBNISSE ANATOMIE, V0045, P00001; Eaton G. F., 1910, Memoirs of the Connecticut Academy of Arts and Sciences New Haven, V2; Farmer CG, 2006, RESP PHYSIOL NEUROBI, V154, P89, DOI 10.1016/j.resp.2006.04.014; Gilmore C. W., 1925, Memoirs of the Carnegie Museum, V10, P347; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Gradstein F.M, 2012, GEOLOGIC TIME SCALE; Harris JD, 1998, NEW MEXICO MUSEUM NA, V13, P1, DOI DOI 10.1080/0022293460865417; Hengst R, 1998, SCIENCE, V281, P47; Hicks JW, 1999, RESP PHYSIOL, V117, P73, DOI 10.1016/S0034-5687(99)00060-2; HOGG DA, 1984, J ANAT, V138, P617; HOLLAND WJ, 1906, MEM CARNEGIE MUS, V2, P225; HOWSE SCB, 1986, ZOOL J LINN SOC-LOND, V88, P307, DOI 10.1111/j.1096-3642.1986.tb02249.x; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; King A. S., 1966, International Review of General and Experimental Zoology, V2, P171; KING A. S., 1956, BRIT VET JOUR, V112, P279; KING A. S., 1957, ACTA ANAT, V31, P220; Krause DW, 2007, J VERTEBR PALEONTOL, V27, P1, DOI 10.1671/0272-4634(2007)27[1:OOTHOD]2.0.CO;2; KUETHE DO, 1988, J EXP BIOL, V136, P1; Larson Peter L., 1997, P65; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; M?ller B., 1908, SMITHSONIAN MISCELLA, V50, P365; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; MARTINEZ RN, PLOS ONE; McLelland J., 1989, P221; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; NICHOLLS EL, 1981, CAN J EARTH SCI, V18, P518, DOI 10.1139/e81-045; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Osmolska H., 1972, PALAEONTOLOGIA POLON, V27, P103; PAUL GS, 2001, P INT S HON JH OSTR, P463; Pennycuick CJ, 1986, ORIGIN BIRDS EVOLUTI, P83; Perez-Moreno Bernardino P., 1999, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V20, P121; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; Perreau J, 1998, CRYPTOGAMIE MYCOL, V19, P1; Perry SF, 2004, RESP PHYSIOL NEUROBI, V144, P125, DOI 10.1016/j.resp.2004.06.018; PERRY SF, 2001, P INT S HON JH OSTR, P429; Powell F.L., 2000, P233, DOI 10.1016/B978-012747605-6/50011-0; RICHARDSON FRANK, 1939, CONDOR, V41, P13, DOI 10.2307/1364267; Ruben JA, 1997, SCIENCE, V278, P1267, DOI 10.1126/science.278.5341.1267; Ruben JA, 1999, SCIENCE, V283, P514, DOI 10.1126/science.283.5401.514; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Scheid P., 1989, P369; SCHMIDTN.K, 1969, CONDOR, V71, P341, DOI 10.2307/1365733; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; SUES HD, J VERT PALEONTOL, V22, P535; VARRICCHIO DJ, 2008, ACTA PALAEO IN PRESS; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	94	93	100	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2008	3	9							e3303	10.1371/journal.pone.0003303	http://dx.doi.org/10.1371/journal.pone.0003303			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MO	18825273	Green Published, gold			2022-12-25	WOS:000264432600001
J	Nakatani, T; Sarraj, B; Ohnishi, M; Densmore, MJ; Taguchi, T; Goetz, R; Mohammadi, M; Lanske, B; Razzaque, MS				Nakatani, Teruyo; Sarraj, Bara; Ohnishi, Mutsuko; Densmore, Michael J.; Taguchi, Takashi; Goetz, Regina; Mohammadi, Moosa; Lanske, Beate; Razzaque, M. Shawkat			In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis	FASEB JOURNAL			English	Article						kidney; vitamin D; PTH; NaPi2a; calcification; survival	MINERAL ION METABOLISM; PARATHYROID-HORMONE; TUMORAL CALCINOSIS; PHYSIOLOGICAL-ROLE; MISSENSE MUTATION; RENAL DAMAGE; MUTANT MICE; COLLAGEN; PROTEIN; COTRANSPORTER	A major breakthrough in systemic phosphate homeostasis regulation was achieved by the demonstration of strikingly similar physical, morphological, and biochemical phenotypes of fibroblast growth factor 23 (Fgf23) and klotho ablated mice, which led to identification of klotho as an Fgf23 signaling cofactor. Here, we generated Fgf23 and klotho double-knockout (Fgf23(-/-)/klotho(-/-)) mice to test the hypothesis whether Fgf23 has a klotho-independent function. Fgf23(-/-)/klotho(-/-) mice are viable and have high serum phosphate levels, similar to Fgf23(-/-) and klotho(-/-) single-knockout mice. In addition, the Fgf23(-/-)/klotho(-/-) mice have increased renal expression of the sodium/phosphate cotransporter NaP(i)2a and of 1-alpha-hydroxylase concomitant with increased serum levels of 1,25-dihydroxyvitamin-D, as also observed in the Fgf23(-/-) and klotho(-/-) mice. Moreover, Fgf23(-/-)/klotho(-/-) mice show soft tissue and vascular calcification, severe muscle wasting, hypogonadism, pulmonary emphysema, distention of intestinal wall, and skin atrophy, all of which are also seen in Fgf23(-/-) and klotho(-/-) mice. Notably, injection of bioactive FGF23 protein into Fgf23(-/-)/klotho(-/-) and klotho(-/-) mice does not lower serum phosphate, whereas in wild-type and Fgf23(-/-) mice, it reduces serum phosphate. Together, these results provide compelling evidence that Fgf23 does not have a klotho-independent role in the regulation of systemic phosphate and vitamin D homeostasis. - Nakatani, T., Sarraj, B., Ohnishi, M., Densmore, M. J., Taguchi, T., Goetz, R., Mohammadi, M., Lanske, B., Razzaque, M. S. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. FASEB J. 23, 433-441 (2009)	[Nakatani, Teruyo; Ohnishi, Mutsuko; Densmore, Michael J.; Lanske, Beate; Razzaque, M. Shawkat] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Sarraj, Bara] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Taguchi, Takashi; Razzaque, M. Shawkat] Nagasaki Univ, Dept Pathol, Sch Biomed Sci, Nagasaki 852, Japan; [Goetz, Regina; Mohammadi, Moosa] NYU, Sch Med, Dept Pharmacol, New York, NY USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Nagasaki University; New York University	Razzaque, MS (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, Rm 304,188 Longwood Ave, Boston, MA 02115 USA.	mrazzaque@hms.harvard.edu	Mohammadi, Moosa/ABA-6745-2020; Goetz, Regina/M-2411-2019; kasaei, fahime/T-7197-2018; Razzaque, Mohammed S./K-4282-2019	Mohammadi, Moosa/0000-0003-2434-9437; Goetz, Regina/0000-0003-3681-4703; Lanske, Beate/0000-0003-4638-804X	U.S. National Institutes of Health [R01-DE13686, R01-DK073944, R01-DK077276]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077276, R01DK073944] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Ms. K. Egashira (Department of Pathology, Nagasaki University School of Biomedical Sciences, Japan) for preparing the histology sections. The research work was supported in part by U.S. National Institutes of Health grants R01-DE13686 (to M.M.), R01-DK073944 (to B.L.), and R01-DK077276 (to M.S.R.).	Bai XY, 2004, ENDOCRINOLOGY, V145, P5269, DOI 10.1210/en.2004-0233; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Keusch I, 1998, KIDNEY INT, V54, P1224, DOI 10.1046/j.1523-1755.1998.00115.x; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lanske B, 2007, CURR OPIN NEPHROL HY, V16, P311, DOI 10.1097/MNH.0b013e3281c55eca; Lanske B, 2007, AGEING RES REV, V6, P73, DOI 10.1016/j.arr.2007.02.002; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Liu D, 2008, AM J NEPHROL, V28, P555, DOI 10.1159/000115290; Liu X, 2006, DRUG METAB REV, V38, P49; Memon F, 2008, KIDNEY INT, V74, P566, DOI 10.1038/ki.2008.218; Miyamoto KI, 2007, AM J NEPHROL, V27, P503, DOI 10.1159/000107069; Nabeshima Y, 2008, AM J NEPHROL, V28, P455, DOI 10.1159/000112824; Pfister MF, 1998, P NATL ACAD SCI USA, V95, P1909, DOI 10.1073/pnas.95.4.1909; Razzaque MS, 2008, NEPHROL DIAL TRANSPL, V23, P459, DOI 10.1093/ndt/gfm702; Razzaque MS, 2007, NAT CLIN PRACT ENDOC, V3, P788, DOI 10.1038/ncpendmet0667; Razzaque MS, 2007, AGEING RES REV, V6, P211, DOI 10.1016/j.arr.2007.06.001; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Razzaque MS, 2006, TRENDS MOL MED, V12, P298, DOI 10.1016/j.molmed.2006.05.002; Razzaque Mohammed S., 2002, Medical Electron Microscopy, V35, P68, DOI 10.1007/s007950200009; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Razzaque MS, 1997, J PATHOL, V183, P24; Razzaque MS, 1998, MODERN PATHOL, V11, P1183; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Taguchi T, 2007, TRENDS MOL MED, V13, P45, DOI 10.1016/j.molmed.2006.12.001; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang H, 2008, J BONE MINER RES, V23, P939, DOI 10.1359/JBMR.080220; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamazaki Y, 2008, J BONE MINER RES, V23, P1509, DOI 10.1359/JBMR.080417; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670; Yu XJ, 2005, CYTOKINE GROWTH F R, V16, P221, DOI 10.1016/j.cytogfr.2005.01.002; Zha Y, 2008, AM J NEPHROL, V28, P755, DOI 10.1159/000128607; Zha Y, 2006, ENDOCRINOLOGY, V147, P5690, DOI 10.1210/en.2006-0302	38	186	209	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					433	441		10.1096/fj.08-114397	http://dx.doi.org/10.1096/fj.08-114397			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18835926	Green Published			2022-12-25	WOS:000262892900015
J	Reutershan, J; Vollmer, I; Stark, S; Wagner, R; Ngamsri, KC; Eltzschig, HK				Reutershan, Joerg; Vollmer, Irene; Stark, Stefanie; Wagner, Rosalyn; Ngamsri, Kristian-Christos; Eltzschig, Holger K.			Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs	FASEB JOURNAL			English	Article						acute lung injury; ARDS; neutrophil; PMN; migration; chemotaxis	BRONCHOALVEOLAR LAVAGE FLUID; ISCHEMIA-REPERFUSION INJURY; DEAMINASE-DEFICIENT MICE; INDUCIBLE FACTOR-I; ECTO-5'-NUCLEOTIDASE CD73; TISSUE-DAMAGE; NUCLEOTIDE PHOSPHOHYDROLYSIS; PULMONARY INFLAMMATION; RECEPTOR PROTECTS; HYPOXIA	Extracellular adenosine has been implicated as anti-inflammatory signaling molecule during acute lung injury (ALI). The main source of extracellular adenosine stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ectoapyrase (CD39) and the ecto-5'-nucleotidase (CD73). In the present study, we hypothesized a critical role of CD39 and CD73 in mediating pulmonary neutrophil (PMN) transmigration during lipopolysaccharide (LPS)-induced lung injury. Initial studies revealed that pulmonary CD39 and CD73 transcript levels were elevated following LPS exposure in vivo. Moreover, LPS-induced accumulation of PMN into the lungs was enhanced in cd39(-/-) or cd73(-/-) mice, particularly into the interstitial and intra-alveolar compartment. Such increases in PMN trafficking were accompanied by corresponding changes in alveolar-capillary leakage. Similarly, inhibition of extracellular nucleotide phosphohydrolysis with the nonspecific ecto-nucleoside-triphosphate-diphosphohydrolases inhibitor POM-1 confirmed increased pulmonary PMN accumulation in wild-type, but not in gene-targeted mice for cd39 or cd73. Finally, treatment with apyrase or nucleotidase was associated with attenuated pulmonary neutrophil accumulation and pulmonary edema during LPS-induced lung injury. Taken together, these data reveal a previously unrecognized role for CD39 and CD73 in attenuating PMN trafficking into the lungs during LPS-induced lung injury and suggest treatment with their soluble compounds as a therapeutic strategy. - Reutershan, J., Vollmer, I., Stark, S., Wagner, R., Ngamsri, K.-C., Eltzschig, H. K. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 23, 473-482 (2009)	[Reutershan, Joerg; Vollmer, Irene; Stark, Stefanie; Wagner, Rosalyn; Ngamsri, Kristian-Christos; Eltzschig, Holger K.] Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Eltzschig, Holger K.] Univ Colorado, Hlth Sci Ctr, Mucosal Inflammat Program, Dept Anesthesiol & Perioperat Med, Denver, CO USA	Eberhard Karls University of Tubingen; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Eltzschig, HK (corresponding author), Univ Colorado Denver, Mucosal Inflammat Program, Dept Anesthesiol & Perioperat Med, 12700 E 19th Ave,Mailstop B112,Res Complex 2,Room, Aurora, CO 80045 USA.	holger.eltzschig@ucdenver.edu			German Research Foundation [RE 1683/3-1]; Foundation for Anesthesia Education and Research	German Research Foundation(German Research Foundation (DFG)); Foundation for Anesthesia Education and Research	We thank Linda F. Thompson and Simon C. Robson for kindly providing us with gene-targeted mice, and Christa E. Mueller for pharmacological compounds. This study was supported by a German Research Foundation grant (RE 1683/3-1 to J.R.) and a Foundation for Anesthesia Education and Research grant to H.K.E.	Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; Day YJ, 2004, AM J PHYSIOL-GASTR L, V286, pG285, DOI 10.1152/ajpgi.00348.2003; DRIVER AG, 1993, AM REV RESPIR DIS, V148, P91, DOI 10.1164/ajrccm/148.1.91; Eckle T, 2008, AM J PHYSIOL-LUNG C, V295, pL718, DOI 10.1152/ajplung.90298.2008; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2008, TRENDS CARDIOVAS MED, V18, P103, DOI 10.1016/j.tcm.2008.01.006; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; FOLKESSON HG, 1995, J CLIN INVEST, V96, P107, DOI 10.1172/JCI118009; Fozard JR, 1999, PULM PHARMACOL THER, V12, P111, DOI 10.1006/pupt.1999.0191; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; GREEN TP, 1988, J LAB CLIN MED, V111, P173; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219; Huszar E, 2002, EUR RESPIR J, V20, P1393, DOI 10.1183/09031936.02.00005002; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Martin TR, 2002, J CLIN INVEST, V110, P1603, DOI 10.1172/JCI200217302; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Olson TS, 2002, AM J PHYSIOL-REG I, V282, pR1245, DOI 10.1152/ajpregu.00540.2001; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Reutershan J, 2006, ANESTHESIOLOGY, V104, P511, DOI 10.1097/00000542-200603000-00019; Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254; Reutershan J, 2007, AM J RESP CRIT CARE, V175, P1027, DOI 10.1164/rccm.200612-1822OC; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Van Linden A, 2007, EXPERT OPIN BIOL TH, V7, P1437, DOI 10.1517/14712598.7.9.1437; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5	59	160	170	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					473	482		10.1096/fj.08-119701	http://dx.doi.org/10.1096/fj.08-119701			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18838482				2022-12-25	WOS:000262892900019
J	Kojima, T; Shimazui, T; Hinotsu, S; Joraku, A; Oikawa, T; Kawai, K; Horie, R; Suzuki, H; Nagashima, R; Yoshikawa, K; Michiue, T; Asashima, M; Akaza, H; Uchida, K				Kojima, T.; Shimazui, T.; Hinotsu, S.; Joraku, A.; Oikawa, T.; Kawai, K.; Horie, R.; Suzuki, H.; Nagashima, R.; Yoshikawa, K.; Michiue, T.; Asashima, M.; Akaza, H.; Uchida, K.			Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling	ONCOGENE			English	Article						CXXC4; Idax; RCC; SNP array	COMPARATIVE GENOMIC HYBRIDIZATION; HIGH-RESOLUTION ANALYSIS; BETA-CATENIN; GENE-EXPRESSION; CANCER; LIVIN; INHIBITOR; PATHWAY; TARGET; IDENTIFICATION	The Wnt signaling pathway is involved in normal embryonic development and controls the homeostatic self-renewal of stem cells in adult tissues. Constitutive activation of Wnt signaling contributes to cancer development and progression. We identified a CXXC4 homozygous deletion at 4q24 in an aggressive renal cell carcinoma (RCC) using single-nucleotide polymorphism (SNP) arrays. CXXC4 encodes Idax, which negatively regulates Wnt signaling by binding to the PDZ domain of Dishevelled. CXXC4 mRNA levels in tumor samples were significantly lower in patients with metastases compared with those without (P = 0.0016). Patients whose tumors had lower CXXC4 expression than normal kidney showed a poorer cause-specific survival outcome than those with higher expression (P = 0.0095). Decreased expression of CXXC4 also correlated with cytoplasmic staining of beta-catenin. Knockdown of CXXC4 induced the nuclear translocation of beta-catenin and altered expression of a set of genes involved in cell proliferation, invasion and survival. Furthermore, reduced expression of CXXC4 by small interfering RNAs promoted cell proliferation and inhibited apoptosis after 5-FU and doxorubicin treatment in RCC cells. These data suggest that CXXC4 plays a critical role in tumor progression of RCC through Wnt signaling. Wnt signaling could thus be a potential molecular target in RCC indicating decreased CXXC4 expression.	[Kojima, T.; Shimazui, T.; Hinotsu, S.; Joraku, A.; Oikawa, T.; Kawai, K.; Akaza, H.] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Mol Biol Oncol, Tsukuba, Ibaraki 3058575, Japan; [Kojima, T.; Horie, R.; Uchida, K.] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Mol Biol Oncol, Tsukuba, Ibaraki, Japan; [Suzuki, H.] MCBI, Div Res, Tsukuba, Ibaraki, Japan; [Yoshikawa, K.] Aichi Med Univ, Sch Med, Dept Pathol, Aichi, Japan; [Michiue, T.; Asashima, M.] Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Aichi Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Uchida, K (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Mol Biol Oncol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	kazuhiko.uchida@cbiri.org	Asashima, Makoto/O-8389-2018	Asashima, Makoto/0000-0002-0012-026X	Japan Society for the Promotion of Science (JSPS), Japan	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Taeko Asano and Miyuki Katto for immunohistochemistry and microarray, respectively. We also thank Noriko Kunita for technical support. This study was performed in part as a collaborative research effort with the Clinical Informatics Research Initiative at the Organ Development Research Laboratory of the National Institute of Advanced Industrial Science and Technology (AIST), Japan. This study was supported by a grant from Scientific Research from the Japan Society for the Promotion of Science (JSPS), Japan.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bilim V, 2000, CLIN CANCER RES, V6, P460; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Crnkovic-Mertens I, 2007, CELL MOL LIFE SCI, V64, P1137, DOI 10.1007/s00018-007-6510-7; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Guinan P, 1997, CANCER, V80, P992, DOI 10.1002/(SICI)1097-0142(19970901)80:5<992::AID-CNCR26>3.0.CO;2-Q; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Jiang F, 2000, CANCER RES, V60, P6503; Jiang F, 1998, J PATHOL, V185, P382; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Kempkensteffen C, 2007, CANCER LETT, V254, P227, DOI 10.1016/j.canlet.2007.03.006; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Kurose K, 2004, J UROLOGY, V171, P1314, DOI 10.1097/01.ju.0000101047.64379.d4; Lee MG, 2006, ONCOGENE, V25, P5807, DOI 10.1038/sj.onc.1209867; Levy DA, 1998, J UROLOGY, V159, P1163, DOI 10.1016/S0022-5347(01)63541-9; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; MITRA AB, 1994, CANCER RES, V54, P4481; Moch H, 1996, CANCER RES, V56, P27; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Ohba K, 2005, J UROLOGY, V174, P461, DOI 10.1097/01.ju.0000165150.46006.92; Qiao QL, 2001, INT J CANCER, V95, P194, DOI 10.1002/1097-0215(20010520)95:3<194::AID-IJC1033>3.3.CO;2-D; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Shimokawa T, 2003, CANCER RES, V63, P6116; Storkel S, 1997, CANCER, V80, P987, DOI 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R; Suzuki H, 1997, ONCOLOGY-BASEL, V54, P252; Swiercz R, 1998, CLIN CANCER RES, V4, P869; Ueta T, 2002, ONCOL REP, V9, P1197; Wagener N, 2007, BRIT J CANCER, V97, P1271, DOI 10.1038/sj.bjc.6604028; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Yeh SH, 1996, GASTROENTEROLOGY, V110, P184, DOI 10.1053/gast.1996.v110.pm8536855; Yoshimoto T, 2007, J PATHOL, V213, P392, DOI 10.1002/path.2239; Yuan D, 2007, MOL CELL BIOCHEM, V306, P171, DOI 10.1007/s11010-007-9567-6; Yuan E, 2005, MOL CANCER RES, V3, P493, DOI 10.1158/1541-7786.MCR-05-0082	41	67	70	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					297	305		10.1038/onc.2008.391	http://dx.doi.org/10.1038/onc.2008.391			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18931698				2022-12-25	WOS:000262501100013
J	Viegas, CSB; Simes, DC; Laize, V; Williamson, MK; Price, PA; Cancela, ML				Viegas, Carla S. B.; Simes, Dina C.; Laize, Vincent; Williamson, Matthew K.; Price, Paul A.; Cancela, M. Leonor			Gla-rich Protein (GRP), A New Vitamin K-dependent Protein Identified from Sturgeon Cartilage and Highly Conserved in Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; GLUTAMYL CARBOXYLASE; SEQUENCE ALIGNMENT; TELEOST FISH; BINDING-SITE; BONE; MATRIX; PROTHROMBIN; EXPRESSION; RESIDUES	We report the isolation of a novel vitamin K-dependent protein from the calcified cartilage of Adriatic sturgeon ( Acipenser nacarii). This 10.2-kDa secreted protein contains 16 gamma-carboxyglutamic acid (Gla) residues in its 74-residue sequence, the highest Gla percent of any known protein, and we have therefore termed it Gla-rich protein (GRP). GRP has a high charge density (36 negative + 16 positive = 20 net negative) yet is insoluble at neutral pH. GRP has orthologs in all taxonomic groups of vertebrates, and a paralog (GRP2) in bony fish; no GRP homolog was found in invertebrates. There is no significant sequence homology between GRP and the Gla-containing region of any presently known vitamin K-dependent protein. Forty-seven GRP sequences were obtained by a combination of cDNA cloning and comparative genomics: all 47 have a propeptide that contains a gamma-carboxylase recognition site and a mature protein with 14 highly conserved Glu residues, each of them being gamma-carboxylated in sturgeon. The protein sequence of GRP is also highly conserved, with 78% identity between sturgeon and human GRP. Analysis of the corresponding gene structures suggests a highly constrained organization, particularly for exon 4, which encodes the core Gla domain. GRP mRNA is found in virtually all rat and sturgeon tissues examined, with the highest expression in cartilage. Cells expressing GRP include chondrocytes, chondroblasts, osteoblasts, and osteocytes. Because of its potential to bind calcium through Gla residues, we suggest that GRP may regulate calcium in the extracellular environment.	[Viegas, Carla S. B.; Simes, Dina C.; Laize, Vincent; Cancela, M. Leonor] Univ Algarve, Ctr Marine Sci CCMAR, P-8005139 Faro, Portugal; [Williamson, Matthew K.; Price, Paul A.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	Universidade do Algarve; University of California System; University of California San Diego	Cancela, ML (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, P-8005139 Faro, Portugal.	lcancela@ualg.pt	Cancela, M. Leonor/F-4665-2012; Laizé, Vincent/B-4463-2008; Viegas, Carla/N-6314-2019; Viegas, Carla CSB/N-6695-2014; Simes, Dina Costa/N-2789-2014	Cancela, M. Leonor/0000-0003-3114-6662; Laizé, Vincent/0000-0001-9565-9198; Viegas, Carla/0000-0002-5765-3665; Viegas, Carla CSB/0000-0002-5765-3665; Simes, Dina Costa/0000-0002-5145-4753	National Institutes of Health [HL58090]; Centre of Marine Sciences; Portuguese Science and Technology Foundation [POCTI/MAR/57921/2004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre of Marine Sciences; Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58090 (to P.A.P.) and a grant from the Centre of Marine Sciences (to M.L.C., V.L ., and D.C.S.) and Project POCTI/MAR/57921/2004 from the Portuguese Science and Technology Foundation (including funds from FEDER and OE) (to D.C.S. and M.L.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; Brown MA, 2002, TOXICON, V40, P447, DOI 10.1016/S0041-0101(01)00233-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Cranenburg ECM, 2007, THROMB HAEMOSTASIS, V98, P120, DOI 10.1160/TH07-04-0266; DEBOERVANDENBERG MAG, 1986, J INVEST DERMATOL, V87, P377, DOI 10.1111/1523-1747.ep12524848; Funari VA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-165; Hallgren KW, 2006, BIOCHEMISTRY-US, V45, P5587, DOI 10.1021/bi051986y; Hansson K, 2006, BIOCHEMISTRY-US, V45, P12828, DOI 10.1021/bi061311a; HAUSCHKA PV, 1975, P NATL ACAD SCI USA, V72, P3925, DOI 10.1073/pnas.72.10.3925; JIE KSG, 1995, ANAL BIOCHEM, V224, P163, DOI 10.1006/abio.1995.1023; Kulman JD, 1997, P NATL ACAD SCI USA, V94, P9058, DOI 10.1073/pnas.94.17.9058; Kulman JD, 2001, P NATL ACAD SCI USA, V98, P1370, DOI 10.1073/pnas.98.4.1370; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Laize V, 2005, J BIOL CHEM, V280, P26659, DOI 10.1074/jbc.M500257200; Laize V, 2006, J BIOL CHEM, V281, P15037, DOI 10.1074/jbc.M600373200; Lin PJ, 2002, J BIOL CHEM, V277, P28584, DOI 10.1074/jbc.M202292200; Lingenfelter SE, 1996, BIOCHEMISTRY-US, V35, P8234, DOI 10.1021/bi9523318; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; NIELSO H, 1997, PROT ENG, V1, P1; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; Pinto JP, 2001, GENE, V270, P77, DOI 10.1016/S0378-1119(01)00426-7; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; RATCLIFFE JV, 1993, J BIOL CHEM, V268, P24339; REHEMTULLA A, 1993, P NATL ACAD SCI USA, V90, P4611, DOI 10.1073/pnas.90.10.4611; Roest Crollius H, 2005, GENOME RES, V15, P1675, DOI 10.1101/gr.3735805; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Simes DC, 2003, J BONE MINER RES, V18, P244, DOI 10.1359/jbmr.2003.18.2.244; SIMES DC, 2008, Patent No. 61136315; SPERLING R, 1978, J BIOL CHEM, V253, P3898; Stanley TB, 1999, J BIOL CHEM, V274, P16940, DOI 10.1074/jbc.274.24.16940; STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730; Surmann-Schmitt C, 2008, J BIOL CHEM, V283, P7082, DOI 10.1074/jbc.M702792200; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; Tagariello A, 2008, MATRIX BIOL, V27, P3, DOI 10.1016/j.matbio.2007.07.004; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; VERMEER C, 1990, BIOCHEM J, V266, P625, DOI 10.1042/bj2660625; Walker CS, 2001, J BIOL CHEM, V276, P7769, DOI 10.1074/jbc.M009576200; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; ZHANG L, 1993, J BIOL CHEM, V268, P12040	41	84	91	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36655	36664		10.1074/jbc.M802761200	http://dx.doi.org/10.1074/jbc.M802761200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18836183	hybrid, Green Published			2022-12-25	WOS:000261840500064
J	Robichaud, JC; Francis, GA; Vance, DE				Robichaud, Julie C.; Francis, Gordon A.; Vance, Dennis E.			A Role for Hepatic Scavenger Receptor Class B, Type I in Decreasing High Density Lipoprotein Levels in Mice That Lack Phosphatidylethanolamine N-Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA HIGH-DENSITY; APOLIPOPROTEIN-A-I; BINDING CASSETTE TRANSPORTERS; CELLULAR CHOLESTEROL EFFLUX; SR-BI; HORMONAL-REGULATION; SECRETION; PROTEIN; GENE; HDL	Phosphatidylethanolamine N-methyltransferase (PEMT) is a liver-specific enzyme that converts phosphatidylethanolamine to phosphatidylcholine (PC). Mice that lack PEMT have reduced plasma levels of PC and cholesterol in high density lipoproteins (HDL). We have investigated the mechanism responsible for this reduction with experiments designed to distinguish between a decreased formation of HDL particles by hepatocytes or an increased hepatic uptake of HDL lipids. Therefore, we analyzed lipid efflux to apoA-I and HDL lipid uptake using primary cultured hepatocytes isolated from Pemt(+/+) and Pemt(+/+) mice. Hepatic levels of the ATP-binding cassette transporter A1 are not significantly different between Pemt genotypes. Moreover, hepatocytes isolated from Pemt(+/+) mice released cholesterol and PC into the medium as efficiently as did hepatocytes from Pemt(+/+) mice. Immunoblotting of liver homogenates showed a 1.5-fold increase in the amount of the scavenger receptor, class B, type 1 (SR-BI) in Pemt(+/+) compared with Pemt(+/+) livers. In addition, there was a 1.5-fold increase in the SR-BI-interacting protein PDZK1. Lipid uptake experiments using radiolabeled HDL particles revealed a greater uptake of [H-3] cholesteryl ethers and [H-3] PC by hepatocytes derived from Pemt(+/+) compared with Pemt(+/+) mice. Furthermore, we observed an increased association of [H-3] cholesteryl ethers in livers of Pemt(+/+) compared with Pemt(+/+)mice after tail vein injection of [H-3] HDL. These results strongly suggest that PEMT is involved in the regulation of plasma HDL levels in mice, mainly via HDL lipid uptake by SR-BI.	[Robichaud, Julie C.; Francis, Gordon A.; Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Robichaud, Julie C.; Francis, Gordon A.; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Francis, Gordon A.] Univ British Columbia, Dept Med, Vancouver, BC V6Z 1Y6, Canada	University of Alberta; University of Alberta; University of British Columbia	Vance, DE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca			Canadian Institutes of Health Research [89793, 12660, 64520, 63605]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institutes of Health Research Grants MOP: 89793, MOP: 12660, MGC: 64520, and STR 63605. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe-Dohmae S, 2006, FEBS LETT, V580, P1178, DOI 10.1016/j.febslet.2005.12.029; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Agellon LB, 1999, HEPATOLOGY, V30, P725, DOI 10.1002/hep.510300305; Ahras M, 2008, J LIPID RES, V49, P1569, DOI 10.1194/jlr.M800055-JLR200; Azhar S, 2002, J LIPID RES, V43, P861; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; BREMER J, 1960, BIOCHIM BIOPHYS ACTA, V37, P173, DOI 10.1016/0006-3002(60)90104-9; CHUNG BH, 1980, J LIPID RES, V21, P284; Cohen DE, 1999, CURR OPIN LIPIDOL, V10, P295, DOI 10.1097/00041433-199908000-00002; Fielding CJ, 2008, N COMP BIOC, P533, DOI 10.1016/B978-044453219-0.50021-0; FIELDING CJ, 1977, ARCH PATHOL LAB MED, V101, P225; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; Folch J., 1959, J BIOL CHEM, V226, P495; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GLASS C, 1985, J BIOL CHEM, V260, P744; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Harder CJ, 2007, J BIOL CHEM, V282, P1445, DOI 10.1074/jbc.M604627200; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kiss RS, 2003, J BIOL CHEM, V278, P10119, DOI 10.1074/jbc.M300137200; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Krieger M, 1999, CURR OPIN LIPIDOL, V10, P491, DOI 10.1097/00041433-199912000-00003; Li ZY, 2007, BBA-MOL CELL BIOL L, V1771, P486, DOI 10.1016/j.bbalip.2007.01.003; Li ZY, 2007, J BIOL CHEM, V282, P10283, DOI 10.1074/jbc.M611726200; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Reaven E, 2004, J LIPID RES, V45, P513, DOI 10.1194/jlr.M300370-JLR200; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P818, DOI 10.1016/j.bbalip.2007.04.019; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P807, DOI 10.1016/j.bbalip.2006.03.003; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider WJ, 2008, N COMP BIOC, P555, DOI 10.1016/B978-044453219-0.50022-2; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Silver DL, 2004, REV ENDOCR METAB DIS, V5, P327, DOI 10.1023/B:REMD.0000045104.38104.8e; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Silver DL, 2001, CURR OPIN LIPIDOL, V12, P497, DOI 10.1097/00041433-200110000-00004; Sporstol M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-5; Stangl H, 2002, J ENDOCRINOL, V175, P663, DOI 10.1677/joe.0.1750663; Sun B, 2006, J LIPID RES, V47, P1700, DOI 10.1194/jlr.M500450-JLR200; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Trigatti B, 2004, BIOCHEM SOC T, V32, P116, DOI 10.1042/BST0320116; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; VANCE DE, 1979, TRENDS BIOCHEM SCI, V4, P145, DOI 10.1016/0968-0004(79)90001-X; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1986, BIOCHIM BIOPHYS ACTA, V875, P501, DOI 10.1016/0005-2760(86)90070-6; VANCE JE, 1990, ANNU REV NUTR, V10, P337, DOI 10.1146/annurev.nu.10.070190.002005; Vance JE, 2008, N COMP BIOC, P507, DOI 10.1016/B978-044453219-0.50020-9; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Waite KA, 2004, BBA-MOL CELL BIOL L, V1636, P175, DOI 10.1016/j.bbalip.2003.10.014; Waite KA, 2002, J NUTR, V132, P68, DOI 10.1093/jn/132.1.68; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; YOKOYAMA S, 1982, J BIOCHEM, V91, P1267, DOI 10.1093/oxfordjournals.jbchem.a133811; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8; Zhang WW, 2003, CIRCULATION, V108, P2258, DOI 10.1161/01.CIR.0000093189.97429.9D	75	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35496	35506		10.1074/jbc.M807433200	http://dx.doi.org/10.1074/jbc.M807433200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18842588	hybrid			2022-12-25	WOS:000261687900021
J	Tanowitz, M; Hislop, JN; von Zastrow, M				Tanowitz, Michael; Hislop, James N.; von Zastrow, Mark			Alternative Splicing Determines the Post-endocytic Sorting Fate of G-protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU-OPIOID-RECEPTOR; MEMBRANE TRAFFICKING; DOWN-REGULATION; DESENSITIZATION; INTERNALIZATION; RESENSITIZATION; EXPRESSION; TOLERANCE; RESPONSES; BRAIN	Mu-type opioid receptors are physiologically important G-protein-coupled receptors that are generally thought to recycle after agonist-induced endocytosis. Here we show that several alternatively spliced receptor variants fail to do so efficiently because of splice-mediated removal of an endocytic sorting sequence that is present specifically in the MOR1 variant. All of the recycling-impaired receptor variants were found to undergo proteolytic down-regulation more rapidly than MOR1, irrespective of moderate differences in endocytic rate, indicating that alternative splicing plays a specific role in distinguishing the trafficking itinerary of receptors after endocytosis. The recycling-impaired MOR1B variant was similar to MOR1 in its ability to mediate opioid-dependent inhibition of adenylyl cyclase, and to undergo opioid-induced desensitization in intact cells. Functional recovery (resensitization) of MOR1B-mediated cellular responsiveness after opioid removal, however, was significantly impaired (4-fold reduction in rate) compared with MOR1. To our knowledge the present results are the first to establish a role of alternative RNA processing in specifying the post-endocytic sorting of G-protein-coupled receptors between divergent and functionally distinct membrane pathways.	[von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), MC 2140,600 16th St, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu			National Institutes of Health; National Institute on Drug Abuse	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health grants (to M.Z.) from the National Institute on Drug Abuse. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; BARE LA, 1994, FEBS LETT, V354, P213, DOI 10.1016/0014-5793(94)01129-X; Bockaert J, 2006, CELL TISSUE RES, V326, P553, DOI 10.1007/s00441-006-0286-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Evangelisti S, 2004, HIST J, V47, P1, DOI 10.1017/S0018246X03003480; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Haberstock-Debic H, 2003, J NEUROSCI, V23, P4324; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; LAW PY, 1982, MOL PHARMACOL, V72, P1; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Narita M, 2003, EUR J NEUROSCI, V18, P3193, DOI 10.1111/j.1460-9568.2003.03052.x; NESTLER EJ, 1993, CRIT REV NEUROBIOL, V7, P23; Pan YX, 1999, MOL PHARMACOL, V56, P396, DOI 10.1124/mol.56.2.396; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Pasternak GW, 2001, TRENDS PHARMACOL SCI, V22, P67, DOI 10.1016/S0165-6147(00)01616-3; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; SHARMA SK, 1977, P NATL ACAD SCI USA, V74, P3365, DOI 10.1073/pnas.74.8.3365; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sternini C, 2000, NEUROSCIENCE, V98, P233, DOI 10.1016/S0306-4522(00)00118-4; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Trafton JA, 2000, J NEUROSCI, V20, P8578; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; ZIMPRICH A, 1995, FEBS LETT, V359, P142, DOI 10.1016/0014-5793(95)00028-8	41	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35614	35621		10.1074/jbc.M806588200	http://dx.doi.org/10.1074/jbc.M806588200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18936093	Green Published, hybrid			2022-12-25	WOS:000261687900034
J	Ryan, TM; Howlett, GJ; Bailey, MF				Ryan, Timothy M.; Howlett, Geoffrey J.; Bailey, Michael F.			Fluorescence Detection of a Lipid-induced Tetrameric Intermediate in Amyloid Fibril Formation by Apolipoprotein C-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDIZED CHOLESTEROL METABOLITES; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; AGGREGATION; MEMBRANES; OLIGOMERS; ATHEROMA; TRIGGER; PLASMA; FORMS	The misfolding and self-assembly of proteins into amyloid fibrils that occurs in several debilitating and age-related diseases is affected by common components of amyloid deposits, notably lipids and lipid complexes. We have examined the effect of the short-chain phospholipids, dihexanoylphosphatidylcholine (DHPC) and dihexanoylphosphatidylserine (DHPS), on amyloid fibril formation by human apolipoprotein C-II (apoC-II). Micellar DHPC and DHPS strongly inhibited apoC-II fibril formation, whereas submicellar levels of these lipids accelerated apoC-II fibril formation to a similar degree. These results indicate that the net negative charge on DHPS, compared with the neutrally charged DHPC, is not critical for either the inhibition or activation process. We also investigated the mechanism for the submicellar, lipid-induced activation of fibril formation. Emission data for fluorescently labeled apoC-II indicated that DHPC and DHPS stimulate the early formation and accumulation of oligomeric species. Sedimentation velocity and equilibrium experiments using a new fluorescence detection system identified a discrete lipid-induced tetramer formed at low apoC-II concentrations in the absence of significant fibril formation. Seeding experiments showed that this tetramer was on the fibril-forming pathway. Fluorescence resonance energy transfer experiments established that this tetramer forms rapidly and is stabilized by submicellar, but not micellar, concentrations of DHPC and DHPS. Several recent studies show that oligomeric intermediates in amyloid fibril formation are toxic. Our results indicate that lipids promote on-pathway intermediates of apoC-II fibril assembly and that the accumulation of a discrete tetrameric intermediate depends on the molecular state of the lipid.	[Ryan, Timothy M.; Howlett, Geoffrey J.; Bailey, Michael F.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Melbourne	Howlett, GJ (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	ghowlett@unimelb.edu.au			Australian Research Council [DP0449510]; National Health and Medical Research Council of Australia [350229]	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant DP0449510 and National Health and Medical Research Council of Australia Grant 350229. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Atcliffe BW, 2001, EUR J BIOCHEM, V268, P2838, DOI 10.1046/j.1432-1327.2001.02164.x; Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Edelstein S J, 1973, Methods Enzymol, V27, P82; EDWARDS K, 1994, BIOCHEMISTRY-US, V33, P13304, DOI 10.1021/bi00249a017; Griffin MDW, 2008, J MOL BIOL, V375, P240, DOI 10.1016/j.jmb.2007.10.038; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hatters DM, 2001, FEBS LETT, V494, P220, DOI 10.1016/S0014-5793(01)02355-9; Hatters DM, 2002, EUR BIOPHYS J BIOPHY, V31, P2, DOI 10.1007/s002490100172; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; JOHNSON RE, 1981, BIOCHEMISTRY-US, V20, P4239, DOI 10.1021/bi00517a044; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Kokalj SJ, 2007, J MOL BIOL, V366, P1569, DOI 10.1016/j.jmb.2006.12.025; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l; MacRaild CA, 2001, BIOCHEMISTRY-US, V40, P5414, DOI 10.1021/bi002821m; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Olofsson A, 2007, J MOL BIOL, V374, P186, DOI 10.1016/j.jmb.2007.08.064; Sanders A, 2004, J MOL BIOL, V336, P165, DOI 10.1016/j.jmb.2003.12.011; Schlame M, 1996, J LIPID RES, V37, P2608; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stewart CR, 2007, J LIPID RES, V48, P2162, DOI 10.1194/jlr.M700098-JLR200; Stewart CR, 2007, BIOCHEMISTRY-US, V46, P5552, DOI 10.1021/bi602554z; TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Zhang QH, 2004, P NATL ACAD SCI USA, V101, P4752, DOI 10.1073/pnas.0400924101; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	41	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35118	35128		10.1074/jbc.M804004200	http://dx.doi.org/10.1074/jbc.M804004200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18852267	Green Published, hybrid			2022-12-25	WOS:000261469100069
J	Feelisch, M; Fernandez, BO; Bryan, NS; Garcia-Saura, MF; Bauer, S; Whitlock, DR; Ford, PC; Janero, DR; Rodriguez, J; Ashrafian, H				Feelisch, Martin; Fernandez, Bernadette O.; Bryan, Nathan S.; Garcia-Saura, Maria Francisca; Bauer, Selena; Whitlock, David R.; Ford, Peter C.; Janero, David R.; Rodriguez, Juan; Ashrafian, Houman			Tissue Processing of Nitrite in Hypoxia AN INTRICATE INTERPLAY OF NITRIC OXIDE-GENERATING AND-SCAVENGING SYSTEMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; MITOCHONDRIAL RESPIRATION; REDUCTASE; NO; DEOXYHEMOGLOBIN; VASODILATION; HEMOGLOBIN; METABOLISM; MODULATION; PHYSIOLOGY	Although nitrite (NO2-) and nitrate (NO3-) have been considered traditionally inert byproducts of nitric oxide (NO) metabolism, recent studies indicate that NO2- represents an important source of NO for processes ranging from angiogenesis through hypoxic vasodilation to ischemic organ protection. Despite intense investigation, the mechanisms through which NO2- exerts its physiological/pharmacological effects remain incompletely understood. We sought to systematically investigate the fate of NO2- in hypoxia from cellular uptake in vitro to tissue utilization in vivo using the Wistar rat as a mammalian model. We find that most tissues (except erythrocytes) produce free NO at rates that are maximal under hypoxia and that correlate robustly with each tissue's capacity for mitochondrial oxygen consumption. By comparing the kinetics of NO release before and after ferricyanide addition in tissue homogenates to mathematical models of NO2- reduction/NO scavenging, we show that the amount of nitrosylated products formed greatly exceeds what can be accounted for by NO trapping. This difference suggests that such products are formed directly from NO2-, without passing through the intermediacy of free NO. Inhibitor and subcellular fractionation studies indicate that NO2- reductase activity involves multiple redundant enzymatic systems (i.e. heme, iron-sulfur cluster, and molybdenum-based reductases) distributed throughout different cellular compartments and acting in concert to elicit NO signaling. These observations hint at conserved roles for the NO2--NO pool in cellular processes such as oxygen-sensing and oxygen-dependent modulation of intermediary metabolism.	[Feelisch, Martin; Fernandez, Bernadette O.] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Feelisch, Martin; Fernandez, Bernadette O.; Bryan, Nathan S.; Garcia-Saura, Maria Francisca; Bauer, Selena; Janero, David R.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Univ Texas Houston, Hlth Sci Ctr, Brown Fdn, Inst Mol Med, Houston, TX 77030 USA; [Whitlock, David R.] Nitroceutic LLC, Dover, MA 02030 USA; [Ford, Peter C.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Janero, David R.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Rodriguez, Juan] Centenary Coll Louisiana, Dept Phys, Shreveport, LA 71134 USA; [Ashrafian, Houman] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Warwick; Boston University; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Santa Barbara; Northeastern University; University of Oxford	Feelisch, M (corresponding author), Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	mf@warwick.ac.uk	Ford, Peter C/D-1826-2011; Fernandez, Bernadette/AAG-7202-2020; Feelisch, Martin/C-3042-2008	Ford, Peter C/0000-0002-5509-9912; Fernandez, Bernadette/0000-0001-6337-0381; Feelisch, Martin/0000-0003-2320-1158; Ashrafian, Houman/0000-0003-3988-378X	National Institutes of Health [HL 69029]; Kirschstein National Research Service; Medical Research Council (MRC Strategic Appointment Scheme); Wellcome Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069029] Funding Source: NIH RePORTER; Medical Research Council [G0701115] Funding Source: researchfish; MRC [G0701115] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (MRC Strategic Appointment Scheme)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 69029 (to M. F.) and the Kirschstein National Research Service Award Cardiovascular Training Grant (to B. O. F. and N. S. B.). This work was also supported by the Medical Research Council (MRC Strategic Appointment Scheme, to M. F.), and a Wellcome Trust CVRI Fellowship (to H. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Alzawahra WF, 2008, AM J PHYSIOL-HEART C, V295, pH499, DOI 10.1152/ajpheart.00374.2008; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Benamar A, 2008, BBA-BIOENERGETICS, V1777, P1268, DOI 10.1016/j.bbabio.2008.06.002; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Castillo L, 1996, P NATL ACAD SCI USA, V93, P11460, DOI 10.1073/pnas.93.21.11460; COHEN JJ, 1979, AM J PHYSIOL, V236, pF423, DOI 10.1152/ajprenal.1979.236.5.F423; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Edmunds NJ, 2003, J PHYSIOL-LONDON, V546, P521, DOI 10.1113/jphysiol.2002.023663; Erusalimsky JD, 2007, ARTERIOSCL THROM VAS, V27, P2524, DOI 10.1161/ATVBAHA.107.151167; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Gladwin MT, 2002, J BIOL CHEM, V277, P27818, DOI 10.1074/jbc.M203236200; Gonzalez FM, 2008, CIRCULATION, V117, P2986, DOI 10.1161/CIRCULATIONAHA.107.748814; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; HULBERT AJ, 1989, AM J PHYSIOL, V256, pR63, DOI 10.1152/ajpregu.1989.256.1.R63; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Kozlov AV, 2003, BRIT J PHARMACOL, V139, P989, DOI 10.1038/sj.bjp.0705323; Kumar D, 2008, P NATL ACAD SCI USA, V105, P7540, DOI 10.1073/pnas.0711480105; Lancaster JR, 2006, CANCER RES, V66, P6459, DOI 10.1158/0008-5472.CAN-05-2900; Li CQ, 2005, CANCER LETT, V226, P1, DOI 10.1016/j.canlet.2004.10.021; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Li HT, 2006, J BIOL CHEM, V281, P12546, DOI 10.1074/jbc.M511803200; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Maher AR, 2008, CIRCULATION, V117, P670, DOI 10.1161/CIRCULATIONAHA.107.719591; Mazzone M, 2008, NATURE, V453, P1194, DOI 10.1038/4531194a; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; PARKS DA, 1986, ACTA PHYSIOL SCAND, V126, P87; RICKWOOD D, 1993, PREPARATIVE CENTRIFU; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Zhou SF, 2005, CLIN PHARMACOKINET, V44, P279, DOI 10.2165/00003088-200544030-00005	39	167	177	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33927	33934		10.1074/jbc.M806654200	http://dx.doi.org/10.1074/jbc.M806654200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835812	Green Published, hybrid			2022-12-25	WOS:000261277700019
J	Ferrari, E; He, ZQ; Palermo, RE; Huang, HC				Ferrari, Eric; He, Zhiqing; Palermo, Robert E.; Huang, H. -C.			Hepatitis C Virus NS5B Polymerase Exhibits Distinct Nucleotide Requirements for Initiation and Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; DE-NOVO INITIATION; NONSTRUCTURAL PROTEIN; IN-VITRO; CRYSTAL-STRUCTURE; STEADY-STATE; HCV RNA; REPLICATION; BINDING; INHIBITORS	The hepatitis C virus (HCV) NS5B protein is an RNA-dependent RNA polymerase (RdRp) essential for replication of the viral RNA genome. Purified NS5B has been reported to exhibit multiple activities in vitro. Using a synthetic heteropolymeric RNA template with dideoxycytidine at its 3'-end, we examined de novo initiation and primer extension in a system devoid of self-priming and terminal nucleotide transferase activities. Products predominantly of template size and its multiples were detected. High concentrations of nucleoside triphosphates (K-m(app) similar to 100 - 400 mu M) corresponding to the first three incorporated nucleotides were found to be required for efficient de novo RNA synthesis. In the presence of initiating di- or trinucleotides, however, the amount of NTP needed to achieve maximal activity dropped 10(3)- to 10(4)-fold, revealing a much reduced nucleotide requirement for elongation (K-m(app) similar to 0.03-0.09 mu M). Accordingly, single round extension from an exogenous primer following preincubation of the enzyme with template and primer could also be supported by <0.1 mu M levels of NTP. De novo synthesis at high NTP concentrations was shown to be preferred over primer extension. On a dideoxycytidine-blocked synthetic RNA template derived from the 3'-end of the HCV(-)UTR, the addition of the corresponding initiating trinucleotide also dramatically reduced the NTP levels needed to achieve efficient RNA synthesis. Thus, distinct nucleotide requirements exist for initiation and elongation steps catalyzed by the HCV NS5B polymerase.	[Ferrari, Eric; He, Zhiqing; Palermo, Robert E.; Huang, H. -C.] Schering Plough Res Inst, Dept Virol, Kenilworth, NJ 07033 USA	Merck & Company; Schering-Plough Research Institute	Huang, HC (corresponding author), Schering Plough Res Inst, Dept Virol, K15-4945,2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	hsueh-cheng.huang@spcorp.com						Ali N, 2002, J VIROL, V76, P12001, DOI 10.1128/JVI.76.23.12001-12007.2002; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Arnold JJ, 1999, J BIOL CHEM, V274, P2706, DOI 10.1074/jbc.274.5.2706; Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Cai ZH, 2005, J VIROL, V79, P11607, DOI 10.1128/JVI.79.18.11607-11617.2005; Carroll S. S., 2006, Infectious Disorders - Drug Targets, V6, P17, DOI 10.2174/187152606776056698; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Cheng CP, 2003, J VIROL, V77, P12033, DOI 10.1128/JVI.77.22.12033-12047.2003; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; Hardy RW, 2003, J VIROL, V77, P2029, DOI 10.1128/JVI.77.3.2029-2037.2003; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; Jia YP, 1997, J BIOL CHEM, V272, P30147, DOI 10.1074/jbc.272.48.30147; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; Kim MJ, 2000, J VIROL, V74, P10312, DOI 10.1128/JVI.74.22.10312-10322.2000; Kim MJ, 2001, P NATL ACAD SCI USA, V98, P4972, DOI 10.1073/pnas.081077198; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lai VCH, 2003, J VIROL, V77, P2295, DOI 10.1128/JVI.77.3.2295-2300.2003; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1998, VIROLOGY, V249, P108, DOI 10.1006/viro.1998.9311; Lohmann V, 1999, J BIOL CHEM, V274, P10807, DOI 10.1074/jbc.274.16.10807; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Nelson HB, 2006, J VIROL, V80, P1181, DOI 10.1128/JVI.80.3.1181-1190.2006; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; Ranjith-Kumar CT, 2001, J VIROL, V75, P8615, DOI 10.1128/JVI.75.18.8615-8623.2001; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Shim JH, 2002, J VIROL, V76, P7030, DOI 10.1128/JVI.76.14.7030-7039.2002; Tomei L, 2000, J GEN VIROL, V81, P759, DOI 10.1099/0022-1317-81-3-759; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vo NV, 2004, BIOCHEMISTRY-US, V43, P10579, DOI 10.1021/bi049773g; Vreede FT, 2008, J VIROL, V82, P6902, DOI 10.1128/JVI.00627-08; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	54	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33893	33901		10.1074/jbc.M803094200	http://dx.doi.org/10.1074/jbc.M803094200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840605	hybrid, Green Published			2022-12-25	WOS:000261277700015
J	Jayakumar, AR; Liu, ML; Moriyama, M; Ramakrishnan, R; Forbush, B; Reddy, PVB; Norenberg, MD				Jayakumar, Arumugam R.; Liu, Mingli; Moriyama, Mitsuaki; Ramakrishnan, Ramugounder; Forbush, Bliss, III; Reddy, Pichili V. B.; Norenberg, Michael D.			Na-K-Cl Cotransporter-1 in the Mechanism of Ammonia-induced Astrocyte Swelling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; ION-TRANSPORT; NA+-K+-2CL(-) COTRANSPORTER; HEPATIC-ENCEPHALOPATHY; PRIMARY CULTURES; BENZODIAZEPINE-RECEPTOR; GLUTAMATE TRANSPORTER; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; TYROSINE KINASE	Brain edema and the consequent increase in intracranial pressure and brain herniation are major complications of acute liver failure (fulminant hepatic failure) and a major cause of death in this condition. Ammonia has been strongly implicated as an important factor, and astrocyte swelling appears to be primarily responsible for the edema. Ammonia is known to cause cell swelling in cultured astrocytes, although the means by which this occurs has not been fully elucidated. A disturbance in one or more of these systems may result in loss of ion homeostasis and cell swelling. In particular, activation of the Na-K-Cl cotransporter (NKCC1) has been shown to be involved in cell swelling in several neurological disorders. We therefore examined the effect of ammonia on NKCC activity and its potential role in the swelling of astrocytes. Cultured astrocytes were exposed to ammonia (NH4Cl; 5 mM), and NKCC activity was measured. Ammonia increased NKCC activity at 24 h. Inhibition of this activity by bumetanide diminished ammonia-induced astrocyte swelling. Ammonia also increased total as well as phosphorylated NKCC1. Treatment with cyclohexamide, a potent inhibitor of protein synthesis, diminished NKCC1 protein expression and NKCC activity. Since ammonia is known to induce oxidative/nitrosative stress, and antioxidants and nitric-oxide synthase inhibition diminish astrocyte swelling, we also examined whether ammonia caused oxidation and/or nitration of NKCC1. Cultures exposed to ammonia increased the state of oxidation and nitration of NKCC1, whereas the antioxidants N-nitro-L-arginine methyl ester and uric acid all significantly diminished NKCC activity. These agents also reduced phosphorylated NKCC1 expression. These results suggest that activation of NKCC1 is an important factor in the mediation of astrocyte swelling by ammonia and that such activation appears to be mediated by NKCC1 abundance as well as by its oxidation/nitration and phosphorylation.	[Jayakumar, Arumugam R.; Liu, Mingli; Moriyama, Mitsuaki; Ramakrishnan, Ramugounder; Reddy, Pichili V. B.; Norenberg, Michael D.] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33101 USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA; [Norenberg, Michael D.] Vet Affairs Med Ctr, Miami, FL 33101 USA; [Moriyama, Mitsuaki] Osaka Prefecture Univ, Lab Integrat Physiol Vet Sci, Osaka 5998531, Japan; [Forbush, Bliss, III] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	University of Miami; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); Osaka Metropolitan University; Yale University	Norenberg, MD (corresponding author), Univ Miami, Sch Med, Dept Pathol D33, POB 016960, Miami, FL 33101 USA.	mnorenbe@med.miami.edu	Rajadas, Jayakumar/AHC-0630-2022	Moriyama, Mitsuaki/0000-0001-8123-8835	National Institutes of Health [DK063311]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK063311. This work was also supported by a Merit Review from the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbruscato TJ, 2004, J PHARMACOL EXP THER, V310, P459, DOI 10.1124/jpet.104.066274; Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Bender AS, 1996, NEUROCHEM RES, V21, P567, DOI 10.1007/BF02527755; Bender AS, 1998, J NEUROSCI RES, V54, P673, DOI 10.1002/(SICI)1097-4547(19981201)54:5<673::AID-JNR12>3.3.CO;2-G; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Chin SS, 1999, CURR EYE RES, V18, P254, DOI 10.1076/ceyr.18.4.254.5359; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; DUCIS I, 1990, BRAIN RES, V531, P318, DOI 10.1016/0006-8993(90)90793-B; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V271, pF619, DOI 10.1152/ajprenal.1996.271.3.F619; ELLIOTT SJ, 1992, AM J PHYSIOL, V263, pH96, DOI 10.1152/ajpheart.1992.263.1.H96; GREGORIOS JB, 1985, J NEUROPATH EXP NEUR, V44, P404, DOI 10.1097/00005072-198507000-00004; GREGORIOS JB, 1985, J NEUROPATH EXP NEUR, V44, P397, DOI 10.1097/00005072-198507000-00003; HAAS M, 1994, AM J PHYSIOL-CELL PH, V267, pC869, DOI 10.1152/ajpcell.1994.267.4.C869; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; HANSSON E, 1986, NEUROCHEM RES, V11, P759, DOI 10.1007/BF00965202; Hazell AS, 1999, P SOC EXP BIOL MED, V222, P99, DOI 10.1046/j.1525-1373.1999.d01-120.x; Hertz L, 1994, HDB NEUROCHEMISTRY, P603; Hoffmann EK, 1995, INT REV CYTOL, V161, P173; Isaacks RE, 1999, NEUROCHEM RES, V24, P51, DOI 10.1023/A:1020928029845; ITZHAK Y, 1994, NEUROSCI LETT, V177, P35, DOI 10.1016/0304-3940(94)90038-8; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; Juncos R, 2005, AM J PHYSIOL-RENAL, V288, pF982, DOI 10.1152/ajprenal.00348.2004; JUURLINK BHJ, 1985, DEV NEUROSCI-BASEL, V7, P263, DOI 10.1159/000112295; Kaplan MR, 1996, ANNU REV PHYSIOL, V58, P649, DOI 10.1146/annurev.ph.58.030196.003245; KIMELBERG HK, 1983, CELL MOL NEUROBIOL, V3, P1, DOI 10.1007/BF00734994; KIMELBERG HK, 1985, BRAIN RES, V361, P125, DOI 10.1016/0006-8993(85)91282-X; KIMELBERG HK, 1987, J PHYSIOL-PARIS, V82, P294; Kintner DB, 2007, AM J PHYSIOL-CELL PH, V292, pC1113, DOI 10.1152/ajpcell.00412.2006; Kintner DB, 2007, FRONT BIOSCI-LANDMRK, V12, P762, DOI 10.2741/2099; KLETZIEN RF, 1975, ANAL BIOCHEM, V68, P537, DOI 10.1016/0003-2697(75)90649-1; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; LYTLE C, 1992, J BIOL CHEM, V267, P25438; MacMillan-Crow LA, 2000, ARCH BIOCHEM BIOPHYS, V377, P350, DOI 10.1006/abbi.2000.1799; MacVicar BA, 2002, GLIA, V37, P114, DOI 10.1002/glia.10023; Mallozzi C, 2001, FEBS LETT, V503, P189, DOI 10.1016/S0014-5793(01)02726-0; MARTINEZ A, 1968, ACTA NEUROPATHOL, V11, P82, DOI 10.1007/BF00692797; Mobasheri A, 1998, HISTOL HISTOPATHOL, V13, P893, DOI 10.14670/HH-13.893; Murthy CRK, 2001, J NEUROSCI RES, V66, P282, DOI 10.1002/jnr.1222; Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883; Norenberg MD, 2007, METAB BRAIN DIS, V22, P219, DOI 10.1007/s11011-007-9062-5; NORENBERG MD, 1990, J NEUROPATH EXP NEUR, V49, P399, DOI 10.1097/00005072-199007000-00004; Norenberg MD, 1996, SEMIN LIVER DIS, V16, P245, DOI 10.1055/s-2007-1007237; Norenberg MD, 2004, METAB BRAIN DIS, V19, P313, DOI 10.1023/B:MEBR.0000043978.91675.79; Norenberg MD, 1997, GLIA, V21, P124; NORENBERG MD, 1991, NEUROCHEM RES, V16, P833, DOI 10.1007/BF00965694; Norenberg MD, 2003, HEPATOLOGY, V37, P245, DOI 10.1053/jhep.2003.50087; Norenberg MD, 1998, METAB BRAIN DIS, V13, P319, DOI 10.1023/A:1020688925901; NORENBERG MD, 1977, LAB INVEST, V36, P618; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; NORENBERG MD, 1987, NEUROCHEM PATHOL, V6, P13, DOI 10.1007/BF02833599; NORENBERG MD, 2001, ASTROCYTES AGING BRA, P477; O'Neill WC, 1999, AM J PHYSIOL-CELL PH, V276, pC995, DOI 10.1152/ajpcell.1999.276.5.C995; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Pichili VBR, 2007, GLIA, V55, P801, DOI 10.1002/glia.20499; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Rao KVR, 2003, J NEUROSCI RES, V74, P891, DOI 10.1002/jnr.10755; Rose CR, 1996, J PHYSIOL-LONDON, V491, P291, DOI 10.1113/jphysiol.1996.sp021216; Rose CR, 1998, J NEUROSCI, V18, P3554; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schomberg SL, 2003, J NEUROPHYSIOL, V89, P159, DOI 10.1152/jn.00229.2002; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; STAUB F, 1994, J NEUROTRAUM, V11, P679, DOI 10.1089/neu.1994.11.679; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1136, DOI 10.1152/ajpcell.00478.2001; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1147, DOI 10.1152/ajpcell.00538.2001; Su G, 2000, AM J PHYSIOL-CELL PH, V279, pC1710; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939, DOI 10.1152/jn.1999.81.4.1939; SWAIN M, 1992, HEPATOLOGY, V15, P449, DOI 10.1002/hep.1840150316; TAS PWL, 1987, BIOCHIM BIOPHYS ACTA, V903, P411, DOI 10.1016/0005-2736(87)90047-2; TAS PWL, 1986, NEUROSCI LETT, V70, P369, DOI 10.1016/0304-3940(86)90581-1; TRABER P, 1989, GASTROENTEROLOGY, V96, P885; Vaquero Javier, 2003, Ann Hepatol, V2, P12; WALZ W, 1992, CAN J PHYSIOL PHARM, V70, pS260, DOI 10.1139/y92-270; XIE YX, 1994, BRAIN RES, V652, P216, DOI 10.1016/0006-8993(94)90230-5; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Yan YP, 2001, BRAIN RES, V911, P43, DOI 10.1016/S0006-8993(01)02649-X; Zhou BG, 1999, NEUROSCI LETT, V276, P145, DOI 10.1016/S0304-3940(99)00816-2	84	99	108	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33874	33882		10.1074/jbc.M804016200	http://dx.doi.org/10.1074/jbc.M804016200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18849345	Green Published, hybrid			2022-12-25	WOS:000261277700012
J	Juarez, O; Nilges, MJ; Gillespie, P; Cotton, J; Barquera, B				Juarez, Oscar; Nilges, Mark J.; Gillespie, Portia; Cotton, Jennifer; Barquera, Blanca			Riboflavin Is an Active Redox Cofactor in the Na+-pumping NADH: Quinone Oxidoreductase (Na+-NQR) from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; REDUCTASE; FLAVIN; MUTAGENESIS; SUBUNITS; PURIFICATION; BINDING; ENDOR; SITE	Here we present new evidence that riboflavin is present as one of four flavins in Na+-NQR. In particular, we present conclusive evidence that the source of the neutral radical is not one of the FMNs and that riboflavin is the center that gives rise to the neutral flavosemiquinone. The riboflavin is a bona fide redox cofactor and is likely to be the last redox carrier of the enzyme, from which electrons are donated to quinone. We have constructed a double mutant that lacks both covalently bound FMN cofactors (NqrB-T236Y/NqrC-T225Y) and have studied this mutant together with the two single mutants (NqrB-T236Y and NqrC-T225Y) and a mutant that lacks the noncovalently bound FAD in NqrF (NqrF-S246A). The double mutant contains riboflavin and FAD in a 0.6:1 ratio, as the only flavins in the enzyme; noncovalently bound flavins were detected. In the oxidized form, the double mutant exhibits an EPR signal consistent with a neutral flavosemiquinone radical, which is abolished on reduction of the enzyme. The same radical can be observed in the FAD deletion mutant. Furthermore, when the oxidized enzyme reacts with ubiquinol (the reduced form of the usual electron acceptor) in a process that reverses the physiological direction of the electron flow, a single kinetic phase is observed. The kinetic difference spectrum of this process is consistent with one-electron reduction of a neutral flavosemiquinone. The presence of riboflavin in the role of a redox cofactor is thus far unique to Na+-NQR.	[Juarez, Oscar; Gillespie, Portia; Cotton, Jennifer; Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Juarez, Oscar; Gillespie, Portia; Cotton, Jennifer; Barquera, Blanca] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Nilges, Mark J.] Univ Illinois, Illinois EPR Res Ctr, Urbana, IL 61801 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Illinois System; University of Illinois Urbana-Champaign	Barquera, B (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Rm 2239,110 8 St, Troy, NY 12180 USA.	barqub@rpi.edu		Cotton, Jennifer/0000-0003-0106-1801; Juarez, Oscar/0000-0002-2915-8413	National Institutes of Health [R01GM 069936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM 069936. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Bogachev AV, 2007, BIOCHEMISTRY-US, V46, P10186, DOI 10.1021/bi700440w; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Duran-Pinedo AE, 2007, MOL MICROBIOL, V64, P1061, DOI 10.1111/j.1365-2958.2007.05717.x; Fadeeva MS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P123, DOI 10.1134/S0006297908020028; Fadeeva MS, 2008, FEMS MICROBIOL LETT, V279, P116, DOI 10.1111/j.1574-6968.2007.01015.x; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; Kay CWM, 1999, BIOCHEMISTRY-US, V38, P16740, DOI 10.1021/bi991442u; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Tao ML, 2006, ACTA CRYSTALLOGR F, V62, P110, DOI 10.1107/S174430910504306X; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697	25	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33162	33167		10.1074/jbc.M806913200	http://dx.doi.org/10.1074/jbc.M806913200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832377	Green Published, hybrid			2022-12-25	WOS:000261183700018
J	Park, E; Lee, JW; Eom, SH; Seol, JH; Chung, CH				Park, Eunyong; Lee, Jung Wook; Eom, Soo Hyun; Seol, Jae Hong; Chung, Chin Ha			Binding of MG132 or Deletion of the Thr Active Sites in HslV Subunits Increases the Affinity of HslV Protease for HslU ATPase and Makes This Interaction Nucleotide-independent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HOMOLOG; DEPENDENT PROTEASE; 20S PROTEASOME; EUKARYOTIC PROTEASOME; PROTEOLYTIC ACTIVITY; CRYSTAL-STRUCTURE; DEGRADATION; COMPLEX; HSIU; INHIBITORS	HslVU is an ATP-dependent protease in bacteria consisting of HslV dodecamer and HslU hexamer. Upon ATP binding, HslU ATPase allosterically activates the catalytic function of HslV protease by 1-2 orders of magnitude. However, relatively little is known about the role of HslV in the control of HslU function. Here we describe the involvement of the N-terminal Thr active sites (Thr-1) of HslV in the communication between HslV and HslU. Binding of proteasome inhibitors to Thr-1 led to a dramatic increase in the interaction between HslV and HslU with a marked increase in ATP hydrolysis by HslU. Moreover, carbobenzoxyleucyl-leucyl-leucinal (MG132) could bind to Thr-1 of free HslV, and this binding induced a tight interaction between HslV and HslU with the activation of HslU ATPase, suggesting that substrate-bound HslV can allosterically regulate HslU function. Unexpectedly, the deletion of Thr-1 also caused a dramatic increase in the affinity between HslV and HslU even in the absence of ATP. Furthermore, the increase in the number of the Thr-1 deletion mutant subunit in place of HslV subunit in a dodecamer led to a proportional increase in the affinity between HslV and HslU with gradual activation of HslU ATPase. Although the molecular mechanism elucidating how the Thr-1 deletion influences the interaction between HslV and HslU remains unknown, these results suggest an additional allosteric mechanism for the control of HslU function by HslV. Taken together, our findings indicate a critical involvement of Thr-1 of HslV in the reciprocal control of HslU function and, thus, for their communication.	[Park, Eunyong; Lee, Jung Wook; Seol, Jae Hong; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Eom, Soo Hyun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST)	Seol, JH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	jhseol@snu.ac.kr; chchung@snu.ac.kr			Korea Research Foundation [KRF-2005-084]; Korea Science and Engineering Foundation [M10533010001]; BK21 Program	Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); BK21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by grants from the Korea Research Foundation Grant KRF-2005-084 and Korea Science and Engineering Foundation Grant M10533010001. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; These two authors were recipients of a fellowship from the BK21 Program and contributed equally to this work.	Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Huang HC, 1997, J BIOL CHEM, V272, P21364, DOI 10.1074/jbc.272.34.21364; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kwon AR, 2003, J MOL BIOL, V330, P185, DOI 10.1016/S0022-2836(03)00580-1; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; Neuwald AF, 1999, GENOME RES, V9, P27; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Seemuller E, 1996, NATURE, V382, P468, DOI 10.1038/382468a0; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yoo SJ, 1997, FEBS LETT, V412, P57, DOI 10.1016/S0014-5793(97)00742-4; Yoo SJ, 1997, BIOCHEM BIOPH RES CO, V238, P581, DOI 10.1006/bbrc.1997.7341; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035	37	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33258	33266		10.1074/jbc.M805411200	http://dx.doi.org/10.1074/jbc.M805411200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838376	Green Published, hybrid			2022-12-25	WOS:000261183700029
J	Guimaraes, AJ; Hamilton, AJ; Guedes, HLD; Nosanchuk, JD; Zancope-Oliveira, RM				Guimaraes, Allan Jefferson; Hamilton, Andrew John; Guedes, Herbert Leonel de M.; Nosanchuk, Joshua Daniel; Zancope-Oliveira, Rosely Maria			Biological Function and Molecular Mapping of M Antigen in Yeast Phase of Histoplasma capsulatum	PLOS ONE			English	Article								Histoplasmosis, due to the intracellular fungus Histoplasma capsulatum, can be diagnosed by demonstrating the presence of antibodies specific to the immunodominant M antigen. However, the role of this protein in the pathogenesis of histoplasmosis has not been elucidated. We sought to structurally and immunologically characterize the protein, determine yeast cell surface expression, and confirm catalase activity. A 3D-rendering of the M antigen by homology modeling revealed that the structures and domains closely resemble characterized fungal catalases. We generated monoclonal antibodies (mAbs) to the protein and determined that the M antigen is present on the yeast cell surface and in cell wall/cell membrane preparations. Similarly, we found that the majority of catalase activity was in extracts containing fungal surface antigens and that the M antigen is not significantly secreted by live yeast cells. The mAbs also identified unique epitopes on the M antigen. The localization of the M antigen to the cell surface of H. capsulatum yeast and the characterization of the protein's major epitopes have important implications since it demonstrates that although the protein may participate in protecting the fungus against oxidative stress it is also accessible to host immune cells and antibody.	[Guimaraes, Allan Jefferson; Nosanchuk, Joshua Daniel] Yeshiva Univ, Albert Einstein Coll Med, Dept Med & Microbiol & Immunol, Div Infect Dis, Bronx, NY USA; [Guimaraes, Allan Jefferson; Guedes, Herbert Leonel de M.; Zancope-Oliveira, Rosely Maria] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Setor Imunodiagnost, Lab Micol, Rio De Janeiro, Brazil; [Hamilton, Andrew John] Kings Coll London, Guys Hosp, St Johns Inst Dermatol, London, England; [Guedes, Herbert Leonel de M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Bioquim Proteinas Peptideos, Rio De Janeiro, Brazil	Yeshiva University; Albert Einstein College of Medicine; Fundacao Oswaldo Cruz; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Fundacao Oswaldo Cruz	Guimaraes, AJ (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Med & Microbiol & Immunol, Div Infect Dis, Bronx, NY USA.	nosanchu@aecom.yu.edu	Guimaraes, Allan J/E-2160-2014; Guimaraes, Allan/AAQ-2343-2020; de Matos Guedes, Herbert L/K-6191-2014; Nosanchuk, Joshua/AAS-7801-2021; Zancope-Oliveira, Rosely/I-1955-2013	Guimaraes, Allan J/0000-0002-2856-9667; Guimaraes, Allan/0000-0002-2856-9667; de Matos Guedes, Herbert L/0000-0002-3819-3069; 	Wellcome Trust [061158/Z/00/JC/KO]; CNPq [476055/2003-2, 306288/2006-0]; FAPERJ [E-26/170.308/2002]; NIH [D43-TW007129, AI52733, AI056070-01A2, AI-51519]; Fogarty International Center; Center for AIDS Research at the Albert Einstein College of Medicine; Montefiore Medical Center; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733, P30AI051519, R01AI056070] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center for AIDS Research at the Albert Einstein College of Medicine; Montefiore Medical Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The Wellcome Trust 061158/Z/00/JC/KO, CNPq 476055/2003-2, and FAPERJ E-26/170.308/2002. A.J.G. was supported in part by an Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH D43-TW007129). J.D.N. is supported in part by NIH AI52733 and AI056070-01A2, and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center (NIH AI-51519). R.M.Z.O. is in part supported by CNPq 306288/2006-0.	ALBUQUERQUE PC, 2003, AN 22 C BRAS MICR 22, P86; Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Allendoerfer R, 1997, J INFECT DIS, V175, P905, DOI 10.1086/513989; Bai ZH, 2003, CRIT REV BIOTECHNOL, V23, P267, DOI 10.1080/07388550390449294; Bleau G, 1998, ANAL BIOCHEM, V263, P13, DOI 10.1006/abio.1998.2801; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calera JA, 1997, INFECT IMMUN, V65, P4718, DOI 10.1128/IAI.65.11.4718-4724.1997; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; DEEPE GS, 1995, INFECT IMMUN, V63, P3151, DOI 10.1128/IAI.63.8.3151-3157.1995; DEEPE GS, 1994, J LAB CLIN MED, V123, P201; DISALVO AF, 1980, J CLIN MICROBIOL, V11, P238, DOI 10.1128/JCM.11.3.238-241.1980; EISSENBERG LG, 1991, CLIN MICROBIOL REV, V4, P411, DOI 10.1128/CMR.4.4.411-421.1991; Garre V, 1998, PHYTOPATHOLOGY, V88, P744, DOI 10.1094/PHYTO.1998.88.8.744; GAUTMAN DK, 2005, APOPTOSIS, V11, P39; Gomez BL, 1997, J CLIN MICROBIOL, V35, P2618, DOI 10.1128/JCM.35.10.2618-2622.1997; GOMEZ FJ, 1991, INFECT IMMUN, V59, P4459, DOI 10.1128/IAI.59.12.4459-4464.1991; Guedes HLD, 2003, J CLIN MICROBIOL, V41, P535, DOI 10.1128/JCM.41.2.535-539.2003; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guimaraes AJ, 2004, J MED MICROBIOL, V53, P509, DOI 10.1099/jmm.0.05469-0; Guimaraes AJ, 2005, 105 GEN M AM SOC MIC; Guimaraes AJ, 2006, BRAZ J MICROBIOL, V37, P1, DOI 10.1590/S1517-83822006000100001; HAMILTON AJ, 1990, T ROY SOC TROP MED H, V84, P425, DOI 10.1016/0035-9203(90)90347-H; Hamilton AJ, 1998, MED MYCOL, V36, P351, DOI 10.1046/j.1365-280X.1998.00174.x; HAMILTON AJ, 1990, J GEN MICROBIOL, V136, P331, DOI 10.1099/00221287-136-2-331; HAMILTON AJ, 1990, J MED VET MYCOL, V28, P479; HOWARD DH, 1983, INFECT IMMUN, V39, P1161, DOI 10.1128/IAI.39.3.1161-1166.1983; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Johnson CH, 2002, MICROBIOL-SGM, V148, P1129, DOI 10.1099/00221287-148-4-1129; KAUFMAN L, 1992, CLIN INFECT DIS, V14, pS23, DOI 10.1093/clinids/14.Supplement_1.S23; KAUFMAN L, 1983, MYCOPATHOLOGIA, V82, P3, DOI 10.1007/BF00436938; KAUFMAN L, 1987, ANNU REV MICROBIOL, V41, P209, DOI 10.1146/annurev.mi.41.100187.001233; Kim KA, 2000, INFECT IMMUN, V68, P3861, DOI 10.1128/IAI.68.7.3861-3866.2000; KLITE PD, 1965, J LAB CLIN MED, V66, P770; Klotz MG, 1997, MOL BIOL EVOL, V14, P951, DOI 10.1093/oxfordjournals.molbev.a025838; KUMAR S, 2008, BRIEF BIOINFORM; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li Yi, 2007, J Biomol Tech, V18, P185; MARESCA B, 1989, MICROBIOL REV, V53, P186, DOI 10.1128/MMBR.53.2.186-209.1989; Mate MJ, 1999, J BIOL CHEM, V274, P27717, DOI 10.1074/jbc.274.39.27717; MEDOFF G, 1987, INFECT IMMUN, V55, P1355, DOI 10.1128/IAI.55.6.1355-1358.1987; Moreira SFI, 2004, YEAST, V21, P173, DOI 10.1002/yea.1077; MURSHUDOV G, 2006, PDB DATA BANK; Nakagawa Y, 2003, MICROBIOL IMMUNOL, V47, P395, DOI 10.1111/j.1348-0421.2003.tb03376.x; NETTO C F, 1955, Arq Cir Clin Exp, V18, P197; Nosanchuk JD, 2003, J CLIN INVEST, V112, P1164, DOI [10.1172/JCI200319361, 10.1172/JCI19361]; Paris S, 2003, INFECT IMMUN, V71, P3551, DOI 10.1128/IAI.71.6.3551-3562.2003; Pizzini CV, 1999, CLIN DIAGN LAB IMMUN, V6, P20, DOI 10.1128/CDLI.6.1.20-23.1999; Pongpom P, 2005, MED MYCOL, V43, P403, DOI 10.1080/13693780400007144; Reiss E, 2000, MED MYCOL, V38, P147, DOI 10.1080/mmy.38.s1.147.159; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; SCOTT EN, 1989, J CLIN MICROBIOL, V27, P300, DOI 10.1128/JCM.27.2.300-304.1989; SELS AA, 1980, EUR J BIOCHEM, V112, P283, DOI 10.1111/j.1432-1033.1980.tb07204.x; Sestero CM, 2006, MYCOPATHOLOGIA, V162, P33, DOI 10.1007/s11046-006-0028-7; Skamnioti P, 2007, MOL PLANT MICROBE IN, V20, P568, DOI 10.1094/MPMI-20-5-0568; STANDARD PG, 1976, J CLIN MICROBIOL, V3, P191; WHEAT J, 1986, J CLIN MICROBIOL, V23, P493, DOI 10.1128/JCM.23.3.493-499.1986; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3; Zancope-Oliveira RM, 1999, INFECT IMMUN, V67, P1947; ZANCOPEOLIVEIRA RM, 1993, J MED VET MYCOL, V31, P29; ZANCOPEOLIVEIRA RM, 1994, CLIN DIAGN LAB IMMUN, V1, P563; ZANCOPEOLIVEIRA RM, 1994, CLIN DIAGN LAB IMMUN, V1, P390	63	35	35	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3449	10.1371/journal.pone.0003449	http://dx.doi.org/10.1371/journal.pone.0003449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927619	Green Published, gold			2022-12-25	WOS:000265122400014
J	Tsuruda, JM; Amdam, GV; Page, RE				Tsuruda, Jennifer M.; Amdam, Gro V.; Page, Robert E., Jr.			Sensory Response System of Social Behavior Tied to Female Reproductive Traits	PLOS ONE			English	Article							COLONY-LEVEL SELECTION; DIVISION-OF-LABOR; HONEY-BEES; FORAGING BEHAVIOR; WORKER STERILITY; JUVENILE-HORMONE; SUCROSE RESPONSIVENESS; VITELLOGENIN; THRESHOLDS; INSECT	Background: Honey bees display a complex set of anatomical, physiological, and behavioral traits that correlate with the colony storage of surplus pollen ( pollen hoarding). We hypothesize that the association of these traits is a result of pleiotropy in a gene signaling network that was co-opted by natural selection to function in worker division of labor and foraging specialization. By acting on the gene network, selection can change a suite of traits, including stimulus/response relationships that affect individual foraging behavior and alter the colony level trait of pollen hoarding. The 'pollen-hoarding syndrome' of honey bees is the best documented syndrome of insect social organization. It can be exemplified as a link between reproductive anatomy ( ovary size), physiology ( yolk protein level), and foraging behavior in honey bee strains selected for pollen hoarding, a colony level trait. The syndrome gave rise to the forager-Reproductive Ground Plan Hypothesis (RGPH), which proposes that the regulatory control of foraging onset and foraging preference toward nectar or pollen was derived from a reproductive signaling network. This view was recently challenged. To resolve the controversy, we tested the associations between reproductive anatomy, physiology, and stimulus/response relationships of behavior in wild-type honey bees. Methodology/Principal Findings: Central to the stimulus/response relationships of honey bee foraging behavior and pollen hoarding is the behavioral trait of sensory sensitivity to sucrose (an important sugar in nectar). To test the linkage of reproductive traits and sensory response systems of social behavior, we measured sucrose responsiveness with the proboscis extension response (PER) assay and quantified ovary size and vitellogenin ( yolk precursor) gene expression in 6-7day-old bees by counting ovarioles (ovary filaments) and by using semiquantitative real time RT-PCR. We show that bees with larger ovaries (more ovarioles) are characterized by higher levels of vitellogenin mRNA expression and are more responsive to sucrose solutions, a trait that is central to division of labor and foraging specialization. Conclusions/Significance: Our results establish that in wild-type honey bees, ovary size and vitellogenin mRNA level covary with the sucrose sensory response system, an important component of foraging behavior. This finding validates links between reproductive physiology and behavioral-trait associations of the pollen-hoarding syndrome of honey bees, and supports the forager-RGPH. Our data address a current evolutionary debate, and represent the first direct demonstration of the links between reproductive anatomy, physiology, and behavioral response systems that are central to the control of complex social behavior in insects.	[Tsuruda, Jennifer M.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Amdam, Gro V.; Page, Robert E., Jr.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem, Biotechnol & Food Sci, As, Norway	University of California System; University of California Davis; Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences	Tsuruda, JM (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	Gro.Amdam@asu.edu			Norwegian Research Council [175413, 180504, 185306]; US National Science Foundation [0615502]; PEW Foundation; National Institute on Aging [P01 AG22500]; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); US National Science Foundation(National Science Foundation (NSF)); PEW Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support to GVA was provided by the Norwegian Research Council (175413, 180504 and 185306), the U. S. National Science Foundation (0615502), and the PEW Foundation. The National Institute on Aging (NIA P01 AG22500) provided support to REP.	Amdam GV, 2007, AM NAT, V170, P37, DOI 10.1086/518183; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; AMDAM GV, 2008, BRAIN BEHAV IN PRESS; Atchley DPD, 2005, PHYSIOL BEHAV, V86, P265, DOI 10.1016/j.physbeh.2005.08.001; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Calderone NW, 1996, ANIM BEHAV, V51, P631, DOI 10.1006/anbe.1996.0068; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Engels W., 1990, Advances in Invertebrate Reproduction, V5, P495; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Humphries MA, 2003, J COMP PHYSIOL A, V189, P555, DOI 10.1007/s00359-003-0433-z; JAYCOX ER, 1974, ANN ENTOMOL SOC AM, V67, P529, DOI 10.1093/aesa/67.4.529; KLOWDEN MJ, 1990, EXPERIENTIA, V46, P660, DOI 10.1007/BF01939928; MAGNARELLI LA, 1978, J MED ENTOMOL, V14, P527, DOI 10.1093/jmedent/14.5.527; Montague CE, 1998, EVOLUTION, V52, P1408, DOI 10.1111/j.1558-5646.1998.tb02022.x; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Oldroyd BP, 1999, P ROY SOC B-BIOL SCI, V266, P1335, DOI 10.1098/rspb.1999.0784; Oldroyd BP, 1999, P ROY SOC B-BIOL SCI, V266, P1875, DOI 10.1098/rspb.1999.0860; OXLEY PR, 2008, GENETICS, V180, P359; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; PAGE RE, 2008, ORG INSECT IN PRESS; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Pankiw T, 2003, BEHAV ECOL SOCIOBIOL, V54, P458, DOI 10.1007/s00265-003-0640-1; Pankiw T, 2004, BEHAV ECOL SOCIOBIOL, V55, P286, DOI 10.1007/s00265-003-0714-0; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; Rueppell O, 2006, GENETICS, V172, P243, DOI 10.1534/genetics.105.046490; Ruppell O, 2004, J HERED, V95, P481, DOI 10.1093/jhered/esh072; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Snodgrass R.E., 1956, ANATOMY HONEY BEE; THAN TT, 1994, PHYSIOL BEHAV, V56, P237, DOI 10.1016/0031-9384(94)90189-9; Thompson GJ, 2006, INSECT MOL BIOL, V15, P637, DOI 10.1111/j.1365-2583.2006.00678.x; West-Eberhard M.J., 1987, P35; West-Eberhard Mary Jane, 1996, P290	41	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3397	10.1371/journal.pone.0003397	http://dx.doi.org/10.1371/journal.pone.0003397			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852894	Green Submitted, gold, Green Published			2022-12-25	WOS:000265121700005
J	Masse, I; Molin, L; Mouchiroud, L; Vanhems, P; Palladino, F; Billaud, M; Solari, F				Masse, Ingrid; Molin, Laurent; Mouchiroud, Laurent; Vanhems, Philippe; Palladino, Francesca; Billaud, Marc; Solari, Florence			A Novel Role for the SMG-1 Kinase in Lifespan and Oxidative Stress Resistance in Caenorhabditis elegans	PLOS ONE			English	Article								The PTEN tumour suppressor encodes a phosphatase, and its daf-18 orthologue in Caenorhabditis elegans negatively regulates the insulin/IGF-1 DAF-2 receptor pathway that influences lifespan in worms and other species. In order to identify new DAF-18 regulated pathways involved in aging, we initiated a candidate RNAi feeding screen for clones that lengthen lifespan. Here, we report that smg-1 inactivation increases average lifespan in a daf-18 dependent manner. Genetic analysis is consistent with SMG-1 acting at least in part in parallel to the canonical DAF-2 receptor pathway, but converging on the transcription factor DAF-16/FOXO. SMG-1 is a serine-threonine kinase which plays a conserved role in nonsense-mediated mRNA decay (NMD) in worms and mammals. In addition, human SMG-1 has also been implicated in the p53-mediated response to genotoxic stress. The effect of smg-1 inactivation on lifespan appears to be unrelated to its NMD function, but requires the p53 tumour suppressor orthologue cep-1. Furthermore, smg-1 inactivation confers a resistance to oxidative stress in a daf-18-, daf-16- and cep-1-dependent manner. We propose that the role of SMG-1 in lifespan regulation is at least partly dependent on its function in oxidative stress resistance. Taken together, our results unveil a novel role for SMG-1 in lifespan regulation.	[Masse, Ingrid; Molin, Laurent; Mouchiroud, Laurent; Billaud, Marc; Solari, Florence] Univ Claude Bernard Lyon 1, CNRS, UMR5201 Domaine Rockefeller, Lab Genet Signalisat Canc, Lyon, France; [Vanhems, Philippe] Univ Lyon 1, CNRS, UMR 5558, Lab Biomet Biol Evol, Lyon, France; [Palladino, Francesca] CNRS, UMR5161, Ecole Normale Superieure Lyon, Lab Biol Mol Cellule, Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet	Masse, I (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, INRA,CNRS,UMR5242, F-69365 Lyon, France.	Marc.Billaud@univ-lyon1.fr; florence.solari@recherche.univ-lyon1.fr	Billaud, Marc N/M-6954-2013; Solari, Florence/G-8907-2017	Solari, Florence/0000-0002-4173-8314; MASSE, Ingrid/0000-0003-3193-970X	CNRS; la Ligue Nationale Contre le Cancer; Region Rhone-Alpes [fellowship]; French Ministry of Research [fellowship]	CNRS(Centre National de la Recherche Scientifique (CNRS)); la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by grants from CNRS and la Ligue Nationale Contre le Cancer. I.M. and L.M. were recipients of a fellowship from the Region Rhone-Alpes and from the French Ministry of Research, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders KR, 2003, EMBO J, V22, P641, DOI 10.1093/emboj/cdg056; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Arum O, 2007, J GERONTOL A-BIOL, V62, P951, DOI 10.1093/gerona/62.9.951; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Crockett DK, 2005, PROTEOMICS, V5, P1250, DOI 10.1002/pmic.200401046; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; DORMAN JB, 1995, GENETICS, V141, P1399; DUSENBERY DB, 1975, GENETICS, V80, P297; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Garigan D, 2002, GENETICS, V161, P1101; GEHEN SC, 2008, ONCOGENE; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Grimson A, 2004, MOL CELL BIOL, V24, P7483, DOI 10.1128/MCB.24.17.7483-7490.2004; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; HODGKIN J, 1989, GENETICS, V123, P301; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Oliveira V, 2008, J BIOL CHEM, V283, P13174, DOI 10.1074/jbc.M708008200; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Solari F, 2005, ONCOGENE, V24, P20, DOI 10.1038/sj.onc.1207978; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	43	44	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3354	10.1371/journal.pone.0003354	http://dx.doi.org/10.1371/journal.pone.0003354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836529	Green Submitted, Green Published, gold			2022-12-25	WOS:000265113500010
J	Chalupnikova, K; Lattmann, S; Selak, N; Iwamoto, F; Fujiki, Y; Nagamine, Y				Chalupnikova, Katerina; Lattmann, Simon; Selak, Nives; Iwamoto, Fumiko; Fujiki, Yukio; Nagamine, Yoshikuni			Recruitment of the RNA Helicase RHAU to Stress Granules via a Unique RNA-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CRYSTAL-STRUCTURE; PROCESSING BODIES; TERMINAL DOMAIN; PROTEIN; BOX; TRANSLATION; EXPORT; SITES; PHOSPHORYLATION	In response to environmental stress, the translation machinery of cells is reprogrammed. The majority of actively translated mRNAs are released from polysomes and driven to specific cytoplasmic foci called stress granules (SGs) where dynamic changes in protein-RNA interaction determine the subsequent fate of mRNAs. Here we show that the DEAH box RNA helicase RHAU is a novel SG-associated protein. Although RHAU protein was originally identified as an AU-rich element-associated protein involved in urokinase-type plasminogen activator mRNA decay, it was not clear whether RHAU could directly interact with RNA. We have demonstrated that RHAU physically interacts with RNA in vitro and in vivo through a newly identified N-terminal RNA-binding domain, which was found to be both essential and sufficient for RHAU localization in SGs. We have also shown that the ATPase activity of RHAU plays a role in the RNA interaction and in the regulation of protein retention in SGs. Thus, our results show that RHAU is the fourth RNA helicase detected in SGs, after rck/p54, DDX3, and eIF4A, and that its association with SGs is dynamic and mediated by an RHAU-specific RNA-binding domain.	[Chalupnikova, Katerina; Lattmann, Simon; Selak, Nives; Iwamoto, Fumiko; Nagamine, Yoshikuni] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Fujiki, Yukio] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Friedrich Miescher Institute for Biomedical Research; Novartis; Kyushu University	Nagamine, Y (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	Yoshikuni.nagamine@fmi.ch	Lattmann, Simon/G-2914-2010	Lattmann, Simon/0000-0002-4639-4602	The Science and Technology Agency of Japan	The Science and Technology Agency of Japan(Japan Science & Technology Agency (JST))	This work was supported in part by CREST grant (to Y.F.) from The Science and Technology Agency of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Askjaer P, 2000, J BIOL CHEM, V275, P11561, DOI 10.1074/jbc.275.16.11561; Baguet A, 2007, J CELL SCI, V120, P2774, DOI 10.1242/jcs.009225; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fujimura K, 2008, RNA, V14, P425, DOI 10.1261/rna.780708; Fujimura K, 2008, EXP CELL RES, V314, P543, DOI 10.1016/j.yexcr.2007.10.024; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Jankowsky E, 2000, NUCLEIC ACIDS RES, V28, P333, DOI 10.1093/nar/28.1.333; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; Jeong Euna, 2004, Genome Inform, V15, P105; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schneider S, 2002, J BIOL CHEM, V277, P15452, DOI 10.1074/jbc.M112473200; Schneider S, 2001, J BIOL CHEM, V276, P21184, DOI 10.1074/jbc.M101964200; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tong J, 2008, COMPUT METH PROG BIO, V90, P148, DOI 10.1016/j.cmpb.2007.12.003; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Valgardsdottir R, 2003, J BIOL CHEM, V278, P21146, DOI 10.1074/jbc.M300888200; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Wagner JDO, 1998, EMBO J, V17, P2926, DOI 10.1093/emboj/17.10.2926; Wang Y, 1998, RNA, V4, P1216, DOI 10.1017/S1355838298980992; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692	50	75	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35186	35198		10.1074/jbc.M804857200	http://dx.doi.org/10.1074/jbc.M804857200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18854321	Green Published, hybrid			2022-12-25	WOS:000261469100075
J	Colon-Gonzalez, F; Leskow, FC; Kazanietz, MG				Colon-Gonzalez, Francheska; Leskow, Federico Coluccio; Kazanietz, Marcelo G.			Identification of an Autoinhibitory Mechanism That Restricts C1 Domain-mediated Activation of the Rac-GAP alpha 2-Chimaerin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMALL-MOLECULE INHIBITOR; PHORBOL ESTER RECEPTORS; TYROSINE PHOSPHORYLATION; DIACYLGLYCEROL-BINDING; INDUCED TRANSLOCATION; NIH 3T3-CELLS; BETA-2-CHIMAERIN; GTPASES; FAMILY	Chimaerins are a family of GTPase activating proteins (GAPs) for the small G-protein Rac that have gained recent attention due to their important roles in development, cancer, neurito-genesis, and T-cell function. Like protein kinase C isozymes, chimaerins possess a C1 domain capable of binding phorbol esters and the lipid second messenger diacylglycerol (DAG) in vitro. Here we identified an autoinhibitory mechanism in alpha 2-chimaerin that restricts access of phorbol esters and DAG, thereby limiting its activation. Although phorbol 12-myristate 13-acetate (PMA) caused limited translocation of wild-type alpha 2-chimaerin to the plasma membrane, deletion of either N- or C-terminal regions greatly sensitize alpha 2-chimaerin for intracellular redistribution and activation. Based on modeling analysis that revealed an occlusion of the ligand binding site in the alpha 2-chimaerin C1 domain, we identified key amino acids that stabilize the inactive conformation. Mutation of these sites renders alpha 2-chimaerin hypersensitive to C1 ligands, as reflected by its enhanced ability to translocate in response to PMA and to inhibit Rac activity and cell migration. Notably, in contrast to PMA, epidermal growth factor promotes full translocation of alpha 2-chimaerin in a phospholipase C-dependent manner, but not of a C1 domain mutant with reduced affinity for DAG (P216A-alpha 2-chimaerin). Therefore, DAG generation and binding to the C1 domain are required but not sufficient for epidermal growth factor- induced alpha 2-chimaerin membrane association. Our studies suggest a role for DAG in anchoring rather than activation of alpha 2-chimaerin. Like other DAG/phorbol ester receptors, including protein kinase C isozymes, alpha 2-chimaerin is subject to auto-inhibition by intramolecular contacts, suggesting a highly regulated mechanism for the activation of this Rac-GAP.	[Colon-Gonzalez, Francheska; Kazanietz, Marcelo G.] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA; [Colon-Gonzalez, Francheska; Kazanietz, Marcelo G.] Univ Penn, Sch Med, ITMAT, Philadelphia, PA 19104 USA; [Leskow, Federico Coluccio] Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1053 Buenos Aires, DF, Argentina	University of Pennsylvania; University of Pennsylvania; University of Buenos Aires	Kazanietz, MG (corresponding author), 1256 Bioimed Res Bldg II-III,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu			National Institutes of Health [CA74197]; NATIONAL CANCER INSTITUTE [R01CA074197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA74197 (to M. G. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; ARECES LB, 1994, J BIOL CHEM, V269, P19553; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bogi K, 1999, FEBS LETT, V456, P27, DOI 10.1016/S0014-5793(99)00927-8; Budas GR, 2007, BIOCHEM SOC T, V35, P1021, DOI 10.1042/BST0351021; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Choi SH, 2008, J BIOL CHEM, V283, P10543, DOI 10.1074/jbc.M707463200; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Kai M, 2007, BBA-MOL CELL RES, V1773, P1407, DOI 10.1016/j.bbamcr.2007.05.004; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Leskow FC, 2006, P NATL ACAD SCI USA, V103, P5373, DOI 10.1073/pnas.0508585103; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Menna PL, 2003, CANCER RES, V63, P2284; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; ORR JW, 1994, J BIOL CHEM, V269, P8383; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Schechtman D, 2004, J BIOL CHEM, V279, P15831, DOI 10.1074/jbc.M310696200; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shen N, 2005, BIOCHEMISTRY-US, V44, P1089, DOI 10.1021/bi0476127; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Siliceo M, 2006, J CELL SCI, V119, P141, DOI 10.1242/jcs.02722; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Wang HB, 2002, J BIOL CHEM, V277, P4541, DOI 10.1074/jbc.M107150200; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yasuda S, 2008, BIOCHEM J, V409, P95, DOI 10.1042/BJ20070848	45	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35247	35257		10.1074/jbc.M806264200	http://dx.doi.org/10.1074/jbc.M806264200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18826946	hybrid, Green Published			2022-12-25	WOS:000261469100080
J	Lau, KF; Chan, WM; Perkinton, MS; Tudor, EL; Chang, RCC; Chan, HYE; McLoughlin, DM; Miller, CCJ				Lau, Kwok-Fai; Chan, Wing-Man; Perkinton, Michael S.; Tudor, Elizabeth L.; Chang, Raymond C. C.; Chan, H. -Y. Edwin; McLoughlin, Declan M.; Miller, Christopher C. J.			Dexras1 Interacts with FE65 to Regulate FE65-Amyloid Precursor Protein-dependent Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; GLYCOGEN-SYNTHASE KINASE-3; APP INTRACELLULAR DOMAIN; RAS-RELATED PROTEIN; AMYLOID-BETA; ALZHEIMERS-DISEASE; ADAPTER PROTEIN; PTB DOMAIN; MOUSE MODEL; EXPRESSION	FE65 is an adaptor protein that binds to and forms a transcriptionally active complex with the gamma-secretase-derived amyloid precursor protein (APP) intracellular domain. The regulatory mechanisms of FE65-APP-mediated transcription are still not clear. In this report, we demonstrate that Dexras1, a Ras family small G protein, binds to FE65 PTB2 domain and potently suppresses the FE65-APP-mediated transcription. The suppression is not via competition for binding of FE65 between Dexras1 and APP because the two proteins can simultaneously bind to the FE65 PTB2 domain. Phosphorylation of FE65 tyrosine 547 within the PTB2 domain has been shown to enhance FE65-APP-mediated transcription but not to influence binding to APP. Here we find that this phosphorylation event reduces the binding between Dexras1 and FE65. We also demonstrate that Dexras1 inhibits the FE65-APP-mediated transcription of glycogen synthase kinase 3 beta(GSK3 beta). Moreover, small interfering RNA knockdown of Dexras1 enhances GSK3 beta expression and increases phosphorylation of Tau, a GSK3 beta substrate. Thus, Dexras1 functions as a suppressor of FE65-APP-mediated transcription, and FE65 tyrosine 547 phosphorylation enhances FE65-APP-mediated transcription, at least in part, by modulating the interaction between FE65 and Dexras1. These findings reveal a novel regulatory mechanism for FE65-APP-mediated signaling.	[Lau, Kwok-Fai; Chan, Wing-Man; Chan, H. -Y. Edwin] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China; [Lau, Kwok-Fai; Chan, Wing-Man; Chan, H. -Y. Edwin] Chinese Univ Hong Kong, Mol Biotechnol Programme, Shatin, Hong Kong, Peoples R China; [Perkinton, Michael S.; Tudor, Elizabeth L.; McLoughlin, Declan M.; Miller, Christopher C. J.] Kings Coll London, Inst Psychiat, Dept Neurosci, MRC Ctr Neurodegenerat Res, London SE5 8AF, England; [Chang, Raymond C. C.] Univ Hong Kong, Dept Anat, Lab Neurodegenerat Dis, Pokfulam, Hong Kong, Peoples R China; [McLoughlin, Declan M.] St Patricks Hosp, Trinity Coll, Dept Psychiat, Dublin 8, Ireland	Chinese University of Hong Kong; Chinese University of Hong Kong; University of London; King's College London; University of Hong Kong; Trinity College Dublin	Lau, KF (corresponding author), Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China.	kflau@cuhk.edu.hk	Chang, Raymond Chuen-Chung/C-1107-2009; Chan, Edwin/A-9478-2011; Miller, Christopher/H-5733-2012	Chang, Raymond Chuen-Chung/0000-0001-8538-7993; Chan, Edwin/0000-0003-4307-474X; Lau, Kwok-Fai/0000-0002-0193-1152; McLoughlin, Declan/0000-0003-4574-2799; Miller, Christopher/0000-0002-5130-1845	Council Hong Kong, a Chinese University of Hong Kong; United Kingdom Medical Research Council, Biotechnology and Biological Sciences Research Council; European Union NeuroNE,; Alzheimer Society; Biotechnology and Biological Sciences Research Council [BB/C506913/1] Funding Source: researchfish; Medical Research Council [G0000749, G0501573] Funding Source: researchfish; MRC [G0501573, G0000749] Funding Source: UKRI	Council Hong Kong, a Chinese University of Hong Kong(Chinese University of Hong Kong); United Kingdom Medical Research Council, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union NeuroNE,; Alzheimer Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Research Grant Council Hong Kong, a Chinese University of Hong Kong direct grant scheme, the Wellcome Trust, United Kingdom Medical Research Council, Biotechnology and Biological Sciences Research Council, European Union NeuroNE, the Alzheimer Society, the Alzheimer Research Trust, and the Alzheimer Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amanatullah D F, 2002, Minerva Endocrinol, V27, P7; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Brogan MD, 2001, NEUROENDOCRINOLOGY, V74, P244, DOI 10.1159/000054691; Brownlees J, 2000, J CELL SCI, V113, P401; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Costello LC, 2002, HORM METAB RES, V34, P417, DOI 10.1055/s-2002-33598; Dai JP, 2004, BRIT J PHARMACOL, V143, P606, DOI 10.1038/sj.bjp.0705995; De Martino MU, 2004, ANN NY ACAD SCI, V1024, P72, DOI 10.1196/annals.1321.006; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Giubilei F, 2001, J NEUROSCI RES, V66, P262, DOI 10.1002/jnr.1219; Graham TE, 2001, ENDOCRINOLOGY, V142, P2631, DOI 10.1210/en.142.6.2631; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hoschl C, 2001, EUR ARCH PSY CLIN N, V251, P81; Jicha GA, 1997, J NEUROCHEM, V69, P2087; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Kesavapany S, 2002, NEUROSCIENCE, V115, P951, DOI 10.1016/S0306-4522(02)00422-0; Kesavapany S, 2001, EUR J NEUROSCI, V13, P241, DOI 10.1046/j.1460-9568.2001.01376.x; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kinoshita A, 2002, J NEUROCHEM, V82, P839, DOI 10.1046/j.1471-4159.2002.01016.x; Klein-Hitpass L, 1998, J MOL MED, V76, P490, DOI 10.1007/s001090050243; Kulstad JJ, 2005, J NEUROPATH EXP NEUR, V64, P139, DOI 10.1093/jnen/64.2.139; Lau KF, 1999, J PEPT RES, V54, P85, DOI 10.1034/j.1399-3011.1999.00083.x; Lau KF, 1999, GENOMICS, V60, P121, DOI 10.1006/geno.1999.5875; Lau KF, 2002, MOL CELL NEUROSCI, V20, P13, DOI 10.1006/mcne.2002.1108; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; MAEDA K, 1991, NEUROBIOL AGING, V12, P161, DOI 10.1016/0197-4580(91)90055-O; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; McLoughlin DM, 2001, J BIOL CHEM, V276, P9303, DOI 10.1074/jbc.M010023200; McLoughlin DM, 1996, FEBS LETT, V397, P197; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Pascualy M, 2000, BIOL PSYCHIAT, V48, P247, DOI 10.1016/S0006-3223(00)00879-9; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Peskind ER, 2001, NEUROLOGY, V56, P1094, DOI 10.1212/WNL.56.8.1094; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Santiard-Baron D, 2005, J NEUROCHEM, V93, P330, DOI 10.1111/j.1471-4159.2005.03026.x; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Standen CL, 2003, MOL CELL NEUROSCI, V24, P851, DOI 10.1016/j.mcn.2003.07.002; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; SWAAB DF, 1994, J NEUROENDOCRINOL, V6, P681, DOI 10.1111/j.1365-2826.1994.tb00635.x; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Thomas JE, 1996, J BIOL CHEM, V271, P28630, DOI 10.1074/jbc.271.45.28630; Touma C, 2004, NEUROBIOL AGING, V25, P893, DOI 10.1016/j.neurobiolaging.2003.09.004; Tu YZ, 1999, BBA-GENE STRUCT EXPR, V1489, P452, DOI 10.1016/S0167-4781(99)00197-9; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zambrano N, 2001, J BIOL CHEM, V276, P19787, DOI 10.1074/jbc.M100792200; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	69	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34728	34737		10.1074/jbc.M801874200	http://dx.doi.org/10.1074/jbc.M801874200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922798	Green Published, hybrid			2022-12-25	WOS:000261469100029
J	Lemke, T; Welling, A; Christel, CJ; Blaich, A; Bernhard, D; Lenhardt, P; Hofmann, F; Moosmang, S				Lemke, Toni; Welling, Andrea; Christel, Carl Johannes; Blaich, Anne; Bernhard, Dominik; Lenhardt, Peter; Hofmann, Franz; Moosmang, Sven			Unchanged beta-Adrenergic Stimulation of Cardiac L-type Calcium Channels in Ca(v)1.2 Phosphorylation Site S1928A Mutant Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CAMP-DEPENDENT PHOSPHORYLATION; CA2+ CHANNELS; SIGNALING COMPLEX; SUBUNITS; LOCALIZATION; REQUIRES; PKA	Phosphorylation of serine 1928 ( Ser(1928)) of the cardiac Ca(v)1.2 subunit of L-type Ca2+ channels has been proposed as the mechanism for regulation of L-type Ca2+ channels by protein kinase A (PKA). To test this directly in vivo, we generated a knock-in mouse with targeted mutation of Ser(1928) to alanine. This mutation did not affect basal L-type current characteristics or regulation of the L-type current by PKA and the beta-adrenergic receptor, whereas the mutation abolished phosphorylation of Cav1.2 by PKA. Therefore, our data show that PKA phosphorylation of Ser(1928) of Ca(v)1.2 is not functionally involved in beta-adrenergic stimulation of Ca(v)1.2-mediated Ca2+ influx into the cardiomyocyte.	[Lemke, Toni; Welling, Andrea; Christel, Carl Johannes; Blaich, Anne; Bernhard, Dominik; Lenhardt, Peter; Hofmann, Franz; Moosmang, Sven] Tech Univ Munich, Inst Pharmakol, D-80802 Munich, Germany	Technical University of Munich	Moosmang, S (corresponding author), Tech Univ Munich, Inst Pharmakol, Biedersteiner Str 29, D-80802 Munich, Germany.	moosmang@ipt.med.tu-muenchen.de	Tuluc, Petronel/C-2527-2011; Welling, Andrea/K-6674-2017	Welling, Andrea/0000-0002-5364-4980	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from Deutsche Forschungsgemeinschaft and Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 To whom correspondence should be addressed.	Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gui PC, 2006, J BIOL CHEM, V281, P14015, DOI 10.1074/jbc.M600433200; Haase H, 2005, FASEB J, V19, P1969, DOI 10.1096/fj.05-3997com; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ludwig A, 1997, J NEUROSCI, V17, P1339; Miriyala J, 2008, CIRC RES, V102, pE54, DOI 10.1161/CIRCRESAHA.108.171736; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; OSTERRIEDER W, 1982, NATURE, V298, P576, DOI 10.1038/298576a0; SCULPTOREANU A, 1993, P NATL ACAD SCI USA, V90, P10135, DOI 10.1073/pnas.90.21.10135; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; ZONG XG, 1995, PFLUG ARCH EUR J PHY, V430, P340, DOI 10.1007/BF00373908	26	90	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34738	34744		10.1074/jbc.M804981200	http://dx.doi.org/10.1074/jbc.M804981200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18829456	Green Published, hybrid			2022-12-25	WOS:000261469100030
J	Stith, CM; Sterling, J; Resnick, MA; Gordenin, DA; Burgers, PM				Stith, Carrie M.; Sterling, Joan; Resnick, Michael A.; Gordenin, Dmitry A.; Burgers, Peter M.			Flexibility of Eukaryotic Okazaki Fragment Maturation through Regulated Strand Displacement Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-DELTA; REPLICATION PROTEIN-A; CELL NUCLEAR ANTIGEN; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; FLAP ENDONUCLEASE-1; LIGATABLE NICK; YEAST; SUBUNIT; ROLES	Okazaki fragment maturation to produce continuous lagging strands in eukaryotic cells requires precise coordination of strand displacement synthesis by DNA polymerase delta (Pol delta) with 5'-flap cutting by FEN1(RAD27) endonuclease. Excessive strand displacement is normally prevented by the 3' -exonuclease activity of Pol delta. This core maturation machinery can be assisted by Dna2 nuclease/helicase that processes long flaps. Our genetic studies show that deletion of the POL32 (third subunit of Pol delta) or PIF1 helicase genes can suppress lethality or growth defects of rad27 Delta pol3-D520V mutants (defective for FEN1RAD27 and the 3' -exonuclease of Pol delta) that produce long flaps and of dna2 Delta mutants that are defective in cutting long flaps. On the contrary, pol32 Delta or pif1 Delta caused lethality of rad27 Delta exo1 Delta double mutants, suggesting that Pol32 and Pif1 are required to generate longer flaps that can be processed by Dna2 in the absence of the short flap processing activities of FEN1(RAD27) and Exo1. The genetic analysis reveals a remarkable flexibility of the Okazaki maturation machinery and is in accord with our biochemical analysis. In vitro, the generation of short flaps by Pol delta is not affected by the presence of Pol32; however, longer flaps only accumulate when Pol32 is present. The presence of FEN1(RAD27) during strand displacement synthesis curtails displacement in favor of flap cutting, thus suggesting an active hand-off mechanism from Pol delta to FEN1(RAD27). Finally, RNA-DNA hybrids are more readily displaced by Pol delta than DNA hybrids, thereby favoring degradation of initiator RNA during Okazaki maturation.	[Sterling, Joan; Resnick, Michael A.; Gordenin, Dmitry A.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Stith, Carrie M.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Washington University (WUSTL)	Gordenin, DA (corresponding author), NIEHS, Mol Genet Lab, NIH, D3-01,101 TW Alexander Dr,POB 12233, Res Triangle Pk, NC 27709 USA.	gordenin@niehs.nih.gov; burgers@biochem.wustl.edu	Dmitry, Gordenin/C-3907-2018; Burgers, Peter M/AAW-6621-2021; resnick, Michael/F-1668-2019	Dmitry, Gordenin/0000-0002-8399-1836; resnick, Michael/0000-0002-8473-7506	National Institutes of Grant [GM32431]; National Institutes of Health [Z01 ES065073]; NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	National Institutes of Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Grant GM32431 (to P. M. B.) and by the Intramural Research Program of National Institutes of Health, Project 1 Z01 ES065073, of NIEHS (to J. M. A. R., and D. A. G.). The costs of publication of this article were in part by the payment of page charges. This article must therefore hereby marked "advertisement" in accordance with 18 U. S. C. Section solely to indicate this fact.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Garg P, 2005, CELL CYCLE, V4, P221; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Huang ME, 2002, GENETICS, V160, P1409; Huang ME, 1999, MOL GEN GENET, V260, P541, DOI 10.1007/s004380050927; Ii M, 2005, CURR GENET, V48, P213, DOI 10.1007/s00294-005-0014-5; Jin YH, 2005, MOL CELL BIOL, V25, P461, DOI 10.1128/MCB.25.1.461-471.2005; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3	41	100	100	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34129	34140		10.1074/jbc.M806668200	http://dx.doi.org/10.1074/jbc.M806668200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18927077	Green Published, hybrid			2022-12-25	WOS:000261277700041
J	Ohtsuji, M; Katsuoka, F; Kobayashi, A; Aburatani, H; Hayes, JD; Yamamoto, M				Ohtsuji, Makiko; Katsuoka, Fumiki; Kobayashi, Akira; Aburatani, Hiroyuki; Hayes, John D.; Yamamoto, Masayuki			Nrf1 and Nrf2 Play Distinct Roles in Activation of Antioxidant Response Element-dependent Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL MAF PROTEINS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; METALLOTHIONEIN-I; ENDOPLASMIC-RETICULUM; EMBRYONIC LETHALITY; EXPRESSION; INDUCTION; STEATOHEPATITIS; DEFICIENCY	Nrf1 is a member of the vertebrate Cap'n'Collar (CNC) transcription factor family that commonly contains a unique basic-leucine zipper domain. Among CNC family members, Nrf2 is known to regulate a battery of antioxidant and xenobiotic-metabolizing enzyme genes through the antioxidant response element (ARE). Although Nrf1 has also been shown to bind the ARE, it is unclear whether it plays a distinct role from Nrf2 in regulating genes with this element. To address this issue in vivo, we generated mice bearing a hepatocyte-specific disruption of the Nrf1 gene. Although Nrf2 knock-out mice did not exhibit liver damage when they were maintained in an unstressed condition, hepatocyte-specific deletion of Nrf1 caused liver damage resembling the human disease non-alcoholic steatohepatitis. Gene expression analysis revealed that the disruption of Nrf1 causes stress that activates a number of ARE-driven genes in an Nrf2-dependent manner, indicating that Nrf2 cannot compensate completely for loss of Nrf1 function in the liver. In contrast, expression of metallothionein-1 and -2 (MT1 and MT2) genes, each of which harbors at least one ARE in its regulatory region, was decreased in the Nrf1-null mutant mice. Whereas Nrf1 and Nrf2 bound the MT1 ARE with comparable affinity, Nrf1 preferentially activated the reporter gene expression through the MT1 ARE. This study has, thus, identified the first ARE-dependent gene that relies exclusively on Nrf1, suggesting that it plays a distinct functional role in regulating ARE-driven genes.	[Ohtsuji, Makiko; Katsuoka, Fumiki; Kobayashi, Akira; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Biochem Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ohtsuji, Makiko; Yamamoto, Masayuki] Japan Sci & Technol Corp, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Ohtsuji, Makiko; Yamamoto, Masayuki] Japan Sci & Technol Corp, Ctr Tsukuba Adv Res Alliance & Exploratory Res Ad, Tsukuba, Ibaraki 3058577, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Hayes, John D.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland	Tohoku University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; University of Dundee	Yamamoto, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem Med, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	masi@mail.tains.tohoku.ac.jp	Kobayashi, Akira/AAN-8003-2020; Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Katsuoka, Fumiki/0000-0003-0939-7887; Kobayashi, Akira/0000-0001-9727-1218; Hayes, John/0000-0002-2927-5548	Exploratory Research for Advanced Technology-Japan Science and Technology Agency; Ministry of Education, Science, Sports, and Culture	Exploratory Research for Advanced Technology-Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Exploratory Research for Advanced Technology-Japan Science and Technology Agency (to M. Y.) and the Ministry of Education, Science, Sports, and Culture (to F. K., A. K., and M. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Beattie JH, 1998, P NATL ACAD SCI USA, V95, P358, DOI 10.1073/pnas.95.1.358; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Daniels PJ, 2003, NUCLEIC ACIDS RES, V31, P6710, DOI 10.1093/nar/gkg913; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Kyo M, 2004, GENES CELLS, V9, P153, DOI 10.1111/j.1356-9597.2004.00711.x; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Onodera K, 1999, J BIOL CHEM, V274, P21162, DOI 10.1074/jbc.274.30.21162; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Suwabe N, 1998, BLOOD, V92, P4108, DOI 10.1182/blood.V92.11.4108.423k29_4108_4118; Suzuki T, 2008, J BIOL CHEM, V283, P2021, DOI 10.1074/jbc.M708352200; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Yeh CT, 2005, CARCINOGENESIS, V26, P2138, DOI 10.1093/carcin/bgi185; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhou ZX, 2002, AM J PATHOL, V160, P2267, DOI 10.1016/S0002-9440(10)61174-1	37	241	244	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33554	33562		10.1074/jbc.M804597200	http://dx.doi.org/10.1074/jbc.M804597200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826952	hybrid, Green Published			2022-12-25	WOS:000261183700060
J	Schneider, K; Meyer-Koenig, U; Hufert, FT				Schneider, Kerstin; Meyer-Koenig, Ursula; Hufert, Frank T.			Human Cytomegalovirus Impairs the Function of Plasmacytoid Dendritic Cells in Lymphoid Organs	PLOS ONE			English	Article								Human dendritic cells (DCs) are the main antigen presenting cells (APC) and can be divided into two main populations, myeloid and plasmacytoid DCs (pDCs), the latter being the main producers of Type I Interferon. The vast majority of pDCs can be found in lymphoid organs, where the main pool of all immune cells is located, but a minority of pDCs also circulate in peripheral blood. Human cytomegalovirus (HCMV) employs multiple mechanisms to evade the immune system. In this study, we could show that pDCs obtained from lymphoid organs (tonsils) (tpDCs) and from blood (bpDCs) are different subpopulations in humans. Interestingly, these populations react in opposite manner to HCMV-infection. TpDCs were fully permissive for HCMV. Their IFN-alpha production and the expression of costimulatory and adhesion molecules were altered after infection. In contrast, in bpDCs HCMV replication was abrogated and the cells were activated with increased IFN-alpha production and upregulation of MHC class I, costimulatory, and adhesion molecules. HCMV-infection of both, tpDCs and bpDCs, led to a decreased T cell stimulation, probably mediated through a soluble factor produced by HCMV-infected pDCs. We propose that the HCMV-mediated impairment of tpDCs is a newly discovered mechanism selectively targeting the host's major population of pDCs residing in lymphoid organs.	[Schneider, Kerstin; Meyer-Koenig, Ursula] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, Freiburg, Germany; [Hufert, Frank T.] Univ Gottingen, Med Ctr, Inst Virol, D-3400 Gottingen, Germany	University of Freiburg; University of Gottingen	Schneider, K (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, Freiburg, Germany.	fhufert@gwdg.de			Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF) [FKZ01KI9951]	Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the "Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF)" grant FKZ01KI9951. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; ALCAMI J, 1991, J GEN VIROL, V72, P2765, DOI 10.1099/0022-1317-72-11-2765; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Arrode G, 2003, CURR TOP MICROBIOL, V276, P277; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Avigan D, 1999, BLOOD REV, V13, P51, DOI 10.1016/S0268-960X(99)90023-1; Beck K, 2003, EUR J IMMUNOL, V33, P1528, DOI 10.1002/eji.200323612; Benedict CA, 2008, J IMMUNOL, V180, P4836, DOI 10.4049/jimmunol.180.7.4836; Briere F, 2002, HUM IMMUNOL, V63, P1081, DOI 10.1016/S0198-8859(02)00746-2; BROWNE H, 1990, NATURE, V347, P770, DOI 10.1038/347770a0; Brune W, 2001, SCIENCE, V291, P303, DOI 10.1126/science.291.5502.303; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Ellsmore V, 2003, J GEN VIROL, V84, P639, DOI 10.1099/vir.0.18812-0; Fuchs A, 2005, BLOOD, V106, P2076, DOI 10.1182/blood-2004-12-4802; Grigoleit U, 2002, BRIT J HAEMATOL, V119, P189, DOI 10.1046/j.1365-2141.2002.03798.x; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hengel H, 1997, CURR OPIN IMMUNOL, V9, P470, DOI 10.1016/S0952-7915(97)80097-0; HILL S, 1994, IMMUNOLOGY, V83, P295; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Kvale EO, 2006, BLOOD, V107, P2022, DOI 10.1182/blood-2005-05-2016; Larsson M, 2004, SEMIN IMMUNOL, V16, P147, DOI 10.1016/j.smim.2004.02.002; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; LIU R, 1994, NUCLEIC ACIDS RES, V22, P2453, DOI 10.1093/nar/22.13.2453; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; MICHELSON S, 1994, J VIROL, V68, P5730, DOI 10.1128/JVI.68.9.5730-5737.1994; Miller DM, 1998, J EXP MED, V187, P675, DOI 10.1084/jem.187.5.675; Moutaftsi M, 2002, BLOOD, V99, P2913, DOI 10.1182/blood.V99.8.2913; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naniche D, 2000, CELL MOL LIFE SCI, V57, P1399, DOI 10.1007/PL00000625; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; Raftery MJ, 2001, IMMUNITY, V15, P997, DOI 10.1016/S1074-7613(01)00239-4; Raftery MJ, 2004, J IMMUNOL, V173, P3383, DOI 10.4049/jimmunol.173.5.3383; Riegler S, 2000, J GEN VIROL, V81, P393, DOI 10.1099/0022-1317-81-2-393; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Sinclair J, 1996, INTERVIROLOGY, V39, P293, DOI 10.1159/000150501; SINCLAIR JH, 1992, J GEN VIROL, V73, P433, DOI 10.1099/0022-1317-73-2-433; Sinzger C, 1996, INTERVIROLOGY, V39, P302, DOI 10.1159/000150502; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Summers KL, 2001, AM J PATHOL, V159, P285, DOI 10.1016/S0002-9440(10)61694-X; Varani S, 2007, J IMMUNOL, V179, P7767, DOI 10.4049/jimmunol.179.11.7767; VONLAER D, 1995, BLOOD, V86, P4086, DOI 10.1182/blood.V86.11.4086.bloodjournal86114086; VONLAER D, 1995, J INFECT DIS, V172, P365, DOI 10.1093/infdis/172.2.365; Wiertz EJHJ, 1997, MOL MED TODAY, V3, P116, DOI 10.1016/S1357-4310(96)10059-9; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411	55	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3482	10.1371/journal.pone.0003482	http://dx.doi.org/10.1371/journal.pone.0003482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941519	Green Published, gold, Green Submitted			2022-12-25	WOS:000265126100013
J	Mehats, C; Franco-Montoya, ML; Boucherat, O; Lopez, E; Schmitz, T; Zana, E; Evain-Brion, D; Bourbon, J; Delacourt, C; Jarreau, PH				Mehats, Celine; Franco-Montoya, Marie-Laure; Boucherat, Olivier; Lopez, Emmanuel; Schmitz, Thomas; Zana, Elodie; Evain-Brion, Daniele; Bourbon, Jacques; Delacourt, Christophe; Jarreau, Pierre-Henri			Effects of Phosphodiesterase 4 Inhibition on Alveolarization and Hyperoxia Toxicity in Newborn Rats	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; BIRTH-WEIGHT INFANTS; GENE-EXPRESSION; BRONCHOPULMONARY DYSPLASIA; POSTNATAL-DEVELOPMENT; CAFFEINE THERAPY; COUNT METHOD; LUNG INJURY; GROWTH; INFLAMMATION	Background: Prolonged neonatal exposure to hyperoxia is associated with high mortality, leukocyte influx in airspaces, and impaired alveolarization. Inhibitors of type 4 phosphodiesterases are potent anti-inflammatory drugs now proposed for lung disorders. The current study was undertaken to determine the effects of the prototypal phosphodiesterase-4 inhibitor rolipram on alveolar development and on hyperoxia-induced lung injury. Methodology/Findings: Rat pups were placed under hyperoxia (FiO(2)>95%) or room air from birth, and received rolipram or its diluent daily until sacrifice. Mortality rate, weight gain and parameters of lung morphometry were recorded on day 10. Differential cell count and cytokine levels in bronchoalveolar lavage and cytokine mRNA levels in whole lung were recorded on day 6. Rolipram diminished weight gain either under air or hyperoxia. Hyperoxia induced huge mortality rate reaching 70% at day 10, which was prevented by rolipram. Leukocyte influx in bronchoalveolar lavage under hyperoxia was significantly diminished by rolipram. Hyperoxia increased transcript and protein levels of IL-6, MCP1, and osteopontin; rolipram inhibited the increase of these proteins. Alveolarization was impaired by hyperoxia and was not restored by rolipram. Under room air, rolipram-treated pups had significant decrease of Radial Alveolar Count. Conclusions: Although inhibition of phosphodiesterases 4 prevented mortality and lung inflammation induced by hyperoxia, it had no effect on alveolarization impairment, which might be accounted for by the aggressiveness of the model. The less complex structure of immature lungs of rolipram-treated pups as compared with diluent-treated pups under room air may be explained by the profound effect of PDE4 inhibition on weight gain that interfered with normal alveolarization.	[Mehats, Celine; Lopez, Emmanuel; Schmitz, Thomas; Zana, Elodie; Evain-Brion, Daniele; Jarreau, Pierre-Henri] INSERM, U767, Paris, France; [Mehats, Celine; Lopez, Emmanuel; Schmitz, Thomas; Evain-Brion, Daniele; Jarreau, Pierre-Henri] Univ Paris 05, Fac Med, Paris, France; [Franco-Montoya, Marie-Laure; Boucherat, Olivier; Bourbon, Jacques; Delacourt, Christophe] INSERM, U841, IMRB, Equipe 06, Creteil, France; [Bourbon, Jacques; Delacourt, Christophe] Univ Paris 12, Fac Med, IFR 10, F-94010 Creteil, France; [Mehats, Celine; Franco-Montoya, Marie-Laure; Boucherat, Olivier; Lopez, Emmanuel; Schmitz, Thomas; Zana, Elodie; Evain-Brion, Daniele; Bourbon, Jacques; Delacourt, Christophe; Jarreau, Pierre-Henri] PremUP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite	Mehats, C (corresponding author), INSERM, U767, Paris, France.	pierre-henri.jarreau@cch.aphp.fr	Delacourt, Christophe/K-6161-2019; Mehats, Celine/D-8650-2017	Mehats, Celine/0000-0002-3677-2024	Universites de Paris	Universites de Paris	This work was supported by a Legs Poix grant of la Chancellerie des Universites de Paris 2006.	Auten RL, 2001, AM J PHYSIOL-LUNG C, V281, pL336, DOI 10.1152/ajplung.2001.281.2.L336; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; BARNETTE MS, 1995, J PHARMACOL EXP THER, V273, P1396; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Boswell-Smith V, 2006, J ALLERGY CLIN IMMUN, V117, P1237, DOI 10.1016/j.jaci.2006.02.045; Boucherat O, 2007, PHYSIOL GENOMICS, V32, P128, DOI 10.1152/physiolgenomics.00108.2007; Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE; BURRI PH, 1974, ANAT REC, V178, P711, DOI 10.1002/ar.1091780405; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; COONEY TP, 1982, THORAX, V37, P580, DOI 10.1136/thx.37.8.580; Dagues N, 2007, TOXICOL SCI, V100, P238, DOI 10.1093/toxsci/kfm161; Deng H, 2000, AM J RESP CRIT CARE, V162, P2316, DOI 10.1164/ajrccm.162.6.9911020; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; DEVISSER YP, 2007, EUR RESP J; Giembycz MA, 2006, BRIT J CLIN PHARMACO, V62, P138, DOI 10.1111/j.1365-2125.2006.02640.x; Hsiao R, 2005, PEDIATRICS, V116, pE43, DOI 10.1542/peds.2004-1379; Huston E, 1996, J BIOL CHEM, V271, P31334, DOI 10.1074/jbc.271.49.31334; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; Larson JL, 1996, PHARMACOL TOXICOL, V78, P44, DOI 10.1111/j.1600-0773.1996.tb00178.x; Lopez E, 2006, AM J RESP CELL MOL, V34, P738, DOI 10.1165/rcmb.2005-0254OC; MASSARO D, 1985, J CLIN INVEST, V76, P1297, DOI 10.1172/JCI112103; Massaro D, 2007, AM J PHYSIOL-LUNG C, V292, pL1313, DOI 10.1152/ajplung.00146.2006; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; NAURECKAS ET, 1994, EUR RESPIR J, V7, P1397, DOI 10.1183/09031936.94.07081397; NIELSON CP, 1990, J ALLERGY CLIN IMMUN, V86, P801, DOI 10.1016/S0091-6749(05)80186-1; Oger S, 2002, J CLIN ENDOCR METAB, V87, P5524, DOI 10.1210/jc.2002-020575; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Saugstad Ola Didrik, 2003, Semin Neonatol, V8, P39, DOI 10.1016/S1084-2756(02)00194-X; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Schmitz T, 2007, J IMMUNOL, V178, P1115, DOI 10.4049/jimmunol.178.2.1115; SCHUDT C, 1991, N-S ARCH PHARMACOL, V344, P682; SCHWABE U, 1976, MOL PHARMACOL, V12, P900; Spina D, 2003, DRUGS, V63, P2575, DOI 10.2165/00003495-200363230-00002; Spoto G, 1998, LIFE SCI, V63, pPL349, DOI 10.1016/S0024-3205(98)00513-X; Tang HF, 2005, AM J RESP CRIT CARE, V171, P823, DOI 10.1164/rccm.200406-771OC; ter Horst SAJ, 2004, J APPL PHYSIOL, V97, P2014, DOI 10.1152/japplphysiol.00452.2004; THOMPSON WJ, 1971, J BIOL CHEM, V246, P3145; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Vozzelli MA, 2004, AM J PHYSIOL-LUNG C, V286, pL488, DOI 10.1152/ajplung.00414.2002; Wagenaar GTA, 2004, FREE RADICAL BIO MED, V36, P782, DOI 10.1016/j.freeradbiomed.2003.12.007; Wang P, 1999, MOL PHARMACOL, V56, P170, DOI 10.1124/mol.56.1.170; Waszak P, 2002, HUM GENE THER, V13, P1873, DOI 10.1089/104303402760372963; WEIBEL ER, 1997, LUNG SCI FDN, P333; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X; Zanardo V, 2002, AM J PERINAT, V19, P379, DOI 10.1055/s-2002-35612; ZELTNER TB, 1987, RESP PHYSIOL, V67, P247, DOI 10.1016/0034-5687(87)90057-0	51	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3445	10.1371/journal.pone.0003445	http://dx.doi.org/10.1371/journal.pone.0003445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941502	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125600007
J	Kolupaeva, V; Laplantine, E; Basilico, C				Kolupaeva, Victoria; Laplantine, Emmanuel; Basilico, Claudio			PP2A-Mediated Dephosphorylation of p107 Plays a Critical Role in Chondrocyte Cell Cycle Arrest by FGF	PLOS ONE			English	Article								FGF signaling inhibits chondrocyte proliferation, a cell type-specific response that is the basis for several genetic skeletal disorders caused by activating FGFR mutations. This phenomenon requires the function of the p107 and p130 members of the Rb protein family, and p107 dephosphorylation is one of the earliest distinguishing events in FGF-induced growth arrest. To determine whether p107 dephoshorylation played a critical role in the chondrocyte response to FGF, we sought to counteract this process by overexpressing in RCS chondrocytes the cyclin D1/cdk4 kinase complex. CyclinD/cdk4-expressing RCS cells became resistant to FGF-induced p107 dephosphorylation and growth arrest, and maintained significantly high levels of cyclin E/cdk2 activity and of phosphorylated p130 at later times of FGF treatment. We explored the involvement of a phosphatase in p107 dephosphorylation. Expression of the SV40 small T-Ag, which inhibits the activity of the PP2A phosphatase, or knockdown of the expression of the PP2A catalytic subunit by RNA interference prevented p107 dephosphorylation and FGF-induced growth arrest of RCS cells. Furthermore, an association between p107 and PP2A was induced by FGF treatment. Our data show that p107 dephosphorylation is a key event in FGF-induced cell cycle arrest and indicate that in chondrocytes FGF activates the PP2A phosphatase to promote p107 dephosphorylation.	[Kolupaeva, Victoria; Laplantine, Emmanuel; Basilico, Claudio] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University	Kolupaeva, V (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	claudio.basilico@med.nyu.edu			NICDR [DE013745]; NCI [T32 CA009161]; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013745] Funding Source: NIH RePORTER	NICDR; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This investigation was supported by PHS Grant DE013745 from the NICDR, and by a postdoctoral fellowship from the NCI Training Grant T32 CA009161 to V.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Aviezer D, 2003, CURR DRUG TARGETS, V4, P353, DOI 10.2174/1389450033490993; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; Bruce JL, 2000, MOL CELL, V6, P737, DOI 10.1016/S1097-2765(00)00072-1; Cheng LY, 2000, J BIOL CHEM, V275, P30317, DOI 10.1074/jbc.M005707200; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Coleman KG, 1997, J BIOL CHEM, V272, P18869, DOI 10.1074/jbc.272.30.18869; Dailey L, 2003, J CELL BIOL, V161, P1053, DOI 10.1083/jcb.200302075; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Farkas T, 2002, J BIOL CHEM, V277, P26741, DOI 10.1074/jbc.M200381200; Garriga J, 2004, CELL CYCLE, V3, P1320, DOI 10.4161/cc.3.10.1183; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Laplantine E, 2002, J CELL BIOL, V158, P741, DOI 10.1083/jcb.200205025; Leng XH, 2002, MOL CELL BIOL, V22, P2242, DOI 10.1128/MCB.22.7.2242-2254.2002; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; MUNGRE S, 1994, J VIROL, V68, P1675, DOI 10.1128/JVI.68.3.1675-1681.1994; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; QIN XQ, 1995, MOL CELL BIOL, V15, P742; Raucci A, 2004, J BIOL CHEM, V279, P1747, DOI 10.1074/jbc.M310384200; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Shtrichman R, 2000, ONCOGENE, V19, P3757, DOI 10.1038/sj.onc.1203705; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Swingle Mark, 2007, V365, P23; Voorhoeve PM, 1999, ONCOGENE, V18, P515, DOI 10.1038/sj.onc.1202316; Vuocolo S, 2003, J BIOL CHEM, V278, P41881, DOI 10.1074/jbc.M302715200; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Xiao ZX, 1996, P NATL ACAD SCI USA, V93, P4633, DOI 10.1073/pnas.93.10.4633; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yeh N, 2007, MOL CELL BIOL, V27, P5161, DOI 10.1128/MCB.02431-06; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhao Q, 2004, J BIOL CHEM, V279, P12560, DOI 10.1074/jbc.M308242200	47	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3447	10.1371/journal.pone.0003447	http://dx.doi.org/10.1371/journal.pone.0003447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927618	Green Published, gold, Green Submitted			2022-12-25	WOS:000265122400013
J	Lu, M; Zhang, QP; Deng, M; Miao, J; Guo, YH; Gao, W; Cui, QH				Lu, Ming; Zhang, Qipeng; Deng, Min; Miao, Jing; Guo, Yanhong; Gao, Wei; Cui, Qinghua			An Analysis of Human MicroRNA and Disease Associations	PLOS ONE			English	Article							EXPRESSION; NETWORK; GENES; RNA; COEXPRESSION; REPRESSION; PROFILES; TARGET	It has been reported that increasingly microRNAs are associated with diseases. However, the patterns among the microRNA-disease associations remain largely unclear. In this study, in order to dissect the patterns of microRNA-disease associations, we performed a comprehensive analysis to the human microRNA-disease association data, which is manually collected from publications. We built a human microRNA associated disease network. Interestingly, microRNAs tend to show similar or different dysfunctional evidences for the similar or different disease clusters, respectively. A negative correlation between the tissue-specificity of a microRNA and the number of diseases it associated was uncovered. Furthermore, we observed an association between microRNA conservation and disease. Finally, we uncovered that microRNAs associated with the same disease tend to emerge as predefined microRNA groups. These findings can not only provide help in understanding the associations between microRNAs and human diseases but also suggest a new way to identify novel disease-associated microRNAs.	[Lu, Ming; Zhang, Qipeng; Deng, Min; Cui, Qinghua] Peking Univ, Hlth Sci Ctr, Dept Med Informat, Beijing 100871, Peoples R China; [Lu, Ming; Zhang, Qipeng; Deng, Min; Guo, Yanhong; Gao, Wei; Cui, Qinghua] Peking Univ, Minist Ed Key Lab Mol Cardiol, Beijing, Peoples R China; [Miao, Jing] Peking Univ First Hosp, Dept Pediat, Beijing, Peoples R China	Peking University; Peking University; Peking University	Cui, QH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Med Informat, Beijing 100871, Peoples R China.	cuiqinghua@bjmu.edu.cn	GUO, Yanhong/B-5325-2012; Guo, Yanhong/D-9764-2012	Miao, Jing/0000-0003-0642-9740	National Basic Research program of China [2007CB512100]; Peking University [985-2-108-121]	National Basic Research program of China(National Basic Research Program of China); Peking University(Peking University)	This research was supported by the National Basic Research program of China (2007CB512100) and the 985 project of Peking University (No. 985-2-108-121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	27	677	705	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3420	10.1371/journal.pone.0003420	http://dx.doi.org/10.1371/journal.pone.0003420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923704	gold, Green Published			2022-12-25	WOS:000265121800015
J	Jiang, DH; Wang, YQ; Wang, YZ; He, YH				Jiang, Danhua; Wang, Yuqi; Wang, Yizhong; He, Yuehui			Repression of FLOWERING LOCUS C and FLOWERING LOCUS T by the Arabidopsis Polycomb Repressive Complex 2 Components	PLOS ONE			English	Article								Polycomb group (PcG) proteins are evolutionarily conserved in animals and plants, and play critical roles in the regulation of developmental gene expression. Here we show that the Arabidopsis Polycomb repressive complex 2 (PRC2) subunits CURLY LEAF (CLF), EMBRYONIC FLOWER 2 (EMF2) and FERTILIZATION INDEPENDENT ENDOSPERM ( FIE) repress the expression of FLOWERING LOCUS C (FLC), a central repressor of the floral transition in Arabidopsis and FLC relatives. In addition, CLF directly interacts with and mediates the deposition of repressive histone H3 lysine 27 trimethylation (H3K27me3) into FLC and FLC relatives, which suppresses active histone H3 lysine 4 trimethylation (H3K4me3) in these loci. Furthermore, we show that during vegetative development CLF and FIE strongly repress the expression of FLOWERING LOCUS T ( FT), a key flowering-time integrator, and that CLF also directly interacts with and mediates the deposition of H3K27me3 into FT chromatin. Our results suggest that PRC2-like complexes containing CLF, EMF2 and FIE, directly interact with and deposit into FT, FLC and FLC relatives repressive trimethyl H3K27 leading to the suppression of active H3K4me3 in these loci, and thus repress the expression of these flowering genes. Given the central roles of FLC and FT in flowering-time regulation in Arabidopsis, these findings suggest that the CLF-containing PRC2-like complexes play a significant role in control of flowering in Arabidopsis.	[Jiang, Danhua; Wang, Yuqi; Wang, Yizhong; He, Yuehui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Jiang, Danhua; Wang, Yuqi; Wang, Yizhong; He, Yuehui] Temasek Life Sci Lab, Singapore, Singapore	National University of Singapore	Jiang, DH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbshy@nus.edu.sg	HE, Yuehui/Y-8792-2018; HE, Yuehui/H-9795-2012	HE, Yuehui/0000-0003-3304-4555; HE, Yuehui/0000-0003-3304-4555; JIANG, DANHUA/0000-0003-0892-8842	Academic Research Fund (AcRF) [R-154-000-294-112, T207B3105]; National University of Singapore; Singapore Ministry of Education [T207B3105]; Temasek Life Sciences Laboratory	Academic Research Fund (AcRF); National University of Singapore(National University of Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Temasek Life Sciences Laboratory(National University of Singapore)	Supported by Academic Research Fund (AcRF) Tier 1 grants (R-154-000-294-112) from the National University of Singapore and an AcRF Tier 2 grant (T207B3105) from the Singapore Ministry of Education and by the Temasek Life Sciences Laboratory to Y.H.	Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Bouveret R, 2006, DEVELOPMENT, V133, P1693, DOI 10.1242/dev.02340; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Choi K, 2007, DEVELOPMENT, V134, P1931, DOI 10.1242/dev.001891; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; He YH, 2004, GENE DEV, V18, P2774, DOI 10.1101/gad.1244504; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jiang D, 2007, PLANT CELL, V19, P2975, DOI 10.1105/tpc.107.052373; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Katz A, 2004, PLANT J, V37, P707, DOI 10.1111/j.1365-313X.2003.01996.x; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Koornneef M, 1998, GENETICS, V148, P885; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Moon YH, 2003, PLANT CELL, V15, P681, DOI 10.1105/tpc.007831; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Niu LF, 2007, EMBO REP, V8, P1190, DOI 10.1038/sj.embor.7401111; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Pien S, 2008, PLANT CELL, V20, P580, DOI 10.1105/tpc.108.058172; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2006, PLANT J, V45, P871, DOI 10.1111/j.1365-313X.2006.02652.x; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; SUNG ZR, 1992, SCIENCE, V258, P1645, DOI 10.1126/science.258.5088.1645; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tie F, 2001, DEVELOPMENT, V128, P275; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	73	213	230	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3404	10.1371/journal.pone.0003404	http://dx.doi.org/10.1371/journal.pone.0003404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852898	Green Published, gold, Green Submitted			2022-12-25	WOS:000265121700009
J	Bruin, JE; Petre, MA; Raha, S; Morrison, KM; Gerstein, HC; Holloway, AC				Bruin, Jennifer E.; Petre, Maria A.; Raha, Sandeep; Morrison, Katherine M.; Gerstein, Hertzel C.; Holloway, Alison C.			Fetal and Neonatal Nicotine Exposure in Wistar Rats Causes Progressive Pancreatic Mitochondrial Damage and Beta Cell Dysfunction	PLOS ONE			English	Article							ENZYME GENE-EXPRESSION; MATERNAL SMOKING; PREGNANCY; APOPTOSIS; GROWTH; BIRTH; OVERWEIGHT; ORIGINS; OBESITY; OVARIAN	Nicotine replacement therapy (NRT) is currently recommended as a safe smoking cessation aid for pregnant women. However, fetal and neonatal nicotine exposure in rats causes mitochondrial-mediated beta cell apoptosis at weaning, and adult-onset dysglycemia, which we hypothesize is related to progressive mitochondrial dysfunction in the pancreas. Therefore in this study we examined the effect of fetal and neonatal exposure to nicotine on pancreatic mitochondrial structure and function during postnatal development. Female Wistar rats were given saline (vehicle control) or nicotine bitartrate (1 mg/kg/d) via subcutaneous injection for 2 weeks prior to mating until weaning. At 3-4, 15 and 26 weeks of age, oral glucose tolerance tests were performed, and pancreas tissue was collected for electron microscopy, enzyme activity assays and islet isolation. Following nicotine exposure mitochondrial structural abnormalities were observed beginning at 3 weeks and worsened with advancing age. Importantly the appearance of these structural defects in nicotine-exposed animals preceded the onset of glucose intolerance. Nicotine exposure also resulted in significantly reduced pancreatic respiratory chain enzyme activity, degranulation of beta cells, elevated islet oxidative stress and impaired glucose-stimulated insulin secretion compared to saline controls at 26 weeks of age. Taken together, these data suggest that maternal nicotine use during pregnancy results in postnatal mitochondrial dysfunction that may explain, in part, the dysglycemia observed in the offspring from this animal model. These results clearly indicate that further investigation into the safety of NRT use during pregnancy is warranted.	[Bruin, Jennifer E.; Petre, Maria A.; Holloway, Alison C.] McMaster Univ, Dept Obstet & Gynecol, Div Reprod Biol, Hamilton, ON, Canada; [Raha, Sandeep; Morrison, Katherine M.] McMaster Univ, Dept Pediat, Hamilton, ON L8S 4L8, Canada; [Gerstein, Hertzel C.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University; McMaster University	Bruin, JE (corresponding author), McMaster Univ, Dept Obstet & Gynecol, Div Reprod Biol, Hamilton, ON, Canada.	hollow@mcmaster.ca	Morrison, Katherine/AAO-8046-2021; Gerstein, Hertzel/ABB-8781-2020; Dalton-O'Reilly, Jessica/AAM-8569-2021; Gerstein, Hertzel C/B-1235-2013	Morrison, Katherine/0000-0002-1737-256X; Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836; Bruin, Jennifer/0000-0003-2326-7819; Raha, Sandeep/0000-0001-7307-3292	Canadian Institutes of Health Research [MOP 86474]; Ontario Women's Health Council; CIHR Institute of Gender and Health Doctoral research award; CIHR Strategic Training Program in Tobacco Research Fellowship; Ashley Studentship for Research in Tobacco Control; Population Health Institute Chair in Diabetes Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council; CIHR Institute of Gender and Health Doctoral research award(Canadian Institutes of Health Research (CIHR)); CIHR Strategic Training Program in Tobacco Research Fellowship(Canadian Institutes of Health Research (CIHR)); Ashley Studentship for Research in Tobacco Control; Population Health Institute Chair in Diabetes Research	Funding for this project was provided by the Canadian Institutes of Health Research (MOP 86474) to Drs. Holloway and Morrison. Ms. Bruin was funded by an Ontario Women's Health Council/CIHR Institute of Gender and Health Doctoral research award and a CIHR Strategic Training Program in Tobacco Research Fellowship. Both Ms. Bruin and Ms. Petre were supported by an Ashley Studentship for Research in Tobacco Control. Dr. Gerstein holds the Population Health Institute Chair in Diabetes Research (sponsored by Aventis). Dr. Raha was provided salary support by Mr. Warren Lammert and Ms. Kathy Corkins and the Hamilton Health Sciences Foundation. We thank the staff of the McMaster University Central Animal Facility, Ms. Jillian Hyslop and Ms. Lisa Kellenberger for their assistance with the animal work and the staff of the McMaster University Electron Microscopy Facility for their excellent technical support with the EM analysis.	Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Bergmann KE, 2003, INT J OBESITY, V27, P162, DOI 10.1038/sj.ijo.802200; Bruin JE, 2008, FREE RADICAL BIO MED, V44, P1919, DOI 10.1016/j.freeradbiomed.2008.02.010; Bruin JE, 2008, TOXICOL SCI, V103, P362, DOI 10.1093/toxsci/kfn012; Bruin JE, 2007, J ENDOCRINOL, V194, P171, DOI 10.1677/JOE-07-0050; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chan CB, 1998, MOL CELL ENDOCRINOL, V136, P119, DOI 10.1016/S0303-7207(97)00220-7; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Faiz A S, 2003, J Matern Fetal Neonatal Med, V13, P175, DOI 10.1080/713605832; Ginzel KH, 2007, J HEALTH PSYCHOL, V12, P215, DOI 10.1177/1359105307074240; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Holloway AC, 2006, ENDOCRINE, V30, P213, DOI 10.1385/ENDO:30:2:213; Holloway AC, 2005, DIABETOLOGIA, V48, P2661, DOI 10.1007/s00125-005-0022-5; Husain K, 2001, ALCOHOL, V25, P89, DOI 10.1016/S0741-8329(01)00176-8; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Leibowitz G, 2002, ENDOCRINOLOGY, V143, P3214, DOI 10.1210/en.2002-220174; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maechler P, 2006, BIOCHEM SOC T, V34, P824, DOI 10.1042/BST0340824; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Marchetti P, 2006, NUTR METAB CARDIOVAS, V16, pS3, DOI 10.1016/j.numecd.2005.10.017; Momose K, 2006, MED MOL MORPHOL, V39, P146, DOI 10.1007/s00795-006-0324-9; Montgomery SM, 2002, BRIT MED J, V324, P26, DOI 10.1136/bmj.324.7328.26; Nordentoft M, 1996, AM J PUBLIC HEALTH, V86, P347, DOI 10.2105/AJPH.86.3.347; Ontario Medical Association, 1999, RETH STOP SMOK MED M; Ozokutan BH, 2005, BIOL NEONATE, V88, P113, DOI 10.1159/000086130; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Robinson JS, 2000, EUR J OBSTET GYN R B, V92, P13, DOI 10.1016/S0301-2115(00)00421-8; Shiverick KT, 1999, PLACENTA, V20, P265, DOI 10.1053/plac.1998.0377; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Silva JP, 2002, BBA-BIOENERGETICS, V1555, P106, DOI 10.1016/S0005-2728(02)00263-3; Simmons RA, 2006, FREE RADICAL BIO MED, V40, P917, DOI 10.1016/j.freeradbiomed.2005.12.018; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tang C, 2007, DIABETES, V56, P2722, DOI 10.2337/db07-0279; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; Vik T, 1996, EARLY HUM DEV, V45, P245, DOI 10.1016/0378-3782(96)01735-5; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WETSCHER GJ, 1995, FREE RADICAL BIO MED, V18, P877, DOI 10.1016/0891-5849(94)00221-5; Wideroe M, 2003, PAEDIATR PERINAT EP, V17, P171, DOI 10.1046/j.1365-3016.2003.00481.x	45	66	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3371	10.1371/journal.pone.0003371	http://dx.doi.org/10.1371/journal.pone.0003371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18852877	Green Published, gold, Green Submitted			2022-12-25	WOS:000265113900007
J	McDougall, SJ; Peters, JH; LaBrant, L; Wang, X; Koop, DR; Andresen, MC				McDougall, Stuart J.; Peters, James H.; LaBrant, Lia; Wang, Xin; Koop, Dennis R.; Andresen, Michael C.			Paired Assessment of Volatile Anesthetic Concentrations with Synaptic Actions Recorded In Vitro	PLOS ONE			English	Article							GABA RELEASE; GENERAL-ANESTHETICS; 2ND-ORDER NEURONS; ISOFLURANE; TRANSMISSION; GLUTAMATE; CURRENTS	The volatile anesthetic isoflurane poses a number of experimental challenges in the laboratory. Due to its rapid evaporation, the open conditions of most in vitro electrophysiological recording systems make the determination of actual isoflurane concentrations a challenge. Since the absolute anesthetic concentration in solution is directly related to efficacy, concentration measurements are important to allow comparisons between laboratory and clinical studies. In this study we quantify the sources of isoflurane loss during experimentation and describe a method for the measurement of isoflurane concentrations using gas chromatography and mass spectrometry simultaneous to in vitro electrophysiological measurements. Serial samples of perfused bath solution allowed correlation of isoflurane concentrations with ongoing biological effects. Saturated physiological solutions contained 13.4 +/- 0.2 mM isoflurane and were diluted to desired "nominal'' concentrations for experiments. The perfusion system established stable isoflurane concentrations within the bath by 2 minutes. However, bath isoflurane concentrations varied substantially and unpredictably between experiments. The magnitudes of such discrepancies in isoflurane concentrations spanned clinically important levels. Our studies suggest that, despite countermeasures, solution handling significantly impacted the isoflurane content in the tissue bath. The magnitude of these discrepancies appears to necessitate systematic direct measurement of bath isoflurane concentrations during most in vitro conditions.	[McDougall, Stuart J.; Peters, James H.; LaBrant, Lia; Andresen, Michael C.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Koop, Dennis R.] Oregon Hlth & Sci Univ, Portland, OR USA; [Wang, Xin] George Washington Univ, Dept Pharmacol & Physiol, Washington, DC USA	Oregon Health & Science University; Oregon Health & Science University; George Washington University	McDougall, SJ (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA.	Andresen.ohsu@gmail.com	McDougall, Stuart/J-8310-2012	McDougall, Stuart/0000-0002-8778-675X; Andresen, Michael/0000-0003-0524-1172	National Institutes of Health [HL-058760]; National Health and Medical Research Council of Australia [Martin Fellow]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041119, F32HL088894, R01HL058760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health (HL-058760) and the National Health and Medical Research Council of Australia for which SJM is a C.J. Martin Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doyle MW, 2004, J NEUROSCI METH, V137, P37, DOI 10.1016/j.jneumeth.2004.02.007; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; Eger EI, 2001, ANESTHESIOLOGY, V94, P915, DOI 10.1097/00000542-200105000-00032; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Hagan CE, 1998, J NEUROSCI METH, V81, P177, DOI 10.1016/S0165-0270(98)00029-6; Haseneder R, 2004, ANESTH ANALG, V98, P1718, DOI 10.1213/01.ANE.0000112309.80017.3F; Hendrickx Jan Fa, 2008, BMC Anesthesiol, V8, P2, DOI 10.1186/1471-2253-8-2; Jin YH, 2004, J NEUROSCI, V24, P9332, DOI 10.1523/JNEUROSCI.1991-04.2004; Jinks SL, 2005, ANESTHESIOLOGY, V103, P567, DOI 10.1097/00000542-200509000-00020; JONES MV, 1992, J PHYSIOL-LONDON, V449, P279, DOI 10.1113/jphysiol.1992.sp019086; KHARASCH ED, 1994, CLIN PHARMACOL THER, V55, P434, DOI 10.1038/clpt.1994.53; MacIver MB, 1996, ANESTHESIOLOGY, V85, P823, DOI 10.1097/00000542-199610000-00018; McDougall SJ, 2008, NEUROPHARMACOLOGY, V54, P552, DOI 10.1016/j.neuropharm.2007.11.001; Peters JH, 2008, ANESTHESIOLOGY, V108, P675, DOI 10.1097/ALN.0b013e318167af9a; Scheller M, 1997, ANESTHESIOLOGY, V86, P118, DOI 10.1097/00000542-199701000-00016; Simon W, 2001, ANESTHESIOLOGY, V94, P1058, DOI 10.1097/00000542-200106000-00021; Westphalen RI, 2006, J PHARMACOL EXP THER, V316, P216, DOI 10.1124/jpet.105.090662; Westphalen RI, 2003, J PHARMACOL EXP THER, V304, P1188, DOI 10.1124/jpet.102.044685; Wu XS, 2004, ANESTHESIOLOGY, V100, P663, DOI 10.1097/00000542-200403000-00029	20	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3372	10.1371/journal.pone.0003372	http://dx.doi.org/10.1371/journal.pone.0003372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841202	Green Published, gold			2022-12-25	WOS:000265113900008
J	Cadotte, AJ; DeMarse, TB; He, P; Ding, MZ				Cadotte, Alex J.; DeMarse, Thomas B.; He, Ping; Ding, Mingzhou			Causal Measures of Structure and Plasticity in Simulated and Living Neural Networks	PLOS ONE			English	Article							PARTIAL DIRECTED COHERENCE; GRANGER CAUSALITY; FUNCTIONAL CONNECTIVITY; NEURONAL AVALANCHES; LINEAR-DEPENDENCE; CORTICAL-NEURONS; DYNAMICS; PATTERNS; FEEDBACK; CULTURE	A major goal of neuroscience is to understand the relationship between neural structures and their function. Recording of neural activity with arrays of electrodes is a primary tool employed toward this goal. However, the relationships among the neural activity recorded by these arrays are often highly complex making it problematic to accurately quantify a network's structural information and then relate that structure to its function. Current statistical methods including cross correlation and coherence have achieved only modest success in characterizing the structural connectivity. Over the last decade an alternative technique known as Granger causality is emerging within neuroscience. This technique, borrowed from the field of economics, provides a strong mathematical foundation based on linear auto-regression to detect and quantify "causal'' relationships among different time series. This paper presents a combination of three Granger based analytical methods that can quickly provide a relatively complete representation of the causal structure within a neural network. These are a simple pairwise Granger causality metric, a conditional metric, and a little known computationally inexpensive subtractive conditional method. Each causal metric is first described and evaluated in a series of biologically plausible neural simulations. We then demonstrate how Granger causality can detect and quantify changes in the strength of those relationships during plasticity using 60 channel spike train data from an in vitro cortical network measured on a microelectrode array. We show that these metrics can not only detect the presence of causal relationships, they also provide crucial information about the strength and direction of that relationship, particularly when that relationship maybe changing during plasticity. Although we focus on the analysis of multichannel spike train data the metrics we describe are applicable to any stationary time series in which causal relationships among multiple measures is desired. These techniques can be especially useful when the interactions among those measures are highly complex, difficult to untangle, and maybe changing over time.	[Cadotte, Alex J.; DeMarse, Thomas B.; He, Ping; Ding, Mingzhou] Univ Florida, Dept Pediat Neurol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Cadotte, AJ (corresponding author), Univ Florida, Dept Pediat Neurol, Gainesville, FL 32610 USA.	tdemarse@bme.ufl.edu						ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Aertsen A, 2001, NOVART FDN SYMP, V239, P193; AERTSEN A, 2001, NOVART FDN SYMP, V239, P204; AERTSEN A, 2001, NOVART FDN SYMP, V239, P234; [Anonymous], 2020, INFECT DIS POVERTY, DOI DOI 10.1186/s40249-020-00640-3; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bernasconi C, 1999, BIOL CYBERN, V81, P199, DOI 10.1007/s004220050556; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; Branch DW, 2000, IEEE T BIO-MED ENG, V47, P290, DOI 10.1109/10.827289; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Cadotte AJ, 2005, J NEURAL ENG, V2, P114, DOI 10.1088/1741-2560/2/4/007; CARNEY P, SEIZURE PREDICTION E; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Eichler M, 2006, BIOL CYBERN, V94, P469, DOI 10.1007/s00422-006-0062-z; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Freiwald WA, 1999, J NEUROSCI METH, V94, P105, DOI 10.1016/S0165-0270(99)00129-6; Gerstein G., 1999, CRC METH NEUROSCI S, P157; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gross G.W., 1999, OSCILLATIONS NEURAL, P3; Guo SX, 2008, J NEUROSCI METH, V172, P79, DOI 10.1016/j.jneumeth.2008.04.011; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Harris RE, 2002, J NEUROPHYSIOL, V88, P188, DOI 10.1152/jn.00722.2001; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jimbo Y, 2000, BIOL CYBERN, V83, P1, DOI 10.1007/PL00007970; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Keinan A, 2004, NEURAL COMPUT, V16, P1887, DOI 10.1162/0899766041336387; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Liang HL, 2000, NEUROREPORT, V11, P2875, DOI 10.1097/00001756-200009110-00009; Liang HL, 2002, NEUROREPORT, V13, P2011, DOI 10.1097/00001756-200211150-00004; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; MORF M, 1978, IEEE T GEOSCI REMOTE, V16, P85, DOI 10.1109/TGE.1978.294569; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Salazar RF, 2004, EUR J NEUROSCI, V20, P1391, DOI 10.1111/j.1460-9568.2004.03579.x; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Sato JR, 2006, NEUROIMAGE, V31, P187, DOI 10.1016/j.neuroimage.2005.11.039; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Tabak J, 2003, NEUROREPORT, V14, P1445, DOI 10.1097/00001756-200308060-00008; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; WHEELER BC, 1986, IEEE T BIO-MED ENG, V33, P1204, DOI 10.1109/TBME.1986.325701; Wiener N, 1956, THEORY PREDICTION MO; Zhu LQ, 2005, MATH BIOSCI ENG, V2, P1; Zhu LQ, 2003, NEURAL COMPUT, V15, P2359, DOI 10.1162/089976603322362392	59	58	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2008	3	10							e3355	10.1371/journal.pone.0003355	http://dx.doi.org/10.1371/journal.pone.0003355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DM	18839039	Green Submitted, Green Published, gold			2022-12-25	WOS:000265113700003
J	Rodriguez, M; Lustigman, S; Montero, E; Oksov, Y; Lobo, CA				Rodriguez, Marilis; Lustigman, Sara; Montero, Estrella; Oksov, Yelena; Lobo, Cheryl A.			PfRH5: A Novel Reticulocyte-Binding Family Homolog of Plasmodium falciparum that Binds to the Erythrocyte, and an Investigation of Its Receptor	PLOS ONE			English	Article								Multiple interactions between parasite ligands and their receptors on the human erythrocyte are a condition of successful Plasmodium falciparum invasion. The identification and characterization of these receptors presents a major challenge in the effort to understand the mechanism of invasion and to develop the means to prevent it. We describe here a novel member of the reticulocyte-binding family homolog (RH) of P. falciparum, PfRH5, and show that it binds to a previously unrecognized receptor on the RBC. PfRH5 is expressed as a 63 kDa protein and localized at the apical end of the invasive merozoite. We have expressed a fragment of PfRH5 which contains the RBC-binding domain and exhibits the same pattern of interactions with the RBC as the parent protein. Attachment is inhibited if the target cells are exposed to high concentrations of trypsin, but not to lower concentrations or to chymotrypsin or neuraminidase. We have determined the affinity, copy number and apparent molecular mass of the receptor protein. Thus, we have shown that PfRH5 is a novel erythrocyte-binding ligand and the identification and partial characterization of the new RBC receptor may indicate the existence of an unrecognized P. falciparum invasion pathway	[Rodriguez, Marilis; Montero, Estrella; Lobo, Cheryl A.] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Blood Borne Parasites, New York, NY 10021 USA; [Lustigman, Sara] New York Blood Ctr, Lindsley Kimball Res Inst, Lab Mol Parasitol, New York, NY USA; [Oksov, Yelena] New York Blood Ctr, Lindsley Kimball Res Inst, New York, NY USA	New York Blood Center; New York Blood Center; New York Blood Center	Rodriguez, M (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Blood Borne Parasites, New York, NY 10021 USA.	clobo@nybloodcenter.org	Montero, Estrella/M-3648-2018	Montero, Estrella/0000-0002-3852-960X	VP fund for new initiatives; New York Blood Center; National Blood Foundation	VP fund for new initiatives; New York Blood Center; National Blood Foundation	This work was supported by the VP fund for new initiatives, (Mohandas Narla) New York Blood Center and the National Blood Foundation.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; Binks RH, 1999, MOL BIOCHEM PARASIT, V103, P123, DOI 10.1016/S0166-6851(99)00115-2; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; DOLAN SA, 1994, MOL BIOCHEM PARASIT, V64, P55, DOI 10.1016/0166-6851(94)90134-1; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; GRATZER WB, 1993, SEMIN HEMATOL, V30, P232; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jennings CV, 2007, INFECT IMMUN, V75, P3531, DOI 10.1128/IAI.00122-07; Khan SM, 2001, MOL BIOCHEM PARASIT, V117, P1, DOI 10.1016/S0166-6851(01)00333-4; Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lobo CA, 2003, MOL BIOCHEM PARASIT, V128, P59, DOI 10.1016/S0166-6851(03)00050-1; Lobo CA, 2006, MOL BIOCHEM PARASIT, V149, P246, DOI 10.1016/j.molbiopara.2006.05.011; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; MITCHELL GH, 1986, BLOOD, V67, P1519; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Reid M, 1997, BLOOD GROUP ANTIGEN; SAMYELLOWE TY, 1988, J CELL BIOL, V106, P1507, DOI 10.1083/jcb.106.5.1507; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Su XZ, 1998, EXP PARASITOL, V89, P262, DOI 10.1006/expr.1998.4299; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WAHLGREN M, 1983, CLIN EXP IMMUNOL, V54, P135	33	78	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3300	10.1371/journal.pone.0003300	http://dx.doi.org/10.1371/journal.pone.0003300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827878	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797200007
J	Pursiheimo, JP; Rantanen, K; Heikkinen, PT; Johansen, T; Jaakkola, PM				Pursiheimo, J-P; Rantanen, K.; Heikkinen, P. T.; Johansen, T.; Jaakkola, P. M.			Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62	ONCOGENE			English	Article						ATG8; autophagy; HIF; prolyl hydroxylase; pVHL; sequestosome 1	SIGNALING ADAPTER P62; UNFOLDED PROTEIN RESPONSE; PROLINE HYDROXYLATION; IMPORTANT MEDIATOR; BODY FORMATION; CANCER-CELLS; HIF-ALPHA; DISEASE; INHIBITION; INCLUSIONS	Sequestosome 1 (SQSTM1/p62) is a multifunctional protein involved in signal transduction, protein degradation and cell transformation. Hypoxia is a common feature of solid tumours that promotes cancer progression. Here, we report that p62 is downregulated in hypoxia in carcinoma cells and that the expression is rapidly restored in response to reoxygenation. The hypoxic p62 down-regulation did not occur at the mRNA level and was independent of the hypoxic signal mediators hypoxia-inducible factor (HIF) and von Hippel-Lindau tumour suppressor protein as well as the activity of HIF-prolyl hydroxylases and was not mediated by proteosomal destruction. Autophagy was activated in hypoxia and was required for p62 degradation. The hypoxic degradation of p62 was blocked by autophagy inhibitors as well as by the attenuation of Atg8/LC3 expression. Downregulation of p62 was required for hypoxic extracellular regulated kinase (ERK)-1/2 phosphorylation. Attenuation of p62 in normoxia activated and forced expression of p62 in hypoxia blocked the activation of ERK-1/2. The results demonstrate that hypoxic activation of autophagy induces clearance of p62 protein and implies a role for p62 in the regulation of hypoxic cancer cell survival responses.	[Pursiheimo, J-P; Rantanen, K.; Heikkinen, P. T.; Jaakkola, P. M.] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Pursiheimo, J-P; Rantanen, K.; Heikkinen, P. T.; Jaakkola, P. M.] Abo Akad Univ, Turku, Finland; [Johansen, T.] Univ Tromso, Inst Med Biol, Dept Biochem, Tromso, Norway; [Jaakkola, P. M.] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; UiT The Arctic University of Tromso; University of Turku	Jaakkola, PM (corresponding author), Univ Turku, Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland.	panjaa@utu.fi	Johansen, Terje/N-2971-2015; Jaakkola, Panu M/B-4355-2012; Johansen, Terje/AAY-1753-2021	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Jaakkola, Panu/0000-0002-2365-4985	Academy of Finland [200779, 210282, 8109024]; Emil Aaltonen Foundation; Sigrid Juselius Foundation; Norwegian Research Council (FUGE); Norwegian Cancer Society	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Norwegian Research Council (FUGE)(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	Taina Kalevo-Mattila is acknowledged for expert technical assistance. The study was supported by The Academy of Finland (grants 200779, 210282 and 8109024), Emil Aaltonen Foundation and Sigrid Juselius Foundation to PMJ, and by grants from the Norwegian Research Council (FUGE) and Norwegian Cancer Society to TJ. PMJ is a research fellow of the Finnish Cancer Institute.	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; EKSTROM P, 1984, J NEUROCHEM, V43, P1342, DOI 10.1111/j.1471-4159.1984.tb05392.x; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Kuusisto E, 2001, BIOCHEM BIOPH RES CO, V280, P223, DOI 10.1006/bbrc.2000.4107; Kwon DS, 2006, EUR J CELL BIOL, V85, P1189, DOI 10.1016/j.ejcb.2006.06.001; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lim JH, 2006, MOL PHARMACOL, V70, P1856, DOI 10.1124/mol.106.028076; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Martin P, 2006, EMBO J, V25, P3524, DOI 10.1038/sj.emboj.7601250; Masson N, 2004, FEBS LETT, V570, P166, DOI 10.1016/j.febslet.2004.06.040; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakaso K, 2004, BRAIN RES, V1012, P42, DOI 10.1016/j.brainres.2004.03.029; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Wooten MW, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/62079; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	45	122	123	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					334	344		10.1038/onc.2008.392	http://dx.doi.org/10.1038/onc.2008.392			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18931699				2022-12-25	WOS:000262550300003
J	Tessmer, I; Yang, Y; Zhai, J; Du, CW; Hsieh, P; Hingorani, MM; Erie, DA				Tessmer, Ingrid; Yang, Yong; Zhai, Jie; Du, Chungwei; Hsieh, Peggy; Hingorani, Manju M.; Erie, Dorothy A.			Mechanism of MutS Searching for DNA Mismatches and Signaling Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MUTS; THERMUS-AQUATICUS; CRYSTAL-STRUCTURE; DAMAGE RECOGNITION; ATPASE ACTIVITY; PROTEIN MUTS; MINOR-GROOVE; BINDING; HYDROLYSIS; DOMAINS	DNA mismatch repair is initiated by the recognition of mismatches by MutS proteins. The mechanism by which MutS searches for and recognizes mismatches and subsequently signals repair remains poorly understood. We used single-molecule analyses of atomic force microscopy images of MutS-DNA complexes, coupled with biochemical assays, to determine the distributions of conformational states, the DNA binding affinities, and the ATPase activities of wild type and two mutants of MutS, with alanine substitutions in the conserved Phe-Xaa-Glu mismatch recognition motif. We find that on homoduplex DNA, the conserved Glu, but not the Phe, facilitates MutS-induced DNA bending, whereas at mismatches, both Phe and Glu promote the formation of an unbent conformation. The data reveal an unusual role for the Phe residue in that it promotes the unbending, not bending, of DNA at mismatch sites. In addition, formation of the specific unbent MutS-DNA conformation at mismatches appears to be required for the inhibition of ATP hydrolysis by MutS that signals initiation of repair. These results provide a structural explanation for the mechanism by which MutS searches for and recognizes mismatches and for the observed phenotypes of mutants with substitutions in the Phe-Xaa-Glu motif.	[Tessmer, Ingrid; Yang, Yong; Erie, Dorothy A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Erie, Dorothy A.] Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA; [Du, Chungwei; Hsieh, Peggy] NIDDK, NIH, Bethesda, MD 20892 USA; [Zhai, Jie; Hingorani, Manju M.] Wesleyan Univ, Dept Biochem & Mol Biol, Middletown, CT 06459 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wesleyan University	Erie, DA (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	derie@unc.edu	Tessmer, Ingrid/O-2810-2013	Tessmer, Ingrid/0000-0002-8353-6315	National Institutes of Health [GM079480]; American Cancer Society [RSG03- 047-04-GMC]; National Science Foundation [0448379]; Intramural Research Program of NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079480, R01GM080294, T32GM008271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM079480 (to D.A.E.). This work was also supported by Grant RSG03- 047-04-GMC from the American Cancer Society (to D.A.E.), National Science Foundation Grant MCB 0448379 (to M.M.H.), and the Intramural Research Program of NIDDK (to P.H. and C.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; ANDERA L, 1994, BIOCHIMIE, V76, P933, DOI 10.1016/0300-9084(94)90018-3; Antony E, 2004, BIOCHEMISTRY-US, V43, P13115, DOI 10.1021/bi049010t; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Biswas I, 1999, J BIOL CHEM, V274, P23673, DOI 10.1074/jbc.274.33.23673; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Drotschmann K, 2001, J BIOL CHEM, V276, P46225, DOI 10.1074/jbc.C100450200; ERIE DA, 1994, SCIENCE, V266, P1562, DOI 10.1126/science.7985026; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Hardwidge PR, 2002, BIOCHEMISTRY-US, V41, P7732, DOI 10.1021/bi020213w; Hardwidge PR, 2002, BIOCHEMISTRY-US, V41, P8277, DOI 10.1021/bi020185h; Holmes SF, 2007, DNA REPAIR, V6, P293, DOI 10.1016/j.dnarep.2006.10.023; Horton JR, 2006, NUCLEIC ACIDS RES, V34, P939, DOI 10.1093/nar/gkj484; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Isaacs RJ, 2004, DNA REPAIR, V3, P455, DOI 10.1016/j.dnarep.2004.01.004; Isaacs RJ, 2002, J MOL BIOL, V319, P191, DOI 10.1016/S0022-2836(02)00265-6; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Lebbink JHG, 2006, EMBO J, V25, P409, DOI 10.1038/sj.emboj.7600936; Leonard DA, 1997, P NATL ACAD SCI USA, V94, P4913, DOI 10.1073/pnas.94.10.4913; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pues H, 1999, BIOCHEMISTRY-US, V38, P1426, DOI 10.1021/bi9818016; Rajski SR, 2000, MUTAT RES-FUND MOL M, V447, P49, DOI 10.1016/S0027-5107(99)00195-5; Salsbury FR, 2006, NUCLEIC ACIDS RES, V34, P2173, DOI 10.1093/nar/gkl238; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; Schofield MJ, 2001, J BIOL CHEM, V276, P45505, DOI 10.1074/jbc.C100449200; Sixma TK, 2001, CURR OPIN STRUC BIOL, V11, P47, DOI 10.1016/S0959-440X(00)00169-X; Strauss-Soukup JK, 1998, BIOCHEMISTRY-US, V37, P1060, DOI 10.1021/bi972146p; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; Yamamoto A, 2000, NUCLEIC ACIDS RES, V28, P3564, DOI 10.1093/nar/28.18.3564; Yang W, 2000, COLD SPRING HARB SYM, V65, P225, DOI 10.1101/sqb.2000.65.225; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708	48	52	53	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36646	36654		10.1074/jbc.M805712200	http://dx.doi.org/10.1074/jbc.M805712200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18854319	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000261840500063
J	Deming, PB; Campbell, SL; Baldor, LC; Howe, AK				Deming, Paula B.; Campbell, Shirley L.; Baldor, Linda C.; Howe, Alan K.			Protein Kinase A Regulates 3-Phosphatidylinositide Dynamics during Platelet-derived Growth Factor-induced Membrane Ruffling and Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; CELL-MIGRATION; PHOSPHATIDYLINOSITOL 3-KINASE; NEUTROPHIL CHEMOTAXIS; ACTIN CYTOSKELETON; ANCHORING PROTEINS; HUMAN FIBROBLASTS; SIGNALING EVENTS; DISTINCT ROLES; FEEDBACK LOOP	Spatial regulation of the cAMP-dependent protein kinase (PKA) is required for chemotaxis in fibroblasts; however, the mechanism(s)by which PKA regulates the cell migration machinery remain largely unknown. Here we report that one function of PKA during platelet-derived growth factor (PDGF)-induced chemotaxis was to promote membrane ruffling by regulating phosphatidylinositol 3,4,5-trisphosphate (PIP3) dynamics. Inhibition of PKA activity dramatically altered membrane dynamics and attenuated formation of peripheral membrane ruffles in response to PDGF. PKA inhibition also significantly decreased the number and size of PIP3-rich membrane ruffles in response to uniform stimulation and to gradients of PDGF. This ruffling defect was quantified using a newly developed method, based on computer vision edge-detection algorithms. PKA inhibition caused a marked attenuation in the bulk accumulation of PIP3 following PDGF stimulation, without effects on PI3-kinase (PI3K) activity. The deficits in PIP3 dynamics correlated with a significant inhibition of growth factor-induced membrane recruitment of endogenous Akt and Rac activation in PKA-inhibited cells. Simultaneous inhibition of PKA and Rac had an additive inhibitory effect on growth factor-induced ruffling dynamics. Conversely, the expression of a constitutively active Rac allele was able to rescue the defect in membrane ruffling and restore the localization of a fluorescent PIP3 marker to membrane ruffles in PKA-inhibited cells, even in the absence of PI3K activity. These data demonstrate that, like Rac, PKA contributes to PIP3 and membrane dynamics independently of direct regulation of PI3K activity and suggest that modulation of PIP3/3-phosphatidylinositol (3-PI) lipids represents a major target for PKA in the regulation of PDGF-induced chemotactic events.	[Campbell, Shirley L.; Baldor, Linda C.; Howe, Alan K.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Deming, Paula B.] Univ Vermont, Dept Med Lab & Radiat Sci, Burlington, VT 05405 USA; [Campbell, Shirley L.; Baldor, Linda C.; Howe, Alan K.] Univ Vermont, Vermont Canc Ctr, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Howe, AK (corresponding author), Univ Vermont, Dept Pharmacol, 149 Beaumont Ave,HSRF 322, Burlington, VT 05405 USA.	alan.howe@uvm.edu		Deming, Paula/0000-0003-3278-1705	National Institutes of Health [GM-074204]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074204 (to A.K.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Barber Mark A, 2006, Bull Cancer, V93, pE44; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cockcroft S, 2007, BBA-MOL CELL BIOL L, V1771, P677, DOI 10.1016/j.bbalip.2007.03.009; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; DEBLAQUIERE J, 1994, J BIOL CHEM, V269, P4812; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; FUKUI Y, 1991, MOL CELL BIOL, V11, P1972, DOI 10.1128/MCB.11.4.1972; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Graves LM, 1996, J BIOL CHEM, V271, P505, DOI 10.1074/jbc.271.1.505; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Hafizi S, 2005, FASEB J, V19, P971, DOI 10.1096/fj.04-2532fje; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HEDBERG KM, 1995, EXP CELL RES, V219, P266, DOI 10.1006/excr.1995.1227; HEDBERG KM, 1993, CELL MOTIL CYTOSKEL, V24, P139, DOI 10.1002/cm.970240207; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Kanamarlapudi V, 2005, BIOCHEM SOC T, V33, P1279, DOI 10.1042/BST0331279; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Ma K, 2008, CELL SIGNAL, V20, P684, DOI 10.1016/j.cellsig.2007.12.004; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; NOBES CD, 1995, J CELL SCI, V108, P225; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Scott JD, 2003, BIOCHEM SOC T, V31, P87, DOI 10.1042/bst0310087; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; WYMANN M, 1994, BIOCHEM J, V298, P517, DOI 10.1042/bj2980517; Yi Q, 2006, BIOTECHNIQUES, V40, P745, DOI 10.2144/000112162	65	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35199	35211		10.1074/jbc.M804448200	http://dx.doi.org/10.1074/jbc.M804448200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936099	Green Published, hybrid			2022-12-25	WOS:000261469100076
J	Frielingsdorf, S; Jakob, M; Klosgen, RB				Frielingsdorf, Stefan; Jakob, Mario; Kloesgen, Ralf Bernd			A Stromal Pool of TatA Promotes Tat-dependent Protein Transport across the Thylakoid Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE SIGNAL PEPTIDE; CYTOCHROME B(6)/F COMPLEX; RIESKE FE/S PROTEIN; ESCHERICHIA-COLI; TRANSLOCATION PATHWAY; ARABIDOPSIS-THALIANA; BACILLUS-SUBTILIS; CHLOROPLASTS; SEC; SYSTEM	In chloroplasts and bacteria, the Tat (twin-arginine translocation) system is engaged in transporting folded passenger proteins across the thylakoid and cytoplasmic membranes, respectively. To date, three membrane proteins (TatA, TatB, and TatC) have been identified to be essential for Tat-dependent protein translocation in the plant system, whereas soluble factors seem not to be required. In contrast, in the bacterial system, several cytosolic chaperones were described to be involved in Tat transport processes. Therefore, we have examined whether stromal or peripherally associated membrane proteins also play a role in Tat transport across the thylakoid membrane. Analyzing both authentic precursors as well as the chimeric 16/23 protein, which allows us to study each step of the translocation process individually, we demonstrate that a soluble form of TatA is present in the chloroplast stroma, which significantly improves the efficiency of Tat-dependent protein transport. Furthermore, this soluble TatA is able to reconstitute the Tat transport properties of thylakoid membranes that are transport-incompetent due to extraction with solutions of chaotropic salts.	[Frielingsdorf, Stefan; Jakob, Mario; Kloesgen, Ralf Bernd] Univ Halle Wittenberg, Inst Biol, D-06120 Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Klosgen, RB (corresponding author), Univ Halle Wittenberg, Inst Biol, Weinbergweg 10, D-06120 Halle, Saale, Germany.	klosgen@pflanzenphys.uni-halle.de	Frielingsdorf, Stefan/AAD-8065-2019	Frielingsdorf, Stefan/0000-0002-4141-7836	state Sachsen-Anhalt (Exzellenzcluster Biowissenschaften, Research Cluster B); Deutsche Forschungsgemeinschaft [KL 862/2-1]	state Sachsen-Anhalt (Exzellenzcluster Biowissenschaften, Research Cluster B); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the state Sachsen-Anhalt (Exzellenzcluster Biowissenschaften, Research Cluster B) and the Deutsche Forschungsgemeinschaft (KL 862/2-1). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Berghofer J, 1999, FEBS LETT, V460, P328, DOI 10.1016/S0014-5793(99)01365-4; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Braun NA, 2007, BIOPHYS J, V93, P1993, DOI 10.1529/biophysj.106.098731; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; De Keersmaeker S, 2005, FEBS LETT, V579, P797, DOI 10.1016/j.febslet.2004.12.059; Fincher V, 2003, EUR J BIOCHEM, V270, P4930, DOI 10.1046/j.1432-1033.2003.03894.x; Frielingsdorf S, 2007, J BIOL CHEM, V282, P24455, DOI 10.1074/jbc.M702630200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Jakob M, 2009, BBA-MOL CELL RES, V1793, P388, DOI 10.1016/j.bbamcr.2008.09.006; Karnauchov I, 1997, FEBS LETT, V408, P206, DOI 10.1016/S0014-5793(97)00427-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maillard J, 2007, P NATL ACAD SCI USA, V104, P15641, DOI 10.1073/pnas.0703967104; Marques JP, 2004, J EXP BOT, V55, P1697, DOI 10.1093/jxb/erh191; Marques JP, 2003, MOL GENET GENOMICS, V269, P381, DOI 10.1007/s00438-003-0846-y; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; Motohashi R, 2001, P NATL ACAD SCI USA, V98, P10499, DOI 10.1073/pnas.181304598; MOULD RM, 1991, J BIOL CHEM, V266, P17286; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Netzer WJ, 1998, TRENDS BIOCHEM SCI, V23, P68, DOI 10.1016/S0968-0004(97)01171-7; Perez-Rodriguez R, 2007, J MOL BIOL, V367, P715, DOI 10.1016/j.jmb.2007.01.027; Pop OI, 2003, J BIOL CHEM, V278, P38428, DOI 10.1074/jbc.M306516200; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; VACHEREAU A, 1989, ANAL BIOCHEM, V179, P206, DOI 10.1016/0003-2697(89)90227-3; Walker MB, 1999, J CELL BIOL, V147, P267, DOI 10.1083/jcb.147.2.267; Westermann M, 2006, BBA-BIOMEMBRANES, V1758, P443, DOI 10.1016/j.bbamem.2006.03.018	47	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33838	33845		10.1074/jbc.M806334200	http://dx.doi.org/10.1074/jbc.M806334200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18842584	Green Published, hybrid			2022-12-25	WOS:000261277700007
J	Huber, C; Martensson, A; Bokoch, GM; Nemazee, D; Gavin, AL				Huber, Christoph; Martensson, Annica; Bokoch, Gary M.; Nemazee, David; Gavin, Amanda L.			FGD2, a CDC42-specific Exchange Factor Expressed by Antigen-presenting Cells, Localizes to Early Endosomes and Active Membrane Ruffles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSION RATIO DISTORTION; FACIOGENITAL DYSPLASIA FGD1; DBL HOMOLOGY DOMAIN; MOUSE BONE-MARROW; DENDRITIC CELLS; RHO-GTPASES; SYNDROME GENE; SELECTIVE ACTIVATION; GDP/GTP EXCHANGE; STRUCTURAL BASIS	Members of the Fgd (faciogenital dysplasia) gene family encode a group of critical guanine nucleotide exchange factors (GEFs), which, by specifically activating Cdc42, control cytoskeleton-dependent membrane rearrangements. In its first characterization, we find that FGD2 is expressed in antigen-presenting cells, including B lymphocytes, macrophages, and dendritic cells. In the B lymphocyte lineage, FGD2 levels change with developmental stage. In both mature splenic B cells and immature bone marrow B cells, FGD2 expression is suppressed upon activation through the B cell antigen receptor. FGD2 has a complex intracellular localization, with concentrations found in membrane ruffles and early endosomes. Although endosomal localization of FGD2 is dependent on a conserved FYVE domain, its C-terminal pleckstrin homology domain mediates recruitment to membrane ruffles. FGD2 overexpression promotes the activation of Cdc42 and leads to elevated JNK1 activity in a Cdc42-but not Rac1-dependent fashion. These findings are consistent with a role of FGD2 in leukocyte signaling and vesicle trafficking in cells specialized to present antigen in the immune system.	[Huber, Christoph; Martensson, Annica; Bokoch, Gary M.; Nemazee, David; Gavin, Amanda L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Gavin, AL (corresponding author), 10550 N Torrey Pines Rd,IMM-29, La Jolla, CA 92037 USA.	agavin@scripps.edu			National Institutes of Health [R01AI033608, R01AI067403]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067403, R01AI033608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI033608 and R01AI067403. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bauer H, 2007, GENE DEV, V21, P143, DOI 10.1101/gad.414807; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Deruytter N, 2004, DIABETES, V53, P3323, DOI 10.2337/diabetes.53.12.3323; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Ducummon CC, 2006, ZYGOTE, V14, P249, DOI 10.1017/S0967199406003790; Egami Y, 2008, EXP CELL RES, V314, P729, DOI 10.1016/j.yexcr.2007.11.018; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Kim Y, 2002, GENES CELLS, V7, P413, DOI 10.1046/j.1365-2443.2002.00524.x; Kjeken R, 2001, BIOCHEM J, V357, P497, DOI 10.1042/0264-6021:3570497; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lyon MF, 2005, NAT GENET, V37, P924, DOI 10.1038/ng0905-924; Muller O, 2001, EMBO J, V20, P5657, DOI 10.1093/emboj/20.20.5657; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Nobes C, 2000, CURR BIOL, V10, pR739, DOI 10.1016/S0960-9822(00)00736-3; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Obaishi H, 1998, J BIOL CHEM, V273, P18697, DOI 10.1074/jbc.273.30.18697; Ono Y, 2000, ONCOGENE, V19, P3050, DOI 10.1038/sj.onc.1203631; Pasteris NG, 1999, GENOMICS, V60, P57, DOI 10.1006/geno.1999.5903; Pasteris NG, 2000, GENE, V242, P237, DOI 10.1016/S0378-1119(99)00518-1; PASTERIS NG, 1994, CELL, V79, P669; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Sanna MG, 1998, P NATL ACAD SCI USA, V95, P6015, DOI 10.1073/pnas.95.11.6015; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stendel C, 2007, AM J HUM GENET, V81, P158, DOI 10.1086/518770; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stofega Mary, 2006, V332, P269; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sutcliffe JG, 2000, P NATL ACAD SCI USA, V97, P1976, DOI 10.1073/pnas.040537997; VAIRO G, 1985, BIOCHEM BIOPH RES CO, V132, P430, DOI 10.1016/0006-291X(85)91040-X; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169; Zhou KM, 1998, J BIOL CHEM, V273, P16782, DOI 10.1074/jbc.273.27.16782; Zhu KJ, 2000, J BIOL CHEM, V275, P25993, DOI 10.1074/jbc.M003780200	56	38	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34002	34012		10.1074/jbc.M803957200	http://dx.doi.org/10.1074/jbc.M803957200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18838382	Green Published, hybrid			2022-12-25	WOS:000261277700027
J	Lim, YB; Park, TJ; Lim, IK				Lim, Young-Bin; Park, Tae Jun; Lim, In Kyoung			B Cell Translocation Gene 2 Enhances Susceptibility of HeLa Cells to Doxorubicin-induced Oxidative Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MESSENGER-RNA; UP-REGULATION; DNA-DAMAGE; EXPRESSION; GROWTH; TIS21; BTG2; CARDIOTOXICITY; OVEREXPRESSION	BTG2(/TIS21/PC3) (B cell translocation gene 2) has been known as a p53 target gene and functions as a tumor suppressor in carcinogenesis of thymus, prostate, kidney, and liver. Although it has been known that the expression of BTG2(/TIS21/PC3) is induced during chemotherapy-mediated apoptosis in cancer cells, a role of BTG2(/TIS21/PC3) in cell death remains to be elucidated. In this study, the mechanism and role of BTG2 involved in the enhancement of doxorubicin (DOXO)-induced cell death were examined. Treatment of HeLa cells with DOXO revealed apoptotic phenomena, such as chromatin condensation and cleavage of poly(ADP-ribose) polymerase and lamin A/C with concomitant increase of BTG2(/TIS21/PC3) expression. Employing infections of Ad-TIS21 virus and lentivirus with short hairpin RNA to BTG2, the effect of BTG2(/TIS21/PC3) on the DOXO-induced apoptosis of HeLa cells and liver cancer cells was evaluated. Not only short hairpin RNA-BTG2 but also N-acetyl-Lcysteine significantly reduced the DOXO-induced HeLa cell death and generation of H2O2. Moreover, forced expression of BTG2(/TIS21/PC3) using adenoviral vector augmented DOXO-induced cancer cell death concomitantly with increase of manganese-superoxide dismutase but not catalase, CuZnSOD, and glutathione peroxidase 1. The increased apoptosis by forced expression of BTG2(/TIS21/PC3) could be inhibited by N-acetyl-Lcysteine and polyethylene glycol-catalase. These results therefore suggest that BTG2(/TIS21/PC3) works as an enhancer of DOXO-induced cell death via accumulation of H2O2 by up-regulating manganese-superoxide dismutase without any other antioxidant enzymes. In summary, BTG2(/TIS21/PC3) enhances cancer cell death by accumulating H2O2 via imbalance of the antioxidant enzymes in response to chemotherapy.	[Lim, Young-Bin; Park, Tae Jun; Lim, In Kyoung] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea	Ajou University	Lim, IK (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea.	iklim@ajou.ac.kr			Korea Science and Engineering Foundation [R01-2006-000-10311-0, M10756040001-07N5604-00110]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Research Grants R01-2006-000-10311-0 and M10756040001-07N5604-00110 from the Korea Science and Engineering Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Bernard D, 2002, ONCOGENE, V21, P4392, DOI 10.1038/sj.onc.1205536; Bernard D, 2001, CANCER RES, V61, P2656; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Buettner GR, 2006, FREE RADICAL BIO MED, V41, P1338, DOI 10.1016/j.freeradbiomed.2006.07.015; Chen JG, 2003, CANCER RES, V63, P7891; Cortes U, 2000, MOL CARCINOGEN, V27, P57, DOI 10.1002/(SICI)1098-2744(200002)27:2<57::AID-MC1>3.3.CO;2-9; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELIOT H, 1984, BIOCHEMISTRY-US, V23, P928, DOI 10.1021/bi00300a021; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gardner R, 2002, FREE RADICAL BIO MED, V32, P1351, DOI 10.1016/S0891-5849(02)00861-4; Hong JW, 2005, J BIOL CHEM, V280, P21256, DOI 10.1074/jbc.M500318200; Islaih M, 2005, MUTAT RES-FUND MOL M, V578, P100, DOI 10.1016/j.mrfmmm.2005.04.012; Kim BC, 2008, STEM CELLS, V26, P2339, DOI 10.1634/stemcells.2008-0327; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kim SW, 2008, MOL CARCINOGEN, V47, P114, DOI 10.1002/mc.20369; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Lee YJ, 1997, BLOOD, V89, P4480, DOI 10.1182/blood.V89.12.4480; Li N, 1998, PROSTATE, V35, P221, DOI 10.1002/(SICI)1097-0045(19980515)35:3<221::AID-PROS8>3.0.CO;2-J; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LIM IK, 1995, J CANCER RES CLIN, V121, P279, DOI 10.1007/BF01209594; Lim IK, 1998, MOL CARCINOGEN, V23, P25, DOI 10.1002/(SICI)1098-2744(199809)23:1<25::AID-MC4>3.0.CO;2-G; LIM RW, 1987, ONCOGENE, V1, P263; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Minotti G, 1999, FASEB J, V13, P199, DOI 10.1096/fasebj.13.2.199; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Pani G, 2000, CANCER RES, V60, P4654; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Park TJ, 2008, HEPATOLOGY, V47, P1533, DOI 10.1002/hep.22212; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Ryu MS, 2004, EXP CELL RES, V299, P159, DOI 10.1016/j.yexcr.2004.05.014; SCOTT MD, 1989, J BIOL CHEM, V264, P2498; SCOTT MD, 1987, J BIOL CHEM, V262, P3640; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tokarska-Schlattner M, 2006, J MOL CELL CARDIOL, V41, P389, DOI 10.1016/j.yjmcc.2006.06.009; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; ZALESKIS G, 1994, MOL PHARMACOL, V46, P901; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	44	33	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33110	33118		10.1074/jbc.M804255200	http://dx.doi.org/10.1074/jbc.M804255200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18840609	hybrid, Green Published			2022-12-25	WOS:000261183700012
J	Panahandeh, S; Maurer, C; Moser, M; DeLisa, MP; Muller, M				Panahandeh, Sascha; Maurer, Carlo; Moser, Michael; DeLisa, Matthew P.; Mueller, Matthias			Following the Path of a Twin-arginine Precursor along the TatABC Translocase of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SEC-INDEPENDENT PROTEIN; FOLDING QUALITY-CONTROL; SIGNAL PEPTIDE BINDING; IN-VIVO; TRANSPORT COMPLEXES; TATC FORM; SYSTEM; COMPONENT; EXPORT	The twin-arginine translocation (Tat) machinery present in bacterial and thylakoidal membranes is able to transport fully folded proteins. Consistent with previous in vivo data, we show that the model Tat substrate TorA-PhoA is translocated by the TatABC translocase of Escherichia coli inner membrane vesicles, only if the PhoA moiety was allowed to fold by disulfide bond formation. Although even unfolded TorA-PhoA was found to physically associate with the Tat translocase of the vesicles, site-specific cross-linking revealed a perturbed interaction of the signal sequence of unfolded TorA-PhoA with the TatBC receptor site. Some of the folded TorA-PhoA precursor accumulated in a partially protease-protected membrane environment, from where it could be translocated into the lumen of the vesicles upon re-installation of an H+-gradient. Translocation arrest occurred in immediate vicinity to TatA. Consistent with a neighborhood to TatA, TorA-PhoA remained protease-resistant in the presence of detergents that are known to preserve the oligomeric structures of TatA. Moreover, entry of TorA-PhoA to the protease-protected environment strictly required the presence of TatA. Collectively, our results are consistent with some degree of quality control by TatBC and a recruitment of TatA to a folded substrate that has functionally engaged the twin-arginine translocase.	[Panahandeh, Sascha] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	University of Freiburg; Cornell University		matthias.mueller@biochemie.uni-freiburg.de	DeLisa, Matthew/AAE-7361-2019	Maurer, H. Carlo/0000-0002-2193-6014; DeLisa, Matthew/0000-0003-3226-1566	European Union [LSHG-CT-2004-005257]; Deutsche Forschungsgemeinschaft; University of Freiburg; NSF [0449080]; NYSTAR James D. Watson Award	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Freiburg; NSF(National Science Foundation (NSF)); NYSTAR James D. Watson Award	This work was supported by Grant LSHG-CT-2004-005257 of the European Union (to S. P. and M. M.), grants from the Deutsche Forschungsgemeinschaft (Collaborative Research Centres 388 and 746, to M. M.), an F. F. Nord fellowship of the University of Freiburg (to C. M.), and an NSF Career Award (CBET 0449080) and a NYSTAR James D. Watson Award (both to M. P. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alder NN, 2003, FEBS LETT, V540, P96, DOI 10.1016/S0014-5793(03)00231-X; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Barrett CML, 2007, J BIOL CHEM, V282, P36206, DOI 10.1074/jbc.M704127200; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Di Cola A, 2005, J CELL BIOL, V171, P281, DOI 10.1083/jcb.200502067; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hatzixanthis K, 2005, P NATL ACAD SCI USA, V102, P8460, DOI 10.1073/pnas.0500737102; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; McDevitt CA, 2005, BIOCHEM BIOPH RES CO, V329, P693, DOI 10.1016/j.bbrc.2005.02.038; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mendel S, 2008, J MOL BIOL, V375, P661, DOI 10.1016/j.jmb.2007.09.087; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Moser Michael, 2007, V390, P63; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	52	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33267	33275		10.1074/jbc.M804225200	http://dx.doi.org/10.1074/jbc.M804225200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18836181	hybrid, Green Published			2022-12-25	WOS:000261183700030
J	Walker, A; Skamel, C; Vorreiter, J; Nassal, M				Walker, Andreas; Skamel, Claudia; Vorreiter, Jolanta; Nassal, Michael			Internal Core Protein Cleavage Leaves the Hepatitis B Virus Capsid Intact and Enhances Its Capacity for Surface Display of Heterologous Whole Chain Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ELECTRON CRYOMICROSCOPY; 3-DIMENSIONAL STRUCTURE; ANTIGENIC DETERMINANTS; MONOCLONAL-ANTIBODIES; STRUCTURAL MODEL; LYME BORRELIOSIS; PARTICLES CLPS; CELL EPITOPES; WILD-TYPE	Virus capsids find increasing use as nanoparticulate platforms for the surface display of heterologous ligands, including as multivalent vaccine carriers. Presentation on the icosahedral hepatitis B virus capsid (HBcAg) is known to strongly enhance immunogenicity of foreign sequences, most efficiently if they are inserted into the dominant c/el B cell epitope, a surface-exposed loop in the center of the constituent core protein primary sequence. Even some complete proteins were successfully inserted but others, e. g. the outer surface protein A (OspA) of the Lyme disease agent Borrelia burgdorferi, impaired formation of capsid-like particles (CLPs). This difference can be rationalized by the requirement for the termini of the insert to fit into the predetermined geometry of the two acceptor sites in the carrier. We reasoned that cleavage of one of the two bonds connecting insert and carrier should relieve these constraints, provided the cleaved protein fragments remain competent to support the particle structure. Indeed, HBcAg CLPs containing a recognition site for tobacco etch virus (TEV) protease in the c/el loop remained intact after cleavage, as did CLPs carrying a 65-residue peptide insertion. Most importantly, in situ cleavage of a core-OspA fusion protein by coexpressed TEV protease strongly enhanced CLP formation compared with the uncleaved protein. These data attest to the high structural stability of the HBcAg CLP and they significantly widen its applicability as a carrier for heterologous proteins. This approach should be adaptable to any protein-based particle with surface-exposed yet sequence-internal loops.	[Walker, Andreas; Skamel, Claudia; Vorreiter, Jolanta; Nassal, Michael] Univ Hosp Freiburg, Dept Internal Med, D-79106 Freiburg, Germany; [Walker, Andreas] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Nassal, M (corresponding author), Univ Hosp Freiburg, Dept Internal Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	nassal2@ukl.uni-freiburg.de	Nassal, Michael/U-4529-2019	Nassal, Michael/0000-0003-2204-9158; Walker, Andreas/0000-0002-8736-0863	Deutsche Forschungsgemeinschaft [NA 154/6-2, 154/8-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (NA 154/6-2 and 154/8-3 within the Priority program SPP 1089 Novel Vaccination Strategies). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amexis G, 2006, J INFECT DIS, V194, P790, DOI 10.1086/506361; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Belnap DM, 2003, P NATL ACAD SCI USA, V100, P10884, DOI 10.1073/pnas.1834404100; BICHKO V, 1993, MOL IMMUNOL, V30, P221, DOI 10.1016/0161-5890(93)90051-C; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bottcher B, 2006, J MOL BIOL, V356, P812, DOI 10.1016/j.jmb.2005.11.053; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Bourne CR, 2006, J VIROL, V80, P11055, DOI 10.1128/JVI.00933-06; Chatterji A, 2002, INTERVIROLOGY, V45, P362, DOI 10.1159/000067929; Conway JF, 1998, J MOL BIOL, V279, P1111, DOI 10.1006/jmbi.1998.1845; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; Ding W, 2000, J MOL BIOL, V302, P1153, DOI 10.1006/jmbi.2000.4119; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Fehr T, 1998, P NATL ACAD SCI USA, V95, P9477, DOI 10.1073/pnas.95.16.9477; Freivalds J, 2006, J BIOTECHNOL, V123, P297, DOI 10.1016/j.jbiotec.2005.11.013; Harris A, 2006, J MOL BIOL, V355, P562, DOI 10.1016/j.jmb.2005.10.035; Hilmer JK, 2008, J MOL BIOL, V375, P581, DOI 10.1016/j.jmb.2007.10.044; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KENNEY JM, 1995, STRUCTURE, V3, P1009, DOI 10.1016/S0969-2126(01)00237-4; Kondo K, 2008, J MED VIROL, V80, P841, DOI 10.1002/jmv.21124; Konig S, 1998, J VIROL, V72, P4997; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; Manayani DJ, 2007, PLOS PATHOG, V3, P1422, DOI 10.1371/journal.ppat.0030142; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Nassal M, 2005, EUR J IMMUNOL, V35, P655, DOI 10.1002/eji.200425449; NASSAL M, 1988, GENE, V66, P279, DOI 10.1016/0378-1119(88)90364-2; NASSAL M, 1992, J MOL BIOL, V225, P1013, DOI 10.1016/0022-2836(92)90101-O; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2008, INT J MED MICROBIOL, V298, P135, DOI 10.1016/j.ijmm.2007.08.002; Nassal M, 2007, J VIROL, V81, P13218, DOI 10.1128/JVI.00846-07; Newman M, 2003, J VIROL, V77, P12950, DOI 10.1128/JVI.77.24.12950-12960.2003; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; PUSHKO P, 1994, VIROLOGY, V202, P912, DOI 10.1006/viro.1994.1413; Rai P, 2006, NAT BIOTECHNOL, V24, P582, DOI 10.1038/nbt1204; Roseman AM, 2005, P NATL ACAD SCI USA, V102, P15821, DOI 10.1073/pnas.0504874102; Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; SCHAIBLE UE, 1990, P NATL ACAD SCI USA, V87, P3768, DOI 10.1073/pnas.87.10.3768; SERWER P, 1995, J CHROMATOGR A, V698, P251, DOI 10.1016/0021-9673(94)01259-H; Singh P, 2006, DRUG DEVELOP RES, V67, P23, DOI 10.1002/ddr.20064; Singh S, 2003, J BIOL CHEM, V278, P18249, DOI 10.1074/jbc.M211408200; Skamel C, 2006, J BIOL CHEM, V281, P17474, DOI 10.1074/jbc.M513571200; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; Taylor KM, 2000, J MOL RECOGNIT, V13, P71; Ulrich R, 1998, ADV VIRUS RES, V50, P141, DOI 10.1016/S0065-3527(08)60808-8; Vogel M, 2005, FEBS LETT, V579, P5211, DOI 10.1016/j.febslet.2005.08.044; Vogel M, 2005, PROTEINS, V58, P478, DOI 10.1002/prot.20312; Voronkova T, 2002, VIRAL IMMUNOL, V15, P627, DOI 10.1089/088282402320914557; Watts NR, 2002, EMBO J, V21, P876, DOI 10.1093/emboj/21.5.876; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zlotnick A, 2003, VIROLOGY, V315, P269, DOI 10.1016/S0042-6822(03)00586-5	61	22	24	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33508	33515		10.1074/jbc.M805211200	http://dx.doi.org/10.1074/jbc.M805211200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826949	hybrid, Green Published			2022-12-25	WOS:000261183700055
J	Wu, XL; Lemon, B; Li, XF; Gupte, J; Weiszmann, J; Stevens, J; Hawkins, N; Shen, WY; Lindberg, R; Chen, JL; Tian, H; Li, Y				Wu, Xinle; Lemon, Bryan; Li, XiaoFan; Gupte, Jamila; Weiszmann, Jennifer; Stevens, Jennitte; Hawkins, Nessa; Shen, Wenyan; Lindberg, Richard; Chen, Jin-Long; Tian, Hui; Li, Yang			C-terminal Tail of FGF19 Determines Its Specificity toward Klotho Co-receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-KLOTHO; METABOLIC-ACTIVITY; STRUCTURAL BASIS; FIBROBLAST; EXPRESSION; MICE; FIBROBLAST-GROWTH-FACTOR-21; PHOSPHATE; FAMILY; GENE	FGF19 subfamily proteins (FGF19, FGF21, and FGF23) are unique members of fibroblast growth factors (FGFs) that regulate energy, bile acid, glucose, lipid, phosphate, and vitamin D homeostasis in an endocrine fashion. Their activities require the presence of alpha or beta Klotho, two related single-pass transmembrane proteins, as co-receptors in relevant target tissues. We previously showed that FGF19 can bind to both alpha and beta Klotho, whereas FGF21 and FGF23 can bind only to either beta Klotho or alpha Klotho, respectively in vitro. To determine the mechanism regulating the binding and specificity among FGF19 subfamily members to Klotho family proteins, chimeric proteins between FGF19 subfamily members or chimeric proteins between Klotho family members were constructed to probe the interaction between those two families. Our results showed that a chimera of FGF19 with the FGF21 C-terminal tail interacts only with beta Klotho and a chimera with the FGF23 C-terminal tail interacts only with alpha Klotho. FGF signaling assays also reflected the change of specificity we observed for the chimeras. These results identified the C-terminal tail of FGF19 as a region necessary for its recognition of Klotho family proteins. In addition, chimeras between alpha and beta Klotho were also generated to probe the regions in Klotho proteins that are important for signaling by this FGF subfamily. Both FGF23 and FGF21 require intact alpha or beta Klotho for signaling, respectively, whereas FGF19 can signal through a Klotho chimera consisting of the N terminus of alpha Klotho and the C terminus of beta Klotho. Our results provide the first glimpse of the regions that regulate the binding specificity between this unique family of FGFs and their co-receptors.	[Wu, Xinle; Lemon, Bryan; Li, XiaoFan; Gupte, Jamila; Weiszmann, Jennifer; Shen, Wenyan; Chen, Jin-Long; Tian, Hui; Li, Yang] Amgen Inc, San Francisco, CA 94080 USA; [Stevens, Jennitte; Hawkins, Nessa; Lindberg, Richard] Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Li, Y (corresponding author), Amgen Inc, San Francisco, CA 94080 USA.	yangl@amgen.com						Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683	18	67	121	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33304	33309		10.1074/jbc.M803319200	http://dx.doi.org/10.1074/jbc.M803319200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829467	Green Published, hybrid			2022-12-25	WOS:000261183700034
J	Asquith, B				Asquith, Becca			The Evolutionary Selective Advantage of HIV-1 Escape Variants and the Contribution of Escape to the HLA-Associated Risk of AIDS Progression	PLOS ONE			English	Article								HIV-1 escape from surveillance by cytotoxic T lymphocytes (CTL) is thought to cause at least transient weakening of immune control. However, the CTL response is highly adaptable and the long-term consequences of viral escape are not fully understood. The objective of this study was to address the question "to what extent does HIV-1 escape from CTL contribute to HLA-associated AIDS progression?'' We combined an analysis of 21 escape events in longitudinally-studied HIV-1 infected people with a population-level analysis of the functional CTL response in 150 subjects (by IFNg ELISpot) and an analysis of the HIV-1 sequence database to quantify the contribution of escape to the HLA-associated rate of AIDS progression. We found that CTL responses restricted by protective HLA class I alleles, which are associated with slow progression to AIDS, recognised epitopes where escape variants had a weak evolutionary selective advantage (P=0.008) and occurred infrequently (P=0.017). Epitopes presented by protective HLA class I alleles were more likely to elicit a CTL response (P=0.001) and less likely to contain sequence variation (P=0.006). A third of between-individual variation in HLA-associated disease risk was predicted by the selective advantage of escape variants: a doubling in the evolutionary selective advantage was associated with a decrease in the AIDS-free period of 1.2 yrs. These results contribute to our understanding of what makes a CTL response protective and why some individuals progress to AIDS more rapidly than others.	[Asquith, Becca] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England	Imperial College London	Asquith, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England.	b.asquith@imperial.ac.uk		Asquith, Becca/0000-0002-5911-3160	RCUK; Medical Research Council [G0601072] Funding Source: researchfish; MRC [G0601072] Funding Source: UKRI	RCUK(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by RCUK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Asquith B, 2007, P NATL ACAD SCI USA, V104, P6365, DOI 10.1073/pnas.0700666104; BAILEY JR, 2006, J EXP MED; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Ganusov VV, 2006, PLOS COMPUT BIOL, V2, P182, DOI 10.1371/journal.pcbi.0020024; Geels MJ, 2006, VIROLOGY, V345, P209, DOI 10.1016/j.virol.2005.09.023; Geels MJ, 2003, J VIROL, V77, P12430, DOI 10.1128/JVI.77.23.12430-12440.2003; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Jamieson BD, 2003, J IMMUNOL, V171, P5372, DOI 10.4049/jimmunol.171.10.5372; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kent SJ, 2005, TRENDS MICROBIOL, V13, P243, DOI 10.1016/j.tim.2005.03.011; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOENIG WJ, 1995, PLAST RECONSTR SURG, V95, P1; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Marsh S. G. E., 2000, HLA FACTSBOOK; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Milicic A, 2005, J VIROL, V79, P13953, DOI 10.1128/JVI.79.22.13953-13962.2005; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; MUNOZ A, 1989, AM J EPIDEMIOL, V130, P530, DOI 10.1093/oxfordjournals.aje.a115367; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Oxenius A, 2004, J INFECT DIS, V190, P713, DOI 10.1086/422760; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; Schreuder GMT, 2005, HUM IMMUNOL, V66, P170, DOI 10.1016/j.humimm.2004.09.017; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Silvestri G, 2003, J CLIN INVEST, V112, P821, DOI 10.1172/JCI200319799; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	47	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3486	10.1371/journal.pone.0003486	http://dx.doi.org/10.1371/journal.pone.0003486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941529	Green Published, Green Submitted, gold			2022-12-25	WOS:000265126100017
J	Yuan, CH; He, QY; Peng, K; Diao, JB; Jiang, LP; Tang, X; Liang, SP				Yuan, Chun-Hua; He, Quan-Yuan; Peng, Kuan; Diao, Jian-Bo; Jiang, Li-Ping; Tang, Xing; Liang, Song-Ping			Discovery of a Distinct Superfamily of Kunitz-Type Toxin (KTT) from Tarantulas	PLOS ONE			English	Article								Background: Kuntiz-type toxins (KTTs) have been found in the venom of animals such as snake, cone snail and sea anemone. The main ancestral function of Kunitz-type proteins was the inhibition of a diverse array of serine proteases, while toxic activities (such as ion-channel blocking) were developed under a variety of Darwinian selection pressures. How new functions were grafted onto an old protein scaffold and what effect Darwinian selection pressures had on KTT evolution remains a puzzle. Principal Findings: Here we report the presence of a new superfamily of KTTs in spiders (Tarantulas: Ornithoctonus huwena and Ornithoctonus hainana), which share low sequence similarity to known KTTs and is clustered in a distinct clade in the phylogenetic tree of KTT evolution. The representative molecule of spider KTTs, HWTX-XI, purified from the venom of O. huwena, is a bi-functional protein which is a very potent trypsin inhibitor (about 30-fold more strong than BPTI) as well as a weak Kv1.1 potassium channel blocker. Structural analysis of HWTX-XI in 3-D by NMR together with comparative function analysis of 18 expressed mutants of this toxin revealed two separate sites, corresponding to these two activities, located on the two ends of the cone-shape molecule of HWTX-XI. Comparison of non-synonymous/synonymous mutation ratios (v) for each site in spider and snake KTTs, as well as PBTI like body Kunitz proteins revealed high Darwinian selection pressure on the binding sites for Kv channels and serine proteases in snake, while only on the proteases in spider and none detected in body proteins, suggesting different rates and patterns of evolution among them. The results also revealed a series of key events in the history of spider KTT evolution, including the formation of a novel KTT family (named sub-Kuntiz-type toxins) derived from the ancestral native KTTs with the loss of the second disulfide bridge accompanied by several dramatic sequence modifications. Conclusions/Significance: These finding illustrate that the two activity sites of Kunitz-type toxins are functionally and evolutionally independent and provide new insights into effects of Darwinian selection pressures on KTT evolution, and mechanisms by which new functions can be grafted onto old protein scaffolds.	[Yuan, Chun-Hua; He, Quan-Yuan; Peng, Kuan; Diao, Jian-Bo; Jiang, Li-Ping; Tang, Xing; Liang, Song-Ping] Hunan Normal Univ, Key Lab Prot Chem & Dev Biol, Minist Educ, Coll Life Sci, Changsha, Hunan, Peoples R China	Hunan Normal University	Yuan, CH (corresponding author), Hunan Normal Univ, Key Lab Prot Chem & Dev Biol, Minist Educ, Coll Life Sci, Changsha, Hunan, Peoples R China.	liangsp@hunnu.edu.cn			National Natural Science Foundation of China [30170193, 30430170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (30170193, 30430170)to SP Liang.	Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; BERNDT KD, 1992, J MOL BIOL, V227, P757, DOI 10.1016/0022-2836(92)90222-6; BERNDT KD, 1993, J MOL BIOL, V234, P735, DOI 10.1006/jmbi.1993.1623; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CREIGHTON TE, 1992, SCIENCE, V256, P111, DOI 10.1126/science.1373519; DEISENHOFER J, 1975, ACTA CRYSTALLOGR B, V31, P238, DOI 10.1107/S0567740875002415; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diao JB, 2003, TOXICON, V42, P715, DOI 10.1016/j.toxicon.2003.08.007; Dy CY, 2006, ACTA CRYSTALLOGR D, V62, P980, DOI [10.1107/S0907444906021123, 10.1107/S0907444906021122]; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Gasparini S, 1998, J BIOL CHEM, V273, P25393, DOI 10.1074/jbc.273.39.25393; He QY, 2008, NUCLEIC ACIDS RES, V36, pD293, DOI 10.1093/nar/gkm832; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KASSELL B, 1965, BIOCHEM BIOPH RES CO, V18, P255, DOI 10.1016/0006-291X(65)90749-7; Katoh E, 2000, BIOPOLYMERS, V54, P44, DOI 10.1002/(SICI)1097-0282(200007)54:1<44::AID-BIP50>3.0.CO;2-Z; King GF, 2004, TOXICON, V43, P471, DOI 10.1016/j.toxicon.2004.02.001; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LANCELIN JM, 1994, NAT STRUCT BIOL, V1, P246, DOI 10.1038/nsb0494-246; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Otlewski J, 2001, ACTA BIOCHIM POL, V48, P419; Sasaki SD, 2004, BIOCHIMIE, V86, P643, DOI 10.1016/j.biochi.2004.09.010; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; SKARZYNSKI T, 1992, J MOL BIOL, V224, P671, DOI 10.1016/0022-2836(92)90552-U; SOKOLOVSKY M, 1992, J NEUROCHEM, V59, P809, DOI 10.1111/j.1471-4159.1992.tb08318.x; STRYDOM DJ, 1977, BIOCHIM BIOPHYS ACTA, V491, P361, DOI 10.1016/0005-2795(77)90279-3; STRYDOM DJ, 1973, NATURE-NEW BIOL, V243, P88; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang FC, 1999, EUR J BIOCHEM, V263, P222, DOI 10.1046/j.1432-1327.1999.00494.x; WANG JF, 1993, ACTA SCI NAT U NORM, V16, P4; Xiao YC, 2004, J BIOL CHEM, V279, P26220, DOI 10.1074/jbc.M401387200; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yuan CH, 2007, J PROTEOME RES, V6, P2792, DOI 10.1021/pr0700192; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	45	93	130	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3414	10.1371/journal.pone.0003414	http://dx.doi.org/10.1371/journal.pone.0003414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923708	Green Published, gold, Green Submitted			2022-12-25	WOS:000265121800012
J	Daetwyler, HD; Villanueva, B; Woolliams, JA				Daetwyler, Hans D.; Villanueva, Beatriz; Woolliams, John A.			Accuracy of Predicting the Genetic Risk of Disease Using a Genome-Wide Approach	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; TRAITS; LOCI; SUSCEPTIBILITY; ASSOCIATION	Background: The prediction of the genetic disease risk of an individual is a powerful public health tool. While predicting risk has been successful in diseases which follow simple Mendelian inheritance, it has proven challenging in complex diseases for which a large number of loci contribute to the genetic variance. The large numbers of single nucleotide polymorphisms now available provide new opportunities for predicting genetic risk of complex diseases with high accuracy. Methodology/Principal Findings: We have derived simple deterministic formulae to predict the accuracy of predicted genetic risk from population or case control studies using a genome-wide approach and assuming a dichotomous disease phenotype with an underlying continuous liability. We show that the prediction equations are special cases of the more general problem of predicting the accuracy of estimates of genetic values of a continuous phenotype. Our predictive equations are responsive to all parameters that affect accuracy and they are independent of allele frequency and effect distributions. Deterministic prediction errors when tested by simulation were generally small. The common link among the expressions for accuracy is that they are best summarized as the product of the ratio of number of phenotypic records per number of risk loci and the observed heritability. Conclusions/Significance: This study advances the understanding of the relative power of case control and population studies of disease. The predictions represent an upper bound of accuracy which may be achievable with improved effect estimation methods. The formulae derived will help researchers determine an appropriate sample size to attain a certain accuracy when predicting genetic risk.	[Daetwyler, Hans D.; Woolliams, John A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Daetwyler, Hans D.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Villanueva, Beatriz] Scottish Agr Coll, Sustainable Livestock Syst, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Wageningen University & Research; Scottish Agricultural College	Daetwyler, HD (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	hans.daetwyler@roslin.ed.ac.uk	Daetwyler, Hans D/H-9775-2019	Daetwyler, Hans D/0000-0002-3018-3640	Marie Curie Host Fellowships; Scottish Executive Environment and Rural Affairs Department (SEERAD); Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish; BBSRC [BBS/E/D/05191133] Funding Source: UKRI	Marie Curie Host Fellowships(European Commission); Scottish Executive Environment and Rural Affairs Department (SEERAD); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HDD is supported by the SABRETRAIN Project, which is funded by the Marie Curie Host Fellowships for Early Stage Research Training, as part of the 6th Framework Program of the European Commission. BV receives support from the Scottish Executive Environment and Rural Affairs Department (SEERAD), and JAW receives funding from the Biotechnology and Biological Sciences Research Council (BBSRC).	Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bijma P, 1999, GENETICS, V151, P1197; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chamberlain AJ, 2007, GENETICS, V177, P1117, DOI 10.1534/genetics.107.077784; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; Falconer D. S, 1996, INTRO QUANTITATIVE G; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Lynch M., 1998, GENETICS ANAL QUANTI; McRae AF, 2002, GENETICS, V160, P1113; Meuwissen THE, 2001, GENETICS, V157, P1819; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; RISCH N, 1991, AM J HUM GENET, V48, P1058; ROBERTSON A, 1961, GENET RES, V2, P189, DOI 10.1017/S0016672300000690; ROBERTSON A, 1949, GENETICS, V34, P395; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; SHRINER D, 2008, NUCLEIC ACIDS RES, P36; SOLBERG TR, 2008, J ANIMAL SC IN PRESS; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Xu SZ, 2003, GENETICS, V163, P789; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589	30	448	461	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3395	10.1371/journal.pone.0003395	http://dx.doi.org/10.1371/journal.pone.0003395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852893	gold, Green Published, Green Submitted			2022-12-25	WOS:000265121700004
J	Vargas, AO; Kohlsdorf, T; Fallon, JF; VandenBrooks, J; Wagner, GP				Vargas, Alexander O.; Kohlsdorf, Tiana; Fallon, John F.; VandenBrooks, John; Wagner, Guenter P.			The Evolution of HoxD-11 Expression in the Bird Wing: Insights from Alligator mississippiensis	PLOS ONE			English	Article							LIMB DEVELOPMENT; GENE-EXPRESSION; SONIC-HEDGEHOG; DIGIT IDENTITY; SHH; HOMOLOGY; ORIGIN; BUD	Background: Comparative morphology identifies the digits of the wing of birds as 1,2 and 3, but they develop at embryological positions that become digits 2, 3 and 4 in other amniotes. A hypothesis to explain this is that a homeotic frame shift of digital identity occurred in the evolution of the bird wing, such that digits 1,2 and 3 are developing from embryological positions 2, 3 and 4. Digit 1 of the mouse is the only digit that shows no late expression of HoxD-11. This is also true for the anterior digit of the bird wing, suggesting this digit is actually a digit 1. If this is the case, we can expect closer relatives of birds to show no HoxD-11 expression only in digit 1. To test this prediction we investigate HoxD-11 expression in crocodilians, the closest living relatives of birds. Methodology/Principal Findings: Using degenerate primers we cloned a 606 nucleotide fragment of exon 1 of the alligator HoxD-11 gene and used it for whole-mount in-situ detection in alligator embryos. We found that in the pentadactyl forelimbs of alligator, as in the mouse, late expression of HoxD-11 is absent only in digit 1. Conclusions/Significance: The ancestral condition for amniotes is that late-phase HoxD-11 expression is absent only in digit 1. The biphalangeal morphology and lack of HoxD-11 expression of the anterior digit of the wing is like digit 1 of alligator and mouse, but its embryological position as digit 2 is derived. HoxD-11 expression in alligator is consistent with the hypothesis that both digit morphology as well as HoxD-11 expression are shifted towards posterior in the bird wing.	[Vargas, Alexander O.; Kohlsdorf, Tiana; Wagner, Guenter P.] Yale Univ, Dept Ecol & Evol Biol, New Haven, CT 06520 USA; [Fallon, John F.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [VandenBrooks, John] Yale Peabody Mus Nat Hist, Dept Geol & Geophys, New Haven, CT USA	Yale University; University of Wisconsin System; University of Wisconsin Madison	Vargas, AO (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile.	thearchosaur@gmail.com	Vargas, Alexander O/L-3788-2017; Kohlsdorf, Tiana/C-3463-2012	Kohlsdorf, Tiana/0000-0002-3873-2042; Wagner, Gunter/0000-0002-3097-002X; Vargas, Alexander/0000-0002-2009-7116	NSF [IOB 002488]; PEW Latin American Program of fellowships in Biomedical sciences	NSF(National Science Foundation (NSF)); PEW Latin American Program of fellowships in Biomedical sciences	Financial support came from NSF grant IOB 002488. Alexander Vargas is a fellow of PEW Latin American Program of fellowships in Biomedical sciences.	Blanco MJ, 1998, DEV GENES EVOL, V208, P175, DOI 10.1007/s004270050172; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Chatterjee S, 1998, SCIENCE, V280, DOI 10.1126/science.280.5362.355a; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Davis AP, 1996, DEVELOPMENT, V122, P1175; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; DONOGHUE MJ, 1989, EVOLUTION, V43, P1137, DOI [10.2307/2409353, 10.1111/j.1558-5646.1989.tb02565.x]; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Lee MSY, 2004, ASSEMBLING THE TREE OF LIFE, P451; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; MULLER GB, 1990, J MORPHOL, V203, P151, DOI 10.1002/jmor.1052030204; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Reno PL, 2008, J EXP ZOOL PART B, V310B, P240, DOI 10.1002/jez.b.21207; Romer AS, 1950, VERTEBRATE BODY; Shapiro Michael D., 2007, P225; Shubin N., 1994, INTERPRETING HIERARC, P201; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P86, DOI 10.1002/jez.b.21023; Wagner GP, 2005, THEOR BIOSCI, V124, P165, DOI 10.1016/j.thbio.2005.07.002; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; Wagner GP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-213; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695	34	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3325	10.1371/journal.pone.0003325	http://dx.doi.org/10.1371/journal.pone.0003325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833328	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797400003
J	Zou, HF; Thomas, SM; Yan, ZW; Grandis, JR; Vogt, A; Li, LY				Zou, Huafei; Thomas, Sufi M.; Yan, Zhen-Wen; Grandis, Jennifer R.; Vogt, Andreas; Li, Lu-Yuan			Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells	FASEB JOURNAL			English	Article						siRNA; mitogenesis; oncogenesis; secretion; therapeutic	GASTRIN-RELEASING-PEPTIDE; PROTEIN-COUPLED RECEPTORS; TGF-ALPHA; TYROSINE PHOSPHORYLATION; EPITHELIAL-CELLS; TUMOR-GROWTH; NUDE-MICE; ACTIVATION; DROSOPHILA; EXPRESSION	Epidermal growth factor receptor (EGFR) is an activated oncogene in many cancers. It can be transactivated by ligands of G protein-coupled receptors (GPCRs). We show here that a novel gene, human rhomboid family-1 (RHBDF1), which was recently reported to have a pivotal role in epithelial cancer cell growth in culture and in xenograft tumors, participates in the modulation of GPCR-mediated EGFR transactivation. The RHBDF1 protein localizes mainly in the endoplasmic reticulum. Silencing the RHBDF1 gene in head and neck squamous cancer cell line 1483 cells with siRNA causes an inhibition of gastrin-releasing peptide (GRP) -induced phosphorylation of EGFR and EGFR-dependent signaling proteins p44/42 MAPK and AKT, accompanied by an inhibition of GRP-induced survival, proliferation, and invasion of the cells. The EGFR signaling pathway itself remains intact, however, as the cells remain responsive to exogenous EGF. In addition, RHBDF1 gene silencing disrupts GRP-stimulated secretion of EGFR ligand TGF-alpha, but not the production of latent TGF-alpha, whereas engineered overexpression of RHBDF1 markedly accelerates the secretion of TGF-alpha. These findings are consistent with the view that RHBDF1 is critically involved in a GPCR ligand-stimulated process leading to the activation of latent EGFR ligands. - Zou, H., Thomas, S. M., Yan, Z.-W., Grandis, J. R., Vogt, A., Li, L.-Y. Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells. FASEB J. 23, 425-432 (2009)	[Zou, Huafei; Thomas, Sufi M.; Yan, Zhen-Wen; Grandis, Jennifer R.; Vogt, Andreas; Li, Lu-Yuan] Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA; [Zou, Huafei; Yan, Zhen-Wen; Li, Lu-Yuan] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Thomas, Sufi M.; Grandis, Jennifer R.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Vogt, Andreas] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, LY (corresponding author), Univ Pittsburgh, Pittsburgh Canc Inst, 5117 Ctr Ave,G12C, Pittsburgh, PA 15213 USA.	lil@upmc.edu	Thomas, Sufi Mary/AFR-1642-2022; Li, Luyuan/E-8951-2012; Thomas, Sufi/O-1487-2018	Thomas, Sufi Mary/0000-0001-5370-0842; Thomas, Sufi/0000-0001-5370-0842	Flight Attendant Medical Research Institute; Henry L. Hillman Foundation; Pennsylvania Department of Health;  [DOD BC073645];  [P01CA78039];  [P50CA097190];  [R01CA098372]; NATIONAL CANCER INSTITUTE [R01CA098372, P01CA078039, P50CA097190] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; Henry L. Hillman Foundation; Pennsylvania Department of Health; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study has been supported in part by grants from Flight Attendant Medical Research Institute (L.Y.L.), the Henry L. Hillman Foundation (L.Y.L.), Pennsylvania Department of Health (L.Y.L.), DOD BC073645 (L.Y.L.), P01CA78039 (A.V.), P50CA097190 (J.R.G.) and R01CA098372 (J.R.G.).	AKIYAMA T, 1985, BIOCHEM BIOPH RES CO, V131, P442, DOI 10.1016/0006-291X(85)91822-4; BERGER MS, 1987, BRIT J CANCER, V56, P533, DOI 10.1038/bjc.1987.238; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Chatzistamou I, 2001, CANCER LETT, V171, P37, DOI 10.1016/S0304-3835(01)00543-2; Culi J, 2004, EMBO J, V23, P1372, DOI 10.1038/sj.emboj.7600132; DEMICHELE MAA, 1994, AM J RESP CELL MOL, V11, P66, DOI 10.1165/ajrcmb.11.1.8018339; Emens Leisha A, 2005, Am J Ther, V12, P243; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Golembo M, 1996, DEVELOPMENT, V122, P3363; Grandis JR, 1996, NAT MED, V2, P237, DOI 10.1038/nm0296-237; GULLICK WJ, 1991, BRIT MED BULL, V47, P87, DOI 10.1093/oxfordjournals.bmb.a072464; Harris A L, 1992, J Natl Cancer Inst Monogr, P181; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Kersemaekers AMF, 1999, CLIN CANCER RES, V5, P577; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; Lango MN, 2002, J NATL CANCER I, V94, P375; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lui VWY, 2003, ONCOGENE, V22, P6183, DOI 10.1038/sj.onc.1206720; McCole DF, 2002, J BIOL CHEM, V277, P42603, DOI 10.1074/jbc.M206487200; Miyazaki M, 1998, EUR J CANCER, V34, P710, DOI 10.1016/S0959-8049(97)10123-X; Nakagawa T, 2005, DEV DYNAM, V233, P1315, DOI 10.1002/dvdy.20450; OZANNE B, 1986, J PATHOL, V149, P9, DOI 10.1002/path.1711490104; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RADULOVIC S, 1994, ACTA ONCOL, V33, P693, DOI 10.3109/02841869409121784; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; RUFFJAMISON S, 1995, P NATL ACAD SCI USA, V92, P4215, DOI 10.1073/pnas.92.10.4215; SACKS PG, 1988, CANCER RES, V48, P2858; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Terashi H, 1998, J DERMATOL SCI, V17, P93, DOI 10.1016/S0923-1811(97)00079-0; Thomas SM, 2005, NEOPLASIA, V7, P426, DOI 10.1593/neo.04454; TODD R, 1989, CARCINOGENESIS, V10, P1553, DOI 10.1093/carcin/10.8.1553; Tsruya R, 2002, GENE DEV, V16, P222, DOI 10.1101/gad.214202; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Vogt A, 2004, ONCOL RES, V14, P305; Xiao DM, 2002, REGUL PEPTIDES, V109, P141, DOI 10.1016/S0167-0115(02)00197-0; Yan ZW, 2008, MOL CANCER THER, V7, P1355, DOI 10.1158/1535-7163.MCT-08-0104; Zhang Q, 2004, CANCER RES, V64, P6166, DOI 10.1158/0008-5472.CAN-04-0504; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103	49	61	64	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					425	432		10.1096/fj.08-112771	http://dx.doi.org/10.1096/fj.08-112771			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18832597	Green Published			2022-12-25	WOS:000262892900014
J	Suzuki, T; Tsuzuku, J; Kawakami, K; Miyasaka, T; Yamamoto, T				Suzuki, T.; Tsuzuku, J.; Kawakami, K.; Miyasaka, T.; Yamamoto, T.			Proteasome-mediated degradation of Tob is pivotal for triggering UV-induced apoptosis	ONCOGENE			English	Article						Tob; apoptosis; DNA damage; proteasome	DNA-DAMAGE; CYTOCHROME-C; CANCER-CELLS; MICE LACKING; CASPASE 9; P53; REPAIR; TRANSCRIPTION; FIBROBLASTS; ACTIVATION	Eukaryotic cells respond to genotoxic stress by inducing cell growth arrest or apoptosis. Although the p53 tumor suppressor largely contributes to the response by regulating antiproliferative or pro-apoptotic genes, some genotoxic stresses including ultraviolet (UV) light induce apoptosis even in the absence of p53. The molecular mechanisms by which cells respond to UV in the p53-independent manner remain to be established. Here, we show that UV-induced stress promotes proteasome-dependent degradation of Tob, triggering an apoptotic signal. We found that Tob with either short deletion or a tag sequence at the C terminus was resistant to UV-induced degradation. Introduction of the degradation-resistant Tob impaired UV-induced apoptosis. Reciprocally, suppression of Tob by small interfering RNA (siRNA) resulted in frequent induction of apoptosis irrespective of the presence of functional p53 even at UV doses that do not promote Tob degradation. Finally, tob-deficient (tob(-/-)) mice and primary embryonic fibroblasts (MEFs) from tob(-/-) mice exhibit increased sensitivity to UV irradiation. Thus, proteasomal clearance of Tob provides a novel p53-independent pathway for UV-induced apoptosis.	[Suzuki, T.; Tsuzuku, J.; Kawakami, K.; Miyasaka, T.; Yamamoto, T.] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Oncol,Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Yamamoto, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Oncol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tyamamot@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr Seiji Takeuchi (University of Fukui, Japan) for technical advice about UV irradiation of animals, and Dr Robert Whittier (Institute of Medical Science, Tokyo, Japan) and Dr Marius Sudol (Weis Center for Research, Danville, PA, USA) for comments on the paper. We also thank members of our laboratory for scientific comments and valuable discussions. This study was supported by a grant for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Dornetshuber R, 2007, CHEM RES TOXICOL, V20, P465, DOI 10.1021/tx600259t; El-Mahdy MA, 2000, MUTAT RES-DNA REPAIR, V459, P135, DOI 10.1016/S0921-8777(99)00066-X; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hiramatsu Y, 2006, CANCER RES, V66, P8477, DOI 10.1158/0008-5472.CAN-06-1603; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lackinger D, 2000, MUTAT RES-FUND MOL M, V457, P113, DOI 10.1016/S0027-5107(00)00133-0; LATONEN L, 2006, BIOCHIM BIOPHYS ACTA, V1755, P71; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Matsuda S, 1996, ONCOGENE, V12, P705; McKay BC, 2001, ONCOGENE, V20, P6805, DOI 10.1038/sj.onc.1204901; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Saldeen J, 2003, MOL CELL BIOCHEM, V243, P113, DOI 10.1023/A:1021651811345; Sasajima H, 2002, EUR J BIOCHEM, V269, P3596, DOI 10.1046/j.1432-1033.2002.03052.x; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tomicic MT, 2005, APOPTOSIS, V10, P1295, DOI 10.1007/s10495-005-1392-3; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang SY, 2006, J BIOL CHEM, V281, P34810, DOI 10.1074/jbc.M607484200; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhao Y, 2008, ONCOGENE, V27, P1, DOI 10.1038/sj.onc.1210625; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	38	13	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					401	411		10.1038/onc.2008.387	http://dx.doi.org/10.1038/onc.2008.387			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18850001				2022-12-25	WOS:000262550300008
J	Dagda, RK; Merrill, RA; Cribbs, JT; Chen, YC; Hell, JW; Usachev, YM; Strack, S				Dagda, Ruben K.; Merrill, Ronald A.; Cribbs, J. Thomas; Chen, Yucui; Hell, Johannes W.; Usachev, Yuriy M.; Strack, Stefan			The Spinocerebellar Ataxia 12 Gene Product and Protein Phosphatase 2A Regulatory Subunit B beta 2 Antagonizes Neuronal Survival by Promoting Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED GTPASE; CYTOCHROME-C RELEASE; NITRIC-OXIDE; CELL-DEATH; APOPTOSIS; PHOSPHORYLATION; DRP1; FAMILY; DEPHOSPHORYLATION	The neurodegenerative disorder spinocerebellar ataxia 12 (SCA12) is caused by CAG repeat expansion in the non-coding region of the PPP2R2B gene. PPP2R2B encodes B beta 1 and B beta 2, alternatively spliced and neuron-specific regulatory subunits of the protein phosphatase 2A (PP2A) holoenzyme. We show here that in PC12 cells and hippocampal neurons, cell stressors induced a rapid translocation of PP2A/B beta 2 to mitochondria to promote apoptosis. Conversely, silencing of PP2A/B beta 2 protected hippocampal neurons against free radical-mediated, excitotoxic, and ischemic insults. Evidence is accumulating that the mitochondrial fission/fusion equilibrium is an important determinant of cell survival. Accordingly, we found that B beta 2 expression induces mitochondrial fragmentation, whereas B beta 2 silencing or inhibition resulted in mitochondrial elongation. Based on epistasis experiments involving Bcl2 and core components of the mitochondrial fission machinery (Fis1 and dynamin-related protein 1), mitochondrial fragmentation occurs upstream of apoptosis and is both necessary and sufficient for hippocampal neuron death. Our data provide the first example of a proapoptotic phosphatase that predisposes to neuronal death by promoting mitochondrial division and point to a possible imbalance of the mitochondrial morphogenetic equilibrium in the pathogenesis of SCA12.	[Strack, Stefan] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Strack, S (corresponding author), Univ Iowa, Carver Coll Med, Dept Pharmacol, 2-432 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu	Hell, Johannes W./P-5085-2019	Usachev, Yuriy/0000-0002-6948-4627; Merrill, Ronald/0000-0002-5276-4163; Dagda, Ruben/0000-0002-9946-9591; Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [NS043254, NS056244, NS054614, NS046450]; American Heart Association [0455653Z]; United Mitochondrial Disease Foundation [04-65]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054614, R01NS043254, R01NS046450, R01NS035563, R56NS056244, F31NS049659, R01NS056244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United Mitochondrial Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS043254, NS056244 (to S. S.), NS054614 (to Y. M. U.), and NS046450 (to Y. W. H.). This work was also supported by American Heart Association Grant-in-Aid 0455653Z (to S. S.) and United Mitochondrial Disease Foundation Grant 04-65 (to S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Cheung ECC, 2007, APOPTOSIS, V12, P979, DOI 10.1007/s10495-007-0745-5; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Dagda RK, 2005, J BIOL CHEM, V280, P27375, DOI 10.1074/jbc.M503693200; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dimmer KS, 2006, PHYSIOLOGY, V21, P233, DOI 10.1152/physiol.00010.2006; Dobson S, 2003, MOL BIOCHEM PARASIT, V126, P239, DOI 10.1016/S0166-6851(02)00293-1; Gonzalez-Alegre P, 2005, J NEUROSCI, V25, P10502, DOI 10.1523/JNEUROSCI.3016-05.2005; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; HOLMES SE, 2006, GENETIC INSTABILITIE, P461; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; James DI, 2008, DEV CELL, V15, P341, DOI 10.1016/j.devcel.2008.08.011; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lim IA, 2003, NEUROPHARMACOLOGY, V45, P738, DOI 10.1016/S0028-3908(03)00276-4; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Schmidt K, 2002, EUR J NEUROSCI, V16, P2039, DOI 10.1046/j.1460-9568.2002.02274.x; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Yuan H, 2007, CELL DEATH DIFFER, V14, P462, DOI 10.1038/sj.cdd.4402046; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	40	61	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36241	36248		10.1074/jbc.M800989200	http://dx.doi.org/10.1074/jbc.M800989200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940801	hybrid, Green Published			2022-12-25	WOS:000261840500019
J	Sauna, ZE; Bohn, SS; Rutledge, R; Dougherty, MP; Cronin, S; May, L; Xia, D; Ambudkar, SV; Golin, J				Sauna, Zuben E.; Bohn, Sherry Supernavage; Rutledge, Robert; Dougherty, Michael P.; Cronin, Susan; May, Leopold; Xia, Di; Ambudkar, Suresh V.; Golin, John			Mutations Define Cross-talk between the N-terminal Nucleotide-binding Domain and Transmembrane Helix-2 of the Yeast Multidrug Transporter Pdr5 POSSIBLE CONSERVATION OF A SIGNALING INTERFACE FOR COUPLING ATP HYDROLYSIS TO DRUG TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; CANDIDA-ALBICANS; ENCODING GENE; RESISTANCE; PROTEIN; MECHANISM; PUMP; ARCHITECTURE; EXPRESSION; ENERGY	The yeast Pdr5 multidrug transporter is an important member of the ATP-binding cassette superfamily of proteins. We describe a novel mutation (S558Y) in transmembrane helix 2 of Pdr5 identified in a screen for suppressors that eliminated Pdr5-mediated cycloheximide hyper-resistance. Nucleotides as well as transport substrates bind to the mutant Pdr5 with an affinity comparable with that for wild-type Pdr5. Wild-type and mutant Pdr5s show ATPase activity with comparable K-m(ATP) values. Nonetheless, drug sensitivity is equivalent in the mutant pdr5 and the pdr5 deletion. Finally, the transport substrate clotrimazole, which is a noncompetitive inhibitor of Pdr5 ATPase activity, has a minimal effect on ATP hydrolysis by the S558Y mutant. These results suggest that the drug sensitivity of the mutant Pdr5 is attributable to the uncoupling of NTPase activity and transport. We screened for amino acid alterations in the nucleotide-binding domains that would reverse the phenotypic effect of the S558Y mutation. A second-site mutation, N242K, located between the Walker A and signature motifs of the N-terminal nucleotide-binding domain, restores significant function. This region of the nucleotide-binding domain interacts with the transmembrane domains via the intracellular loop-1 (which connects transmembrane helices 2 and 3) in the crystal structure of Sav1866, a bacterial ATP-binding cassette drug transporter. These structural studies are supported by biochemical and genetic evidence presented here that interactions between transmembrane helix 2 and the nucleotide-binding domain, via the intracellular loop-1, may define at least part of the translocation pathway for coupling ATP hydrolysis to drug transport.	[Bohn, Sherry Supernavage; Dougherty, Michael P.; Golin, John] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA; [May, Leopold] Catholic Univ Amer, Dept Chem, Washington, DC 20064 USA; [Sauna, Zuben E.; Rutledge, Robert; Xia, Di; Ambudkar, Suresh V.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Cronin, Susan] Immaculata Univ, Dept Biol, Immaculata, PA 19345 USA	Catholic University of America; Catholic University of America; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Golin, J (corresponding author), Catholic Univ Amer, Dept Biol, McCort Ward Bldg 103, Washington, DC 20064 USA.	golin@cua.edu	Ambudkar, Suresh V/L-1317-2016; Sauna, Zuben E./AAA-7149-2019		National Institutes of Health (Intramural Research Program, Center for Cancer Research, NCI); National Institutes of Health [GM07721]; NATIONAL CANCER INSTITUTE [ZIABC010319, ZIABC010030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007721] Funding Source: NIH RePORTER	National Institutes of Health (Intramural Research Program, Center for Cancer Research, NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (Intramural Research Program, Center for Cancer Research, NCI). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant GM07721.	AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Thozee CP, 2007, MOL MICROBIOL, V63, P811, DOI 10.1111/j.1365-2958.2006.05562.x; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Golin J, 2003, J BIOL CHEM, V278, P5963, DOI 10.1074/jbc.M210908200; Golin J, 2007, BIOCHEMISTRY-US, V46, P13109, DOI 10.1021/bi701414f; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hanson L, 2005, BIOCHEMISTRY-US, V44, P9703, DOI 10.1021/bi0502994; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Nakamura K, 2001, ANTIMICROB AGENTS CH, V45, P3366, DOI 10.1128/AAC.45.12.3366-3374.2001; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Posteraro B, 2003, MOL MICROBIOL, V47, P357, DOI 10.1046/j.1365-2958.2003.03281.x; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Rutledge RM, 2008, MOL GENET GENOMICS, V279, P573, DOI 10.1007/s00438-008-0334-5; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Schumacher MA, 2003, RES MICROBIOL, V154, P69, DOI 10.1016/S0923-2508(02)00013-X; Shukla S, 2006, BIOCHEMISTRY-US, V45, P2425, DOI 10.1021/bi0519147; Shukla S, 2003, EUKARYOT CELL, V2, P1361, DOI 10.1128/EC.2.6.1361-1375.2003; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	36	51	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35010	35022		10.1074/jbc.M806446200	http://dx.doi.org/10.1074/jbc.M806446200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842589	hybrid, Green Published			2022-12-25	WOS:000261469100058
J	Song, JJ; Kingston, RE				Song, Ji-Joon; Kingston, Robert E.			WDR5 Interacts with Mixed Lineage Leukemia (MLL) Protein via the Histone H3-binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MOLECULAR RECOGNITION; H3; COMPLEX	WDR5 is a component of the mixed lineage leukemia (MLL) complex, which methylates lysine 4 of histone H3, and was identified as a methylated Lys-4 histone H3-binding protein. Here, we present a crystal structure of WDR5 bound to an MLL peptide. Surprisingly, we find that WDR5 utilizes the same pocket shown to bind histone H3 for this MLL interaction. Furthermore, the WDR5-MLL interaction is disrupted preferentially by mono- and di-methylated Lys-4 histone H3 over unmodified and tri-methylated Lys-4 histone H3. These data implicate a delicate interplay between the effector, WDR5, the catalytic subunit, MLL, and the substrate, histone H3, of the MLL complex. We suggest that the activity of the MLL complex might be regulated through this interplay.	[Kingston, Robert E.] Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kingston, RE (corresponding author), Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu	Song, Ji-Joon/C-1721-2011		National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by grants from the National Institutes of Health (to R. E. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	10	135	147	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35258	35264		10.1074/jbc.M806900200	http://dx.doi.org/10.1074/jbc.M806900200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18840606	Green Published, hybrid			2022-12-25	WOS:000261469100081
J	Su, N; Kilberg, MS				Su, Nan; Kilberg, Michael S.			C/EBP Homology Protein (CHOP) Interacts with Activating Transcription Factor 4 (ATF4) and Negatively Regulates the Stress-dependent Induction of the Asparagine Synthetase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DEPRIVATION; ENDOPLASMIC-RETICULUM STRESS; MAMMALIAN-CELLS; ARGININE/LYSINE TRANSPORTER; TRANSLATIONAL REGULATION; EIF2-ALPHA KINASE; RESPONSE ELEMENTS; BINDING PROTEINS; NUCLEAR-PROTEIN; EXPRESSION	C/EBP homology protein (CHOP), a stress-induced transcription factor, is involved in transcriptional regulation, cell cycle, and apoptosis. The present studies identified CHOP as an interacting partner of activating transcription factor (ATF) 4 in a yeast two-hybrid screen and confirmed their interaction in HEK293T cells. CHOP protein levels rose modestly and transiently during amino acid deprivation, whereas endoplasmic reticulum stress caused a much higher and sustained expression of CHOP protein. Exogenous CHOP expression enhanced the TRB3 gene induction by amino acid deprivation. Conversely, CHOP suppressed the induction of the endogenous asparagine synthetase (ASNS) gene and inhibited transcription from a reporter gene driven by the ASNS promoter following activation by ATF4 or amino acid deprivation. Short interfering RNA-mediated knockdown of CHOP further enhanced the induction of ASNS by either amino acid deprivation or endoplasmic reticulum stress. The CHOP-dependent repression of the ASNS gene required the entire CHOP protein, arguing against the possibility of simple sequestration of ATF4 by the CHOP leucine zipper domain, and chromatin immunoprecipitation analysis showed association of CHOP with the ASNS and TRB3 promoters. Interestingly, chromatin immunoprecipitation also showed that CHOP was associated with the C/EBP-ATF composite site regions of the SNAT2, VEGF, and CAT-1 genes, despite no significant effect on their expression after exogenous CHOP overexpression. Collectively, the results document that CHOP is a member of the transcription factor network that controls the stress-induced regulation of specific C/EBP-ATF-containing genes, such as ASNS.	[Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	su, nan/GRS-5213-2022		National Institutes of Health [DK-52064, DK70647]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052064, R01DK070647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-52064 and DK70647 (NIDDK) (to M.S.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Al Sarraj J, 2005, BIOL CHEM, V386, P873, DOI 10.1515/BC.2005.102; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Barber GN, 2005, CELL DEATH DIFFER, V12, P563, DOI 10.1038/sj.cdd.4401643; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mazumder Suparna, 2008, V414, P13; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sood R, 2000, GENETICS, V154, P787; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yoon S, 2004, P NATL ACAD SCI USA, V101, P11713, DOI 10.1073/pnas.0404652101; Yu VWC, 2005, J CELL BIOL, V169, P591, DOI 10.1083/jcb.200412139; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	121	127	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35106	35117		10.1074/jbc.M806874200	http://dx.doi.org/10.1074/jbc.M806874200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940792	Green Published, hybrid			2022-12-25	WOS:000261469100068
J	Yang, L; Zhang, L; Wu, QY; Boyd, DD				Yang, Lin; Zhang, Li; Wu, Qiuyu; Boyd, Douglas D.			Unbiased Screening for Transcriptional Targets of ZKSCAN3 Identifies Integrin beta 4 and Vascular Endothelial Growth Factor as Downstream Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER PROGRESSION; WIDE ASSOCIATION SCAN; CARCINOMA-CELLS; TYROSINE KINASE; HUMAN BREAST; SIGNALING PATHWAY; TUMOR PROGRESSION; BINDING DOMAIN; IN-VIVO; K-RAS	We previously described the novel zinc finger protein ZKSCAN3 as a new "driver" of colon cancer progression. To investigate the underlying mechanism and because the predicted structural features (tandem zinc fingers) are often present in transcription factors, we hypothesized that ZKSCAN3 regulates the expression of a gene(s) favoring tumor progression. We employed unbiased screening to identify a DNA binding motif and candidate downstream genes. Cyclic amplification and selection of targets using a random oligonucleotide library and ZKSCAN3 protein identified KRDGGG as the DNA recognition motif. In expression profiling, 204 genes were induced 2-29-fold, and 76 genes reduced 2-5-fold by ZKSCAN3. To enrich for direct targets, we eliminated genes under-represented (< 3) for the ZKSCAN3 binding motif (identified by CAST-ing) in 2 kilobases of regulatory sequence. Up-regulated putative downstream targets included genes contributing to growth (c-Met-related tyrosine kinase (MST1R), MEK2; the guanine nucleotide exchanger RasGRP2, insulin-like growth factor-2, integrin beta 4), cell migration (MST1R), angiogenesis (vascular endothelial growth factor), and proteolysis (MMP26; cathepsin D; PRSS3 (protease serine 3)). We pursued integrin beta 4 (induced up to 6-fold) as a candidate target because it promotes breast cancer tumorigenicity and stimulates phosphatidyl 3-kinase implicated in colorectal cancer progression. ZKSCAN3 overexpression/silencing modulated integrin beta 4 expression, confirming the array analysis. Moreover, ZKSCAN3 bound to the integrin beta 4 promoter in vitro and in vivo, and the integrin beta 4-derived ZKSCAN3 motif fused upstream of a tk-Luc reporter conferred ZKSCAN3 sensitivity. Integrin beta 4 knockdown by short hairpin RNA countered ZKSCAN3-augmented anchorage-independent colony formation. We also demonstrate vascular endothelial growth factor as a direct ZKSCAN3 target. Thus, ZKSCAN3 regulates the expression of several genes favoring tumor progression including integrin beta 4.	[Yang, Lin; Wu, Qiuyu; Boyd, Douglas D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Zhang, Li] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Boyd, DD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	dboyd@mdanderson.org		Zhang, Li/0000-0003-0517-7860	National Institutes of Health Grants [CA58311, DE10845]; NATIONAL CANCER INSTITUTE [R01CA058311, R56CA058311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010845] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA58311 and DE10845 (to D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahnen DJ, 1998, CANCER RES, V58, P1149; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Bernet A, 2007, GASTROENTEROLOGY, V133, P1840, DOI 10.1053/j.gastro.2007.08.009; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Calistri D, 2005, J CELL PHYSIOL, V204, P484, DOI 10.1002/jcp.20310; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Chao C, 1996, CANCER RES, V56, P4811; CHOWDHURY K, 1992, MECH DEVELOP, V39, P129, DOI 10.1016/0925-4773(92)90040-Q; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Chung SK, 2007, GASTROENTEROLOGY, V132, P2459, DOI 10.1053/j.gastro.2007.04.024; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Delfino FJ, 2006, J BIOL CHEM, V281, P8829, DOI 10.1074/jbc.M507331200; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Fenton JI, 2005, CANCER EPIDEM BIOMAR, V14, P1646, DOI 10.1158/1055-9965.EPI-04-0916; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Heyer J, 1999, ONCOGENE, V18, P5325, DOI 10.1038/sj.onc.1203036; Hoffmann A, 2008, MOL CELL BIOL, V28, P6078, DOI 10.1128/MCB.00842-08; Huang CX, 2007, EXP CELL RES, V313, P254, DOI 10.1016/j.yexcr.2006.10.009; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Izumi Y, 2005, ARTERIOSCL THROM VAS, V25, P1877, DOI 10.1161/01.ATV.0000174801.76234.bd; Johansen KA, 2003, MECH DEVELOP, V120, P1139, DOI 10.1016/j.mod.2003.08.001; Kawamoto K, 1998, ONCOLOGY-BASEL, V55, P242, DOI 10.1159/000011858; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li JN, 2005, GASTROENTEROLOGY, V128, P1907, DOI 10.1053/j.gastro.2005.02.067; Li YQ, 2006, MOL BIOL REP, V33, P287, DOI 10.1007/s11033-006-9019-5; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; LU H, 2004, BIOCHEM BIOPH RES CO, V320, P45; Luo KT, 2006, GENE, V367, P89, DOI 10.1016/j.gene.2005.09.023; Ma X, 2007, LIFE SCI, V81, P1141, DOI 10.1016/j.lfs.2007.08.006; MORIKAWA K, 1988, CANCER RES, V48, P1943; Ni HH, 2005, ONCOGENE, V24, P6820, DOI 10.1038/sj.onc.1208848; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sebzda T, 2005, J EXP THER ONCOL, V5, P145; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Spensberger D, 2008, BIOCHEMISTRY-US, V47, P6418, DOI 10.1021/bi800267f; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Takaoka AS, 1998, J BIOL CHEM, V273, P33848, DOI 10.1074/jbc.273.50.33848; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu XM, 2004, ONCOGENE, V23, P8464, DOI 10.1038/sj.onc.1207907; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2008, CANCER RES, V68, P4321, DOI 10.1158/0008-5472.CAN-08-0407; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	59	39	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35295	35304		10.1074/jbc.M806965200	http://dx.doi.org/10.1074/jbc.M806965200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940803	Green Published, hybrid			2022-12-25	WOS:000261469100085
J	Geraldes, P; Yagi, K; Ohshiro, Y; He, ZH; Maeno, Y; Yamamoto-Hiraoka, J; Rask-Madsen, C; Chung, SW; Perrella, MA; King, GL				Geraldes, Pedro; Yagi, Kunimasa; Ohshiro, Yuzuru; He, Zhiheng; Maeno, Yasuhiro; Yamamoto-Hiraoka, Junko; Rask-Madsen, Christian; Chung, Su Wol; Perrella, Mark A.; King, George L.			Selective Regulation of Heme Oxygenase-1 Expression and Function by Insulin through IRS1/Phosphoinositide 3-Kinase/Akt-2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NRF2 TRANSCRIPTION FACTOR; PROTEIN-KINASE-C; OXIDATIVE STRESS; EPITHELIAL-CELLS; NITRIC-OXIDE; GENE; ANTIOXIDANT; ACTIVATION; RESISTANCE; APOPTOSIS	Heme oxygenase 1 (HO-1) is a representative mediator of antioxidants and cytoprotectants against various stress stimuli including oxidants in vascular cells. Intensive insulin treatment can delay the onset and progression of diabetic retinopathy and other vascularopathies, yet little is known about insulin regulation of anti-apoptotic and antioxidant molecules such as HO-1 in vascular cells. Intravitreous injection or in vitro addition of insulin increased HO-1 protein expression in rat retina and in cultured bovine retinal pericytes, retinal endothelial cells, and retinal pigment epithelial cells. In bovine retinal pericytes, insulin induced mRNA and protein expression of HO-1 in a time- and concentration-dependent manner. Using HO-1 promoter analysis, the luciferase reporter assay showed that induction of HO-1 expression by insulin is mediated by additional response elements in the ho-1 promoter gene, which was not responsive to antioxidants. Insulin-induced HO-1 mRNA expression through activation of PI3-kinase/Akt pathway without affecting ERK and p38 MAPK. Overexpression of an adenoviral vector of native IRS1, IRS2, and Akt dominant negative or small interfering RNA transfection of Akt1 and Akt2 targeted gene demonstrated that insulin regulated HO-1 expression via IRS1 and Akt2 pathway, selectively. Further, insulin treatment prevented H2O2-induced NF-kappa B and caspase-8 activation and apoptosis via the IRS1/PI3K/Akt2/HO-1 pathway in the pericytes. In conclusion, we suggest that the anti-apoptotic properties of insulin are mediated partly by increasing HO-1 expression at transcriptional level via IRS1/PI3K/Akt2 activation, a potential explanation for how insulin is retarding the progression of microvascular complications induced by diabetes.	[Geraldes, Pedro; Yagi, Kunimasa; Ohshiro, Yuzuru; He, Zhiheng; Maeno, Yasuhiro; Yamamoto-Hiraoka, Junko; Rask-Madsen, Christian; King, George L.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Chung, Su Wol] Univ Ulsan, Coll Nat Sci, Sch Biol Sci & Technol, Ulsan 630749, South Korea; [Chung, Su Wol; Perrella, Mark A.] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02215 USA; [King, George L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; University of Ulsan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	King, GL (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	George.King@joslin.harvard.edu	Ohshiro, Yuzuru/HHS-7520-2022; Yagi, Kunimasa/AAA-8666-2021	Ohshiro, Yuzuru/0000-0002-9345-3759; Yagi, Kunimasa/0000-0002-6805-6428; Rask-Madsen, Christian/0000-0002-8548-466X	National Institutes of Health [5 R01 DK053105-09A1, NEI 5 R01 EY016150-02, P30 DK36836, R01HL60788]; American Diabetes Association Research [1-08-RA-93]; NATIONAL EYE INSTITUTE [R01EY016150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK053105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research(American Diabetes Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 R01 DK053105-09A1 and NEI 5 R01 EY016150-02 (to G. L. K.), Grant P30 DK36836, and Grant R01HL60788 (to M. A. P.). This work was also supported by American Diabetes Association Research Grant 1-08-RA-93. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Aikawa R, 2002, CYTOKINE, V18, P179, DOI 10.1006/cyto.2001.1007; Alam J, 2000, J BIOL CHEM, V275, P27694; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; AUTHOR AB, 1993, NEW ENGL J MED, V329, P977; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bronson SK, 2003, J CLIN INVEST, V111, P1817, DOI 10.1172/JCI200318927; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Camhi SL, 1998, AM J RESP CELL MOL, V18, P226, DOI 10.1165/ajrcmb.18.2.2910; Chung SW, 2005, J BIOL CHEM, V280, P4578, DOI 10.1074/jbc.M409125200; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; Cukiernik M, 2003, CURR EYE RES, V27, P301, DOI 10.1076/ceyr.27.5.301.17227; Duckworth W C, 2001, Curr Atheroscler Rep, V3, P383, DOI 10.1007/s11883-001-0076-x; Egan BM, 2001, AM J HYPERTENS, V14, p116S, DOI 10.1016/S0895-7061(01)02078-7; Farhangkhoee H, 2003, J MOL CELL CARDIOL, V35, P1439, DOI 10.1016/j.yjmcc.2003.09.007; Gerstein HC, 1996, DIABETES CARE, V19, P1225, DOI 10.2337/diacare.19.11.1225; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Gong PF, 2004, ARCH BIOCHEM BIOPHYS, V432, P252, DOI 10.1016/j.abb.2004.09.024; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hara E, 1999, BIOCHEM PHARMACOL, V58, P227, DOI 10.1016/S0006-2952(99)00097-0; Harrison EM, 2006, FEBS J, V273, P2345, DOI 10.1111/j.1742-4658.2006.05224.x; Hayashi K, 2001, DIABETES RES CLIN PR, V52, P85, DOI 10.1016/S0168-8227(01)00218-2; Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim J, 2002, BIOCHEM BIOPH RES CO, V292, P1010, DOI 10.1006/bbrc.2002.6751; KING GL, 1987, DIABETES, V36, P1460, DOI 10.2337/diabetes.36.12.1460; KING GL, 1985, J CLIN INVEST, V75, P1028, DOI 10.1172/JCI111764; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Kobayashi T, 2007, INVEST OPHTH VIS SCI, V48, P2350, DOI 10.1167/iovs.06-1357; Kowluru RA, 2001, ACTA DIABETOL, V38, P179, DOI 10.1007/s592-001-8076-6; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; KUTTY RK, 1994, J CELL PHYSIOL, V159, P371; KUWABARA T, 1963, ARCH OPHTHALMOL-CHIC, V69, P492, DOI 10.1001/archopht.1963.00960040498013; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Masuya Y, 1998, J BIOCHEM-TOKYO, V124, P628; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MOTTERLINI R, 1993, J APPL PHYSIOL, V75, P2224, DOI 10.1152/jappl.1993.75.5.2224; Mustata GT, 2005, DIABETES, V54, P517, DOI 10.2337/diabetes.54.2.517; Pugazhenthi S, 2007, AM J PHYSIOL-ENDOC M, V293, pE645, DOI 10.1152/ajpendo.00111.2007; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sekine O, 2002, J BIOL CHEM, V277, P36631, DOI 10.1074/jbc.M206266200; SELBY JV, 1990, JAMA-J AM MED ASSOC, V263, P1954, DOI 10.1001/jama.263.14.1954; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Shannon H, 2000, NEW ENGL J MED, V342, P381; SHIBAHARA S, 1988, SEMIN HEMATOL, V25, P370; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Wagner M, 2003, KIDNEY INT, V63, P1564, DOI 10.1046/j.1523-1755.2003.00897.x; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87	54	49	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34327	34336		10.1074/jbc.M807036200	http://dx.doi.org/10.1074/jbc.M807036200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854316	hybrid, Green Published			2022-12-25	WOS:000261277700060
J	Li, JX; Niu, XL; Madamanchi, NR				Li, Juxiang; Niu, Xi-Lin; Madamanchi, Nageswara R.			Leukocyte Antigen-related Protein Tyrosine Phosphatase Negatively Regulates Hydrogen Peroxide-induced Vascular Smooth Muscle Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; OXIDATIVE-STRESS; INSULIN-RECEPTOR; REVERSIBLE INACTIVATION; SIGNAL-TRANSDUCTION; CASPASE ACTIVATION; NEURITE OUTGROWTH; REDOX REGULATION; DOWN-REGULATION; JNK ACTIVATION	Reactive oxygen species (ROS) have been implicated in vascular smooth muscle cell (VSMC) apoptosis, a hallmark of advanced atherosclerotic lesions. Transient oxidation and inactivation of protein-tyrosine phosphatases play a critical role in cellular response to ROS production. However, the function of leukocyte antigen-related (LAR) protein-tyrosine phosphatase in ROS signaling is not known. To determine the expression of LAR in ROS-induced apoptosis, we investigated hydrogen peroxide-induced cell death and signaling in aortic VSMCs from wild-type and LAR(-/-) mice. Histone- associated DNA fragmentation and caspase-3/7 activity were significantly enhanced, mitochondrial membrane integrity was compromised, and cell viability was significantly decreased following H2O2 treatment in LAR(-/-) VSMCs compared with wild-type cells. Stronger and sustained increase in autophosphorylation and activity of Fyn, an Src family tyrosine kinase, was observed in LAR(-/-) cells compared with wild-type cells following H2O2 treatment. LAR binds to activated Fyn in H2O2-treated VSMCs, and recombinant LAR dephosphorylates phosphorylated-Fyn in vitro. In addition, LAR deficiency enhanced H2O2-induced phosphorylation of Janus kinase 2 (JAK2), signal transducer and activator of transcription 3 (STAT3), and p38 mitogen-activated protein kinase (MAPK). PP2, a Fyn-specific inhibitor, blocked JAK2, STAT3, and p38 MAPK activation and significantly attenuated apoptosis induced by H2O2. AG490, a JAK2-specific inhibitor, significantly attenuated H2O2-induced apoptosis, and blocked H2O2-induced activation of STAT3, but not p38 MAPK in both wild-type and LAR(-/-) VSMCs. Attenuation of Fyn expression by short hairpin RNA significantly decreased H2O2-induced downstream signaling and apoptosis in VSMCs. Together, these data indicate that LAR regulates Fyn/JAK2/STAT3 and Fyn/p38 MAPK pathways involved in ROS-induced apoptosis.	[Li, Juxiang; Niu, Xi-Lin; Madamanchi, Nageswara R.] Univ N Carolina, Dept Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Madamanchi, NR (corresponding author), Univ N Carolina, Dept Med, Carolina Cardiovasc Biol Ctr, 7312B Med Biomol Res Bldg, Chapel Hill, NC 27599 USA.	nrmadama@med.unc.edu		Madamanchi, Nageswara/0000-0003-0590-0908	National Institutes of Health [HL-5735]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant HL-5735. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003; Abe JI, 2000, J BIOL CHEM, V275, P1739, DOI 10.1074/jbc.275.3.1739; Ahmad F, 1997, J BIOL CHEM, V272, P448; Ahmed-Choudhury J, 2006, CELL SIGNAL, V18, P456, DOI 10.1016/j.cellsig.2005.05.015; Amiri F, 1999, J BIOL CHEM, V274, P32382, DOI 10.1074/jbc.274.45.32382; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bauriedel G, 1999, CARDIOVASC RES, V41, P480, DOI 10.1016/S0008-6363(98)00318-6; Channon KM, 1996, CARDIOVASC RES, V32, P962; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Diep QN, 2000, HYPERTENSION, V36, P851, DOI 10.1161/01.HYP.36.5.851; GENG YJ, 1995, AM J PATHOL, V147, P251; Grethe S, 2004, EXP CELL RES, V298, P632, DOI 10.1016/j.yexcr.2004.05.007; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Guo ZM, 2002, MECH AGEING DEV, V123, P1121, DOI 10.1016/S0047-6374(02)00008-8; HAN DKM, 1995, AM J PATHOL, V147, P267; Hao Q, 2006, FREE RADICAL BIO MED, V41, P302, DOI 10.1016/j.freeradbiomed.2006.04.011; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kappert K, 2006, ARTERIOSCL THROM VAS, V26, P2644, DOI 10.1161/01.ATV.0000246777.30819.85; KULAS DT, 1995, J BIOL CHEM, V270, P2435, DOI 10.1074/jbc.270.6.2435; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lee CK, 2006, PROTEOMICS, V6, P6455, DOI 10.1002/pmic.200600124; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; LONGO FM, 1993, J BIOL CHEM, V268, P26503; Lu Y, 2006, J BIOL CHEM, V281, P36683, DOI 10.1074/jbc.M607374200; Madamanchi NR, 2001, J BIOL CHEM, V276, P18915, DOI 10.1074/jbc.M008802200; Mascareno E, 2001, CIRCULATION, V104, P325, DOI 10.1161/01.CIR.104.3.325; Mayer BJ, 1997, CURR BIOL, V7, pR295, DOI 10.1016/S0960-9822(06)00141-2; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Moon SK, 2001, AM J PHYSIOL-HEART C, V280, pH2779, DOI 10.1152/ajpheart.2001.280.6.H2779; Mori-Abe A, 2003, J ENDOCRINOL, V178, P417, DOI 10.1677/joe.0.1780417; Niu XL, 2007, J BIOL CHEM, V282, P19808, DOI 10.1074/jbc.M610452200; Pollman MJ, 1999, CIRC RES, V84, P113; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Ren JM, 1998, DIABETES, V47, P493, DOI 10.2337/diabetes.47.3.493; Ricci JE, 2001, FASEB J, V15, P1777, DOI 10.1096/fj.00-0665fje; Rosini P, 2004, J BIOL CHEM, V279, P14016, DOI 10.1074/jbc.M305356200; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Sandberg EM, 2004, J BIOL CHEM, V279, P34547, DOI 10.1074/jbc.M405045200; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Schaapveld RQJ, 1997, DEV BIOL, V188, P134, DOI 10.1006/dbio.1997.8630; Sgorbissa A, 1999, J CELL SCI, V112, P4475; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; SMITH C, 1992, BIOCHEM J, V286, P901, DOI 10.1042/bj2860901; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tang H, 2005, J BIOL CHEM, V280, P23918, DOI 10.1074/jbc.M503498200; Tisi MA, 2000, J NEUROBIOL, V42, P477, DOI 10.1002/(SICI)1097-4695(200003)42:4<477::AID-NEU8>3.0.CO;2-B; Tsujikawa K, 2002, MOL CANCER RES, V1, P155; Tsujikawa K, 2001, MOL ENDOCRINOL, V15, P271, DOI 10.1210/me.15.2.271; Uddin S, 1997, BIOCHEM BIOPH RES CO, V235, P83, DOI 10.1006/bbrc.1997.6741; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; von der Thusen JH, 2002, CIRCULATION, V105, P2064, DOI 10.1161/01.CIR.0000015502.97828.93; Weng LP, 1998, CURR BIOL, V8, P247, DOI 10.1016/S0960-9822(98)70106-X; Weng LP, 1999, GENES CELLS, V4, P185, DOI 10.1046/j.1365-2443.1999.00251.x; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang T, 2003, J NEUROSCI, V23, P3353; Yeo TT, 1997, J NEUROSCI RES, V47, P348, DOI 10.1002/(SICI)1097-4547(19970201)47:3<348::AID-JNR13>3.0.CO;2-Y; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; YU Q, 1992, ONCOGENE, V7, P1051	71	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34260	34272		10.1074/jbc.M806087200	http://dx.doi.org/10.1074/jbc.M806087200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854310	Green Published, hybrid			2022-12-25	WOS:000261277700054
J	Colzato, LS; van den Wildenberg, WPM; Hommel, B				Colzato, Lorenza S.; van den Wildenberg, Wery P. M.; Hommel, Bernhard			Reduced Spontaneous Eye Blink Rates in Recreational Cocaine Users: Evidence for Dopaminergic Hypoactivity	PLOS ONE			English	Article							IMPAIRED INHIBITORY CONTROL; SPONTANEOUS EYEBLINK RATE; COGNITIVE CONTROL; PARKINSONS-DISEASE; PREFRONTAL CORTEX; MONKEYS; DYSFUNCTION; MECHANISMS; ADDICTION; RECEPTORS	Chronic use of cocaine is associated with a reduced density of dopaminergic D2 receptors in the striatum, with negative consequences for cognitive control processes. Increasing evidence suggests that cognitive control is also affected in recreational cocaine consumers. This study aimed at linking these observations to dopaminergic malfunction by studying the spontaneous eyeblink rate (EBR), a marker of striatal dopaminergic functioning, in adult recreational users and a cocaine-free sample that was matched on age, race, gender, and personality traits. Correlation analyses show that EBR is significantly reduced in recreational users compared to cocaine-free controls, suggesting that cocaine use induces hypoactivity in the subcortical dopamine system.	[Colzato, Lorenza S.; Hommel, Bernhard] Leiden Univ, Inst Psychol Res, Leiden, Netherlands; [van den Wildenberg, Wery P. M.] Univ Amsterdam, Amsterdam Ctr Study Adapt Control Brain & Behav, Psychol Dept, NL-1012 WX Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Amsterdam	Colzato, LS (corresponding author), Leiden Univ, Inst Psychol Res, Leiden, Netherlands.	colzato@fsw.leidenuniv.nl	Colzato, Lorenza S/H-6296-2013; Hommel, Bernhard/F-8173-2010	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280	Netherlands Organization for Scientific Research (NWO) [VENI]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The research of LSC and WPMvdW is supported by a VENI grant from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Barbato G, 2000, PSYCHIAT RES, V93, P145, DOI 10.1016/S0165-1781(00)00108-6; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; BLIN O, 1990, BRIT J CLIN PHARMACO, V30, P769, DOI 10.1111/j.1365-2125.1990.tb03848.x; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bolla KI, 1998, J NEUROPSYCH CLIN N, V10, P280, DOI 10.1176/jnp.10.3.280; CASCELLA NG, 1991, BRIT J PSYCHIAT, V159, P217, DOI 10.1192/bjp.159.2.217; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Colzato LS, 2007, NEUROPSYCHOLOGIA, V45, P2387, DOI 10.1016/j.neuropsychologia.2007.03.004; Colzato LS, 2005, EUR J NEUROSCI, V21, P591, DOI 10.1111/j.1460-9568.2005.03868.x; COLZATO LS, PERS INDIV IN PRESS; COLZATO LS, 2008, COCAINE COGNIT UNPUB; COLZATO LS, NEUROPSYCHO IN PRESS; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Deuschl G, 1998, J NEUROL NEUROSUR PS, V64, P320, DOI 10.1136/jnnp.64.3.320; Dreisbach G, 2005, BEHAV NEUROSCI, V119, P483, DOI 10.1037/0735-7044.119.2.483; Eysenck HJ., 1993, MANUAL EYSENCK PERSO, DOI 10.1037/t05461-000; Fillmore MT, 2005, EXP CLIN PSYCHOPHARM, V13, P200, DOI 10.1037/1064-1297.13.3.200; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; FREED WJ, 1980, BIOL PSYCHIAT, V15, P329; Hershey T, 2004, COGNITIVE BRAIN RES, V20, P438, DOI 10.1016/j.cogbrainres.2004.03.018; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; Kleven MS, 1996, J PHARMACOL EXP THER, V279, P1211; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; POPE HG, 1995, DRUG ALCOHOL DEPEN, V38, P25, DOI 10.1016/0376-8716(95)01097-I; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Raven JohnC., 1988, ADV PROGRESSIVE MATR; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Seeman P, 2006, SYNAPSE, V60, P319, DOI 10.1002/syn.20303; SHUKLA D, 1985, NEUROLOGY, V35, P286, DOI 10.1212/WNL.35.2.286; Spencer TJ, 2002, ARCH NEUROL-CHICAGO, V59, P314, DOI 10.1001/archneur.59.2.314; Stein DJ, 2002, LANCET, V360, P397, DOI 10.1016/S0140-6736(02)09620-4; Taylor JR, 1999, EXP NEUROL, V158, P214, DOI 10.1006/exnr.1999.7093; van der Post J, 2004, J PSYCHOPHARMACOL, V18, P109, DOI 10.1177/0269881104042832; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406	42	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3461	10.1371/journal.pone.0003461	http://dx.doi.org/10.1371/journal.pone.0003461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IG	18941515	Green Published, gold, Green Submitted			2022-12-25	WOS:000265126100002
J	Mugnier, B; Nal, B; Verthuy, C; Boyer, C; Lam, D; Chasson, L; Nieoullon, V; Chazal, G; Guo, XJ; He, HT; Rueff-Juy, D; Alcover, A; Ferrier, P				Mugnier, Benedicte; Nal, Beatrice; Verthuy, Christophe; Boyer, Claude; Lam, David; Chasson, Lionel; Nieoullon, Vincent; Chazal, Genevieve; Guo, Xiao-Jun; He, Hai-Tao; Rueff-Juy, Dominique; Alcover, Andres; Ferrier, Pierre			Coronin-1A Links Cytoskeleton Dynamics to TCR alpha beta-Induced Cell Signaling	PLOS ONE			English	Article								Actin polymerization plays a critical role in activated T lymphocytes both in regulating T cell receptor (TCR)-induced immunological synapse (IS) formation and signaling. Using gene targeting, we demonstrate that the hematopoietic specific, actin-and Arp2/3 complex-binding protein coronin-1A contributes to both processes. Coronin-1A-deficient mice specifically showed alterations in terminal development and the survival of alpha beta T cells, together with defects in cell activation and cytokine production following TCR triggering. The mutant T cells further displayed excessive accumulation yet reduced dynamics of F-actin and the WASP-Arp2/3 machinery at the IS, correlating with extended cell-cell contact. Cell signaling was also affected with the basal activation of the stress kinases sAPK/JNK1/2; and deficits in TCR-induced Ca(2+) influx and phosphorylation and degradation of the inhibitor of NF-kappa B (I kappa B). Coronin-1A therefore links cytoskeleton plasticity with the functioning of discrete TCR signaling components. This function may be required to adjust TCR responses to selecting ligands accounting in part for the homeostasis defect that impacts alpha beta T cells in coronin-1A deficient mice, with the exclusion of other lympho/hematopoietic lineages.	[Mugnier, Benedicte; Nal, Beatrice; Verthuy, Christophe; Boyer, Claude; Lam, David; Chasson, Lionel; Guo, Xiao-Jun; He, Hai-Tao; Ferrier, Pierre] Univ Aix Marseille, Ctr Immunol Marseille Luminy, Marseille, France; [Mugnier, Benedicte; Nal, Beatrice; Verthuy, Christophe; Boyer, Claude; Lam, David; Chasson, Lionel; Guo, Xiao-Jun; He, Hai-Tao; Ferrier, Pierre] CNRS, UMR 6102, Marseille, France; [Mugnier, Benedicte; Nal, Beatrice; Verthuy, Christophe; Boyer, Claude; Lam, David; Chasson, Lionel; Guo, Xiao-Jun; He, Hai-Tao; Ferrier, Pierre] Inserm, U 631, Marseille, France; [Nieoullon, Vincent; Chazal, Genevieve] Inst Biol Dev Marseille, Inserm, U 382, Marseille, France; [Guo, Xiao-Jun] Univ Aix Marseille, Lab Interact Mol Syst Membranaires, Marseille, France; [Nal, Beatrice; Alcover, Andres] CNRS, URA 1961, Unite Biol Cellulaire Lymphocytes, Paris, France; [Rueff-Juy, Dominique] Inst Pasteur, Unite Immunophysiopathol Infect, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mugnier, B (corresponding author), Univ Aix Marseille, Ctr Immunol Marseille Luminy, Marseille, France.	ferrier@ciml.univ-mrs.fr	HE, Hai-Tao/O-6551-2016; Guo, Xiao-Jun/M-9454-2016; NAL, Beatrice/GYU-8888-2022; Lam, David/AAI-3657-2020	HE, Hai-Tao/0000-0002-6594-290X; Nal, Beatrice/0000-0003-3452-7524; Alcover, Andres/0000-0002-9507-3450	Inserm; CNRS; Association pour la Recherche sur le Cancer (ARC) [fellowship]; Fondation Princesse Grace de Monaco; Commission of the European Communities; Ministere de l'Education Nationale et de la Recherche [ACI #108]; Ligue Nationale Contre le Cancer [fellowship]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation Princesse Grace de Monaco; Commission of the European Communities(European Commission); Ministere de l'Education Nationale et de la Recherche; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by Inserm, CNRS, the Association pour la Recherche sur le Cancer (ARC), the Fondation Princesse Grace de Monaco, and the Commission of the European Communities (to PF); and from the Ministere de l'Education Nationale et de la Recherche (ACI #108) (to PF and AA). BN was supported by fellowships from the Ligue Nationale Contre le Cancer and ARC. BM was supported by a fellowship from ARC.	Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Auphan-Anezin N, 2003, J IMMUNOL, V170, P2442, DOI 10.4049/jimmunol.170.5.2442; Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Cemerski S, 2006, CURR OPIN IMMUNOL, V18, P298, DOI 10.1016/j.coi.2006.03.011; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Davanture S, 2005, J IMMUNOL, V175, P3140, DOI 10.4049/jimmunol.175.5.3140; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FORGER N, 2006, SCIENCE, V313, P839; Freitas AA, 1996, EUR J IMMUNOL, V26, P2640, DOI 10.1002/eji.1830261115; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Grogan A, 1997, J CELL SCI, V110, P3071; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Hommel M, 2007, J IMMUNOL, V179, P2250, DOI 10.4049/jimmunol.179.4.2250; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Kappes DJ, 2005, NAT IMMUNOL, V6, P761, DOI 10.1038/ni1230; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; Machesky LM, 1997, BIOCHEM J, V328, P105; Manicassamy S, 2008, J IMMUNOL, V180, P106, DOI 10.4049/jimmunol.180.1.106; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; OBERHUBER H, 1991, J BIOL CHEM, V266, P1437; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rosentreter A, 2007, EXP CELL RES, V313, P878, DOI 10.1016/j.yexcr.2006.12.015; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Schuller S, 2001, CELL MICROBIOL, V3, P785, DOI 10.1046/j.1462-5822.2001.00155.x; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; VALERA A, 1994, HUM GENE THER, V5, P449, DOI 10.1089/hum.1994.5.4-449; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856; Yasutomo K, 2000, J IMMUNOL, V165, P3015, DOI 10.4049/jimmunol.165.6.3015	63	58	58	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3467	10.1371/journal.pone.0003467	http://dx.doi.org/10.1371/journal.pone.0003467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941544	Green Published, gold, Green Submitted			2022-12-25	WOS:000265125900011
J	Mathew-Fenn, RS; Das, R; Silverman, JA; Walker, PA; Harbury, PAB				Mathew-Fenn, Rebecca S.; Das, Rhiju; Silverman, Joshua A.; Walker, Peter A.; Harbury, Pehr A. B.			A Molecular Ruler for Measuring Quantitative Distance Distributions	PLOS ONE			English	Article							INTERCALATIVE BINDING; NUCLEIC-ACIDS; RAY; ETHIDIUM; SCATTERING; SUBUNIT; DNA	We report a novel molecular ruler for measurement of distances and distance distributions with accurate external calibration. Using solution X-ray scattering we determine the scattering interference between two gold nanocrystal probes attached site-specifically to a macromolecule of interest. Fourier transformation of the interference pattern provides a model-independent probability distribution for the distances between the probe centers-of-mass. To test the approach, we measure end-to-end distances for a variety of DNA structures. We demonstrate that measurements with independently prepared samples and using different X-ray sources are highly reproducible, we demonstrate the quantitative accuracy of the first and second moments of the distance distributions, and we demonstrate that the technique recovers complex distribution shapes. Distances measured with the solution scattering-interference ruler match the corresponding crystallographic values, but differ from distances measured previously with alternate ruler techniques. The X-ray scattering interference ruler should be a powerful tool for relating crystal structures to solution structures and for studying molecular fluctuations.	[Mathew-Fenn, Rebecca S.; Das, Rhiju; Silverman, Joshua A.; Walker, Peter A.; Harbury, Pehr A. B.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Mathew-Fenn, Rebecca S.; Harbury, Pehr A. B.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Mathew-Fenn, RS (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	harbury@cmgm.stanford.edu		Das, Rhiju/0000-0001-7497-0972	National Institutes of Health [GM068126-01]; National Science Foundation; U.S. Department of Energy [W-31-109-Eng-38]; NIH Director's Pioneer Award [DP OD000429-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (GM068126-01 to P.B.H.). We acknowledge additional funding from the National Institutes of Health (training grant fellowship to R.S.F., and support of SSRL), the National Science Foundation (graduate fellowship to R.D.), the U.S. Department of Energy (Contract W-31-109-Eng-38 to APS and support of SSRL), and the NIH Director's Pioneer Award DP OD000429-01 to P.B.H.	Ackerson CJ, 2005, J AM CHEM SOC, V127, P6550, DOI 10.1021/ja046114i; Bai Y, 2005, P NATL ACAD SCI USA, V102, P1035, DOI 10.1073/pnas.0404448102; Balasubramanian R, 2005, J AM CHEM SOC, V127, P8126, DOI 10.1021/ja050793v; Beno MA, 2001, NUCL INSTRUM METH A, V467, P690, DOI 10.1016/S0168-9002(01)00455-7; Cai Q, 2006, NUCLEIC ACIDS RES, V34, P4722, DOI 10.1093/nar/gkl546; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; CAPEL MS, 1988, J MOL BIOL, V200, P65, DOI 10.1016/0022-2836(88)90334-8; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chen LL, 1996, J MOL BIOL, V261, P658, DOI 10.1006/jmbi.1996.0491; Davies DB, 1996, BIOPOLYMERS, V38, P745, DOI 10.1002/(SICI)1097-0282(199602)38:6<745::AID-BIP6>3.0.CO;2-V; GRAVES DE, 1983, ANAL BIOCHEM, V134, P73, DOI 10.1016/0003-2697(83)90265-8; Hastie T, 2001, ELEMENTS STAT LEARNI, P214; HOPPE W, 1972, ISRAEL J CHEM, V10, P321; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; KASTRUP RV, 1978, BIOCHEMISTRY-US, V17, P4855, DOI 10.1021/bi00616a002; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KRATKY O, 1948, MONATSH CHEM, V78, P295, DOI 10.1007/BF01141535; KRATKY O, 1947, MONATSH CHEM, V77, P224, DOI 10.1007/BF00899014; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Lipfert J, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194484; MATHEWFENN RS, 2008, SCI REMEASU IN PRESS; MIAKELYE RC, 1983, BIOPHYS J, V41, P287, DOI 10.1016/S0006-3495(83)84440-3; NELSON JW, 1984, BIOPOLYMERS, V23, P213, DOI 10.1002/bip.360230205; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Petrascu AM, 1998, J MACROMOL SCI PHYS, VB37, P463, DOI 10.1080/00222349808220487; Schaaff TG, 1998, J PHYS CHEM B, V102, P10643, DOI 10.1021/jp9830528; Schaaff TG, 2004, ANAL CHEM, V76, P6187, DOI 10.1021/ac0353482; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; SKILLING J, 1999, QUANTIFIED MAXIMUM E; Svergun D, 1987, STRUCTURE ANAL SMALL, DOI 10.1007/978-1-4757-6624-0_1; TSAI CC, 1975, P NATL ACAD SCI USA, V72, P628, DOI 10.1073/pnas.72.2.628; VAINSHTEIN BK, 1980, FEBS LETT, V116, P107, DOI 10.1016/0014-5793(80)80539-4; WIKISOURCE FREE LIB	34	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3229	10.1371/journal.pone.0003229	http://dx.doi.org/10.1371/journal.pone.0003229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927606	Green Published, gold, Green Submitted			2022-12-25	WOS:000265122400001
J	Honma, A; Takakura, K; Nishida, T				Honma, Atsushi; Takakura, Koh-ichi; Nishida, Takayoshi			Optimal-Foraging Predator Favors Commensalistic Batesian Mimicry	PLOS ONE			English	Article							WARNING COLORATION; MUELLERIAN MIMICRY; RISK-TAKING; MODEL; PREY; MEMORY; PALATABILITY; BUTTERFLIES; EVOLUTION; SELECTION	Background: Mimicry, in which one prey species (the Mimic) imitates the aposematic signals of another prey (the Model) to deceive their predators, has attracted the general interest of evolutionary biologists. Predator psychology, especially how the predator learns and forgets, has recently been recognized as an important factor in a predator-prey system. This idea is supported by both theoretical and experimental evidence, but is also the source of a good deal of controversy because of its novel prediction that in a Model/Mimic relationship even a moderately unpalatable Mimic increases the risk of the Model (quasi-Batesian mimicry). Methodology/Principal Findings: We developed a psychology-based Monte Carlo model simulation of mimicry that incorporates a "Pavlovian'' predator that practices an optimal foraging strategy, and examined how various ecological and psychological factors affect the relationships between a Model prey species and its Mimic. The behavior of the predator in our model is consistent with that reported by experimental studies, but our simulation's predictions differed markedly from those of previous models of mimicry because a more abundant Mimic did not increase the predation risk of the Model when alternative prey were abundant. Moreover, a quasi-Batesian relationship emerges only when no or very few alternative prey items were available. Therefore, the availability of alternative prey rather than the precise method of predator learning critically determines the relationship between Model and Mimic. Moreover, the predation risk to the Model and Mimic is determined by the absolute density of the Model rather than by its density relative to that of the Mimic. Conclusions/Significance: Although these predictions are counterintuitive, they can explain various kinds of data that have been offered in support of competitive theories. Our model results suggest that to understand mimicry in nature it is important to consider the likely presence of alternative prey and the possibility that predation pressure is not constant.	[Honma, Atsushi; Nishida, Takayoshi] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto, Japan; [Takakura, Koh-ichi] Osaka City Inst Publ Hlth & Environm Sci, Osaka, Japan	Kyoto University	Honma, A (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan.	honma@ethol.zool.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Kyoto University	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto University	AH was supported in part as a member of the 21st Century COE program for Innovative Food and Environmental Studies Pioneered by Entomomimetic Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and also financially supported in part by the Global COE Program A06 to Kyoto University. These sponsors did not have any role in the scientific activity itself.	ALCOCK J, 1970, ANIM BEHAV, V18, P733, DOI 10.1016/0003-3472(70)90019-9; AVERY ML, 1985, J WILDLIFE MANAGE, V49, P1116, DOI 10.2307/3801404; Bates HW., 1862, T LINN SOC LOND, V23, P495, DOI [DOI 10.1111/J.1096-3642.1860.TB00146.X, 10.1111/j.1096-3642.1860.tb00146.x]; BENSON WW, 1977, EVOLUTION, V31, P454, DOI 10.1111/j.1558-5646.1977.tb01031.x; BOUTON ME, 1994, J EXP PSYCHOL-ANIM B, V20, P219, DOI 10.1037/0097-7403.20.3.219; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; BROWER JV, 1960, AM NAT, V94, P271, DOI 10.1086/282128; BROWER JV, 1958, EVOLUTION, V12, P32, DOI 10.1111/j.1558-5646.1958.tb02926.x; Bush Robert R., 1955, STOCHASTIC MODELS LE; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Dall SRX, 2002, PHILOS T R SOC B, V357, P1519, DOI 10.1098/RSTB.2002.1061; DILL LM, 1975, CAN J ZOOL, V53, P1614, DOI 10.1139/z75-195; Endler J.A., 1991, P169; Fisher R.A., 1930, GENETICAL THEORY NAT; Franks DW, 2004, P ROY SOC B-BIOL SCI, V271, P191, DOI 10.1098/rspb.2003.2582; Gavrilets S, 1998, J THEOR BIOL, V191, P415, DOI 10.1006/jtbi.1997.0615; GETTY T, 1985, AM NAT, V125, P239, DOI 10.1086/284339; GITTLEMAN JL, 1980, ANIM BEHAV, V28, P897, DOI 10.1016/S0003-3472(80)80150-3; GREIGSMITH PW, 1987, ETHOLOGY, V74, P155; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING CS, 1959, CAN ENTOMOL, V91, P292; HOLLING CS, 1963, P INT C ZOOL WASHING, V4, P166; Holmgren NMA, 1999, BIOL J LINN SOC, V66, P145; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HUHEEY J E, 1988, American Naturalist, V131, pS22, DOI 10.1086/284765; HUHEEY JE, 1980, J HERPETOL, V14, P223, DOI 10.2307/1563543; HUHEEY JE, 1976, EVOLUTION, V30, P86, DOI 10.1111/j.1558-5646.1976.tb00884.x; HUHEEY JE, 1964, ECOLOGY, V45, P185, DOI 10.2307/1937125; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Joron M, 2005, J THEOR BIOL, V237, P87, DOI 10.1016/j.jtbi.2005.04.005; Joron M, 1999, EVOL ECOL, V13, P721, DOI 10.1023/A:1010875213123; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kokko H, 2003, ECOL LETT, V6, P1068, DOI 10.1046/j.1461-0248.2003.00532.x; KRAEMER PJ, 1993, COMPAR COGN, P87; KREBS JR, 1977, ANIM BEHAV, V25, P30, DOI 10.1016/0003-3472(77)90064-1; Lindstrom L, 2001, P NATL ACAD SCI USA, V98, P9181, DOI 10.1073/pnas.161071598; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1111/j.1095-8312.1995.tb01057.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 2001, P NATL ACAD SCI USA, V98, P8928, DOI 10.1073/pnas.171326298; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; NICHOLSON A. J., 1927, AUSTRALIAN ZOOL, V5, P10; OWEN RE, 1984, J THEOR BIOL, V109, P217, DOI 10.1016/S0022-5193(84)80004-1; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; PLATT AP, 1971, EVOLUTION, V25, P692, DOI 10.1111/j.1558-5646.1971.tb01927.x; Poulton E. B., 1909, Annals of the Entomological Society of America, V2; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rowland HM, 2007, NATURE, V448, P64, DOI 10.1038/nature05899; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SHEPPARD PM, 1977, EVOLUTION, V31, P452, DOI 10.1111/j.1558-5646.1977.tb01030.x; Sherratt TN, 2004, J THEOR BIOL, V228, P217, DOI 10.1016/j.jtbi.2003.12.009; Sherratt TN, 2003, OIKOS, V103, P93, DOI 10.1034/j.1600-0706.2003.12576.x; Skelhorn J, 2006, ANIM BEHAV, V71, P1111, DOI 10.1016/j.anbehav.2005.08.011; Spear N. E., 1971, P45; Spear NE, 1978, PROCESSING MEMORIES; Speed MP, 1999, ANIM BEHAV, V57, P203, DOI 10.1006/anbe.1998.0943; SPEED MP, 1993, ANIM BEHAV, V45, P571, DOI 10.1006/anbe.1993.1067; Speed MP, 2000, P ROY SOC B-BIOL SCI, V267, P725, DOI 10.1098/rspb.2000.1063; Speed MP, 1999, EVOL ECOL, V13, P755, DOI 10.1023/A:1010871106763; Speed MP, 1999, BIOL J LINN SOC, V67, P281, DOI 10.1006/bijl.1998.0310; Srygley RB, 1998, BIOL J LINN SOC, V64, P41, DOI 10.1006/bijl.1997.0200; Stephens D.W., 1986, pi; SWYNNERTON CFM, 1915, P ENTOMOL SOC LOND, V1, pR32; TURNER JRG, 1987, ECOL ENTOMOL, V12, P81, DOI 10.1111/j.1365-2311.1987.tb00987.x; TURNER JRG, 1984, BIOL J LINN SOC, V23, P247, DOI 10.1111/j.1095-8312.1984.tb00143.x; Turner JRG, 1996, PHILOS T ROY SOC B, V351, P1157, DOI 10.1098/rstb.1996.0100; TURNER JRG, 1995, BIODIVERSITY EVOLUTI, P131; TURNER JRG, 1984, BIOL BUTTERFLIES, P141; Wickler W., 1968, MIMICRY PLANTS ANIMA; Zahavi Amotz, 1997, HANDICAP PRINCIPLE M	72	10	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3411	10.1371/journal.pone.0003411	http://dx.doi.org/10.1371/journal.pone.0003411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432GP	18923676	Green Published, Green Submitted, gold			2022-12-25	WOS:000265121800009
J	David-Jurgens, M; Churs, L; Berkefeld, T; Zepka, RF; Dinse, HR				David-Juergens, Marianne; Churs, Lydia; Berkefeld, Thomas; Zepka, Roberto F.; Dinse, Hubert R.			Differential Effects of Aging on Fore- and Hindpaw Maps of Rat Somatosensory Cortex	PLOS ONE			English	Article								Getting older is associated with a decline of cognitive and sensorimotor abilities, but it remains elusive whether age-related changes are due to accumulating degenerational processes, rendering them largely irreversible, or whether they reflect plastic, adaptational and presumably compensatory changes. Using aged rats as a model we studied how aging affects neural processing in somatosensory cortex. By multi-unit recordings in the fore- and hindpaw cortical maps we compared the effects of aging on receptive field size and response latencies. While in aged animals response latencies of neurons of both cortical representations were lengthened by approximately the same amount, only RFs of hindpaw neurons showed severe expansion with only little changes of forepaw RFs. To obtain insight into parallel changes of walking behavior, we recorded footprints in young and old animals which revealed a general age-related impairment of walking. In addition we found evidence for a limb-specific deterioration of the hindlimbs that was not observed in the forelimbs. Our results show that age-related changes of somatosensory cortical neurons display a complex pattern of regional specificity and parameter-dependence indicating that aging acts rather selectively on cortical processing of sensory information. The fact that RFs of the fore- and hindpaws do not co-vary in aged animals argues against degenerational processes on a global scale. We therefore conclude that age-related alterations are composed of plastic-adaptive alterations in response to modified use and degenerational changes developing with age. As a consequence, age-related changes need not be irreversible but can be subject to amelioration through training and stimulation.	[David-Juergens, Marianne; Churs, Lydia; Berkefeld, Thomas; Zepka, Roberto F.; Dinse, Hubert R.] Ruhr Univ Bochum, Inst Neuroinformat, Dept Theoret Biol, Neural Plast Lab, Bochum, Germany	Ruhr University Bochum	David-Jurgens, M (corresponding author), Ruhr Univ Bochum, Inst Neuroinformat, Dept Theoret Biol, Neural Plast Lab, Bochum, Germany.	hubert.dinse@neuroinformatik.ruhr-uni-bochum.de		dinse, hubert/0000-0001-9024-0451	Deutsche Forschungsgemeinschaft [Di 334/10]; Sandoz Foundation for Gerontological Research [EU-94-1-029]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sandoz Foundation for Gerontological Research	This research was supported by the Deutsche Forschungsgemeinschaft (Di 334 / 10 to HD) and by a Research Grant of the Sandoz Foundation for Gerontological Research (EU-94-1-029).	Abbott A, 2004, NATURE, V428, P116, DOI 10.1038/428116a; AHMAD A, 1993, J COMP NEUROL, V334, P631, DOI 10.1002/cne.903340410; Bergman E, 2002, NEUROBIOL AGING, V23, P271, DOI 10.1016/S0197-4580(01)00274-3; Bock O, 2002, NEUROSCI BIOBEHAV R, V26, P761, DOI 10.1016/S0149-7634(02)00063-5; CONNOR JR, 1982, EXP NEUROL, V78, P466, DOI 10.1016/0014-4886(82)90064-4; Coq JO, 2001, NEUROSCIENCE, V104, P705, DOI 10.1016/S0306-4522(01)00123-3; CUMMINS RA, 1973, NATURE, V243, P516, DOI 10.1038/243516a0; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Dinse HR, 1997, ADV NEUROL, V73, P159; Dinse HR, 2006, ANN NEUROL, V60, P88, DOI 10.1002/ana.20862; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Floel A, 2005, STROKE, V36, P530, DOI 10.1161/01.STR.0000154867.01422.76; GARDNER EP, 1989, J NEUROPHYSIOL, V62, P1437, DOI 10.1152/jn.1989.62.6.1437; Godde B, 1996, NEUROREPORT, V8, P281, DOI 10.1097/00001756-199612200-00056; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim CBY, 1997, ANAT REC, V247, P119, DOI 10.1002/(SICI)1097-0185(199701)247:1<119::AID-AR14>3.0.CO;2-S; Klapdor K, 1997, J NEUROSCI METH, V75, P49, DOI 10.1016/S0165-0270(97)00042-3; KLITGAARD H, 1989, J APPL PHYSIOL, V67, P1409, DOI 10.1152/jappl.1989.67.4.1409; Kornatz KW, 2005, J APPL PHYSIOL, V98, P2072, DOI 10.1152/japplphysiol.01149.2004; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Liepert J, 1995, ELECTROMYOGR MOTOR C, V97, P382, DOI 10.1016/0924-980X(95)00194-P; MARSHALL JF, 1982, J GERONTOL, V37, P548, DOI 10.1093/geronj/37.5.548; Martin GM, 2001, SCIENCE, V294, P13, DOI 10.1126/science.294.5540.13; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Peters A, 1997, NEUROBIOL AGING, V18, P29, DOI 10.1016/S0197-4580(96)00208-4; Ragert P, 2004, NEUROSCI LETT, V356, P91, DOI 10.1016/j.neulet.2003.11.034; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reinke H, 1996, NEUROSCI LETT, V216, P171, DOI 10.1016/S0304-3940(96)13039-1; SAITO S, 1994, J NEUROSCI RES, V39, P57, DOI 10.1002/jnr.490390108; Sathian K, 1997, NEUROLOGY, V49, P168, DOI 10.1212/WNL.49.1.168; Sawaki L, 2003, ANN NEUROL, V53, P521, DOI 10.1002/ana.10529; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; SCHUURMAN T, 1989, NIMODIPINE CENTRAL N, P195; Smith CD, 2005, NEUROBIOL AGING, V26, P883, DOI 10.1016/j.neurobiolaging.2004.08.014; SNYDER DL, 1990, J GERONTOL, V45, pB52, DOI 10.1093/geronj/45.2.B52; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; SPEAR PD, 1994, J NEUROPHYSIOL, V72, P402, DOI 10.1152/jn.1994.72.1.402; SPENGLER F, 1995, NEUROREPORT, V6, P469, DOI 10.1097/00001756-199502000-00016; Sprott RL, 1997, EXP GERONTOL, V32, P205, DOI 10.1016/S0531-5565(96)00065-4; Stevens JC, 1996, SOMATOSENS MOT RES, V13, P153, DOI 10.3109/08990229609051403; Stevens JC, 1996, J EXP PSYCHOL-APPL, V2, P91, DOI 10.1037/1076-898X.2.2.91; STOLL S, 1990, ARCH GERONTOL GERIAT, V10, P261, DOI 10.1016/0167-4943(90)90027-4; Tremblay F, 2003, SOMATOSENS MOT RES, V20, P127, DOI 10.1080/0899022031000105154; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WIETHOLTER H, 1990, J NEUROSCI METH, V32, P199, DOI 10.1016/0165-0270(90)90141-2; WOITTIEZ RD, 1985, J MORPHOL, V184, P375, DOI 10.1002/jmor.1051840311; WOODWARD KL, 1993, SOMATOSENS MOT RES, V10, P63, DOI 10.3109/08990229309028824; Xerri C, 2005, BEHAV BRAIN RES, V162, P207, DOI 10.1016/j.bbr.2005.03.003; XERRI C, 1994, J NEUROSCI, V14, P1710, DOI 10.1523/JNEUROSCI.14-03-01710.1994	56	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3399	10.1371/journal.pone.0003399	http://dx.doi.org/10.1371/journal.pone.0003399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852896	gold, Green Published, Green Submitted			2022-12-25	WOS:000265121700007
J	De Filippis, L; Ferrari, D; Nodari, LR; Amati, B; Snyder, E; Vescovi, AL				De Filippis, Lidia; Ferrari, Daniela; Nodari, Laura Rota; Amati, Bruno; Snyder, Evan; Vescovi, Angelo Luigi			Immortalization of Human Neural Stem Cells with the c-Myc Mutant T58A	PLOS ONE			English	Article								Human neural stem cells (hNSC) represent an essential source of renewable brain cells for both experimental studies and cell replacement therapies. Their relatively slow rate of proliferation and physiological senescence in culture make their use cumbersome under some experimental and pre-clinical settings. The immortalization of hNSC with the v-myc gene (v-IhNSC) has been shown to generate stem cells endowed with enhanced proliferative capacity, which greatly facilitates the study of hNSCs, both in vitro and in vivo. Despite the excellent safety properties displayed by v-IhNSCs - which do not transform in vitro and are not tumorigenic in vivo - the v-myc gene contains several mutations and recombination elements, whose role(s) and effects remains to be elucidated, yielding unresolved safety concerns. To address this issue, we used a c-myc T58A retroviral vector to establish an immortal cell line (T-IhNSC) from the same hNSCs used to generate the original v-IhNSCs and compared their characteristics with the latter, with hNSC and with hNSC immortalized using c-myc wt (c-IhNSC). T-IhNSCs displayed an enhanced self-renewal ability, with their proliferative capacity and clonogenic potential being remarkably comparable to those of v-IhNSC and higher than wild type hNSCs and c-IhNSCs. Upon growth factors removal, T-IhNSC promptly gave rise to well-differentiated neurons, astrocytes and most importantly, to a heretofore undocumented high percentage of human oligodendrocytes (up to 23%). Persistent growth-factor dependence, steady functional properties, lack of ability to generate colonies in soft-agar colony-forming assay and to establish tumors upon orthotopic transplantation, point to the fact that immortalization by c-myc T58A does not bring about tumorigenicity in hNSCs. Hence, this work describes a novel and continuous cell line of immortalized human multipotent neural stem cells, in which the immortalizing agent is represented by a single gene which, in turn, carries a single and well characterized mutation. From a different perspective, these data report on a safe approach to increase human neural stem cells propagation in culture, without altering their basic properties. These T-IhNSC line provides a versatile model for the elucidation of the mechanisms involved in human neural stem cells expansion and for development of high throughput assays for both basic and translational research on human neural cell development. The improved proclivity of T-IhNSC to generate human oligodendrocytes propose T-IhNSC as a feasible candidate for the design of experimental and, perhaps, therapeutic approaches in demyelinating diseases.	[De Filippis, Lidia; Ferrari, Daniela; Nodari, Laura Rota; Vescovi, Angelo Luigi] Univ Bicocca Millan, Milan, Italy; [Amati, Bruno] Ist Oncol Europeo, Milan, Italy; [Snyder, Evan] Burnham Inst Med Res, Stem Cell & Regenerat Program, La Jolla, CA USA	University of Milano-Bicocca; IRCCS European Institute of Oncology (IEO); Sanford Burnham Prebys Medical Discovery Institute	De Filippis, L (corresponding author), Univ Bicocca Millan, Milan, Italy.	defilippis.lidia@hsr.it	Amati, Bruno/AAM-3418-2020; Vescovi, Angelo Luigi/A-4919-2015; Ferrari, Daniela/AHE-7647-2022; De Filippis, Lidia/H-3098-2017	Vescovi, Angelo Luigi/0000-0002-1742-4112; Ferrari, Daniela/0000-0001-7251-9854; Amati, Bruno/0000-0002-2958-1799; De Filippis, Lidia/0000-0002-2196-9430	ONLUS association Neurothon; Cariplo; Ministero della Sanita	ONLUS association Neurothon; Cariplo(Fondazione Cariplo); Ministero della Sanita(Ministry of Health, Italy)	The studies performed in this paper were funded by ONLUS association Neurothon, Cariplo and by Ministero della Sanita which provided essential financial support for all the experiments.	Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI 10.1227/01.NEU.0000311081.50648.4C; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; DEFILIPPIS L, 2007, STEM CELLS; Francis JS, 2006, J NEUROSCI RES, V84, P151, DOI 10.1002/jnr.20866; FRYKBERG L, 1987, ONCOGENE, V1, P415; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gritti A, 1996, J NEUROSCI, V16, P1091; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; Lee CM, 1999, ONCOGENE, V18, P2997, DOI 10.1038/sj.onc.1202786; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Martinez-Serrano Alberto, 2001, Current Gene Therapy, V1, P279, DOI 10.2174/1566523013348562; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; PAPAS TS, 1985, CANCER RES, V45, P4568; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; PULVERER BJ, 1994, ONCOGENE, V9, P59; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; SYMONDS G, 1989, ONCOGENE, V4, P285; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Villa A, 2002, BRAIN RES BULL, V57, P789, DOI 10.1016/S0361-9230(01)00776-6; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	36	30	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3310	10.1371/journal.pone.0003310	http://dx.doi.org/10.1371/journal.pone.0003310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18836552	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797300003
J	Huber, S; Schrader, J; Fritz, G; Presser, K; Schmitt, S; Waisman, A; Luth, S; Blessing, M; Herkel, J; Schramm, C				Huber, Samuel; Schrader, Joerg; Fritz, Gerhard; Presser, Katrin; Schmitt, Steffen; Waisman, Ari; Lueth, Stefan; Blessing, Manfred; Herkel, Johannes; Schramm, Christoph			P38 MAP Kinase Signaling Is Required for the Conversion of CD4+CD25-T Cells into iTreg	PLOS ONE			English	Article								CD4+CD25+ regulatory T cells (Treg) are important mediators of immune tolerance. A subset of Treg can be generated in the periphery by TGF-beta dependent conversion of conventional CD4+CD25- T cells into induced Treg (iTreg). In chronic viral infection or malignancy, such induced iTreg, which limit the depletion of aberrant or infected cells, may be of pathogenic relevance. To identify potential targets for therapeutic intervention, we investigated the TGF-beta signaling in Treg. In contrast to conventional CD4+ T cells, Treg exhibited marked activation of the p38 MAP kinase pathway. Inhibition of p38 MAP kinase activity prevented the TGF-beta-dependent conversion of CD4+CD25- T cells into Foxp3+ iTreg in vitro. Of note, the suppressive capacity of nTreg was not affected by inhibiting p38 MAP kinase. Our findings indicate that signaling via p38 MAP kinase seems to be important for the peripheral generation of iTreg; p38 MAP kinase could thus be a therapeutic target to enhance immunity to chronic viral infection or cancer.	[Huber, Samuel; Schrader, Joerg; Presser, Katrin; Lueth, Stefan; Herkel, Johannes; Schramm, Christoph] Univ Klinikum Hamburg Eppendorf, Med Klin, Hamburg, Germany; [Fritz, Gerhard] Univ Giessen, Inst Pharmakol & Toxikol, D-35390 Giessen, Germany; [Schmitt, Steffen] Univ Heidelberg, DKFZ, D-6900 Heidelberg, Germany; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Med Klin, D-6500 Mainz, Germany; [Blessing, Manfred] Univ Leipzig, Biotechnol Biomedizin Zent, Leipzig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Justus Liebig University Giessen; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Leipzig University	Huber, S (corresponding author), Univ Klinikum Hamburg Eppendorf, Med Klin, Hamburg, Germany.	cschramm@uke.de	Waisman, Ari/C-7383-2015	Waisman, Ari/0000-0003-4304-8234; Herkel, Johannes/0000-0001-9055-9999; Huber, Samuel/0000-0001-9325-8227; Schramm, Christoph/0000-0002-4264-1928; Luth, Stefan/0000-0001-9946-0960	Novartis Research Foundation; Universitat Hamburg; DFG [SCHR781/1-1 SCHR781/1-2 HE 3532/2-1]; Werner-Otto Stiftung	Novartis Research Foundation; Universitat Hamburg; DFG(German Research Foundation (DFG)); Werner-Otto Stiftung	DFG SCHR781/1-1 SCHR781/1-2 HE 3532/2-1, Novartis Research Foundation, Universitat Hamburg NWF-07/04, Werner-Otto Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HS, 2007, BLOOD, V109, P4351, DOI 10.1182/blood-2006-09-047563; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; HORWITZ DA, 2008, TRENDS IMMUNOL; Huber S, 2006, FRONT BIOSCI-LANDMRK, V11, P1014, DOI 10.2741/1859; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kogkopoulou O, 2006, J LEUKOCYTE BIOL, V79, P1052, DOI 10.1189/jlb.0705418; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Salojin KV, 1999, J IMMUNOL, V163, P844; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Suri-Payer E, 1999, EUR J IMMUNOL, V29, P669, DOI 10.1002/(SICI)1521-4141(199902)29:02<669::AID-IMMU669>3.0.CO;2-J; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang J, 1999, J IMMUNOL, V162, P3819	31	56	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3302	10.1371/journal.pone.0003302	http://dx.doi.org/10.1371/journal.pone.0003302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827879	Green Submitted, Green Published, gold			2022-12-25	WOS:000264797200008
J	Faridmoayer, A; Fentabil, MA; Haurat, MF; Yi, W; Woodward, R; Wang, PG; Feldman, MF				Faridmoayer, Amirreza; Fentabil, Messele A.; Haurat, M. Florencia; Yi, Wen; Woodward, Robert; Wang, Peng George; Feldman, Mario F.			Extreme Substrate Promiscuity of the Neisseria Oligosaccharyl Transferase Involved in Protein O-Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; PSEUDOMONAS-AERUGINOSA 1244-PILIN; ESCHERICHIA-COLI; PILIN GLYCOSYLATION; BACTERIAL OLIGOSACCHARYLTRANSFERASE; PSEUDOMONAS-AERUGINOSA-1244 PILIN; CAMPYLOBACTER-JEJUNI; SURFACE EXPRESSION; ANTIGEN; LIPOPOLYSACCHARIDE	Neisseria meningitidis PglL belongs to a novel family of bacterial oligosaccharyltransferases (OTases) responsible for O-glycosylation of type IV pilins. Although members of this family are widespread among pathogenic bacteria, there is little known about their mechanism. Understanding the O-glycosylation process may uncover potential targets for therapeutic intervention, and can open new avenues for the exploitation of these pathways for biotechnological purposes. In this work, we demonstrate that PglL is able to transfer virtually any glycan from the undecaprenyl pyrophosphate (UndPP) carrier to pilin in engineered Escherichia coli and Salmonella cells. Surprisingly, PglL was also able to interfere with the peptidoglycan biosynthetic machinery and transfer peptidoglycan subunits to pilin. This represents a previously unknown post-translational modification in bacteria. Given the wide range of glycans transferred by PglL, we reasoned that substrate specificity of PglL lies in the lipid carrier. To test this hypothesis we developed an in vitro glycosylation system that employed purified PglL, pilin, and the lipid farnesyl pyrophosphate (FarPP) carrying a pentasaccharide that had been synthesized by successive chemical and enzymatic steps. Although FarPP has different stereochemistry and a significantly shorter aliphatic chain than the natural lipid substrate, the pentasaccharide was still transferred to pilin in our system. We propose that the primary roles of the lipid carrier during O-glycosylation are the translocation of the glycan into the periplasm, and the positioning of the pyrophosphate linker and glycan adjacent to PglL. The unique characteristics of PglL make this enzyme a promising tool for glycoengineering novel glycan-based vaccines and therapeutics.	[Faridmoayer, Amirreza; Haurat, M. Florencia; Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Fentabil, Messele A.] Univ Alberta, Dept Chem, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB T6G 2E9, Canada; [Yi, Wen; Woodward, Robert; Wang, Peng George] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Yi, Wen; Woodward, Robert; Wang, Peng George] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University of Alberta; University of Alberta; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Feldman, MF (corresponding author), Univ Alberta, Dept Biol Sci, CW405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mfeldman@ualberta.ca	Haurat, M Florencia/ABA-2634-2020; Yi, Wen/M-5905-2014; Feldman, Mario/A-2637-2014; Yi, Wen/C-8756-2009; WANG, Peng/GSN-5263-2022	Haurat, M Florencia/0000-0001-7569-2783; Feldman, Mario/0000-0003-4497-0976; 	Alberta Ingenuity Centre for Carbohydrate Science (AICCS); Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation (CFI); University of Alberta, the Alberta Ingenuity Fund; Alberta Heritage Foundation for Medical Research (AHFMR)	Alberta Ingenuity Centre for Carbohydrate Science (AICCS); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); University of Alberta, the Alberta Ingenuity Fund(University of Alberta); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported by grants from the Alberta Ingenuity Centre for Carbohydrate Science (AICCS), the Natural Sciences and Engineering Research Council (NSERC), the Canada Foundation for Innovation (CFI), the University of Alberta, the Alberta Ingenuity Fund, and the Alberta Heritage Foundation for Medical Research (AHFMR) (to M. F. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; BUNDLE DR, 1994, BIOCHEMISTRY-US, V33, P5172, DOI 10.1021/bi00183a022; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Chen MM, 2007, BIOCHEMISTRY-US, V46, P14342, DOI 10.1021/bi701956x; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Drummelsmith J, 1999, MOL MICROBIOL, V31, P1321, DOI 10.1046/j.1365-2958.1999.01277.x; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; GOLDBERG JB, 1992, P NATL ACAD SCI USA, V89, P10716, DOI 10.1073/pnas.89.22.10716; Guan ZQ, 2005, ANAL BIOCHEM, V345, P336, DOI 10.1016/j.ab.2005.07.002; Hoare A, 2006, INFECT IMMUN, V74, P1555, DOI 10.1128/IAI.74.3.1555-1564.2006; Horzempa J, 2008, CLIN VACCINE IMMUNOL, V15, P590, DOI 10.1128/CVI.00476-07; IELPI L, 1993, J BACTERIOL, V175, P2490, DOI 10.1128/JB.175.9.2490-2500.1993; JANSSON PE, 1987, CARBOHYD RES, V161, P273, DOI 10.1016/S0008-6215(00)90084-3; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; NEAL BL, 1993, J BACTERIOL, V175, P7115, DOI 10.1128/jb.175.21.7115-7118.1993; Power PM, 2006, BIOCHEM BIOPH RES CO, V347, P904, DOI 10.1016/j.bbrc.2006.06.182; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Qutyan M, 2007, MOL MICROBIOL, V66, P1444, DOI 10.1111/j.1365-2958.2007.06001.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Templin MF, 1999, EMBO J, V18, P4108, DOI 10.1093/emboj/18.15.4108; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y	33	93	104	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34596	34604		10.1074/jbc.M807113200	http://dx.doi.org/10.1074/jbc.M807113200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930921	Green Published, hybrid			2022-12-25	WOS:000261469100014
J	Lammers, M; Meyer, S; Kuhlmann, D; Wittinghofer, A				Lammers, Michael; Meyer, Simon; Kuehlmann, Dorothee; Wittinghofer, Alfred			Specificity of Interactions between mDia Isoforms and Rho Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMIN; ACTIN NUCLEATION FACTOR; PROLINE-RICH LIGANDS; HOMOLOGY-2 DOMAIN; STRUCTURAL BASIS; BINDING PROTEIN; CAPPING PROTEIN; BARBED-END; CELLULAR-TRANSFORMATION; MAMMALIAN HOMOLOG	Formins are key regulators of actin nucleation and polymerization. They contain formin homology 1 (FH1) and 2 (FH2) domains as the catalytic machinery for the formation of linear actin cables. A subclass of formins constitutes the Diaphanous-related formins, members of which are regulated by the binding of a small GTP-binding protein of the Rho subfamily. Binding of these molecular switch proteins to the regulatory N-terminal mDia(N), including the GTPase-binding domain, leads to the release of auto-inhibition. From the three mDia isoforms, mDia1 is activated only by Rho (RhoA, -B, and -C), in contrast to mDia2 and -3, which is also activated by Rac and Cdc42. Little is known about the determinants of specificity. Here we report on the interactions of RhoA, Rac1, and Cdc42 with mDia1 and an mDia1 mutant (mDia(N)-Thr-Ser-His (TSH)), which based on structural information should mimic mDia2 and -3. Specificity is analyzed by biochemical studies and a structural analysis of a complex between Cdc42 center dot Gpp(NH)p and mDia(N)-TSH. A triple NNN motif in mDia1 (amino acids 164-166), corresponding to the TSH motif in mDia2/3 (amino acids 183-185 and 190-192), and the epitope interacting with the Rho insert helix are essential for high affinity binding. The triple N motif of mDia1 allows tight interaction with Rho because of the presence of Phe-106, whereas the corresponding His-104 in Rac and Cdc42 forms a complementary interface with the TSH motif in mDia2/3. We also show that the F106H and H104F mutations drastically alter the affinities and thermodynamics of mDia interactions.	[Lammers, Michael; Meyer, Simon; Kuehlmann, Dorothee; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, Otto Hahn Str 11, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Lammers, Michael/AAX-1164-2020	Lammers, Michael/0000-0003-4168-4640				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Arai R, 2002, J CELL SCI, V115, P887; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; DeLano WL, 2002, PYMOL USERS MANUAL; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karnoub AE, 2001, MOL CELL BIOL, V21, P2847, DOI 10.1128/MCB.21.8.2847-2857.2001; Kato T, 2001, J CELL SCI, V114, P775; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, NAT CELL BIOL, V6, P1158, DOI 10.1038/ncb1204-1158; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Leung DW, 2005, P NATL ACAD SCI USA, V102, P5685, DOI 10.1073/pnas.0406472102; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, ACTA CRYSTALLOGR F, V61, P225, DOI 10.1107/S1744309105001065; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VAN AL, 1997, GENE DEV, V11, P2295; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001	75	76	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35236	35246		10.1074/jbc.M805634200	http://dx.doi.org/10.1074/jbc.M805634200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18829452	Green Published, hybrid			2022-12-25	WOS:000261469100079
J	Cao, Y; Siegel, D; Oswald, F; Knochel, W				Cao, Ying; Siegel, Doreen; Oswald, Franz; Knoechel, Walter			Oct25 Represses Transcription of Nodal/Activin Target Genes by Interaction with Signal Transducers during Xenopus Gastrulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; NODAL-RELATED SIGNALS; HOMEOBOX GENE; DEVELOPMENTAL REGULATORS; MOLECULAR-MECHANISMS; HISTONE DEACETYLASE; SPEMANNS ORGANIZER; AXIS FORMATION; MESODERM; INDUCTION	The balance between differentiation signals and signals maintaining the undifferentiated state of embryonic cells ensures proper formation of germ layers. The nodal/activin pathway represents one of the major signaling chains responsible for the differentiation of embryonic cells into mesodermal and endodermal germ layers, while Oct4 is one of the major players in the maintenance of an undifferentiated state. Here we show that Oct25, an Oct4 homologue in Xenopus, antagonizes the activity of nodal/activin signaling by inhibiting the transcription of its target genes, Gsc and Mix2. The inhibitory effect is achieved by forming repression complexes on the promoters of Gsc and Mix2 between Oct25 and the signal transducers of the nodal/activin pathway, WBSCR11, FAST1, and Smad2. We have analyzed the significance of the Oct binding site for its inhibitory effect within the Gsc promoter. Albeit VP16-Oct25 fusion protein demonstrated a stimulating effect and EVE-Oct25 revealed a repression effect on an artificial reporter that is composed of eight repeats of Oct binding motifs, both fusions, like wild-type Oct25, inhibited mesendoderm formation and the activity of Gsc and Mix2 promoters. These results suggest that the regulatory effect of Oct25 on the expression of Gsc and Mix2 is mediated by specific protein/protein interactions. Furthermore, we demonstrate that histone deacetylase activities are not required for the inhibitory effect of Oct25. Our results provide a novel view in that Oct25 controls the nodal/activin pathway and thus maintains the undifferentiated state of embryonic cells in preventing them from premature differentiation.	[Cao, Ying; Siegel, Doreen; Knoechel, Walter] Univ Ulm, Inst Biochem, D-89091 Ulm, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med 1, D-89091 Ulm, Germany	Ulm University; Ulm University	Knochel, W (corresponding author), Univ Ulm, Inst Biochem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	walter.knoechel@uni-ulm.de	Oswald, Franz/AAO-9584-2020	Cao, Ying/0000-0001-8286-9591	Deutsche Forschungsgemeinschaft [SFB497/A1, SFB497/B9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants (SFB497/A1)( to W. K.) and (SFB497/B9) (to F.O.) from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agius E, 2000, DEVELOPMENT, V127, P1173; ARIIZUMI T, 1991, International Journal of Developmental Biology, V35, P407; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Cao Y, 2007, EMBO J, V26, P2942, DOI 10.1038/sj.emboj.7601736; Cao Y, 2006, MECH DEVELOP, V123, P614, DOI 10.1016/j.mod.2006.06.004; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HINKLEY CS, 1992, MOL CELL BIOL, V12, P638, DOI 10.1128/MCB.12.2.638; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; JONES CM, 1995, DEVELOPMENT, V121, P3651; Joseph EM, 1997, DEV BIOL, V184, P367, DOI 10.1006/dbio.1997.8510; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Laurent MN, 1997, DEVELOPMENT, V124, P4905; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemaire P, 1998, DEVELOPMENT, V125, P2371; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; NIEHRS C, 1993, CELL, V72, P491, DOI 10.1016/0092-8674(93)90069-3; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Ramsdell AF, 1998, TRENDS GENET, V14, P459, DOI 10.1016/S0168-9525(98)01599-6; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; STEINBEISSER H, 1993, DEVELOPMENT, V118, P499; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vize PD, 1996, DEV BIOL, V177, P226, DOI 10.1006/dbio.1996.0158; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	45	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34168	34177		10.1074/jbc.M803532200	http://dx.doi.org/10.1074/jbc.M803532200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922797	hybrid, Green Published			2022-12-25	WOS:000261277700045
J	Jones, CN; Jones, CI; Graham, WD; Agris, PF; Spremulli, LL				Jones, Christie N.; Jones, Christopher I.; Graham, William D.; Agris, Paul F.; Spremulli, Linda L.			A Disease-causing Point Mutation in Human Mitochondrial tRNA(Met) Results in tRNA Misfolding Leading to Defects in Translational Initiation and Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNAS; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; HIGHER-ORDER STRUCTURE; STEADY-STATE LEVELS; FACTOR TU; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; DNA	The mitochondrial tRNA genes are hot spots for mutations that lead to human disease. A single point mutation (T4409C) in the gene for human mitochondrial tRNAMet (hmtRNA(Met)) has been found to cause mitochondrial myopathy. This mutation results in the replacement of U8 in hmtRNA(Met) with a C8. The hmtRNAMet serves both in translational initiation and elongation in human mitochondria making this tRNA of particular interest in mitochondrial protein synthesis. Here we show that the single 8U -> C mutation leads to a failure of the tRNA to respond conformationally to Mg2+. This mutation results in a drastic disruption of the structure of the hmtRNAMet, which significantly reduces its aminoacylation. The small fraction of hmtRNAMet that can be aminoacylated is not formylated by the mitochondrial Met-tRNA transformylase preventing its function in initiation, and it is unable to form a stable ternary complex with elongation factor EF-Tu preventing any participation in chain elongation. We have used structural probing and molecular reconstitution experiments to examine the structures formed by the normal and mutated tRNAs. In the presence of Mg2+, the normal tRNA displays the structural features expected of a tRNA. However, even in the presence of Mg2+, the mutated tRNA does not form the cloverleaf structure typical of tRNAs. Thus, we believe that this mutation has disrupted a critical Mg2+-binding site on the tRNA required for formation of the biologically active structure. This work establishes a foundation for understanding the physiological consequences of the numerous mitochondrial tRNA mutations that result in disease in humans.	[Jones, Christopher I.; Graham, William D.; Agris, Paul F.] N Carolina State Univ, Dept Struct & Mol Biol, Raleigh, NC 27695 USA; [Jones, Christie N.; Spremulli, Linda L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Agris, PF (corresponding author), N Carolina State Univ, Dept Struct & Mol Biol, Campus Box 7622, Raleigh, NC 27695 USA.	Paul_Agris@ncsu.edu; Linda_Spremulli@unc.edu			National Institutes of Health [GM32734, GM23037]; United Mitochondrial Disease Foundation; National Science Foundation [MCB 548602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023037, R01GM032734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32734 (to L. L. S.) and GM23037. This work was also supported by a United Mitochondrial Disease Foundation grant (to L. L. S. and P. F. A.) and National Science Foundation Grant MCB 548602 (to P. F. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Ashraf SS, 2000, CELL BIOCHEM BIOPHYS, V33, P241, DOI 10.1385/CBB:33:3:241; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; Bacman SR, 2003, BIOCHEM J, V374, P131, DOI 10.1042/BJ20030222; Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k; BAEYENS KJ, 1995, NAT STRUCT BIOL, V2, P56, DOI 10.1038/nsb0195-56; Bonnefond L, 2008, RNA, V14, P641, DOI 10.1261/rna.938108; Bullard JM, 1999, BBA-GENE STRUCT EXPR, V1446, P102, DOI 10.1016/S0167-4781(99)00077-9; Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200; CENATIEMPO Y, 1987, BIOCHEMISTRY-US, V26, P5070, DOI 10.1021/bi00390a028; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Dirheimer G., 1995, P93; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Hunter S.E., 2004, RNA BIOL, V2, P95; Hunter SE, 2004, MITOCHONDRION, V4, P21, DOI 10.1016/j.mito.2004.04.003; Jones CI, 2006, J MOL BIOL, V362, P771, DOI 10.1016/j.jmb.2006.07.036; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Levinger L, 2001, NUCLEIC ACIDS RES, V29, P4334, DOI 10.1093/nar/29.21.4334; Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104; Lombes A, 1998, HUM MUTAT, pS175; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; Schwartzbach C J, 1996, Methods Enzymol, V264, P248, DOI 10.1016/S0076-6879(96)64025-7; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886; Spencer AC, 2004, BIOCHEMISTRY-US, V43, P9743, DOI 10.1021/bi049639w; SPRINZL M, 1980, NUCLEIC ACIDS RES, V8, P4737, DOI 10.1093/nar/8.20.4737; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; STEIN A, 1976, BIOCHEMISTRY-US, V15, P160, DOI 10.1021/bi00646a025; Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875; WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347; WATANABE Y, 1994, NUCLEIC ACIDS RES, V22, P5378, DOI 10.1093/nar/22.24.5378; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006; Wittenhagen LM, 2003, NUCLEIC ACIDS RES, V31, P596, DOI 10.1093/nar/gkg131; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543; YOKOGAWA T, 1991, NUCLEIC ACIDS RES, V19, P6101, DOI 10.1093/nar/19.22.6101; Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548	53	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34445	34456		10.1074/jbc.M806992200	http://dx.doi.org/10.1074/jbc.M806992200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835817	Green Published, hybrid			2022-12-25	WOS:000261277700072
J	Panopoulos, P; Mauro, VP				Panopoulos, Panagiotis; Mauro, Vincent P.			Antisense Masking Reveals Contributions of mRNA- rRNA Base Pairing to Translation of Gtx and FGF2 mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; MOLECULAR-WEIGHT FORMS; AUG-INITIATED FORMS; ALTERNATIVE TRANSLATION; ESCHERICHIA-COLI; GENE-EXPRESSION; ENTRY SITE; CODONS; CUG; DNA	We previously showed that a 9-nucleotide sequence from the 5' leader of the Gtx homeodomain mRNA facilitates translation initiation by base pairing to 18S rRNA. These earlier studies tested the Gtx element in isolation; we now assess the physiological relevance of this element in the context of two natural mRNAs that contain this sequence in their 5' leaders, Gtx itself and FGF2(fibroblast growth factor 2). 2'-O-Methyl-modified RNA oligonucleotides were employed to block mRNA-rRNA base pairing by targeting either the Gtx-binding site in 18S rRNA or Gtx elements in recombinant mRNAs containing the Gtx or FGF2 5' leaders linked to a reporter cistron. Studies in cell-free lysates and transfected COS-7 cells showed that translation of mRNAs containing the Gtx or FGF2 5' leaders was decreased by > 50% when oligonucleotides targeting either the rRNA or mRNA were used. Specificity was demonstrated by showing that translation of the recombinant mRNAs was unaffected by control oligonucleotides. In addition, the specific oligonucleotides did not affect the translation of recombinant mRNAs in which the Gtx elements were mutated. Experiments performed using constructs containing Gtx and FGF2 5' leader and coding sequences ruled out possible effects of the reporter cistron. Furthermore, two-dimensional gel electrophoresis revealed that the oligonucleotides used in this study had little overall effect on the proteomes of cells transfected with these oligonucleotides. This study demonstrates that mRNA-rRNA base pairing affects the expression of two cellularm RNAs and describes a new approach for investigating putative mRNA-rRNA base pairing interactions in mammalian cells.	Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Mauro, VP (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	vmauro@scripps.edu			National Institutes of Health [GM078071]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078071 (to V. P. M.). This work was also supported by the Skaggs Institute for Chemical Biology ( to P. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnaud E, 1999, MOL CELL BIOL, V19, P505; Awatramani R, 1997, J NEUROSCI, V17, P6657; BIKFALVI A, 1995, J CELL BIOL, V129, P233, DOI 10.1083/jcb.129.1.233; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2004, P NATL ACAD SCI USA, V101, P9590, DOI 10.1073/pnas.0308759101; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P18077, DOI 10.1073/pnas.0608212103; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; COUDERC B, 1991, CELL REGUL, V2, P709, DOI 10.1091/mbc.2.9.709; CUMMINS LL, 1995, NUCLEIC ACIDS RES, V23, P2019, DOI 10.1093/nar/23.11.2019; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; HOGREFE HH, 1990, J BIOL CHEM, V265, P5561; Hu MCY, 1999, P NATL ACAD SCI USA, V96, P1339, DOI 10.1073/pnas.96.4.1339; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; MATVEEVA OV, 1993, NUCLEIC ACIDS RES, V21, P1007, DOI 10.1093/nar/21.4.1007; Mauro VP, 1997, P NATL ACAD SCI USA, V94, P422, DOI 10.1073/pnas.94.2.422; Mignone Flavio, 2002, Appl Bioinformatics, V1, P145; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; QUARTO N, 1991, J CELL PHYSIOL, V147, P311, DOI 10.1002/jcp.1041470217; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SCHEPER GC, 1994, FEBS LETT, V352, P271, DOI 10.1016/0014-5793(94)00975-9; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Stein D, 1997, ANTISENSE NUCLEIC A, V7, P151, DOI 10.1089/oli.1.1997.7.151; Vagner S, 1996, J CELL BIOL, V135, P1391, DOI 10.1083/jcb.135.5.1391; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116	30	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33087	33093		10.1074/jbc.M804904200	http://dx.doi.org/10.1074/jbc.M804904200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832380	Green Published, hybrid			2022-12-25	WOS:000261183700009
J	Cardo-Vila, M; Zurita, AJ; Giordano, RJ; Sun, J; Rangel, R; Guzman-Rojas, L; Anobom, CD; Valente, AP; Almeida, FCL; Lahdenranta, J; Kolonin, MG; Arap, W; Pasqualini, R				Cardo-Vila, Marina; Zurita, Amado J.; Giordano, Ricardo J.; Sun, Jessica; Rangel, Roberto; Guzman-Rojas, Liliana; Anobom, Cristiane D.; Valente, Ana P.; Almeida, Fabio C. L.; Lahdenranta, Johanna; Kolonin, Mikhail G.; Arap, Wadih; Pasqualini, Renata			A Ligand Peptide Motif Selected from a Cancer Patient Is a Receptor-Interacting Site within Human Interleukin-11	PLOS ONE			English	Article								Interleukin-11 (IL-11) is a pleiotropic cytokine approved by the FDA against chemotherapy-induced thrombocytopenia. From a combinatorial selection in a cancer patient, we isolated an IL-11-like peptide mapping to domain I of the IL-11 (sequence CGRRAGGSC). Although this motif has ligand attributes, it is not within the previously characterized interacting sites. Here we design and validate in-tandem binding assays, site-directed mutagenesis and NMR spectroscopy to show (i) the peptide mimics a receptor-binding site within IL-11, (ii) the binding of CGRRAGGSC to the IL-11R alpha is functionally relevant, (iii) Arg(4) and Ser(8) are the key residues mediating the interaction, and (iv) the IL-11-like motif induces cell proliferation through STAT3 activation. These structural and functional results uncover an as yet unrecognized receptor-binding site in human IL-11. Given that IL-11R alpha has been proposed as a target in human cancer, our results provide clues for the rational design of targeted drugs.	[Cardo-Vila, Marina; Zurita, Amado J.; Giordano, Ricardo J.; Sun, Jessica; Rangel, Roberto; Guzman-Rojas, Liliana; Lahdenranta, Johanna; Kolonin, Mikhail G.; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Anobom, Cristiane D.; Valente, Ana P.; Almeida, Fabio C. L.] Fed Univ, Natl NMR Ctr, BR-21941 Rio De Janeiro, Brazil	University of Texas System; UTMD Anderson Cancer Center	Cardo-Vila, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	warap@mdanderson.org; rpasqual@mdanderson.org	Bom, Cristiane Dinis Ano/X-9461-2019; Rangel, Roberto/AHE-6583-2022; Almeida, Fabio/O-4989-2018; Valente, Ana Paula/J-3010-2017; Giordano, Ricardo/A-2074-2010	Rangel, Roberto/0000-0002-9088-7957; Almeida, Fabio/0000-0001-6046-7006; Valente, Ana Paula/0000-0001-7219-1123; Giordano, Ricardo/0000-0001-8116-6771; Kolonin, Mikhail/0000-0002-3743-7869	National Cancer Institute; U.S. Department of Defense; Prostate Cancer Foundation; Marcus Foundation; Gillson-Longenbaugh Foundation; Susan G. Komen Breast Cancer Foundation; Instituto de Salud Carlos III (Spain); Odyssey Program of The University of Texas M. D. Anderson Cancer Center; National Research Council (Brazil); Rio de Janeiro State Research Support Foundation; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Marcus Foundation; Gillson-Longenbaugh Foundation; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Odyssey Program of The University of Texas M. D. Anderson Cancer Center; National Research Council (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Support Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Specialized Program in Research Excellence (SPORE) of the National Cancer Institute (to WA and RP), from the U.S. Department of Defense (to MGK, WA, and RP), and by awards from the Prostate Cancer Foundation, the Marcus Foundation and the Gillson-Longenbaugh Foundation (to WA and RP). MCV received a postdoctoral fellowship from the Susan G. Komen Breast Cancer Foundation. AJZ received a postdoctoral fellowship from the Instituto de Salud Carlos III (Spain); RR is a Scholar from the Odyssey Program of The University of Texas M. D. Anderson Cancer Center. CDA received a predoctoral fellowship from the National Research Council (Brazil). FCLA and APV received support from the Rio de Janeiro State Research Support Foundation and the National Research Council (Brazil). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Boulanger MJ, 2004, J MOL BIOL, V335, P641, DOI 10.1016/j.jmb.2003.10.070; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Campbell CL, 2001, AM J PATHOL, V158, P25, DOI 10.1016/S0002-9440(10)63940-5; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Ciapponi L, 1995, J BIOL CHEM, V270, P31249, DOI 10.1074/jbc.270.52.31249; Cruzeiro-Silva C, 2007, BBA-BIOMEMBRANES, V1768, P3182, DOI 10.1016/j.bbamem.2007.08.022; Cwirla SE, 1997, SCIENCE, V276, P1696, DOI 10.1126/science.276.5319.1696; Czupryn M, 1995, ANN NY ACAD SCI, V762, P152; CZUPRYN MJ, 1995, J BIOL CHEM, V270, P978, DOI 10.1074/jbc.270.2.978; Dahmen H, 1998, BIOCHEM J, V331, P695, DOI 10.1042/bj3310695; Du XX, 1997, BLOOD, V89, P3897, DOI 10.1182/blood.V89.11.3897; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; FOURCIN M, 1994, EUR J IMMUNOL, V24, P277, DOI 10.1002/eji.1830240143; Giordano RJ, 2005, CHEM BIOL, V12, P1075, DOI 10.1016/j.chembiol.2005.07.008; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Greiser JS, 2002, J BIOL CHEM, V277, P26959, DOI 10.1074/jbc.M204113200; Grotzinger J, 1999, BIOL CHEM, V380, P803, DOI 10.1515/BC.1999.100; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Harmegnies D, 2003, BIOCHEM J, V375, P23, DOI 10.1042/BJ20030459; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hermanns HM, 2005, NAT STRUCT MOL BIOL, V12, P476, DOI 10.1038/nsmb0605-476; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kurth I, 1999, J IMMUNOL, V162, P1480; Lebeau B, 1997, FEBS LETT, V407, P141, DOI 10.1016/S0014-5793(97)00326-8; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; Muller-Newen G, 2000, J BIOL CHEM, V275, P4579, DOI 10.1074/jbc.275.7.4579; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; PANAYOTATOS N, 1995, J BIOL CHEM, V270, P14007, DOI 10.1074/jbc.270.23.14007; Pentz RD, 2005, NAT MED, V11, P1145, DOI 10.1038/nm1105-1145; Pentz RD, 2003, HASTINGS CENT REP, V33, P20, DOI 10.2307/3527910; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199; Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Schuster B, 2003, FEBS LETT, V538, P113, DOI 10.1016/S0014-5793(03)00154-6; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Tacken I, 1999, EUR J BIOCHEM, V265, P645, DOI 10.1046/j.1432-1327.1999.00755.x; Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	62	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3452	10.1371/journal.pone.0003452	http://dx.doi.org/10.1371/journal.pone.0003452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941632	gold, Green Published, Green Submitted			2022-12-25	WOS:000265125600011
J	Yang, PH; Wang, JW; Gong, GC; Sun, XZ; Zhang, R; Du, Z; Liu, Y; Li, R; Ding, FR; Tang, B; Dai, YP; Li, N				Yang, Penghua; Wang, Jianwu; Gong, Guochun; Sun, Xiuzhu; Zhang, Ran; Du, Zhuo; Liu, Ying; Li, Rong; Ding, Fangrong; Tang, Bo; Dai, Yunping; Li, Ning			Cattle Mammary Bioreactor Generated by a Novel Procedure of Transgenic Cloning for Large-Scale Production of Functional Human Lactoferrin	PLOS ONE			English	Article							RECOMBINANT HUMAN LACTOFERRIN; ESCHERICHIA-COLI; BOVINE LACTOFERRIN; HUMAN-MILK; IN-VITRO; EXPRESSION; IRON; MICE; COWS; CHROMATOGRAPHY	Large-scale production of biopharmaceuticals by current bioreactor techniques is limited by low transgenic efficiency and low expression of foreign proteins. In general, a bacterial artificial chromosome (BAC) harboring most regulatory elements is capable of overcoming the limitations, but transferring BAC into donor cells is difficult. We describe here the use of cattle mammary bioreactor to produce functional recombinant human lactoferrin (rhLF) by a novel procedure of transgenic cloning, which employs microinjection to generate transgenic somatic cells as donor cells. Bovine fibroblast cells were co-microinjected for the first time with a 150-kb BAC carrying the human lactoferrin gene and a marker gene. The resulting transfection efficiency of up to 15.79x10(-2) percent was notably higher than that of electroporation and lipofection. Following somatic cell nuclear transfer, we obtained two transgenic cows that secreted rhLF at high levels, 2.5 g/l and 3.4 g/l, respectively. The rhLF had a similar pattern of glycosylation and proteolytic susceptibility as the natural human counterpart. Biochemical analysis revealed that the iron-binding and releasing properties of rhLF were identical to that of native hLF. Importantly, an antibacterial experiment further demonstrated that rhLF was functional. Our results indicate that co-microinjection with a BAC and a marker gene into donor cells for somatic cell cloning indeed improves transgenic efficiency. Moreover, the cattle mammary bioreactors generated with this novel procedure produce functional rhLF on an industrial scale.	[Yang, Penghua; Wang, Jianwu; Gong, Guochun; Sun, Xiuzhu; Zhang, Ran; Du, Zhuo; Tang, Bo; Dai, Yunping; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Liu, Ying; Li, Rong; Ding, Fangrong; Tang, Bo] Beijing Genprotein Biotechnol Comp, Beijing, Peoples R China	China Agricultural University	Yang, PH (corresponding author), Yangtze Univ, Coll Life Sci, Jinzhou, Hubei, Peoples R China.	ninglbau@public3.bta.net.cn	Du, Zhuo/AAD-2263-2019; Liu, Ying/T-5064-2019	Du, Zhuo/0000-0002-6322-4656; 	State High-tech Research Development Program of China	State High-tech Research Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the State High-tech Research Development Program of China.	Baveye S, 1999, CLIN CHEM LAB MED, V37, P281, DOI 10.1515/CCLM.1999.049; BROCK JH, 1980, ARCH DIS CHILD, V55, P417, DOI 10.1136/adc.55.6.417; Brophy B, 2003, NAT BIOTECHNOL, V21, P157, DOI 10.1038/nbt783; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chong DKX, 2000, TRANSGENIC RES, V9, P71, DOI 10.1023/A:1008977630179; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; DAVIDSON LA, 1987, ACTA PAEDIATR SCAND, V76, P733, DOI 10.1111/j.1651-2227.1987.tb10557.x; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eyestone WH, 1999, THERIOGENOLOGY, V51, P509, DOI 10.1016/S0093-691X(98)00244-1; FOLEY AA, 1987, ANAL BIOCHEM, V162, P296, DOI 10.1016/0003-2697(87)90040-6; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Gong GC, 2004, MOL REPROD DEV, V69, P278, DOI 10.1002/mrd.20130; Hejna JA, 1998, NUCLEIC ACIDS RES, V26, P1124, DOI 10.1093/nar/26.4.1124; Hyvonen P, 2006, INFECT IMMUN, V74, P6206, DOI 10.1128/IAI.00238-06; Isamida T, 1998, J VET MED SCI, V60, P241, DOI 10.1292/jvms.60.241; IYER S, 1993, EUR J CLIN NUTR, V47, P232; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; KRIMPENFORT P, 1991, BIO-TECHNOL, V9, P844, DOI 10.1038/nbt0991-844; LEGRAND D, 1995, FEBS LETT, V365, P57, DOI 10.1016/0014-5793(95)00441-B; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; LIANG QW, 1993, J AGR FOOD CHEM, V41, P1800, DOI 10.1021/jf00034a053; Liu ZL, 2004, ANIM BIOTECHNOL, V15, P21, DOI 10.1081/ABIO-120029810; Lonnerdal B, 2006, AM J CLIN NUTR, V83, P305; LONNERDAL B, 1995, ANNU REV NUTR, V15, P93, DOI 10.1146/annurev.nu.15.070195.000521; Lopez M, 1997, GLYCOBIOLOGY, V7, P635, DOI 10.1093/glycob/7.5.635; Magin-Lachmann C, 2004, J GENE MED, V6, P195, DOI 10.1002/jgm.481; Naot D, 2005, CLIN MED RES, V3, P93, DOI 10.3121/cmr.3.2.93; Nuijens JH, 1997, J BIOL CHEM, V272, P8802, DOI 10.1074/jbc.272.13.8802; Palmano KP, 2002, J CHROMATOGR A, V947, P307, DOI 10.1016/S0021-9673(01)01563-1; PETIT BS, 2003, EUR J BIOCHEM, V270, P3235; PLATENBURG GJ, 1994, TRANSGENIC RES, V3, P99, DOI 10.1007/BF01974087; ROSENKRANS C F JR, 1991, Theriogenology, V35, P266, DOI 10.1016/0093-691X(91)90242-6; Salmon V, 1998, PROTEIN EXPRES PURIF, V13, P127, DOI 10.1006/prep.1998.0886; SPIK G, 1982, EUR J BIOCHEM, V121, P413, DOI 10.1111/j.1432-1033.1982.tb05803.x; STOWELL KM, 1991, BIOCHEM J, V276, P349, DOI 10.1042/bj2760349; Takahashi S, 2004, CLONING STEM CELLS, V6, P165, DOI 10.1089/1536230041372265; Tian XC, 2005, P NATL ACAD SCI USA, V102, P6261, DOI 10.1073/pnas.0500140102; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; van Veen HA, 2004, EUR J BIOCHEM, V271, P678, DOI 10.1111/j.1432-1033.2003.03965.x; van Veen HA, 2002, ANAL BIOCHEM, V309, P60, DOI 10.1016/S0003-2697(02)00273-7; VANBERKEL PHC, 1995, BIOCHEM J, V312, P107, DOI 10.1042/bj3120107; Vorland LH, 1999, APMIS, V107, P971, DOI 10.1111/j.1699-0463.1999.tb01499.x; Wakabayashi H, 2002, J MED MICROBIOL, V51, P844, DOI 10.1099/0022-1317-51-10-844; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wall RJ, 1999, LIVEST PROD SCI, V59, P243, DOI 10.1016/S0301-6226(99)00030-5; Walsh MK, 2003, CLONING STEM CELLS, V5, P213, DOI 10.1089/153623003769645875; WARD PP, 1992, GENE, V122, P219, DOI 10.1016/0378-1119(92)90054-S; WARD PP, 1995, BIO-TECHNOL, V13, P498, DOI 10.1038/nbt0595-498; Wee G, 2006, J BIOL CHEM, V281, P6048, DOI 10.1074/jbc.M511340200; XIE HX, 1983, CELL STRUCT FUNCT, V8, P315, DOI 10.1247/csf.8.315; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zhang XF, 2005, BIOCHEM BIOPH RES CO, V333, P58, DOI 10.1016/j.bbrc.2005.05.072; Zhao CJ, 2006, ANIM BIOTECHNOL, V17, P13, DOI 10.1080/10495390500460940; Zimecki M, 2004, INFLAMM RES, V53, P292, DOI 10.1007/s00011-004-1257-1	55	89	111	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3453	10.1371/journal.pone.0003453	http://dx.doi.org/10.1371/journal.pone.0003453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941633	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125600012
J	Clarke, TF; Clark, PL				Clarke, Thomas F., IV; Clark, Patricia L.			Rare Codons Cluster	PLOS ONE			English	Article								Most amino acids are encoded by more than one codon. These synonymous codons are not used with equal frequency: in every organism, some codons are used more commonly, while others are more rare. Though the encoded protein sequence is identical, selective pressures favor more common codons for enhanced translation speed and fidelity. However, rare codons persist, presumably due to neutral drift. Here, we determine whether other, unknown factors, beyond neutral drift, affect the selection and/or distribution of rare codons. We have developed a novel algorithm that evaluates the relative rareness of a nucleotide sequence used to produce a given protein sequence. We show that rare codons, rather than being randomly scattered across genes, often occur in large clusters. These clusters occur in numerous eukaryotic and prokaryotic genomes, and are not confined to unusual or rarely expressed genes: many highly expressed genes, including genes for ribosomal proteins, contain rare codon clusters. A rare codon cluster can impede ribosome translation of the rare codon sequence. These results indicate additional selective pressures govern the use of synonymous codons, and specifically that local pauses in translation can be beneficial for protein biogenesis.	[Clarke, Thomas F., IV; Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Clarke, TF (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	pclark1@nd.edu	Clark, Patricia/C-9850-2009	Clark, Patricia/0000-0001-5462-8248	NIH [GM74807]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074807] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by an award from the NIH (GM74807). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Clark PL, 2001, J BIOL CHEM, V276, P25411, DOI 10.1074/jbc.M008490200; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Gu WJ, 2003, IEEE T NANOBIOSCI, V2, P150, DOI 10.1109/TNB.2003.817024; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Makhoul CH, 2002, J BIOMOL STRUCT DYN, V20, P413, DOI 10.1080/07391102.2002.10506859; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Smith NGC, 2001, J MOL EVOL, V53, P225, DOI 10.1007/s002390010212; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/pro.5560051003; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; TSAI CJ, J MOL BIOL IN PRESS; VARENNE S, 1986, J THEOR BIOL, V120, P99, DOI 10.1016/S0022-5193(86)80020-0; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; VARENNE S, 1989, BIOCHIMIE, V71, P1221, DOI 10.1016/0300-9084(89)90027-8; Widmann M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-207	27	129	133	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3412	10.1371/journal.pone.0003412	http://dx.doi.org/10.1371/journal.pone.0003412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923675	Green Published, gold, Green Submitted			2022-12-25	WOS:000265121800010
J	Lewinsohn, DA; Zalwango, S; Stein, CM; Mayanja-Kizza, H; Okwera, A; Boom, WH; Mugerwa, RD; Whalen, CC				Lewinsohn, Deborah A.; Zalwango, Sarah; Stein, Catherine M.; Mayanja-Kizza, Harriet; Okwera, Alphonse; Boom, W. Henry; Mugerwa, Roy D.; Whalen, Christopher C.			Whole Blood Interferon-Gamma Responses to Mycobacterium tuberculosis Antigens in Young Household Contacts of Persons with Tuberculosis in Uganda	PLOS ONE			English	Article								Background: Due to immunologic immaturity, IFN-gamma-producing T cell responses may be decreased in young children compared to adults, thus we hypothesized that IFN-gamma responses to mycobacterial antigens in household contacts exposed to Mycobacterium tuberculosis (Mtb) would be impaired in young children relative to adults. The objective of this study was to compare whole blood IFN-gamma production in response to mycobacterial antigens between children and adults in Uganda. Methodology/Principal Findings: We studied household contacts of persons with culture-positive pulmonary tuberculosis (TB) enrolled in a cohort study conducted in Kampala, Uganda. Whole blood IFN-gamma production in response to Mtb culture-filtrate antigens was measured by ELISA and compared between infants (<2 years old, n = 80), young children (2 < 5 years old, n = 216), older children (5 < 15 years old, n = 443) and adults (>= 15 years old, n = 528). We evaluated the relationship between IFN-gamma responses and the tuberculin skin test (TST), and between IFN-gamma responses and epidemiologic factors that reflect exposure to Mtb, and the effect of prior BCG vaccination on IFN-gamma responses. Young household contacts demonstrated robust IFN-gamma responses comparable to those of adults that were associated with TST and known risk factors for infection. There was no effect of prior BCG immunization on the IFN-gamma response. Conclusions/Significance: Young children in a TB endemic setting can mount robust IFN-gamma responses generally comparable to those of adults, and as in adults, these responses correlated with the TST and known epidemiologic risk factors for Mtb infection.	[Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Zalwango, Sarah; Mayanja-Kizza, Harriet; Okwera, Alphonse; Mugerwa, Roy D.] Uganda CWRU, Res Collaborat, Kampala, Uganda; [Whalen, Christopher C.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Stein, Catherine M.; Boom, W. Henry; Whalen, Christopher C.] Case Western Reserve Univ, Sch Med, TB Res Unit, Cleveland, OH 44106 USA; [Stein, Catherine M.; Mayanja-Kizza, Harriet; Mugerwa, Roy D.] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Okwera, Alphonse] Mulago Hosp, Kampala, Uganda; [Okwera, Alphonse] Natl TB & Leprosy Program, Kampala, Uganda; [Boom, W. Henry] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Boom, W. Henry] Univ Hosp Case Med Ctr, Cleveland, OH USA	Oregon Health & Science University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Makerere University; Mulago National Referral Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Lewinsohn, DA (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	lewinsde@ohsu.edu	Stein, Catherine/P-9498-2019; Mayanja-Kizza, Harriet/AAM-5372-2020	Stein, Catherine/0000-0002-9763-5023; Mayanja-Kizza, Harriet/0000-0002-9297-6208	Tuberculosis Research Unit (TBRU); United States National Institutes of Allergy and Infectious Diseases [NO1-AI-45244, AI-95383]; United States National Institutes of Health and Human Services [HHSN266200700022C, NO1-AI-70022]; National Center for Research Resources [RR03655]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383, N01AI045244] Funding Source: NIH RePORTER	Tuberculosis Research Unit (TBRU); United States National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States National Institutes of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole by the Tuberculosis Research Unit (TBRU), established with Federal funds from the United States National Institutes of Allergy and Infectious Diseases & the United States National Institutes of Health and Human Services, under Contract Nos. NO1-AI-45244/AI-95383 and HHSN266200700022C / NO1-AI-70022. Some of the results of this paper were obtained by using the program package S.A.G.E., which is supported by a U.S. Public Health Service Resource Grant (RR03655) from the National Center for Research Resources. Funders had no role in study design, data collection and analysis, and interpretation of data; writing of the paper; and decision to submit it for publication.	Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Kampmann B, 2006, LANCET, V368, P282, DOI 10.1016/S0140-6736(06)69064-8; Lewinsohn DA, 2004, INT J TUBERC LUNG D, V8, P658; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Mudido PM, 1999, INT J TUBERC LUNG D, V3, P891; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Nelson Lisa J, 2004, Semin Pediatr Infect Dis, V15, P150, DOI 10.1053/j.spid.2004.05.007; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Okada K, 2008, EPIDEMIOL INFECT, V136, P1179, DOI 10.1017/S0950268807009831; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Tsiouris SJ, 2006, INT J TUBERC LUNG D, V10, P939; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55; 2007, SAGE 5 4 STAT ANAL G	21	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3407	10.1371/journal.pone.0003407	http://dx.doi.org/10.1371/journal.pone.0003407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923705	Green Published, Green Submitted, gold			2022-12-25	WOS:000265121800006
J	Wu, ST; Zhang, Y				Wu, Sitao; Zhang, Yang			ANGLOR: A Composite Machine-Learning Algorithm for Protein Backbone Torsion Angle Prediction	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; SUPPORT VECTOR MACHINES; PATTERN-RECOGNITION; LOCAL-STRUCTURE; SEQUENCE; RESTRAINTS; DYNAMICS; SERVER	We developed a composite machine-learning based algorithm, called ANGLOR, to predict real-value protein backbone torsion angles from amino acid sequences. The input features of ANGLOR include sequence profiles, predicted secondary structure and solvent accessibility. In a large-scale benchmarking test, the mean absolute error (MAE) of the phi/psi prediction is 28 degrees/46 degrees, which is similar to 10% lower than that generated by software in literature. The prediction is statistically different from a random predictor (or a purely secondary-structure-based predictor) with p-value <1.0X10(-300) (or <1.0X10(-148)) by Wilcoxon signed rank test. For some residues (ILE, LEU, PRO and VAL) and especially the residues in helix and buried regions, the MAE of phi angles is much smaller (10-20 degrees) than that in other environments. Thus, although the average accuracy of the ANGLOR prediction is still low, the portion of the accurately predicted dihedral angles may be useful in assisting protein fold recognition and ab initio 3D structure modeling.	[Wu, Sitao; Zhang, Yang] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Wu, ST (corresponding author), Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA.	yzhang@ku.edu	Wu, Sitao/E-8098-2011; YZ, YZ/B-3243-2011		Alfred P. Sloan Foundation; NSF Career Award [0746198]; NIH [GM-083107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083107] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported in part by the Alfred P. Sloan Foundation, NSF Career Award 0746198, and NIH grant GM-083107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Branden C., 1999, INTRO PROTEIN STRUCT; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Chang C.-C., LIBSVM LIB SUPPORT V; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern Alexandre G, 2004, In Silico Biol, V4, P381; Dor O, 2007, PROTEINS, V68, P76, DOI 10.1002/prot.21408; Fitzkee NC, 2004, PROTEIN SCI, V13, P633, DOI 10.1110/ps.03503304; Haykin S., 1999, NEURAL NEWORKS COMPR; HOBOHM U, 1994, PROTEIN SCI, V3, P522; Huang YM, 2006, BIOINFORMATICS, V22, P413, DOI 10.1093/bioinformatics/bti828; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Kuang R, 2004, BIOINFORMATICS, V20, P1612, DOI 10.1093/bioinformatics/bth136; Mooney C, 2006, J COMPUT BIOL, V13, P1489, DOI 10.1089/cmb.2006.13.1489; Neal S, 2006, MAGN RESON CHEM, V44, pS158, DOI 10.1002/mrc.1832; Nissen S., FAST ARTIFICIAL NEUR; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Wood MJ, 2005, PROTEINS, V59, P476, DOI 10.1002/prot.20435; WU S, PROTEINS; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zaman MH, 2003, J MOL BIOL, V331, P693, DOI 10.1016/S0022-2836(03)00765-4; Zhang C, 2002, P NATL ACAD SCI USA, V99, P3581, DOI 10.1073/pnas.052003799; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zimmermann O, 2006, BIOINFORMATICS, V22, P3009, DOI 10.1093/bioinformatics/btl489	32	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3400	10.1371/journal.pone.0003400	http://dx.doi.org/10.1371/journal.pone.0003400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923703	Green Submitted, Green Published, gold			2022-12-25	WOS:000265121800002
J	Kitazoe, Y; Kishino, H; Hasegawa, M; Nakajima, N; Thorne, JL; Tanaka, M				Kitazoe, Yasuhiro; Kishino, Hirohisa; Hasegawa, Masami; Nakajima, Noriaki; Thorne, Jeffrey L.; Tanaka, Masashi			Adaptive Threonine Increase in Transmembrane Regions of Mitochondrial Proteins in Higher Primates	PLOS ONE			English	Article								Background: The mitochondrial (mt) gene tree of placental mammals reveals a very strong acceleration of the amino acid (AA) replacement rate and a change in AA compositional bias in the lineage leading to the higher primates (simians), in contrast to the nuclear gene tree. Whether this acceleration and compositional bias were caused by adaptive evolution at the AA level or directional mutation pressure at the DNA level has been vigorously debated. Methodology/Principal Findings: Our phylogenetic analysis indicates that the rate acceleration in the simian lineage is accompanied by a marked increase in threonine (Thr) residues in the transmembrane helix regions of mt DNA-encoded proteins. This Thr increase involved the replacement of hydrophobic AAs in the membrane interior. Even after accounting for lack of independence due to phylogeny, a regression analysis reveals a statistical significant positive correlation between Thr composition and longevity in primates. Conclusion/Significance: Because crucial roles of Thr and Ser in membrane proteins have been proposed to be the formation of hydrogen bonds enhancing helix-helix interactions, the Thr increase detected in the higher primates might be adaptive by serving to reinforce stability of mt proteins in the inner membrane. The correlation between Thr composition in the membrane interior and the longevity of animals is striking, especially because some mt functions are thought to be involved in aging.	[Kitazoe, Yasuhiro; Nakajima, Noriaki] Kochi Med Sch, Ctr Med Informat Sci, Kochi, Japan; [Kishino, Hirohisa] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Hasegawa, Masami] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China; [Thorne, Jeffrey L.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA; [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longevity & Hlth, Tokyo, Japan	Kochi University; University of Tokyo; Fudan University; University of North Carolina; North Carolina State University; Tokyo Metropolitan Institute of Gerontology	Kitazoe, Y (corresponding author), Kochi Med Sch, Ctr Med Informat Sci, Kochi, Japan.	kitazoey@kochi-u.ac.jp	Kishino, Hirohisa/U-9311-2019		Japan Society for the Promotion of Science (JSPS) [B-19300094]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [A-15200051]; Third-Term Comprehensive 10-year Strategy for Cancer Control; Program Research Grants for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare of Japan [17A-10]; Takeda Science Foundation [I-2007]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Third-Term Comprehensive 10-year Strategy for Cancer Control(Ministry of Health, Labour and Welfare, Japan); Program Research Grants for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare of Japan; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a Grant-in-Aid for Scientific Research (B-19300094) from the Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research (A-15200051 to M.T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Third-Term Comprehensive 10-year Strategy for Cancer Control (to M.T.), grant 17A-10 from the Program Research Grants for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare of Japan (to M.T.), and a grant from the Takeda Science Foundation (I-2007 to M.T.).	Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Adkins RM, 1996, MOL BIOL EVOL, V13, P1393, DOI 10.1093/oxfordjournals.molbev.a025586; Andrews TD, 1998, J MOL EVOL, V47, P249, DOI 10.1007/PL00006382; Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; COOPER GM, 2006, CELL MOL APPROACH, P433; COWAN R, 1990, Peptide Research, V3, P75; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Goldberg A, 2003, P NATL ACAD SCI USA, V100, P5873, DOI 10.1073/pnas.0931463100; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Kitazoe Y, 2005, MOL BIOL EVOL, V22, P704, DOI 10.1093/molbev/msi051; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Lehmann G, 2008, REJUV RES, V11, P409, DOI 10.1089/rej.2008.0676; Moosmann B, 2008, AGING CELL, V7, P32, DOI 10.1111/j.1474-9726.2007.00349.x; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Okabayashi T, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-41; PERNA NT, 1995, MOL BIOL EVOL, V12, P359; Pham NA, 2004, MICROSC MICROANAL, V10, P247, DOI 10.1017/S143192760404005X; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; ROHFL FJ, 2001, EVOLUTION, V55, P2143; Schmitz J, 2002, MOL BIOL EVOL, V19, P544, DOI 10.1093/oxfordjournals.molbev.a004110; SPEAKMAN JR, 2008, J EXP BIO, V208, P1717; SUEOKA N, 1992, J MOL EVOL, V34, P95, DOI 10.1007/BF00182387; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Wu W, 1997, J MOL EVOL, V44, P477, DOI 10.1007/PL00006172; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; SOSUI WWW SERVER CLA; TMHMM SERVER V 2 0 P	34	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3343	10.1371/journal.pone.0003343	http://dx.doi.org/10.1371/journal.pone.0003343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836526	Green Published, Green Submitted, gold			2022-12-25	WOS:000265113500007
J	Wu, F; Gehring, H				Wu, Fang; Gehring, Heinz			Structural requirements for novel coenzyme-substrate derivatives to inhibit intracellular ornithine decarboxylase and cell proliferation	FASEB JOURNAL			English	Article						transition-state mimics; DFMO; polyamine metabolism; pyridoxyl-amino acid analogs; drug design; anti-cancer compounds	POLYAMINE METABOLISM; ENZYME-INHIBITORS; CRYSTAL-STRUCTURE; CANCER; GROWTH; DIFLUOROMETHYLORNITHINE; ANTIBODIES; DISCOVERY; APOPTOSIS; ANALOGS	Creating transition-state mimics has proven to be a powerful strategy in developing inhibitors to treat malignant diseases in several cases. In the present study, structurally diverse coenzyme-substrate derivatives mimicking this type for pyridoxal 5'-phosphate-dependent human ornithine decarboxylase (hODC), a potential anticancer target, were designed, synthesized, and tested to elucidate the structural requirements for optimal inhibition of intracellular ODC as well as of tumor cell proliferation. Of 23 conjugates, phosphopyridoxyl- and pyridoxyl-L-tryptophan methyl ester (pPTME, PTME) proved significantly more potent in suppression proliferation (IC50 up to 25 mu M) of glioma cells (LN229) than alpha-DL-difluoromethylornithine (DFMO), a medically used irreversible inhibitor of ODC. In agreement with molecular modeling predictions, the inhibitory action of pPTME and PTME toward intracellular ODC of LN229 cells exceeded that of the previous designed lead compound POB. The inhibitory active compounds feature hydrophobic side chain fragments and a kind of polyamine motif (-NH-(CHX)(4)-NH-). In addition, they induce, as polyamine analogs often do, the activity of the polyamine catabolic enzymes polyamine oxidase and spermine/spermidine N-1-acetyltransferase up to 250 and 780%, respectively. The dual-action mode of these compounds in LN229 cells affects the intracellular polyamine metabolism and might underlie the more favorable cell proliferation inhibition in comparison with DFMO.-Wu, F., Gehring, H. Structural requirements for novel coenzyme-substrate derivatives to inhibit intracellular ornithine decarboxylase and cell proliferation. FASEB J.23, 565-574 (2009)	[Wu, Fang; Gehring, Heinz] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Gehring, H (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	gehring@bioc.uzh.ch	Wu, Fang/B-1945-2008	Wu, Fang/0000-0002-4194-2243				Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; Dai HQ, 1999, CANCER RES, V59, P4944; Dufe VT, 2007, BIOCHEM J, V405, P261, DOI 10.1042/BJ20070188; Duranton B, 2002, CELL BIOL TOXICOL, V18, P381, DOI 10.1023/A:1020863506170; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; EWING TJA, 1998, DOCK 4 0 USER MANUAL; FLAMIGNI F, 1984, BIOCHIM BIOPHYS ACTA, V802, P245, DOI 10.1016/0304-4165(84)90168-5; GEISTLICH A, 1993, EXP CELL RES, V204, P329, DOI 10.1006/excr.1993.1040; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; GLIKMAN P, 1989, CANCER RES, V49, P1371; Gramatikova S, 2002, J IMMUNOL METHODS, V269, P99, DOI 10.1016/S0022-1759(02)00227-2; Gramatikova SI, 1996, J BIOL CHEM, V271, P30583, DOI 10.1074/jbc.271.48.30583; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; HELLER JS, 1975, BIOCHIM BIOPHYS ACTA, V403, P197, DOI 10.1016/0005-2744(75)90022-4; IKAWA M, 1967, ARCH BIOCHEM BIOPHYS, V118, P497, DOI 10.1016/0003-9861(67)90378-5; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; KAMETANI T, 1972, J MED CHEM, V15, P203, DOI 10.1021/jm00272a021; Khomutov AR, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1159, DOI 10.1023/A:1020919525067; KHOMUTOV RM, 1971, BIOCHEM J, V124, P99, DOI 10.1042/bj1240099; KUMAGAI H, 1969, AGR BIOL CHEM TOKYO, V33, P1210, DOI 10.1080/00021369.1969.10859449; Levin VA, 2003, CLIN CANCER RES, V9, P981; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Messing E, 2006, J UROLOGY, V176, P500, DOI 10.1016/j.juro.2006.03.061; Nickel KP, 1999, CANCER LETT, V140, P105, DOI 10.1016/S0304-3835(99)00063-4; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; RASO V, 1975, BIOCHEMISTRY-US, V14, P591, DOI 10.1021/bi00674a020; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; ROBSON LC, 1980, VITAMIN B6 METABOLIS, P205; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; Silverman RB, 2008, ANGEW CHEM INT EDIT, V47, P3500, DOI 10.1002/anie.200704280; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; Ulrich S, 2006, CANCER RES, V66, P7348, DOI 10.1158/0008-5472.CAN-05-2777; Vlastos AT, 2005, CLIN CANCER RES, V11, P390; Vujcic S, 2000, J BIOL CHEM, V275, P38319, DOI 10.1074/jbc.M003270200; Vujcic S, 2003, BIOCHEM J, V370, P19, DOI 10.1042/BJ20021779; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wallick CJ, 2005, ONCOGENE, V24, P5606, DOI 10.1038/sj.onc.1208808; Wu F, 2008, FASEB J, V22, P890, DOI 10.1096/fj.07-9566com; Wu F, 2007, MOL CANCER THER, V6, P1831, DOI 10.1158/1535-7163.MCT-07-0045; ZHANG Z, 1991, P NATL ACAD SCI USA, V88, P10407, DOI 10.1073/pnas.88.23.10407	48	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					565	574		10.1096/fj.08-115121	http://dx.doi.org/10.1096/fj.08-115121			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18922879				2022-12-25	WOS:000262892900028
J	McConnell, BK; Popovic, Z; Mal, N; Lee, K; Bautista, J; Forudi, F; Schwartzman, R; Jin, JP; Penn, M; Bond, M				McConnell, Bradley K.; Popovic, Zoran; Mal, Niladri; Lee, Kwangdeok; Bautista, James; Forudi, Farhad; Schwartzman, Raul; Jin, J. -P.; Penn, Marc; Bond, Meredith			Disruption of Protein Kinase A Interaction with A-kinase-anchoring Proteins in the Heart in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-I; DILATED CARDIOMYOPATHY; RYANODINE-RECEPTOR; MU-CALPAIN; RAT HEART; PHOSPHORYLATION; COMPLEX; DEGRADATION; ISCHEMIA; BINDING	Protein kinase A (PKA)-dependent phosphorylation is regulated by targeting of PKA to its substrate as a result of binding of regulatory subunit, R, to A-kinase-anchoring proteins (AKAPs). We investigated the effects of disrupting PKA targeting to AKAPs in the heart by expressing the 24-amino acid regulatory subunit RII-binding peptide, Ht31, its inactive analog, Ht31P, or enhanced green fluorescent protein by adenoviral gene transfer into rat hearts in vivo. Ht31 expression resulted in loss of the striated staining pattern of type II PKA (RII), indicating loss of PKA from binding sites on endogenous AKAPs. In the absence of isoproterenol stimulation, Ht31-expressing hearts had decreased +dP/dt(max) and -dP/dt(min) but no change in left ventricular ejection fraction or stroke volume and decreased end diastolic pressure versus controls. This suggests that cardiac output is unchanged despite decreased +dP/dt and -dP/dt. There was also no difference in PKA phosphorylation of cardiac troponin I (cTnI), phospholamban, or ryanodine receptor (RyR(2)). Upon isoproterenol infusion, +dP/dt(max) and -dP/dt(min) did not differ between Ht31 hearts and controls. At higher doses of isoproterenol, left ventricular ejection fraction and stroke volume increased versus isoproterenol-stimulated controls. This occurred in the context of decreased PKA phosphorylation of cTnI, RyR2, and phospholamban versus controls. We previously showed that expression of N-terminal-cleaved cTnI (cTnIND) in transgenic mice improves cardiac function. Increased cTnI N-terminal truncation was also observed in Ht31-expressing hearts versus controls. Increased cTnI-ND may help compensate for reduced PKA phosphorylation as occurs in heart failure.	[McConnell, Bradley K.; Bond, Meredith] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Bond, Meredith] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Mal, Niladri; Schwartzman, Raul; Penn, Marc] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Popovic, Zoran; Lee, Kwangdeok; Forudi, Farhad; Penn, Marc] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Bautista, James; Jin, J. -P.] Northwestern Univ, Fienberg Sch Med, Evanston, IL 60201 USA; [Bautista, James; Jin, J. -P.] Evanston NW Healthcare, Sect Mol Cardiol, Evanston, IL 60201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Northwestern University; Feinberg School of Medicine; NorthShore University Health System	McConnell, BK (corresponding author), Univ Houston, Dept Pharmacol & Pharmaceut Sci, Coll Pharm, 4800 Calhoun Rd,Bldg SR-2,Rm 460, Houston, TX 77204 USA.	bkmcconn@central.uh.edu	Jin, Jian-Ping/AAD-1149-2020	popovic, zoran/0000-0001-5692-2299; Jin, JP/0000-0001-9932-1063	National Institutes of Health [HL085487, HL56256, AG16613, HL074400, HL76491, HL078773]; National Aeronautics and Space Administration [NNA04CK26G]; American Heart Association [0465470U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085487, R01HL078773, R01HL056256, P01HL076491, R01HL074400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085487 (to B. M.), HL56256 and AG16613 (to M. B.), HL074400 and HL76491 (to M. P.), and HL078773 (to J.-P. Jin). This work was also supported by National Aeronautics and Space Administration Grant NNA04CK26G (to J.-P. Jin) and by the American Heart Association, midAtlantic affiliate, Beginning Grant-in-aid 0465470U (to B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Askari A, 2004, J AM COLL CARDIOL, V43, P1908, DOI 10.1016/j.jacc.2003.12.045; Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Barta J, 2003, MOL CELL BIOCHEM, V251, P83, DOI 10.1023/A:1025485916872; CARR DW, 1991, J BIOL CHEM, V266, P14188; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; del Monte Federica, 2003, Methods Mol Biol, V219, P179; DILISA F, 1995, BIOCHEM J, V308, P57, DOI 10.1042/bj3080057; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6745, DOI 10.1021/bi962226d; ELVIRA M, 1993, J BIOL CHEM, V268, P14294; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Feng J, 2001, CIRCULATION, V103, P2035; GAASCH WH, 1990, CIRCULATION, V81, P1644, DOI 10.1161/01.CIR.81.5.1644; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Kockskamper J, 2001, PFLUG ARCH EUR J PHY, V441, P807, DOI 10.1007/s004240000485; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Matsui T, 2001, CIRCULATION, V104, P330; McConnell BK, 1997, AM J PHYSIOL-HEART C, V273, pH1440, DOI 10.1152/ajpheart.1997.273.3.H1440; McConnell BK, 1998, AM J PHYSIOL-HEART C, V274, pH385, DOI 10.1152/ajpheart.1998.274.2.H385; McConnell BK, 1999, J CLIN INVEST, V104, P1235, DOI 10.1172/JCI7377; McDonough JL, 1999, CIRC RES, V84, P9; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Popovic ZB, 2006, AM J PHYSIOL-HEART C, V291, pH762, DOI 10.1152/ajpheart.00081.2006; Potet F, 2001, AM J PHYSIOL-HEART C, V280, pH2038, DOI 10.1152/ajpheart.2001.280.5.H2038; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Sumandea CA, 2007, CIRCULATION, V116, P189; Thijssen VLJL, 2004, CIRCULATION, V110, P770, DOI 10.1161/01.CIR.0000138849.03311.C6; Yang JC, 1998, J CELL BIOL, V142, P511, DOI 10.1083/jcb.142.2.511; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Zakhary DR, 2000, CIRCULATION, V101, P1459, DOI 10.1161/01.CIR.101.12.1459; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505	42	51	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1583	1592		10.1074/jbc.M806321200	http://dx.doi.org/10.1074/jbc.M806321200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18945669	hybrid, Green Published			2022-12-25	WOS:000262330100026
J	Molnar, A; Borbely, A; Czuriga, D; Ivetta, SM; Szilagyi, S; Hertelendi, Z; Pasztor, ET; Balogh, A; Galajda, Z; Szerafin, T; Jaquet, K; Papp, Z; Edes, I; Toth, A				Molnar, Andrea; Borbely, Attila; Czuriga, Daniel; Ivetta, Siket M.; Szilagyi, Szabolcs; Hertelendi, Zita; Pasztor, Eniko T.; Balogh, Agnes; Galajda, Zoltan; Szerafin, Tamas; Jaquet, Kornelia; Papp, Zoltan; Edes, Istvan; Toth, Attila			Protein Kinase C Contributes to the Maintenance of Contractile Force in Human Ventricular Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-I; CONGESTIVE-HEART-FAILURE; MYOFILAMENT DYSFUNCTION; MOLECULAR HETEROGENEITY; PHOSPHORYLATION SITES; ACTOMYOSIN MGATPASE; PKC PHOSPHORYLATION; ANCHORING PROTEINS; MYOCARDIAL-CELLS; MOUSE HEARTS	Prolonged Ca2+ stimulations often result in a decrease in contractile force of isolated, demembranated human ventricular cardiomyocytes, whereas intact cells are likely to be protected from this deterioration. We hypothesized that cytosolic protein kinase C (PKC) contributes to this protection. Prolonged contracture (10 min) of demembranated human cardiomyocytes at half-maximal Ca2+ resulted in a 37 +/- 5% reduction of active force (p < 0.01), whereas no decrease (2 +/- 3% increase) was observed in the presence of the cytosol (reconstituted myocytes). The PKC inhibitors GF109203X and Go6976 (10 mu mol/liter) partially antagonized the cytosol-mediated protection (15 +/- 5 and 9 +/- 2% decrease in active force, p < 0.05). Quantitation of PKC isoform expression revealed the dominance of the Ca2+-dependent PKC alpha over PKC delta and PKC epsilon (189 +/- 31, 7 +/- 3, and 7 +/- 2 ng/mg protein, respectively). Ca2+ stimulations of reconstituted human cardiomyocytes resulted in the translocation of endogenous PKC alpha, but not PKC beta 1, delta, and epsilon from the cytosol to the contractile system (PKC alpha association: control, 5 +/- 3 arbitrary units; +Ca2+, 39 +/- 8 arbitrary units; p < 0.01, EC50,Ca = 645 nmol/liter). One of the PKC alpha-binding proteins were identified as the thin filament regulatory protein cardiac troponin I (TnI). Finally, the Ca2+-dependent interaction between PKC alpha and TnI was confirmed using purified recombinant proteins (binding without Ca2+ was only 28 +/- 18% of that with Ca2+). Our data suggest that PKC alpha translocates to the contractile system and anchors to TnI in a Ca2+-dependent manner in the human heart, contributing to the maintenance of contractile force.	[Molnar, Andrea; Borbely, Attila; Czuriga, Daniel; Ivetta, Siket M.; Szilagyi, Szabolcs; Hertelendi, Zita; Pasztor, Eniko T.; Balogh, Agnes; Papp, Zoltan; Edes, Istvan; Toth, Attila] Univ Debrecen, Fac Med, Med & Hlth Sci Ctr, Div Clin Physiol,Inst Cardiol, H-4032 Debrecen, Hungary; [Galajda, Zoltan; Szerafin, Tamas] Univ Debrecen, Ctr Cardiac Surg, Inst Cardiol, H-4032 Debrecen, Hungary; [Jaquet, Kornelia] Ruhr Univ Kliniken, St Josef Hosp Bergmannsheil, Forsch Labor Mol Kardiol, D-44791 Bochum, Germany	University of Debrecen; University of Debrecen; Ruhr University Bochum	Toth, A (corresponding author), Univ Debrecen, Fac Med, Med & Hlth Sci Ctr, Div Clin Physiol,Inst Cardiol, 22 Moricz Zs Krt, H-4032 Debrecen, Hungary.	atitoth@dote.hu	Czuriga, Daniel/AAL-5090-2020; Édes, István/B-8795-2011; Papp, Zoltán/HDO-3347-2022; Tóth, Attila/F-4859-2010	Tóth, Attila/0000-0001-6503-3653; Czuriga, Daniel/0000-0002-6972-0781	OTKA [F048873, K68077, K68363]; ETT [430/2006]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ETT	This work was supported by Hungarian Research Fund Grants OTKA F048873 and K68077 (to A. T.) and K68363 (to Z. P.) and by Hungarian Ministry of Health Grant ETT 430/2006 (to A. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288; Belin RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2344, DOI 10.1152/ajpheart.00541.2006; BILCHICK KC, 2006, AM J PHYSIOL, V292, pH318; Borbely A, 2005, CARDIOVASC RES, V67, P225, DOI 10.1016/j.cardiores.2005.03.025; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Braun MU, 2003, CARDIOVASC RES, V59, P658, DOI 10.1016/S0008-6363(03)00470-X; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; DAMRON DS, 1995, CIRC RES, V76, P1011, DOI 10.1161/01.RES.76.6.1011; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Goldberg M, 1996, BIOCHEM PHARMACOL, V51, P1089, DOI 10.1016/0006-2952(96)00046-9; Goldspink PH, 2004, CIRC RES, V95, P424, DOI 10.1161/01.RES.0000138299.85648.92; GU X, 1994, CIRC RES, V75, P926, DOI 10.1161/01.RES.75.5.926; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Huang XP, 2004, J CELL SCI, V117, P1971, DOI 10.1242/jcs.01044; Huang XP, 2002, EXP BIOL MED, V227, P1039, DOI 10.1177/153537020222701113; Jalili T, 1999, AM J PHYSIOL-HEART C, V277, pH2298, DOI 10.1152/ajpheart.1999.277.6.H2298; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Jonjev ZS, 2003, J THORAC CARDIOV SUR, V126, P1880, DOI 10.1016/S0022-5223(03)01326-6; KARMAZYN M, 1993, CARDIOVASC RES, V27, P915, DOI 10.1093/cvr/27.6.915; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; Maasch C, 2000, FASEB J, V14, P1653, DOI 10.1096/fj.14.11.1653; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Montgomery DE, 2002, AM J PHYSIOL-HEART C, V282, pH2397, DOI 10.1152/ajpheart.00714.2001; Murphy Stephen, 2005, Cardiol Rev, V13, P3; Narolska NA, 2006, CIRC RES, V99, P1012, DOI 10.1161/01.RES.0000248753.30340.af; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Noguchi T, 2004, CIRCULATION, V110, P982, DOI 10.1161/01.CIR.0000139334.43109.F9; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; NOLAND TA, 1992, BIOCHEM J, V288, P123, DOI 10.1042/bj2880123; Pyle WG, 2002, AM J PHYSIOL-HEART C, V283, pH1215, DOI 10.1152/ajpheart.00128.2002; Roman BB, 2004, AM J PHYSIOL-HEART C, V286, pH2089, DOI 10.1152/ajpheart.00582.2003; RYBIN VO, 1994, CIRC RES, V74, P299, DOI 10.1161/01.RES.74.2.299; Sakthivel S, 2005, J BIOL CHEM, V280, P703, DOI 10.1074/jbc.M409513200; Scruggs SB, 2006, J MOL CELL CARDIOL, V40, P465, DOI 10.1016/j.yjmcc.2005.12.009; Shin HG, 2000, CARDIOVASC RES, V48, P285, DOI 10.1016/S0008-6363(00)00185-1; Simonis G, 2007, MOL CELL BIOCHEM, V305, P103, DOI 10.1007/s11010-007-9533-3; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021; VENEMA RC, 1993, J BIOL CHEM, V268, P2705; VENEMA RC, 1993, BIOCHEM J, V294, P401, DOI 10.1042/bj2940401	46	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1031	1039		10.1074/jbc.M807600200	http://dx.doi.org/10.1074/jbc.M807600200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18854307	hybrid			2022-12-25	WOS:000262122900039
J	Chi, YH; Haller, K; Ward, MD; Semmes, OJ; Li, Y; Jeang, KT				Chi, Ya-Hui; Haller, Kerstin; Ward, Michael D.; Semmes, O. John; Li, Yan; Jeang, Kuan-Teh			Requirements for Protein Phosphorylation and the Kinase Activity of Polo-like Kinase 1 (Plk1) for the Kinetochore Function of Mitotic Arrest Deficiency Protein 1 (Mad1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; YEAST SACCHAROMYCES-CEREVISIAE; SMALL-MOLECULE INHIBITOR; BUDDING YEAST; BOX DOMAIN; CELLULAR-TRANSFORMATION; MPS1 KINASE; HUMAN LUNG; IN-VITRO	Mitotic arrest deficiency protein 1 (Mad1) is associated with microtubule-unattached kinetochores in mitotic cells and is a component of the spindle assembly checkpoint (SAC). Here, we have studied the phosphorylation of Mad1 and mapped using liquid chromatography-tandem mass spectrometry several phosphorylated amino acids in this protein. One phosphorylated residue, Thr(680), was characterized to be important for the kinetochore localization of Mad1 and its SAC function. We also found that in mitotic cells Mad1 co-immunoprecipitated with Plk1. Depletion of cellular Plk1 using small interfering RNAs and inhibition of the kinase activity of Plk1 using a kinase-dead mutant or a small molecule inhibitor attenuated Mad1 phosphorylation and its association with kinetochores. Collectively, these findings indicate mechanistic roles contributed by protein phosphorylation and Plk1 to the SAC activity of Mad1.	[Chi, Ya-Hui; Haller, Kerstin; Li, Yan; Jeang, Kuan-Teh] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Ward, Michael D.; Semmes, O. John] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Ctr Biomed Proteom, Norfolk, VA 23501 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Eastern Virginia Medical School	Jeang, KT (corresponding author), Bldg 4,Rm 306,9000 Rockville Pike, Bethesda, MD 20892 USA.	kj7e@nih.gov	Jeang, Kuan-Teh/A-2424-2008; Chi, Ya-Hui/B-1080-2010; Semmes, Oliver/GQA-5179-2022; Chi, Ya-Hui/ABE-8550-2020	Chi, Ya-Hui/0000-0002-9216-0938	National Institutes of Health; NIAID; NATIONAL CANCER INSTITUTE [R01CA076595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported through intramural funding from the NIAID, National Institutes of Health. To whom correspondence should be addressed: Bldg. 4, Rm. 306, 9000 Rockville Pike, Bethesda, MD 20892-0460. Tel.: 301-496-6680; Fax: 301-480-3686; E- mail: kj7e@ nih. gov.	Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Campbell MS, 2001, J CELL SCI, V114, P953; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Chi YH, 2007, J CELL BIOCHEM, V102, P531, DOI 10.1002/jcb.21484; Chung EN, 2002, MOL BIOL CELL, V13, P1501, DOI 10.1091/mbc.02-01-0003; Coe BR, 2006, GENE CHROMOSOME CANC, V45, P11, DOI 10.1002/gcc.20260; Dai W, 2003, FRONT BIOSCI-LANDMRK, V8, pD1128, DOI 10.2741/1129; Eckerdt F, 2006, CANCER RES, V66, P6895, DOI 10.1158/0008-5472.CAN-06-0358; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Gaillard S, 2001, J VIROL, V75, P9799, DOI 10.1128/JVI.75.20.9799-9807.2001; Gemma A, 2001, LUNG CANCER-J IASLC, V32, P289, DOI 10.1016/S0169-5002(00)00223-3; Haller K, 2006, ONCOGENE, V25, P2137, DOI 10.1038/sj.onc.1209259; Hardwick KG, 1999, GENETICS, V152, P509; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068; Iwanaga Y, 2002, J BIOL CHEM, V277, P31005, DOI 10.1074/jbc.M110666200; Iwanaga Y, 2007, CANCER RES, V67, P160, DOI 10.1158/0008-5472.CAN-06-3326; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kasai T, 2002, J BIOL CHEM, V277, P5187, DOI 10.1074/jbc.M110295200; Kienitz A, 2005, ONCOGENE, V24, P4301, DOI 10.1038/sj.onc.1208589; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Lowery DM, 2004, CELL CYCLE, V3, P128; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Osaka F, 1997, MOL CELL BIOL, V17, P3388, DOI 10.1128/MCB.17.6.3388; Osaki M, 2007, VIRCHOWS ARCH, V451, P771, DOI 10.1007/s00428-007-0470-z; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; SCARANO FJ, 1994, J VIROL, V68, P2355, DOI 10.1128/JVI.68.4.2355-2361.1994; Seeley TW, 1999, BIOCHEM BIOPH RES CO, V257, P589, DOI 10.1006/bbrc.1999.0514; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Takahashi T, 1999, ONCOGENE, V18, P4295, DOI 10.1038/sj.onc.1202807; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; WANG YC, 1995, MOL CELL BIOL, V15, P6838; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Weinstein J, 1997, J BIOL CHEM, V272, P28501, DOI 10.1074/jbc.272.45.28501; Wong OK, 2006, MOL BIOL CELL, V17, P4390, DOI 10.1091/mbc.E06-04-0346; Wong OK, 2005, J CELL BIOL, V170, P709, DOI 10.1083/jcb.200502163; Wu HY, 2000, ONCOGENE, V19, P4557, DOI 10.1038/sj.onc.1203803; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	74	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35834	35844		10.1074/jbc.M804967200	http://dx.doi.org/10.1074/jbc.M804967200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18922800	hybrid, Green Published			2022-12-25	WOS:000261687900058
J	Gao, X; Wen, J; Zhang, L; Li, X; Ning, YH; Meng, AM; Chen, YG				Gao, Xia; Wen, Jun; Zhang, Long; Li, Xiang; Ning, Yuanheng; Meng, Anming; Chen, Ye-Guang			Dapper1 Is a Nucleocytoplasmic Shuttling Protein That Negatively Modulates Wnt Signaling in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APC TUMOR-SUPPRESSOR; BETA-CATENIN; SUBCELLULAR-LOCALIZATION; FUNCTIONAL INTERACTION; REGULATOR; PATHWAY; COMPLEX; TARGET; AXIN; TCF	Wnt signaling, via the activation of the canonical beta-catenin and lymphoid enhancer factor (LEF)/T-cell factor pathway, plays an important role in embryogenesis and cancer development by regulating the expression of genes involved in cell proliferation, differentiation, and survival. Dapper (Dpr), as a Dishevelled interactor, has been suggested to modulate Wnt signaling by promoting Dishevelled degradation. Here, we provide evidence that Dpr1 shuttles between the cytoplasm and the nucleus. Although overexpressed Dpr1 was mainly found in the cytoplasm, endogenous Dpr1 was localized over the cell, and Wnt1 induced its nuclear export. Treatment with leptomycin B induced nuclear accumulation of both endogenous and overexpressed Dpr1. We further identified the nuclear localization signal and the nuclear export signal within Dpr1. Using reporter assay and in vivo zebrafish embryo assay, we demonstrated that the forced nuclearly localized Dpr1 possessed the ability to antagonize Wnt signaling. Dpr1 interacted with beta-catenin and LEF1 and disrupted their complex formation. Furthermore, Dpr1 could associate with histone deacetylase 1 (HDAC1) and enhance the LEF1-HDAC1 interaction. Together, our findings suggest that Dpr1 negatively modulates the basal activity of Wnt/beta-catenin signaling in the nucleus by keeping LEF1 in the repressive state. Thus, Dpr1 controls Wnt/beta-catenin signaling in both the cytoplasm and the nucleus.	[Gao, Xia; Wen, Jun; Zhang, Long; Li, Xiang; Ning, Yuanheng; Meng, Anming; Chen, Ye-Guang] Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Meng, Anming/A-4785-2012; Zhang, Long/AAT-6571-2021	Zhang, Long/0000-0001-8139-0474; Meng, Anming/0000-0001-7228-3431	National Natural Science Foundation of China [30430360, 30671033]; 973 Program [2004CB720002, 2006CB943401, 2006CB910102]; 863 Program [2006AA02Z172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30430360 and 30671033, 973 Program Grant 2004CB720002, 2006CB943401, and 2006CB910102, and 863 Program Grant 2006AA02Z172 ( to Y.-G.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Brott BK, 2005, DEV CELL, V8, P703, DOI 10.1016/j.devcel.2005.02.012; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Katoh M, 2003, INT J ONCOL, V22, P907; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yau TO, 2005, ONCOGENE, V24, P1607, DOI 10.1038/sj.onc.1208340; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	53	47	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35679	35688		10.1074/jbc.M804088200	http://dx.doi.org/10.1074/jbc.M804088200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18936100	hybrid			2022-12-25	WOS:000261687900042
J	Garcia-Roves, PM; Osler, ME; Holmstrom, MH; Zierath, JR				Garcia-Roves, Pablo M.; Osler, Megan E.; Holmstrom, Maria H.; Zierath, Juleen R.			Gain-of-function R225Q Mutation in AMP-activated Protein Kinase gamma 3 Subunit Increases Mitochondrial Biogenesis in Glycolytic Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-METABOLISM; GENE-EXPRESSION; GLYCOGEN-CONTENT; ENHANCER FACTOR; EXERCISE; ADAPTATION; GLUCOSE; GLUT4; TRANSCRIPTION; HOMEOSTASIS	AMP-activated protein kinase (AMPK) is a heterotrimeric complex, composed of a catalytic subunit (alpha) and two regulatory subunits (beta and gamma), that works as a cellular energy sensor. The existence of multiple heterotrimeric complexes provides a molecular basis for the multiple roles of this highly conserved signaling system. The AMPK gamma 3 subunit is predominantly expressed in skeletal muscle, mostly in type II glycolytic fiber types. We determined whether the AMPK gamma 3 subunit has a role in signaling pathways that mediate mitochondrial biogenesis in skeletal muscle. We provide evidence that overexpression or ablation of the AMPK gamma 3 subunit does not appear to play a critical role in defining mitochondrial content in resting skeletal muscle. However, overexpression of a mutant form (R225Q) of the AMPK gamma 3 subunit (Tg-AMPK gamma 3(225Q)) increases mitochondrial biogenesis in glycolytic skeletal muscle. These adaptations are associated with an increase in expression of the co-activator PGC-1 alpha and several transcription factors that regulate mitochondrial biogenesis, including NRF-1, NRF-2, and TFAM. Succinate dehydrogenase staining, a marker of the oxidative profile of individual fibers, was also increased in transversal skeletal muscle sections of white gastrocnemius muscle from Tg-AMPK gamma 3(225Q) mice, independent of changes in fiber type composition. In conclusion, a single nucleotide mutation (R225Q) in the AMPK gamma 3 subunit is associated with mitochondrial biogenesis in glycolytic skeletal muscle, concomitant with increased expression of the co-activator PGC-1 alpha and several transcription factors that regulate mitochondrial proteins, without altering fiber type composition.	[Garcia-Roves, Pablo M.; Osler, Megan E.; Holmstrom, Maria H.; Zierath, Juleen R.] Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, S-17177 Stockholm, Sweden	Karolinska Institutet	Zierath, JR (corresponding author), Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, Von Eulers Vag 4,4th Floor, S-17177 Stockholm, Sweden.	Juleen.Zierath@ki.se	Roves, Pablo Garcia/A-7113-2015; Garcia-Roves, Pablo M./X-4585-2018	Garcia-Roves, Pablo M./0000-0002-8371-2067; Zierath, Juleen/0000-0001-6891-7497	European Foundation for the Study of Diabetes; Swedish Research Council; Swedish Diabetes Association; Strategic Research Foundation; Knut and Alice Wallenberg Foundation; Novo Nordisk Research Foundation; Research and Education, Karolinska University Hospital; Commission of the European Communities [LSHM-CT-2004-005272]; EXGENESIS [LSHM-CT-2004-512013]	European Foundation for the Study of Diabetes; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Strategic Research Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Research and Education, Karolinska University Hospital; Commission of the European Communities(European Commission); EXGENESIS(European Commission)	This work was supported by the European Foundation for the Study of Diabetes, Swedish Research Council, Swedish Diabetes Association, Strategic Research Foundation (INGVAR II and Center for Functional Genetics), Knut and Alice Wallenberg Foundation, Novo Nordisk Research Foundation, Research and Education, Karolinska University Hospital, and Commission of the European Communities Contract LSHM-CT-2004-005272 EXGENESIS and Contract LSHM-CT-2004-512013 EUGENE2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Al-Khalili L, 2004, AM J PHYSIOL-CELL PH, V286, pC1410, DOI 10.1152/ajpcell.00444.2003; Athea Y, 2007, DIABETES, V56, P786, DOI 10.2337/db06-0187; Barnes BR, 2005, DIABETES, V54, P3484, DOI 10.2337/diabetes.54.12.3484; Barnes BR, 2005, FASEB J, V19, P773, DOI 10.1096/fj.04-3221com; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Costford SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000903; Fitts RH, 2003, AM J PHYS MED REHAB, V82, P320, DOI 10.1097/01.PHM.0000059336.40487.9C; Gao G, 1996, J BIOL CHEM, V271, P8675, DOI 10.1074/jbc.271.15.8675; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hodgson JA, 2005, J EXP BIOL, V208, P3761, DOI 10.1242/jeb.01825; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004; Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016; JAGER S, 2007, P NATL ACAD SCI USA; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Ju JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE347, DOI 10.1152/ajpendo.00238.2004; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Long YC, 2005, DIABETOLOGIA, V48, P2354, DOI 10.1007/s00125-005-1962-5; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nilsson EC, 2006, J BIOL CHEM, V281, P7244, DOI 10.1074/jbc.M510461200; Ojuka EO, 2002, AM J PHYSIOL-ENDOC M, V283, pE1040, DOI 10.1152/ajpendo.00242.2002; Putman CT, 2003, J PHYSIOL-LONDON, V551, P169, DOI 10.1113/jphysiol.2003.04069; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; SCHANTZ P, 1982, MUSCLE NERVE, V5, P628, DOI 10.1002/mus.880050807; SCHANTZ P, 1983, CLIN PHYSIOL, V3, P141, DOI 10.1111/j.1475-097X.1983.tb00685.x; SCHIAFFINO S, 1973, J HISTOCHEM CYTOCHEM, V21, P142, DOI 10.1177/21.2.142; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Weyrich P, 2007, DIABETOLOGIA, V50, P2097, DOI 10.1007/s00125-007-0788-8; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	54	131	134	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35724	35734		10.1074/jbc.M805078200	http://dx.doi.org/10.1074/jbc.M805078200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18838377	Green Published, hybrid			2022-12-25	WOS:000261687900046
J	Rofougaran, R; Crona, M; Vodnala, M; Sjoberg, BM; Hofer, A				Rofougaran, Reza; Crona, Mikael; Vodnala, Munender; Sjoberg, Britt-Marie; Hofer, Anders			Oligomerization Status Directs Overall Activity Regulation of the Escherichia coli Class Ia Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHATE REDUCTASE; PROTEIN R1; ALLOSTERIC REGULATION; TRYPANOSOMA-BRUCEI; ELECTROPHORETIC MOBILITY; SUBUNIT INTERACTION; ENZYMATIC SYNTHESIS; RECOMBINANT MOUSE; EFFECTOR-BINDING; ATP-CONE	Ribonucleotide reductase (RNR) is a key enzyme for the synthesis of the four DNA building blocks. Class Ia RNRs contain two subunits, denoted R1 (alpha) and R2 (beta). These enzymes are regulated via two nucleotide-binding allosteric sites on the R1 subunit, termed the specificity and overall activity sites. The specificity site binds ATP, dATP, dTTP, or dGTP and determines the substrate to be reduced, whereas the overall activity site binds dATP (inhibitor) or ATP. By using gas-phase electrophoretic mobility macromolecule analysis and enzyme assays, we found that the Escherichia coli class Ia RNR formed an inhibited alpha(4)beta(4) complex in the presence of dATP and an active alpha(2)beta(2) complex in the presence of ATP (main substrate: CDP), dTTP (substrate: GDP) or dGTP (substrate: ADP). The R1-R2 interaction was 30-50 times stronger in the alpha(4)beta(4) complex than in the alpha(4)beta(4) complex, which was in equilibrium with free alpha(2) and beta(2) subunits. Studies of a known E. coli R1 mutant (H59A) showed that deficient dATP inhibition correlated with reduced ability to form alpha(4)beta(4) complexes. ATP could also induce the formation of a generally inhibited alpha(4)beta(4) complex in the E. coli RNR but only when used in combination with high concentrations of the specificity site effectors, dTTP/dGTP. Both allosteric sites are therefore important for alpha(4)beta(4) formation and overall activity regulation. The E. coli RNR differs from the mammalian enzyme, which is stimulated by ATP also in combination with dGTP/dTTP and forms active and inactive alpha(6)beta(2) complexes.	[Rofougaran, Reza; Vodnala, Munender; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Crona, Mikael; Sjoberg, Britt-Marie] Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden	Umea University; Stockholm University	Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	anders.hofer@medchem.umu.se		Hofer, Anders/0000-0003-2890-2957; Vodnala, Munender/0000-0002-6219-6243; Crona, Mikael/0000-0002-6420-6097; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Cancer Foundation; Swedish Research Council; Kempe Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation	This work was supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, and the Kempe Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravind L, 2000, J MOL MICROB BIOTECH, V2, P191; Bacher G, 2001, J MASS SPECTROM, V36, P1038, DOI 10.1002/jms.208; Berg J, 2002, BIOCHEMISTRY-US, P702; Birgander PL, 2005, J BIOL CHEM, V280, P14997, DOI 10.1074/jbc.M500565200; Birgander PL, 2004, J BIOL CHEM, V279, P14496, DOI 10.1074/jbc.M310142200; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BROWN NC, 1969, J MOL BIOL, V46, P25, DOI 10.1016/0022-2836(69)90055-2; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; CARAS IW, 1988, MOL CELL BIOL, V8, P2698, DOI 10.1128/MCB.8.7.2698; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; CORY JG, 1985, J BIOL CHEM, V260, P2001; DAVIS R, 1994, J BIOL CHEM, V269, P23171; Ekberg M, 1996, J BIOL CHEM, V271, P20655, DOI 10.1074/jbc.271.34.20655; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; ERIKSSON S, 1977, J BIOL CHEM, V252, P6132; ERIKSSON S, 1989, ALLOSTERIC ENZYMES, P189; Hendricks SP, 1997, J BIOL CHEM, V272, P2861, DOI 10.1074/jbc.272.5.2861; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Ingemarson R, 1996, BIOCHEMISTRY-US, V35, P8603, DOI 10.1021/bi960184n; Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Kasrayan A, 2004, J BIOL CHEM, V279, P31050, DOI 10.1074/jbc.M400693200; Kaufman SL, 1996, ANAL CHEM, V68, P1895, DOI 10.1021/ac951128f; Kaufman SL, 2000, ANAL CHIM ACTA, V406, P3, DOI 10.1016/S0003-2670(99)00597-8; LARSSON A, 1966, J BIOL CHEM, V241, P2540; LARSSON A, 1966, J BIOL CHEM, V241, P2533; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; ORMO M, 1990, ANAL BIOCHEM, V189, P138, DOI 10.1016/0003-2697(90)90059-I; Reichard P, 2000, J BIOL CHEM, V275, P33021, DOI 10.1074/jbc.M005337200; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; SJOBERG BM, 1986, J BIOL CHEM, V261, P5658; SJOBERG BM, 1987, J BIOL CHEM, V262, P9736; Thelander L, 1978, Methods Enzymol, V51, P227; THELANDER L, 1973, J BIOL CHEM, V248, P4591; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; WEINBERG G, 1981, P NATL ACAD SCI-BIOL, V78, P2447, DOI 10.1073/pnas.78.4.2447	44	65	66	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35310	35318		10.1074/jbc.M806738200	http://dx.doi.org/10.1074/jbc.M806738200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18835811	hybrid			2022-12-25	WOS:000261687900002
J	Oliveira, TF; Vonrhein, C; Matias, PM; Venceslau, SS; Pereira, IAC; Archer, M				Oliveira, Tania F.; Vonrhein, Clemens; Matias, Pedro M.; Venceslau, Sofia S.; Pereira, Ines A. C.; Archer, Margarida			The Crystal Structure of Desulfovibrio vulgaris Dissimilatory Sulfite Reductase Bound to DsrC Provides Novel Insights into the Mechanism of Sulfate Respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR; PROSTHETIC GROUPS; DSRMKJOP COMPLEX; SIROHEME; PURIFICATION; CLUSTER; SUBUNIT; PROTEIN; HILDENBOROUGH; EVOLUTION	Sulfate reduction is one of the earliest types of energy metabolism used by ancestral organisms to sustain life. Despite extensive studies, many questions remain about the way respiratory sulfate reduction is associated with energy conservation. A crucial enzyme in this process is the dissimilatory sulfite reductase (dSiR), which contains a unique siroheme-[4Fe4S] coupled cofactor. Here, we report the structure of desulfoviridin from Desulfovibrio vulgaris, in which the dSiR DsrAB (sulfite reductase) subunits are bound to the DsrC protein. The alpha(2)beta(2)gamma(2) assembly contains two siroheme-[4Fe4S] cofactors bound by DsrB, two sirohydrochlorins and two [4Fe4S] centers bound by DsrA, and another four [4Fe4S] centers in the ferredoxin domains. A sulfite molecule, coordinating the siroheme, is found at the active site. The DsrC protein is bound in a cleft between DsrA and DsrB with its conserved C-terminal cysteine reaching the distal side of the siroheme. We propose a novel mechanism for the process of sulfite reduction involving DsrAB, DsrC, and the DsrMKJOP membrane complex (a membrane complex with putative disulfide/thiol reductase activity), in which two of the six electrons for reduction of sulfite derive from the membrane quinone pool. These results show that DsrC is involved in sulfite reduction, which changes the mechanism of sulfate respiration. This has important implications for models used to date ancient sulfur metabolism based on sulfur isotope fractionations.	[Oliveira, Tania F.; Matias, Pedro M.; Venceslau, Sofia S.; Pereira, Ines A. C.; Archer, Margarida] Univ Nova Lisboa, ITQB, P-2780157 Oeiras, Portugal; [Vonrhein, Clemens] Global Phasing Ltd, Cambridge CB3 0AX, England	Universidade Nova de Lisboa; Global Phasing Limited	Pereira, IAC (corresponding author), Univ Nova Lisboa, ITQB, Av Republ EAN, P-2780157 Oeiras, Portugal.	ipereira@itqb.unl.pt; archer@itqb.unl.pt	Matias, Pedro M/B-7180-2008; Pereira, Inês/C-2748-2009; Venceslau, Sofia/M-2882-2016	Matias, Pedro M/0000-0001-6170-451X; Pereira, Inês/0000-0003-3283-4520; Venceslau, Sofia/0000-0001-8774-1351; Oliveira, Tania/0000-0003-0843-7541; Archer, Margarida/0000-0001-8419-5420	Fundacao para a Ciencia e Tecnologia (Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal) [PTDC/QUI/68368/06, PPCDT/BIA-PRO/55621/2004]; Fundo Europeu de Desenvolvimento Regional program; Fundacao para a Ciencia e Tecnologia-Programa Operacional Ciencia, Tecnologia, Inovacao fellowships [SFRH/BD/29519/2006, SFRH/BD/30648/2006]	Fundacao para a Ciencia e Tecnologia (Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal)(Portuguese Foundation for Science and Technology); Fundo Europeu de Desenvolvimento Regional program; Fundacao para a Ciencia e Tecnologia-Programa Operacional Ciencia, Tecnologia, Inovacao fellowships(Portuguese Foundation for Science and Technology)	This work was supported by the Research Grants PTDC/QUI/68368/06 and PPCDT/BIA-PRO/55621/2004 funded by Fundacao para a Ciencia e Tecnologia (Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal) and Fundo Europeu de Desenvolvimento Regional program and by Fundacao para a Ciencia e Tecnologia-Programa Operacional Ciencia, Tecnologia, Inovacao fellowships SFRH/BD/29519/2006 (to T. F. O.) and SFRH/BD/30648/2006 (to S. S. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akagi J.M, 1995, BIOTECH HAN, P89; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; ARENDSEN AF, 1993, BIOCHEMISTRY-US, V32, P10323, DOI 10.1021/bi00090a007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; CHANG CK, 1981, P NATL ACAD SCI USA, V78, P2652, DOI 10.1073/pnas.78.5.2652; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; Cort JR, 2001, EUR J BIOCHEM, V268, P5842, DOI 10.1046/j.0014-2956.2001.02529.x; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; DAHL C, 1993, J GEN MICROBIOL, V139, P1817, DOI 10.1099/00221287-139-8-1817; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhillon A, 2005, ASTROBIOLOGY, V5, P18, DOI 10.1089/ast.2005.5.18; DRAKE HL, 1978, J BACTERIOL, V136, P916, DOI 10.1128/JB.136.3.916-923.1978; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; FAUQUE G, 1990, BIOCHIM BIOPHYS ACTA, V1040, P112, DOI 10.1016/0167-4838(90)90154-8; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hamann N, 2007, BIOCHEMISTRY-US, V46, P12875, DOI 10.1021/bi700679u; Haveman SA, 2003, J BACTERIOL, V185, P4345, DOI 10.1128/JB.185.15.4345-4353.2003; Hipp WM, 1997, MICROBIOL-UK, V143, P2891, DOI 10.1099/00221287-143-9-2891; Hoek J, 2008, MICROBIAL SULFUR METABOLISM, P273, DOI 10.1007/978-3-540-72682-1_21; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; JANICK PA, 1982, BIOCHEMISTRY-US, V21, P3538, DOI 10.1021/bi00258a003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KARKHOFFSCHWEIZER RAR, 1993, EUR J BIOCHEM, V211, P501, DOI 10.1111/j.1432-1033.1993.tb17576.x; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; KOBAYASHI K, 1982, FEBS LETT, V142, P235, DOI 10.1016/0014-5793(82)80142-7; Loy A, 2008, MICROBIAL SULFUR METABOLISM, P46, DOI 10.1007/978-3-540-72682-1_5; Mander GJ, 2005, FEBS LETT, V579, P4600, DOI 10.1016/j.febslet.2005.07.029; Marritt SJ, 1996, EUR J BIOCHEM, V238, P724, DOI 10.1111/j.1432-1033.1996.0724w.x; MATTHEWS JC, 1995, BIOCHEMISTRY-US, V34, P5248, DOI 10.1021/bi00015a039; Molitor M, 1998, MICROBIOL-SGM, V144, P529, DOI 10.1099/00221287-144-2-529; MOURA I, 1988, J AM CHEM SOC, V110, P1075, DOI 10.1021/ja00212a013; MURPHY MJ, 1973, J BIOL CHEM, V248, P6911; Oliveira TF, 2008, J STRUCT BIOL, V164, P236, DOI 10.1016/j.jsb.2008.07.007; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15726; Pearson AR, 2007, BIOCHEMISTRY-US, V46, P8340, DOI 10.1021/bi700086r; PECK HD, 1982, PHILOS T R SOC B, V298, P443, DOI 10.1098/rstb.1982.0091; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; PIERIK AJ, 1991, EUR J BIOCHEM, V195, P505, DOI 10.1111/j.1432-1033.1991.tb15731.x; PIERIK AJ, 1992, EUR J BIOCHEM, V205, P111, DOI 10.1111/j.1432-1033.1992.tb16757.x; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; POSTGATE J, 1959, NATURE, V183, P481, DOI 10.1038/183481b0; Sander J, 2006, ARCH MICROBIOL, V186, P357, DOI 10.1007/s00203-006-0156-y; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schiffer A, 2008, J MOL BIOL, V379, P1063, DOI 10.1016/j.jmb.2008.04.027; Schnell R, 2005, J BIOL CHEM, V280, P27319, DOI 10.1074/jbc.M502560200; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; STEUBER J, 1994, ARCH MICROBIOL, V162, P255, DOI 10.1007/s002030050134; Swamy U, 2005, BIOCHEMISTRY-US, V44, P16054, DOI 10.1021/bi050981y; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; Whittaker MM, 2003, J BIOL CHEM, V278, P22090, DOI 10.1074/jbc.M300112200; WOLFE BM, 1994, EUR J BIOCHEM, V223, P79, DOI 10.1111/j.1432-1033.1994.tb18968.x; YOUNG LJ, 1988, BIOCHEMISTRY-US, V27, P5984, DOI 10.1021/bi00416a023	60	118	122	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34141	34149		10.1074/jbc.M805643200	http://dx.doi.org/10.1074/jbc.M805643200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18829451	Green Published, hybrid			2022-12-25	WOS:000261277700042
J	Tchesnokov, EP; Obikhod, A; Schinazi, RF; Gotte, M				Tchesnokov, Egor P.; Obikhod, Aleksandr; Schinazi, Raymond F.; Gotte, Matthias			Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE TRANSLOCATION; MOLECULAR-MECHANISMS; NUCLEOSIDE ANALOGS; PRIMER UNBLOCKING; INFECTED PATIENTS; NAIVE PATIENTS; RATCHET MODEL; IN-VITRO; RESISTANCE	Entecavir (ETV) is a potent antiviral nucleoside analogue that is used to treat hepatitis B virus (HBV) infection. Recent clinical studies have demonstrated that ETV is also active against the human immunodeficiency virus type 1 (HIV-1). Unlike all approved nucleoside analogue reverse transcriptase RT) inhibitors (NRTIs), ETV contains a 3'-hydroxyl group that allows further nucleotide incorporation events to occur. Thus, the mechanism of inhibition probably differs from classic chain termination. Here, we show that the incorporated ETV-monophosphate (MP) can interfere with three distinct stages of DNA synthesis. First, incorporation of the next nucleotide at position n + 1 following ETV-MP is compromised, although DNA synthesis eventually continues. Second, strong pausing at position n + 3 suggests a long range effect, referred to as "delayed chain-termination." Third, the incorporated ETV-MP can also act as a "base pair confounder" during synthesis of the second DNA strand, when the RT enzyme needs to pass the inhibitor in the template. Enzyme kinetics revealed that delayed chain termination is the dominant mechanism of action. High resolution foot-printing experiments suggest that the incorporated ETV-MP "repels" the 3'-end of the primer from the active site of HIV-1 RT, which, in turn, diminishes incorporation of the natural nucleotide substrate at position n + 4. Most importantly, delayed chain termination protects ETV-MP from phosphorolytic excision, which represents a major resistance mechanism for approved NRTIs. Collectively, these findings provide a rationale and important tools for the development of novel, more potent delayed chain terminators as anti-HIV agents.	[Tchesnokov, Egor P.; Gotte, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Obikhod, Aleksandr; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res, Atlanta, GA 30322 USA; [Obikhod, Aleksandr; Schinazi, Raymond F.] Vet Affairs Med Res, Atlanta, GA 30322 USA	McGill University; Emory University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca			National Institutes of Health [5R37-AI-041980, 4R37-AI-025899, 5P30-AI-50409]; Canadian Institutes for Health Research (CIHR); United States Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI025899, P30AI050409, R37AI041980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R37-AI-041980, 4R37-AI-025899, and 5P30-AI-50409 (CFAR) (to R. F. S.). This study was also supported by the Canadian Institutes for Health Research (CIHR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. Supported in part by the United States Department of Veterans Affairs.	Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; Benhamou Y, 2003, NEW ENGL J MED, V348, P177, DOI 10.1056/NEJM200301093480218; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Colonno RJ, 2006, HEPATOLOGY, V44, P1656, DOI 10.1002/hep.21422; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Deval J, 2007, ANTIMICROB AGENTS CH, V51, P2920, DOI 10.1128/AAC.00186-07; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Domaoal RA, 2008, J BIOL CHEM, V283, P5452, DOI 10.1074/jbc.M707834200; Fontaine H, 1999, ANN INTERN MED, V131, P716, DOI 10.7326/0003-4819-131-9-199911020-00027; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Gutfreund KS, 2000, J HEPATOL, V33, P469, DOI 10.1016/S0168-8278(00)80284-6; Hirsch MS, 2007, NEW ENGL J MED, V356, P2641, DOI 10.1056/NEJMe078045; Isel C, 2001, J BIOL CHEM, V276, P48725, DOI 10.1074/jbc.M108352200; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; Lin PF, 2008, ANTIMICROB AGENTS CH, V52, P1759, DOI 10.1128/AAC.01313-07; Ling R, 1996, HEPATOLOGY, V24, P711, DOI 10.1053/jhep.1996.v24.pm0008781347; Manalakopoulos S, 2008, ALIMENT PHARM THER, V27, P266, DOI 10.1111/j.1365-2036.2007.03567.x; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Marquez VE, 2004, J AM CHEM SOC, V126, P543, DOI 10.1021/ja037929e; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Miller MD, 2001, NUCLEOS NUCLEOT NUCL, V20, P1025, DOI 10.1081/NCN-100002483; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nunez M, 2002, AIDS, V16, P2352, DOI 10.1097/00002030-200211220-00023; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sasadeusz J, 2008, AIDS, V22, P947, DOI 10.1097/QAD.0b013e3282ffde91; Sasadeusz Joe, 2007, J Hepatol, V47, P872, DOI 10.1016/j.jhep.2007.09.002; SCHINAZI RF, 1992, ANTIMICROB AGENTS CH, V36, P2423, DOI 10.1128/AAC.36.11.2423; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Seifer M, 1998, ANTIMICROB AGENTS CH, V42, P3200, DOI 10.1128/AAC.42.12.3200; SEVERINI A, 1995, ANTIMICROB AGENTS CH, V39, P1430, DOI 10.1128/AAC.39.7.1430; Sherman M, 2006, GASTROENTEROLOGY, V130, P2039, DOI 10.1053/j.gastro.2006.04.007; Soriano V, 2008, AIDS, V22, P911, DOI 10.1097/QAD.0b013e3282f82b96; Sulkowski MS, 2008, J INFECT DIS, V197, pS279, DOI 10.1086/533414; Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009; Telesnitsky A., 1997, P121; Tenney DJ, 2007, ANTIMICROB AGENTS CH, V51, P902, DOI 10.1128/AAC.00833-06; Tenney DJ, 2004, ANTIMICROB AGENTS CH, V48, P3498, DOI 10.1128/AAC.48.9.3498-3507.2004; Thibault V, 1999, J CLIN MICROBIOL, V37, P3013, DOI 10.1128/JCM.37.9.3013-3016.1999; van Bommel F, 2002, HEPATOLOGY, V36, P507, DOI 10.1053/jhep.2002.35328; Villet S, 2006, GASTROENTEROLOGY, V131, P1253, DOI 10.1053/j.gastro.2006.08.013; WAINBERG MA, 1995, AIDS, V9, P351, DOI 10.1097/00002030-199509040-00006; Yuan HJ, 2007, CURR MOL MED, V7, P185, DOI 10.2174/156652407780059159	57	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34218	34228		10.1074/jbc.M806797200	http://dx.doi.org/10.1074/jbc.M806797200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18940786	Green Published, hybrid			2022-12-25	WOS:000261277700050
J	Moncrieffe, MC; Grossmann, JG; Gay, NJ				Moncrieffe, Martin C.; Grossmann, J. Guenter; Gay, Nicholas J.			Assembly of Oligomeric Death Domain Complexes during Toll Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REL PROTEIN DORSAL; DROSOPHILA MYD88; PELLE KINASE; ADAPTER; TOLL-LIKE-RECEPTOR-4; SUPERFAMILY; ACTIVATION; MECHANISM; POLARITY; PATHWAY	The Drosophila Toll receptor is activated by the endogenous protein ligand Spatzle in response to microbial stimuli in immunity and spatial cues during embryonic development. Downstream signaling is mediated by the adaptor proteins Tube, the kinase Pelle, and the Drosophila homologue of myeloid differentiation primary response protein (dMyD88). Here we have characterized heterodimeric (dMyD88-Tube) and heterotrimeric (dMyD88-Tube-Pelle) death domain complexes. We show that both the heterodimeric and heterotrimeric complexes form kidney-shaped structures and that Tube is bivalent and has separate high affinity binding sites for dMyD88 and Pelle. Additionally we found no interaction between the isolated death domains of Pelle and dMyD88. These results indicate that the mode of assembly of the heterotrimeric dMyD88-Tube-Pelle complex downstream of the activated Toll receptor is unique. The measured dissociation constants for the interaction between the death domains of dMyD88 and Tube and of Pelle and a preformed dMyD88-Tube complex are used to propose a model of the early postreceptor events in Drosophila Toll receptor signaling.	[Moncrieffe, Martin C.; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Grossmann, J. Guenter] Univ Liverpool, Sch Biol Sci, Mol Biophys Grp, Liverpool L69 7ZB, Merseyside, England	University of Cambridge; University of Liverpool	Moncrieffe, MC (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Ct Rd, Cambridge CB2 1GA, England.	mcm35@cam.ac.uk			UK Biotechnology and Biological Sciences Research Council (BBSRC); MRC [G0400007] Funding Source: UKRI; Medical Research Council [G0400007] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from the UK Biotechnology and Biological Sciences Research Council (BBSRC) (to N. J. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; Chen LY, 2006, CURR BIOL, V16, P1183, DOI 10.1016/j.cub.2006.05.050; Drier EA, 1999, GENE DEV, V13, P556, DOI 10.1101/gad.13.5.556; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Edwards DN, 1997, DEVELOPMENT, V124, P3855; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; ISODA K, 1994, P NATL ACAD SCI USA, V91, P5350, DOI 10.1073/pnas.91.12.5350; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Moncrieffe MC, 2005, FEBS LETT, V579, P3920, DOI 10.1016/j.febslet.2005.06.009; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; RAY RP, 1991, DEVELOPMENT, V113, P35; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Schiffmann DA, 1999, BIOCHEMISTRY-US, V38, P11722, DOI 10.1021/bi9904252; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; Shen BH, 1998, DEVELOPMENT, V125, P4719; Shen BH, 2002, DEVELOPMENT, V129, P1925; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Weber CH, 2001, FEBS LETT, V492, P171, DOI 10.1016/S0014-5793(01)02162-7; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	44	53	54	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33447	33454		10.1074/jbc.M805427200	http://dx.doi.org/10.1074/jbc.M805427200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829464	Green Published, hybrid			2022-12-25	WOS:000261183700049
J	Comabella, M; Craig, DW; Camina-Tato, M; Morcillo, C; Lopez, C; Navarro, A; Rio, J; Montalban, X; Martin, R				Comabella, Manuel; Craig, David W.; Camina-Tato, Montse; Morcillo, Carlos; Lopez, Cristina; Navarro, Arcadi; Rio, Jordi; Montalban, Xavier; Martin, Roland		BiomarkerMS Study Grp	Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms	PLOS ONE			English	Article								Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system with an important genetic component and strongest association driven by the HLA genes. We performed a pooling-based genome-wide association study of 500,000 SNPs in order to find new loci associated with the disease. After applying several criteria, 320 SNPs were selected from the microarrays and individually genotyped in a first and independent Spanish Caucasian replication cohort. The 8 most significant SNPs validated in this cohort were also genotyped in a second US Caucasian replication cohort for confirmation. The most significant association was obtained for SNP rs3129934, which neighbors the HLA-DRB/DQA loci and validates our pooling-based strategy. The second strongest association signal was found for SNP rs1327328, which resides in an unannotated region of chromosome 13 but is in linkage disequilibrium with nearby functional elements that may play important roles in disease susceptibility. This region of chromosome 13 has not been previously identified in MS linkage genome screens and represents a novel risk locus for the disease.	[Comabella, Manuel; Camina-Tato, Montse; Lopez, Cristina; Rio, Jordi; Montalban, Xavier] HUVH, CEM Cat, UNIC, Barcelona, Spain; [Craig, David W.] Translat Genom Res Inst TGen, Neurogenom Div, Phoenix, AZ USA; [Morcillo, Carlos; Navarro, Arcadi] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona, Spain; [Morcillo, Carlos] Natl Inst Bioinformat INB, Barcelona, Spain; [Navarro, Arcadi; Martin, Roland] Inst Catalana Recerca Estudis Avancats ICREA, Barcelona, Spain; NINDS, NIH, Bethesda, MD USA	Hospital Universitari Vall d'Hebron; Translational Genomics Research Institute; Pompeu Fabra University; ICREA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Comabella, M (corresponding author), HUVH, CEM Cat, UNIC, Barcelona, Spain.	mcomabel@ir.vhebron.net	Navarro, Arcadi/F-1592-2011; Craig, David Wesley/K-6961-2019; Montalban, Xavier/J-5938-2016	Navarro, Arcadi/0000-0003-2162-8246; Craig, David Wesley/0000-0003-2040-1955; Montalban, Xavier/0000-0002-0098-9918; Martin, Roland/0000-0002-0982-1329; Comabella Lopez, Manuel/0000-0002-2373-6657; Rio, Jordi/0000-0003-4546-7627; Lopez Garcia, Cristina/0000-0002-2861-929X	Spain's National Institute for Bioinformatics; ICREA Funding Source: Custom	Spain's National Institute for Bioinformatics; ICREA(ICREA)	The Institute for Neuroimmunology and Clinical MS Research is supported by the Gemeinnutzige Hertie Foundation. This work has been supported by Spain's National Institute for Bioinformatics, a platform of Genoma Espana.	Barcellos LF, 2002, BRAIN, V125, P150; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Faust PL, 2005, J INHERIT METAB DIS, V28, P369, DOI 10.1007/s10545-005-7059-y; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Gootjes J, 2004, EUR J HUM GENET, V12, P115, DOI 10.1038/sj.ejhg.5201090; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Iglesias AH, 2004, J NEUROIMMUNOL, V150, P163, DOI 10.1016/j.jneuroim.2004.01.017; Krause Cindy, 2006, Hum Mutat, V27, P1157, DOI 10.1002/humu.9462; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MORCILLOSUAREZ C, 2008, BIOINFORMAT IN PRESS; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Oksenberg JR, 2005, GENES IMMUN, V6, P375, DOI 10.1038/sj.gene.6364237; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rane S, 2007, CELL CYCLE, V6, P1850, DOI 10.4161/cc.6.15.4551; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Villoslada P, 2002, J NEUROIMMUNOL, V130, P194, DOI 10.1016/S0165-5728(02)00215-1; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593	22	84	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3490	10.1371/journal.pone.0003490	http://dx.doi.org/10.1371/journal.pone.0003490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941528	Green Published, gold			2022-12-25	WOS:000265126100021
J	Chavanas, S; Adoue, V; Mechin, MC; Ying, SB; Dong, SJ; Duplan, H; Charveron, M; Takahara, H; Serre, G; Simon, M				Chavanas, Stephane; Adoue, Veronique; Mechin, Marie-Claire; Ying, Shibo; Dong, Sijun; Duplan, Helene; Charveron, Marie; Takahara, Hidenari; Serre, Guy; Simon, Michel			Long-Range Enhancer Associated with Chromatin Looping Allows AP-1 Regulation of the Peptidylarginine Deiminase 3 Gene in Differentiated Keratinocyte	PLOS ONE			English	Article							NUCLEAR-FACTOR-Y; ACTIVATOR PROTEIN-1 ACTIVATION; NF-Y; TRANSCRIPTION FACTORS; PROMOTER ACTIVITY; PROXIMAL PROMOTER; GROWTH-FACTOR; EXPRESSION; SP1; MOUSE	Transcription control at a distance is a critical mechanism, particularly for contiguous genes. The peptidylarginine deiminases (PADs) catalyse the conversion of protein-bound arginine into citrulline (deimination), a critical reaction in the pathophysiology of multiple sclerosis, Alzheimer's disease and rheumatoid arthritis, and in the metabolism of the major epidermal barrier protein filaggrin, a strong predisposing factor for atopic dermatitis. PADs are encoded by 5 clustered PADI genes (1p35-6). Unclear are the mechanisms controlling the expression of the gene PADI3 encoding the PAD3 isoform, a strong candidate for the deimination of filaggrin in the terminally differentiating epidermal keratinocyte. We describe the first PAD Intergenic Enhancer (PIE), an evolutionary conserved non coding segment located 86-kb from the PADI3 promoter. PIE is a strong enhancer of the PADI3 promoter in Ca2+- differentiated epidermal keratinocytes, and requires bound AP-1 factors, namely c-Jun and c-Fos. As compared to proliferative keratinocytes, calcium stimulation specifically associates with increased local DNase I hypersensitivity around PIE, and increased physical proximity of PIE and PADI3 as assessed by Chromosome Conformation Capture. The specific AP-1 inhibitor nordihydroguaiaretic acid suppresses the calcium-induced increase of PADI3 mRNA levels in keratinocytes. Our findings pave the way to the exploration of deimination control during tumorigenesis and wound healing, two conditions for which AP-1 factors are critical, and disclose that long-range transcription control has a role in the regulation of the gene PADI3. Since invalidation of distant regulators causes a variety of human diseases, PIE results to be a plausible candidate in association studies on deimination-related disorders or atopic disease.	[Chavanas, Stephane; Adoue, Veronique; Mechin, Marie-Claire; Serre, Guy; Simon, Michel] Univ Toulouse 3, CNRS, UMR 5165, CHU Purpan, F-31062 Toulouse, France; [Ying, Shibo; Dong, Sijun; Takahara, Hidenari] Ibaraki Univ, Sch Agr, Dept Appl Biol Resource Sci, Ami, Ibaraki, Japan; [Duplan, Helene; Charveron, Marie] Inst Rech Pierre Fabre, Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Ibaraki University; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chavanas, S (corresponding author), Univ Toulouse 3, CNRS, UMR 5165, CHU Purpan, F-31062 Toulouse, France.	chavanas@udear.cnrs.fr	Simon, Michel/B-7308-2011; DONG, SIJUN/C-8807-2018; Chavanas, stephane/K-1183-2014; Ying, Shibo/K-2514-2016	Simon, Michel/0000-0003-3655-6329; chavanas, stephane/0000-0003-4323-2656; Takahara, Hidenari/0000-0003-2373-8588; Ying, Shibo/0000-0001-5275-9383; Adoue, Veronique/0000-0003-3548-7456	Institut National de la Sante et de la Recherche Medicale (INSERM); Paul Sabatier University (UPS); Centre National de la Recherche Scientifique (CNRS); European Social Fund (ESF); European Regional Development Fund (ERDF); Pierre-Fabre Research Institute (CERPER, Toulouse)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Paul Sabatier University (UPS); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Social Fund (ESF)(European Social Fund (ESF)); European Regional Development Fund (ERDF)(European Commission); Pierre-Fabre Research Institute (CERPER, Toulouse)	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Paul Sabatier University (UPS), Centre National de la Recherche Scientifique (CNRS), European Social Fund (ESF), European Regional Development Fund (ERDF) and Pierre-Fabre Research Institute (CERPER, Toulouse).	Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; Chen WX, 1998, J BIOL CHEM, V273, P32176, DOI 10.1074/jbc.273.48.32176; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOMANN FE, 1994, CELL GROWTH DIFFER, V5, P9; DONG S, 2007, J INVEST DERMATOL; Dong S, 2007, MOL ENDOCRINOL, V21, P1617, DOI 10.1210/me.2006-0550; Dong S, 2006, BIOCHEM J, V397, P449, DOI 10.1042/BJ20051939; Dong SJ, 2005, J INVEST DERMATOL, V124, P1026, DOI 10.1111/j.0022-202X.2005.23690.x; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Ge YB, 2001, BIOCHEM J, V357, P97, DOI 10.1042/0264-6021:3570097; Germain S, 1998, J BIOL CHEM, V273, P25292, DOI 10.1074/jbc.273.39.25292; Gonzales M, 2002, MOL CARCINOGEN, V34, P102, DOI 10.1002/mc.10052; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Layon ME, 2007, J MOL BIOL, V366, P737, DOI 10.1016/j.jmb.2006.11.094; Liang FQ, 2001, J BIOL CHEM, V276, P1516, DOI 10.1074/jbc.M006350200; Liu GY, 2006, APOPTOSIS, V11, P183, DOI 10.1007/s10495-006-3715-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lok CN, 2002, BIOCHEM J, V368, P741, DOI 10.1042/BJ20020791; Magan N, 2003, BIOCHEM J, V374, P723, DOI 10.1042/BJ20030032; Martin N, 2004, GENOME RES, V14, P2430, DOI 10.1101/gr.2709404; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Neub A, 2007, J INVEST DERMATOL, V127, P2453, DOI 10.1038/sj.jid.5700864; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Park S, 2004, J CELL BIOCHEM, V91, P973, DOI 10.1002/jcb.10768; Park S, 1998, CANCER LETT, V127, P23, DOI 10.1016/S0304-3835(97)00543-0; Ransone Lynn J., 1993, Gene Expression, V3, P37; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Romano RA, 2006, J INVEST DERMATOL, V126, P1469, DOI 10.1038/sj.jid.5700297; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Rubtsov MA, 2006, P NATL ACAD SCI USA, V103, P17690, DOI 10.1073/pnas.0603819103; Ruocco KM, 2007, J BIOMOL SCREEN, V12, P133, DOI 10.1177/1087057106296686; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; Senshu T, 1996, BIOCHEM BIOPH RES CO, V225, P712, DOI 10.1006/bbrc.1996.1240; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sim EUH, 2002, ONCOGENE, V21, P2948, DOI 10.1038/sj.onc.1205373; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Teixe T, 2008, MOL IMMUNOL, V45, P2905, DOI 10.1016/j.molimm.2008.01.033; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Vilar JMG, 2005, CURR OPIN GENET DEV, V15, P136, DOI 10.1016/j.gde.2005.02.005; Virolle T, 1998, J BIOL CHEM, V273, P17318, DOI 10.1074/jbc.273.28.17318; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wang YN, 2003, J BIOL CHEM, V278, P45848, DOI 10.1074/jbc.M302630200; Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200; Yamaguchi H, 1999, BIOCHEM J, V340, P767, DOI 10.1042/0264-6021:3400767; Zhao JQ, 2003, FEBS LETT, V536, P111, DOI 10.1016/S0014-5793(03)00038-3	66	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3408	10.1371/journal.pone.0003408	http://dx.doi.org/10.1371/journal.pone.0003408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923650	Green Submitted, gold, Green Published			2022-12-25	WOS:000265122200002
J	Isik, N; Hereld, D; Jin, T				Isik, Nilgun; Hereld, Dale; Jin, Tian			Fluorescence Resonance Energy Transfer Imaging Reveals that Chemokine-Binding Modulates Heterodimers of CXCR4 and CCR5 Receptors	PLOS ONE			English	Article								Background: Dimerization has emerged as an important feature of chemokine G-protein-coupled receptors. CXCR4 and CCR5 regulate leukocyte chemotaxis and also serve as a co-receptor for HIV entry. Both receptors are recruited to the immunological synapse during T-cell activation. However, it is not clear whether they form heterodimers and whether ligand binding modulates the dimer formation. Methodology/Principal Findings: Using a sensitive Fluorescence Resonance Energy Transfer (FRET) imaging method, we investigated the formation of CCR5 and CXCR4 heterodimers on the plasma membrane of live cells. We found that CCR5 and CXCR4 exist as constitutive heterodimers and ligands of CCR5 and CXCR4 promote different conformational changes within these preexisting heterodimers. Ligands of CCR5, in contrast to a ligand of CXCR4, induced a clear increase in FRET efficiency, indicating that selective ligands promote and stabilize a distinct conformation of the heterodimers. We also found that mutations at C-terminus of CCR5 reduced its ability to form heterodimers with CXCR4. In addition, ligands induce different conformational transitions of heterodimers of CXCR4 and CCR5 or CCR5(STA) and CCR5(Delta 4). Conclusions/Significance: Taken together, our data suggest a model in which CXCR4 and CCR5 spontaneously form heterodimers and ligand-binding to CXCR4 or CCR5 causes different conformational changes affecting heterodimerization, indicating the complexity of regulation of dimerization/function of these chemokine receptors by ligand binding.	[Isik, Nilgun; Hereld, Dale; Jin, Tian] NIAID, Chemotaxis Signal Sect, Immunogenet Lab, NIH,Twinbrook Facil 2, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Isik, N (corresponding author), NIAID, Chemotaxis Signal Sect, Immunogenet Lab, NIH,Twinbrook Facil 2, Rockville, MD USA.	tjin@niaid.nih.gov			IATAP program from NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000928, Z01AI000928] Funding Source: NIH RePORTER	IATAP program from NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by IATAP program from NIH.	Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hereld D, 2008, EUR J IMMUNOL, V38, P334, DOI 10.1002/eji.200738101; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; JIN T, 2008, CHEMOTAXIS CHEMOKINE; Kramer JM, 2006, J IMMUNOL, V176, P711, DOI 10.4049/jimmunol.176.2.711; Lazzarino DA, 2000, IMMUNOL LETT, V74, P189, DOI 10.1016/S0165-2478(00)00258-3; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murphy PM, 2000, PHARMACOL REV, V52, P145; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; SIEGEL RM, 2000, SCI STKE, pPL1; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Strange PG, 2008, CURR OPIN DRUG DISC, V11, P196; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu X, 2007, J CELL BIOL, V178, P141, DOI 10.1083/jcb.200611096; Yi L, 2006, J BIOL CHEM, V281, P35446, DOI 10.1074/jbc.M607302200	27	46	50	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3424	10.1371/journal.pone.0003424	http://dx.doi.org/10.1371/journal.pone.0003424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923649	gold, Green Published, Green Submitted			2022-12-25	WOS:000265122200005
J	Pecze, L; Szabo, K; Szell, M; Josvay, K; Kaszas, K; Kusz, E; Letoha, T; Prorok, J; Koncz, I; Toth, A; Kemeny, L; Vizler, C; Olah, Z				Pecze, Laszlo; Szabo, Kornelia; Szell, Marta; Josvay, Katalin; Kaszas, Krisztian; Kusz, Erzsebet; Letoha, Tamas; Prorok, Janos; Koncz, Istvan; Toth, Andras; Kemeny, Lajos; Vizler, Csaba; Olah, Zoltan			Human Keratinocytes Are Vanilloid Resistant	PLOS ONE			English	Article							CAPSAICIN RECEPTOR TRPV1; POSTHERPETIC NEURALGIA; DIFFERENTIAL EXPRESSION; MICE LACKING; 1 VR1; RAT; PAIN; CELLS; NEURONS; CHANNEL	Background: Use of capsaicin or resiniferatoxin (RTX) as analgesics is an attractive therapeutic option. RTX opens the cation channel inflammatory pain/vanilloid receptor type 1 (TRPV1) permanently and selectively removes nociceptive neurons by Ca2+-cytotoxicity. Paradoxically, not only nociceptors, but non-neuronal cells, including keratinocytes express full length TRPV1 mRNA, while patient dogs and experimental animals that underwent topical treatment or anatomically targeted molecular surgery have shown neither obvious behavioral, nor pathological side effects. Methods: To address this paradox, we assessed the vanilloid sensitivity of the HaCaT human keratinocyte cell line and primary keratinocytes from skin biopsies. Results: Although both cell types express TRPV1 mRNA, neither responded to vanilloids with Ca2+-cytotoxicity. Only ectopic overproduction of TRPV1 rendered HaCaT cells sensitive to low doses (1-50 nM) of vanilloids. The TRPV1-mediated and nonreceptor specific Ca2+-cytotoxity ([RTX] > 15 mu M) could clearly be distinguished, thus keratinocytes were indeed resistant to vanilloid-induced, TRPV1-mediated Ca2+-entry. Having a wider therapeutic window than capsaicin, RTX was effective in subnanomolar range, but even micromolar concentrations could not kill human keratinocytes. Keratinocytes showed orders of magnitudes lower TRPV1 mRNA level than sensory ganglions, the bona fide therapeutic targets in human pain management. In addition to TRPV1, TRPV1b, a dominant negative splice variant was also noted in keratinocytes. Conclusion: TRPV1B expression, together with low TRPV1 expression, may explain the vanilloid paradox: even genuinely TRPV1 mRNA positive cells can be spared with therapeutic (up to micromolar) doses of RTX. This additional safety information might be useful for planning future human clinical trials.	[Pecze, Laszlo; Josvay, Katalin; Kaszas, Krisztian; Kusz, Erzsebet; Letoha, Tamas; Vizler, Csaba; Olah, Zoltan] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary; [Szabo, Kornelia; Szell, Marta] Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary; [Letoha, Tamas] Univ Szeged, Dept Med Chem, Albert Szent Gyorgyi Med & Pharm Ctr, Szeged, Hungary; [Prorok, Janos; Koncz, Istvan; Toth, Andras] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Albert Szent Gyorgyi Med & Pharm Ctr, Szeged, Hungary; [Kemeny, Lajos] Univ Szeged, Dept Dermatol & Allergol, Albert Szent Gyorgyi Med & Pharm Ctr, Szeged, Hungary; [Olah, Zoltan] Acheuron Ltd, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Szeged University; Szeged University; Szeged University	Pecze, L (corresponding author), Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary.	oz@acheuron.com	Letoha, Tamas/ABG-6348-2020; Kemeny, Lajos/ABF-1339-2021	Kemeny, Lajos/0000-0002-2119-9501	Hungarian Ministry of Health [552/2006]; National Office for Research and Technology [OM-00051/2005, OMFB-01575/2006, OMFB-01576/2006, OMFB-01630/2006]; Anyos Jedlik Program [NKFP-1-00019/2005, GVOP-3.3.1-05/1.-2005-05-0057/3.0]; Zoltan Magyary Postdoctoral Fellowship Fund; Hungarian Academy of Sciences [Janos Bolyai Research Scholarship];  [MC-IRG030854-PAINKILLER]	Hungarian Ministry of Health; National Office for Research and Technology(National Office for Research and Technology); Anyos Jedlik Program; Zoltan Magyary Postdoctoral Fellowship Fund; Hungarian Academy of Sciences(Hungarian Academy of Sciences); 	This work has been supported by grants of the Hungarian Ministry of Health (552/2006), and the National Office for Research and Technology (OM-00051/2005 and OMFB-01575/2006). ZO was also supported by MC-IRG030854-PAINKILLER; Anyos Jedlik Program NKFP-1-00019/2005; GVOP-3.3.1-05/1.-2005-05-0057/3.0. CV was also supported by grants of the National Office for Research and Technology (OM-00051/2005 and OMFB-01575/2006) and the Hungarian Ministry of Health (552/2006). TL was also supported by grants of the National Office for Research and Technology (OMFB-01576/2006 and OMFB-01630/2006) and the Zoltan Magyary Postdoctoral Fellowship Fund. This paper was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Alper BS, 2002, J FAM PRACTICE, V51, P121; Argoff Charles E, 2003, Curr Pain Headache Rep, V7, P34, DOI 10.1007/s11916-003-0007-3; Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V354, P50, DOI 10.1016/j.bbrc.2006.12.179; Basu S, 2005, P NATL ACAD SCI USA, V102, P5120, DOI 10.1073/pnas.0407780102; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Bodo E, 2005, AM J PATHOL, V166, P985, DOI 10.1016/S0002-9440(10)62320-6; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brown DC, 2005, ANESTHESIOLOGY, V103, P1052, DOI 10.1097/00000542-200511000-00020; BUCCI FA, 1988, AM J OPHTHALMOL, V106, P758, DOI 10.1016/0002-9394(88)90727-1; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Denda M, 2001, BIOCHEM BIOPH RES CO, V285, P1250, DOI 10.1006/bbrc.2001.5299; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gopinath Preethi, 2005, BMC Womens Health, V5, P2, DOI 10.1186/1472-6874-5-2; Guler AD, 2002, J NEUROSCI, V22, P6408; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; HUTSAI M, 1992, NEUROSCI LETT, V143, P251, DOI 10.1016/0304-3940(92)90276-D; Inoue K, 2002, BIOCHEM BIOPH RES CO, V291, P124, DOI 10.1006/bbrc.2002.6393; JENSEN PKA, 1990, VIRCHOWS ARCH B, V59, P17, DOI 10.1007/BF02899382; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kofalvi A, 2006, NEUROSCI LETT, V403, P151, DOI 10.1016/j.neulet.2006.04.030; Levey DJ, 2006, OECOLOGIA, V150, P61, DOI 10.1007/s00442-006-0496-y; Liapi A, 2005, EUR J NEUROSCI, V22, P825, DOI 10.1111/j.1460-9568.2005.04270.x; LYNN B, 1990, PAIN, V41, P61, DOI 10.1016/0304-3959(90)91110-5; Macho A, 1999, CELL DEATH DIFFER, V6, P155, DOI 10.1038/sj.cdd.4400465; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Nagy I, 2004, EUR J PHARMACOL, V500, P351, DOI 10.1016/j.ejphar.2004.07.037; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; O'Connell PJ, 2005, FEBS LETT, V579, P5135, DOI 10.1016/j.febslet.2005.08.023; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Olah Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000545; Paramio JM, 1998, ONCOGENE, V17, P949, DOI 10.1038/sj.onc.1202031; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Pivarcsi A, 2001, ARCH DERMATOL RES, V293, P206, DOI 10.1007/s004030100217; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Sathianathan V, 2003, EUR J NEUROSCI, V18, P2477, DOI 10.1046/j.1460-9568.2003.03004.x; Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c; Southall MD, 2003, J PHARMACOL EXP THER, V304, P217, DOI 10.1124/jpet.102.040675; Stander S, 2001, J AM ACAD DERMATOL, V44, P471, DOI 10.1067/mjd.2001.110059; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szallasi A, 2006, N-S ARCH PHARMACOL, V373, P273, DOI 10.1007/s00210-006-0072-3; Tahim AS, 2005, NEUROSCIENCE, V136, P539, DOI 10.1016/j.neuroscience.2005.08.005; Tender GC, 2005, J NEUROSURG, V102, P522, DOI 10.3171/jns.2005.102.3.0522; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Vos MH, 2006, J NEUROCHEM, V99, P1088, DOI 10.1111/j.1471-4159.2006.04145.x; WATSON CPN, 1988, PAIN, V35, P289, DOI 10.1016/0304-3959(88)90139-X; WINTER J, 1992, NEUROSCI LETT, V146, P48, DOI 10.1016/0304-3940(92)90169-8; WINTER J, 1995, BRIT J ANAESTH, V75, P157, DOI 10.1093/bja/75.2.157; Witte DG, 2002, J BIOMOL SCREEN, V7, P466, DOI 10.1177/108705702237679	62	43	43	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3419	10.1371/journal.pone.0003419	http://dx.doi.org/10.1371/journal.pone.0003419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852901	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000265121700012
J	Pirozhkova, I; Petrov, A; Dmitriev, P; Laoudj, D; Lipinski, M; Vassetzky, Y				Pirozhkova, Iryna; Petrov, Andrei; Dmitriev, Petr; Laoudj, Dalila; Lipinski, Marc; Vassetzky, Yegor			A Functional Role for 4qA/B in the Structural Rearrangement of the 4q35 Region and in the Regulation of FRG1 and ANT1 in Facioscapulohumeral Dystrophy	PLOS ONE			English	Article								The number of D4Z4 repeats in the subtelomeric region of chromosome 4q is strongly reduced in patients with Facio-Scapulo-Humeral Dystrophy (FSHD). We performed chromosome conformation capture (3C) analysis to document the interactions taking place among different 4q35 markers. We found that the reduced number of D4Z4 repeats in FSHD myoblasts was associated with a global alteration of the three-dimensional structure of the 4q35 region. Indeed, differently from normal myoblasts, the 4qA/B marker interacted directly with the promoters of the FRG1 and ANT1 genes in FSHD cells. Along with the presence of a newly identified transcriptional enhancer within the 4qA allele, our demonstration of an interaction occurring between chromosomal segments located megabases away on the same chromosome 4q allows to revisit the possible mechanisms leading to FSHD.	[Pirozhkova, Iryna; Petrov, Andrei; Dmitriev, Petr; Lipinski, Marc; Vassetzky, Yegor] Univ Paris 11, CNRS, UMR Interact Mol & Canc 8126, Inst Cancerol Gustave Roussy, Villejuif, France; [Laoudj, Dalila] Univ Montpellier 1, INSERM, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Pirozhkova, I (corresponding author), Univ Paris 11, CNRS, UMR Interact Mol & Canc 8126, Inst Cancerol Gustave Roussy, Villejuif, France.	vassetzky@igr.fr	Vassetzky, Yegor/M-3383-2019; Vassetzky, Yegor S/C-6447-2008	Vassetzky, Yegor/0000-0003-3101-7043; Vassetzky, Yegor S/0000-0003-3101-7043; Pirozhkova, Iryna/0000-0001-8196-7069	Association Francaise contre les Myopathies (AFM) [fellowship]; Fondation pour la Recherche Medicale [fellowship]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants to YSV and DL from the Association Francaise contre les Myopathies (AFM). IP was a recipient of an AFM fellowship, and AP of a fellowship from the Fondation pour la Recherche Medicale.	BARRO M, 2008, J CELL MOL IN PRESS; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; DMITRIEV P, 2008, NEUROMUSCUL IN PRESS, DOI DOI 10.1016/J.NMD.2008.1009.1004; Eivazova ER, 2007, GENES IMMUN, V8, P35, DOI 10.1038/sj.gene.6364349; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabellini D, 2005, NATURE; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; LI K, 1990, J BIOL CHEM, V265, P20585; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Stout K, 1999, CHROMOSOME RES, V7, P323, DOI 10.1023/A:1009287111661; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; van Koningsbruggen S, 2007, CHROMOSOMA, V116, P53, DOI 10.1007/s00412-006-0083-3; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327	32	36	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3389	10.1371/journal.pone.0003389	http://dx.doi.org/10.1371/journal.pone.0003389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852887	Green Submitted, Green Published, gold			2022-12-25	WOS:000265121600012
J	Mack, B; Gires, O				Mack, Brigitte; Gires, Olivier			CD44s and CD44v6 Expression in Head and Neck Epithelia	PLOS ONE			English	Article								Background: CD44 splice variants are long-known as being associated with cell transformation. Recently, the standard form of CD44 (CD44s) was shown to be part of the signature of cancer stem cells (CSCs) in colon, breast, and in head and neck squamous cell carcinomas (HNSCC). This is somewhat in contradiction to previous reports on the expression of CD44s in HNSCC. The aim of the present study was to clarify the actual pattern of CD44 expression in head and neck epithelia. Methods: Expression of CD44s and CD44v6 was analysed by immunohistochemistry with specific antibodies in primary head and neck tissues. Scoring of all specimens followed a two-parameters system, which implemented percentages of positive cells and staining intensities from - to +++ (score = % x intensity; resulting max. score 300). In addition, cell surface expression of CD44s and CD44v6 was assessed in lymphocytes and HNSCC. Results: In normal epithelia CD44s and CD44v6 were expressed in 60-95% and 50-80% of cells and yielded mean scores with a standard error of a mean (SEM) of 249.5 +/- 14.5 and 198 +/- 11.13, respectively. In oral leukoplakia and in moderately differentiated carcinomas CD44s and CD44v6 levels were slightly increased (278.9 +/- 7.16 and 242 +/- 11.7; 291.8 +/- 5.88 and 287.3 +/- 6.88). Carcinomas in situ displayed unchanged levels of both proteins whereas poorly differentiated carcinomas consistently expressed diminished CD44s and CD44v6 levels. Lymphocytes and HNSCC lines strongly expressed CD44s but not CD44v6. Conclusion: CD44s and CD44v6 expression does not distinguish normal from benign or malignant epithelia of the head and neck. CD44s and CD44v6 were abundantly present in the great majority of cells in head and neck tissues, including carcinomas. Hence, the value of CD44s as a marker for the definition of a small subset of cells (i.e. less than 10%) representing head and neck cancer stem cells may need revision.	[Mack, Brigitte] Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany; [Gires, Olivier] Univ Munich, Head & Neck Res Dept, German Res Ctr Environm Hlth, Helmholtz Zent Munchen,Clin Cooperat Grp Mol Oncol, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Mack, B (corresponding author), Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.	olivier.gires@med.uni-muenchen.de	Gires, Olivier/V-2689-2017	Gires, Olivier/0000-0002-2292-7064				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Gires O, 2008, ATLAS GENET CYTOGENE; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HeroldMende C, 1996, J PATHOL, V179, P66, DOI 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5; Kawano T, 2004, AURIS NASUS LARYNX, V31, P35, DOI 10.1016/j.anl.2003.09.005; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Marhaba R, 2005, CELL SIGNAL, V17, P961, DOI 10.1016/j.cellsig.2004.11.017; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pries R, 2008, IN VIVO, V22, P89; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Reichart PA, 2005, ORAL ONCOL, V41, P551, DOI 10.1016/j.oraloncology.2004.12.003; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Soukka T, 1997, CANCER RES, V57, P2281; Staibano S, 2007, BRIT J CANCER, V97, P1545, DOI 10.1038/sj.bjc.6604070; TROWBRIDGE IS, 1982, IMMUNOGENETICS, V15, P299, DOI 10.1007/BF00364338; Van Hal NLW, 1999, INT J CANCER, V82, P837, DOI 10.1002/(SICI)1097-0215(19990909)82:6<837::AID-IJC12>3.3.CO;2-8; Van Hal NLW, 1999, CLIN CANCER RES, V5, P3534; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464	30	121	126	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3360	10.1371/journal.pone.0003360	http://dx.doi.org/10.1371/journal.pone.0003360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18852874	Green Published, gold			2022-12-25	WOS:000265114100005
J	Dowd, SE; Wolcott, RD; Sun, Y; McKeehan, T; Smith, E; Rhoads, D				Dowd, Scot E.; Wolcott, Randall D.; Sun, Yan; McKeehan, Trevor; Smith, Ethan; Rhoads, Daniel			Polymicrobial Nature of Chronic Diabetic Foot Ulcer Biofilm Infections Determined Using Bacterial Tag Encoded FLX Amplicon Pyrosequencing (bTEFAP)	PLOS ONE			English	Article								Background: Diabetic extremity ulcers are associated with chronic infections. Such ulcer infections are too often followed by amputation because there is little or no understanding of the ecology of such infections or how to control or eliminate this type of chronic infection. A primary impediment to the healing of chronic wounds is biofilm phenotype infections. Diabetic foot ulcers are the most common, disabling, and costly complications of diabetes. Here we seek to derive a better understanding of the polymicrobial nature of chronic diabetic extremity ulcer infections. Methods and Findings: Using a new bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP) approach we have evaluated the bacterial diversity of 40 chronic diabetic foot ulcers from different patients. The most prevalent bacterial genus associated with diabetic chronic wounds was Corynebacterium spp. Findings also show that obligate anaerobes including Bacteroides, Peptoniphilus, Fingoldia, Anaerococcus, and Peptostreptococcus spp. are ubiquitous in diabetic ulcers, comprising a significant portion of the wound biofilm communities. Other major components of the bacterial communities included commonly cultured genera such as Streptococcus, Serratia, Staphylococcus and Enterococcus spp. Conclusions: In this article, we highlight the patterns of population diversity observed in the samples and introduce preliminary evidence to support the concept of functional equivalent pathogroups (FEP). Here we introduce FEP as consortia of genotypically distinct bacteria that symbiotically produce a pathogenic community. According to this hypothesis, individual members of these communities when they occur alone may not cause disease but when they coaggregate or consort together into a FEP the synergistic effect provides the functional equivalence of well-known pathogens, such as Staphylococcus aureus, giving the biofilm community the factors necessary to maintain chronic biofilm infections. Further work is definitely warranted and needed in order to prove whether the FEPs concept is a viable hypothesis. The findings here also suggest that traditional culturing methods may be extremely biased as a diagnostic tool as they select for easily cultured organisms such as Staphylococcus aureus and against difficult to culture bacteria such as anaerobes. While PCR methods also have bias, further work is now needed in comparing traditional culture results to high-resolution molecular diagnostic methods such as bTEFAP.	[Dowd, Scot E.; Sun, Yan; McKeehan, Trevor] Res & Testing Lab, Lubbock, TX USA; [Wolcott, Randall D.; Rhoads, Daniel] Southwest Region Wound Care Ctr, Lubbock, TX USA; [Dowd, Scot E.; Smith, Ethan] Med Biofilm Res Inst, Lubbock, TX USA		Dowd, SE (corresponding author), Res & Testing Lab, Lubbock, TX USA.	sdowd@pathogenresearch.org	Rhoads, Daniel/AAN-5250-2020; Dowd, Scot E/M-5386-2017	Rhoads, Daniel/0000-0002-7636-5191; Dowd, Scot E/0000-0002-6296-1427	Research and Testing Laboratory	Research and Testing Laboratory	Research was funded by Research and Testing Laboratory internal research funds.	Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BESSMAN AN, 1992, DIABETES CARE, V15, P1531, DOI 10.2337/diacare.15.11.1531; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Bowler P G, 1999, J Wound Care, V8, P216; Bowler PG, 1999, INT J DERMATOL, V38, P573, DOI 10.1046/j.1365-4362.1999.00738.x; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Bradshaw DJ, 1996, MICROBIOL-UK, V142, P623, DOI 10.1099/13500872-142-3-623; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; BROOK I, 1987, CRC CR REV MICROBIOL, V14, P171, DOI 10.3109/10408418709104438; Brook I, 1998, INT J DERMATOL, V37, P426, DOI 10.1046/j.1365-4362.1998.00445.x; BROOK I, 1988, SURGERY, V104, P843; CARTWRIGHT CP, 1994, J CLIN MICROBIOL, V32, P1825, DOI 10.1128/JCM.32.7.1825-1826.1994; *CDCDFWC, 1999, DIABETES CARE, V22, P1354; CEILLEY RI, 1977, ARCH DERMATOL, V113, P646, DOI 10.1001/archderm.113.5.646; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davis Stephen C, 2006, Curr Diab Rep, V6, P439, DOI 10.1007/s11892-006-0076-x; Dowd SE, 2007, FOODBORNE PATHOG DIS, V4, P187, DOI 10.1089/fpd.2006.0075; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; HANSSON C, 1995, ACTA DERM-VENEREOL, V75, P24; HARTEMANNHEURTI.A, 2008, DIABETES METAB; Howell-Jones RS, 2005, J ANTIMICROB CHEMOTH, V55, P143, DOI 10.1093/jac/dkh513; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; KONTIAINEN S, 1988, ACTA DERM-VENEREOL, V68, P240; MACFARLANE DE, 1986, T ROY SOC TROP MED H, V80, P553, DOI 10.1016/0035-9203(86)90137-9; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MAYRAND D, 1980, INFECT IMMUN, V27, P44, DOI 10.1128/IAI.27.1.44-50.1980; *MMWR, 2003, MMWR-MORBID MORTAL W, V52, P1098; *NAT DIAB INF CLEA, 2005, NAT DIAB STAT; Palmer RJ, 2006, J BACTERIOL, V188, P4117, DOI 10.1128/JB.01958-05; Palumbo P.J, 1985, DIABETES AM DIABETES; PECORARO RE, 1991, DIABETES, V40, P1305, DOI 10.2337/diabetes.40.10.1305; Percival SL, 2008, WOUND REPAIR REGEN, V16, P52, DOI 10.1111/j.1524-475X.2007.00350.x; Ramsey SD, 1999, PHARMACOECONOMICS, V16, P285, DOI 10.2165/00019053-199916030-00005; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Rasmussen K, 1998, BIOTECHNOL BIOENG, V59, P302, DOI 10.1002/(SICI)1097-0290(19980805)59:3<302::AID-BIT6>3.0.CO;2-F; ROTSTEIN OD, 1988, CAN J MICROBIOL, V34, P352, DOI 10.1139/m88-064; SMITH ADAM, 2004, WOUND CARE PRACTICE, P3; SUNDQVIST GK, 1979, INFECT IMMUN, V25, P685, DOI 10.1128/IAI.25.2.685-693.1979; Trengove N J, 1996, J Wound Care, V5, P277; Urbancic-Rovan V, 2000, DIABETIC MED, V17, P814, DOI 10.1046/j.1464-5491.2000.00374-2.x; von Graevenitz A, 1998, INFECTION, V26, P40; WHEAT LJ, 1986, ARCH INTERN MED, V146, P1935, DOI 10.1001/archinte.146.10.1935; Wolcott R D, 2008, J Wound Care, V17, P145; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682	52	374	389	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3326	10.1371/journal.pone.0003326	http://dx.doi.org/10.1371/journal.pone.0003326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833331	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797400004
J	Antony, J; Kellershohn, K; Mohr-Andra, M; Kebig, A; Prilla, S; Muth, M; Heller, E; Disingrini, T; Dallanoce, C; Bertoni, S; Schrobang, J; Trankle, C; Kostenis, E; Christopoulos, A; Holtje, HD; Barocelli, E; De Amici, M; Holzgrabe, U; Mohr, K				Antony, Johannes; Kellershohn, Kerstin; Mohr-Andrae, Marion; Kebig, Anna; Prilla, Stefanie; Muth, Mathias; Heller, Eberhard; Disingrini, Teresa; Dallanoce, Clelia; Bertoni, Simona; Schrobang, Jasmin; Traenkle, Christian; Kostenis, Evi; Christopoulos, Arthur; Hoeltje, Hans-Dieter; Barocelli, Elisabetta; De Amici, Marco; Holzgrabe, Ulrike; Mohr, Klaus			Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity	FASEB JOURNAL			English	Article						agonism; allosterism; muscarinic acetylcholine receptor; signal trafficking; subtype selectivity; dynamic mass redistribution	MUSCARINIC ACETYLCHOLINE-RECEPTORS; PROTEIN-COUPLED RECEPTORS; COMMON ALLOSTERIC SITE; 7-TRANSMEMBRANE RECEPTORS; MOLECULAR-MECHANISMS; LIGAND-BINDING; OXOTREMORINE-M; M-2 RECEPTOR; AMINO-ACIDS; MODULATORS	Selective modulation of cell function by G protein-coupled receptor (GPCR) activation is highly desirable for basic research and therapy but difficult to achieve. We present a novel strategy toward this goal using muscarinic acetylcholine receptors as a model. The five subtypes bind their physiological transmitter in the highly conserved orthosteric site within the transmembrane domains of the receptors. Orthosteric muscarinic activators have no binding selectivity and poor signaling specificity. There is a less well conserved allosteric site at the extracellular entrance of the binding pocket. To gain subtype-selective receptor activation, we synthesized two hybrids fusing a highly potent oxotremorine-like orthosteric activator with M-2-selective bis(ammonio)alkane-type allosteric fragments. Radioligand binding in wild-type and mutant receptors supplemented by receptor docking simulations proved M-2 selective and true allosteric/orthosteric binding. G protein activation measurements using orthosteric and allosteric blockers identified the orthosteric part of the hybrid to engender receptor activation. Hybrid-induced dynamic mass redistribution in CHO-hM(2) cells disclosed pathway-specific signaling. Selective receptor activation (M-2>M-1>M-3) was verified in living tissue preparations. As allosteric sites are increasingly recognized on GPCRs, the dualsteric concept of GPCR targeting represents a new avenue toward potent agonists for selective receptor and signaling pathway activation. - Antony, J., Kellershohn, K., Mohr-Andra, M., Kebig, A., Prilla, S., Muth, M., Heller, E., Disingrini, T., Dallanoce, C., Bertoni, S., Schrobang, J., Trankle, C., Kostenis, E., Christopoulos, A., Holtje, H.-D., Barocelli, E., De Amici, M., Holzgrabe, U., Mohr, K. Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity. FASEB J. 23, 442-450 (2009)	[Antony, Johannes; Kellershohn, Kerstin; Mohr-Andrae, Marion; Kebig, Anna; Prilla, Stefanie; Traenkle, Christian; Mohr, Klaus] Univ Bonn, Pharmacol & Toxicol Sect, Inst Pharm, D-53121 Bonn, Germany; [Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, D-53121 Bonn, Germany; [Muth, Mathias; Heller, Eberhard; Holzgrabe, Ulrike] Univ Wurzburg, Dept Pharmaceut Chem, Inst Pharm, Wurzburg, Germany; [Disingrini, Teresa; Dallanoce, Clelia; De Amici, Marco] Univ Milan, Inst Med & Toxicol Chem Pietro Pratesi, Milan, Italy; [Bertoni, Simona; Barocelli, Elisabetta] Univ Parma, Dept Pharmacol Biol & Appl Chem Sci, I-43100 Parma, Italy; [Schrobang, Jasmin; Hoeltje, Hans-Dieter] Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Christopoulos, Arthur] Monash Univ, Drug Discovery Biol Lab, Dept Pharmacol, Clayton, Vic 3800, Australia	University of Bonn; University of Bonn; University of Wurzburg; University of Milan; University of Parma; Heinrich Heine University Dusseldorf; Monash University	Mohr, K (corresponding author), Univ Bonn, Pharmacol & Toxicol Sect, Inst Pharm, Gerhard Domagk Str 3, D-53121 Bonn, Germany.	k.mohr@uni-bonn.de	Christopoulos, Arthur/B-6207-2013; Barocelli, Elisabetta/C-4509-2013; Bertoni, Simona/AAJ-8961-2020; De Amici, Marco/F-9684-2015	Christopoulos, Arthur/0000-0003-4442-3294; Dallanoce, Clelia/0000-0002-7383-1484; Holzgrabe, Ulrike/0000-0002-0364-7278; De Amici, Marco/0000-0002-0236-0662	Deutsche Forschungsgemeinschaft (DFG); University of Milan [MO821/1-4, HO1368/7-4]; DFG-funded research training group [GRK677]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Milan; DFG-funded research training group(German Research Foundation (DFG))	The work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG) to K.M. and U.H. (MO821/1-4, HO1368/7-4) and a grant from the University of Milan to M.D.A. (FIRST 2006). J.A. received a scholarship of the DFG-funded research training group GRK677. E.K. and K. M. are members of Bonn University Center for Innovative Drugs and Therapies. The skillful laboratory work of S. Jepards (GRK677-funded undergraduate research student) is acknowledged. A.C. is a Senior Research Fellow of the National Health and Medical Research Council of Australia. We thank Corning Life Sciences for making the Epic system available to us.	Barocelli E, 2000, LIFE SCI, V67, P717, DOI 10.1016/S0024-3205(00)00661-5; Birdsall NJM, 2005, MINI-REV MED CHEM, V5, P523, DOI 10.2174/1389557054023251; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Dallanoce C, 1999, BIOORGAN MED CHEM, V7, P1539, DOI 10.1016/S0968-0896(99)00107-8; Disingrini T, 2006, J MED CHEM, V49, P366, DOI 10.1021/jm050769s; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Fang Ye, 2007, Journal of Pharmacological and Toxicological Methods, V55, P314, DOI 10.1016/j.vascn.2006.11.001; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; FURCHGOTT RF, 1967, ANN NY ACAD SCI, V144, P882, DOI 10.1111/j.1749-6632.1967.tb53817.x; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; HILF G, 1989, EUR J BIOCHEM, V186, P725, DOI 10.1111/j.1432-1033.1989.tb15266.x; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kostenis E, 1996, TRENDS PHARMACOL SCI, V17, P280, DOI 10.1016/0165-6147(96)10034-1; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Lanzafame A, 1996, EUR J PHARMACOL, V316, P27, DOI 10.1016/S0014-2999(96)00639-5; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Mistry R, 2005, BRIT J PHARMACOL, V144, P566, DOI 10.1038/sj.bjp.0706090; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Raasch A, 2002, J MED CHEM, V45, P3809, DOI 10.1021/jm020871e; Shirey JK, 2008, NAT CHEM BIOL, V4, P42, DOI 10.1038/nchembio.2007.55; STOCKTON JM, 1983, MOL PHARMACOL, V23, P551; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Trankle C, 2005, MOL PHARMACOL, V68, P1597, DOI 10.1124/mol.105.017707; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; Trankle C, 1998, MOL PHARMACOL, V53, P304, DOI 10.1124/mol.53.2.304; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Wess J, 2005, MOL PHARMACOL, V68, P1506, DOI 10.1124/mol.105.019141; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379	35	112	114	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					442	450		10.1096/fj.08-114751	http://dx.doi.org/10.1096/fj.08-114751			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18842964				2022-12-25	WOS:000262892900016
J	Graham, JD; Hanson, AR; Croft, AJ; Fox, AH; Clarke, CL				Graham, J. Dinny; Hanson, Adrienne R.; Croft, Amanda J.; Fox, Archa H.; Clarke, Christine L.			Nuclear matrix binding is critical for progesterone receptor movement into nuclear foci	FASEB JOURNAL			English	Article						intranuclear trafficking; breast cancer	GLUCOCORTICOID-RECEPTOR; ESTROGEN-RECEPTOR; LIVING CELLS; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; SUBNUCLEAR DISTRIBUTION; BIOLOGICAL-CONTROL; ANDROGEN RECEPTOR; LIGAND; LOCALIZATION	The ovarian hormone progesterone is essential for normal breast development, and progesterone analogues are implicated in increasing breast cancer risk. The progesterone receptor (PR) is a transcription factor that, when ligand activated, moves rapidly into nuclear foci associated with transcriptional activity. However, the role of intranuclear trafficking signals in the focal location of PR is unknown. We have identified a mutation in PR that ablates its binding to the nuclear matrix and prevents PR movement into nuclear foci. Nuclear matrix binding mutants lack transcriptional activity and inhibit dimerization, demonstrating the critical role of matrix binding for PR dynamics and activity. DNA binding of PR is required for fidelity of location in foci, as DNA binding domain (DBD) mutants form aberrant foci with reduced mobility and altered tethering to the nucleus. Mutations in either the nuclear matrix targeting sequence or DBD domains were dominant in preventing wild-type receptor from moving to appropriate nuclear locations, demonstrating that both partner proteins in a PR dimer must have intact intranuclear trafficking signals for correct receptor positioning within the nucleus. This study has demonstrated that positioning of PR in foci within the nucleus is critically regulated by intranuclear trafficking signals, which play a key role in transcriptional activity and are relevant to its action in normal and malignant breast cells.-Graham, J. D., Hanson, A. R., Croft, A. C., Fox, A. H., Clarke, C. L. Nuclear matrix binding is critical for progesterone receptor movement into nuclear foci. FASEB J. 23, 546-556 (2009)	[Graham, J. Dinny; Croft, Amanda J.; Clarke, Christine L.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Hanson, Adrienne R.; Fox, Archa H.] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Perth, WA 6009, Australia	University of Sydney; Westmead Institute for Medical Research; University of Western Australia	Clarke, CL (corresponding author), Westmead Millennium Inst, Westmead Inst Canc Res, Darcy Rd, Westmead, NSW 2145, Australia.	christine_clarke@wmi.usyd.edu.au	Fox, Archa H/H-9219-2014; Clarke, Christine/B-7127-2009	Fox, Archa H/0000-0003-1962-270X; Clarke, Christine/0000-0001-7568-111X	National Health and Medical Research Council of Australia; National Breast Cancer Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	These studies were supported by grants from the National Health and Medical Research Council of Australia and the National Breast Cancer Foundation.	Arnett-Mansfield RL, 2007, MOL ENDOCRINOL, V21, P14, DOI 10.1210/me.2006-0041; Arnett-Mansfield RL, 2004, J CLIN ENDOCR METAB, V89, P1429, DOI 10.1210/jc.2003-031111; BARRACK ER, 1983, ENDOCRINOLOGY, V113, P430, DOI 10.1210/endo-113-1-430; Conneely OM, 2003, STEROIDS, V68, P771, DOI 10.1016/S0039-128X(03)00126-0; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; DeFranco DB, 2000, CRIT REV EUKAR GENE, V10, P39; DeFranco DB, 2002, MOL ENDOCRINOL, V16, P1449, DOI 10.1210/me.16.7.1449; DEMARZO AM, 1991, P NATL ACAD SCI USA, V88, P72, DOI 10.1073/pnas.88.1.72; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; GRONEMEYER H, 1991, ANNU REV GENET, V25, P89, DOI 10.1146/annurev.ge.25.120191.000513; GUIOCHONMANTEL A, 1991, EMBO J, V10, P3851, DOI 10.1002/j.1460-2075.1991.tb04954.x; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Li XT, 2004, MECH AGEING DEV, V125, P669, DOI 10.1016/j.mad.2004.04.007; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Martin S, 2003, CHROMOSOME RES, V11, P461, DOI 10.1023/A:1024926710797; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; METZGER DA, 1990, ENDOCRINOLOGY, V126, P2190, DOI 10.1210/endo-126-4-2190; Milhon J, 1997, MOL ENDOCRINOL, V11, P1795, DOI 10.1210/me.11.12.1795; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Mote PA, 1999, J CLIN ENDOCR METAB, V84, P2963, DOI 10.1210/jc.84.8.2963; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2003, STEROIDS, V68, P953, DOI 10.1016/S0039-128X(03)00138-7; SCHUCHARD M, 1991, BIOCHEMISTRY-US, V30, P9516, DOI 10.1021/bi00103a019; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; TAKIMOTO GS, 1992, P NATL ACAD SCI USA, V89, P3050, DOI 10.1073/pnas.89.7.3050; Tang YT, 1996, MOL CELL BIOL, V16, P1989; Tang YT, 1998, MOL ENDOCRINOL, V12, P1420, DOI 10.1210/me.12.9.1420; Tetel MJ, 1997, MOL ENDOCRINOL, V11, P1114, DOI 10.1210/me.11.8.1114; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; VANSTEENSEL B, 1995, J CELL SCI, V108, P3003; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Zaidi SK, 2007, NAT REV CANCER, V7, P454, DOI 10.1038/nrc2149; Zaidi SK, 2004, J BIOL CHEM, V279, P43363, DOI 10.1074/jbc.R400020200; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	47	8	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					546	556		10.1096/fj.08-113639	http://dx.doi.org/10.1096/fj.08-113639			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18931262				2022-12-25	WOS:000262892900026
J	Gunning, AP; Bongaerts, RJM; Morris, VJ				Gunning, A. Patrick; Bongaerts, Roy J. M.; Morris, Victor J.			Recognition of galactan components of pectin by galectin-3	FASEB JOURNAL			English	Article						flow cytometry; AFM; antimetastasis activity; polygalacturonic acid; RGI	ATOMIC-FORCE MICROSCOPY; HUMAN BREAST-CARCINOMA; RHAMNOGALACTURONAN-I; CITRUS PECTIN; CELL-ADHESION; APOPTOSIS; ARABINOGALACTAN; INHIBITORS; CANCER; POLYSACCHARIDES	It has been reported that modified forms of pectin possess anticancer activity. To account for this bioactivity, it has been proposed that fragments of pectin molecules can act by binding to and inhibiting the various roles of the mammalian protein galectin 3 (Gal3) in cancer progression and metastasis. Despite this clear molecular hypothesis and evidence for the bioactivity of modified pectin, the structural origins of the "bioactive fragments" of pectin molecules are currently ill defined. By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin galactan to the recombinant form of human Gal3. Present studies suggest that bioactivity resides in the neutral sugar side chains of pectin polysaccharides and that these components could be isolated and modified to optimize bioactivity. - Gunning, A. P., Bongaerts, R. J. M., Morris, V. J. Recognition of galactan components of pectin by galectin-3. FASEB J. 23, 415-424 (2009)	[Gunning, A. Patrick; Bongaerts, Roy J. M.; Morris, Victor J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Gunning, AP (corresponding author), Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	patrick.gunning@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; BEUTH J, 1988, CLIN EXP METASTAS, V6, P115, DOI 10.1007/BF01784842; BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3; Birdsall B, 2001, BIOCHEMISTRY-US, V40, P4859, DOI 10.1021/bi002907f; Collins PM, 2007, ACTA CRYSTALLOGR D, V63, P415, DOI 10.1107/S090744490605270X; COLQUHOUN IJ, 1990, CARBOHYD RES, V206, P131, DOI 10.1016/0008-6215(90)84012-J; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Gunning AP, 2008, FASEB J, V22, P2331, DOI 10.1096/fj.07-100578; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; INOHARA H, 1995, CANCER RES, V55, P3267; Kuwabara I, 1996, J IMMUNOL, V156, P3939; LEROUGE P, 1993, CARBOHYD RES, V243, P359, DOI 10.1016/0008-6215(93)87039-U; Mazurek N, 2007, J BIOL CHEM, V282, P21337, DOI 10.1074/jbc.M608810200; MEYER G, 1988, APPL PHYS LETT, V53, P1045, DOI 10.1063/1.100061; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Nangia-Makker P, 2002, TRENDS MOL MED, V8, P187, DOI 10.1016/S1471-4914(02)02295-5; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Obro J, 2004, PHYTOCHEMISTRY, V65, P1429, DOI 10.1016/j.phytochem.2004.05.002; Olano-Martin E, 2003, ANTICANCER RES, V23, P341; Parris M. Kidd, 1996, ALTERN MED REV, V1, P4; PIENTA KJ, 1995, J NATL CANCER I, V87, P348, DOI 10.1093/jnci/87.5.348; PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438; Renard CMGC, 1996, CARBOHYD RES, V286, P139, DOI 10.1016/0008-6215(96)00056-0; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Sathisha UV, 2007, GLYCOCONJUGATE J, V24, P497, DOI 10.1007/s10719-007-9042-3; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Sorme P, 2003, METHOD ENZYMOL, V363, P157; Sorme PA, 2003, FASEB J, V17, pA162; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; THIBAULT JF, 1993, CARBOHYD RES, V238, P271, DOI 10.1016/0008-6215(93)87019-O; Touhami A, 2003, MICROBIOL-SGM, V149, P2873, DOI 10.1099/mic.0.26431-0; Touhami A, 2003, LANGMUIR, V19, P1745, DOI 10.1021/la026145w; UHLENBRUCK G, 1986, NATURWISSENSCHAFTEN, V73, P626, DOI 10.1007/BF00368781; Warfield PR, 1997, INVAS METAST, V17, P101; WONG CK, 1994, J INT MED RES, V22, P299, DOI 10.1177/030006059402200601; Yapo BM, 2007, CARBOHYD POLYM, V69, P426, DOI 10.1016/j.carbpol.2006.12.024; Zubieta MR, 2006, AM J PATHOL, V168, P1666, DOI 10.2353/ajpath.2006.050971	40	121	128	2	42	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					415	424		10.1096/fj.08-106617	http://dx.doi.org/10.1096/fj.08-106617			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18832596				2022-12-25	WOS:000262892900013
J	Mallappa, C; Singh, A; Ram, H; Chattopadhyay, S				Mallappa, Chandrashekara; Singh, Aparna; Ram, Hathi; Chattopadhyay, Sudip			GBF1, a Transcription Factor of Blue Light Signaling in Arabidopsis, Is Degraded in the Dark by a Proteasome-mediated Pathway Independent of COP1 and SPA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOCHROME-A; BZIP PROTEINS; GENE-EXPRESSION; HIGHER-PLANTS; PHOTOMORPHOGENIC GROWTH; G-BOX; HY5; TRANSDUCTION; RECEPTORS; ELEMENTS	Arabidopsis GBF1/ZBF2 is a bZIP transcription factor that plays dual but opposite regulatory roles in cryptochrome-mediated blue light signaling. Here, we show the genetic and molecular interrelation of GBF1 with two well characterized negative regulators of light signaling, COP1 and SPA1, in photomorphogenic growth and light-regulated gene expression. Our results further reveal that GBF1 protein is less abundant in the dark-grown seedlings and is degraded by a proteasome-mediated pathway independent of COP1 and SPA1. Furthermore, COP1 physically interacts with GBF1 and is required for the optimum accumulation of GBF1 protein in light-grown seedlings. Taken together, this study provides a mechanistic view of concerted function of three important regulators in Arabidopsis seedling development.	[Mallappa, Chandrashekara; Singh, Aparna; Ram, Hathi; Chattopadhyay, Sudip] Natl Inst Plant Genome Res, Lab 101, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, S (corresponding author), Natl Inst Plant Genome Res, Lab 101, Aruna Asaf Ali Marg, New Delhi 110067, India.	sudipchatto@yahoo.com	Singh, Aparna/D-3237-2011; Chattopadhyay, Sudip/P-8491-2014	Ram, Dr Hasthi/0000-0003-0893-3895	Dept. of Science and Technology, Government of India	Dept. of Science and Technology, Government of India	This work is supported in part by a Ramanna Fellowship grant from the Dept. of Science and Technology, Government of India (to S. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Baumgardt RL, 2002, PLANTA, V215, P745, DOI 10.1007/s00425-002-0801-x; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chattopadhyay S, 1998, PLANT J, V15, P69, DOI 10.1046/j.1365-313X.1998.00180.x; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Fittinghoff K, 2006, PLANT J, V47, P577, DOI 10.1111/j.1365-313X.2006.02812.x; FOSTER R, 1994, FASEB J, V8, P192, DOI 10.1096/fasebj.8.2.8119490; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; Hoecker U, 1999, SCIENCE, V284, P496, DOI 10.1126/science.284.5413.496; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Huq E, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P151, DOI 10.1002/352760510X.ch7; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; Laubinger S, 2004, PLANT CELL, V16, P2293, DOI 10.1105/tpc.104.024216; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Mallappa C, 2006, J BIOL CHEM, V281, P22190, DOI 10.1074/jbc.M601172200; MCNELLIS TW, 1994, PLANT CELL, V6, P487, DOI 10.1105/tpc.6.4.487; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Moller SG, 2003, PLANT CELL, V15, P1111, DOI 10.1105/tpc.008649; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Puente P, 1996, EMBO J, V15, P3732, DOI 10.1002/j.1460-2075.1996.tb00743.x; Saijo Y, 2003, GENE DEV, V17, P2642, DOI 10.1101/gad.1122903; Schepens I, 2004, CURR OPIN PLANT BIOL, V7, P564, DOI 10.1016/j.pbi.2004.07.004; SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Terzaghi WB, 1997, PLANT J, V11, P967, DOI 10.1046/j.1365-313X.1997.11050967.x; Wang H., 2004, ARXIVCS010056V2, P1; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yang JP, 2005, PLANT J, V43, P131, DOI 10.1111/j.1365-313X.2005.02433.x; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205	48	33	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35772	35782		10.1074/jbc.M803437200	http://dx.doi.org/10.1074/jbc.M803437200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18930926	hybrid			2022-12-25	WOS:000261687900051
J	Li, HY; Das, A; Sibhatu, H; Jamal, J; Sligar, SG; Poulos, TL				Li, Huiying; Das, Aditi; Sibhatu, Hiruy; Jamal, Joumana; Sligar, Stephen G.; Poulos, Thomas L.			Exploring the Electron Transfer Properties of Neuronal Nitric-oxide Synthase by Reversal of the FMN Redox Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-REDUCTION POTENTIALS; FLAVOPROTEIN DOMAIN; FUNCTIONAL INTERACTIONS; FLAVIN MONONUCLEOTIDE; BACILLUS-MEGATERIUM; OUTPUT STATE; CALMODULIN; HEME; FLAVODOXIN; MECHANISM	In nitric-oxide synthase ( NOS) the FMN can exist as the fully oxidized ( ox), the one-electron reduced semiquinone (sq), or the two-electron fully reduced hydroquinone (hq). InNOS and microsomal cytochrome P450 reductase the sq/hq redox potential is lower than that of the ox/sq couple, and hence it is the hq form of FMN that delivers electrons to the heme. Like NOS, cytochrome P450BM3 has the FAD/FMN reductase fused to the C-terminal end of the heme domain, but in P450BM3 the ox/sq and sq/hq redox couples are reversed, so it is the sq that transfers electrons to the heme. This difference is due to an extra Gly residue found in the FMN binding loop in NOS compared with P450BM3. We have deleted residue Gly-810 from the FMN binding loop in neuronal NOS ( nNOS) to give Delta G810 so that the shorter binding loop mimics that in cytochrome P450BM3. As expected, the ox/sq redox potential now is lower than the sq/ hq couple. Delta G810 exhibits lower NO synthase activity but normal levels of cytochrome c reductase activity. However, unlike the wild-type enzyme, the cytochrome c reductase activity of Delta G810 is insensitive to calmodulin binding. In addition, calmodulin binding to Delta G810 does not result in a large increase in FMN fluorescence as in wild-type nNOS. These results indicate that the FMN domain in Delta G810 is locked in a unique conformation that is no longer sensitive to calmodulin binding and resembles the "on" output state of the calmodulin-boundwild-type nNOS with respect to the cytochrome c reduction activity.	[Li, Huiying; Sibhatu, Hiruy; Jamal, Joumana; Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Li, Huiying; Sibhatu, Hiruy; Jamal, Joumana; Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Li, Huiying; Sibhatu, Hiruy; Jamal, Joumana; Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Das, Aditi; Sligar, Stephen G.] Univ Illinois, Dept Biochem, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Das, Aditi; Sligar, Stephen G.] Univ Illinois, Dept Chem, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Das, Aditi; Sligar, Stephen G.] Univ Illinois, Coll Med, Urbana, IL 61801 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	poulos@uci.edu	Li, HY/G-3987-2010		National Institutes of Health [GM31756]; National Science Foundation [EEC-0647560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031756, R37GM031756, R01GM057353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31756 ( to S. G. S.) and GM57353 ( to T. L. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.Supported by National Science Foundation postdoctoral Grant EEC-0647560.	ABU SH, 1993, P NATL ACAD SCI USA, V90, P10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; ANDERSON RF, 1983, BIOCHIM BIOPHYS ACTA, V722, P158, DOI 10.1016/0005-2728(83)90169-X; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Du M, 2003, J BIOL CHEM, V278, P6002, DOI 10.1074/jbc.M209606200; DUBOURDIEU M, 1975, BIOCHIM BIOPHYS ACTA, V376, P519, DOI 10.1016/0005-2728(75)90172-3; Dutton P L, 1978, Methods Enzymol, V54, P411; EDMONDSO.DE, 1972, BIOCHEMISTRY-US, V11, P1133, DOI 10.1021/bi00757a003; ENTSCH B, 1972, ARCH BIOCHEM BIOPHYS, V151, P378, DOI 10.1016/0003-9861(72)90512-7; Feng CJ, 2006, BIOCHEMISTRY-US, V45, P6354, DOI 10.1021/bi060223n; FULCO AJ, 1991, ANNU REV PHARMACOL, V31, P177; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garnaud PE, 2004, BIOCHEMISTRY-US, V43, P11035, DOI 10.1021/bi049312v; GHISLA S, 1986, BIOCHEM J, V239, P1; Ghosh DK, 2006, J BIOL CHEM, V281, P14173, DOI 10.1074/jbc.M509937200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Hanley SC, 2004, BIOCHEM BIOPH RES CO, V325, P1418, DOI 10.1016/j.bbrc.2004.10.189; HEVEL JM, 1991, J BIOL CHEM, V266, P22789; Hoover DM, 1999, J MOL BIOL, V294, P725, DOI 10.1006/jmbi.1999.3152; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Li HY, 2006, J BIOL INORG CHEM, V11, P753, DOI 10.1007/s00775-006-0123-8; Li HY, 2002, BIOCHEMISTRY-US, V41, P13868, DOI 10.1021/bi020417c; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MATSUOKA A, 1994, J BIOL CHEM, V269, P20335; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; MAYHEW SG, 1971, BIOCHIM BIOPHYS ACTA, V235, P289, DOI 10.1016/0005-2744(71)90207-5; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Murataliev MB, 1996, BIOCHEMISTRY-US, V35, P15029, DOI 10.1021/bi961667u; Murataliev MB, 1997, BIOCHEMISTRY-US, V36, P8401, DOI 10.1021/bi970026b; MURPHY ME, 1994, METHOD ENZYMOL, V233, P240; Narayanasami R, 1997, NITRIC OXIDE-BIOL CH, V1, P39, DOI 10.1006/niox.1996.0103; NARHI LO, 1986, J BIOL CHEM, V261, P7160; NARHI LO, 1987, J BIOL CHEM, V262, P6683; Nishida CR, 2001, J BIOL CHEM, V276, P20116, DOI 10.1074/jbc.M101548200; Nishino Y, 2007, ARCH BIOCHEM BIOPHYS, V465, P254, DOI 10.1016/j.abb.2007.05.021; PACE C, 1986, BIOCHEMISTRY-US, V25, P2516, DOI 10.1021/bi00357a035; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; RAMAN CS, 2000, PORPHYRIN HDB, V4, P293; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Schrammel A, 1998, BBA-PROTEIN STRUCT M, V1387, P257, DOI 10.1016/S0167-4838(98)00138-1; Sevrioukova I, 1996, BIOCHEMISTRY-US, V35, P7058, DOI 10.1021/bi960060a; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WATT W, 1991, J MOL BIOL, V218, P195, DOI 10.1016/0022-2836(91)90884-9; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804	65	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34762	34772		10.1074/jbc.M806949200	http://dx.doi.org/10.1074/jbc.M806949200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18852262	Green Published, hybrid			2022-12-25	WOS:000261469100033
J	Ritter, E; Stehfest, K; Berndt, A; Hegemann, P; Bartl, FJ				Ritter, Eglof; Stehfest, Katja; Berndt, Andre; Hegemann, Peter; Bartl, Franz J.			Monitoring Light-induced Structural Changes of Channelrhodopsin-2 by UV-visible and Fourier Transform Infrared Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FTIR DIFFERENCE SPECTROSCOPY; VIBRATIONAL SPECTROSCOPY; PHOTOPHOBIC RESPONSES; SENSORY RHODOPSIN; PROTON-TRANSFER; SCHIFF-BASE; CHLAMYDOMONAS-REINHARDTII; BACTERIORHODOPSIN MUTANTS; CONFORMATIONAL-CHANGES; DROSOPHILA LARVAE	Channelrhodopsin-2 (ChR2) is a microbial type rhodopsin and a light-gated cation channel that controls phototaxis in Chlamydomonas. We expressed ChR2 in COS-cells, purified it, and subsequently investigated this unusual photoreceptor by flash photolysis and UV-visible and Fourier transform infrared difference spectroscopy. Several transient photoproducts of the wild type ChR2 were identified, and their kinetics and molecular properties were compared with those of the ChR2 mutant E90Q. Based on the spectroscopic data we developed a model of the photocycle comprising six distinguishable intermediates. This photocycle shows similarities to the photocycle of the ChR2-related Channelrhodopsin of Volvox but also displays significant differences. We show that molecular changes include retinal isomerization, changes in hydrogen bonding of carboxylic acids, and large alterations of the protein backbone structure. These alterations are stronger than those observed in the photocycle of other microbial rhodopsins like bacteriorhodopsin and are related to those occurring in animal rhodopsins. UV-visible and Fourier transform infrared difference spectroscopy revealed two late intermediates with different time constants of tau=6 and 40 s that exist during the recovery of the dark state. The carboxylic side chain of Glu(90) is involved in the slow transition. The molecular changes during the ChR2 photocycle are discussed with respect to other members of the rhodopsin family.	[Ritter, Eglof; Bartl, Franz J.] Charite Univ Med Berlin, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Stehfest, Katja; Berndt, Andre; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Hegemann, Peter; Bartl, Franz J.] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Bartl, FJ (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys, Charite Pl 1, D-10117 Berlin, Germany.	franz.bartl@charite.de		Berndt, Andre/0000-0003-4758-5598; Hegemann, Peter/0000-0003-3589-6452	Deutsche Forschungsgemeinschaft [SFB 498]; Cluster of Excellence: Unifying Concepts in Catalysis	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence: Unifying Concepts in Catalysis(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 498 and funds from Cluster of Excellence: Unifying Concepts in Catalysis (to P.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; BOUSCHE O, 1991, BIOCHEMISTRY-US, V30, P5395, DOI 10.1021/bi00236a010; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Eaton J.W., 2002, GNU OCTAVE MANUAL; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Garczarek F, 2004, BIOPHYS J, V87, P2676, DOI 10.1529/biophysj.104.046433; GERWERT K, 1986, EMBO J, V5, P805, DOI 10.1002/j.1460-2075.1986.tb04285.x; Govorunova EG, 2004, BIOPHYS J, V86, P2342, DOI 10.1016/S0006-3495(04)74291-5; Heberle J, 2000, BIOPHYS CHEM, V85, P229, DOI 10.1016/S0301-4622(99)00154-4; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HEGEMANN P, 1991, BIOPHYS J, V60, P1477, DOI 10.1016/S0006-3495(91)82183-X; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kandori H, 2002, BIOCHEMISTRY-US, V41, P4554, DOI 10.1021/bi0120749; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LAWSON MA, 1991, BIOPHYS J, V60, P1490, DOI 10.1016/S0006-3495(91)82184-1; LECOUTRE J, 1995, P NATL ACAD SCI USA, V92, P4962, DOI 10.1073/pnas.92.11.4962; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Maeda A, 1999, BIOCHEMISTRY-US, V38, P8800, DOI 10.1021/bi9907072; MAEDA A, 1994, BIOCHEMISTRY-US, V33, P1713, DOI 10.1021/bi00173a013; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nikolic Konstantin, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1626; OESTERHELT D, 1973, EUR J BIOCHEM, V37, P316, DOI 10.1111/j.1432-1033.1973.tb02990.x; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Patzelt H, 2002, P NATL ACAD SCI USA, V99, P9765, DOI 10.1073/pnas.132253899; PFEFFERLE JM, 1991, BIOCHEMISTRY-US, V30, P6548, DOI 10.1021/bi00240a027; Ritter E, 2007, J BIOL CHEM, V282, P10720, DOI 10.1074/jbc.M610658200; ROTHSCHILD KJ, 1992, J BIOL CHEM, V267, P1615; ROTHSCHILD KJ, 1992, J BIOENERG BIOMEMBR, V24, P147, DOI 10.1007/BF00762674; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Siebert F, 1995, ISRAEL J CHEM, V35, P309; SIEBERT F, 1995, METHOD ENZYMOL, V246, P501; SIEBERT F, 1983, EUR J BIOCHEM, V136, P119, DOI 10.1111/j.1432-1033.1983.tb07714.x; Siebert F., 2008, VIBRATIONAL SPECTROS; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tittor J, 2002, J MOL BIOL, V319, P555, DOI 10.1016/S0022-2836(02)00307-8; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	53	136	168	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35033	35041		10.1074/jbc.M806353200	http://dx.doi.org/10.1074/jbc.M806353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18927082	Green Published, hybrid			2022-12-25	WOS:000261469100060
J	Weinstein, MM; Yin, L; Beigneux, AP; Davies, BSJ; Gin, P; Estrada, K; Melford, K; Bishop, JR; Esko, JD; Dallinga-Thie, GM; Fong, LG; Bensadoun, A; Young, SG				Weinstein, Michael M.; Yin, Liya; Beigneux, Anne P.; Davies, Brandon S. J.; Gin, Peter; Estrada, Kristine; Melford, Kristan; Bishop, Joseph R.; Esko, Jeffrey D.; Dallinga-Thie, Geesje M.; Fong, Loren G.; Bensadoun, Andre; Young, Stephen G.			Abnormal Patterns of Lipoprotein Lipase Release into the Plasma in GPIHBP1-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; HEPARAN-SULFATE PROTEOGLYCANS; ENDOTHELIAL-CELLS; BINDING; RECEPTOR; CHYLOMICRONS; DEFICIENCY; IDENTIFICATION; LIPOLYSIS; PROTEINS	GPIHBP1-deficient mice (Gpihbp1(-/-)) exhibit severe chylomicronemia. GPIHBP1 is located within capillaries of muscle and adipose tissue, and expression of GPIHBP1 in Chinese hamster ovary cells confers upon those cells the ability to bind lipoprotein lipase (LPL). However, there has been absolutely no evidence that GPIHBP1 actually interacts with LPL in vivo. Heparin is known to release LPL from its in vivo binding sites, allowing it to enter the plasma. After an injection of heparin, we reasoned that LPL bound to GPIHBP1 in capillaries would be released very quickly, and we hypothesized that the kinetics of LPL entry into the plasma would differ in Gpihbp1(-/-) and control mice. Indeed, plasma LPL levels peaked very rapidly (within 1 min) after heparin in control mice. In contrast, plasma LPL levels in Gpihbp1(-/-) mice were much lower 1 min after heparin and increased slowly over 15 min. In keeping with that result, plasma triglycerides fell sharply within 10 min after heparin in wild-type mice, but were negligibly altered in the first 15 min after heparin in Gpihbp1(-/-) mice. Also, an injection of Intralipid released LPL into the plasma of wild-type mice but was ineffective in releasing LPL in Gpihbp1(-/-) mice. The observed differences in LPL release cannot be ascribed to different tissue stores of LPL, as LPL mass levels in tissues were similar in Gpihbp1(-/-) and control mice. The differences in LPL release after intravenous heparin and Intralipid strongly suggest that GPIHBP1 represents an important binding site for LPL in vivo.	[Weinstein, Michael M.; Yin, Liya; Beigneux, Anne P.; Davies, Brandon S. J.; Gin, Peter; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Weinstein, Michael M.; Estrada, Kristine; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Melford, Kristan; Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Bishop, Joseph R.; Dallinga-Thie, Geesje M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of California System; University of California San Diego	Fong, LG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	lfong@mednet.ucla.edu; ab55@cornell.edu; sgyoung@mednet.ucla.edu		dallinga-thie, geesje/0000-0001-5412-5923; Davies, Brandon/0000-0002-7168-8522; Young, Stephen/0000-0001-7270-3176	National Institutes of Health Postdoctoral Fellowship Awards [HL66621, HL66600, 5P01HL090553, HL087228, GM33063]; American Heart Association's National Office and Ruth L. Kirschstein Grant [0735026N, NRSA T32HL69766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, U01HL066600, U01HL066621, T32HL069766, R01HL087228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063, R01GM033063] Funding Source: NIH RePORTER	National Institutes of Health Postdoctoral Fellowship Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association's National Office and Ruth L. Kirschstein Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Postdoctoral Fellowship Awards HL66621, HL66600, 5P01HL090553 (to P. G.), HL087228 (to S. G. Y.), and GM33063 (to J. D. E.). This work was also supported by Scientist Development Award 0735026N (to A. P. B.) from the American Heart Association's National Office and Ruth L. Kirschstein Grant NRSA T32HL69766 (to M. M. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; BENSADOU.A, 1974, J BIOL CHEM, V249, P2220; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BENSADOUN A, 2007, ADIPOSE TISSUE HLTH; BRUNZELL JD, 1980, METABOLISM, V29, P624, DOI 10.1016/0026-0495(80)90106-7; BRUNZELL JD, 2001, METABOLIC MOL BASES, P2789; CARDIN AD, 1984, THROMB RES, V34, P541, DOI 10.1016/0049-3848(84)90258-5; CARDIN AD, 1987, BIOCHEMISTRY-US, V26, P5513, DOI 10.1021/bi00391a045; CHENG CF, 1981, J BIOL CHEM, V256, P2893; Gin P, 2007, BBA-MOL CELL BIOL L, V1771, P1464, DOI 10.1016/j.bbalip.2007.10.005; Goldberg IJ, 1996, J LIPID RES, V37, P693; HANSEN LM, 1976, ANN SURG, V184, P80, DOI 10.1097/00000658-197607000-00014; HAVEL RJ, 2001, METABOLIC MOL BASES, P2705; Hocquette JF, 1998, COMP BIOCHEM PHYS B, V121, P201, DOI 10.1016/S0305-0491(98)10090-1; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; KORN ED, 1955, J BIOL CHEM, V215, P15; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Obunike JC, 2001, J BIOL CHEM, V276, P8934, DOI 10.1074/jbc.M008813200; Page S, 2006, J BIOL CHEM, V281, P13931, DOI 10.1074/jbc.M600995200; Peterfy M, 2007, NAT GENET, V39, P1483, DOI 10.1038/ng.2007.24; SAXENA U, 1991, J BIOL CHEM, V266, P17516; SAXENA U, 1991, P NATL ACAD SCI USA, V88, P2254, DOI 10.1073/pnas.88.6.2254; Sendak RA, 1998, J LIPID RES, V39, P1310; Strauss JG, 2001, J BIOL CHEM, V276, P36083, DOI 10.1074/jbc.M104430200; VENIANT MM, 2007, MURINE ATHEROSCLEROS; Wang J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-23; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wu GS, 2003, J BIOL CHEM, V278, P11925, DOI 10.1074/jbc.M212736200; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	29	62	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34511	34518		10.1074/jbc.M806067200	http://dx.doi.org/10.1074/jbc.M806067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845532	Green Published, hybrid			2022-12-25	WOS:000261469100005
J	Hudson, BI; Kalea, AZ; Arriero, MD; Harja, E; Boulanger, E; D'Agati, V; Schmidt, AM				Hudson, Barry I.; Kalea, Anastasia Z.; Arriero, Maria del Mar; Harja, Evis; Boulanger, Eric; D'Agati, Vivette; Schmidt, Ann Marie			Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; NEURITE OUTGROWTH; ACTIN NUCLEATION; SURFACE RECEPTOR; SMALL GTPASE; RHO-GTPASE; PROTEIN; FORMIN; PATHWAY; BINDING	Cellular migration is a fundamental process linked to diverse pathological states such as diabetes and its complications, atherosclerosis, inflammation, and cancer. The receptor for advanced glycation end products ( RAGE) is a multiligand cell surface macromolecule which binds distinct ligands that accumulate in these settings. RAGE-ligand interaction evokes central changes in key biological properties of cells, including proliferation, generation of inflammatory mediators, and migration. Although RAGE-dependent signal transduction is critically dependent on its short cytoplasmic domain, to date the proximate mechanism by which this RAGE domain engages and stimulates cytoplasmic signaling pathways has yet to be identified. Here we show that the RAGE cytoplasmic domain interacts with Diaphanous-1 (Dia-1) both in vitro and in vivo. We employed the human RAGE cytoplasmic domain as "bait" in the yeast two-hybrid assay and identified the formin homology (FH1) domain of Dia-1 as a potential binding partner of this RAGE domain. Immunoprecipitation studies revealed that the RAGE cytoplasmic domain interacts with the FH1 domain of Dia-1. Down-regulation of Dia-1 expression by RNA interference blocks RAGE-mediated activation of Rac-1 and Cdc42 and, in parallel, RAGE ligand-stimulated cellular migration. Taken together, these findings indicate that the interaction of the RAGE cytoplasmic domain with Dia-1 is required to transduce extracellular environmental cues evoked by binding of RAGE ligands to their cell surface receptor, a chief consequence of which is Rac-1 and Cdc42 activation and cellular migration. Because RAGE and Dia-1 are implicated in the regulation of inflammatory, vascular, and transformed cell migration, these findings highlight this interaction as a novel target for therapeutic intervention in inflammation, atherosclerosis, diabetes, and cancer.	[Hudson, Barry I.; Kalea, Anastasia Z.; Arriero, Maria del Mar; Harja, Evis; Boulanger, Eric; Schmidt, Ann Marie] Columbia Univ, Med Ctr, Div Surg Sci, Dept Surg, New York, NY 10032 USA; [D'Agati, Vivette] Columbia Univ, Med Ctr, Div Surg Sci, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Schmidt, AM (corresponding author), Columbia Univ, Coll Phys & Surg, Div Surg Sci, Dept Surg, 630 W 168th St,P&S 17-401, New York, NY 10032 USA.	ams11@columbia.edu	Kalea, Anastasia Z./G-4053-2010; Hudson, Barry/B-3122-2009	Hudson, Barry/0000-0001-7647-8121; Kalea, Anastasia Z./0000-0001-5775-3984; BOULANGER, Eric/0000-0002-5204-2849	National Institutes of Health [HL60901, CA 087677]; Juvenile Diabetes Research Foundation; Surgical Research Fund; NATIONAL CANCER INSTITUTE [R01CA087677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Surgical Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60901 and CA 087677 (United States Public Health Service). This work was also funded by the Juvenile Diabetes Research Foundation and by the Surgical Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Bai CX, 2008, EMBO J, V27, P1345, DOI 10.1038/emboj.2008.70; Barbieri MA, 2004, CURR TOP MICROBIOL, V286, P1; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Gill MB, 2004, J CELL SCI, V117, P2709, DOI 10.1242/jcs.01113; Goulimari P, 2008, MOL BIOL CELL, V19, P30, DOI 10.1091/mbc.E06-11-1045; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huang JS, 2001, J CELL BIOCHEM, V81, P102, DOI 10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kislinger T, 2001, ARTERIOSCL THROM VAS, V21, P905, DOI 10.1161/01.ATV.21.6.905; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Krebs A, 2001, J CELL SCI, V114, P3663; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Satoh S, 2001, J BIOL CHEM, V276, P39290, DOI 10.1074/jbc.M107026200; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SCHMIDT AM, 1993, J CLIN INVEST, V91, P2155, DOI 10.1172/JCI116442; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wang LY, 2008, J NEUROSCI RES, V86, P1254, DOI 10.1002/jnr.21578; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23	45	242	252	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34457	34468		10.1074/jbc.M801465200	http://dx.doi.org/10.1074/jbc.M801465200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922799	Green Published, hybrid			2022-12-25	WOS:000261277700073
J	Veiga-da-Cunha, M; Vleugels, W; Maliekal, P; Matthijs, G; Van Schaftingen, E				Veiga-da-Cunha, Maria; Vleugels, Wendy; Maliekal, Pushpa; Matthijs, Gert; Van Schaftingen, Emile			Mammalian Phosphomannomutase PMM1 Is the Brain IMP-sensitive Glucose-1,6-bisphosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; GLUCOSE 1,6-BISPHOSPHATE; KINETIC-PROPERTIES; PHOSPHOGLUCOMUTASE; PHOSPHOFRUCTOKINASE; HEXOKINASE; GENE; 1,6-DIPHOSPHATE; BISPHOSPHATASE; DEHYDROGENASE	Glucose 1,6-bisphosphate (Glc-1,6-P-2) concentration in brain is much higher than what is required for the functioning of phosphoglucomutase, suggesting that this compound has a role other than as a cofactor of phosphomutases. In cell-free systems, Glc-1,6-P-2 is formed from 1,3-bisphosphoglycerate and Glc-6-P by two related enzymes: PGM2L1 (phosphoglucomutase 2-like 1) and, to a lesser extent, PGM2 (phosphoglucomutase 2). It is hydrolyzed by the IMP-stimulated brain Glc-1,6-bisphosphatase of still unknown identity. Our aim was to test whether Glc-1,6-bisphosphatase corresponds to the phosphomannomutase PMM1, an enzyme of mysterious physiological function sharing several properties with Glc1,6- bisphosphatase. We show that IMP, but not other nucleotides, stimulated by > 100-fold (K-a approximate to 20 mu M) the intrinsic Glc-1,6-bisphosphatase activity of recombinant PMM1 while inhibiting its phosphoglucomutase activity. No such effects were observed with PMM2, an enzyme paralogous to PMM1 that physiologically acts as a phosphomannomutase in mammals. Transfection of HEK293T cells with PGM2L1, but not the related enzyme PGM2, caused an approximate to 20-fold increase in the concentration of Glc-1,6-P-2. Transfection with PMM1 caused a profound decrease (> 5-fold) in Glc-1,6-P-2 in cells that were or were not cotransfected with PGM2L1. Furthermore, the concentration of Glc-1,6-P-2 in wild type mouse brain decreased with time after ischemia, where as it did not change in PMM1-deficient mouse brain. Taken together, these data show that PMM1 corresponds to the IMP-stimulated Glc-1,6-bisphosphatase and that this enzyme is responsible for the degradation of Glc- 1,6-P-2 in brain. In addition, the role of PGM2L1 as the enzyme responsible for the synthesis of the elevated concentrations of Glc- 1,6-P-2 in brain is established.	[Veiga-da-Cunha, Maria] Catholic Univ Louvain, de Duve Inst, Physiol Chem Lab, Grp Rech Metab, B-1200 Brussels, Belgium; [Vleugels, Wendy; Matthijs, Gert] Univ Leuven, Ctr Human Genet, Mol Diagnost Lab, B-3000 Louvain, Belgium	Universite Catholique Louvain; KU Leuven	Veiga-da-Cunha, M (corresponding author), Catholic Univ Louvain, de Duve Inst, Physiol Chem Lab, Grp Rech Metab, Ave Hippocrate 75, B-1200 Brussels, Belgium.	maria.veiga@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Van Schaftingen, Emile/0000-0002-6199-7647; Matthijs, Gert/0000-0001-6710-1912				ACCORSI A, 1986, MECH AGEING DEV, V36, P133, DOI 10.1016/0047-6374(86)90014-X; ACCORSI A, 1989, PREP BIOCHEM, V19, P251, DOI 10.1080/10826068908544915; BEITNER R, 1975, BIOCHIM BIOPHYS ACTA, V397, P355, DOI 10.1016/0005-2744(75)90125-4; BEITNER R, 1979, BIOCHIM BIOPHYS ACTA, V583, P266, DOI 10.1016/0304-4165(79)90434-3; BONTEMPS F, 1993, BIOCHEM J, V290, P679, DOI 10.1042/bj2900679; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Cromphout K, 2006, MOL CELL BIOL, V26, P5621, DOI 10.1128/MCB.02357-05; Cromphout K, 2005, EUR J NEUROSCI, V22, P991, DOI 10.1111/j.1460-9568.2005.04266.x; Gemayel R, 2007, FEBS J, V274, P4360, DOI 10.1111/j.1742-4658.2007.05948.x; GERBER G, 1974, EUR J BIOCHEM, V45, P39, DOI 10.1111/j.1432-1033.1974.tb03527.x; GUHA SK, 1982, J BIOL CHEM, V257, P6634; GUHA SK, 1983, BIOCHEMISTRY-US, V22, P1356, DOI 10.1021/bi00275a006; KOSTER JF, 1972, BIOCHIM BIOPHYS ACTA, V258, P763, DOI 10.1016/0005-2744(72)90177-5; KRZANOWS.J, 1969, BIOCHEM BIOPH RES CO, V34, P816, DOI 10.1016/0006-291X(69)90253-8; LELOIR LF, 1948, ARCH BIOCHEM, V19, P339; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; MARCUS CJ, 1976, J BIOL CHEM, V251, P2963; Matthijs G, 1997, NAT GENET, V16, P316, DOI 10.1038/ng0797-316; Matthijs G, 1997, GENOMICS, V40, P41, DOI 10.1006/geno.1996.4536; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Messana I, 1998, J BIOL CHEM, V273, P15329, DOI 10.1074/jbc.273.25.15329; PASSONNEAU JV, 1969, J BIOL CHEM, V244, P902; PIATTI E, 1992, ARCH BIOCHEM BIOPHYS, V293, P117, DOI 10.1016/0003-9861(92)90373-5; Pirard M, 1999, BIOCHEM J, V339, P201, DOI 10.1042/0264-6021:3390201; Pirard M, 1997, FEBS LETT, V411, P251, DOI 10.1016/S0014-5793(97)00704-7; RIJKSEN G, 1977, FEBS LETT, V80, P61, DOI 10.1016/0014-5793(77)80407-9; ROSE IA, 1975, J BIOL CHEM, V250, P3466; ROSE IA, 1974, BIOCHEM BIOPH RES CO, V59, P1333, DOI 10.1016/0006-291X(74)90460-4; ROSE ZB, 1986, TRENDS BIOCHEM SCI, V11, P253, DOI 10.1016/0968-0004(86)90188-X; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1	34	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33988	33993		10.1074/jbc.M805224200	http://dx.doi.org/10.1074/jbc.M805224200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18927083	Green Published, hybrid			2022-12-25	WOS:000261277700025
J	Watanabe, Y; Sato, K				Watanabe, Yuuki; Sato, Katsufumi			Functional Dorsoventral Symmetry in Relation to Lift-Based Swimming in the Ocean Sunfish Mola mola	PLOS ONE			English	Article								The largest (up to 2 tons) and a globally distributed teleost-the ocean sunfish Mola mola-is commonly regarded as a planktonic fish because of its unusual shape including absence of caudal fin. This common view was recently questioned because the horizontal movements of the ocean sunfish tracked by acoustic telemetry were independent of ocean currents. However, direct information regarding their locomotor performance under natural conditions is still lacking. By using multi-sensor tags, we show that sunfish indeed swam continuously with frequent vertical movements at speeds of 0.4-0.7 m s(-1), which is similar to the records of other large fishes such as salmons, marlins, and pelagic sharks. The acceleration data revealed that they stroked their dorsal and anal fins synchronously (dominant frequency, 0.3-0.6 Hz) to generate a lift-based thrust, as penguins do using two symmetrical flippers. Morphological studies of sunfish (mass, 2-959 kg) showed that the dorsal and anal fins had similar external (symmetrical shape and identical area) and internal (identical locomotory muscle mass) features; however, the muscle shape differed markedly. We conclude that ocean sunfish have functional dorsoventral symmetry with regards to the non-homologous dorsal and anal fins that act as a pair of vertical hydrofoils. Although sunfish lack a swimbladder, we found that they are neutrally buoyant independent of depth because of their subcutaneous gelatinous tissue that has low density and is incompressible. Efficient lift-based swimming in conjunction with neutral buoyancy enables sunfish to travel long distances both horizontally and vertically.	[Sato, Katsufumi] Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan; [Watanabe, Yuuki] Natl Inst Polar Res, Tokyo, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Watanabe, Y (corresponding author), Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan.	watanabe.yuuki@nipr.ac.jp	Watanabe, Yuuki/D-5079-2012	Watanabe, Yuuki/0000-0001-9731-1769	Japan Society for the Promotion of Science [19255001, Fellowships for Young Scientists]; Bio-logging Science of The University of Tokyo (UTBLS)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bio-logging Science of The University of Tokyo (UTBLS)	This work was funded by the Japan Society for the Promotion of Science (19255001), the JSPS Research Fellowships for Young Scientists (to Y.W.), and the program "Bio-logging Science of The University of Tokyo (UTBLS)" led by N. Miyazaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M.N., 1967, FUNCTIONAL DESIGN FI; Alexander RM., 2003, PRINCIPLES ANIMAL LO; Arreola VI, 1996, P ROY SOC B-BIOL SCI, V263, P1689, DOI 10.1098/rspb.1996.0247; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; BLAKE RW, 1978, J MAR BIOL ASSOC UK, V58, P73, DOI 10.1017/S0025315400024401; BLOCK BA, 1992, J EXP BIOL, V166, P267; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Cartamil DP, 2004, MAR ECOL PROG SER, V266, P245, DOI 10.3354/meps266245; CORNER EDS, 1969, PROC R SOC SER B-BIO, V171, P415, DOI 10.1098/rspb.1969.0003; Gordon MS, 1996, J FISH BIOL, V49, P319; Gregory WK, 1934, COPEIA, V4, P145; Hoerner S. F, 1965, HOERNER FLUID DYNAMI, V2nd; Hove JR, 2001, J EXP BIOL, V204, P1459; Johnson GD, 2005, J MORPHOL, V266, P11, DOI 10.1002/jmor.10242; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; KAWAKAMI Y, 2005, B TOTTORI PREF MUS, V42, P29; MAGNUSON JJ, 1970, COPEIA, P56, DOI 10.2307/1441976; McCANN CHARLES, 1961, REC DOMINION MUS, V4, P7; Nelson JS, 1994, FISHES WORLD, DOI 10.1002/9781119174844; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2008, J EXP BIOL, V211, P58, DOI 10.1242/jeb.009811; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Tanaka H, 2005, MAR ECOL PROG SER, V291, P307, DOI 10.3354/meps291307; Tanaka H, 2001, J EXP BIOL, V204, P3895; Vogel S., 1994, LIFE MOVING FLUIDS P; Walker JA, 2000, P ROY SOC B-BIOL SCI, V267, P1875, DOI 10.1098/rspb.2000.1224; Watanabe Y, 2008, J ZOOL, V275, P381, DOI 10.1111/j.1469-7998.2008.00451.x; Watanabe Y, 2004, MAR ECOL PROG SER, V279, P283, DOI 10.3354/meps279283; Webb Paul W., 1993, P47; WEBB PW, 1984, AM ZOOL, V24, P107; WEIHS D, 1973, NATURE, V245, P48, DOI 10.1038/245048a0; YANCEY PH, 1989, MAR BIOL, V103, P453, DOI 10.1007/BF00399577; Zar JH, 1999, BIOSTATISTICAL ANAL	33	38	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3446	10.1371/journal.pone.0003446	http://dx.doi.org/10.1371/journal.pone.0003446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941510	gold, Green Published, Green Submitted			2022-12-25	WOS:000265126100001
J	Wan, XF; Nguyen, T; Davis, CT; Smith, CB; Zhao, ZM; Carrel, M; Inui, K; Do, HT; Mai, DT; Jadhao, S; Balish, A; Shu, B; Luo, F; Emch, M; Matsuoka, Y; Lindstrom, SE; Cox, NJ; Nguyen, CV; Klimov, A; Donis, RO				Wan, Xiu-Feng; Nguyen, Tung; Davis, C. Todd; Smith, Catherine B.; Zhao, Zi-Ming; Carrel, Margaret; Inui, Kenjiro; Do, Hoa T.; Mai, Duong T.; Jadhao, Samadhan; Balish, Amanda; Shu, Bo; Luo, Feng; Emch, Michael; Matsuoka, Yumiko; Lindstrom, Stephen E.; Cox, Nancy J.; Nguyen, Cam V.; Klimov, Alexander; Donis, Ruben O.			Evolution of Highly Pathogenic H5N1 Avian Influenza Viruses in Vietnam between 2001 and 2007	PLOS ONE			English	Article							INFERENCE; VACCINATION; EMERGENCE; OUTBREAK; MRBAYES	Highly pathogenic avian influenza (HPAI) H5N1 viruses have caused dramatic economic losses to the poultry industry of Vietnam and continue to pose a serious threat to public health. As of June 2008, Vietnam had reported nearly one third of worldwide laboratory confirmed human H5N1 infections. To better understand the emergence, spread and evolution of H5N1 in Vietnam we studied over 300 H5N1 avian influenza viruses isolated from Vietnam since their first detection in 2001. Our phylogenetic analyses indicated that six genetically distinct H5N1 viruses were introduced into Vietnam during the past seven years. The H5N1 lineage that evolved following the introduction in 2003 of the A/duck/Hong Kong/821/2002-like viruses, with clade 1 hemagglutinin (HA), continued to predominate in southern Vietnam as of May 2007. A virus with a clade 2.3.4 HA newly introduced into northern Vietnam in 2007, reassorted with pre-existing clade 1 viruses, resulting in the emergence of novel genotypes with neuraminidase (NA) and/or internal gene segments from clade 1 viruses. A total of nine distinct genotypes have been present in Vietnam since 2001, including five that were circulating in 2007. At least four of these genotypes appear to have originated in Vietnam and represent novel H5N1 viruses not reported elsewhere. Geographic and temporal analyses of H5N1 infection dynamics in poultry suggest that the majority of viruses containing new genes were first detected in northern Vietnam and subsequently spread to southern Vietnam after reassorting with pre-existing local viruses in northern Vietnam. Although the routes of entry and spread of H5N1 in Vietnam remain speculative, enhanced poultry import controls and virologic surveillance efforts may help curb the entry and spread of new HPAI viral genes.	[Wan, Xiu-Feng; Davis, C. Todd; Smith, Catherine B.; Zhao, Zi-Ming; Jadhao, Samadhan; Balish, Amanda; Shu, Bo; Matsuoka, Yumiko; Lindstrom, Stephen E.; Cox, Nancy J.; Klimov, Alexander; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Wan, Xiu-Feng; Zhao, Zi-Ming] Georgia Inst Technol, Sch Biol, Atlanta, GA USA; [Nguyen, Tung; Inui, Kenjiro; Do, Hoa T.; Mai, Duong T.; Nguyen, Cam V.] Natl Ctr Vet Diagnost, Dept Anim Hlth, Hanoi, Vietnam; [Carrel, Margaret; Emch, Michael] Univ N Carolina, Dept Geography, Chapel Hill, NC USA; [Inui, Kenjiro] Food & Agr Org Vietnam, Hanoi, Vietnam; [Luo, Feng] Clemson Univ, Sch Comput, Clemson, SC 29631 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; Food & Agriculture Organization of the United Nations (FAO); Clemson University	Wan, XF (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	rvd6@cdc.gov			Centers for Disease Control and Prevention; NSF [BCS-0717688, EPS-0447660]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NSF(National Science Foundation (NSF))	This work was funded in part by the Centers for Disease Control and Prevention. ME and XFW were partially supported by NSF Award BCS-0717688 and FL by NSF EPSCoT grant EPS-0447660.	Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Bao YM, 2004, J VIROL, V78, P7291, DOI 10.1128/JVI.78.14.7291-7298.2004; Capua I, 2007, VACCINE, V25, P4987, DOI 10.1016/j.vaccine.2007.01.113; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; CHEN H, 2006, P NATL ACAD SCI US; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Ellis TM, 2004, AVIAN PATHOL, V33, P405, DOI 10.1080/03079450410001724012; *FAO, 2006, BIRD FLU OUTBR CONT; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; SWOFFORD DL, 1998, PAUP PHYLOGENIC ANAL; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Wan X-F., 1998, ISOLATION CHARACTERI; Wan XF, 2005, ARCH VIROL, V150, P1257, DOI 10.1007/s00705-004-0474-9; WAN XF, 2008, J BIOINFORM IN PRESS; Wan XF, 2007, BIOINFORMATICS, V23, P2368, DOI 10.1093/bioinformatics/btm354; Wan YF, 2007, AVIAN DIS, V51, P434, DOI 10.1637/7625-042706R1.1; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; *WHO, 2007, CUM NUMB CONF HUM CA; *WHO, 2008, EMERG INFECT DIS JUL; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhao ZM, 2008, J GEN VIROL, V89, P2182, DOI 10.1099/vir.0.2008/001875-0; Zwickl D., 2006, GARLI GENETIC ALGORI	37	95	97	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3462	10.1371/journal.pone.0003462	http://dx.doi.org/10.1371/journal.pone.0003462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941631	Green Published, gold, Green Submitted			2022-12-25	WOS:000265125900006
J	Alelu-Paz, R; Iturrieta-Zuazo, I; Byne, W; Haroutunian, V; Garcia-Villanueva, M; Rabano, A; Garcia-Amado, M; Prensa, L; Gimenez-Amaya, JM				Alelu-Paz, Raul; Iturrieta-Zuazo, Ignacio; Byne, William; Haroutunian, Vahram; Garcia-Villanueva, Mercedes; Rabano, Alberto; Garcia-Amado, Maria; Prensa, Lucia; Manuel Gimenez-Amaya, Jose			A New Antigen Retrieval Technique for Human Brain Tissue	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; SUBSTANCE-P; MONOCLONAL-ANTIBODIES; FORMALIN FIXATION; NUCLEAR ANTIGEN; IMMUNOHISTOCHEMISTRY; PARAFFIN; PROTEIN; HEAT; IMMUNOREACTIVITY	Immunohistochemical staining of tissues is a powerful tool used to delineate the presence or absence of an antigen. During the last 30 years, antigen visualization in human brain tissue has been significantly limited by the masking effect of fixatives. In the present study, we have used a new method for antigen retrieval in formalin-fixed human brain tissue and examined the effectiveness of this protocol to reveal masked antigens in tissues with both short and long formalin fixation times. This new method, which is based on the use of citraconic acid, has not been previously utilized in brain tissue although it has been employed in various other tissues such as tonsil, ovary, skin, lymph node, stomach, breast, colon, lung and thymus. Thus, we reported here a novel method to carry out immunohistochemical studies in free-floating human brain sections. Since fixation of brain tissue specimens in formaldehyde is a commonly method used in brain banks, this new antigen retrieval method could facilitate immunohistochemical studies of brains with prolonged formalin fixation times.	[Alelu-Paz, Raul; Iturrieta-Zuazo, Ignacio; Garcia-Amado, Maria; Prensa, Lucia; Manuel Gimenez-Amaya, Jose] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain; [Iturrieta-Zuazo, Ignacio; Garcia-Amado, Maria] Univ Navarra, Clin Univ, Lab Neuromorfol Funcion, E-31080 Pamplona, Spain; [Byne, William; Haroutunian, Vahram] Mount Sinai Sch Med, Dept Psychiat, New York, NY USA; [Byne, William; Haroutunian, Vahram] Bronx Vet Affairs Med Ctr, Bronx, NY USA; [Garcia-Villanueva, Mercedes] Hosp Ramon & Cajal, Dept Anat Patol, Madrid, Spain; [Rabano, Alberto] Hosp Alcorcon, Lab Neuropatol, Madrid, Spain	Autonomous University of Madrid; University of Navarra; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Hospital Universitario Ramon y Cajal; Alcorcon Foundation University Hospital	Alelu-Paz, R (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain.	josemanuel.gimenezamaya@uam.es	byne, william/AAS-2338-2021; Waldvogel, Henry/D-6691-2012; Garcia-Amado Sancho, Maria/K-2705-2014	Alelu-Paz, Raul/0000-0002-3686-6506; Waldvogel, Henry/0000-0003-2165-8568; Garcia-Amado Sancho, Maria/0000-0001-6778-5680; Prensa Sepulveda, Lucia/0000-0003-2217-3271	Spanish Ministerio de Educacion y Ciencia [BFU2006-01189]	Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This study was supported by a grant from the Spanish Ministerio de Educacion y Ciencia (BFU2006-01189). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alelu-Paz R, 2007, J NEURAL TRANSM, V114, P969, DOI 10.1007/s00702-007-0633-8; BANKFALVI A, 1994, J PATHOL, V174, P223, DOI 10.1002/path.1711740312; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CELIO MR, 1990, CELL CALCIUM, V11, P599, DOI 10.1016/0143-4160(90)90014-L; CHEN Y, 1993, MOL PHARMACOL, V44, P8; CUELLO AC, 1979, P NATL ACAD SCI USA, V76, P3532, DOI 10.1073/pnas.76.7.3532; CUELLO AC, 1984, J HISTOCHEM CYTOCHEM, V32, P947, DOI 10.1177/32.9.6086744; Dapson RW, 2007, BIOTECH HISTOCHEM, V82, P133, DOI 10.1080/10520290701567916; EVERS P, 1994, J HISTOCHEM CYTOCHEM, V42, P1555, DOI 10.1177/42.12.7983356; Fortin M, 1998, NEUROSCIENCE, V84, P537, DOI 10.1016/S0306-4522(97)00486-7; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; HELANDER KG, 1994, BIOTECH HISTOCHEM, V69, P177, DOI 10.3109/10520299409106282; HIRAI T, 1989, BRAIN RES REV, V14, P1, DOI 10.1016/0165-0173(89)90007-6; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; IGARASHI H, 1994, APMIS, V102, P295, DOI 10.1111/j.1699-0463.1994.tb04879.x; Jones E.G., 1998, Handbook of Chemical Neuroanatomy, V14, P1; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Jones EG, 1985, THALAMUS; KALIN NH, 1988, BRAIN RES, V457, P130, DOI 10.1016/0006-8993(88)90064-9; KAWAI K, 1994, PATHOL INT, V44, P759; Keeble JE, 2004, NEUROSCI LETT, V361, P176, DOI 10.1016/j.neulet.2003.12.020; Kiernan J.A., 2018, MICROSC TODAY, V8, P8, DOI [10.1017/S1551929500057060, DOI 10.1017/S1551929500057060]; MASON JT, 1991, J HISTOCHEM CYTOCHEM, V39, P225, DOI 10.1177/39.2.1987266; Morel A, 1997, J COMP NEUROL, V387, P588, DOI 10.1002/(SICI)1096-9861(19971103)387:4<588::AID-CNE8>3.0.CO;2-Z; Munkle MC, 2000, J CHEM NEUROANAT, V19, P155, DOI 10.1016/S0891-0618(00)00060-0; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; Napier TC, 1999, ANN NY ACAD SCI, V877, P176, DOI 10.1111/j.1749-6632.1999.tb09268.x; NORTON AJ, 1994, J PATHOL, V173, P371, DOI 10.1002/path.1711730413; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; olszewski j, 1952, THALAMUS MACACA MULA; PASHA T, 1995, LAB INVEST, V72, pA167; Pearse A.G.E., 1968, HISTOCHEMISTRY THEOR; Pileri SA, 1997, J PATHOL, V183, P116; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; SCHMAUSS C, 1984, J PHARMACOL EXP THER, V228, P1; Shi SR, 1999, J HISTOTECHNOL, V22, P177; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SHI SR, 1995, J HISTOCHEM CYTOCHEM, V43, P193, DOI 10.1177/43.2.7822775; Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; SUURMEIJER AJH, 1993, EUR J MORPHOL, V31, P144; Taylor CR, 1995, CAP TODAY, V9, P16; Uroz V, 2004, SYNAPSE, V51, P173, DOI 10.1002/syn.10298; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	46	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3378	10.1371/journal.pone.0003378	http://dx.doi.org/10.1371/journal.pone.0003378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852880	gold, Green Published, Green Submitted			2022-12-25	WOS:000265121600004
J	Fragoso-Loyo, H; Cabiedes, J; Orozco-Narvaez, A; Davila-Maldonado, L; Atisha-Fregoso, Y; Diamond, B; Llorente, L; Sanchez-Guerrero, J				Fragoso-Loyo, Hilda; Cabiedes, Javier; Orozco-Narvaez, Alejandro; Davila-Maldonado, Luis; Atisha-Fregoso, Yemil; Diamond, Betty; Llorente, Luis; Sanchez-Guerrero, Jorge			Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; GLUTAMATE-RECEPTOR ANTIBODIES; ANTIPHOSPHOLIPID ANTIBODIES; ASSOCIATION; MANIFESTATIONS; PERMEABILITY; PREVALENCE; DISEASE; DAMAGE	Background: Despite the uncertainty in the diagnosis of neuropsychiatric involvement in systemic lupus erythematosus (SLE), attempts have been made to record the association of certain antibodies in serum with neuropsychiatric (NP) manifestations. We aimed to assess the behaviour and the association of serum and cerebrospinal fluid (CSF) autoantibodies with NP manifestations in SLE patients (NPSLE). Methodology/Principal Findings: Forty-seven SLE patients, hospitalized because of NP manifestations were included. They were evaluated at hospitalization and six months later, and serum and CSF samples were obtained at each evaluation. As controls, serum samples were taken from 49 non-NPSLE patients at hospitalization and six months later; serum and CSF samples were also obtained from 6 SLE patients with septic meningitis, 16 surgical SLE patients and 25 patients without autoimmune diseases. Antinuclear, anti-dsDNA, anti-ribosomal P, Anti-N-Methyl-D-Aspartate receptor (NMDAR), anticardiolipin, and anti-beta 2 glycoprotein-I antibodies were measured. In serum, anti-ribosomal P, anti-NMDAR, and other antibodies did not differentiate among SLE groups, and the levels of all antibodies were similar among the SLE groups. Sixmonths later, this scenario remained unchanged and the decrease in the levels of some autoantibodies reflected a decline in disease activity, rather than a change in NPSLE. In CSF, only the presence and the levels of anti-NMDAR antibodies showed a characteristic distribution in central NPSLE and septic meningitis patients. Six months later the prevalence of most antibodies in CSF did not change, however the levels of anti-dsDNA, anti-ribosomal P, and anti-NMDAR decreased. Conclusion: In NPSLE, autoantibodies in serum do not reflect their behaviour in CSF. All autoantibodies were elevated in septic meningitis reflecting the global penetration of serum antibodies into the CSF in this condition. Anti-NMDAR antibodies in CSF identified patients with central NPSLE; their continued presence in CSF 6 months after neurologic symptoms raise questions regarding the conditions under which they are pathogenic.	[Fragoso-Loyo, Hilda; Cabiedes, Javier; Atisha-Fregoso, Yemil; Llorente, Luis; Sanchez-Guerrero, Jorge] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Orozco-Narvaez, Alejandro; Davila-Maldonado, Luis] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Neurol, Mexico City, DF, Mexico; [Diamond, Betty] Feinstein Inst Med Res, Manhasset, NY USA	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Northwell Health	Fragoso-Loyo, H (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico.	jsanchezguerrero7@gmail.com	Llorente, Luis/GQP-7202-2022	Llorente, Luis/0000-0002-3464-3747				Abbott NJ, 2003, LUPUS, V12, P908, DOI 10.1191/0961203303lu501oa; Abdel-Rahman A, 2002, NEUROBIOL DIS, V10, P306, DOI 10.1006/nbdi.2002.0524; Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Appenzeller S, 2005, ARTHRITIS RHEUM-US, V52, P2783, DOI 10.1002/art.21271; BLUESTEIN HG, 1981, AM J MED, V70, P240, DOI 10.1016/0002-9343(81)90756-7; BONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Correale J, 2007, AUTOIMMUNITY, V40, P148, DOI 10.1080/08916930601183522; DEVINSKY O, 1988, ANN NEUROL, V23, P380, DOI 10.1002/ana.410230411; Esposito P, 2002, J PHARMACOL EXP THER, V303, P1061, DOI 10.1124/jpet.102.038497; Fragoso-Loyo H, 2007, ARTHRITIS RHEUM-US, V56, P1242, DOI 10.1002/art.22451; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Greenwood DLV, 2002, AUTOIMMUNITY, V35, P79, DOI 10.1080/08916930290016547; HANLY JG, 1992, J RHEUMATOL, V19, P732; Hanly JG, 2004, J RHEUMATOL, V31, P2156; Hanly JG, 2006, J RHEUMATOL, V33, P1553; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; HAY EM, 1993, BRIT J RHEUMATOL, V32, P329; HERRANZ MT, 1994, ARTHRITIS RHEUM, V37, P568, DOI 10.1002/art.1780370418; Isshi K, 1998, ARTHRITIS RHEUM, V41, P1819, DOI 10.1002/1529-0131(199810)41:10<1819::AID-ART14>3.3.CO;2-P; Jennekens FGI, 2002, RHEUMATOLOGY, V41, P619, DOI 10.1093/rheumatology/41.6.619; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kozora E, 2005, COGN BEHAV NEUROL, V18, P159, DOI 10.1097/01.wnn.0000181543.05064.4b; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Mikdashi J, 2004, RHEUMATOLOGY, V43, P1555, DOI 10.1093/rheumatology/keh384; PEREIRA RMR, 1992, LUPUS, V1, P175; Ruiz-Irastorza G, 2001, LANCET, V357, P1027, DOI 10.1016/S0140-6736(00)04239-2; Sanchez-Guerrero J, 2008, NAT CLIN PRACT RHEUM, V4, P112, DOI 10.1038/ncprheum0726; SCHNEEBAUM AB, 1991, AM J MED, V90, P54, DOI 10.1016/0002-9343(91)90506-S; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TOUBI E, 1995, AM J MED, V99, P397, DOI 10.1016/S0002-9343(99)80188-0; WEST SG, 1995, AM J MED, V99, P153, DOI 10.1016/S0002-9343(99)80135-1; Yoshio T, 2006, ARTHRITIS RHEUM, V54, P675, DOI 10.1002/art.21547; Zandman-Goddard G, 2007, SEMIN ARTHRITIS RHEU, V36, P297, DOI 10.1016/j.semarthrit.2006.11.003	36	123	130	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3347	10.1371/journal.pone.0003347	http://dx.doi.org/10.1371/journal.pone.0003347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836530	Green Published, gold, Green Submitted			2022-12-25	WOS:000265113500009
J	Spoden, G; Freitag, K; Husmann, M; Boller, K; Sapp, M; Lambert, C; Florin, L				Spoden, Gilles; Freitag, Kirsten; Husmann, Matthias; Boller, Klaus; Sapp, Martin; Lambert, Carsten; Florin, Luise			Clathrin- and Caveolin-Independent Entry of Human Papillomavirus Type 16-Involvement of Tetraspanin-Enriched Microdomains (TEMs)	PLOS ONE			English	Article								Background: Infectious entry of human papillomaviruses into their host cells is an important step in the viral life cycle. For cell binding these viruses use proteoglycans as initial attachment sites. Subsequent transfer to a secondary receptor molecule seems to be involved in virus uptake. Depending on the papillomavirus subtype, it has been reported that entry occurs by clathrin- or caveolin-mediated mechanisms. Regarding human papillomavirus type 16 (HPV16), the primary etiologic agent for development of cervical cancer, clathrin- mediated endocytosis was described as infectious entry pathway. Methodology/Principal Findings: Using immunofluorescence and infection studies we show in contrast to published data that infectious entry of HPV16 occurs in a clathrin- and caveolin-independent manner. Inhibition of clathrin- and caveolin/raft-dependent endocytic pathways by dominant-negative mutants and siRNA-mediated knockdown, as well as inhibition of dynamin function, did not impair infection. Rather, we provide evidence for involvement of tetraspanin-enriched microdomains (TEMs) in HPV16 endocytosis. Following cell attachment, HPV16 particles colocalized with the tetraspanins CD63 and CD151 on the cell surface. Notably, tetraspanin-specific antibodies and siRNA inhibited HPV16 cell entry and infection, confirming the importance of TEMs for infectious endocytosis of HPV16. Conclusions/Significance: Tetraspanins fulfill various roles in the life cycle of a number of important viral pathogens, including human immunodeficiency virus (HIV) and hepatitis C virus (HCV). However, their involvement in endocytosis of viral particles has not been proven. Our data indicate TEMs as a novel clathrin- and caveolin-independent invasion route for viral pathogens and especially HPV16.	[Spoden, Gilles; Freitag, Kirsten; Husmann, Matthias; Lambert, Carsten; Florin, Luise] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Mainz, Germany; [Boller, Klaus] Paul Ehrlich Inst, Langen, Germany; [Sapp, Martin] LSU, Hlth Sci Ctr, Ctr Mol Tumor Virol, Feist Weiller Canc Ctr, Dept Microbiol & Immunol, Shreveport, LA USA	Johannes Gutenberg University of Mainz; Paul Ehrlich Institute; Louisiana State University System; Louisiana State University; Louisiana State University Health Sciences Center at Shreveport	Spoden, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Mainz, Germany.	lambert@uni-mainz.de			Deutsche Forschungsgemeinschaft [SFB 490/D2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (SFB 490/D2).	Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Bousarghin L, 2003, J VIROL, V77, P3846, DOI 10.1128/JVI.77.6.3846-3850.2003; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Culp TD, 2006, VIROLOGY, V347, P147, DOI 10.1016/j.virol.2005.11.025; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; EVANDER M, 1997, J VIROL, V71; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Giroglou T, 2001, VACCINE, V19, P1783, DOI 10.1016/S0264-410X(00)00370-4; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Ho SH, 2006, J VIROL, V80, P6487, DOI 10.1128/JVI.02539-05; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Leder C, 2001, J VIROL, V75, P9201, DOI 10.1128/JVI.75.19.9201-9209.2001; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMillan NAJ, 1999, VIROLOGY, V261, P271, DOI 10.1006/viro.1999.9825; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rommel O, 2005, J MED VIROL, V75, P114, DOI 10.1002/jmv.20245; SAPP M, 1994, J GEN VIROL, V75, P3375, DOI 10.1099/0022-1317-75-12-3375; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Smith JL, 2007, J VIROL, V81, P9922, DOI 10.1128/JVI.00988-07; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Swedlow JR, 2007, METHOD CELL BIOL, V81, P447, DOI 10.1016/S0091-679X(06)81021-6; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; von Lindern JJ, 2003, J VIROL, V77, P3624, DOI 10.1128/JVI.77.6.3624-3633.2003; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004	58	158	162	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3313	10.1371/journal.pone.0003313	http://dx.doi.org/10.1371/journal.pone.0003313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18836553	Green Submitted, Green Published, gold			2022-12-25	WOS:000264797300004
J	Motamayor, JC; Lachenaud, P; Mota, JWDE; Loor, R; Kuhn, DN; Brown, JS; Schnell, RJ				Motamayor, Juan C.; Lachenaud, Philippe; da Silva e Mota, Jay Wallace; Loor, Rey; Kuhn, David N.; Brown, J. Steven; Schnell, Raymond J.			Geographic and Genetic Population Differentiation of the Amazonian Chocolate Tree (Theobroma cacao L)	PLOS ONE			English	Article							INTERNATIONAL-COCOA-GENEBANK; MICROSATELLITE MARKERS; SPECIES RICHNESS; DIVERSITY; GERMPLASM; DIVERSIFICATION; VARIABILITY; SIMULATION; INFERENCE; TRINIDAD	Numerous collecting expeditions of Theobroma cacao L. germplasm have been undertaken in Latin-America. However, most of this germplasm has not contributed to cacao improvement because its relationship to cultivated selections was poorly understood. Germplasm labeling errors have impeded breeding and confounded the interpretation of diversity analyses. To improve the understanding of the origin, classification, and population differentiation within the species, 1241 accessions covering a large geographic sampling were genotyped with 106 microsatellite markers. After discarding mislabeled samples, 10 genetic clusters, as opposed to the two genetic groups traditionally recognized within T. cacao, were found by applying Bayesian statistics. This leads us to propose a new classification of the cacao germplasm that will enhance its management. The results also provide new insights into the diversification of Amazon species in general, with the pattern of differentiation of the populations studied supporting the palaeoarches hypothesis of species diversification. The origin of the traditional cacao cultivars is also enlightened in this study.	[Motamayor, Juan C.; Kuhn, David N.; Brown, J. Steven; Schnell, Raymond J.] ARS, USDA, Subtrop Hort Res Stn, Miami, FL USA; [Motamayor, Juan C.] MARS Inc, Hackettstown, NJ USA; [Lachenaud, Philippe] CIRAD Bios, UPR, Montpellier, France; [da Silva e Mota, Jay Wallace] CEPLAC SUPOR AMAZONIA, Belem, Para, Brazil; [Loor, Rey] INIAP, Estac Expt Pichilingue, Los Rios, Ecuador	United States Department of Agriculture (USDA); Mars; CIRAD	Motamayor, JC (corresponding author), ARS, USDA, Subtrop Hort Res Stn, Miami, FL USA.	juan.motamayor@effem.com			U.S. Department of Agriculture [6631-21000-012-00D]; MARS Inc	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); MARS Inc	Funded by the U.S. Department of Agriculture (Project Number: 6631-21000-012-00D) and MARS Inc. The funders had no role in study design, data collection or analysis, writing the paper, or the decision to submit it for publication. The publication contents are solely the responsibility of the authors and do not necessarily represent the official views of USDA nor MARS Inc.	Allen J.B., 1983, COCOA GROWERS B, V34, P74; Bartley BGD, 2005, GENETIC DIVERSITY OF CACAO AND ITS UTILIZATION: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9780851996196.0000; BEKELE FL, 2004, EXAMINING PHENOTYPIC; Bekele FL, 2006, GENET RESOUR CROP EV, V53, P933, DOI 10.1007/s10722-004-6692-x; Brown JS, 2005, J AM SOC HORTIC SCI, V130, P366, DOI 10.21273/JASHS.130.3.366; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; Cervantes-Martinez C, 2006, TREE GENET GENOMES, V2, P152, DOI 10.1007/s11295-006-0038-0; CHALMERS WS, 1973, REPORT VISIT ECUADOR; Cheesman E. E., 1944, TROP AGRIC [TRINIDAD], V21, P144; CHEVENET F, 2006, TREEDYN ANNOTATIONS; *CORP M, 2006, MAPINFO PROF; Cuatrecasas J., 1964, CONTRIB US NAT MUS, V35, P379, DOI DOI 10.1016/0165-5728(95)00055-7; DELACRUZ M, 1995, NATURE, V375, P542, DOI 10.1038/375542a0; *ESRI, 2006, ARCGIS 9 0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 2005, EVOLUTIONARY BIOINFO; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Goudet J., 2001, FSTAT PROGRAM ESTIMA; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J., 1977, Amazoniana, V6, P161; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lachenaud P, 2005, ACTA BOT GALLICA, V152, P325, DOI 10.1080/12538078.2005.10515493; Lanaud C, 1999, MOL ECOL, V8, P2141, DOI 10.1046/j.1365-294x.1999.00802.x; LANGELLA O., 1999, POPULATIONS POPULATI; LAURENT V, 1994, THEOR APPL GENET, V88, P193, DOI 10.1007/BF00225897; Lerceteau E, 1997, THEOR APPL GENET, V95, P10, DOI 10.1007/s001220050527; LOCKWOOD G, 1985, SPAN, V28, P14; Lougheed SC, 1999, P ROY SOC B-BIOL SCI, V266, P1829, DOI 10.1098/rspb.1999.0853; Mao, 1999, POPGENE VERSION 1 3; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Motamayor JC, 2003, HEREDITY, V91, P322, DOI 10.1038/sj.hdy.6800298; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; MOTAMAYOR JC, 2001, ETUDE DIVERSITE GENE; Motilal L, 2003, GENET RESOUR CROP EV, V50, P799, DOI 10.1023/A:1025950902827; Pound F.J., 1938, ARCH CACAO RES, VVol. 1, P20; PRANCE G T, 1973, Acta Amazonica, V3, P5; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2004, DOCUMENTATION STRUCT; Pugh T, 2004, THEOR APPL GENET, V108, P1151, DOI 10.1007/s00122-003-1533-4; REMSEN JV, 1983, BIOTROPICA, V15, P223, DOI 10.2307/2387833; Schnell RJ, 2005, J AM SOC HORTIC SCI, V130, P181, DOI 10.21273/JASHS.130.2.181; Sereno ML, 2006, CONSERV GENET, V7, P13, DOI 10.1007/s10592-005-7568-0; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Sounigo O, 2005, GENET RESOUR CROP EV, V52, P1111, DOI 10.1007/s10722-004-6110-4; WADSWORTH RM, 2000, INT COCOA GERMPLASM, V51; WARREN J, 1992, COCOA BREEDING 21 CE, P215; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; YIN JPT, 2004, EXPT AGR, V40	50	271	275	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3311	10.1371/journal.pone.0003311	http://dx.doi.org/10.1371/journal.pone.0003311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827930	Green Published, gold			2022-12-25	WOS:000264797200013
J	Burkhead, JL; Morgan, CT; Shinde, U; Haddock, G; Lutsenko, S				Burkhead, Jason L.; Morgan, Clinton T.; Shinde, Ujwal; Haddock, Gabrielle; Lutsenko, Svetlana			COMMD1 Forms Oligomeric Complexes Targeted to the Endocytic Membranes via Specific Interactions with Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; N-TERMINAL DOMAIN; COPPER TOXICOSIS; PHOSPHOINOSITIDE-BINDING; MURR1; CHANNEL; CELLS; GENE; UBIQUITINATION; IDENTIFICATION	Copper metabolism Murr1 domain 1 (COMMD1) is a 21-kDa protein involved in copper export from the liver, NF-kappa B signaling, HIV infection, and sodium transport. The precise function of COMMD and the mechanism through which COMMD1 performs its multiple roles are not understood. Recombinant COMMD1 is a soluble protein, yet in cells COMMD1 is largely seen as targeted to cellular membranes. Using co-localization with organelle markers and cell fractionation, we determined that COMMD1 is located in the vesicles of the endocytic pathway, whereas little COMMD1 is detected in either the trans-Golgi network or lysosomes. The mechanism of COMMD1 recruitment to cell membranes was investigated using lipid-spotted arrays and liposomes. COMMD1 specifically binds phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) in the absence of other proteins and does not bind structural lipids; the phosphorylation of PtdIns at position 4 is essential for COMMD1 binding. Proteolytic sensitivity and molecular modeling experiments identified two distinct domains in the structure of COMMD1. The C-terminal domain appears sufficient for lipid binding, because both the full-length and C-terminal domain proteins bind to PtdIns(4,5)P-2. In native conditions, endogenous COMMD1 forms large oligomeric complexes both in the cytosol and at the membrane; interaction with PtdIns(4,5)P-2 increases the stability of oligomers. Altogether, our results suggest that COMMD1 is a scaffold protein in a distinct sub-compartment of endocytic pathway and offer first clues to its role as a regulator of structurally unrelated membrane transporters.	[Burkhead, Jason L.; Morgan, Clinton T.; Shinde, Ujwal; Haddock, Gabrielle; Lutsenko, Svetlana] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Lutsenko, S (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lutsenko@ohsu.edu	Burkhead, Jason/C-9612-2013; Morgan, Clinton/AAM-7410-2021	Burkhead, Jason/0000-0001-5457-311X; 	National Institutes of Health [R01 DK071865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK071865 ( to S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; de Bie P, 2006, BIOCHEM J, V398, P63, DOI 10.1042/BJ20051664; Huang Y, 2008, J BIOL CHEM, V283, P11453, DOI 10.1074/jbc.M708544200; JOHNSON GF, 1981, HEPATOLOGY, V1, P243, DOI 10.1002/hep.1840010309; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kawamura M, 2002, VET PATHOL, V39, P747, DOI 10.1354/vp.39-6-747; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Knodler A, 2005, BIOTECHNIQUES, V38, P858, DOI 10.2144/05386BM02; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; MAINE GN, 2008, BIOCH J IN PRESS; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Muller P, 2007, J BIOL INORG CHEM, V12, P495, DOI 10.1007/s00775-006-0201-y; Narindrasorasak S, 2007, BIOCHEMISTRY-US, V46, P3116, DOI 10.1021/bi0620656; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; Sommerhalter M, 2007, J MOL BIOL, V365, P715, DOI 10.1016/j.jmb.2006.10.030; SORMUNEN R, 1993, LAB INVEST, V68, P652; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; TWEDT DC, 1979, J AM VET MED ASSOC, V175, P269; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	37	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					696	707		10.1074/jbc.M804766200	http://dx.doi.org/10.1074/jbc.M804766200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18940794	Green Published, hybrid			2022-12-25	WOS:000261974800074
J	Noborio-Hatano, K; Kikuchi, J; Takatoku, M; Shimizu, R; Wada, T; Ueda, M; Nobuyoshi, M; Oh, I; Sato, K; Suzuki, T; Ozaki, K; Mori, M; Nagai, T; Muroi, K; Kano, Y; Furukawa, Y; Ozawa, K				Noborio-Hatano, K.; Kikuchi, J.; Takatoku, M.; Shimizu, R.; Wada, T.; Ueda, M.; Nobuyoshi, M.; Oh, I.; Sato, K.; Suzuki, T.; Ozaki, K.; Mori, M.; Nagai, T.; Muroi, K.; Kano, Y.; Furukawa, Y.; Ozawa, K.			Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma	ONCOGENE			English	Article						myeloma; bortezomib; drug resistance; cell adhesion; VLA-4	NF-KAPPA-B; MARROW STROMAL CELLS; BONE-MARROW; CAM-DR; BINDING-SITES; APOPTOSIS; LEUKEMIA; SUPPRESSES; ACTIVATION; MOLECULES	Multiple myeloma ( MM) is incurable, mainly because of cell adhesion-mediated drug resistance (CAM-DR). In this study, we performed functional screening using short hairpin RNA (shRNA) to de. ne the molecule(s) responsible for CAM-DR of MM. Using four bona. de myeloma cell lines (KHM-1B, KMS12-BM, RPMI8226 and U266) and primary myeloma cells, we identified CD29 (beta 1-integrin), CD44, CD49d (alpha 4-integrin, a subunit of VLA-4), CD54 ( intercellular adhesion molecule-1 (ICAM-1)), CD138 (syndecan-1) and CD184 (CXC chemokine receptor-4 (CXCR4)) as major adhesion molecules expressed on MM. shRNA-mediated knockdown of CD49d but not CD44, CD54, CD138 and CD184 significantly reversed CAM-DR of myeloma cells to bortezomib, vincristine, doxorubicin and dexamethasone. Experiments using blocking antibodies yielded almost identical results. Bortezomib was relatively resistant to CAM-DR because of its ability to specifically down-regulate CD49d expression. This property was unique to bortezomib and was not observed in other anti-myeloma drugs. Pretreatment with bortezomib was able to ameliorate CAM-DR of myeloma cells to vincristine and dexamethasone. These results suggest that VLA-4 plays a critical role in CAM-DR of MM cells. The combination of bortezomib with conventional anti-myeloma drugs may be effective in overcoming CAM-DR of MM.	[Kikuchi, J.; Shimizu, R.; Wada, T.; Furukawa, Y.] Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi 3290498, Japan; [Noborio-Hatano, K.; Takatoku, M.; Ueda, M.; Nobuyoshi, M.; Oh, I.; Sato, K.; Suzuki, T.; Ozaki, K.; Mori, M.; Nagai, T.; Muroi, K.; Furukawa, Y.; Ozawa, K.] Jichi Med Univ, Dept Internal Med, Div Hematol, Shimotsuke, Tochigi 3290498, Japan	Jichi Medical University; Jichi Medical University	Furukawa, Y (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	furuyu@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418	Ministry of Health, Welfare, and Labor of Japan; Ministry of Education, Science, Sports, and Technology of Japan; Jichi Medical School Young Investigator Award	Ministry of Health, Welfare, and Labor of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Jichi Medical School Young Investigator Award	This study was supported in part by grants from the Ministry of Health, Welfare, and Labor of Japan, and Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Technology of Japan. KN-H and JK are winners of the Jichi Medical School Young Investigator Award.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Cook G, 1997, ACTA HAEMATOL-BASEL, V97, P81; Corso A, 2005, CANCER, V104, P118, DOI 10.1002/cncr.21104; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Drexler Hans G, 2003, Hum Cell, V16, P101, DOI 10.1111/j.1749-0774.2003.tb00140.x; Duechler M, 2005, LEUKEMIA, V19, P260, DOI 10.1038/sj.leu.2403592; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Hazlehurst LA, 2000, ONCOGENE, V19, P4319, DOI 10.1038/sj.onc.1203782; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Horton TM, 2006, CANCER CHEMOTH PHARM, V58, P13, DOI 10.1007/s00280-005-0135-z; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kikuchi J, 2005, LEUKEMIA, V19, P1934, DOI 10.1038/sj.leu.2403951; Kikuchi J, 2007, STEM CELLS, V25, P2439, DOI 10.1634/stemcells.2007-0207; Kirschner KM, 2006, J BIOL CHEM, V281, P31930, DOI 10.1074/jbc.M602668200; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Landowski TH, 2003, ONCOGENE, V22, P2417, DOI 10.1038/sj.onc.1206315; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Michigami T, 2000, BLOOD, V96, P1953, DOI 10.1182/blood.V96.5.1953.h8001953_1953_1960; Mitsiades N, 2002, BLOOD, V99, P4525, DOI 10.1182/blood.V99.12.4525; Miyakoshi S, 2006, BLOOD, V107, P3492, DOI 10.1182/blood-2005-11-4541; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Mori Y, 2004, BLOOD, V104, P2149, DOI 10.1182/blood-2004-01-0236; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; NOBORIOHATANO K, 2007, JPN J CLIN HEMATOL, V48, pA1093; Odgerel T, 2008, ONCOGENE, V27, P3102, DOI 10.1038/sj.onc.1210980; Olson DL, 2005, MOL CANCER THER, V4, P91; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; ROSEN GD, 1994, J BIOL CHEM, V269, P15652; Schmidmaier R, 2006, INT J BIOL MARKER, V21, P218, DOI 10.1177/172460080602100404; TAKATOKU M, 2004, JPN J CLIN HEMATOL, V45, P144; Tatsumi T, 1996, JPN J CANCER RES, V87, P837, DOI 10.1111/j.1349-7006.1996.tb02108.x; Yanamandra N, 2006, CLIN CANCER RES, V12, P591, DOI 10.1158/1078-0432.CCR-05-1792; Zutter MM, 1997, BLOOD, V90, P678, DOI 10.1182/blood.V90.2.678.678_678_689	41	132	134	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					231	242		10.1038/onc.2008.385	http://dx.doi.org/10.1038/onc.2008.385			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18850009				2022-12-25	WOS:000262501100007
J	Franco, R; DeHaven, WI; Sifre, MI; Bortner, CD; Cidlowski, JA				Franco, Rodrigo; DeHaven, Wayne I.; Sifre, Maria I.; Bortner, Carl D.; Cidlowski, John A.			Glutathione Depletion and Disruption of Intracellular Ionic Homeostasis Regulate Lymphoid Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PLASMA-MEMBRANE DEPOLARIZATION; REDUCED GLUTATHIONE; VOLUME DECREASE; K+ CHANNELS; OXIDATIVE STRESS; NA+/K+-ATPASE; MEDIATED APOPTOSIS; POTASSIUM CHANNELS; CHLORIDE CHANNELS	Intracellular glutathione (GSH) depletion is an important hallmark of apoptosis. We have recently shown that GSH depletion by its extrusion regulates apoptosis independently of excessive reactive oxygen species accumulation. However, the mechanisms by which GSH depletion regulates apoptosis are still unclear. Because disruption of intracellular ionic homeostasis, associated with apoptotic volume decrease (AVD), is necessary for the progression of apoptotic cell death, we sought to evaluate the relationship between GSH transport and ionic homeostasis during Fas ligand (FasL)-induced apoptosis in Jurkat cells. GSH depletion in response to FasL was paralleled by distinct degrees of AVD identified by differences in cellular forward scatter and electronic impedance analysis. Inhibition of GSH efflux prevented AVD, K+ loss, and the activation of two distinct ionic conductances, mediated by Kv1.3 and outward rectifying Cl- channels. Reciprocally, stimulation of GSH loss accelerated the loss of K+, AVD, and consequently the progression of the execution phase of apoptosis. Although high extracellular K+ inhibited FasL-induced apoptosis, GSH depletion was largely independent of K+ loss. These results suggest that deregulation of GSH and ionic homeostasis converge in the regulation of apoptosis in lymphoid cells.	[Franco, Rodrigo; DeHaven, Wayne I.; Sifre, Maria I.; Bortner, Carl D.; Cidlowski, John A.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Lab Signal Transduct, NIH, POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	cidlows1@mail.nih.gov	Cidlowski, John A/G-2548-2019; Franco, Rodrigo/D-9470-2013	Cidlowski, John A/0000-0003-1420-0516; Franco, Rodrigo/0000-0003-3241-8615	National Institutes of Health grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102486, Z01ES102486, Z01ES090079, ZIAES090079] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by a National Institutes of Health grant (intramural research program of the NIEHS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; BLOKZIJL H, 2008, J BIOL CHEM, V284; Bortner CD, 2008, J BIOL CHEM, V283, P7219, DOI 10.1074/jbc.M707809200; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bortner CD, 2007, METHOD ENZYMOL, V428, P161, DOI 10.1016/S0076-6879(07)28009-7; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; Bortner CD, 2003, J BIOL CHEM, V278, P39176, DOI 10.1074/jbc.M303516200; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Brunner T, 2003, SEMIN IMMUNOL, V15, P167, DOI 10.1016/S1044-5323(03)00035-6; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Cai S, 1997, J MEMBRANE BIOL, V158, P147, DOI 10.1007/s002329900252; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Chiba T, 1996, EUR J IMMUNOL, V26, P1164, DOI 10.1002/eji.1830260530; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Circu ML, 2009, BIOCHEM PHARMACOL, V77, P76, DOI 10.1016/j.bcp.2008.09.011; Cui YH, 2003, LAB INVEST, V83, P527, DOI 10.1097/01.LAB.0000065015.02412.48; Dallaporta B, 1998, J IMMUNOL, V160, P5605; Deas O, 1997, INT IMMUNOL, V9, P117, DOI 10.1093/intimm/9.1.117; Devadas S, 2003, FREE RADICAL BIO MED, V35, P648, DOI 10.1016/S0891-5849(03)00391-5; Ernest NJ, 2008, J CELL SCI, V121, P290, DOI 10.1242/jcs.017343; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Fico A, 2008, FREE RADICAL BIO MED, V45, P211, DOI 10.1016/j.freeradbiomed.2008.04.017; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Franklin CC, 2002, AM J PATHOL, V160, P1887, DOI 10.1016/S0002-9440(10)61135-2; Friend KB, 2004, DRUG-EDUC PREV POLIC, V11, P1, DOI 10.1080/0968763031000105038; GHIBELLI L, 1995, BIOCHEM BIOPH RES CO, V216, P313, DOI 10.1006/bbrc.1995.2626; Ghibelli L, 1998, FASEB J, V12, P479, DOI 10.1096/fasebj.12.6.479; Gilbert M, 1997, J CELL PHYSIOL, V171, P299, DOI 10.1002/(SICI)1097-4652(199706)171:3<299::AID-JCP8>3.0.CO;2-J; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Gulbins E, 1996, IMMUNOLOGY, V89, P205, DOI 10.1046/j.1365-2567.1996.d01-743.x; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hall AG, 1999, ADV EXP MED BIOL, V457, P199; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hammond CL, 2004, TOXICOL APPL PHARM, V195, P12, DOI 10.1016/j.taap.2003.10.008; Haouzi D, 2001, HEPATOLOGY, V33, P1181, DOI 10.1053/jhep.2001.24235; He YY, 2003, J BIOL CHEM, V278, P8058, DOI 10.1074/jbc.M207781200; HEDLEY DW, 1994, CYTOMETRY, V15, P349, DOI 10.1002/cyto.990150411; Heimlich G, 2006, J BIOL CHEM, V281, P2232, DOI 10.1074/jbc.M507367200; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Jiao JD, 2006, BIOCHEM BIOPH RES CO, V340, P277, DOI 10.1016/j.bbrc.2005.11.175; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Karki P, 2007, CELL DEATH DIFFER, V14, P2068, DOI 10.1038/sj.cdd.4402221; KLASSEN NV, 1993, INT J RADIAT BIOL, V64, P571, DOI 10.1080/09553009314551791; Kohno T, 1996, J IMMUNOL, V156, P4722; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Laberge RM, 2007, BIOCHEM PHARMACOL, V73, P1727, DOI 10.1016/j.bcp.2007.02.005; Lang F, 2006, CONTRIB NEPHROL, V152, P142, DOI 10.1159/000096321; Liuzzi F, 2003, ANN NY ACAD SCI, V1010, P441, DOI 10.1196/annals.1299.080; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Marchan R, 2008, BBA-BIOMEMBRANES, V1778, P2413, DOI 10.1016/j.bbamem.2008.06.011; Marzolini C, 2004, PHARMACOGENOMICS, V5, P273, DOI 10.1517/phgs.5.3.273.29831; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Merendino N, 2005, NUTR CANCER, V52, P225, DOI 10.1207/s15327914nc5202_12; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Nobel CSI, 2000, APOPTOSIS, V5, P153, DOI 10.1023/A:1009684713784; Oda T, 1999, J BIOCHEM-TOKYO, V126, P715, DOI 10.1093/oxfordjournals.jbchem.a022508; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Osbild S, 2006, ANTICANCER RES, V26, P3595; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Panayiotidis MI, 2006, ACTA PHYSIOL, V187, P205, DOI 10.1111/j.1748-1716.2006.01562.x; Patel AJ, 2004, PFLUG ARCH EUR J PHY, V448, P261, DOI 10.1007/s00424-004-1255-8; Pervaiz S, 2002, BIOCHEM BIOPH RES CO, V290, P1145, DOI 10.1006/bbrc.2001.6274; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Rozanski GJ, 2002, J MOL CELL CARDIOL, V34, P1623, DOI 10.1006/jmcc.2002.2112; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shiffer Z, 2001, BIOCHEM BIOPH RES CO, V289, P1320, DOI 10.1006/bbrc.2001.6127; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; SPENCER RH, 1993, BIOCHEM BIOPH RES CO, V191, P201, DOI 10.1006/bbrc.1993.1203; Storey NM, 2003, J BIOL CHEM, V278, P33319, DOI 10.1074/jbc.M300443200; Szabo I, 1996, J BIOL CHEM, V271, P20465, DOI 10.1074/jbc.271.34.20465; Szabo I, 1998, P NATL ACAD SCI USA, V95, P6169, DOI 10.1073/pnas.95.11.6169; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Trompier D, 2004, CANCER RES, V64, P4950, DOI 10.1158/0008-5472.CAN-04-0143; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Varghese J, 2003, APOPTOSIS, V8, P363, DOI 10.1023/A:1024121017841; Wang XQ, 2003, J CELL SCI, V116, P2099, DOI 10.1242/jcs.00420; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; William R, 1997, BLOOD, V89, P4175, DOI 10.1182/blood.V89.11.4175; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yin W, 2007, LEUKEMIA, V21, P1669, DOI 10.1038/sj.leu.2404791; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Zeidner G, 2001, J BIOL CHEM, V276, P35564, DOI 10.1074/jbc.M105189200	97	40	41	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36071	36087		10.1074/jbc.M807061200	http://dx.doi.org/10.1074/jbc.M807061200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940791	hybrid, Green Published			2022-12-25	WOS:000261840500003
J	Wong, KW; Mohammadi, S; Isberg, RR				Wong, Ka-Wing; Mohammadi, Sina; Isberg, Ralph R.			The Polybasic Region of Rac1 Modulates Bacterial Uptake Independently of Self-association and Membrane Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOTUBERCULOSIS INVASIN PROTEIN; RESONANCE ENERGY-TRANSFER; YERSINIA-PSEUDOTUBERCULOSIS; RHO GTPASES; MAMMALIAN-CELLS; NUCLEAR-LOCALIZATION; PLASMA-MEMBRANE; LIVE CELLS; N-WASP; INTEGRINS	The COOH-terminal polybasic region (PBR) of Rac1, a Rho family GTPase member, is required for Rac1 self-association, membrane localization, nuclear translocation, and interaction with downstream effectors. We previously demonstrated that phosphatidylinositol-4-phosphate 5-kinase, one of the effectors that requires the polybasic region for interaction, is necessary for efficient invasin-promoted uptake of Yersinia pseudotuberculosis by nonphagocytic cells. Here we further examined the role of this region in invasin-promoted uptake. Using fluorescence resonance energy transfer experiments (FRET), we determined that engagement of integrin receptors by invasin caused elevated levels of Rac1 self-association at the site of bacterial adhesion in a PBR-dependent fashion. Self-association could be disrupted using several strategies: translocation of the Yersinia YopT prenylcysteine protease into host cells, inactivation of the Rac1 isoprenylation signal that is required for membrane localization, and elimination of the PBR. Disruption in each case impaired invasin-promoted uptake. To determine if there is a role for the PBR in Rac1 effector signaling that was independent of its role in membrane localization or multimerization, we examined the effect of the PBR in the context of a Rac1 derivative that was targeted to the membrane via an NH2-terminal lipid tail. The membrane-targeted Rac1 derivative restored significant invasin-promoted bacterial uptake in a PBR-dependent manner and yet displayed no detectable self-association. This study indicates that, in addition to its role in promoting membrane localization, the PBR exerts a positive effect on Rac1-controlled bacterial uptake that is independent of Rac1 self-association, most likely due to signaling to downstream effectors.	[Wong, Ka-Wing; Mohammadi, Sina; Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Isberg, Ralph R.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA	Tufts University; Howard Hughes Medical Institute; Tufts University	Isberg, RR (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, 136 Harrison Ave, Boston, MA 02111 USA.	Ralph.Isberg@tufts.edu			National Institutes of Health [R37AI23538]; NIDDK [P30DK34928]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant R37AI23538 and NIDDK Program Project Award Grant P30DK34928. This work was also supported by the Howard Hughes Medical Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Anikovsky M, 2008, BIOPHYS J, V95, P1349, DOI 10.1529/biophysj.107.124313; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Gibson RM, 2001, BIOCHEM J, V359, P285, DOI 10.1042/0264-6021:3590285; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; LEONG JM, 1995, EMBO J, V14, P422, DOI 10.1002/j.1460-2075.1995.tb07018.x; Logsdon LK, 2006, INFECT IMMUN, V74, P1516, DOI 10.1128/IAI.74.3.1516-1527.2006; McGee K, 2001, FEBS LETT, V509, P59, DOI 10.1016/S0014-5793(01)03139-8; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Modha R, 2008, J BIOL CHEM, V283, P1492, DOI 10.1074/jbc.M706760200; NHIEU GTV, 1991, J BIOL CHEM, V266, P24367; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; TAKAI Y, 1995, METHOD ENZYMOL, V250, P122; Takenawa T, 2001, J CELL SCI, V114, P1801; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wong KW, 2006, J BIOL CHEM, V281, P40379, DOI 10.1074/jbc.M605387200; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Wong KW, 2003, J EXP MED, V198, P603, DOI 10.1084/jem.20021363; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang BL, 2001, J BIOL CHEM, V276, P8958, DOI 10.1074/jbc.M008720200	39	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35954	35965		10.1074/jbc.M804717200	http://dx.doi.org/10.1074/jbc.M804717200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18940795	Green Published, hybrid			2022-12-25	WOS:000261687900070
J	Tauskela, JS; Fang, H; Hewitt, M; Brunette, E; Ahuja, T; Thivierge, JP; Comas, T; Mealing, GAR				Tauskela, Joseph S.; Fang, Hung; Hewitt, Melissa; Brunette, Eric; Ahuja, Tarun; Thivierge, Jean-Philippe; Comas, Tanya; Mealing, Geoffrey A. R.			Elevated Synaptic Activity Preconditions Neurons against an in Vitro Model of Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; METHYL-D-ASPARTATE; EXTRASYNAPTIC NMDA RECEPTORS; CALCIUM OSCILLATIONS; CORTICAL-NEURONS; REGULATED KINASE; NUCLEAR CALCIUM; GENE-EXPRESSION; CELL-DEATH; TOLERANCE	Tolerance to otherwise lethal cerebral ischemia in vivo or to oxygen-glucose deprivation (OGD) in vitro can be induced by prior transient exposure to N-methyl-D-aspartic acid (NMDA): preconditioning in this manner activates extrasynaptic and synaptic NMDA receptors and can require bringing neurons to the "brink of death." We considered if this stressful requirement could be minimized by the stimulation of primarily synaptic NMDA receptors. Subjecting cultured cortical neurons to prolonged elevations in electrical activity induced tolerance to OGD. Specifically, exposing cultures to a K+-channel blocker, 4-aminopyridine (20-2500 mu M), and a GABA(A) receptor antagonist, bicuculline (50 mu M) (4-AP/bic), for 1-2 days resulted in potent tolerance to normally lethal OGD applied up to 3 days later. Preconditioning induced phosphorylation of ERK1/2 and CREB which, along with Ca2+ spiking and OGD tolerance, was eliminated by tetrodotoxin. Antagonists of NMDA receptors or L-type voltage-gated Ca2+ channels (L-VGCCs) applied during preconditioning decreased Ca2+ spiking, phosphorylation of ERK1/2 and CREB, and OGD tolerance more effectively when combined, particularly at the lowest 4-AP concentration. Inhibiting ERK1/2 or Ca2+/calmodulin-dependent protein kinases (CaMKs) also reduced Ca2+ spiking and OGD tolerance. Preconditioning resulted in altered neuronal excitability for up to 3 days following 4-AP/bic washout, based on field potential recordings obtained from neurons cultured on 64-channel multielectrode arrays. Taken together, the data are consistent with action potential-driven co-activation of primarily synaptic NMDA receptors and L-VGCCs, resulting in parallel phosphorylation of ERK1/2 and CREB and involvement of CaMKs, culminating in a potent, prolonged but reversible, OGD-tolerant phenotype.	[Tauskela, Joseph S.; Hewitt, Melissa; Brunette, Eric; Ahuja, Tarun; Comas, Tanya; Mealing, Geoffrey A. R.] Inst Biol Sci, Natl Res Council, Synapt Therapies & Devices Grp, Ottawa, ON K1A 0R6, Canada; [Fang, Hung] Inst Biol Sci, Natl Res Council, Glycosyltransferases & Neuroglyc Grp, Ottawa, ON K1A 0R6, Canada; [Thivierge, Jean-Philippe] Indiana Univ, Dept Physiol & Brain Sci, Bloomington, IN 47405 USA	National Research Council Canada; National Research Council Canada; Indiana University System; Indiana University Bloomington	Tauskela, JS (corresponding author), Inst Biol Sci, Natl Res Council, Synapt Therapies & Devices Grp, Bldg M 54,Montreal Rd Campus, Ottawa, ON K1A 0R6, Canada.	joe.tauskela@nrc-cnrc.gc.ca			Heart & Stroke Foundation of Ontario; Canadian Stroke Network	Heart & Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Stroke Network	This work was supported by the Heart & Stroke Foundation of Ontario (to Paul Morley) and the Canadian Stroke Network (to P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Baron C, 1996, J NEUROCHEM, V66, P1005; Bond A, 1999, EUR J PHARMACOL, V380, P91, DOI 10.1016/S0014-2999(99)00523-3; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Debanne D, 2006, EPILEPSIA, V47, P247, DOI 10.1111/j.1528-1167.2006.00416.x; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Duszczyk M, 2005, NEUROTOX RES, V7, P283, DOI 10.1007/BF03033886; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fujiki M, 2004, J NEUROTRAUM, V21, P459, DOI 10.1089/089771504323004601; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Grabb MC, 1999, J NEUROSCI, V19, P1657; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; KATO H, 1992, NEUROSCI LETT, V139, P118, DOI 10.1016/0304-3940(92)90871-4; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Lange-Asschenfeldt C, 2005, NEUROSCI LETT, V384, P87, DOI 10.1016/j.neulet.2005.04.053; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; MARTEL MA, 2008, NEUROSCIENC IN PRESS; Marunaka Y, 2003, BIOCHEM PHARMACOL, V66, P1083, DOI 10.1016/S0006-2952(03)00456-8; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Miao B, 2005, J BIOL CHEM, V280, P21693, DOI 10.1074/jbc.M500003200; Mulholland PJ, 2008, NEUROSCIENCE, V151, P419, DOI 10.1016/j.neuroscience.2007.11.001; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Nishimura M, 2008, NEUROBIOL DIS, V29, P267, DOI 10.1016/j.nbd.2007.08.018; Ogita K, 2005, NEUROPHARMACOLOGY, V48, P810, DOI 10.1016/j.neuropharm.2004.12.018; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pivovarova NB, 2008, J NEUROCHEM, V104, P1686, DOI 10.1111/j.1471-4159.2007.05080.x; Plamondon H, 1999, J CEREBR BLOOD F MET, V19, P1296, DOI 10.1097/00004647-199912000-00002; Raval AP, 2003, J NEUROSCI, V23, P384, DOI 10.1523/JNEUROSCI.23-02-00384.2003; ROGAWSKI MA, 1983, BRAIN RES, V280, P180, DOI 10.1016/0006-8993(83)91190-3; Semenov DG, 2002, NEUROSIGNALS, V11, P329, DOI 10.1159/000068255; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Tanaka M, 2007, NEUROCHEM RES, V32, P988, DOI 10.1007/s11064-006-9259-8; Tapia R, 1999, NEUROCHEM INT, V34, P23, DOI 10.1016/S0197-0186(98)00061-8; Tauskela JS, 2005, FASEB J, V19, P1734, DOI 10.1096/fj.05-3795fje; Tauskela JS, 2004, CEREBRAL ISCHEMIC TOLERANCE, P45; Tauskela JS, 2001, NEUROSCIENCE, V107, P571, DOI 10.1016/S0306-4522(01)00381-5; Tauskela JS, 1999, BRAIN RES, V827, P143, DOI 10.1016/S0006-8993(99)01322-0; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tremblay R, 2000, J NEUROSCI, V20, P7183; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Wang XQ, 2003, J PHARMACOL EXP THER, V305, P502, DOI 10.1124/jpet.102.045013; Wrang ML, 2004, NEUROREPORT, V15, P1151, DOI 10.1097/00001756-200405190-00014; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	63	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34667	34676		10.1074/jbc.M805624200	http://dx.doi.org/10.1074/jbc.M805624200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845540	Green Published, hybrid			2022-12-25	WOS:000261469100022
J	Abalos, GC; Cruite, JT; Bellon, A; Hemmers, S; Akagi, J; Mastrianni, JA; Williamson, RA; Solforosi, L				Abalos, Gil C.; Cruite, Justin T.; Bellon, Anne; Hemmers, Saskia; Akagi, Junya; Mastrianni, James A.; Williamson, R. Anthony; Solforosi, Laura			Identifying Key Components of the PrPC-PrPSc Replicative Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-RESISTANT STATE; PRION PROTEIN; SCRAPIE ISOFORM; IN-VITRO; NEUROBLASTOMA-CELLS; MONOCLONAL-ANTIBODY; TRANSGENIC MICE; SPECIES BARRIER; CULTURED-CELLS; CELLULAR PRP	In prion disease, direct interaction between the cellular prion protein (PrPC) and its misfolded disease-associated conformer PrPSc is a crucial, although poorly understood step promoting the formation of nascent PrPSc and prion infectivity. Recently, we hypothesized that three regions of PrP (corresponding to amino acid residues 23-33, 98-110, and 136-158) interacting specifically and robustly with PrPSc, likely represent peptidic components of one flank of the prion replicative interface. In this study, we created epitope-tagged mouse PrPC molecules in which the PrP sequences 23-33, 98-110, and 136-158 were modified. These novel PrP molecules were individually expressed in the prion-infected neuroblastoma cell line (ScN2a) and the conversion of each mutated mouse PrPC substrate to PrPSc compared with that of the epitope-tagged wild-type mouse PrPC. Mutations within PrP 98-110, substituting all 4 wild-type lysine residues with alanine residues, prevented conversion to PrPSc. Furthermore, when residues within PrP 136 140 were collectively scrambled, changed to alanines, or amino acids at positions 136, 137, and 139 individually replaced by alanine, conversion to PrPSc was similarly halted. However, other PrP molecules containing mutations within regions 23-33 and 101-104 were able to readily convert to PrPSc. These results suggest that PrP sequence comprising residues 98-110 and 136-140 not only participates in the specific binding interaction between PrPC and PrPSc, but also in the process leading to conversion of PrPSc-sequestered PrPC into its disease-associated form.	[Abalos, Gil C.; Cruite, Justin T.; Bellon, Anne; Akagi, Junya; Williamson, R. Anthony; Solforosi, Laura] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Hemmers, Saskia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Akagi, Junya] KANEKA Corp, Takasago, Hyogo 6768688, Japan; [Mastrianni, James A.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	Scripps Research Institute; Scripps Research Institute; Kaneka Corporation; University of Chicago	Williamson, RA (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	williamson@calmune.com; lsolf@scripps.edu			National Institutes of Health [AG004243, NS053504, NS046037]; Department of Defense [DAMD 17-03-1-0511]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046037, R01NS053504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AG004243, NS053504, and NS046037, and the Department of Defense Grant DAMD 17-03-1-0511. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Billeter M, 1997, P NATL ACAD SCI USA, V94, P7281, DOI 10.1073/pnas.94.14.7281; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2001, TRENDS BIOCHEM SCI, V26, P235, DOI 10.1016/S0968-0004(01)01792-3; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Lawson VA, 2004, J BIOL CHEM, V279, P13689, DOI 10.1074/jbc.M303697200; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Norstrom EM, 2006, J VIROL, V80, P8521, DOI 10.1128/JVI.00366-06; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r	37	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34021	34028		10.1074/jbc.M804475200	http://dx.doi.org/10.1074/jbc.M804475200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18826953	hybrid, Green Published			2022-12-25	WOS:000261277700029
J	Kim, AY; Bommelje, CC; Lee, BE; Yonekawa, Y; Choi, L; Morris, LG; Huang, GC; Kaufman, A; Ryan, RJH; Hao, B; Ramanathan, Y; Singh, B				Kim, Alexander Y.; Bommelje, Claire C.; Lee, Benjamin E.; Yonekawa, Yoshihiro; Choi, Lydia; Morris, Luc G.; Huang, Guochang; Kaufman, Andrew; Ryan, Russel J. H.; Hao, Bing; Ramanathan, Y.; Singh, Bhuvanesh			SCCRO (DCUN1D1) Is an Essential Component of the E3 Complex for Neddylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMAS; E2 CONJUGATING ENZYMES; CULLIN NEDDYLATION; NEDD8 MODIFICATION; UBIQUITIN LIGASES; COP9 SIGNALOSOME; STRUCTURAL BASIS; CUL1; SCF; AMPLIFICATION	Covalent modification of cullins by the ubiquitin-like protein NEDD8 (neddylation) regulates protein ubiquitination by promoting the assembly of cullin-RING ligase E3 complexes. Like ubiquitination, neddylation results from an enzymatic cascade involving the sequential activity of a dedicated E1 (APPBP1/Uba3), E2 (Ubc12), and an ill-defined E3. We show that SCCRO (also known as DCUN1D1) binds to the components of the neddylation pathway (Cullin-ROC1, Ubc12, and CAND1) and augments but is not required for cullin neddylation in reactions using purified recombinant proteins. We also show that SCCRO recruits Ubc12 similar to NEDD8 to the CAND1-Cul1-ROC1 complex but that this is not sufficient to dissociate or overcome the inhibitory effects of CAND1 on cullin neddylation in purified protein assays. In contrast to findings in cellular systems where no binding is seen, we show that SCCRO and CAND1 can bind to the neddylated Cul1-ROC1 complex in assays using purified recombinant proteins. Although neddylated (not unneddylated) Cul1-ROC1 is released from CAND1 upon incubation with testis lysate from SCCRO+/+ mice, the addition of recombinant SCCRO is required to achieve the same results in lysate from SCCRO-/- mice. Combined, these results suggest that SCCRO is an important component of the neddylation E3 complex that functions to recruit charged E2 and is involved in the release of inhibitory effects of CAND1 on cullin-RING ligase E3 complex assembly and activity.	[Kim, Alexander Y.; Bommelje, Claire C.; Lee, Benjamin E.; Yonekawa, Yoshihiro; Choi, Lydia; Morris, Luc G.; Huang, Guochang; Kaufman, Andrew; Ryan, Russel J. H.; Ramanathan, Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Lab Epithelial Canc Biol, Dept Surg, New York, NY 10065 USA; [Bommelje, Claire C.] Erasmus MC, Dept Otolaryngol, NL-3015 CE Rotterdam, Netherlands; [Hao, Bing] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; University of Connecticut	Ramanathan, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Epithelial Canc Biol, Dept Surg, 1275 York Ave, New York, NY 10065 USA.	ramanaty@mskcc.org; singhb@mskcc.org		Ryan, Russell/0000-0001-8174-3962	American College of Surgeons	American College of Surgeons	This work was supported in part a George H. A. Clowes Memorial Research Career Development Award from the American College of Surgeons (to B. S.), a Clinical Innovator Award from Flight Attendant Medical Research Institute ( to B. S. and Y.R.), the T.J. Martel Fund ( to B. S. and V. Rusch), the Falcone Fund (to B.S. and J. Shah), an National Institutes of Health training grant (to L.C.), and a Matheson Fellowship (to Y. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 S. C. Section 1734 solely to indicate this fact.	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Hwang JW, 2003, FEBS LETT, V541, P102, DOI 10.1016/S0014-5793(03)00321-1; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Singh B, 2002, AM J PATHOL, V161, P365, DOI 10.1016/S0002-9440(10)64191-0; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Singh B, 2001, CANCER RES, V61, P4506; Sufan RI, 2006, NEOPLASIA, V8, P956, DOI 10.1593/neo.06520; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	36	66	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33211	33220		10.1074/jbc.M804440200	http://dx.doi.org/10.1074/jbc.M804440200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826954	Green Published, hybrid			2022-12-25	WOS:000261183700024
J	Park, KS; Wiederkehr, A; Kirkpatrick, C; Mattenberger, Y; Martinou, JC; Marchetti, P; Demaurex, N; Wollheim, CB				Park, Kyu-Sang; Wiederkehr, Andreas; Kirkpatrick, Clare; Mattenberger, Yves; Martinou, Jean-Claude; Marchetti, Piero; Demaurex, Nicolas; Wollheim, Claes B.			Selective Actions of Mitochondrial Fission/Fusion Genes on Metabolism-Secretion Coupling in Insulin-releasing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL; MAMMALIAN-CELLS; PANCREATIC-ISLETS; FUSION MEDIATORS; PROTEIN; APOPTOSIS; HFIS1; FIS1; CA2+; HETEROGENEITY	Mitochondria form filamentous networks that undergo continuous fission/fusion. In the pancreatic beta-cells, mitochondria are essential for the transduction of signals linking nutrient metabolism to insulin granule exocytosis. Here we have studied mitochondrial networks in the insulinoma cell line INS-1E, primary rat and human beta-cells. We have further investigated the impact of mitochondrial fission/fusion on metabolism-secretion coupling in INS-1E cells. Overexpression of hFis1 caused dramatic mitochondrial fragmentation, whereas Mfn1 evoked hyperfusion and the aggregation of mitochondria. Cells overexpressing hFis1 or Mfn1 showed reduced mitochondrial volume, lowered cellular ATP levels, and as a consequence, impaired glucose-stimulated insulin secretion. Decreased mitochondrial ATP generation was partially compensated for by enhanced glycolysis as indicated by increased lactate production in these cells. Dominant-negative Mfn1 elicited mitochondrial shortening and fragmentation of INS-1E cell mitochondria, similar to hFis1. However, the mitochondrial volume, cytosolic ATP levels, and glucose-stimulated insulin secretion were little affected. We conclude that mitochondrial fragmentation per se does not impair metabolism-secretion coupling. Through their impact on mitochondrial bioenergetics and distribution, hFis1 and Mfn1 activities influence mitochondrial signal generation thereby insulin exocytosis.	[Park, Kyu-Sang; Wiederkehr, Andreas; Kirkpatrick, Clare; Demaurex, Nicolas; Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Mattenberger, Yves; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, I-56126 Pisa, Italy	University of Geneva; University of Geneva; University of Pisa	Wollheim, CB (corresponding author), 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Claes.Wollheim@medecine.unige.ch	Kirkpatrick, Clare L/M-1890-2018; Marchetti, Piero/J-7439-2013	Kirkpatrick, Clare L/0000-0001-8564-8559; Marchetti, Piero/0000-0003-4907-0635; Mattenberger, Yves/0000-0002-1651-7691; Demaurex, Nicolas/0000-0002-9933-6772; martinou, Jean-claude/0000-0002-9847-2051; Park, Kyu-Sang/0000-0003-0322-9807	Swiss National Foundation; EuroDia [LSHM-CT-2006-518153]; European Community-funded project under framework program 6; Korea Research Foundation [KRF-2006-013-E00082]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); EuroDia; European Community-funded project under framework program 6(European Commission); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the Swiss National Foundation and EuroDia (Grant LSHM-CT-2006-518153), a European Community-funded project under framework program 6 (to C. B. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; A recipient of a fellowship from the Korea Research Foundation Grant (KRF-2006-013-E00082).	Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Brun T, 2004, J CELL BIOL, V167, P1123, DOI 10.1083/jcb.200405148; Celik M, 2001, DIABETIC MED, V18, P685, DOI 10.1046/j.1464-5491.2001.05302.x; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Frieden M, 2005, J BIOL CHEM, V280, P43198, DOI 10.1074/jbc.M510279200; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Koc F, 2006, INT J NEUROSCI, V116, P103, DOI 10.1080/00207450500341431; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188; Maechler P, 1998, J BIOL CHEM, V273, P20770, DOI 10.1074/jbc.273.33.20770; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Noda M, 2002, J BIOL CHEM, V277, P41817, DOI 10.1074/jbc.M207690200; Noske AB, 2008, J STRUCT BIOL, V161, P298, DOI 10.1016/j.jsb.2007.09.015; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang YC, 2006, MOL PHARMACOL, V70, P1424, DOI 10.1124/mol.106.024323; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	47	92	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33347	33356		10.1074/jbc.M806251200	http://dx.doi.org/10.1074/jbc.M806251200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832378	Green Published, hybrid			2022-12-25	WOS:000261183700039
J	Seko, A; Yamashita, K				Seko, Akira; Yamashita, Katsuko			Activation of beta 1,3-N-Acetylglucosaminyltransferase-2(beta 3Gn-T2) by beta 3Gn-T8 POSSIBLE INVOLVEMENT OF beta 3Gn-T8 IN INCREASING POLY-N-ACETYLLACTOSAMINE CHAINS IN DIFFERENTIATED HL-60 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE-GLYCOPROTEINS; CHONDROITIN-POLYMERIZING FACTOR; HEPARAN-SULFATE POLYMERIZATION; O-MANNOSYLTRANSFERASE ACTIVITY; COMPLEX-FORMATION; LINKED OLIGOSACCHARIDES; GOLGI LOCALIZATION; ENZYMATIC-ACTIVITY; CYSTEINE RESIDUES; TUMOR SUPPRESSORS	Enzymatic activities of some glycosyltransferases are markedly increased via complex formation with other transferases or cofactor proteins. We previously showed that beta 1,3-N-acetylglucosaminyltransferase-2 (beta 3Gn-T2) and beta 3Gn-T8 can form a heterodimer in vitro and that the complex exhibits much higher enzymatic activity than either enzyme alone (Seko, A., and Yamashita, K. (2005) Glycobiology 15, 943-951). Here we examined this activation and the biological significance of complex formation in differentiated HL-60 cells. beta 3Gn-T2 and -T8 were co-immunoprecipitated from the lysates of both-transfected COS-7 cells, indicating their association in vivo. We prepared inactive mutants of both enzymes by destroying the DXD motifs. The mixture of mutated beta 3Gn-T2 and intact beta 3Gn-T8 did not exhibit any activation, whereas the mixture of intact beta 3Gn-T2 and mutated beta 3Gn-T8 had increased activity, indicating the activation of beta 3Gn-T2 via complex formation. Next, we compared expression levels of beta 3Gn-T1-T8 in HL-60 cells and DMSO-treated differentiated HL-60 cells, which produce larger poly-N-acetyllactosamine chains. The expression level of beta 3Gn-T8 in the differentiated cells was 2.6-fold higher than in the untreated cells. Overexpression of beta 3Gn-T8, but not beta 3Gn-T2, induced an increase in poly-N-acetyllactosamine chains in HL-60 cells. These results raise a possibility that up-regulation of beta 3Gn-T8 in differentiated HL-60 cells increases poly-Nacetyllactosamine chains by activating intrinsic beta 3Gn-T2.	[Seko, Akira; Yamashita, Katsuko] Tokyo Inst Technol, Innovat Res Initiat, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Yamashita, Katsuko] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Yamashita, K (corresponding author), Tokyo Inst Technol, Innovat Res Initiat, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	kyamashi@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [14082208]; New Energy and Industrial Technology Development Organization	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by Grant-in-Aid for Scientific Research on Priority Area(s) 14082208 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the New Energy and Industrial Technology Development Organization. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bieberich E, 2002, BIOCHEMISTRY-US, V41, P11479, DOI 10.1021/bi0259958; Borsig L, 1998, GLYCOBIOLOGY, V8, P259, DOI 10.1093/glycob/8.3.259; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; Chen C, 2000, J BIOL CHEM, V275, P13819, DOI 10.1074/jbc.275.18.13819; de Graffenried CL, 2004, J BIOL CHEM, V279, P40035, DOI 10.1074/jbc.M405709200; Gentzsch M, 1995, FEBS LETT, V377, P128, DOI 10.1016/0014-5793(95)01324-5; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; Izumikawa T, 2006, J BIOL CHEM, V281, P1929, DOI 10.1074/jbc.M509138200; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; LEE N, 1990, J BIOL CHEM, V265, P20476; Li JH, 2000, J BIOL CHEM, V275, P41476, DOI 10.1074/jbc.M007480200; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Nagai N, 2004, J CELL SCI, V117, P3331, DOI 10.1242/jcs.01191; Nilsson T, 1996, J CELL SCI, V109, P1975; Ouzzine M, 2000, J BIOL CHEM, V275, P28254; Qian R, 2001, J BIOL CHEM, V276, P28641, DOI 10.1074/jbc.M103664200; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Seko A, 2004, FEBS LETT, V556, P216, DOI 10.1016/S0014-5793(03)01440-6; Seko A, 2006, TRENDS GLYCOSCI GLYC, V18, P209, DOI 10.4052/tigg.18.209; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; Terada M, 2005, J BIOL CHEM, V280, P10897, DOI 10.1074/jbc.M413092200; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; VARKI A, 1999, ESSENTIALS GLYCOBIOL, P211; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; YAMASHITA K, 1981, J BIOL CHEM, V256, P4789	36	29	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33094	33100		10.1074/jbc.M806933200	http://dx.doi.org/10.1074/jbc.M806933200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826941	hybrid, Green Published			2022-12-25	WOS:000261183700010
J	Cubbon, RM; Abbas, A; Wheatcroft, SB; Kilcullen, N; Das, R; Morrell, C; Barth, JH; Kearney, MT; Hall, AS				Cubbon, Richard M.; Abbas, Afroze; Wheatcroft, Stephen B.; Kilcullen, Niamh; Das, Raj; Morrell, Christine; Barth, Julian H.; Kearney, Mark T.; Hall, Alistair S.		EMMACE 2 Investigators	Diabetes Mellitus and Mortality after Acute Coronary Syndrome as a First or Recurrent Cardiovascular Event	PLOS ONE			English	Article								Background: Diabetes Mellitus (DM) is associated with adverse cardiovascular prognosis. However, the risk associated with DM may vary between individuals according to their overall cardiovascular risk burden. Therefore, we aimed to determine whether DM is associated with poor outcome in patients presenting with Acute Coronary Syndrome (ACS) according to the index episode being a first or recurrent cardiovascular event. Methods and Findings: We conducted a retrospective analysis of a prospective cohort study involving 2499 consecutively admitted patients with confirmed ACS in 11 UK hospitals during 2003. Usual care was provided for all participants. Demographic factors, co-morbidity and treatment (during admission and at discharge) factors were recorded. The primary outcome was all cause mortality (median 2 year follow up), compared for cohorts with and without DM according to their prior cardiovascular disease (CVD) disease status. Adjusted analyses were performed with Cox proportional hazards regression analysis. Within the entire cohort, DM was associated with an unadjusted 45% increase in mortality. However, in patients free of a history of CVD, mortality of those with and without DM was similar (18.8% and 19.7% respectively; p=0.74). In the group with CVD, mortality of patients with DM was significantly higher than those without DM (46.7% and 33.2% respectively; p, 0.001). The age and sex adjusted interaction between DM and CVD in predicting mortality was highly significant (p=0.002) and persisted after accounting for comorbidities and treatment factors (p=0.006). Of patients free of CVD, DM was associated with smaller elevation of Troponin I (p < 0.001). However in patients with pre-existing CVD Troponin I was similar (p=0.992). Conclusions: DM is only associated with worse outcome after ACS in patients with a pre-existing history of CVD. Differences in the severity of myocyte necrosis may account for this. Further investigation is required, though our findings suggest that aggressive primary prevention of CVD in patients with DM may have beneficially modified their first presentation with (and mortality after) ACS.	[Cubbon, Richard M.; Abbas, Afroze; Wheatcroft, Stephen B.; Kearney, Mark T.] Univ Leeds, LIGHT Labs, Leeds Inst Genet Hlth & Therapeut, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England; [Kilcullen, Niamh; Das, Raj; Morrell, Christine; Hall, Alistair S.] Leeds Gen Infirmary, C NET Grp, Leeds, W Yorkshire, England; [Barth, Julian H.] Leeds Gen Infirmary, Dept Clin Biochem & Immunol, Leeds, W Yorkshire, England	University of Leeds; Leeds General Infirmary; Leeds General Infirmary	Cubbon, RM (corresponding author), Univ Leeds, LIGHT Labs, Leeds Inst Genet Hlth & Therapeut, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England.	m.t.kearney@leeds.ac.uk	Hall, Alistair/K-1953-2019; Barth, Julian H/F-6028-2010		Beckman Coulter; AstraZeneca; Sanofi-Aventis; British Heart Foundation [fellowships]	Beckman Coulter; AstraZeneca(AstraZeneca); Sanofi-Aventis(Sanofi-Aventis); British Heart Foundation(British Heart Foundation)	Beckman Coulter, AstraZeneca and Sanofi-Aventis provided research grants for the EMMACE-2 study. Dr. Cubbon and Dr. Abbas receive support from British Heart Foundation clinical PhD fellowships. Dr. Wheatcroft receives support from a British Heart Foundation intermediate fellowship. Dr. Das and Dr. Kilcullen were supported by British Heart Foundation junior research fellowships; the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Das R, 2006, HEART, V92, P21, DOI 10.1136/hrt.2004.046441; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Evans JMM, 2002, BRIT MED J, V324, P939, DOI 10.1136/bmj.324.7343.939; Goraya TY, 2002, J AM COLL CARDIOL, V40, P946, DOI 10.1016/S0735-1097(02)02065-X; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Howard BV, 2006, DIABETES CARE, V29, P391, DOI 10.2337/diacare.29.02.06.dc05-1299; Kleiman NS, 2005, HEART, V91, P1121, DOI 10.1136/hrt.2004.056085; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Natali A, 2000, DIABETOLOGIA, V43, P632, DOI 10.1007/s001250051352; Ryden L, 2007, EUR HEART J SUPPL, V9, pC3, DOI 10.1093/eurheartj/ehl261	11	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3483	10.1371/journal.pone.0003483	http://dx.doi.org/10.1371/journal.pone.0003483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941531	Green Submitted, Green Published, gold			2022-12-25	WOS:000265126100014
J	Hannoush, RN				Hannoush, Rami N.			Kinetics of Wnt-Driven beta-Catenin Stabilization Revealed by Quantitative and Temporal Imaging	PLOS ONE			English	Article								The Wnt/beta-catenin signal transduction pathway regulates a broad range of developmental processes. Aberrant activation of the Wnt pathway leads to cancer and degenerative diseases. beta-catenin is a key signaling molecule that is frequently used as a direct monitor of Wnt pathway activation. This paper describes a multi-parametric method for quantitative analysis of cellular beta-catenin protein levels in a rapid and high-throughput manner. The assay offers temporally resolved detection of Wnt-stimulated accumulation of beta-catenin, simultaneously detecting cell number, and it sheds light onto the kinetics of posttranslational stabilization of beta-catenin.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech	Hannoush, RN (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	hannoush.rami@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was funded by Genentech, Inc.	Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Smith PJ, 1999, J IMMUNOL METHODS, V229, P131, DOI 10.1016/S0022-1759(99)00116-7; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	17	38	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3498	10.1371/journal.pone.0003498	http://dx.doi.org/10.1371/journal.pone.0003498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941539	Green Published, Green Submitted, gold			2022-12-25	WOS:000265126100025
J	Serandour, J; Reynaud, S; Willison, J; Patouraux, J; Gaude, T; Ravanel, P; Lemperiere, G; Raveton, M				Serandour, Julien; Reynaud, Stephane; Willison, John; Patouraux, Joelle; Gaude, Thierry; Ravanel, Patrick; Lemperiere, Guy; Raveton, Muriel			Ubiquitous Water-Soluble Molecules in Aquatic Plant Exudates Determine Specific Insect Attraction	PLOS ONE			English	Article								Plants produce semio-chemicals that directly influence insect attraction and/or repulsion. Generally, this attraction is closely associated with herbivory and has been studied mainly under atmospheric conditions. On the other hand, the relationship between aquatic plants and insects has been little studied. To determine whether the roots of aquatic macrophytes release attractive chemical mixtures into the water, we studied the behaviour of mosquito larvae using olfactory experiments with root exudates. After testing the attraction on Culex and Aedes mosquito larvae, we chose to work with Coquillettidia species, which have a complex behaviour in nature and need to be attached to plant roots in order to obtain oxygen. This relationship is non-destructive and can be described as commensal behaviour. Commonly found compounds seemed to be involved in insect attraction since root exudates from different plants were all attractive. Moreover, chemical analysis allowed us to identify a certain number of commonly found, highly water-soluble, low-molecular-weight compounds, several of which ( glycerol, uracil, thymine, uridine, thymidine) were able to induce attraction when tested individually but at concentrations substantially higher than those found in nature. However, our principal findings demonstrated that these compounds appeared to act synergistically, since a mixture of these five compounds attracted larvae at natural concentrations (0.7 nM glycerol, <0.5 nM uracil, 0.6 nM thymine, 2.8 nM uridine, 86 nM thymidine), much lower than those found for each compound tested individually. These results provide strong evidence that a mixture of polyols (glycerol), pyrimidines (uracil, thymine), and nucleosides (uridine, thymidine) functions as an efficient attractive signal in nature for Coquillettidia larvae. We therefore show for the first time, that such commonly found compounds may play an important role in plant-insect relationships in aquatic eco-systems.	[Serandour, Julien; Reynaud, Stephane; Patouraux, Joelle; Gaude, Thierry; Ravanel, Patrick; Lemperiere, Guy; Raveton, Muriel] Univ Grenoble 1, Lab Ecol Alpine, Equipe Perturbat Environm & Xenobiot, CNRS,UMR 5553, Grenoble, France; [Willison, John] CEA Grenoble, Inst Rech Technol Sci Vivant, UJF, CEA, CNRS, UMR 5249,Lab Chim Biol Metaux, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Serandour, J (corresponding author), Univ Grenoble 1, Lab Ecol Alpine, Equipe Perturbat Environm & Xenobiot, CNRS,UMR 5553, BP 53, Grenoble, France.	muriel.raveton@ujf-grenoble.fr	Reynaud, Stephane/H-5493-2013; Raveton, Muriel/K-1403-2013	Reynaud, Stephane/0000-0003-0248-0602; 				Apperson CS, 2002, J MED ENTOMOL, V39, P777, DOI 10.1603/0022-2585-39.5.777; Bartlet E, 1997, ENTOMOL EXP APPL, V85, P257, DOI 10.1023/A:1003140219888; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bosak PJ, 2002, J AM MOSQUITO CONTR, V18, P280; Cancrini G, 2006, J MED ENTOMOL, V43, P574, DOI 10.1603/0022-2585(2006)43[574:NVODIR]2.0.CO;2; Carr W.E.S., 1988, P3; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Chaton PF, 2001, PESTIC BIOCHEM PHYS, V69, P183, DOI 10.1006/pest.2000.2536; CLEMENTS AN, 1999, BIOL MOSQUITOES, V2, P74; Cupp EW, 2007, J MED ENTOMOL, V44, P117, DOI 10.1603/0022-2585(2007)44[117:WNVIIM]2.0.CO;2; Cupp EW, 2003, AM J TROP MED HYG, V68, P495, DOI 10.4269/ajtmh.2003.68.495; D'Alessandro M, 2006, ANALYST, V131, P24, DOI 10.1039/b507589k; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; EVANS WG, 1982, J CHEM ECOL, V8, P671, DOI 10.1007/BF00989636; Ferry A, 2007, J CHEM ECOL, V33, P2064, DOI 10.1007/s10886-007-9373-3; Fink P, 2007, MAR FRESHW BEHAV PHY, V40, P155, DOI 10.1080/10236240701602218; FOOTE BA, 1995, ANNU REV ENTOMOL, V40, P417, DOI 10.1146/annurev.en.40.010195.002221; HOULIHAN DF, 1969, J ZOOL, V159, P249; Kalinova J, 2007, J AGR FOOD CHEM, V55, P6453, DOI 10.1021/jf070795u; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; KAUFMAN MG, 2007, SOIL BIOL BIOCHEM, DOI DOI 10.1007/S00248-007-9310-6; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kidd PS, 2001, J EXP BOT, V52, P1339, DOI 10.1093/jexbot/52.359.1339; KLINGER TS, 1985, MAR BEHAV PHYSIOL, V11, P327, DOI 10.1080/10236248509387057; Kramer C, 2008, SOIL BIOL BIOCHEM, V40, P425, DOI 10.1016/j.soilbio.2007.09.016; Kumar R, 2006, CURR SCI INDIA, V91, P885; LAURENCE B. R., 1960, BULL ENT RES, V51, P491, DOI 10.1017/S0007485300055127; Manda H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-113; Mandalakas AM, 2005, EMERG INFECT DIS, V11, P1774, DOI 10.3201/eid1111.040933; MANN KH, 1984, J EXP MAR BIOL ECOL, V79, P233, DOI 10.1016/0022-0981(84)90197-7; Marko MD, 2005, J CHEM ECOL, V31, P2857, DOI 10.1007/s10886-005-8399-7; MAY B M, 1970, New Zealand Entomologist, V4, P7; METCALF RL, 1992, CHEM ECOLOGY PLANT K, P64; MILLER V, 1976, J CHROMATOGR, V119, P355, DOI 10.1016/S0021-9673(00)86799-0; Rahman YJ, 2000, J CHEM ECOL, V26, P679, DOI 10.1023/A:1005428221952; Raveton M, 1997, PESTIC BIOCHEM PHYS, V58, P199, DOI 10.1006/pest.1997.2303; Rejmankova Eliska, 2000, Aquatic Ecology, V34, P413, DOI 10.1023/A:1011416006562; ROSELAND CR, 1992, ENTOMOL EXP APPL, V62, P99, DOI 10.1007/BF00345480; SAGLIO P, 1990, J FISH BIOL, V37, P887, DOI 10.1111/j.1095-8649.1990.tb03592.x; Serandour J, 2006, ENTOMOL EXP APPL, V120, P195, DOI 10.1111/j.1570-7458.2006.00444.x; TAKABAYASHI J, 1995, J CHEM ECOL, V21, P273, DOI 10.1007/BF02036717; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; Vinson S.B., 1987, P 6 INT S INS PLANT, P109; WAGNER KG, 1992, INT REV CYTOL, V134, P1, DOI 10.1016/S0074-7696(08)62027-6; Wei J. N., 2007, PLOS ONE, V9, P1; Weissburg MJ, 2002, J CHEM ECOL, V28, P1953, DOI 10.1023/A:1020741710060; Wenger K, 2005, J ENVIRON QUAL, V34, P2187, DOI 10.2134/jeq2004.0409; Wu C.-Y., 1990, Chinese Journal of Entomology, V10, P151; Xia S, 2007, PLOS BIOL, V5, P2398, DOI 10.1371/journal.pbio.0050264; Yoon HR, 2007, ARCH PHARM RES, V30, P387, DOI 10.1007/BF02977623	53	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3350	10.1371/journal.pone.0003350	http://dx.doi.org/10.1371/journal.pone.0003350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841203	gold, Green Submitted, Green Published			2022-12-25	WOS:000265113900005
J	Yang, CC; Shih, YH; Ko, MH; Hsu, SY; Cheng, H; Fu, YS				Yang, Chang-Ching; Shih, Yang-Hsin; Ko, Miau-Hwa; Hsu, Shao-Yun; Cheng, Henrich; Fu, Yu-Show			Transplantation of Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly after Complete Transection of the Rat Spinal Cord	PLOS ONE			English	Article								Background: Human umbilical mesenchymal stem cells (HUMSCs) isolated from Wharton's jelly of the umbilical cord can be easily obtained and processed compared with embryonic or bone marrow stem cells. These cells may be a valuable source in the repair of spinal cord injury. Methodology/Principal Findings: We examine the effects of HUMSC transplantation after complete spinal cord transection in rats. Approximately 5610 5 HUMSCs were transplanted into the lesion site. Three groups of rats were implanted with either untreated HUMSCs (referred to as the stem cell group), or HUMSCs treated with neuronal conditioned medium (NCM) for either three days or six days (referred to as NCM-3 and NCM-6 days, respectively). The control group received no HUMSCs in the transected spinal cord. Three weeks after transplantation, significant improvements in locomotion were observed in all the three groups receiving HUMSCs (stem cell, NCM-3 and NCM-6 days groups). This recovery was accompanied by increased numbers of regenerated axons in the corticospinal tract and neurofilament-positive fibers around the lesion site. There were fewer microglia and reactive astrocytes in both the rostral and caudal stumps of the spinal cord in the stem cell group than in the control group. Transplanted HUMSCs survived for 16 weeks and produced large amounts of human neutrophil-activating protein-2, neurotrophin-3, basic fibroblast growth factor, glucocorticoid induced tumor necrosis factor receptor, and vascular endothelial growth factor receptor 3 in the host spinal cord, which may help spinal cord repair. Conclusions/Significance: Transplantation of HUMSCs is beneficial to wound healing after spinal cord injury in rats.	[Yang, Chang-Ching; Hsu, Shao-Yun] Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei 112, Taiwan; [Shih, Yang-Hsin] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Shih, Yang-Hsin] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Ko, Miau-Hwa] China Med Univ, Sch Med, Dept Anat, Taichung, Taiwan; [Cheng, Henrich] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Neural Regenerat Lab, Taipei, Taiwan; [Cheng, Henrich] Natl Yang Ming Univ, Sch Med, Dept Pharmacol, Taipei, Taiwan; [Fu, Yu-Show] Natl Yang Ming Univ, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan; [Fu, Yu-Show] Taipei City Hosp, Dept Ed & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; China Medical University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Yang, CC (corresponding author), Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei 112, Taiwan.	hc_cheng@vghtpe.gov.tw; ysfu@ym.edu.tw			National Science Council [NSC97-2314-B-075-011-MY3]; Taipei Veterans General Hospital [V96C1-102]; Ministry of Education, Aim for the Top University Plan [97A-C-T159]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by the Grant NSC97-2314-B-075-011-MY3 from the National Science Council, Grant V96C1-102 from the Taipei Veterans General Hospital, Grant 97A-C-T159 from Ministry of Education, Aim for the Top University Plan.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; BJORKLUND A, 1993, NATURE, V362, P414, DOI 10.1038/362414a0; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Fu YS, 2004, J BIOMED SCI, V11, P652, DOI 10.1159/000079678; Gibson CL, 2005, GLIA, V50, P417, DOI 10.1002/glia.20143; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Horner PJ, 2000, J NEUROSCI, V20, P2218; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P52; Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P50; Kassam Amin, 2004, Ear Nose Throat J, V83, P246; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kitamura Y, 2005, J PHARMACOL SCI, V97, P289, DOI 10.1254/jphs.SC0040129; Kitamura Y, 2004, J PHARMACOL SCI, V94, P203, DOI 10.1254/jphs.94.203; Kojima A, 2000, J NEUROPATH EXP NEUR, V59, P687, DOI 10.1093/jnen/59.8.687; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee TT, 1999, J NEUROTRAUM, V16, P347, DOI 10.1089/neu.1999.16.347; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Marti HH, 1998, P NATL ACAD SCI USA, V95, P15809, DOI 10.1073/pnas.95.26.15809; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Perrin LA, 2004, GENE THER, V11, P512, DOI 10.1038/sj.gt.3302173; Petter-Puchner AH, 2007, EXP TOXICOL PATHOL, V58, P237, DOI 10.1016/j.etp.2006.07.004; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Robinson CJ, 2001, J CELL SCI, V114, P853; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Song S, 2004, EXP NEUROL, V185, P191, DOI 10.1016/j.expneurol.2003.09.003; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; Teng YD, 1999, J NEUROSCI, V19, P7037, DOI 10.1523/JNEUROSCI.19-16-07037.1999; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Tsai EC, 2005, J NEUROPATH EXP NEUR, V64, P230, DOI 10.1093/jnen/64.3.230; Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	68	182	207	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3336	10.1371/journal.pone.0003336	http://dx.doi.org/10.1371/journal.pone.0003336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18852872	Green Published, gold, Green Submitted			2022-12-25	WOS:000265113500004
J	Baumgartner, W; Fidler, F; Weth, A; Habbecke, M; Jakob, P; Butenweg, C; Bohme, W				Baumgartner, Werner; Fidler, Florian; Weth, Agnes; Habbecke, Martin; Jakob, Peter; Butenweg, Christoph; Boehme, Wolfgang			Investigating the Locomotion of the Sandfish in Desert Sand Using NMR-Imaging	PLOS ONE			English	Article								The sandfish (Scincus scincus) is a lizard having the remarkable ability to move through desert sand for significant distances. It is well adapted to living in loose sand by virtue of a combination of morphological and behavioural specializations. We investigated the bodyform of the sandfish using 3D-laserscanning and explored its locomotion in loose desert sand using fast nuclear magnetic resonance (NMR) imaging. The sandfish exhibits an in-plane meandering motion with a frequency of about 3 Hz and an amplitude of about half its body length accompanied by swimming-like (or trotting) movements of its limbs. No torsion of the body was observed, a movement required for a digging-behaviour. Simple calculations based on the Janssen model for granular material related to our findings on bodyform and locomotor behaviour render a local decompaction of the sand surrounding the moving sandfish very likely. Thus the sand locally behaves as a viscous fluid and not as a solid material. In this fluidised sand the sandfish is able to "swim'' using its limbs.	[Baumgartner, Werner; Weth, Agnes] Rhein Westfal TH Aachen, Dept Cellular Neurob, Aachen, Germany; [Fidler, Florian; Jakob, Peter] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany; [Habbecke, Martin] Rhein Westfal TH Aachen, Inst Computergraph & Multimedia, Aachen, Germany; [Butenweg, Christoph] Rhein Westfal TH Aachen, Chair Struct Stat & Dyn, Aachen, Germany; [Boehme, Wolfgang] Zool Forschungsmuseum Alexander Koenig ZFMK, Bonn, Germany	RWTH Aachen University; University of Wurzburg; RWTH Aachen University; RWTH Aachen University; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Baumgartner, W (corresponding author), Rhein Westfal TH Aachen, Dept Cellular Neurob, Aachen, Germany.	werner@bio2.rwth-aachen.de	Baumgartner, Werner/C-5013-2012	Baumgartner, Werner/0000-0002-3160-2050; Jakob, Peter/0000-0002-3481-5545				Anderson S.C, 1999, LIZARDS IRAN; Arnold E.N, 1977, Bulletin Br Mus nat Hist (Zool), V31, P189; ARNOLD EN, 1995, J ZOOL, V235, P351, DOI 10.1111/j.1469-7998.1995.tb01758.x; Baumgartner W, 2007, J BIONIC ENG, V4, P1, DOI 10.1016/S1672-6529(07)60006-7; BELLAIRS A, 1971, REPTILIEN; Besl P. J., 1988, Machine Vision and Applications, V1, P127, DOI 10.1007/BF01212277; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bons J, 1996, AMPHIBIENS REPTILES; BRANDT JF, 1829, MED ZOOLOGIE ODER GE; DISI JF, 2001, AMPHIBIANS REPTILES; DURAN J, 2000, SANDS POWDERS GRAINS; El Toubi M. R., 1938, Bulletin of the Faculty of Science Cairo, V14, P5; Geniez P, 2004, AMPHIBIANS REPTILES; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Halloy Monique, 1998, Herpetological Monographs, V12, P1, DOI 10.2307/1467019; Hartmann U.-K., 1989, Herpetofauna (Weinstadt), V11, P12; Hartmann U.-K., 1989, Herpetofauna (Weinstadt), V11, P17; HARTMANN UK, 1986, BIOL APOTHEKERSKINKS; HORNUNG A, 2006, P 4 EUR S GEOM PROC, P41; Laurenti JN, 1768, SPECIMEN MEDICUM EXH; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V1, DOI 10.5962/bhl.title.542; LUKE C, 1986, BIOL J LINN SOC, V27, P1, DOI 10.1111/j.1095-8312.1986.tb01723.x; MERTENS R, 1972, Salamandra, V8, P117; Nance HA, 2007, AFR J HERPETOL, V56, P39, DOI 10.1080/21564574.2007.9635552; Pough FH, 2001, HERPETOLOGY; RECHENBERG I, 2004, REIBUNG VERSCHLEISS; SUKHANOV BV, 1968, OBSHCHAYA SISTEMA SI; TERCAFS RR, 1961, B SOC ROY ZOOL ANVER, V10, P3	28	39	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3309	10.1371/journal.pone.0003309	http://dx.doi.org/10.1371/journal.pone.0003309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18836551	Green Published, Green Submitted, gold			2022-12-25	WOS:000264797200012
J	Russell, MR; Jamieson, WL; Dolloff, NG; Fatatis, A				Russell, M. R.; Jamieson, W. L.; Dolloff, N. G.; Fatatis, A.			The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells	ONCOGENE			English	Article						skeletal metastasis; prostate adenocarcinoma; PDGFR alpha	PHASE-II TRIAL; IMATINIB MESYLATE; BONE-MARROW; BIOCHEMICAL RELAPSE; MOUSE MODEL; SURVIVAL; PROGRESSION; MECHANISMS; EXPRESSION; PATHWAY	Bone resorption by osteoclasts is thought to promote the proliferation of prostate cancer cells disseminated to the skeleton (Mundy, 2002). Using a mouse model of experimental metastasis, we found that although late-stage metastatic tumors were indeed surrounded by osteoclasts, these cells were spatially unrelated to the small foci of cancer cells in early-stage metastases. This is the first evidence that survival and growth of disseminated prostate cancer cells immediately after their extravasation may not depend on osteoclast involvement. Interestingly, prostate cancer cells expressing the alpha-receptor for platelet-derived growth factor (PDGFR alpha) progress during early-stages of skeletal dissemination, whereas cells expressing lower levels or lacking this receptor fail to survive after extravasation in the bone marrow. However, non-metastatic cells acquire bone-metastatic potential upon ectopic overexpression of PDGFR alpha. Finally, functional blockade of human PDGFR alpha on prostate cancer cells utilizing a novel humanized monoclonal antibody-soon to undergo phase-II clinical trials-significantly impairs the establishment of early skeletal metastases. In conclusion, our results strongly implicate PDGFR alpha in prostate cancer bone tropism through its promotion of survival and progression of early-metastatic foci, providing ground for therapeutic strategies aimed at preventing or containing the initial progression of skeletal metastases in patients affected by prostate adenocarcinoma.	[Russell, M. R.; Jamieson, W. L.; Dolloff, N. G.; Fatatis, A.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Fatatis, A.] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19102 USA	Drexel University; Drexel University	Fatatis, A (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, 245 N 15th St,New Coll Bldg MS488, Philadelphia, PA 19102 USA.	afatatis@drexelmed.edu			NIH [GM067892]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The cDNA for human PDGFR alpha was a kind gift of Dr Carl-Henrik Heldin (Ludwig Institute for Cancer Research, Uppsala, Sweden). We thank Dr Olimpia Meucci (Department of Pharmacology and Physiology) for critically reading the manuscript and helpful discussion, Dr Mark Stearns (Department of Pathology and Laboratory Medicine) for helpful discussion, Dr Gregg Johannes (Department of Pathology and Laboratory Medicine) for help with the PDGFR alpha-expressing vector, Mr Michael Amatangelo for his contribution to the immuno-detection of PDGFR alpha in human tissues and Dr Nick Loizos (ImClone Systems Inc., New York, NY, USA) for kindly providing the IMC-3G3 antibody. This study was supported in part by the NIH Grant GM067892 to AF.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bajaj GK, 2007, UROLOGY, V69, P526, DOI 10.1016/j.urology.2006.12.006; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Canon JR, 2008, CLIN EXP METASTAS, V25, P119, DOI 10.1007/s10585-007-9127-1; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Dolloff NG, 2007, CANCER RES, V67, P555, DOI 10.1158/0008-5472.CAN-06-2593; Dolloff NG, 2005, ONCOGENE, V24, P6848, DOI 10.1038/sj.onc.1208815; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fritz V, 2007, BONE, V40, P1032, DOI 10.1016/j.bone.2006.11.026; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Jamieson WL, 2008, CANCER RES, V68, P1715, DOI 10.1158/0008-5472.CAN-07-1315; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Lee YP, 2002, CANCER RES, V62, P5564; Lin AM, 2006, BJU INT, V98, P763, DOI 10.1111/j.1464-410X.2006.06396.x; Loizos N, 2005, MOL CANCER THER, V4, P369; Mathew P, 2004, J CLIN ONCOL, V22, P3323, DOI 10.1200/JCO.2004.10.116; Mathew P, 2007, CLIN CANCER RES, V13, P5816, DOI 10.1158/1078-0432.CCR-07-1269; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nemeth JA, 1999, CANCER RES, V59, P1987; Paget S, 1889, LANCET, V133, P571, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Rao K, 2005, PROSTATE, V62, P115, DOI 10.1002/pros.20130; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; ROSS RW, 2006, CANC MED, P1431; Schneider A, 2005, ENDOCRINOLOGY, V146, P1727, DOI 10.1210/en.2004-1211; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Thorarinsdottir HK, 2008, CLIN CANCER RES, V14, P3386, DOI 10.1158/1078-0432.CCR-07-1616; van der Pluijm G, 2005, CANCER RES, V65, P7682, DOI 10.1158/0008-5472.CAN-04-4188; Vantyghem SA, 2005, CLIN EXP METASTAS, V22, P351, DOI 10.1007/s10585-005-0745-1; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	33	33	38	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					412	421		10.1038/onc.2008.390	http://dx.doi.org/10.1038/onc.2008.390			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18850002				2022-12-25	WOS:000262550300009
J	Baba, T; Convery, PA; Matsumura, N; Whitaker, RS; Kondoh, E; Perry, T; Huang, Z; Bentley, RC; Mori, S; Fujii, S; Marks, JR; Berchuck, A; Murphy, SK				Baba, T.; Convery, P. A.; Matsumura, N.; Whitaker, R. S.; Kondoh, E.; Perry, T.; Huang, Z.; Bentley, R. C.; Mori, S.; Fujii, S.; Marks, J. R.; Berchuck, A.; Murphy, S. K.			Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells	ONCOGENE			English	Article						CD133; ovarian cancer; cancer-initiating cell; DNA methylation; xenograft	STEM-CELLS; OVARIAN-CANCER; HEMATOPOIETIC STEM; INITIATING CELLS; GENE-EXPRESSION; IDENTIFICATION; GLIOBLASTOMA; CARCINOMA; TUMORS; AC133	The cancer stem cell hypothesis posits that malignant growth arises from a rare population of progenitor cells within a tumor that provide it with unlimited regenerative capacity. Such cells also possess increased resistance to chemotherapeutic agents. Resurgence of chemoresistant disease after primary therapy typifies epithelial ovarian cancer and may be attributable to residual cancer stem cells, or cancer-initiating cells, that survive initial treatment. As the cell surface marker CD133 identifies cancer-initiating cells in a number of other malignancies, we sought to determine the potential role of CD133+ cells in epithelial ovarian cancer. We detected CD133 on ovarian cancer cell lines, in primary cancers and on purified epithelial cells from ascitic fluid of ovarian cancer patients. We found CD133+ ovarian cancer cells generate both CD133+ and CD133- daughter cells, whereas CD133- cells divide symmetrically. CD133+ cells exhibit enhanced resistance to platinum-based therapy, drugs commonly used as first-line agents for the treatment of ovarian cancer. Sorted CD133+ ovarian cancer cells also form more aggressive tumor xenografts at a lower inoculum than their CD133- progeny. Epigenetic changes may be integral to the behavior of cancer progenitor cells and their progeny. In this regard, we found that CD133 transcription is controlled by both histone modi. cations and promoter methylation. Sorted CD133- ovarian cancer cells treated with DNA methyltransferase and histone deacetylase inhibitors show a synergistic increase in cell surface CD133 expression. Moreover, DNA methylation at the ovarian tissue active P2 promoter is inversely correlated with CD133 transcription. We also found that promoter methylation increases in CD133- progeny of CD133+ cells, with CD133+ cells retaining a less methylated or unmethylated state. Taken together, our results show that CD133 expression in ovarian cancer is directly regulated by epigenetic modi. cations and support the idea that CD133 demarcates an ovarian cancer-initiating cell population. The activity of these cells may be epigenetically detected and such cells might serve as pertinent chemotherapeutic targets for reducing disease recurrence.	[Baba, T.; Convery, P. A.; Matsumura, N.; Whitaker, R. S.; Kondoh, E.; Perry, T.; Huang, Z.; Berchuck, A.; Murphy, S. K.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27708 USA; [Baba, T.; Matsumura, N.; Kondoh, E.; Fujii, S.] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto, Japan; [Bentley, R. C.; Murphy, S. K.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Mori, S.; Marks, J. R.; Berchuck, A.; Murphy, S. K.] Duke Inst Genome Sci & Policy, Durham, NC USA; [Marks, J. R.] Duke Univ, Dept Surg, Durham, NC USA	Duke University; Kyoto University; Duke University; Duke University; Duke University	Murphy, SK (corresponding author), Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, 2185 F CIEMAS,Box 91012,101 Sci Dr, Durham, NC 27708 USA.	murph035@mc.duke.edu	Murphy, Susan/R-3903-2019	Murphy, Susan/0000-0001-8298-7272; Matsumura, Noriomi/0000-0002-4512-7975; Kondoh, Eiji/0000-0002-8379-3143; BABA, Tsukasa/0000-0003-0066-3747	Kislak-Fields Family Fund; Duke Comprehensive Cancer Center; Gail Parkins Memorial Ovarian Awareness Fund	Kislak-Fields Family Fund; Duke Comprehensive Cancer Center; Gail Parkins Memorial Ovarian Awareness Fund	We thank Drs John Lancaster, Jeffrey Boyd, Thomas Hamilton, Gordon Mills and Jean Hurteau for providing many of the cell lines used in these studies; Dr William E Grizzle for preparing tissue microarrays; Mike Cook for help with flow cytometry and Nancy Glover and Julie Fuller for the preparation of slides used for immunohistochemistry. This study was supported by the Kislak-Fields Family Fund, the Duke Comprehensive Cancer Center, and the Gail Parkins Memorial Ovarian Awareness Fund.	Balch C, 2007, BIOESSAYS, V29, P842, DOI 10.1002/bies.20619; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; FERRANDINA G, 2007, INT J GYNECOL CANCER, V14, P14; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Huang ZQ, 2006, NUCLEIC ACIDS RES, V34, P555, DOI 10.1093/nar/gkj468; HURTEAU J, 1994, CANCER, V74, P93, DOI 10.1002/1097-0142(19940701)74:1<93::AID-CNCR2820740117>3.0.CO;2-P; JACOBS IJ, 1992, J NATL CANCER I, V84, P1793, DOI 10.1093/jnci/84.23.1793; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Ma DQ, 2007, MOL PSYCHIATR, V12, P376, DOI 10.1038/sj.mp.4001927; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma Yanping, 2002, Zhonghua Nei Ke Za Zhi, V41, P798; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; MOK CH, 1992, CANCER RES, V52, P5119; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ruau D, 2008, STEM CELLS, V31, P31; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	42	337	365	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					209	218		10.1038/onc.2008.374	http://dx.doi.org/10.1038/onc.2008.374			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18836486				2022-12-25	WOS:000262501100005
J	Bogacheva, O; Bogachev, O; Menon, M; Dev, A; Houde, E; Valoret, EI; Prosser, HM; Creasy, CL; Pickering, SJ; Grau, E; Rance, K; Livi, GP; Karur, V; Erickson-Miller, CL; Wojchowski, DM				Bogacheva, Olga; Bogachev, Oleg; Menon, Madhu; Dev, Arvind; Houde, Estelle; Valoret, Elizabeth I.; Prosser, Haydn M.; Creasy, Caretha L.; Pickering, Susan J.; Grau, Evelyn; Rance, Kim; Livi, George P.; Karur, Vinit; Erickson-Miller, Connie L.; Wojchowski, Don M.			DYRK3 Dual-specificity Kinase Attenuates Erythropoiesis during Anemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATES CELL-SURVIVAL; PROTEIN; PHOSPHORYLATION; FAMILY; ACTIVATION; MIRK/DYRK1B; MODULATION; RECEPTOR; GENES; PHENOTYPE	During anemia erythropoiesis is bolstered by several factors including KIT ligand, oncostatin-M, glucocorticoids, and erythropoietin. Less is understood concerning factors that limit this process. Experiments performed using dual-specificity tyrosine-regulated kinase-3 (DYRK3) knock-out and transgenic mice reveal that erythropoiesis is attenuated selectively during anemia. DYRK3 is restricted to erythroid progenitor cells and testes. DYRK3(-/-) mice exhibited essentially normal hematological profiles at steady state and reproduced normally. In response to hemolytic anemia, however, reticulocyte production increased severalfold due to DYRK3 deficiency. During 5-fluorouracil-induced anemia, both reticulocyte and red cell formation in DYRK3(-/-) mice were elevated. In short term transplant experiments, DYRK3(-/-) progenitors also supported enhanced erythroblast formation, and erythropoietic advantages due to DYRK3-deficiency also were observed in 5-fluorou-racil-treated mice expressing a compromised erythropoietin receptor EPOR-HM allele. As analyzed ex vivo, DYRK3(-/-) erythroblasts exhibited enhanced CD71(pos)Ter119(pos) cell formation and 3HdT incorporation. Transgenic pA2gata1-DYRK3 mice, in contrast, produced fewer reticulocytes during hemolytic anemia, and pA2gata1-DYRK3 progenitors were compromised in late pro-erythroblast formation ex vivo. Finally, as studied in erythroid K562 cells, DYRK3 proved to effectively inhibit NFAT (nuclear factor of activatedT cells) transcriptional response pathways and to co-immunoprecipitate with NFATc3. Findings indicate that DYRK3 attenuates (and possibly apportions) red cell production selectively during anemia.	[Bogacheva, Olga; Bogachev, Oleg; Menon, Madhu; Dev, Arvind; Houde, Estelle; Karur, Vinit; Wojchowski, Don M.] Maine Med Ctr Res Inst, Stem & Progenitor Cell Biol Program, Div Mol Med, Scarborough, ME 04074 USA; [Valoret, Elizabeth I.; Creasy, Caretha L.; Livi, George P.; Erickson-Miller, Connie L.] GlaxoSmithKline, Collegeville, PA 19426 USA; [Prosser, Haydn M.; Pickering, Susan J.; Grau, Evelyn; Rance, Kim] GlaxoSmithKline, Harlow CM19 5AW, Essex, England	Maine Medical Center; GlaxoSmithKline; GlaxoSmithKline	Wojchowski, DM (corresponding author), Maine Med Ctr Res Inst, Stem & Progenitor Cell Biol Program, Div Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	wojchd@mmc.org		menon, madhu/0000-0002-4075-4961	National Institutes of Health [RO1 DK059472, P20 RR18789]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK059472 and P20 RR18789 (in particular its core facility resources; National Center for Research Resources). E. Valoret, H. Prosser, C. Creasy, S. Pickering, E. Grau, K. Rance, G. Livi, and C. Erickson- Miller are ( or have been) employees of GlaxoSmithKline. The costs of publication of this article were defrayed in part by the of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adayev T, 2006, BIOCHEM BIOPH RES CO, V351, P1060, DOI 10.1016/j.bbrc.2006.10.169; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Callero MA, 2007, CELL PHYSIOL BIOCHEM, V20, P319, DOI 10.1159/000107518; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; de Graaf K, 2004, J BIOL CHEM, V279, P4612, DOI 10.1074/jbc.M310794200; Deng XB, 2006, CANCER RES, V66, P4149, DOI 10.1158/0008-5472.CAN-05-3089; Epstein CJ, 2006, NATURE, V441, P582, DOI 10.1038/441582a; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Geiger JN, 2001, BLOOD, V97, P901, DOI 10.1182/blood.V97.4.901; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Jin K, 2007, CANCER RES, V67, P7247, DOI 10.1158/0008-5472.can-06-4099; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Li K, 2002, J BIOL CHEM, V277, P47052, DOI 10.1074/jbc.M205374200; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Longmore GD, 2006, J CLIN INVEST, V116, P626, DOI 10.1172/JCI27988; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Lyons BL, 2003, EXP HEMATOL, V31, P234, DOI 10.1016/S0301-472X(02)01031-7; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Mercer SE, 2006, CANCER RES, V66, P5143, DOI 10.1158/0008-5472.CAN-05-1539; Miller CP, 2002, BLOOD, V99, P898, DOI 10.1182/blood.V99.3.898; Mirandola P, 2006, BLOOD, V107, P508, DOI 10.1182/blood-2005-07-2676; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Pircher TJ, 2000, ONCOGENE, V19, P3684, DOI 10.1038/sj.onc.1203684; Pratt ZL, 2007, J MOL BIOL, V368, P30, DOI 10.1016/j.jmb.2007.01.046; Quinn J, 2007, CYTOM PART A, V71A, P612, DOI 10.1002/cyto.a.20416; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Sacher F, 2007, MOL CELL ENDOCRINOL, V267, P80, DOI 10.1016/j.mce.2006.12.041; Sarna MK, 2003, ONCOGENE, V22, P3221, DOI 10.1038/sj.onc.1206381; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, PLOS BIOL, V5, P2296, DOI 10.1371/journal.pbio.0050252; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; SYTKOWSKI AJ, 2007, SCI STKE, pPE38, DOI DOI 10.1126/STKE.3952007.PE38; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taminato A, 2002, MOL BIOL CELL, V13, P2266, DOI 10.1091/mbc.01-11-0555; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Zhang DY, 2005, GENOMICS, V85, P117, DOI 10.1016/j.ygeno.2004.08.021; Zhang DY, 2001, EXP HEMATOL, V29, P1278, DOI 10.1016/S0301-472X(01)00725-1	52	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36665	36675		10.1074/jbc.M807844200	http://dx.doi.org/10.1074/jbc.M807844200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18854306	Green Published, hybrid			2022-12-25	WOS:000261840500065
J	Shi, LH; Ko, S; Kim, S; Echchgadda, I; Oh, TS; Song, CS; Chatterjee, B				Shi, Liheng; Ko, Soyoung; Kim, Soyoung; Echchgadda, Ibtissam; Oh, Tae-Sung; Song, Chung S.; Chatterjee, Bandana			Loss of Androgen Receptor in Aging and Oxidative Stress through Myb Protooncoprotein-regulated Reciprocal Chromatin Dynamics of p53 and Poly(ADP-ribose) Polymerase PARP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION; GENE; EXPRESSION; COREPRESSOR; PROTEIN; FAMILY; LIVER; SPECIFICITY	Poly(ADP-ribosyl)ation of transcription factors and coregulators, mediated by the poly(ADP-ribose) polymerase PARP-1, has been emerging as an important epigenetic mechanism that controls transcriptional dynamics in response to diverse intra- and extracellular signals. PARP-1 activity is also implicated in the regulation of mammalian lifespan. Herein we show that transcriptional down-regulation of androgen receptor (AR) in the aging rat liver and in oxidatively stressed hepatoma cells involves exchange of a PARP-1-associated, p/CAF-containing coactivator assembly for a p53-interacting, Groucho/TLE1-, and mSin3A-induded corepressor complex at an age- and oxidant-responsive DNA element (age- dependent factor (ADF) element) in the AR promoter. The coregulator switch is mediated by B-Myb and c-Myb, which bind to the ADF element and physically associate with PARP-1 and the tumor suppressor p53. Heterogeneous nuclear ribonucleoprotein K, residing at the ADF element in association with PARP-1, may serve a platform role in stabilizing the activating complex. PARP-1 coactivated B-Myb- and c-Myb-mediated transactivation of the AR promoter, and p53 antagonized the B-Myb/c-Myb-induced AR promoter activation. PARP-1, heterogeneous nuclear ribonucleoprotein K, B-Myb, and c-Myb each serves as a positive regulator of cellular AR content, whereas p53 negatively regulates AR expression. Our results identify a shared, PARP-1-regulated sensing mechanism that coordinates transcriptional repression of AR during aging and in response to oxidative stress. This study may provide insights as to how advancing age and intracellular redox balance might influence androgen-regulated physiology.	[Shi, Liheng; Ko, Soyoung; Kim, Soyoung; Echchgadda, Ibtissam; Oh, Tae-Sung; Song, Chung S.; Chatterjee, Bandana] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [Chatterjee, Bandana] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Chatterjee, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	chatterjee@uthscsa.edu			National Institutes of Health [AG-10486, AG-19660]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG010486, R01AG010486, R01AG019660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG-10486 and AG-19660. This work was also supported by a merit review grant from Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alimirah F, 2007, NEOPLASIA, V9, P1152, DOI 10.1593/neo.07769; BOIX L, 1995, J HEPATOL, V22, P616, DOI 10.1016/0168-8278(95)80217-7; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bowerman B, 2005, SCIENCE, V308, P1119, DOI 10.1126/science.1113356; Cai Y, 2003, ENDOCRINOLOGY, V144, P2311, DOI 10.1210/en.2002-0129; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; KEMP CJ, 1989, P NATL ACAD SCI USA, V86, P7505, DOI 10.1073/pnas.86.19.7505; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Li XL, 2002, MOL CELL BIOL, V22, P3663, DOI 10.1128/MCB.22.11.3663-3673.2002; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miglarese MR, 1996, J BIOL CHEM, V271, P22697, DOI 10.1074/jbc.271.37.22697; MOTICELLI S, 2001, MOL IMMUNOL, V38, P1129; Muiras ML, 1998, J MOL MED-JMM, V76, P346, DOI 10.1007/s001090050226; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nantermet P, 2008, ENDOCRINOLOGY, V149, P1551, DOI 10.1210/en.2007-1151; Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7; OCHI T, 1989, TOXICOLOGY, V55, P69, DOI 10.1016/0300-483X(89)90175-3; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Roy AK, 2002, AGEING RES REV, V1, P367, DOI 10.1016/S1568-1637(02)00006-5; Roy AK, 1996, EXP GERONTOL, V31, P83, DOI 10.1016/0531-5565(95)00020-8; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Seo YK, 2007, GENE, V386, P218, DOI 10.1016/j.gene.2006.10.006; Song CS, 1998, J BIOL CHEM, V273, P21856, DOI 10.1074/jbc.273.34.21856; SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349; Stains JP, 2005, BIOCHEM J, V385, P613, DOI 10.1042/BJ20040680; SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837; SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400; Supakar PC, 1996, BIOL SIGNAL, V5, P170; Tanikawa J, 2004, J BIOL CHEM, V279, P55393, DOI 10.1074/jbc.M411658200; Wang LG, 1999, BIOCHEM BIOPH RES CO, V259, P21, DOI 10.1006/bbrc.1999.0655; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; Yaklichkin S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-201; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001	53	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36474	36485		10.1074/jbc.M805980200	http://dx.doi.org/10.1074/jbc.M805980200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18945670	Green Published, hybrid			2022-12-25	WOS:000261840500045
J	Fukunaga, E; Inoue, Y; Komiya, S; Horiguchi, K; Goto, K; Saitoh, M; Miyazawa, K; Koinuma, D; Hanyu, A; Imamura, T				Fukunaga, Erina; Inoue, Yasumichi; Komiya, Setsuro; Horiguchi, Kana; Goto, Kouichiro; Saitoh, Masao; Miyazawa, Keiji; Koinuma, Daizo; Hanyu, Aki; Imamura, Takeshi			Smurf2 Induces Ubiquitin-dependent Degradation of Smurf1 to Prevent Migration of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; LIGASE SMURF2; UP-REGULATION; SMAD7; TARGETS; RHOA; PHOSPHORYLATION; INHIBITION; EXPRESSION; PLASTICITY	Ubiquitin-dependent protein degradation is involved in various biological processes, and accumulating evidence suggests that E3 ubiquitin ligases play important roles in cancer development. Smad ubiquitin regulatory factor 1 (Smurf1) and Smurf2 are E3 ubiquitin ligases, which suppress transforming growth factor-beta (TGF-beta) family signaling through degradation of Smads and receptors for TGF-beta and bone morphogenetic proteins. In addition, Smurf1 has been reported to promote RhoA ubiquitination and degradation and regulate cell motility, suggesting the involvement of Smurf1 in cancer progression. However, the regulation and biological function of Smurf1 and Smurf2 in cancer development remain to be elucidated. In the present study, we show the post-translational regulation of Smurf1 by Smurf2 and the functional differences between Smurf1 and Smurf2 in the progression of breast cancer cells. Smurf2 interacted with Smurf1 and induced its ubiquitination and degradation, whereas Smurf1 failed to induce degradation of Smurf2. Knockdown of Smurf2 in human breast cancer MDA-MB-231 cells resulted in increases in the levels of Smurf1 protein, and enhancement of cell migration in vitro and bone metastasis in vivo. Of note, knockdown of Smurf1, but not of Smurf2, enhanced TGF-beta signaling in MDA-MB-231 cells, suggesting that increased an protein level of Smurf1 offsets the effect of Smurf2 knockdown on TGF-beta signaling. These results indicate that two related E3 ubiquitin ligases, Smurf1 and Smurf2, act in the same direction in TGF-beta family signaling but play opposite roles in cell migration.	[Fukunaga, Erina; Inoue, Yasumichi; Koinuma, Daizo; Hanyu, Aki; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Tokyo 1358550, Japan; [Fukunaga, Erina; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent, Dept Neuromusculoskeletal Disorder Orthopaed Surg, Kagoshima 8908520, Japan; [Horiguchi, Kana; Goto, Kouichiro; Saitoh, Masao; Miyazawa, Keiji] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan	Japanese Foundation for Cancer Research; Kagoshima University; University of Tokyo	Imamura, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014; Koinuma, Daizo/Y-8716-2018	Koinuma, Daizo/0000-0001-5611-2122	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Space Forum	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	This work was supported by grants-in-aid for scientific research (KAKENHI) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the "Ground-based Research Program for Space Utilization" promoted by the Japan Space Forum. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Boyer L, 2006, MOL BIOL CELL, V17, P2489, DOI 10.1091/mbc.E05-09-0876; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Ebisawa T, 1999, J CELL SCI, V112, P3519; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fukuchi M, 2002, CANCER RES, V62, P7162; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tajima Y, 2003, J BIOL CHEM, V278, P10716, DOI 10.1074/jbc.M212663200; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhang H, 2004, GENE DEV, V18, P3028, DOI 10.1101/gad.1253004; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	33	71	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35660	35667		10.1074/jbc.M710496200	http://dx.doi.org/10.1074/jbc.M710496200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18927080	hybrid			2022-12-25	WOS:000261687900040
J	Meyer, P; Evrin, C; Briozzo, P; Joly, N; Barzu, O; Gilles, AM				Meyer, Philippe; Evrin, Cecile; Briozzo, Pierre; Joly, Nathalie; Barzu, Octavian; Gilles, Anne-Marie			Structural and Functional Characterization of Escherichia coli UMP Kinase in Complex with Its Allosteric Regulator GTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTP; SOFTWARE; BACTERIA; BINDING; SYSTEM; GENE	Bacterial UMP kinases are essential enzymes involved in the multistep synthesis of UTP. They are hexamers regulated by GTP (allosteric activator) and UTP (inhibitor). We describe here the 2.8 angstrom crystal structure of Escherichia coli UMP kinase bound to GTP. The GTP-binding site, situated at 15 angstrom from the UMP-binding site and at 24 angstrom from the ATP-binding site, is delineated by two contiguous dimers. The overall structure, as compared with those bound to UMP, UDP, or UTP, shows a rearrangement of its quaternary structure: GTP induces an 11 degrees opening of the UMP kinase dimer, resulting in a tighter dimer-dimer interaction. A nucleotide-free UMP kinase dimer has an intermediate opening. Superposition of our structure with that of archaeal UMP kinases, which are also hexamers, shows that a loop appears to hamper any GTP binding in archeal enzymes. This would explain the absence of activating effect of GTP on this group of UMP kinases. Among GTP-binding residues, the Asp-93 is the most conserved in bacterial UMP kinases. In the previously published structures of E. coli UMP kinase, this residue was shown to be involved in hydrogen bonds between the subunits of a dimer. Its substitution by an alanine decreases the cooperativity for UTP binding and suppresses the reversal by GTP of UTP inhibition. This demonstrates that the previously described mutual exclusion of these two nucleotides is mediated by Asp-93.	[Briozzo, Pierre; Joly, Nathalie] AgroParisTech, INRA, UMR Chim Biol 206, F-78550 Thiverval Grignon, France; [Meyer, Philippe; Briozzo, Pierre] CNRS, Lab Enzymol & Biochim Struct, UPR 3082, F-91198 Gif Sur Yvette, France; [Evrin, Cecile; Barzu, Octavian; Gilles, Anne-Marie] Inst Pasteur, CNRS, Unite Genet Genomes Bacteriens, URA2171, F-75724 Paris 15, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Briozzo, P (corresponding author), AgroParisTech, INRA, UMR Chim Biol 206, F-78550 Thiverval Grignon, France.	briozzo@grignon.inra.fr			Centre National de la Recherche Scientifique [UPR 9063, URA 2185, 2171]; Institut National de la Recherche Agronomique [UMR 206]; Institut Pasteur [AC02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique; Institut Pasteur(European Commission)	This work was supported by Centre National de la Recherche Scientifique Grants UPR 9063 and URA 2185 and 2171, Institut National de la Recherche Agronomique Grant UMR 206, and Institut Pasteur Grant AC02. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BLONDIN C, 1994, ANAL BIOCHEM, V220, P219, DOI 10.1006/abio.1994.1326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREED J, 2006, Patent No. 2006018618; Briozzo P, 2005, J BIOL CHEM, V280, P25533, DOI 10.1074/jbc.M501849200; BRUNGER A, 1992, NATURE, V355, P372; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bucurenci N, 1998, J BACTERIOL, V180, P473, DOI 10.1128/JB.180.3.473-477.1998; Crowe J, 1994, Methods Mol Biol, V31, P371; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Egeblad-Welin L, 2007, FEBS J, V274, P6403, DOI 10.1111/j.1742-4658.2007.06157.x; EVRIN C, 2006, THESIS U PARIS 7; Evrin C, 2007, J BIOL CHEM, V282, P7242, DOI 10.1074/jbc.M606963200; Fassy F, 2004, BIOCHEM J, V384, P619, DOI 10.1042/BJ20040440; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Jensen KS, 2007, BIOCHEMISTRY-US, V46, P2745, DOI 10.1021/bi0618159; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SE, 2007, INFECT IMMUN, V75, P2795, DOI 10.1128/IAI.01499-06; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x; Picard V, 1997, Methods Mol Biol, V67, P183; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Sakamoto H, 2004, MICROBIOL-SGM, V150, P2153, DOI 10.1099/mic.0.26996-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SERINA L, 1995, BIOCHEMISTRY-US, V34, P5066, DOI 10.1021/bi00015a018; Serina L, 1996, BIOCHEMISTRY-US, V35, P7003, DOI 10.1021/bi960062v; SMALLSHAW JD, 1992, LIFE SCI ADV, V11, P59; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YAMANAKA K, 1992, J BACTERIOL, V174, P7517, DOI 10.1128/JB.174.23.7517-7526.1992	35	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36011	36018		10.1074/jbc.M802614200	http://dx.doi.org/10.1074/jbc.M802614200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945668	hybrid			2022-12-25	WOS:000261687900075
J	Firth, JD; Uitto, VJ; Putnins, EE				Firth, James D.; Uitto, Veli-Jukka; Putnins, Edward E.			Mechanical Induction of an Epithelial Cell Chymase Associated with Wound Edge Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEUM CHYMOTRYPTIC ENZYME; NADPH OXIDASE ACTIVATION; SEROSAL MAST-CELLS; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; LINE HMC-1; DEGRANULATION; MACROPHAGES; GENERATION; INHIBITION	Chymase is a chymotrypsin-like serine protease predominantly produced by mast cells. In this study, human cutaneous and gingival keratinocytes, ovary surface epithelia, and a porcine epithelial cell line were assayed by homology-based cloning, and the amplified DNA fragment was identified as a chymase. In vitro, chymase could not be induced by serum or cytokine treatment alone. Chymase was activated 3-fold within 60 min in basal media by scratch wounding cultured monolayers and further potentiated over 10-fold at 18 h by additional serum and cytokine treatment. Chymase activity was cell-associated and found to peak within 24 h of wounding and then steadily decreased as cultures healed, reaching baseline levels before confluence was reestablished. Affinity column purified enzyme effectively degraded fibronectin and was found by Western blot analysis using a human chymase antibody to be of about 30 kDa. Immunostaining revealed chymase activation at the wound edge colocalizing with reactive oxygen species generation. Specifically, chymase activation was attenuated by inhibition of nitric oxide, superoxide, and peroxynitrite. Exogenous peroxynitrite but not hydrogen peroxide also resulted in chymase activation in unwounded monolayers. Disruption of cytoskeletal stress fibers by cytochalasin D attenuated both wound-activated chymase and reactive oxygen species generation. Chymase inhibitor chymostatin reduced the loss of cell-cell contacts and the onset of porcine and human skin epithelial cell migration at the wound edge. This shows that an epithelial chymase is rapidly activated by a ligand-independent mechanism following mechanical stress via cytoskeletal and reactive oxygen species signaling and is associated with the onset of epithelial cell migration.	[Firth, James D.; Putnins, Edward E.] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Uitto, Veli-Jukka] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Surg, FIN-00290 Helsinki, Finland	University of British Columbia; University of Helsinki; Helsinki University Central Hospital	Putnins, EE (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, 2199 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	putnins@interchange.ubc.ca			Canadian Institutes of Health Research [MOP-82830]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-82830 (to E.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bankers-Fulbright JL, 2001, J CELL PHYSIOL, V189, P306, DOI 10.1002/jcp.10022; Bengtsson T, 2006, CELL BIOL INT, V30, P154, DOI 10.1016/j.cellbi.2005.10.017; Bidani A, 2000, LUNG, V178, P91, DOI 10.1007/s004080000012; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Cougnon M, 2002, AM J PHYSIOL-CELL PH, V282, pC1445, DOI 10.1152/ajpcell.00410.2001; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Ekholm E, 1998, ACTA DERM-VENEREOL, V78, P343; Firth JD, 2004, J INVEST DERMATOL, V122, P222, DOI 10.1046/j.0022-202X.2003.22124.x; Firth JD, 1996, J PERIODONTAL RES, V31, P345, DOI 10.1111/j.1600-0765.1996.tb00502.x; Freitas I, 2002, EXP GERONTOL, V37, P591, DOI 10.1016/S0531-5565(01)00226-1; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Guo CY, 2001, J CLIN INVEST, V107, P703, DOI 10.1172/JCI9997; HAN Z, 2007, AM J PHYSIOL, V92, pC1103; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Huttunen M, 2000, EXP DERMATOL, V9, P258, DOI 10.1034/j.1600-0625.2000.009004258.x; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Kadi A, 2007, CLIN HEMORHEOL MICRO, V37, P131; Kishi K, 2007, HYPERTENS RES, V30, P77, DOI 10.1291/hypres.30.77; KRUK PA, 1994, EXP CELL RES, V215, P97, DOI 10.1006/excr.1994.1320; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Lindstedt KA, 2001, FASEB J, V15, P1377, DOI 10.1096/fj.00-0273com; Lindstedt L, 2001, ATHEROSCLEROSIS, V155, P87, DOI 10.1016/S0021-9150(00)00544-X; Maruichi M, 2004, EXP EYE RES, V79, P111, DOI 10.1016/j.exer.2004.02.009; May RC, 2001, J CELL SCI, V114, P1061; Miyazaki M, 2000, J Renin Angiotensin Aldosterone Syst, V1, P23, DOI 10.3317/jraas.2000.004; Nikolic DL, 2006, AM J PHYSIOL-CELL PH, V291, pC68, DOI 10.1152/ajpcell.00411.2005; Nishikori Y, 1998, ARCH DERMATOL RES, V290, P553, DOI 10.1007/s004030050351; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Pernas-Sueiras O, 2006, J CELL BIOCHEM, V99, P1397, DOI 10.1002/jcb.21010; Qian Y, 2005, J BIOL CHEM, V280, P3875, DOI 10.1074/jbc.M403788200; Rajan S, 2000, AM J RESP CELL MOL, V23, P304, DOI 10.1165/ajrcmb.23.3.4098; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Rice DC, 2002, HYPERTENSION, V39, P502, DOI 10.1161/hy0202.102834; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; SCHICK B, 1984, J IMMUNOL, V132, P2571; Shan J, 2007, NITRIC OXIDE-BIOL CH, V17, P25, DOI 10.1016/j.niox.2007.05.001; Sheth PD, 2003, BIOCHEM PHARMACOL, V66, P2251, DOI 10.1016/j.bcp.2003.08.002; SONDELL B, 1994, J HISTOCHEM CYTOCHEM, V42, P459, DOI 10.1177/42.4.7510318; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Suzuki Y, 2005, CHEM IMMUNOL ALLERGY, V87, P32, DOI 10.1159/000087569; Swindle EJ, 2002, J IMMUNOL, V169, P5866, DOI 10.4049/jimmunol.169.10.5866; Tchougounova E, 2001, J BIOL CHEM, V276, P3772, DOI 10.1074/jbc.M008434200; URATA H, 1994, J HYPERTENS, V12, pS17; URATA H, 1991, J BIOL CHEM, V266, P17173; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; van Zyp JV, 2004, AM J SURG, V188, P467, DOI 10.1016/j.amjsurg.2004.07.005; Yoshimaru T, 2006, FREE RADICAL BIO MED, V40, P1949, DOI 10.1016/j.freeradbiomed.2006.01.023	51	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34983	34993		10.1074/jbc.M801975200	http://dx.doi.org/10.1074/jbc.M801975200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845543	Green Published, hybrid			2022-12-25	WOS:000261469100055
J	Zhao, HR; Sohail, A; Sun, Q; Shi, QZ; Kim, S; Mobashery, S; Fridman, R				Zhao, Huiren; Sohail, Anjum; Sun, Qing; Shi, Qicun; Kim, Seaho; Mobashery, Shahriar; Fridman, Rafael			Identification and Role of the Homodimerization Interface of the Glycosylphosphatidylinositol-anchored Membrane Type 6 Matrix Metalloproteinase (MMP25)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-MATRIX METALLOPROTEINASE; PROMMP-2 ACTIVATION; TISSUE INHIBITORS; CRYSTAL-STRUCTURE; BREAST-CARCINOMA; STRUCTURAL BASIS; CELL-SURFACE; HL60 CELLS; MT1-MMP; OLIGOMERIZATION	The membrane type (MT) 6 matrix metalloproteinase (MMP) (MMP25) is a glycosylphosphatidylinositol-anchored matrix metalloproteinase (MMP) that is highly expressed in leukocytes and in some cancer tissues. We previously showed that natural MT6-MMP is expressed on the cell surface as a major reduction-sensitive form of M-r 120, likely representing enzyme homodimers held by disulfide bridges. Among the membrane type-MMPs, the stem region of MT6-MMP contains three cysteine residues at positions 530, 532, and 534 which may contribute to dimerization. A systematic site-directed mutagenesis study of the Cys residues in the stem region shows that Cys(532) is involved in MT6-MMP dimerization by forming an intermolecular disulfide bond. The mutagenesis data also suggest that Cys(530) and Cys(534) form an intramolecular disulfide bond. The experimental observations on cysteines were also investigated by computational studies of the stem peptide, which validate these proposals. Dimerization is not essential for transport of MT6-MMP to the cell surface, partitioning into lipid rafts or cleavage of alpha-1-proteinase inhibitor. However, monomeric forms of MT6-MMP exhibited enhanced autolysis and metalloprotease-dependent degradation. Collectively, these studies establish the stem region of MT6-MMP as the dimerization interface, an event whose outcome imparts protease stability to the protein.	[Fridman, Rafael] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Zhao, Huiren; Sohail, Anjum; Sun, Qing; Kim, Seaho; Fridman, Rafael] Barbara Ann Karmanos Canc, Proteases & Canc Program, Detroit, MI 48201 USA; [Shi, Qicun; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Shi, Qicun; Mobashery, Shahriar] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; University of Notre Dame; University of Notre Dame; Walther Cancer Institute	Fridman, R (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 540 E Canfield Ave, Detroit, MI 48201 USA.	rfridman@med.wayne.edu		Sohail, Anjum/0000-0001-5567-9645	National Institutes of Health [CA-61986]; NATIONAL CANCER INSTITUTE [R01CA122417, R01CA061986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-61986 (to R.F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Cho JA, 2008, J BIOL CHEM, V283, P17391, DOI 10.1074/jbc.M708943200; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gorman JJ, 2002, MASS SPECTROM REV, V21, P183, DOI 10.1002/mas.10025; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Han GW, 2003, P NATL ACAD SCI USA, V100, P9214, DOI 10.1073/pnas.1533326100; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Jacob C, 2002, INT IMMUNOPHARMACOL, V2, P1647, DOI 10.1016/S1567-5769(02)00141-8; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1997, BIOL CHEM, V378, P151; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2007, TRAFFIC, V8, P251, DOI 10.1111/j.1600-0854.2006.00522.x; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Puente XS, 1996, CANCER RES, V56, P944; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Solomon KR, 1998, BIOCHEM J, V334, P325, DOI 10.1042/bj3340325; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; Trayner ID, 1998, LEUKEMIA RES, V22, P537, DOI 10.1016/S0145-2126(98)00041-1; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; Zhang WL, 2007, BIOCHEMISTRY-US, V46, P10113, DOI 10.1021/bi700777x; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhuang LY, 2002, CANCER RES, V62, P2227; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	48	20	20	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35023	35032		10.1074/jbc.M806553200	http://dx.doi.org/10.1074/jbc.M806553200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936094	hybrid, Green Published			2022-12-25	WOS:000261469100059
J	Koussevitzky, S; Suzuki, N; Huntington, S; Armijo, L; Sha, W; Cortes, D; Shulaev, V; Mittler, R				Koussevitzky, Shai; Suzuki, Nobuhiro; Huntington, Serena; Armijo, Leigh; Sha, Wei; Cortes, Diego; Shulaev, Vladimir; Mittler, Ron			Ascorbate Peroxidase 1 Plays a Key Role in the Response of Arabidopsis thaliana to Stress Combination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRASSULACEAN ACID METABOLISM; OXYGEN GENE NETWORK; REACTIVE OXYGEN; OXIDATIVE STRESS; HEAT-STRESS; ENERGY-DISSIPATION; ELECTRON-TRANSPORT; DROUGHT STRESS; ABIOTIC STRESS; CELL-DEATH	Within their natural habitat plants are subjected to a combination of different abiotic stresses, each with the potential to exacerbate the damage caused by the others. One of the most devastating stress combinations for crop productivity, which frequently occurs in the field, is drought and heat stress. In this study we conducted proteomic and metabolic analysis of Arabidopsis thaliana plants subjected to a combination of drought and heat stress. We identified 45 different proteins that specifically accumulated in Arabidopsis in response to the stress combination. These included enzymes involved in reactive oxygen detoxification, malate metabolism, and the Calvin cycle. The accumulation of malic enzyme during the combined stress corresponded with enhanced malic enzyme activity, a decrease in malic acid, and lower amounts of oxaloacetate, suggesting that malate metabolism plays an important role in the response of Arabidopsis to the stress combination. Cytosolic ascorbate peroxidase 1 (APX1) protein and mRNA accumulated during the stress combination. When exposed to heat stress combined with drought, an APX1-deficient mutant (apx1) accumulated more hydrogen peroxide and was significantly more sensitive to the stress combination than wild type. In contrast, mutants deficient in thylakoid or stromal/mitochondrial APXs were not more sensitive to the stress combination than apx1 or wild type. Our findings suggest that cytosolic APX1 plays a key role in the acclimation of plants to a combination of drought and heat stress.	[Koussevitzky, Shai; Suzuki, Nobuhiro; Huntington, Serena; Armijo, Leigh; Mittler, Ron] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Sha, Wei; Cortes, Diego; Shulaev, Vladimir] Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Mittler, Ron] Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel	Nevada System of Higher Education (NSHE); University of Nevada Reno; Hebrew University of Jerusalem	Mittler, R (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Mail Stop 200, Reno, NV 89557 USA.	ronm@unr.edu	Mittler, Ron/ABE-6496-2020; Suzuki, Nobuhiro/Y-2851-2019	Suzuki, Nobuhiro/0000-0002-0225-1597	National Institutes of Health [RR-03-008, P20 RR16464-05]; National Science Foundation [IBN-0420033, NSF-0431327, IOS-0743954]; The Nevada Agricultural Experimental Station [03055517]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); The Nevada Agricultural Experimental Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants RR-03-008 and P20 RR16464-05 from the IDeA Network of Biomedical Research Excellence. This work was also supported by National Science Foundation Grants IBN-0420033, NSF-0431327, and IOS-0743954 and The Nevada Agricultural Experimental Station (Publication 03055517). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Carter C, 1998, PLANT MOL BIOL, V38, P929, DOI 10.1023/A:1006038117130; Chang CCC, 2004, PLANT J, V38, P499, DOI 10.1111/j.1365-313X.2004.02066.x; Cheng YX, 2007, BIOTECHNOL LETT, V29, P1129, DOI 10.1007/s10529-007-9347-0; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Cushman JC, 1999, ANNU REV PLANT PHYS, V50, P305, DOI 10.1146/annurev.arplant.50.1.305; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ishikawa A, 2003, PLANT CELL PHYSIOL, V44, P255, DOI 10.1093/pcp/pcg031; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Luhua S, 2008, PLANT PHYSIOL, V148, P280, DOI 10.1104/pp.108.124875; Maeda H, 2006, PLANT CELL, V18, P2710, DOI 10.1105/tpc.105.039404; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; MITTLER R, 1992, J BIOL CHEM, V267, P21802; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; MITTLER R, 1991, PLANT PHYSIOL, V97, P962, DOI 10.1104/pp.97.3.962; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mullineaux PM, 2006, PLANT PHYSIOL, V141, P346, DOI 10.1104/pp.106.078162; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Raines CA, 2006, PLANT CELL ENVIRON, V29, P331, DOI 10.1111/j.1365-3040.2005.01488.x; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Sheen J, 1999, ANNU REV PLANT PHYS, V50, P187, DOI 10.1146/annurev.arplant.50.1.187; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Spinola MC, 2008, PHYSIOL PLANTARUM, V133, P516, DOI 10.1111/j.1399-3054.2008.01088.x; Stenzel I, 2003, PLANT MOL BIOL, V51, P895, DOI 10.1023/A:1023049319723; STUHLFAUTH T, 1990, PLANT PHYSIOL, V92, P1053, DOI 10.1104/pp.92.4.1053; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; WINTER K, 1982, PLANT PHYSIOL, V69, P300, DOI 10.1104/pp.69.2.300	51	266	282	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34197	34203		10.1074/jbc.M806337200	http://dx.doi.org/10.1074/jbc.M806337200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18852264	hybrid, Green Published			2022-12-25	WOS:000261277700048
J	Rass, U; Ahel, I; West, SC				Rass, Ulrich; Ahel, Ivan; West, Stephen C.			Molecular Mechanism of DNA Deadenylation by the Neurological Disease Protein Aprataxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; HISTIDINE TRIAD SUPERFAMILY; NUCLEOTIDE-BINDING PROTEINS; SINGLE-STRAND; POLY(ADP-RIBOSE) POLYMERASE; LIGASE-III; NEURODEGENERATIVE DISEASE; 3-DIMENSIONAL STRUCTURE; ESCHERICHIA-COLI; TUMOR-SUPPRESSOR	The human neurological disease known as ataxia with oculomotor apraxia 1 is caused by mutations in the APTX gene that encodes Aprataxin (APTX) protein. APTX is a member of the histidine triad superfamily of nucleotide hydrolases and transferases but is distinct from other family members in that it acts upon DNA. The target of APTX is 5' -adenylates at DNA nicks or breaks that result from abortive DNA ligation reactions. In this work, we show that APTX acts as a nick sensor, which provides a mechanism to assess the adenylation status of unsealed nicks. When an adenylated nick is encountered by APTX, base pairing at the 5' terminus of the nick is disrupted as the adenylate is accepted into the active site of the enzyme. Adenylate removal occurs by a two-step process that proceeds through a transient AMP-APTX covalent intermediate. These results pinpoint APTX as the first protein to adopt canonical histidine triad-type reaction chemistry for the repair of DNA.	[Rass, Ulrich; Ahel, Ivan; West, Stephen C.] Canc Res UK, Clare Hall Labs, London Res Inst, S Mimms EN6 3LD, Herts, England	Cancer Research UK	West, SC (corresponding author), Canc Res UK, Clare Hall Labs, London Res Inst, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk		West, Stephen/0000-0001-8848-9418; Ahel, Ivan/0000-0002-9446-3756; Rass, Ulrich/0000-0001-9275-9062	Cancer Research UK; Louis-Jeantet Foundation; European Union DNA Repair Consortium	Cancer Research UK(Cancer Research UK); Louis-Jeantet Foundation; European Union DNA Repair Consortium(European Commission)	This work was supported by Cancer Research UK, the Louis-Jeantet Foundation, and the European Union DNA Repair Consortium. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1997, NAT STRUCT BIOL, V4, P231, DOI 10.1038/nsb0397-231; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Gu MG, 2004, MOL CELL, V14, P67, DOI 10.1016/S1097-2765(04)00180-7; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Hirano M, 2007, ANN NEUROL, V61, P162, DOI 10.1002/ana.21078; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200; Lavin MF, 2008, DNA REPAIR, V7, P1061, DOI 10.1016/j.dnarep.2008.03.008; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; Lima CD, 1997, STRUCTURE, V5, P763, DOI 10.1016/S0969-2126(97)00231-1; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Mosesso P, 2005, CELL MOL LIFE SCI, V62, P485, DOI 10.1007/s00018-004-4441-0; OLSSON M, 1980, J BIOL CHEM, V255, P569; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200; Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808; Seraphin B., 1992, DNA Sequence, V3, P177, DOI 10.3109/10425179209034013; WEDEKIND JE, 1995, BIOCHEMISTRY-US, V34, P11049, DOI 10.1021/bi00035a010	34	35	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33994	34001		10.1074/jbc.M807124200	http://dx.doi.org/10.1074/jbc.M807124200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18836178	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000261277700026
J	Xu, K; Nowak, I; Kirchner, M; Xu, YJ				Xu, Ke; Nowak, Iwona; Kirchner, Michele; Xu, Yujia			Recombinant Collagen Studies Link the Severe Conformational Changes Induced by Osteogenesis Imperfecta Mutations to the Disruption of a Set of Interchain Salt Bridges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; I COLLAGEN; MOLECULAR-STRUCTURE; STABILITY; PEPTIDE; STABILIZATION; MECHANISM; BINDING; PROTEIN; STEP	The clinical severity of Osteogenesis Imperfecta (OI), also known as the brittle bone disease, relates to the extent of conformational changes in the collagen triple helix induced by Gly substitution mutations. The lingering question is why Gly substitutions at different locations of collagen cause different disruptions of the triple helix. Here, we describe markedly different conformational changes of the triple helix induced by two Gly substitution mutations placed only 12 residues apart. The effects of the Gly substitutions were characterized using a recombinant collagen fragment modeling the 63-residue segment of the alpha 1 chain of type I collagen containing no Hyp (residues 877-939) obtained from Escherichia coli. Two Gly -> Ser substitutions at Gly-901 and Gly-913 associated with, respectively, mild and severe OI variants were introduced by site-directed mutagenesis. Biophysical characterization and limited protease digestion experiments revealed that while the substitution at Gly-901 causes relatively minor destabilization of the triple helix, the substitution at Gly-913 induces large scale unfolding of an unstable region C-terminal to the mutation site. This extensive unfolding is caused by the intrinsic low stability of the C-terminal region of the helix and the mutation induced disruption of a set of salt bridges, which functions to lock this unstable region into the triple helical conformation. The extensive conformational changes associated with the loss of the salt bridges highlight the long range impact of the local interactions of triple helix and suggest a new mechanism by which OI mutations cause severe conformational damages in collagen.	[Xu, Ke; Nowak, Iwona; Kirchner, Michele; Xu, Yujia] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Xu, YJ (corresponding author), CUNY Hunter Coll, Dept Chem, 695 Pk Ave, New York, NY 10021 USA.	yujia.xu@hunter.cuny.edu	Xu, Ke/C-1253-2013		National Institutes of Health [3S06-GM060654-06S1]; National Science Foundation (NSF) [DBI0521709]; PSC-CUNY [60042-34 35, 67874-0036]; Gender Equity Program at Hunter (NSF Advanced Transformation Award); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM060654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); PSC-CUNY; Gender Equity Program at Hunter (NSF Advanced Transformation Award); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 3S06-GM060654-06S1. This work was also supported by National Science Foundation (NSF) Grant DBI0521709, PSC-CUNY Grants 60042-34 35 and 67874-0036, and the Gender Equity Program at Hunter (NSF Advanced Transformation Award). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; BYERS PH, 1993, OSTEOGENESIS IMPERFE, P317; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200; Kielty Cay M., 1993, P103; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Liu XY, 1998, BIOCHEMISTRY-US, V37, P15528, DOI 10.1021/bi981147u; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342; PRIVALOV PL, 1979, J MOL BIOL, V127, P203, DOI 10.1016/0022-2836(79)90240-7; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1771, DOI 10.1002/bip.1968.360061213; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023; Xu YJ, 2002, BIOCHEMISTRY-US, V41, P8143, DOI 10.1021/bi015952b; Yang W, 1997, BIOCHEMISTRY-US, V36, P6930, DOI 10.1021/bi970051h	28	28	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34337	34344		10.1074/jbc.M805485200	http://dx.doi.org/10.1074/jbc.M805485200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845533	Green Published, hybrid			2022-12-25	WOS:000261277700061
J	Coady, TH; Baughan, TD; Shababi, M; Passini, MA; Lorson, CL				Coady, Tristan H.; Baughan, Travis D.; Shababi, Monir; Passini, Marco A.; Lorson, Christian L.			Development of a Single Vector System that Enhances Trans-Splicing of SMN2 Transcripts	PLOS ONE			English	Article								RNA modalities are developing as a powerful means to re-direct pathogenic pre-mRNA splicing events. Improving the efficiency of these molecules in vivo is critical as they move towards clinical applications. Spinal muscular atrophy (SMA) is caused by loss of SMN1. A nearly identical copy gene called SMN2 produces low levels of functional protein due to alternative splicing. We previously reported a trans-splicing RNA (tsRNA) that re-directed SMN2 splicing. Now we show that reducing the competition between endogenous splices sites enhanced the efficiency of trans-splicing. A single vector system was developed that expressed the SMN tsRNA and a splice-site blocking antisense (ASO-tsRNA). The ASO-tsRNA vector significantly elevated SMN levels in primary SMA patient fibroblasts, within the central nervous system of SMA mice and increased SMN-dependent in vitro snRNP assembly. These results demonstrate that the ASO-tsRNA strategy provides insight into the trans-splicing mechanism and a means of significantly enhancing trans-splicing activity in vivo.	[Coady, Tristan H.; Shababi, Monir; Lorson, Christian L.] Univ Missouri, Bond Life Sci Ctr, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Baughan, Travis D.; Lorson, Christian L.] Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Passini, Marco A.] Genzyme Corp, Framingham, MA USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Sanofi-Aventis; Genzyme Corporation	Coady, TH (corresponding author), Univ Missouri, Bond Life Sci Ctr, Dept Vet Pathobiol, Columbia, MO 65211 USA.	lorsonc@missouri.edu			MDA; FightSMA; National Institutes of Health [R01 NS41584, R01 HD054413];  [T32 GM008396]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041584] Funding Source: NIH RePORTER	MDA(Muscular Dystrophy Association); FightSMA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	T.H.C. is supported by Training Grant T32 GM008396. This work was funded by grants from the MDA (M.S.), FightSMA (C.L.L.) and the National Institutes of Health (C.L.L, R01 NS41584; R01 HD054413).	Baughan T, 2006, MOL THER, V14, P54, DOI 10.1016/j.ymthe.2006.01.012; BUTCHBACH ME, 2007, NEUROBIOL DIS; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Coady TH, 2007, MOL THER, V15, P1471, DOI 10.1038/sj.mt.6300222; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; DiMatteo D, 2008, EXP CELL RES, V314, P878, DOI 10.1016/j.yexcr.2007.10.012; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Garcia-Blanco MA, 2003, J CLIN INVEST, V112, P474, DOI 10.1172/JCI200319462; Hengge UR, 2008, J INVEST DERMATOL, V128, P499, DOI 10.1038/sj.jid.5701241; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; MARQUIS J, 2007, MOL THER; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Rodriguez-Martin T, 2005, P NATL ACAD SCI USA, V102, P15659, DOI 10.1073/pnas.0503150102; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Sumner Charlotte J, 2006, NeuroRx, V3, P235, DOI 10.1016/j.nurx.2006.01.010; Wally V, 2008, J INVEST DERMATOL, V128, P568, DOI 10.1038/sj.jid.5701152; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Wood M, 2007, PLOS GENET, V3, P845, DOI 10.1371/journal.pgen.0030109; Zayed H, 2007, MOL THER, V15, P1273, DOI 10.1038/sj.mt.6300178	27	66	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3468	10.1371/journal.pone.0003468	http://dx.doi.org/10.1371/journal.pone.0003468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941511	Green Submitted, Green Published, gold			2022-12-25	WOS:000265126100003
J	Sorber, K; Chiu, C; Webster, D; Dimon, M; Ruby, JG; Hekele, A; DeRisi, JL				Sorber, Katherine; Chiu, Charles; Webster, Dale; Dimon, Michelle; Ruby, J. Graham; Hekele, Armin; DeRisi, Joseph L.			The Long March: A Sample Preparation Technique that Enhances Contig Length and Coverage by High-Throughput Short-Read Sequencing	PLOS ONE			English	Article								High-throughput short-read technologies have revolutionized DNA sequencing by drastically reducing the cost per base of sequencing information. Despite producing gigabases of sequence per run, these technologies still present obstacles in resequencing and de novo assembly applications due to biased or insufficient target sequence coverage. We present here a simple sample preparation method termed the "long march'' that increases both contig lengths and target sequence coverage using high-throughput short-read technologies. By incorporating a Type IIS restriction enzyme recognition motif into the sequencing primer adapter, successive rounds of restriction enzyme cleavage and adapter ligation produce a set of nested sub-libraries from the initial amplicon library. Sequence reads from these sub-libraries are offset from each other with enough overlap to aid assembly and contig extension. We demonstrate the utility of the long march in resequencing of the Plasmodium falciparum transcriptome, where the number of genomic bases covered was increased by 39%, as well as in metagenomic analysis of a serum sample from a patient with hepatitis B virus (HBV)-related acute liver failure, where the number of HBV bases covered was increased by 42%. We also offer a theoretical optimization of the long march for de novo sequence assembly.	[Sorber, Katherine; Chiu, Charles; Webster, Dale; Dimon, Michelle; Ruby, J. Graham; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Webster, Dale; Dimon, Michelle] Univ Calif San Francisco, Biol & Med Informat Program, San Francisco, CA 94143 USA; [Hekele, Armin] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Chiu, Charles] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [DeRisi, Joseph L.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Sorber, K (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	joe@derisilab.ucsf.edu		Chiu, Charles/0000-0003-2915-2094; Lontok, Katherine/0000-0001-7127-340X	Howard Hughes Medical Institute; Doris Duke Charitable Foundation; David and Lucile Packard Foundation; National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Howard Hughes Medical Institute, Doris Duke Charitable Foundation and David and Lucile Packard Foundation grants to JLD. KS was supported in part by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; HADI SM, 1979, J MOL BIOL, V134, P655, DOI 10.1016/0022-2836(79)90372-3; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; JANULAITIS A, 1983, FEBS LETT, V151, P243, DOI 10.1016/0014-5793(83)80078-7; Knight R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng030; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Mashayekhi F, 2007, ANAL BIOCHEM, V363, P275, DOI 10.1016/j.ab.2007.02.002; MathieuDaude F, 1996, NUCLEIC ACIDS RES, V24, P2080, DOI 10.1093/nar/24.11.2080; OKAMOTO H, 1986, J GEN VIROL, V67, P2305, DOI 10.1099/0022-1317-67-11-2305; PETRUSYTE M, 1988, GENE, V74, P89, DOI 10.1016/0378-1119(88)90259-4; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Salas-Solano O, 1998, ANAL CHEM, V70, P3996, DOI 10.1021/ac980457f; Sanger F, 1992, Biotechnology, V24, P104; Seo TS, 2004, P NATL ACAD SCI USA, V101, P5488, DOI 10.1073/pnas.0401138101; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Siegel AF, 2000, GENOMICS, V68, P237, DOI 10.1006/geno.2000.6303; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; Wai CT, 2005, J VIRAL HEPATITIS, V12, P192, DOI 10.1111/j.1365-2893.2005.00581.x; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07	29	25	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3495	10.1371/journal.pone.0003495	http://dx.doi.org/10.1371/journal.pone.0003495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941527	gold, Green Published, Green Submitted			2022-12-25	WOS:000265126100024
J	Nienhaus, A; Kromark, K; Raulf-Heimsoth, M; van Kampen, V; Merget, R				Nienhaus, Albert; Kromark, Kathrin; Raulf-Heimsoth, Monika; van Kampen, Vera; Merget, Rolf			Outcome of Occupational Latex Allergy-Work Ability and Quality of Life	PLOS ONE			English	Article							NATURAL-RUBBER LATEX; HEALTH-CARE WORKERS; INDEX DLQI; ASTHMA; QUESTIONNAIRE; IMPACT; SENSITIZATION; IMPAIRMENT; PREVALENCE; VALIDATION	Objective: The quality of life (QOL) and work ability of health care workers allergic to natural rubber latex (NRL) were assessed after implementation of regulations on powder-free NRL gloves in Germany. Methods: 196 HCW with reported NRL allergy answered a questionnaire (response rate 58%) containing the Work Ability Index (WAI), Mini Asthma Quality of Life Questionnaire (MiniAQLQ), and Dermatology Life Quality Index (DLQI). Results: 63.2% still had NRL-related symptoms during the last 6 month. However on a scale from 0 to 10, the intensity of NRL-related symptoms decreased from 8.5 before to 2.3 after implementation of regulations on powder-free NRL gloves. A higher number of subjects were able to avoid NRL in the private than in the work environment (85% vs. 61%). NRL-related symptoms decreased and WAI increased with successful avoidance of NRL at workplace (b = 0.23, p = 0.003). QOL was only little affected by NRL allergy (mean: MiniAQLQ = 6.0; DLQI = 4.1). Conclusions: Although there was improvement after implementation of powder-free NRL gloves, there is still a considerable number of HCW with NRL-related symptoms. Further investigations on latex avoidance and the cause of persisiting allergic symptoms in HCW with NRL allergy are therefore needed.	[Nienhaus, Albert; Kromark, Kathrin] Inst Statutory Accid Insurance Hlth & Welf Serv, Hamburg, Germany; [Raulf-Heimsoth, Monika; van Kampen, Vera; Merget, Rolf] Ruhr Univ Bochum, German Social Accident Insurance, Res Inst Occupat Med, BGFA, Bochum, Germany	Ruhr University Bochum	Nienhaus, A (corresponding author), Inst Statutory Accid Insurance Hlth & Welf Serv, Hamburg, Germany.	albert.nienhaus@bgw-online.de	van Kampen, Vera/AAH-3657-2019					Acero S, 2003, J INVEST ALLERG CLIN, V13, P155; Al-Otaibi S, 2005, OCCUP MED-OXFORD, V55, P88, DOI 10.1093/occmed/kqi001; Allmers H, 2004, J ALLERGY CLIN IMMUN, V114, P347, DOI 10.1016/j.jaci.2004.05.054; Allmers H, 2002, J ALLERGY CLIN IMMUN, V110, P318, DOI 10.1067/mai.2002.126461; ARELLANO R, 1992, ANESTHESIOLOGY, V77, P905, DOI 10.1097/00000542-199211000-00011; Edelstam G, 2002, INT ARCH OCC ENV HEA, V75, P267, DOI 10.1007/s00420-001-0296-y; Filon FL, 2006, OCCUP ENVIRON MED, V63, P121, DOI 10.1136/oem.2003.011460; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Gradwell C, 2002, BRIT J DERMATOL, V147, P513, DOI 10.1046/j.1365-2133.2002.04901.x; Groneberg DA, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-3; Hachem JP, 2002, CONTACT DERMATITIS, V46, P220, DOI 10.1034/j.1600-0536.2002.460406.x; Hahn HB, 2001, J AM ACAD DERMATOL, V45, P44, DOI 10.1067/mjd.2001.110880; Hemery ML, 2004, ALLERGY, V59, P1013, DOI 10.1111/j.1398-9995.2004.00484.x; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Horwitz IB, 2000, J OCCUP ENVIRON MED, V42, P932, DOI 10.1097/00043764-200009000-00018; Hutchings CV, 2001, CONTACT DERMATITIS, V45, P17, DOI 10.1034/j.1600-0536.2001.045001017.x; Ilmarinen J, 1997, SCAND J WORK ENV HEA, V23, P49; Ind PW, 2004, RESP MED, V98, P464, DOI 10.1016/j.rmed.2003.07.010; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kernick D, 2000, BRIT J GEN PRACT, V50, P555; Korniewicz Denise M, 2005, AAOHN J, V53, P388; Kujala VM, 1997, AM J IND MED, V32, P197, DOI 10.1002/(SICI)1097-0274(199709)32:3<197::AID-AJIM3>3.0.CO;2-V; Latza U, 2005, INT ARCH OCC ENV HEA, V78, P394, DOI 10.1007/s00420-004-0594-2; Lewis V, 2004, J INVEST DERM SYMP P, V9, P169, DOI 10.1111/j.1087-0024.2004.09113.x; Lewis VJ, 2004, CONTACT DERMATITIS, V51, P317, DOI 10.1111/j.0105-1873.2004.0459i.x; Pinnock H, 2005, J CLIN EPIDEMIOL, V58, P809, DOI 10.1016/j.jclinepi.2005.01.010; RAULFHEIMSOTH M, 2003, AKTUEL DERMATOL, V29, P176; Reilly MC, 2003, J AM ACAD DERMATOL, V48, P128, DOI 10.1067/mjd.2003.128; Rueff F, 2004, ANN ALLERG ASTHMA IM, V92, P530, DOI 10.1016/S1081-1206(10)61760-7; Schwartz C, 2006, QUAL LIFE RES, V15, P1503, DOI 10.1007/s11136-006-0008-x; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Thinschmidt M, 2007, ZENTRALBLATT ARB ARB, V57, P212, DOI 10.1007/BF03349124; TUOMI K, 1991, SCAND J WORK ENV HEA, V17, P67; Turjanmaa K, 2002, J ALLERGY CLIN IMMUN, V110, pS70, DOI 10.1067/mai.2002.125332; Vandenplas O, 2002, J ALLERGY CLIN IMMUN, V109, P125, DOI 10.1067/mai.2002.120760; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; YASSIN MS, 1994, ANN ALLERGY, V72, P245	38	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3459	10.1371/journal.pone.0003459	http://dx.doi.org/10.1371/journal.pone.0003459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941629	Green Published, gold			2022-12-25	WOS:000265125900004
J	Starck, SR; Ow, YK; Jiang, V; Tokuyama, M; Rivera, M; Qi, X; Roberts, RW; Shastri, N				Starck, Shelley R.; Ow, Yongkai; Jiang, Vivian; Tokuyama, Maria; Rivera, Mark; Qi, Xin; Roberts, Richard W.; Shastri, Nilabh			A Distinct Translation Initiation Mechanism Generates Cryptic Peptides for Immune Surveillance	PLOS ONE			English	Article							MESSENGER-RNA; PROTEIN-SYNTHESIS; ENTRY SITE; RIBOSOME; COMPLEXES; CODON; DEGRADATION; BRUCEANTIN; INHIBITORS; PRODUCTS	MHC class I molecules present a comprehensive mixture of peptides on the cell surface for immune surveillance. The peptides represent the intracellular protein milieu produced by translation of endogenous mRNAs. Unexpectedly, the peptides are encoded not only in conventional AUG initiated translational reading frames but also in alternative cryptic reading frames. Here, we analyzed how ribosomes recognize and use cryptic initiation codons in the mRNA. We find that translation initiation complexes assemble at non-AUG codons but differ from canonical AUG initiation in response to specific inhibitors acting within the peptidyl transferase and decoding centers of the ribosome. Thus, cryptic translation at non-AUG start codons can utilize a distinct initiation mechanism which could be differentially regulated to provide peptides for immune surveillance.	[Starck, Shelley R.; Ow, Yongkai; Jiang, Vivian; Tokuyama, Maria; Rivera, Mark; Shastri, Nilabh] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Qi, Xin] Univ Texas, Southwestern Med Ctr, Dept Biochem, Howard Hughes Med Inst, Dallas, TX USA; [Roberts, Richard W.] Univ So Calif, Dept Chem, Chem Engn, & Biol, Los Angeles, CA USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Southern California	Starck, SR (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	nshastri@socrates.berkeley.edu			NIH [NRSA fellowship]; Cancer Research Institute [postdoctoral fellowship]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute	S.R.S. was supported in part by an NIH training grant, a postdoctoral fellowship from the Cancer Research Institute and the NRSA fellowship from the National Institutes of Health. This research was supported by grants from the National Institutes of Health to N.S..	ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; CIGAN AM, 1988, SCIENCE, V242, P93, DOI 10.1126/science.3051379; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; DOUDNA JA, 2007, TRANSLATIONAL CONTRO, P129; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; KOLB M, 1982, J MED CHEM, V25, P550, DOI 10.1021/jm00347a014; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; KOZAK M, 1978, J BIOL CHEM, V253, P6568; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; Kozak M, 1998, NUCLEIC ACIDS RES, V26, P4853, DOI 10.1093/nar/26.21.4853; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUPCHAN SM, 1975, J ORG CHEM, V40, P648, DOI 10.1021/jo00893a023; Lee J, 1999, BIOORG MED CHEM LETT, V9, P1365, DOI 10.1016/S0960-894X(99)00206-1; LIAO LL, 1976, MOL PHARMACOL, V12, P167; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; MERRICK WC, 2000, PROTEIN BIOSYNTHESIS, P89; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Rajbhandary Uttam L., 1995, P511; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; RODRIGUEZFONSECA C, 1995, J MOL BIOL, V247, P224, DOI 10.1006/jmbi.1994.0135; Sarnow P, 2003, J VIROL, V77, P2801, DOI 10.1128/JVI.77.5.2801-2806.2003; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	47	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3460	10.1371/journal.pone.0003460	http://dx.doi.org/10.1371/journal.pone.0003460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941630	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125900005
J	Juleff, N; Windsor, M; Reid, E; Seago, J; Zhang, ZD; Monaghan, P; Morrison, IW; Charleston, B				Juleff, Nicholas; Windsor, Miriam; Reid, Elizabeth; Seago, Julian; Zhang, Zhidong; Monaghan, Paul; Morrison, Ivan W.; Charleston, Bryan			Foot-and-Mouth Disease Virus Persists in the Light Zone of Germinal Centres	PLOS ONE			English	Article								Foot-and-mouth disease virus (FMDV) is one of the most contagious viruses of animals and is recognised as the most important constraint to international trade in animals and animal products. Two fundamental problems remain to be understood before more effective control measures can be put in place. These problems are the FMDV "carrier state'' and the short duration of immunity after vaccination which contrasts with prolonged immunity after natural infection. Here we show by laser capture microdissection in combination with quantitative real-time reverse transcription polymerase chain reaction, immunohistochemical analysis and corroborate by in situ hybridization that FMDV locates rapidly to, and is maintained in, the light zone of germinal centres following primary infection of naive cattle. We propose that maintenance of non-replicating FMDV in these sites represents a source of persisting infectious virus and also contributes to the generation of long-lasting antibody responses against neutralising epitopes of the virus.	[Juleff, Nicholas; Windsor, Miriam; Reid, Elizabeth; Seago, Julian; Zhang, Zhidong; Monaghan, Paul; Charleston, Bryan] Inst Anim Hlth, Pirbright Lab, Surrey, England; [Juleff, Nicholas; Morrison, Ivan W.] Univ Edinburgh, Ctr Trop Vet Med, Easter Bush Vet Ctr, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Edinburgh	Juleff, N (corresponding author), Inst Anim Hlth, Pirbright Lab, Surrey, England.	nicholas.juleff@bbsrc.ac.uk	Monaghan, Paul/H-1973-2013	zhang, zhidong/0000-0002-2186-7661; Zhang, Zhixiang/0000-0002-1161-5065; Charleston, Bryan/0000-0002-6952-9338	Biotechnology and Biological Sciences Research Council, United Kingdom; Biotechnology and Biological Sciences Research Council [BBS/B/00549] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the Biotechnology and Biological Sciences Research Council, United Kingdom. B.C. is a Jenner Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Brocchi E, 1998, VET QUART, V20, pS20; Brocchi EC A., 1983, ATTI SOC ITALIANA SC, V36, P576; COOK JKA, 1993, AVIAN PATHOL, V22, P257, DOI 10.1080/03079459308418919; CUNLIFFE HR, 1964, CORNELL VET, V54, P501; DeDiego M, 1997, ARCH VIROL, V142, P2021, DOI 10.1007/s007050050219; Doel TR, 2005, CURR TOP MICROBIOL, V288, P103; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; DONALDSON AI, 1989, RES VET SCI, V46, P9, DOI 10.1016/S0034-5288(18)31109-3; Gatto D, 2007, J IMMUNOL, V178, P67, DOI 10.4049/jimmunol.178.1.67; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; HOWARD C, 1991, VET IMMUNOL IMMUNOP, V27, P1, DOI 10.1016/0165-2427(91)90066-L; Ilott MC, 1997, EPIDEMIOL INFECT, V118, P181, DOI 10.1017/S0950268896007376; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Lefevre EA, 2007, J LEUKOCYTE BIOL, V82, P666, DOI 10.1189/jlb.0107050; Liebler-Tenorio EM, 2006, VET RES, V37, P257, DOI 10.1051/vetres:2006001; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; MASON PW, 1993, VIROLOGY, V192, P568, DOI 10.1006/viro.1993.1073; Monaghan P, 2005, J GEN VIROL, V86, P2769, DOI 10.1099/vir.0.81172-0; Murphy MLP, 1999, VIRUS RES, V62, P67, DOI 10.1016/S0168-1702(99)00050-7; Murray SE, 2004, J NEUROIMMUNOL, V156, P31, DOI 10.1016/j.jneuroim.2004.06.015; Perry BD, 2007, VET REC, V160, P238, DOI 10.1136/vr.160.7.238; Quan M, 2004, J COMP PATHOL, V131, P294, DOI 10.1016/j.jcpa.2004.05.002; Rigden RC, 2002, IMMUNOLOGY, V106, P537, DOI 10.1046/j.1365-2567.2002.01460.x; Rouiller I, 1998, J VIROL, V72, P2373, DOI 10.1128/JVI.72.3.2373-2387.1998; Simon ID, 2007, J VIROL, V81, P2078, DOI 10.1128/JVI.02525-06; Smith BA, 2001, J IMMUNOL, V166, P690, DOI 10.4049/jimmunol.166.1.690; SUTMOLLER P, 1965, VET REC, V77, P968, DOI 10.1136/vr.77.33.968; SZAKAL AK, 1988, J IMMUNOL, V140, P341; TEW JG, 1979, IMMUNOLOGY, V37, P69; Valarcher JF, 2003, J VIROL, V77, P8426, DOI 10.1128/JVI.77.15.8426-8439.2003; Vosloo W, 1996, J GEN VIROL, V77, P1457, DOI 10.1099/0022-1317-77-7-1457; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x; Zhang ZD, 2004, J GEN VIROL, V85, P2567, DOI 10.1099/vir.0.80011-0	40	63	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3434	10.1371/journal.pone.0003434	http://dx.doi.org/10.1371/journal.pone.0003434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941503	Green Published, gold, Green Submitted			2022-12-25	WOS:000265125600003
J	Milne, K; Barnes, RO; Girardin, A; Mawer, MA; Nesslinger, NJ; Ng, A; Nielsen, JS; Sahota, R; Tran, E; Webb, JR; Wong, MQ; Wick, DA; Wray, A; McMurtrie, E; Kobel, M; Kalloger, SE; Gilks, CB; Watson, PH; Nelson, BH				Milne, Katy; Barnes, Rebecca O.; Girardin, Adam; Mawer, Melanie A.; Nesslinger, Nancy J.; Ng, Alvin; Nielsen, Julie S.; Sahota, Robert; Tran, Eric; Webb, John R.; Wong, May Q.; Wick, Darin A.; Wray, Andrew; McMurtrie, Elissa; Koebel, Martin; Kalloger, Steven E.; Gilks, C. Blake; Watson, Peter H.; Nelson, Brad H.			Tumor-Infiltrating T Cells Correlate with NY-ESO-1-Specific Autoantibodies in Ovarian Cancer	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; INTRAPERITONEAL ADOPTIVE IMMUNOTHERAPY; FOLATE BINDING-PROTEIN; ACTIVATED KILLER-CELL; RECOMBINANT INTERLEUKIN-2; BREAST-CANCER; LYMPHOCYTES RECOGNIZE; HER2/NEU EXPRESSION; ANTIGEN-EXPRESSION; INTERFERON-GAMMA	Background: Tumor-infiltrating CD8+ T cells are correlated with prolonged progression-free and overall survival in epithelial ovarian cancer (EOC). A significant fraction of EOC patients mount autoantibody responses to various tumor antigens, however the relationship between autoantibodies and tumor-infiltrating T cells has not been investigated in EOC or any other human cancer. We hypothesized that autoantibody and T cell responses may be correlated in EOC and directed toward the same antigens. Methodology and Principal Findings: We obtained matched serum and tumor tissue from 35 patients with high-grade serous ovarian cancer. Serum samples were assessed by ELISA for autoantibodies to the common tumor antigen NY-ESO-1. Tumor tissue was examined by immunohistochemistry for expression of NY-ESO-1, various T cell markers (CD3, CD4, CD8, CD25, FoxP3, TIA-1 and Granzyme B) and other immunological markers (CD20, MHC class I and MHC class II). Lymphocytic infiltrates varied widely among tumors and included cells positive for CD3, CD8, TIA-1, CD25, FoxP3 and CD4. Twenty-six percent (9/35) of patients demonstrated serum IgG autoantibodies to NY-ESO-1, which were positively correlated with expression of NY-ESO-1 antigen by tumor cells (r = 0.57, p = 0.0004). Autoantibodies to NY-ESO-1 were associated with increased tumor-infiltrating CD8+, CD4+ and FoxP3+ cells. In an individual HLA-A2+ patient with autoantibodies to NY-ESO-1, CD8+ T cells isolated from solid tumor and ascites were reactive to NY-ESO-1 by IFN-gamma ELISPOT and MHC class I pentamer staining. Conclusion and Significance: We demonstrate that tumor-specific autoantibodies and tumor-infiltrating T cells are correlated in human cancer and can be directed against the same target antigen. This implies that autoantibodies may collaborate with tumor-infiltrating T cells to influence clinical outcomes in EOC. Furthermore, serological screening methods may prove useful for identifying clinically relevant T cell antigens for immunotherapy.	[Milne, Katy; Barnes, Rebecca O.; Girardin, Adam; Mawer, Melanie A.; Nesslinger, Nancy J.; Ng, Alvin; Nielsen, Julie S.; Sahota, Robert; Tran, Eric; Webb, John R.; Wong, May Q.; Wick, Darin A.; Wray, Andrew; Watson, Peter H.; Nelson, Brad H.] BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Girardin, Adam; Tran, Eric; Webb, John R.; Watson, Peter H.; Nelson, Brad H.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 2Y2, Canada; [McMurtrie, Elissa] BC Canc Agcy, Victoria, BC, Canada; [Koebel, Martin; Kalloger, Steven E.; Gilks, C. Blake] Vancouver Gen Hosp, Dept Anat Pathol, Vancouver, BC, Canada; [Watson, Peter H.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Nelson, Brad H.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of Victoria; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Milne, K (corresponding author), BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada.	bnelson@bccancer.bc.ca	Kalloger, Steve/B-3949-2010; Nelson, Brad H/K-2622-2014; Köbel, Martin/A-7373-2011	Watson, Peter/0000-0002-1642-0638; Kobel, Martin/0000-0002-6615-2037; Nelson, Brad/0000-0002-4445-5539; Milne, Katy/0000-0001-5616-1821	British Columbia Cancer Foundation; Canary Foundation; U.S. Department of Defense [OC000018]	British Columbia Cancer Foundation; Canary Foundation; U.S. Department of Defense(United States Department of Defense)	British Columbia Cancer Foundation, Canary Foundation, U.S. Department of Defense (OC000018). None of the sponsors had any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Akahiro Jun-ichi, 2004, Int J Clin Oncol, V9, P42, DOI 10.1007/s10147-003-0360-6; AOKI Y, 1991, CANCER RES, V51, P1934; Bagnoli M, 2007, MOL CANCER THER, V6, P762, DOI 10.1158/1535-7163.MCT-06-0357; BAMIAS A, 2007, GYNECOL ONCOL; Bookman MA, 2005, INT J GYNECOL CANCER, V15, P212, DOI 10.1111/j.1525-1438.2005.00444.x; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Carson WE, 2004, CLIN CANCER RES, V10, P3401, DOI 10.1158/1078-0432.CCR-1016-03; Chan OTM, 2000, CANCER IMMUNOL IMMUN, V49, P181, DOI 10.1007/s002620000122; Chatterjee M, 2006, CANCER RES, V66, P1181, DOI 10.1158/0008-5472.CAN-04-2962; Crane IJ, 2005, CRIT REV IMMUNOL, V25, P75, DOI 10.1615/CritRevImmunol.v25.i2.10; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dadmarz R D, 1996, Cancer J Sci Am, V2, P263; Demaria S, 2001, CLIN CANCER RES, V7, P3025; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Duncan TJ, 2007, CLIN CANCER RES, V13, P4139, DOI 10.1158/1078-0432.CCR-06-2833; Fitzpatrick FA, 2003, INT IMMUNOPHARMACOL, V3, P1699, DOI 10.1016/j.intimp.2003.08.007; Freedman R S, 1996, Cancer Treat Res, V82, P115; Freedman RS, 1996, HUM GENE THER, V7, P1351, DOI 10.1089/hum.1996.7.11-1351; FREEDMAN RS, 1994, J IMMUNOTHER, V16, P198, DOI 10.1097/00002371-199410000-00004; Freedman RS, 2000, CLIN CANCER RES, V6, P2268; Fujimoto K, 2006, ANTICANCER RES, V26, P4015; Fujita K, 1995, CLIN CANCER RES, V1, P501; Gadducci A, 1999, GYNECOL ONCOL, V72, P76, DOI 10.1006/gyno.1998.5101; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61; GILKS CB, 2008, HUMAN PATHO IN PRESS; Gimotty PA, 2007, DIS MARKERS, V23, P445, DOI 10.1155/2007/508350; Goedegebuure PS, 1997, CELL IMMUNOL, V175, P150, DOI 10.1006/cimm.1996.1055; Goodell V, 2006, J CLIN ONCOL, V24, P762, DOI 10.1200/JCO.2005.03.2813; HALAPI E, 1993, CANCER IMMUNOL IMMUN, V36, P191, DOI 10.1007/BF01741091; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hayashi K, 1999, GYNECOL ONCOL, V74, P86, DOI 10.1006/gyno.1999.5430; Helal TE, 2004, PATHOL ONCOL RES, V10, P80, DOI 10.1007/BF02893460; Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396; Hogdall EVS, 2002, APMIS, V110, P545, DOI 10.1034/j.1600-0463.2002.11007805.x; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; IKARASHI H, 1994, CANCER RES, V54, P190; IOANNIDES CG, 1991, CANCER RES, V51, P4257; IOANNIDES CG, 1991, J IMMUNOL, V146, P1700; Kanavaros P, 2000, LEUKEMIA LYMPHOMA, V38, P317, DOI 10.3109/10428190009087022; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kooi S, 1996, CELL IMMUNOL, V174, P116, DOI 10.1006/cimm.1996.0301; Kusuda T, 2005, ONCOL REP, V13, P1153; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; LAMBECK A, 2007, INT J CANC; LINEHAN DC, 1995, SURG ONCOL, V4, P41, DOI 10.1016/S0960-7404(10)80030-1; Luborsky JL, 2005, AM J REPROD IMMUNOL, V54, P55, DOI 10.1111/j.1600-0897.2005.00287.x; Marth C, 2004, AM J OBSTET GYNECOL, V191, P1598, DOI 10.1016/j.ajog.2004.05.007; Mayerhofer K, 1999, ANTICANCER RES, V19, P875; MOORE DH, 1990, GYNECOL ONCOL, V38, P458, DOI 10.1016/0090-8258(90)90091-X; Negus RPM, 1997, AM J PATHOL, V150, P1723; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Nijman HW, 2001, EUR J OBSTET GYN R B, V94, P114, DOI 10.1016/S0301-2115(00)00294-3; Odunsi K, 2003, CANCER RES, V63, P6076; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ozols RF, 2000, SEMIN ONCOL, V27, P47; Pappas J, 2005, CELL IMMUNOL, V234, P81, DOI 10.1016/j.cellimm.2005.05.001; PEOPLES GE, 1993, J IMMUNOL, V151, P5481; Peoples GE, 1998, ANN SURG ONCOL, V5, P743, DOI 10.1007/BF02303486; PEOPLES GE, 1993, J IMMUNOL, V151, P5472; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; Peoples GE, 1999, CLIN CANCER RES, V5, P4214; PEOPLES GE, 1994, J IMMUNOL, V152, P4993; PEOPLES GE, 1993, SURGERY, V114, P227; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; Riesbeck K, 1999, ANTI-CANCER DRUG, V10, P219, DOI 10.1097/00001813-199902000-00011; Rolland P, 2007, CLIN CANCER RES, V13, P3591, DOI 10.1158/1078-0432.CCR-06-2087; Santin AD, 2004, INT J GYNECOL CANCER, V14, P64, DOI 10.1111/j.1048-891x.2004.014175.x; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shah CA, 2008, GYNECOL ONCOL, V109, P215, DOI 10.1016/j.ygyno.2008.01.010; STEIS RG, 1990, J CLIN ONCOL, V8, P1618, DOI 10.1200/JCO.1990.8.10.1618; STEWART JA, 1990, CANCER RES, V50, P6302; Stone B, 2003, INT J CANCER, V104, P73, DOI 10.1002/ijc.10900; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Tsavaris N, 2002, BRIT J CANCER, V87, P21, DOI 10.1038/sj.bjc.6600347; TSUDA H, 1994, GYNECOL ONCOL, V52, P218, DOI 10.1006/gyno.1994.1034; Tsuda N, 2007, CANCER RES, V67, P8378, DOI 10.1158/0008-5472.CAN-07-0327; URBA WJ, 1989, J NATL CANCER I, V81, P602, DOI 10.1093/jnci/81.8.602; Vogl FD, 2000, BRIT J CANCER, V83, P1338, DOI 10.1054/bjoc.2000.1446; Wasserfall CH, 2006, AUTOIMMUN REV, V5, P424, DOI 10.1016/j.autrev.2005.12.002; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Woo EY, 2001, CANCER RES, V61, P4766; Yakirevich E, 2003, CLIN CANCER RES, V9, P6453; YOSHINO I, 1994, J IMMUNOL, V152, P2393; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	89	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3409	10.1371/journal.pone.0003409	http://dx.doi.org/10.1371/journal.pone.0003409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923710	Green Submitted, gold, Green Published			2022-12-25	WOS:000265121800007
J	Volinia, S; Mascellani, N; Marchesini, J; Veronese, A; Ormondroyd, E; Alder, H; Palatini, J; Negrini, M; Croce, CM				Volinia, Stefano; Mascellani, Nicoletta; Marchesini, Jlenia; Veronese, Angelo; Ormondroyd, Elizabeth; Alder, Hansjuerg; Palatini, Jeff; Negrini, Massimo; Croce, Carlo M.			Genome Wide Identification of Recessive Cancer Genes by Combinatorial Mutation Analysis	PLOS ONE			English	Article								We devised a novel procedure to identify human cancer genes acting in a recessive manner. Our strategy was to combine the contributions of the different types of genetic alterations to loss of function: amino-acid substitutions, frame-shifts, gene deletions. We studied over 20,000 genes in 3 Gigabases of coding sequences and 700 array comparative genomic hybridizations. Recessive genes were scored according to nucleotide mismatches under positive selective pressure, frame-shifts and genomic deletions in cancer. Four different tests were combined together yielding a cancer recessive p-value for each studied gene. One hundred and fifty four candidate recessive cancer genes (p-value < 1.5 x 10(-7), FDR = 0.39) were identified. Strikingly, the prototypical cancer recessive genes TP53, PTEN and CDKN2A all ranked in the top 0.5% genes. The functions significantly affected by cancer mutations are exactly overlapping those of known cancer genes, with the critical exception for the absence of tyrosine kinases, as expected for a recessive gene-set.	[Volinia, Stefano; Mascellani, Nicoletta; Marchesini, Jlenia] Univ Ferrara, I-44100 Ferrara, Italy; [Volinia, Stefano; Alder, Hansjuerg; Palatini, Jeff; Croce, Carlo M.] Ohio State Univ, Comprehensive Canc Ctr, Dept Mol Virol, Immunol & Mol Genet, Columbus, OH USA; [Veronese, Angelo; Negrini, Massimo] Univ Ferrara, Ctr Interdipt Ricerca Cancro, Dipartimento Med Sperimentale Diagnost, I-44100 Ferrara, Italy; [Ormondroyd, Elizabeth] Inst Canc Res, Surrey, England	University of Ferrara; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara; University of London; Institute of Cancer Research - UK	Volinia, S (corresponding author), Univ Ferrara, I-44100 Ferrara, Italy.	carlo.croce@osumc.edu	Negrini, Massimo/J-2377-2016; Veronese, Angelo/I-4292-2019; Volinia, Stefano/A-3029-2010; Young, Richard A/F-6495-2012; marchesini, jlenia jm/K-2872-2016; Volinia, Stefano/AAA-9264-2019	Negrini, Massimo/0000-0002-0007-1920; Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; marchesini, jlenia jm/0000-0002-1911-5938; Volinia, Stefano/0000-0003-0910-3893; Veronese, Angelo/0000-0002-1451-1392; Palatini, Jeffrey/0000-0001-9280-4417; Ormondroyd, Elizabeth/0000-0002-9116-4064	National Cancer Institute [P01CA76259]; AIRC; PRRIITT Regione Emilia Romagna; MIUR; NATIONAL CANCER INSTITUTE [P01CA076259] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AIRC(Fondazione AIRC per la ricerca sul cancro); PRRIITT Regione Emilia Romagna(Regione Emilia Romagna); MIUR(Ministry of Education, Universities and Research (MIUR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Program Project Grant No. P01CA76259 from the National Cancer Institute (CMC) and by grants from AIRC, PRRIITT Regione Emilia Romagna and MIUR (SV).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davison AC, 1997, BOOTSTRAP METHODS TH; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Efron B., 1994, INTRO BOOTSTRAP; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Murphy JA, 2004, HUM MUTAT, V24, P296, DOI 10.1002/humu.20083; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Qiu P, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-4; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stratton M, 2008, NAT BIOTECHNOL, V26, P65, DOI 10.1038/nbt0108-65; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; 1997, BREAST CANC LINKAGE, V349, P1505	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3380	10.1371/journal.pone.0003380	http://dx.doi.org/10.1371/journal.pone.0003380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846217	Green Published, Green Submitted, gold			2022-12-25	WOS:000265114500009
J	Watts, KM; Hunstad, DA				Watts, Kristin M.; Hunstad, David A.			Components of SurA Required for Outer Membrane Biogenesis in Uropathogenic Escherichia coli	PLOS ONE			English	Article								Background: SurA is a periplasmic peptidyl-prolyl isomerase ( PPIase) and chaperone of Escherichia coli and other Gram-negative bacteria. In contrast to other PPIases, SurA appears to have a distinct role in chaperoning newly synthesized porins destined for insertion into the outer membrane. Previous studies have indicated that the chaperone activity of SurA rests in its "core module'' (the N- plus C-terminal domains), based on in vivo envelope phenotypes and in vitro binding and protection of non-native substrates. Methodology/Principal Findings: In this study, we determined the components of SurA required for chaperone activity using in vivo phenotypes relevant to disease causation by uropathogenic E. coli (UPEC), namely membrane resistance to permeation by antimicrobials and maturation of the type 1 pilus usher FimD. FimD is a SurA-dependent, integral outer membrane protein through which heteropolymeric type 1 pili, which confer bladder epithelial binding and invasion capacity upon uropathogenic E. coli, are assembled and extruded. Consistent with prior results, the in vivo chaperone activity of SurA in UPEC rested primarily in the core module. However, the PPIase domains I and II were not expendable for wild-type resistance to novobiocin in broth culture. Steady-state levels of FimD were substantially restored in the UPEC surA mutant complemented with the SurA N- plus C-terminal domains. The addition of PPIase domain I augmented FimD maturation into the outer membrane, consistent with a model in which domain I enhances stability of and/or substrate binding by the core module. Conclusions/Significance: Our results confirm the core module of E. coli SurA as a potential target for novel anti-infective development.	[Watts, Kristin M.; Hunstad, David A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Hunstad, David A.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Watts, KM (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	dhunstad@wustl.edu		Hunstad, David/0000-0002-9848-0975	National Institutes of Health [DK067894, DK076556]; Child Health Research Center of Excellence at Washington University [K12-HD01487]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK067894, R03DK076556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Child Health Research Center of Excellence at Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK067894 and DK076556 (to D.A.H.) and by the Child Health Research Center of Excellence at Washington University (K12-HD01487). Funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bitto E, 2004, FEBS LETT, V568, P94, DOI 10.1016/j.febslet.2004.05.014; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200; HORNE SM, 1995, ARCH MICROBIOL, V163, P357, DOI 10.1007/s002030050215; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; LIU J, 1990, P NATL ACAD SCI USA, V87, P4028, DOI 10.1073/pnas.87.11.4028; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Ramm K, 2000, J BIOL CHEM, V275, P17106, DOI 10.1074/jbc.M910234199; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; Sydenham M, 2000, INFECT IMMUN, V68, P1109, DOI 10.1128/IAI.68.3.1109-1115.2000; Webb HM, 2001, J BIOL CHEM, V276, P45622, DOI 10.1074/jbc.M107508200; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069	31	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3359	10.1371/journal.pone.0003359	http://dx.doi.org/10.1371/journal.pone.0003359			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836534	Green Published, gold			2022-12-25	WOS:000265113500012
J	Nakagawa, T; Kollmeyer, TM; Morlan, BW; Anderson, SK; Bergstralh, EJ; Davis, BJ; Asmann, YW; Klee, GG; Ballman, KV; Jenkins, RB				Nakagawa, Tohru; Kollmeyer, Thomas M.; Morlan, Bruce W.; Anderson, S. Keith; Bergstralh, Eric J.; Davis, Brian J.; Asmann, Yan W.; Klee, George G.; Ballman, Karla V.; Jenkins, Robert B.			A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy	PLOS ONE			English	Article							NEOADJUVANT HORMONAL-THERAPY; RADIATION-THERAPY; RADICAL PROSTATECTOMY; CLINICAL-SIGNIFICANCE; ANDROGEN DEPRIVATION; BIOCHEMICAL FAILURE; CHROMOSOME 8Q24; GENE; EXPRESSION; ANTIGEN	Background: Many men develop a rising PSA after initial therapy for prostate cancer. While some of these men will develop a local or metastatic recurrence that warrants further therapy, others will have no evidence of disease progression. We hypothesized that an expression biomarker panel can predict which men with a rising PSA would benefit from further therapy. Methodology/Principal Findings: A case-control design was used to test the association of gene expression with outcome. Systemic (SYS) progression cases were men post-prostatectomy who developed systemic progression within 5 years after PSA recurrence. PSA progression controls were matched men post-prostatectomy with PSA recurrence but no evidence of clinical progression within 5 years. Using expression arrays optimized for paraffin-embedded tissue RNA, 1021 cancer-related genes were evaluated-including 570 genes implicated in prostate cancer progression. Genes from 8 previously reported marker panels were included. A systemic progression model containing 17 genes was developed. This model generated an AUC of 0.88 (95% CI: 0.84-0.92). Similar AUCs were generated using 3 previously reported panels. In secondary analyses, the model predicted the endpoints of prostate cancer death (in SYS cases) and systemic progression beyond 5 years (in PSA controls) with hazard ratios 2.5 and 4.7, respectively (log-rank p-values of 0.0007 and 0.0005). Genes mapped to 8q24 were significantly enriched in the model. Conclusions/Significance: Specific gene expression patterns are significantly associated with systemic progression after PSA recurrence. The measurement of gene expression pattern may be useful for determining which men may benefit from additional therapy after PSA recurrence.	[Nakagawa, Tohru; Kollmeyer, Thomas M.; Klee, George G.; Jenkins, Robert B.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Morlan, Bruce W.; Anderson, S. Keith; Bergstralh, Eric J.; Asmann, Yan W.; Ballman, Karla V.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Davis, Brian J.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Nakagawa, T (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	rjenkins@mayo.edu		Ballman, Karla/0000-0002-4492-0357; Davis, Brian/0000-0002-8288-1096	NIH [P50 CA91956]; Richard M. Schulze Family Foundation; Minnesota Department of Employment and Economic Development; Ministry of Health, Labor and Welfare of Japan [Grant-in-Aid]; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard M. Schulze Family Foundation; Minnesota Department of Employment and Economic Development; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the P50 CA91956 Mayo Prostate Cancer SPORE grant from the NIH, and the Richard M. Schulze Family Foundation. It was also supported by the Minnesota Department of Employment and Economic Development from the State's legislative appropriation for the Minnesota Partnership for Biotechnology and Medical Genomics. Tohru Nakagawa was supported in part by a Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan.	Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Ballman KV, 2004, BIOINFORMATICS, V20, P2778, DOI 10.1093/bioinformatics/bth327; BERGSTRALH EJ, 1995, EPIDEMIOLOGY, V6, P271; Bibikova M, 2004, CLIN CHEM, V50, P2384, DOI 10.1373/clinchem.2004.037432; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; D'Amico AV, 2003, J CLIN ONCOL, V21, P2163, DOI 10.1200/JCO.2003.01.075; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Gleave ME, 2001, J UROLOGY, V166, P500, DOI 10.1016/S0022-5347(05)65971-X; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Harald C, 1999, MATH METHODS STAT; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kestin LL, 2004, INT J RADIAT ONCOL, V60, P453, DOI 10.1016/j.ijrobp.2004.03.013; Kube DM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-25; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LaTulippe E, 2002, CANCER RES, V62, P4499; Lawton CA, 2001, INT J RADIAT ONCOL, V49, P937, DOI 10.1016/S0360-3016(00)01516-9; Luo J, 2001, CANCER RES, V61, P4683; Magee JA, 2001, CANCER RES, V61, P5692; Moul JW, 2004, J UROLOGY, V171, P1141, DOI 10.1097/01.JU.0000113794.34810.D0; Moul JW, 2000, J UROLOGY, V163, P1632, DOI 10.1016/S0022-5347(05)67511-8; Patel DA, 2005, J CLIN ONCOL, V23, P6157, DOI 10.1200/JCO.2005.01.2336; Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6; Pinover WH, 2003, CANCER-AM CANCER SOC, V97, P1127, DOI 10.1002/cncr.11166; PORKKA KP, 2007, GENE CHROMOSOME CANC, V39, P1; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sandler HM, 2000, INT J RADIAT ONCOL, V48, P629, DOI 10.1016/S0360-3016(00)00717-3; Saramaki O, 2001, AM J PATHOL, V159, P2089, DOI 10.1016/S0002-9440(10)63060-X; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Savinainen KJ, 2006, PROSTATE, V66, P1144, DOI 10.1002/pros.20452; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Severi G, 2007, CANCER EPIDEM BIOMAR, V16, P610, DOI 10.1158/1055-9965.EPI-06-0872; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tollefson MK, 2007, MAYO CLIN PROC, V82, P422, DOI 10.4065/82.4.422; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tsuchiya N, 2002, GENE CHROMOSOME CANC, V34, P363, DOI 10.1002/gcc.10064; Tsuchiya N, 2002, AM J PATHOL, V160, P1799, DOI 10.1016/S0002-9440(10)61126-1; Wang L, 2007, CANCER RES, V67, P2944, DOI 10.1158/0008-5472.CAN-06-3186; Welsh JB, 2001, CANCER RES, V61, P5974; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; ZELEFSKY MJ, 1994, INT J RADIAT ONCOL, V29, P755, DOI 10.1016/0360-3016(94)90563-0	56	143	165	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2318	10.1371/journal.pone.0002318	http://dx.doi.org/10.1371/journal.pone.0002318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18846227	Green Published, gold, Green Submitted			2022-12-25	WOS:000262268500046
J	Mishra, P; Bhakuni, V				Mishra, Parul; Bhakuni, Vinod			Self-assembly of Bacteriophage-associated Hyaluronate Lyase (HYLP2) into an Enzymatically Active Fibrillar Film	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRILS; ELECTRON-MICROSCOPY; THIOFLAVINE-T; PROTEIN; AGGREGATION; CONFORMATIONS; MECHANISM; FILAMENTS; PATHWAYS; FEATURES	The in vitro assembly of a soluble protein into its mature fibrillar form is usually accompanied by loss of its functional activity. Our study is the first demonstration of a natural enzyme (Hy1P2) retaining its enzymatic activity on conversion from pre-fibril to mature fibril and supports the contention that minor conformational changes in the native folded form of a protein can lead to the formation of a functional fibril. Hyaluronate lyase (Hy1P2) is a natural enzyme of bacteriophage 10403 of Streptococcus pyogenes. AtpH5.0, the enzyme undergoes partial unfolding localized in its N-terminal domain while the C-terminal domain maintains its folded trimeric conformation. This structural variant of Hy1P2 retains about 70% enzymatic activity with hyaluronan. It further self-assembles into a fibrillar film in vitro through solvent-exposed nonpolar surfaces and intermolecular beta-sheet formation by the beta-strands in the protein. Interestingly, the mature fibrillar film of Hy1P2 also retains about 60 and 20% enzymatic activity for hyaluronic acid and chondroitin sulfate, respectively. The possession of broad substrate specificity by the fibrillar form of Hy1P2 indicates that fluctuations in pH, which do not lead to loss of functionality of Hy1P2, might assist in bacterial pathogenesis. The formation of fibrillar film-like structure has been observed for the first time among the hyaluronidase enzymes. After acquiring this film-like structure in bacteriophage, Hy1P2 still retains its enzymatic activity, which establishes that these fibrils are a genuinely acquired protein fold/structure.	[Mishra, Parul; Bhakuni, Vinod] Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Bhakuni, V (corresponding author), Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India.	bhakuniv@rediffmail.com	Mishra, Parul/AAY-2911-2020	Mishra, Parul/0000-0002-2989-7371	Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Supported by the Council of Scientific and Industrial Research, New Delhi, India.	Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; de Laureto PP, 2005, FEBS J, V272, P2176, DOI 10.1111/j.1742-4658.2005.04638.x; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; FINK AL, 1999, PROTEIN STRUCTURES M, P140; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; GLENNER GG, 1972, J HISTOCHEM CYTOCHEM, V20, P821, DOI 10.1177/20.10.821; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Inouye H, 2000, J STRUCT BIOL, V130, P123, DOI 10.1006/jsbi.2000.4258; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jimenez JL, 2001, J MOL BIOL, V311, P241, DOI 10.1006/jmbi.2001.4863; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; KRAMER MR, 2006, NATURE, V6, P533; Lackowicz JR., 2006, PRINCIPLES FLUORESCE, V3, DOI 10.1007/978-0-387-46312-4; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Marris E, 2006, NATURE, V444, P985, DOI 10.1038/444985a; MAXTED WR, 1952, NATURE, V170, P1020, DOI 10.1038/1701020b0; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mishra P, 2006, J BIOL CHEM, V281, P7143, DOI 10.1074/jbc.M510991200; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; POLVERINO D, 2003, J MOL BIOL, V334, P129; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; TAN YJ, 1995, J MOL BIOL, V254, P980, DOI 10.1006/jmbi.1995.0670; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wetzel R, 1996, CELL, V86, P699, DOI 10.1016/S0092-8674(00)80143-9; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	44	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5240	5249		10.1074/jbc.M806730200	http://dx.doi.org/10.1074/jbc.M806730200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	18849564	hybrid			2022-12-25	WOS:000263416600054
J	Lippuner, C; Paape, D; Paterou, A; Brand, J; Richardson, M; Smith, AJ; Hoffmann, K; Brinkmann, V; Blackburn, C; Aebischer, T				Lippuner, Christoph; Paape, Daniel; Paterou, Athina; Brand, Janko; Richardson, Melville; Smith, Andrew J.; Hoffmann, Kirstin; Brinkmann, Volker; Blackburn, Clare; Aebischer, Toni			Real-time imaging of Leishmania mexicana-infected early phagosomes: a study using primary macrophages generated from green fluorescent protein-Rab5 transgenic mice	FASEB JOURNAL			English	Article						embryonic stem cells; inducible gene expression; doxycycline; wortmannin; reverse tetracycline transactivator; lipophosphoglycan	EMBRYONIC STEM-CELLS; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; PARASITOPHOROUS VACUOLES; MURINE MACROPHAGES; GLYCOPROTEIN GP63; PHAGOCYTOSIS; MATURATION; LIPOPHOSPHOGLYCAN	The small GTPase Rab5 is a key regulator of endosome/phagosome maturation and in intravesicular infections marks a phagosome stage at which decisions over pathogen replication or destruction are integrated. It is currently unclear whether Leishmania-infected phagosomes uniformly pass through a Rab5(+) stage on their intracellular path to compartments with late endosomal/early lysosomal characteristics. Differences in routes and final compartments could have consequences for accessibility to antileishmanial drugs. Here, we generated a unique gfp-rab5 transgenic mouse model to visualize Rab5 recruitment to early parasite-containing phagosomes in primary host cells. Using real-time fluorescence imaging of phagosomes carrying Leishmania mexicana, we determined that parasite-infested phagosomes follow a uniform sequence of transient Rab5 recruitment. Residence in Rab5(+) compartments was much shorter compared with phagosomes harboring latex beads. Furthermore, a comparative analysis of parasite life-cycle stages and mutants deficient in lpg1, the gene encoding the enzyme required for synthesis of the dominant surface lipophosphoglycan, indicated that parasite surface ligands and host cell receptors modulate pathogen residence times in Rab5(+) phagosomes, but, as far as tested, had no significant effect on intracellular L. mexicana survival or replication. - Lippuner, C., Paape, D., Paterou, A., Brand, J., Richardson, M., Smith, A. J., Hoffmann, K., Brinkmann, V., Blackburn, C., Aebischer, T. Real-time imaging of Leishmania mexicana-infected early phagosomes: a study using primary macrophages generated from green fluorescent protein-Rab5 transgenic mice. FASEB J. 23, 483-491 (2009)	[Paape, Daniel; Paterou, Athina; Aebischer, Toni] Univ Edinburgh, Marie Curie Team Pathogen Habitats, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Lippuner, Christoph; Paape, Daniel; Brand, Janko; Hoffmann, Kirstin; Aebischer, Toni] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Brinkmann, Volker] Max Planck Inst Infect Biol, Cent Microscopy Unit, Berlin, Germany; [Richardson, Melville; Smith, Andrew J.; Blackburn, Clare] Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh; Max Planck Society; Max Planck Society; University of Edinburgh	Aebischer, T (corresponding author), Univ Edinburgh, Marie Curie Team Pathogen Habitats, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland.	toni.aebischer@ed.ac.uk	Blackburn, Clare/AAM-7954-2020; Blackburn, Clare/B-2847-2009; Brinkmann, Volker/A-6015-2009; Paape, Daniel/G-1665-2015	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X; Paape, Daniel/0000-0003-4355-8058; Aebischer, Toni/0000-0002-4875-8457; Lippuner, Christoph/0000-0003-2872-9381	Deutsche Forschungsgemeinschaft [Ae16/3-1]; European Molecular Biology Organization [ASTF 171-2002]; Marie Curie Excellence Award; Boehringer Ingelheim Foundation; Medical Research Council [G0700711B] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie Excellence Award(European Commission); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Nichols for blastocyst injections; S. Moese (Max Planck Institute for Infection Biology, Berlin, Germany), S. Bronson (University of North Carolina, Chapel Hill, NC, USA), A. Galmiche (Max Planck Institute for Infection Biology), D. Colby (University of Edinburgh, Edinburgh, UK), and D. Hills (University of Edinburgh) for DNA constructs and reagents; U. Klemm for continuous advice on ES cell cultures; and U. Schaible and M. Drab for helpful comments on the manuscript. The study was supported by grants from the Deutsche Forschungsgemeinschaft (Ae16/3-1) and the European Molecular Biology Organization (ASTF 171-2002) and by a Marie Curie Excellence Award to T. A. C. L. was supported by the Boehringer Ingelheim Foundation. Finally, we also acknowledge the continuous support of T. F. Meyer. The authors have no conflicting commercial interests.	Aderem A, 2003, J INFECT DIS, V187, pS340, DOI 10.1086/374747; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Aebischer T, 2005, EUR J IMMUNOL, V35, P476, DOI 10.1002/eji.200425674; Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; Antoine JC, 2004, ADV PARASIT, V58, P1, DOI 10.1016/S0065-308X(04)58001-6; Antoine JC, 1998, TRENDS MICROBIOL, V6, P392, DOI 10.1016/S0966-842X(98)01324-9; BAHR V, 1993, MOL BIOCHEM PARASIT, V58, P107, DOI 10.1016/0166-6851(93)90095-F; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Bennett CL, 2001, EUR J IMMUNOL, V31, P876, DOI 10.1002/1521-4141(200103)31:3&lt;876::AID-IMMU876&gt;3.0.CO;2-I; BLACKWELL JM, 1985, IMMUNOL LETT, V11, P227, DOI 10.1016/0165-2478(85)90172-5; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Courret N, 2002, J CELL SCI, V115, P2303; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Duclos S, 2000, CELL MICROBIOL, V2, P365, DOI 10.1046/j.1462-5822.2000.00066.x; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GUY RA, 1993, INFECT IMMUN, V61, P1553, DOI 10.1128/IAI.61.4.1553-1558.1993; HANDMAN E, 1985, EMBO J, V4, P329, DOI 10.1002/j.1460-2075.1985.tb03633.x; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Ilg T, 2000, EMBO J, V19, P1953, DOI 10.1093/emboj/19.9.1953; Kima PE, 2000, J EXP MED, V191, P1063, DOI 10.1084/jem.191.6.1063; Lindmark H, 2004, EXP CELL RES, V300, P335, DOI 10.1016/j.yexcr.2004.06.025; Lodge R, 2005, CLIN IMMUNOL, V114, P256, DOI 10.1016/j.clim.2004.07.018; Love DC, 1998, EXP PARASITOL, V88, P161, DOI 10.1006/expr.1998.4232; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Morehead J, 2002, INFECT IMMUN, V70, P4571, DOI 10.1128/IAI.70.8.4571-4580.2002; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; PETERS C, 1995, J CELL SCI, V108, P3715; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Russell DG, 2007, CELL MICROBIOL, V9, P849, DOI 10.1111/j.1462-5822.2007.00920.x; Russell DG, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217a; RUSSELL DG, 1986, J IMMUNOL, V136, P2613; RUSSELL DG, 1987, EUR J BIOCHEM, V164, P213, DOI 10.1111/j.1432-1033.1987.tb11013.x; Schaible UE, 1998, J IMMUNOL, V160, P1290; Scott CC, 2003, J MEMBRANE BIOL, V193, P137, DOI 10.1007/s00232-002-2008-2; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; TALAMASROHANA P, 1990, J IMMUNOL, V144, P4817; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; Tighe H, 1998, IMMUNOL TODAY, V19, P89, DOI 10.1016/S0167-5699(97)01201-2; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	54	18	18	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					483	491		10.1096/fj.08-108712	http://dx.doi.org/10.1096/fj.08-108712			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18927250	Green Submitted			2022-12-25	WOS:000262892900020
J	Zhang, Y; Zhang, M; Dong, H; Yong, S; Li, X; Olashaw, N; Kruk, PA; Cheng, JQ; Bai, W; Chen, J; Nicosia, SV; Zhang, X				Zhang, Y.; Zhang, M.; Dong, H.; Yong, S.; Li, X.; Olashaw, N.; Kruk, P. A.; Cheng, J. Q.; Bai, W.; Chen, J.; Nicosia, S. V.; Zhang, X.			Deacetylation of cortactin by SIRT1 promotes cell migration	ONCOGENE			English	Article						SIRT1; cancer; migration; cortactin; deacetylation; p300	TYROSINE PHOSPHORYLATION; HISTONE DEACETYLASES; CALORIE RESTRICTION; EMS1 GENE; ACETYLATION; ACTIN; P53; OVEREXPRESSION; AMPLIFICATION; TRANSCRIPTION	Cortactin binds F-actin and promotes cell migration. We showed earlier that cortactin is acetylated. Here, we identify SIRT1 (a class III histone deacetylase) as a cortactin deacetylase and p300 as a cortactin acetylase. We show that SIRT1 deacetylates cortactin in vivo and in vitro and that the SIRT1 inhibitor EX-527 increases amounts of acetylated cortactin in ovarian cancer cells. We also show that p300 acetylates cortactin in vivo and that cells lacking or depleted of p300 express less-acetylated cortactin than do control cells. Deletion analysis mapped the SIRT1-binding domain of cortactin to its repeat region, which also binds F-actin. Mouse embryo fibroblasts (MEFs) lacking sir2 alpha (the mouse homolog of SIRT1) migrated more slowly than did wildtype cells. The expression of SIRT1 in sir2 alpha-null cells restored migratory capacity, as did expression of a deacetylation-mimetic mutant of cortactin. SIRT1 and cortactin were more abundant in breast tumor tissue than in their normal counterparts, whereas SIRT1 expression inversely correlates with the ratio of acetylation cortactin versus total cortactin. These data suggest that deacetylation of cortactin is associated with high levels of SIRT1 and tumorigenesis. Finally, breast and ovarian cancer cell lines expressing an acetylation mimetic mutant of cortactin are less motile than that of control cells, whereas cells expressing the deacetylation mimetic mutant of cortactin migrate faster than that of control cells in Transwell migration assays. In summary, our results suggest that cortactin is a novel substrate for SIRT1 and p300 and, for the first time, a possible role for SIRT1 in cell motility through deacetylation of cortactin.	[Zhang, Y.; Zhang, M.; Dong, H.; Yong, S.; Li, X.; Kruk, P. A.; Bai, W.; Nicosia, S. V.; Zhang, X.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Olashaw, N.; Kruk, P. A.; Cheng, J. Q.; Bai, W.; Chen, J.; Zhang, X.] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL USA; [Nicosia, S. V.] H Lee Moffitt Canc Ctr & Res Inst, Expt Therapeut Program, Tampa, FL USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Zhang, X (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC11, Tampa, FL 33612 USA.	xzhang1@health.usf.edu	Kruk, Patricia/I-6489-2012; Bai, Wenlong/A-8977-2013	Bai, Wenlong/0000-0002-9536-0556	USE College of Medicine; H Lee Moffitt Cancer Center; USE New Researcher grant; Marsha Rivkin Center Scientific Scholar award; Bankhead-Coley Biomedical Research Program New Investigator Research Grant	USE College of Medicine; H Lee Moffitt Cancer Center; USE New Researcher grant; Marsha Rivkin Center Scientific Scholar award; Bankhead-Coley Biomedical Research Program New Investigator Research Grant	We are indebted to Dr Edward Seto for sirtuins plasmids. We thank Dr Michael W McBurney for sir2 alpha<SUP>+/+</SUP> and sir2 alpha / MEFs; Dr James A DeCaprio for p300<SUP>+/+</SUP> and p300 / MEFs; Dr Don F Cameron for microscope usage; Drs Srikumar Chellappan, Gloria Ferreira, Mike Yuan, Zheng Shen, Mei Sun and Hua Yang for helpful discussions; Ms Kathleen Merkler for critical reading of this manuscript and Dr Ulmesh Jinwal for technical assistance. We also thank the H Lee Moffitt Cancer Center Analytic Microscopy Core Facility for their technical support and H Lee Moffitt Cancer Center Tissue Procurement for breast and ovarian tissues. This work was supported partly by 'Start-up' funds from the USE College of Medicine and H Lee Moffitt Cancer Center, an USE New Researcher grant, a Marsha Rivkin Center Scientific Scholar award for ovarian cancer research and a Bankhead-Coley Biomedical Research Program New Investigator Research Grant to XZ.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Bringuier PP, 1996, ONCOGENE, V12, P1747; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Campbell DH, 1999, CANCER RES, V59, P5376; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Kessels MM, 2005, NAT CELL BIOL, V7, P448, DOI 10.1038/ncb0505-448; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Leipe DD, 1997, NUCLEIC ACIDS RES, V25, P3693, DOI 10.1093/nar/25.18.3693; Li YS, 2001, CANCER RES, V61, P6906; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ohsawa S, 2006, FEBS LETT, V580, P5875, DOI 10.1016/j.febslet.2006.09.051; Patel AM, 1996, ONCOGENE, V12, P31; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rodrigo JP, 2000, CLIN CANCER RES, V6, P3177; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Timpson P, 2005, CANCER RES, V65, P3273, DOI 10.1158/0008-5472.CAN-04-2118; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wolf G, 2006, NUTR REV, V64, P89, DOI [10.1111/j.1753-4887.2006.tb00192.x, 10.1301/nr.2006.feb.89-92]; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yuan BZ, 2003, J MOL DIAGN, V5, P48, DOI 10.1016/S1525-1578(10)60451-5; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	60	159	162	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					445	460		10.1038/onc.2008.388	http://dx.doi.org/10.1038/onc.2008.388			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18850005				2022-12-25	WOS:000262550300012
J	Denison, FC; Hiscock, NJ; Carling, D; Woods, A				Denison, Fiona C.; Hiscock, Natalie J.; Carling, David; Woods, Angela			Characterization of an Alternative Splice Variant of LKB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; JEGHERS CANCER SYNDROME; TUMOR-SUPPRESSOR; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; UPSTREAM KINASE; IN-VITRO; C-ZETA; PHOSPHORYLATION; COMPLEX	LKB1 is an upstream activating kinase for the AMP-activated protein kinase (AMPK) and at least 12 other AMPK-related kinases. LKB1 therefore acts as a master kinase regulating the activity of a wide range of downstream kinases, which themselves have diverse physiological roles. Here we identify a second form of LKB1 generated by alternative splicing of the LKB1 gene. The two LKB1 proteins have different C-terminal sequences generating a 50-kDa form (termed LKB1(L)) and a 48-kDa form (LKB1(S)). LKB1(L) is widely expressed in mouse tissues, whereas LKB1S has a restricted tissue distribution with predominant expression in the testis. LKB1(S), like LKB1(L), forms a complex with MO25 and STRAD, and phosphorylates and activates AMPK both in vitro and in intact cells. A phosphorylation site (serine 431 in mouse) and a farnesylation site (cysteine 433 in mouse) within LKB1(L) are not conserved in LKB1(S) raising the possibility that these sites might be involved in differential regulation and/or localization of the two forms of LKB1. However, we show that phosphorylation of serine 431 has no effect on LKB1(L) activity and that both LKB1(L) and LKB1(S) have similar patterns of subcellular localization. These results indicate that the physiological significance of the different forms of LKB1 is not related directly to differences in the C-terminal sequences but may be due to their differential patterns of tissue distribution.	[Denison, Fiona C.; Carling, David; Woods, Angela] Ctr Clin Sci, MRC, Cellular Stress Grp, London W12 0NN, England; [Hiscock, Natalie J.] Personalised Vital Platform, Unilever Discover, Sharnbrook MK44 1LQ, Beds, England	Unilever	Carling, D (corresponding author), Ctr Clin Sci, MRC, Cellular Stress Grp, Du Cane Rd, London W12 0NN, England.	dcarling@imperial.ac.uk; angela.woods@imperial.ac.uk	Carling, David/F-1943-2014	Carling, David/0000-0002-2316-1830	Medical Research Council; European Commission [LSHM-CT-2004-005272, LSH-CT-2005-518181]; Medical Research Council [MC_U120027537] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and European Commission Grants LSHM-CT-2004-005272 and LSH-CT-2005-518181 (to D. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490	35	26	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					67	76		10.1074/jbc.M806153200	http://dx.doi.org/10.1074/jbc.M806153200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18854309	hybrid			2022-12-25	WOS:000261974800008
J	Smith, JR; Clarke, PA; de Billy, E; Workman, P				Smith, J. R.; Clarke, P. A.; de Billy, E.; Workman, P.			Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors	ONCOGENE			English	Article						CDC37; cochaperone; HSP90; client; 17-AAG	SHOCK-PROTEIN 90; MOLECULAR CHAPERONE; SIGNAL-TRANSDUCTION; TARGETING SUBUNIT; QUALITY-CONTROL; ATPASE ACTIVITY; BREAST-CANCER; GROWTH ARREST; IN-VITRO; COMPLEX	The cochaperone CDC37 promotes the association of HSP90 with the protein kinase subset of client proteins to maintain their stability and signalling functions. HSP90 inhibitors induce depletion of clients, which include several oncogenic kinases. We hypothesized that the targeting of CDC37 using siRNAs would compromise the maturation of these clients and increase the sensitivity of cancer cells to HSP90 inhibitors. Here, we show that silencing of CDC37 in human colon cancer cells diminished the association of kinase clients with HSP90 and reduced levels of the clients ERBB2, CRAF, CDK4 and CDK6, as well as phosphorylated AKT. CDC37 silencing promoted the proteasome-mediated degradation of kinase clients, suggesting a degradation pathway independent from HSP90 binding. Decreased cell signalling through kinase clients was also demonstrated by reduced phosphorylation of downstream substrates and colon cancer cell proliferation was subsequently reduced by the inhibition of the G1/S-phase transition. Furthermore, combining CDC37 silencing with the HSP90 inhibitor 17-AAG induced more extensive and sustained depletion of kinase clients and potentiated cell cycle arrest and apoptosis. These results support an essential role for CDC37 in concert with HSP90 in maintaining oncogenic protein kinase clients and endorse the therapeutic potential of targeting CDC37 in cancer.	[Smith, J. R.; Clarke, P. A.; de Billy, E.; Workman, P.] Inst Canc Res, Haddow Labs, Signal Transduct & Mol Pharmacol Team, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England	Cancer Research UK; University of London; Institute of Cancer Research - UK	Workman, P (corresponding author), Inst Canc Res, Haddow Labs, Signal Transduct & Mol Pharmacol Team, Canc Res UK Ctr Canc Therapeut, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	paul.workman@icr.ac.uk	de billy, emmanuel/AAA-6095-2020	Clarke, Paul/0000-0001-9342-1290; de Crespin de Billy, emmanuel/0000-0002-3610-7083	Cancer Research UK [CUK] [C309/A8274]; Institute of Cancer Research	Cancer Research UK [CUK](Cancer Research UK); Institute of Cancer Research	We thank our colleagues in the Signal Transduction and Molecular Pharmacology Team and Chaperone Project Team for helpful discussions. Our work is supported by Cancer Research UK [CUK] Programme Grant number C309/A8274. JRS is the recipient of a studentship from The Institute of Cancer Research. PW is a Cancer Research UK Life Fellow.	Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Banerji U, 2008, MOL CANCER THER, V7, P737, DOI 10.1158/1535-7163.MCT-08-0145; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Clarke PA, 2000, ONCOGENE, V19, P4125, DOI 10.1038/sj.onc.1203753; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Fang YF, 1998, MOL CELL BIOL, V18, P3727, DOI 10.1128/MCB.18.7.3727; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Gray PJ, 2007, CANCER RES, V67, P11942, DOI 10.1158/0008-5472.CAN-07-3162; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Holford J, 1998, BRIT J CANCER, V77, P366, DOI 10.1038/bjc.1998.59; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Hostein I, 2001, CANCER RES, V61, P4003; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Lamphere L, 1997, ONCOGENE, V14, P1999, DOI 10.1038/sj.onc.1201036; Lavictoire SJ, 2003, J BIOL CHEM, V278, P5292, DOI 10.1074/jbc.M209494200; Lee P, 2002, J CELL BIOL, V159, P1051, DOI 10.1083/jcb.200210121; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McDonald E, 2006, CURR TOP MED CHEM, V6, P1091, DOI 10.2174/156802606777812004; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Pacey S, 2006, HANDB EXP PHARM, V172, P331; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schwarze SR, 2003, CANCER RES, V63, P4614; Sharp SY, 2007, MOL CANCER THER, V6, P1198, DOI 10.1158/1535-7163.MCT-07-0149; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Smith J.R., 2007, DRUG DISCOV TODAY TH, V4, P219, DOI [10.1016/j.ddstr.2008.02.005, DOI 10.1016/J.DDSTR.2008.02.005]; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Stepanova L, 1997, METHOD ENZYMOL, V283, P220; Stepanova L, 2000, MOL CELL BIOL, V20, P4462, DOI 10.1128/MCB.20.12.4462-4473.2000; Turnbull EL, 2005, FEBS J, V272, P4129, DOI 10.1111/j.1742-4658.2005.04825.x; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu WP, 2003, CANCER RES, V63, P7777; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yun BG, 2005, EXP CELL RES, V307, P212, DOI 10.1016/j.yexcr.2005.03.003; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	62	96	98	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					157	169		10.1038/onc.2008.380	http://dx.doi.org/10.1038/onc.2008.380			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18931700	Green Accepted			2022-12-25	WOS:000262501100001
J	Nurnberg, A; Brauer, AU; Wettschureck, N; Offermanns, S				Nuernberg, Alexander; Braeuer, Anja U.; Wettschureck, Nina; Offermanns, Stefan			Antagonistic Regulation of Neurite Morphology through G(q)/G(11) and G(12)/G(13)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PROTEASE-ACTIVATED RECEPTORS; RHO-FAMILY GTPASES; LYSOPHOSPHATIDIC ACID; GROWTH CONE; NERVOUS-SYSTEM; G(12) FAMILY; RETRACTION; THROMBIN; CELLS	The induction of neurite retraction and growth cone collapse via G-protein-coupled receptors is involved in developmental as well as regenerative processes. The role of individual G-protein-mediated signaling processes in the regulation of neurite morphology is still incompletely understood. Using primary neurons from brains lacking G alpha(q)/G alpha(11) or G alpha(12)/G alpha(13), we show here that G(12)/G(13)-mediated signaling is absolutely required for neurite retraction and growth cone collapse induced by the blood-borne factors lysophosphatidic acid and thrombin. Interestingly, the effects of lysophosphatidic acid were mediated mainly by G(13), whereas thrombin effects required G(12). Surprisingly, lack of G alpha(q)/G alpha(11) resulted in overshooting responses to both stimuli, indicating that G(q)/G(11)-mediated signaling most likely via activation of Rac antagonizes the effects of G(12)/G(13).	[Nuernberg, Alexander; Wettschureck, Nina; Offermanns, Stefan] Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany; [Braeuer, Anja U.] Charite Univ Med Berlin, Ctr Anat, Inst Cell Biol & Neurobiol, D-10115 Berlin, Germany; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany	Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Offermanns, S (corresponding author), Univ Heidelberg, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	stefan.offermanns@pharma.uni-heidelberg.de	Wettschureck, Nina/L-3651-2017; Bräuer, Anja/N-3692-2019; Braeuer, Anja/K-8339-2013; Offermanns, Stefan/L-3313-2017	Wettschureck, Nina/0000-0001-6858-1460; Offermanns, Stefan/0000-0001-8676-6805	German Research Foundation [SFB 488]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the Collaborative Research Center 488 of the German Research Foundation (SFB 488). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Chun J, 2000, ANN NY ACAD SCI, V905, P110; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Couvillon AD, 2006, CELL SIGNAL, V18, P715, DOI 10.1016/j.cellsig.2005.06.012; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fritsche J, 1999, MOL CELL NEUROSCI, V14, P398, DOI 10.1006/mcne.1999.0777; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukushima N, 2004, J CELL BIOCHEM, V92, P993, DOI 10.1002/jcb.20093; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gratacap MP, 2001, J BIOL CHEM, V276, P47906, DOI 10.1074/jbc.M104442200; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Katoh H, 1996, J BIOL CHEM, V271, P29780, DOI 10.1074/jbc.271.47.29780; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Moers A, 2008, MOL CELL BIOL, V28, P1480, DOI 10.1128/MCB.00651-07; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Noorbakhsh F, 2003, NAT REV NEUROSCI, V4, P981, DOI 10.1038/nrn1255; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Postma FR, 1996, EMBO J, V15, P2388, DOI 10.1002/j.1460-2075.1996.tb00595.x; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Rasband W., 2006, IMAGEJ; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rosenfeldt Hans, 2006, J Mol Signal, V1, P8, DOI 10.1186/1750-2187-1-8; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Tigyi G, 1996, J NEUROCHEM, V66, P537; van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Wettschureck N, 2005, MOL CELL BIOL, V25, P1942, DOI 10.1128/MCB.25.5.1942-1948.2005; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; Yamaguchi Y, 2003, J BIOL CHEM, V278, P14936, DOI 10.1074/jbc.M301409200; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Yang SA, 2004, J BIOL CHEM, V279, P42331, DOI 10.1074/jbc.M404335200; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	50	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35526	35531		10.1074/jbc.M804972200	http://dx.doi.org/10.1074/jbc.M804972200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18854320	hybrid			2022-12-25	WOS:000261687900024
J	Lad, Y; Jiang, P; Ruskamo, S; Harburger, DS; Ylanne, J; Campbell, ID; Calderwood, DA				Lad, Yatish; Jiang, Pengju; Ruskamo, Salla; Harburger, David S.; Ylanne, Jari; Campbell, Iain D.; Calderwood, David A.			Structural Basis of the Migfilin-Filamin Interaction and Competition with Integrin beta Tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKBONE DYNAMICS; BINDING; ADHESIONS	A link between sites of cell adhesion and the cytoskeleton is essential for regulation of cell shape, motility, and signaling. Migfilin is a recently identified adaptor protein that localizes at cell-cell and cell-extracellular matrix adhesion sites, where it is thought to provide a link to the cytoskeleton by interacting with the actin cross-linking protein filamin. Here we have used x-ray crystallography, NMR spectroscopy, and protein-protein interaction studies to investigate the molecular basis of migfilin binding to filamin. We report that the N-terminal portion of migfilin can bind all three human filamins (FLNa, -b, or -c) and that there are multiple migfilin-binding sites in FLNa. Human filamins are composed of an N-terminal actin-binding domain followed by 24 immunoglobulin-like (IgFLN) domains and we find that migfilin binds preferentially to IgFLNa21 and more weakly to IgFLNa19 and -22. The filamin-binding site in migfilin is localized between Pro5 and Pro19 and binds to the CD face of the IgFLNa21 beta-sandwich. This interaction is similar to the previously characterized beta 7 integrin-IgFLNa21 interaction and migfilin and integrin beta tails can compete with one another for binding to IgFLNa21. This suggests that competition between filamin ligands for common binding sites on IgFLN domains may provide a general means of modulating filamin interactions and signaling. In this specific case, displacement of integrin tails from filamin by migfilin may provide a mechanism for switching between different integrin-cytoskeleton linkages.	[Lad, Yatish; Harburger, David S.; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Lad, Yatish; Harburger, David S.; Calderwood, David A.] Yale Univ, Sch Med, Interdepartmental Program Vasc Biol & Transplanta, New Haven, CT 06520 USA; [Jiang, Pengju; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, FIN-40014 Jyvaskyla, Finland	Yale University; Yale University; University of Oxford; University of Jyvaskyla	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142; Ruskamo, Salla/0000-0002-9740-9077; Ylanne, Jari/0000-0003-4627-021X	National Institutes of Health [GM068600]; Academy of Finland [114713]; BBSRC [BB/F006845/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F006845/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068600 (to D.A.C.). This work was also supported by Academy of Finland Grant 114713 (to J.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Papachristou DJ, 2007, HISTOPATHOLOGY, V51, P499, DOI 10.1111/j.1365-2559.2007.02791.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Stossel TP, 2003, DEV CELL, V4, P444, DOI 10.1016/S1534-5807(03)00098-4; Takafuta T, 2003, J BIOL CHEM, V278, P12175, DOI 10.1074/jbc.M209339200; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200	37	89	93	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35154	35163		10.1074/jbc.M802592200	http://dx.doi.org/10.1074/jbc.M802592200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18829455	Green Published, hybrid			2022-12-25	WOS:000261469100072
J	Levin-Salomon, V; Kogan, K; Ahn, NG; Livnah, O; Engelberg, D				Levin-Salomon, Vered; Kogan, Konstantin; Ahn, Natalie G.; Livnah, Oded; Engelberg, David			Isolation of Intrinsically Active (MEK-independent) Variants of the ERK Family of Mitogen-activated Protein (MAP) Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; OF-FUNCTION MUTATION; N-TERMINAL KINASE; STRESS-RESPONSE; YEAST; PATHWAY; CANCER; CELLS; PHOSPHORYLATION; TRANSDUCTION	MAPKs are key components of cell signaling pathways with a unique activation mechanism: i.e. dual phosphorylation of neighboring threonine and tyrosine residues. The ERK enzymes form a subfamily of MAPKs involved in proliferation, differentiation, development, learning, and memory. The exact role of each Erk molecule in these processes is not clear. An efficient strategy for addressing this question is to activate individually each molecule, for example, by expressing intrinsically active variants of them. However, such molecules were not produced so far. Here, we report on the isolation, via a specifically designed genetic screen, of six variants ( each carries a point mutation) of the yeast MAPK Mpk1/Erk that are active, independent of upstream phosphorylation. One of the activating mutations, R68S, occurred in a residue conserved in the mammalian Erk1 (Arg-84) and Erk2 (Arg-65) and in the Drosophila ERK Rolled (Arg-80). Replacing this conserved Arg with Ser rendered these MAPKs intrinsically active to very high levels when tested in vitro as recombinant proteins. Combination of the Arg to Ser mutation with the sevenmaker mutation ( producing Erk2(R65S+D319N) and Rolled(R80S+D334N)) resulted in even higher activity ( 45 and 70%, respectively, in reference to fully active dually phosphorylated Erk2 or Rolled). Erk2(R65S) and Erk2(R65S+D319N) were found to be spontaneously active also when expressed in human HEK293 cells. We further revealed the mechanism of action of the mutants and show that it involves acquisition of autophosphorylation activity. Thus, a first generation of Erk molecules that are spontaneously active in vitro and in vivo has been obtained.	[Levin-Salomon, Vered; Kogan, Konstantin; Livnah, Oded; Engelberg, David] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel; [Ahn, Natalie G.] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Engelberg, D (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	engelber@cc.huji.ac.il			U.S-Israel Binational Science Foundation [2005002]; Israel Science Foundation [656/06]	U.S-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This study was supported by U.S-Israel Binational Science Foundation Grant 2005002 and by the Israel Science Foundation Grant 656/06. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aebersold DM, 2004, MOL CELL BIOL, V24, P10000, DOI 10.1128/MCB.24.22.10000-10015.2004; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Askari N, 2006, MOL CELL ENDOCRINOL, V252, P231, DOI 10.1016/j.mce.2006.03.015; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; Bell M, 2003, J BIOL CHEM, V278, P14603, DOI 10.1074/jbc.C300006200; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162, DOI 10.1128/MCB.12.3.1162; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cripe LD, 2002, LEUKEMIA, V16, P799, DOI 10.1038/sj.leu.2402457; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; Emrick MA, 2001, J BIOL CHEM, V276, P46469, DOI 10.1074/jbc.M107708200; Engelberg D, 2006, METHODS, V40, P255, DOI 10.1016/j.ymeth.2006.06.014; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Ferrer I, 2001, BRAIN PATHOL, V11, P144; Garcia M, 2002, J NEUROSCI, V22, P2174, DOI 10.1523/JNEUROSCI.22-06-02174.2002; Gioeli D, 1999, CANCER RES, V59, P279; GOLDSMITH EJ, 1994, CURR OPIN STRUC BIOL, V4, P833, DOI 10.1016/0959-440X(94)90264-X; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hall JP, 1996, MOL CELL BIOL, V16, P6715; Hou XS, 1997, GENE DEV, V11, P1728, DOI 10.1101/gad.11.13.1728; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuperstein F, 2002, EUR J NEUROSCI, V16, P44, DOI 10.1046/j.1460-9568.2002.02056.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; LEVINSALOMON V, 2008, BIOCH J IN PRESS; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lin SY, 2002, MOL CARCINOGEN, V35, P21, DOI 10.1002/mc.10070; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin H, 1996, CURR GENET, V29, P516; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pei JJ, 2001, J ALZHEIMERS DIS, V3, P41, DOI 10.3233/JAD-2001-3107; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Price DT, 1999, J UROLOGY, V162, P1537, DOI 10.1016/S0022-5347(05)68354-1; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; SANGHERA JS, 1992, MOL BIOL CELL, V3, P775, DOI 10.1091/mbc.3.7.775; Sato N, 1997, BIOCHEM BIOPH RES CO, V232, P637, DOI 10.1006/bbrc.1997.6341; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; SILHAVY TJ, 1984, EXPT GENE FUSION, P75; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; van Montfrans C, 2002, BIOCHEM PHARMACOL, V64, P789, DOI 10.1016/S0006-2952(02)01140-1; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yung Y, 2001, J BIOL CHEM, V276, P35280, DOI 10.1074/jbc.M105995200; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0	68	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34500	34510		10.1074/jbc.M806443200	http://dx.doi.org/10.1074/jbc.M806443200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18829462	Green Published, hybrid			2022-12-25	WOS:000261469100004
J	Dehring, DAK; Adler, AS; Hosseini, A; Hicke, L				Dehring, Deborah A. Klos; Adler, Adam S.; Hosseini, Ava; Hicke, Linda			A C-terminal Sequence in the Guanine Nucleotide Exchange Factor Sec7 Mediates Golgi Association and Interaction with the Rsp5 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR-1; MEMBRANE-PROTEINS; FUNCTIONAL DIVERSITY; DIRECT BINDING; NEDD4 FAMILY; YEAST; DOMAIN; TRANSPORT; ARF; RECEPTOR	Arf GTPases control vesicle formation from different intracellular membranes and are regulated by Arf guanine nucleotide exchange factors (GEFs). Outside of their conserved catalytic domains, known as Sec7 domains, little is known about Arf GEFs. Rsp5 is a yeast ubiquitin ligase that regulates numerous membrane trafficking events and carries a C2 domain that is specifically required for trans-Golgi network to vacuole transport. In a screen for proteins that interact with the Rsp5 C2 domain we identified Sec7, the GEF that acts on Golgi-associated Arfs. The Rsp5-Sec7 interaction is direct, occurs in vivo, and is conserved among mammalian Rsp5 and Sec7 homologues. A 50-amino acid region near the Sec7 C terminus is required for Rsp5 binding and for normal Sec7 localization. Binding of Sec7 to Rsp5 is dependent on the presence of the phosphoinositide 3-kinase Vps34, suggesting that phosphatidylinositol 3-phosphate (PI(3) P) plays a role in regulating this interaction. Overexpression of Sec7 significantly suppresses the growth and sorting defects of an rsp5 C2 domain point mutant. These observations identify a new functional region within the Sec7/BIG family of Arf GEFs that is required for trans-Golgi network localization.	[Dehring, Deborah A. Klos; Adler, Adam S.; Hosseini, Ava; Hicke, Linda] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Hicke, L (corresponding author), Hogan Hall 2-100,2205 Tech Dr, Evanston, IL 60208 USA.	l-hicke@northwestern.edu		Adler, Adam/0000-0001-9301-0037	National Institutes of Health [DK53257, DK61299]; Training Grant [T32GM08061]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061299, R01DK053257, R56DK061299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53257 and DK61299 ( to L. H.) and Training Grant T32GM08061 ( to D. A. K. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Deitz SB, 2000, TRAFFIC, V1, P172, DOI 10.1034/j.1600-0854.2000.010209.x; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Donaldson JG, 2005, BIOCHEM SOC T, V33, P1276, DOI 10.1042/BST0331276; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; FRANZUSOFF A, 1992, NATURE, V355, P173, DOI 10.1038/355173a0; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; James P, 1996, GENETICS, V144, P1425; Jones S, 1999, GENETICS, V152, P1543; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Seron K, 1998, MOL BIOL CELL, V9, P2873, DOI 10.1091/mbc.9.10.2873; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Stack JH, 1993, CURR OPIN CELL BIOL, V5, P641, DOI 10.1016/0955-0674(93)90134-C; STACK JH, 1994, J BIOL CHEM, V269, P31552; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Watson H, 2007, MOL BIOL CELL, V18, P1781, DOI 10.1091/mbc.E06-10-0887; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wolf JR, 1996, BIOCHEM BIOPH RES CO, V224, P126, DOI 10.1006/bbrc.1996.0995; Xu KF, 2005, P NATL ACAD SCI USA, V102, P2784, DOI 10.1073/pnas.0409871102; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	80	10	10	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34188	34196		10.1074/jbc.M806023200	http://dx.doi.org/10.1074/jbc.M806023200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18832381	Green Published, hybrid			2022-12-25	WOS:000261277700047
J	Moon, SH; Jenkins, CM; Mancuso, DJ; Turk, J; Gross, RW				Moon, Sung Ho; Jenkins, Christopher M.; Mancuso, David J.; Turk, John; Gross, Richard W.			Smooth Muscle Cell Arachidonic Acid Release, Migration, and Proliferation Are Markedly Attenuated in Mice Null for Calcium-independent Phospholipase A(2)beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED DISCRIMINATION; PROTEIN-COUPLED RECEPTORS; CYTOSOLIC PHOSPHOLIPASE; NITRIC-OXIDE; SUICIDE INHIBITION; ALPHA-CHYMOTRYPSIN; HALOENOL LACTONES; EXPRESS GROUP; IDENTIFICATION; ACTIVATION	Pharmacologic evidence suggests that the lipid products generated by one or more calcium-independent phospholipases A(2) (iPLA(2)s) participate in the regulation of vascular tone through smooth muscle cell (SMC) Ca2+ signaling and the release of arachidonic acid. However, the recent identification of new members of the iPLA(2) family, each inhibitable by (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one, has rendered definitive identification of the specific enzyme(s) mediating these processes difficult. Accordingly, we used iPLA(2)beta(-/-) mice to demonstrate that iPLA(2)beta is responsible for the majority of thapsigargin and ionophore (A23187)-induced arachidonic acid release from SMCs. Both thapsigargin and A23187 stimulated robust [H-3] arachidonate (AA) release from wild-type aortic SMCs that was dramatically attenuated in iPLA(2)beta(-/-) mice (>80% reduction at 5 min; p < 0.01). Moreover, iPLA(2)beta(-/-) mice displayed defects in SMC Ca2+ homeostasis and decreased SMC migration and proliferation in a model of vascular injury. Ca2+-store depletion resulted in the rapid entry of external Ca2+ into wild-type aortic SMCs that was significantly slower in iPLA(2)beta-null cells (p < 0.01). Furthermore, SMCs from iPLA(2)beta-null mesenteric arterial explants demonstrated decreased proliferation and migration. The defects in migration and proliferation in iPLA(2)beta-null SMCs were restored by 2 mu M AA. Remarkably, the cyclooxygenase-2-specific inhibitor, NS-398, prevented AA-induced rescue of SMC migration and proliferation in iPLA(2)beta-/- mice. Moreover, PGE(2) alone rescued proliferation and migration in iPLA(2)beta-/- mice. We conclude that iPLA(2)beta is an important mediator of AA release and prostaglandin E-2 production in SMCs, modulating vascular tone, cellular signaling, proliferation, and migration.	[Moon, Sung Ho; Jenkins, Christopher M.; Mancuso, David J.; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Turk, John] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Moon, Sung Ho; Jenkins, Christopher M.; Mancuso, David J.; Turk, John; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278-10, 2RO1HL41250-13]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041250, P01HL057278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278-10 and 2RO1HL41250-13. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALONSO F, 1986, BIOCHIM BIOPHYS ACTA, V878, P273, DOI 10.1016/0005-2760(86)90156-6; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Benimetskaya L, 1997, NAT MED, V3, P414, DOI 10.1038/nm0497-414; CHAKRAVARTY PK, 1982, J BIOL CHEM, V257, P610; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; DUBEY RK, 1994, CELL TISSUE RES, V275, P133, DOI 10.1007/BF00305381; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; FINK KL, 1984, CIRC RES, V55, P585, DOI 10.1161/01.RES.55.5.585; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HAZEN SL, 1991, J BIOL CHEM, V266, P14526; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Herbert SP, 2006, J BIOL CHEM, V281, P35709, DOI 10.1074/jbc.M600699200; HETNER Y, 2000, J BIOL CHEM, V275, P37542; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Hu ZW, 2002, J PHARMACOL EXP THER, V303, P563, DOI 10.1124/jpet.102.037705; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jenkins CM, 2006, J BIOL CHEM, V281, P15615, DOI 10.1074/jbc.M511623200; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kaneyuki U, 2007, VASC PHARMACOL, V46, P286, DOI 10.1016/j.vph.2006.11.002; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Kim J, 2006, CELL SIGNAL, V18, P1695, DOI 10.1016/j.cellsig.2006.01.009; Kita Y, 2006, BBA-MOL CELL BIOL L, V1761, P1317, DOI 10.1016/j.bbalip.2006.08.001; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; LEPPERT D, 1995, FASEB J, V9, P1473, DOI 10.1096/fasebj.9.14.7589989; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; LOEB LA, 1986, J BIOL CHEM, V261, P467; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Nieves D, 2007, APOPTOSIS, V12, P1979, DOI 10.1007/s10495-007-0123-3; PETERSGOLDEN M, 1993, BIOCHEM BIOPH RES CO, V196, P147, DOI 10.1006/bbrc.1993.2227; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schneider G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-164; Seegers HC, 2002, J PHARMACOL EXP THER, V302, P918, DOI 10.1124/jpet.302.3.918; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; STEIN CA, 1995, NAT MED, V1, P1119, DOI 10.1038/nm1195-1119; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thompson MD, 2006, MOL DIAGN THER, V10, P353, DOI 10.1007/BF03256212; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Ulven T, 2006, CURR TOP MED CHEM, V6, P1427, DOI 10.2174/15680266106061427; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Wolf MJ, 1996, J BIOL CHEM, V271, P20989, DOI 10.1074/jbc.271.35.20989; Wolf MJ, 1996, J BIOL CHEM, V271, P30879, DOI 10.1074/jbc.271.48.30879; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; WOLF RA, 1985, J BIOL CHEM, V260, P7295; Wu WT, 2005, ENDOCRINOLOGY, V146, P3387, DOI 10.1210/en.2004-1654; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yedgar S, 2006, BBA-MOL CELL BIOL L, V1761, P1373, DOI 10.1016/j.bbalip.2006.08.003; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Young W, 2000, CIRC RES, V86, P906, DOI 10.1161/01.RES.86.8.906; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	70	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33975	33987		10.1074/jbc.M805817200	http://dx.doi.org/10.1074/jbc.M805817200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18927078	Green Published, hybrid			2022-12-25	WOS:000261277700024
J	Perez-Monjaras, A; Cervantes-Roldan, R; Meneses-Morales, I; Gravel, RA; Reyes-Carmona, S; Solorzano-Vargas, S; Gonzalez-Noriega, A; Leon-Del-Rio, A				Perez-Monjaras, Anylu; Cervantes-Roldan, Rafael; Meneses-Morales, Ivan; Gravel, Roy A.; Reyes-Carmona, Sandra; Solorzano-Vargas, Sergio; Gonzalez-Noriega, Alfonso; Leon-Del-Rio, Alfonso			Impaired Biotinidase Activity Disrupts Holocarboxylase Synthetase Expression in Late Onset Multiple Carboxylase Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPIONYL-COA CARBOXYLASE; BASAL GANGLIA DISEASE; MESSENGER-RNA; RAT-LIVER; PYRUVATE-CARBOXYLASE; ESCHERICHIA-COLI; BRAIN; BIOTINYLATION; CELLS; METABOLISM	Biotinidase catalyzes the hydrolysis of the vitamin biotin from proteolytically degraded biotin-dependent carboxylases. This key reaction makes the biotin available for reutilization in the biotinylation of newly synthesized apocarboxylases. This latter reaction is catalyzed by holocarboxylase synthetase (HCS) via synthesis of 5'-biotinyl-AMP (B-AMP) from biotin and ATP, followed by transfer of the biotin to a specific lysine residue of the apocarboxylase substrate. In addition to carboxylase activation, B-AMP is also a key regulatory molecule in the transcription of genes encoding apocarboxylases and HCS itself. In humans, genetic deficiency of HCS or biotinidase results in the life-threatening disorder biotin-responsive multiple carboxylase deficiency, characterized by a reduction in the activities of all biotin-dependent carboxylases. Although the clinical manifestations of both disorders are similar, they differ in some unique neurological characteristics whose origin is not fully understood. In this study, we show that biotinidase deficiency not only reduces net carboxylase biotinylation, but it also impairs the expression of carboxylases and HCS by interfering with the B-AMP-dependent mechanism of transcription control. We propose that biotinidase-deficient patients may develop a secondary HCS deficiency disrupting the altruistic tissue-specific biotin allocation mechanism that protects brain metabolism during biotin starvation.	[Perez-Monjaras, Anylu; Cervantes-Roldan, Rafael; Meneses-Morales, Ivan; Reyes-Carmona, Sandra; Solorzano-Vargas, Sergio; Leon-Del-Rio, Alfonso] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico; [Perez-Monjaras, Anylu; Cervantes-Roldan, Rafael; Meneses-Morales, Ivan; Reyes-Carmona, Sandra; Solorzano-Vargas, Sergio; Leon-Del-Rio, Alfonso] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Mol Biol & Biotecnol, Mexico City 04510, DF, Mexico; [Gravel, Roy A.; Gonzalez-Noriega, Alfonso] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Calgary	Leon-Del-Rio, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Ciudad Univ, Mexico City 04510, DF, Mexico.	leon@biomedicas.unam.mx	Solorzano-Vargas, R Sergio/D-4869-2016; Leon-Del-Rio, Alfonso/L-5932-2019; Meneses-Morales, Ivan/F-6765-2018	Meneses-Morales, Ivan/0000-0002-3146-1374; Leon-Del-Rio, Alfonso/0000-0001-7683-5109; Reyes, Sandra/0000-0002-1015-5079; Perez Monjaras, Anylu del Carmen/0000-0002-4955-9652	Consejo Nacional de Ciencia y Tecnologia [48862]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN220206-3]; Universidad Nacional Autonoma de Mexico	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by Consejo Nacional de Ciencia y Tecnologia Grant 48862 and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Grant IN220206-3 and funds from the Universidad Nacional Autonoma de Mexico. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhisivam B, 2007, INDIAN PEDIATR, V44, P228; BAUMGARTNER ER, 1989, PEDIATR RES, V26, P260, DOI 10.1203/00006450-198909000-00021; BHAGAVAN HN, 1970, J NEUROCHEM, V17, P289, DOI 10.1111/j.1471-4159.1970.tb02213.x; Borboni P, 1996, ACTA DIABETOL, V33, P154; BURRI BJ, 1985, AM J HUM GENET, V37, P326; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; CHAUHAN J, 1991, J BIOL CHEM, V266, P10035; CHIANG GS, 1974, P SOC EXP BIOL MED, V146, P21, DOI 10.3181/00379727-146-38035; COLE H, 1994, J BIOL CHEM, V269, P6566; COLLINS JC, 1988, J BIOL CHEM, V263, P11280; DAKSHINAMURTI K, 1970, CAN J BIOCHEM CELL B, V48, P493, DOI 10.1139/o70-079; De la Vega LA, 2000, AM J PHYSIOL-CELL PH, V279, pC2037, DOI 10.1152/ajpcell.2000.279.6.C2037; DEODHAR AD, 1970, LIFE SCI 2-BIOCH GEN, V9, P581, DOI 10.1016/0024-3205(70)90166-9; Dupuis L, 1996, HUM MOL GENET, V5, P1011, DOI 10.1093/hmg/5.7.1011; Dupuis L, 1999, MOL GENET METAB, V66, P80, DOI 10.1006/mgme.1998.2785; Hassel B, 2000, MOL NEUROBIOL, V22, P21, DOI 10.1385/MN:22:1-3:021; Heller AJ, 2002, HEARING RES, V173, P62, DOI 10.1016/S0378-5955(02)00609-3; HERON B, 1993, ARCH FR PEDIATR, V50, P875; Knight HC, 1998, MAMM GENOME, V9, P327, DOI 10.1007/s003359900760; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; LO W, 1991, J NUTR SCI VITAMINOL, V37, P567, DOI 10.3177/jnsv.37.567; Maeda Y, 1996, J NUTR, V126, P61, DOI 10.1093/jn/126.1.61; Narang MA, 2004, HUM MOL GENET, V13, P15, DOI 10.1093/hmg/ddh006; Norrgard K J, 1998, Hum Mutat, V11, P410, DOI 10.1002/(SICI)1098-1004(1998)11:5<410::AID-HUMU10>3.3.CO;2-#; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; Pacheco-Alvarez D, 2005, MOL GENET METAB, V85, P301, DOI 10.1016/j.ymgme.2005.04.001; Pacheco-Alvarez D, 2004, J BIOL CHEM, V279, P52312, DOI 10.1074/jbc.M407056200; Pacheco-Alvarez D, 2002, ARCH MED RES, V33, P439, DOI 10.1016/S0188-4409(02)00399-5; PISPA J, 1965, ANN MED EXP BIOL F S, V43, P1; Rodriguez-Melendez R, 2001, J NUTR, V131, P1909, DOI 10.1093/jn/131.7.1909; Rodriguez-Melendez R, 1999, MOL GENET METAB, V66, P16, DOI 10.1006/mgme.1998.2777; SANDER JE, 1982, NEUROLOGY, V32, P878, DOI 10.1212/WNL.32.8.878; SCHULZ PE, 1988, NEUROLOGY, V38, P1326, DOI 10.1212/WNL.38.8.1326; Solorzano-Vargas RS, 2002, P NATL ACAD SCI USA, V99, P5325, DOI 10.1073/pnas.082097699; Straussberg R, 2002, NEUROLOGY, V59, P983, DOI 10.1212/WNL.59.7.983; Subramanian VS, 2006, AM J PHYSIOL-CELL PH, V291, pC851, DOI 10.1152/ajpcell.00105.2006; SUCHY SF, 1985, NEUROLOGY, V35, P1510, DOI 10.1212/WNL.35.10.1510; WEINER D, 1991, BIOCHEM MED METAB B, V46, P344, DOI 10.1016/0885-4505(91)90083-W; WOLF B, 1985, J INHERIT METAB DIS, V8, P53, DOI 10.1007/BF01800660; Wolf B., 2001, METABOLIC MOL BASES, V3935, P3962, DOI DOI 10.1097/MAO.0000000000002044; Wolf Barry, 2005, Hum Mutat, V25, P413, DOI 10.1002/humu.9329	42	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34150	34158		10.1074/jbc.M806985200	http://dx.doi.org/10.1074/jbc.M806985200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845537	hybrid, Green Published			2022-12-25	WOS:000261277700043
J	Tagliabracci, VS; Girard, JM; Segvich, D; Meyer, C; Turnbull, J; Zhao, XC; Minassian, BA; DePaoli-Roach, AA; Roach, PJ				Tagliabracci, Vincent S.; Girard, Jean Marie; Segvich, Dyann; Meyer, Catalina; Turnbull, Julie; Zhao, Xiaochu; Minassian, Berge A.; DePaoli-Roach, Anna A.; Roach, Peter J.			Abnormal Metabolism of Glycogen Phosphate as a Cause for Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; DUAL-SPECIFICITY PHOSPHATASE; PROTEIN PHOSPHATASE-1; CORPORA-AMYLACEA; MUSCLE GLYCOGEN; PHOSPHORYLATION; SYNTHASE; ACCUMULATION; STARCH; MALIN	Lafora disease is a progressive myoclonus epilepsy with onset in the teenage years followed by neurodegeneration and death within 10 years. A characteristic is the widespread formation of poorly branched, insoluble glycogen-like polymers (polyglucosan) known as Lafora bodies, which accumulate in neurons, muscle, liver, and other tissues. Approximately half of the cases of Lafora disease result from mutations in the EPM2A gene, which encodes laforin, a member of the dual specificity protein phosphatase family that is able to release the small amount of covalent phosphate normally present in glycogen. In studies of Epm2a(-/-) mice that lack laforin, we observed a progressive change in the properties and structure of glycogen that paralleled the formation of Lafora bodies. At three months, glycogen metabolism remained essentially normal, even though the phosphorylation of glycogen has increased 4-fold and causes altered physical properties of the polysaccharide. By 9 months, the glycogen has overaccumulated by 3-fold, has become somewhat more phosphorylated, but, more notably, is now poorly branched, is insoluble in water, and has acquired an abnormal morphology visible by electron microscopy. These glycogen molecules have a tendency to aggregate and can be recovered in the pellet after low speed centrifugation of tissue extracts. The aggregation requires the phosphorylation of glycogen. The aggregrated glycogen sequesters glycogen synthase but not other glycogen metabolizing enzymes. We propose that laforin functions to suppress excessive glycogen phosphorylation and is an essential component of the metabolism of normally structured glycogen.	[Tagliabracci, Vincent S.; Segvich, Dyann; Meyer, Catalina; DePaoli-Roach, Anna A.; Roach, Peter J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Girard, Jean Marie; Turnbull, Julie; Zhao, Xiaochu; Minassian, Berge A.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Roach, PJ (corresponding author), 635 Barnhill Dr,MS405A, Indianapolis, IN 46202 USA.	proach@iupui.edu			National Institutes of Health [DK27221]; Canadian Institutes for Health Research; Canada Research Chair in Pediatric Neurogenetics; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027221, R01DK027221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Pediatric Neurogenetics(Canada Research Chairs); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK27221 (to P. J. R.). This work was also supported by funds from the Canadian Institutes for Health Research (to J. M. G. and B. A. M.), a Canada Research Chair in Pediatric Neurogenetics (to B. A. M.), and an American Heart Association Predoctoral fellowship (to V. S. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aschenbach WG, 2001, J BIOL CHEM, V276, P39959, DOI 10.1074/jbc.M105518200; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Bergmeyer H. V., 1974, METHOD ENZYMAT AN, V2, P1196; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Chan Elayne M, 2005, Adv Neurol, V95, P47; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103; DROCHMANS P, 1962, J ULTRA MOL STRUCT R, V6, P141, DOI 10.1016/S0022-5320(62)90050-3; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; FONTANA JD, 1980, FEBS LETT, V109, P85, DOI 10.1016/0014-5793(80)81317-2; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; GUNJASMITH Z, 1970, FEBS LETT, V12, P101, DOI 10.1016/0014-5793(70)80573-7; Ianzano Leonarda, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9376; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; LIU R, 2008, MOL CELL BI IN PRESS; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; LOMAKO J, 1994, BIOFACTORS, V4, P167; Lomako J, 2004, BBA-GEN SUBJECTS, V1673, P45, DOI 10.1016/j.bbagen.2004.03.017; LOMAKO J, 1993, FEBS LETT, V329, P263, DOI 10.1016/0014-5793(93)80234-L; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Nakajima Hiromu, 2002, Current Molecular Medicine (Hilversum), V2, P197, DOI 10.2174/1566524024605734; Pederson BA, 2003, BIOCHEM BIOPH RES CO, V305, P826, DOI 10.1016/S0006-291X(03)00862-3; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; ROACH PJ, 1977, MOL CELL BIOCHEM, V15, P179, DOI 10.1007/BF01734108; Roach PJ, 1997, PROG NUCLEIC ACID RE, V57, P289, DOI 10.1016/S0079-6603(08)60284-6; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; SKURAT AV, 1993, J BIOL CHEM, V268, P14701; SMYTHE C, 1991, EUR J BIOCHEM, V200, P625, DOI 10.1111/j.1432-1033.1991.tb16225.x; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002	51	129	130	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33816	33825		10.1074/jbc.M807428200	http://dx.doi.org/10.1074/jbc.M807428200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18852261	hybrid, Green Published			2022-12-25	WOS:000261277700005
J	O'Brien, K; Matlin, AJ; Lowell, AM; Moore, MJ				O'Brien, Kristine; Matlin, Arianne J.; Lowell, April M.; Moore, Melissa J.			The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL INTERACTION; REPORTER ASSAY; TRI-SNRNP; SPLICEOSOME; COMPLEX; EXPRESSION; PROTEIN; TARGET	Membrane-permeable compounds that reversibly inhibit a particular step in gene expression are highly useful tools for cell biological and biochemical/structural studies. In comparison with other gene expression steps where multiple small molecule effectors are available, very few compounds have been described that act as general inhibitors of pre-mRNA splicing. Here we report construction and validation of a set of mammalian cell lines suitable for the identification of small molecule inhibitors of pre-mRNA splicing. Using these cell lines, we identified the natural product isoginkgetin as a general inhibitor of both the major and minor spliceosomes. Isoginkgetin inhibits splicing both in vivo and in vitro at similar micromolar concentrations. It appears to do so by preventing stable recruitment of the U4/U5/U6 tri-small nuclear ribonucleoprotein, resulting in accumulation of the prespliceosomal A complex. Like two other recently reported general pre-mRNA splicing inhibitors, isoginkgetin has been previously described as an anti-tumor agent. Our results suggest that splicing inhibition is the mechanistic basis of the anti-tumor activity of isoginkgetin. Thus, pre-mRNA splicing inhibitors may represent a novel avenue for development of new anti-cancer agents.	[O'Brien, Kristine; Matlin, Arianne J.; Moore, Melissa J.] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; [O'Brien, Kristine; Matlin, Arianne J.; Lowell, April M.; Moore, Melissa J.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [O'Brien, Kristine; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01655 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; University of Massachusetts System; University of Massachusetts Worcester	Moore, MJ (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, HHMI, LRB 825,364 Plantat St, Worcester, MA 01605 USA.	Melissa.Moore@umassmed.edu			National Institutes of Health [R01-GM35007]; NCI [N01-CO-12400]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM35007 (to M.J.M.) and the National Institutes of Health, NCI, Initiative for Chemical Genetics, under Contract N01-CO-12400. This work was performed with the assistance of the Chemical Biology Platform of the Broad Institute of Harvard and MIT. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABMAYR SM, 1988, GENE DEV, V2, P542, DOI 10.1101/gad.2.5.542; Albert BJ, 2007, J AM CHEM SOC, V129, P2648, DOI 10.1021/ja067870m; Bakkour N, 2007, PLOS PATHOG, V3, P1530, DOI 10.1371/journal.ppat.0030159; BRODY E, 1985, SCIENCE, V228, P963, DOI 10.1126/science.3890181; Burns CG, 2002, MOL CELL BIOL, V22, P801, DOI 10.1128/MCB.22.3.801-815.2002; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; Jurica MS, 2008, NAT CHEM BIOL, V4, P3, DOI 10.1038/nchembio0108-3; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kang SS, 2005, BIOORG MED CHEM LETT, V15, P3588, DOI 10.1016/j.bmcl.2005.05.078; Kim HP, 2008, ARCH PHARM RES, V31, P265, DOI 10.1007/s12272-001-1151-3; Kim SJ, 1997, SKIN PHARMACOL, V10, P200, DOI 10.1159/000211505; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; LEE SJ, 1995, LIFE SCI, V57, P551, DOI 10.1016/0024-3205(95)00305-P; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; LESSER CF, 1993, GENETICS, V133, P851; Levinson N, 2006, RNA, V12, P925, DOI 10.1261/rna.8306; Mathew R, 2008, NAT STRUCT MOL BIOL, V15, P435, DOI 10.1038/nsmb.1415; Matlin AJ, 2007, ADV EXP MED BIOL, V623, P14, DOI 10.1007/978-0-387-77374-2_2; Nakajima H, 1996, J ANTIBIOT, V49, P1204; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Reichert V, 2000, NUCLEIC ACIDS RES, V28, P416, DOI 10.1093/nar/28.2.416; Roberts GC, 1996, EMBO J, V15, P6301, DOI 10.1002/j.1460-2075.1996.tb01020.x; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; STUTZ F, 1994, EMBO J, V13, P4096, DOI 10.1002/j.1460-2075.1994.tb06727.x; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Wang Q, 2005, MOL CELL BIOL, V25, P10745, DOI 10.1128/MCB.25.24.10745-10754.2005; Yoon SO, 2006, MOL CANCER THER, V5, P2666, DOI 10.1158/1535-7163.MCT-06-0321	38	130	132	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33147	33154		10.1074/jbc.M805556200	http://dx.doi.org/10.1074/jbc.M805556200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826947	Green Published, hybrid			2022-12-25	WOS:000261183700016
J	Vaillant, DC; Copeland, SJ; Davis, C; Thurston, SF; Abdennur, N; Copeland, JW				Vaillant, Dominique C.; Copeland, Sarah J.; Davis, Chris; Thurston, Susan F.; Abdennur, Nezar; Copeland, John W.			Interaction of the N- and C-terminal Autoregulatory Domains of FRL2 Does Not Inhibit FRL2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; FORMIN HOMOLOGY PROTEIN; ACTIN DYNAMICS; FISSION YEAST; CELL-DIVISION; SRF ACTIVITY; FH2 DOMAIN; PROFILIN; POLYMERIZATION; MDIA1	Formin homology proteins are a highly conserved family of cytoskeletal remodeling proteins best known for their ability to induce the formation of long unbranched actin filaments. They accomplish this by nucleating the de novo polymerization of F-actin and also by acting as F-actin barbed end "leaky cappers" that allow filament elongation while antagonizing the function of capping proteins. More recently, it has been reported that the FH2 domains of FRL1 and mDia2 and the plant formin AFH1 are able to bind and bundle actin filaments via distinct mechanisms. We find that like FRL1, FRL2 and FRL3 are also able to bind and bundle actin filaments. In the case of FRL3, this activity is dependent upon a proximal DAD/WH2-like domain that is found C-terminal to the FH2 domain. In addition, we show that, like other Diaphanous-related formins, FRL3 activity is subject to autoregulation mediated by the interaction between its N-terminal DID and C-terminal DAD. In contrast, the DID and DAD of FRL2 also interact in vivo and in vitro but without inhibiting FRL2 activity. These data suggest that current models describing DID/DAD autoregulation via steric hindrance of FH2 activity must be revised. Finally, unlike other formins, we find that the FH2 and N-terminal dimerization domains of FRL2 and FRL3 are able to form hetero-oligomers.	[Vaillant, Dominique C.; Copeland, Sarah J.; Davis, Chris; Thurston, Susan F.; Abdennur, Nezar; Copeland, John W.] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Copeland, JW (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Fac Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	john.copeland@uottawa.ca		Abdennur, Nezar/0000-0001-5814-0864	Heart and Stroke Foundation of Ontario [NA 5762]; Canadian Institutes of Health [68816]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	Supported by Heart and Stroke Foundation of Ontario Grant NA 5762 and Canadian Institutes of Health Research Grant 68816.	Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Katoh M, 2003, INT J ONCOL, V22, P1161; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Loomis PA, 2006, J CELL SCI, V119, P1655, DOI 10.1242/jcs.02869; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3	35	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33750	33762		10.1074/jbc.M803156200	http://dx.doi.org/10.1074/jbc.M803156200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18835814	Green Published, hybrid			2022-12-25	WOS:000261183700081
J	Medawar, A; Virolle, T; Rostagno, P; de la Forest-Divonne, S; Gambaro, K; Rouleau, M; Aberdam, D				Medawar, Alain; Virolle, Thierry; Rostagno, Philippe; de la Forest-Divonne, Stephanie; Gambaro, Karen; Rouleau, Matthieu; Aberdam, Daniel			Delta Np63 Is Essential for Epidermal Commitment of Embryonic Stem Cells	PLOS ONE			English	Article								In vivo studies have demonstrated that p63 plays complex and pivotal roles in pluristratified squamous epithelial development, but its precise function and the nature of the isoform involved remain controversial. Here, we investigate the role of p63 in epithelial differentiation, using an in vitro ES cell model that mimics the early embryonic steps of epidermal development. We show that the Delta Np63 isoform is activated soon after treatment with BMP-4, a morphogen required to commit differentiating ES cells from a neuroectodermal to an ectodermal cell fate. Delta Np63 gene expression remains high during epithelial development. P63 loss of function drastically prevents ectodermal cells to commit to the K5/K14-positive stratified epithelial pathway while gain of function experiments show that Delta Np63 allows this commitment. Interestingly, other epithelial cell fates are not affected, allowing the production of K5/K18-positive epithelial cells. Therefore, our results demonstrate that Delta Np63 may be dispensable for some epithelial differentiation, but is necessary for the commitment of ES cells into K5/K14-positive squamous stratified epithelial cells.	[Medawar, Alain; Virolle, Thierry; Rostagno, Philippe; de la Forest-Divonne, Stephanie; Gambaro, Karen; Rouleau, Matthieu; Aberdam, Daniel] Fac Med Nice, INSERM, U898, F-06034 Nice, France; [Medawar, Alain; Virolle, Thierry; Rostagno, Philippe; de la Forest-Divonne, Stephanie; Gambaro, Karen; Rouleau, Matthieu; Aberdam, Daniel] Univ Nice, Sophia Antipolis, F-06108 Nice, France; [Aberdam, Daniel] INSERTECH, Technion, Haifa, Israel	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Medawar, A (corresponding author), Fac Med Nice, INSERM, U898, U210, F-06034 Nice, France.	aberdam@unice.fr	Virolle, Thierry/E-5838-2016; Rouleau, Matthieu/D-5774-2016; Aberdam, Daniel/G-3299-2013	Rouleau, Matthieu/0000-0002-0075-9880; Aberdam, Daniel/0000-0002-4019-5418	Sixth EEC Framework Program within the EPISTEM project [LSHB-CT-2005-019067]; Agence Nationale pour la Recherche; INSERM; Association Francaise de Dermatologie; Societe de Recherche Dermatologique (SRD); Institut National Contre le Cancer (INCa)	Sixth EEC Framework Program within the EPISTEM project; Agence Nationale pour la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise de Dermatologie; Societe de Recherche Dermatologique (SRD); Institut National Contre le Cancer (INCa)(Institut National du Cancer (INCA) France)	This work was supported by the Sixth EEC Framework Program within the EPISTEM project (LSHB-CT-2005-019067), the Agence Nationale pour la Recherche "projet blanc", INSERM and Association Francaise de Dermatologie, the Societe de Recherche Dermatologique (SRD) and the Institut National Contre le Cancer (INCa).	Aberdam D, 2007, CELL CYCLE, V6, P291, DOI 10.4161/cc.6.3.3800; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Candi E, 2006, J CELL SCI, V119, P4617, DOI 10.1242/jcs.03265; Chikh A, 2007, BIOCHEM BIOPH RES CO, V361, P1, DOI 10.1016/j.bbrc.2007.06.069; Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Gambaro K, 2006, CELL DEATH DIFFER, V13, P1075, DOI 10.1038/sj.cdd.4401799; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Koster MI, 2006, DEV BIOL, V289, P253, DOI 10.1016/j.ydbio.2005.10.041; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Romano RA, 2007, J INVEST DERMATOL, V127, P1175, DOI 10.1038/sj.jid.5700652; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	26	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3441	10.1371/journal.pone.0003441	http://dx.doi.org/10.1371/journal.pone.0003441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927616	Green Published, gold, Green Submitted			2022-12-25	WOS:000265122400011
J	Baird, NA; Etter, PD; Atwood, TS; Currey, MC; Shiver, AL; Lewis, ZA; Selker, EU; Cresko, WA; Johnson, EA				Baird, Nathan A.; Etter, Paul D.; Atwood, Tressa S.; Currey, Mark C.; Shiver, Anthony L.; Lewis, Zachary A.; Selker, Eric U.; Cresko, William A.; Johnson, Eric A.			Rapid SNP Discovery and Genetic Mapping Using Sequenced RAD Markers	PLOS ONE			English	Article								Single nucleotide polymorphism (SNP) discovery and genotyping are essential to genetic mapping. There remains a need for a simple, inexpensive platform that allows high-density SNP discovery and genotyping in large populations. Here we describe the sequencing of restriction-site associated DNA (RAD) tags, which identified more than 13,000 SNPs, and mapped three traits in two model organisms, using less than half the capacity of one Illumina sequencing run. We demonstrated that different marker densities can be attained by choice of restriction enzyme. Furthermore, we developed a barcoding system for sample multiplexing and fine mapped the genetic basis of lateral plate armor loss in threespine stickleback by identifying recombinant breakpoints in F(2) individuals. Barcoding also facilitated mapping of a second trait, a reduction of pelvic structure, by in silico re-sorting of individuals. To further demonstrate the ease of the RAD sequencing approach we identified polymorphic markers and mapped an induced mutation in Neurospora crassa. Sequencing of RAD markers is an integrated platform for SNP discovery and genotyping. This approach should be widely applicable to genetic mapping in a variety of organisms.	[Baird, Nathan A.; Etter, Paul D.; Shiver, Anthony L.; Lewis, Zachary A.; Selker, Eric U.; Johnson, Eric A.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Atwood, Tressa S.] Floragenex, Eugene, OR USA; [Currey, Mark C.; Cresko, William A.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Baird, NA (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	eric-johnson@molbio.uoregon.edu	赵, 鹏/B-8401-2009; Cresko, William/H-4010-2014	Johnson, Eric/0000-0003-1037-4228; Cresko, William/0000-0002-3496-8074; Lewis, Zachary/0000-0002-1735-8266	National Human Genome Research Institute [R21HG003834]; National Institute of General Medical Sciences [R24GM79486, GM025690]; National Science Foundation [IOS-0642264]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG003834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM079486, R01GM025690] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by grant R21HG003834 from the National Human Genome Research Institute (E.A.J.), grants R24GM79486 (E.A.J. and W.A.C.) and GM025690 (E.U.S.) from the National Institute of General Medical Sciences, and grant IOS-0642264 from the National Science Foundation (W.A.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chen D, 2008, NAT METHODS, V5, P323, DOI [10.1038/NMETH.1191, 10.1038/nmeth.1191]; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Coyne KJ, 2004, APPL ENVIRON MICROB, V70, P5298, DOI 10.1128/AEM.70.9.5298-5304.2004; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Lai CQ, 2007, NAT METHODS, V4, P839, DOI 10.1038/NMETH1084; Lewis ZA, 2007, GENETICS, V177, P1163, DOI 10.1534/genetics.107.078147; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Stickney HL, 2002, GENOME RES, V12, P1929, DOI 10.1101/gr.777302; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	18	2219	2321	19	827	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3376	10.1371/journal.pone.0003376	http://dx.doi.org/10.1371/journal.pone.0003376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852878	gold, Green Published, Green Submitted			2022-12-25	WOS:000265121600002
J	Shi, YL; Xu, QL; Seemanaplli, SV; McShan, K; Liang, FT				Shi, Yanlin; Xu, Qilong; Seemanaplli, Sunita V.; McShan, Kristy; Liang, Fang Ting			Common and Unique Contributions of Decorin-Binding Proteins A and B to the Overall Virulence of Borrelia burgdorferi	PLOS ONE			English	Article							LYME-DISEASE; OUTER SURFACE; EXPRESSION; INFECTION; IMMUNITY; LIPOPROTEINS; PLASMID-28-1; MODEL; DBPA	As an extracellular bacterium, the Lyme disease spirochete Borrelia burgdorferi resides primarily in the extracellular matrix and connective tissues and between host cells during mammalian infection, where decorin and glycosaminoglycans are abundantly found, so its interactions with these host ligands potentially affect various aspects of infection. Decorin-binding proteins (Dbps) A and B, encoded by a 2-gene operon, are outer surface lipoproteins with similar molecular weights and share approximately 40% identity, and both bind decorin and glycosaminoglycans. To investigate how DbpA and DbpB contribute differently to the overall virulence of B. burgdorferi, a dbpAB mutant was modified to overproduce the adhesins. Overproduction of either DbpA or DbpB resulted in restoration of the infectivity of the mutant to the control level, measured by 50% infectious dose (ID50), indicating that the two virulence factors are interchangeable in this regard. Overproduction of DbpA also allowed the mutant to disseminate to some but not all distal tissues slightly slower than the control, but the mutant with DbpB overproduction showed severely impaired dissemination to all tissues that were analyzed. The mutant with DbpA overproduction colonized all tissues, albeit generating bacterial loads significantly lower than the control in heart and joint, while the mutant overproducing DbpB remained severely defective in heart colonization and registered bacterial loads substantially lower than the control in joint. Taken together, the study indicated that DbpA and DbpB play a similar role in contribution to infectivity as measured by ID50 value but contribute differently to dissemination and tissue colonization.	[Shi, Yanlin; Xu, Qilong; Seemanaplli, Sunita V.; McShan, Kristy; Liang, Fang Ting] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Shi, YL (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	fliang@vetmed.lsu.edu			NIH/NIAMS; Arthritis Foundation Investigators award; NIH/NCRR [P20RR020159]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation Investigators award; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was financed by a career development award and a grant from NIH/NIAMS, an Arthritis Foundation Investigators award, and P20RR020159 from NIH/NCRR.	Barthold SW, 2006, INFECT IMMUN, V74, P4817, DOI 10.1128/IAI.00469-06; BARTHOLD SW, 1991, J INFECT DIS, V163, P419, DOI 10.1093/infdis/163.2.419; Blevins JS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-82; Brown EL, 2001, J CLIN INVEST, V107, P845, DOI 10.1172/JCI11692; BURGDORFER W, 1988, ANN NY ACAD SCI, V539, P172, DOI 10.1111/j.1749-6632.1988.tb31851.x; Cabello FC, 2007, TRENDS MICROBIOL, V15, P350, DOI 10.1016/j.tim.2007.06.003; Coburn J, 2005, MOL MICROBIOL, V57, P1182, DOI 10.1111/j.1365-2958.2005.04759.x; Cox DL, 1996, P NATL ACAD SCI USA, V93, P7973, DOI 10.1073/pnas.93.15.7973; Feng SL, 1998, INFECT IMMUN, V66, P2827, DOI 10.1128/IAI.66.6.2827-2835.1998; Fischer JR, 2003, P NATL ACAD SCI USA, V100, P7307, DOI 10.1073/pnas.1231043100; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; GUO BP, 1995, INFECT IMMUN, V63, P3467, DOI 10.1128/IAI.63.9.3467-3472.1995; Hagman KE, 2000, INFECT IMMUN, V68, P4759, DOI 10.1128/IAI.68.8.4759-4764.2000; Hagman KE, 1998, INFECT IMMUN, V66, P2674, DOI 10.1128/IAI.66.6.2674-2683.1998; Hanson MS, 1998, INFECT IMMUN, V66, P2143, DOI 10.1128/IAI.66.5.2143-2153.1998; JOHNSON RC, 1984, J CLIN MICROBIOL, V20, P1099, DOI 10.1128/JCM.20.6.1099-1101.1984; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liang FT, 2004, MICROB PATHOGENESIS, V37, P35, DOI 10.1016/j.micpath.2004.02.007; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schulze RJ, 2006, MOL MICROBIOL, V59, P1473, DOI 10.1111/j.1365-2958.2006.05039.x; Seiler KP, 1996, CURR OPIN IMMUNOL, V8, P503, DOI 10.1016/S0952-7915(96)80038-0; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Shi YL, 2006, INFECT IMMUN, V74, P6509, DOI 10.1128/IAI.00740-06; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; XU Q, 2008, MICROBIOLOG IN PRESS; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu Q, 2007, INFECT IMMUN, V75, P4272, DOI 10.1128/IAI.00560-07; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005	33	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3340	10.1371/journal.pone.0003340	http://dx.doi.org/10.1371/journal.pone.0003340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833332	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797400009
J	Pan, JA; Peng, XX; Gao, YJ; Li, ZL; Lu, XL; Chen, YZ; Ishaq, M; Liu, D; DeDiego, ML; Enjuanes, L; Guo, DY				Pan, Ji'An; Peng, Xiaoxue; Gao, Yajing; Li, Zhilin; Lu, Xiaolu; Chen, Yingzhao; Ishaq, Musarat; Liu, Dan; DeDiego, Marta L.; Enjuanes, Luis; Guo, Deyin			Genome-Wide Analysis of Protein-Protein Interactions and Involvement of Viral Proteins in SARS-CoV Replication	PLOS ONE			English	Article								Analyses of viral protein-protein interactions are an important step to understand viral protein functions and their underlying molecular mechanisms. In this study, we adopted a mammalian two-hybrid system to screen the genome-wide intraviral protein-protein interactions of SARS coronavirus (SARS-CoV) and therefrom revealed a number of novel interactions which could be partly confirmed by in vitro biochemical assays. Three pairs of the interactions identified were detected in both directions: non-structural protein (nsp) 10 and nsp14, nsp10 and nsp16, and nsp7 and nsp8. The interactions between the multifunctional nsp10 and nsp14 or nsp16, which are the unique proteins found in the members of Nidovirales with large RNA genomes including coronaviruses and toroviruses, may have important implication for the mechanisms of replication/transcription complex assembly and functions of these viruses. Using a SARS-CoV replicon expressing a luciferase reporter under the control of a transcription regulating sequence, it has been shown that several viral proteins (N, X and SUD domains of nsp3, and nsp12) provided in trans stimulated the replicon reporter activity, indicating that these proteins may regulate coronavirus replication and transcription. Collectively, our findings provide a basis and platform for further characterization of the functions and mechanisms of coronavirus proteins.	[Pan, Ji'An; Peng, Xiaoxue; Gao, Yajing; Li, Zhilin; Lu, Xiaolu; Chen, Yingzhao; Ishaq, Musarat; Liu, Dan; Guo, Deyin] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [DeDiego, Marta L.; Enjuanes, Luis] Campus Univ Autonoma, Dept Mol & Cell Biol, CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Wuhan University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Pan, JA (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	dguo@whu.edu.cn	Li, Zhilin/AAB-2229-2020; De Diego, Marta Lopez/B-2307-2017; Li, Zhilin/D-2535-2017; Enjuanes, Luis/F-7845-2016; Guo, Deyin/A-9498-2011; Pan, Ji-An/G-6142-2012	De Diego, Marta Lopez/0000-0002-7888-7372; Li, Zhilin/0000-0003-2867-2848; Guo, Deyin/0000-0002-8297-0814; Enjuanes, Luis/0000-0002-0854-0226; Gao, Yajing/0000-0001-7878-1466	China "973" [2006CB504300]; China Natural Science Foundation [30570394]; Ministry of Education "111" project [B06018]; EU DISSECT [SP22-CT-2004-511060]; CICYT [BIO2007-60978]	China "973"(National Basic Research Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education "111" project(Ministry of Education, China - 111 Project); EU DISSECT; CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT))	China "973" basic research program (grant 2006CB504300), China Natural Science Foundation (grant 30570394) and the Ministry of Education "111" project #B06018, the EU DISSECT project (SP22-CT-2004-511060) and the CICYT (BIO2007-60978) project from Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan F, 2004, J VIROL, V78, P12683, DOI 10.1128/JVI.78.22.12683-12688.2004; Almazan F, 2006, J VIROL, V80, P10900, DOI 10.1128/JVI.00385-06; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; Bhardwaj K, 2004, J VIROL, V78, P12218, DOI 10.1128/JVI.78.22.12218-12224.2004; Bhardwaj K, 2008, J BIOL CHEM, V283, P3655, DOI 10.1074/jbc.M708375200; Chen P, 2007, J BIOCHEM MOL BIOL, V40, P649; Choi IR, 2000, VIROLOGY, V267, P185, DOI 10.1006/viro.1999.0117; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Donaldson EF, 2007, J VIROL, V81, P6356, DOI 10.1128/JVI.02805-06; Donaldson EF, 2007, J VIROL, V81, P7086, DOI 10.1128/JVI.00049-07; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; Egloff MP, 2004, P NATL ACAD SCI USA, V101, P3792, DOI 10.1073/pnas.0307877101; Enjuanes L, 2006, ANNU REV MICROBIOL, V60, P211, DOI 10.1146/annurev.micro.60.080805.142157; Fielding BC, 2006, BIOCHEM BIOPH RES CO, V343, P1201, DOI 10.1016/j.bbrc.2006.03.091; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Frieman MB, 2006, ADV EXP MED BIOL, V581, P149; Ginalski K, 2006, CELL CYCLE, V5, P2414, DOI 10.4161/cc.5.20.3361; Graham RL, 2005, J VIROL, V79, P13399, DOI 10.1128/JVI.79.21.13399-13411.2005; Guarino LA, 2005, J MOL BIOL, V353, P1106, DOI 10.1016/j.jmb.2005.09.007; Guo DY, 2001, J GEN VIROL, V82, P935, DOI 10.1099/0022-1317-82-4-935; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; He RT, 2004, BIOCHEM BIOPH RES CO, V316, P476, DOI 10.1016/j.bbrc.2004.02.074; Huang C, 2007, J VIROL, V81, P5423, DOI 10.1128/JVI.02307-06; Huang C, 2006, J VIROL, V80, P7287, DOI 10.1128/JVI.00414-06; Hussain S, 2005, J VIROL, V79, P5288, DOI 10.1128/JVI.79.9.5288-5295.2005; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; Imberta I, 2008, VIRUS RES, V133, P136, DOI 10.1016/j.virusres.2007.11.017; Ito N, 2005, J VIROL, V79, P3182, DOI 10.1128/JVI.79.5.3182-3186.2005; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Joseph JS, 2007, J VIROL, V81, P6700, DOI 10.1128/JVI.02817-06; Joseph JS, 2006, J VIROL, V80, P7894, DOI 10.1128/JVI.00467-06; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Law AHY, 2007, J VIROL, V81, P416, DOI 10.1128/JVI.02336-05; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Luo Y, 1997, BIOTECHNIQUES, V22, P350, DOI 10.2144/97222pf02; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Oostra M, 2007, J VIROL, V81, P12323, DOI 10.1128/JVI.01506-07; Peti W, 2005, J VIROL, V79, P12905, DOI 10.1128/JVI.79.20.12905-12913.2005; Putics A, 2005, J VIROL, V79, P12721, DOI 10.1128/JVI.79.20.12721-12731.2005; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Renzi F, 2006, P NATL ACAD SCI USA, V103, P12365, DOI 10.1073/pnas.0602426103; Ricagno S, 2006, P NATL ACAD SCI USA, V103, P11892, DOI 10.1073/pnas.0601708103; Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06; Schaecher SR, 2007, J VIROL, V81, P718, DOI 10.1128/JVI.01691-06; Schelle B, 2005, J VIROL, V79, P6620, DOI 10.1128/JVI.79.11.6620-6630.2005; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Stadler K, 2005, CURR MOL MED, V5, P677, DOI 10.2174/156652405774641124; Su D, 2006, J VIROL, V80, P7902, DOI 10.1128/JVI.00483-06; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Uetz P, 2004, GENOME RES, V14, P2029, DOI 10.1101/gr.2583304; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; von Grotthuss M, 2003, CELL, V113, P701, DOI 10.1016/S0092-8674(03)00424-0; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Zell R, 2005, J GEN VIROL, V86, P2763, DOI 10.1099/vir.0.81144-0; Zhai YJ, 2005, NAT STRUCT MOL BIOL, V12, P980, DOI 10.1038/nsmb999; Zhu Y, 2005, VIRUS GENES, V30, P93, DOI 10.1007/s11262-004-4586-9	73	98	101	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3299	10.1371/journal.pone.0003299	http://dx.doi.org/10.1371/journal.pone.0003299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827877	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797200006
J	Goransson, M; Andersson, MK; Forni, C; Stahlberg, A; Andersson, C; Olofsson, A; Mantovani, R; Aman, P				Goransson, M.; Andersson, M. K.; Forni, C.; Stahlberg, A.; Andersson, C.; Olofsson, A.; Mantovani, R.; Aman, P.			The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappa B target genes by interaction with NFKBIZ	ONCOGENE			English	Article						MLS/RCLS; FUS; DDIT3; NF-kappa B; NFKBIZ; sarcoma	RNA-BINDING PROTEIN; TLS-CHOP; EXPRESSION PATTERNS; GENOMIC STRUCTURE; FUS/TLS-CHOP; TRANSCRIPTION; EWS; ZETA; INTERLEUKIN-6; TRANSLOCATION	FUS (also called TLS), EWSR1 and TAF15 (also called TAF2N) are related genes involved in tumor type-specific fusion oncogenes in human malignancies. The FUS-DDIT3 fusion oncogene results from a t(12;16)(q13;p11) chromosome translocation and has a causative role in the initiation of myxoid/round cell liposarcomas (MLS/RCLS). The FUS-DDIT3 protein induces increased expression of the CAAT/enhancer-binding protein (C/EBP) and nuclear factor-kappa B (NF-kappa)-controlled gene IL8, and the N-terminal FUS part is required for this activation. Chromatin immunoprecipitation analysis showed that FUS-DDIT3 binds the IL8 promoter. Expression studies of the IL8 promoter harboring a C/EBP-NF-kappa B composite site pinpointed the importance of NF-kappa B for IL8 expression in FUS-DDIT3-expressing cells. We therefore probed for possible interaction of FUS-DDIT3 with members of the NF-kappa B family. The nuclear factor NFKBIZ colocalizes with FUS-DDIT3 in nuclear structures, and immunoprecipitation experiments showed that FUS-DDIT3 binds the C-terminal of NFKBIZ. We also report that additional NF-kappa B-controlled genes are upregulated at the mRNA level in FUS-DDIT3-expressing cell lines and they can be induced by NFKBIZ. Taken together, the results indicate that FUS-DDIT3 deregulates some NF-kappa B-controlled genes through interactions with NFKBIZ. Similar mechanisms may be a part of the transformation process in other tumor types carrying FUS, EWSR1 and TAF15 containing fusion oncogenes.	[Goransson, M.; Andersson, M. K.; Andersson, C.; Olofsson, A.; Aman, P.] Univ Gothenburg, LLCR, Dept Pathol, Sahlgrenska Acad, SE-41345 Gothenburg, Sweden; [Forni, C.; Mantovani, R.] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy; [Stahlberg, A.] Univ Gothenburg, Sahlgrenska Acad, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, SE-41345 Gothenburg, Sweden	University of Gothenburg; University of Milan; University of Gothenburg	Aman, P (corresponding author), Univ Gothenburg, LLCR, Dept Pathol, Sahlgrenska Acad, Gula Straket 8, SE-41345 Gothenburg, Sweden.	pierre.aman@llcr.med.gu.se		Aman, Pierre/0000-0002-1482-8875; Stahlberg, Anders/0000-0003-4243-0191	Inga-Britt and Arne Lundberg Research Foundation; Swedish Cancer Society; Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; AIRC; Swedish Research Council	Inga-Britt and Arne Lundberg Research Foundation; Swedish Cancer Society(Swedish Cancer Society); Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; AIRC(Fondazione AIRC per la ricerca sul cancro); Swedish Research Council	We thank Ulric Pedersen for image processing. This work was supported by grants from the Inga-Britt and Arne Lundberg Research Foundation, the Swedish Cancer Society, Assar Gabrielssons Research Foundation and the Johan Jansson Foundation for Cancer Research. RM was supported by an AIRC grant. AS is supported by a postdoctoral fellowship award from the Swedish Research Council.	AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Aman P, 1996, GENOMICS, V37, P1, DOI 10.1006/geno.1996.0513; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; BIEGEL JA, 1993, GENE CHROMOSOME CANC, V7, P119, DOI 10.1002/gcc.2870070210; Bratt T, 2000, BBA-PROTEIN STRUCT M, V1482, P318, DOI 10.1016/S0167-4838(00)00154-0; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Chen ZD, 1998, NUCLEIC ACIDS RES, V26, P1126, DOI 10.1093/nar/26.4.1126; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DIFFIN F, 1994, J CLIN PATHOL, V47, P562, DOI 10.1136/jcp.47.6.562; Engstrom K, 2006, AM J PATHOL, V168, P1642, DOI 10.2353/ajpath.2006.050872; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Goransson M, 2002, EXP CELL RES, V278, P125, DOI 10.1006/excr.2002.5566; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Kovar H, 2005, SEMIN CANCER BIOL, V15, P189, DOI 10.1016/j.semcancer.2005.01.004; KOVAR H, 1994, KLIN PADIATR, V206, P196, DOI 10.1055/s-2008-1046605; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Morohoshi F, 1998, GENE, V221, P191, DOI 10.1016/S0378-1119(98)00463-6; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Nakopoulou L, 1999, HUM PATHOL, V30, P436, DOI 10.1016/S0046-8177(99)90120-X; OHNO T, 1993, CANCER RES, V53, P5859; Oikawa K, 2006, AM J SURG PATHOL, V30, P351; Olofsson A, 2004, INT J ONCOL, V25, P1349; Panagopoulos I, 1996, ONCOGENE, V12, P489; PANAGOPOULOS I, 1994, CANCER RES, V54, P6500; Perez-Losada J, 2000, ONCOGENE, V19, P6015, DOI 10.1038/sj.onc.1204018; Perez-Losada J, 2000, ONCOGENE, V19, P2413, DOI 10.1038/sj.onc.1203572; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; SANCHEZGARCIA I, 1994, P NATL ACAD SCI USA, V91, P7869, DOI 10.1073/pnas.91.17.7869; Schwarzbach MHM, 2004, ONCOGENE, V23, P6798, DOI 10.1038/sj.onc.1207840; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Sun SC, 2003, CANCER METAST REV, V22, P405, DOI 10.1023/A:1023733231406; Thelin-Jarnum S, 1999, INT J CANCER, V83, P30, DOI 10.1002/(SICI)1097-0215(19990924)83:1<30::AID-IJC6>3.0.CO;2-4; Thelin-Jarnum S, 2002, INT J CANCER, V97, P446, DOI 10.1002/ijc.1632; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; Zinszner H, 1997, ONCOGENE, V14, P451, DOI 10.1038/sj.onc.1200854	50	48	51	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					270	278		10.1038/onc.2008.378	http://dx.doi.org/10.1038/onc.2008.378			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18850010				2022-12-25	WOS:000262501100010
J	Mourtada-Maarabouni, M; Pickard, MR; Hedge, VL; Farzaneh, F; Williams, GT				Mourtada-Maarabouni, M.; Pickard, M. R.; Hedge, V. L.; Farzaneh, F.; Williams, G. T.			GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer	ONCOGENE			English	Article						apoptosis; snoRNA; growth arrest; oncogenesis; breast cancer; drug resistance	EXPRESSION CLONING REVEALS; HUMAN PROSTATIC-CARCINOMA; SMALL NUCLEOLAR RNAS; SNORNA HOST GENE; B-CELL LYMPHOMA; GROWTH-ARREST; FUNCTIONAL EXPRESSION; MOLECULAR REGULATION; NONCODING RNAS; IN-VITRO	Effective control of both cell survival and cell proliferation is critical to the prevention of oncogenesis and to successful cancer therapy. Using functional expression cloning, we have identified GAS5 ( growth arrest-specific transcript 5) as critical to the control of mammalian apoptosis and cell population growth. GAS5 transcripts are subject to complex post-transcriptional processing and some, but not all, GAS5 transcripts sensitize mammalian cells to apoptosis inducers. We have found that, in some cell lines, GAS5 expression induces growth arrest and apoptosis independently of other stimuli. GAS5 transcript levels were significantly reduced in breast cancer samples relative to adjacent unaffected normal breast epithelial tissues. The GAS5 gene has no significant protein-coding potential but expression encodes small nucleolar RNAs (snoRNAs) in its introns. Taken together with the recent demonstration of tumor suppressor characteristics in the related snoRNA U50, our observations suggest that such snoRNAs form a novel family of genes controlling oncogenesis and sensitivity to therapy in cancer.	[Mourtada-Maarabouni, M.; Pickard, M. R.; Hedge, V. L.; Williams, G. T.] Univ Keele, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Mourtada-Maarabouni, M.; Pickard, M. R.; Hedge, V. L.; Williams, G. T.] Univ Keele, Sch Life Sci, Keele ST5 5BG, Staffs, England; [Farzaneh, F.] Kings Coll London, Dept Haematol Med, Rayne Inst, London WC2R 2LS, England	Keele University; Keele University; University of London; King's College London	Williams, GT (corresponding author), Univ Keele, Inst Sci & Technol Med, Huxley Bldg, Keele ST5 5BG, Staffs, England.	bia19@biol.keele.ac.uk; g.t.williams@keele.ac.uk	Farzaneh, Farzin/B-4902-2009; Williams, Gwyn/GQY-7555-2022	Farzaneh, Farzin/0000-0002-9275-2415; Williams, Gwyn/0000-0003-4556-9930; /0000-0001-8324-1325	Wellcome Trust; Breast Cancer Campaign; Leukemia Research Fund; BBSRC; BBSRC [BB/E005896/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E005896/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Campaign; Leukemia Research Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Ms Ria Kishen, Dr Helen Kalirai and Professor Philip Rudland of the Liverpool Cancer Tissue Bank Research Centre for breast cancer and normal breast epithelial RNA samples, Professor Norman Maitland for PNT2C2 and P4E6 cells, and the Wellcome Trust, Breast Cancer Campaign, Leukemia Research Fund and BBSRC for financial support.	BERTHON P, 1995, INT J ONCOL, V6, P333; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; DANIELSEN M, 1983, MOL CELL BIOL, V3, P1310, DOI 10.1128/MCB.3.7.1310; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; FAN SJ, 1995, CANCER RES, V55, P1649; Fleming JV, 1998, BIOCHEM J, V330, P573; Fontanier-Razzaq N, 2002, J NUTR, V132, P2137, DOI 10.1093/jn/132.8.2137; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; KAIGHN ME, 1979, INVEST UROL, V17, P16; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lam M, 1997, CELL DEATH DIFFER, V4, P283, DOI 10.1038/sj.cdd.4400249; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Maitland NJ, 2001, RADIAT RES, V155, P133, DOI 10.1667/0033-7587(2001)155[0133:IVMTSC]2.0.CO;2; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Morrison LE, 2007, GENE CHROMOSOME CANC, V46, P397, DOI 10.1002/gcc.20419; Mourtacla-Maarabouni M, 2005, J LEUKOCYTE BIOL, V78, P503, DOI 10.1189/jlb.0205070; Mourtada-Maarabouni M, 2004, ONCOGENE, V23, P9419, DOI 10.1038/sj.onc.1208048; Mourtada-Maarabouni M, 2003, CELL DEATH DIFFER, V10, P1016, DOI 10.1038/sj.cdd.4401274; Mourtada-Maarabouni M, 2003, GENES CELLS, V8, P109, DOI 10.1046/j.1365-2443.2003.00619.x; Mourtada-Maarabouni M, 2002, APOPTOSIS, V7, P421, DOI 10.1023/A:1020083008017; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Mourtada-Maarabouni M, 2006, EXP CELL RES, V312, P1745, DOI 10.1016/j.yexcr.2006.02.009; Muller AJ, 1998, MAMM GENOME, V9, P773, DOI 10.1007/s003359900862; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nupponen NN, 2001, CANCER METAST REV, V20, P155, DOI 10.1023/A:1015557308033; Raho G, 2000, GENE, V256, P13, DOI 10.1016/S0378-1119(00)00363-2; Rossini GP, 2001, TOXICON, V39, P763, DOI 10.1016/S0041-0101(00)00202-6; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SMALE G, 1992, ANAL BIOCHEM, V203, P352, DOI 10.1016/0003-2697(92)90324-Z; Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stange DE, 2006, CLIN CANCER RES, V12, P345, DOI 10.1158/1078-0432.CCR-05-1633; Sutherland LC, 2000, ONCOGENE, V19, P3774, DOI 10.1038/sj.onc.1203720; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Thomadaki H, 2007, ANN NY ACAD SCI, V1095, P35, DOI 10.1196/annals.1397.005; Tsuji H, 2003, CARCINOGENESIS, V24, P1257, DOI 10.1093/carcin/bgg071; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vitali P, 2005, M S-MED SCI, V21, P1017; WARRI AM, 1993, JNCI-J NATL CANCER I, V85, P1412, DOI 10.1093/jnci/85.17.1412; Williams GT, 2004, CANCER IMMUNOL IMMUN, V53, P160, DOI 10.1007/s00262-003-0476-6; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Williams GT, 2006, GENE THER MOL BIOL, V10B, P255	61	630	678	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					195	208		10.1038/onc.2008.373	http://dx.doi.org/10.1038/onc.2008.373			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18836484				2022-12-25	WOS:000262501100004
J	Burd, CJ; Kinyamu, HK; Miller, FW; Archer, TK				Burd, Craig J.; Kinyamu, H. Karimi; Miller, Frederick W.; Archer, Trevor K.			UV Radiation Regulates Mi-2 through Protein Translation and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; REMODELING COMPLEX; P53 TRANSLATION; MUSCLE DISEASE; BREAST-CANCER; CHROMATIN; DERMATOMYOSITIS; AUTOANTIBODIES; EXPRESSION; MYOSITIS	Dermatomyositis (DM) is an autoimmune disease, which is often accompanied by the development of disease-specific autoantibodies directed against the SNF2-superfamily helicase, Mi-2. Recent evidence suggests that ultraviolet radiation exposure may be an important risk factor for the development of not only the disease but also specific autoimmunity against Mi-2. Consequently, we investigated the effects of ultraviolet radiation on Mi-2 protein expression. We observed an increase in protein levels upon ultraviolet radiation exposure in cell culture systems. These changes in expression occur quite rapidly, are maximized just 1 h following exposure, and are unique to Mi-2 when compared with other members of the NuRD complex. Changes in protein levels are not mediated through transcriptional mechanisms. Treatment results in a more efficiently translated message through regulatory elements in the 5'-UTR region of the transcript. Investigation into protein half-life further demonstrated increased stability of Mi-2 following UV exposure. Taken together, we describe a system by which Mi-2 protein expression can be quickly increased following UV exposure and then maintained up to 16 h later. These data provide a novel regulation of an important transcriptional regulator and provide insight into the possible mechanisms of the development of DM and associated autoantibodies.	[Burd, Craig J.; Kinyamu, H. Karimi; Archer, Trevor K.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Miller, Frederick W.] NIEHS, Environm Autoimmunity Grp, Off Clin Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, MD D4-01,POB 12233, Res Triangle Pk, NC 27709 USA.	archer1@niehs.nih.gov	Archer, Trevor K/E-5191-2019; kinyamu, Harriet/AAG-9069-2019; Miller, Frederick/D-2431-2019	kinyamu, Harriet/0000-0002-2377-7408; Miller, Frederick/0000-0003-2831-9593; Archer, Trevor K/0000-0001-7651-3644; Burd, Craig/0000-0002-6899-6751	Intramural Research Program of the NIEHS [Z01 ES071006-09]; National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES071006, ZIAES101074, Z01ES102445, ZICES102445, Z01ES071006, Z01ES101074] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Program Grant Z01 ES071006-09 in the Intramural Research Program of the NIEHS, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; Callen JP, 2006, CLIN DERMATOL, V24, P363, DOI 10.1016/j.clindermatol.2006.07.001; Casciola-Rosen L, 2005, J EXP MED, V201, P591, DOI 10.1084/jem.20041367; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Devereux TR, 1999, CANCER RES, V59, P6087; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Fryer CJ, 2000, J BIOL CHEM, V275, P17771, DOI 10.1074/jbc.M908729199; Fujita N, 2004, MOL ENDOCRINOL, V18, P2937, DOI 10.1210/me.2004-0258; Ghirardello A, 2005, AUTOIMMUNITY, V38, P79, DOI 10.1080/08916930400022681; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Levine SM, 2006, CURR OPIN RHEUMATOL, V18, P620, DOI 10.1097/01.bor.0000245721.02512.77; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Okada S, 2003, ARTHRITIS RHEUM-US, V48, P2285, DOI 10.1002/art.11090; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Roux S, 1998, J RHEUMATOL, V25, P395; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Schnabel Armin, 2005, Curr Rheumatol Rep, V7, P99, DOI 10.1007/s11926-005-0061-4; Sillibourne JE, 2007, MOL BIOL CELL, V18, P3667, DOI 10.1091/mbc.E06-07-0604; Sordet C, 2006, JOINT BONE SPINE, V73, P646, DOI 10.1016/j.jbspin.2006.04.005; Stevens AM, 2003, RHEUMATOLOGY, V42, P34, DOI 10.1093/rheumatology/keg025; Suber TL, 2008, NAT CLIN PRACT RHEUM, V4, P201, DOI 10.1038/ncprheum0760; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; TARGOFF IN, 1985, ARTHRITIS RHEUM, V28, P796, DOI 10.1002/art.1780280711; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	33	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34976	34982		10.1074/jbc.M805383200	http://dx.doi.org/10.1074/jbc.M805383200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922793	Green Published, hybrid			2022-12-25	WOS:000261469100054
J	Finger, EC; Lee, NY; You, HJ; Blobe, GC				Finger, Elizabeth C.; Lee, Nam Y.; You, Hye-jin; Blobe, Gerard C.			Endocytosis of the Type III Transforming Growth Factor-beta (TGF-beta) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-beta Signaling and Receptor Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-DEPENDENT ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; LIGAND-BINDING; EMERGING ROLES; INTERNALIZATION; EXPRESSION; CAVEOLAE; PROTEIN; CANCER; BETAGLYCAN	Transforming growth factor-beta(TGF-beta) signals through three highly conserved cell surface receptors, the type III TGF-beta receptor (T beta RIII), the type II TGF-beta receptor (T beta RII), and the type I TGF-beta receptor (T beta RI) to regulate diverse cellular processes including cell proliferation, differentiation, migration, and apoptosis. Although T beta RI and T beta RII undergo ligand-independent endocytosis by both clathrin-mediated endocytosis, resulting in enhanced signaling, and clathrin-independent endocytosis, resulting in receptor degradation, the mechanism and function of T beta RIII endocytosis is poorly understood. T beta RIII is a heparan sulfate proteoglycan with a short cytoplasmic tail that functions as a TGF-beta superfamily co-receptor, contributing to TGF-beta signaling through mechanisms yet to be fully defined. We have reported previously that T beta RIII endocytosis, mediated by a novel interaction with beta arrestin-2, results in decreased TGF-beta signaling. Here we demonstrate that T beta RIII undergoes endocytosis in a ligand and glycosaminoglycan modification-independent and cytoplasmic domain-dependent manner, with the interaction of Thr-841 in the cytoplasmic domain of T beta RIII with beta-arrestin2 enhancing T beta RIII endocytosis. T beta RIII undergoes both clathrin-mediated and clathrin-independent endocytosis. Importantly, inhibition of the clathrin-independent, lipid raft pathway, but not of the clathrin-dependent pathway, results in decreased TGF-beta 1 induced Smad2 and p38 phosphorylation, supporting a specific role for clathrin-independent endocytosis of T beta RIII in regulating both Smad-dependent and Smad-independent TGF-beta signaling.	[Finger, Elizabeth C.; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Lee, Nam Y.; You, Hye-jin; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27708 USA	Duke University; Duke University	Blobe, GC (corresponding author), B354 LSRC,Box 91004 DUMC, Durham, NC 27708 USA.	blobe001@mc.duke.edu	You, Hye Jin/AAF-7666-2019; Lee, Nam/H-3073-2016; Blobe, Gerard/AAJ-5945-2020; YOU, HYEJIN/K-8951-2019	You, Hye Jin/0000-0001-5566-5171; Blobe, Gerard/0000-0002-4274-8901; 	National Institutes of Health [R01-CA106307]; NATIONAL CANCER INSTITUTE [R01CA106307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA106307 (NCI; to G. C. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anders RA, 1997, MOL BIOL CELL, V8, P2133, DOI 10.1091/mbc.8.11.2133; ANDRES JL, 1992, J BIOL CHEM, V267, P5927; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Buchanan FG, 2006, CELL CYCLE, V5, P2060, DOI 10.4161/cc.5.18.3212; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; CHEIFETZ S, 1989, J BIOL CHEM, V264, P12025; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Deng XB, 1999, CELL GROWTH DIFFER, V10, P11; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Ehrlich M, 2001, J CELL SCI, V114, P1777; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Hempel N, 2007, CANCER RES, V67, P5231, DOI 10.1158/0008-5472.CAN-07-0035; Kirkbride KC, 2005, TRENDS BIOCHEM SCI, V30, P611, DOI 10.1016/j.tibs.2005.09.003; Kirkbride KC, 2003, EXPERT OPIN BIOL TH, V3, P251; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Leof EB, 2000, TRENDS CELL BIOL, V10, P343, DOI 10.1016/S0962-8924(00)01795-5; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Luttrell LM, 2002, J CELL SCI, V115, P455; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McDonald PH, 2001, CELL SIGNAL, V13, P683, DOI 10.1016/S0898-6568(01)00203-0; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; OKA Y, 1986, J BIOL CHEM, V261, P9090; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; You HJ, 2007, CARCINOGENESIS, V28, P2491, DOI 10.1093/carcin/bgm195	55	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34808	34818		10.1074/jbc.M804741200	http://dx.doi.org/10.1074/jbc.M804741200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845534	hybrid, Green Published			2022-12-25	WOS:000261469100037
J	Patel, V; Booker, M; Kramer, M; Ross, L; Celatka, CA; Kennedy, LM; Dvorin, JD; Duraisingh, MT; Sliz, P; Wirth, DF; Clardy, J				Patel, Vishal; Booker, Michael; Kramer, Martin; Ross, Leila; Celatka, Cassandra A.; Kennedy, Leah M.; Dvorin, Jeffrey D.; Duraisingh, Manoj T.; Sliz, Piotr; Wirth, Dyann F.; Clardy, Jon			Identification and Characterization of Small Molecule Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MALARIA; PYRIMIDINE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; CHLOROQUINE; RESISTANCE; ENZYMES; BINDING; DRUG; LEFLUNOMIDE	Plasmodium falciparum causes the most deadly form of malaria and accounts for over one million deaths annually. The malaria parasite is unable to salvage pyrimidines and relies on de novo biosynthesis for survival. Dihydroorotate dehydrogenase (DHOD), a mitochondrially localized flavoenzyme, catalyzes the rate-limiting step of this pathway and is therefore an attractive antimalarial chemotherapeutic target. Using a target-based high throughput screen, we have identified a series of potent, species-specific inhibitors of P. falciparum DHOD (pfDHOD) that are also efficacious against three cultured strains (3D7, HB3, and Dd2) of P. falciparum. The primary antimalarial mechanism of action of these compounds was confirmed to be inhibition of pfDHOD through a secondary assay with transgenic malaria parasites, and the structural basis for enzyme inhibition was explored through in silico structure-based docking and site-directed mutagenesis. Compound-mediated cytotoxicity was not observed with human dermal fibroblasts or renal epithelial cells. These data validate pfDHOD as an antimalarial drug target and provide chemical scaffolds with which to begin medicinal chemistry efforts.	[Patel, Vishal; Ross, Leila; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Patel, Vishal; Dvorin, Jeffrey D.; Duraisingh, Manoj T.; Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Booker, Michael; Kramer, Martin; Celatka, Cassandra A.; Kennedy, Leah M.] Genzyme Corp, Drug & Biomat Res & Dev, Waltham, MA 02451 USA; [Dvorin, Jeffrey D.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Sliz, Piotr] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Sanofi-Aventis; Genzyme Corporation; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Clardy, J (corresponding author), 240 Longwood Ave,C-643, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu		Ross, Leila/0000-0003-4360-5213; Sliz, Piotr/0000-0002-6522-0835; Dvorin, Jeffrey/0000-0002-5883-7271	National Institutes of Health [NIH R21NS053660, R21NS059404, K12-HD000850]; National Science Foundation Graduate Research Fellowship Program; Medicines for Malaria Venture, Harvard Malaria Initiative; Broad Institute of Harvard and Massachusetts Institute of Technology [2737380]; Humanitarian Assistance for Neglected Diseases Initiate of Genzyme Corp; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059404, R21NS053660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Medicines for Malaria Venture, Harvard Malaria Initiative; Broad Institute of Harvard and Massachusetts Institute of Technology; Humanitarian Assistance for Neglected Diseases Initiate of Genzyme Corp(Sanofi-AventisGenzyme Corporation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH R21NS053660 (USPHS to J.C.), R21NS059404 (to J.C.), and K12-HD000850 (NICHD to J.D.D.). This work was also supported by National Science Foundation Graduate Research Fellowship Program (to V.P.), Medicines for Malaria Venture, Harvard Malaria Initiative (to D.F.W.), SPARC Grant 2737380 from the Broad Institute of Harvard and Massachusetts Institute of Technology, and the Humanitarian Assistance for Neglected Diseases Initiate of Genzyme Corp. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALEMAN V, 1967, J BIOL CHEM, V242, P4087; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Baldwin J, 2002, J BIOL CHEM, V277, P41827, DOI 10.1074/jbc.M206854200; BANYAL HS, 1982, LIFE SCI, V31, P1141, DOI 10.1016/0024-3205(82)90088-1; Bjornberg O, 2001, ARCH BIOCHEM BIOPHYS, V391, P286, DOI 10.1006/abbi.2001.2409; CADIGAN FC, 1968, T ROY SOC TROP MED H, V62, P562, DOI 10.1016/0035-9203(68)90145-4; CAROLINE DF, 1969, J BACTERIOL, V100, P1371, DOI 10.1128/JB.100.3.1371-1377.1969; CHARLES LJ, 1962, B WORLD HEALTH ORGAN, V26, P103; CHEN GX, 1987, MOL PHARMACOL, V31, P430; CHEN JJ, 1976, ARCH BIOCHEM BIOPHYS, V176, P82, DOI 10.1016/0003-9861(76)90143-0; CHULAY JD, 1983, EXP PARASITOL, V55, P138, DOI 10.1016/0014-4894(83)90007-3; CLYDE DF, 1954, T ROY SOC TROP MED H, V48, P495, DOI 10.1016/0035-9203(54)90085-1; Copeland RA, 2000, J BIOL CHEM, V275, P33373, DOI 10.1074/jbc.M004451200; DENISDUPHIL M, 1989, BIOCHEM CELL BIOL, V67, P612, DOI 10.1139/o89-094; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; EAKIN RT, 1969, ARCH BIOCHEM BIOPHYS, V134, P160, DOI 10.1016/0003-9861(69)90262-8; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; GEARY TG, 1983, J PARASITOL, V69, P577, DOI 10.2307/3281373; GERO AM, 1981, AUST J EXP BIOL MED, V59, P477, DOI 10.1038/icb.1981.41; GERO AM, 1985, BIOCHEM MED METAB B, V34, P70, DOI 10.1016/0006-2944(85)90063-8; Goldenberg MM, 1999, CLIN THER, V21, P1837, DOI 10.1016/S0149-2918(00)86732-6; GREENE S, 1995, BIOCHEM PHARMACOL, V50, P861, DOI 10.1016/0006-2952(95)00255-X; GUTTERIDGE WE, 1979, BIOCHIM BIOPHYS ACTA, V582, P390, DOI 10.1016/0304-4165(79)90131-4; Hansen M, 2004, PROTEIN SCI, V13, P1031, DOI 10.1110/ps.03533004; Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0; HESS U, 1983, AM J TROP MED HYG, V32, P217, DOI 10.4269/ajtmh.1983.32.217; HILL B, 1981, INT J BIOCHEM, V13, P303, DOI 10.1016/0020-711X(81)90082-3; HINES V, 1989, BIOCHEMISTRY-US, V28, P1222, DOI 10.1021/bi00429a040; Hurt DE, 2006, BIOORG MED CHEM LETT, V16, P1610, DOI 10.1016/j.bmcl.2005.12.029; Hurt DE, 2006, ACTA CRYSTALLOGR D, V62, P312, DOI 10.1107/S0907444905042642; JEARNPIPATKUL A, 1980, EXPERIENTIA, V36, P1063, DOI 10.1007/BF01965970; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Jordan DB, 2000, ARCH BIOCHEM BIOPHYS, V378, P84, DOI 10.1006/abbi.2000.1823; KENNEDY J, 1973, ARCH BIOCHEM BIOPHYS, V157, P369, DOI 10.1016/0003-9861(73)90651-6; Knecht W, 1997, PROTEIN EXPRES PURIF, V10, P89, DOI 10.1006/prep.1996.0714; Knecht W, 1996, EUR J BIOCHEM, V240, P292, DOI 10.1111/j.1432-1033.1996.0292h.x; KRUNGKRAI J, 1993, EXP PARASITOL, V77, P136, DOI 10.1006/expr.1993.1070; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; MAHONEY LE, 1968, LANCET, V2, P1139; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; Marcinkeviciene J, 2000, BIOCHEM PHARMACOL, V60, P339, DOI 10.1016/S0006-2952(00)00348-8; Marcinkeviciene J, 2000, ARCH BIOCHEM BIOPHYS, V377, P178, DOI 10.1006/abbi.2000.1769; McLean JE, 2001, BIOCHEMISTRY-US, V40, P2194, DOI 10.1021/bi001810q; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; MILLER RW, 1969, CAN J BIOCHEM CELL B, V47, P725, DOI 10.1139/o69-110; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Nara T, 2000, GENE, V257, P209, DOI 10.1016/S0378-1119(00)00411-X; Neidhardt Edie A., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P183; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; PETERS W, 1969, LANCET, V2, P54; PHIFER KO, 1966, EXP PARASITOL, V19, P102, DOI 10.1016/0014-4894(66)90058-0; POWELL G, 1969, J BIOL CHEM, V244, P4793; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Rowland P, 1997, STRUCTURE, V5, P239, DOI 10.1016/S0969-2126(97)00182-2; RUMANS LW, 1979, LANCET, V2, P580; SCHUELER FW, 1964, J PHARMACOL EXP THER, V143, P278; Skophammer RG, 2007, MOL BIOL EVOL, V24, P1761, DOI 10.1093/molbev/msm096; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Subbayya INS, 1997, INDIAN J MED RES, V106, P79; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; TAYLOR ML, 1971, J BACTERIOL, V105, P1015, DOI 10.1128/JB.105.3.1015-1027.1971; TAYLOR WH, 1964, J BACTERIOL, V88, P105, DOI 10.1128/JB.88.1.105-110.1964; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VANDERPLAS J, 1983, J BACTERIOL, V153, P1027, DOI 10.1128/JB.153.2.1027-1037.1983; VLEUGELS MPH, 1982, TROP GEOGR MED, V34, P263; Wang P, 1997, MOL MICROBIOL, V23, P979, DOI 10.1046/j.1365-2958.1997.2821646.x; WILLIAMS JC, 1973, J BACTERIOL, V115, P1071, DOI 10.1128/JB.115.3.1071-1076.1973; YOUNG MD, 1963, AM J TROP MED HYG, V12, P305, DOI 10.4269/ajtmh.1963.12.305; YOUNG MD, 1961, AM J TROP MED HYG, V10, P317, DOI 10.4269/ajtmh.1961.10.317; Zameitat E, 2004, FEBS LETT, V568, P129, DOI 10.1016/j.febslet.2004.05.017; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	74	75	79	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35078	35085		10.1074/jbc.M804990200	http://dx.doi.org/10.1074/jbc.M804990200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842591	Green Published, hybrid			2022-12-25	WOS:000261469100065
J	Vukcevic, M; Spagnoli, GC; Iezzi, G; Zorzato, F; Treves, S				Vukcevic, Mirko; Spagnoli, Giulio C.; Iezzi, Giandomenica; Zorzato, Francesco; Treves, Susan			Ryanodine Receptor Activation by Ca(v)1.2 Is Involved in Dendritic Cell Major Histocompatibility Complex Class II Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE DIHYDROPYRIDINE RECEPTOR; CA2+ RELEASE CHANNELS; CALCIUM-CHANNELS; MATURATION; IDENTIFICATION; MECHANISMS; MUTATIONS; DIFFERENTIATION; HOMEOSTASIS; INHIBITION	Dendritic cells express the skeletal muscle ryanodine receptor (RyR1), yet little is known concerning its physiological role and activation mechanism. Here we show that dendritic cells also express the Ca(v)1.2 subunit of the L-type Ca2+ channel and that release of intracellular Ca2+ via RyR1 depends on the presence of extracellular Ca2+ and is sensitive to ryanodine and nifedipine. Interestingly, RyR1 activation causes a very rapid increase in expression of major histocompatibility complex II molecules on the surface of dendritic cells, an effect that is also observed upon incubation of mouse BM12 dendritic cells with transgenic T cells whose T cell receptor is specific for the I-A(bm12) protein. Based on the present results, we suggest that activation of the RyR1 signaling cascade may be important in the early stages of infection, providing the immune system with a rapid mechanism to initiate an early response, facilitating the presentation of antigens to T cells by dendritic cells before their full maturation.	[Vukcevic, Mirko; Treves, Susan] Univ Basel Hosp, Dept Anaesthesia, CH-4031 Basel, Switzerland; [Vukcevic, Mirko; Treves, Susan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Spagnoli, Giulio C.; Iezzi, Giandomenica] Univ Basel Hosp, Inst Surg Res, CH-4031 Basel, Switzerland; [Zorzato, Francesco] Univ Ferrara, Gen Pathol sect, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy	University of Basel; University of Basel; University of Basel; University of Ferrara	Treves, S (corresponding author), Univ Basel Hosp, Dept Anaesthesia, Hebelstr 20, CH-4031 Basel, Switzerland.	susan.treves@unibas.ch		Treves, Susan/0000-0002-0007-9631; Iezzi, Giandomenica/0000-0001-5841-495X	Swiss National Science Foundation [3200B0-114597, 31600-117383, 3200B0-104060]; Swiss Muscle Foundation; Association Francaise Contre les Myopathies	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Muscle Foundation; Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by Swiss National Science Foundation Grants 3200B0-114597, 31600-117383 and 3200B0-104060 and by Swiss Muscle Foundation and Association Francaise Contre les Myopathies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; Bracci L, 2007, J CELL SCI, V120, P2232, DOI 10.1242/jcs.007203; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Ducreux S, 2006, BIOCHEM J, V395, P259, DOI 10.1042/BJ20051282; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Goth SR, 2006, ENVIRON HEALTH PERSP, V114, P1083, DOI 10.1289/ehp.8881; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Hosoi E, 2001, J IMMUNOL, V167, P4887, DOI 10.4049/jimmunol.167.9.4887; KWAN CY, 1990, AM J PHYSIOL, V258, pC1006, DOI 10.1152/ajpcell.1990.258.6.C1006; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; O'Connell PJ, 2002, FEBS LETT, V512, P67, DOI 10.1016/S0014-5793(01)03321-X; Panyi G, 2004, IMMUNOL LETT, V92, P55, DOI 10.1016/j.imlet.2003.11.020; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; Ralevic V, 1998, PHARMACOL REV, V50, P413; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schuhmeier RP, 2005, BIOPHYS J, V88, P1765, DOI 10.1529/biophysj.104.051318; Sedej S, 2004, J PHYSIOL-LONDON, V555, P769, DOI 10.1113/jphysiol.2003.058271; Sei Y, 1999, J BIOL CHEM, V274, P5995, DOI 10.1074/jbc.274.9.5995; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Tarroni P, 1997, J BIOL CHEM, V272, P19808, DOI 10.1074/jbc.272.32.19808; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Uemura Y, 2007, BIOCHEM BIOPH RES CO, V362, P510, DOI 10.1016/j.bbrc.2007.08.024; Vignali S, 2006, J PHYSIOL-LONDON, V572, P691, DOI 10.1113/jphysiol.2005.102368; Wehrens XHT, 2003, TRENDS BIOCHEM SCI, V28, P671, DOI 10.1016/j.tibs.2003.10.003; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; ZIMANYI I, 1992, MOL PHARMACOL, V42, P1049	51	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34913	34922		10.1074/jbc.M804472200	http://dx.doi.org/10.1074/jbc.M804472200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18927079	Green Published, hybrid			2022-12-25	WOS:000261469100048
J	Yu, Z; Koningstein, G; Pop, A; Luirink, J				Yu, Zhong; Koningstein, Gregory; Pop, Ana; Luirink, Joen			The Conserved Third Transmembrane Segment of YidC Contacts Nascent Escherichia coli Inner Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; SYNTHASE SUBUNIT-C; INSERTION; BIOGENESIS; SECY; ATP; REQUIREMENTS; TRANSLOCATION; SUBSTRATE; TRANSPORT	Escherichia coli YidC is a polytopic inner membrane protein that plays an essential and versatile role in the biogenesis of inner membrane proteins. YidC functions in Sec-dependent membrane insertion but acts also independently as a separate insertase for certain small membrane proteins. We have used a site-specific cross-linking approach to show that the conserved third transmembrane segment of YidC contacts the transmembrane domains of both nascent Sec-dependent and -independent substrates, indicating a generic recognition of insertion intermediates by YidC. Our data suggest that specific residues of the third YidC transmembrane segment alpha-helix is oriented toward the transmembrane domains of nascent inner membrane proteins that, in contrast, appear quite flexibly positioned at this stage in biogenesis.	[Yu, Zhong; Koningstein, Gregory; Pop, Ana; Luirink, Joen] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Luirink, J (corresponding author), Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	joen.luirink@falw.vu.nl	Luirink, Joen/AAB-8658-2021	Luirink, J./0000-0001-8431-0804				Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Houben ENG, 2004, EMBO REP, V5, P970, DOI 10.1038/sj.embor.7400261; Houben ENG, 2002, J BIOL CHEM, V277, P35880, DOI 10.1074/jbc.M205556200; Houben ENG, 2000, FEBS LETT, V476, P229, DOI 10.1016/S0014-5793(00)01735-X; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; LERNER CG, 1990, NUCLEIC ACIDS RES, V18, P4631, DOI 10.1093/nar/18.15.4631; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Sauri A, 2007, J MOL BIOL, V366, P366, DOI 10.1016/j.jmb.2006.11.052; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Urbanus ML, 2002, J BIOL CHEM, V277, P12718, DOI 10.1074/jbc.M200311200; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2005, CURR OPIN MICROBIOL, V8, P182, DOI 10.1016/j.mib.2005.02.004; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yuan J, 2007, J BACTERIOL, V189, P8961, DOI 10.1128/JB.01365-07	41	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34635	34642		10.1074/jbc.M804344200	http://dx.doi.org/10.1074/jbc.M804344200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18840604	Green Published, hybrid			2022-12-25	WOS:000261469100018
J	Chen, JL; Lin, HH; Kim, KJ; Lin, AN; Forman, HJ; Ann, DK				Chen, Jo-Lin; Lin, Her H.; Kim, Kwang-Jin; Lin, Anning; Forman, Henry J.; Ann, David K.			Novel Roles for Protein Kinase C delta-dependent Signaling Pathways in Acute Hypoxic Stress-induced Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; PKC-DELTA; APOPTOSIS; MACROAUTOPHAGY; ACTIVATION; PHOSPHORYLATION; INDUCTION; CANCER; DEATH; LC3	Macroautophagy, a tightly orchestrated intracellular process for bulk degradation of cytoplasmic proteins or organelles, is believed to be essential for cell survival or death in response to stress conditions. Recent observations indicate that autophagy is an adaptive response in cells subjected to prolonged hypoxia. However, the signaling mechanisms that activate autophagy under acute hypoxic stress are not clearly understood. In this study, we show that acute hypoxic stress by treatment with 1% O-2 or desferroxamine, a hypoxia-mimetic agent, of cells renders a rapid induction of LC3-II level changes and green fluorescent protein-LC3 puncta accumulation, hallmarks of autophagic processing, and that this process involves protein kinase C delta (PKC delta), and occurs prior to the induction of BNIP3 (Bcl-2/adenovirus E1B 19-kDa interacting protein 3). Interestingly, hypoxic stress leads to a rapid and transient activation of JNK in Pa-4 or mouse embryo fibroblast cells. Acute hypoxic stress-induced changes in LC3-II level and JNK activation are attenuated in Pa-4 cells by dominant negative PKC delta KD or in mouse embryo fibroblast/PKC delta-null cells. Intriguingly, the requirement of PKC delta is not apparent for starvation-induced autophagy. The importance of PKC delta in hypoxic stress-induced adaptive responses is further supported by our findings that inhibition of PKC delta-facilitated autophagy by 3-methyladenine or Atg5 knock-out renders a greater prevalence of cell death following prolonged desferroxamine treatment, whereas PKC delta- or JNK1-deficient cells exhibit resistance to extended hypoxic exposure. These results uncover dual roles of PKC delta-dependent signaling in the cell fate determination upon hypoxic exposure.	[Chen, Jo-Lin; Lin, Her H.; Ann, David K.] City Hope Natl Med Ctr, Dept Clin & Mol Pharmacol, Duarte, CA 91010 USA; [Chen, Jo-Lin; Kim, Kwang-Jin; Ann, David K.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90033 USA; [Kim, Kwang-Jin; Ann, David K.] Univ So Calif, Dept Med, Los Angeles, CA 90033 USA; [Kim, Kwang-Jin] Univ So Calif, Will Rogers Inst, Pulm Res Ctr, Los Angeles, CA 90033 USA; [Lin, Anning] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; [Forman, Henry J.] Univ Calif, Sch Nat Sci, Merced, CA 95344 USA	City of Hope; University of Southern California; University of Southern California; University of Southern California; University of Chicago; University of California System; University of California Merced	Ann, DK (corresponding author), City Hope Natl Med Ctr, Dept Clin & Mol Pharmacol, KCRB Rm 1028,1500 E Duarte Rd, Duarte, CA 91010 USA.	dann@coh.org		Forman, Henry Jay/0000-0001-5838-2791	National Institutes of Health [DE 10742, DE 14183, HL 38658, HL 64365]; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038658, R01HL064365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE 10742 and DE 14183 (to D. K. A.) and HL 38658 and HL 64365 (to K. J. K.). This work was also supported in part by the Hastings Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Borger DR, 2008, BIOCHEM BIOPH RES CO, V370, P230, DOI 10.1016/j.bbrc.2008.03.056; Clavijo C, 2007, AM J PHYSIOL-CELL PH, V292, pC2150, DOI 10.1152/ajpcell.00425.2006; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Egami Y, 2008, EXP CELL RES, V314, P729, DOI 10.1016/j.yexcr.2007.11.018; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Leitges M, 2001, J CLIN INVEST, V108, P1505; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nguyen HV, 2006, AM J PATHOL, V168, P1452, DOI 10.2353/ajpath.2006.050782; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Papandreou I, 2008, CELL DEATH DIFFER, V15, P1572, DOI 10.1038/cdd.2008.84; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Qi X, 2007, J MOL CELL CARDIOL, V43, P420, DOI 10.1016/j.yjmcc.2007.07.061; Rami A, 2008, AUTOPHAGY, V4, P227, DOI 10.4161/auto.5339; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Song KS, 2008, AUTOPHAGY, V4, P650, DOI 10.4161/auto.6057; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang H, 2008, AM J RESP CELL MOL, V38, P483, DOI 10.1165/rcmb.2007-0260OC; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	58	43	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34432	34444		10.1074/jbc.M804239200	http://dx.doi.org/10.1074/jbc.M804239200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18836180	Green Published, hybrid			2022-12-25	WOS:000261277700071
J	Kan, JS; Zou, L; Zhang, JJ; Wu, RT; Wang, ZY; Liang, C				Kan, Junsuo; Zou, Lan; Zhang, Jingjing; Wu, Rentian; Wang, Ziyi; Liang, Chun			Origin Recognition Complex (ORC) Mediates Histone 3 Lysine 4 Methylation through Cooperation with Spp1 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; H3 LYSINE-4; MCM PROTEINS; SET1 COMPLEX; COMPASS; ASSOCIATION; INITIATION; HETEROCHROMATIN; ACTIVATION; CHECKPOINT	The heterohexameric origin recognition complex (ORC) has been implicated in many cellular activities, including DNA replication, transcriptional control, heterochromatin assembly, centromere and telomere function, and so on. Here, we report a new function for ORC in mediating histone methylation. Using the yeast two-hybrid system, we identify a physical interaction between Orc2p and Spp1p, a member of the Set1 complex, and we demonstrate the interaction between the endogenous ORC and Spp1p by co-immunoprecipitation from yeast extracts. Furthermore, we find that Orc2p physically interacts with trimethylated histone 3 lysine 4 (H3K4) on chromatin by co-immunoprecipitation. Finally, we show that the trimethylation of H3K4 is decreased in orc2-1 cells and abolished in orc2-1, spp1 Delta double mutants. Our data reveal a novel facet of ORC in mediating histone methylation in collaboration with Spp1p and demonstrate a connection between ORC and chromatin structure via the Set1 complex.	[Liang, Chun] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Canc Res, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Liang, C (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	bccliang@ust.hk	Wu, Rentian/Q-7413-2017	Wu, Rentian/0000-0003-3862-6394	Hong Kong Research Grants Council [HKUST6114/04M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by a grant from the Hong Kong Research Grants Council (Grant HKUST6114/04M). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Hou ZG, 2005, P NATL ACAD SCI USA, V102, P8489, DOI 10.1073/pnas.0503525102; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schramke V, 2001, GENE DEV, V15, P1845, DOI 10.1101/gad.193901; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Shore D, 2001, CURR BIOL, V11, pR816, DOI 10.1016/S0960-9822(01)00493-6; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Wood A, 2005, NAT STRUCT MOL BIOL, V12, P839, DOI 10.1038/nsmb1005-839; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276; Zhang YX, 2002, CELL, V109, P849, DOI 10.1016/S0092-8674(02)00805-X	39	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33803	33807		10.1074/jbc.C800182200	http://dx.doi.org/10.1074/jbc.C800182200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845545	Green Published, hybrid			2022-12-25	WOS:000261277700003
J	Savelieva, KV; Zhao, SL; Pogorelov, VM; Rajan, I; Yang, Q; Cullinan, E; Lanthorn, TH				Savelieva, Katerina V.; Zhao, Shulei; Pogorelov, Vladimir M.; Rajan, Indrani; Yang, Qi; Cullinan, Emily; Lanthorn, Thomas H.			Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants	PLOS ONE			English	Article							TARGETED DISRUPTION; MICE; RECEPTORS; MUTATION; POLYMORPHISMS; ASSOCIATION; DISORDERS; RESPONSES; EFFICACY; VARIANTS	The neurotransmitter serotonin (5-HT) plays an important role in both the peripheral and central nervous systems. The biosynthesis of serotonin is regulated by two rate-limiting enzymes, tryptophan hydroxylase-1 and -2 (TPH1 and TPH2). We used a gene-targeting approach to generate mice with selective and complete elimination of the two known TPH isoforms. This resulted in dramatically reduced central 5-HT levels in Tph2 knockout (TPH2KO) and Tph1/Tph2 double knockout (DKO) mice; and substantially reduced peripheral 5-HT levels in DKO, but not TPH2KO mice. Therefore, differential expression of the two isoforms of TPH was reflected in corresponding depletion of 5-HT content in the brain and periphery. Surprisingly, despite the prominent and evolutionarily ancient role that 5-HT plays in both vertebrate and invertebrate physiology, none of these mutations resulted in an overt phenotype. TPH2KO and DKO mice were viable and normal in appearance. Behavioral alterations in assays with predictive validity for antidepressants were among the very few phenotypes uncovered. These behavioral changes were subtle in the TPH2KO mice; they were enhanced in the DKO mice. Herein, we confirm findings from prior descriptions of TPH1 knockout mice and present the first reported phenotypic evaluations of Tph2 and Tph1/Tph2 knockout mice. The behavioral effects observed in the TPH2 KO and DKO mice strongly confirm the role of 5-HT and its synthetic enzymes in the etiology and treatment of affective disorders.	[Savelieva, Katerina V.; Zhao, Shulei; Pogorelov, Vladimir M.; Rajan, Indrani; Yang, Qi; Cullinan, Emily; Lanthorn, Thomas H.] Lexicon Pharmaceut Inc, The Woodlands, TX USA	Lexicon Pharmaceuticals	Savelieva, KV (corresponding author), Lexicon Pharmaceut Inc, The Woodlands, TX USA.	ksavelieva@lexpharma.com						Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; Ballenger JC, 1999, BIOL PSYCHIAT, V46, P1579, DOI 10.1016/S0006-3223(99)00220-6; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Begovic Amra, 2004, Bosn J Basic Med Sci, V4, P79; Bonasera SJ, 2000, PHARMACOL THERAPEUT, V88, P133, DOI 10.1016/S0163-7258(00)00087-5; Bourin M, 2005, BEHAV BRAIN RES, V164, P266, DOI 10.1016/j.bbr.2005.06.015; Buhot MC, 1997, CURR OPIN NEUROBIOL, V7, P243, DOI 10.1016/S0959-4388(97)80013-X; Coon H, 2005, AM J MED GENET B, V135B, P42, DOI 10.1002/ajmg.b.30168; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Delorme R, 2006, BIOL PSYCHIAT, V60, P202, DOI 10.1016/j.biopsych.2005.12.014; Dodick DW, 2007, CNS DRUGS, V21, P73, DOI 10.2165/00023210-200721010-00006; DRUGAN RC, 1989, PHARMACOL BIOCHEM BE, V33, P649, DOI 10.1016/0091-3057(89)90403-6; Ericsson M, 1996, ADDICT BEHAV, V21, P733, DOI 10.1016/0306-4603(96)00032-9; Gershon Michael D, 2003, Rev Gastroenterol Disord, V3 Suppl 2, pS25; Goodman WK, 1999, J CLIN PSYCHIAT, V60, P27; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Haavik J, 2008, HUM MUTAT, V29, P891, DOI 10.1002/humu.20700; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Julius D, 1998, P NATL ACAD SCI USA, V95, P15153, DOI 10.1073/pnas.95.26.15153; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kobayashi T, 2008, PSYCHOPHARMACOLOGY, V197, P567, DOI 10.1007/s00213-008-1070-6; Kugaya A, 2003, NEUROPSYCHOPHARMACOL, V28, P413, DOI 10.1038/sj.npp.1300036; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; Leo RJ, 2006, CURR OPIN INVEST DR, V7, P637; Li X, 2006, LIFE SCI, V78, P1933, DOI 10.1016/j.lfs.2005.08.002; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Liu SM, 2008, VITIS, V47, P55; Londei T, 1998, BEHAV BRAIN RES, V94, P249, DOI 10.1016/S0166-4328(97)00162-9; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; Martin JR, 1998, J PHARMACOL EXP THER, V286, P913; McKinney J, 2008, MOL PSYCHIATR, V13, P365, DOI 10.1038/sj.mp.4002152; Millan MJ, 2004, J PHARMACOL EXP THER, V309, P921, DOI 10.1124/jpet.103.062414; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; POGORELOV VM, 2008, EXPT MODELS IN PRESS; Renard CE, 2003, FUND CLIN PHARMACOL, V17, P449, DOI 10.1046/j.1472-8206.2003.00160.x; RENSON J, 1962, J BIOL CHEM, V237, P2261; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Serretti A, 2005, PROG NEURO-PSYCHOPH, V29, P1074, DOI 10.1016/j.pnpbp.2005.03.013; Sheehan K, 2005, MOL PSYCHIATR, V10, P944, DOI 10.1038/sj.mp.4001698; Sheehan K, 2007, NEUROSCI LETT, V412, P105, DOI 10.1016/j.neulet.2006.10.043; Singh VP, 2001, BRAIN RES, V915, P218, DOI 10.1016/S0006-8993(01)02854-2; Sommer Claudia, 2006, Curr Pain Headache Rep, V10, P101, DOI 10.1007/s11916-006-0020-4; Veenstra-VanderWeele Jeremy, 2003, Mol Interv, V3, P72, DOI 10.1124/mi.3.2.72; Wallace J Mark, 2007, Curr Pain Headache Rep, V11, P208, DOI 10.1007/s11916-007-0192-6; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Zhao S, 2006, NEUROSCIENCE, V140, P321, DOI 10.1016/j.neuroscience.2006.01.049; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	52	193	199	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3301	10.1371/journal.pone.0003301	http://dx.doi.org/10.1371/journal.pone.0003301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923670	Green Published, gold, Green Submitted			2022-12-25	WOS:000265121800001
J	Kuballa, P; Huett, A; Rioux, JD; Daly, MJ; Xavier, RJ				Kuballa, Petric; Huett, Alan; Rioux, John D.; Daly, Mark J.; Xavier, Ramnik J.			Impaired Autophagy of an Intracellular Pathogen Induced by a Crohn's Disease Associated ATG16L1 Variant	PLOS ONE			English	Article								The genetic risk factors predisposing individuals to the development of inflammatory bowel disease are beginning to be deciphered by genome-wide association studies. Surprisingly, these new data point towards a critical role of autophagy in the pathogenesis of Crohn's disease. A single common coding variant in the autophagy protein ATG16L1 predisposes individuals to the development of Crohn's disease: while ATG16L1 encoding threonine at amino acid position 300 (ATG16L1*300T) confers protection, ATG16L1 encoding for alanine instead of threonine (ATG16L1*300A, also known as T300A) mediates risk towards the development of Crohn's disease. Here we report that, in human epithelial cells, the Crohn's disease-associated ATG16L1 coding variant shows impairment in the capture of internalized Salmonella within autophagosomes. Thus, we propose that the association of ATG16L1*300A with increased risk of Crohn's disease is due to impaired bacterial handling and lowered rates of bacterial capture by autophagy.	[Kuballa, Petric; Huett, Alan; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02115 USA; [Rioux, John D.; Daly, Mark J.] Harvard Univ, Massachusetts Inst Technol, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; [Rioux, John D.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Daly, Mark J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universite de Montreal; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kuballa, P (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02115 USA.	xavier@molbio.mgh.harvard.edu	Huett, Alan/AAI-7998-2020; Rioux, John D/A-9599-2015; Daly, Mark J/B-2453-2017	Huett, Alan/0000-0001-7385-5585; Rioux, John D/0000-0001-7560-8326; Daly, Mark J/0000-0002-0949-8752	Deutsche Forschungsgemeinschaft [KU2511/1-1]; CCIB; National Institutes of Allergy and Infectious Diseases [AI065687, AI067152]; National Institute of Diabetes and Digestive and Kidney Diseases [DK064869, DK062432]; Crohn's and Colitis Foundation of America [SRA512];  [AI062773];  [HL88297]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, P01AI065687, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064869, U01DK062432, P30DK040561] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CCIB; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PK is supported by a fellowship award from the Deutsche Forschungsgemeinschaft (KU2511/1-1). RJX is supported by the following grants: AI062773, HL88297 and CCIB development funds. JDR is funded by grants from the National Institutes of Allergy and Infectious Diseases (AI065687; AI067152) from the National Institute of Diabetes and Digestive and Kidney Diseases (DK064869; DK062432) and the Crohn's and Colitis Foundation of America (SRA512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kuballa P, 2007, J BIOL CHEM, V282, P65, DOI 10.1074/jbc.M605117200; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zheng HR, 2004, DNA SEQUENCE, V15, P303, DOI 10.1080/10425170400004104	21	259	271	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3391	10.1371/journal.pone.0003391	http://dx.doi.org/10.1371/journal.pone.0003391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852889	gold, Green Published, Green Submitted			2022-12-25	WOS:000265121600014
J	Hikita, ST; Kosik, KS; Clegg, DO; Bamdad, C				Hikita, Sherry T.; Kosik, Kenneth S.; Clegg, Dennis O.; Bamdad, Cynthia			MUC1*Mediates the Growth of Human Pluripotent Stem Cells	PLOS ONE			English	Article								The MUC1 protein is aberrantly expressed on an estimated 75% of all human solid tumor cancers. We recently reported that a transmembrane cleavage product, MUC1*, is the predominant form of the protein on cancer cells [1]. Further, our evidence indicated that MUC1* functions as a growth factor receptor on tumor cells, while the full-length protein appeared to have no growth promoting activity. Here, we report that MUC1* acts as a growth factor receptor on undifferentiated human embryonic stem cells (hESCs). Cleavage of the full-length ectodomain to form MUC1*, a membrane receptor, appears to make binding to its ligand, NM23, possible. Unexpectedly, we found that newly differentiated cells no longer express the cleaved form, MUC1*, or its ligand, NM23. Newly differentiated stem cells exclusively present full-length MUC1. Antibody-induced dimerization of the MUC1* receptor on hESCs stimulated cell growth to a far greater degree than currently used methods that require the addition of exogenous basic fibroblast growth factor (bFGF) as well as factors secreted by fibroblast "feeder cells''. Further, MUC1* mediated growth was shown to be independent of growth stimulated by bFGF or the milieu of factors secreted by feeder cells. Stimulating the MUC1* receptor with either the cognate antibody or its ligand NM23 enabled hESC growth in a feeder cell-free system and produced pluripotent colonies that resisted spontaneous differentiation. These findings suggest that this primal growth mechanism could be utilized to propagate large numbers of pluripotent stem cells for therapeutic interventions.	[Hikita, Sherry T.; Kosik, Kenneth S.; Clegg, Dennis O.] Univ Calif Santa Barbara, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA; [Hikita, Sherry T.; Kosik, Kenneth S.; Clegg, Dennis O.] Univ Calif Santa Barbara, Dept Mol, Cellular & Dev Biol, Santa Barbara, CA USA; [Kosik, Kenneth S.; Clegg, Dennis O.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA USA; [Bamdad, Cynthia] Minerva Biotechnol, Waltham, MA USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hikita, ST (corresponding author), Univ Calif Santa Barbara, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA.	cbamdad@minervabio.com			W.M. Keck Foundation; California Institute for Regenerative Medicine; Advanced Cell Technology, Inc.; Chemicon / Millipore Corp.; TriCounties Blood Bank; Santa Barbara Cottage Hospital	W.M. Keck Foundation(W.M. Keck Foundation); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Advanced Cell Technology, Inc.; Chemicon / Millipore Corp.; TriCounties Blood Bank; Santa Barbara Cottage Hospital	Dr. Ken Kosik is supported in part by the W.M. Keck Foundation. The Center for Stem Cell Biology and Engineering was supported by grants from the California Institute for Regenerative Medicine, Advanced Cell Technology, Inc., Chemicon / Millipore Corp., the TriCounties Blood Bank, Santa Barbara Cottage Hospital, and private individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Baruch A, 1997, INT J CANCER, V71, P741; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Dalton S, 2008, REGEN MED, V3, P181, DOI 10.2217/17460751.3.2.181; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; DZIADEK MA, 1983, EMBO J, V2, P549, DOI 10.1002/j.1460-2075.1983.tb01461.x; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; HENDRIKA M, 1997, INT J CANCER, V72, P87; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kim YI, 2003, BIOCHEM BIOPH RES CO, V307, P281, DOI 10.1016/S0006-291X(03)01195-1; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Mountford JC, 2008, TRANSFUSION MED, V18, P1, DOI 10.1111/j.1365-3148.2007.00807.x; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Okabe-Kado J, 2002, LEUKEMIA LYMPHOMA, V43, P859, DOI 10.1080/10428190290017006; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; Thathiah A, 2003, J BIOL CHEM, V278, P3386, DOI 10.1074/jbc.M208326200; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	35	59	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3312	10.1371/journal.pone.0003312	http://dx.doi.org/10.1371/journal.pone.0003312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833326	Green Published, Green Submitted, gold			2022-12-25	WOS:000264797400001
J	Dominguez-Bello, MG; Perez, ME; Bortolini, MC; Salzano, FM; Pericchi, LR; Zambrano-Guzman, O; Linz, B				Dominguez-Bello, Maria G.; Perez, Maria E.; Bortolini, Maria C.; Salzano, Francisco M.; Pericchi, Luis R.; Zambrano-Guzman, Orlisbeth; Linz, Bodo			Amerindian Helicobacter pylori Strains Go Extinct, as European Strains Expand Their Host Range	PLOS ONE			English	Article								We studied the diversity of bacteria and host in the H. pylori-human model. The human indigenous bacterium H. pylori diverged along with humans, into African, European, Asian and Amerindian groups. Of these, Amerindians have the least genetic diversity. Since niche diversity widens the sets of resources for colonizing species, we predicted that the Amerindian H. pylori strains would be the least diverse. We analyzed the multilocus sequence (7 housekeeping genes) of 131 strains: 19 cultured from Africans, 36 from Spanish, 11 from Koreans, 43 from Amerindians and 22 from South American Mestizos. We found that all strains that had been cultured from Africans were African strains (hpAfrica1), all from Spanish were European (hpEurope) and all from Koreans were hspEAsia but that Amerindians and Mestizos carried mixed strains: hspAmerind and hpEurope strains had been cultured from Amerindians and hpEurope and hpAfrica1 were cultured from Mestizos. The least genetically diverse H. pylori strains were hspAmerind. Strains hpEurope were the most diverse and showed remarkable multilocus sequence mosaicism (indicating recombination). The lower genetic structure in hpEurope strains is consistent with colonization of a diversity of hosts. If diversity is important for the success of H. pylori, then the low diversity of Amerindian strains might be linked to their apparent tendency to disappear. This suggests that Amerindian strains may lack the needed diversity to survive the diversity brought by non-Amerindian hosts.	[Dominguez-Bello, Maria G.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Perez, Maria E.; Pericchi, Luis R.] Univ Puerto Rico, Dept Math, San Juan, PR 00936 USA; [Bortolini, Maria C.; Salzano, Francisco M.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Zambrano-Guzman, Orlisbeth] Univ Pedagogica Expt Libertador, Bilingual Intercult Dept, Puerto Ayacucho, Venezuela; [Linz, Bodo] Max Planck Inst Infektionsbiol, Dept Mol Biol, Berlin, Germany	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; Universidade Federal do Rio Grande do Sul; Max Planck Society	Dominguez-Bello, MG (corresponding author), Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA.	mgdbello@uprr.pr	Salzano, Francisco M/L-7916-2015; Pericchi, Luis/W-5342-2018; Perez, Maria-Eglee/W-3868-2017	Pericchi, Luis/0000-0002-7096-3596; Perez, Maria-Eglee/0000-0001-8641-8405	UPR intramural FIPI [880314]; BMBF [0313930B]	UPR intramural FIPI; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by UPR intramural FIPI grant 880314. B.L. was supported by ERA-Net grant BMBF 0313930B to Mark Achtman.	ACOSTA M, 2002, THESIS U CENTRAL VEN; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ARENDS T, 1992, ESTRUCTURA GENETICA; Armbrecht I, 2004, SCIENCE, V304, P284, DOI 10.1126/science.1094981; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; CASTRO D, 1993, B SOC ESP ANTROP BIO, V14, P21; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; DOMINGUEZBELLO MG, 2008, EVOLUTION HELICOBACT; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gandon S, 1998, TRENDS ECOL EVOL, V13, P214, DOI 10.1016/S0169-5347(98)01358-5; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Ghose C, 2005, J CLIN MICROBIOL, V43, P2635, DOI 10.1128/JCM.43.6.2635-2641.2005; Gonzalez M., 1997, EPE'97. 7th European Conference on Power Electronics and Applications, P78; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Horai S, 1996, AM J HUM GENET, V59, P579; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAYRISSE M, 1966, INDIAN SOC VENEZUELA; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Loureiro CL, 2002, J MED VIROL, V68, P357, DOI 10.1002/jmv.10211; MARTINEZ H, 2003, THESIS U CENTRAL VEN; MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124; PARSONNET J, 1994, WESTERN J MED, V161, P60; Picornell A, 2005, AM J PHYS ANTHROPOL, V128, P119, DOI 10.1002/ajpa.10423; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Reineking B, 2006, ECOL MODEL, V199, P486, DOI 10.1016/j.ecolmodel.2006.03.038; Rodriguez-Larralde A, 2001, INTERCIENCIA, V26, P8; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Torres MM, 2006, AM J HUM BIOL, V18, P59, DOI 10.1002/ajhb.20461; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Zambrano O., 2000, REV ESP ANTROP BIOL, V21, P111; ZAMBRANOGUZMAN O, 1999, THESIS U CENTRAL VEN	53	40	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3307	10.1371/journal.pone.0003307	http://dx.doi.org/10.1371/journal.pone.0003307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830403	Green Published, gold			2022-12-25	WOS:000264797300001
J	van Gorp, AGM; Vos, KED; Brenkman, AB; Bremer, A; van den Broek, N; Zwartkruis, F; Hershey, JW; Burgering, BMT; Calkhoven, CF; Coffer, PJ				van Gorp, A. G. M.; van der Vos, K. E.; Brenkman, A. B.; Bremer, A.; van den Broek, N.; Zwartkruis, F.; Hershey, J. W.; Burgering, B. M. T.; Calkhoven, C. F.; Coffer, P. J.			AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B	ONCOGENE			English	Article						eIF4B; mTOR; MEK; PKB; translation	MESSENGER-RNA TRANSLATION; HELICASE ACTIVITY; MTOR; CANCER; EIF4B; AKT; RECRUITMENT; DEFICIENCY; RAPAMYCIN; PEPTIDE	Eukaryotic translation initiation factor 4B (eIF4B) plays a critical role during the initiation of protein synthesis and its activity can be regulated by multiple phosphorylation events. In a search for novel protein kinase B (PKB/c-akt) substrates, we identified eIF4B as a potential target. Using an in vitro kinase assay, we found that PKB can directly phosphorylate eIF4B on serine 422 (ser422). Activation of a conditional PKB mutant, interleukin-3 (IL-3) or insulin stimulation resulted in PKB-dependent phosphorylation of this residue in vivo. This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 or pharmacological inhibition of PKB. Pretreatment of cells with rapamycin, inhibiting mTOR or U0126 to inhibit MEK, had little effect on eIF4B ser422 phosphorylation. In contrast, following amino-acid refeeding, eIF4B ser422 phosphorylation was found to be mammalian target of rapamycin (mTOR)-dependent. We further identified eIF4B ser406 as a novel mitogen-regulated phosphorylation site. Insulin-induced phosphorylation of eIF4B ser406 was dependent on both MEK and mTOR activity. Utilizing a novel translational control luciferase assay, we could further demonstrate that phosphorylation of ser406 or ser422 is essential for optimal translational activity of eIF4B. These data provide novel insights into complex multikinase regulation of eIF4B phosphorylation and reveal an important mechanism by which PKB can regulate translation, potentially critical for the transforming capacity of this AGC kinase family member.	[van Gorp, A. G. M.; van der Vos, K. E.; Coffer, P. J.] Univ Med Ctr Utrecht, Mol Immunol Lab, Dept Immunol, Utrecht, Netherlands; [Brenkman, A. B.; van den Broek, N.] Univ Med Ctr Utrecht, Dept Endocrinol & Metab Dis, Utrecht, Netherlands; [Bremer, A.; Calkhoven, C. F.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Zwartkruis, F.; Burgering, B. M. T.] Univ Med Ctr Utrecht, Dept Physiol Chem, Ctr Biomed Genet, Utrecht, Netherlands; [Hershey, J. W.] Univ Calif Davis, Dept Biol Chem, Sch Med, Davis, CA 95616 USA; [Coffer, P. J.] Univ Med Ctr Utrecht, Dept Pediat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Utrecht University; Utrecht University Medical Center; University of California System; University of California Davis; Utrecht University; Utrecht University Medical Center	Coffer, PJ (corresponding author), Univ Med Ctr, Mol Immunol Lab, Dept Immunol KC 020852, Lundlaan 6, NL-3584 CA Utrecht, Netherlands.	P.J.Coffer@umcutrecht.nl	Coffer, Paul/AAF-7970-2020; Coffer, Paul J/A-5769-2009	Calkhoven, Cornelis/0000-0001-6318-7210	Dutch Scientific Organization [917.36.316]	Dutch Scientific Organization(Netherlands Organization for Scientific Research (NWO))	AGM van Gorp and KE van der Vos were supported by a grant from the Dutch Scientific Organization (NWO; ZonMw 917.36.316).	BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; Calkhoven CF, 2000, GENE DEV, V14, P1920; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; DUNCAN R, 1985, J BIOL CHEM, V260, P5493; DUNCAN R, 1984, J BIOL CHEM, V259, P1882; GANI R, 1976, EXP CELL RES, V97, P249, DOI 10.1016/0014-4827(76)90614-5; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; LAWSON TG, 1989, BIOCHEMISTRY-US, V28, P4729, DOI 10.1021/bi00437a033; LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, MOL CELL BIOL, V16, P5328; Methot N, 1996, RNA, V2, P38; NARANDA T, 1994, J BIOL CHEM, V269, P14465; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pandolfi PP, 2004, ONCOGENE, V23, P3134, DOI 10.1038/sj.onc.1207618; Parker PJ, 2001, BIOCHEM SOC T, V29, P860, DOI 10.1042/0300-5127:0290860; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; van Gorp AGM, 2006, CANCER RES, V66, P10760, DOI 10.1158/0008-5472.CAN-06-1111; Wiesenthal V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj029; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200	42	61	62	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					95	106		10.1038/onc.2008.367	http://dx.doi.org/10.1038/onc.2008.367			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18836482				2022-12-25	WOS:000262294100010
J	Wang, JH; Palzkill, T; Chow, DC				Wang, Jihong; Palzkill, Timothy; Chow, Dar-Chone			Structural Insight into the Kinetics and Delta Cp of Interactions between TEM-1 beta-Lactamase and beta-Lactamase Inhibitory Protein (BLIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIMETRIC ENTHALPIES; CONTACT RESIDUES; GROWTH-HORMONE; PHAGE DISPLAY; VANT-HOFF; HOT-SPOT; BINDING; INTERFACE; THERMODYNAMICS; RECOGNITION	In a previous study, we examined thermodynamic parameters for 20 alanine mutants in beta-lactamase inhibitory protein( BLIP) for binding to TEM-1 beta-lactamase. Here we have determined the structures of two thermodynamically distinctive complexes of BLIP mutants with TEM-1 beta-lactamase. The complex BLIP Y51A-TEM-1 is a tight binding complex with the most negative binding heat capacity change ( Delta G = similar to-13 kcal mol(-1) and Delta Cp = similar to-0.8 kcal mol(-1) K-1) among all of the mutants, whereas BLIP W150A-TEM-1 is a weak complex with one of the least negative binding heat capacity changes (Delta G = similar to-8.5 kcal mol(-1) and Delta Cp = similar to-0.27 kcal mol(-1) K-1). We previously determined that BLIP Tyr(51) is a canonical and Trp(150) an anti-canonical TEM-1-contact residue, where canonical refers to the alanine substitution resulting in a matched change in the hydrophobicity of binding free energy. Structure determination indicates a rearrangement of the interactions between Asp(49) of the W150A BLIP mutant and the catalytic pocket of TEM-1. The Asp(49) of W150A moves more than 4 angstrom to form two new hydrogen bonds while losing four original hydrogen bonds. This explains the anti-canonical nature of the Trp(150) to alanine substitution, and also reveals a strong long distance coupling between Trp(150) and Asp(49) of BLIP, because these two residues are more than 25 angstrom apart. Kinetic measurements indicate that the mutations influence the dissociation rate but not the association rate. Further analysis of the structures indicates that an increased number of interface-trapped water molecules correlate with poor interface packing in a mutant. It appears that the increase of interface-trapped water molecules is inversely correlated with negative binding heat capacity changes.	[Wang, Jihong; Chow, Dar-Chone] Univ Houston, Dept Chem, Houston, TX 77204 USA; [Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine	Chow, DC (corresponding author), Univ Houston, Dept Chem, Univ Pk, Houston, TX 77204 USA.	dchow@mail.uh.edu			American Heart Association [0435186N]; University of Houston; Institute for Molecular Design; National Institutes of Health [AI32956]; National Science Foundation [DBI-9871464]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032956, R37AI032956] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Houston; Institute for Molecular Design; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Scientist Development Grant 0435186N from the American Heart Association and startup funding from University of Houston and the Institute for Molecular Design ( to D. C.). This work was also supported in part by National Institutes of Health Grant AI32956 ( to T. P.). Data used in this publication were collected at the Gulf Coast Protein Crystallography Beamline at the Center for Advanced Microstructures and Devices. This beamline is supported by the National Science Foundation Grant DBI-9871464 with co-funding from the National Institutes of Health ( NIGMS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albeck S, 1999, BIOCHEMISTRY-US, V38, P11, DOI 10.1021/bi981772z; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Cantu C, 1997, J BIOL CHEM, V272, P29144, DOI 10.1074/jbc.272.46.29144; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Dauter Z, 2003, METHOD ENZYMOL, V368, P288, DOI 10.1016/S0076-6879(03)68016-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fletcher S, 2007, CURR TOP MED CHEM, V7, P922, DOI 10.2174/156802607780906735; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; GOMEZ J, 1995, J MOL BIOL, V252, P337, DOI 10.1006/jmbi.1995.0501; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIBBITS KA, 1994, BIOCHEMISTRY-US, V33, P3584, DOI 10.1021/bi00178a015; Horn JR, 2001, BIOCHEMISTRY-US, V40, P1774, DOI 10.1021/bi002408e; Horn JR, 2002, BIOCHEMISTRY-US, V41, P7501, DOI 10.1021/bi025626b; Huang WZ, 2000, J BIOL CHEM, V275, P14964, DOI 10.1074/jbc.M001285200; Huang WZ, 2003, PROTEIN ENG, V16, P853, DOI 10.1093/protein/gzg108; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikura T, 2004, CHEM PHYS, V307, P111, DOI 10.1016/j.chemphys.2004.05.010; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Janin J, 2008, SCIENCE, V319, P165, DOI 10.1126/science.1152930; Janin J, 2007, ACTA CRYSTALLOGR D, V63, P1, DOI 10.1107/S090744490603575X; Kouadio JLK, 2005, J BIOL CHEM, V280, P25524, DOI 10.1074/jbc.M502167200; Ladbury JE, 2004, CURR OPIN STRUC BIOL, V14, P562, DOI 10.1016/j.sbi.2004.08.001; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Majiduddin FK, 2002, INT J MED MICROBIOL, V292, P127, DOI 10.1078/1438-4221-00198; MURPHY KP, 1993, PROTEINS, V15, P113, DOI 10.1002/prot.340150203; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearce KH, 1996, BIOCHEMISTRY-US, V35, P10300, DOI 10.1021/bi960513b; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Reichmann D, 2008, BIOCHEMISTRY-US, V47, P1051, DOI 10.1021/bi7019639; Reynolds KA, 2006, J BIOL CHEM, V281, P26745, DOI 10.1074/jbc.M603878200; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Rudgers GW, 2001, PROTEIN ENG, V14, P487, DOI 10.1093/protein/14.7.487; Rudgers GW, 2001, ANTIMICROB AGENTS CH, V45, P3279, DOI 10.1128/AAC.45.12.3279-3286.2001; SCHWARZ FP, 1995, EUR J BIOCHEM, V228, P388; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Sundberg EJ, 2000, BIOCHEMISTRY-US, V39, P15375, DOI 10.1021/bi000704l; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; TSUMOTO K, 1994, J BIOL CHEM, V269, P28777; Wang JH, 2007, J BIOL CHEM, V282, P17676, DOI 10.1074/jbc.M611548200; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Whitty A, 2006, NAT CHEM BIOL, V2, P112, DOI 10.1038/nchembio0306-112; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Zhang Z, 2004, J BIOL CHEM, V279, P42860, DOI 10.1074/jbc.M406157200; Zhang Z, 2003, J BIOL CHEM, V278, P45706, DOI 10.1074/jbc.M308572200	60	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					595	609		10.1074/jbc.M804089200	http://dx.doi.org/10.1074/jbc.M804089200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18840610	hybrid, Green Published			2022-12-25	WOS:000261974800065
J	Errasti-Murugarren, E; Molina-Arcas, M; Casado, FJ; Pastor-Anglada, M				Errasti-Murugarren, Ekaitz; Molina-Arcas, Miriam; Casado, Fco Javier; Pastor-Anglada, Marcal			A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum	FASEB JOURNAL			English	Article						alternative splicing; CNT; protein turnover	CHRONIC LYMPHOCYTIC-LEUKEMIA; FUNCTIONAL-CHARACTERIZATION; RAT-LIVER; SUBCELLULAR-LOCALIZATION; MAMMALIAN-CELLS; PLASMA-MEMBRANE; EXPRESSION; COTRANSPORTER; DIFFERENTIATION; IDENTIFICATION	Nucleoside transporters are plasma membrane proteins essential for nucleoside salvage. Among them, human concentrative nucleoside transporter 3 (hCNT3, SLC28A3) plays an essential role in this process because of its broader substrate selectivity and higher concentrative ability than the other members of the SLC28 protein family, hCNT1 and hCNT2. The aim of this study was to characterize an isoform of hCNT3, encoded by an alternatively spliced SLC28A3-related mRNA, the first identified for a CNT protein. This variant, named hCNT3ins, is the result of the insertion of 176 bp corresponding to an intron located between exons 2 and 3 of the gene. This insertion results in a shift of the reading frame, yielding a protein lacking 69 residues of the N terminus. hCNT3 and hCNT3ins mRNAs are simultaneously expressed both in normal and transformed cells and are differentially regulated by activation and differentiation. Because of the N-terminal deletion, hCNT3ins is retained in the endoplasmic reticulum, where it shows a typical hCNT3-related activity. hCNT3ins exhibits a shorter half-life than its plasma membrane counterpart, being degraded via a proteasome-dependent pathway. We suggest that this novel hCNT3 isoform would be involved in the salvage of intracellular nucleosides from the lumen of the endoplasmic reticulum to the cytoplasm.-Errasti-Murugarren, E., Molina-Arcas, M., Casado, F. J., Pastor-Anglada, M. A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum. FASEB J. 23, 172-182 (2009)	[Errasti-Murugarren, Ekaitz; Molina-Arcas, Miriam; Casado, Fco Javier; Pastor-Anglada, Marcal] Univ Barcelona, Dept Bioquim & Biol Mol, Fac Biol, Inst Biomed,CIBER EHD, E-08028 Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona	Pastor-Anglada, M (corresponding author), Univ Barcelona, Dept Bioquim & Biol Mol, Fac Biol, Inst Biomed,CIBER EHD, Avda Diagonal 645, E-08028 Barcelona, Spain.	mpastor@ub.edu	Molina-Arcas, Miriam/R-4908-2019; Errasti-Murugarren, Ekaitz/G-9723-2015; Pastor Anglada, Marcal/C-3730-2017	Molina-Arcas, Miriam/0000-0002-8176-8948; Errasti-Murugarren, Ekaitz/0000-0002-6054-7900; Pastor Anglada, Marcal/0000-0003-3712-1773; Casado Merediz, Francisco Javier/0000-0003-0192-841X	Fondo de Investigaciones Sanitarias; Ministerio de Sanidad y Consumo [PI-020934]; Ministerio de Educacion y Ciencia [BFU2006-07556/BFI]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia e Innovacion [SAF2005-01259, SAF2008-00577]; Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE); Centro de Investigacion Biomedica en Red (CIBER-EHD); Ministerio de Sanidad y Consumo, and Departament d'Universitats, Recerca i Socitat de la Informacio (DURSI); Generalitat de Catalunya [2005SGR00315]; Ministerio de Educacion y Ciencia	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia e Innovacion(Spanish Government); Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE); Centro de Investigacion Biomedica en Red (CIBER-EHD); Ministerio de Sanidad y Consumo, and Departament d'Universitats, Recerca i Socitat de la Informacio (DURSI); Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by grants from Fondo de Investigaciones Sanitarias, Ministerio de Sanidad y Consumo (PI-020934), Ministerio de Educacion y Ciencia (BFU2006-07556/BFI), and Fundacion Ramon Areces to F.J.C.; and from Ministerio de Educacion y Ciencia e Innovacion (SAF2005-01259 and SAF2008-00577), Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE), Centro de Investigacion Biomedica en Red (CIBER-EHD), Ministerio de Sanidad y Consumo, and Departament d'Universitats, Recerca i Socitat de la Informacio (DURSI), Generalitat de Catalunya (2005SGR00315) to M.P.-A. E.E.-M. was the recipient of a Formacion de Profesorado Universitario (FPU) fellowship from Ministerio de Educacion y Ciencia.	Alfalah M, 2006, J BIOL CHEM, V281, P11894, DOI 10.1074/jbc.M511364200; Ayalon-Soffer M, 1999, FEBS LETT, V460, P112, DOI 10.1016/S0014-5793(99)01321-6; Badagnani I, 2005, PHARMACOGENOMICS J, V5, P157, DOI 10.1038/sj.tpj.6500303; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Banhegyi G, 1997, J BIOL CHEM, V272, P13584, DOI 10.1074/jbc.272.21.13584; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; BISCHOFF E, 1975, EUR J BIOCHEM, V51, P353, DOI 10.1111/j.1432-1033.1975.tb03935.x; BISCHOFF E, 1976, EUR J BIOCHEM, V62, P279, DOI 10.1111/j.1432-1033.1976.tb10158.x; Damaraju S, 2005, PHARMACOGENET GENOM, V15, P173, DOI 10.1097/01213011-200503000-00006; Duflot S, 2004, MOL CELL BIOL, V24, P2710, DOI 10.1128/MCB.24.7.2710-2719.2004; Duflot S, 2002, EXP CELL RES, V281, P77, DOI 10.1006/excr.2002.5641; Errasti-Murugarren E, 2008, MOL PHARMACOL, V73, P379, DOI 10.1124/mol.107.041848; Failer BU, 2002, J BIOL CHEM, V277, P36978, DOI 10.1074/jbc.M201656200; Fernandez-Veledo S, 2006, BIOCHEM J, V395, P337, DOI 10.1042/BJ20051232; FRANCO R, 1986, NEUROCHEM RES, V11, P407, DOI 10.1007/BF00965015; Gloeckner-Hofmann K, 2006, ONCOLOGY-BASEL, V70, P238, DOI 10.1159/000094541; GOLDFISC.S, 1971, J HISTOCHEM CYTOCHEM, V19, P349, DOI 10.1177/19.6.349; Gorner K, 2004, J BIOL CHEM, V279, P6943, DOI 10.1074/jbc.M309204200; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; Handa M, 2001, GENE, V262, P301, DOI 10.1016/S0378-1119(00)00555-2; Harris MJ, 2004, J GASTROEN HEPATOL, V19, P819, DOI 10.1111/j.1440-1746.2004.03347.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hu HK, 2006, MOL PHARMACOL, V69, P1542, DOI 10.1124/mol.105.018945; Kabuss R, 2005, GLYCOBIOLOGY, V15, P905, DOI 10.1093/glycob/cwi085; Kapetanovich L, 2005, MOL BIOL CELL, V16, P835, DOI 10.1091/mbc.e04-09-0785; Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200; Leuzzi R, 2001, BIOCHEM J, V357, P557, DOI 10.1042/0264-6021:3570557; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Mackey JR, 2005, BLOOD, V105, P767, DOI 10.1182/blood-2004-03-1046; Mangravite LM, 2003, AM J PHYSIOL-RENAL, V284, pF902, DOI 10.1152/ajprenal.00215.2002; Mani RS, 1998, J BIOL CHEM, V273, P30818, DOI 10.1074/jbc.273.46.30818; Minuesa G, 2008, J PHARMACOL EXP THER, V324, P558, DOI 10.1124/jpet.107.131482; Molina-Arcas M, 2003, BLOOD, V101, P2328, DOI 10.1182/blood-2002-07-2236; Molina-Arcas M, 2005, LEUKEMIA, V19, P64, DOI 10.1038/sj.leu.2403582; Monni M, 2001, EUR J BIOCHEM, V268, P2020, DOI 10.1046/j.1432-1327.2001.02079.x; Ngo LY, 2001, AM J PHYSIOL-GASTR L, V280, pG475, DOI 10.1152/ajpgi.2001.280.3.G475; PASYK EA, 1995, J BIOL CHEM, V270, P12347, DOI 10.1074/jbc.270.21.12347; REESJONES R, 1984, BIOCHEMISTRY-US, V23, P2236, DOI 10.1021/bi00305a022; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Rodriguez-Mulero S, 2005, KIDNEY INT, V68, P665, DOI 10.1111/j.1523-1755.2005.00444.x; Rubio-Aliaga I, 2004, J BIOL CHEM, V279, P2754, DOI 10.1074/jbc.M305556200; RUIZMONTASELL B, 1992, J MEMBRANE BIOL, V128, P227; Slugoski MD, 2008, J BIOL CHEM, V283, P24922, DOI 10.1074/jbc.M801793200; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Toan SV, 2003, PFLUG ARCH EUR J PHY, V447, P195, DOI 10.1007/s00424-003-1166-0; Villanueva A, 1998, ONCOGENE, V17, P1969, DOI 10.1038/sj.onc.1202118; WACHSTEIN M, 1964, J HISTOCHEM CYTOCHEM, V12, P40, DOI 10.1177/12.1.40; Wang YJ, 2003, J CELL BIOCHEM, V88, P1012, DOI 10.1002/jcb.10451; Wu SK, 2005, J DRUG TARGET, V13, P521, DOI 10.1080/10611860500403099	52	33	33	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					172	182		10.1096/fj.08-113902	http://dx.doi.org/10.1096/fj.08-113902			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18827020				2022-12-25	WOS:000262095500020
J	Blokzijl, H; Van Steenpaal, A; Borght, SV; Bok, LIH; Libbrecht, L; Tamminga, M; Geuken, M; Roskams, TAD; Dijkstra, G; Moshage, H; Jansen, PLM; Faber, KN				Blokzijl, Hans; Van Steenpaal, Axel; Borght, Sara Vander; Bok, Lisette I. H.; Libbrecht, Louis; Tamminga, Marieke; Geuken, Mariska; Roskams, Tania A. D.; Dijkstra, Gerard; Moshage, Han; Jansen, Peter L. M.; Faber, Klaas Nico			Up-regulation and Cytoprotective Role of Epithelial Multidrug Resistance-associated Protein 1 in Inflammatory Bowel Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; P-GLYCOPROTEIN; ULCERATIVE-COLITIS; INDUCED APOPTOSIS; DRUG-RESISTANCE; EXPRESSION; GENE; GLUTATHIONE; TRANSPORT; MDR1	MRP1 (multidrug resistance-associated protein 1) is well known for its role in providing multidrug resistance to cancer cells. In addition, MRP1 has been associated with both pro- and anti-inflammatory functions in nonmalignant cells. The pro- inflammatory function is evident from the fact that MRP1 is a high affinity transporter for cysteinyl-leukotriene C-4 (LTC4), a lipid mediator of inflammation. It remains unexplained, however, why the absence of Mrp1 leads to increased intestinal epithelial damage in mice treated with dextran-sodium sulfate, a model for inflammatory bowel disease (IBD). We found that MRP1 expression is induced in the inflamed intestine of IBD patients, e. g. Crohn disease and ulcerative colitis. Increased MRP1 expression was detected at the basolateral membrane of intestinal epithelial cells. To study a putative role for MRP1 in protecting epithelial cells against inflammatory cues, we manipulated MRP1 levels in human epithelial DLD-1 cells and exposed these cells to cytokines and anti-Fas. Inhibition of MRP1 (by MK571 or RNA interference) resulted in increased cytokine- and anti-Fas-induced apoptosis of DLD-1 cells. Opposite effects, e. g. protection of DLD-1 cells against cytokine- and anti-Fas-induced apoptosis, were observed after recombinant MRP1 overexpression. Inhibition of LTC4 synthesis reduced anti-Fas-induced apoptosis when MRP1 function was blocked, suggesting that LTC4 is the pro- apoptotic compound exported by epithelial MRP1 during inflammation. These data show that MRP1 protects intestinal epithelial cells against inflammation-induced apoptotic cell death and provides a functional role for MRP1 in the inflamed intestinal epithelium of IBD patients.	[Blokzijl, Hans; Van Steenpaal, Axel; Bok, Lisette I. H.; Tamminga, Marieke; Geuken, Mariska; Dijkstra, Gerard; Moshage, Han; Faber, Klaas Nico] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands; [Borght, Sara Vander; Libbrecht, Louis; Roskams, Tania A. D.] Univ Leuven, Dept Pathol, B-3000 Louvain, Belgium; [Jansen, Peter L. M.] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; KU Leuven; University of Amsterdam; Academic Medical Center Amsterdam	Faber, KN (corresponding author), POB 30-001, NL-9700 RB Groningen, Netherlands.	k.n.faber@med.umcg.nl	Jansen, Peter LM/I-4509-2013	/0000-0003-4563-7462; Moshage, Han/0000-0002-4764-0246; Roskams, Tania/0000-0002-2816-1530				Albermann N, 2005, BIOCHEM PHARMACOL, V70, P949, DOI 10.1016/j.bcp.2005.06.018; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Blokzijl H, 2007, INFLAMM BOWEL DIS, V13, P710, DOI 10.1002/ibd.20088; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4; Brant SR, 2003, AM J HUM GENET, V73, P1282, DOI 10.1086/379927; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Dijkstra G, 2004, J PATHOL, V204, P296, DOI 10.1002/path.1656; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Flens MJ, 1996, AM J PATHOL, V148, P1237; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hammond CL, 2001, J HEPATOL, V34, P946, DOI 10.1016/S0168-8278(01)00037-X; Han SY, 2000, BIOL PHARM BULL, V23, P420; Hayashi H, 1998, APOPTOSIS, V3, P431, DOI 10.1023/A:1009662619907; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Kwak JY, 2000, CELL IMMUNOL, V203, P84, DOI 10.1006/cimm.2000.1682; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Luo M, 2003, HISTOL HISTOPATHOL, V18, P587, DOI 10.14670/HH-18.587; Michalsky MP, 2001, J PEDIATR SURG, V36, P1130, DOI 10.1053/jpsu.2001.25730; Nies AT, 2008, EXPERT OPIN DRUG MET, V4, P545, DOI [10.1517/17425255.4.5.545, 10.1517/17425255.4.5.545 ]; NISHIKAWA M, 1995, J GASTROENTEROL, V30, P34, DOI 10.1007/BF01211372; Panwala CM, 1998, J IMMUNOL, V161, P5733; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Plass JRM, 2002, HEPATOLOGY, V35, P589, DOI 10.1053/jhep.2002.31724; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; Ros JE, 2003, J PATHOL, V200, P553, DOI 10.1002/path.1379; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Scheffer GL, 2000, CANCER RES, V60, P5269; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Sharma J. N., 2006, Inflammopharmacology, V14, P10, DOI 10.1007/s10787-006-1496-6; Strater J, 1997, GASTROENTEROLOGY, V113, P160, DOI 10.1016/S0016-5085(97)70091-X; Strater J, 2000, ANN NY ACAD SCI, V915, P162; Taketo MM, 2002, BBA-MOL CELL BIOL L, V1585, P72, DOI 10.1016/S1388-1981(02)00326-8; Ten Hove T, 2002, DIGEST DIS SCI, V47, P2056, DOI 10.1023/A:1019629013945; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Van Limbergen J, 2007, AM J GASTROENTEROL, V102, P2820, DOI 10.1111/j.1572-0241.2007.01527.x; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Vander Borght S, 2005, J PATHOL, V207, P471, DOI 10.1002/path.1852; VANDULLEMEN H, 1997, SCAND J GASTROENTERO, V223, pS92; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Yukawa M, 2002, INT J COLORECTAL DIS, V17, P70, DOI 10.1007/s003840100340; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	51	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35630	35637		10.1074/jbc.M804374200	http://dx.doi.org/10.1074/jbc.M804374200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18838379	hybrid			2022-12-25	WOS:000261687900036
J	Ransom, JF; King, IN; Garg, V; Srivastava, D				Ransom, Joshua F.; King, Isabelle N.; Garg, Vidu; Srivastava, Deepak			A Rare Human Sequence Variant Reveals Myocardin Autoinhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MUSCLE GENE-EXPRESSION; TRANSCRIPTION FACTOR-B; CARDIOVASCULAR DEVELOPMENT; DIFFERENTIATION; HEART; COACTIVATORS; HYPERTROPHY; REQUIREMENT; MODULATION	Myocardin (MYOCD) is a transcriptional co-activator that promotes cardiac or smooth muscle gene programs through its interaction with myocyte-enhancing factor (MEF2) or serumresponse factor (SRF). Isoforms of MYOCD with a truncated amino terminus show increased activity when compared with those with the full-length amino terminus, but how this is achieved remains unknown. We identified a rare human sequence variation in MYOCD in a patient with congenital heart disease that resulted in a missense mutation at codon 259 (K259R). This variation created a hypomorphic cardiac isoform with impaired SRF binding and transactivation capacity but did not impair the smooth muscle isoform of MYOCD, which lacks the amino terminus. Consistent with differential effects of the amino terminus on the K259R mutation, we found that the cardiac-specific amino terminus acted in an autoinhibitory fashion to bind MYOCD via specific negatively charged residues and thereby repressed SRF-dependent MYOCD activity. This effect was exaggerated in the MYOCD-K259R mutant. The amino terminus was sufficient to impair MYOCD-dependent fibroblast conversion into smooth muscle cells as well as cardiomyocyte hypertrophy. These findings identify a novel mechanism that regulates levels of MYOCD-dependent activation of the SRF genetic program differentially in cardiac and smooth muscle.	[Ransom, Joshua F.; King, Isabelle N.; Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ransom, Joshua F.; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Ransom, Joshua F.; King, Isabelle N.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Garg, Vidu] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Garg, Vidu] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	Garg, Vidu/E-3101-2011; Garg, Vidu/D-8240-2012	Garg, Vidu/0000-0002-3778-5927; Ransom, Joshua/0000-0002-3591-0288	National Institutes of Health [R01 HL080592]; University of Texas Southwestern Cardiovascular Training [5-T32-HL007360]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079260, T32HL007360, R01HL080592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Cardiovascular Training; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL080592 and by University of Texas Southwestern Cardiovascular Training Grant NIH 5-T32-HL007360. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Oh J, 2004, MOL CELL BIOL, V24, P8519, DOI 10.1128/MCB.24.19.8519-8528.2004; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Peterson JR, 2004, J CELL BIOCHEM, V93, P68, DOI 10.1002/jcb.20184; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	28	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35845	35852		10.1074/jbc.M805909200	http://dx.doi.org/10.1074/jbc.M805909200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18852265	hybrid, Green Published			2022-12-25	WOS:000261687900059
J	Tanuma, N; Kim, SE; Beullens, M; Tsubaki, Y; Mitsuhashi, S; Nomura, M; Kawamura, T; Isono, K; Koseki, H; Sato, M; Bollen, M; Kikuchi, K; Shima, H				Tanuma, Nobuhiro; Kim, Sei-Eun; Beullens, Monique; Tsubaki, Yao; Mitsuhashi, Shinya; Nomura, Miyuki; Kawamura, Takeshi; Isono, Kyoichi; Koseki, Haruhiko; Sato, Masami; Bollen, Mathieu; Kikuchi, Kunimi; Shima, Hiroshi			Nuclear Inhibitor of Protein Phosphatase-1 (NIPP1) Directs Protein Phosphatase-1 (PP1) to Dephosphorylate the U2 Small Nuclear Ribonucleoprotein Particle (snRNP) Component, Spliceosome-associated Protein 155 (Sap155)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; C-TERMINUS; IN-VIVO; PHOSPHORYLATION; KINASE; REGULATOR; INACTIVATION; EXPRESSION; COMPLEX; BINDS	Pre-mRNA splicing entails reversible phosphorylation of spliceosomal proteins. Recent work has revealed essential roles for Ser/Thr phosphatases, such as protein phosphatase-1 (PP1), in splicing, but how these phosphatases are regulated is largely unknown. We show that nuclear inhibitor of PP1 (NIPP1), a major PP1 interactor in the vertebrate nucleus, recruits PP1 to Sap155 (spliceosome-associated protein 155), an essential component of U2 small nuclear ribonucleoprotein particles, and promotes Sap155 dephosphorylation. C-terminally truncated NIPP1 (NIPP1-Delta C) formed a hyper-active holoenzyme with PP1, rendering PP1 minimally phosphorylated on an inhibitory site. Forced expression of NIPP1-WT and -Delta C resulted in slight and severe decreases in Sap155 hyperphosphorylation, respectively, and the latter was accompanied with inhibition of splicing. PP1 overexpression produced similar effects, whereas small interfering RNA-mediated NIPP1 knockdown enhanced Sap155 hyperphosphorylation upon okadaic acid treatment. NIPP1 did not inhibit but rather stimulated Sap155 dephosphorylation by PP1 in vitro through facilitating Sap155/PP1 interaction. Further analysis revealed that NIPP1 specifically recognizes hyperphosphorylated Sap155 thorough its Forkhead-associated domain and dissociates from Sap155 after dephosphorylation by associated PP1. Thus NIPP1 works as a molecular sensor for PP1 to recognize phosphorylated Sap155.	[Tanuma, Nobuhiro; Nomura, Miyuki; Sato, Masami; Shima, Hiroshi] Miyagi Canc Ctr, Res Inst, Div Canc Chemotherapy, Natori, Miyagi 9811293, Japan; [Tanuma, Nobuhiro; Kim, Sei-Eun; Tsubaki, Yao; Mitsuhashi, Shinya; Kikuchi, Kunimi] Hokkaido Univ, Inst Med Genet, Div Biochem Oncol & Immunol, Sapporo, Hokkaido 0600815, Japan; [Mitsuhashi, Shinya] Hokkaido Univ, Res Fac Agr, Div Appl Biosci, Sapporo, Hokkaido 0600815, Japan; [Beullens, Monique; Bollen, Mathieu] Katholieke Univ Leuven, Fac Med, Lab Biosignaling & Therapeut, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Kawamura, Takeshi] Univ Tokyo, RCAST, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Isono, Kyoichi; Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan	Miyagi Cancer Center; Hokkaido University; Hokkaido University; KU Leuven; University of Tokyo; RIKEN	Tanuma, N (corresponding author), Miyagi Canc Ctr, Res Inst, Div Canc Chemotherapy, Natori, Miyagi 9811293, Japan.	tanuma-no872@pref.miyagi.jp; shima-hi632@pref.miyagi.jp	Koseki, Haruhiko/I-3825-2014; Mitsuhashi, Shinya/A-4337-2012	Koseki, Haruhiko/0000-0001-8424-5854; Isono, Kyoichi/0000-0002-4609-8985	Japan Society for the Promotion of Science of Japan	Japan Society for the Promotion of Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research (B and C) provided by the Japan Society for the Promotion of Science of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Banerjee H, 2004, RNA, V10, P240, DOI 10.1261/rna.5153204; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; BEULLENS M, 1993, J BIOL CHEM, V268, P13172; Beullens M, 2002, J BIOL CHEM, V277, P19855, DOI 10.1074/jbc.M200847200; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Boudrez A, 2002, J BIOL CHEM, V277, P31834, DOI 10.1074/jbc.M204427200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; Friend K, 2007, MOL CELL, V28, P240, DOI 10.1016/j.molcel.2007.09.026; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Johnson D, 1997, EUR J BIOCHEM, V244, P931, DOI 10.1111/j.1432-1033.1997.00931.x; Kim SE, 2000, INT J ONCOL, V16, P751; Kumeta H, 2008, J BIOMOL NMR, V40, P219, DOI 10.1007/s10858-008-9222-x; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Misteli T, 1999, CURR BIOL, V9, pR198, DOI 10.1016/S0960-9822(99)80128-6; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; TAKIZAWA N, 1994, J BIOCHEM-TOKYO, V116, P411, DOI 10.1093/oxfordjournals.jbchem.a124540; Tran HT, 2004, MOL CELL PROTEOMICS, V3, P257, DOI 10.1074/mcp.M300115-MCP200; Trinkle-Mulcahy L, 1999, J CELL SCI, V112, P157; Van Eynde A, 2004, MOL CELL BIOL, V24, P5863, DOI 10.1128/MCB.24.13.5863-5874.2004; VAN EYNDE A, 1994, BIOCHEM J, V297, P447, DOI 10.1042/bj2970447; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Weiser DC, 2004, J BIOL CHEM, V279, P48904, DOI 10.1074/jbc.M404416200; YAMANO H, 1994, EMBO J, V13, P5310, DOI 10.1002/j.1460-2075.1994.tb06865.x; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	41	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35805	35814		10.1074/jbc.M805468200	http://dx.doi.org/10.1074/jbc.M805468200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18842582	hybrid			2022-12-25	WOS:000261687900055
J	Lei, XY; Zhang, S; Bohrer, A; Ramanadham, S				Lei, Xiaoyong; Zhang, Sheng; Bohrer, Alan; Ramanadham, Sasanka			Calcium-independent Phospholipase A(2) (iPLA(2)beta)-mediated Ceramide Generation Plays a Key Role in the Cross-talk between the Endoplasmic Reticulum (ER) and Mitochondria during ER Stress-induced Insulin-secreting Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; CYTOCHROME-C RELEASE; TYPE-2 DIABETES-MELLITUS; TANDEM MASS-SPECTROMETRY; SARCOENDOPLASMIC RETICULUM; CASPASE-12 ACTIVATION; ARACHIDONIC-ACID; OXIDATIVE STRESS; PATHWAY; ISLETS	Endoplasmic reticulum ( ER) stress induces INS-1 cell apoptosis by a pathway involving Ca2+-independent phospholipase A(2) (iPLA(2)beta)-mediated ceramide generation, but the mechanism by which iPLA(2)beta and ceramides contribute to apoptosis is not well understood. We report here that both caspase-12 and caspase-3 are activated in INS-1 cells following induction of ER stress with thapsigargin, but only caspase-3 cleavage is amplified in iPLA(2)beta overexpressing INS-1 cells (OE), relative to empty vector-transfected cells, and is suppressed by iPLA(2)beta inhibition. ER stress also led to the release of cytochrome c and Smac and, unexpectedly, their accumulation in the cytosol is amplified in OE cells. These findings raise the likelihood that iPLA(2)beta participates in ER stress-induced apoptosis by activating the intrinsic apoptotic pathway. Consistent with this possibility, we find that ER stress promotes iPLA(2)beta accumulation in the mitochondria, opening of mitochondrial permeability transition pore, and loss in mitochondrial membrane potential (Delta Psi) in INS-1 cells and that these changes are amplified in OE cells. ER stress also led to greater ceramide generation in ER and mitochondria fractions of OE cells. Exposure to ceramide alone induces loss in Delta Psi and apoptosis and these are suppressed by forskolin. ER stress-induced mitochondrial dysfunction and apoptosis are also inhibited by forskolin, as well as by inactivation of iPLA(2)beta or NSMase, suggesting that iPLA(2)beta-mediated generation of ceramides via sphingomyelin hydrolysis during ER stress affect the mitochondria. In support, inhibition of iPLA(2)beta or NSMase prevents cytochrome c release. Collectively, our findings indicate that the iPLA(2)beta-ceramide axis plays a critical role in activating the mitochondrial apoptotic pathway in insulin-secreting cells during ER stress.	[Lei, Xiaoyong; Zhang, Sheng; Bohrer, Alan; Ramanadham, Sasanka] Washington Univ, Sch Med, Dept Med, Mass Spectrometry Resource & Div Endocrinol Metab, St Louis, MO 63110 USA	Washington University (WUSTL)	Ramanadham, S (corresponding author), Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	sramanad@dom.wustl.edu			National Institutes of Health [R01-DK69455, R37-DK34388, P41-RR00954, P60-DK20579, P30DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, R01DK069455, P60DK020579, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK69455, R37-DK34388, P41-RR00954, P60-DK20579, and P30DK56341. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; CORBETT JA, 1992, DIABETES, V41, P897, DOI 10.2337/diabetes.41.8.897; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; Darios F, 2003, J NEUROCHEM, V84, P643, DOI 10.1046/j.1471-4159.2003.01590.x; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Di Sano F, 2006, J BIOL CHEM, V281, P2693, DOI 10.1074/jbc.M509110200; Diaz-Horta O, 2002, DIABETES, V51, P1815, DOI 10.2337/diabetes.51.6.1815; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Falluel-Morel A, 2004, J NEUROCHEM, V91, P1231, DOI 10.1111/j.1471-4159.2004.02810.x; Fensome AC, 2002, BIOCHEM J, V365, P69, DOI 10.1042/BJ20020120; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gijon MA, 1997, SEMIN CELL DEV BIOL, V8, P297, DOI 10.1006/scdb.1997.0151; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Hajnoczky G, 2000, J PHYSIOL-LONDON, V529, P69, DOI 10.1111/j.1469-7793.2000.00069.x; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hasenjager A, 2004, ONCOGENE, V23, P4523, DOI 10.1038/sj.onc.1207594; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P437, DOI 10.1016/S1044-0305(99)00150-6; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kong JY, 2005, MOL CELL BIOCHEM, V278, P39, DOI 10.1007/s11010-005-1979-6; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KRONCKE KD, 1993, BIOCHIM BIOPHYS ACTA, V1182, P221, DOI 10.1016/0925-4439(93)90144-P; Kudva Yogish C., 1997, P119; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ma ZM, 1997, J BIOL CHEM, V272, P11118; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Morales MC, 2007, FREE RADICAL RES, V41, P591, DOI 10.1080/10715760701218558; Muranaka S, 2004, FREE RADICAL RES, V38, P613, DOI 10.1080/10715760410001694035; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Predescu SA, 2007, J BIOL CHEM, V282, P17166, DOI 10.1074/jbc.M608996200; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Rath GM, 2006, INT J BIOCHEM CELL B, V38, P2219, DOI 10.1016/j.biocel.2006.07.004; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shiraishi H, 2006, J CELL SCI, V119, P3958, DOI 10.1242/jcs.03160; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Socha L, 2003, ANN NY ACAD SCI, V1005, P178, DOI 10.1196/annals.1288.022; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; TAMIYAKOIZUMI K, 1989, J BIOCHEM, V106, P593, DOI 10.1093/oxfordjournals.jbchem.a122901; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Turk J, 2004, CAN J PHYSIOL PHARM, V82, P824, DOI 10.1139/Y04-064; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Wilkins WP, 2008, CURR DRUG TARGETS, V9, P683, DOI 10.2174/138945008785132385; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	83	76	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34819	34832		10.1074/jbc.M807409200	http://dx.doi.org/10.1074/jbc.M807409200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936091	Green Published, hybrid			2022-12-25	WOS:000261469100038
J	Wang, KP; Wang, CH; Xiao, F; Wang, HX; Wu, ZG				Wang, Kepeng; Wang, Chihao; Xiao, Fang; Wang, Haixia; Wu, Zhenguo			JAK2/STAT2/STAT3 Are Required for Myogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; SATELLITE CELL-PROLIFERATION; EMBRYONIC STEM-CELLS; GROWTH-FACTOR-II; SIGNALING PATHWAYS; ADULT MYOGENESIS; TYROSINE KINASE; GENE-EXPRESSION; MEF2 PROTEINS; STAT3	Skeletal muscle satellite cell-derived myoblasts are mainly responsible for postnatal muscle growth and injury-induced regeneration. However, the cellular signaling pathways that control proliferation and differentiation of myoblasts remain poorly defined. Recently, we found that JAK1/STAT1/STAT3 not only participate in myoblast proliferation but also actively prevent them from premature differentiation. Unexpectedly, we found that a related pathway consisting of JAK2, STAT2, and STAT3 is required for early myogenic differentiation. Interference of this pathway by either a small molecule inhibitor or small interfering RNA inhibits myogenic differentiation. Consistently, all three molecules are activated upon differentiation. The pro-differentiation effect of JAK2/STAT2/STAT3 is partially mediated by MyoD and MEF2. Interestingly, the expression of the IGF2 gene and the HGF gene is also regulated by JAK2/STAT2/STAT3, suggesting that this pathway could also promote differentiation by regulating signaling molecules known to be involved in myogenic differentiation. In summary, our current study reveals a novel role for the JAK2/STAT2/STAT3 pathway in myogenic differentiation.	[Wang, Kepeng; Wang, Chihao; Xiao, Fang; Wang, Haixia; Wu, Zhenguo] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Wu, ZG (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	bczgwu@ust.hk	Wang, Kepeng/F-8363-2014	Wang, Kepeng/0000-0001-6428-4709; Wu, Zhenguo/0000-0003-3049-8324	Hong Kong Research Grant Council [663007, CA06/07.SC02]; Hong Kong University Grant Committee [AoE/B-15/01]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); Hong Kong University Grant Committee	This work was supported by Hong Kong Research Grant Council Grants 663007 and CA06/07.SC02 (to Z.W.) and Area of Excellence Scheme AoE/B-15/01 from the Hong Kong University Grant Committee. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; CHENG TC, 1992, J CELL BIOL, V119, P1649, DOI 10.1083/jcb.119.6.1649; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; FLIER JS, 1989, NEW ENGL J MED, V321, P1383, DOI 10.1056/NEJM198911163212007; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9; Garcia R, 1998, J BIOMED SCI, V5, P79, DOI 10.1159/000025316; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kataoka Y, 2003, J BIOL CHEM, V278, P44178, DOI 10.1074/jbc.M304884200; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Stewart CEH, 1996, J CELL PHYSIOL, V169, P23, DOI 10.1002/(SICI)1097-4652(199610)169:1<23::AID-JCP3>3.0.CO;2-G; Stewart CEH, 1996, J BIOL CHEM, V271, P11330, DOI 10.1074/jbc.271.19.11330; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tamir Y, 2000, J BIOL CHEM, V275, P34424, DOI 10.1074/jbc.M005815200; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zong CS, 1998, J BIOL CHEM, V273, P28065, DOI 10.1074/jbc.273.43.28065	57	95	99	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34029	34036		10.1074/jbc.M803012200	http://dx.doi.org/10.1074/jbc.M803012200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835816	hybrid, Green Published			2022-12-25	WOS:000261277700030
J	Kalantari, P; Narayan, V; Natarajan, SK; Muralidhar, K; Gandhi, UH; Vunta, H; Henderson, AJ; Prabhu, KS				Kalantari, Parisa; Narayan, Vivek; Natarajan, Sathish K.; Muralidhar, Kambadur; Gandhi, Ujjawal H.; Vunta, Hema; Henderson, Andrew J.; Prabhu, K. Sandeep			Thioredoxin Reductase-1 Negatively Regulates HIV-1 Transactivating Protein Tat-dependent Transcription in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; REDOX REGULATION; CONTROLLED-TRIAL; T-CELLS; TYPE-1; SUPPLEMENTATION; MORTALITY; MECHANISM; WOMEN	Epidemiological studies suggest a correlation between severity of acquired immunodeficiency syndrome (AIDS) and selenium deficiency, indicating a protective role for this anti-oxidant during HIV infection. Here we demonstrate that thioredoxin reductase-1 (TR1), a selenium-containing pyridine nucleotide-disulfide oxidoreductase that reduces protein disulfides to free thiols, negatively regulates the activity of the HIV-1 encoded transcriptional activator, Tat, in human macrophages. We used a small interfering RNA approach as well as a high affinity substrate of TR1, ebselen, to demonstrate that Tat-dependent transcription and HIV-1 replication were significantly increased in human macrophages when TR1 activity was reduced. The increase in HIV-1 replication in TR1 small interfering RNA-treated cells was independent of the redox-sensitive transcription factor, NF-kappa B. These studies indicate that TR-1 acts as a negative regulator of Tat-dependent transcription. Furthermore, in vitro biochemical assays with recombinant Tat protein confirmed that TR1 targets two disulfide bonds within the Cys-rich motif required for efficient HIV-1 transactivation. Increasing TR1 expression along with other selenoproteins by supplementing with selenium suggests a potential inexpensive adjuvant therapy for HIV/AIDS patients.	[Henderson, Andrew J.] Boston Univ, Sch Med, Dept Med, Ctr HIV AIDS Care & Res, Boston, MA 02118 USA; [Kalantari, Parisa; Narayan, Vivek; Muralidhar, Kambadur; Gandhi, Ujjawal H.; Vunta, Hema; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Kalantari, Parisa; Narayan, Vivek; Muralidhar, Kambadur; Gandhi, Ujjawal H.; Vunta, Hema; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Natarajan, Sathish K.] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA	Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Nebraska System; University of Nebraska Lincoln	Henderson, AJ (corresponding author), Boston Univ, Sch Med, Dept Med, Ctr HIV AIDS Care & Res, Boston, MA 02118 USA.	andrew.henderson@bmc.org; ksp4@psu.edu		Henderson, Andrew/0000-0002-9299-5302; Narayan, Vivek/0000-0002-3232-7898	National Institutes of Health [R01 AI062467, R01 DK077152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI062467 (to A.J.H.) and R01 DK077152 (to K.S.P.) from the Public Health Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Baum MK, 1998, NUTR REV, V56, pS135; Baum MK, 1997, J ACQ IMMUN DEF SYND, V15, P370, DOI 10.1097/00042560-199708150-00007; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Bourgeois CF, 2002, MOL CELL BIOL, V22, P1079, DOI 10.1128/MCB.22.4.1079-1093.2002; Burbano Ximena, 2002, HIV Clin Trials, V3, P483; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gladyshev VN, 1999, P NATL ACAD SCI USA, V96, P835, DOI 10.1073/pnas.96.3.835; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; Kaiser JD, 2006, JAIDS-J ACQ IMM DEF, V42, P523, DOI 10.1097/01.qai.0000230529.25083.42; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kirsch T, 1996, PROTEIN EXPRES PURIF, V8, P75, DOI 10.1006/prep.1996.0076; KOKEN SEC, 1994, J BIOL CHEM, V269, P8366; Kupka R, 2005, EUR J CLIN NUTR, V59, P1250, DOI 10.1038/sj.ejcn.1602236; Kupka R, 2004, J NUTR, V134, P2556, DOI 10.1093/jn/134.10.2556; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; McClelland RS, 2004, JAIDS-J ACQ IMM DEF, V37, P1657, DOI 10.1097/00126334-200412150-00021; McDermid JM, 2002, J ACQ IMMUN DEF SYND, V29, P158, DOI 10.1097/00042560-200202010-00008; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; NEWMAN GW, 1994, J EXP MED, V180, P359, DOI 10.1084/jem.180.1.359; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Ogunro P S, 2006, Niger Postgrad Med J, V13, P1; Patki AH, 1996, CELL IMMUNOL, V169, P40, DOI 10.1006/cimm.1996.0088; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Shor-Posner G, 2003, INT J PSYCHIAT MED, V33, P55, DOI 10.2190/PFFD-D920-V041-N5KD; STADTMAN TC, 1990, ANNU REV BIOCHEM, V59, P111, DOI 10.1146/annurev.bi.59.070190.000551; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	43	56	57	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33183	33190		10.1074/jbc.M807403200	http://dx.doi.org/10.1074/jbc.M807403200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18835810	Green Published, hybrid			2022-12-25	WOS:000261183700021
J	Tachado, SD; Li, X; Swan, K; Patel, N; Koziel, H				Tachado, Souvenir D.; Li, Xin; Swan, Katharine; Patel, Naimish; Koziel, Henry			Constitutive Activation of Phosphatidylinositol 3-Kinase Signaling Pathway Down-regulates TLR4-mediated Tumor Necrosis Factor-alpha Release in Alveolar Macrophages from Asymptomatic HIV-positive Persons in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	103rd International Conference of the American-Thoracic-Society	MAY 18-23, 2007	San Francisco, CA	Amer Thorac Soc			HUMAN-IMMUNODEFICIENCY-VIRUS; NEF PROTEIN; CYTOKINE PRODUCTION; MANNOSE RECEPTOR; INTERLEUKIN-10; AKT; KINASE; INFECTION; BINDING; IL-12	Alveolar macrophages represent critical effector cells of innate immunity to infectious challenge in the lungs and recognize bacterial pathogens through pattern recognition receptors such as Toll-like receptors (TLRs). Phosphatidylinositol 3-kinse (PI3K) regulates TLR-mediated cytokine release, but whether HIV infection influences PI3K signaling pathway and alters TLR4-mediated macrophage response has not been investigated. In the current study, surface TLR4 expression were similar but TLR4 activation (lipid A, 10 mu g/ml) resulted in lower TNF-alpha release by HIV+ human macrophages compared with healthy cells. Pharmacological inhibition of PI3K (LY294002) normalized TNF-alpha release in HIV+ macrophages and augments ERK1/2 mitogen-activated protein kinase phosphorylation in response to lipid A. Importantly, HIV+ macrophages demonstrated increased constitutive phosphatidylinositol 3,4,5-trisphosphate formation, increased phosphorylation of downstream signaling molecules Akt and glycogen synthase kinase-3 beta(GSK-3 beta) at Ser(9), and reduced PTEN protein expression. As a functional assessment of GSK-3 beta phosphorylation, TLR4-mediated interleukin-10 release was significantly higher in HIV+ human macrophages compared with healthy cells. Incubation of human macrophages with exogenous HIV Nef protein induced phosphorylation of Akt and GSK-3 beta(whereas phosphorylation was reduced by PI3K inhibition) and promoted interleukin-10 release. Taken together, these data demonstrate increased constitutive activation of the PI3K signaling pathway in HIV+ macrophages and support the concept that PI3K activation (by HIV proteins such as Nef) may contribute to reduced TLR4-mediated TNF-alpha release in HIV+ human macrophages and impair host cell response to infectious challenge.	[Tachado, Souvenir D.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Tachado, SD (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Dept Med, 330 Brookline Ave,Kirstein Bldg,Rm KSB-023, Boston, MA 02215 USA.	stachado@bidmc.harvard.edu		Tachado, Souvenir/0000-0002-8368-6102	NHLBI NIH HHS [R01-HL063655] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063655] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AMEISEN JC, 1989, AIDS RES HUM RETROV, V5, P279, DOI 10.1089/aid.1989.5.279; Benito N, 2001, J ACQ IMMUN DEF SYND, V27, P35, DOI 10.1097/00126334-200105010-00006; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Brightbill HD, 2000, IMMUNOLOGY, V101, P1, DOI 10.1046/j.1365-2567.2000.00093.x; Brigino E, 1997, P NATL ACAD SCI USA, V94, P3178, DOI 10.1073/pnas.94.7.3178; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao XH, 2004, J IMMUNOL, V172, P4851, DOI 10.4049/jimmunol.172.8.4851; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Feikin DR, 2004, LANCET INFECT DIS, V4, P445, DOI 10.1016/S1473-3099(04)01060-6; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FOLKS TM, 1988, J IMMUNOL, V140, P1117; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Fujii Y, 1996, FEBS LETT, V393, P105, DOI 10.1016/0014-5793(96)00862-9; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Graziani A, 1996, J BIOL CHEM, V271, P6590, DOI 10.1074/jbc.271.12.6590; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Klber MA, 2008, CLIN IMMUNOL, V126, P315, DOI 10.1016/j.clim.2007.10.002; Koziel H, 1998, J CLIN INVEST, V102, P1332, DOI 10.1172/JCI560; Lalani I, 1997, ANN ALLERG ASTHMA IM, V79, P469, DOI 10.1016/S1081-1206(10)63052-9; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Maris NA, 2006, EUR RESPIR J, V28, P622, DOI 10.1183/09031936.06.00010806; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Park IW, 1999, AM J RESP CELL MOL, V20, P864, DOI 10.1165/ajrcmb.20.5.3547; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; ROGY MA, 1995, J EXP MED, V181, P2289, DOI 10.1084/jem.181.6.2289; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Tachado SD, 2005, AM J RESP CELL MOL, V33, P610, DOI 10.1165/rcmb.2004-0341OC; Tachado SD, 2007, J LEUKOCYTE BIOL, V81, P205, DOI 10.1189/jlb.1005580; Wallace JM, 1997, AM J RESP CRIT CARE, V155, P72, DOI 10.1164/ajrccm.155.1.9001292; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Zhang JM, 2004, INFECT IMMUN, V72, P3147, DOI 10.1128/IAI.72.6.3147-3160.2004	41	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33191	33198		10.1074/jbc.M805067200	http://dx.doi.org/10.1074/jbc.M805067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	376KY	18826950	Green Published, hybrid			2022-12-25	WOS:000261183700022
J	Thuault, S; Tan, EJ; Peinado, H; Cano, A; Heldin, CH; Moustakas, A				Thuault, Sylvie; Tan, E-Jean; Peinado, Hector; Cano, Amparo; Heldin, Carl-Henrik; Moustakas, Aristidis			HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; PROGRESSION	Epithelial-mesenchymal transition (EMT) is important during embryonic cell layer movement and tumor cell invasiveness. EMT converts adherent epithelial cells to motile mesenchymal cells, favoring metastasis in the context of cancer progression. Transforming growth factor-beta (TGF-beta) triggers EMT via intracellular Smad transducers and other signaling proteins. We previously reported that the high mobility group A2 (HMGA2) gene is required for TGF-beta to elicit EMT in mammary epithelial cells. In the present study we investigated the molecular mechanisms by which HMGA2 induces EMT. We found that HMGA2 regulates expression of many important repressors of E-cadherin. Among these, we analyzed in detail the zinc-finger transcription factor SNAIL1, which plays key roles in tumor progression and EMT. We demonstrate that HMGA2 directly binds to the SNAIL1 promoter and acts as a transcriptional regulator of SNAIL1 expression. Furthermore, we observed that HMGA2 cooperates with the TGF-beta/Smad pathway in regulating SNAIL1 gene expression. The mechanism behind this cooperation involves physical interaction between these factors, leading to an increased binding of Smads to the SNAIL1 promoter. SNAIL1 seems to play the role of a master effector downstream of HMGA2 for induction of EMT, as SNAIL1 knock-down partially reverts HMGA2-induced loss of epithelial differentiation. The data propose that HMGA2 acts in a gene-specific manner to orchestrate the transcriptional network necessary for the EMT program.	[Thuault, Sylvie; Tan, E-Jean; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Peinado, Hector; Cano, Amparo] Univ Autonoma Madrid, Fac Med, CSIC, Dept Bioquim,Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain	Ludwig Institute for Cancer Research; Uppsala University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Moustakas, A (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, Box 595, SE-75124 Uppsala, Sweden.	aris.moustakas@licr.uu.se	Tan, E-Jean/J-3425-2019; Peinado, Hector/A-6417-2013	Tan, E-Jean/0000-0002-4631-174X; Peinado, Hector/0000-0002-4256-3413; THUAULT, Sylvie/0000-0003-0133-3803	Ludwig Institute for Cancer Research; Swedish Cancer Society [4855-B03-01XAC, CAN 2006/1078]; Spanish Ministry of Education and Science [SAF2007-63051]; Consolider-Ingenio [2010-26102]; Marie Curie Research Training Network [MRTN-2005-005428]	Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Spanish Ministry of Education and Science(Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie Curie Research Training Network(European Commission)	This work was supported by Ludwig Institute for Cancer Research and the Swedish Cancer Society Projects 4855-B03-01XAC and CAN 2006/1078 (to A. M.) and Spanish Ministry of Education and Science Grants SAF2007-63051 and Consolider-Ingenio 2010-26102 (to A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program project MRTN-2005-005428.	Cattaruzzi G, 2007, NUCLEIC ACIDS RES, V35, P1751, DOI 10.1093/nar/gkl1106; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Noro B, 2003, BIOCHEMISTRY-US, V42, P4569, DOI 10.1021/bi026605k; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	22	283	301	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33437	33446		10.1074/jbc.M802016200	http://dx.doi.org/10.1074/jbc.M802016200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832382	Green Published, hybrid			2022-12-25	WOS:000261183700048
J	Ai, J; Druhan, LJ; Loveland, MJ; Avalos, BR				Ai, Jing; Druhan, Lawrence J.; Loveland, Megan J.; Avalos, Belinda R.			G-CSFR Ubiquitination Critically Regulates Myeloid Cell Survival and Proliferation	PLOS ONE			English	Article								The granulocyte colony-stimulating factor receptor (G-CSFR) is a critical regulator of granulopoiesis. Mutations in the G-CSFR in patients with severe congenital neutropenia (SCN) transforming to acute myelogenous leukemia (AML) have been shown to induce hypersensitivity and enhanced growth responses to G-CSF. Recent studies have demonstrated the importance of the ubiquitin/proteasome system in the initiation of negative signaling by the G-CSFR. To further investigate the role of ubiquitination in regulating G-CSFR signaling, we generated a mutant form of the G-CSFR (K762R/G-CSFR) which abrogates the attachment of ubiquitin to the lysine residue at position 762 of the G-CSFR that is deleted in the Delta 716 G-CSFR form isolated from patients with SCN/AML. In response to G-CSF, mono-/polyubiquitination of the G-CSFR was impaired in cells expressing the mutant K762R/G-CSFR compared to cells transfected with the WT G-CSFR. Cells stably transfected with the K762R/G-CSFR displayed a higher proliferation rate, increased sensitivity to G-CSF, and enhanced survival following cytokine depletion, similar to previously published data with the Delta 716 G-CSFR mutant. Activation of the signaling molecules Stat5 and Akt were also increased in K762R/G-CSFR transfected cells in response to G-CSF, and their activation remained prolonged after G-CSF withdrawal. These results indicate that ubiquitination is required for regulation of G-CSFR-mediated proliferation and cell survival. Mutations that disrupt G-CSFR ubiquitination at lysine 762 induce aberrant receptor signaling and hyperproliferative responses to G-CSF, which may contribute to leukemic transformation.	[Ai, Jing; Druhan, Lawrence J.; Loveland, Megan J.] Ohio State Univ, Heart & Lung Res Inst, Columbus, OH 43210 USA; [Avalos, Belinda R.] Ohio State Univ, Div Hematol Oncol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Ai, J (corresponding author), Ohio State Univ, Heart & Lung Res Inst, Columbus, OH 43210 USA.	belinda.avalos@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institute of Diabetes and Digestive and Kidney Diseases [R21-DK068639]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068639] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R21-DK068639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2008, J LEUKOCYTE BIOL, V83, P1277, DOI 10.1189/jlb.1107751; AVALOS BR, 1995, BLOOD, V85, P3117, DOI 10.1182/blood.V85.11.3117.bloodjournal85113117; AVALOS BR, 1990, BLOOD, V75, P851; Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; BEGLEY CG, 1988, EXP HEMATOL, V16, P71; DEMETRI GD, 1991, BLOOD, V78, P2791; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; Dong F, 2001, J IMMUNOL, V167, P6447, DOI 10.4049/jimmunol.167.11.6447; DONG F, 1993, MOL CELL BIOL, V13, P7774, DOI 10.1128/MCB.13.12.7774; Druhan LJ, 2005, BLOOD, V105, P584, DOI 10.1182/blood-2004-07-2613; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; HAMMOND WP, 1992, BLOOD, V79, P2536; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Hermans MHA, 2003, BLOOD, V101, P2584, DOI 10.1182/blood-2002-07-2062; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Hunter MG, 2000, BLOOD, V95, P2132, DOI 10.1182/blood.V95.6.2132; Hunter MG, 2004, J IMMUNOL, V173, P5036, DOI 10.4049/jimmunol.173.8.5036; Irandoust MI, 2007, EMBO J, V26, P1782, DOI 10.1038/sj.emboj.7601640; ISHIZAKAIKEDA E, 1993, P NATL ACAD SCI USA, V90, P123, DOI 10.1073/pnas.90.1.123; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Kindwall-Keller TL, 2008, CYTOKINE, V43, P114, DOI 10.1016/j.cyto.2008.04.015; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; SCHMITZ S, 1993, EXP HEMATOL, V21, P755; SCHMITZ S, 1994, CELL PROLIFERAT, V27, P655, DOI 10.1111/j.1365-2184.1994.tb01380.x; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Tidow N, 1997, BLOOD, V89, P2369, DOI 10.1182/blood.V89.7.2369; Touw IP, 1996, LEUKEMIA RES, V20, P629, DOI 10.1016/0145-2126(96)00017-3; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Yen CH, 2000, J IMMUNOL, V165, P6372, DOI 10.4049/jimmunol.165.11.6372; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3422	10.1371/journal.pone.0003422	http://dx.doi.org/10.1371/journal.pone.0003422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923646	Green Submitted, Green Published, gold			2022-12-25	WOS:000265122200003
J	Yamaguchi-Kabata, Y; Shimada, MK; Hayakawa, Y; Minoshima, S; Chakraborty, R; Gojobori, T; Imanishi, T				Yamaguchi-Kabata, Yumi; Shimada, Makoto K.; Hayakawa, Yosuke; Minoshima, Shinsei; Chakraborty, Ranajit; Gojobori, Takashi; Imanishi, Tadashi			Distribution and Effects of Nonsense Polymorphisms in Human Genes	PLOS ONE			English	Article								Background: A great amount of data has been accumulated on genetic variations in the human genome, but we still do not know much about how the genetic variations affect gene function. In particular, little is known about the distribution of nonsense polymorphisms in human genes despite their drastic effects on gene products. Methodology/Principal Findings: To detect polymorphisms affecting gene function, we analyzed all publicly available polymorphisms in a database for single nucleotide polymorphisms (dbSNP build 125) located in the exons of 36,712 known and predicted protein-coding genes that were defined in an annotation project of all human genes and transcripts (H-InvDB ver3.8). We found a total of 252,555 single nucleotide polymorphisms ( SNPs) and 8,479 insertion and deletions in the representative transcripts in these genes. The SNPs located in ORFs include 40,484 synonymous and 53,754 nonsynonymous SNPs, and 1,258 SNPs that were predicted to be nonsense SNPs or read-through SNPs. We estimated the density of nonsense SNPs to be 0.85x10(-3) per site, which is lower than that of nonsynonymous SNPs (2.1x10(-3) per site). On average, nonsense SNPs were located 250 codons upstream of the original termination codon, with the substitution occurring most frequently at the first codon position. Of the nonsense SNPs, 581 were predicted to cause nonsense-mediated decay (NMD) of transcripts that would prevent translation. We found that nonsense SNPs causing NMD were more common in genes involving kinase activity and transport. The remaining 602 nonsense SNPs are predicted to produce truncated polypeptides, with an average truncation of 75 amino acids. In addition, 110 read-through SNPs at termination codons were detected. Conclusion/Significance: Our comprehensive exploration of nonsense polymorphisms showed that nonsense SNPs exist at a lower density than nonsynonymous SNPs, suggesting that nonsense mutations have more severe effects than amino acid changes. The correspondence of nonsense SNPs to known pathological variants suggests that phenotypic effects of nonsense SNPs have been reported for only a small fraction of nonsense SNPs, and that nonsense SNPs causing NMD are more likely to be involved in phenotypic variations. These nonsense SNPs may include pathological variants that have not yet been reported. These data are available from Transcript View of H-InvDB and VarySysDB (http://h-invitational.jp/varygene/).	[Yamaguchi-Kabata, Yumi; Shimada, Makoto K.; Hayakawa, Yosuke; Gojobori, Takashi; Imanishi, Tadashi] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo, Japan; [Shimada, Makoto K.; Hayakawa, Yosuke] Japan Biol Informat Consortium, Japan Biol Informat Res Ctr, Tokyo, Japan; [Minoshima, Shinsei] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan; [Chakraborty, Ranajit] Univ Cincinnati, Ctr Genome Informat, Cincinnati, OH 45221 USA; [Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Ctr Informat Biol, Mishima, Shizuoka, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hamamatsu University School of Medicine; University of Cincinnati; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Yamaguchi-Kabata, Y (corresponding author), RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan.	t.imanishi@aist.go.jp	SHIMADA, Makoto K./K-4613-2015; Imanishi, Tadashi/R-3076-2019	SHIMADA, Makoto K./0000-0003-0067-0082; Imanishi, Tadashi/0000-0002-1182-9127	Ministry of Economy, Trade and Industry of Japan (METI); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Biological Informatics Consortium (JBIC)	Ministry of Economy, Trade and Industry of Japan (METI); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Biological Informatics Consortium (JBIC)	This research is financially supported by the Ministry of Economy, Trade and Industry of Japan (METI), the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and the Japan Biological Informatics Consortium (JBIC).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHANG JC, 1979, P NATL ACAD SCI USA, V76, P2886, DOI 10.1073/pnas.76.6.2886; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Fay JC, 2001, GENETICS, V158, P1227; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han A, 2007, BIOINFORMATICS, V23, P397, DOI 10.1093/bioinformatics/btl593; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; MIMORI A, 1991, AM J HUM GENET, V48, P103; Minoshima S, 2001, NUCLEIC ACIDS RES, V29, P327, DOI 10.1093/nar/29.1.327; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; NEI M, 1986, MOL BIOL EVOL, V3, P418; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sherry ST, 1999, GENOME RES, V9, P677; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Takeda J, 2006, NUCLEIC ACIDS RES, V34, P3917, DOI 10.1093/nar/gkl507; THEIN SL, 1990, P NATL ACAD SCI USA, V87, P3924, DOI 10.1073/pnas.87.10.3924; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yamasaki C, 2005, GENE, V364, P99, DOI 10.1016/j.gene.2005.05.036; Yamasaki C, 2008, NUCLEIC ACIDS RES, V36, pD793, DOI 10.1093/nar/gkm999; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272	46	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3393	10.1371/journal.pone.0003393	http://dx.doi.org/10.1371/journal.pone.0003393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852891	gold, Green Submitted, Green Published			2022-12-25	WOS:000265121700002
J	Sponarova, J; Nystrom, SN; Westermark, GT				Sponarova, Jana; Nystrom, Sofia N.; Westermark, Gunilla T.			AA-Amyloidosis Can Be Transferred by Peripheral Blood Monocytes	PLOS ONE			English	Article								Spongiform encephalopathies have been reported to be transmitted by blood transfusion even prior to the clinical onset. Experimental AA-amyloidosis shows similarities with prion disease and amyloid-containing organ-extracts can prime a recipient for the disease. In this systemic form of amyloidosis N-terminal fragments of the acute-phase reactant apolipoprotein serum amyloid A are the main amyloid protein. Initial amyloid deposits appear in the perifollicular region of the spleen, followed by deposits in the liver. We used the established murine model and induced AA-amyloidosis in NMRI mice by intravenous injections of purified amyloid fibrils ('amyloid enhancing factor') combined with inflammatory challenge (silver nitrate subcutaneously). Blood plasma and peripheral blood monocytes were isolated, sonicated and re-injected into new recipients followed by an inflammatory challenge during a three week period. When the animals were sacrificed presence of amyloid was analyzed in spleen sections after Congo red staining. Our result shows that some of the peripheral blood monocytes, isolated from animals with detectable amyloid, contained amyloid-seed that primed for AA-amyloid. The seeding material seems to have been phagocytosed by the cells since the AA-precursor (SAA1) was found not be expressed by the monocytes. Plasma recovered from mice with AA amyloidosis lacked seeding capacity. Amyloid enhancing activity can reside in monocytes recovered from mice with AA-amyloidosis and in a prion-like way trigger amyloid formation in conjunction with an inflammatory disorder. Human AA-amyloidosis resembles the murine form and every individual is expected to be exposed to conditions that initiate production of the acute-phase reactant. The monocyte-transfer mechanism should be eligible for the human disease and we point out blood transfusion as a putative route for transfer of amyloidosis.	[Sponarova, Jana; Nystrom, Sofia N.; Westermark, Gunilla T.] Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Fac Hlth Sci, Linkoping, Sweden	Linkoping University	Sponarova, J (corresponding author), Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Fac Hlth Sci, Linkoping, Sweden.	Gunwe@ibk.liu.se	Sponarova, Jana/AAM-6003-2020; NystrÃm, Sofia/GYQ-5893-2022	Sponarova, Jana/0000-0002-6345-6879; Nystrom, Sofia/0000-0002-0145-4966	Swedish Research Council; European Union FP6 Program	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union FP6 Program(European Commission)	This work was supported by the Swedish Research Council and the European Union FP6 Program without any interference in the performance of the study.	Aguzzi A, 2000, HAEMATOLOGICA, V85, P3; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; AXELRAD MA, 1982, LAB INVEST, V47, P139; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; CHA Y, 1990, J BIOL CHEM, V265, P5008; CHRONOPOULOS S, 1994, J PATHOL, V173, P361, DOI 10.1002/path.1711730412; EIN D, 1972, BIOCHEM BIOPH RES CO, V46, P498, DOI 10.1016/S0006-291X(72)80166-9; Fu XY, 2004, FEBS LETT, V563, P179, DOI 10.1016/S0014-5793(04)00295-9; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; HARDT F, 1968, ACTA PATHOL MIC SC, V73, P549; HOL PR, 1986, VIRCHOWS ARCH B, V52, P273, DOI 10.1007/BF02889968; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kanitakis J, 2004, NEW ENGL J MED, V351, P2661, DOI 10.1056/NEJM200412163512523; KISILEVSKY R, 1983, LAB INVEST, V48, P53; Kluve-Beckerman B, 1999, AM J PATHOL, V155, P123, DOI 10.1016/S0002-9440(10)65107-3; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; NIEWOLD TA, 1987, LAB INVEST, V56, P544; PETERS L, 2008, MPD SNPS; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Rocken C, 2001, AM J PATHOL, V158, P1029, DOI 10.1016/S0002-9440(10)64050-3; ROKITA H, 1987, J IMMUNOL, V139, P3849; SHIRAHAMA T, 1980, AM J PATHOL, V99, P539; SHIRAHAMA T, 1990, LAB INVEST, V62, P61; SLETTEN K, 1974, EUR J BIOCHEM, V41, P117, DOI 10.1111/j.1432-1033.1974.tb03251.x; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; Sorby R, 2008, AMYLOID, V15, P20, DOI 10.1080/13506120701815332; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; TEILUM G, 1964, ACTA PATHOL MIC SC, V61, P21, DOI 10.1111/apm.1964.61.1.21; Thorn CF, 2004, SCAND J IMMUNOL, V59, P152, DOI 10.1111/j.0300-9475.2004.01369.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; URIELISHOVAL S, 1994, AM J PATHOL, V145, P650; WERDELIN O, 1966, ACTA PATHOL MIC SC, V68, P1; WESTERMARK GT, 1989, SCAND J IMMUNOL, V30, P605, DOI 10.1111/j.1365-3083.1989.tb02468.x; WESTERMARK GT, 1987, LAB INVEST, V57, P57; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; YAMAMOTO K, 1985, P NATL ACAD SCI USA, V82, P2915, DOI 10.1073/pnas.82.9.2915	41	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3308	10.1371/journal.pone.0003308	http://dx.doi.org/10.1371/journal.pone.0003308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830411	Green Published, Green Submitted, gold			2022-12-25	WOS:000264797300002
J	Huang, YC; Hessler, NA				Huang, Ya-Chun; Hessler, Neal A.			Social Modulation during Songbird Courtship Potentiates Midbrain Dopaminergic Neurons	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; FINCHES TAENIOPYGIA-GUTTATA; NUCLEUS-ACCUMBENS DOPAMINE; BASAL GANGLIA CIRCUIT; MALE PRAIRIE VOLES; ZEBRA FINCH; MALE RATS; ACUTE AMPHETAMINE; SEXUAL-BEHAVIOR; UNDIRECTED SONG	Synaptic transmission onto dopaminergic neurons of the mammalian ventral tegmental area (VTA) can be potentiated by acute or chronic exposure to addictive drugs. Because rewarding behavior, such as social affiliation, can activate the same neural circuitry as addictive drugs, we tested whether the intense social interaction of songbird courtship may also potentiate VTA synaptic function. We recorded glutamatergic synaptic currents from VTA of male zebra finches who had experienced distinct social and behavioral conditions during the previous hour. The level of synaptic transmission to VTA neurons, as assayed by the ratio of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) to N-methyl-D-aspartic acid (NMDA) glutamate receptor mediated synaptic currents, was increased after males sang to females, and also after they saw females without singing, but not after they sang while alone. Potentiation after female exposure alone did not appear to result from stress, as it was not blocked by inhibition of glucocorticoid receptors. This potentiation was restricted to synapses of dopaminergic projection neurons, and appeared to be expressed postsynaptically. This study supports a model in which VTA dopaminergic neurons are more strongly activated during singing used for courtship than during non-courtship singing, and thus can provide social context-dependent modulation to forebrain areas. More generally, these results demonstrate that an intense social encounter can trigger the same pathways of neuronal plasticity as addictive drugs.	[Huang, Ya-Chun; Hessler, Neal A.] RIKEN Brain Sci Inst, Vocal Behav Mech Lab, Wako, Saitama, Japan	RIKEN	Huang, YC (corresponding author), RIKEN Brain Sci Inst, Vocal Behav Mech Lab, Wako, Saitama, Japan.	hessler@brain.riken.jp	hessler, neal/A-7328-2010		RIKEN Brain Science Institute	RIKEN Brain Science Institute	Funding provided by RIKEN Brain Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Castelino CB, 2007, J COMP NEUROL, V502, P544, DOI 10.1002/cne.21337; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Curtis JT, 2005, PHYSIOL BEHAV, V86, P338, DOI 10.1016/j.physbeh.2005.08.022; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dunn AM, 1996, ETHOLOGY, V102, P529; Dunn AM, 1996, ETHOLOGY, V102, P540; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Fisher HE, 2006, PHILOS T R SOC B, V361, P2173, DOI 10.1098/rstb.2006.1938; Gale SD, 2008, J COMP NEUROL, V508, P824, DOI 10.1002/cne.21700; Gale SD, 2006, J NEUROPHYSIOL, V96, P2295, DOI 10.1152/jn.01040.2005; GEISLER S, 2007, NEUROPSYCHOPHARM; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Kelley AE, 2002, J NEUROSCI, V22, P3306; Landys MM, 2004, J EXP BIOL, V207, P143, DOI 10.1242/jeb.00734; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lynch KS, 2008, PHYSIOL BEHAV, V93, P870, DOI 10.1016/j.physbeh.2007.12.004; Manzoni OJ, 1999, J NEUROSCI, V19, P6629; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Peters YM, 2005, BIOL PSYCHIAT, V57, P1205, DOI 10.1016/j.biopsych.2005.02.011; Robinson DL, 2002, J NEUROSCI, V22, P10477; Robinson DL, 2001, NEUROREPORT, V12, P2549, DOI 10.1097/00001756-200108080-00051; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Yanagihara S, 2006, EUR J NEUROSCI, V24, P3619, DOI 10.1111/j.1460-9568.2006.05228.x; ZANN R, 1996, ZEBRA FINCH	50	47	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3281	10.1371/journal.pone.0003281	http://dx.doi.org/10.1371/journal.pone.0003281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RU	18827927	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797200003
J	Han, PP; Yuan, YJ				Han, Pei-pei; Yuan, Ying-jin			Lipidomic analysis reveals activation of phospholipid signaling in mechanotransduction of Taxus cuspidata cells in response to shear stress	FASEB JOURNAL			English	Article						phospholipase; phosphatidic acid; mechanical stress; plant cell culture; metabolomics; LC; MS/MS	PHOSPHATIDIC-ACID ACCUMULATION; METHYL JASMONATE; NITRIC-OXIDE; BACCATIN-III; PACLITAXEL; INTEGRINS	Lipid signaling involved in mechanotransduction processes in response to shear stress in plants remained elusive. To understand the responses of phospholipids in shear stress-induced mechanotransduction, a lipidomic approach was employed to profile phospholipid species of Taxus cuspidata cells under laminar shear stress. A total of 99 phospholipid species were profiled quantitatively, using the LC/ESI/MSn procedure. Potential biomarkers were found by the principal component analysis (PCA) as well as partial least squares (PLS) combined with variable influence in the projection (VIP). Phosphatidic acid (PA) and lysophosphatidylcholine (LysoPC) were two important lipid groups that were responsible for the discrimination between shear stress induced and control cells. Further research revealed that shear stress enhanced the activation of phospholipase D (PLD) and phospholipase C (PLC) compared with control cells and consequently increased PA content in shear stress induced T. cuspidata cells. These results demonstrate that phospholipids and related phospholipases play important roles in mechanotransduction of T. cuspidata cells in response to shear stress.-Han, P.-P., Yuan, Y.-J. Lipidomic analysis reveals activation of phospholipid signaling in mechanotransduction of Taxus cuspidata cells in response to shear stress. FASEB J. 23, 623-630 (2009)	[Yuan, Ying-jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; Tianjin Univ, Dept Pharmaceut Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Yuan, YJ (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn			National Science Fund of China [20425620]; Key Program grant [20736006]; National Basic Research Program of China [2007CB714301]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); Key Program grant; National Basic Research Program of China(National Basic Research Program of China)	This work was funded by a National Science Fund of China for Distinguished Young Scholars grant (project 20425620), a Key Program grant (project 20736006), and the National Basic Research Program of China ("973" Program: 2007CB714301).	Baumert BM, 1999, J NON-NEWTON FLUID, V83, P33, DOI 10.1016/S0377-0257(98)00132-3; BHAGYALAKSHMI A, 1992, J VASC RES, V29, P443, DOI 10.1159/000158963; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Bogre L, 1996, NATURE, V383, P489, DOI 10.1038/383489a0; Cazzolli R, 2006, IUBMB LIFE, V58, P457, DOI 10.1080/15216540600871142; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Distefano AM, 2008, PLANT CELL ENVIRON, V31, P187, DOI 10.1111/j.1365-3040.2007.01756.x; Drissner D, 2007, SCIENCE, V318, P265, DOI 10.1126/science.1146487; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Gao H, 2007, BIOTECHNOL PROGR, V23, P673, DOI 10.1021/bp060329+; Gomez-Merino FC, 2004, J BIOL CHEM, V279, P8230, DOI 10.1074/jbc.M312187200; Gong YW, 2006, J BIOTECHNOL, V123, P185, DOI 10.1016/j.jbiotec.2005.11.003; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Gus-Mayer S, 1998, P NATL ACAD SCI USA, V95, P8398, DOI 10.1073/pnas.95.14.8398; Han RB, 2004, BIOTECHNOL PROGR, V20, P507, DOI 10.1021/bp034242p; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; KNIGHT MR, 1992, P NATL ACAD SCI USA, V89, P4967, DOI 10.1073/pnas.89.11.4967; Lagarde M, 2003, BBA-MOL CELL BIOL L, V1634, P61, DOI 10.1016/j.bbalip.2003.11.002; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Laxalt AM, 2007, J BIOL CHEM, V282, P21160, DOI 10.1074/jbc.M701212200; Lee S, 2001, PLANT J, V26, P479, DOI 10.1046/j.1365-313x.2001.01037.x; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Nakagawa Y, 2007, P NATL ACAD SCI USA, V104, P3639, DOI 10.1073/pnas.0607703104; Palazon J, 2003, J BIOTECHNOL, V101, P157, DOI 10.1016/S0168-1656(02)00318-8; Ruelland E, 2002, PLANT PHYSIOL, V130, P999, DOI 10.1104/pp.006080; Sang YM, 2001, PLANT PHYSIOL, V126, P1449, DOI 10.1104/pp.126.4.1449; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Skinner DZ, 2005, CROP SCI, V45, P1858, DOI 10.2135/cropsci2004.0721; Song K, 2004, IEEE SYS MAN CYBERN, P1354; TAKAHASHI H, 1984, PHYSIOL PLANTARUM, V61, P405, DOI 10.1111/j.1399-3054.1984.tb06347.x; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Wakelam MJO, 2007, METHOD ENZYMOL, V432, P233, DOI 10.1016/S0076-6879(07)32010-7; Wang XL, 2007, PROTEOMICS, V7, P588, DOI 10.1002/pmic.200600568; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P131, DOI 10.1016/S0169-7439(01)00156-3; Yang RYK, 2003, J BIOTECHNOL, V100, P13, DOI 10.1016/S0168-1656(02)00226-2; Yang S, 2008, BBA-MOL CELL BIOL L, V1781, P123, DOI 10.1016/j.bbalip.2007.11.005; Yang S, 2007, BBA-MOL CELL BIOL L, V1771, P600, DOI 10.1016/j.bbalip.2007.02.011; Yukimune Y, 1996, NAT BIOTECHNOL, V14, P1129, DOI 10.1038/nbt0996-1129; Zhang WH, 2003, PLANT CELL, V15, P2285, DOI 10.1105/tpc.013961; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003	50	24	25	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					623	630		10.1096/fj.08-119362	http://dx.doi.org/10.1096/fj.08-119362			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18922880				2022-12-25	WOS:000262892900033
J	Budzik, JM; Oh, SY; Schneewind, O				Budzik, Jonathan M.; Oh, So-Young; Schneewind, Olaf			Cell Wall Anchor Structure of BcpA Pili in Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL SURFACE-PROTEINS; AUREUS SORTASE; LPXTG MOTIF; HEME-IRON; PEPTIDOGLYCAN; STREPTOCOCCI; PURIFICATION; SUBSTRATE; ENVELOPE; PEPTIDE	Assembly of pili in Gram-positive bacteria and their attachment to the cell wall envelope are mediated by sortases. In Bacillus cereus and its close relative Bacillus anthracis, the major pilin protein BcpA is cleaved between the threonine and the glycine of its C-terminal LPXTG motif sorting signal by the pilin-specific sortase D. The resulting acyl enzyme intermediate is relieved by the nucleophilic attack of the side-chain amino group of lysine within the YPKN motif of another BcpA subunit. Cell wall anchoring of assembled BcpA pili requires sortase A, which also cleaves the LPXTG sorting signal of BcpA between its threonine and glycine residues. We show here that sortases A and D require only the C-terminal sorting signal of BcpA for substrate cleavage. Unlike sortase D, which accepts the YPKN motif as a nucleophile, sortase A forms an amide bond between the BcpA C-terminal carboxyl group of threonine and the side-chain amino group of diaminopimelic acid within the cell wall peptidoglycan of bacilli. These results represent the first demonstration of a cell wall anchor structure for pili, which are deposited by sortase A into the envelope of many different microbes.	[Budzik, Jonathan M.; Oh, So-Young; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			National Institutes of Health; United States Public Health Service [AI38897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI038897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, United States Public Health Service Grant AI38897 (to O.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 A trainee of National Institutes of Health Medical Scientist Training Program Grant GM07281 at The University of Chicago. 2 A member of and supported by the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (NIAID, NIH Award 1-U54-AI-057153).	Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; CALANDRA GB, 1980, INFECT IMMUN, V28, P1033; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; GHUYSEN J. M., 1965, BIOCHEMISTRY, V4, P2245, DOI 10.1021/bi00886a043; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HIGASHI Y, 1967, P NATL ACAD SCI USA, V57, P1878, DOI 10.1073/pnas.57.6.1878; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Maresso AW, 2007, J BIOL CHEM, V282, P23129, DOI 10.1074/jbc.M701857200; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; Severin A, 2004, MICROB DRUG RESIST, V10, P77, DOI 10.1089/1076629041310082; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; TonThat H, 1997, J BIOL CHEM, V272, P22285, DOI 10.1074/jbc.272.35.22285; TONTHAT H, 2004, MOL MICROBIOL, V53, P1147, DOI DOI 10.1111/J.1365-2958.2004.04193.X; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156	48	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36676	36686		10.1074/jbc.M806796200	http://dx.doi.org/10.1074/jbc.M806796200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940793	Green Published, hybrid			2022-12-25	WOS:000261840500066
J	Yogalingam, G; Pendergast, AM				Yogalingam, Gouri; Pendergast, Ann Marie			Abl Kinases Regulate Autophagy by Promoting the Trafficking and Function of Lysosomal Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TYROSINE KINASE; FAMILY KINASES; C-ABL; MONITORING AUTOPHAGY; IMATINIB; GROWTH; MTOR; ORGANIZATION; INHIBITION	Autophagy is a lysosome-dependent degradative pathway that regulates the turnover of intracellular organelles, parasites, and long-lived proteins. Deregulation of autophagy results in a variety of pathological conditions, but little is known regarding the mechanisms that link normal cellular and pathological signals to the regulation of distinct stages in the autophagy pathway. Here we uncover a novel role for the Abl family kinases in the regulation of the late stages of autophagy. Inhibition, depletion, or knockout of of the Abl family kinases, Abl and Arg, resulted in a dramatic reduction in the intracellular activities of the lysosomal glycosidases alpha-galactosidase, alpha-mannosidase and neuraminidase. Inhibition of Abl kinases also reduced the processing of the precursor forms of cathepsin D and cathepsin L to their mature, lysosomal forms, which coincided with the impaired turnover of long- lived cytosolic proteins and accumulation of autophagosomes. Furthermore, defective lysosomal degradation of long-lived proteins in the absence of Abl kinase signaling was accompanied by a perinuclear redistribution of lysosomes and increased glycosylation and stability of lysosome-associated membrane proteins, which are known to be substrates for lysosomal enzymes and play a role in regulating lysosome mobility. Our findings reveal a role for Abl kinases in the regulation of late-stage autophagy and have important implications for therapies that employ pharmacological inhibitors of the Abl kinases.	[Yogalingam, Gouri; Pendergast, Ann Marie] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Pendergast, AM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	pende014@mc.duke.edu		Pendergast, Ann Marie/0000-0002-1250-6880	National Institutes of Health [CA70940]; NATIONAL CANCER INSTITUTE [R01CA070940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA70940 (to A.M.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Appel S, 2005, CLIN CANCER RES, V11, P1928, DOI 10.1158/1078-0432.CCR-04-1713; Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; KOMINAMI E, 1988, FEBS LETT, V231, P225, DOI 10.1016/0014-5793(88)80736-1; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martin M, 2005, MOL BIOL CELL, V16, P4225, DOI 10.1091/mbc.E05-02-0116; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Van Glabbeke M, 2006, EUR J CANCER, V42, P2277, DOI 10.1016/j.ejca.2006.03.029; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhang Peilin, 2003, Mol Cancer, V2, P1	48	81	83	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35941	35953		10.1074/jbc.M804543200	http://dx.doi.org/10.1074/jbc.M804543200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945674	Green Published, hybrid			2022-12-25	WOS:000261687900069
J	Kang, JS; Colon, S; Hellmark, T; Sado, Y; Hudson, BG; Borza, DB				Kang, Jeong Suk; Colon, Selene; Hellmark, Thomas; Sado, Yoshikazu; Hudson, Billy G.; Borza, Dorin-Bogdan			Identification of Noncollagenous Sites Encoding Specific Interactions and Quaternary Assembly of alpha 3 alpha 4 alpha 5(IV) Collagen IMPLICATIONS FOR ALPORT GENE THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; IV COLLAGEN; NC1 DOMAINS; GOODPASTURE AUTOANTIBODIES; RENAL-TRANSPLANTATION; CRYSTAL-STRUCTURE; IMMUNE-RESPONSES; STRUCTURAL BASIS; HEMOPHILIA-A; CROSS-LINKS	Defective assembly of alpha 3 alpha 4 alpha 5(IV) collagen in the glomerular basement membrane causes Alport syndrome, a hereditary glomerulonephritis progressing to end-stage kidney failure. Assembly of collagen IV chains into heterotrimeric molecules and networks is driven by their noncollagenous (NC1) domains, but the sites encoding the specificity of these interactions are not known. To identify the sites directing quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen, correctly folded NC1 chimeras were produced, and their interactions with other NC1 monomers were evaluated. All alpha 1/alpha 5 chimeras containing alpha 5NC1 residues 188-227 replicated the ability of alpha 5NC1 to bind to alpha 3NC1 and co-assemble into NC1 hexamers. Conversely, substitution of alpha 5NC1 residues 188-227 by alpha 1NC1 abolished these quaternary interactions. The amino-terminal 58 residues of alpha 3NC1 encoded binding to alpha 5NC1, but this interaction was not sufficient for hexamer co-assembly. Because alpha 5NC1 residues 188-227 are necessary and sufficient for assembly into alpha 3 alpha 4 alpha 5NC1 hexamers, whereas the immunodominant alloantigenic sites of alpha 5NC1 do not encode specific quaternary interactions, the findings provide a basis for the rational design of less immunogenic alpha 5(IV) collagen constructs for the gene therapy of X-linked Alport patients.	[Borza, Dorin-Bogdan] Vanderbilt Univ, Div Nephrol, Dept Med, Med Ctr, Nashville, TN 37232 USA; [Hudson, Billy G.; Borza, Dorin-Bogdan] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.; Borza, Dorin-Bogdan] Vanderbilt Univ, Ctr Matrix Biol, Nashville, TN 37232 USA; [Hellmark, Thomas] Lund Univ, Kidney Res Lab, SE-22184 Lund, Sweden; [Sado, Yoshikazu] Shigei Med Res Inst, Okayama 701, Japan	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Lund University	Borza, DB (corresponding author), Vanderbilt Univ, Div Nephrol, Dept Med, Med Ctr, S-3223 Med Ctr N, Nashville, TN 37232 USA.	Dorin-Bogdan.Borza@vanderbilt.edu	Borza, Dorin-Bogdan/AAF-2156-2020; Hellmark, Thomas/U-6289-2017	Borza, Dorin-Bogdan/0000-0003-4568-279X; Hellmark, Thomas/0000-0002-2952-1155; Hudson, Billy/0000-0002-5420-4100	National Institutes of Health [R01 DK080799, P01 DK065123, R21 AI069874]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018381, R01DK080799, P01DK065123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK080799, P01 DK065123, and R21 AI069874 (to D.-B.B.) and R37 DK18381 (to B.G.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; Borza DB, 2002, J BIOL CHEM, V277, P40075, DOI 10.1074/jbc.M207769200; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Borza DB, 2007, NEPHRON EXP NEPHROL, V106, pE37, DOI 10.1159/000101791; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Brainwood D, 1998, KIDNEY INT, V53, P762, DOI 10.1046/j.1523-1755.1998.00794.x; Ferrer A, 2000, GENE THER, V7, P1439, DOI 10.1038/sj.gt.3301259; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gunnarsson A, 2000, J BIOL CHEM, V275, P30844, DOI 10.1074/jbc.M004717200; Harvey SJ, 2003, AM J PATHOL, V162, P873, DOI 10.1016/S0002-9440(10)63883-7; Heidet L, 2003, AM J PATHOL, V163, P1633, DOI 10.1016/S0002-9440(10)63520-1; Heikkila P, 2001, GENE THER, V8, P882, DOI 10.1038/sj.gt.3301342; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; Hellmark T, 1999, KIDNEY INT, V55, P936, DOI 10.1046/j.1523-1755.1999.055003936.x; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kalluri R, 2000, TRANSPLANTATION, V69, P679, DOI 10.1097/00007890-200002270-00038; Kang JS, 2007, J BIOL CHEM, V282, P10670, DOI 10.1074/jbc.M611892200; Kashtan CE, 2006, PEDIATR TRANSPLANT, V10, P651, DOI 10.1111/j.1399-3046.2006.00528.x; Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Parker ET, 2004, BLOOD, V104, P704, DOI 10.1182/blood-2003-11-3891; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Sarkar R, 2000, HUM GENE THER, V11, P881, DOI 10.1089/10430340050015491; Shull R, 1996, BLOOD, V88, P377; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Tryggvason K, 1997, KIDNEY INT, V51, P1493, DOI 10.1038/ki.1997.205; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; Wang XP, 2005, J AM SOC NEPHROL, V16, P3563, DOI 10.1681/ASN.2005060670; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359	35	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35070	35077		10.1074/jbc.M806396200	http://dx.doi.org/10.1074/jbc.M806396200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930919	Green Published, hybrid			2022-12-25	WOS:000261469100064
J	Li, YK; Zhang, Y; Dorweiler, B; Cui, DY; Wang, T; Woo, CW; Brunkan, CS; Wolberger, C; Imai, SI; Tabas, I				Li, Yankun; Zhang, Yuan; Dorweiler, Bernhard; Cui, Dongying; Wang, Tao; Woo, Connie W.; Brunkan, Cynthia S.; Wolberger, Cynthia; Imai, Shin-ichiro; Tabas, Ira			Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-ENHANCING FACTOR; ENDOPLASMIC-RETICULUM STRESS; TYPE-2 DIABETES-MELLITUS; CHOLESTEROL-LOADED MACROPHAGES; TUMOR-ASSOCIATED MACROPHAGES; UNFOLDED PROTEIN RESPONSE; LOW-DENSITY-LIPOPROTEIN; ER STRESS; MOLECULAR-MECHANISMS; BIOSYNTHETIC ENZYME	Macrophages play key roles in obesity-associated pathophysiology, including inflammation, atherosclerosis, and cancer, and processes that affect the survival-death balance of macrophages may have an important impact on obesity-related diseases. Adipocytes and other cells secrete a protein called extracellular nicotinamide phosphoribosyltransferase (eNampt; also known as pre-B cell colony enhancing factor or visfatin), and plasma levels of eNampt increase in obesity. Herein we tested the hypothesis that eNampt could promote cell survival in macrophages subjected to endoplasmic reticulum ( ER) stress, a process associated with obesity and obesity-associated diseases. We show that eNampt potently blocks macrophage apoptosis induced by a number of ER stressors. The mechanism involves a two-step sequential process: rapid induction of interleukin 6 (IL-6) secretion, followed by IL-6-mediated autocrine/paracrine activation of the prosurvival signal transducer STAT3. The ability of eNampt to trigger this IL-6/STAT3 cell survival pathway did not depend on the presence of the Nampt enzymatic substrate nicotinamide in the medium, could not be mimicked by the Nampt enzymatic product nicotinamide mononucleotide (NMN), was not blocked by the Nampt enzyme inhibitor FK866, and showed no correlation with enzyme activity in a series of site-directed mutant Nampt proteins. Thus, eNampt protects macrophages from ER stress-induced apoptosis by activating an IL-6/STAT3 signaling pathway via a nonenzymatic mechanism. These data suggest a novel action and mechanism of eNampt that could affect the balance of macrophage survival and death in the setting of obesity, which in turn could play important roles in obesity-associated diseases.	[Li, Yankun; Zhang, Yuan; Dorweiler, Bernhard; Cui, Dongying; Woo, Connie W.; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Univ Hosp, Dept Cardiothorac & Vasc Surg, Mainz, Germany; [Wang, Tao; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Wang, Tao; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Brunkan, Cynthia S.; Imai, Shin-ichiro] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Columbia University; Columbia University; Columbia University; Johannes Gutenberg University of Mainz; University Hospital Mainz; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Washington University (WUSTL)	Tabas, I (corresponding author), Columbia Univ, Dept Med, 630 W 168th St, New York, NY 10032 USA.	iat1@columbia.edu	Woo, Connie/AAX-2588-2020	Wolberger, Cynthia/0000-0001-8578-2969	National Institutes of Health [R01 HL075662, P01 HL087123, AG024150]; United States Army Medical Research and Materiel Command (USAMRMC) [W81XWH-06-1-0212]; Glenn Foundation; Ellison Medical Foundation; American Diabetes Association; Juvenile Diabetes Research Foundation; Deutsche Forschungsgemeinschaft [DO1289/2-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Glenn Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL075662 and P01 HL087123 ( to I. T.) and National Institutes of Health, NIA, Grant AG024150. This work was also supported by United States Army Medical Research and Materiel Command (USAMRMC) Grant W81XWH-06-1-0212 ( to I. T.); grants from the Glenn Foundation, Ellison Medical Foundation, American Diabetes Association, and Juvenile Diabetes Research Foundation ( to S. I.); and Deutsche Forschungsgemeinschaft Grant DO1289/2-1 ( to B. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Cook AD, 2003, J IMMUNOL, V171, P4816, DOI 10.4049/jimmunol.171.9.4816; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Haider DG, 2006, J PEDIATR GASTR NUTR, V43, P548, DOI 10.1097/01.mpg.0000235749.50820.b3; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Irigaray P, 2007, BIOMED PHARMACOTHER, V61, P665, DOI 10.1016/j.biopha.2007.10.008; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Knorre A, 2002, BIOL CHEM, V383, P271, DOI 10.1515/BC.2002.029; Lang R, 2005, IMMUNOBIOLOGY, V210, P63, DOI 10.1016/j.imbio.2005.05.001; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Libby Peter, 1993, Current Opinion in Lipidology, V4, P355, DOI 10.1097/00041433-199310000-00003; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Marriott HM, 2006, J IMMUNOL, V177, P6480, DOI 10.4049/jimmunol.177.9.6480; Matarese G, 2007, CURR PHARM DESIGN, V13, P3676, DOI 10.2174/138161207783018635; Miselis NR, 2008, MOL CANCER THER, V7, P788, DOI 10.1158/1535-7163.MCT-07-0579; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Nielsen M, 1997, P NATL ACAD SCI USA, V94, P6764, DOI 10.1073/pnas.94.13.6764; Nowell MA, 2006, ARTHRITIS RHEUM-US, V54, P2084, DOI 10.1002/art.21942; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Porta C, 2007, ADV EXP MED BIOL, V604, P67, DOI 10.1007/978-0-387-69116-9_5; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sandeep S, 2007, METABOLISM, V56, P565, DOI 10.1016/j.metabol.2006.12.005; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196; Tsutsumi S, 2003, FEBS LETT, V534, P49, DOI 10.1016/S0014-6793(02)03773-0; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	61	161	173	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34833	34843		10.1074/jbc.M805866200	http://dx.doi.org/10.1074/jbc.M805866200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945671	hybrid, Green Published			2022-12-25	WOS:000261469100039
J	Nomura, T; Quesada, AL; Kutchan, TM				Nomura, Taiji; Quesada, Alfonso Lara; Kutchan, Toni M.			The New beta-D-Glucosidase in Terpenoid-Isoquinoline Alkaloid Biosynthesis in Psychotria ipecacuanha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION CULTURES; MONOTERPENOID INDOLE ALKALOIDS; ALANGIUM-LAMARCKII THW; STRICTOSIDINE SYNTHASE; CATHARANTHUS-ROSEUS; KEY INTERMEDIATE; SUBCELLULAR-LOCALIZATION; RAUVOLFIA-SERPENTINA; MOLECULAR-CLONING; FREE-EXTRACTS	Ipecac alkaloids produced in the medicinal plant Psychotria ipecacuanha such as emetine and cephaeline possess a monoterpenoid-tetrahydroisoquinoline skeleton, which is formed by condensation of dopamine and secologanin. Deglucosylation of one of the condensed products N-deacetylisoipecoside(1 alpha(S)-epimer) is considered to be a part of the reactions for emetine biosynthesis, whereas its 1 beta(R)-epimer N-deacetylipecoside is converted to ipecoside in P. ipecacuanha. Here, we isolated a cDNA clone Ipeglu1 encoding Ipecac alkaloid beta-D-glucosidase from P. ipecacuanha. The deduced protein showed 54 and 48% identities to raucaffricine beta-glucosidase and strictosidine beta-glucosidase, respectively. Recombinant IpeGlu1 enzyme preferentially hydrolyzed glucosidic Ipecac alkaloids except for their lactams, but showed poor or no activity toward other substrates, including terpenoid-indole alkaloid glucosides. Liquid chromatography-tandem mass spectrometry analysis of deglucosylated products of N-deacetylisoipecoside revealed spontaneous transitions of the highly reactive aglycons, one of which was supposed to be the intermediate for emetine biosynthesis. IpeGlu1 activity was extremely poor toward 7-O-methyl and 6,7-O,O-dimethyl derivatives. However, 6-O-methyl derivatives were hydrolyzed as efficiently as non-methylated substrates, suggesting the possibility of 6-O-methylation prior to deglucosylation by IpeGlu1. In contrast to the strictosidine beta-glucosidase that stereospecifically hydrolyzes 3 alpha(S)-epimer in terpenoid-indole alkaloid biosynthesis, IpeGlu1 lacked stereospecificity for its substrates where 1 beta(R)-epimers were preferred to 1 alpha(S)-epimers, although ipecoside (1 beta(R)) is a major alkaloidal glucoside in P. ipecacuanha, suggesting the compartmentalization of IpeGlu1 from ipecoside. These facts have significant implications for distinct physiological roles of 1 alpha(S)- and 1 beta(R)-epimers and for the involvement of IpeGlu1 in the metabolic fate of both of them.	[Nomura, Taiji; Kutchan, Toni M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Quesada, Alfonso Lara; Kutchan, Toni M.] Leibniz Inst Pflanzenbiochem, D-06120 Halle, Germany	Donald Danforth Plant Science Center; Leibniz Institut fur Pflanzenbiochemie	Nomura, T (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tnomura@danforthcenter.org	Kutchan, Toni/L-4625-2013	Nomura, Taiji/0000-0003-4876-9866				Barleben L, 2007, PLANT CELL, V19, P2886, DOI 10.1105/tpc.106.045682; BATTERSB.AR, 1969, J CHEM SOC C, P1193, DOI 10.1039/j39690001193; Battersby A. R., 1971, CHEM COMMUN, P901; BATTERSBY AR, 1969, J CHEM SOC C, P1187, DOI 10.1039/j39690001187; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BHAKUNI DS, 1983, J CHEM SOC PERK T 1, P1949, DOI 10.1039/p19830001949; BRACHER D, 1992, ARCH BIOCHEM BIOPHYS, V294, P717, DOI 10.1016/0003-9861(92)90746-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; De-Eknamkul W, 2000, PHYTOCHEMISTRY, V55, P177, DOI 10.1016/S0031-9422(00)00260-0; DeEknamkul W, 1997, PHYTOCHEMISTRY, V45, P477, DOI 10.1016/S0031-9422(96)00828-X; DEWAAL A, 1995, BIOCHEM J, V306, P571, DOI 10.1042/bj3060571; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fujii T, 1998, ALKALOIDS CHEM BIOL, V51, P271; Geerlings A, 2000, J BIOL CHEM, V275, P3051, DOI 10.1074/jbc.275.5.3051; Gerasimenko I, 2002, EUR J BIOCHEM, V269, P2204, DOI 10.1046/j.1432-1033.2002.02878.x; HAMPP N, 1988, PHYTOCHEMISTRY, V27, P3811, DOI 10.1016/0031-9422(88)83023-1; ITOH A, 1995, J NAT PRODUCTS, V58, P1228, DOI 10.1021/np50122a011; Jain S, 2002, PHYTOCHEMISTRY, V60, P853, DOI 10.1016/S0031-9422(02)00057-2; JANOT MM, 1953, ALKALOIDS-CHEM BIOL, V3, P363; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Luijendijk TJC, 1996, J CHEM ECOL, V22, P1355, DOI 10.1007/BF02027718; Luijendijk TJC, 1998, PLANT PHYSIOL BIOCH, V36, P419, DOI 10.1016/S0981-9428(98)80205-2; MCKNIGHT TD, 1991, PLANTA, V185, P148, DOI 10.1007/BF00194055; NAGAKURA N, 1978, PLANTA MED, V34, P381, DOI 10.1055/s-0028-1097467; NAGAKURA N, 1978, J CHEM SOC CHEM COMM, P896, DOI 10.1039/c39780000896; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; Ounaroon A, 2003, PLANT J, V36, P808, DOI 10.1046/j.1365-313X.2003.01928.x; PFITZNER U, 1989, PLANTA MED, P525, DOI 10.1055/s-2006-962086; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; RUEFFER M, 1978, TETRAHEDRON LETT, P1593; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHOEB A, 1975, J CHEM SOC PERK T 1, P1245, DOI 10.1039/p19750001245; STEVENS LH, 1993, PLANT CELL REP, V12, P573, DOI 10.1007/BF00233063; STEVENS LH, 1993, PHYTOCHEMISTRY, V33, P99, DOI 10.1016/0031-9422(93)85403-E; STOCKIGT J, 1977, J CHEM SOC CHEM COMM, P646, DOI 10.1039/c39770000646; STOCKIGT J, 1977, J CHEM SOC CHEM COMM, P164, DOI 10.1039/c39770000164; STOCKIGT J, 1977, FEBS LETT, V79, P233, DOI 10.1016/0014-5793(77)80794-1; STOCKIGT J, 1976, FEBS LETT, V70, P267, DOI 10.1016/0014-5793(76)80772-7; TREIMER JF, 1979, EUR J BIOCHEM, V101, P225, DOI 10.1111/j.1432-1033.1979.tb04235.x; Warzecha H, 2000, PHYTOCHEMISTRY, V54, P657, DOI 10.1016/S0031-9422(00)00175-8; Yamazaki Y, 2003, PLANT CELL PHYSIOL, V44, P395, DOI 10.1093/pcp/pcg051	41	38	39	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34650	34659		10.1074/jbc.M806953200	http://dx.doi.org/10.1074/jbc.M806953200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18927081	Green Published, hybrid			2022-12-25	WOS:000261469100020
J	Parkash, V; Leppanen, VM; Virtanen, H; Jurvansuu, JM; Bespalov, MM; Sidorova, YA; Runeberg-Roos, P; Saarma, M; Goldman, A				Parkash, Vimal; Leppanen, Veli-Matti; Virtanen, Heidi; Jurvansuu, Jaana M.; Bespalov, Maxim M.; Sidorova, Yulia A.; Runeberg-Roos, Pia; Saarma, Mart; Goldman, Adrian			The Structure of the Glial Cell Line-derived Neurotrophic Factor-Coreceptor Complex INSIGHTS INTO RET SIGNALING AND HEPARIN BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDNF FAMILY LIGANDS; TYROSINE KINASE; RECEPTOR COMPLEX; GROWTH-FACTOR; GFR-ALPHA-1; ACTIVATION; SULFATE; DOMAIN; NEURTURIN; ARTEMIN	Glial cell line-derived neurotrophic factor (GDNF), a neuronal survival factor, binds its co-receptor GDNF family receptor alpha 1 (GFR alpha 1) in a 2: 2 ratio and signals through the receptor tyrosine kinase RET. We have solved the GDNF(2).GFR alpha 1(2) complex structure at 2.35 angstrom resolution in the presence of a heparin mimic, sucrose octasulfate. The structure of our GDNF(2).GFR alpha 1(2) complex and the previously published artemin(2).GFR alpha 3(2) complex are unlike in three ways. First, we have experimentally identified residues that differ in the ligand-GFR alpha interface between the two structures, in particular ones that buttress the key conserved Arg(GFR alpha)-Glu(ligand)-Arg(GFR alpha) interaction. Second, the flexible GDNF ligand "finger" loops fit differently into the GFR alpha s, which are rigid. Third, and we believe most importantly, the quaternary structure of the two tetramers is dissimilar, because the angle between the two GDNF monomers is different. This suggests that the RET-RET interaction differs in different ligand(2)-co-receptor(2)-RET2 heterohexamer complexes. Consistent with this, we showed that GDNF(2).GFR alpha 1(2) and artemin(2).GFR alpha 3(2) signal differently in a mitogen-activated protein kinase assay. Furthermore, we have shown by mutagenesis and enzyme-linked immunosorbent assays of RET phosphorylation that RET probably interacts with GFR alpha 1 residues Arg-190, Lys-194, Arg-197, Gln-198, Lys-202, Arg-257, Arg-259, Glu-323, and Asp-324 upon both domains 2 and 3. Interestingly, in our structure, sucrose octasulfate also binds to the Arg(190)-Lys(202) region in GFR alpha 1 domain 2. This may explain how GDNF.GFR alpha 1 can mediate cell adhesion and how heparin might inhibit GDNF signaling through RET.	[Goldman, Adrian] Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, Bioctr 3, FIN-00014 Helsinki, Finland; [Goldman, Adrian] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Goldman, A (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, Bioctr 3, Viikinkaari 1, FIN-00014 Helsinki, Finland.	adrian.goldman@helsinki.fi	Bespalov, Maxim/O-2817-2016; Jurvansuu, Jaana/H-1599-2012; Jurvansuu, Jaana/AAZ-8835-2020; Sidorova, Yulia/L-5340-2019	Bespalov, Maxim/0000-0002-8754-5753; Jurvansuu, Jaana/0000-0002-7801-3237; Goldman, Adrian/0000-0001-8032-9700; Sidorova, Yulia/0000-0001-8230-0530; Leppanen, Veli-Matti/0000-0001-7100-965X	Academy of Finland [1111771, 1114752, 70891, 1105237, 1109071]; Sigrid Juselius Foundation; Biocentrum Helsinki; Neuroscience Centre	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Neuroscience Centre	This work was supported by Academy of Finland Grants 1111771 and 1114752 (to A.G.), 70891 (to V.-M.L.), and 1105237 and 1109071 (to M.S.) and by grants from the Sigrid Juselius Foundation (to A.G. and M.S.), Biocentrum Helsinki (to A.G. and M.S.), and the Neuroscience Centre (to A.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alfano I, 2007, BIOCHEM J, V404, P131, DOI 10.1042/BJ20061747; Amoresano A, 2005, CELL SIGNAL, V17, P717, DOI 10.1016/j.cellsig.2004.10.012; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Baloh RH, 2000, J BIOL CHEM, V275, P3412, DOI 10.1074/jbc.275.5.3412; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Cabrera JR, 2006, J BIOL CHEM, V281, P14330, DOI 10.1074/jbc.M509572200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coulpier M, 2002, J BIOL CHEM, V277, P1991, DOI 10.1074/jbc.M107992200; Davies JA, 2003, GROWTH FACTORS, V21, P109, DOI 10.1080/08977190310001621005; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Lakhani VT, 2007, ANNU REV MED, V58, P253, DOI 10.1146/annurev.med.58.100305.115303; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Lee RHK, 2006, J NEUROSCI RES, V83, P80, DOI 10.1002/jnr.20701; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindahl M, 2001, J BIOL CHEM, V276, P9344, DOI 10.1074/jbc.M008279200; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rickard SM, 2003, GLYCOBIOLOGY, V13, P419, DOI 10.1093/glycob/cwg046; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Shults CW, 1996, NEUROREPORT, V7, P627, DOI 10.1097/00001756-199601310-00060; Silvian L, 2006, BIOCHEMISTRY-US, V45, P6801, DOI 10.1021/bi060035x; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; Virtanen H, 2005, BIOCHEM J, V387, P817, DOI 10.1042/BJ20041257; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Yasuhara T, 2007, ACTA MED OKAYAMA, V61, P51	48	62	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35164	35172		10.1074/jbc.M802543200	http://dx.doi.org/10.1074/jbc.M802543200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845535	hybrid, Green Published			2022-12-25	WOS:000261469100073
J	Sanada, T; Takaesu, G; Mashima, R; Yoshida, R; Kobayashi, T; Yoshimura, A				Sanada, Takahito; Takaesu, Giichi; Mashima, Ryuichi; Yoshida, Ryoko; Kobayashi, Takashi; Yoshimura, Akihiko			FLN29 Deficiency Reveals Its Negative Regulatory Role in the Toll-like Receptor (TLR) and Retinoic Acid-inducible Gene I (RIG-I)-like Helicase Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR CYLD; RIG-I; ADAPTER PROTEIN; ANTIVIRAL RESPONSES; KAPPA-B; INTERFERON; VIRUS; A20; INDUCTION	FLN29 was identified as an interferon (IFN)-inducible gene, and it has been shown to suppress Toll-like receptor 4-mediated NF-kappa B activation by binding to TRAF6. To elucidate the physiological roles of FLN29, we generated FLN29-deficient mice. FLN29 deficiency resulted in hyper-response to LPS both in vivo and in vitro, demonstrating the negative regulatory role of FLN29 in TLR4 signaling. Furthermore, we found that FLN29(-/-) mice exhibited increased susceptibility to poly(I:C)induced septic shock compared with WT mice. FLN29(-/-) fibroblasts were highly resistant to vesicular stomatitis virus infection, and these cells produced more IFN-beta than WT cells did in response to not only intracellular poly(I:C) but also overexpression of IPS-1. Forced expression of FLN29 inhibited the IPS-1-dependent activation of both NF-kappa B and IRF3. We also found that FLN29 could interact with TRIF, IPS-1, TRAF3, and TRAF6. Together, these results suggest that FLN29, in addition to playing a negative regulatory role in the TLR4 signaling pathway, negatively regulates the RIG-I-like helicase signaling pathway at the level of IPS-1/TRAF6 and IPS-1/TRAF3 complexes.	[Sanada, Takahito; Takaesu, Giichi; Yoshida, Ryoko; Kobayashi, Takashi; Yoshimura, Akihiko] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan; [Mashima, Ryuichi] Univ Tokyo, Inst Med Sci, Div Genet, Tokyo 1088639, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 332001, Japan	Kyushu University; University of Tokyo; Keio University; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013	Takaesu, Giichi/0000-0002-1581-1055	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); Nakatomi Foundation; Takeda Science Foundation; Kato Memorial Trust Foundation for Nanbyo Research; Suzuken Memorial Foundation; Japan Intractable Disease Research Foundation; Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Trust Foundation for Nanbyo Research; Suzuken Memorial Foundation; Japan Intractable Disease Research Foundation; Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research Fund	This work was supported in part by special Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the Nakatomi Foundation, the Takeda Science Foundation, The Kato Memorial Trust Foundation for Nanbyo Research, the Suzuken Memorial Foundation, the Japan Intractable Disease Research Foundation, the Mitsubishi Pharma Research Foundation, the Uehara Memorial Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Yakult Bioscience Research Foundation, and the Princess Takamatsu Cancer Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Mashima R, 2005, J BIOL CHEM, V280, P41289, DOI 10.1074/jbc.M508221200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200	26	42	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33858	33864		10.1074/jbc.M806923200	http://dx.doi.org/10.1074/jbc.M806923200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18849341	Green Published, hybrid			2022-12-25	WOS:000261277700010
J	Lu, P; Rha, GB; Melikishvili, M; Wu, GT; Adkins, BC; Fried, MG; Chi, YI				Lu, Peng; Rha, Geun Bae; Melikishvili, Manana; Wu, Guangteng; Adkins, Brandon C.; Fried, Michael G.; Chi, Young-In			Structural Basis of Natural Promoter Recognition by a Unique Nuclear Receptor, HNF4 alpha DIABETES GENE PRODUCT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; CIRCULAR-DICHROISM SPECTRA; RETINOID-X-RECEPTOR; FACTOR 4-ALPHA; RESPONSE ELEMENTS; TRANSCRIPTIONAL ACTIVITY; LIGAND SPECIFICITY; INSULIN-SECRETION; VISCERAL ENDODERM; CENTRAL REGULATOR	HNF4 alpha ( hepatocyte nuclear factor 4 alpha) plays an essential role in the development and function of vertebrate organs, including hepatocytes and pancreatic beta-cells by regulating expression of multiple genes involved in organ development, nutrient transport, and diverse metabolic pathways. As such, HNF4 alpha is a culprit gene product for a monogenic and dominantly inherited form of diabetes, known as maturity onset diabetes of the young (MODY). As a unique member of the nuclear receptor superfamily, HNF4 alpha recognizes target genes containing two hexanucleotide direct repeat DNA-response elements separated by one base pair (DR1) by exclusively forming a cooperative homodimer. We describe here the 2.0 angstrom crystal structure of human HNF4 alpha DNA binding domain in complex with a high affinity promoter element of another MODY gene, HNF1 alpha, which reveals the molecular basis of unique target gene selection/recognition, DNA binding cooperativity, and dysfunction caused by diabetes-causing mutations. The predicted effects of MODY mutations have been tested by a set of biochemical and functional studies, which show that, in contrast to other MODY gene products, the subtle disruption of HNF4 alpha molecular function can cause significant effects in afflicted MODY patients.	[Chi, Young-In] Univ Kentucky, Struct Biol Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Chi, YI (corresponding author), Univ Kentucky, Struct Biol Ctr, Dept Mol & Cellular Biochem, 741 S Limestone Ave, Lexington, KY 40536 USA.	ychi@uky.edu			National Institutes of Health [P20RR20171, GM070662]; Juvenile Diabetes Research Foundation [1-2004-506]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR20171 from the COBRE program of the National Center for Research Resources ( to Y. I. C.) and National Institutes of Health Grant GM070662 ( to M. G. F.). This work was also supported by Juvenile Diabetes Research Foundation Grant 1-2004-506 ( to Y. I. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggelidou E, 2006, FEBS J, V273, P1948, DOI 10.1111/j.1742-4658.2006.05208.x; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P156, DOI 10.1016/j.abb.2006.05.008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chi YI, 2002, MOL CELL, V10, P1129, DOI 10.1016/S1097-2765(02)00704-9; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Duncan SA, 1997, DEVELOPMENT, V124, P279; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Gragnoli C, 1997, DIABETES, V46, P1648, DOI 10.2337/diabetes.46.10.1648; Guo HT, 2006, BIOCHEM J, V394, P379, DOI 10.1042/BJ20051730; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hertz R, 2005, J BIOL CHEM, V280, P24451, DOI 10.1074/jbc.M500732200; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Holmbeck SMA, 1998, J MOL BIOL, V284, P533, DOI 10.1006/jmbi.1998.2207; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Jakob M, 2007, NUCLEIC ACIDS RES, V35, P2705, DOI 10.1093/nar/gkm162; Jiang GQ, 1997, J BIOL CHEM, V272, P1218, DOI 10.1074/jbc.272.2.1218; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Kritis AA, 1996, GENE, V173, P275, DOI 10.1016/0378-1119(96)00183-7; Kulkarni RN, 2004, SCIENCE, V303, P1311, DOI 10.1126/science.1095486; Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lu P, 2008, ACTA CRYSTALLOGR F, V64, P313, DOI 10.1107/S1744309108007136; Lu P, 2007, BIOCHEMISTRY-US, V46, P12071, DOI 10.1021/bi7010527; Malecki MT, 1999, DIABETIC MED, V16, P193, DOI 10.1046/j.1464-5491.1999.00073.x; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIURA N, 1993, NUCLEIC ACIDS RES, V21, P3731, DOI 10.1093/nar/21.16.3731; Monney CT, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9050; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oxombre B, 2004, BIOCHEM J, V383, P573, DOI 10.1042/BJ20040473; Oxombre W, 2002, J MOL MED-JMM, V80, P423, DOI 10.1007/s00109-002-0340-8; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pearson ER, 2005, DIABETOLOGIA, V48, P878, DOI 10.1007/s00125-005-1738-y; Petrescu AD, 2005, J BIOL CHEM, V280, P16714, DOI 10.1074/jbc.M405906200; Petrescu AD, 2002, J BIOL CHEM, V277, P23988, DOI 10.1074/jbc.M201241200; Pruhova S, 2003, DIABETOLOGIA, V46, P291, DOI 10.1007/s00125-002-1010-7; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Schroeder F, 2005, LIPIDS, V40, P559, DOI 10.1007/s11745-005-1416-y; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Sladek FM, 1998, DIABETES, V47, P985, DOI 10.2337/diabetes.47.6.985; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Tsodikov OV, 2001, BIOPHYS J, V81, P1960, DOI 10.1016/S0006-3495(01)75847-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Vaxillaire M, 2006, ENDOCRIN METAB CLIN, V35, P371, DOI 10.1016/j.ecl.2006.02.009; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhao Q, 2000, J MOL BIOL, V296, P509, DOI 10.1006/jmbi.1999.3457	80	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33685	33697		10.1074/jbc.M806213200	http://dx.doi.org/10.1074/jbc.M806213200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829458	Green Published, hybrid			2022-12-25	WOS:000261183700075
J	Ato, M; Ikebe, T; Kawabata, H; Takemori, T; Watanabe, H				Ato, Manabu; Ikebe, Tadayoshi; Kawabata, Hiroki; Takemori, Toshitada; Watanabe, Haruo			Incompetence of Neutrophils to Invasive Group A streptococcus Is Attributed to Induction of Plural Virulence Factors by Dysfunction of a Regulator	PLOS ONE			English	Article							SHOCK-LIKE SYNDROME; STREPTOLYSIN-O; CYSTEINE PROTEASE; ENHANCING EVASION; PYOGENES; PATHOGENESIS; INFECTIONS; EXPRESSION; MODULATE; GENE	Group A streptococcus (GAS) causes variety of diseases ranging from common pharyngitis to life-threatening severe invasive diseases, including necrotizing fasciitis and streptococcal toxic shock-like syndrome. The characteristic of invasive GAS infections has been thought to attribute to genetic changes in bacteria, however, no clear evidence has shown due to lack of an intriguingly study using serotype-matched isolates from clinical severe invasive GAS infections. In addition, rare outbreaks of invasive infections and their distinctive pathology in which infectious foci without neutrophil infiltration hypothesized us invasive GAS could evade host defense, especially neutrophil functions. Herein we report that a panel of serotype-matched GAS, which were clinically isolated from severe invasive but not from non-invaive infections, could abrogate functions of human polymorphnuclear neutrophils (PMN) in at least two independent ways; due to inducing necrosis to PMN by enhanced production of a pore-forming toxin streptolysin O (SLO) and due to impairment of PMN migration via digesting interleukin-8, a PMN attracting chemokine, by increased production of a serine protease ScpC. Expression of genes was upregulated by a loss of repressive function with the mutation of csrS gene in the all emm49 severe invasive GAS isolates. The csrS mutants from clinical severe invasive GAS isolates exhibited high mortality and disseminated infection with paucity of neutrophils, a characteristic pathology seen in human invasive GAS infection, in a mouse model. However, GAS which lack either SLO or ScpC exhibit much less mortality than the csrS-mutated parent invasive GAS isolate to the infected mice. These results suggest that the abilities of GAS to abrogate PMN functions can determine the onset and severity of invasive GAS infection.	[Ato, Manabu] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Ikebe, Tadayoshi; Kawabata, Hiroki; Watanabe, Haruo] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Takemori, Toshitada] Riken Res Ctr Allergy & Immunol, Lab Immunol Memory, Kanagawa, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); RIKEN	Ato, M (corresponding author), Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan.	tdikebe@nih.go.jp	Ato, Manabu/K-6452-2019	Ato, Manabu/0000-0002-3178-2645	Ministry of Health, Labour and Welfare of Japan [H19-Shinkou-Ippan-002]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant (H19-Shinkou-Ippan-002, to H.W) from the Ministry of Health, Labour and Welfare of Japan.	Ato M, 2002, NAT IMMUNOL, V3, P1185, DOI 10.1038/ni861; Bakleh M, 2005, CLIN INFECT DIS, V40, P410, DOI 10.1086/427286; Bhakdi S, 1996, ARCH MICROBIOL, V165, P73, DOI 10.1007/s002030050300; BHAKDI S, 1985, INFECT IMMUN, V48, P713, DOI 10.1128/IAI.48.3.713-719.1985; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Eriksson BKG, 1998, CLIN INFECT DIS, V27, P1428, DOI 10.1086/515012; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Hasegawa T, 2004, MICROBES INFECT, V6, P1073, DOI 10.1016/j.micinf.2004.06.001; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; HIRSCH JG, 1963, J EXP MED, V118, P223, DOI 10.1084/jem.118.2.223; Ikebe T, 2005, JPN J INFECT DIS, V58, P272; Ikebe T, 2004, JPN J INFECT DIS, V57, P187; Ikebe T, 2003, EPIDEMIOL INFECT, V130, P569, DOI 10.1017/S0950268803008331; ITH A, 2005, LANCET INFECT DIS, V5, P494; Iversen PO, 2002, AM J PHYSIOL-REG I, V282, pR166, DOI 10.1152/ajpregu.2002.282.1.R166; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; MARHOFFER W, 1992, DIABETES CARE, V15, P256, DOI 10.2337/diacare.15.2.256; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Miyoshi-Akiyama T, 2005, J INFECT DIS, V192, P107, DOI 10.1086/430617; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Propst-Graham KL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-94; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Sierig G, 2003, INFECT IMMUN, V71, P446, DOI 10.1128/IAI.71.1.446-455.2003; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; Voyich JM, 2004, MICROBES INFECT, V6, P1117, DOI 10.1016/j.micinf.2004.05.022; Walev I, 2001, FASEB J, V15, P237, DOI 10.1096/fj.01-0572fje; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612	44	45	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3455	10.1371/journal.pone.0003455	http://dx.doi.org/10.1371/journal.pone.0003455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941623	gold, Green Published, Green Submitted			2022-12-25	WOS:000265125900003
J	Lovell, PV; Clayton, DF; Replogle, KL; Mello, CV				Lovell, Peter V.; Clayton, David F.; Replogle, Kirstin L.; Mello, Claudio V.			Birdsong "Transcriptomics": Neurochemical Specializations of the Oscine Song System	PLOS ONE			English	Article								Background: Vocal learning is a rare and complex behavioral trait that serves as a basis for the acquisition of human spoken language. In songbirds, vocal learning and production depend on a set of specialized brain nuclei known as the song system. Methodology/Principal Findings: Using high-throughput functional genomics we have identified,200 novel molecular markers of adult zebra finch HVC, a key node of the song system. These markers clearly differentiate HVC from the general pallial region to which HVC belongs, and thus represent molecular specializations of this song nucleus. Bioinformatics analysis reveals that several major neuronal cell functions and specific biochemical pathways are the targets of transcriptional regulation in HVC, including: 1) cell-cell and cell-substrate interactions (e. g., cadherin/catenin-mediated adherens junctions, collagen-mediated focal adhesions, and semaphorin-neuropilin/plexin axon guidance pathways); 2) cell excitability (e. g., potassium channel subfamilies, cholinergic and serotonergic receptors, neuropeptides and neuropeptide receptors); 3) signal transduction (e. g., calcium regulatory proteins, regulators of G-protein-related signaling); 4) cell proliferation/death, migration and differentiation (e. g., TGF-beta/BMP and p53 pathways); and 5) regulation of gene expression (candidate retinoid and steroid targets, modulators of chromatin/nucleolar organization). The overall direction of regulation suggest that processes related to cell stability are enhanced, whereas proliferation, growth and plasticity are largely suppressed in adult HVC, consistent with the observation that song in this songbird species is mostly stable in adulthood. Conclusions/Significance: Our study represents one of the most comprehensive molecular genetic characterizations of a brain nucleus involved in a complex learned behavior in a vertebrate. The data indicate numerous targets for pharmacological and genetic manipulations of the song system, and provide novel insights into mechanisms that might play a role in the regulation of song behavior and/or vocal learning.	[Lovell, Peter V.; Mello, Claudio V.] Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR USA; [Clayton, David F.; Replogle, Kirstin L.] Univ Illinois, Urbana, IL USA	Oregon Health & Science University; University of Illinois System; University of Illinois Urbana-Champaign	Lovell, PV (corresponding author), Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR USA.	melloc@ohsu.edu	Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488; Mello, Claudio/0000-0002-9826-8421	NIH/NIDCD [DC002853]; NIH/NINDS [NS054267, NS045264]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045264, F32NS054267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002853, R29DC002853] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH/NIDCD grant DC002853 (to CVM), and NIH/NINDS grant NS054267 (to PVL), and Initiative NIH/NINDS grant NS045264 (to DFC).	Agate RJ, 2002, BIOL REPROD, V66, P1127, DOI 10.1095/biolreprod66.4.1127; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1992, J NEUROBIOL, V23, P396, DOI 10.1002/neu.480230406; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; Bailey DJ, 2002, J NEUROBIOL, V52, P43, DOI 10.1002/neu.10070; BRENOWITZ EA, 1991, J NEUROSCI, V11, P1367; Brenowitz EA, 1997, J NEUROBIOL, V33, P517, DOI 10.1002/(SICI)1097-4695(19971105)33:5<517::AID-NEU3>3.0.CO;2-7; Dabrowski M, 2003, J NEUROCHEM, V85, P1279, DOI 10.1046/j.1471-4159.2003.01753.x; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Duffy DL, 1999, BRAIN RES, V844, P78, DOI 10.1016/S0006-8993(99)01915-0; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; GEORGE JM, 1992, MOL BRAIN RES, V12, P323, DOI 10.1016/0169-328X(92)90134-W; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Hofmann HA, 2003, J NEUROBIOL, V54, P272, DOI 10.1002/neu.10172; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Jarvis ED, 1997, NEUROREPORT, V8, P2073, DOI 10.1097/00001756-199705260-00052; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; KIRN JR, 1991, J NEUROSCI, V11, P1756; Li R, 1997, BRAIN RES, V763, P239, DOI 10.1016/S0006-8993(97)00417-4; Li XC, 2007, P NATL ACAD SCI USA, V104, P6834, DOI 10.1073/pnas.0701619104; Lomax MI, 2000, HEARING RES, V147, P293, DOI 10.1016/S0378-5955(00)00139-8; Lombardo F, 2004, FASEB J, V18, P52, DOI 10.1096/fj.03-0521com; Malyala A, 2004, NEUROCHEM RES, V29, P1189, DOI 10.1023/B:NERE.0000023606.13670.1d; Massengill JL, 1997, J NEUROSCI, V17, P3136; Mello C V, 1997, Methods Mol Biol, V85, P205; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Reiner A, 2004, ANN NY ACAD SCI, V1016, P77, DOI 10.1196/annals.1298.013; Renn SCP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-42; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Rho JY, 2004, ENDOCR RES, V30, P257, DOI 10.1081/ERC-120039579; ROUSSELOT P, 1995, J COMP NEUROL, V356, P629, DOI 10.1002/cne.903560411; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; RYAN SM, 1981, J COMP NEUROL, V202, P211, DOI 10.1002/cne.902020207; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Shea SD, 2003, NEURON, V40, P1213, DOI 10.1016/S0896-6273(03)00723-2; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; SHEN P, 1994, MOL BRAIN RES, V24, P227, DOI 10.1016/0169-328X(94)90136-8; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Takita J, 2004, GENE CHROMOSOME CANC, V40, P120, DOI 10.1002/gcc.20021; Torres-Munoz JE, 2004, MOL BRAIN RES, V127, P105, DOI 10.1016/j.molbrainres.2004.05.017; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Velho TAF, 2007, J COMP NEUROL, V500, P477, DOI 10.1002/cne.21180; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; WATSON JT, 1988, J COMP NEUROL, V274, P255, DOI 10.1002/cne.902740209; WEISER M, 1995, J NEUROSCI, V15, P4298; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Wilbrecht L, 2003, MENT RETARD DEV D R, V9, P135, DOI 10.1002/mrdd.10073; Wilbrecht L, 2006, J NEUROSCI, V26, P9135, DOI 10.1523/JNEUROSCI.4869-05.2006; Wild JM, 2005, J COMP NEUROL, V483, P76, DOI 10.1002/cne.20403; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wood WE, 2008, DEV NEUROBIOL, V68, P1213, DOI 10.1002/dneu.20642; Zeigler H. P., 2004, BEHAV NEUROBIOLOGY B, V1016	64	70	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3440	10.1371/journal.pone.0003440	http://dx.doi.org/10.1371/journal.pone.0003440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941504	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125600004
J	Okubadejo, N; Britton, A; Crews, C; Akinyemi, R; Hardy, J; Singleton, A; Bras, J				Okubadejo, Njideka; Britton, Angela; Crews, Cynthia; Akinyemi, Rufus; Hardy, John; Singleton, Andrew; Bras, Jose			Analysis of Nigerians with Apparently Sporadic Parkinson Disease for Mutations in LRRK2, PRKN and ATXN3	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; COMMON FOUNDER; GENE; ONSET; G2019S; POLYMORPHISMS; FAMILIES	Several genetic variations have been associated with Parkinson disease in different populations over the past few years. Although a considerable number of worldwide populations have been screened for these variants, results from Sub-Saharan populations are very scarce in the literature. In the present report we have screened a cohort of Parkinson disease patients (n = 57) and healthy controls (n = 51) from Nigeria for mutations in the genes PRKN, LRRK2 and ATXN3. No pathogenic mutations were found in any of the genes. Hence, common pathogenic mutations in these genes, observed in several different populations, are not a frequent cause of Parkinson disease in Nigeria.	[Okubadejo, Njideka] Univ Lagos, Coll Med, Dept Med, Neurol Unit, Lagos, Nigeria; [Britton, Angela; Crews, Cynthia; Singleton, Andrew; Bras, Jose] NIA, Lab Neurogenet, NIH, Bethesda, MD USA; [Akinyemi, Rufus] Fed Med Ctr, Dept Med, Neurol Unit, Abeokuta, Nigeria; [Hardy, John] Reta Lila Weston Inst, Inst Neurol, Dept Mol Neurosci & Neurodegenerat Dis, London, England; [Bras, Jose] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3000 Coimbra, Portugal	University of Lagos; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; Universidade de Coimbra	Okubadejo, N (corresponding author), Univ Lagos, Coll Med, Dept Med, Neurol Unit, Lagos, Nigeria.	brasj@mail.nih.gov	Bras, Jose MT/A-1428-2011; Hardy, John/C-2451-2009; Singleton, Andrew B/C-3010-2009	Hardy, John/0000-0002-3122-0423; Okubadejo, Njideka/0000-0003-2975-8803; Bras, Jose/0000-0001-8186-0333; Akinyemi, Rufus/0000-0001-5286-428X	Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services [Z01-AG000957-05]; Portuguese FCT [SFRH/BD/29647/2006]; NATIONAL INSTITUTE ON AGING [Z01AG000957] Funding Source: NIH RePORTER; Medical Research Council [G0701075] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Portuguese FCT(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services; Annual Report number Z01-AG000957-05 and Portuguese FCT grant #SFRH/BD/29647/2006.	Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bras JM, 2005, MOVEMENT DISORD, V20, P1653, DOI 10.1002/mds.20682; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Gwinn-Hardy K, 2001, ARCH NEUROL-CHICAGO, V58, P296, DOI 10.1001/archneur.58.2.296; Gwinn-Hardy K, 2000, NEUROLOGY, V55, P800, DOI 10.1212/WNL.55.6.800; Hoehn MM, 2001, NEUROLOGY, V57, pS11; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein C, 2007, LANCET NEUROL, V6, P652, DOI 10.1016/S1474-4422(07)70174-6; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lesage S, 2005, AM J HUM GENET, V77, P330, DOI 10.1086/432422; Lincoln SJ, 2003, MOVEMENT DISORD, V18, P1306, DOI 10.1002/mds.10601; Lucking CB, 2003, ARCH NEUROL-CHICAGO, V60, P1253, DOI 10.1001/archneur.60.9.1253; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Okubadejo NU, 2008, PARKINSONISM RELAT D, V14, P177, DOI 10.1016/j.parkreldis.2007.08.006; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paisan-Ruiz C, 2008, HUM MUTAT, V29, P485, DOI 10.1002/humu.20668; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Simon-Sanchez J, 2008, HUM MUTAT, V29, P315, DOI 10.1002/humu.20626; Subramony SH, 2002, MOVEMENT DISORD, V17, P1068, DOI 10.1002/mds.10241; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	26	46	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3421	10.1371/journal.pone.0003421	http://dx.doi.org/10.1371/journal.pone.0003421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927607	gold, Green Published, Green Submitted			2022-12-25	WOS:000265122400002
J	Selvarajoo, K; Takada, Y; Gohda, J; Helmy, M; Akira, S; Tomita, M; Tsuchiya, M; Inoue, J; Matsuo, K				Selvarajoo, Kumar; Takada, Yasunari; Gohda, Jin; Helmy, Mohamed; Akira, Shizuo; Tomita, Masaru; Tsuchiya, Masa; Inoue, Jun-ichiro; Matsuo, Koichi			Signaling Flux Redistribution at Toll-Like Receptor Pathway Junctions	PLOS ONE			English	Article								Various receptors on cell surface recognize specific extracellular molecules and trigger signal transduction altering gene expression in the nucleus. Gain or loss-of-function mutations of one molecule have shown to affect alternative signaling pathways with a poorly understood mechanism. In Toll-like receptor (TLR) 4 signaling, which branches into MyD88- and TRAM-dependent pathways upon lipopolysaccharide (LPS) stimulation, we investigated the gain or loss-of-function mutations of MyD88. We predict, using a computational model built on the perturbation-response approach and the law of mass conservation, that removal and addition of MyD88 in TLR4 activation, enhances and impairs, respectively, the alternative TRAM-dependent pathway through signaling flux redistribution (SFR) at pathway branches. To verify SFR, we treated MyD88- deficient macrophages with LPS and observed enhancement of TRAM-dependent pathway based on increased IRF3 phosphorylation and induction of Cxcl10 and Ifit2. Furthermore, increasing the amount of MyD88 in cultured cells showed decreased TRAM binding to TLR4. Investigating another TLR4 pathway junction, from TRIF to TRAF6, RIP1 and TBK1, the removal of MyD88- dependent TRAF6 increased expression of TRAM-dependent Cxcl10 and Ifit2. Thus, we demonstrate that SFR is a novel mechanism for enhanced activation of alternative pathways when molecules at pathway junctions are removed. Our data suggest that SFR may enlighten hitherto unexplainable intracellular signaling alterations in genetic diseases where gain or loss-of-function mutations are observed.	[Selvarajoo, Kumar; Helmy, Mohamed; Tomita, Masaru; Tsuchiya, Masa] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Takada, Yasunari; Matsuo, Koichi] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 108, Japan; [Gohda, Jin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo, Japan; [Akira, Shizuo] Osaka Univ, Res Inst Microb Dis, Dept Host Defense, Suita, Osaka 565, Japan	Keio University; Keio University; University of Tokyo; Osaka University	Selvarajoo, K (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	kumar@ttck.keio.ac.jp; matsuo@sc.itc.keio.ac.jp	Matsuo, Koichi/K-5695-2012; Akira, Shizuo/C-3134-2009	Matsuo, Koichi/0000-0002-1490-8955; Helmy, Mohamed/0000-0002-9561-7956; Selvarajoo, Kumar/0000-0002-0314-9666	Keio University [Differing Fields Collaboration]; Naito Foundation; CREST of Japan, Science and Technology, and Tsuruoka City Yamagata prefecture	Keio University; Naito Foundation(Naito Memorial Foundation); CREST of Japan, Science and Technology, and Tsuruoka City Yamagata prefecture	This study is funded by the Differing Fields Collaboration Grant from Keio University, a grant-in-aid for Scientific Research on Priority Areas and the Naito Foundation, CREST of Japan, Science and Technology, and Tsuruoka City Yamagata prefecture. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Carpenter S, 2007, CELL MICROBIOL, V9, P1891, DOI 10.1111/j.1462-5822.2007.00965.x; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Ray N, 2006, INT IMMUNOL, V18, P671, DOI 10.1093/intimm/dxl004; Ross J, 2008, J PHYS CHEM A, V112, P2134, DOI 10.1021/jp711313e; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Selvarajoo K, 2006, FEBS LETT, V580, P1457, DOI 10.1016/j.febslet.2006.01.046; SELVARAJOO K, 2007, INTRO SYSTEMS BIOL, P449; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Vance W, 2002, P NATL ACAD SCI USA, V99, P5816, DOI 10.1073/pnas.022049699; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yeo ZX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000776	32	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3430	10.1371/journal.pone.0003430	http://dx.doi.org/10.1371/journal.pone.0003430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927610	gold, Green Submitted, Green Published			2022-12-25	WOS:000265122400005
J	Burioni, R; Mancini, N; De Marco, D; Clementi, N; Perotti, M; Nitti, G; Sassi, M; Canducci, F; Shvela, K; Bagnarelli, P; Mascola, JR; Clementi, M				Burioni, Roberto; Mancini, Nicasio; De Marco, Donata; Clementi, Nicola; Perotti, Mario; Nitti, Giovanni; Sassi, Monica; Canducci, Filippo; Shvela, Krisha; Bagnarelli, Patrizia; Mascola, John R.; Clementi, Massimo			Anti-HIV-1 Response Elicited in Rabbits by Anti-Idiotype Monoclonal Antibodies Mimicking the CD4-Binding Site	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS; CD4-BOUND STATE; HIV-1 ENVELOPE; FAB FRAGMENTS; CD4 RECEPTOR; GP120; VACCINE; PROTECTION	Antibodies against conserved epitopes on HIV-1 envelope glycoproteins (Env), such as the gp120 CD4-binding site (CD4bs), could contribute to protection against HIV-1. Env-based immunogens inducing such a response could be a major component of future anti-HIV-1 strategies. In this proof-of-concept study we describe the generation of two anti-idiotype (AI) murine antibodies mimicking the CD4bs epitope. Sera were collected from long-term non-progressor patients to obtain CD4bs-directed IgG, through sequential purification steps. The purified IgG were then used as Fab fragments to immunize mice for hybridoma generation. Two hybridomas (P1 and P2), reacting only against the CD4bs-directed IgG, were identified and characterized. The P1 and P2 antibodies were shown to recognize the idiotype of the broadly neutralizing anti-CD4bs human mAb b12. Both P1 and P2 Fabs were able to induce a strong anti-gp120 response in rabbits. Moreover, the rabbits' sera were shown to neutralize two sensitive tier 1 strains of HIV-1 in an Env-pseudotype neutralization assay. In particular, 3/5 rabbits in the P1 group and 1/5 in the P2 group showed greater than 80% neutralizing activity against the HXB2 pseudovirus. Two rabbits also neutralized the pseudovirus HIV-MN. Overall, these data describe the first anti-idiotypic vaccine approach performed to generate antibodies to the CD4bs of the HIV-1 gp120. Although future studies will be necessary to improve strength and breadth of the elicited neutralizing response, this proof-of-concept study documents that immunogens designed on the idiotype of broadly neutralizing Abs are feasible and could help in the design of future anti-HIV strategies.	[Burioni, Roberto; Mancini, Nicasio; De Marco, Donata; Clementi, Nicola; Perotti, Mario; Nitti, Giovanni; Sassi, Monica; Canducci, Filippo; Clementi, Massimo] Univ Vita Salute San Raffaele, Ist Sci San Raffaele Diagnost & Ric San Raf, Lab Microbiol & Virol, Milan, Italy; [Shvela, Krisha; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA; [Bagnarelli, Patrizia] Univ Politecn Marche, Lab Viro, Ancona, Italy	Vita-Salute San Raffaele University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Marche Polytechnic University	Burioni, R (corresponding author), Univ Vita Salute San Raffaele, Ist Sci San Raffaele Diagnost & Ric San Raf, Lab Microbiol & Virol, Milan, Italy.	burioni.roberto@hsr.it	Bagnarelli, Patrizia/AAL-2750-2020; Clementi, Massimo/F-6646-2013; Clementi, Nicola/G-8545-2014; Mancini, Nicasio/AAN-6203-2020; Mascola, John/AAI-7193-2021; Burioni, Roberto/F-2396-2012	Bagnarelli, Patrizia/0000-0001-5231-9660; Clementi, Nicola/0000-0002-1822-9861; Clementi, Massimo/0000-0002-7461-5898; Canducci, Filippo/0000-0002-5637-6205; MANCINI, Nicasio/0000-0003-0637-0910	Intramural Research Program of the Vaccine Research Center, NIAID, NI	Intramural Research Program of the Vaccine Research Center, NIAID, NI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported, in part, by the Intramural Research Program of the Vaccine Research Center, NIAID, NI to J.R.M..	BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Braibant M, 2006, AIDS, V20, P1923, DOI 10.1097/01.aids.0000247113.43714.5e; Burioni R, 1998, J IMMUNOL METHODS, V217, P195, DOI 10.1016/S0022-1759(98)00102-1; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 2000, NAT MED, V6, P123, DOI 10.1038/72200; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen XN, 2001, NAT MED, V7, P1225, DOI 10.1038/nm1101-1225; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dorgham K, 2005, AIDS RES HUM RETROV, V21, P82, DOI 10.1089/aid.2005.21.82; HARIHARAN K, 1993, J VIROL, V67, P953, DOI 10.1128/JVI.67.2.953-960.1993; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Huber M, 2007, J INTERN MED, V262, P5, DOI 10.1111/j.1365-2796.2007.01819.x; Humbert M, 2007, EUR J IMMUNOL, V37, P501, DOI 10.1002/eji.200636560; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Mantis NJ, 2007, J IMMUNOL, V179, P3144, DOI 10.4049/jimmunol.179.5.3144; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Plotkin SA, 2001, PEDIATR INFECT DIS J, V20, P63, DOI 10.1097/00006454-200101000-00013; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; Scala G, 1999, J IMMUNOL, V162, P6155; Srivastava IK, 2005, HUM VACCINES, V1, P45, DOI 10.4161/hv.1.2.1764; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	41	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3423	10.1371/journal.pone.0003423	http://dx.doi.org/10.1371/journal.pone.0003423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923648	Green Submitted, Green Published, gold			2022-12-25	WOS:000265122200004
J	Kaur, H; Goodman, C; Thompson, E; Thompson, KA; Masanja, I; Kachur, SP; Abdulla, S				Kaur, Harparkash; Goodman, Catherine; Thompson, Eloise; Thompson, Katy-Anne; Masanja, Irene; Kachur, S. Patrick; Abdulla, Salim			A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in Tanzania	PLOS ONE			English	Article								Introduction: Retail pharmaceutical products are commonly used to treat fever and malaria in sub-Saharan African countries. Small scale studies have suggested that poor quality antimalarials are widespread throughout the region, but nationwide data are not available that could lead to generalizable conclusions about the extent to which poor quality drugs are available in African communities. This study aimed to assess the quality of antimalarials available from retail outlets across mainland Tanzania. Methods and Findings: We systematically purchased samples of oral antimalarial tablets from retail outlets across 21 districts in mainland Tanzania in 2005. A total of 1080 antimalarial formulations were collected including 679 antifol antimalarial samples (394 sulfadoxine/pyrimethamine and 285 sulfamethoxypyrazine/pyrimethamine), 260 amodiaquine samples, 63 quinine samples, and 51 artemisinin derivative samples. A systematic subsample of 304 products was assessed for quality by laboratory based analysis to determine the amount of the active ingredient and dissolution profile by following the published United States Pharmacopoeia (USP) monogram for the particular tablet being tested. Products for which a published analytical monogram did not exist were assessed on amount of active ingredient alone. Overall 38 or 12.2% of the samples were found to be of poor quality. Of the antifolate antimalarial drugs tested 13.4% were found to be of poor quality by dissolution and content analysis using high-performance liquid chromatography (HPLC). Nearly one quarter (23.8%) of quinine tablets did not comply within the tolerance limits of the dissolution and quantification analysis. Quality of amodiaquine drugs was relatively better but still unacceptable as 7.5% did not comply within the tolerance limits of the dissolution analysis. Formulations of the artemisinin derivatives all contained the stated amount of active ingredient when analysed using HPLC alone. Conclusions: Substandard antimalarial formulations were widely available in Tanzania at the time of this study. No products were detected that did not contain any amount of the stated active ingredient. Quinine and sulfadoxine/pyrimethamine products were the most widely available and also the most likely to be of poor quality. Substandard products were identified in all parts of the country and were labeled as made by both domestic and international manufacturers. With the expansion of the retail pharmaceutical sector as a delivery channel for antimalarial formulations the need for regular nationwide monitoring of their quality will become increasingly important.	[Kaur, Harparkash] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England; [Goodman, Catherine] London Sch Hyg & Trop Med, Hlth Policy Unit, London, England; [Thompson, Eloise] London Sch Hyg & Trop Med, Immunol Unit, London, England; [Thompson, Katy-Anne] London Sch Hyg & Trop Med, London, England; [Masanja, Irene; Abdulla, Salim] Ifakara Hlth Res & Dev Ctr, Dar Es Salaam, Tanzania; [Kachur, S. Patrick] US Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Centers for Disease Control & Prevention - USA	Kaur, H (corresponding author), London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England.	Harparkash.Kaur@lshtm.ac.uk; cgoodman@nairobi.kemri-wellcome.org	Kachur, Patrick/ABE-7220-2021	Goodman, Catherine/0000-0002-2241-3485	US Centers for Disease Control and Prevention; US Agency for International Development; Wellcome Trust; UK Department for International Development; Bill and Melinda Gates Foundation	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Agency for International Development(United States Agency for International Development (USAID)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Department for International Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was completed as part of the Interdisciplinary Monitoring Project for Antimalarial Combination Therapy in Tanzania (IMPACT-Tz) with funding from the US Centers for Disease Control and Prevention, the US Agency for International Development and the Wellcome Trust. Catherine Goodman's participation was partially supported by the Consortium for Research in Equitable Health Systems which is funded by the UK Department for International Development. H. Kaur is grateful to the Gates Malaria Partnership for providing support for the analytical facility through an award from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AA, 2007, J CLIN PHARM THER, V32, P429, DOI 10.1111/j.1365-2710.2007.00847.x; [Anonymous], 11 NIH FOG INT CTR; Atemnkeng MA, 2007, TROP MED INT HEALTH, V12, P68, DOI 10.1111/j.1365-3156.2006.01769.x; Basco LK, 2004, AM J TROP MED HYG, V70, P245, DOI 10.4269/ajtmh.2004.70.245; Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; BATTERBY A, 2003, IMPROVING SUPPLY DIS, P1; BRAUN M, 2005, QUALITY ASSESSMENT A; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; Goodman C., 2004, THESIS U LONDON; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; *GOV TANZ CLINT FD, TANZ PIL ACT SUBS RE; HANSON K, 2008, BMC PUBLI H IN PRESS; HETZEL M, 2006, MAL J, V5; Kachur SP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-25; Minzi OMS, 2003, J CLIN PHARM THER, V28, P117, DOI 10.1046/j.1365-2710.2003.00470.x; Newton PN, 2008, PLOS MED, V5, P209, DOI 10.1371/journal.pmed.0050032; Risha PG, 2002, TROP MED INT HEALTH, V7, P701, DOI 10.1046/j.1365-3156.2002.00937.x; *TANZ NAT COORD ME, 2007, GLOB FUND PROP ROUND; *US PHARM CONV INC, 2000, M WASH DC APR 12 16; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; World Health Organization, 1999, DEF DIAGN CLASS DI 1; [No title captured]	23	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3403	10.1371/journal.pone.0003403	http://dx.doi.org/10.1371/journal.pone.0003403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923672	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000265121800004
J	Zhou, WY; Alonso, S; Takai, D; Lu, SC; Yamamoto, F; Perucho, M; Huang, S				Zhou, Wenyun; Alonso, Sergio; Takai, Daisaku; Lu, Shelly C.; Yamamoto, Fumiichiro; Perucho, Manuel; Huang, Shi			Requirement of RIZ1 for Cancer Prevention by Methyl-Balanced Diet	PLOS ONE			English	Article								Background: The typical Western diet is not balanced in methyl nutrients that regulate the level of the methyl donor S-adenosylmethionine (SAM) and its derivative metabolite S-adenosylhomocysteine (SAH), which in turn may control the activity of certain methyltransferases. Feeding rodents with amino acid defined and methyl-imbalanced diet decreases hepatic SAM and causes liver cancers. RIZ1 (PRDM2 or KMT8) is a tumor suppressor and functions in transcriptional repression by methylating histone H3 lysine 9. Methodology/Principal Findings: Here we show that a methyl-balanced diet conferred additional survival benefits compared to a tumor-inducing methyl-imbalanced diet only in mice with wild type RIZ1 but not in mice deficient in RIZ1. While absence of RIZ1 was tumorigenic in mice fed the balanced diet, its presence did not prevent tumor formation in mice fed the imbalanced diet. Microarray and gene expression analysis showed that, unlike most of its related enzymes, RIZ1 was upregulated by methyl-balanced diet. Methyl-balanced diet did not fully repress oncogenes such as c-Jun in the absence of RIZ1. Higher RIZ1 activity was associated with greater H3 lysine 9 methylation in RIZ1 target genes as shown by chromatin immunoprecipiation analysis. Conclusions/Significance: The data identify RIZ1 as a critical target of methyl-balanced diet in cancer prevention. The molecular understanding of dietary carcinogenesis may help people make informed choices on diet, which may greatly reduce the incidence of cancer.	[Zhou, Wenyun; Alonso, Sergio; Takai, Daisaku; Yamamoto, Fumiichiro; Perucho, Manuel; Huang, Shi] La Jolla Canc Res Fdn, Canc Res Ctr, Burnham Inst Med Res, La Jolla, CA 92037 USA; [Lu, Shelly C.] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA USA; [Huang, Shi] Fudan Univ, Ctr Evolutionary Biol, Inst Biomed Sci, Shanghai, Peoples R China	Sanford Burnham Prebys Medical Discovery Institute; University of Southern California; Fudan University	Huang, S (corresponding author), La Jolla Canc Res Fdn, Canc Res Ctr, Burnham Inst Med Res, La Jolla, CA 92037 USA.	shuangtheman@yahoo.com	Alonso, Sergio/GVR-8346-2022; Alonso, Sergio/G-5145-2011; Yamamoto, Fumiichiro/F-1478-2016; Lu, Shelly/AAH-5937-2021	Alonso, Sergio/0000-0001-6497-892X; Yamamoto, Fumiichiro/0000-0001-9690-7034; Lu, Shelly/0000-0003-2128-5407; Perucho, Manuel/0000-0002-2169-2662	NIH [CA105347, CA63585, CA087069, DK51719, AA13847, AT001576]; NATIONAL CANCER INSTITUTE [R01CA087069, R37CA063585, R01CA105347, R01CA063585] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT001576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grant CA105347 to S.H., CA63585 to M.P., CA087069 to F.Y., and DK51719, AA13847 and AT001576 to S.C.L.	Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Briknarova K, 2008, BIOCHEM BIOPH RES CO, V366, P807, DOI 10.1016/j.bbrc.2007.12.034; BUYSE IM, 1995, P NATL ACAD SCI USA, V92, P4467, DOI 10.1073/pnas.92.10.4467; DE SC, 1996, P NATL ACAD SCI USA, V93, P7149, DOI DOI 10.1073/PNAS.93.14.7149; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Huang S., 2008, HISTONE METHYLATION; Kim KC, 2003, CANCER RES, V63, P7619; Liu LM, 1997, J BIOL CHEM, V272, P2984, DOI 10.1074/jbc.272.5.2984; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; MIKOL YB, 1983, CARCINOGENESIS, V4, P1619, DOI 10.1093/carcin/4.12.1619; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051; SHIVAPURKAR N, 1986, J NATL CANCER I, V77, P213; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; WILSON MJ, 1984, BIOCHEM J, V218, P987, DOI 10.1042/bj2180987; Yamamoto F, 2001, ELECTROPHORESIS, V22, P1946, DOI 10.1002/1522-2683(200106)22:10<1946::AID-ELPS1946>3.0.CO;2-Y	20	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3390	10.1371/journal.pone.0003390	http://dx.doi.org/10.1371/journal.pone.0003390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852888	Green Published, Green Submitted, gold			2022-12-25	WOS:000265121600013
J	Ersdal, HL; Verkuyl, DAA; Bjorklund, K; Bergstrom, S				Ersdal, Hege Langli; Verkuyl, Douwe A. A.; Bjorklund, Kenneth; Bergstrom, Staffan			Symphysiotomy in Zimbabwe; Postoperative Outcome, Width of the Symphysis Joint, and Knowledge, Attitudes and Practice among Doctors and Midwives	PLOS ONE			English	Article							OBSTRUCTED LABOR; CESAREAN-SECTION; BREECH	Background: Obstructed labour remains one of the leading causes of maternal and foetal death and morbidity in poorly resourced areas of the world, where the 24 hours availability of a caesarean section (CS) cannot be guaranteed, and the CS related mortality rate is still high. In these settings, reinstatement of symphysiotomy has been advocated. The objectives were, in 1994; to study perioperative and long-term complications of symphysiotomy and compare them to those related to CS for similar indications, in 1996; to measure the symphyseal width after symphysiotomy and compare it to that after normal vaginal delivery, and, in 1998; to assess knowledge, attitudes and practice related to symphysiotomy among doctors and midwives in Zimbabwe. Methods and Findings: Thirty-four women who had undergone symphysiotomy and 29 women who had undergone a CS for obstructed labour were interviewed. The symphyseal widths of 19 women with a previous symphysiotomy were compared to that of 92 women with previous normal vaginal deliveries, using ultrasound technique. Forty-one doctors and 39 midwives, in three central hospitals and seven district hospitals in Zimbabwe, were interviewed about symphysiotomy. None of the 34 women reported serious soft tissue injuries or infections post symphysiotomy. Long-term complications after symphysiotomy do not differ notably from those after CS for similar indications. The intra-articular width of the symphysis pubis is increased after a symphysiotomy. Seventy-nine of the 80 interviewed health care workers knew about symphysiotomy. One obstetrician had performed symphysiotomies. Two-thirds of the participants considered symphysiotomy an obsolete and second-class operation, but lifesaving and appropriate in remote areas of Zimbabwe. Ten of 13 midwives in remote areas wanted to carry out symphysiotomies themselves. Conclusions: No severe complications due to symphysiotomy were revealed in this study. The results suggest that a modest permanent enlargement of the pelvis post symphysiotomy (together with the absence of a scarred uterus) may facilitate subsequent vaginal delivery. Doctors and midwives working in district hospitals have a more positive attitude to symphysiotomies than the colleagues in central hospitals. Obstetricians (who would have to do the teaching), working in the large urban hospitals almost exclude symphysiotomy as an alternative management in Zimbabwe.	[Ersdal, Hege Langli; Bjorklund, Kenneth; Bergstrom, Staffan] Karolinska Inst, Div Int Hlth IHCAR, Stockholm, Sweden; [Verkuyl, Douwe A. A.] United Bulawayo Hosp, Dept Obstet & Gynaecol, Bulawayo, Zimbabwe	Karolinska Institutet	Ersdal, HL (corresponding author), Karolinska Inst, Div Int Hlth IHCAR, Stockholm, Sweden.	hege@ersdal.com			The Research Council of Norway	The Research Council of Norway(Research Council of Norway)	The work presented is partly financed by The Research Council of Norway (student scholarship for the first auther HLE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ABOUZAHR C, 1998, HLTH DIMENSIONS SEX, P243; BARRY AP, 1952, IRAN MED J, V6, P49; BERGSTROM S, 1994, GYNECOL OBSTET INVES, V38, P31, DOI 10.1159/000292441; BIRD GC, 1967, E AFR MED J, V43, P51; Bjorklund K, 2002, BJOG-INT J OBSTET GY, V109, P236, DOI 10.1111/j.1471-0528.2002.01214.x; Bjorklund K, 1996, GYNECOL OBSTET INVES, V42, P151, DOI 10.1159/000291932; DEXEUS S, 1954, Rev Esp Obstet Ginecol, V13, P358; Ezegwui HU, 2004, INT J GYNECOL OBSTET, V85, P272, DOI 10.1016/j.ijgo.2003.09.017; FRANK F, 1910, MONATSCHR GEBURTSHIL, V22, P680; GEBBIE D, 1982, CLIN OBSTET GYNAECOL, V9, P663; GLASTER E, 1999, J GYNECOL OBST BIO R, V28, P519; Goodwin TM, 1997, AM J OBSTET GYNECOL, V177, P463, DOI 10.1016/S0002-9378(97)70218-7; GREISEN G, 1999, INT J GYNECOL OBSTET, V23, P203; Hartfield V J, 1975, Trop Doct, V5, P76; HARTFIELD VJ, 1973, J OBSTET GYN BR COMM, V80, P508; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; KUPFERBERG H, 1927, MONATSSCHR GYNAK GEB, V76, P176; LASBREY AH, 1963, S AFR MED J, V37, P231; MENTICOGLOU SM, 1990, AUST NZ J OBSTET GYN, V30, P1, DOI 10.1111/j.1479-828X.1990.tb03185.x; Mola Glen D. L., 1995, Papua New Guinea Medical Journal, V38, P172; MOLA M, 1981, PNG MED J, V24, P103; OLIVELLA JR, 1935, ARCH MED INT, V1, P254; Onah HE, 2004, INT J GYNECOL OBSTET, V84, P79, DOI 10.1016/S0020-7292(03)00269-8; Onah HE, 2002, INT J GYNECOL OBSTET, V76, P321, DOI 10.1016/S0020-7292(01)00578-1; Pape GL, 1999, TROP DOCT, V29, P248, DOI 10.1177/004947559902900421; PEYTAVIN C, 1931, THESIS; RAMOS AP, 1948, OBSTET GINEC LAT AM, V6, P3; SEEDAT EK, 1962, LANCET, V1, P554; SPENCER JAD, 1987, BRIT J OBSTET GYNAEC, V94, P716, DOI 10.1111/j.1471-0528.1987.tb03183.x; Sunday-Adeoye I M, 2004, J Obstet Gynaecol, V24, P525, DOI 10.1080/01443610410001722572; van Eygen L, 2008, TROP DOCT, V38, P36, DOI 10.1258/td.2007.005019; VANROOSMALEN J, 1990, AM J OBSTET GYNECOL, V163, P1; VANROOSMALEN J, 1987, INT J GYNECOL OBSTET, V25, P451, DOI 10.1016/0020-7292(87)90061-0; Verkuyl DAA, 2007, PLOS MED, V4, P401, DOI 10.1371/journal.pmed.0040071; World Health Organisation, 1999, RED MAT MORT JOINT W; Wykes CB, 2003, BJOG-INT J OBSTET GY, V110, P219; ZARATE E, 1931, ARCH GYNAKOL, V147, P759; 2002, BJOG, V109	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3317	10.1371/journal.pone.0003317	http://dx.doi.org/10.1371/journal.pone.0003317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846216	Green Published, Green Submitted, gold			2022-12-25	WOS:000265114500001
J	Sun, DX; Martinez, CO; Ochoa, O; Ruiz-Willhite, L; Bonilla, JR; Centonze, VE; Waite, LL; Michalek, JE; McManus, LM; Shireman, PK				Sun, Dongxu; Martinez, Carlo O.; Ochoa, Oscar; Ruiz-Willhite, Lourdes; Bonilla, Jose R.; Centonze, Victoria E.; Waite, Lindsay L.; Michalek, Joel E.; McManus, Linda M.; Shireman, Paula K.			Bone marrow-derived cell regulation of skeletal muscle regeneration	FASEB JOURNAL			English	Article						CC chemokine receptor 2; CCR2; chimera; inflammation; monocyte/macrophage; myogenic progenitor cell	HEMATOPOIETIC STEM-CELLS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CC-CHEMOKINE RECEPTOR-2; SATELLITE CELLS; IN-VIVO; PROGENITOR CELLS; CCR2-/-MICE; ALTERED INFLAMMATION; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS	Limb regeneration requires the coordination of multiple stem cell populations to recapitulate the process of tissue formation. Therefore, bone marrow (BM) -derived cell regulation of skeletal muscle regeneration was examined in mice lacking the CC chemokine receptor 2 (CCR2). Myofiber size, numbers of myogenic progenitor cells (MPCs), and recruitment of BM-derived cells and macrophages were assessed after cardiotoxin-induced injury of chimeric mice produced by transplanting BM from wild-type (WT) or CCR2(-/-) mice into irradiated WT or CCR2(-/-) host mice. Regardless of the host genotype, muscle regeneration and recruitment of BM-derived cells and macrophages were similar in mice replenished with WT BM, whereas BM-derived cells and macrophage accumulation were decreased and muscle regeneration was impaired in all animals receiving CCR2(-/-) BM. Furthermore, numbers of MPCs (CD34(+)/Sca-1(-)/CD45(-) cells) were significantly increased in mice receiving CCR2(-/-) BM despite the decreased size of regenerated myofibers. Thus, the expression of CCR2 on BM-derived cells regulated macrophage recruitment into injured muscle, numbers of MPC, and the extent of regenerated myofiber size, all of which were independent of CCR2 expression on host-derived cells. Future studies in regenerative medicine must include consideration of the role of BM-derived cells, possibly macrophages, in CCR2-dependent events that regulate effective skeletal muscle regeneration. - Sun, D., Martinez, C. O., Ochoa, O., Ruiz-Willhite, L., Bonilla, J. R., Centonze, V. E., Waite, L. L., Michalek, J. E., McManus, L. M., Shireman, P. K. Bone marrow-derived cell regulation of skeletal muscle regeneration. FASEB J. 23, 382-395 (2009)	[Sun, Dongxu; Martinez, Carlo O.; Ochoa, Oscar; Ruiz-Willhite, Lourdes; Bonilla, Jose R.; Shireman, Paula K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA; [Centonze, Victoria E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell & Struct Biol, San Antonio, TX 78229 USA; [Waite, Lindsay L.; Michalek, Joel E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [McManus, Linda M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [McManus, Linda M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA; [McManus, Linda M.; Shireman, Paula K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Shireman, Paula K.] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Shireman, Paula K.] Audie L Murphy Mem Vet Adm Med Ctr, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Shireman, PK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, 7703 Floyd Curl Dr,MC 7741, San Antonio, TX 78229 USA.	shireman@uthscsa.edu		SHIREMAN, PAULA/0000-0002-9701-5422; Jones, Lindsay/0000-0002-4219-8356	UTHSCSA; San Antonio Cancer Institute [CA54174]; Nathan Shock Center [AG013319]; Veterans Administration Merit Review; San Antonio Area Foundation [Sun-UTHSCSA-060104]; National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL074236, F32HL090196];  [AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL090196, R01HL074236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, P01AG019316] Funding Source: NIH RePORTER	UTHSCSA; San Antonio Cancer Institute; Nathan Shock Center; Veterans Administration Merit Review(US Department of Veterans Affairs); San Antonio Area Foundation; National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the expert technical assistance of Michael D. Wetzel and Jimmy Wewer in these studies. A portion of the statistical analyses was expertly performed by Lee Ann Zarzabal. The flow cytometry portion of this work was performed at the Institutional Flow Cytometry Core of the University of Texas Health Science Center, San Antonio (UTHSCSA). Images were generated in the UTHSCSA Core Optical Imaging Facility, which is supported by UTHSCSA, CA54174 (San Antonio Cancer Institute), AG013319 (Nathan Shock Center), and AG19316. These studies were supported, in part, by a Veterans Administration Merit Review grant, the San Antonio Area Foundation (Sun-UTHSCSA-060104), and the National Institutes of Health (R01HL074236 and F32HL090196) from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no relationships that pose a conflict of interest for these studies.	Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bartoli C, 2001, ACTA NEUROPATHOL, V102, P385; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Belperio JA, 2001, J CLIN INVEST, V108, P547, DOI 10.1172/JCI200112214; CANTINI M, 1994, BIOCHEM BIOPH RES CO, V202, P1688, DOI 10.1006/bbrc.1994.2129; CANTINI M, 1995, J NEUROPATH EXP NEUR, V54, P121, DOI 10.1097/00005072-199501000-00014; Cantini M, 2002, NEUROL SCI, V23, P189, DOI 10.1007/s100720200060; CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187; Carulli MT, 2005, ARTHRITIS RHEUM-US, V52, P3772, DOI 10.1002/art.21396; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Cotter MJ, 2001, AM J PATHOL, V159, P473, DOI 10.1016/S0002-9440(10)61719-1; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3; Dzenko KA, 2005, MICROVASC RES, V70, P53, DOI 10.1016/j.mvr.2005.04.005; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayes IM, 1998, ARTERIOSCL THROM VAS, V18, P397, DOI 10.1161/01.ATV.18.3.397; Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5; Hilbe W, 2004, J CLIN PATHOL, V57, P965, DOI 10.1136/jcp.2004.016444; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kurihara T, 1996, J BIOL CHEM, V271, P11603, DOI 10.1074/jbc.271.20.11603; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; Lee S, 2006, FREE RADICAL BIO MED, V41, P1174, DOI 10.1016/j.freeradbiomed.2006.07.005; Li HQ, 2004, CANCER RES, V64, P6137, DOI 10.1158/0008-5472.CAN-04-1287; Li P, 2005, AM J PATHOL, V167, P637, DOI 10.1016/S0002-9440(10)62039-1; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Massimino ML, 1997, BIOCHEM BIOPH RES CO, V235, P754, DOI 10.1006/bbrc.1997.6823; Maus U, 2002, AM J RESP CRIT CARE, V166, P268, DOI 10.1164/rccm.2112012; Maus UA, 2005, AM J PHYSIOL-LUNG C, V288, pL350, DOI 10.1152/ajplung.00061.2004; Merly F, 1999, MUSCLE NERVE, V22, P724, DOI 10.1002/(SICI)1097-4598(199906)22:6<724::AID-MUS9>3.0.CO;2-O; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nguyen HX, 2005, J PHYSIOL-LONDON, V565, P403, DOI 10.1113/jphysiol.2005.085506; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Okuma T, 2004, J PATHOL, V204, P594, DOI 10.1002/path.1667; PimoradyEsfahani A, 1997, MUSCLE NERVE, V20, P158, DOI 10.1002/(SICI)1097-4598(199702)20:2<158::AID-MUS4>3.0.CO;2-B; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reyes M, 2005, BLOOD, V106, P3646, DOI 10.1182/blood-2004-12-4603; ROBERTSON TA, 1993, EXP CELL RES, V207, P321, DOI 10.1006/excr.1993.1199; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; Schober A, 2004, CIRC RES, V95, P1125, DOI 10.1161/01.RES.0000149518.86865.3e; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shireman PK, 2007, J VASC SURG, V45, p48A, DOI 10.1016/j.jvs.2007.02.030; Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Sonnet C, 2006, J CELL SCI, V119, P2497, DOI 10.1242/jcs.02988; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Wareing MD, 2007, J LEUKOCYTE BIOL, V81, P793, DOI 10.1189/jlb.0506299; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yang XQ, 2006, INT J CANCER, V118, P335, DOI 10.1002/ijc.21371; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	71	78	78	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					382	395		10.1096/fj.07-095901	http://dx.doi.org/10.1096/fj.07-095901			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18827026	Green Published, hybrid			2022-12-25	WOS:000262892900010
J	Emami, K; Topakas, E; Nagy, T; Henshaw, J; Jackson, KA; Nelson, KE; Mongodin, EF; Murray, JW; Lewis, RJ; Gilbert, HJ				Emami, Kaveh; Topakas, Evangelos; Nagy, Tibor; Henshaw, Joanna; Jackson, Kelly A.; Nelson, Karen E.; Mongodin, Emmanuel F.; Murray, James W.; Lewis, Richard J.; Gilbert, Harry J.			Regulation of the Xylan-degrading Apparatus of Cellvibrio japonicus by a Novel Two-component System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENS SUBSP CELLULOSA; HYDROLASE FAMILY-51 ARABINOFURANOSIDASE; CARBOHYDRATE-BINDING MODULES; CELL WALL HYDROLASES; PHOQ SENSOR DOMAIN; PSEUDOMONAS-FLUORESCENS; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; LIGAND-BINDING	The microbial degradation of lignocellulose biomass is not only an important biological process but is of increasing industrial significance in the bioenergy sector. The mechanism by which the plant cell wall, an insoluble composite structure, activates the extensive repertoire of microbial hydrolytic enzymes required to catalyze its degradation is poorly understood. Here we have used a transposon mutagenesis strategy to identify a genetic locus, consisting of two genes that modulate the expression of xylan side chain-degrading enzymes in the saprophytic bacterium Cellvibrio japonicus. Significantly, the locus encodes a two-component signaling system, designated AbfS (sensor histidine kinase) and AbfR (response regulator). The AbfR/S two-component system is required to activate the expression of the suite of enzymes that remove the numerous side chains from xylan, but not the xylanases that hydrolyze the beta 1,4-linked xylose polymeric backbone of this polysaccharide. Studies on the recombinant sensor domain of AbfS (AbfS(SD)) showed that it bound to decorated xylans and arabinoxylo-oligosaccharides, but not to undecorated xylo-oligosaccharides or other plant structural polysaccharides/oligosaccharides. The crystal structure of AbfS(SD) was determined to a resolution of 2.6 angstrom. The overall fold of AbfS(SD) is that of a classical Per Arndt Sim domain with a central antiparallel four-stranded beta-sheet flanked by alpha-helices. Our data expand the number of molecules known to bind to the sensor domain of two-component histidine kinases to include complex carbohydrates. The biological rationale for a regulatory system that induces enzymes that remove the side chains of xylan, but not the hydrolases that cleave the backbone of the polysaccharide, is discussed.	[Emami, Kaveh; Topakas, Evangelos; Nagy, Tibor; Henshaw, Joanna; Jackson, Kelly A.; Murray, James W.; Lewis, Richard J.; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Nelson, Karen E.; Mongodin, Emmanuel F.] Inst Genom Res, Rockville, MD 20850 USA	Newcastle University - UK; J. Craig Venter Institute	Lewis, RJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	r.lewis@ncl.ac.uk; h.j.gilbert@ncl.ac.uk	Topakas, Evangelos/C-6528-2012; Topakas, Evangelos/J-7554-2019; Mongodin, Emmanuel/AAF-1850-2020	Topakas, Evangelos/0000-0003-0078-5904; Mongodin, Emmanuel/0000-0003-3833-7437; Emami, Kaveh/0000-0003-0182-0070; Murray, James/0000-0002-8897-0161; Jackson, Kelly/0000-0001-9116-3769; lewis, richard/0000-0003-2641-8643	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D000475/1] Funding Source: researchfish; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aro N, 2001, J BIOL CHEM, V276, P24309, DOI 10.1074/jbc.M003624200; Bartolome B, 1997, APPL ENVIRON MICROB, V63, P208; Beylot MH, 2001, BIOCHEM J, V358, P599, DOI 10.1042/0264-6021:3580599; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BORGSTAHL GEO, 1995, BIOCHEMISTRY-US, V34, P6278, DOI 10.1021/bi00019a004; Brett CT, 1996, PHYSL BIOCH PLANT CE; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cowtan K, 2001, ACTA CRYSTALLOGR D, V57, P1435, DOI 10.1107/S0907444901010812; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Emami K, 2002, J BACTERIOL, V184, P4124, DOI 10.1128/JB.184.15.4124-4133.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS P, 1993, CCP4 DARESBURY STUDY; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; FERREIRA LMA, 1993, BIOCHEM J, V294, P349, DOI 10.1042/bj2940349; Firbank SJ, 2008, J MOL BIOL, V381, P529, DOI 10.1016/j.jmb.2008.06.004; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; Golby P, 1999, J BACTERIOL, V181, P1238, DOI 10.1128/JB.181.4.1238-1248.1999; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; HARRIS GW, 1994, STRUCTURE, V2, P1107, DOI 10.1016/S0969-2126(94)00112-X; Hasper AA, 2000, MOL MICROBIOL, V36, P193, DOI 10.1046/j.1365-2958.2000.01843.x; Hazlewood GP, 1998, PROG NUCLEIC ACID RE, V61, P211, DOI 10.1016/S0079-6603(08)60828-4; Hazlewood GP, 1998, BIOCHEM SOC T, V26, P185, DOI 10.1042/bst0260185; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaspar S, 1999, MOL MICROBIOL, V33, P858, DOI 10.1046/j.1365-2958.1999.01536.x; Kaspar S, 2002, ARCH MICROBIOL, V177, P313, DOI 10.1007/s00203-001-0393-z; KELLETT LE, 1990, BIOCHEM J, V272, P369, DOI 10.1042/bj2720369; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; LESLIE AGW, 1992, JOINT CCCP4 ESF EAMC, V26; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Miyazaki K, 2003, J BACTERIOL, V185, P2219, DOI 10.1128/JB.185.7.2219-2226.2003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy T, 2002, J BACTERIOL, V184, P4925, DOI 10.1128/JB.184.17.4925-4929.2002; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sticklen M, 2006, CURR OPIN BIOTECH, V17, P315, DOI 10.1016/j.copbio.2006.05.003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tomme P, 1996, BIOCHEMISTRY-US, V35, P13885, DOI 10.1021/bi961185i; WANG P, 1997, XYLANASES STREPTOMYC, P25; Zientz E, 1998, J BACTERIOL, V180, P5421, DOI 10.1128/JB.180.20.5421-5425.1998	68	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1086	1096		10.1074/jbc.M805100200	http://dx.doi.org/10.1074/jbc.M805100200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18922794	hybrid			2022-12-25	WOS:000262122900045
J	Wang, Y; Branicky, R; Stepanyan, Z; Carroll, M; Guimond, MP; Hihi, A; Hayes, S; McBride, K; Hekimi, S				Wang, Ying; Branicky, Robyn; Stepanyan, Zaruhi; Carroll, Melissa; Guimond, Marie-Pierre; Hihi, Abdelmadjid; Hayes, Steve; McBride, Kevin; Hekimi, Siegfried			The Anti-neurodegeneration Drug Clioquinol Inhibits the Aging-associated Protein CLK-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; AMYLOID BETA-PEPTIDE; LACKING COENZYME-Q; CAENORHABDITIS-ELEGANS; LIFE-SPAN; ALZHEIMERS-DISEASE; UBIQUINONE BIOSYNTHESIS; ESCHERICHIA-COLI; OXIDATIVE DAMAGE; TRANSGENIC MICE	The development of neurodegenerative diseases such as Alzheimer, Parkinson, and Huntington disease is strongly age-dependent. Discovering drugs that act on the high rate of aging in older individuals could be a means of combating these diseases. Reduction of the activity of the mitochondrial enzyme CLK-1 (also known as COQ7) slows down aging in Caenorhabditis elegans and in mice. Clioquinol is a metal chelator that has beneficial effects in several cellular and animal models of neurodegenerative diseases as well as on Alzheimer disease patients. Here we show that clioquinol inhibits the activity of mammalian CLK-1 in cultured cells, an inhibition that can be blocked by iron or cobalt cations, suggesting that chelation is involved in the mechanism of action of clioquinol on CLK-1. We also show that treatment of nematodes and mice with clioquinol mimics a variety of phenotypes produced by mutational reduction of CLK-1 activity in these organisms. These results suggest that the surprising action of clioquinol on several age-dependent neurodegenerative diseases with distinct etiologies might result from a slowing down of the aging process through action of the drug on CLK-1. Our findings support the hypothesis that pharmacologically targeting aging-associated proteins could help relieve age-dependent diseases.	[Carroll, Melissa; Guimond, Marie-Pierre; Hihi, Abdelmadjid; Hayes, Steve; McBride, Kevin] Chronogen Inc, Montreal, PQ H1W 4A4, Canada; [Wang, Ying; Branicky, Robyn; Stepanyan, Zaruhi; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	McBride, K (corresponding author), Chronogen Inc, Montreal, PQ H1W 4A4, Canada.	kevinmcbride@sympatico.ca; Siegfried.Hekimi@McGill.Ca			National Science and Engineering Research Council of Canada; National Cancer Institute of Canada, McGill University; Chronogen Inc	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Cancer Institute of Canada, McGill University; Chronogen Inc	This work was supported in part by grants from the National Science and Engineering Research Council of Canada, the National Cancer Institute of Canada, McGill University, and a research contract from Chronogen Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Branicky R, 2006, MOL CELL BIOL, V26, P3976, DOI 10.1128/MCB.26.10.3976-3985.2006; Caragounis A, 2007, BIOCHEM J, V407, P435, DOI 10.1042/BJ20070579; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; CHRONOGEN INC, 2008, Patent No. 2008014602; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Du T, 2008, J PHARMACOL EXP THER, V324, P360, DOI 10.1124/jpet.107.130377; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881; Hihi AK, 2003, J BIOL CHEM, V278, P41013, DOI 10.1074/jbc.M305034200; Ibach B, 2005, PHARMACOPSYCHIATRY, V38, P178, DOI 10.1055/s-2005-871241; Jiang N, 2001, J BIOL CHEM, V276, P29218, DOI 10.1074/jbc.M103686200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kwon O, 2000, FEMS MICROBIOL LETT, V186, P157, DOI 10.1016/S0378-1097(00)00134-8; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Regland B, 2001, DEMENT GERIATR COGN, V12, P408, DOI 10.1159/000051288; Ritchie CW, 2004, EXPERT OPIN INV DRUG, V13, P1585, DOI 10.1517/13543784.13.12.1585; Saiki R, 2008, AGING CELL, V7, P291, DOI 10.1111/j.1474-9726.2008.00378.x; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; TSUBAKI T, 1971, LANCET, V1, P696, DOI 10.1016/S0140-6736(71)92699-7; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; WONG A, 1995, GENETICS, V139, P1247; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788	40	41	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					314	323		10.1074/jbc.M807579200	http://dx.doi.org/10.1074/jbc.M807579200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18927074	hybrid			2022-12-25	WOS:000261974800036
J	Del Re, DP; Miyamoto, S; Brown, JH				Del Re, Dominic P.; Miyamoto, Shigeki; Brown, Joan Heller			Focal Adhesion Kinase as a RhoA-activable Signaling Scaffold Mediating Akt Activation and Cardiomyocyte Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; CELL-SURVIVAL; SH2 DOMAINS; MAP-KINASE; IN-VITRO; PROTEIN; INHIBITION; APOPTOSIS	RhoA a small G-protein that has an established role in cell growth and in regulation of the actin cytoskeleton. Far less is known about whether RhoA can modulate cell fate. We previously reported that sustained RhoA activation induces cardiomyocyte apoptosis (Del Re, D. P., Miyamoto, S., and Brown, J. H. (2007) J. Biol. Chem. 282, 8069-8078). Here we demonstrate that less chronic RhoA activation affords a survival advantage, protecting cardiomyocytes from apoptotic insult induced by either hydrogen peroxide treatment or glucose deprivation. Under conditions where RhoA is protective, we observe Rho kinase-dependent cytoskeletal rearrangement and activation of focal adhesion kinase (FAK). Activation of endogenous cardiomyocyte FAK leads to its increased association with the p85 regulatory subunit of phosphatidylinositol-3-kinase (PI3K) and to concomitant activation of Akt. Treatment of isolated perfused hearts with sphingosine 1-phosphate recapitulates this response. The pathway by which RhoA mediates cardiomyocyte Akt activation is demonstrated to require Rho kinase, FAK and PI3K, but not Src, based on studies with pharmacological inhibitors (Y-27632, LY294002, PF271 and PP2) and inhibitory protein expression (FAK-related nonkinase). Inhibition of RhoA-mediated Akt activation at any of these steps, including inhibition of FAK, prevents RhoA from protecting cardiomyocytes against apoptotic insult. We further demonstrate that stretch of cardiomyocytes, which activates endogenous RhoA, induces the aforementioned signaling pathway, providing a physiologic context in which RhoA-mediated FAK phosphorylation can activate PI3K and Akt. We suggest that RhoA-mediated effects on the cardiomyocyte cytoskeleton provide a novel mechanism for protection from apoptosis.	[Del Re, Dominic P.; Miyamoto, Shigeki; Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Del Re, Dominic P.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu	Miyamoto, Shigeki/L-4004-2019	Del Re, Dominic/0000-0002-5504-9114	National Institutes of Health [HL28143]; American Heart Association [AHA55243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028143, R37HL028143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL28143 (to J.H.B.). This work was also supported by American Heart Association Grant AHA55243 (to S.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JW, 1998, CIRC RES, V83, P167, DOI 10.1161/01.RES.83.2.167; Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Bachelot C, 1996, BBA-MOL CELL RES, V1311, P45, DOI 10.1016/0167-4889(95)00176-X; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Berestetskaya YV, 1998, J BIOL CHEM, V273, P27816, DOI 10.1074/jbc.273.43.27816; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; De Sarno L, 2005, BRAIN RES, V1041, P112, DOI 10.1016/j.brainres.2005.01.081; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; DiMichele LA, 2006, CIRC RES, V99, P636, DOI 10.1161/01.RES.0000240498.44752.d6; Eble DM, 2000, AM J PHYSIOL-HEART C, V278, pH1695, DOI 10.1152/ajpheart.2000.278.5.H1695; Esteve P, 1998, ONCOGENE, V17, P1855, DOI 10.1038/sj.onc.1202082; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Franchini KG, 2000, CIRC RES, V87, P558, DOI 10.1161/01.RES.87.7.558; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Heidkamp MC, 2003, AM J PHYSIOL-HEART C, V285, pH1684, DOI 10.1152/ajpheart.00016.2003; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; KUMAGAI N, 1993, FEBS LETT, V329, P273, DOI 10.1016/0014-5793(93)80236-N; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Matsui T, 2001, CIRCULATION, V104, P330; Means CK, 2007, AM J PHYSIOL-HEART C, V292, pH2944, DOI 10.1152/ajpheart.01331.2006; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moorman JP, 1999, ONCOGENE, V18, P47, DOI 10.1038/sj.onc.1202262; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Peng X, 2006, J CLIN INVEST, V116, P217, DOI 10.1172/JCI24497; RANKIN S, 1994, FEBS LETT, V354, P315, DOI 10.1016/0014-5793(94)01148-6; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Shi JJ, 2008, J MOL CELL CARDIOL, V44, P551, DOI 10.1016/j.yjmcc.2007.11.018; Sinnett-Smith J, 2001, EXP CELL RES, V266, P292, DOI 10.1006/excr.2001.5219; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Taylor JM, 2000, J BIOL CHEM, V275, P19250, DOI 10.1074/jbc.M909099199; Thorburn J, 1997, EMBO J, V16, P1888, DOI 10.1093/emboj/16.8.1888; Torsoni AS, 2005, AM J PHYSIOL-HEART C, V289, pH1488, DOI 10.1152/ajpheart.00692.2004; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Xu LH, 1998, CELL GROWTH DIFFER, V9, P999; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	66	87	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35622	35629		10.1074/jbc.M804036200	http://dx.doi.org/10.1074/jbc.M804036200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18854312	Green Published, hybrid			2022-12-25	WOS:000261687900035
J	Wagner, MC; Rhodes, G; Wang, E; Pruthi, V; Arif, E; Saleem, MA; Wean, SE; Garg, P; Verma, R; Holzman, LB; Gattone, V; Molitoris, BA; Nihalani, D				Wagner, Mark C.; Rhodes, George; Wang, Exing; Pruthi, Vikas; Arif, Ehtesham; Saleem, Moin A.; Wean, Sarah E.; Garg, Puneet; Verma, Rakesh; Holzman, Lawrence B.; Gattone, Vince; Molitoris, Bruce A.; Nihalani, Deepak			Ischemic Injury to Kidney Induces Glomerular Podocyte Effacement and Dissociation of Slit Diaphragm Proteins Neph1 and ZO-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-RENAL-FAILURE; TIGHT JUNCTION; ACTIN CYTOSKELETON; ATP DEPLETION; TYROSINE PHOSPHORYLATION; DIABETIC-NEPHROPATHY; EPITHELIAL TISSUES; ZONULA OCCLUDENS-1; E-CADHERIN; POLYMERIZATION	Glomerular injury is often characterized by the effacement of podocytes, loss of slit diaphragms, and proteinuria. Renal ischemia or the loss of blood flow to the kidneys has been widely associated with tubular and endothelial injury but rarely has been shown to induce podocyte damage and disruption of the slit diaphragm. In this study, we have used an in vivo rat ischemic model to demonstrate that renal ischemia induces podocyte effacement with loss of slit diaphragm and proteinuria. Biochemical analysis of the ischemic glomerulus shows that ischemia induces rapid loss of interaction between slit diaphragm junctional proteins Neph1 and ZO-1. To further understand the effect of ischemia on molecular interactions between slit diaphragm proteins, a cell culture model was employed to study the binding between Neph1 and ZO-1. Under physiologic conditions, Neph1 co-localized with ZO-1 at cell-cell contacts in cultured human podocytes. Induction of injury by ATP depletion resulted in rapid loss of Neph1 and ZO-1 binding and redistribution of Neph1 and ZO-1 proteins from cell membrane to the cytoplasm. Recovery resulted in increased Neph1 tyrosine phosphorylation, restoring Neph1 and ZO-1 binding and their localization at the cell membrane. We further demonstrate that tyrosine phosphorylation of Neph1 mediated by Fyn results in significantly increased Neph1 and ZO-1 binding, suggesting a critical role for Neph1 tyrosine phosphorylation in reorganizing the Neph1-ZO-1 complex. This study documents that renal ischemia induces dynamic changes in the molecular interactions between slit diaphragm proteins, leading to podocyte damage and proteinuria.	[Wagner, Mark C.; Rhodes, George; Wang, Exing; Pruthi, Vikas; Arif, Ehtesham; Wean, Sarah E.; Gattone, Vince; Molitoris, Bruce A.; Nihalani, Deepak] Indiana Univ, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA; [Saleem, Moin A.] Univ Bristol, Bristol Royal Hosp Children, Childrens Renal Unit, Bristol BS2 8BJ, Avon, England; [Garg, Puneet; Verma, Rakesh; Holzman, Lawrence B.] Univ Michigan, Sch Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Saleem, Moin A.] Dept Vet Affairs, Ann Arbor, MI 48105 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Bristol Royal Hospital For Children; University of Bristol; University of Michigan System; University of Michigan	Nihalani, D (corresponding author), Indiana Univ, Dept Med, Div Nephrol, 950 W Walnut St,R2-254, Indianapolis, IN 46202 USA.	dnihalan@iupui.edu	Arif, Ehtesham/AAV-8272-2020; nihalani, deepak/AAK-9453-2020	Pruthi, Vikas/0000-0002-3666-5552; Holzman, Lawrence/0000-0002-8961-234X; Saleem, Moin/0000-0002-9808-4518; Arif, Ehtesham/0000-0001-9638-3189; Garg, Puneet/0000-0001-7439-459X	National Institutes of Health, NIDDK [K01 DK072047-03, RO1 DK069408, P-50 DK061594]; Indiana University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069408, P50DK061594, K01DK072047, K08DK081403] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Indiana University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant K01 DK072047-03 (to D.N.) and Grants RO1 (DK069408) and P-50 (DK061594) (to B.M.). This work was also supported by a Research Support Funds Grant from Indiana University (to D.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ANDREWS P, 1988, J ELECTRON MICR TECH, V9, P115, DOI 10.1002/jemt.1060090203; Ashworth SL, 2004, AM J PHYSIOL-RENAL, V286, pF988, DOI 10.1152/ajprenal.00168.2003; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; BACALLAO R, 1994, J CELL SCI, V107, P3301; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; BARNES JL, 1981, LAB INVEST, V45, P378; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Kelly KJ, 2000, SEMIN NEPHROL, V20, P4; KURIHARA H, 1992, AM J PATHOL, V141, P805; KURIHARA H, 1992, P NATL ACAD SCI USA, V89, P7075, DOI 10.1073/pnas.89.15.7075; Kwon O, 2002, AM J PHYSIOL-RENAL, V282, pF1012, DOI 10.1152/ajprenal.00294.2001; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x; Lowenborg EKM, 2000, NEPHROL DIAL TRANSPL, V15, P1547, DOI 10.1093/ndt/15.10.1547; MANDEL LJ, 1994, J CELL SCI, V107, P3315; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Molitoris BA, 2003, J AM SOC NEPHROL, V14, P265, DOI 10.1097/01.ASN.0000048852.53881.D9; Molitoris BA, 2008, NAT CLIN PRACT NEPHR, V4, P154, DOI 10.1038/ncpneph0723; National Institutes of Health, 1996, GUID CAR US LAB AN; NIHALANI D, 2007, MOL CELL BIOL; Obeidova H, 2006, Prague Med Rep, V107, P5; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Parikh CR, 2007, J INVEST MED, V55, P333, DOI 10.2310/6650.2007.00015; Patari-Sampo A, 2006, ANN MED, V38, P483, DOI 10.1080/07853890600978149; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Rincon-Choles H, 2006, DIABETES, V55, P894, DOI 10.2337/diabetes.55.04.06.db05-0355; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sutton TA, 1998, SEMIN NEPHROL, V18, P490; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wang LM, 2005, J AM SOC NEPHROL, V16, P3611, DOI 10.1681/ASN.2005020167; Wolf G, 2007, NEPHRON PHYSIOL, V106, P26, DOI 10.1159/000101797; Ye JM, 1999, AM J PHYSIOL-RENAL, V277, pF524, DOI 10.1152/ajprenal.1999.277.4.F524; Yin M, 2002, RENAL FAILURE, V24, P147, DOI 10.1081/JDI-120004092	57	61	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35579	35589		10.1074/jbc.M805507200	http://dx.doi.org/10.1074/jbc.M805507200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18922801	hybrid, Green Published			2022-12-25	WOS:000261687900030
J	Dieteren, CEJ; Willems, PHGM; Vogel, RO; Swarts, HG; Fransen, J; Roepman, R; Crienen, G; Smeitink, JAM; Nijtmans, LGJ; Koopman, WJH				Dieteren, Cindy E. J.; Willems, Peter H. G. M.; Vogel, Rutger O.; Swarts, Herman G.; Fransen, Jack; Roepman, Ronald; Crienen, Gijs; Smeitink, Jan A. M.; Nijtmans, Leo G. J.; Koopman, Werner J. H.			Subunits of Mitochondrial Complex I Exist as Part of Matrix- and Membrane-associated Subcomplexes in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATERAL DIFFUSION; INNER MEMBRANE; DYNAMICS; IDENTIFICATION; TRAFFICKING; COMPONENTS; MOTILITY; MOBILITY; RAS	Mitochondrial complex I (CI) is a large assembly of 45 different subunits, and defects in its biogenesis are the most frequent cause of mitochondrial disorders. In vitro evidence suggests a stepwise assembly process involving pre-assembled modules. However, whether these modules also exist in vivo is as yet unresolved. To answer this question, we here applied submitochondrial fluorescence recovery after photobleaching to HEK293 cells expressing 6 GFP-tagged subunits selected on the basis of current CI assembly models. We established that each subunit was partially present in a virtually immobile fraction, possibly representing the holo-enzyme. Four subunits (NDUFV1, NDUFV2, NDUFA2, and NDUFA12) were also present as highly mobile matrix-soluble monomers, whereas, in sharp contrast, the other two subunits (NDUFB6 and NDUFS3) were additionally present in a slowly mobile fraction. In the case of the integral membrane protein NDUFB6, this fraction most likely represented one or more membrane-bound subassemblies, whereas biochemical evidence suggested that for the NDUFS3 protein this fraction most probably corresponded to a matrix-soluble subassembly. Our results provide first time evidence for the existence of CI subassemblies in mitochondria of living cells.	[Dieteren, Cindy E. J.; Vogel, Rutger O.; Smeitink, Jan A. M.; Nijtmans, Leo G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands; [Dieteren, Cindy E. J.; Willems, Peter H. G. M.; Swarts, Herman G.; Crienen, Gijs; Koopman, Werner J. H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Fransen, Jack] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6500 HB Nijmegen, Netherlands; [Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Willems, Peter H. G. M.; Fransen, Jack; Koopman, Werner J. H.] Radboud Univ Nijmegen, Med Ctr, Microscop Imaging Ctr Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Nijtmans, LGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, Geert Grootepl 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.	l.nijtmans@cukz.umcn.nl	Smeitink, Jan A.M./D-6064-2011; Koopman, Werner J.H./AAC-9668-2020; Smeitink, Jan/C-1351-2013; Nijtmans, L.G.J./L-4549-2015; Koopman, Werner J.H./D-3592-2009; Dieteren, Cindy E.J./D-6042-2011; Roepman, Ronald/B-1339-2014; Fransen, Jack/E-8924-2010; Willems, P.H.G.M./L-4759-2015	Koopman, Werner J.H./0000-0002-5340-6747; Koopman, Werner J.H./0000-0002-5340-6747; Roepman, Ronald/0000-0002-5178-8163; Fransen, Jack/0000-0002-0571-7639; Willems, P.H.G.M./0000-0002-0915-1599	Radboud University Nijmegen Medical Centre; Netherlands Organization for Health Research and Development [903-46-176]; NWO ( Netherlands Organization for Scientific [911-02-008]	Radboud University Nijmegen Medical Centre; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); NWO ( Netherlands Organization for Scientific(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Radboud University Nijmegen Medical Centre ( RUNMC, to W. J. H. K. and L. G. J. N.) and equipment grants of ZON ( Netherlands Organization for Health Research and Development, 903-46-176) and NWO ( Netherlands Organization for Scientific Research, No: 911-02-008). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292; Cardol P, 2008, BBA-BIOENERGETICS, V1777, P388, DOI 10.1016/j.bbabio.2008.01.001; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CHAZOTTE B, 1991, J BIOL CHEM, V266, P5973; Chen Y, 2006, METHODS, V39, P147, DOI 10.1016/j.ymeth.2006.05.008; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; GUPTE SS, 1991, BIOCHIM BIOPHYS ACTA, V1069, P131, DOI 10.1016/0005-2736(91)90114-N; Haggie PM, 2002, J BIOL CHEM, V277, P40782, DOI 10.1074/jbc.M207456200; HOETS SJ, 2008, AM J HUM GENET, V82, P1306; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Koopman WJH, 2007, BBA-BIOENERGETICS, V1767, P940, DOI 10.1016/j.bbabio.2007.03.013; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LAZAROU M, 2008, BIOCH BIOPH IN PRESS; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lenaz G, 2007, AM J PHYSIOL-CELL PH, V292, pC1221, DOI 10.1152/ajpcell.00263.2006; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Olveczky BP, 1998, BIOPHYS J, V74, P2722, DOI 10.1016/S0006-3495(98)77978-0; Picard D, 2006, EXP CELL RES, V312, P3949, DOI 10.1016/j.yexcr.2006.08.026; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Vogel RO, 2007, MOL GENET METAB, V91, P176, DOI 10.1016/j.ymgme.2007.02.007; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Zuo DM, 2007, NUCLEIC ACIDS RES, V35, pD680, DOI 10.1093/nar/gkl898	34	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34753	34761		10.1074/jbc.M807323200	http://dx.doi.org/10.1074/jbc.M807323200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18826940	Green Published, hybrid			2022-12-25	WOS:000261469100032
J	Majtan, T; Singh, LR; Wang, LQ; Kruger, WD; Kraus, JP				Majtan, Tomas; Singh, Laishram R.; Wang, Liqun; Kruger, Warren D.; Kraus, Jan P.			Active Cystathionine beta-Synthase Can Be Expressed in Heme-free Systems in the Presence of Metal-substituted Porphyrins or a Chemical Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; ADENOSYL-L-METHIONINE; ALZHEIMERS-DISEASE; LIGAND SWITCH; MUTATIONS; PROTEIN; YEAST; TRANSSULFURATION; BINDING; ENZYME	Cystathionine beta-synthase (CBS), a key enzyme in the metabolism of homocysteine, has previously been shown to require a heme co-factor for maximal activity. However, the biochemical function of the CBS heme is not well defined. Here, we show that expression of human CBS in heme-deficient strains of Saccharomyces cerevisiae and Escherichia coli results in production of an enzyme that is misfolded and degraded. Addition of exogenous heme, porphyrins with non-iron metal, or porphyrin lacking metal entirely produced stable and active CBS enzyme. Purification of recombinant CBS enzyme expressed in the presence of various metalloporphyrins confirmed that Mn(III) and Co (III) had 30-60% of the specific activity of Fe(III)-CBS, and still responded to allosteric activation by S-adenosyl-L-methionine. Treatment of S. cerevisiae with the chemical chaperone trimethylamine-N-oxide resulted in near complete restoration of function to human CBS produced in a heme-deficient strain. Taken together, these results suggest that porphyrin moiety of the heme plays a critical role in proper CBS folding and assembly, but that the metal ion is not essential for this function or for allosteric regulation by S-adenosyl-L-methionine.	[Majtan, Tomas; Kraus, Jan P.] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA; [Majtan, Tomas] Slovak Acad Sci, Inst Mol Biol, Dept Genom & Biotechnol, Bratislava 84551, Slovakia; [Singh, Laishram R.; Wang, Liqun; Kruger, Warren D.] Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Slovak Academy of Sciences; Fox Chase Cancer Center	Kraus, JP (corresponding author), Univ Colorado, Dept Pediat, Aurora, CO 80045 USA.	jan.kraus@ucdenver.edu	Kruger, Warren/Y-2541-2018; kruger, warren/A-6407-2008; Majtan, Tomas/AAE-8426-2021	kruger, warren/0000-0002-4990-3695; Majtan, Tomas/0000-0002-2751-2124	National Institutes of Health [HL065217-06A2]; American Heart Association [AHA 2-5-80663]; Jerome Lejeune Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Jerome Lejeune Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL065217-06A2. This work was also supported by American Heart Association Grant AHA 2-5-80663, the Jerome Lejeune Foundation (to J. P. K.), and a generous gift from Margie McGlynn. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bender AT, 2002, J INORG BIOCHEM, V91, P625, DOI 10.1016/S0162-0134(02)00430-0; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bruno S, 2001, J BIOL CHEM, V276, P16, DOI 10.1074/jbc.C000588200; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Evande R, 2004, ARCH BIOCHEM BIOPHYS, V427, P188, DOI 10.1016/j.abb.2004.04.027; FABRY TL, 1968, BIOCHIM BIOPHYS ACTA, V160, P118, DOI 10.1016/0005-2795(68)90072-X; Frank N, 2008, ARCH BIOCHEM BIOPHYS, V470, P64, DOI 10.1016/j.abb.2007.11.006; Frank N, 2006, BIOCHEMISTRY-US, V45, P11021, DOI 10.1021/bi060737m; Gupta K, 2006, ACTA CRYSTALLOGR D, V62, P151, DOI 10.1107/S0907444905036309; Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jhee KH, 2000, J BIOL CHEM, V275, P11541, DOI 10.1074/jbc.C000056200; KERY V, 1995, ARCH BIOCHEM BIOPHYS, V316, P24, DOI 10.1006/abbi.1995.1005; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; KERY V, 1994, J BIOL CHEM, V269, P25283; KIM IC, 1976, BIOCHEMISTRY-US, V15, P4925, DOI 10.1021/bi00667a027; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JM, 1988, J BACTERIOL, V170, P1021, DOI 10.1128/jb.170.2.1021-1025.1988; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maclean KN, 2000, J INORG BIOCHEM, V81, P161, DOI 10.1016/S0162-0134(00)00100-8; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; MILLS JL, 1996, J NUTR, V126, P756; Mudd S., 2001, METABOLIC MOL BASES, P2007; Nozaki T, 2001, J BIOL CHEM, V276, P6516, DOI 10.1074/jbc.M009774200; Oliveriusova J, 2002, J BIOL CHEM, V277, P48386, DOI 10.1074/jbc.M207087200; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Stojiljkovic I, 2001, EXPERT OPIN INV DRUG, V10, P309, DOI 10.1517/13543784.10.2.309; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; UMANOFF H, 1988, J BACTERIOL, V170, P4969, DOI 10.1128/jb.170.10.4969-4971.1988; Vadon-Le Goff S, 2001, BIOCHEM BIOPH RES CO, V283, P487, DOI 10.1006/bbrc.2001.4807; Woodward JJ, 2007, NAT METHODS, V4, P43, DOI 10.1038/NMETH984	45	44	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34588	34595		10.1074/jbc.M805928200	http://dx.doi.org/10.1074/jbc.M805928200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18849566	hybrid, Green Published			2022-12-25	WOS:000261469100013
J	Liu, X; Zhao, DZ; Qin, LL; Li, J; Zeng, HY				Liu, Xin; Zhao, Dezheng; Qin, Liuliang; Li, Jian; Zeng, Huiyan			Transcription Enhancer Factor 3 (TEF3) Mediates the Expression of Down Syndrome Candidate Region 1 Isoform 1 (DSCR1-1L) in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; INHIBITS CALCINEURIN; GENE-EXPRESSION; MULTIGENE FAMILY; OXIDATIVE STRESS; SKELETAL-MUSCLE; MESSENGER-RNA; TEA DOMAIN; PROTEIN; ANGIOGENESIS	The Down syndrome candidate region 1 gene (DSCR1) can be expressed as four isoforms, one of which is the well-studied isoform 4 (DSCR1-4) that is induced by VEGF-A(165) to provide a negative feedback loop in the VEGF-A(165)-induced angiogenesis. We reported previously that another DSCR1 isoform, DSCR1-1L, was also up-regulated by VEGF-A(165) in cultured endothelial cells and in several in vivo models of pathological angiogenesis and that different from DSCR1-4, DSCR1-1L overexpression alone induced cultured endothelial cell proliferation and promoted angiogenesis in Matrigel assays. It was reported recently that tumor growth was greatly repressed in DSCR1 knock-out mice. Although DSCR1-4 transcription was primarily regulated by NFAT, the mechanism regulating DSCR1-1L expression was still unknown. We developed human DSCR1-1L promoter-driven luciferase system and found that deletion of a putative conserved M-CAT site located 1426-bp upstream of the translation start site blunted promoter activity. We further showed that knockdown of TEF3, not other members of TEF family inhibited VEGF-A(165)-induced DSCR1-1L expression. We also demonstrated that TEF3 directly interacted with the putative M-CAT site in the DSCR1-1L promoter in vitro and in vivo. Finally, overexpression of TEF3 isoform 1, not isoform 3, in HUVEC was sufficient to induce DSCR1-1L expression even in the absence of VEGF-A(165) stimulation. Taken together, we elucidated a novel function of transcriptional factor TEF3. TEF3 was required for DSCR1-1L expression through binding to the M-CAT site in its promoter and could be an attractive target for anti-angiogenesis therapy.	[Zeng, Huiyan] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zhao, Dezheng] Beth Israel Deaconess Med Ctr, Dept Gastroenterol, Boston, MA 02215 USA; [Li, Jian] Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA 02215 USA; [Liu, Xin; Zhao, Dezheng; Zeng, Huiyan] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Zeng, HY (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, 99 Brookline Ave RN 270F, Boston, MA 02215 USA.	hzeng@caregroup.harvard.edu			ACS [RSG-05-118-01-CSM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082837] Funding Source: NIH RePORTER	ACS(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by ACS Grant RSG-05-118-01-CSM. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Appukuttan B, 2007, INVEST OPHTH VIS SCI, V48, P3775, DOI 10.1167/iovs.06-1172; Azakie A, 2005, AM J PHYSIOL-CELL PH, V289, pC1522, DOI 10.1152/ajpcell.00126.2005; Azakie A, 1996, J BIOL CHEM, V271, P8260, DOI 10.1074/jbc.271.14.8260; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Chen JX, 2004, J APPL PHYSIOL, V96, P612, DOI 10.1152/japplphysiol.00728.2003; Cho YJ, 2005, ARCH BIOCHEM BIOPHYS, V439, P121, DOI 10.1016/j.abb.2005.05.002; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; Faruqi SA, 2002, CANCER GENET CYTOGEN, V138, P165, DOI 10.1016/S0165-4608(02)00596-4; FRIGERIO JM, 1995, HUM MOL GENET, V4, P37, DOI 10.1093/hmg/4.1.37; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hsu DKW, 1996, J BIOL CHEM, V271, P13786, DOI 10.1074/jbc.271.23.13786; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; Ilan N, 2003, LAB INVEST, V83, P1105, DOI 10.1097/01.LAB.0000083531.84403.8B; Jacquemin P, 1996, J BIOL CHEM, V271, P21775, DOI 10.1074/jbc.271.36.21775; Jiang SW, 1999, MOL ENDOCRINOL, V13, P879, DOI 10.1210/me.13.6.879; Kaneko KJ, 1998, DEV GENET, V22, P43, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;43::AID-DVG5&gt;3.0.CO;2-7; Leahy KP, 1999, ARCH BIOCHEM BIOPHYS, V368, P67, DOI 10.1006/abbi.1998.1059; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Mann KM, 2004, J CELL BIOL, V165, P483, DOI 10.1083/jcb.200402105; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Qin LL, 2006, MOL CANCER RES, V4, P811, DOI 10.1158/1541-7786.MCR-06-0126; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200; Smucker JD, 1999, GYNECOL ONCOL, V74, P512, DOI 10.1006/gyno.1999.5453; Stewart AFR, 1996, GENOMICS, V37, P68, DOI 10.1006/geno.1996.0522; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; VERHEST A, 1991, 4 INT WORKSH CHROM S; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Yasunami M, 1996, BIOCHEM BIOPH RES CO, V228, P365, DOI 10.1006/bbrc.1996.1667; Yockey CE, 1996, J BIOL CHEM, V271, P3727, DOI 10.1074/jbc.271.7.3727; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200	50	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34159	34167		10.1074/jbc.M806338200	http://dx.doi.org/10.1074/jbc.M806338200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840614	Green Published, hybrid			2022-12-25	WOS:000261277700044
J	Milstein, O; Tseng, SY; Starr, T; Llodra, J; Nans, A; Liu, ML; Wild, MK; van der Merwe, PA; Stokes, DL; Reisner, Y; Dustin, ML				Milstein, Oren; Tseng, Su-Yi; Starr, Toby; Llodra, Jaime; Nans, Andrea; Liu, Mengling; Wild, Martin K.; van der Merwe, P. Anton; Stokes, David L.; Reisner, Yair; Dustin, Michael L.			Nanoscale Increases in CD2-CD48-mediated Intermembrane Spacing Decrease Adhesion and Reorganize the Immunological Synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-RECEPTOR MICROCLUSTERS; ANTIGEN RECOGNITION; ACTIVATION; CD2; COMPLEX; DIMENSIONS; MOLECULES; SURFACE; DOMAIN; ICAM-1	The relationship between intermembrane spacing, adhesion efficiency, and lateral organization of adhesion receptors has not been established for any adhesion system. We have utilized the CD2 ligand CD48 with two (wild type CD48 (CD48-WT)), four (CD48-CD2), or five (CD48-CD22) Ig-like domains. CD48-WT was 10-fold more efficient in mediating adhesion than CD48-CD2 or CD48-CD22. Electron tomography of contact areas with planar bilayers demonstrated average intermembrane spacing of 12.8 nm with CD48-WT, 14.7 nm with CD48-CD2, and 15.6 nm with CD48-CD22. Both CD48-CD2 and CD48-CD22 chimeras segregated completely from CD48-WT in mixed contact areas. In contrast, CD48-CD2 and CD48-CD22 co-localized when mixed contacts were formed. Confocal imaging of immunological synapses formed between primary T lymphocytes and Chinese hamster ovary cells presenting major histocompatibility complex-peptide complexes, and different forms of CD48 demonstrated that CD48-CD2 and CD48-CD22 induce an eccentric CD2/T cell antigen receptor cluster. We propose that this reorganization of the immunological synapse sequesters the T cell antigen receptor in a location where it cannot interact with its ligand and dramatically reduces T cell sensitivity.	[Milstein, Oren; Tseng, Su-Yi; Starr, Toby; Dustin, Michael L.] NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA; [Llodra, Jaime; Nans, Andrea; Stokes, David L.] NYU, Sch Med, Program Struct Biol, Helen & Martin Kimmel Ctr Biol & Med,Skirball Ins, New York, NY 10016 USA; [Liu, Mengling] NYU, Inst Canc, Div Biostat, New York, NY 10016 USA; [Milstein, Oren; Reisner, Yair] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Wild, Martin K.] Max Planck Inst Mol Med, D-48149 Munster, Germany; [van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	New York University; New York University; New York University; Weizmann Institute of Science; Max Planck Society; University of Oxford	Dustin, ML (corresponding author), NYU, Sch Med, Program Mol Pathogenesis, 540 1st Ave, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020; van der Merwe, P. Anton/F-8539-2011; Reisner, Yair/AAA-4772-2019	Liu, Mengling/0000-0001-9758-8522; Dustin, Michael/0000-0003-4983-6389; Reisner, Yair/0000-0002-3354-6945	National Institutes of Health [AI43542, GM071044, P30 CA016087]; European Molecular Biology Organization Fellowship [ASTF.49.00-05]; Leukemia and Lymphoma Society Fellowship [5456-04]; MRC [G9722488] Funding Source: UKRI; Medical Research Council [G9722488] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043542, R37AI043542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071044] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0741914] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization Fellowship(European Molecular Biology Organization (EMBO)); Leukemia and Lymphoma Society Fellowship(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants AI43542 (to M. L. D.), GM071044 (to D. L. S.), and P30 CA016087 (to M. L.). This work was also supported by European Molecular Biology Organization Fellowship ASTF.49.00-05 (to O. M.) and Leukemia and Lymphoma Society Fellowship 5456-04 (to S. Y. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; BOCKENSTEDT LK, 1988, J IMMUNOL, V141, P1904; BROWN MH, 1989, NATURE, V339, P551, DOI 10.1038/339551a0; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; CARPEN O, 1991, J CELL BIOL, V115, P861, DOI 10.1083/jcb.115.3.861; CHAN PY, 1992, MOL BIOL CELL, V3, P157, DOI 10.1091/mbc.3.2.157; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin M. L., 2007, CURRENT PROTOCOLS IM; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Gaglia JL, 2001, CELL IMMUNOL, V213, P83, DOI 10.1006/cimm.2001.1867; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tseng SY, 2005, J IMMUNOL, V175, P7829, DOI 10.4049/jimmunol.175.12.7829; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	39	52	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34414	34422		10.1074/jbc.M804756200	http://dx.doi.org/10.1074/jbc.M804756200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18826951	hybrid, Green Published			2022-12-25	WOS:000261277700069
J	Guan, Y; Abdelwahab, S; Kamin-Lewis, R; DeVico, AL; Lewis, GK				Guan, Yongjun; Abdelwahab, Sayed; Kamin-Lewis, Roberta; DeVico, Anthony L.; Lewis, George K.			'Self-Protection' of Individual CD4(+) T Cells against R5 HIV-1 Infection by the Synthesis of Anti-Viral CCR5 Ligands	PLOS ONE			English	Article								It is well established that paracrine secretion of anti-viral CCR5 ligands by CD8(+) and CD4(+) T cells can block the infection of activated CD4(+) T cells by R5 and dual-tropic isolates of HIV-1. By contrast, because CD4(+) T cells can be infected by HIV-1 and at least some subsets secrete anti-viral CCR5 ligands, it is possible that these ligands protect against HIV-1 via autocrine as well as paracrine pathways. Here we use a model primary CD4(+) T cell response in vitro to show that individual CD4(+) T cells that secrete anti-viral CCR5 ligands are 'self-protected' against infection with R5 but not X4 strains of HIV-1. This protection is selective for CD4(+) T cells that secrete anti-viral CCR5 ligands in that activated CD4(+) T cells in the same cultures remain infectable with R5 HIV-1. These data are most consistent with an autocrine pathway of protection in this system and indicate a previously unappreciated selective pressure on the emergence of viral variants and CD4(+) T cell phenotypes during HIV-1 infection.	[Guan, Yongjun; Abdelwahab, Sayed; Kamin-Lewis, Roberta; DeVico, Anthony L.; Lewis, George K.] Univ Maryland, Sch Med, Inst Human Virol, Div Basic Sci & Vaccine Res, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Guan, Y (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Div Basic Sci & Vaccine Res, Baltimore, MD 21201 USA.	glewis@ihv.umaryland.edu	Guan, Yongjun/V-8117-2019; Abdelwahab, Sayed F./P-1481-2016	Guan, Yongjun/0000-0001-6546-2095; Abdelwahab, Sayed F./0000-0002-9636-7485	NIH; Institute of Human Virology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Human Virology	The work was supported by NIH grants to GKL AND AD and intramural funds from the Institute of Human Virology. The funders had no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Bagley KC, 2005, INFECT IMMUN, V73, P413, DOI 10.1128/IAI.73.1.413-421.2005; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Bueno C, 2006, IMMUNITY, V25, P67, DOI 10.1016/j.immuni.2006.04.012; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cocchi F, 2000, P NATL ACAD SCI USA, V97, P13812, DOI 10.1073/pnas.240469997; Criado G, 2004, J IMMUNOL, V172, P222, DOI 10.4049/jimmunol.172.1.222; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Garzino-Demo A, 1999, P NATL ACAD SCI USA, V96, P11986, DOI 10.1073/pnas.96.21.11986; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kamin-Lewis R, 2001, P NATL ACAD SCI USA, V98, P9283, DOI 10.1073/pnas.161298998; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Paxton WA, 1999, IMMUNOL LETT, V66, P71, DOI 10.1016/S0165-2478(98)00154-0; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Paxton WA, 2001, J INFECT DIS, V183, P1678, DOI 10.1086/320701; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Riley JL, 1998, J VIROL, V72, P8273, DOI 10.1128/JVI.72.10.8273-8280.1998; Roederer M, 1997, Semin Immunol, V9, P389, DOI 10.1006/smim.1997.0097; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sabbe R, 2001, J VIROL, V75, P661, DOI 10.1128/JVI.75.2.661-671.2001; Selin LK, 2004, IMMUNITY, V20, P5, DOI 10.1016/S1074-7613(03)00356-X; Sun LL, 2004, INT IMMUNOL, V16, P1623, DOI 10.1093/intimm/dxh164; Wasik TJ, 1999, J IMMUNOL, V162, P4355; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3857, DOI 10.1073/pnas.95.7.3857	43	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3481	10.1371/journal.pone.0003481	http://dx.doi.org/10.1371/journal.pone.0003481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941536	Green Published, gold, Green Submitted			2022-12-25	WOS:000265126100012
J	Chung, H; Young, DJ; Lopez, CG; Le, TAT; Lee, JK; Ream-Robinson, D; Huang, SC; Carethers, JM				Chung, Heekyung; Young, Dennis J.; Lopez, Claudia G.; Le, Thuy-Anh T.; Lee, Jeffrey K.; Ream-Robinson, Deena; Huang, Sherry C.; Carethers, John M.			Mutation Rates of TGFBR2 and ACVR2 Coding Microsatellites in Human Cells with Defective DNA Mismatch Repair	PLOS ONE			English	Article								Microsatellite instability promotes colonic tumorigenesis through generating frameshift mutations at coding microsatellites of tumor suppressor genes, such as TGFBR2 and ACVR2. As a consequence, signaling through these TGF beta family receptors is abrogated in DNA Mismatch repair (MMR)-deficient tumors. How these mutations occur in real time and mutational rates of these human coding sequences have not previously been studied. We utilized cell lines with different MMR deficiencies (hMLH1(-/-), hMSH6(-/-), hMSH3(-/-), and MMR-proficient) to determine mutation rates. Plasmids were constructed in which exon 3 of TGFBR2 and exon 10 of ACVR2 were cloned +1 bp out of frame, immediately after the translation initiation codon of an enhanced GFP (EGFP) gene, allowing a -1 bp frameshift mutation to drive EGFP expression. Mutation-resistant plasmids were constructed by interrupting the coding microsatellite sequences, preventing frameshift mutation. Stable cell lines were established containing portions of TGFBR2 and ACVR2, and nonfluorescent cells were sorted, cultured for 7-35 days, and harvested for flow cytometric mutation detection and DNA sequencing at specific time points. DNA sequencing revealed a 21 bp frameshift mutation (A(9) in TGFBR2 and A(7) in ACVR2) in the fluorescent cells. Two distinct fluorescent populations, M1 (dim, representing heteroduplexes) and M2 (bright, representing full mutants) were identified, with the M2 fraction accumulating over time. hMLH1 deficiency revealed 11 (5.91 x 10(-4)) and 15 (2.18 x 10(-4)) times higher mutation rates for the TGFBR2 and ACVR2 microsatellites compared to hMSH6 deficiency, respectively. The mutation rate of the TGFBR2 microsatellite was similar to 3 times higher in both hMLH1 and hMSH6 deficiencies than the ACVR2 microsatellite. The -1 bp frameshift mutation rates of TGFBR2 and ACVR2 microsatellite sequences are dependent upon the human MMR background.	[Chung, Heekyung; Lopez, Claudia G.; Le, Thuy-Anh T.; Lee, Jeffrey K.; Ream-Robinson, Deena; Carethers, John M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Young, Dennis J.; Carethers, John M.] Univ Calif San Diego, Rebecca & John Moores Comprehensive Canc Ctr, La Jolla, CA 92093 USA; [Huang, Sherry C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Carethers, John M.] VA San Diego Hlthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Chung, H (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jcarethers@ucsd.edu	Lopez, Claudia/GXN-1686-2022		United States Public Health Service [DK067287]; UCSD Digestive Diseases Research Development Center [DK080506]; VA Research Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287, R24DK080506] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); UCSD Digestive Diseases Research Development Center; VA Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the United States Public Health Service (DK067287 to JMC), the UCSD Digestive Diseases Research Development Center (DK080506), and the VA Research Service (Merit Review Award to JMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Akiyama Y, 1997, CANCER RES, V57, P3920; Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Boyer JC, 2008, MUTAT RES-FUND MOL M, V640, P89, DOI 10.1016/j.mrfmmm.2007.12.005; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Gasche C, 2003, P NATL ACAD SCI USA, V100, P1914, DOI 10.1073/pnas.0437965100; Grady WM, 1998, CANCER RES, V58, P3101; GRADY WM, 2008, GASTROENTER IN PRESS, V135; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Hempen PM, 2003, CANCER RES, V63, P994; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Jung BH, 2007, GASTROENTEROLOGY, V132, P633, DOI 10.1053/j.gastro.2006.11.018; JUNG BH, 2008, TXB GASTROE IN PRESS; KOI M, 1994, CANCER RES, V54, P4308; Luria SE, 1943, GENETICS, V28, P491; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Marra G, 1996, GASTROENTEROL CLIN N, V25, P755, DOI 10.1016/S0889-8553(05)70273-9; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1995, CANCER RES, V55, P5548; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Twerdi CD, 1999, P NATL ACAD SCI USA, V96, P2875, DOI 10.1073/pnas.96.6.2875; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698	30	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3463	10.1371/journal.pone.0003463	http://dx.doi.org/10.1371/journal.pone.0003463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941508	gold, Green Published, Green Submitted			2022-12-25	WOS:000265125900007
J	Guerra, B; Fuentes, T; Delgado-Guerra, S; Guadalupe-Grau, A; Olmedillas, H; Santana, A; Ponce-Gonzalez, JG; Dorado, C; Calbet, JAL				Guerra, Borja; Fuentes, Teresa; Delgado-Guerra, Safira; Guadalupe-Grau, Amelia; Olmedillas, Hugo; Santana, Alfredo; Gustavo Ponce-Gonzalez, Jesus; Dorado, Cecilia; Calbet, Jose A. L.			Gender Dimorphism in Skeletal Muscle Leptin Receptors, Serum Leptin and Insulin Sensitivity	PLOS ONE			English	Article								To determine if there is a gender dimorphism in the expression of leptin receptors (OB-R170, OB-R128 and OB-R98) and the protein suppressor of cytokine signaling 3 (SOCS3) in human skeletal muscle, the protein expression of OB-R, perilipin A, SOCS3 and alpha-tubulin was assessed by Western blot in muscle biopsies obtained from the m. vastus lateralis in thirty-four men (age = 27.1 +/- 6.8 yr) and thirty-three women (age = 26.7 +/- 6.7 yr). Basal serum insulin concentration and HOMA were similar in both genders. Serum leptin concentration was 3.4 times higher in women compared to men (P<0.05) and this difference remained significant after accounting for the differences in percentage of body fat or soluble leptin receptor. OB-R protein was 41% (OB-R170, P<0.05) and 163% (OB-R128, P<0.05) greater in women than men. There was no relationship between OB-R expression and the serum concentrations of leptin or 17 beta-estradiol. In men, muscle OB-R128 protein was inversely related to serum free testosterone. In women, OB-R98 and OB-R128 were inversely related to total serum testosterone concentration, and OB-R128 to serum free testosterone concentration. SOCS3 protein expression was similar in men and women and was not related to OB-R. In women, there was an inverse relationship between the logarithm of free testosterone and SCOS3 protein content in skeletal muscle (r = -0.46, P<0.05). In summary, there is a gender dimorphism in skeletal muscle leptin receptors expression, which can be partly explained by the influence of testosterone. SOCS3 expression in skeletal muscle is not up-regulated in women, despite very high serum leptin concentrations compared to men. The circulating form of the leptin receptor can not be used as a surrogate measure of the amount of leptin receptors expressed in skeletal muscles.	[Guerra, Borja; Fuentes, Teresa; Delgado-Guerra, Safira; Guadalupe-Grau, Amelia; Olmedillas, Hugo; Santana, Alfredo; Gustavo Ponce-Gonzalez, Jesus; Dorado, Cecilia; Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Santana, Alfredo] Chilhood Hosp Materno Infantil Las Palmas, Genet Unit, Las Palmas Gran Canaria, Spain; [Santana, Alfredo] Hosp Gran Canaria Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria	Guerra, B (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Campus Univ Tafira S-N, Las Palmas Gran Canaria, Spain.	lopezcalbet@gmail.com	Fuentes, Teresa/K-7227-2014; PONCE GONZALEZ, JESUS G/R-1836-2019; Calbet, Jose A L/H-6693-2015; Olmedillas, Hugo/F-4809-2015; Guerra, Borja/G-9739-2015; Dorado García, Cecilia/ABC-2792-2021; Guadalupe-Grau, Amelia/H-4961-2016; Cecilia, Dorado-Garcia/B-4586-2010; RODRIGUEZ, ALFREDO SANTANA/AAE-2934-2019; Guerra, Borja/ABE-1138-2021; González, Jesús Gustavo Ponce/H-9500-2015	Fuentes, Teresa/0000-0003-1286-8731; PONCE GONZALEZ, JESUS G/0000-0002-5982-7761; Calbet, Jose A L/0000-0002-9215-6234; Olmedillas, Hugo/0000-0003-4625-2759; Guerra, Borja/0000-0003-4355-5682; Guadalupe-Grau, Amelia/0000-0003-2573-4572; Cecilia, Dorado-Garcia/0000-0001-6616-6810; RODRIGUEZ, ALFREDO SANTANA/0000-0002-1075-9948; Guerra, Borja/0000-0003-4355-5682; González, Jesús Gustavo Ponce/0000-0002-5982-7761; antunez, Ariel/0000-0002-2548-7885	Ministerio de Educacion y Ciencia [BFI2003-09638, BFU2006-13784, FEDER]; Gobierno de Canarias [PI2005/177]; Universidad de Las Palmas de Gran Canaria, Spain [UNI2006/05]; Recursos Humanos y Difusion de la Investigacion Program (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain)	Ministerio de Educacion y Ciencia(Spanish Government); Gobierno de Canarias; Universidad de Las Palmas de Gran Canaria, Spain; Recursos Humanos y Difusion de la Investigacion Program (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain)(Instituto de Salud Carlos III)	This study was supported by grants from the Ministerio de Educacion y Ciencia (BFI2003-09638, BFU2006-13784 and FEDER), Gobierno de Canarias (PI2005/177) and Universidad de Las Palmas de Gran Canaria, Spain (UNI2006/05). Borja Guerra is a fellow of the Recursos Humanos y Difusion de la Investigacion Program (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain). The sponsors of this study had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Alonso A, 2007, EXP BIOL MED, V232, P542; Ara I, 2006, BRIT J NUTR, V96, P1053, DOI 10.1017/BJN20061956; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Brann DW, 1999, STEROIDS, V64, P659, DOI 10.1016/S0039-128X(99)00049-5; Caprio M, 1999, ENDOCRINOLOGY, V140, P4939, DOI 10.1210/en.140.11.4939; Castrogiovanni D, 2003, ENDOCRINE, V22, P203, DOI 10.1385/ENDO:22:3:203; Chan JL, 2002, DIABETES, V51, P2105, DOI 10.2337/diabetes.51.7.2105; Cohen P, 2005, J BIOL CHEM, V280, P10034, DOI 10.1074/jbc.M413684200; Cornish J, 2002, J ENDOCRINOL, V175, P405, DOI 10.1677/joe.0.1750405; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gallagher D, 2005, AM J CLIN NUTR, V81, P903, DOI 10.1093/ajcn/81.4.903; Ge HF, 2002, J BIOL CHEM, V277, P45898, DOI 10.1074/jbc.M205825200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guerra B, 2007, J APPL PHYSIOL, V102, P1786, DOI 10.1152/japplphysiol.01313.2006; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; Hikita M, 2000, BIOCHEM BIOPH RES CO, V271, P703, DOI 10.1006/bbrc.2000.2692; Ishikawa T, 2007, ANDROLOGIA, V39, P22, DOI 10.1111/j.1439-0272.2006.00754.x; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Kamikubo Y, 2008, BIOCHEM J, V410, P595, DOI 10.1042/BJ20071137; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammert A, 2001, BIOCHEM BIOPH RES CO, V283, P982, DOI 10.1006/bbrc.2001.4885; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Liu ZJ, 2007, HORM METAB RES, V39, P489, DOI 10.1055/s-2007-981680; LUNDBY C, 2006, J PHYSL; Luukkaa V, 1998, J CLIN ENDOCR METAB, V83, P3243, DOI 10.1210/jc.83.9.3243; Machinal F, 1999, ENDOCRINOLOGY, V140, P1567, DOI 10.1210/en.140.4.1567; Mannucci E, 1998, EUR J ENDOCRINOL, V139, P198, DOI 10.1530/eje.0.1390198; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muoio DM, 2002, BEST PRACT RES CL EN, V16, P653, DOI 10.1053/beem.2002.0223; MYERS MG, 2007, ANN REV PHYSL; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Ramsay TG, 2005, J ANIM SCI, V83, P2501; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Seron K, 2006, BIOCHEM BIOPH RES CO, V348, P1232, DOI 10.1016/j.bbrc.2006.07.068; Shimizu H, 1997, J ENDOCRINOL, V154, P285, DOI 10.1677/joe.0.1540285; Sinha MK, 1996, J CLIN INVEST, V98, P1277, DOI 10.1172/JCI118913; Stein K, 2006, J CLIN ENDOCR METAB, V91, P1021, DOI 10.1210/jc.2005-1394; Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V283, pE187, DOI 10.1152/ajpendo.00542.2001; Steinberg GR, 2006, J CLIN ENDOCR METAB, V91, P3592, DOI 10.1210/jc.2006-0638; TARNOPOLSKY LJ, 1990, J APPL PHYSIOL, V68, P302, DOI 10.1152/jappl.1990.68.1.302; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tena-Sempere M, 2001, J ENDOCRINOL, V170, P413, DOI 10.1677/joe.0.1700413; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Dielen FMH, 2002, J CLIN ENDOCR METAB, V87, P1708, DOI 10.1210/jc.87.4.1708; Wabitsch M, 1997, J CLIN INVEST, V100, P808, DOI 10.1172/JCI119595; Wang MY, 1998, P NATL ACAD SCI USA, V95, P714, DOI 10.1073/pnas.95.2.714; Wong SL, 2004, J CLIN ENDOCR METAB, V89, P2672, DOI 10.1210/jc.2003-031931; Zachow RJ, 1999, BIOL REPROD, V61, P1104, DOI 10.1095/biolreprod61.4.1104; Zhang FM, 2005, VITAM HORM, V71, P345, DOI 10.1016/S0083-6729(05)71012-8; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	57	46	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3466	10.1371/journal.pone.0003466	http://dx.doi.org/10.1371/journal.pone.0003466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941624	Green Published, gold			2022-12-25	WOS:000265125900010
J	Hoshikawa, S; Ogata, T; Fujiwara, S; Nakamura, K; Tanaka, S				Hoshikawa, Shinya; Ogata, Toru; Fujiwara, Sayaka; Nakamura, Kozo; Tanaka, Sakae			A Novel Function of RING Finger Protein 10 in Transcriptional Regulation of the Myelin-Associated Glycoprotein Gene and Myelin Formation in Schwann Cells	PLOS ONE			English	Article								Myelin-associated glycoprotein (MAG) has been detected in Schwann cells prior to the onset of myelination, suggesting its functions in the initiation of myelination. However, transcriptional regulatory mechanisms of MAG remain to be elucidated. Here, we analyzed the promoter of the MAG gene by using luciferase reporter systems in the primary rat Schwann cells. We identified a novel cis-acting element located 160 bp upstream from the MAG transcription initiation site. Using the identified cis-element as a bait, we performed yeast one-hybrid screening and isolated a cDNA encoding a RNF10 as a putative trans-acting protein. When overexpressed in Schwann cells, RNF10 enhanced the activity of the MAG promoter. When RNF10 expression in Schwann cells was knocked down by siRNA, endogenous MAG mRNA and protein expression decreased. Furthermore, we evaluated myelin synthesis using Schwann cell-DRG neuron cocultures. When Schwann cells were infected with retrovirus expressing RNF10 siRNA, myelin formation was inhibited. These data suggest that RNF10 regulates MAG expression and is required for myelin formation.	[Hoshikawa, Shinya; Fujiwara, Sayaka; Nakamura, Kozo; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113, Japan; [Hoshikawa, Shinya; Ogata, Toru] Natl Rehab Ctr, Res Inst, Div Motor Dysfunct, Tokorozawa, Saitama, Japan	University of Tokyo	Hoshikawa, S (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113, Japan.	ogata@rehab.go.jp	Ogata, Toru/ADC-3560-2022; Tanaka, Sakae/Y-3061-2019	Ogata, Toru/0000-0001-9011-8640; Tanaka, Sakae/0000-0001-9210-9414	Ministry of Education, Science and Culture of Japan [Grant-in-Aid]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant-in-Aid for Exploratory Research and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan	BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; EINHEBER S, 1995, J CELL BIOL, V129, P443, DOI 10.1083/jcb.129.2.443; Erb M, 2006, MOL CELL NEUROSCI, V31, P613, DOI 10.1016/j.mcn.2005.12.001; GRUBINSKA B, 1994, J NEUROSCI RES, V39, P233, DOI 10.1002/jnr.490390302; Hakli M, 2001, J BIOL CHEM, V276, P23653, DOI 10.1074/jbc.M009891200; Konat GW, 1996, ACTA NEUROBIOL EXP, V56, P281; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; Laszkiewicz I, 1997, J NEUROSCI RES, V50, P928; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lin JJ, 2005, MOL CELL BIOCHEM, V275, P75, DOI 10.1007/s11010-005-0823-3; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; OWENS GC, 1989, GLIA, V2, P119, DOI 10.1002/glia.440020208; Poukka H, 2000, J CELL SCI, V113, P2991; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Salzer JL, 1997, NEURON, V18, P843, DOI 10.1016/S0896-6273(00)80323-2; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schaumburg Jochen, 2000, Silva Gabreta, V4, P29; Seki N, 2000, J HUM GENET, V45, P38, DOI 10.1007/s100380050007; TRAPP BD, 1982, J CELL BIOL, V92, P877, DOI 10.1083/jcb.92.3.877; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211	24	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3464	10.1371/journal.pone.0003464	http://dx.doi.org/10.1371/journal.pone.0003464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941509	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125900008
J	Ryge, J; Westerdahl, AC; Alstrom, P; Kiehn, O				Ryge, Jesper; Westerdahl, Ann-Charlotte; Alstrom, Preben; Kiehn, Ole			Gene Expression Profiling of Two Distinct Neuronal Populations in the Rodent Spinal Cord	PLOS ONE			English	Article							LEFT-RIGHT COORDINATION; FALSE DISCOVERY RATE; Y MESSENGER-RNA; MOTOR-NEURONS; COMMISSURAL INTERNEURONS; MICROARRAY ANALYSIS; SUBUNIT COMPOSITION; POTASSIUM CHANNELS; LOCOMOTOR-ACTIVITY; RAT	Background: In the field of neuroscience microarray gene expression profiles on anatomically defined brain structures are being used increasingly to study both normal brain functions as well as pathological states. Fluorescent tracing techniques in brain tissue that identifies distinct neuronal populations can in combination with global gene expression profiling potentially increase the resolution and specificity of such studies to shed new light on neuronal functions at the cellular level. Methodology/Principal Findings: We examine the microarray gene expression profiles of two distinct neuronal populations in the spinal cord of the neonatal rat, the principal motor neurons and specific interneurons involved in motor control. The gene expression profiles of the respective cell populations were obtained from amplified mRNA originating from 50-250 fluorescently identified and laser microdissected cells. In the data analysis we combine a new microarray normalization procedure with a conglomerate measure of significant differential gene expression. Using our methodology we find 32 genes to be more expressed in the interneurons compared to the motor neurons that all except one have not previously been associated with this neuronal population. As a validation of our method we find 17 genes to be more expressed in the motor neurons than in the interneurons and of these only one had not previously been described in this population. Conclusions/Significance: We provide an optimized experimental protocol that allows isolation of gene transcripts from fluorescent retrogradely labeled cell populations in fresh tissue, which can be used to generate amplified aRNA for microarray hybridization from as few as 50 laser microdissected cells. Using this optimized experimental protocol in combination with our microarray analysis methodology we find 49 differentially expressed genes between the motor neurons and the interneurons that reflect the functional differences between these two cell populations in generating and transmitting the motor output in the rodent spinal cord.	[Ryge, Jesper; Westerdahl, Ann-Charlotte; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Stockholm, Sweden; [Alstrom, Preben] CORE AS, Frederiksberg, Denmark	Karolinska Institutet	Ryge, J (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Stockholm, Sweden.	jesper.ryge@ki.se; o.kiehn@ki.se	kiehn, ole/AAB-1262-2019; kiehn, ole/AAT-7881-2021	Kiehn, Ole/0000-0002-5954-469X; Ryge, Jesper/0000-0003-1992-7298	Karolinska Institutet; Swedish Medical Research Council; NIH; Schellenberg Foundation	Karolinska Institutet(Karolinska Institutet); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schellenberg Foundation	This work was supported by Karolinska Institutet, The Swedish Medical Research Council, NIH and The Schellenberg Foundation.	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; *AFF, 2002, STAT ALG DESCR DOC S; Akinori M, 1998, PROG NEUROBIOL, V54, P499, DOI 10.1016/S0301-0082(97)00077-4; Alizadeh AA, 2001, J PATHOL, V195, P41, DOI 10.1002/path.889; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertrand S, 2002, EUR J NEUROSCI, V16, P1741, DOI 10.1046/j.1460-9568.2002.02233.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; Butt SJB, 2002, J NEUROSCI, V22, P9961; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; Campagna JA, 1997, MOL CELL NEUROSCI, V8, P377, DOI 10.1006/mcne.1997.0596; Cazalets JR, 1998, ANN NY ACAD SCI, V860, P168, DOI 10.1111/j.1749-6632.1998.tb09047.x; Coleman SK, 1999, J NEUROCHEM, V73, P849, DOI 10.1046/j.1471-4159.1999.0730849.x; CRONE C, 1988, J PHYSIOL-LONDON, V405, P321, DOI 10.1113/jphysiol.1988.sp017335; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Cui DP, 2006, PHYSIOL GENOMICS, V24, P276, DOI 10.1152/physiolgenomics.00109.2005; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Date Y, 2000, NEUROSCI LETT, V288, P87, DOI 10.1016/S0304-3940(00)01195-2; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Deuchars SA, 2001, NEUROSCIENCE, V106, P433, DOI 10.1016/S0306-4522(01)00277-9; Di Giovanni S, 2004, FASEB J, V18, P153, DOI 10.1096/fj.04-2694fje; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Diaz E, 2006, NAT NEUROSCI, V9, P10, DOI 10.1038/nn0106-10; Dumoulin A, 1999, J CELL SCI, V112, P811; Edwards L, 2002, J COMP NEUROL, V443, P154, DOI 10.1002/cne.10115; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Fernandez-Medarde A, 2007, NEUROSCIENCE, V146, P272, DOI 10.1016/j.neuroscience.2007.01.022; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GLOVER JC, 1986, J NEUROSCI METH, V18, P243, DOI 10.1016/0165-0270(86)90011-7; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hernandez-Pineda R, 1999, J NEUROPHYSIOL, V82, P1512, DOI 10.1152/jn.1999.82.3.1512; Hokfelt T, 2007, PEPTIDES, V28, P365, DOI 10.1016/j.peptides.2006.07.024; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Jankowska E, 2003, J NEUROSCI, V23, P1867; Johanson RA, 2000, J NEUROSCI, V20, P2860; Jordan LM, 2002, PROG BRAIN RES, V137, P125; Julien JP, 1998, BRAIN PATHOL, V8, P759, DOI 10.1111/j.1750-3639.1998.tb00199.x; Kettunen P, 2005, NEURON, V45, P95, DOI 10.1016/j.neuron.2004.12.022; KIEHN O, 1992, NEUROSCI LETT, V143, P243, DOI 10.1016/0304-3940(92)90274-B; Kiehn O, 2008, BRAIN RES REV, V57, P56, DOI 10.1016/j.brainresrev.2007.07.002; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Lindholm T, 2004, NEUROREPORT, V15, P649, DOI 10.1097/00001756-200403220-00015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MADERDRUT JL, 1986, BRAIN RES, V377, P29, DOI 10.1016/0006-8993(86)91187-X; MARTI E, 1992, NEUROREPORT, V3, P401, DOI 10.1097/00001756-199205000-00006; Minson JB, 2001, AUTON NEUROSCI-BASIC, V93, P14, DOI 10.1016/S1566-0702(01)00324-1; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mori K, 2004, NEUROSCI RES, V48, P439, DOI 10.1016/j.neures.2003.12.012; Naef F, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.040902; Nagao S, 1997, NEUROSCIENCE, V78, P929; Nakayama K, 2002, J NEUROSCI, V22, P10388; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Plumier JCL, 1997, J COMP NEUROL, V384, P409; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Rasband MN, 2001, J COMP NEUROL, V429, P166, DOI 10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; REN WZ, 1994, MOL BRAIN RES, V22, P173, DOI 10.1016/0169-328X(94)90045-0; RESTREPO CE, 2005, 7491 SOC NEUR; Robinson D, 1997, J COMP NEUROL, V389, P94, DOI 10.1002/(SICI)1096-9861(19971208)389:1<94::AID-CNE7>3.0.CO;2-9; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Samigullin D, 2004, J PHYSIOL-LONDON, V561, P149, DOI 10.1113/jphysiol.2004.073494; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Schousboe A, 2000, NEUROCHEM RES, V25, P1241, DOI 10.1023/A:1007692012048; Schulz S, 1998, NEUROSCI LETT, V257, P37, DOI 10.1016/S0304-3940(98)00803-9; Schutz B, 2004, J COMP NEUROL, V476, P32, DOI 10.1002/cne.20211; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; SEGOND VB, 1999, BRAIN RES, V816, P254; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Shoemaker DD, 2002, CURR OPIN MICROBIOL, V5, P334, DOI 10.1016/S1369-5274(02)00327-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stokke MF, 2002, J COMP NEUROL, V446, P349, DOI 10.1002/cne.10211; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Taccola G, 2004, EUR J NEUROSCI, V19, P533, DOI 10.1111/j.0953-816X.2003.03148.x; Toepfer M, 1999, CELL MOL NEUROBIOL, V19, P297; Tomiyama M, 2001, J NEUROL SCI, V189, P65, DOI 10.1016/S0022-510X(01)00561-5; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uwabe K, 1997, NEUROSCIENCE, V80, P501, DOI 10.1016/S0306-4522(97)00112-7; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Wallis K, 2008, J NEUROSCI, V28, P1904, DOI 10.1523/JNEUROSCI.5163-07.2008; Watson WD, 2003, J NEUROCHEM, V87, P30, DOI 10.1046/j.1471-4159.2003.01962.x; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wiese S, 1999, EUR J NEUROSCI, V11, P1668, DOI 10.1046/j.1460-9568.1999.00585.x; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; Wilczak N, 2003, LANCET, V361, P1007, DOI 10.1016/S0140-6736(03)12828-0; WORKMAN C, 2002, GENOME BIOL, V0003; Yamuy J, 2004, J NEUROSCI, V24, P5336, DOI 10.1523/JNEUROSCI.4812-03.2004; YIN KJ, 1995, ANAT REC, V241, P579, DOI 10.1002/ar.1092410415; Zhou L, 1998, J NEUROSCI, V18, P7200	112	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3415	10.1371/journal.pone.0003415	http://dx.doi.org/10.1371/journal.pone.0003415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923679	gold, Green Published, Green Submitted			2022-12-25	WOS:000265121800013
J	Stenner, MP; Waschbisch, A; Buck, D; Doerck, S; Einsele, H; Toyka, KV; Wiendl, H				Stenner, Max-Philipp; Waschbisch, Anne; Buck, Dorothea; Doerck, Sebastian; Einsele, Hermann; Toyka, Klaus V.; Wiendl, Heinz			Effects of Natalizumab Treatment on Foxp3+T Regulatory Cells	PLOS ONE			English	Article								Background: Natalizumab, a monoclonal humanized antibody targeting the alpha-4 chain of very late activation antigen 4 (VLA-4) exerts impressive therapeutic effects in patients with relapsing-remitting multiple sclerosis. Our objective was to study impacts of Natalizumab therapy on Foxp3+ T regulatory cells (Tregs) in multiple sclerosis (MS) patients. Methodology: A combined approach of in vitro and ex vivo experiments using T cells isolated from the peripheral blood of healthy donors and Natalizumab treated MS patients was chosen. We determined binding of Natalizumab and its effects on the frequency, transmigratory behaviour and suppressive function of Tregs. Principal Findings: Binding of Natalizumab and expression of CD49d (alpha-4 chain of VLA-4) differed between non-regulatory and regulatory cells. Albeit Foxp3+ Tregs had lower levels of CD49d, Natalizumab blocked the transmigration of Foxp3+ Tregs similar to non-regulatory T cells. The frequency of peripheral blood Tregs was unaffected by Natalizumab treatment. Natalizumab does not alter the suppressive capacity of CD4+CD25(high)CD127(low)Foxp3+ Tregs under in vitro conditions. Furthermore, the impaired function of Tregs in MS patients is not restored by Natalizumab treatment. Conclusions: We provide a first detailed analysis of Natalizumab effects on the regulatory T cell population. Our prospective study shows that Foxp3+ Tregs express lower levels of VLA-4 and bind less Natalizumab. We further the understanding of the mechanisms of action of Natalizumab by demonstrating that unlike other immunomodulatory drugs the beneficial therapeutic effects of the monoclonal antibody are largely independent of alterations in Treg frequency or function.	[Stenner, Max-Philipp; Waschbisch, Anne; Buck, Dorothea; Doerck, Sebastian; Toyka, Klaus V.; Wiendl, Heinz] Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany; [Einsele, Hermann] Julius Maximilians Univ, Dept Internal Med 2, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Stenner, MP (corresponding author), Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany.	heinz.wiendl@klinik.uni-wuerzburg.de	Wiendl, Heinz/AAX-6041-2021	Wiendl, Heinz/0000-0003-4310-3432	Deutsche Forschungsgemeinschaft [Wi 1722/3-2]; BiogenIdec	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BiogenIdec(Biogen)	This study was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG, Wi 1722/3-2, to H.W.) and by BiogenIdec (to H.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baecher-Allan C, 2004, J EXP MED, V200, P273, DOI 10.1084/jem.20040812; Bluestone JA, 2007, NAT REV IMMUNOL, V7, P650, DOI 10.1038/nri2137; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; de Andres C, 2007, J NEUROIMMUNOL, V182, P204, DOI 10.1016/j.jneuroim.2006.09.012; Engelhardt B, 2008, NEURODEGENER DIS, V5, P16, DOI 10.1159/000109933; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Feger U, 2007, BLOOD, V110, P568, DOI 10.1182/blood-2006-11-057125; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kappos L, 2007, LANCET NEUROL, V6, P431, DOI 10.1016/S1474-4422(07)70078-9; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Kleinschnitz C., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P35; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Prat A, 1999, ANN NEUROL, V46, P253, DOI 10.1002/1531-8249(199908)46:2<253::AID-ANA16>3.0.CO;2-C; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SATO T, 1995, J IMMUNOL, V155, P2938; SCHWAB N, 2008, J NEUROIMMUNOL; Seale AC, 2008, J CLIN LAB ANAL, V22, P153, DOI 10.1002/jcla.20234; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Stuve O, 2007, CNS DRUG REV, V13, P79, DOI 10.1111/j.1527-3458.2007.00003.x; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Stuve O, 2006, ARCH NEUROL-CHICAGO, V63, P1383, DOI 10.1001/archneur.63.10.1383; Theien BE, 2001, J CLIN INVEST, V107, P995, DOI 10.1172/JCI11717; Uhm JH, 1999, ANN NEUROL, V46, P319, DOI 10.1002/1531-8249(199909)46:3<319::AID-ANA7>3.0.CO;2-N; Valencia X, 2007, NAT CLIN PRACT RHEUM, V3, P619, DOI 10.1038/ncprheum0624; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	39	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3319	10.1371/journal.pone.0003319	http://dx.doi.org/10.1371/journal.pone.0003319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836525	Green Published, gold, Green Submitted			2022-12-25	WOS:000265113500001
J	Berdasco, M; Alcazar, R; Garcia-Ortiz, MV; Ballestar, E; Fernandez, AF; Roldan-Arjona, T; Tiburcio, AF; Altabella, T; Buisine, N; Quesneville, H; Baudry, A; Lepiniec, L; Alaminos, M; Rodriguez, R; Lloyd, A; Colot, V; Bender, J; Canal, MJ; Esteller, M; Fraga, MF				Berdasco, Maria; Alcazar, Ruben; Victoria Garcia-Ortiz, Maria; Ballestar, Esteban; Fernandez, Agustin F.; Roldan-Arjona, Teresa; Tiburcio, Antonio F.; Altabella, Teresa; Buisine, Nicolas; Quesneville, Hadi; Baudry, Antoine; Lepiniec, Loic; Alaminos, Miguel; Rodriguez, Roberto; Lloyd, Alan; Colot, Vincent; Bender, Judith; Jesus Canal, Maria; Esteller, Manel; Fraga, Mario F.			Promoter DNA Hypermethylation and Gene Repression in Undifferentiated Arabidopsis Cells	PLOS ONE			English	Article								Maintaining and acquiring the pluripotent cell state in plants is critical to tissue regeneration and vegetative multiplication. Histone-based epigenetic mechanisms are important for regulating this undifferentiated state. Here we report the use of genetic and pharmacological experimental approaches to show that Arabidopsis cell suspensions and calluses specifically repress some genes as a result of promoter DNA hypermethylation. We found that promoters of the MAPK12, GSTU10 and BXL1 genes become hypermethylated in callus cells and that hypermethylation also affects the TTG1, GSTF5, SUVH8, fimbrin and CCD7 genes in cell suspensions. Promoter hypermethylation in undifferentiated cells was associated with histone hypoacetylation and primarily occurred at CpG sites. Accordingly, we found that the process specifically depends on MET1 and DRM2 methyltransferases, as demonstrated with DNA methyltransferase mutants. Our results suggest that promoter DNA methylation may be another important epigenetic mechanism for the establishment and/or maintenance of the undifferentiated state in plant cells.	[Berdasco, Maria; Ballestar, Esteban; Fernandez, Agustin F.; Esteller, Manel; Fraga, Mario F.] Spanish Natl Canc Ctr CNIO, Mol Pathol Programme, Canc Epigenet Lab, Madrid, Spain; [Berdasco, Maria; Rodriguez, Roberto; Jesus Canal, Maria] Univ Oviedo, Plant Epigenet Lab, Oviedo, Spain; [Berdasco, Maria; Esteller, Manel] Catalan Inst Oncol ICO, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Alcazar, Ruben; Tiburcio, Antonio F.; Altabella, Teresa] Univ Barcelona, Fac Farm, Unitat Fisiol Vegetal, E-08007 Barcelona, Spain; [Victoria Garcia-Ortiz, Maria; Roldan-Arjona, Teresa] Univ Cordoba, Dept Genet, Cordoba, Spain; [Buisine, Nicolas; Colot, Vincent] Univ Evry Val Essonne, INRA, UMR1165, CNRS, Unite Rech Genom Vegetale, Evry, France; [Quesneville, Hadi] INRA, Unite Rech Genom Info, Evry, France; [Baudry, Antoine; Lepiniec, Loic] Inst Natl Rech Agronom 204, Unite Mixte Rech, Lab Biol Semences, Versailles, France; [Alaminos, Miguel] Univ Granada, Dept Histol, E-18071 Granada, Spain; [Lloyd, Alan] Univ Texas, Inst Cellular & Mol Biol, Austin, TX USA; [Bender, Judith] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA; [Fraga, Mario F.] Ctr Nacl Biotecnol, CSIC, Dept Immunol & Oncol, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Oviedo; Catalan Institute of Oncology; University of Barcelona; Universidad de Cordoba; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; University of Granada; University of Texas System; University of Texas Austin; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Berdasco, M (corresponding author), Spanish Natl Canc Ctr CNIO, Mol Pathol Programme, Canc Epigenet Lab, Madrid, Spain.	mffraga@cnio.es	Quesneville, Hadi/AAG-1048-2020; ALAMINOS, MIGUEL/N-9960-2016; Esteller, Manel/L-5956-2014; Lepiniec, Loic/G-5808-2012; Cañal, María Jesús/L-1005-2014; Alcazar, Ruben/E-7720-2010; Roldan, Antonio/F-6241-2013; García-Ortiz, M Victoria/L-1623-2014; Fraga, Mario F/H-7824-2017; Fernandez, Agustin F./N-7302-2014; Roldan-Arjona, Teresa/H-5976-2015; Alcazar, Ruben/S-6391-2019; Ballestar, Esteban/ABG-8561-2020; ALTABELLA, TERESA/M-5034-2018	Quesneville, Hadi/0000-0003-3001-4908; ALAMINOS, MIGUEL/0000-0003-4876-2672; Esteller, Manel/0000-0003-4490-6093; Lepiniec, Loic/0000-0002-5845-3323; Cañal, María Jesús/0000-0002-1639-9672; García-Ortiz, M Victoria/0000-0001-6527-4908; Fraga, Mario F/0000-0001-8450-2603; Fernandez, Agustin F./0000-0002-3792-4085; Roldan-Arjona, Teresa/0000-0003-2842-3956; Ballestar, Esteban/0000-0002-1400-2440; Alcazar, Ruben/0000-0002-3567-7586; ALTABELLA, TERESA/0000-0002-6915-5823	Health, Education and Science Departments of the Spanish Government [FIS01-04, PI061267, I+D+I MCYT08-03, FU2004-02073/BMC, MEC09-05]; European Grant [TRANSFOG LSHC-CT-2004-503438]; Spanish Association Against Cancer (AECC)	Health, Education and Science Departments of the Spanish Government; European Grant; Spanish Association Against Cancer (AECC)	This work was supported by the Health (FIS01-04) (PI061267), Education and Science (I+D+I MCYT08-03, FU2004-02073/BMC and Consolider MEC09-05) Departments of the Spanish Government, the European Grant TRANSFOG LSHC-CT-2004-503438, and the Spanish Association Against Cancer (AECC). M.B. is funded by the Association Against Cancer (AECC).	Avivi Y, 2004, DEV DYNAM, V230, P12, DOI 10.1002/dvdy.20006; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Costa S, 2007, TRENDS CELL BIOL, V17, P101, DOI 10.1016/j.tcb.2006.12.005; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Doerner P, 2006, CURR BIOL, V16, pR56, DOI 10.1016/j.cub.2006.01.001; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Grafi G, 2004, TRENDS BIOTECHNOL, V22, P388, DOI 10.1016/j.tibtech.2004.06.001; Grafi G, 2004, DEV BIOL, V268, P1, DOI 10.1016/j.ydbio.2003.12.027; Grafi G, 2007, DEV BIOL, V306, P838, DOI 10.1016/j.ydbio.2007.03.023; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Koornneef M., 1981, ARABID INF SERV, V18, P45; Koukalova B, 2005, PLANT PHYSIOL, V139, P275, DOI 10.1104/pp.105.061788; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Mathur J, 1998, PLANT J, V13, P707, DOI 10.1046/j.1365-313X.1998.00059.x; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Payne CT, 2000, GENETICS, V156, P1349; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Tessadori F, 2007, J CELL SCI, V120, P1200, DOI 10.1242/jcs.000026; Vanyushin BF, 2006, CURR TOP MICROBIOL, V301, P67; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Williams L, 2003, DEV DYNAM, V228, P113, DOI 10.1002/dvdy.10348; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	43	87	92	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3306	10.1371/journal.pone.0003306	http://dx.doi.org/10.1371/journal.pone.0003306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827894	Green Submitted, Green Published, gold			2022-12-25	WOS:000264797200011
J	Monahan, TS; Andersen, ND; Martin, MC; Malek, JY; Shrikhande, GV; Pradhan, L; Ferran, C; LoGerfo, FW				Monahan, Thomas S.; Andersen, Nicholas D.; Martin, Michelle C.; Malek, Junaid Y.; Shrikhande, Gautam V.; Pradhan, Leena; Ferran, Christiane; LoGerfo, Frank W.			MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein	FASEB JOURNAL			English	Article						bypass graft; RNA interference; small interfering RNA; gene therapy; transfection; protein kinase C	PROTEIN-KINASE-C; BYPASS GRAFTS; ARTERIAL INJURY; ORGAN-CULTURE; GROWTH-FACTOR; RAT AORTA; IN-VITRO; PROLIFERATION; MIGRATION; EXPRESSION	Intimal hyperplasia (IH) limits the patency of all cardiovascular vein bypass grafts. We previously found the myristoylated alanine-rich C kinase substrate (MARCKS), a key protein kinase C (PKC) substrate, to be up-regulated in canine models of IH. Here, we further characterize the role of MARCKS in IH and examine the phenotypic consequences of MARCKS silencing by small interfering RNA (siRNA) transfection in human vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) in vitro and use a rapid 10-min nonviral siRNA transfection technique to determine the effects of MARCKS silencing in human saphenous vein cultured ex vivo. We demonstrate MARCKS silencing attenuates VSMC migration and arrests VSMC proliferation in part through the up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). Conversely, MARCKS silencing had little or no effect on EC migration or proliferation. These phenotypic changes culminated in reduced neointimal formation in cultured human saphenous vein. These data identify MARCKS as a pathogenic contributor to IH and indicate therapeutic MARCKS silencing could selectively suppress the "atherogenic," proliferative phenotype of VSMCs without collateral harm to the endothelium. This approach could be readily translated to the clinic to silence MARCKS in vein bypass grafts prior to implantation.-Monahan, T. S., Andersen, N. D., Martin, M. C., Malek, J. Y., Shrikhande, G. V., Pradhan, L., Ferran, C., LoGerfo, F. W. MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein. FASEB J. 23, 557-564 (2009)	[Monahan, Thomas S.; Andersen, Nicholas D.; Martin, Michelle C.; Malek, Junaid Y.; Shrikhande, Gautam V.; Pradhan, Leena; Ferran, Christiane; LoGerfo, Frank W.] Beth Israel Deaconess Med Ctr, Div Vasc Surg, Dept Surg, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center	Andersen, ND (corresponding author), Beth Israel Deaconess Med Ctr, Div Vasc Surg, Dept Surg, 4 Blackfan Cir,HIM Bldg,Rm 131, Boston, MA 02115 USA.	nicholas.andersen@duke.edu		Andersen, Nicholas/0000-0002-0905-1694	National Institutes of Health (NIH) [T32, HL021796, HL086741, HL080130, HL007734]; Howard Hughes Medical Institute; von Liebig Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086741, T32HL007734, R01HL080130, R01HL021796] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); von Liebig Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Ian Driscoll, Faramarz Edalat, Monica Jain, and Lena Caron for help with transfection experiments, and Scott Damrauer for careful reading of the manuscript. This work was supported by National Institutes of Health (NIH) T32 Harvard-Longwood Research Training in Vascular Surgery grant HL007734 ( to T. S. M., M. C. M., J.Y.M., and G. V. M.); a Howard Hughes Medical Institute Research Training Fellowship for Medical Students (to N.D.A.); NIH R01 grants HL021796, HL086741 (to C. F., and F. W. L.), and HL080130 (to C. F.); and the von Liebig Foundation (to L. P. and F. W. L.).	Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Allaire E, 1997, ANN THORAC SURG, V63, P582; Andersen ND, 2007, J AM COLL SURGEONS, V204, P399, DOI 10.1016/j.jamcollsurg.2006.12.029; Andrassy M, 2005, CIRC RES, V96, P476, DOI 10.1161/01.RES.0000156903.37007.d1; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; BOERBOOM LE, 1985, J THORAC CARDIOV SUR, V90, P756; Castro C, 2003, J BIOL CHEM, V278, P4482, DOI 10.1074/jbc.M204716200; Chen DH, 1997, J CLIN INVEST, V99, P2334, DOI 10.1172/JCI119414; CLOWES AW, 1983, LAB INVEST, V49, P327; Conte MS, 2007, J VASC SURG, V45, p74A, DOI 10.1016/j.jvs.2007.02.031; DAVIES MG, 1995, EUR J VASC ENDOVASC, V9, P7, DOI 10.1016/S1078-5884(05)80218-7; Disatnik MH, 2004, J CELL SCI, V117, P4469, DOI 10.1242/jcs.01309; Disatnik MH, 2002, J CELL SCI, V115, P2151; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Dulong S, 2004, BIOCHEM J, V382, P1015, DOI 10.1042/BJ20040347; Gallant C, 2005, J CELL SCI, V118, P3595, DOI 10.1242/jcs.02493; George SJ, 2000, CIRCULATION, V101, P296, DOI 10.1161/01.CIR.101.3.296; Hall JL, 2000, CIRC RES, V87, P574, DOI 10.1161/01.RES.87.7.574; Herbert JM, 1996, J BIOL CHEM, V271, P25928; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Itoh H, 2001, AM J PHYSIOL-HEART C, V281, pH359, DOI 10.1152/ajpheart.2001.281.1.H359; Izzard TD, 2002, CARDIOVASC RES, V53, P242, DOI 10.1016/S0008-6363(01)00444-8; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kalish JA, 2004, J VASC SURG, V39, P645, DOI 10.1016/j.jvs.2003.10.049; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; LOGERFO FW, 1981, SURGERY, V90, P1015; Mann MJ, 1999, LANCET, V354, P1493, DOI 10.1016/S0140-6736(99)09405-2; Mann MJ, 1999, P NATL ACAD SCI USA, V96, P6411, DOI 10.1073/pnas.96.11.6411; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; Porter KE, 1996, EUR J VASC ENDOVASC, V11, P48, DOI 10.1016/S1078-5884(96)80134-1; RAMOS JR, 1976, ANN SURG, V183, P205, DOI 10.1097/00000658-197603000-00001; Raptis AE, 2001, EXP CLIN ENDOCR DIAB, V109, pS424, DOI 10.1055/s-2001-18600; Schonwasser DC, 1996, FEBS LETT, V395, P1; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; SOYOMBO AA, 1995, J THORAC CARDIOV SUR, V109, P2, DOI 10.1016/S0022-5223(95)70415-9; SOYOMBO AA, 1990, AM J PATHOL, V137, P1401; Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031; Stone D, 2002, J BIOMED MATER RES, V59, P160, DOI 10.1002/jbm.1229; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; TSOPANOGLOU NE, 1993, J VASC RES, V30, P202, DOI 10.1159/000158995; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Willis DJ, 2004, J SURG RES, V120, P27, DOI 10.1016/j.jss.2003.12.014; Zhao Y, 2000, AM J PHYSIOL-CELL PH, V279, pC1611, DOI 10.1152/ajpcell.2000.279.5.C1611	45	24	24	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					557	564		10.1096/fj.08-114173	http://dx.doi.org/10.1096/fj.08-114173			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18940893	Green Published			2022-12-25	WOS:000262892900027
J	Surgucheva, I; Shestopalov, VI; Surguchov, A				Surgucheva, Irina; Shestopalov, Valery I.; Surguchov, Andrei			Effect of gamma-Synuclein Silencing on Apoptotic Pathways in Retinal Ganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEVATED INTRAOCULAR-PRESSURE; OPTIC-NERVE HEAD; GENE-EXPRESSION; ALPHA-SYNUCLEIN; EXPERIMENTAL GLAUCOMA; TRABECULAR MESHWORK; BAD PHOSPHORYLATION; SURVIVAL SIGNALS; DEATH; ACTIVATION	gamma-Synuclein (Syn G) is highly expressed in retinal ganglion cells and the loss of these cells in glaucoma is associated with significant reduction of the intracellular Syn G level. However, a causative relationship between these two events has not been established. Here we show that the knockdown of Syn G results in a decreased viability of the immortalized retinal ganglion cells (RGC-5). The Syn G silencing reduces phosphorylation of serine 112 (Ser(112)) in Bad protein, a member of the Bcl-2 family that plays a critical role in apoptotic cell death signaling. Our gene expression analysis data suggests that changes in Bad phosphorylation status may be caused by a coordinated shift in activities of kinases controlling Bad phosphorylation and phosphatases catalyzing its dephosphorylation. Moreover, increased phosphorylation of Bad-sequestering protein 14-3-3 detected in these cells is also pro-apoptotic. These results suggest that the homeostatic level of Syn G in RGC-5 cells is required for transcriptional regulation of protein kinases and phosphatases, controlling phosphorylation of Bad and 14-3-3. Lowering Syn G causes Bad dephosphorylation, dissociation from phosphorylated 14-3-3, and translocation to mitochondria where it initiates apoptotic death cascade.	[Surgucheva, Irina; Surguchov, Andrei] Vet Adm Med Ctr, Lab Retinal Biol, Kansas City, MO 64128 USA; [Surgucheva, Irina; Surguchov, Andrei] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; [Shestopalov, Valery I.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Shestopalov, Valery I.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Miami; Bascom Palmer Eye Institute; University of Miami	Surguchov, A (corresponding author), Vet Adm Med Ctr, Lab Retinal Biol, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	asurguchov@kumc.edu	Shestopalov, Valery/AAE-9838-2020	Shestopalov, Valery/0000-0002-1568-6637	National Institutes of Health [EY02687, EY017991, P30 EY014801]; Veterans Affairs Merit Review; Glaucoma Foundation; Midwest Biomedical Research Foundation (MBRF); University of Miami Department of Ophthalmology from Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY002687, R21EY017991, P30EY014801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Glaucoma Foundation; Midwest Biomedical Research Foundation (MBRF); University of Miami Department of Ophthalmology from Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY02687, EY017991, and Center Grant P30 EY014801. This work was also supported by a Veterans Affairs Merit Review grant, The Glaucoma Foundation, Midwest Biomedical Research Foundation (MBRF), and an unrestricted grant to the University of Miami Department of Ophthalmology from Research to Prevent Blindness. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Charles I, 2005, INVEST OPHTH VIS SCI, V46, P1330, DOI 10.1167/iovs.04-0363; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Diskin S, 2006, INVEST OPHTH VIS SCI, V47, P1491, DOI 10.1167/iovs.05-0736; Farkas RH, 2004, INVEST OPHTH VIS SCI, V45, P2503, DOI 10.1167/iovs.03-1391; Fortune B, 2004, INVEST OPHTH VIS SCI, V45, P1854, DOI 10.1167/iovs.03-1411; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Golubnitschaja-Labudova O, 2000, CURR EYE RES, V21, P867, DOI 10.1076/ceyr.21.5.867.5534; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Han JY, 2008, J NEUROSCI RES, V86, P3221, DOI 10.1002/jnr.21759; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hu XF, 2007, BRIT J CANCER, V96, P918, DOI 10.1038/sj.bjc.6603641; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; Hui L, 2005, J BIOL CHEM, V280, P35829, DOI 10.1074/jbc.M504192200; Ivanov D, 2006, FEBS LETT, V580, P331, DOI 10.1016/j.febslet.2005.12.017; Jia TL, 1999, CANCER RES, V59, P742; Jiang YF, 2004, CANCER RES, V64, P4539, DOI 10.1158/0008-5472.CAN-03-3650; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kamada H, 2007, J CEREBR BLOOD F MET, V27, P521, DOI 10.1038/sj.jcbfm.9600367; Khalyfa A, 2007, MOL VIS, V13, P293; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kim HS, 2005, BRAIN RES, V1057, P17, DOI 10.1016/j.brainres.2005.07.005; Klumpp S, 2003, NEUROCHEM INT, V42, P555, DOI 10.1016/S0197-0186(02)00174-2; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kuhn M, 2007, NEUROGENETICS, V8, P71, DOI 10.1007/s10048-007-0079-z; Lee SW, 2007, J ETHNOPHARMACOL, V111, P213, DOI 10.1016/j.jep.2006.11.012; Levin Leonard A, 2008, Am J Manag Care, V14, pS11; Li YY, 2006, CANCER RES, V66, P6741, DOI 10.1158/0008-5472.CAN-05-4272; Liton P, 2006, MOL VIS, V12, P774; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Morgan JE, 2000, BRIT J OPHTHALMOL, V84, P303, DOI 10.1136/bjo.84.3.303; Nickells RW, 2007, CAN J OPHTHALMOL, V42, P278, DOI 10.3129/canjophthalmol.i07-036; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ohi N, 2006, AM J PATHOL, V168, P1097, DOI 10.2353/ajpath.2006.050462; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Piri N, 2006, MOL VIS, V12, P1660; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Springer JE, 2000, J NEUROSCI, V20, P7246; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Surgucheva IG, 2003, ARCH BIOCHEM BIOPHYS, V410, P167, DOI 10.1016/S0003-9861(02)00664-1; Surgucheva I, 2008, MOL VIS, V14, P1540; Surguchov A, 2001, J NEUROSCI RES, V65, P68, DOI 10.1002/jnr.1129; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Tezel G, 2005, EXP EYE RES, V81, P207, DOI 10.1016/j.exer.2005.01.022; Tezel G., 2007, GLAUCOMA CHEM IMMUNO, V92, P221; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wan X, 2002, CELL DEATH DIFFER, V9, P414, DOI 10.1038/sj.cdd.4400982; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang XJ, 2008, INVEST OPHTH VIS SCI, V49, P2483, DOI 10.1167/iovs.07-1344; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	74	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36377	36385		10.1074/jbc.M806660200	http://dx.doi.org/10.1074/jbc.M806660200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18936092	Green Published, hybrid			2022-12-25	WOS:000261840500035
J	Araie, H; Suzuki, I; Shiraiwa, Y				Araie, Hiroya; Suzuki, Iwane; Shiraiwa, Yoshihiro			Identification and Characterization of a Selenoprotein, Thioredoxin Reductase, in a Unicellular Marine Haptophyte Alga, Emiliania huxleyi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN; SELENIUM; SELENOCYSTEINE; NADPH; CLASSIFICATION; CHLOROPLAST; PREDICTION; PROTEINS; DYNAMICS; SEQUENCE	We found six selenoproteins (EhSEP1-6) in the coccolithophorid Emiliania huxleyi (Haptophyceae) using the Se-75 radiotracer technique. Previously, the most abundant selenoprotein, EhSEP2, was identified as a novel selenoprotein, a protein disulfide isomerase-like protein (Obata, T., and Shiraiwa, Y. ( 2005) J. Biol. Chem. 280, 18462-18468). The present study focused on the second abundant selenoprotein, EhSEP1, in the same cells and analyzed its molecular properties and regulation of gene expression by selenium. The cDNA sequence of EhSEP1 consists of 1950 base pairs encoding a putative product of 495 amino acids with a calculated molecular mass of 52.2 kDa. The nucleotide and amino acid sequences of EhSEP1 showed strong similarities to those of the enzyme thioredoxin reductase (TR) 1 in the public databases. The EhSEP1 protein contains redox-active cysteine residues in the putative FAD binding domain of the pyridine nucleotide-disulfide oxidoreductase class-1 domain, a dimerization domain, and a C-terminal Gly-Cys-Sec (selenocysteine)-Gly sequence that is known to function as an additional redox center. In the 3'-untranslated region of EhSEP1 cDNA, we found a selenocysteine insertion sequence ( SECIS) that is similar to the SECIS found previously in animals. The expression of EhSEP1 showed almost the same pattern under both selenium-sufficient and selenium-deficient conditions. Conversely, TR activity gradually increased 4-fold within ca. 70 h when cells were transferred to the medium containing 10 nM selenite. These data show that selenium is essential for the induction of TR activity at the translational level but not at the transcriptional level in this alga.	[Araie, Hiroya; Suzuki, Iwane; Shiraiwa, Yoshihiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Shiraiwa, Y (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan.	emilhux@biol.tsukuba.ac.jp	Shiraiwa, Yoshihiro/AAD-2501-2022		Ministry of Education, Culture, Sports, Science, and Technology [15657026]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant-in-aid for Scientific Research in an exploratory research area (15657026) from the Ministry of Education, Culture, Sports, Science, and Technology (to Y.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agorio A, 2003, J BIOL CHEM, V278, P12920, DOI 10.1074/jbc.M209266200; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brown K M, 2001, Public Health Nutr, V4, P593; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Danbara A, 1999, PLANT CELL PHYSIOL, V40, P762, DOI 10.1093/oxfordjournals.pcp.a029603; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Grundner-Culemann E, 1999, RNA, V5, P625, DOI 10.1017/S1355838299981542; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; Hanawa Y., 2004, JPN J PHYCOL S, V52, P95; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; Hishiya S, 2008, PLANT CELL PHYSIOL, V49, P11, DOI 10.1093/pcp/pcm158; Jacquot JP, 1997, NEW PHYTOL, V136, P543, DOI 10.1046/j.1469-8137.1997.00784.x; Kim HY, 2006, BIOCHEMISTRY-US, V45, P13697, DOI 10.1021/bi0611614; Krol A, 2002, BIOCHIMIE, V84, P765, DOI 10.1016/S0300-9084(02)01405-0; Kryukov GV, 2004, EMBO REP, V5, P538, DOI 10.1038/sj.embor.7400126; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Martinez JM, 2007, APPL ENVIRON MICROB, V73, P554, DOI 10.1128/AEM.00864-06; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Novoselov SV, 2002, EMBO J, V21, P3681, DOI 10.1093/emboj/cdf372; Obata T, 2005, J BIOL CHEM, V280, P18462, DOI 10.1074/jbc.M501517200; Obata T, 2004, PLANT CELL PHYSIOL, V45, P1434, DOI 10.1093/pcp/pch164; PRICE NM, 1988, PLANT PHYSIOL, V86, P192, DOI 10.1104/pp.86.1.192; RUSSEL M, 1988, J BIOL CHEM, V263, P9015; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; Spinola MC, 2008, PHYSIOL PLANTARUM, V133, P516, DOI 10.1111/j.1399-3054.2008.01088.x; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; VENDELAND SC, 1995, P NATL ACAD SCI USA, V92, P8749, DOI 10.1073/pnas.92.19.8749	36	22	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35329	35336		10.1074/jbc.M805472200	http://dx.doi.org/10.1074/jbc.M805472200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945673	Green Submitted, hybrid			2022-12-25	WOS:000261687900004
J	Liu, M; Aneja, R; Sun, XD; Xie, SB; Wang, HX; Wu, XJ; Dong, T; Li, MG; Joshi, HC; Zhou, J				Liu, Min; Aneja, Ritu; Sun, Xiaodong; Xie, Songbo; Wang, Hongxia; Wu, Xiaojing; Dong, Tang; Li, Minggang; Joshi, Harish C.; Zhou, Jun			Parkin Regulates Eg5 Expression by Hsp70 Ubiquitination-dependent Inactivation of c-Jun NH2-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LIGASE; MICROTUBULES; DEGRADATION; ACTIVATION; MECHANISMS; PROMOTES; SPINDLE	Eg5 is a motor protein of the kinesin family that is critical for spindle assembly during mitosis and has recently been implicated in tumorigenesis. It is largely unknown how Eg5 expression is regulated in cells. In this study, we present the first evidence that the cellular Eg5 level is down-regulated by Parkin, an E3 ubiquitin ligase well known for its role in the development of Parkinson disease. Our data show that Parkin does not trigger Eg5 protein degradation through the ubiquitin-proteasome pathway. Instead, Parkin represses Eg5 gene transcription by blocking c-Jun binding to the activator protein 1 site present in the Eg5 promoter. Our data further show that Parkin inactivates c-Jun NH2-terminal kinase (JNK), resulting in decreased phosphorylation of c-Jun. The inactivation of JNK is further mediated by multiple monoubiquitination of Hsp70. Importantly, both the ubiquitination of Hsp70 and the subsequent inactivation of the JNK-c-Jun pathway are crucial for Parkin to down-regulate Eg5 expression. These results thus uncover a novel function for Parkin in modulating the expression of Eg5 through the Hsp70-JNK-c-Jun signaling pathway.	[Liu, Min; Sun, Xiaodong; Xie, Songbo; Wang, Hongxia; Wu, Xiaojing; Dong, Tang; Li, Minggang; Zhou, Jun] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Joshi, Harish C.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Nankai University; University System of Georgia; Georgia State University; Emory University	Zhou, J (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn	Xie, Songbo/AAD-9850-2020; Zhou, Jun/D-4654-2017; Wang, Hongxia/D-8812-2014	Zhou, Jun/0000-0001-7858-8260; Dong, Jin-Tang/0000-0003-2349-5782	Ministry of Education [107025]; Scientific Research Foundation; Ministry of Education, Tianjin Natural Science Foundation [07JCZDJC03000]; National Key Scientific Program of China [2007CB914802, 2007CB914503]	Ministry of Education; Scientific Research Foundation; Ministry of Education, Tianjin Natural Science Foundation; National Key Scientific Program of China	This work was supported by the Key Project of the Ministry of Education Grant 107025, the Scientific Research Foundation for the Returned Overseas Chinese Scholars of the Ministry of Education, Tianjin Natural Science Foundation Grant 07JCZDJC03000, and National Key Scientific Program of China Grants 2007CB914802 and 2007CB914503. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Duhl DM, 2005, CURR OPIN DRUG DISC, V8, P431; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Hansen GM, 1999, ONCOGENE, V18, P6531, DOI 10.1038/sj.onc.1203023; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jankowski Marek, 2007, Postepy Biochem, V53, P297; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Koushika SP, 2008, BIOESSAYS, V30, P10, DOI 10.1002/bies.20695; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Liu M, 2007, J BIOL CHEM, V282, P17581, DOI 10.1074/jbc.M702206200; Liu M, 2006, J BIOL CHEM, V281, P18090, DOI 10.1074/jbc.M601324200; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Nowicki MO, 2003, ONCOGENE, V22, P3952, DOI 10.1038/sj.onc.1206620; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	28	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35783	35788		10.1074/jbc.M806860200	http://dx.doi.org/10.1074/jbc.M806860200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18845538	hybrid			2022-12-25	WOS:000261687900052
J	Creacy, SD; Routh, ED; Iwamoto, F; Nagamine, Y; Akman, SA; Vaughn, JP				Creacy, Steven D.; Routh, Eric D.; Iwamoto, Fumiko; Nagamine, Yoshikuni; Akman, Steven A.; Vaughn, James P.			G4 Resolvase 1 Binds Both DNA and RNA Tetramolecular Quadruplex with High Affinity and Is the Major Source of Tetramolecular Quadruplex G4-DNA and G4-RNA Resolving Activity in HeLa Cell Lysates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GENOME; PROMOTER REGION; C-MYC; PROTEIN; TRANSCRIPTION; GENE; RECOMBINATION; NUCLEOLIN; STABILITY; MOLECULE	Quadruplex structures that result from stacking of guanine quartets in nucleic acids possess such thermodynamic stability that their resolution in vivo is likely to require specific recognition by specialized enzymes. We previously identified the major tetramolecular quadruplex DNA resolving activity in HeLa cell lysates as the gene product of DHX36 (Vaughn, J. P., Creacy, S. D., Routh, E. D., Joyner-Butt, C., Jenkins, G. S., Pauli, S., Nagamine, Y., and Akman, S. A. (2005) J. Biol Chem. 280, 38117 38120), naming the enzyme G4 Resolvase 1 (G4R1). G4R1 is also known as RHAU, an RNA helicase associated with the AU-rich sequence of mRNAs. We now show that G4R1/RHAU binds to and resolves tetramolecular RNA quadruplex as well as tetramolecular DNA quadruplex structures. The apparent K-d values of G4R1/RHAU for tetramolecular RNA quadruplex and tetramolecular DNA quadruplex were exceptionally low: 39 +/- 6 and 77 +/- 6 pM, respectively, as measured by gel mobility shift assay. In competition studies tetramolecular RNA quadruplex structures inhibited tetramolecular DNA quadruplex structure resolution by G4R1/RHAU more efficiently than tetramolecular DNA quadruplex structures inhibited tetramolecular RNA quadruplex structure resolution. Down-regulation of G4R1/RHAU in HeLa T-REx cells by doxycycline-inducible short hairpin RNA caused an 8-fold loss of RNA and DNA tetramolecular quadruplex resolution, consistent with G4R1/RHAU representing the major tetramolecular quadruplex helicase activity for both RNA and DNA structures in HeLa cells. This study demonstrates for the first time the RNA quadruplex resolving enzymatic activity associated with G4R1/RHAU and its exceptional binding affinity, suggesting a potential novel role for G4R1/RHAU in targeting in vivo RNA quadruplex structures.	[Creacy, Steven D.; Routh, Eric D.; Akman, Steven A.; Vaughn, James P.] Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Creacy, Steven D.; Routh, Eric D.; Akman, Steven A.; Vaughn, James P.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; [Iwamoto, Fumiko; Nagamine, Yoshikuni] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Wake Forest University; Wake Forest University; Friedrich Miescher Institute for Biomedical Research; Novartis	Akman, SA (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	sakman@wfubmc.edu; jvaughn@wfubmc.edu		Routh, Eric/0000-0002-7371-1802	National Institutes of Health [P30-CA12197]; Wake Forest Comprehensive Cancer Center; Ware Foundation; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest Comprehensive Cancer Center; Ware Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant P30-CA12197. This work was also supported by a grant to the Wake Forest Comprehensive Cancer Center and a gift from the Ware Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arhin GK, 2002, NUCLEIC ACIDS RES, V30, P1842, DOI 10.1093/nar/30.8.1842; Arthanari H, 2001, CHEM BIOL, V8, P221, DOI 10.1016/S1074-5521(01)00007-2; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Boan F, 2004, FEBS LETT, V571, P112, DOI 10.1016/j.febslet.2004.06.062; Chang CC, 2006, ANAL CHEM, V78, P2810, DOI 10.1021/ac052218f; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Connor AC, 2006, J AM CHEM SOC, V128, P4986, DOI 10.1021/ja056097c; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; GUSCHLBAUER W, 1990, J BIOMOL STRUCT DYN, V8, P491, DOI 10.1080/07391102.1990.10507825; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Harrington C, 1997, J BIOL CHEM, V272, P24631, DOI 10.1074/jbc.272.39.24631; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Kostadinov R, 2006, NUCLEIC ACIDS RES, V34, pD119, DOI 10.1093/nar/gkj073; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lew A, 2000, P NATL ACAD SCI USA, V97, P12508, DOI 10.1073/pnas.97.23.12508; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Zhang SS, 2004, ACTA BIOCH BIOPH SIN, V36, P177, DOI 10.1093/abbs/36.3.177	40	131	143	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34626	34634		10.1074/jbc.M806277200	http://dx.doi.org/10.1074/jbc.M806277200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842585	Green Published, hybrid			2022-12-25	WOS:000261469100017
J	Kachirskaia, I; Shi, XB; Yamaguchi, H; Tanoue, K; Wen, H; Wang, EW; Appella, E; Gozani, O				Kachirskaia, Ioulia; Shi, Xiaobing; Yamaguchi, Hiroshi; Tanoue, Kan; Wen, Hong; Wang, Evelyn W.; Appella, Ettore; Gozani, Or			Role for 53BP1 Tudor Domain Recognition of p53 Dimethylated at Lysine 382 in DNA Damage Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H4; METHYLATION; METHYLTRANSFERASE; REPRESSION; PR-SET7; BREAKS; SET8	Modification of histone proteins by lysine methylation is a principal chromatin regulatory mechanism (Shi, Y., and Whet-stine, J. R. (2007) Mol. Cell 25, 1-14). Recently, lysine methylation has been shown also to play a role in regulating non-histone proteins, including the tumor suppressor protein p53 (Huang, J., and Berger, S. L. (2008) Curr. Opin. Genet. Dev. 18, 152-158). Here, we identify a novel p53 species that is dimethylated at lysine 382 (p53K382me2) and show that the tandem Tudor domain of the DNA damage response mediator 53BP1 acts as an "effector" for this mark. We demonstrate that the 53BP1 tandem Tudor domain recognizes p53K382me2 with a selectivity relative to several other protein lysine methylation sites and saturation states. p53K382me2 levels increase with DNA damage, and recognition of this modification by 53BP1 facilitates an interaction between p53 and 53BP1. The generation of p53K382me2 promotes the accumulation of p53 protein that occurs upon DNA damage, and this increase in p53 levels requires 53BP1. Taken together, our study identifies a novel p53 modification, demonstrates a new effector function for the 53BP1 tandem Tudor domain, and provides insight into how DNA damage signals are transduced to stabilize p53.	[Kachirskaia, Ioulia; Shi, Xiaobing; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Yamaguchi, Hiroshi; Tanoue, Kan; Appella, Ettore] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Wen, Hong; Wang, Evelyn W.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University	Gozani, O (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ogozani@stanford.edu	Gozani, Or P/I-6157-2013	Wen, Hong/0000-0001-8739-4572; Shi, Xiaobing/0000-0001-5242-8189; Gozani, Or/0000-0002-1365-4463	National Institutes of Health [GM079641]; NATIONAL CANCER INSTITUTE [ZIABC005599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM079641 (to O.G.) and the Intramural Research Program of the National Institutes of Health (to E. A. and H. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Al Rashid ST, 2005, CANCER RES, V65, P10810, DOI 10.1158/0008-5472.CAN-05-0729; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Gottifredi V, 2000, COLD SPRING HARB SYM, V65, P483, DOI 10.1101/sqb.2000.65.483; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang TTK, 2008, J PEDIATR-US, V152, P158, DOI 10.1016/j.jpeds.2007.09.032; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182	20	67	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34660	34666		10.1074/jbc.M806020200	http://dx.doi.org/10.1074/jbc.M806020200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18840612	hybrid, Green Published			2022-12-25	WOS:000261469100021
J	Kintses, B; Yang, ZH; Malnasi-Csizmadia, A				Kintses, Balint; Yang, Zhenhui; Malnasi-Csizmadia, Andras			Experimental Investigation of the Seesaw Mechanism of the Relay Region That Moves the Myosin Lever Arm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; RECOVERY STROKE; MOTOR DOMAIN; MUSCLE-CONTRACTION; II MOTOR; NUCLEOTIDE; STATES; ACTIVATION; TRANSITION; RESOLUTION	A seesaw-like movement of the relay region upon the recovery step of myosin was recently simulated in silico. In this model the relay helix tilts around its pivoting point formed by a phenylalanine cluster (Phe(481), Phe(482), and Phe(652)), which moves the lever arm of myosin. To study the effect of the elimination of the proposed pivoting point, these phenylalanines were mutated to alanines in two Dictyostelium myosin II motor domain constructs (M-F481A,M- F482A and M-F652A). The relay movement was followed by the fluorescence change of Trp(501) located in the relay region. The steady-state and transient kinetic fluorescence experiments showed that the lack of the phenylalanine fulcrum perturbs the formation of the "up" lever arm state, and only moderate effects were found in the nucleotide binding, the formation of the "down" lever arm position, and the ATP hydrolysis steps. We conclude that the lack of the fulcrum decouples the distal part of the relay from the nucleotide binding site upon the recovery step. Our molecular dynamics simulations also showed that the conformation of the motor is not perturbed by the mutation in the down lever arm state, however, the lack of the pivoting point rearranges the dynamic pattern of the kink region of the relay helix.	[Kintses, Balint; Yang, Zhenhui; Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	Eotvos Lorand University	Malnasi-Csizmadia, A (corresponding author), Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary.	malna@.elte.hu	Csizmadia, András Málnási/K-7632-2018	Csizmadia, András Málnási/0000-0002-2430-8398; Kintses, Balint/0000-0003-0844-0310	The European Research Council [208319]	The European Research Council(European Research Council (ERC))	This work was supported by The European Research Council under the European Community's Seventh Framework Program FP7/2007-2013/ERC Grant 208319. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bauer CB, 2000, J BIOL CHEM, V275, P38494, DOI 10.1074/jbc.M005585200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Conibear PB, 2003, NAT STRUCT BIOL, V10, P831, DOI 10.1038/nsb986; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Gyimesi M, 2008, BIOCHEMISTRY-US, V47, P283, DOI 10.1021/bi701554a; HARRIS MJ, 2008, EUR BIOPHYS IN PRESS; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; Ho BK, 2003, PROTEIN SCI, V12, P2508, DOI 10.1110/ps.03235203; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Koppole S, 2007, STRUCTURE, V15, P825, DOI 10.1016/j.str.2007.06.008; Liang WC, 1998, P NATL ACAD SCI USA, V95, P12844, DOI 10.1073/pnas.95.22.12844; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Mesentean S, 2007, J MOL BIOL, V367, P591, DOI 10.1016/j.jmb.2006.12.058; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Urbanke C, 2001, BIOCHEM J, V358, P165, DOI 10.1042/0264-6021:3580165; Yu HB, 2007, PLOS COMPUT BIOL, V3, P199, DOI 10.1371/journal.pcbi.0030021; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023	26	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34121	34128		10.1074/jbc.M805848200	http://dx.doi.org/10.1074/jbc.M805848200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854311	hybrid, Green Published			2022-12-25	WOS:000261277700040
J	Chang, A; Lim, MH; Lee, SW; Robb, EJ; Nazar, RN				Chang, Ancheol; Lim, Myung-Ho; Lee, Shin-Woo; Robb, E. Jane; Nazar, Ross N.			Tomato Phenylalanine Ammonia-Lyase Gene Family, Highly Redundant but Strongly Underutilized	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGROBACTERIUM-TUMEFACIENS; DNA METHYLATION; DUPLICATE GENES; EXPRESSION; EVOLUTION; IDENTIFICATION; CONSEQUENCES; ORGANIZATION; SEQUENCE; VECTOR	Phenylalanine ammonia-lyase ( PAL) is an important enzyme in both plant development and pathogen defense. In all plants it is encoded by a multi-gene family, ranging in copy number from four in Arabidopsis to a dozen or more copies in some higher plants. Many studies indicate that alternate genes are differentially regulated in response to environmental stimuli. In this study, Southern blot and dot blot analyses in tomato indicate a surprisingly large family of related sequences with similar to 26 copies in the diploid genome, some easily distinguished by restriction enzyme digestion. Analyses of a BAC genome library suggest that the genes are generally not clustered. A more detailed comparison of the gene sequences using PCR to isolate the individual copies and reverse transcription-PCR to study the transcripts that they encode indicates a significant diversity in the gene sequences themselves, but surprisingly only one mRNA transcript can be detected even when additional expression is induced by pathogen growth or wounding. Consistent with previous reports in other plants, a parallel study with a closely related plant, the potato, indicates a much broader utilization of the PAL genes, highlighting the unusual nature of this family in tomato and of the mechanism(s) that silences so many members. Plant transformation analyses further demonstrate the presence of very active silencing, suggesting aggressive competition between PAL gene duplication and copy inactivation during PAL gene evolution.	[Chang, Ancheol; Lim, Myung-Ho; Lee, Shin-Woo; Robb, E. Jane; Nazar, Ross N.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Nazar, RN (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rnnazar@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; BERNARDS MA, 1991, PLANT PHYSIOL, V97, P1494, DOI 10.1104/pp.97.4.1494; Budiman MA, 2000, GENOME RES, V10, P129; CRAMER CL, 1989, PLANT MOL BIOL, V12, P367, DOI 10.1007/BF00017577; Cushman JC, 1995, METHOD CELL BIOL, V50, P113, DOI 10.1016/S0091-679X(08)61026-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GERARD GF, 1987, FOCUS, V9, P5; Heinz R, 1998, PHYSIOL MOL PLANT P, V52, P385, DOI 10.1006/pmpp.1998.0163; HOAGLUND DR, 1950, CIRCULAR CALIFORNIA, V347; HOEKEMA A, 1983, NATURE, V303, P179, DOI 10.1038/303179a0; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Jacobsen SE, 1999, CURR BIOL, V9, pR617, DOI 10.1016/S0960-9822(99)80388-1; JOOS HJ, 1992, EUR J BIOCHEM, V204, P621, DOI 10.1111/j.1432-1033.1992.tb16675.x; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Kumar A, 2001, PLANT PHYSIOL, V127, P230, DOI 10.1104/pp.127.1.230; LEE SW, 1992, J BIOL CHEM, V267, P11824; LEE SW, 1994, EUR J BIOCHEM, V226, P109, DOI 10.1111/j.1432-1033.1994.tb20031.x; LEE SW, 1992, PLANT MOL BIOL, V18, P345, DOI 10.1007/BF00034961; LIANG X, 1989, P NATL ACAD SCI USA, V86, P9284, DOI 10.1073/pnas.86.23.9284; LIANG XW, 1989, J BIOL CHEM, V264, P14486; LIAO Y, 1996, PLANT GENE REGISTER; LOIS R, 1989, EMBO J, V8, P1641, DOI 10.1002/j.1460-2075.1989.tb03554.x; LOIS R, 1989, BIOSCI Z NATURFORSCH, V47, P90; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Morris K, 2005, CELL MOL LIFE SCI, V62, P3057, DOI 10.1007/s00018-005-5182-4; Sambrook J., 1989, MOL CLONING LAB MANU, V2; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; THOMPSON GA, 1990, PLANT MOL BIOL, V15, P755, DOI 10.1007/BF00016125; Van der Hoeven R, 2002, PLANT CELL, V14, P1441, DOI 10.1105/tpc.010478; WANNER LA, 1995, PLANT MOL BIOL, V27, P327, DOI 10.1007/BF00020187; Yu H, 2003, PLANT CELL REP, V22, P167, DOI 10.1007/s00299-003-0699-1	38	75	88	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33591	33601		10.1074/jbc.M804428200	http://dx.doi.org/10.1074/jbc.M804428200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838378	Green Published, hybrid			2022-12-25	WOS:000261183700065
J	Chung, YM; Lee, SB; Kim, HJ; Park, SH; Kim, JJ; Chung, JS; Do Yoo, Y				Chung, Young Min; Lee, Seung Baek; Kim, Hyung Jung; Park, Seon Ho; Kim, Jung Jin; Chung, Jin Sil; Do Yoo, Young			Replicative Senescence Induced by Romo1-derived Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; MITOCHONDRIAL-DNA; LIFE-SPAN; CELL-PROLIFERATION; SIGNALING PATHWAYS; FREE-RADICALS; HUMAN BRAIN; AGING MICE; ROS	Persistent accumulation of DNA damage induced by reactive oxygen species (ROS) is proposed to be a major contributor toward the aging process. Furthermore, an increase in age-associated ROS is strongly correlated with aging in various species, including humans. Here we showed that the enforced expression of the ROS modulator 1 (Romo1) triggered premature senescence by ROS production, and this also contributed toward induction of DNA damage. Romo1-derived ROS was found to originate in the mitochondrial electron transport chain. Romo1 expression gradually increased in proportion to population doublings of IMR-90 human fibroblasts. An increase in ROS production in these cells with high population doubling was blocked by the Romo1 knockdown using Romo1 small interfering RNA. Romo1 knockdown also inhibited the progression of replicative senescence. Based on these results, we suggest that age-related ROS levels increase, and this contributes to replicative senescence, which is directly associated with Romo1 expression.	[Chung, Young Min; Lee, Seung Baek; Park, Seon Ho; Kim, Jung Jin; Chung, Jin Sil; Do Yoo, Young] Korea Univ, Coll Med, Grad Sch Med, Brain Korea Program Biomed Sci 21, Seoul 136705, South Korea; [Kim, Hyung Jung] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 135270, South Korea	Korea University; Korea University Medicine (KU Medicine); Yonsei University; Yonsei University Health System	Do Yoo, Y (corresponding author), Korea Univ, Coll Med, Anam Hosp, 126-1,5Ka, Seoul 136705, South Korea.	ydy1130@korea.ac.kr	Chung, Young Min/AAV-7656-2020		Korea Government (MEST) [FG06-2-20]; Basic Research Program of the Korea Science and Engineering Foundation [R01-2006-000-10113-0]; Research Center for Woman's Diseases of the Korea Science and Engineering Foundation [R11-2005017-01001-0]	Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Research Program of the Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Research Center for Woman's Diseases of the Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Grant FG06-2-20 from the 21st Century Frontier Functional Human Genome Project funded by the Korea Government (MEST), by Grant R01-2006-000-10113-0 from the Basic Research Program of the Korea Science and Engineering Foundation, and by Grant R11-2005017-01001-0 from the Research Center for Woman's Diseases of the Korea Science and Engineering Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arora-Kuruganti P, 1999, J NEURO-ONCOL, V44, P213, DOI 10.1023/A:1006315332098; ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Caporossi D, 2003, FREE RADICAL BIO MED, V35, P1355, DOI 10.1016/j.freeradbiomed.2003.08.008; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hwang IT, 2007, BIOCHEM BIOPH RES CO, V359, P304, DOI 10.1016/j.bbrc.2007.05.088; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ishii N, 2007, CORNEA, V26, pS3, DOI 10.1097/ICO.0b013e31812f6745; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Laurent A, 2005, CANCER RES, V65, P948; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Liu SL, 2002, ARCH BIOCHEM BIOPHYS, V406, P173, DOI 10.1016/S0003-9861(02)00430-7; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Martin V, 2007, FREE RADICAL BIO MED, V42, P1715, DOI 10.1016/j.freeradbiomed.2007.02.028; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miwa S, 2004, ANN NY ACAD SCI, V1019, P388, DOI 10.1196/annals.1297.069; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Na AR, 2008, BIOCHEM BIOPH RES CO, V369, P672, DOI 10.1016/j.bbrc.2008.02.098; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sekharam M, 1998, TOXICOL APPL PHARM, V149, P210, DOI 10.1006/taap.1997.8361; Shawi M, 2008, MECH AGEING DEV, V129, P3, DOI 10.1016/j.mad.2007.11.007; Sigaud S, 2005, ANTIOXID REDOX SIGN, V7, P6, DOI 10.1089/ars.2005.7.6; Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Yoo YA, 2005, MOL CELL BIOL, V25, P6603, DOI 10.1128/MCB.25.15.6603-6616.2005; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	46	54	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33763	33771		10.1074/jbc.M805334200	http://dx.doi.org/10.1074/jbc.M805334200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18836179	hybrid, Green Published			2022-12-25	WOS:000261183700082
J	Sagaspe, P; Taillard, J; Akerstedt, T; Bayon, V; Espie, S; Chaumet, G; Bioulac, B; Philip, P				Sagaspe, Patricia; Taillard, Jacques; Akerstedt, Torbjorn; Bayon, Virginie; Espie, Stephane; Chaumet, Guillaume; Bioulac, Bernard; Philip, Pierre			Extended Driving Impairs Nocturnal Driving Performances	PLOS ONE			English	Article							MOTOR-VEHICLE CRASHES; AUTOMOBILE DRIVERS; SLEEP RESTRICTION; DAYTIME SLEEPINESS; TRAFFIC ACCIDENTS; FALLING ASLEEP; TRUCK DRIVERS; FATIGUE; WORK; RISK	Though fatigue and sleepiness at the wheel are well-known risk factors for traffic accidents, many drivers combine extended driving and sleep deprivation. Fatigue-related accidents occur mainly at night but there is no experimental data available to determine if the duration of prior driving affects driving performance at night. Participants drove in 3 nocturnal driving sessions (3-5am, 1-5am and 9pm-5am) on open highway. Fourteen young healthy men (mean age [+/- SD] = 23.4 [+/- 61.7] years) participated Inappropriate line crossings (ILC) in the last hour of driving of each session, sleep variables, self-perceived fatigue and sleepiness were measured. Compared to the short (3-5am) driving session, the incidence rate ratio of inappropriate line crossings increased by 2.6 (95% CI, 1.1 to 6.0; P<.05) for the intermediate (1-5am) driving session and by 4.0 (CI, 1.7 to 9.4; P<.001) for the long (9pm-5am) driving session. Compared to the reference session (9-10pm), the incidence rate ratio of inappropriate line crossings were 6.0 (95% CI, 2.3 to 15.5; P<.001), 15.4 (CI, 4.6 to 51.5; P<.001) and 24.3 (CI, 7.4 to 79.5; P<.001), respectively, for the three different durations of driving. Self-rated fatigue and sleepiness scores were both positively correlated to driving impairment in the intermediate and long duration sessions (P<.05) and increased significantly during the nocturnal driving sessions compared to the reference session (P<.01). At night, extended driving impairs driving performances and therefore should be limited.	[Sagaspe, Patricia; Taillard, Jacques; Chaumet, Guillaume; Bioulac, Bernard; Philip, Pierre] CHU Pellegrin, GENPPHASS, Bordeaux, France; [Sagaspe, Patricia; Espie, Stephane] INRETS, MSIS, Paris, France; [Taillard, Jacques; Bioulac, Bernard; Philip, Pierre] CNRS, UMR 5227, Bordeaux, France; [Akerstedt, Torbjorn] Karolinska Sleep Inst, Stockholm, Sweden; [Bayon, Virginie] Hop Hotel Dieu, Paris, France; [Chaumet, Guillaume; Bioulac, Bernard; Philip, Pierre] Univ Bordeaux 2, F-33076 Bordeaux, France	CHU Bordeaux; Universite Gustave-Eiffel; Institut National de Recherche sur les Transports et leur Securite (INRETS); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite de Bordeaux	Sagaspe, P (corresponding author), CHU Pellegrin, GENPPHASS, Bordeaux, France.	pr.philip@free.fr	PHILIP, Pierre/AAS-8889-2020; Taillard, Jacques/H-5063-2018	PHILIP, Pierre/0000-0003-3267-634X; Taillard, Jacques/0000-0001-9067-8189; SAGASPE, Patricia/0000-0003-2845-1199	French National Agency for Research (ANR); Program for Research on Transport (PREDIT GO3 VIGISIM)	French National Agency for Research (ANR)(French National Research Agency (ANR)); Program for Research on Transport (PREDIT GO3 VIGISIM)	This research was supported by a grant from the French National Agency for Research (ANR) and the Program for Research on Transport (PREDIT GO3 VIGISIM).	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Arnold PK, 1997, ACCIDENT ANAL PREV, V29, P471, DOI 10.1016/S0001-4575(97)00026-2; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BOVERIE S, 2008, IFAC WORLD C SEOUL K; CARSKADON MA, 1981, PSYCHOPHYSIOLOGY, V18, P107, DOI 10.1111/j.1469-8986.1981.tb02921.x; CARSKADON MA, 1979, PERCEPT MOTOR SKILL, V48, P495, DOI 10.2466/pms.1979.48.2.495; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; DEMENT WC, 1982, SLEEP, V5, pS56, DOI 10.1093/sleep/5.S2.S56; Folkard S, 2005, IND HEALTH, V43, P20, DOI 10.2486/indhealth.43.20; Folkard S, 2006, CHRONOBIOL INT, V23, P1181, DOI 10.1080/07420520601096443; Folkard S, 2006, AM J IND MED, V49, P953, DOI 10.1002/ajim.20307; FROBERG JE, 1977, BIOL PSYCHOL, V5, P119, DOI 10.1016/0301-0511(77)90008-4; GRANDJEAN E, 1979, BRIT J IND MED, V36, P175; HAMELIN P, 1987, ERGONOMICS, V30, P1323, DOI 10.1080/00140138708966026; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; KANEKO T, 1992, ACCIDENT ANAL PREV, V24, P437, DOI 10.1016/0001-4575(92)90055-N; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; LAVIE P, 1986, ELECTROEN CLIN NEURO, V63, P414, DOI 10.1016/0013-4694(86)90123-9; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; Mitler MM, 1997, NEW ENGL J MED, V337, P755, DOI 10.1056/NEJM199709113371106; Nabi H, 2006, BRIT MED J, V333, P75, DOI 10.1136/bmj.38863.638194.AE; OHANLON JF, 1995, NEUROPSYCHOBIOLOGY, V31, P81, DOI 10.1159/000119177; OHANLON JF, 1986, ACTA PSYCHIAT SCAND, V74, P95, DOI 10.1111/j.1600-0447.1986.tb08985.x; Pack AI, 1995, ACCIDENT ANAL PREV, V27, P769, DOI 10.1016/0001-4575(95)00034-8; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Philip P, 2003, SLEEP, V26, P277, DOI 10.1093/sleep/26.3.277; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Philip P, 1996, J PSYCHOSOM RES, V41, P279, DOI 10.1016/0022-3999(96)00127-4; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475; Philip P, 2006, ANN INTERN MED, V144, P785, DOI 10.7326/0003-4819-144-11-200606060-00004; Powell NB, 2001, LARYNGOSCOPE, V111, P887, DOI 10.1097/00005537-200105000-00024; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; RAMAEKERS JG, 1994, EUR J CLIN PHARMACOL, V47, P261, DOI 10.1007/BF02570506; Reyner LA, 1998, INT J LEGAL MED, V111, P120, DOI 10.1007/s004140050131; Sagaspe P, 2007, SLEEP, V30, P1808, DOI 10.1093/sleep/30.12.1808; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8	38	65	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3493	10.1371/journal.pone.0003493	http://dx.doi.org/10.1371/journal.pone.0003493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IG	18941525	Green Published, gold, Green Submitted			2022-12-25	WOS:000265126100023
J	Regulapati, R; Bhasi, A; Singh, CK; Senapathy, P				Regulapati, Rahul; Bhasi, Ashwini; Singh, Chandan Kumar; Senapathy, Periannan			Origination of the Split Structure of Spliceosomal Genes from Random Genetic Sequences	PLOS ONE			English	Article								The mechanism by which protein-coding portions of eukaryotic genes came to be separated by long non-coding stretches of DNA, and the purpose for this perplexing arrangement, have remained unresolved fundamental biological problems for three decades. We report here a plausible solution to this problem based on analysis of open reading frame (ORF) length constraints in the genomes of nine diverse species. If primordial nucleic acid sequences were random in sequence, functional proteins that are innately long would not be encoded due to the frequent occurrence of stop codons. The best possible way that a long protein-coding sequence could have been derived was by evolving a split-structure from the random DNA (or RNA) sequence. Results of the systematic analyses of nine complete genome sequences presented here suggests that perhaps the major underlying structural features of split-genes have evolved due to the indigenous occurrence of split protein-coding genes in primordial random nucleotide sequence. The results also suggest that intron-rich genes containing short exons may have been the original form of genes intrinsically occurring in random DNA, and that intron-poor genes containing long exons were perhaps derived from the original intron-rich genes.	[Regulapati, Rahul] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Bhasi, Ashwini; Senapathy, Periannan] Genome Int Corp, Madison, WI USA; [Singh, Chandan Kumar; Senapathy, Periannan] Int Ctr Advanced Genom & Proteom, Dept Bioinformat, Chennai, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Regulapati, R (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	ps@genome.com	Senapathy, Periannan/N-1120-2019		Genome International Corporation	Genome International Corporation	This project has been internally funded by Genome International Corporation. This project is purely an academic project, fulfilling the academic interest of the corresponding author, who owns the company.	Bhasi A, 2007, BIOINFORMATICS, V23, P1815, DOI 10.1093/bioinformatics/btm084; Bhattacharya D, 1996, MOL BIOL EVOL, V13, P978, DOI 10.1093/oxfordjournals.molbev.a025666; BLAKE CCF, 1978, NATURE, V273, P267, DOI 10.1038/273267a0; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; CAVALIERSMITH T, 1985, NATURE, V315, P283, DOI 10.1038/315283b0; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; de Souza SJ, 2003, GENETICA, V118, P117, DOI 10.1023/A:1024193323397; De Souza SJ, 1998, P NATL ACAD SCI USA, V95, P5094, DOI 10.1073/pnas.95.9.5094; deSouza SJ, 1996, P NATL ACAD SCI USA, V93, P14632, DOI 10.1073/pnas.93.25.14632; DOOLITTLE WF, 1978, NATURE, V272, P581, DOI 10.1038/272581a0; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Labedan B, 1999, J MOL EVOL, V49, P461, DOI 10.1007/PL00006569; LEWIN B, 1994, GENES, V5; Logsdon JM, 2004, P NATL ACAD SCI USA, V101, P11195, DOI 10.1073/pnas.0404148101; Long MY, 2000, MOL BIOL EVOL, V17, P1789, DOI 10.1093/oxfordjournals.molbev.a026279; Lu Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-102; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; Nei M., 1987, MOL EVOLUTIONARY GEN; Palmer JD, 1991, CURR OPIN GENET DEV, V1, P470, DOI 10.1016/S0959-437X(05)80194-7; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; Robart AR, 2005, CYTOGENET GENOME RES, V110, P589, DOI 10.1159/000084992; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Roy SW, 2003, P NATL ACAD SCI USA, V100, P7158, DOI 10.1073/pnas.1232297100; Roy SW, 2003, GENETICA, V118, P251, DOI 10.1023/A:1024190617462; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; SENAPATHY P, 1988, P NATL ACAD SCI USA, V85, P1129, DOI 10.1073/pnas.85.4.1129; SENAPATHY P, 1995, SCIENCE, V268, P1366, DOI 10.1126/science.7761858; SENAPATHY P, 1986, P NATL ACAD SCI USA, V83, P2133, DOI 10.1073/pnas.83.7.2133; SENAPATHY P, 1994, INDEPENDENT BIRTH OR; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; SUBAKSHARPE H, 1966, COLD SPRING HARB SYM, V31, P737, DOI 10.1101/SQB.1966.031.01.094	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3456	10.1371/journal.pone.0003456	http://dx.doi.org/10.1371/journal.pone.0003456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941625	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125600014
J	van Oppen, MJH; Lutz, A; De'ath, G; Peplow, L; Kininmonth, S				van Oppen, Madeleine J. H.; Lutz, Adrian; De'ath, Glenn; Peplow, Lesa; Kininmonth, Stuart			Genetic Traces of Recent Long-Distance Dispersal in a Predominantly Self-Recruiting Coral	PLOS ONE			English	Article								Background: Understanding of the magnitude and direction of the exchange of individuals among geographically separated subpopulations that comprise a metapopulation (connectivity) can lead to an improved ability to forecast how fast coral reef organisms are likely to recover from disturbance events that cause extensive mortality. Reef corals that brood their larvae internally and release mature larvae are believed to show little exchange of larvae over ecological times scales and are therefore expected to recover extremely slowly from large-scale perturbations. Methodology/Principal Findings: Using analysis of ten DNA microsatellite loci, we show that although Great Barrier Reef (GBR) populations of the brooding coral, Seriatopora hystrix, are mostly self-seeded and some populations are highly isolated, a considerable amount of sexual larvae (up to similar to 4%) has been exchanged among several reefs 10 s to 100 s km apart over the past few generations. Our results further indicate that S. hystrix is capable of producing asexual propagules with similar long-distance dispersal abilities (similar to 1.4% of the sampled colonies had a multilocus genotype that also occurred at another sampling location), which may aid in recovery from environmental disturbances. Conclusions/Significance: Patterns of connectivity in this and probably other GBR corals are complex and need to be resolved in greater detail through genetic characterisation of different cohorts and linkage of genetic data with fine-scale hydrodynamic models.	[van Oppen, Madeleine J. H.; Lutz, Adrian; De'ath, Glenn; Peplow, Lesa; Kininmonth, Stuart] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	van Oppen, MJH (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	m.vanoppen@aims.gov.au	van Oppen, Madeleine JH/C-3261-2008; Kininmonth, Stuart/N-9299-2013; Lutz, Adrian/O-9805-2016	Kininmonth, Stuart/0000-0001-9198-3396; Lutz, Adrian/0000-0002-8392-3921; van Oppen, Madeleine/0000-0003-4607-0744	Australian Institute of Marine Science	Australian Institute of Marine Science	All the work was funded by the Australian Institute of Marine Science. Design and conduct of the study, the collection, analysis, and interpretation of the data, and the preparation of the manuscript was conducted by the authors.	Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; ATODA K, 1951, REPORTS TOHOKU U, V19, P48; AYRE DJ, 1994, EVOLUTION, V48, P1183, DOI 10.1111/j.1558-5646.1994.tb05304.x; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; Ayre DJ, 2000, EVOLUTION, V54, P1590; BAIRD AH, 2001, THESIS J COOK U TOWN; BARTON NH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P13; Benjamini Y, 2001, ANN STAT, V29, P1165; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; Brinkman R, 2002, ESTUAR COAST SHELF S, V54, P655, DOI 10.1006/ecss.2001.0850; Cantin NE, 2007, MAR ECOL PROG SER, V344, P81, DOI 10.3354/meps07059; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harrison P.L., 1990, P133; Hartl D., 1989, PRINCIPLES POPULATIO; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Johnson MS, 2006, EVOLUTION, V60, P2498; JOKIEL PL, 1984, CORAL REEFS, V3, P113, DOI 10.1007/BF00263761; Luick JL, 2007, CONT SHELF RES, V27, P757, DOI 10.1016/j.csr.2006.11.020; Mackenzie JB, 2004, MOL ECOL, V13, P9, DOI 10.1046/j.1365-294X.2003.02019.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Negri AP, 2002, MAR POLLUT BULL, V44, P111, DOI 10.1016/S0025-326X(01)00128-X; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palumbi SR, 2003, ECOL APPL, V13, pS146; PEAKALL R, 2005, GENALEX, V6; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; SAMMARCO PW, 1982, MAR ECOL PROG SER, V10, P57, DOI 10.3354/meps010057; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; Sherman CDH, 2006, CORAL REEFS, V25, P7, DOI 10.1007/s00338-005-0053-x; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; STEINBERG C. R., 2007, CLIMATE CHANGE GREAT, P52; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Underwood JN, 2006, MOL ECOL NOTES, V6, P176, DOI 10.1111/j.1471-8286.2005.01183.x; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; Veron J. E. N., 2000, CORALS WORLD, V2; Wachenfeld D., 2007, CLIMATE CHANGE GREAT, P1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitaker K, 2006, MAR ECOL PROG SER, V306, P115, DOI 10.3354/meps306115; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Young AG, 2002, BIOL CONSERV, V106, P71, DOI 10.1016/S0006-3207(01)00230-0	55	72	73	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3401	10.1371/journal.pone.0003401	http://dx.doi.org/10.1371/journal.pone.0003401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852897	Green Published, Green Submitted, gold			2022-12-25	WOS:000265121700008
J	Siniscalchi, M; Quaranta, A; Rogers, LJ				Siniscalchi, Marcello; Quaranta, Angelo; Rogers, Lesley J.			Hemispheric Specialization in Dogs for Processing Different Acoustic Stimuli	PLOS ONE			English	Article							ORIENTING ASYMMETRIES; LATERALIZED BEHAVIOR; CANIS-FAMILIARIS; RHESUS-MONKEYS; PAW PREFERENCE; VOCALIZATIONS; PERCEPTION; CALLS; COMMUNICATION; BRAIN	Considerable experimental evidence shows that functional cerebral asymmetries are widespread in animals. Activity of the right cerebral hemisphere has been associated with responses to novel stimuli and the expression of intense emotions, such as aggression, escape behaviour and fear. The left hemisphere uses learned patterns and responds to familiar stimuli. Although such lateralization has been studied mainly for visual responses, there is evidence in primates that auditory perception is lateralized and that vocal communication depends on differential processing by the hemispheres. The aim of the present work was to investigate whether dogs use different hemispheres to process different acoustic stimuli by presenting them with playbacks of a thunderstorm and their species-typical vocalizations. The results revealed that dogs usually process their species-typical vocalizations using the left hemisphere and the thunderstorm sounds using the right hemisphere. Nevertheless, conspecific vocalizations are not always processed by the left hemisphere, since the right hemisphere is used for processing vocalizations when they elicit intense emotion, including fear. These findings suggest that the specialisation of the left hemisphere for intraspecific communication is more ancient that previously thought, and so is specialisation of the right hemisphere for intense emotions.	[Siniscalchi, Marcello; Quaranta, Angelo] Univ Bari, Dept Anim Prod, Bari, Italy; [Rogers, Lesley J.] Univ New England, Ctr Neurosci & Anim Behaviour, Armidale, NSW, Australia	Universita degli Studi di Bari Aldo Moro; University of New England	Siniscalchi, M (corresponding author), Univ Bari, Dept Anim Prod, Bari, Italy.	m.siniscalchi@veterinaria.uniba.it	Rogers, Lesley J./Y-5722-2019	Rogers, Lesley J./0000-0002-9956-1769; Lauwereyns, Jan/0000-0003-0551-2550; Quaranta, Angelo/0000-0001-7835-2485	Giovanni Putignano Educational Award	Giovanni Putignano Educational Award	This work was supported by grant from the Giovanni Putignano Educational Award to M.S.	ADAMS CL, 1987, DEV NEUROPSYCHOL, V3, P175, DOI 10.1080/87565648709540375; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; BOUISSOU MF, 1995, BEHAV PROCESS, V34, P81, DOI 10.1016/0376-6357(94)00056-M; Boye M, 2005, EUR J NEUROSCI, V21, P1727, DOI 10.1111/j.1460-9568.2005.04005.x; Bradshaw JL., 1993, EVOLUTION LATERAL AS; Branson NJ, 2006, J COMP PSYCHOL, V120, P176, DOI 10.1037/0735-7036.120.3.176; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Feddersen-Petersen DU, 2000, ARCH TIERZUCHT, V43, P387, DOI 10.5194/aab-43-387-2000; George I, 2002, CR BIOL, V325, P197, DOI 10.1016/S1631-0691(02)01430-0; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Gil-da-Costa R, 2006, P ROY SOC B-BIOL SCI, V273, P2313, DOI 10.1098/rspb.2006.3580; Hauser MD, 1998, ANIM BEHAV, V56, P41, DOI 10.1006/anbe.1998.0738; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; HAUSER MD, 1993, SCIENCE, V261, P475, DOI 10.1126/science.8332914; Henderson JV, 2000, APPL ANIM BEHAV SCI, V69, P241, DOI 10.1016/S0168-1591(00)00132-5; Hook-Costigan MA, 1998, NEUROPSYCHOLOGIA, V36, P1265, DOI 10.1016/S0028-3932(98)00037-2; Molnar C, 2008, ANIM COGN, V11, P389, DOI 10.1007/s10071-007-0129-9; Ohl Frauke, 1996, Zoologische Beitraege, V37, P199; Palleroni A, 2003, SCIENCE, V299, P1195, DOI 10.1126/science.1078813; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Quaranta A, 2004, BEHAV BRAIN RES, V153, P521, DOI 10.1016/j.bbr.2004.01.009; Rogers L., 2003, SPIRIT WILD DOG WORL; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Rogers LJ., 2002, COMP VERTEBRATE LATE; Scheumann M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-3; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; Teufel C, 2007, ANIM BEHAV, V73, P249, DOI 10.1016/j.anbehav.2006.04.011; Vallortigara G, 2008, PLOS BIOL, V6, P208, DOI 10.1371/journal.pbio.0060042; Wells DL, 2003, BEHAV PROCESS, V61, P27, DOI 10.1016/S0376-6357(02)00161-4; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016	34	116	117	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3349	10.1371/journal.pone.0003349	http://dx.doi.org/10.1371/journal.pone.0003349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432DQ	18843371	Green Submitted, Green Published, gold			2022-12-25	WOS:000265114100001
J	Beltran, S; Cezilly, F; Boissier, J				Beltran, Sophie; Cezilly, Frank; Boissier, Jerome			Genetic Dissimilarity between Mates, but Not Male Heterozygosity, Influences Divorce in Schistosomes	PLOS ONE			English	Article							MICROSATELLITE MARKERS; MANSONI; CHOICE; BIRDS; OYSTERCATCHER; RELATEDNESS; SIMILARITY; PAIRS; LOCI	Background: Correlational studies strongly suggest that both genetic similarity and heterozygosity can influence female mate choice. However, the influence of each variable has usually been tested independently, although similarity and heterozygosity might be correlated. We experimentally determined the relative influence of genetic similarity and heterozygosity in divorce and re-mating in the monogamous endoparasite Schistosoma mansoni. Methodology/Principal Findings: We performed sequential infections of vertebrate hosts with controlled larval populations of parasites, where sex and individual genetic diversity and similarity were predetermined before infection. Divorce rate increased significantly when females were given the opportunity to increase genetic dissimilarity through re-mating with a new partner, independently of the intensity of male-male competition. We found however no evidence for females attempting to maximize the level of heterozygosity of their reproductive partner through divorce. Conclusions/Significance: Female preference for genetically dissimilar males should result in more heterozygous offspring. Because genetic heterozygosity might partly determine the ability of parasites to counter host resistance, adaptive divorce could be an important factor in the evolutionary arms race between schistosomes and their hosts.	[Beltran, Sophie; Boissier, Jerome] Univ Perpignan, CNRS, EPHE UPVD, Lab Biol & Ecol Trop & Mediterraneenne,UMR 5244, F-66025 Perpignan, France; [Cezilly, Frank] Univ Bourgogne, UMR CNRS 5561 Biogeosci, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Beltran, S (corresponding author), Univ Perpignan, CNRS, EPHE UPVD, Lab Biol & Ecol Trop & Mediterraneenne,UMR 5244, F-66025 Perpignan, France.	boissier@univ.perp.fr	BOISSIER, Jérôme/B-2996-2010; Beltran, Sophie/AAE-1075-2019; BELTRAN-BECH, Sophie/A-9070-2010	Beltran, Sophie/0000-0003-4379-0463; BELTRAN-BECH, Sophie/0000-0003-4379-0463	French Ministere de l'Enseignement Superieur et de la Recherche; CNRS; Agence Nationale de la Recherche (Program Monogamix)	French Ministere de l'Enseignement Superieur et de la Recherche; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (Program Monogamix)(French National Research Agency (ANR))	This work was supported financially by the French Ministere de l'Enseignement Superieur et de la Recherche, the CNRS and the Agence Nationale de la Recherche (Program Monogamix).	Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Beltran S, 2008, TRENDS PARASITOL, V24, P386, DOI 10.1016/j.pt.2008.05.009; Bishop JM, 2007, BIOL LETTERS, V3, P176, DOI 10.1098/rsbl.2006.0607; Black J.M., 1996, PARTNERSHIPS BIRDS S; Blair L, 2001, MOL ECOL NOTES, V1, P93, DOI 10.1046/j.1471-8278.2001.00042.x; Boissier J, 2000, PARASITOLOGY, V121, P379, DOI 10.1017/S0031182099006393; Boissier J, 2001, MOL BIOCHEM PARASIT, V112, P139, DOI 10.1016/S0166-6851(00)00344-3; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Castillo-Chavez C, 2008, MATH BIOSCI, V211, P333, DOI 10.1016/j.mbs.2007.11.001; *CDC, 2004, SCHIST FACT SHEET; Cezilly F, 2000, BEHAV PROCESS, V51, P83, DOI 10.1016/S0376-6357(00)00120-0; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; CLOUGH ER, 1981, J PARASITOL, V67, P535, DOI 10.2307/3280487; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Curtis J, 2001, MOL ECOL NOTES, V1, P143, DOI 10.1046/j.1471-8278.2001.00053.x; Dhondt AA, 2002, TRENDS ECOL EVOL, V17, P55, DOI 10.1016/S0169-5347(01)02407-7; Dubois F, 2002, BEHAV ECOL SOCIOBIOL, V52, P357, DOI 10.1007/s00265-002-0521-z; Durand P, 2000, MOL ECOL, V9, P997, DOI 10.1046/j.1365-294x.2000.00939-4.x; DUVALL RH, 1967, AM J TROP MED HYG, V16, P483, DOI 10.4269/ajtmh.1967.16.483; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hatchwell BJ, 2000, P ROY SOC B-BIOL SCI, V267, P813, DOI 10.1098/rspb.2000.1076; Heg D, 2003, ANIM BEHAV, V66, P175, DOI 10.1006/anbe.2003.2188; Jeschke JM, 2007, BEHAV ECOL, V18, P460, DOI 10.1093/beheco/arl109; Kempenaers B, 1998, ANIM BEHAV, V56, P737, DOI 10.1006/anbe.1998.0800; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; Mone H, 2004, ADV PARASIT, V57, P89, DOI 10.1016/S0065-308X(04)57002-1; Pica-Mattoccia L, 2000, PARASITOLOGY, V120, P495, DOI 10.1017/S0031182099005685; Prugnolle F, 2004, J PARASITOL, V90, P507, DOI 10.1645/GE-150R; Prugnolle F, 2002, MOL ECOL, V11, P1231, DOI 10.1046/j.1365-294X.2002.01518.x; PRUGNOLLE F, COMMUNICATION; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roberts SC, 2006, J EVOLUTION BIOL, V19, P558, DOI 10.1111/j.1420-9101.2005.01003.x; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; Rodrigues NB, 2002, MEM I OSWALDO CRUZ, V97, P71, DOI 10.1590/S0074-02762002000900015; Smith SB, 2005, J AVIAN BIOL, V36, P146, DOI 10.1111/j.0908-8857.2005.03417.x; Taborsky B, 1999, J AVIAN BIOL, V30, P143, DOI 10.2307/3677123; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Wang JL, 2002, GENETICS, V160, P1203; Weatherhead PJ, 1999, BEHAV ECOL, V10, P619, DOI 10.1093/beheco/10.6.619	40	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3328	10.1371/journal.pone.0003328	http://dx.doi.org/10.1371/journal.pone.0003328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841198	Green Published, gold, Green Submitted			2022-12-25	WOS:000265113900001
J	Milloy, MJS; Kerr, T; Tyndall, M; Montaner, J; Wood, E				Milloy, M-J. S.; Kerr, Thomas; Tyndall, Mark; Montaner, Julio; Wood, Evan			Estimated Drug Overdose Deaths Averted by North America's First Medically-Supervised Safer Injection Facility	PLOS ONE			English	Article							NONFATAL HEROIN OVERDOSE; USERS; COHORT; RISK; INTERVENTION; AUSTRALIA; MORTALITY	Background: Illicit drug overdose remains a leading cause of premature mortality in urban settings worldwide. We sought to estimate the number of deaths potentially averted by the implementation of a medically supervised safer injection facility (SIF) in Vancouver, Canada. Methodology/Principal Findings: The number of potentially averted deaths was calculated using an estimate of the local ratio of non-fatal to fatal overdoses. Inputs were derived from counts of overdose deaths by the British Columbia Vital Statistics Agency and non-fatal overdose rates from published estimates. Potentially-fatal overdoses were defined as events within the SIF that required the provision of naloxone, a 911 call or an ambulance. Point estimates and 95% Confidence Intervals (95% CI) were calculated using a Monte Carlo simulation. Between March 1, 2004 and July 1, 2008 there were 1004 overdose events in the SIF of which 453 events matched our definition of potentially fatal. In 2004, 2005 and 2006 there were 32, 37 and 38 drug-induced deaths in the SIF's neighbourhood. Owing to the wide range of non-fatal overdose rates reported in the literature (between 5% and 30% per year) we performed sensitivity analyses using non-fatal overdose rates of 50, 200 and 300 per 1,000 person years. Using these model inputs, the number of averted deaths were, respectively: 50.9 (95% CI: 23.6-78.1); 12.6 (95% CI: 9.6-15.7); 8.4 (95% CI: 6.5-10.4) during the study period, equal to 1.9 to 11.7 averted deaths per annum. Conclusions/Significance: Based on a conservative estimate of the local ratio of non-fatal to fatal overdoses, the potentially fatal overdoses in the SIF during the study period could have resulted in between 8 and 51 deaths had they occurred outside the facility, or from 6% to 37% of the total overdose mortality burden in the neighborhood during the study period. These data should inform the ongoing debates over the future of the pilot project.	[Milloy, M-J. S.; Kerr, Thomas; Tyndall, Mark; Montaner, Julio; Wood, Evan] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Milloy, M-J. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Kerr, Thomas; Tyndall, Mark; Montaner, Julio; Wood, Evan] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia	Milloy, MJS (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	uhri-ew@cfenet.ubc.ca	Montaner, Julio/K-7621-2012; Milloy, M-J/AAY-3618-2020	Tyndall, Mark/0000-0003-4450-5679	Health Canada; Canadian Institutes of Health Research; Vancouver Coastal Health	Health Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Vancouver Coastal Health	The SIF evaluation was originally funded by a contribution from Health Canada, although the views expressed in this analysis do not represent the official policies of Health Canada. The evaluation is now supported by the Canadian Institutes of Health Research and Vancouver Coastal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN M, 2008, COST BENEFIT COST EF; Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168; BENNETT GA, 1999, ACCIDENTAL OVERDOSE; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; *BRIT COL VIT STAT, 2002, ANN REP 2001 BRIT CO; *BRIT COL VIT STAT, 2005, ANN REP 2004 BRIT CO; *BRIT COL VIT STAT, 1999, ANN REP 1998 BRIT CO; *BRIT COL VIT STAT, 2006, ANN REP 2005 BRIT CO; *BRIT COL VIT STAT, 2001, ANN REP 2000 BRIT CO; *BRIT COL VIT STAT, 2007, ANN REP 2006 BRIT CO; *BRIT COL VIT STAT, 2000, ANN REP 1999 BRIT CO; *BRIT COL VIT STAT, 2003, ANN REP 2002 BRIT CO; *BRIT COL VIT STAT, 2004, ANN REP 2003 BRIT CO; Coffin PO, 2007, ACAD EMERG MED, V14, P616, DOI 10.1111/j.1553-2712.2007.tb01846.x; Darke S, 2005, DRUG ALCOHOL REV, V24, P425, DOI 10.1080/09595230500286005; Darke S, 2003, ADDICTION, V98, P1169, DOI 10.1046/j.1360-0443.2003.00474.x; Darke S, 2003, J URBAN HEALTH, V80, P189, DOI 10.1093/jurban/jtg022; Darke S, 1996, ADDICTION, V91, P405, DOI 10.1111/j.1360-0443.1996.tb02289.x; Darke S, 2007, J URBAN HEALTH, V84, P283, DOI 10.1007/s11524-006-9156-0; Degenhardt Louisa, 2005, J Clin Forensic Med, V12, P187, DOI 10.1016/j.jcfm.2004.11.003; Fischer B, 2004, CAN MED ASSOC J, V171, P235, DOI 10.1503/cmaj.1031416; Fischer B, 2006, CAN J PUBLIC HEALTH, V97, P384, DOI 10.1007/BF03405347; Gossop M, 1996, BRIT MED J, V313, P402; Hulse GK, 1999, ADDICTION, V94, P221, DOI 10.1046/j.1360-0443.1999.9422216.x; Kerr T, 2005, LANCET, V366, P316, DOI 10.1016/S0140-6736(05)66475-6; Kerr T, 2007, INT J DRUG POLICY, V18, P37, DOI 10.1016/j.drugpo.2006.12.008; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; Kerr T, 2006, INT J DRUG POLICY, V17, P436, DOI 10.1016/j.drugpo.2006.05.008; McGregor C, 1998, ADDICTION, V93, P701, DOI 10.1046/j.1360-0443.1998.9357016.x; Milloy MJS, 2008, AM J DRUG ALCOHOL AB, V34, P499, DOI 10.1080/00952990802122457; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P1263, DOI 10.1001/jama.279.16.1263-a; Ochoa KC, 2005, DRUG ALCOHOL DEPEN, V80, P297, DOI 10.1016/j.drugalcdep.2005.04.012; OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x; POSCHADE S, 2003, EVALUATION ARBEIT DR; Remis R.S, 1998, CONSORTIUM CHARACTER; SCHECHTER MT, 1999, GUESSTIMATING NUMBER; SELBY P, 2007, CANADIAN MED ASS J E; *STAND COMM HLTH P, 2008, EV THURSD MAY 29 200; Uniting, 2021, UN MED SUP INJ CTR; Van Beek I., 2004, CRIT PUBLIC HEALTH, V14, P391, DOI DOI 10.1080/09581590400027528; Vingoe L., 1999, J SUBST USE, V4, P88, DOI DOI 10.3109/14659899909053019; Warner-Smith M, 2002, ADDICTION, V97, P963, DOI 10.1046/j.1360-0443.2002.00132.x; Wood E, 2006, NEW ENGL J MED, V354, P2512, DOI 10.1056/NEJMc052939; Wood E, 2000, AIDS, V14, P1229, DOI 10.1097/00002030-200006160-00021; Wood E, 2006, AM J PUBLIC HEALTH, V96, P770, DOI 10.2105/AJPH.2004.057828; Wood E, 2006, ADDICTION, V101, P689, DOI 10.1111/j.1360-0443.2006.01385.x; Wood E, 2004, CAN MED ASSOC J, V171, P731, DOI 10.1503/cmaj.1040774; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863; Wood Evan, 2004, Harm Reduct J, V1, P9, DOI 10.1186/1477-7517-1-9; WOOD RA, 2008, INT J DRUG POLICY; 2007, MMWR MORBIDITY MORTA, V56, P93	51	80	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2008	3	10							e3351	10.1371/journal.pone.0003351	http://dx.doi.org/10.1371/journal.pone.0003351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432DM	18839040	Green Published, gold, Green Submitted			2022-12-25	WOS:000265113700001
J	Rae, C; Koudelka, KJ; Destito, G; Estrada, MN; Gonzalez, MJ; Manchester, M				Rae, Chris; Koudelka, Kristopher J.; Destito, Giuseppe; Estrada, Mayra N.; Gonzalez, Maria J.; Manchester, Marianne			Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs)	PLOS ONE			English	Article								Background: Cowpea Mosaic Virus (CPMV) is increasingly being used as a nanoparticle platform for multivalent display of molecules via chemical bioconjugation to the capsid surface. A growing variety of applications have employed the CPMV multivalent display technology including nanoblock chemistry, in vivo imaging, and materials science. CPMV nanoparticles can be inexpensively produced from experimentally infected cowpea plants at high yields and are extremely stable. Although CPMV has not been shown to replicate in mammalian cells, uptake in mammalian cells does occur in vitro and in vivo. Thus, inactivation of the virus RNA genome is important for biosafety considerations, however the surface characteristics and chemical reactivity of the particles must be maintained in order to preserve chemical and structural functionality. Methodology/Principal Findings: Short wave (254 nm) UV irradiation was used to crosslink the RNA genome within intact particles. Lower doses of UV previously reported to inactivate CPMV infectivity inhibited symptoms on inoculated leaves but did not prohibit systemic virus spread in plants, whereas higher doses caused aggregation of the particles and an increase in chemical reactivity further indicating broken particles. Intermediate doses of 2.0-2.5 J/cm(2) were shown to maintain particle structure and chemical reactivity, and cellular binding properties were similar to CPMV-WT. Conclusions: These studies demonstrate that it is possible to inactivate CPMV infectivity while maintaining particle structure and function, thus paving the way for further development of CPMV nanoparticles for in vivo applications.	[Rae, Chris; Koudelka, Kristopher J.; Destito, Giuseppe; Estrada, Mayra N.; Gonzalez, Maria J.; Manchester, Marianne] Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA	Scripps Research Institute	Rae, C (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA.	marim@scripps.edu		Manchester, Marianne/0000-0002-7143-5744	NIH [CA112075]; NATIONAL CANCER INSTITUTE [R01CA112075] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH CA112075 to M.M. The NIH was not involved in any way in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Brennan FR, 1999, MICROBIOL-SGM, V145, P211, DOI 10.1099/13500872-145-1-211; Brennan FR, 1999, VACCINE, V17, P1846, DOI 10.1016/S0264-410X(98)00485-X; Brennan FR, 1999, J VIROL, V73, P930, DOI 10.1128/JVI.73.2.930-938.1999; Brennan FR, 1999, MICROBIOL-SGM, V145, P2061, DOI 10.1099/13500872-145-8-2061; Chatterji A, 2004, CHEM BIOL, V11, P855, DOI 10.1016/j.chembiol.2004.04.011; DEJAGER CP, 1970, VIROLOGY, V41, P281, DOI 10.1016/0042-6822(70)90080-2; Destito G, 2007, CHEM BIOL, V14, P1152, DOI 10.1016/j.chembiol.2007.08.015; Durrani Z, 1998, J IMMUNOL METHODS, V220, P93, DOI 10.1016/S0022-1759(98)00145-8; Gilleland HE, 2000, FEMS IMMUNOL MED MIC, V27, P291, DOI 10.1111/j.1574-695X.2000.tb01442.x; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Horowitz B, 1995, Curr Opin Hematol, V2, P484; Koudelka KJ, 2007, J VIROL, V81, P1632, DOI 10.1128/JVI.00960-06; Langeveld JPM, 2001, VACCINE, V19, P3661, DOI 10.1016/S0264-410X(01)00083-4; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Lin TW, 1999, VIROLOGY, V265, P20, DOI 10.1006/viro.1999.0038; LOMONOSSOFF GP, 1991, PROG BIOPHYS MOL BIO, V55, P107, DOI 10.1016/0079-6107(91)90003-B; MCINTOSH PD, 1999, FOREST PRACTICES NEW, V1, P17; Medintz IL, 2005, LANGMUIR, V21, P5501, DOI 10.1021/la0468287; Nuanualsuwan S, 2003, APPL ENVIRON MICROB, V69, P350, DOI 10.1128/AEM.69.1.350-357.2003; Ochoa WF, 2006, CHEM BIOL, V13, P771, DOI 10.1016/j.chembiol.2006.05.014; Phelps JP, 2007, J VIROL METHODS, V141, P146, DOI 10.1016/j.jviromet.2006.12.008; PORTA C, 1994, VIROLOGY, V202, P949, DOI 10.1006/viro.1994.1417; Portney NG, 2005, LANGMUIR, V21, P2098, DOI 10.1021/la047525f; RAE CS, 2005, VIROLOGY; Raja KS, 2003, BIOMACROMOLECULES, V4, P472, DOI 10.1021/bm025740+; Raja KS, 2003, CHEMBIOCHEM, V4, P1348, DOI 10.1002/cbic.200300759; RAJA KS, 2004, ARTIFICIAL IN PRESS; Sapsford KE, 2006, BIOSENS BIOELECTRON, V21, P1668, DOI 10.1016/j.bios.2005.09.003; Sen Gupta S, 2005, BIOCONJUGATE CHEM, V16, P1572, DOI 10.1021/bc050147l; Singh Pratik, 2006, J Nanobiotechnology, V4, P2, DOI 10.1186/1477-3155-4-2; Steinmetz NF, 2006, LANGMUIR, V22, P3488, DOI 10.1021/la060078e; Steinmetz NF, 2006, SMALL, V2, P530, DOI 10.1002/smll.200500453; Steinmetz NF, 2008, BIOMACROMOLECULES, V9, P456, DOI 10.1021/bm700797b; Steinmetz NF, 2007, ORG BIOMOL CHEM, V5, P2891, DOI 10.1039/b708175h; Steinmetz NF, 2006, LANGMUIR, V22, P10032, DOI 10.1021/la0621362; VANKAMME.A, 1968, VIROLOGY, V34, P312, DOI 10.1016/0042-6822(68)90241-9; VANKAMMEN A, 1970, VIROLOGY, V41, P274, DOI 10.1016/0042-6822(70)90079-6; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wang Q, 2002, ANGEW CHEM INT EDIT, V41, P459; Wang Q, 2002, CHEM BIOL, V9, P813, DOI 10.1016/S1074-5521(02)00166-7; WANG Q, 2002, CHEM BIOL, V9; YOUNG M, 2008, ANN REV PHYTOPATHOL	42	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3315	10.1371/journal.pone.0003315	http://dx.doi.org/10.1371/journal.pone.0003315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830402	Green Published, Green Submitted, gold			2022-12-25	WOS:000264797300006
J	Fiorillo, CD				Fiorillo, Christopher D.			Towards a General Theory of Neural Computation Based on Prediction by Single Neurons	PLOS ONE			English	Article								Although there has been tremendous progress in understanding the mechanics of the nervous system, there has not been a general theory of its computational function. Here I present a theory that relates the established biophysical properties of single generic neurons to principles of Bayesian probability theory, reinforcement learning and efficient coding. I suggest that this theory addresses the general computational problem facing the nervous system. Each neuron is proposed to mirror the function of the whole system in learning to predict aspects of the world related to future reward. According to the model, a typical neuron receives current information about the state of the world from a subset of its excitatory synaptic inputs, and prior information from its other inputs. Prior information would be contributed by synaptic inputs representing distinct regions of space, and by different types of non-synaptic, voltage-regulated channels representing distinct periods of the past. The neuron's membrane voltage is proposed to signal the difference between current and prior information ("prediction error'' or "surprise''). A neuron would apply a Hebbian plasticity rule to select those excitatory inputs that are the most closely correlated with reward but are the least predictable, since unpredictable inputs provide the neuron with the most "new'' information about future reward. To minimize the error in its predictions and to respond only when excitation is "new and surprising,'' the neuron selects amongst its prior information sources through an anti-Hebbian rule. The unique inputs of a mature neuron would therefore result from learning about spatial and temporal patterns in its local environment, and by extension, the external world. Thus the theory describes how the structure of the mature nervous system could reflect the structure of the external world, and how the complexity and intelligence of the system might develop from a population of undifferentiated neurons, each implementing similar learning algorithms.	[Fiorillo, Christopher D.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Fiorillo, CD (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	chris@monkeybiz.stanford.edu	Fiorillo, Christopher Dante/C-1718-2011	Fiorillo, Christopher/0000-0002-7232-9505				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BARLOW H, 1989, COMP NEUR S, P54; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BELL CC, 1993, P NATL ACAD SCI USA, V90, P4650, DOI 10.1073/pnas.90.10.4650; Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dayan P., 2001, THEORETICAL NEUROSCI; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Dickinson A., 1980, CONT ANIMAL LEARNING; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Hawkins J, 2004, INTELLIGENCE; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Jaynes E.T., 2003, PROBABILITY THEORY L; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marr D., 1982, VISION; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; PALMIERI F, 1993, IEEE T NEURAL NETWOR, V4, P748, DOI 10.1109/72.248453; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Rieke F., 1997, SPIKES EXPLORING NEU; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; VONHELMHOLZ H, 1896, TREATISE PHYSL OPTIC; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	42	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3298	10.1371/journal.pone.0003298	http://dx.doi.org/10.1371/journal.pone.0003298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827880	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797200005
J	Cobb, NJ; Apetri, AC; Surewicz, WK				Cobb, Nathan J.; Apetri, Adrian C.; Surewicz, Witold K.			Prion Protein Amyloid Formation under Native-like Conditions Involves Refolding of the C-terminal alpha-Helical Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; IN-VITRO; NMR STRUCTURE; SCRAPIE; CONVERSION; FIBRILS; PRPSC; SITE; CONFORMATION; PATHWAY	Transmissible spongiform encephalopathies are associated with conformational conversion of the cellular prion protein, PrPC, into a proteinase K-resistant, amyloid-like aggregate, PrPSc. Although the structure of PrPSc remains enigmatic, recent studies have afforded increasingly detailed characterization of recombinant PrP amyloid. However, all previous studies were performed using amyloid fibrils formed in the presence of denaturing agents that significantly alter the folding state(s) of the precursor monomer. Here we report that PrP amyloid can also be generated under physiologically relevant conditions, where the monomeric protein is natively folded. Remarkably, site-directed spin labeling studies reveal that these fibrils possess a beta-core structure nearly indistinguishable from that of amyloid grown under denaturing conditions, where the C-terminal alpha-helical domain of the PrP monomer undergoes major refolding to a parallel and in-register beta-structure upon conversion. The structural similarity of fibrils formed under drastically different conditions strongly suggests that the common beta-sheet architecture within the similar to 160-220 core region represents a distinct global minimum in the PrP conversion free energy landscape. We also show that the N-terminal region of fibrillar PrP displays conformational plasticity, undergoing a reversible structural transition with an apparent pK(a) of similar to 5.3. The C-terminal region, on the other hand, retains its beta-structure over the pH range 1-11, whereas more alkaline buffer conditions denature the fibrils into constituent PrP monomers. This profile of pH-dependent stability is reminiscent of the behavior of brain-derived PrPSc, suggesting a substantial degree of structural similarity within the beta-core region of these PrP aggregates.	[Cobb, Nathan J.; Apetri, Adrian C.; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	witold.surewicz@case.edu			National Institutes of Health [NS 38604, AG 14359]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 38604 and AG 14359.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; BROWN P, 1986, J INFECT DIS, V153, P1145, DOI 10.1093/infdis/153.6.1145; Calzolai L, 2003, J BIOL CHEM, V278, P35592, DOI 10.1074/jbc.M303005200; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; Caughey B, 2001, ADV VIRUS RES, V56, P277, DOI 10.1016/S0065-3527(01)56031-5; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kasermann F, 2003, J GEN VIROL, V84, P3173, DOI 10.1099/vir.0.19355-0; Korth C, 2000, J GEN VIROL, V81, P2555, DOI 10.1099/0022-1317-81-10-2555; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1981, P NATL ACAD SCI-BIOL, V78, P4606, DOI 10.1073/pnas.78.7.4606; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; Suzuki SY, 2008, J VET MED SCI, V70, P159, DOI 10.1292/jvms.70.159; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Weissmann C, 2005, CELL, V122, P165, DOI 10.1016/j.cell.2005.07.001; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	50	46	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34704	34711		10.1074/jbc.M806701200	http://dx.doi.org/10.1074/jbc.M806701200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930924	Green Published, hybrid			2022-12-25	WOS:000261469100026
J	De Pascale, G; Lloyd, AJ; Schouten, JA; Gilbey, AM; Roper, DI; Dowson, CG; Bugg, TDH				De Pascale, Gianfranco; Lloyd, Adrian J.; Schouten, James A.; Gilbey, Andrea M.; Roper, David I.; Dowson, Christopher G.; Bugg, Timothy D. H.			Kinetic Characterization of Lipid II-Ala:Alanyl-tRNA Ligase (MurN) from Streptococcus pneumoniae using Semisynthetic Aminoacyl-lipid II Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CELL-WALLS; HIGH-LEVEL PENICILLIN; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; ANTIBIOTIC TOLERANCE; INTERPEPTIDE BRIDGES; VIRIDESCENS FEMX; PEPTIDOGLYCAN; RESISTANCE; PENTAPEPTIDE	MurM and MurN are tRNA-dependent ligases that catalyze the addition of the first (L-Ala/L-Ser) and second (L-Ala) amino acid onto lipid II substrates in the biosynthesis of the peptidoglycan layer of Streptococcus pneumoniae. We have previously characterized the first ligase, MurM (Lloyd, A. J., Gilbey, A. M., Blewett, A. M., De Pascale, G., El Zoeiby, A., Levesque, R. C., Catherwood, A. C., Tomasz, A., Bugg, T. D., Roper, D. I., and Dowson, C. G. (2008) J. Biol. Chem. 283, 6402-6417). In order to characterize the second ligase MurN, we have developed a chemoenzymatic route to prepare the lipid II-Ala and lipid II-Ser substrates. Recombinant MurN enzymes from penicillin-resistant (159) and - sensitive (Pn16) S. pneumoniae were expressed and purified as MBP fusion proteins and reconstituted using a radiochemical assay. MurN ligases from strains 159 and Pn16 both showed a 20-fold higher catalytic efficiency for lipid II-L-Ala over lipid II-L-Ser, with no activity against unmodified lipid II, and similar kinetic parameters were measured for MurN from penicillin-resistant and penicillin-sensitive strains. These results concur with the peptidoglycan analysis of S. pneumoniae, in which the major cross-link observed is L-Ala-L-Ala. The combined action of ligases Mur M and MurN is therefore required in order to rationalize the high level of dipeptide cross-links in penicillin-resistant S. pneumoniae, with ligase MurM showing the major difference between penicillin-resistant and penicillin-sensitive strains.	[De Pascale, Gianfranco; Schouten, James A.; Bugg, Timothy D. H.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [De Pascale, Gianfranco; Lloyd, Adrian J.; Gilbey, Andrea M.; Roper, David I.; Dowson, Christopher G.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Bugg, TDH (corresponding author), Univ Warwick, Dept Chem, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	T.D.Bugg@warwick.ac.uk	Dowson, Chris/N-6195-2014; Roper, David I/A-2323-2011; Dowson, Christopher/ABG-5083-2021	Dowson, Chris/0000-0002-8294-8836; Roper, David I/0000-0003-0009-621X; Dowson, Christopher/0000-0002-8294-8836; Lloyd, Adrian/0000-0002-4638-4586	Medical Research Council [G0400848]; Wellcome Trust [066443]; Biotechnology and Biological Sciences Research Council; Medical Research Fund (University of Warwick); European Community Framework 6 COBRA; Medical Research Council [G0701400] Funding Source: researchfish; MRC [G0400848, G0701400] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Fund (University of Warwick); European Community Framework 6 COBRA(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0400848, Wellcome Trust Grant 066443, a Biotechnology and Biological Sciences Research Council studentship, the Medical Research Fund (University of Warwick), and the European Community Framework 6 COBRA network. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARCUS VA, 1995, FEMS MICROBIOL LETT, V126, P299, DOI 10.1016/0378-1097(95)00026-2; BERGERBACHI B, 1989, MOL GEN GENET, V219, P263; Biarrotte-Sorin S, 2004, STRUCTURE, V12, P257, DOI 10.1016/j.str.2004.01.006; Bouhss A, 2001, J BACTERIOL, V183, P5122, DOI 10.1128/JB.183.17.5122-5127.2001; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; BUGG T, 1999, COMPREHENSIVE NATURA, P241; El Zoeiby A, 2001, FEMS MICROBIOL LETT, V201, P229, DOI 10.1016/S0378-1097(01)00268-3; Filipe SR, 2000, J BIOL CHEM, V275, P27768; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Filipe SR, 2001, MICROB DRUG RESIST, V7, P303, DOI 10.1089/10766290152773310; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; Filipe SR, 2001, J BIOL CHEM, V276, P39618, DOI 10.1074/jbc.M106425200; Filipe SR, 2000, J BACTERIOL, V182, P6798, DOI 10.1128/JB.182.23.6798-6805.2000; GHUYSEN JM, 1968, BIOCHEMISTRY-US, V7, P1450, DOI 10.1021/bi00844a030; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Hegde SS, 2001, J BIOL CHEM, V276, P6998, DOI 10.1074/jbc.M008591200; Hegde SS, 2003, J BIOL CHEM, V278, P22861, DOI 10.1074/jbc.M301565200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Lee SK, 2005, APPL ENVIRON MICROB, V71, P6856, DOI 10.1128/AEM.71.11.6856-6862.2005; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Maillard AP, 2005, J BACTERIOL, V187, P3833, DOI 10.1128/JB.187.11.3833-3838.2005; MATSUHASHI M, 1965, P NATL ACAD SCI USA, V54, P587, DOI 10.1073/pnas.54.2.587; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000; PETIT JF, 1968, J BIOL CHEM, V243, P757; PLAPP R, 1970, J BIOL CHEM, V245, P3667; PROMEGA, 1996, PROTOCOLS APPL GUIDE; Reddy SG, 1999, J AM CHEM SOC, V121, P1175, DOI 10.1021/ja983850b; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Rohrer S, 2003, ANTIMICROB AGENTS CH, V47, P837, DOI 10.1128/AAC.47.3.837-846.2003; Sambrook J., 1989, MOL CLONING LAB MANU; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Smith AM, 2001, ANTIMICROB AGENTS CH, V45, P2393, DOI 10.1128/AAC.45.8.2393-2396.2001; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tschierske M, 1999, FEMS MICROBIOL LETT, V171, P97, DOI 10.1016/S0378-1097(98)00586-2; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999	41	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34571	34579		10.1074/jbc.M805807200	http://dx.doi.org/10.1074/jbc.M805807200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842590	Green Published, hybrid			2022-12-25	WOS:000261469100011
J	Dekker, J				Dekker, Job			Mapping in Vivo Chromatin Interactions in Yeast Suggests an Extended Chromatin Fiber with Regional Variation in Compaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER-ORDER STRUCTURE; CEREVISIAE LINKER HISTONE; LINKING NUMBER CHANGE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME CONFORMATION; NUCLEOSOMAL ARRAYS; H4-K16 ACETYLATION; MODEL; DNA; ARCHITECTURE	The higher order arrangement of nucleosomes and the level of compaction of the chromatin fiber play important roles in the control of gene expression and other genomic activities. Analysis of chromatin in vitro has suggested that under near physiological conditions chromatin fibers can become highly compact and that the level of compaction can be modulated by histone modifications. However, less is known about the organization of chromatin fibers in living cells. Here, we combine chromosome conformation capture (3C) data with distance measurements and polymer modeling to determine the in vivo mass density of a transcriptionally active 95-kb GC-rich domain on chromosome III of the yeast Saccharomyces cerevisiae. In contrast to previous reports, we find that yeast does not form a compact fiber but that chromatin is extended with a mass per unit length that is consistent with a rather loose arrangement of nucleosomes. Analysis of 3C data from a neighboring AT-rich chromosomal domain indicates that chromatin in this domain is more compact, but that mass density is still well below that of a canonical 30 nm fiber. Our approach should be widely applicable to scale 3C data to real spatial dimensions, which will facilitate the quantification of the effects of chromatin modifications and transcription on chromatin fiber organization.	[Dekker, Job] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Lazare Res Bldg,Rm 519,364 Plantat St, Worcester, MA 01605 USA.	Job.Dekker@umassmed.edu			National Institutes of Health [HG003143]; Keck Foundation; Cystic Fibrosis Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grant HG003143. This work was also supported by the Keck Foundation and the Cystic Fibrosis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ATHEY BD, 1990, J CELL BIOL, V111, P795, DOI 10.1083/jcb.111.3.795; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Belmont AS, 1999, CURR OPIN CELL BIOL, V11, P307, DOI 10.1016/S0955-0674(99)80041-6; Ben-Aroya S, 2004, MOL CELL, V15, P221, DOI 10.1016/j.molcel.2004.06.002; Bressan DA, 2004, J CELL BIOL, V164, P361, DOI 10.1083/jcb.200311063; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r116; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; Freidkin I, 2001, NUCLEIC ACIDS RES, V29, P4043, DOI 10.1093/nar/29.19.4043; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gheldof N, 2006, P NATL ACAD SCI USA, V103, P12463, DOI 10.1073/pnas.0605343103; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Kepper N, 2008, BIOPHYS J, V95, P3692, DOI 10.1529/biophysj.107.121079; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Marin A, 2003, YEAST, V20, P703, DOI 10.1002/yea.992; McBryant SJ, 2008, MOL CELL BIOL, V28, P3563, DOI 10.1128/MCB.01389-07; MIELE A, 2006, CURRENT PROTOCOLS MO, V74; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; NORTON VG, 1990, J BIOL CHEM, V265, P19848; OSTASHEVSKY JY, 1994, J BIOMOL STRUCT DYN, V11, P813, DOI 10.1080/07391102.1994.10508034; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Rydberg B, 1998, J MOL BIOL, V284, P71, DOI 10.1006/jmbi.1998.2150; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon P, 2002, EMBO J, V21, P2282, DOI 10.1093/emboj/21.9.2282; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; van Holde KE., 1989, SPRINGER SERIES MOL; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; VANHOLDE K, 1995, J BIOL CHEM, V270, P8373, DOI 10.1074/jbc.270.15.8373; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Wedemann G, 2002, BIOPHYS J, V82, P2847, DOI 10.1016/S0006-3495(02)75627-0; WIDOM J, 1989, ANNU REV BIOPHYS BIO, V18, P365, DOI 10.1146/annurev.biophys.18.1.365; Wolffe A., 1998, CHROMATIN STRUCTURE; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; WOODCOCK CL, 1995, TRENDS CELL BIOL, V5, P272, DOI 10.1016/S0962-8924(00)89038-8; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; Wu CY, 2007, EMBO REP, V8, P1129, DOI 10.1038/sj.embor.7401115; Yokota H, 1997, CHROMOSOME RES, V5, P157, DOI 10.1023/A:1018438729203	62	108	109	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34532	34540		10.1074/jbc.M806479200	http://dx.doi.org/10.1074/jbc.M806479200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930918	hybrid, Green Published			2022-12-25	WOS:000261469100007
J	Yamada, K; Hashimoto, T; Yabuki, C; Nagae, Y; Tachikawa, M; Strickland, DK; Liu, Q; Bu, G; Basak, JM; Holtzman, DM; Ohtsuki, S; Terasaki, T; Iwatsubo, T				Yamada, Kaoru; Hashimoto, Tadafumi; Yabuki, Chiori; Nagae, Yusuke; Tachikawa, Masanori; Strickland, Dudley K.; Liu, Qiang; Bu, Guojun; Basak, Jacob M.; Holtzman, David M.; Ohtsuki, Sumio; Terasaki, Tetsuya; Iwatsubo, Takeshi			The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid beta Peptides in an in Vitro Model of the Blood-Brain Barrier Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; ALPHA-2-MACROGLOBULIN RECEPTOR; PRECURSOR PROTEIN; PLASMINOGEN-ACTIVATOR; LIGAND-BINDING; CLEARANCE; ALPHA(2)-MACROGLOBULIN; DEGRADATION; TRANSPORT	The metabolism of amyloid beta peptide (A beta) in the brain is crucial to the pathogenesis of Alzheimer disease. A body of evidence suggests that A beta is actively transported from brain parenchyma to blood across the blood-brain barrier (BBB), although the precise mechanism remains unclear. To unravel the cellular and molecular mechanism of A beta transport across the BBB, we established a new in vitro model of the initial internalization step of A beta transport using TR-BBB cells, a conditionally immortalized endothelial cell line from rat brain. We show that TR-BBB cells rapidly internalize A beta through a receptor-mediated mechanism. We also provide evidence that A beta internalization is mediated by LRP1 (low density lipoprotein receptor-related protein 1), since administration of LRP1 antagonist, receptor-associated protein, neutralizing antibody, or small interference RNAs all reduced A beta uptake. Despite the requirement of LRP1-dependent internalization, A beta does not directly bind to LRP1 in an in vitro binding assay. Unlike TR-BBB cells, mouse embryonic fibroblasts endogenously expressing functional LRP1 and exhibiting the authentic LRP1-mediated endocytosis (e.g. of tissue plasminogen activator) did not show rapid A beta uptake. Based on these data, we propose that the rapid LRP1-dependent internalization of A beta occurs under the BBB-specific cellular context and that TR-BBB is a useful tool for analyzing the molecular mechanism of the rapid transport of A beta across BBB.	[Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, Tokyo 1130033, Japan; [Yamada, Kaoru; Hashimoto, Tadafumi; Yabuki, Chiori; Nagae, Yusuke; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neurosci, Tokyo 1130033, Japan; [Hashimoto, Tadafumi; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan; [Tachikawa, Masanori; Ohtsuki, Sumio; Terasaki, Tetsuya] Tohoku Univ, Dept Mol Biopharm & Genet, Sendai, Miyagi 980, Japan; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Liu, Qiang; Bu, Guojun] Washington Univ, Sch Med, Dept Pediat Cell Biol & Physiol, St Louis, MO 63110 USA; [Basak, Jacob M.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University of Tokyo; University of Tokyo; University of Tokyo; Tohoku University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL); Washington University (WUSTL)	Iwatsubo, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iwatsubo@mol.f.u-tokyo.ac.jp	Ohtsuki, Sumio/S-4360-2016; Yamada, Kaoru/GSD-3923-2022; Terasaki, Tetsuya/K-6730-2012; Liu, Qiang/E-9245-2011; Hashimoto, Tadafumi/A-7723-2013	Ohtsuki, Sumio/0000-0003-4634-7133; Yamada, Kaoru/0000-0003-3696-0604; Terasaki, Tetsuya/0000-0002-6332-7575; Hashimoto, Tadafumi/0000-0001-5442-4800	National Institutes of Health [R01 AG027924, AG13956]; Core Research for Evolutional Science and Technology of Japan Science and Technology agency; National Institute of Biomedical Innovation; Japan Society for the Promotion of Science; Takeda Science Foundation; NATIONAL INSTITUTE ON AGING [R01AG013956, R01AG027924, R37AG013956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Research for Evolutional Science and Technology of Japan Science and Technology agency(Core Research for Evolutional Science and Technology (CREST)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG027924 (to G. B.) and AG13956 (to D. H.). This work was also supported by Core Research for Evolutional Science and Technology of Japan Science and Technology agency, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by grants-in-aid from the Japan Society for the Promotion of Science (to T. H. and K. Y.) and from the Takeda Science Foundation (to K. Y.), Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; BU GJ, 1993, J BIOL CHEM, V268, P13002; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; Hosoya K, 2000, J DRUG TARGET, V8, P357, DOI 10.3109/10611860008997912; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Lee SH, 2006, J BIOCHEM, V139, P391, DOI 10.1093/jb/mvj039; LEVEUGLE B, 1994, NEUROREPORT, V5, P1389, DOI 10.1097/00001756-199406000-00025; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Narita M, 1997, J NEUROCHEM, V69, P1904; NAZER B, 2008, J NEUROBIOL, V30, P94; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Sarafanov AG, 2001, J BIOL CHEM, V276, P11970, DOI 10.1074/jbc.M008046200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shiiki T, 2004, J NEUROSCI, V24, P9632, DOI 10.1523/JNEUROSCI.2236-04.2004; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tanabe S, 1999, J PHARMACOL EXP THER, V290, P561; Terasaki T, 2001, BIOL PHARM BULL, V24, P111, DOI 10.1248/bpb.24.111; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WILLNOW TE, 1994, J CELL SCI, V107, P719; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yazawa H, 2001, FASEB J, V15, P2454, DOI 10.1096/fj.01-0251com; Ziere GJ, 1996, EUR J BIOCHEM, V242, P703, DOI 10.1111/j.1432-1033.1996.0703r.x; ZLOKOVIC BV, 1995, PHARM RES-DORDR, V12, P1395, DOI 10.1023/A:1016254514167	55	87	90	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34554	34562		10.1074/jbc.M801487200	http://dx.doi.org/10.1074/jbc.M801487200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940800	Green Published, hybrid			2022-12-25	WOS:000261469100009
J	Wang, N; Glidden, EJ; Murphy, SR; Pearse, BR; Hebert, DN				Wang, Ning; Glidden, Emily J.; Murphy, Stephanie R.; Pearse, Bradley R.; Hebert, Daniel N.			The Cotranslational Maturation Program for the Type II Membrane Glycoprotein Influenza Neuraminidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; SECRETORY PATHWAY; UDP-GLC; VIRUS HEMAGGLUTININ; PROTEIN MATURATION; LIVING CELLS; CALNEXIN; GLUCOSYLTRANSFERASE	The earliest steps in nascent protein maturation greatly affect its overall efficiency. Constraints placed on maturing proteins at these early stages limit available conformations and help to direct the native maturation process. For type II membrane proteins, these cotranslational constraints include N- and C- terminal membrane tethering, chaperone binding, and disulfide bond formation. The cotranslational maturation process for the type II membrane glycoprotein influenza neuraminidase (NA) was investigated to provide a deeper understanding of these initial endoplasmic reticulum events. The type II orientation provides experimental advantages to monitor the first maturation steps. Calnexin was shown to cotranslationally interact with NA prior to calreticulin. These interactions were required for the efficient maturation of NA as it prematurely formed intramolecular disulfides and aggregated when calnexin and calreticulin interactions were abolished. Lectin chaperone binding slowed the NA maturation process, increasing its fidelity. Carbohydrates were required for NA maturation in a regio-specific manner. A subset of NA formed intermolecular disulfides and oligomerized cotranslationally. This fraction increased in the absence of calnexin and calreticulin binding. NA dimerization also occurred for an NA mutant lacking the critical large loop disulfide bond, indicating that dimerization did not require proper NA oxidation. The strict evaluation of proper maturation carried out by the quality control machinery was instilled at the tetramerization step. This study illustrates the type II membrane protein maturation process and shows how important cotranslational events contribute to the proper cellular maturation of glycoproteins.	[Wang, Ning; Glidden, Emily J.; Murphy, Stephanie R.; Pearse, Bradley R.; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Wang, Ning; Pearse, Bradley R.; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hebert, DN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	dhebert@biochem.umass.edu			National Institutes of Health Chemistry-Biology Interface [T32GM00815]; U. S. Public Health Service [CA79864]; NATIONAL CANCER INSTITUTE [R01CA079864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515] Funding Source: NIH RePORTER	National Institutes of Health Chemistry-Biology Interface(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Chemistry-Biology Interface Training Grant T32GM00815 (to B. R. P.). This work was also supported by U. S. Public Health Service Grant CA79864 (to D. N. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Braakman I, 2000, TRAFFIC, V1, P533, DOI 10.1034/j.1600-0854.2000.010702.x; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; Chen W, 2000, MOL BIOL CELL, V11, P765, DOI 10.1091/mbc.11.2.765; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; COLMAN PM, 1985, CURR TOP MICROBIOL I, V114, P178; COLMAN PM, 1989, INFLUENZA VIRUSES, P175; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gilmore R, 1996, EMBO J, V15, P2651, DOI 10.1002/j.1460-2075.1996.tb00625.x; GILMORE R, 1991, METHOD CELL BIOL, V34, P223; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; KUNDU A, 1991, MOL CELL BIOL, V11, P2675, DOI 10.1128/MCB.11.5.2675; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MUNK K, 1992, GLYCOBIOLOGY, V2, P233, DOI 10.1093/glycob/2.3.233; NILSSON I, 1993, J BIOL CHEM, V268, P5798; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pearse BR, 2008, J CELL BIOL, V181, P309, DOI 10.1083/jcb.200712068; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Taylor SC, 2003, EMBO REP, V4, P405, DOI 10.1038/sj.embor.embor797; TULIP WR, 1991, J MOL BIOL, V221, P487, DOI 10.1016/0022-2836(91)80069-7; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2	55	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33826	33837		10.1074/jbc.M806897200	http://dx.doi.org/10.1074/jbc.M806897200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18849342	Green Published, hybrid			2022-12-25	WOS:000261277700006
J	Gao, MH; Tang, T; Guo, T; Miyanohara, A; Yajima, T; Pestonjamasp, K; Feramisco, JR; Hammond, HK				Gao, Mei Hua; Tang, Tong; Guo, Tracy; Miyanohara, Atsushi; Yajima, Toshitaka; Pestonjamasp, Kersi; Feramisco, James R.; Hammond, H. Kirk			Adenylyl Cyclase Type VI Increases Akt Activity and Phospholamban Phosphorylation in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; ENHANCED MYOCARDIAL-CONTRACTILITY; FORKHEAD TRANSCRIPTION FACTORS; ISCHEMIA-REPERFUSION INJURY; RAT VENTRICULAR MYOCYTES; II INHIBITION PROTECTS; SARCOPLASMIC-RETICULUM; TRANSGENIC MICE; HEART-FAILURE; BETA(1)-ADRENERGIC RECEPTOR	Increased expression of adenylyl cyclase VI has beneficial effects on the heart, but strategies that increase cAMP production in cardiac myocytes usually are harmful. Might adenylyl cyclase VI have beneficial effects unrelated to increased beta-adrenergic receptor-mediated signaling? We previously reported that adenylyl cyclase VI reduces cardiac phospholamban expression. Our focus in the current studies is how adenylyl cyclase VI influences phospholamban phosphorylation. In cultured cardiac myocytes, increased expression of adenylyl cyclase VI activates Akt by phosphorylation at serine 473 and threonine 308 and is associated with increased nuclear phospho-Akt. Activated Akt phosphorylates phospholamban, a process that does not require beta-adrenergic receptor stimulation or protein kinase A activation. These previously unrecognized signaling events would be predicted to promote calcium handling and increase contractile function of the intact heart independently of beta-adrenergic receptor activation. We speculate that phospholamban phosphorylation, through activation of Akt, may be an important mechanism by which adenylyl cyclase VI increases the function of the failing heart.	[Gao, Mei Hua; Tang, Tong; Hammond, H. Kirk] Vet Adm San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Gao, Mei Hua; Tang, Tong; Guo, Tracy; Miyanohara, Atsushi; Yajima, Toshitaka; Pestonjamasp, Kersi; Feramisco, James R.; Hammond, H. Kirk] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Miyanohara, Atsushi; Pestonjamasp, Kersi; Feramisco, James R.] Univ Calif San Diego, Canc Ctr Microscopy Shared Resource, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hammond, HK (corresponding author), VASDHS III A, 3-A,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	khammond@ucsd.edu		Pestonjamasp, Kersi/0000-0001-8586-303X	National Institutes of Health [5P01HL066941, HL081741, HL088426-01]; American Heart Association [0865147F]; Department of Veterans Affairs;  [0765064Y]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081741, R01HL088426, P01HL066941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P01HL066941, HL081741, and HL088426-01 ( to H. K. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1 Supported by Grant-In-Aid 0765064Y.; 2 Supported by Grant-In-Aid 0865147F from the Western States Affiliate of the American Heart Association.; 3 Supported by a Merit grant from the Department of Veterans Affairs.	Ahmet I, 2004, CIRCULATION, V110, P1083, DOI 10.1161/01.CIR.0000139844.15045.F9; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Allen BG, 1996, MOL CELL BIOCHEM, V155, P91; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Babu CVS, 2005, ELECTROPHORESIS, V26, P3765, DOI [10.1002/elps.20050007, 10.1002/elps.200500007]; Bartel S, 2000, J MOL CELL CARDIOL, V32, P2173, DOI 10.1006/jmcc.2000.1243; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Breitenlechner CB, 2005, J MED CHEM, V48, P163, DOI 10.1021/jm049701n; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Engelhardt S, 2001, MOL PHARMACOL, V60, P712; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; FUJII J, 1989, J BIOL CHEM, V264, P12950; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Fukunaga K, 2005, J PHARMACOL SCI, V98, P205, DOI 10.1254/jphs.FMJ05001X3; Gao MH, 2004, J BIOL CHEM, V279, P38797, DOI 10.1074/jbc.M405701200; Gao MH, 1998, P NATL ACAD SCI USA, V95, P1038, DOI 10.1073/pnas.95.3.1038; Gao MH, 1999, CIRCULATION, V99, P1618, DOI 10.1161/01.CIR.99.12.1618; Gao MH, 2002, CARDIOVASC RES, V56, P197, DOI 10.1016/S0008-6363(02)00539-4; Gao YS, 2002, EUR J PHARMACOL, V436, P227, DOI 10.1016/S0014-2999(02)01261-X; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Ibrahimi A, 1999, AM J PHYSIOL-CELL PH, V276, pC487, DOI 10.1152/ajpcell.1999.276.2.C487; Ishikawa Y, 1997, CIRC RES, V80, P297, DOI 10.1161/01.RES.80.3.297; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kaliman P, 2005, J BIOL CHEM, V280, P8016, DOI 10.1074/jbc.M412845200; Kim D, 2002, J BIOCHEM MOL BIOL, V35, P106; Kudlacek O, 2001, J BIOL CHEM, V276, P3010, DOI 10.1074/jbc.M007910200; LAI NC, 2005, CIRCULATION S, V112, P64; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Ogata Y, 2003, DRUG NEWS PERSPECT, V16, P446, DOI 10.1358/dnp.2003.16.7.829356; Onda T, 2001, J BIOL CHEM, V276, P47785, DOI 10.1074/jbc.M107233200; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; RAEYMAEKERS L, 1988, BIOCHEM J, V252, P269, DOI 10.1042/bj2520269; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Roth DM, 2002, CIRCULATION, V105, P1989, DOI 10.1161/01.CIR.0000014968.54967.D3; Roth DM, 1999, CIRCULATION, V99, P3099, DOI 10.1161/01.CIR.99.24.3099; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; SIBLEY DR, 1987, MOL NEUROBIOL, V1, P121, DOI 10.1007/BF02935266; TADA M, 1979, J BIOL CHEM, V254, P319; TADA M, 1980, J BIOL CHEM, V255, P1985; Tang T, 2004, AM J PHYSIOL-HEART C, V287, pH1906, DOI 10.1152/ajpheart.00356.2004; Tsujita Y, 2006, P NATL ACAD SCI USA, V103, P11946, DOI 10.1073/pnas.0510138103; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Vittone L, 2008, FRONT BIOSCI-LANDMRK, V13, P5988, DOI 10.2741/3131; Woods YL, 2002, BIOCHEM SOC T, V30, P391, DOI 10.1042/bst0300391; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang QH, 2005, CELL CALCIUM, V37, P259, DOI 10.1016/j.ceca.2004.10.007; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005	61	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33527	33535		10.1074/jbc.M805825200	http://dx.doi.org/10.1074/jbc.M805825200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838385	hybrid, Green Published			2022-12-25	WOS:000261183700057
J	Li, YH; Werner, H; Puschel, AW				Li, Ying-Hua; Werner, Hendrikje; Pueschel, Andreas W.			Rheb and mTOR Regulate Neuronal Polarity through Rap1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LOCALIZATION; CAP-DEPENDENT TRANSLATION; UBIQUITIN LIGASE SMURF2; CELL-GROWTH; ACTIN CYTOSKELETON; AXON PROJECTIONS; TOR COMPLEX-2; DIRECT TARGET; ESTABLISHMENT; PROTEIN	The development of polarized hippocampal neurons with a single axon and multiple dendrites depends on the activity of phosphoinositide 3-kinase (PI3K) and the GTPase Rap1B. Here we show that PI3K regulates axon specification and elongation through the GTPase Rheb and its target mammalian target of rapamycin (mTOR). Overexpression of Rheb induces the formation of multiple axons, whereas its suppression by RNA interference blocks axon specification. mTOR is a central regulator of translation that phosphorylates eIF4E-binding proteins like 4E-BP1. Axon formation was suppressed by inhibition of mTOR and expression of mTOR-insensitive 4E-BP1 mutants. Inhibition of PI3K or mTOR reduced the level of Rap1B, which acts downstream of Rheb and mTOR. The ubiquitin E3 ligase Smurf2 mediates the restriction of Rap1B by initiating its degradation. Suppression of Smruf2 by RNA interference is able to compensate the loss of Rheb. These results indicate that the mTOR pathway is required to counteract the Smurf2-initiated degradation of Rap1B during the establishment of neuronal polarity.	[Li, Ying-Hua; Werner, Hendrikje; Pueschel, Andreas W.] Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, D-48149 Munster, Germany	University of Munster	Puschel, AW (corresponding author), Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, Schlosspl 5, D-48149 Munster, Germany.	apuschel@uni-muenster.de			Deutsche Forschungsgemeinschaft [SPP1111, SFB 629]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SPP1111 and SFB 629 (to A.W.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Blackshear PJ, 1997, J BIOL CHEM, V272, P31510, DOI 10.1074/jbc.272.50.31510; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Catalano SM, 1998, MOL CELL NEUROSCI, V11, P173, DOI 10.1006/mcne.1998.0687; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gartner A, 2006, J CELL SCI, V119, P3927, DOI 10.1242/jcs.03159; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Huang YS, 2004, CURR OPIN CELL BIOL, V16, P308, DOI 10.1016/j.ceb.2004.03.002; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oinuma I, 2007, J BIOL CHEM, V282, P303, DOI 10.1074/jbc.M607979200; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Tabata H, 2003, J NEUROSCI, V23, P9996; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, MOL CELL BIOL, V22, P1674, DOI 10.1128/MCB.22.6.1674-1683.2002; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; White FA, 2000, DEV BIOL, V225, P79, DOI 10.1006/dbio.2000.9822; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	70	56	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33784	33792		10.1074/jbc.M802431200	http://dx.doi.org/10.1074/jbc.M802431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18842593	Green Published, hybrid			2022-12-25	WOS:000261183700084
J	Prouzet-Mauleon, V; Lefebvre, F; Thoraval, D; Crouzet, M; Doignon, F				Prouzet-Mauleon, Valerie; Lefebvre, Fabien; Thoraval, Didier; Crouzet, Marc; Doignon, Francois			Phosphoinositides Affect both the Cellular Distribution and Activity of the F-BAR-containing RhoGAP Rgd1p in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; RAS SUPERFAMILY GENES; FAMILY SMALL GTPASES; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; MEMBRANE INVAGINATION; DOMAIN PROTEINS; PLASMA-MEMBRANE; BUD FORMATION; LOW-PH	Cell polarity is a key element of development in most eukaryotes. The Rho GTPase-activating protein Rgd1p positively regulates the GTPase activity of Rho3p and Rho4p, which are involved in bud growth and cytokinesis, respectively, in the budding yeast Saccharomyces cerevisiae. Rgd1p contains an F-BAR domain at its N-terminal end in addition to its RhoGAP domain at its C-terminal end. We demonstrate here that phospholipids discriminate between the GTPase activities of Rho3p and Rho4p through Rgd1p and specifically stimulate the RhoGAP activity on Rho4p. The central region of the protein contiguous to the F-BAR domain is required for this stimulation. The F-BAR region binds to phosphoinositides in vitro and also plays a key role in the localization of Rgd1p to the bud tip and neck during the cell cycle. Studies of heat-sensitive mutants lacking phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-biphosphate suggested that Rgd1p initially binds to Golgi membranes via phosphatidylinositol 4-phosphate and is then transported to the plasma membrane, where it binds phosphatidylinositol 4,5-biphosphate. We demonstrate here the dual effects of phosphoinositides on a RhoGTPase-activating protein. Phosphoinositides both regulate the recruitment and trafficking of Rgd1p to membranes via the F-BAR domain and specifically stimulate GTPase-activating protein activity, consistent with functional interplay between lipids, RhoGAP, and its related GTPases in yeast growth.	Univ Bordeaux, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France; CNRS, UMR 5095, F-33076 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Doignon, F (corresponding author), Univ Bordeaux 2, Box 64,146 Rue Leo Saignat, F-33076 Bordeaux, France.	doignon@u-bordeaux2.fr	DOIGNON, François/AAX-8788-2020	DOIGNON, François/0000-0002-9007-2408; Prouzet-Mauleon, Valerie/0000-0001-5432-6231	CNRS; UB2; Vytas Bankaitis (University of North Carolina, Chapel Hill); Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union [2003227]	CNRS(Centre National de la Recherche Scientifique (CNRS)); UB2; Vytas Bankaitis (University of North Carolina, Chapel Hill); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union(European Commission)	This work was supported by CNRS and UB2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; We thank Marco Geymonat and Steve Sedgwick (National Institute for Medical Research, London) for providing the plasmid and the yeast strain for optimized protein production in yeast. We thank Isabelle Sagot for providing the pRS305-3xGFP and for assistance with microscopy. The heat-sensitive strains AAY104, SEY6210, and AAY202 were generously provided by Chris Stefan (University of California, San Diego), and strain CTY1568 was obtained from Vytas Bankaitis (University of North Carolina, Chapel Hill). We thank Erzsebet Ligeti (Semmelweis University, Budapest) for receiving VPM in her laboratory and Magdolna Levay for kind help. DNA sequencing was performed at the Genotyping and Sequencing Facility of the University of Bordeaux (supported by Conseil Regional d'Aquitaine Grants 20030304002FA and 20040305003FA and European Union Grant FEDER 2003227).	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; AHMED S, 1995, METHOD ENZYMOL, V256, P114; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; de Bettignies G, 2001, GENETICS, V159, P1435; De Bettignies G, 1999, YEAST, V15, P1719, DOI 10.1002/(SICI)1097-0061(199912)15:16<1719::AID-YEA499>3.0.CO;2-F; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doignon F, 1999, FEBS LETT, V459, P458, DOI 10.1016/S0014-5793(99)01293-4; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Fernandes H, 2006, MICROBIOL-SGM, V152, P695, DOI 10.1099/mic.0.28231-0; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gatti X, 2005, GENE, V351, P159, DOI 10.1016/j.gene.2005.03.034; Geymonat M, 2007, GENE, V399, P120, DOI 10.1016/j.gene.2007.05.001; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Heath RJW, 2008, J CELL SCI, V121, P1054, DOI 10.1242/jcs.021113; Imai J, 1996, GENETICS, V142, P359; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Ligeti E, 2006, METHOD ENZYMOL, V406, P104, DOI 10.1016/S0076-6879(06)06009-5; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; MATSUI Y, 1992, GENE, V114, P43, DOI 10.1016/0378-1119(92)90705-T; MATSUI Y, 1992, MOL CELL BIOL, V12, P5690, DOI 10.1128/MCB.12.12.5690; Molnar G, 2001, BIOCHEMISTRY-US, V40, P10542, DOI 10.1021/bi011158e; Moskwa P, 2005, J BIOL CHEM, V280, P6716, DOI 10.1074/jbc.M412563200; Motizuki M, 2008, BBA-GEN SUBJECTS, V1780, P179, DOI 10.1016/j.bbagen.2007.10.003; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Rose MD., 1990, METHODS YEAST GENETI; Roumanie O, 2000, MOL MICROBIOL, V36, P1403, DOI 10.1046/j.1365-2958.2000.01958.x; Roumanie O, 2005, J CELL BIOL, V170, P583, DOI 10.1083/jcb.200504108; Roumanie O, 2002, CURR GENET, V40, P317, DOI 10.1007/s00294-001-0268-5; Roumanie O, 2001, FEBS LETT, V506, P149, DOI 10.1016/S0014-5793(01)02906-4; Routt SM, 2005, TRAFFIC, V6, P1157, DOI 10.1111/j.1600-0854.2005.00350.x; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; VAN AL, 1997, GENE DEV, V11, P2295; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	56	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33249	33257		10.1074/jbc.M805161200	http://dx.doi.org/10.1074/jbc.M805161200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18845541	Green Published, hybrid			2022-12-25	WOS:000261183700028
J	Sato, T; Ananda, K; Cheng, CI; Suh, EJ; Narayanan, S; Wolfe, MS				Sato, Toru; Ananda, Kuppanna; Cheng, Cathy I.; Suh, Eric J.; Narayanan, Saravanakumar; Wolfe, Michael S.			Distinct Pharmacological Effects of Inhibitors of Signal Peptide Peptidase and gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTRAMEMBRANE PROTEOLYSIS; ASPARTIC PROTEASE; ACTIVE-SITE; ALZHEIMERS-DISEASE; BINDING SITE; PRESENILIN; SUBSTRATE; COMPLEX; ENDOPROTEOLYSIS	Signal peptide peptidase (SPP) and gamma-secretase are intramembrane aspartyl proteases that bear similar active site motifs but with opposite membrane topologies. Both proteases are inhibited by the same aspartyl protease transition-state analogue inhibitors, further evidence that these two enzymes have the same basic cleavage mechanism. Here we report that helical peptide inhibitors designed to mimic SPP substrates and interact with the SPP initial substrate-binding site (the "docking site") inhibit both SPP and gamma-secretase, but with submicromolar potency for SPP. SPP was labeled by helical peptide and transition-state analogue affinity probes but at distinct sites. Nonsteroidal anti-inflammatory drugs, which shift the site of proteolysis by SPP and gamma-secretase, did not affect the labeling of SPP or gamma-secretase by the helical peptide or transition-state analogue probes. On the other hand, another class of previously reported gamma-secretase modulators, naphthyl ketones, inhibited SPP activity as well as selective proteolysis by gamma-secretase. These naphthyl ketones significantly disrupted labeling of SPP by the helical peptide probe but did not block labeling of SPP by the transition-state analogue probe. With respect to gamma-secretase, the naphthyl ketone modulators allowed labeling by the transition-state analogue probe but not the helical peptide probe. Thus, the naphthyl ketones appear to alter the docking sites of both SPP and gamma-secretase. These results indicate that pharmacological effects of the four different classes of inhibitors (transition-state analogues, helical peptides, nonsteroidal anti-inflammatory drugs, and naphthyl ketones) are distinct from each other, and they reveal similarities and differences with how they affect SPP and gamma-secretase.	[Wolfe, Michael S.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, MS (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu			National Institutes of Health [GM79555, NS41355, AG17574]; Uehara Memorial Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM79555, NS41355, and AG17574 ( to M. S. W.). This work was also supported by a research fellowship from the Uehara Memorial Foundation ( to T. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Bihel F, 2004, J MED CHEM, V47, P3931, DOI 10.1021/jm049788c; Brown GR, 2000, BIOORG MED CHEM LETT, V10, P575, DOI 10.1016/S0960-894X(00)00051-2; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; KARLE IL, 1990, BIOCHEMISTRY-US, V29, P6747, DOI 10.1021/bi00481a001; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TOMITA T, 2007, ARCH PHARM, V377, P295; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	38	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33287	33295		10.1074/jbc.M805670200	http://dx.doi.org/10.1074/jbc.M805670200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829463	Green Published, hybrid			2022-12-25	WOS:000261183700032
J	Bonnet, E; Touyarot, K; Alfos, S; Pallet, V; Higueret, P; Abrous, DN				Bonnet, Emilie; Touyarot, Katia; Alfos, Serge; Pallet, Veronique; Higueret, Paul; Abrous, Djoher Nora			Retinoic Acid Restores Adult Hippocampal Neurogenesis and Reverses Spatial Memory Deficit in Vitamin A Deprived Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DIFFERENTIAL EXPRESSION; HYPO-EXPRESSION; RECEPTORS; NEURONS; GROWTH; INDUCTION; SURVIVAL; BRAIN; ONSET	A dysfunction of retinoid hippocampal signaling pathway has been involved in the appearance of affective and cognitive disorders. However, the underlying neurobiological mechanisms remain unknown. Hippocampal granule neurons are generated throughout life and are involved in emotion and memory. Here, we investigated the effects of vitamin A deficiency (VAD) on neurogenesis and memory and the ability of retinoic acid (RA) treatment to prevent VAD-induced impairments. Adult retinoid-deficient rats were generated by a vitamin A-free diet from weaning in order to allow a normal development. The effects of VAD and/or RA administration were examined on hippocampal neurogenesis, retinoid target genes such as neurotrophin receptors and spatial reference memory measured in the water maze. Long-term VAD decreased neurogenesis and led to memory deficits. More importantly, these effects were reversed by 4 weeks of RA treatment. These beneficial effects may be in part related to an up-regulation of retinoid-mediated molecular events, such as the expression of the neurotrophin receptor TrkA. We have demonstrated for the first time that the effect of vitamin A deficient diet on the level of hippoccampal neurogenesis is reversible and that RA treatment is important for the maintenance of the hippocampal plasticity and function.	[Bonnet, Emilie; Touyarot, Katia; Alfos, Serge; Pallet, Veronique; Higueret, Paul] Univ Bordeaux 1, Nutr & Neurosci Lab, F-33405 Talence, France; [Bonnet, Emilie; Touyarot, Katia; Alfos, Serge; Pallet, Veronique; Higueret, Paul; Abrous, Djoher Nora] Univ Bordeaux 2, F-33076 Bordeaux, France; [Abrous, Djoher Nora] Bordeaux Neurosci Res Ctr, INSERM 862, Neurogenesis & Pathophysiol Lab, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bonnet, E (corresponding author), Univ Bordeaux 1, Nutr & Neurosci Lab, F-33405 Talence, France.	k.touyarot@istab.u-bordeaux1.fr	Abrous, Nora-Djoher/N-6977-2017	abrous, nora/0000-0002-8589-305X; ALFOS, Serge/0000-0001-7092-4370	University of Bordeaux 1; University of Bordeaux 2; Conseil Regional d'Aquitaine; French National Institute Of Health and Medical Research (INSERM)	University of Bordeaux 1; University of Bordeaux 2; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); French National Institute Of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by University of Bordeaux 1 and Bordeaux 2, the Conseil Regional d'Aquitaine and the French National Institute Of Health and Medical Research (INSERM).	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ABROUS DN, 2008, NEUROGENESIS HIPPOCA, P445; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Bremmer JD, 2008, PROG NEURO-PSYCHOPH, V32, P315, DOI 10.1016/j.pnpbp.2007.07.001; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Carta M, 2006, NEUROSCIENCE, V139, P1163, DOI 10.1016/j.neuroscience.2006.01.027; Cellerino A, 1996, NEUROSCIENCE, V70, P613, DOI 10.1016/S0306-4522(96)83001-6; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Crandall J, 2004, P NATL ACAD SCI USA, V101, P5111, DOI 10.1073/pnas.0306336101; Drager UC, 1997, PROG RETIN EYE RES, V16, P323, DOI 10.1016/S1350-9462(96)00029-8; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; DUPRET D, 2008, PLOSONE IN PRESS; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eichenbaum H, 1999, BEHAV BRAIN RES, V103, P123, DOI 10.1016/S0166-4328(99)00044-3; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Feart C, 2005, NEUROBIOL AGING, V26, P729, DOI 10.1016/j.neurobiolaging.2004.06.004; Ferguson SA, 2007, NEUROTOXICOL TERATOL, V29, P219, DOI 10.1016/j.ntt.2006.10.008; Frielingsdorf H, 2007, NEUROBIOL DIS, V26, P47, DOI 10.1016/j.nbd.2006.11.015; Goodman AB, 1998, P NATL ACAD SCI USA, V95, P7240, DOI 10.1073/pnas.95.13.7240; Goodman AB, 2003, P NATL ACAD SCI USA, V100, P2901, DOI 10.1073/pnas.0437937100; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Haskell GT, 2005, J NEUROSCI, V25, P7636, DOI 10.1523/JNEUROSCI.0485-05.2005; Hellweg R, 1997, MOL BRAIN RES, V45, P177, DOI 10.1016/S0169-328X(96)00310-5; HOLST A, 1997, EUR J NEUROSCI, V9, P2169; Husson M, 2004, MOL BRAIN RES, V123, P7, DOI 10.1016/j.molbrainres.2003.12.012; Husson M, 2006, NEUROBIOL DIS, V23, P1, DOI 10.1016/j.nbd.2006.01.008; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; KIM YW, 1994, J BIOCHEM TOXICOL, V9, P225, DOI 10.1002/jbt.2570090502; Klein RL, 2000, BRAIN RES, V875, P144, DOI 10.1016/S0006-8993(00)02634-2; KOBAYASHI M, 1994, FEBS LETT, V356, P60, DOI 10.1016/0014-5793(94)01238-5; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Krugers HJ, 2007, SYNAPSE, V61, P221, DOI 10.1002/syn.20359; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; LECLERCQ M, 1981, REV I PASTEUR LYON, V14, P475; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; McCaffery P, 2000, CYTOKINE GROWTH F R, V11, P233, DOI 10.1016/S1359-6101(00)00002-2; McCaffery PJ, 2003, EUR J NEUROSCI, V18, P457, DOI 10.1046/j.1460-9568.2003.02765.x; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; Mey J, 2006, J NEUROBIOL, V66, P757, DOI 10.1002/neu.20238; Mingaud F, 2008, J NEUROSCI, V28, P279, DOI 10.1523/JNEUROSCI.4065-07.2008; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; Palha JA, 2006, BRAIN RES REV, V51, P61, DOI 10.1016/j.brainresrev.2005.10.001; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; RODRIGUEZTEBAR A, 1991, DEVELOPMENT, V112, P813; Russell RM, 2000, AM J CLIN NUTR, V71, P878; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sommer A, 1995, VITAMIN A DEFICIENCY, V3rd; Stancampiano R, 2007, NEUROREPORT, V18, P241, DOI 10.1097/WNR.0b013e3280115c0c; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang TW, 2005, DEVELOPMENT, V132, P2721, DOI 10.1242/dev.01867; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Xie P, 1997, NEUROREPORT, V8, P1067, DOI 10.1097/00001756-199703240-00001; Zetterstrom RH, 1999, EUR J NEUROSCI, V11, P407, DOI 10.1046/j.1460-9568.1999.00444.x; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562	70	88	94	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3487	10.1371/journal.pone.0003487	http://dx.doi.org/10.1371/journal.pone.0003487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941534	Green Published, Green Submitted, gold			2022-12-25	WOS:000265126100018
J	Dilernia, DA; Jones, L; Rodriguez, S; Turk, G; Rubio, AE; Pampuro, S; Gomez-Carrillo, M; Bautista, C; Deluchi, G; Benetucci, J; Lasala, MB; Lourtau, L; Losso, MH; Perez, H; Cahn, P; Salomon, H				Alberto Dilernia, Dario; Jones, Leandro; Rodriguez, Sabrina; Turk, Gabriela; Rubio, Andrea E.; Pampuro, Sandra; Gomez-Carrillo, Manuel; Bautista, Christian; Deluchi, Gabriel; Benetucci, Jorge; Beatriz Lasala, Maria; Lourtau, Leonardo; Losso, Marcelo Horacio; Perez, Hector; Cahn, Pedro; Salomon, Horacio			HLA-Driven Convergence of HIV-1 Viral Subtypes B and F Toward the Adaptation to Immune Responses in Human Populations	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSE; CTL ESCAPE; VIREMIA; SELECTION; POLYMORPHISMS; TRANSMISSION; ASSOCIATION; PHYLOGENIES; DIVERSITY; EVOLUTION	Background: Cytotoxic T-Lymphocyte (CTL) response drives the evolution of HIV-1 at a host-level by selecting HLA-restricted escape mutations. Dissecting the dynamics of these escape mutations at a population-level would help to understand how HLA-mediated selection drives the evolution of HIV-1. Methodology/Principal Findings: We undertook a study of the dynamics of HIV-1 CTL-escape mutations by analyzing through statistical approaches and phylogenetic methods the viral gene gag sequenced in plasma samples collected between the years 1987 and 2006 from 302 drug-naive HIV-positive patients. By applying logistic regression models and after performing correction for multiple test, we identified 22 potential CTL-escape mutations (p-value<0.05; q-value<0.2); 10 of these associations were confirmed in samples biologically independent by a Bayesian Markov Chain Monte-Carlo method. Analyzing their prevalence back in time we found that escape mutations that are the consensus residue in samples collected after 2003 have actually significantly increased in time in one of either B or F subtype until becoming the most frequent residue, while dominating the other viral subtype. Their estimated prevalence in the viral subtype they did not dominate was lower than 30% for the majority of samples collected at the end of the 80's. In addition, when screening the entire viral region, we found that the 75% of positions significantly changing in time (p<0.05) were located within known CTL epitopes. Conclusions: Across HIV Gag protein, the rise of polymorphisms from independent origin during the last twenty years of epidemic in our setting was related to an association with an HLA allele. The fact that these mutations accumulated in one of either B or F subtypes have also dominated the other subtype shows how this selection might be causing a convergence of viral subtypes to variants which are more likely to evade the immune response of the population where they circulate.	[Alberto Dilernia, Dario; Turk, Gabriela; Rubio, Andrea E.; Pampuro, Sandra; Gomez-Carrillo, Manuel; Salomon, Horacio] Univ Buenos Aires, Fac Med, Dept Microbiol, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina; [Jones, Leandro] Estac Fotobiol Playa Union, Chubut, Argentina; [Rodriguez, Sabrina] INTA Castelar, Ctr Investigac Ciencias Vet Agronom, Inst Virol, Buenos Aires, DF, Argentina; [Bautista, Christian] Univ Nacl Mayor San Marcos, Inst Med Trop Daniel A Carrion, Lima, Peru; [Deluchi, Gabriel; Benetucci, Jorge] Capital Fed, Hosp Enfermedades Infecciosas Francisco Javier, Dept Enfermedades Infecciosas, Buenos Aires, DF, Argentina; [Beatriz Lasala, Maria] Capital Fed, Hosp Clin Jose de San Martin, Div Infectol, Buenos Aires, DF, Argentina; [Lourtau, Leonardo; Losso, Marcelo Horacio] Hosp Gen Agudos Jose Maria Ramos Mejia, Serv Inmunocomprometidos, Buenos Aires, DF, Argentina; [Perez, Hector; Cahn, Pedro] Capital Fed, Hosp Gen Agudos Juan A Fernandez, Unid Enfermedades Infecciosas, Buenos Aires, DF, Argentina; [Cahn, Pedro] Capital Fed, Fdn Huesped, Buenos Aires, DF, Argentina	University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidad Nacional Mayor de San Marcos; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; University of Buenos Aires	Dilernia, DA (corresponding author), Univ Buenos Aires, Fac Med, Dept Microbiol, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina.	hsalomon@fmed.uba.ar	PEREZ, HECTOR M./S-9366-2019	Jones, Leandro/0000-0002-5877-4194; Bautista, Christian/0000-0002-1228-0754	Argentinean National Research Council (CONICET)	Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	DAD, LJ, GT, SP, MGC and HS are supported by the Argentinean National Research Council (CONICET).	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Altfeld M, 2006, TRENDS IMMUNOL, V27, P504, DOI 10.1016/j.it.2006.09.007; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BRUMME ZL, 2008, J VIROL; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FRAHM N, 2006, HIV MOL IMMUNOLOGY D; Geels MJ, 2006, VIROLOGY, V345, P209, DOI 10.1016/j.virol.2005.09.023; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goulder PJR, 1997, EUR J IMMUNOL, V27, P1515, DOI 10.1002/eji.1830270630; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heckerman D, 2007, J COMPUT BIOL, V14, P736, DOI 10.1089/cmb.2007.R013; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07	39	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3429	10.1371/journal.pone.0003429	http://dx.doi.org/10.1371/journal.pone.0003429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941505	Green Published, gold, Green Submitted			2022-12-25	WOS:000265125900001
J	Shlush, LI; Atzmon, G; Weisshof, R; Behar, D; Yudkovsky, G; Barzilai, N; Skorecki, K				Shlush, Liran I.; Atzmon, Gil; Weisshof, Roni; Behar, Doron; Yudkovsky, Guenady; Barzilai, Nir; Skorecki, Karl			Ashkenazi Jewish Centenarians Do Not Demonstrate Enrichment in Mitochondrial Haplogroup J	PLOS ONE			English	Article								Background: Association of mitochondrial haplogroup J with longevity has been reported in several population subgroups. While studies from northern Italy and Finland, have described a higher frequency of haplogroup J among centenarians in comparison to non-centenarian, several other studies could not replicate these results and suggested various explanations for the discrepancy. Methodology/Principal Findings: We have evaluated haplogroup frequencies among Ashkenazi Jewish centenarians using two different sets of matched controls. No difference was observed in the haplogroup J frequencies between the centenarians or either matched control group, despite adequate statistical power to detect such a difference. Furthermore, the lack of association was robust to population substructure in the Ashkenazi Jewish population. Given this discrepancy with the previous reported associations in the northern Italian and the Finnish populations, we conducted re-analysis of these previously published data, which supported one of several possible explanations: i) inadequate matching of cases and controls; ii) inadequate adjustment for multiple comparison testing; iii) cryptic population stratification. Conclusions/Significance: There does not exist a universal association of mitochondrial haplogroup J with longevity across all population groups. Reported associations in specialized populations may reflect genetic or other interactions specific to those populations or else cryptic confounding influences, such as inadequate matching attributable to population substructure, which are of general relevance to all studies of the possible association of mitochondrial DNA haplogroups with common complex phenotypes.	[Shlush, Liran I.; Weisshof, Roni; Yudkovsky, Guenady; Skorecki, Karl] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Shlush, Liran I.; Behar, Doron; Yudkovsky, Guenady; Skorecki, Karl] Mol Med Lab, Rambam Hlth Care Campus, Haifa, Israel; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Dept Med, Diabetes Res & Training Ctr, Inst Aging Res, Bronx, NY USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Yeshiva University; Albert Einstein College of Medicine	Shlush, LI (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.	lshlush@tx.technion.ac.il			Israel Science Foundation; Legacy Heritage Fund; Veronique Elek Fund of the Canadian Technion Society; Arthur and Rosalinde Gilbert Fund of the American Technion Society; Microsoft TCI	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund; Veronique Elek Fund of the Canadian Technion Society; Arthur and Rosalinde Gilbert Fund of the American Technion Society; Microsoft TCI(Microsoft)	Support for this study was provided by the Israel Science Foundation, by the Legacy Heritage Fund, the Veronique Elek Fund of the Canadian Technion Society, the Arthur and Rosalinde Gilbert Fund of the American Technion Society, and a Microsoft TCI grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich D, 1997, AM J HUM GENET, V60, P505; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Behar DM, 2004, EUR J HUM GENET, V12, P355, DOI 10.1038/sj.ejhg.5201156; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Cohen T, 2004, ANN HUM BIOL, V31, P38, DOI 10.1080/0301446032000159255; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Feder J, 2007, EUR J HUM GENET, V15, P498, DOI 10.1038/sj.ejhg.5201764; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ivanova R, 1998, GERONTOLOGY, V44, P349, DOI 10.1159/000022041; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; MEINER V, 1991, AM J HUM GENET, V49, P443; Mogentale-Profizi N, 2001, ANN HUM GENET, V65, P153, DOI 10.1017/S0003480001008545; Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Perls TT, 1999, AGE AGEING, V28, P193, DOI 10.1093/ageing/28.2.193; Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8; Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002105; Stenico M, 1998, P ROY SOC B-BIOL SCI, V265, P555, DOI 10.1098/rspb.1998.0330; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Templeton AR, 2008, BIOESSAYS, V30, P470, DOI 10.1002/bies.20745; Torroni A, 1996, GENETICS, V144, P1835; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	40	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3425	10.1371/journal.pone.0003425	http://dx.doi.org/10.1371/journal.pone.0003425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923645	Green Published, Green Submitted, gold			2022-12-25	WOS:000265122200006
J	Hailer, F; Leonard, JA				Hailer, Frank; Leonard, Jennifer A.			Hybridization among Three Native North American Canis Species in a Region of Natural Sympatry	PLOS ONE			English	Article								Background: Population densities of many species throughout the world are changing due to direct persecution as well as anthropogenic habitat modification. These changes may induce or increase the frequency of hybridization among taxa. If extensive, hybridization can threaten the genetic integrity or survival of endangered species. Three native species of the genus Canis, coyote (C. latrans), Mexican wolf (C. lupus baileyi) and red wolf (C. rufus), were historically sympatric in Texas, United States. Human impacts caused the latter two to go extinct in the wild, although they survived in captive breeding programs. Morphological data demonstrate historic reproductive isolation between all three taxa. While the red wolf population was impacted by introgressive hybridization with coyotes as it went extinct in the wild, the impact of hybridization on the Texas populations of the other species is not clear. Methodology/Principal Findings: We surveyed variation at maternally and paternally inherited genetic markers (mitochondrial control region sequence and Y chromosome microsatellites) in coyotes from Texas, Mexican wolves and red wolves from the captive breeding programs, and a reference population of coyotes from outside the historic red wolf range. Levels of variation and phylogenetic analyses suggest that hybridization has occasionally taken place between all three species, but that the impact on the coyote population is very small. Conclusion/Significance: Our results demonstrate that the factors driving introgressive hybridization in sympatric Texan Canis are multiple and complex. Hybridization is not solely determined by body size or sex, and density-dependent effects do not fully explain the observed pattern either. No evidence of hybridization was identified in the Mexican wolf captive breeding program, but introgression appears to have had a greater impact on the captive red wolves.	[Hailer, Frank; Leonard, Jennifer A.] Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden; [Hailer, Frank; Leonard, Jennifer A.] Smithsonian Inst, Natl Mus Nat Hist, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Washington, DC USA	Uppsala University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Hailer, F (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden.	jennifer.leonard@ebc.uu.se	Hailer, Frank/C-9114-2012; Hailer, Frank/Y-3595-2019; Leonard, Jennifer/A-7894-2010	Hailer, Frank/0000-0002-2340-1726; Hailer, Frank/0000-0002-2340-1726; Leonard, Jennifer/0000-0003-0291-7819	Carl Trygger Foundation; Swedish Research Council	Carl Trygger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Carl Trygger Foundation and Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2003, MOL ECOL, V12, P2175, DOI 10.1046/j.1365-294X.2003.01895.x; Adams JR, 2003, MOL ECOL, V12, P541, DOI 10.1046/j.1365-294X.2003.01708.x; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Boitani Luigi, 2003, P317; Carbyn L.N., 1987, P358; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Coyne JA, 2004, SPECIATION, V37; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Fredrickson RJ, 2006, CONSERV BIOL, V20, P1272, DOI 10.1111/j.1523-1739.2006.00401.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; GarciaMoreno J, 1996, CONSERV BIOL, V10, P376, DOI 10.1046/j.1523-1739.1996.10020376.x; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; GOTTELLI D, 1994, MOL ECOL, V3, P301, DOI 10.1111/j.1365-294X.1994.tb00070.x; Hedrick PW, 2008, MOL ECOL, V17, P344, DOI 10.1111/j.1365-294X.2007.03400.x; Hedrick PW, 1997, ZOO BIOL, V16, P47, DOI 10.1002/(SICI)1098-2361(1997)16:1<47::AID-ZOO7>3.0.CO;2-B; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Konishi M, 2004, CONSERV GENET, V5, P463, DOI 10.1023/B:COGE.0000041027.64785.77; Kyle CJ, 2006, CONSERV GENET, V7, P273, DOI 10.1007/s10592-006-9130-0; LEHMAN N, 1991, EVOLUTION, V45, P104, DOI 10.1111/j.1558-5646.1991.tb05270.x; LEHMAN N, 1991, GENETICS, V128, P405; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Leonard JA, 2008, BIOL LETTERS, V4, P95, DOI 10.1098/rsbl.2007.0354; Lode T, 2005, J HERED, V96, P89, DOI 10.1093/jhered/esi021; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; McCARLEY HOWARD, 1962, SOUTHWESTERN NAT, V7, P227, DOI 10.2307/3668845; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; NEI M, 1978, GENETICS, V89, P583; Nowak RM, 2002, SOUTHEAST NAT, V1, P95, DOI 10.1656/1528-7092(2002)001[0095:TOSOWI]2.0.CO;2; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; Olivier M, 1999, CHROMOSOME RES, V7, P223, DOI 10.1023/A:1009203500926; PARADISO JL, 1968, AM MIDL NAT, V80, P529, DOI 10.2307/2423543; Pilgrim KL, 1998, J WILDLIFE MANAGE, V62, P683, DOI 10.2307/3802344; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Roy MS, 1996, CONSERV BIOL, V10, P1413, DOI 10.1046/j.1523-1739.1996.10051413.x; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMITZ OJ, 1985, J MAMMAL, V66, P402, DOI 10.2307/1381262; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358; Sundqvist AK, 2001, MOL ECOL, V10, P1959, DOI 10.1046/j.1365-294X.2001.01326.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vila C, 2003, HEREDITY, V90, P17, DOI 10.1038/sj.hdy.6800175; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; WAYNE RK, 1991, NATURE, V351, P565, DOI 10.1038/351565a0; Wilson PJ, 2000, CAN J ZOOL, V78, P2156, DOI 10.1139/cjz-78-12-2156; Young S.P., 1944, WOLVES N AM; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	57	78	80	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3333	10.1371/journal.pone.0003333	http://dx.doi.org/10.1371/journal.pone.0003333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841199	Green Published, Green Accepted, gold			2022-12-25	WOS:000265113900003
J	Tachado, SD; Samrakandi, MM; Cirillo, JD				Tachado, Souvenir D.; Samrakandi, Mustapha M.; Cirillo, Jeffrey D.			Non-Opsonic Phagocytosis of Legionella pneumophila by Macrophages Is Mediated by Phosphatidylinositol 3-Kinase	PLOS ONE			English	Article								Background: Legionella pneumophila, is an intracellular pathogen that causes Legionnaires' disease in humans, a potentially lethal pneumonia. L. pneumophila has the ability to enter and replicate in the host and is essential for pathogenesis. Methodology/Principal Findings: Phagocytosis was measured by cell invasion assays. Construction of PI3K mutant by PCR cloning and expression of dominant negative mutant was detected by Western blot. PI3K activity was measured by P-32 labeling and detection of phospholipids products by thin layer chromatography. Infection of macrophages with virulent L. pneumophila stimulated the formation of phosphatidylinositol 3-phosphate (PIP3), a phosphorylated lipid product of PI3K whereas two structurally distinct phosphatidylinositol 3 kinase (PI3K) inhibitors, wortmannin and LY294002, reduced L. pneumophila entry into macrophages in a dose-dependent fashion. Furthermore, PI3K activation led to Akt stimulation, a serine/threonine kinase, which was also inhibited by wortmannin and LY294002. In contrast, PI3K and protein kinase B (PKB/Akt) activities were lower in macrophages infected with an avirulent bacterial strain. Only virulent L. pneumophila increased lipid kinase activity present in immunoprecipitates of the p85 alpha subunit of class I PI3K and tyrosine phosphorylated proteins. In addition, macrophages expressing a specific dominant negative mutant of PI3K reduced L. pneumophila entry into these cells. Conclusion/Significance: Entry of L. pneumophila is mediated by PI3K/Akt signaling pathway. These results suggest an important role for PI3K and Akt in the L. pneumophila infection process. They point to possible novel strategies for undermining L. pneumophila host uptake and reducing pathogenesis of Legionnaires' disease.	[Tachado, Souvenir D.; Samrakandi, Mustapha M.; Cirillo, Jeffrey D.] Texas A&M Hlth Sci Ctr, Dept Microb & Mol Pathogenesis, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Tachado, SD (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm & Crit Med, Dept Med, Boston, MA 02215 USA.	jdcirillo@medicine.tamhsc.edu	Cirillo, Jeffrey D./L-4286-2019	Cirillo, Jeffrey D./0000-0003-3058-2702; Tachado, Souvenir/0000-0002-8368-6102	National Institutes of Health [AI40165]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI40165 (JDC).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Allen LAH, 2002, CURR BIOL, V12, P1762, DOI 10.1016/S0960-9822(02)01216-2; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Briand G, 1997, VIROLOGY, V228, P171, DOI 10.1006/viro.1996.8399; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Cirillo SLG, 2002, MICROBIOL-SGM, V148, P1667, DOI 10.1099/00221287-148-6-1667; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Coxon PY, 1998, INFECT IMMUN, V66, P2905, DOI 10.1128/IAI.66.6.2905-2913.1998; DAVIS GS, 1983, J INFECT DIS, V148, P823, DOI 10.1093/infdis/148.5.823; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; ENGLEBERG NC, 1984, INFECT IMMUN, V44, P222, DOI 10.1128/IAI.44.2.222-227.1984; Forney JR, 1999, INFECT IMMUN, V67, P844, DOI 10.1128/IAI.67.2.844-852.1999; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; GLAVIN FL, 1979, ANN INTERN MED, V90, P555, DOI 10.7326/0003-4819-90-4-555; GREENBERG S, 1995, TRENDS CELL BIOL, V5, P93, DOI 10.1016/S0962-8924(00)88957-6; HORWITZ MA, 1984, CELL, V36, P27, DOI 10.1016/0092-8674(84)90070-9; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; Khelef N, 2001, INFECT IMMUN, V69, P5157, DOI 10.1128/IAI.69.8.5157-5161.2001; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lin YL, 1998, BIOCHEM BIOPH RES CO, V246, P172, DOI 10.1006/bbrc.1998.8488; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; MOFFAT JF, 1994, MOL MICROBIOL, V12, P693, DOI 10.1111/j.1365-2958.1994.tb01057.x; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Procyk KJ, 1999, INFECT IMMUN, V67, P1011, DOI 10.1128/IAI.67.3.1011-1017.1999; Ravetch J, 2007, IMMUNOL REV, V219, P5, DOI 10.1111/j.1600-065X.2007.00568.x; REYNOLDS HY, 1974, J LAB CLIN MED, V84, P559; Salh B, 1998, J IMMUNOL, V161, P6947; Samrakandi MM, 2002, J CLIN MICROBIOL, V40, P1352, DOI 10.1128/JCM.40.4.1352-1362.2002; Stokes RW, 1998, J IMMUNOL, V160, P5514; Susa M, 1999, INFECT IMMUN, V67, P4490, DOI 10.1128/IAI.67.9.4490-4498.1999; Tachado SD, 2005, AM J RESP CELL MOL, V33, P610, DOI 10.1165/rcmb.2004-0341OC; Tachado SD, 2007, J LEUKOCYTE BIOL, V81, P205, DOI 10.1189/jlb.1005580; Todorov AG, 2000, J BIOL CHEM, V275, P32182, DOI 10.1074/jbc.M909440199; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Villalta F, 1998, BIOCHEM BIOPH RES CO, V249, P247, DOI 10.1006/bbrc.1998.9127; WADOWSKY RM, 1988, APPL ENVIRON MICROB, V54, P2677, DOI 10.1128/AEM.54.11.2677-2682.1988; Wilkowsky SE, 2001, EXP CELL RES, V264, P211, DOI 10.1006/excr.2000.5123; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; YAMAMOTO Y, 1992, INFECT IMMUN, V60, P3452, DOI 10.1128/IAI.60.8.3452-3455.1992; YANO H, 1993, J BIOL CHEM, V268, P25846	52	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3324	10.1371/journal.pone.0003324	http://dx.doi.org/10.1371/journal.pone.0003324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830409	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797300012
J	Jastrzebska, B; Golczak, M; Fotiadis, D; Engel, A; Palczewski, K				Jastrzebska, Beata; Golczak, Marcin; Fotiadis, Dimitrios; Engel, Andreas; Palczewski, Krzysztof			Isolation and functional characterization of a stable complex between photoactivated rhodopsin and the G protein, transducin	FASEB JOURNAL			English	Article						sucrose gradient; detergent; rhodopsin regeneration	ROD OUTER SEGMENTS; G-ALPHA-SUBUNITS; COUPLED RECEPTOR; CRYSTAL-STRUCTURE; METARHODOPSIN-II; OPSIN STABILITY; ACTIVATION; DIMERS; PHOTOTRANSDUCTION; STABILIZATION	Transitory binding between photoactivated rhodopsin (Rho* or Meta II) and the G protein transducin (Gt-GDP) is the first step in the visual signaling cascade. Light causes photoisomerization of the 11-cis-retinylidene chromophore in rhodopsin (Rho) to all-trans-retinylidene, which induces conformational changes that allow Gt-GDP to dock onto the Rho* surface. GDP then dissociates from Gt, leaving a transient nucleotide-empty Rho*-Gt(e) complex before GTP becomes bound, and Gt-GTP then dissociates from Rho*. Further biochemical advances are required before structural studies of the various Rho*-Gt complexes can be initiated. Here, we describe the isolation of n-dodecyl-beta-maltoside solubilized, stable, functionally active, Rho*-Gt(e), Rhoe*-Gt(e), and 9-cis-retinal/11-cis-retinal regenerated Rho-Gt(e) complexes by sucrose gradient centrifugation. In these complexes, Rho* spectrally remained in its Meta II state, and Gt(e) retained its ability to interact with GTP gamma S. Removal of all-trans-retinylidene from Rho*-Gt(e) had no effect on the stability of the Rho(e)*-Gt(e) complex. Moreover, opsin in the Rho(e)*-Gt(e) complex with an empty nucleotide-binding pocket in Gt and an empty retinoid-binding pocket in Rho was regenerated up to 75% without complex dissociation. These results indicate that once Rho* couples with Gt, the chromophore plays a minor role in stabilizing this complex. Moreover, in complexes regenerated with 9-cis-retinal/11-cis-retinal, Rho retains a conformation similar to Rho* that is stabilized by Gte apo-protein. - Jastrzebska, B., Golczak, M., Fotiadis, D., Engel, A., and Palczewski, K.. Isolation and functional characterization of a stable complex between photoactivated rhodopsin and the G protein, transducin. FASEB J. 23, 371-381 (2009)	[Jastrzebska, Beata; Golczak, Marcin] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Fotiadis, Dimitrios; Engel, Andreas] Univ Basel, Biozentrum, ME Muller Inst Microscopy, Basel, Switzerland; [Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland	Case Western Reserve University; University of Basel; University of Bern	Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Wood Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	bxj27@case.edu			U. S. National Institutes of Health [EY09339, GM 079191, P30 EY11373]; Swiss National Foundation (SNF) [3100A0 - 108299]; Amgen Inc.; NATIONAL EYE INSTITUTE [P30EY011373, R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079191] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Amgen Inc.(Amgen); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Leslie T. Webster Jr. and Thomas Angel (Case Western Reserve University) for valuable comments on the manuscript. This research was supported by U. S. National Institutes of Health grants EY09339, GM 079191, and P30 EY11373, the Swiss National Foundation (SNF grant 3100A0 - 108299 to A.E.), and by an unrestricted grant from Amgen Inc.	Angel TE, 2006, VISION RES, V46, P4547, DOI 10.1016/j.visres.2006.08.015; Aris L, 2001, J BIOL CHEM, V276, P2333, DOI 10.1074/jbc.M002533200; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Kisselev OG, 2003, STRUCTURE, V11, P367, DOI 10.1016/S0969-2126(03)00045-5; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Loewen MC, 2001, P NATL ACAD SCI USA, V98, P4888, DOI 10.1073/pnas.051633098; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; McKibbin C, 2007, J MOL BIOL, V374, P1319, DOI 10.1016/j.jmb.2007.10.018; McKibbin C, 2007, J MOL BIOL, V374, P1309, DOI 10.1016/j.jmb.2007.10.013; NAVON SE, 1984, J BIOL CHEM, V259, P6686; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P240; Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5; Salamon Z, 1996, BIOPHYS J, V71, P283, DOI 10.1016/S0006-3495(96)79224-X; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; SCHLEICHER A, 1987, J MEMBRANE BIOL, V95, P271, DOI 10.1007/BF01869489; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Struthers M, 2000, BIOCHEMISTRY-US, V39, P7938, DOI 10.1021/bi000771f; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Yan F, 2008, BIOCHEMISTRY-US, V47, P1567, DOI 10.1021/bi701476b; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	45	25	25	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					371	381		10.1096/fj.07-114835	http://dx.doi.org/10.1096/fj.07-114835			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18827025	Green Published			2022-12-25	WOS:000262892900009
J	Crosetto, N; Bienko, M; Hibbert, RG; Perica, T; Ambrogio, C; Kensche, T; Hofmann, K; Sixma, TK; Dikic, I				Crosetto, Nicola; Bienko, Marzena; Hibbert, Richard G.; Perica, Tina; Ambrogio, Chiara; Kensche, Tobias; Hofmann, Kay; Sixma, Titia K.; Dikic, Ivan			Human Wrnip1 Is Localized in Replication Factories in a Ubiquitin-binding Zinc Finger-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS48-LINKED POLYUBIQUITIN CHAIN; DNA-DAMAGE TOLERANCE; WERNER HELICASE; PHYSICAL INTERACTION; GENOME STABILITY; POLYMERASE-ETA; TARGETS BRCA1; UBA DOMAIN; IN-VITRO; PROTEIN	Wrnip1 (Werner helicase-interacting protein 1) has been implicated in the bypass of stalled replication forks in bakers' yeast. However, the function(s) of human Wrnip1 has remained elusive so far. Here we report that Wrnip1 is distributed inside heterogeneous structures detectable in nondamaged cells throughout the cell cycle. In an attempt to characterize these structures, we found that Wrnip1 resides in DNA replication factories. Upon treatments that stall replication forks, such as UVC light, the amount of chromatin-bound Wrnip1 and the number of foci significantly increase, further implicating Wrnip1 in DNA replication. Interestingly, the nuclear pattern of Wrnip1 appears to extend to a broader landscape, as it can be detected in promyelocytic leukemia nuclear bodies. The presence of Wrnip1 into these heterogeneous subnuclear structures requires its ubiquitin-binding zinc finger (UBZ) domain, which is able to interact with different ubiquitin (Ub) signals, including mono-Ub and chains linked via lysine 48 and 63. Moreover, the oligomerization of Wrnip1 mediated by its C terminus is also important for proper subnuclear localization. Our study is the first to reveal the composite and regulated topography of Wrnip1 in the human nucleus, highlighting its potential role in replication and other nuclear transactions.	[Crosetto, Nicola; Bienko, Marzena; Perica, Tina; Kensche, Tobias; Dikic, Ivan] Goethe Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany; [Crosetto, Nicola; Bienko, Marzena; Perica, Tina; Kensche, Tobias; Dikic, Ivan] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60590 Frankfurt, Germany; [Hibbert, Richard G.; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Ambrogio, Chiara] Univ Turin, Ctr Expt Res & Med Studies, I-10126 Turin, Italy; [Ambrogio, Chiara] Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy; [Hofmann, Kay] Miltenyi Biotec GmbH, MACS Mol Business Unit, Bioinformat Grp, D-50829 Cologne, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Netherlands Cancer Institute; University of Turin; University of Turin; Miltenyi Biotec	Dikic, I (corresponding author), Goethe Univ Frankfurt, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Bienko, Magda/AAM-8867-2020; Hofmann, Kay/D-6714-2011; Dikic, Ivan/O-4650-2015	Bienko, Magda/0000-0002-6499-9082; Hofmann, Kay/0000-0002-2289-9083; Dikic, Ivan/0000-0001-8156-9511; Perica, Tina/0000-0003-3152-8425; Ambrogio, Chiara/0000-0003-4122-701X; Sixma, Titia K/0000-0001-6180-0632	Deutsche Forschungsgemeineschaft [DI 931/3-1]; Cluster of Excellence "Macromolecular Complexes" of the Frankfurt "J.W. Goethe" University; NWO-CW	Deutsche Forschungsgemeineschaft(German Research Foundation (DFG)); Cluster of Excellence "Macromolecular Complexes" of the Frankfurt "J.W. Goethe" University; NWO-CW(Netherlands Organization for Scientific Research (NWO))	This work was supported by Deutsche Forschungsgemeineschaft Grant DI 931/3-1 and grants from the Cluster of Excellence "Macromolecular Complexes" of the Frankfurt "J.W. Goethe" University (to I.D.) and NWO-CW (to T.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Hayashi T, 2008, GENES GENET SYST, V83, P95, DOI 10.1266/ggs.83.95; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hishida T, 2002, EMBO J, V21, P2019, DOI 10.1093/emboj/21.8.2019; Hishida T, 2001, P NATL ACAD SCI USA, V98, P8283, DOI 10.1073/pnas.121009098; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kawabe Y, 2001, J BIOL CHEM, V276, P20364, DOI 10.1074/jbc.C100035200; Kawabe YI, 2006, DNA REPAIR, V5, P816, DOI 10.1016/j.dnarep.2006.04.006; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Pageau GJ, 2006, J CELL BIOL, V175, P693, DOI 10.1083/jcb.200602055; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Suzuki T, 2001, ONCOGENE, V20, P2551, DOI 10.1038/sj.onc.1204344; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Tsurimoto T, 2005, GENES CELLS, V10, P13, DOI 10.1111/j.1365-2443.2004.00812.x; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; von Kobbe C, 2002, J CELL SCI, V115, P3901, DOI 10.1242/jcs.00076; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yoshimura A, 2006, BIOL PHARM BULL, V29, P2192, DOI 10.1248/bpb.29.2192; Yuasa MS, 2006, GENES CELLS, V11, P731, DOI 10.1111/j.1365-2443.2006.00974.x	49	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35173	35185		10.1074/jbc.M803219200	http://dx.doi.org/10.1074/jbc.M803219200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842586	Green Published, hybrid			2022-12-25	WOS:000261469100074
J	Fang, S; Tsang, S; Jones, R; Ponugoti, B; Yoon, H; Wu, SY; Chiang, CM; Willson, TM; Kemper, JK				Fang, Sungsoon; Tsang, Stephanie; Jones, Ryan; Ponugoti, Bhaskar; Yoon, Hyeryoung; Wu, Shwu-Yuan; Chiang, Cheng-Ming; Willson, Timothy M.; Kemper, Jongsook Kim			The p300 Acetylase Is Critical for Ligand-activated Farnesoid X Receptor (FXR) Induction of SHP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE FEEDBACK-REGULATION; NUCLEAR-RECEPTOR; BILE-ACID; DNA-BINDING; REGULATES TRANSCRIPTION; SMALL-INTESTINE; CHOLESTEROL; COACTIVATOR; METABOLISM; MECHANISMS	The primary bile acid receptor farnesoid X receptor (FXR) maintains lipid and glucose homeostasis by regulating expression of numerous bile acid-responsive genes, including an orphan nuclear receptor and metabolic regulator SHP. Using SHP as a model gene, we studied how FXR activity is regulated by p300 acetylase. FXR interaction with p300 and their recruitment to the SHP promoter and acetylated histone levels at the promoter were increased by FXR agonists in mouse liver and HepG2 cells. In contrast, p300 recruitment and acetylated histones at the promoter were not detected in FXR-null mice. p300 directly interacted with and acetylated FXR in vitro. Overexpression of p300 wild type increased, whereas a catalytically inactive p300 mutant decreased, acetylated FXR levels and FXR transactivation in cells. While similar results were observed with a related acetylase, CBP, GCN5 did not enhance FXR transactivation, and its recruitment to the promoter was not increased by FXR agonists, suggesting functional specificity of acetylases in FXR signaling. Down-regulation of p300 by siRNA decreased acetylated FXR and acetylated histone levels, and occupancy of FXR at the promoter, resulting in substantial inhibition of SHP expression. These results indicate that p300 acts as a critical coactivator of FXR induction of SHP by acetylating histones at the promoter and FXR itself. Surprisingly, p300 down-regulation altered expression of other metabolic FXR target genes involved in lipoprotein and glucose metabolism, such that beneficial lipid and glucose profiles would be expected. These unexpected findings suggest that inhibition of hepatic p300 activity may be beneficial for treating metabolic diseases.	[Fang, Sungsoon; Tsang, Stephanie; Jones, Ryan; Ponugoti, Bhaskar; Yoon, Hyeryoung; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Willson, Timothy M.] GlaxoSmithKline, Discovery Med Chem, Res Triangle Pk, NC 27709 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; GlaxoSmithKline	Kemper, JK (corresponding author), 407 S Goodwin Ave, Urbana, IL 61801 USA.	jongsook@uiuc.edu	PONUGOTI, BHASKAR/H-2230-2011; feinstein, doug/M-9414-2019		National Institutes of Health [CA103867, CA124760, DK062777, AHA 0756028Z]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062777, R01DK080032, R01DK062777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103867 and CA124760 (to C.M.C.) and DK062777 and AHA 0756028Z (to J.K.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ananthanarayanan M, 2004, J BIOL CHEM, V279, P54348, DOI 10.1074/jbc.M410021200; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kraus WL, 2002, EUR J BIOCHEM, V269, P2275, DOI 10.1046/j.1432-1033.2002.02889.x; Kuninger D, 2004, HUM GENE THER, V15, P1287, DOI 10.1089/hum.2004.15.1287; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LAZAR MA, 2003, NUCL RECEPT SIGNAL, V1, P2001; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lee YK, 2002, J BIOL CHEM, V277, P2463, DOI 10.1074/jbc.M105161200; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Muraoka M, 1996, ONCOGENE, V12, P1565; Nakahara M, 2005, J BIOL CHEM, V280, P42283, DOI 10.1074/jbc.M507454200; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Rizzo G, 2005, MOL PHARMACOL, V68, P551, DOI 10.1124/mol.105.012104; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Torra IP, 2004, J BIOL CHEM, V279, P36184, DOI 10.1074/jbc.M405126200; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang L, 2006, MOL ENDOCRINOL, V20, P2671, DOI 10.1210/me.2006-0224; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Willson TM, 2001, MED RES REV, V21, P513, DOI 10.1002/med.1023; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	56	51	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35086	35095		10.1074/jbc.M803531200	http://dx.doi.org/10.1074/jbc.M803531200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842595	hybrid, Green Published			2022-12-25	WOS:000261469100066
J	Kanzaki, T; Iizuka, R; Takahashi, K; Maki, K; Masuda, R; Sahlan, M; Yebenes, H; Valpuesta, JM; Oka, T; Furutani, M; Ishii, N; Kuwajima, K; Yohda, M				Kanzaki, Taro; Iizuka, Ryo; Takahashi, Kazunobu; Maki, Kosuke; Masuda, Rie; Sahlan, Muhamad; Yebenes, Hugo; Valpuesta, Jose M.; Oka, Toshihiko; Furutani, Masahiro; Ishii, Noriyuki; Kuwajima, Kunihiro; Yohda, Masafumi			Sequential Action of ATP-dependent Subunit Conformational Change and Interaction between Helical Protrusions in the Closure of the Built-in Lid of Group II Chaperonins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ALLOSTERIC TRANSITIONS; TRANSIENT KINETIC-ANALYSIS; THERMOCOCCUS STRAIN KS-1; EUKARYOTIC CHAPERONIN; CYTOPLASMIC CHAPERONIN; CIS-CAVITY; PROTEIN; GROEL; THERMOSOME; SUBSTRATE	ATP drives the conformational change of the group II chaperonin from the open lid substrate-binding conformation to the closed lid conformation to encapsulate an unfolded protein in the central cavity. The detailed mechanism of this conformational change remains unknown. To elucidate the intra-ring cooperative action of subunits for the conformational change, we constructed Thermococcus chaperonin complexes containing mutant subunits in an ordered manner and examined their folding and conformational change abilities. Chaperonin complexes containing wild-type subunits and mutant subunits with impaired ATP-dependent conformational change ability or ATP hydrolysis activity, one by one, exhibited high protein refolding ability. The effects of the mutant subunits correlate with the number and order in the ring. In contrast, the use of a mutant lacking helical protrusion severely affected the function. Interestingly, these mutant chaperonin complexes also exhibited ATP-dependent conformational changes as demonstrated by small angle x-ray scattering, protease digestion, and changes in fluorescence of the fluorophore attached to the tip of the helical protrusion. However, their conformational change is likely to be transient. They captured denatured proteins even in the presence of ATP, whereas addition of ATP impaired the ability of the wild-type chaperonin to protect citrate synthase from thermal aggregation. These results suggest that ATP binding/hydrolysis causes the independent conformational change of the subunit, and further conformational change for the complete closure of the lid is induced and stabilized by the interaction between helical protrusions.	[Kanzaki, Taro; Iizuka, Ryo; Masuda, Rie; Sahlan, Muhamad; Yohda, Masafumi] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Iizuka, Ryo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Takahashi, Kazunobu; Kuwajima, Kunihiro] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Takahashi, Kazunobu] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Maki, Kosuke] Nagoya Univ, Grad Sch Sci, Dept Phys, Aichi 4648602, Japan; [Yebenes, Hugo; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Oka, Toshihiko] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Kanagawa 2238522, Japan; [Furutani, Masahiro] Sekisui Chem Co Ltd, Minase Res Inst, Osaka 6188589, Japan; [Ishii, Noriyuki] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058566, Japan; [Kuwajima, Kunihiro] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Dept Funct Mol Sci, Okazaki, Aichi 4448787, Japan	Tokyo University of Agriculture & Technology; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); University of Tokyo; Nagoya University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Keio University; Sekisui Chemical Co Ltd; National Institute of Advanced Industrial Science & Technology (AIST); Graduate University for Advanced Studies - Japan	Yohda, M (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	yohda@cc.tuat.ac.jp	Oka, Toshihiko/C-3757-2015; Valpuesta, José M/T-1977-2017; Valpuesta, Jose M/AAA-6002-2019; Yohda, Masafumi/A-5149-2013; Ishii, Noriyuki/E-5661-2011	Oka, Toshihiko/0000-0002-1676-9231; Valpuesta, José M/0000-0001-7468-8053; Yohda, Masafumi/0000-0001-8307-9671; Ishii, Noriyuki/0000-0002-4120-6203; Yebenes, Hugo/0000-0002-0448-217X; Iizuka, Ryo/0000-0002-9328-5628; Sahlan, Muhamad/0000-0001-6360-3691	Ministry of Education, Science, Sports, Culture, and Technology; Tokyo University of Agriculture and Technology [17028013, 19370038, 20059013]; National Project on Protein Structural and Functional Analyses; Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, Culture, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo University of Agriculture and Technology; National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is a part of the 21st Century Center of Excellence Program of the "Future Nano-Materials" Research and Education Project supported by the Ministry of Education, Science, Sports, Culture, and Technology through Tokyo University of Agriculture and Technology and supported in part by Grants-in-aids for Scientific Research 17028013, 19370038, and 20059013 and a grant from the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Science, Sports, and Culture of Japan ( to M.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai M, 2003, J MOL BIOL, V329, P779, DOI 10.1016/S0022-2836(03)00511-4; Arai M, 2002, J MOL BIOL, V321, P121, DOI 10.1016/S0022-2836(02)00566-1; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Bigotti MG, 2005, J MOL BIOL, V348, P13, DOI 10.1016/j.jmb.2005.01.066; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Furutani M, 2005, PROTEIN SCI, V14, P341, DOI 10.1110/ps.041043905; Furutani M, 1998, J BIOL CHEM, V273, P28399, DOI 10.1074/jbc.273.43.28399; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Gutsche I, 2001, J STRUCT BIOL, V135, P139, DOI 10.1006/jsbi.2001.4373; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Iizuka R, 2005, J BIOL CHEM, V280, P40375, DOI 10.1074/jbc.M506785200; Iizuka R, 2004, J BIOL CHEM, V279, P18834, DOI 10.1074/jbc.M400839200; Iizuka R, 2003, J BIOL CHEM, V278, P44959, DOI 10.1074/jbc.M305484200; Iizuka R, 2001, BIOCHEM BIOPH RES CO, V289, P1118, DOI 10.1006/bbrc.2001.6139; Kafri G, 2003, J MOL BIOL, V326, P981, DOI 10.1016/S0022-2836(03)00046-9; Kafri G, 2001, PROTEIN SCI, V10, P445, DOI 10.1110/ps.44401; KAGAWA HK, 1995, J MOL BIOL, V253, P712, DOI 10.1006/jmbi.1995.0585; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; Klunker D, 2003, J BIOL CHEM, V278, P33256, DOI 10.1074/jbc.M302018200; Kurimoto E, 2008, PROTEINS, V70, P1257, DOI 10.1002/prot.21606; Lin P, 1997, P NATL ACAD SCI USA, V94, P10780, DOI 10.1073/pnas.94.20.10780; Llorca O, 1999, NAT STRUCT BIOL, V6, P639; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Rivenzon-Segal D, 2005, NAT STRUCT MOL BIOL, V12, P233, DOI 10.1038/nsmb901; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; Yoshida T, 2002, J MOL BIOL, V315, P73, DOI 10.1006/jmbi.2001.5220; Yoshida T, 1997, J MOL BIOL, V273, P635, DOI 10.1006/jmbi.1997.1337	39	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34773	34784		10.1074/jbc.M805303200	http://dx.doi.org/10.1074/jbc.M805303200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18854314	Green Published, hybrid			2022-12-25	WOS:000261469100034
J	Rylski, M; Amborska, R; Zybura, K; Mioduszewska, B; Michaluk, P; Jaworski, J; Kaczmarek, L				Rylski, Marcin; Amborska, Renata; Zybura, Katarzyna; Mioduszewska, Barbara; Michaluk, Piotr; Jaworski, Jacek; Kaczmarek, Leszek			Yin Yang 1 Is a Critical Repressor of Matrix Metalloproteinase-9 Expression in Brain Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YIN-YANG-1; ELEMENT-BINDING PROTEIN; HISTONE MODIFICATIONS; NEUROTROPHIC-FACTOR; PROXIMAL REGION; GELATINASE-B; IN-VIVO; YY1; RECRUITMENT; PROMOTER	Membrane depolarization controls long lasting adaptive neuronal changes in brain physiology and pathology. Such responses are believed to be gene expression-dependent. Notably, however, only a couple of gene repressors active in nondepolarized neurons have been described. In this study, we show that in the unstimulated rat hippocampus in vivo, as well as in the nondepolarized brain neurons in primary culture, the transcriptional regulator Yin Yang 1 (YY1) is bound to the proximal Mmp-9 promoter and strongly represses Mmp-9 transcription. Furthermore, we demonstrate that monoubiquitinated and CtBP1 (C-terminal binding protein 1)-bound YY1 regulates Mmp-9 mRNA synthesis in rat brain neurons controlling its transcription apparently via HDAC3-dependent histone deacetylation. In conclusion, our data suggest that YY1 exerts, via epigenetic mechanisms, a control over neuronal expression of MMP-9. Because MMP-9 has recently been shown to play a pivotal role in physiological and pathological neuronal plasticity, YY1 may be implicated in these phenomena as well.	[Rylski, Marcin; Amborska, Renata; Zybura, Katarzyna; Mioduszewska, Barbara; Michaluk, Piotr; Kaczmarek, Leszek] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Michaluk, Piotr] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Michaluk, Piotr] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; [Jaworski, Jacek] Int Inst Mol & Cell Biol, Mol & Cellular Neurobiol Lab, PL-02109 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Rylski, M (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, Pasteura 3, PL-02093 Warsaw, Poland.	m.rylski@gmail.com; l.kaczmarek@nencki.gov.pl	Rylski, Marcin/AAB-9277-2021; Michaluk, Piotr/AAR-5238-2021; Kaczmarek, Leszek/AHA-0076-2022; Kaczmarek, Leszek/B-6171-2008	Michaluk, Piotr/0000-0003-2306-3314; Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; Rylski, Marcin/0000-0002-9892-8979; Zybura-Broda, Katarzyna/0000-0002-4117-2613; Jaworski, Jacek/0000-0001-8760-7865	Polish Ministry of Science and Higher Education [2 P04A 081 29]; 7 FP European Union	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); 7 FP European Union(European Commission)	This work was supported by the Polish Ministry of Science and Higher Education Grant 2 P04A 081 29 and 7 FP European Union Grant MemStick. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Antoniv TT, 2005, J BIOL CHEM, V280, P35417, DOI 10.1074/jbc.M502681200; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Barath P, 2004, EUR J BIOCHEM, V271, P1781, DOI 10.1111/j.1432-1033.2004.04090.x; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Dubberke R, 1998, PFLUG ARCH EUR J PHY, V437, P79, DOI 10.1007/s004240050750; Dzwonek J, 2004, FEBS LETT, V567, P129, DOI 10.1016/j.febslet.2004.03.070; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; GUO B, 1995, P NATL ACAD SCI USA, V92, P10526, DOI 10.1073/pnas.92.23.10526; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Hering H, 2003, J NEUROSCI, V23, P11759; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Huang YF, 2002, J NEUROSCI, V22, P8422; INOUYE CJ, 1994, J BIOL CHEM, V269, P6506; Jaworski J, 2003, J NEUROSCI, V23, P4519; Jia YH, 2006, NEUROSCI LETT, V403, P103, DOI 10.1016/j.neulet.2006.04.027; KACZMAREK L, 2002, IMMEDIATE EARLY GENE; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; Konopacki FA, 2007, NEUROSCIENCE, V150, P31, DOI 10.1016/j.neuroscience.2007.08.026; LEE TC, 1992, P NATL ACAD SCI USA, V89, P9814, DOI 10.1073/pnas.89.20.9814; Luke MPS, 2006, J BIOL CHEM, V281, P33226, DOI 10.1074/jbc.M606584200; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Masson V, 2004, FASEB J, V18, P234, DOI 10.1096/fj.04-2140fje; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Meldrum B, 2002, EPILEPSY RES, V50, P33, DOI 10.1016/S0920-1211(02)00066-9; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; Mohan R, 1998, J BIOL CHEM, V273, P25903, DOI 10.1074/jbc.273.40.25903; Mokrani H, 2006, MOL CELL BIOL, V26, P8551, DOI 10.1128/MCB.00420-06; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; SCHORMAIR C, 1993, BRAIN RES BULL, V32, P329, DOI 10.1016/0361-9230(93)90196-I; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Sucharov CC, 2006, AM J PHYSIOL-CELL PH, V291, pC1029, DOI 10.1152/ajpcell.00059.2006; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Taniura H, 2006, HISTOL HISTOPATHOL, V21, P785, DOI 10.14670/HH-21.785; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; WALDEN J, 1988, BRAIN RES, V473, P294, DOI 10.1016/0006-8993(88)90858-X; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wright JW, 2003, BRAIN RES, V963, P252, DOI 10.1016/S0006-8993(02)04036-2; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zhao T., 2008, Experimental Oncology, V30, P60	57	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35140	35153		10.1074/jbc.M804540200	http://dx.doi.org/10.1074/jbc.M804540200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940814	Green Published, hybrid			2022-12-25	WOS:000261469100071
J	Cha, SS; Il Jung, H; Jeon, H; An, YJ; Kim, IK; Yun, S; Ahn, HJ; Chung, KC; Lee, SH; Suh, PG; Kang, SO				Cha, Sun-Shin; Il Jung, Ha; Jeon, Hyesung; An, Young Jun; Kim, In-Kwon; Yun, Sanguk; Ahn, Hyun Jin; Chung, Kwang Chul; Lee, Sang Hee; Suh, Pann-Ghill; Kang, Sa-Ouk			Crystal Structure of Filamentous Aggregates of Human DJ-1 Formed in an Inorganic Phosphate-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; MULTIPLE SYSTEM ATROPHY; OXIDATIVE STRESS; DROSOPHILA DJ-1; ALPHA-SYNUCLEIN; PROTEIN DJ-1; CELL-DEATH; FERTILITY; L166P; INACTIVATION	Mutations in the DJ-1 gene have been implicated in the autosomal recessive early onset parkinsonism. DJ-1 is a soluble dimeric protein with critical roles in response to oxidative stress and in neuronal maintenance. However, several lines of evidence suggest the existence of a nonfunctional aggregated form of DJ-1 in the brain of patients with some neurodegenerative diseases. Here, we show that inorganic phosphate, an important anion that exhibits elevated levels in patients with Parkinson disease, transforms DJ-1 into filamentous aggregates. According to the 2.4-angstrom crystal structure, DJ-1 dimers are linearly stacked through P-i-mediated interactions to form protofilaments, which are then bundled into a filamentous assembly.	[Cha, Sun-Shin; Il Jung, Ha; An, Young Jun] Korea Ocean Res & Dev Inst, Marine & Extreme Genome Res Ctr, Ansan 426744, South Korea; [Jeon, Hyesung] Korea Inst Sci & Technol, Seoul 130650, South Korea; [Kim, In-Kwon; Kang, Sa-Ouk] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Yun, Sanguk; Suh, Pann-Ghill] POSTECH, Dept Life Sci, Pohang 790784, South Korea; [Il Jung, Ha; An, Young Jun; Lee, Sang Hee] Myongji Univ, Dept Biol Sci, Yongin 449728, South Korea; [Ahn, Hyun Jin; Chung, Kwang Chul] Yonsei Univ, Dept Biol, Seoul 120749, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Myongji University; Yonsei University	Cha, SS (corresponding author), Korea Ocean Res & Dev Inst, Marine & Extreme Genome Res Ctr, Ansan 426744, South Korea.	chajung@kordi.re.kr; kangsaou@snu.ac.kr	Cha, Sun Shin/B-7370-2009; Suh, Pann-Ghill/F-3610-2010; Lee, Sang Hee/A-3200-2012	Lee, Sang Hee/0000-0002-5660-7122; Cha, Sun-Shin/0000-0002-0913-8706	Functional Proteomics Center Program; Korea Ministry of Science and Technology; Marine & Extreme Genome Research Center Program; Ministry of Land, Transport, and Maritime Affairs, Republic of Korea; BK21 Project, Republic of Korea	Functional Proteomics Center Program; Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Marine & Extreme Genome Research Center Program; Ministry of Land, Transport, and Maritime Affairs, Republic of Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); BK21 Project, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Functional Proteomics Center Program, Korea Ministry of Science and Technology and by the Marine & Extreme Genome Research Center Program, Ministry of Land, Transport, and Maritime Affairs, Republic of Korea. This work was also supported by Korea Institute of Science and Technology institutional grants and a Research Fellowship of the BK21 Project, Republic of Korea (to I. K. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340; Barbiroli B, 1999, MOVEMENT DISORD, V14, P430, DOI 10.1002/1531-8257(199905)14:3<430::AID-MDS1007>3.0.CO;2-S; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; BROWN GG, 1989, NEUROLOGY, V39, P1423, DOI 10.1212/WNL.39.11.1423; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Huai Q, 2003, FEBS LETT, V549, P171, DOI 10.1016/S0014-5793(03)00764-6; Jin JH, 2005, MOL BRAIN RES, V134, P119, DOI 10.1016/j.molbrainres.2004.10.003; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Klinefelter GR, 1997, J ANDROL, V18, P139; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; LIU F, 2008, J NEUROCHEM; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Rizzu P, 2004, ANN NEUROL, V55, P113, DOI 10.1002/ana.10782; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Wagenfeld A, 1998, BIOL REPROD, V58, P1257, DOI 10.1095/biolreprod58.5.1257; Welch JE, 1998, J ANDROL, V19, P385; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Yanagisawa D, 2008, J CEREBR BLOOD F MET, V28, P563, DOI 10.1038/sj.jcbfm.9600553; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102	44	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34069	34075		10.1074/jbc.M804243200	http://dx.doi.org/10.1074/jbc.M804243200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922803	Green Published, hybrid			2022-12-25	WOS:000261277700035
J	Volk, APD; Heise, CK; Hougen, JL; Artman, CM; Volk, KA; Wessels, D; Soll, DR; Nauseef, WM; Lamb, FS; Moreland, JG				Volk, A. Paige Davis; Heise, Christine K.; Hougen, Jami L.; Artman, Christopher M.; Volk, Kenneth A.; Wessels, Deborah; Soll, David R.; Nauseef, William M.; Lamb, Fred S.; Moreland, Jessica G.			ClC-3 and IClswell are Required for Normal Neutrophil Chemotaxis and Shape Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-VOLUME REGULATION; CHLORIDE CHANNEL; NADPH-OXIDASE; POLYMORPHONUCLEAR LEUKOCYTES; MURINE NEUTROPHILS; PH REGULATION; ION CHANNELS; CL-CHANNELS; ACTIVATION; MIGRATION	Polymorphonuclear leukocytes undergo directed movement to sites of infection, a complex process known as chemotaxis. Extension of the polymorphonuclear leukocyte (PMN) leading edge toward a chemoattractant in association with uropod retraction must involve a coordinated increase/decrease in membrane, redistribution of cell volume, or both. Deficits in PMN phagocytosis and trans-endothelial migration, both highly motile PMN functions, suggested that the anion transporters, ClC-3 and IClswell, are involved in cell motility and shape change (Moreland, J. G., Davis, A. P., Bailey, G., Nauseef, W. M., and Lamb, F. S. (2006) J. Biol. Chem. 281, 12277-12288). We hypothesized that ClC-3 and IClswell are required for normal PMN chemotaxis through regulation of cell volume and shape change. Using complementary chemotaxis assays, EZ-TAXIScan (TM) and dynamic imaging analysis software, we analyzed the directed cell movement and morphology of PMNs lacking normal anion transporter function. Murine Clcn3(-/-) PMNs and human PMNs treated with anion transporter inhibitors demonstrated impaired chemotaxis in response to formyl peptide. This included decreased cell velocity and failure to undergo normal cycles of elongation and retraction. Impaired chemotaxis was not due to a diminished number of formyl peptide receptors in either murine or human PMNs, as measured by flow cytometry. Murine Clcn3(-/-) and Clcn3(-/-) PMNs demonstrated a similar regulatory volume decrease, indicating that the IClswell response to hypotonic challenge was intact in these cells. We further demonstrated that IClswell is essential for shape change during human PMN chemotaxis. We speculate that ClC-3 and IClswell have unique roles in regulation of PMN chemotaxis; IClswell through direct effects on PMN volume and ClC-3 through regulation of IClswell.	[Volk, A. Paige Davis; Heise, Christine K.; Hougen, Jami L.; Artman, Christopher M.; Volk, Kenneth A.; Lamb, Fred S.; Moreland, Jessica G.] Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [Wessels, Deborah; Soll, David R.] Univ Iowa, Coll Med, Dept Biol Sci, WM Keck Dynam Image Anal Facil, Iowa City, IA 52242 USA; [Nauseef, William M.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Volk, A. Paige Davis; Heise, Christine K.; Hougen, Jami L.; Artman, Christopher M.; Nauseef, William M.; Moreland, Jessica G.] Univ Iowa, Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Volk, A. Paige Davis; Heise, Christine K.; Hougen, Jami L.; Artman, Christopher M.; Nauseef, William M.; Moreland, Jessica G.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Volk, APD (corresponding author), 7770-C JPP UIHC,200 Hawkins Dr, Iowa City, IA 52242 USA.	paige-volk@uiowa.edu		Nauseef, William/0000-0003-4032-757X; Lamb, Fred/0000-0003-2955-5133	National Institutes of Health [HD-041922, HD-047349, HD-18577, AI-34879, HL-62483, AI-067533, AI-073872]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018577, T32HD041922] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL062483, R01HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073872, R01AI034879, R56AI034879, R21AI067533] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HD-041922 and HD-047349 (to A. P. D. V.), HD-18577 (to D. R. S.), AI-34879 (to W. M. N.), HL-62483 (to F. S. L.), and AI-067533 and AI-073872 (to J. G. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BORREGAARD N, 1993, EUR J HAEMATOL, V51, P187; Browe DM, 2004, J GEN PHYSIOL, V124, P273, DOI 10.1085/jgp.200409040; CALA A, 1990, CHLORIDE CHANNELS CA; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; Demaurex N, 1996, J CELL BIOL, V133, P1391, DOI 10.1083/jcb.133.6.1391; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; DOWNEY GP, 1995, J CELL PHYSIOL, V163, P96, DOI 10.1002/jcp.1041630111; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Garcia-Duran M, 1999, CIRC RES, V85, P1020; Geiger J, 2003, CELL MOTIL CYTOSKEL, V56, P27, DOI 10.1002/cm.10133; Greenwood IA, 1998, AM J PHYSIOL-HEART C, V275, pH1524, DOI 10.1152/ajpheart.1998.275.5.H1524; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; Hermoso M, 2002, J BIOL CHEM, V277, P40066, DOI 10.1074/jbc.M205132200; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; KELLY MEM, 1994, J PHYSIOL-LONDON, V475, P377, DOI 10.1113/jphysiol.1994.sp020079; Kim MJ, 2004, CLIN EXP IMMUNOL, V138, P453, DOI 10.1111/j.1365-2249.2004.02635.x; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; KRAUSE KH, 1990, J CLIN INVEST, V85, P491, DOI 10.1172/JCI114464; Lala A, 1997, BIOCHEM PHARMACOL, V54, P381, DOI 10.1016/S0006-2952(97)00191-3; Lang F, 1998, CELL PHYSIOL BIOCHEM, V8, P1, DOI 10.1159/000016269; Lavigne MC, 2002, CELL IMMUNOL, V218, P7, DOI 10.1016/S0008-8749(02)00564-6; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Liu L, 1998, J IMMUNOL, V160, P2463; Mao JW, 2007, CELL PHYSIOL BIOCHEM, V19, P249, DOI 10.1159/000100644; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; MATSUDA JJ, 2008, FASEB J, V22; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; MORELAND JG, 2007, J BIOL CHEM; Nobles M, 2004, AM J PHYSIOL-CELL PH, V287, pC1426, DOI 10.1152/ajpcell.00549.2002; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; ROSENGREN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1623, DOI 10.1152/ajpcell.1994.267.6.C1623; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; SENGELOV H, 1993, J IMMUNOL, V150, P1535; SHIMIZU Y, 1993, BIOCHEM PHARMACOL, V45, P1743; SIMCHOWITZ L, 1991, AM J PHYSIOL, V261, pC906, DOI 10.1152/ajpcell.1991.261.5.C906; SIMCHOWITZ L, 1986, J GEN PHYSIOL, V88, P167, DOI 10.1085/jgp.88.2.167; SIMCHOWITZ L, 1993, AM J PHYSIOL, V265, pC143, DOI 10.1152/ajpcell.1993.265.1.C143; SOLL DR, 1988, J CELL BIOCHEM, V37, P177, DOI 10.1002/jcb.240370205; Soll DR, 1995, INT REV CYTOL, V163, P43; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Stepanovic V, 2004, CELL MOTIL CYTOSKEL, V57, P158, DOI 10.1002/cm.10164; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; STODDARD JS, 1993, AM J PHYSIOL, V265, pC156, DOI 10.1152/ajpcell.1993.265.1.C156; SUGAWARA T, 1995, J PHARMACOL TOXICOL, V33, P91, DOI 10.1016/1056-8719(94)00062-9; VALVERDE MA, 1993, PFLUG ARCH EUR J PHY, V425, P552, DOI 10.1007/BF00374885; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; VARNUM B, 1984, J CELL BIOL, V99, P1151, DOI 10.1083/jcb.99.3.1151; Wang J, 2005, JPN J PHYSIOL, V55, P379, DOI 10.2170/jjphysiol.S655; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; Weylandt KH, 2001, J BIOL CHEM, V276, P17461, DOI 10.1074/jbc.M011667200; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	58	43	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34315	34326		10.1074/jbc.M803141200	http://dx.doi.org/10.1074/jbc.M803141200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840613	hybrid, Green Published			2022-12-25	WOS:000261277700059
J	Inagaki, M; Omori, E; Kim, JY; Komatsu, Y; Scott, G; Ray, MK; Yamada, G; Matsumoto, K; Mishina, Y; Ninomiya-Tsuji, J				Inagaki, Maiko; Omori, Emily; Kim, Jae-Young; Komatsu, Yoshihiro; Scott, Greg; Ray, Manas K.; Yamada, Gen; Matsumoto, Kunihiro; Mishina, Yuji; Ninomiya-Tsuji, Jun			TAK1-binding Protein 1, TAB1, Mediates Osmotic Stress-induced TAK1 Activation but Is Dispensable for TAK1-mediated Cytokine Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; KINASE TAK1; TRANSDUCTION PATHWAY; IN-VIVO; IL-1; COMPLEX; MAPKKK; JNK; IKK; AUTOPHOSPHORYLATION	TAK1 kinase is an indispensable intermediate in several cytokine signaling pathways including tumor necrosis factor, interleukin-1, and transforming growth factor-beta signaling pathways. TAK1 also participates in stress-activated intracellular signaling pathways such as osmotic stress signaling pathway. TAK1-binding protein 1 (TAB1) is constitutively associated with TAK1 through its C-terminal region. Although TAB1 is known to augment TAK1 catalytic activity when it is overexpressed, the role of TAB1 under physiological conditions has not yet been identified. In this study, we determined the role of TAB1 in TAK1 signaling by analyzing TAB1-deficient mouse embryonic fibroblasts (MEFs). Tumor necrosis factor- and interleukin-1-induced activation of TAK1 was entirely normal in Tab1-deficient MEFs and could activate both mitogen-activated protein kinases and NF-kappa B. In contrast, we found that osmotic stress-induced activation of TAK1 was largely impaired in Tab1-deficient MEFs. Furthermore, we showed that the C-terminal 68 amino acids of TAB1 were sufficient to mediate osmotic stress-induced TAK1 activation. Finally, we attempted to determine the mechanism by which TAB1 activates TAK1. We found that TAK1 is spontaneously activated when the concentration is increased and that it is totally dependent on TAB1. Cell shrinkage under the osmotic stress condition increases the concentration of TAB1-TAK1 and may oligomerize and activate TAK1 in a TAB1-dependent manner. These results demonstrate that TAB1 mediates TAK1 activation only in a subset of TAK1 pathways that are mediated through spontaneous oligomerization of TAB1-TAK1.	[Inagaki, Maiko; Omori, Emily; Kim, Jae-Young; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Komatsu, Yoshihiro; Mishina, Yuji] NIEHS, Mol Dev Biol Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Komatsu, Yoshihiro; Yamada, Gen] Kumamoto Univ, Grad Sch Mol & Genom Pharm, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; [Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; [Matsumoto, Kunihiro] Japan Sci & Technol Agcy, Tokyo, Japan; [Mishina, Yuji] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA	University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kumamoto University; Nagoya University; Japan Science & Technology Agency (JST); University of Michigan System; University of Michigan	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu		Kim, Jae-Young/0000-0001-6700-1372; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [ES071003-10, GM068812]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIGES102425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES071003-10 (Y.M.) and GM068812 (to J.N.-T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Inagaki M, 2008, GENESIS, V46, P431, DOI 10.1002/dvg.20418; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kitamura T, 1998, INT J HEMATOL, V67, P351; Komatsu Y, 2002, MECH DEVELOP, V119, P239, DOI 10.1016/S0925-4773(02)00391-X; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Roger F, 1999, J BIOL CHEM, V274, P34103, DOI 10.1074/jbc.274.48.34103; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179	40	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33080	33086		10.1074/jbc.M807574200	http://dx.doi.org/10.1074/jbc.M807574200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829460	Green Published, hybrid			2022-12-25	WOS:000261183700008
J	Zanotto, PMD; Krakauer, DC				de Andrade Zanotto, Paolo Marinho; Krakauer, David C.			Complete Genome Viral Phylogenies Suggests the Concerted Evolution of Regulatory Cores and Accessory Satellites	PLOS ONE			English	Article							DNA-SEQUENCE DISSIMILARITY; NEODIPRION-SERTIFER; DISTANCE; VIRUS; GENE; LIKELIHOOD; ALIGNMENT; IDENTIFICATION; BACULOVIRUSES; HERPESVIRUS	We consider the concerted evolution of viral genomes in four families of DNA viruses. Given the high rate of horizontal gene transfer among viruses and their hosts, it is an open question as to how representative particular genes are of the evolutionary history of the complete genome. To address the concerted evolution of viral genes, we compared genomic evolution across four distinct, extant viral families. For all four viral families we constructed DNA-dependent DNA polymerase-based (DdDp) phylogenies and in addition, whole genome sequence, as quantitative descriptions of inter-genome relationships. We found that the history of the polymerase gene was highly predictive of the history of the genome as a whole, which we explain in terms of repeated, co-divergence events of the core DdDp gene accompanied by a number of satellite, accessory genetic loci. We also found that the rate of gene gain in baculovirus and poxviruses proceeds significantly more quickly than the rate of gene loss and that there is convergent acquisition of satellite functions promoting contextual adaptation when distinct viral families infect related hosts. The congruence of the genome and polymerase trees suggests that a large set of viral genes, including polymerase, derive from a phylogenetically conserved core of genes of host origin, secondarily reinforced by gene acquisition from common hosts or co-infecting viruses within the host. A single viral genome can be thought of as a mutualistic network, with the core genes acting as an effective host and the satellite genes as effective symbionts. Larger virus genomes show a greater departure from linkage equilibrium between core and satellites functions.	[de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Inst Ciencias Biomed ICB 2, Sao Paulo, Brazil; [Krakauer, David C.] Santa Fe Inst, Santa Fe, NM USA	Universidade de Sao Paulo; The Santa Fe Institute	Zanotto, PMD (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed ICB 2, Sao Paulo, Brazil.	pzanotto@usp.br	de A. Zanotto, Paolo M./B-9286-2019	de A. Zanotto, Paolo M./0000-0002-8167-0625	Santa Fe Institute (USA); FAPESP (Brazil) [07/55282-0]; CNPq PQ Productivity Scholarship	Santa Fe Institute (USA); FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq PQ Productivity Scholarship	This work was funded by both the Santa Fe Institute (USA) and FAPESP (Brazil), project number 07/55282-0. PMAZ has a CNPq PQ Productivity Scholarship.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alba MM, 2001, GENOME RES, V11, P43, DOI 10.1101/gr.149801; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWES C, 1967, VIRUSES EVOLUTION; Auch AF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-350; Bell PJL, 2001, J MOL EVOL, V53, P251; Bideshi DK, 2003, J GEN VIROL, V84, P2531, DOI 10.1099/vir.0.19256-0; Booy FP, 1996, VIROLOGY, V215, P134, DOI 10.1006/viro.1996.0016; BRAITHWAITE DK, 1999, NUCLEIC ACIDS RES, V21, P787; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Wolff JL, 2008, J GEN VIROL, V89, P1202, DOI 10.1099/vir.0.83581-0; Chen F, 1996, VIROLOGY, V219, P170, DOI 10.1006/viro.1996.0234; CHIAHSIUNG C, 2002, J VIROL, V76, P9024; Oliveira JVD, 2006, J GEN VIROL, V87, P3233, DOI 10.1099/vir.0.82161-0; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EIGEN M, 1979, HYPERCYCLE PRINCIPLE, P86; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Forterre P, 2005, BIOCHIMIE, V87, P793, DOI 10.1016/j.biochi.2005.03.015; Garcia-Maruniak A, 2004, J VIROL, V78, P7036, DOI 10.1128/JVI.78.13.7036-7051.2004; Green R G, 1935, Science, V82, P443, DOI 10.1126/science.82.2132.443; HAWTIN RE, 1995, VIROLOGY, V212, P673, DOI 10.1006/viro.1995.1525; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; Herniou EA, 2004, J VIROL, V78, P3244, DOI 10.1128/JVI.78.7.3244-3251.2004; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Hohl M, 2007, SYST BIOL, V56, P206, DOI 10.1080/10635150701294741; HUTCHINSON CA, 1999, SCIENCE, V286, P5447; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; KRAKAUER DC, 2007, PROTOCELLS BRIDGING; Laidlaw Patrick P, 1938, VIRUS DIS VIRUSES; Lauzon HAM, 2006, J GEN VIROL, V87, P1477, DOI 10.1099/vir.0.81727-0; MADDISON DR, 2005, MACCLADE 4 RELEASE V; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Monier A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-456; Montague MG, 2000, P NATL ACAD SCI USA, V97, P5334, DOI 10.1073/pnas.97.10.5334; Morse Stephen S., 1994, P1; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; PAGE RDM, 1990, CLADISTICS, V6, P119, DOI 10.1111/j.1096-0031.1990.tb00532.x; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Page RDM, 2002, TANGLED TREES PHYLOG; Pertsemlidis A, 2001, GENOME BIOL, V2; Peterson SN, 2001, GENOME BIOL, V2; POSSEE RD, 1997, BACULOVIRUSES, P109; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Rambaut A, 2014, TRACER V1 6; RAO VB, 1988, J MOL BIOL, V200, P475, DOI 10.1016/0022-2836(88)90537-2; Romano CM, 2006, ARCH VIROL, V151, P2215, DOI 10.1007/s00705-006-0792-1; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Senkevich TG, 1997, VIROLOGY, V233, P19, DOI 10.1006/viro.1997.8607; Spencer M, 2005, MOL BIOL EVOL, V22, P1161, DOI 10.1093/molbev/msi123; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wu TJ, 1997, BIOMETRICS, V53, P1431, DOI 10.2307/2533509; Wu TJ, 2001, BIOMETRICS, V57, P441, DOI 10.1111/j.0006-341X.2001.00441.x; ZANOTTO PMD, 1993, J INVERTEBR PATHOL, V62, P147, DOI 10.1006/jipa.1993.1090	60	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3500	10.1371/journal.pone.0003500	http://dx.doi.org/10.1371/journal.pone.0003500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941535	Green Submitted, Green Published, gold			2022-12-25	WOS:000265126100026
J	Srikrishnan, AK; Venkatesh, KK; Solomon, S; Thamburaj, E; Anand, S; Kosalaraman, KG; Balakrishnan, P; Mayer, KH				Srikrishnan, A. K.; Venkatesh, Kartik K.; Solomon, Suniti; Thamburaj, Easter; Anand, S.; Kosalaraman, K. G.; Balakrishnan, Pachamuthu; Mayer, Kenneth H.			Expansion of HIV Laboratory Diagnostic Services in Chennai, India 2001-2006: Is the Growth Commensurate with the Need?	PLOS ONE			English	Article							PREGNANT-WOMEN; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; GULF STATES; ATTITUDES; DISEASE; URBAN; PUNE; INFECTION; HIV/AIDS	Objective: To describe the changes in HIV services provided and the patient population utilizing voluntary counseling and testing (VCT) services at private testing laboratories in Chennai, India in 2001 and 2006. Methods: In 2001, a cross-sectional descriptive survey was conducted to assess the services provided and client population of 1,031 private laboratories. A subset of labs (9%) that had been surveyed in 2001 were also studied in 2006. Results: In 2001, significantly more high volume labs (. 10 HIV tests per month) offered HIV diagnostic tests than low volume labs (, 10 HIV test per month) (p<0.001). More high volume labs (20.0%) provided pre-test counseling as part of HIV testing than low volume labs (11.1%) (p = 0.003). Between 2001 and 2006, the number of labs that provided HIV diagnostic tests significantly increased, including ELISA (87.8% vs. 40.0%), Western Blot (84.4% vs. 13.3%), and Tridot (98.9% vs. 72.2%) (p<0.001). Also the number of labs that reported greater than 10 women seeking HIV testing per month significantly increased from 14.5% to 79.0% (p = 0.006). More labs provided pre-test counseling in 2006 (34.4%) than in 2001 (21.1%) (p = 0.046). Conclusions: Though HIV diagnostic testing services have increasingly become available, counseling services have not expanded commensurately. Further outreach and education is necessary to expand comprehensive HIV VCT services in both urban and rural India.	[Srikrishnan, A. K.; Solomon, Suniti; Thamburaj, Easter; Anand, S.; Kosalaraman, K. G.; Balakrishnan, Pachamuthu] VHS, YRG CARE, Madras, Tamil Nadu, India; [Venkatesh, Kartik K.; Mayer, Kenneth H.] Brown Univ, Sch Med, Div Infect Dis, Miriam Hosp, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital	Srikrishnan, AK (corresponding author), VHS, YRG CARE, Madras, Tamil Nadu, India.	Kenneth_Mayer@Brown.edu	Balakrishnan, Pachamuthu/ABV-6282-2022	Balakrishnan, Pachamuthu/0000-0002-1710-9155	Brown University's AIDS International Research and Training Program of the Fogarty International Center at the National Institutes of Health (NIH), USA [D43TW00237]; Lifespan/Tufts/Brown Center for AIDS Research (CFAR) of the NIH, USA [P30 AI42853]; FOGARTY INTERNATIONAL CENTER [D43TW000237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER	Brown University's AIDS International Research and Training Program of the Fogarty International Center at the National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Lifespan/Tufts/Brown Center for AIDS Research (CFAR) of the NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to the research survey staff at the YRG Centre for AIDS Research and Education, VHS, Chennai, India, for their facilitation of the study. The authors would like to thank Brown University's AIDS International Research and Training Program of the Fogarty International Center at the National Institutes of Health (NIH), USA, (grant no. D43TW00237), and the Lifespan/Tufts/Brown Center for AIDS Research (CFAR) of the NIH, USA (grant no. #P30 AI42853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, INCR ACC HIV TEST CO; Anvikar AR, 2005, ACTA TROP, V93, P289, DOI 10.1016/j.actatropica.2004.10.009; Bentley ME, 1998, AIDS, V12, P1869, DOI 10.1097/00002030-199814000-00019; Bharucha KE, 2005, INT J STD AIDS, V16, P553, DOI 10.1258/0956462054679250; Brown H, 2001, INT J STD AIDS, V12, P390, DOI 10.1258/0956462011923345; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Day JH, 2003, AIDS CARE, V15, P665, DOI 10.1080/0954012030001595140; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; KANDELA P, 1994, BRIT MED J, V308, P617, DOI 10.1136/bmj.308.6929.617b; Kielmann K, 2005, SOC SCI MED, V61, P1540, DOI 10.1016/j.socscimed.2005.02.008; Kumarasamy N, 2005, CLIN INFECT DIS, V41, P1525, DOI 10.1086/497267; Kumarasamy N, 2003, CLIN INFECT DIS, V36, P79, DOI 10.1086/344756; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; *NACO, NACO HIV TEST MAN LA; *NACO, 2001, COUNTR SCEN 2000 200; *NACO, 2006, FACTS FIG; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Rogers A, 2006, AIDS PATIENT CARE ST, V20, P803, DOI 10.1089/apc.2006.20.803; Shah SA, 1999, INT J STD AIDS, V10, P812, DOI 10.1258/0956462991913600; Sheikh K, 2005, NATL MED J INDIA, V18, P32; Sinha PK, 2003, JAIDS-J ACQ IMM DEF, V33, P407, DOI 10.1097/00126334-200307010-00017; Solomon S, 2004, AIDS EDUC PREV, V16, P155, DOI 10.1521/aeap.16.3.5.155.35534; Solomon S, 1998, INT J STD AIDS, V9, P98, DOI 10.1258/0956462981921756; Solomon S., 2000, AIDS BEHAV, V4, P71, DOI 10.1023/A:1009540908691; Solomon S, 2006, AIDS BEHAV, V10, P415, DOI 10.1007/s10461-006-9070-1; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; *UNAIDS, 2000, VOL COUNS TEST VCT U; *UNAIDS, 2007, UNAIDS WHO AIDS EP U; *UNAIDS, 2004, KNOW MOR NO MOR AIDS	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3471	10.1371/journal.pone.0003471	http://dx.doi.org/10.1371/journal.pone.0003471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IE	18941613	Green Published, gold, Green Submitted			2022-12-25	WOS:000265125900014
J	Lizano, S; Luo, F; Tengra, FK; Bessen, DE				Lizano, Sergio; Luo, Feng; Tengra, Farah K.; Bessen, Debra E.			Impact of Orthologous Gene Replacement on the Circuitry Governing Pilus Gene Transcription in Streptococci	PLOS ONE			English	Article							VIRULENCE GENES; PYOGENES; RECOMBINATION; EXPRESSION; ROFA; EVOLUTION; REGULATOR; SELECTION; ANTIGENS; NETWORK	Background: The evolutionary history of several genes of the bacterial pathogen Streptococcus pyogenes strongly suggests an origin in another species, acquired via replacement of the counterpart gene (ortholog) following a recombination event. An example of orthologous gene replacement is provided by the nra/rofA locus, which encodes a key regulator of pilus gene transcription. Of biological importance is the previous finding that the presence of the nra- and rofA-lineage alleles, which are similar to 35% divergent, correlates strongly with genetic markers for streptococcal infection at different tissue sites in the human host (skin, throat). Methodology/Principal Findings: In this report, the impact of orthologous gene replacement targeting the nra/rofA locus is experimentally addressed. Replacement of the native nra-lineage allele with a rofA-lineage allele, plus their respective upstream regions, preserved the polarity of Nra effects on pilus gene transcription (i.e., activation) in the skin strain Alab49. Increased pilus gene transcription in the rofA chimera correlated with a higher rate of bacterial growth at the skin. The transcriptional regulator MsmR, which represses nra and pilus gene transcription in the Alab49 parent strain, has a slight activating effect on pilus gene expression in the rofA chimera construct. Conclusions/Significance: Data show that exchange of orthologous forms of a regulatory gene is stable and robust, and pathogenicity is preserved. Yet, new phenotypes may also be introduced by altering the circuitry within a complex transcriptional regulatory network. It is proposed that orthologous gene replacement via interspecies exchange is an important mechanism in the evolution of highly recombining bacteria such as S. pyogenes.	[Lizano, Sergio; Luo, Feng; Tengra, Farah K.; Bessen, Debra E.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY USA	New York Medical College	Lizano, S (corresponding author), IDEXX Labs, Westbrook, ME USA.	debra_bessen@nymc.edu			NIH [R01-AI053826]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053826] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work was supported by funding from the N.I.H. (R01-AI053826).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ANDERSON R M, 1991; Anderson RM, 1998, BIOMED RES REP, P23; Beckert S, 2001, INFECT IMMUN, V69, P534, DOI 10.1128/IAI.69.1.534-537.2001; Bessen DE, 2005, J BACTERIOL, V187, P4163, DOI 10.1128/JB.187.12.4163-4172.2005; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; FOGG GC, 1994, MOL MICROBIOL, V11, P671, DOI 10.1111/j.1365-2958.1994.tb00345.x; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Kalia A, 2002, INFECT IMMUN, V70, P1971, DOI 10.1128/IAI.70.4.1971-1983.2002; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2002, MICROBIOL-SGM, V148, P1501, DOI 10.1099/00221287-148-5-1501; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Kwinn LA, 2007, J BACTERIOL, V189, P1322, DOI 10.1128/JB.01256-06; LEBLANC DJ, 1991, ANTIMICROB AGENTS CH, V35, P1804, DOI 10.1128/AAC.35.9.1804; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizano S, 2007, J BACTERIOL, V189, P1426, DOI 10.1128/JB.01179-06; Luo F, 2008, INFECT IMMUN, V76, P2490, DOI 10.1128/IAI.01567-07; Luo F, 2008, MICROB PATHOGENESIS, V45, P217, DOI 10.1016/j.micpath.2008.05.009; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nakata M, 2005, MOL MICROBIOL, V57, P786, DOI 10.1111/j.1365-2958.2005.04730.x; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; Scaramuzzino DA, 2000, INFECT IMMUN, V68, P2880, DOI 10.1128/IAI.68.5.2880-2887.2000; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Svensson MD, 2002, MICROBIOL-SGM, V148, P3933, DOI 10.1099/00221287-148-12-3933; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101	34	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3450	10.1371/journal.pone.0003450	http://dx.doi.org/10.1371/journal.pone.0003450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941636	Green Published, gold, Green Submitted			2022-12-25	WOS:000265125600009
J	Curry, JM; Eubank, TD; Roberts, RD; Wang, YJ; Pore, N; Maity, A; Marsh, CB				Curry, Jennifer M.; Eubank, Tim D.; Roberts, Ryan D.; Wang, Yijie; Pore, Nabendu; Maity, Amit; Marsh, Clay B.			M-CSF Signals through the MAPK/ERK Pathway via Sp1 to Induce VEGF Production and Induces Angiogenesis In Vivo	PLOS ONE			English	Article								Background: M-CSF recruits mononuclear phagocytes which regulate processes such as angiogenesis and metastases in tumors. VEGF is a potent activator of angiogenesis as it promotes endothelial cell proliferation and new blood vessel formation. Previously, we reported that in vitro M-CSF induces the expression of biologically-active VEGF from human monocytes. Methodology and Results: In this study, we demonstrate the molecular mechanism of M-CSF-induced VEGF production. Using a construct containing the VEGF promoter linked to a luciferase reporter, we found that a mutation reducing HIF binding to the VEGF promoter had no significant effect on luciferase production induced by M-CSF stimulation. Further analysis revealed that M-CSF induced VEGF through the MAPK/ERK signaling pathway via the transcription factor, Sp1. Thus, inhibition of either ERK or Sp1 suppressed M-CSF-induced VEGF at the mRNA and protein level. M-CSF also induced the nuclear localization of Sp1, which was blocked by ERK inhibition. Finally, mutating the Sp1 binding sites within the VEGF promoter or inhibiting ERK decreased VEGF promoter activity in M-CSF-treated human monocytes. To evaluate the biological significance of M-CSF induced VEGF production, we used an in vivo angiogenesis model to illustrate the ability of M-CSF to recruit mononuclear phagocytes, increase VEGF levels, and enhance angiogenesis. Importantly, the addition of a neutralizing VEGF antibody abolished M-CSF-induced blood vessel formation. Conclusion: These data delineate an ERK- and Sp1-dependent mechanism of M-CSF induced VEGF production and demonstrate for the first time the ability of M-CSF to induce angiogenesis via VEGF in vivo.	[Curry, Jennifer M.; Eubank, Tim D.; Roberts, Ryan D.; Wang, Yijie; Marsh, Clay B.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Curry, Jennifer M.; Roberts, Ryan D.; Marsh, Clay B.] Ohio State Univ, Coll Med & Publ Hlth, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Eubank, Tim D.; Wang, Yijie; Marsh, Clay B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Pore, Nabendu; Maity, Amit] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Pennsylvania	Curry, JM (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	clay.marsh@osumc.edu	Eubank, Tim/E-3043-2011; Roberts, Ryan D/D-2573-2013	Roberts, Ryan D/0000-0001-5028-744X; Eubank, Tim/0000-0002-8225-7824; Maity, Amit/0000-0001-7151-2845				Baran CP, 2004, CURR PHARM DESIGN, V10, P855, DOI 10.2174/1381612043452866; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Besse A, 2000, CYTOKINE, V12, P522, DOI 10.1006/cyto.1999.0580; Bhatt NY, 2002, J IMMUNOL, V169, P6427, DOI 10.4049/jimmunol.169.11.6427; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Eubank TD, 2004, IMMUNITY, V21, P831, DOI 10.1016/j.immuni.2004.10.011; Eubank TD, 2003, J IMMUNOL, V171, P2637, DOI 10.4049/jimmunol.171.5.2637; FALKENBURG JHF, 1990, J IMMUNOL, V144, P4657; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Green M, 2000, J HEMATOTH STEM CELL, V9, P237, DOI 10.1089/152581600319450; Gridelli C, 2007, ONCOLOGIST, V12, P1183, DOI 10.1634/theoncologist.12-10-1183; HAMILTON JA, 1988, J CELL PHYSIOL, V134, P405, DOI 10.1002/jcp.1041340311; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Junttila I, 2003, J LEUKOCYTE BIOL, V73, P281, DOI 10.1189/jlb.0702359; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Leonard-Barton D, 1990, ORGAN SCI, V1, P248, DOI 10.1287/orsc.1.3.248; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Majer M, 2007, ANTI-CANCER AGENT ME, V7, P492, DOI 10.2174/187152007781668742; Mancino AT, 2001, J SURG RES, V100, P18, DOI 10.1006/jsre.2001.6204; Marsh CB, 1999, J IMMUNOL, V162, P6217; McDermott RS, 2002, EUR CYTOKINE NETW, V13, P121; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; MISAGO M, 1993, INT J HEMATOL, V58, P43; Novak EM, 2003, GENE THER, V10, P1992, DOI 10.1038/sj.gt.3302111; Okazaki T, 2007, AM J PATHOL, V171, P1093, DOI 10.2353/ajpath.2007.061191; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Ramos MC, 2004, BIOL CHEM, V385, P75, DOI 10.1515/BC.2004.010; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sasaki A, 2006, SURGERY, V139, P755, DOI 10.1016/j.surg.2005.10.009; Scholl SM, 1996, BREAST CANCER RES TR, V39, P275, DOI 10.1007/BF01806155; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; Tojo N, 1999, BBA-MOL CELL RES, V1452, P275, DOI 10.1016/S0167-4889(99)00127-5; Varney ML, 2005, J INTERF CYTOK RES, V25, P674, DOI 10.1089/jir.2005.25.674; Varney ML, 2002, IN VIVO, V16, P471; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; WANG JM, 1988, J IMMUNOL, V141, P575; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J; Yuan A, 2000, INT J CANCER, V89, P475, DOI 10.1002/1097-0215(20001120)89:6<475::AID-IJC2>3.0.CO;2-T	43	74	77	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3405	10.1371/journal.pone.0003405	http://dx.doi.org/10.1371/journal.pone.0003405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852899	Green Published, Green Submitted, gold			2022-12-25	WOS:000265121700010
J	Percival, JM; Anderson, KNE; Gregorevic, P; Chamberlain, JS; Froehner, SC				Percival, Justin M.; Anderson, Kendra N. E.; Gregorevic, Paul; Chamberlain, Jeffrey S.; Froehner, Stanley C.			Functional Deficits in nNOS mu-Deficient Skeletal Muscle: Myopathy in nNOS Knockout Mice	PLOS ONE			English	Article								Skeletal muscle nNOSm (neuronal nitric oxide synthase mu) localizes to the sarcolemma through interaction with the dystrophin-associated glycoprotein (DAG) complex, where it synthesizes nitric oxide (NO). Disruption of the DAG complex occurs in dystrophinopathies and sarcoglycanopathies, two genetically distinct classes of muscular dystrophy characterized by progressive loss of muscle mass, muscle weakness and increased fatigability. DAG complex instability leads to mislocalization and downregulation of nNOSm; but this is thought to play a minor role in disease pathogenesis. This view persists without knowledge of the role of nNOS in skeletal muscle contractile function in vivo and has influenced gene therapy approaches to dystrophinopathy, the majority of which do not restore sarcolemmal nNOSm. We address this knowledge gap by evaluating skeletal muscle function in nNOS knockout (KN1) mice using an in situ approach, in which the muscle is maintained in its normal physiological environment. nNOS-deficiency caused reductions in skeletal muscle bulk and maximum tetanic force production in male mice only. Furthermore, nNOS-deficient muscles from both male and female mice exhibited increased susceptibility to contraction-induced fatigue. These data suggest that aberrant nNOSm signaling can negatively impact three important clinical features of dystrophinopathies and sarcoglycanopathies: maintenance of muscle bulk, force generation and fatigability. Our study suggests that restoration of sarcolemmal nNOSm expression in dystrophic muscles may be more important than previously appreciated and that it should be a feature of any fully effective gene therapy-based intervention.	[Percival, Justin M.; Anderson, Kendra N. E.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Gregorevic, Paul; Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Gregorevic, Paul; Chamberlain, Jeffrey S.; Froehner, Stanley C.] Univ Washington, Senator Paul D Wellstone MD Cooperat Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Percival, JM (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	justinp2@u.washington.edu	Gregorevic, Paul/AAH-6040-2021	Gregorevic, Paul/0000-0002-7418-8945; Chamberlain, Jeffrey/0000-0001-5299-0059	NIH [NS046788, NS33145, U54 HD047175]; Parent Project for Muscular Dystrophy Research Fellowship; MDA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD047175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145, P01NS046788] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parent Project for Muscular Dystrophy Research Fellowship; MDA(Muscular Dystrophy Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS046788 and NS33145 (S.C.F.), NIH grant U54 HD047175 (S.C.F. and J.S.C.), a Parent Project for Muscular Dystrophy Research Fellowship (J.M.P) and a MDA Development Grant (J.M.P).	Adams ME, 2004, J NEUROSCI, V24, P10302, DOI 10.1523/JNEUROSCI.3408-04.2004; Ameredes BT, 1999, J APPL PHYSIOL, V87, P142, DOI 10.1152/jappl.1999.87.1.142; Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Chao DS, 1996, J EXP MED, V184, P609, DOI 10.1084/jem.184.2.609; Crosbie RH, 2002, FASEB J, V16, P1786, DOI 10.1096/fj.02-0519com; Dellorusso C, 2001, J MUSCLE RES CELL M, V22, P467, DOI 10.1023/A:1014587918367; Eu JP, 2003, P NATL ACAD SCI USA, V100, P15229, DOI 10.1073/pnas.2433468100; Gregorevic P, 2004, MUSCLE NERVE, V30, P295, DOI 10.1002/mus.20082; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Haller R, 2004, MYOLOGY, V3rd, P665; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Matecki S, 2001, NEUROMUSCULAR DISORD, V11, P171, DOI 10.1016/S0960-8966(00)00179-6; Mongini T, 2002, NEUROPEDIATRICS, V33, P109, DOI 10.1055/s-2002-32374; Odom GL, 2007, BBA-MOL BASIS DIS, V1772, P243, DOI 10.1016/j.bbadis.2006.09.007; Reid MB, 1998, COMP BIOCHEM PHYS A, V119, P211, DOI 10.1016/S1095-6433(97)00417-0; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; SOCKOLOV R, 1977, ARCH PHYS MED REHAB, V58, P195; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Vermeer S, 2004, PEDIATR NEUROL, V30, P291, DOI 10.1016/j.pediatrneurol.2003.11.006; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007	31	66	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3387	10.1371/journal.pone.0003387	http://dx.doi.org/10.1371/journal.pone.0003387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852886	gold, Green Published			2022-12-25	WOS:000265121600011
J	Ding, GH; Yu, ZH; Zhao, J; Wang, Z; Li, Y; Xing, XB; Wang, CA; Liu, L; Li, YX				Ding, Guohui; Yu, Zhonghao; Zhao, Jing; Wang, Zhen; Li, Yun; Xing, Xiaobin; Wang, Chuan; Liu, Lei; Li, Yixue			Tree of Life Based on Genome Context Networks	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; RNA SECONDARY STRUCTURE; SYMBIOBACTERIUM-THERMOPHILUM; SEQUENCE; EVOLUTION; DATABASE; RECONSTRUCTION; PHYLOGENOMICS; BACTERIUM; INSIGHTS	Efforts in phylogenomics have greatly improved our understanding of the backbone tree of life. However, due to the systematic error in sequence data, a sequence-based phylogenomic approach leads to well-resolved but statistically significant incongruence. Thus, independent test of current phylogenetic knowledge is required. Here, we have devised a distance-based strategy to reconstruct a highly resolved backbone tree of life, on the basis of the genome context networks of 195 fully sequenced representative species. Along with strongly supporting the monophylies of three superkingdoms and most taxonomic sub-divisions, the derived tree also suggests some intriguing results, such as high G+C gram positive origin of Bacteria, classification of Symbiobacterium thermophilum and Alcanivorax borkumensis in Firmicutes. Furthermore, simulation analyses indicate that addition of more gene relationships with high accuracy can greatly improve the resolution of the phylogenetic tree. Our results demonstrate the feasibility of the reconstruction of highly resolved phylogenetic tree with extensible gene networks across all three domains of life. This strategy also implies that the relationships between the genes (gene network) can define what kind of species it is.	[Ding, Guohui; Wang, Zhen; Li, Yun; Xing, Xiaobin; Wang, Chuan; Liu, Lei; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China; [Ding, Guohui; Wang, Zhen; Li, Yun; Xing, Xiaobin] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Yu, Zhonghao; Zhao, Jing; Li, Yixue] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai, Peoples R China; [Zhao, Jing; Liu, Lei; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences	Ding, GH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China.	yxli@sibs.ac.cn	Zhao, Jing/S-3581-2019; Yu, Zhonghao/F-5459-2011	Zhao, Jing/0000-0002-2439-2876; Yu, Zhonghao/0000-0001-7144-9356; Li, Yun/0000-0001-8414-2724	973 National Key Basic Research Program of China [2006CB910705, 2003CB715901, 2002CB512801]	973 National Key Basic Research Program of China(National Basic Research Program of China)	The 973 National Key Basic Research Program of China (grant no. 2006CB910705, 2003CB715901, 2002CB512801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JF, 2007, NATURE, V445, P610, DOI 10.1038/445610a; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Danchin A., 2002, DELPHIC BOAT WHAT GE; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Heymans M, 2003, BIOINFORMATICS, V19, pi138, DOI 10.1093/bioinformatics/btg1018; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Koch AL, 2003, TRENDS MICROBIOL, V11, P166, DOI 10.1016/S0966-842X(03)00063-5; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Kurland CG, 2005, BIOESSAYS, V27, P741, DOI 10.1002/bies.20258; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lewontin RC, 2002, ANNU REV GENET, V36, P1, DOI 10.1146/annurev.genet.36.052902.102704; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Ogurtsov AY, 2006, BIOINFORMATICS, V22, P1317, DOI 10.1093/bioinformatics/btl083; Ohno M, 2000, INT J SYST EVOL MICR, V50, P1829, DOI 10.1099/00207713-50-5-1829; Perriere G, 2000, GENOME RES, V10, P379, DOI 10.1101/gr.10.3.379; Podani J, 2001, NAT GENET, V29, P54, DOI 10.1038/ng708; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneiker S, 2006, NAT BIOTECHNOL, V24, P997, DOI 10.1038/nbt1232; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830; Wang ML, 2006, MOL BIOL EVOL, V23, P2444, DOI 10.1093/molbev/msl117; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; Whitfield J, 2007, NATURE, V446, P247, DOI 10.1038/446247a; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Zhang Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-252	49	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3357	10.1371/journal.pone.0003357	http://dx.doi.org/10.1371/journal.pone.0003357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18852873	Green Published, gold, Green Submitted			2022-12-25	WOS:000265114100003
J	Lihoreau, M; Zimmer, C; Rivault, C				Lihoreau, Mathieu; Zimmer, Cedric; Rivault, Colette			Mutual Mate Choice: When it Pays Both Sexes to Avoid Inbreeding	PLOS ONE			English	Article							BLATTELLA-GERMANICA; SEXUAL SELECTION; REPRODUCTIVE SUCCESS; KIN RECOGNITION; COCKROACH; PREFERENCES; PHEROMONE; COMPATIBILITY; EVOLUTION; RATIOS	Theoretical models of sexual selection predict that both males and females of many species should benefit by selecting their mating partners. However, empirical evidence testing and validating this prediction is scarce. In particular, whereas inbreeding avoidance is expected to induce sexual conflicts, in some cases both partners could benefit by acting in concert and exerting mutual mate choice for non-assortative pairings. We tested this prediction with the gregarious cockroach Blattella germanica (L.). We demonstrated that males and females base their mate choice on different criteria and that choice occurs at different steps during the mating sequence. Males assess their relatedness to females through antennal contacts before deciding to court preferentially non-siblings. Conversely, females biased their choice towards the most vigorously courting males that happened to be non-siblings. This study is the first to demonstrate mutual mate choice leading to close inbreeding avoidance. The fact that outbred pairs were more fertile than inbred pairs strongly supports the adaptive value of this mating system, which includes no "best phenotype'' as the quality of two mating partners is primarily linked to their relatedness. We discuss the implications of our results in the light of inbreeding conflict models.	[Lihoreau, Mathieu; Zimmer, Cedric; Rivault, Colette] Univ Rennes 1, CNRS, UMR Ethos 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Lihoreau, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethos 6552, Campus Beaulieu, Rennes, France.	mathieu.lihoreau@univ-rennes1.fr	Lihoreau, Mathieu/H-7623-2013; Zimmer, Cédric/C-5654-2011	Zimmer, Cedric/0000-0001-8160-2836; Lihoreau, Mathieu/0000-0002-2463-2040	CNRS; University of Rennes 1	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1	CNRS, University of Rennes 1	ADMUNDSEN T, 2001, P NATL ACAD SCI USA, V98, P13155; Anderson WW, 2007, P NATL ACAD SCI USA, V104, P4484, DOI 10.1073/pnas.0611152104; Andersson Malte, 1994; Archie EA, 2007, MOL ECOL, V16, P4138, DOI 10.1111/j.1365-294X.2007.03483.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bateson P., 1983, P257; BELL WJ, 1978, J INSECT PHYSIOL, V24, P369, DOI 10.1016/0022-1910(78)90077-X; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; BREED M D, 1975, Zeitschrift fuer Tierpsychologie, V39, P24; CHENOWETH SF, 2003, EVOL DEV, P2326; CLUTTONBROCK TH, 1991, NATURE, V351, P58; COCHRAN DG, 1979, ENTOMOL EXP APPL, V26, P259, DOI 10.1111/j.1570-7458.1979.tb02927.x; Cornwell P.B., 1968, COCKROACH, V1; Darwin C., 1874, DESCENT MAN SELECTIO; Drickamer LC, 2003, ANIM BEHAV, V65, P105, DOI 10.1006/anbe.2002.2027; Eliyahu D, 2008, J CHEM ECOL, V34, P229, DOI 10.1007/s10886-007-9409-8; Gowaty PA, 2002, EVOLUTION, V56, P2537, DOI 10.1111/j.0014-3820.2002.tb00178.x; GWYNNE DT, 1981, SCIENCE, V213, P779, DOI 10.1126/science.213.4509.779; HILL GE, 1993, EVOLUTION, V47, P1515, DOI 10.1111/j.1558-5646.1993.tb02172.x; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1997, BEHAV ECOL SOCIOBIOL, V40, P51, DOI 10.1007/s002650050315; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; JONES IL, 1993, NATURE, V362, P238, DOI 10.1038/362238a0; Kokko H, 2001, ECOL LETT, V4, P159, DOI 10.1046/j.1461-0248.2001.00212.x; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kokko H, 2002, PHILOS T R SOC B, V357, P319, DOI 10.1098/rstb.2001.0926; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; LIHOREAU M, BEHAV ECOL IN PRESS; Lihoreau M, 2008, ANIM BEHAV, V75, P1965, DOI 10.1016/j.anbehav.2007.12.006; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; McCullagh P, 1989, GEN LINEAR MODELS; MOORE AJ, 1988, ANIM BEHAV, V36, P303, DOI 10.1016/S0003-3472(88)80278-1; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; MULLINS DE, 1980, NATURE, V283, P567, DOI 10.1038/283567a0; Nojima S, 1999, NATURWISSENSCHAFTEN, V86, P193, DOI 10.1007/s001140050596; Nojima S, 2005, SCIENCE, V307, P1104, DOI 10.1126/science.1107163; OWENS IPF, 1994, P ROY SOC B-BIOL SCI, V258, P93, DOI 10.1098/rspb.1994.0148; PARKER AG, 1983, MATE CHOICE, P141; Parker G.A., 1979, P123; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; RIVAULT C, 1990, ENTOMOL EXP APPL, V57, P85, DOI 10.1007/BF00349598; RIVAULT C, 1989, ENTOMOL EXP APPL, V53, P247, DOI 10.1007/BF00162856; ROTH LM, 1952, AM MIDL NAT, V47, P66, DOI 10.2307/2421700; Ryan KK, 2001, BEHAV ECOL SOCIOBIOL, V50, P436; Servedio MR, 2006, EVOLUTION, V60, P674; SIMMONS LW, 1991, ANIM BEHAV, V41, P493, DOI 10.1016/S0003-3472(05)80852-8; Singer TL, 1998, AM ZOOL, V38, P394; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vander Meer RK., 1998, PHEROMONE COMMUNICAT, P159; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585	56	52	53	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3365	10.1371/journal.pone.0003365	http://dx.doi.org/10.1371/journal.pone.0003365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18843373	Green Published, gold, Green Submitted			2022-12-25	WOS:000265114100007
J	Jung, KH; Dardick, C; Bartley, LE; Cao, PJ; Phetsom, J; Canlas, P; Seo, YS; Shultz, M; Ouyang, S; Yuan, Q; Frank, BC; Ly, E; Zheng, L; Jia, Y; Hsia, AP; An, K; Chou, HH; Rocke, D; Lee, GC; Schnable, PS; An, G; Buell, CR; Ronald, PC				Jung, Ki-Hong; Dardick, Christopher; Bartley, Laura E.; Cao, Peijian; Phetsom, Jirapa; Canlas, Patrick; Seo, Young-Su; Shultz, Michael; Ouyang, Shu; Yuan, Qiaoping; Frank, Bryan C.; Ly, Eugene; Zheng, Li; Jia, Yi; Hsia, An-Ping; An, Kyungsook; Chou, Hui-Hsien; Rocke, David; Lee, Geun Cheol; Schnable, Patrick S.; An, Gynheung; Buell, C. Robin; Ronald, Pamela C.			Refinement of Light-Responsive Transcript Lists Using Rice Oligonucleotide Arrays: Evaluation of Gene-Redundancy	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; RUBISCO ACTIVASE; MICROARRAY DATA; PLANT PEROXISOMES; DRAFT SEQUENCE; ARABIDOPSIS; EXPRESSION; FAMILY; ANNOTATION; PROTEIN	Studies of gene function are often hampered by gene-redundancy, especially in organisms with large genomes such as rice (Oryza sativa). We present an approach for using transcriptomics data to focus functional studies and address redundancy. To this end, we have constructed and validated an inexpensive and publicly available rice oligonucleotide near-whole genome array, called the rice NSF45K array. We generated expression profiles for light-vs. dark-grown rice leaf tissue and validated the biological significance of the data by analyzing sources of variation and confirming expression trends with reverse transcription polymerase chain reaction. We examined trends in the data by evaluating enrichment of gene ontology terms at multiple false discovery rate thresholds. To compare data generated with the NSF45K array with published results, we developed publicly available, web-based tools (www.ricearray.org). The Oligo and EST Anatomy Viewer enables visualization of EST-based expression profiling data for all genes on the array. The Rice Multi-platform Microarray Search Tool facilitates comparison of gene expression profiles across multiple rice microarray platforms. Finally, we incorporated gene expression and biochemical pathway data to reduce the number of candidate gene products putatively participating in the eight steps of the photorespiration pathway from 52 to 10, based on expression levels of putatively functionally redundant genes. We confirmed the efficacy of this method to cope with redundancy by correctly predicting participation in photorespiration of a gene with five paralogs. Applying these methods will accelerate rice functional genomics.	[Jung, Ki-Hong; Bartley, Laura E.; Cao, Peijian; Phetsom, Jirapa; Canlas, Patrick; Seo, Young-Su; Shultz, Michael; Rocke, David; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Dardick, Christopher] USDA ARS, Appalachian Fruit Res Stat, Kearneysville, WV USA; [Ouyang, Shu; Yuan, Qiaoping; Frank, Bryan C.; Ly, Eugene; Zheng, Li; Buell, C. Robin] J Craig Venter Inst, Rockville, MD USA; [Jia, Yi; Hsia, An-Ping; Chou, Hui-Hsien; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA 50011 USA; [An, Kyungsook; An, Gynheung] Pohang Univ Sci & Technol, Funct Genom Ctr, Pohang, South Korea; [Lee, Geun Cheol] Konkuk Univ, Coll Business Adm, Seoul, South Korea	University of California System; University of California Davis; United States Department of Agriculture (USDA); J. Craig Venter Institute; Iowa State University; Pohang University of Science & Technology (POSTECH); Konkuk University	Jung, KH (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu	Rocke, David M/I-7044-2013; Jung, Ki Hong/L-5570-2019; Jia, Yi/F-7476-2010; Bartley, Laura/AAF-2217-2020; Ronald, Pamela/AAK-7664-2020; Cao, Peijian/U-6776-2019	Rocke, David M/0000-0002-3958-7318; Jung, Ki Hong/0000-0003-0427-5901; Bartley, Laura/0000-0001-8610-7551; Schnable, Patrick/0000-0001-9169-5204; Buell, C Robin/0000-0002-6727-4677; Yuan, Qiaoping/0000-0002-5880-8702	National Science Foundation Plant Genome Program [DBI0313887]; USDA [2004-35604-14226]; NIH [5R01GM055962-0]; Biogreen 21 Program [20070401-034-001-007-03-00]; National Research Laboratory Program funded by the Ministry of Science and Technology [M10600000270-06J0000-27010]; Korea Research Foundation [KRF-2005-C00155]; Hatch Act; State of Iowa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER	National Science Foundation Plant Genome Program(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogreen 21 Program(Rural Development Administration (RDA), Republic of Korea); National Research Laboratory Program funded by the Ministry of Science and Technology; Korea Research Foundation(National Research Foundation of Korea); Hatch Act(United States Department of Agriculture (USDA)); State of Iowa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by a competitive grants from the National Science Foundation Plant Genome Program (award: #DBI0313887), the USDA (# 2004-35604-14226) and the NIH (#5R01GM055962-0) to P.C. Ronald, a grant from the Biogreen 21 Program (20070401-034-001-007-03-00) to G. An, and a grant from the National Research Laboratory Program funded by the Ministry of Science and Technology (M10600000270-06J0000-27010) to G. An. K.H. Jung was supported by a Korea Research Foundation Grant (KRF-2005-C00155). Support was also provided by the Hatch Act and State of Iowa funds.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; *AFF, 2001, AFF MICR SUIT US GUI; Affymetrix, 2002, STAT ALG DESCR DOC; Ain R, 2004, P NATL ACAD SCI USA, V101, P16543, DOI 10.1073/pnas.0406185101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Boldt R, 2005, PLANT CELL, V17, P2413, DOI 10.1105/tpc.105.033993; Britten RJ, 2005, P NATL ACAD SCI USA, V102, P5466, DOI 10.1073/pnas.0501008102; Budhu A, 2007, CARCINOGENESIS, V28, P1552, DOI 10.1093/carcin/bgm075; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 1999, GENOME RES, V9, P825, DOI 10.1101/gr.9.9.825; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; EDWARDS JW, 1989, PLANT CELL, V1, P241, DOI 10.1105/tpc.1.2.241; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b; Feuillet C, 2002, ANN BOT-LONDON, V89, P3, DOI 10.1093/aob/mcf008; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Green JA, 2004, P NATL ACAD SCI USA, V101, P16397, DOI 10.1073/pnas.0406934101; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hiei Y, 1997, PLANT MOL BIOL, V35, P205, DOI 10.1023/A:1005847615493; Igarashi D, 2003, PLANT J, V33, P975, DOI 10.1046/j.1365-313X.2003.01688.x; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jeon JS, 2001, PLANT SCI, V161, P211, DOI 10.1016/S0168-9452(01)00414-9; Jiao YL, 2005, PLANT CELL, V17, P3239, DOI 10.1105/tpc.105.035840; Johns MA, 2007, FUNCT INTEGR GENOMIC, V7, P135, DOI 10.1007/s10142-006-0036-1; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Jung KH, 2008, NAT REV GENET, V9, P91, DOI 10.1038/nrg2286; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Jung KH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000164; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Komari T, 1998, CURR OPIN PLANT BIOL, V1, P161, DOI 10.1016/S1369-5266(98)80019-8; Komatsu S, 2003, MOL CELL PROTEOMICS, V2, P2, DOI 10.1074/mcp.R200008-MCP200; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; LAN Y, 1992, PLANT PHYSIOL, V99, P304, DOI 10.1104/pp.99.1.304; Leegood RC, 2007, NAT BIOTECHNOL, V25, P539, DOI 10.1038/nbt0507-539; Li MN, 2007, PLANT PHYSIOL, V144, P1797, DOI 10.1104/pp.107.101600; Liepman AH, 2001, PLANT J, V25, P487, DOI 10.1046/j.1365-313x.2001.00961.x; Lu RX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-314; Ma LG, 2005, GENOME RES, V15, P1274, DOI 10.1101/gr.3657405; Matsumoto F, 2004, PLANT PHYSIOL, V135, P2379, DOI 10.1104/pp.104.042408; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Miki D, 2005, PLANT PHYSIOL, V138, P1903, DOI 10.1104/pp.105.063933; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Pollock SV, 2003, PLANT PHYSIOL, V133, P1854, DOI 10.1104/pp.103.032078; Raghavachari N, 2003, ANAL BIOCHEM, V312, P101, DOI 10.1016/S0003-2697(02)00440-2; Ren XY, 2005, PLANT PHYSIOL, V138, P923, DOI 10.1104/pp.104.055673; Rensink W, 2005, GENOME, V48, P598, DOI 10.1139/G05-034; Rensink Willem Albert, 2005, Functional & Integrative Genomics, V5, P201, DOI 10.1007/s10142-005-0141-6; Reumann S, 2006, BBA-MOL CELL RES, V1763, P1496, DOI 10.1016/j.bbamcr.2006.09.008; Richards KD, 1998, PLANT PHYSIOL, V116, P409, DOI 10.1104/pp.116.1.409; Rocke DM, 2004, SEMIN CELL DEV BIOL, V15, P703, DOI 10.1016/j.semcdb.2004.09.007; Rohila JS, 2006, PLANT J, V46, P1, DOI 10.1111/j.1365-313X.2006.02671.x; Sharma A, 2002, BIOCHEM BIOPH RES CO, V290, P690, DOI 10.1006/bbrc.2001.6269; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shimamoto K, 2002, ANNU REV PLANT BIOL, V53, P399, DOI 10.1146/annurev.arplant.53.092401.134447; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Somerville CR, 2001, PLANT PHYSIOL, V125, P20, DOI 10.1104/pp.125.1.20; Stangeland B, 2005, J EXP BOT, V56, P2495, DOI 10.1093/jxb/eri242; Sterck L, 2007, CURR OPIN PLANT BIOL, V10, P199, DOI 10.1016/j.pbi.2007.01.004; STITT M, 1984, PLANT PHYSIOL, V75, P554, DOI 10.1104/pp.75.3.554; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voll LM, 2006, PLANT PHYSIOL, V140, P59, DOI 10.1104/pp.105.071399; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Yang DH, 1998, PLANT PHYSIOL, V118, P827, DOI 10.1104/pp.118.3.827; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan QP, 2005, PLANT PHYSIOL, V138, P17, DOI 10.1104/pp.104.059063; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	86	89	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3337	10.1371/journal.pone.0003337	http://dx.doi.org/10.1371/journal.pone.0003337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836531	Green Published, gold, Green Submitted			2022-12-25	WOS:000265113500005
J	Yumoto, N; Wakatsuki, S; Kurisaki, T; Hara, Y; Osumi, N; Frisen, J; Sehara-Fujisawa, A				Yumoto, Norihiro; Wakatsuki, Shuji; Kurisaki, Tomohiro; Hara, Yoshinobu; Osumi, Noriko; Frisen, Jonas; Sehara-Fujisawa, Atsuko			Meltrin beta/ADAM19 Interacting with EphA4 in Developing Neural Cells Participates in Formation of the Neuromuscular Junction	PLOS ONE			English	Article								Background: Development of the neuromuscular junction (NMJ) is initiated by the formation of postsynaptic specializations in the central zones of muscles, followed by the arrival of motor nerve terminals opposite the postsynaptic regions. The post- and presynaptic components are then stabilized and modified to form mature synapses. Roles of ADAM (A Disintegrin And Metalloprotease) family proteins in the formation of the NMJ have not been reported previously. Principal Findings: We report here that Meltrin beta, ADAM19, participates in the formation of the NMJ. The zone of acetylcholine receptor alpha mRNA distribution was broader and excess sprouting of motor nerve terminals was more prominent in meltrin beta-deficient than in wild-type embryonic diaphragms. A microarray analysis revealed that the preferential distribution of ephrin-A5 mRNA in the synaptic region of muscles was aberrant in the meltrin beta-deficient muscles. Excess sprouting of motor nerve terminals was also found in ephrin-A5 knockout mice, which lead us to investigate a possible link between Meltrin beta and ephrin-A5-Eph signaling in the development of the NMJ. Meltrin beta and EphA4 interacted with each other in developing motor neurons, and both of these proteins localized in the NMJ. Coexpression of Meltrin beta and EphA4 strongly blocked vesicular internalization of ephrin-A5-EphA4 complexes without requiring the protease activity of Meltrin beta, suggesting a regulatory role of Meltrin beta in ephrin-A5-Eph signaling. Conclusion: Meltrin beta plays a regulatory role in formation of the NMJ. The endocytosis of ephrin-Eph complexes is required for efficient contact-dependent repulsion between ephrin and Eph. We propose that Meltrin beta stabilizes the interaction between ephrin-A5 and EphA4 by regulating endocytosis of the ephrinA5-EphA complex negatively, which would contribute to the fine-tuning of the NMJ during development.	[Yumoto, Norihiro; Wakatsuki, Shuji; Kurisaki, Tomohiro; Sehara-Fujisawa, Atsuko] Kyoto Univ, Dept Growth Regulat, Inst Frontier Med Sci, Kyoto, Japan; [Hara, Yoshinobu; Osumi, Noriko] Tohoku Univ, Sch Med, Ctr Translat & Advanced Anim Res CTTAR, Div Dev Neurosci, Sendai, Miyagi, Japan; [Frisen, Jonas] Medical Nobel Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Kyoto University; Tohoku University	Yumoto, N (corresponding author), Kyoto Univ, Dept Growth Regulat, Inst Frontier Med Sci, Kyoto, Japan.	asehara@frontier.kyoto-u.ac.jp	Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452; hara, Yoshinobu/0000-0001-6339-5116	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare; CREST (Core Research for Evolutional Science and Technology); Japan Science and Technology Corporation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); CREST (Core Research for Evolutional Science and Technology)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST))	Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare, Research Grant from CREST (Core Research for Evolutional Science and Technology), the Japan Science and Technology Corporation	Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Holmberg J, 2002, TRENDS NEUROSCI, V25, P239, DOI 10.1016/S0166-2236(02)02149-5; Inoue D, 1998, J BIOL CHEM, V273, P4180, DOI 10.1074/jbc.273.7.4180; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012; Komatsu K, 2007, DEV BIOL, V303, P82, DOI 10.1016/j.ydbio.2006.10.037; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; Lai KO, 2001, MOL CELL NEUROSCI, V17, P1034, DOI 10.1006/mcne.2001.0997; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marignani PA, 2001, J CELL BIOL, V154, P177, DOI 10.1083/jcb.200103134; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; MARTIN PT, 1995, SCIENCE, V269, P413, DOI 10.1126/science.7618109; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Weinl C, 2003, DEVELOPMENT, V130, P1635, DOI 10.1242/dev.00386; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	52	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3322	10.1371/journal.pone.0003322	http://dx.doi.org/10.1371/journal.pone.0003322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830404	Green Submitted, Green Published, gold			2022-12-25	WOS:000264797300010
J	Jones, HN; Woollett, LA; Barbour, N; Prasad, PD; Powell, TL; Jansson, T				Jones, Helen N.; Woollett, Laura A.; Barbour, Nicolette; Prasad, Puttur D.; Powell, Theresa L.; Jansson, Thomas			High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice	FASEB JOURNAL			English	Article; Proceedings Paper	55th Annual Meeting of the Society-for-Gynecologic-Investigation	MAR 26-29, 2008	San Diego, CA	Soc Gynecol Invest		maternal obesity; macrosomia	AMINO-ACID TRANSPORTER; INTRAUTERINE GROWTH RESTRICTION; ACTIVATED-RECEPTOR-GAMMA; MATERNAL OBESITY; GLUCOSE-TRANSPORTER; METABOLIC SYNDROME; UNITED-STATES; EXPRESSION; LEPTIN; ADIPONECTIN	Maternal overweight and obesity in pregnancy often result in fetal overgrowth, which increases the risk for the baby to develop metabolic syndrome later in life. However, the mechanisms underlying fetal overgrowth are not established. We developed a mouse model and hypothesized that a maternal high-fat (HF) diet causes up-regulation of placental nutrient transport, resulting in fetal overgrowth. C57BL/6J female mice were fed a control (11% energy from fat) or HF (32% energy from fat) diet for 8 wk before mating and throughout gestation and were studied at embryonic day 18.5. The HF diet increased maternal adiposity, as assessed by fat pad weight, and circulating maternal leptin, decreased serum adiponectin concentrations, and caused a marked increase in fetal growth (+43%). The HF diet also increased transplacental transport of glucose (5-fold) and neutral amino acids (10-fold) in vivo. In microvillous plasma membranes (MVMs) isolated from placentas of HF-fed animals, protein expression of glucose transporter 1 (GLUT1) was increased 5-fold, and protein expression of sodium-coupled neutral amino acid transporter (SNAT) 2 was elevated 9-fold. In contrast, MVM protein expression of GLUT 3 or SNAT4 was unaltered. These data suggest that up-regulation of specific placental nutrient transporter isoforms constitute a mechanism linking maternal high-fat diet and obesity to fetal overgrowth.-Jones, H. N., Woollett, L. A., Barbour, N., Prasad, P. D., Powell, T. L., Jansson, T. High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J. 23, 271-278 (2009)	[Jones, Helen N.] Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Cincinnati, OH 45267 USA; [Jones, Helen N.; Barbour, Nicolette; Powell, Theresa L.; Jansson, Thomas] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Prasad, Puttur D.] Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Georgia; Augusta University	Jones, HN (corresponding author), Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	helen.jones@uc.edu	Powell, Theresa/AAE-4249-2020	Powell, Theresa/0000-0001-7410-1080	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034089, R03HD058032, R56HD034089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630] Funding Source: NIH RePORTER; NICHD NIH HHS [R03HD058032, R03 HD058032, R01 HD034089, HD34089, R56 HD034089, HD058032] Funding Source: Medline; NIDDK NIH HHS [U24 DK059630, DK59630] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ananth CV, 2002, SEMIN PERINATOL, V26, P260, DOI 10.1053/sper.2002.34772; BOILEAU P, 1995, J CLIN INVEST, V96, P309, DOI 10.1172/JCI118036; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; BOWERS GN, 1966, CLIN CHEM, V12, P70; Caminos JE, 2005, J CLIN ENDOCR METAB, V90, P4276, DOI 10.1210/jc.2004-0930; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Clifton PM, 1998, PROSTAG LEUKOTR ESS, V59, P191, DOI 10.1016/S0952-3278(98)90062-X; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; DEVASKAR SU, 1994, AM J OBSTET GYNECOL, V171, P1316, DOI 10.1016/0002-9378(94)90154-6; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Ericsson A, 2005, AM J PHYSIOL-REG I, V288, pR656, DOI 10.1152/ajpregu.00407.2004; Ericsson A, 2005, HUM REPROD, V20, P521, DOI 10.1093/humrep/deh596; Fang X, 2005, J MOL ENDOCRINOL, V35, P465, DOI 10.1677/jme.1.01877; Gallou-Kabani C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1095, DOI 10.1152/ajpendo.00390.2006; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Han J, 2005, DIABETOLOGIA, V48, P1810, DOI 10.1007/s00125-005-1854-8; Hendler I, 2005, AM J OBSTET GYNECOL, V193, P979, DOI 10.1016/j.ajog.2005.06.041; Holemans K, 2004, AM J OBSTET GYNECOL, V190, P858, DOI 10.1016/j.ajog.2003.09.025; Jansson N, 2003, J CLIN ENDOCR METAB, V88, P1205, DOI 10.1210/jc.2002-021332; Jansson N, 2008, AM J CLIN NUTR, V87, P1743, DOI 10.1093/ajcn/87.6.1743; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Jansson T, 2002, DIABETES, V51, P2214, DOI 10.2337/diabetes.51.7.2214; Jansson T, 1999, AM J OBSTET GYNECOL, V180, P163, DOI 10.1016/S0002-9378(99)70169-9; Jansson T, 2001, AM J OBSTET GYNECOL, V184, P111, DOI 10.1067/mob.2001.108075; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; KARL PI, 1992, AM J PHYSIOL, V262, pC834, DOI 10.1152/ajpcell.1992.262.4.C834; KARNIK HB, 1990, DEV PHARMACOL THERAP, V14, P135, DOI 10.1159/000480930; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; KURUVILLA AG, 1994, J CLIN INVEST, V94, P689, DOI 10.1172/JCI117386; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lesage J, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740037; Ling R, 2001, BBA-BIOMEMBRANES, V1512, P15, DOI 10.1016/S0005-2736(01)00310-8; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Muhlhausler BS, 2007, ENDOCRINOLOGY, V148, P878, DOI 10.1210/en.2006-1115; Novak D, 2006, PLACENTA, V27, P510, DOI 10.1016/j.placenta.2005.05.002; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogura K, 1999, J ENDOCRINOL, V160, P443, DOI 10.1677/joe.0.1600443; PERLOW JH, 1992, AM J OBSTET GYNECOL, V167, P958, DOI 10.1016/S0002-9378(12)80019-6; RAMSAY JE, 2006, J CLIN ENDOCR METAB, V87, P4231; Rosenbloom A, 2000, DIABETES CARE, V23, P381; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; SARKKINEN ES, 1994, AM J CLIN NUTR, V59, P364, DOI 10.1093/ajcn/59.2.364; Sattar N, 1998, ACTA OBSTET GYN SCAN, V77, P278, DOI 10.1034/j.1600-0412.1998.770304.x; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR234; Umekawa T, 2008, ENDOCRINOLOGY, V149, P3980, DOI 10.1210/en.2007-1682; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	55	225	230	0	47	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					271	278		10.1096/fj.08-116889	http://dx.doi.org/10.1096/fj.08-116889			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18827021	Green Published			2022-12-25	WOS:000262095500029
J	Lee, SH; Kim, J; Kim, WH; Lee, YM				Lee, S. H.; Kim, J.; Kim, W-H; Lee, Y. M.			Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells	ONCOGENE			English	Article						hypoxia; RUNX3; histone methylation; histone deacetylation; G9a; HDAC1	HELICOBACTER-PYLORI; DNA METHYLATION; GENE-EXPRESSION; E-CADHERIN; GROWTH; HYPERMETHYLATION; DEACETYLASE; REPRESSION; METHYLTRANSFERASE; UBIQUITINATION	RUNX3 is a tumor suppressor that is silenced in cancer following hypermethylation of its promoter. The effects of hypoxia in tumor suppressor gene (TSG) transcription are largely unknown. Here, we investigated hypoxia-induced silencing mechanisms of RUNX3. The expression of RUNX3 was downregulated in response to hypoxia in human gastric cancer cells at the transcriptional level. This downregulation was abolished following treatment with the histone deacetylase ( HDAC) inhibitor trichostatin A (TSA) and cytosine methylation inhibitor 5-aza-2-deoxycytidine (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in RUNX3 silencing by hypoxia. DNA methylation PCR and bisulfite-sequencing data revealed that hypoxia did not affect the methylation of RUNX3 promoter. A chromatin immunoprecipitation (ChIP) assay revealed increased histone H3-lysine 9 dimethylation and decreased H3 acetylation in the RUNX3 promoter following hypoxia. Hypoxia resulted in the upregulation of G9a histone methyltransferase (HMT) and HDAC1; additionally, overexpression of G9a and HDAC1 attenuated RUNX3 expression. The overexpression of G9a and HDAC1, but not their mutants, inhibited the nuclear localization and expression of RUNX3. Diminished mRNA expression and nuclear localization of RUNX3 during hypoxia was abolished by siRNA-mediated knockdown of G9a and HDAC1. This study suggests that hypoxia silences RUNX3 by epigenetic histone regulation during the progression of gastric cancer.	[Lee, S. H.; Lee, Y. M.] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Dept Nat Sci, Taegu 702701, South Korea; [Kim, J.; Kim, W-H] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, J.; Kim, W-H] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Kyungpook National University; Seoul National University (SNU); Seoul National University (SNU)	Lee, YM (corresponding author), Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Dept Nat Sci, Taegu 702701, South Korea.	lym@knu.ac.kr	Kim, Wooho/G-3703-2011		National R&D Program for Cancer Control, Ministry of Health and Welfare [0520120-1]; Korea Science and Engineering Foundation (KOSEF) [MOST; R01-2006-000-11046-0]	National R&D Program for Cancer Control, Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation)	Expression vectors of full-length HDAC1 and HDAC1 mutants were kindly provided by Dr Kyu-Won Kim (Seoul National University), GFP-tagged human G9a expression vector, pEGFP-hG9a, and its SET domain deletion mutant, pEGFP-hG9a (Delta SET) were by Martin Walsh (Mount Sinai School of Medicine, New York, NY, USA) and myc-tagged RUNX3 plasmids in pCS4 was by Dr Suk-Chul Bae (Chungbuk National University, Korea). This work was supported by National R&D Program for Cancer Control, Ministry of Health and Welfare (0520120-1) and the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST; R01-2006-000-11046-0).	Anderson C, 2006, MOL DIAGN THER, V10, P345, DOI 10.1007/BF03256211; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Box AH, 2004, CARCINOGENESIS, V25, P2325, DOI 10.1093/carcin/bgh274; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Chan AOO, 2003, AM J PATHOL, V163, P370, DOI 10.1016/S0002-9440(10)63663-2; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Ekstrom AM, 2001, GASTROENTEROLOGY, V121, P784, DOI 10.1053/gast.2001.27999; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Fahrner JA, 2002, CANCER RES, V62, P7213; Gibbons RJ, 2005, HUM MOL GENET, V14, pR85, DOI 10.1093/hmg/ddi106; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huang CH, 2007, BIOCHEM PHARMACOL, V73, P990, DOI 10.1016/j.bcp.2006.12.013; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kim JH, 2001, COMPOS INTERFACE, V7, P443, DOI 10.1163/156855400750262932; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Liu YL, 1998, NUCLEIC ACIDS RES, V26, P1038, DOI 10.1093/nar/26.4.1038; Meng AX, 2005, RADIOTHER ONCOL, V76, P168, DOI 10.1016/j.radonc.2005.06.025; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen CT, 2002, CANCER RES, V62, P6456; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Shaw J, 2006, CIRC RES, V99, P1347, DOI 10.1161/01.RES.0000251744.06138.50; Takebayashi S, 2001, BIOCHEM BIOPH RES CO, V288, P921, DOI 10.1006/bbrc.2001.5863; Tamaru H, 2003, MOL CELL BIOL, V23, P2379, DOI 10.1128/MCB.23.7.2379-2394.2003; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Ushijima T, 2004, CANCER CELL, V5, P121, DOI 10.1016/S1535-6108(04)00033-9; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wei DY, 2005, CANCER RES, V65, P4809, DOI 10.1158/0008-5472.CAN-04-3741; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125	47	114	122	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					184	194		10.1038/onc.2008.377	http://dx.doi.org/10.1038/onc.2008.377			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18850007				2022-12-25	WOS:000262501100003
J	Vasudevan, S; Yuan, J; Osapay, G; Tran, P; Tai, K; Liang, W; Kumar, V; Selsted, ME; Cocco, MJ				Vasudevan, Sheeja; Yuan, Jun; Oesapay, George; Tran, Patti; Tai, Kenneth; Liang, Warren; Kumar, Vasanth; Selsted, Michael E.; Cocco, Melanie J.			Synthesis, Structure, and Activities of an Oral Mucosal alpha-Defensin from Rhesus Macaque	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; SALT BRIDGE; CRYPTDIN-4; SYSTEM; NP-2	The oral cavity is an environment challenged by a large variety of pathogens. Consequently, the antimicrobial peptides expressed in that environment are interesting as they evolved to defend against a broad spectrum of bacteria and fungi. Here we report the discovery of new alpha-defensins from rhesus macaque oral mucosa and determine the first alpha-defensin structure from that species. The new peptides were identified by sequencing of reverse transcriptase-PCR products obtained from oral mucosal tissues, disclosing three mucosal alpha-defensins, termed rhesus macaque oral alpha-defensins (ROADs). The peptide corresponding to fully processed ROAD-1 was synthesized, subjected to folding/ oxidation conditions, and purified. ROAD-1 was active against Staphylococcus aureus, Escherichia coli, and Candida albicans in a concentration-dependent manner. Wedetermined the structure of ROAD-1 using NMR spectroscopy and find that the synthetic peptide adopts the canonical disulfide pairing and alpha-defensin fold. The antimicrobial mechanism of defensins has been correlated with their ability to disrupt and permeabilize the cell envelope, activities that depend on the surface features of the folded peptide. Although ROAD-1 maintains the defensin fold, the oral defensin displays distinct surface features when compared with other alpha-defensin structures.	[Vasudevan, Sheeja; Tai, Kenneth; Cocco, Melanie J.] Univ Calif Irvine, Sch Med, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Yuan, Jun; Oesapay, George; Tran, Patti; Liang, Warren; Kumar, Vasanth; Selsted, Michael E.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Selsted, ME (corresponding author), Univ Calif Irvine, Sch Med, Dept Mol Biol & Biochem, D440 Med Sci 1, Irvine, CA 92697 USA.	michael.selsted@uci.edu; mcocco@uci.edu	Cocco, Melanie J/B-7929-2010	Cocco, Melanie J/0000-0003-4039-5863	National Institutes of Health [DE15517, AI229331, AI58129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE15517, AI229331, and AI58129 ( to M. E. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Dale BA, 2005, CURR ISSUES MOL BIOL, V7, P119; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hristova K, 1997, J BIOL CHEM, V272, P24224, DOI 10.1074/jbc.272.39.24224; Jing WG, 2004, BIOCHEMISTRY-US, V43, P15759, DOI 10.1021/bi048645p; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar S, 2001, IBM J RES DEV, V45, P499, DOI 10.1147/rd.453.0499; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; McManus AM, 2000, BIOCHEMISTRY-US, V39, P15757, DOI 10.1021/bi000457l; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Ouellette AJ, 1999, INFECT IMMUN, V67, P6643; PARDI A, 1992, BIOCHEMISTRY-US, V31, P11357, DOI 10.1021/bi00161a013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, INFECT IMMUN, V72, P1470, DOI 10.1128/IAI.72.3.1470-1478.2004; Tang YQ, 1999, INFECT IMMUN, V67, P6139, DOI 10.1128/IAI.67.11.6139-6144.1999; Thennarasu S, 1999, BIOCHEM BIOPH RES CO, V254, P281, DOI 10.1006/bbrc.1998.9933; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wong JH, 2007, CURR PROTEIN PEPT SC, V8, P446, DOI 10.2174/138920307782411446; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wuthrich K, 1986, NMR PROTEINS NUCL AC	34	6	6	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35869	35877		10.1074/jbc.M806915200	http://dx.doi.org/10.1074/jbc.M806915200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18930922	Green Published, hybrid			2022-12-25	WOS:000261687900062
J	Berniakovich, I; Trinei, M; Stendardo, M; Migliaccio, E; Minucci, S; Bernardi, P; Pelicci, PG; Giorgio, M				Berniakovich, Ina; Trinei, Mirella; Stendardo, Massimo; Migliaccio, Enrica; Minucci, Saverio; Bernardi, Paolo; Pelicci, Pier Giuseppe; Giorgio, Marco			p66(Shc)-generated Oxidative Signal Promotes Fat Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; HYDROGEN-PEROXIDE; INSULIN-RECEPTOR; ADIPOCYTE DIFFERENTIATION; UNCOUPLING PROTEINS; 3T3-L1 ADIPOCYTES; REDOX REGULATION; ADAPTER PROTEIN; ADIPOSE-TISSUE; GENE PROTECTS	Reactive oxygen species (ROS) and insulin signaling in the adipose tissue are critical determinants of aging and age-associated diseases. It is not clear, however, if they represent independent factors or they are mechanistically linked. We investigated the effects of ROS on insulin signaling using as model system the p66(Shc)-null mice. p66(Shc) is a redox enzyme that generates mitochondrial ROS and promotes aging in mammals. We report that insulin activates the redox enzyme activity of p66(Shc) specifically in adipocytes and that p66(Shc)-generated ROS regulate insulin signaling through multiple mechanisms, including AKT phosphorylation, Foxo localization, and regulation of selected insulin target genes. Deletion of p66(Shc) resulted in increased mitochondrial uncoupling and reduced triglyceride accumulation in adipocytes and in vivo increased metabolic rate and decreased fat mass and resistance to diet-induced obesity. In addition, p66(Shc-/-) mice showed impaired thermo-insulation. These findings demonstrate that p66(Shc)-generated ROS regulate the effect of insulin on the energetic metabolism in mice and suggest that intracellular oxidative stress might accelerate aging by favoring fat deposition and fat-related disorders.	[Berniakovich, Ina; Stendardo, Massimo; Migliaccio, Enrica; Minucci, Saverio; Pelicci, Pier Giuseppe; Giorgio, Marco] European Inst Oncol, I-20141 Milan, Italy; [Berniakovich, Ina; Stendardo, Massimo; Migliaccio, Enrica; Pelicci, Pier Giuseppe; Giorgio, Marco] Firc Inst Mol Oncol, I-20139 Milan, Italy; [Trinei, Mirella; Minucci, Saverio] Genextra SpA, I-20139 Milan, Italy; [Bernardi, Paolo] Univ Padua, Dipartimento Sci Biochim, I-35128 Padua, Italy; [Pelicci, Pier Giuseppe] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20142 Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Padua; University of Milan	Giorgio, M (corresponding author), Ist Europeo Oncol, Via Ripamonti 435, I-20139 Milan, Italy.	marco.giorgio@ifom-ieo-campus.it	Migliaccio, Enrica/AAQ-8880-2020; Giorgio, Marco/I-9425-2012; Minucci, Saverio/J-9669-2012; Bernardi, Paolo/C-3656-2008; Pelicci, Pier Giuseppe/AAL-6572-2020	Giorgio, Marco/0000-0002-5842-6042; Bernardi, Paolo/0000-0001-9187-3736; 	National Institutes of Health [1P01AG025532-01A1]; Associazione Italiana per la Ricerca sul Cancro; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01AG025532-01A1. This work was also supported by grants from Associazione Italiana per la Ricerca sul Cancro. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bevan P, 2001, J CELL SCI, V114, P1429; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; CHAMPIGNY O, 1992, MOL CELL ENDOCRINOL, V86, P73, DOI 10.1016/0303-7207(92)90177-8; Cho KJ, 2003, J BIOL CHEM, V278, P34823, DOI 10.1074/jbc.M210747200; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Harman D, 1998, ANN NY ACAD SCI, V854, P1, DOI 10.1111/j.1749-6632.1998.tb09886.x; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kao AW, 1997, ENDOCRINOLOGY, V138, P2474, DOI 10.1210/en.138.6.2474; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; Kim JR, 2006, EXP MOL MED, V38, P162, DOI 10.1038/emm.2006.20; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; MAY JM, 1979, J BIOL CHEM, V254, P9017; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Sjogren K, 2001, J NUTR, V131, P2963, DOI 10.1093/jn/131.11.2963; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Weindruch R., 1988, RETARDATION AGING DI; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F	41	128	130	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34283	34293		10.1074/jbc.M804362200	http://dx.doi.org/10.1074/jbc.M804362200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18838380	hybrid, Green Published			2022-12-25	WOS:000261277700056
J	Cheung, WD; Sakabe, K; Housley, MP; Dias, WB; Hart, GW				Cheung, Win D.; Sakabe, Kaoru; Housley, Michael P.; Dias, Wagner B.; Hart, Gerald W.			O-Linked beta-N-Acetylglucosaminyltransferase Substrate Specificity Is Regulated by Myosin Phosphatase Targeting and Other Interacting Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLE; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; TETRATRICOPEPTIDE REPEATS; IN-VIVO; PHOSPHORYLATION; NUCLEAR; GLCNACYLATION; ROLES; GLYCOSYLATION	O-GlcNAc-transferase (OGT) substrate specificity is regulated by transiently interacting proteins. To further examine the regulation of OGT, we have identified 27 putative OGT-interacting proteins through a yeast two-hybrid screen. Two of these proteins, Trak1 (OIP106) and O-GlcNA case, have been shown previously to interact with and regulate OGT. We demonstrate here that MYPT1 and CARM1 also interact with and target OGT. MYPT1 and CARM1 are substrates of OGT in vitro and in vivo. MYPT1 and CARM1 also function to alter OGT substrate specificity in vitro. Furthermore depletion of MYPT1 in Neuro-2a neuroblastoma cells alters GlcNA cylation of several proteins under basal conditions, suggesting that MYPT1 regulates OGT substrate specificity in vivo.	[Cheung, Win D.; Sakabe, Kaoru; Housley, Michael P.; Dias, Wagner B.; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Dias, Wagner/B-1401-2016	Dias, Wagner/0000-0002-8378-8846; Hart, Gerald/0000-0001-7812-4351	National Institutes of Health [R01 HD13563, R01 CA42486]; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD13563 and R01 CA42486 (to G. W. H.). This work was also supported by a National Science Foundation graduate research fellowship (to W. D. C.). Under a licensing agreement between The Johns Hopkins University, Covance Research Products, Sigma-Aldrich, and Santa Cruz Biotechnology, G. W. H. receives royalties from the sale of the CTD110.6 O-GlcNAc antibody. The terms of this agreement are managed by The Johns Hopkins University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cieniewski-Bernard C, 2004, MOL CELL PROTEOMICS, V3, P577, DOI 10.1074/mcp.M400024-MCP200; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hedou J, 2007, J BIOL CHEM, V282, P10360, DOI 10.1074/jbc.M606787200; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Marz P, 2006, J BIOL CHEM, V281, P20263, DOI 10.1074/jbc.M601563200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; Nolte D, 2002, MAMM GENOME, V13, P62, DOI 10.1007/s00335-001-2108-9; Okamoto R, 2005, TRANSGENIC RES, V14, P337, DOI 10.1007/s11248-005-3453-3; Riu IH, 2008, BIOCHEM BIOPH RES CO, V372, P203, DOI 10.1016/j.bbrc.2008.05.034; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	37	119	120	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33935	33941		10.1074/jbc.M806199200	http://dx.doi.org/10.1074/jbc.M806199200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840611	Green Published, hybrid			2022-12-25	WOS:000261277700020
J	Hao, N; Zeng, YX; Elston, TC; Dohlman, HG				Hao, Nan; Zeng, Yaxue; Elston, Timothy C.; Dohlman, Henrik G.			Control of MAPK Specificity by Feedback Phosphorylation of Shared Adaptor Protein Ste50	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; SIGNAL-TRANSDUCTION; RESPONSE PATHWAY; OSMOTIC-STRESS; INVASIVE GROWTH; PLASMA-MEMBRANE; KINASE CASCADE; STE11P MAPKKK; SAM DOMAIN	Many different signaling pathways share common components but nevertheless invoke distinct physiological responses. In yeast, the adaptor protein Ste50 functions in multiple mitogen-activated protein (MAP) kinase pathways, each with unique dynamical and developmental properties. Although Kss1 activity is sustained and promotes invasive growth, Hog1 activity is transient and promotes cell adaptation to osmotic stress. Here we show that osmotic stress activates Kss1 as well as Hog1. We show further that Hog1 phosphorylates Ste50 and that phosphorylation of Ste50 limits the duration of Kss1 activation and prevents invasive growth under high osmolarity growth conditions. Thus feedback regulation of a shared component can restrict the activity of a competing MAP kinase to ensure signal fidelity.	[Zeng, Yaxue; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Hao, Nan; Elston, Timothy C.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu	Hao, Nan/O-3462-2016	Hao, Nan/0000-0003-2857-4789; Dohlman, Henrik/0000-0003-2443-0729				Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Bhattacharjya S, 2004, J MOL BIOL, V344, P1071, DOI 10.1016/j.jmb.2004.09.018; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Davenport KD, 1999, GENETICS, V153, P1091; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Erdman S, 2001, GENETICS, V159, P919; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grimshaw SJ, 2004, J BIOL CHEM, V279, P2192, DOI 10.1074/jbc.M305605200; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Jansen G, 2001, MOL GENET GENOMICS, V265, P102, DOI 10.1007/s004380000394; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1998, MOL CELL BIOL, V18, P5788, DOI 10.1128/MCB.18.10.5788; RAD MR, 1992, MOL GEN GENET, V236, P145; Rad MR, 1998, MOL GEN GENET, V259, P29, DOI 10.1007/s004380050785; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Truckses DM, 2006, MOL CELL BIOL, V26, P912, DOI 10.1128/MCB.26.3.912-928.2006; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706; Wu CL, 2003, EUKARYOT CELL, V2, P949, DOI 10.1128/EC.2.5.949-961.2003; Xu G, 1996, MOL MICROBIOL, V20, P773, DOI 10.1111/j.1365-2958.1996.tb02516.x; Zaragoza O, 2000, ANTON LEEUW INT J G, V78, P187, DOI 10.1023/A:1026594407609	45	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33798	33802		10.1074/jbc.C800179200	http://dx.doi.org/10.1074/jbc.C800179200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854322	Green Published, hybrid			2022-12-25	WOS:000261277700002
J	Ogawa, E; Okuyama, R; Egawa, T; Nagoshi, H; Obinata, M; Tagami, H; Ikawa, S; Aiba, S				Ogawa, Eisaku; Okuyama, Ryuhei; Egawa, Teie; Nagoshi, Hirokazu; Obinata, Masuo; Tagami, Hachiro; Ikawa, Shuntaro; Aiba, Setsuya			p63/p51-induced Onset of Keratinocyte Differentiation via the c-Jun N-terminal Kinase Pathway Is Counteracted by Keratinocyte Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 HOMOLOG; STEM-CELLS; P63; SKIN; EXPRESSION; COMMITMENT; PROTEIN; PROLIFERATION; PSORIASIS; EPIDERMIS	p63/p51, a homolog of the tumor suppressor protein p53, is chiefly expressed in epithelial tissues, including the epidermis. p63 affects cell death similar to p53, and also plays important roles in the development of epithelial tissues and the maintenance of epithelial stem cells. Because it remains unclear how p63 regulates epithelial cell differentiation, we examined the function(s) of p63 in keratinocyte differentiation through the use of a keratinocyte culture system. Delta Np63 alpha(Delta Np51B), a p63 isoform specifically expressed in basal keratinocytes, suppressed the differentiation of specific late-stage proteins, such as filaggrin and loricrin. In contrast, Delta Np63 alpha induced keratin 1 (K1), which is expressed at the start of differentiation, via c-Jun N-terminal kinase (JNK)/AP-1 activation. However, p63 did not induce K1 expression in the basal layer in vivo, although basal keratinocytes had high levels of p63. This discrepancy was explained by the suppression of K1 expression by dermis-secreted keratinocyte growth factor. This suppression occurred via extracellular signal-related kinase (ERK) signaling, and counteracted the p63-mediated induction of K1. Thus, a precise balance between p63 and keratinocyte growth factor mediates the onset of epithelial cell differentiation, through JNK and ERK signaling. These data may provide mechanistic explanations for the pathological features of skin diseases, including psoriasis.	[Ogawa, Eisaku; Okuyama, Ryuhei; Egawa, Teie; Tagami, Hachiro; Aiba, Setsuya] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi 9808574, Japan; [Nagoshi, Hirokazu; Obinata, Masuo; Ikawa, Shuntaro] Tohoku Univ, Dept Cell Biol, Inst Dev Aging & Canc, Sendai, Miyagi 9808574, Japan; [Nagoshi, Hirokazu; Ikawa, Shuntaro] Tohoku Univ, Interdisciplinary Res Ctr, Ikawa Grp, Sendai, Miyagi 9808574, Japan	Tohoku University; Tohoku University; Tohoku University	Okuyama, R (corresponding author), 1-1 Seriyo Machi,Aoba Ku, Sendai, Miyagi 9808574, Japan.	rokuyama@mail.tains.tohoku.ac.jp	井川, 俊太郎/L-5911-2015		Ministry of Education, Culture, Sports, Science, and Technology of the Japanese	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Finch PW, 1997, AM J PATHOL, V151, P1619; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Fomenkov A, 2003, J BIOL CHEM, V278, P23906, DOI 10.1074/jbc.M300746200; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Glickman JN, 2001, HUM PATHOL, V32, P1157, DOI 10.1053/hupa.2001.28951; Haase I, 2001, J CLIN INVEST, V108, P527, DOI 10.1172/JCI200112153; Honeycutt KA, 2004, J INVEST DERM SYMP P, V9, P261, DOI 10.1111/j.1087-0024.2004.09312.x; Hu H, 2002, INT J CANCER, V102, P580, DOI 10.1002/ijc.10739; HUFF CA, 1993, J BIOL CHEM, V268, P377; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Koster MI, 2005, J INVEST DERM SYMP P, V10, P118, DOI 10.1111/j.1087-0024.2005.200416.x; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; LU B, 1994, J BIOL CHEM, V269, P7443; Massion PP, 2003, CANCER RES, V63, P7113; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mills AA, 2006, CURR OPIN GENET DEV, V16, P38, DOI 10.1016/j.gde.2005.12.001; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Ogawa E, 2008, ONCOGENE, V27, P848, DOI 10.1038/sj.onc.1210682; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Ridky TW, 2004, CELL CYCLE, V3, P621; SCHRODER JM, 1995, J INVEST DERMATOL, V105, P20; Shen CS, 2005, J DERMATOL, V32, P236, DOI 10.1111/j.1346-8138.2005.tb00755.x; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8	41	33	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34241	34249		10.1074/jbc.M804101200	http://dx.doi.org/10.1074/jbc.M804101200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18849344	Green Published, hybrid			2022-12-25	WOS:000261277700052
J	Racek, T; Buhlmann, S; Rust, F; Knoll, S; Alla, V; Putzer, BM				Racek, Tomas; Buhlmann, Sven; Ruest, Franziska; Knoll, Susanne; Alla, Vijay; Puetzer, Brigitte M.			Transcriptional Repression of the Prosurvival Endoplasmic Reticulum Chaperone GRP78/BIP by E2F1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CARCINOMA-CELL-LINES; NF-Y CBF; STRESS-RESPONSE; GENE-EXPRESSION; BREAST-CANCER; TFII-I; E2F1-INDUCED APOPTOSIS; DRUG-RESISTANCE; BINDING-SITE	The endoplasmic reticulum chaperone GRP78/BIP plays a central role in the prosurvival machinery, and its enhanced expression has been implicated in drug resistance, carcinogenesis, and metastasis. E2F1, as part of an antitumor safeguard mechanism, promotes apoptosis regardless of functional p53. Using cells that are defective in p53, we show that E2F1 represses GRP78/BIP at the transcriptional level, and this requires its DNA binding domain. Analysis of human GRP78/BIP promoter reporter constructs revealed that the region between -371 and -109 of the proximal promoter contains major E2F1-responsive elements. Toward understanding the underlying mechanism of this regulation, we performed chromatin immunoprecipitation and gel shift assays, demonstrating that E2F1 directly binds to GC-rich regions in the distal GC-box and endoplasmic reticulum stress response element -126 by interfering with the binding of positive regulatory proteins Sp1 and TFII-I of the ER stress response element-binding factor complex. We further show that TFII-I, which is required for optimal stress induction of GRP78/BIP, is suppressed by E2F1 on the protein level. Finally, our studies suggest a molecular link between the inhibition of GRP78/BIP and E2F1-mediated chemosensitization of tumor cells, underscoring its relevance for cancer treatment. Together, the data provide a new mechanism for the incompletely understood tumor suppressor function of E2F1.	[Racek, Tomas; Buhlmann, Sven; Ruest, Franziska; Knoll, Susanne; Alla, Vijay; Puetzer, Brigitte M.] Univ Rostock, Biomed Res Ctr, Dept Vectorol & Expt Gene Therapy, D-18055 Rostock, Germany	University of Rostock	Putzer, BM (corresponding author), Schillingallee 69, D-18055 Rostock, Germany.	brigitte.puetzer@med.uni-rostock.de			Forschungsforderung der Medizinischen Fakultat der Rostocker Universitat [889007]	Forschungsforderung der Medizinischen Fakultat der Rostocker Universitat	This work was supported by Forschungsforderung der Medizinischen Fakultat der Rostocker Universitat Grant 889007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdelrahim M, 2005, J BIOL CHEM, V280, P16508, DOI 10.1074/jbc.C500030200; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blais A, 2002, J BIOL CHEM, V277, P31679, DOI 10.1074/jbc.M204554200; Brown JM, 1998, CANCER RES, V58, P1408; Chen M, 2002, CIRCULATION, V106, P2707, DOI 10.1161/01.CIR.0000038706.30661.86; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Desgranges ZP, 2005, MOL CELL BIOL, V25, P10940, DOI 10.1128/MCB.25.24.10940-10952.2005; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Dong DZ, 2004, HUM GENE THER, V15, P553, DOI 10.1089/104303404323142006; Dong YB, 2002, CANCER RES, V62, P1776; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Eischen CM, 2001, ONCOGENE, V20, P6983, DOI 10.1038/sj.onc.1204892; Elliott MJ, 2002, TUMOR BIOL, V23, P76, DOI 10.1159/000059708; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Fueyo J, 1998, NAT MED, V4, P685, DOI 10.1038/nm0698-685; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Hunt KK, 1997, CANCER RES, V57, P4722; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Joshi B, 2007, BIOCHEM J, V401, P155, DOI 10.1042/BJ20060364; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Li WW, 1997, MOL CELL BIOL, V17, P54, DOI 10.1128/MCB.17.1.54; Li ZP, 2006, PROTEOMICS, V6, P5735, DOI 10.1002/pmic.200600290; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Liu TJ, 1999, CANCER GENE THER, V6, P163, DOI 10.1038/sj.cgt.7700007; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Meng RD, 1999, INT J ONCOL, V14, P5; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rodicker F, 2001, CANCER RES, V61, P7052; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Shin EK, 1996, J BIOL CHEM, V271, P12261, DOI 10.1074/jbc.271.21.12261; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Stanelle J, 2003, CARDIOVASC RES, V59, P512, DOI 10.1016/S0008-6363(03)00392-4; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; SUGAWARA S, 1993, CANCER RES, V53, P6001; vanGinkel PR, 1997, J BIOL CHEM, V272, P18367, DOI 10.1074/jbc.272.29.18367; Wang Y, 2000, J BIOL CHEM, V275, P27013; Watanabe G, 1998, MOL CELL BIOL, V18, P3212, DOI 10.1128/MCB.18.6.3212; Won JJ, 2002, FASEB J, V16, P1943, DOI 10.1096/fj.02-0311fje; Wu S, 2008, BIOCHEM BIOPH RES CO, V365, P75, DOI 10.1016/j.bbrc.2007.10.145; Yang HL, 1999, CLIN CANCER RES, V5, P2242; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Zhang Ping-an, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P410	67	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34305	34314		10.1074/jbc.M803925200	http://dx.doi.org/10.1074/jbc.M803925200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840615	Green Published, hybrid			2022-12-25	WOS:000261277700058
J	Duan, Q; Chen, HB; Costa, M; Dai, W				Duan, Qing; Chen, Haobin; Costa, Max; Dai, Wei			Phosphorylation of H3S10 Blocks the Access of H3K9 by Specific Antibodies and Histone Methyltransferase IMPLICATION IN REGULATING CHROMATIN DYNAMICS AND EPIGENETIC INHERITANCE DURING MITOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME CONDENSATION; HETEROCHROMATIN; MAINTENANCE; METHYLATION; SERINE-10; ACTIVATION; CELLS	Post-translational modifications of histones play a critical role in regulating genome structures and integrity. We have focused on the regulatory relationship between covalent modifications of histone H3 lysine 9 (H3K9) and H3S10 during the cell cycle. Immunofluorescence microscopy revealed that H3S10 phosphorylation in HeLa, A549, and HCT116 cells was high during prophase, prometaphase, and metaphase, whereas H3K9 monomethylation (H3K9me1) and dimethylation (H3K9me2), but not H3K9 trimethylation (H3K9me3), were significantly suppressed. When H3S10 phosphorylation started to diminish during anaphase, H3K9me1 and H3K9me2 signals reemerged. Western blot analyses confirmed that mitotic histones, extracted in an SDS-containing buffer, had little H3K9me1 and H3K9me2 signals but abundant H3K9me3 signals. However, when mitotic histones were extracted in the same buffer without SDS, the difference in H3K9me1 and H3K9me2 signals between interphase and mitotic cells disappeared. Removal of H3S10 phosphorylation by pretreatment with lambda-phosphatase unmasked mitotic H3K9me1 and H3K9me2 signals detected by both fluorescence microscopy and Western blotting. Further, H3S10 phosphorylation completely blocked methylation of H3K9 but not demethylation of the same residue in vitro. Given that several conserved motifs consisting of a Lys residue immediately followed by a Ser residue are present in histone tails, our studies reveal a potential new mechanism by which phosphorylation not only regulates selective access of methylated lysines by cellular factors but also serves to preserve methylation patterns and epigenetic programs during cell division.	[Duan, Qing; Chen, Haobin; Costa, Max; Dai, Wei] NYU, Sch Med, Dept Environm Med & Pharmacol, Tuxedo Pk, NY 10987 USA	New York University	Dai, W (corresponding author), NYU, Sch Med, Dept Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@med.nyu.edu	costa, max/H-1754-2012	Dai, Wei/0000-0003-0169-8327	NATIONAL CANCER INSTITUTE [R01CA090658] Funding Source: NIH RePORTER; NCI NIH HHS [CA090658] Funding Source: Medline; NIEHS NIH HHS [ES005512] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BODE AM, 2005, SCI STKE, pRE4; Bui HT, 2007, REPRODUCTION, V133, P371, DOI 10.1530/REP-06-0099; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Houben A, 2007, BBA-GENE STRUCT EXPR, V1769, P308, DOI 10.1016/j.bbaexp.2007.01.002; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kaszas E, 2000, J CELL SCI, V113, P3217; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; Krouwels IM, 2005, J CELL BIOL, V170, P537, DOI 10.1083/jcb.200502154; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Van Hooser A, 1998, J CELL SCI, V111, P3497; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	22	66	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33585	33590		10.1074/jbc.M803312200	http://dx.doi.org/10.1074/jbc.M803312200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18835819	hybrid, Green Published			2022-12-25	WOS:000261183700064
J	Patel, A; Vought, VE; Dharmarajan, V; Cosgrove, MS				Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.			A Conserved Arginine-containing Motif Crucial for the Assembly and Enzymatic Activity of the Mixed Lineage Leukemia Protein-1 Core Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 LYSINE-4; H3-LYS(4) METHYLTRANSFERASE COMPLEX; SET-DOMAIN PROTEIN; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; MOLECULAR RECOGNITION; DROSOPHILA-TRITHORAX; NUCLEOSOME MOBILITY; BINDING MODULES; METHYLATION	The mixed lineage leukemia protein-1 (MLL1) belongs to the SET1 family of histone H3 lysine 4 methyltransferases. Recent studies indicate that the catalytic subunits of SET1 family members are regulated by interaction with a conserved core group of proteins that include the WD repeat protein-5 (WDR5), retinoblastoma-binding protein-5 (RbBP5), and the absent small homeotic-2-like protein (Ash2L). It has been suggested that WDR5 functions to bridge the interactions between the catalytic and regulatory subunits of SET1 family complexes. However, the molecular details of these interactions are unknown. To gain insight into the interactions among these proteins, we have determined the biophysical basis for the interaction between the human WDR5 and MLL1. Our studies reveal that WDR5 preferentially recognizes a previously unidentified and conserved arginine-containing motif, called the "Win" or WDR5 interaction motif, which is located in the N-SET region of MLL1 and other SET1 family members. Surprisingly, our structural and functional studies show that WDR5 recognizes arginine 3765 of the MLL1 Win motif using the same arginine binding pocket on WDR5 that was previously shown to bind histone H3. We demonstrate that WDR5's recognition of arginine 3765 of MLL1 is essential for the assembly and enzymatic activity of the MLL1 core complex in vitro.	[Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Cosgrove, MS (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA.	mscosgro@syr.edu			March of Dimes Birth Defects Foundation [5-FY06-585]; Syracuse University; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); Syracuse University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Research Grant 5-FY06-585 from the March of Dimes Birth Defects Foundation (to M. S. C.) and by funds from Syracuse University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cosgrove MS, 2007, EXPERT REV PROTEOMIC, V4, P465, DOI 10.1586/14789450.4.4.465; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; COUTURE J, 2006, NAT STRUCT MOL BIOL; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katsani KR, 2001, GENE DEV, V15, P2197, DOI 10.1101/gad.201901; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Rasio D, 1996, CANCER RES, V56, P1766; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Rozovskaia T, 2000, ONCOGENE, V19, P351, DOI 10.1038/sj.onc.1203307; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P26; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	61	134	140	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32162	32175		10.1074/jbc.M806317200	http://dx.doi.org/10.1074/jbc.M806317200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18829457	hybrid			2022-12-25	WOS:000260893700003
J	Cenciarini, C; Courtois, S; Raoult, D; La Scola, B				Cenciarini, Claire; Courtois, Sophie; Raoult, Didier; La Scola, Bernard			Influence of Long Time Storage in Mineral Water on RNA Stability of Pseudomonas aeruginosa and Escherichia coli after Heat Inactivation	PLOS ONE			English	Article								Background: Research of RNA viability markers was previously studied for many bacterial species. Few and different targets of each species have been checked and motley results can be found in literature. No research has been done about Pseudomonas aeruginosa in this way. Methodology/Principal Findings: Disappearance of 48 transcripts was analyzed by two-steps reverse transcription and real time polymerase chain reaction (RT-PCR) after heat-killing of Pseudomonas aeruginosa previously stored in mineral water or not. Differential results were obtained for each target. 16S rRNA, 23S rRNA, groEL, and rpmE were showed as the most persistent transcripts and rplP, rpV, rplE and rpsD were showed as the most labile transcripts after P. aeruginosa death. However, the labile targets appeared more persistent in bacteria previously stored in mineral water than freshly cultivated (non stored). These nine transcripts were also analyzed in Escherichia coli after heat-killing and different to opposite results were obtained, notably for groEL which was the most labile transcript of E. coli. Moreover, opposite results were obtained between mineral water stored and freshly cultivated E. coli. Conclusions and Significance: This study highlights four potential viability markers for P. aeruginosa and four highly persistent transcripts. In a near future, these targets could be associated to develop an efficient viability kit. The present study also suggests that it would be difficult to determine universal RNA viability markers for environmental bacteria, since opposite results were obtained depending on the bacterial species and the physiological conditions.	[Cenciarini, Claire; Courtois, Sophie] CIRSEE Suez Environm, Le Pecq, France; [Cenciarini, Claire; Raoult, Didier; La Scola, Bernard] Univ Aix Marseille 2, Fac Med, URMITE, CNRS IRD, UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Cenciarini, C (corresponding author), CIRSEE Suez Environm, Le Pecq, France.	bernard.lascola@medecine.univ-mrs.fr	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974; Courtois, Sophie/0000-0002-3213-6418				Aellen S, 2006, ANTIMICROB AGENTS CH, V50, P1913, DOI 10.1128/AAC.00869-05; Armisen TG, 2004, WATER SCI TECHNOL, V50, P271; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Bartoloni JA, 2006, J AM DENT ASSOC, V137, P363, DOI 10.14219/jada.archive.2006.0186; Baudart J, 2002, APPL ENVIRON MICROB, V68, P5057, DOI 10.1128/AEM.68.10.5057-5063.2002; Baudart J, 2005, FEMS MICROBIOL LETT, V243, P405, DOI 10.1016/j.femsle.2005.01.001; Bentsink L, 2002, J APPL MICROBIOL, V93, P647, DOI 10.1046/j.1365-2672.2002.01725.x; BISCHOFBERGER T, 1990, INT J FOOD MICROBIOL, V11, P51, DOI 10.1016/0168-1605(90)90039-8; Branger S, 2003, J CLIN MICROBIOL, V41, P4435, DOI 10.1128/JCM.41.9.4435-4437.2003; BUTTIAUX R, 1960, ANN I PASTEUR LILLE, P43; CHURRUCA E, 2007, INT J FOOD MICROBIOL; Cools I, 2006, J MICROBIOL METH, V66, P313, DOI 10.1016/j.mimet.2005.12.004; Coutard F, 2005, J APPL MICROBIOL, V98, P951, DOI 10.1111/j.1365-2672.2005.02534.x; Deza MA, 2005, LETT APPL MICROBIOL, V40, P341, DOI 10.1111/j.1472-765X.2005.01679.x; Fykse EM, 2007, APPL ENVIRON MICROB, V73, P1457, DOI 10.1128/AEM.01635-06; Garcia-Armisen T, 2004, J MICROBIOL METH, V58, P269, DOI 10.1016/j.mimet.2004.04.014; Hallier-Soulier S, 2003, ENVIRON MICROBIOL, V5, P592, DOI 10.1046/j.1462-2920.2003.00442.x; Hellyer TJ, 1999, J CLIN MICROBIOL, V37, P290, DOI 10.1128/JCM.37.2.290-295.1999; JOSEPHSON KL, 1993, APPL ENVIRON MICROB, V59, P3513, DOI 10.1128/AEM.59.10.3513-3515.1993; Keer JT, 2003, J MICROBIOL METH, V53, P175, DOI 10.1016/S0167-7012(03)00025-3; Klancnik A, 2006, INT J FOOD MICROBIOL, V112, P200, DOI 10.1016/j.ijfoodmicro.2006.03.015; Klein PG, 1997, APPL ENVIRON MICROB, V63, P4441, DOI 10.1128/AEM.63.11.4441-4448.1997; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Kyte JA, 2005, CANCER GENE THER, V12, P579, DOI 10.1038/sj.cgt.7700837; Leclerc H, 1998, TECHNOLOGY BOTTLED W, P223; Lleo MD, 2000, APPL ENVIRON MICROB, V66, P4564; Marois C, 2002, VET MICROBIOL, V89, P17, DOI 10.1016/S0378-1135(02)00159-1; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; McKillip JL, 1999, J FOOD PROTECT, V62, P839, DOI 10.4315/0362-028X-62.8.839; McKillip JL, 1998, APPL ENVIRON MICROB, V64, P4264; Min JH, 2002, ANAL BIOCHEM, V303, P186, DOI 10.1006/abio.2002.5593; Noce L, 2000, J Can Dent Assoc, V66, P262; Oliver JD, 2005, J MICROBIOL, V43, P93; Periago PM, 2002, APPL ENVIRON MICROB, V68, P3486, DOI 10.1128/AEM.68.7.3486-3495.2002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piqueres P, 2006, RES MICROBIOL, V157, P345, DOI 10.1016/j.resmic.2005.09.003; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Regnault B, 2000, INT J FOOD MICROBIOL, V55, P281, DOI 10.1016/S0168-1605(00)00204-X; Ricicova M, 2003, FEMS YEAST RES, V4, P119, DOI 10.1016/S1567-1356(03)00145-4; Rozen S, 2000, Methods Mol Biol, V132, P365; SHARMA JK, 1992, NUCLEIC ACIDS RES, V20, P6117, DOI 10.1093/nar/20.22.6117; Sheridan GEC, 1998, APPL ENVIRON MICROB, V64, P1313; Sheridan GEC, 1999, LETT APPL MICROBIOL, V29, P375, DOI 10.1046/j.1472-765X.1999.00644.x; Simpkins SA, 2000, LETT APPL MICROBIOL, V30, P75, DOI 10.1046/j.1472-765X.2000.00670.x; Sung KD, 2004, AVIAN DIS, V48, P254, DOI 10.1637/7062; Sung K, 2005, FOODBORNE PATHOG DIS, V2, P130, DOI 10.1089/fpd.2005.2.130; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Szita G, 2007, LETT APPL MICROBIOL, V45, P42, DOI 10.1111/j.1472-765X.2007.02145.x; Uyttendaele M, 1997, INT J FOOD MICROBIOL, V37, P13, DOI 10.1016/S0168-1605(97)00039-1; VANDERVLIET GME, 1994, ANTIMICROB AGENTS CH, V38, P1959, DOI 10.1128/AAC.38.9.1959; Villarino A, 2000, RES MICROBIOL, V151, P755, DOI 10.1016/S0923-2508(00)01141-4; WILLIAMS HN, 1994, CAN J MICROBIOL, V40, P127, DOI 10.1139/m94-020; Yaron S, 2002, J APPL MICROBIOL, V92, P633, DOI 10.1046/j.1365-2672.2002.01563.x; Zietz BP, 2006, J APPL MICROBIOL, V100, P1239, DOI 10.1111/j.1365-2672.2006.02875.x	54	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3443	10.1371/journal.pone.0003443	http://dx.doi.org/10.1371/journal.pone.0003443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941615	gold, Green Published, Green Submitted			2022-12-25	WOS:000265125600005
J	Nanda, S; Havert, MB; Calderon, GM; Thomson, M; Jacobson, C; Kastner, D; Liang, TJ				Nanda, Santosh; Havert, Michael B.; Calderon, Gloria M.; Thomson, Michael; Jacobson, Christian; Kastner, Daniel; Liang, T. Jake			Hepatic Transcriptome Analysis of Hepatitis C Virus Infection in Chimpanzees Defines Unique Gene Expression Patterns Associated with Viral Clearance	PLOS ONE			English	Article								Hepatitis C virus infection leads to a high rate of chronicity. Mechanisms of viral clearance and persistence are still poorly understood. In this study, hepatic gene expression analysis was performed to identify any molecular signature associated with the outcome of hepatitis C virus (HCV) infection in chimpanzees. Acutely HCV-infected chimpanzees with self-limited infection or progression to chronicity were studied. Interferon stimulated genes were induced irrespective of the outcome of infection. Early induction of a set of genes associated with cell proliferation and immune activation was associated with subsequent viral clearance. Specifically, two of the genes: interleukin binding factor 3 (ILF3) and cytotoxic granule-associated RNA binding protein (TIA1), associated with robust T-cell response, were highly induced early in chimpanzees with self-limited infection. Up-regulation of genes associated with CD8+ T cell response was evident only during the clearance phase of the acute self-limited infection. The induction of these genes may represent an initial response of cellular injury and proliferation that successfully translates to a "danger signal'' leading to induction of adaptive immunity to control viral infection. This primary difference in hepatic gene expression between self-limited and chronic infections supports the concept that successful activation of HCV-specific T-cell response is critical in clearance of acute HCV infection.	[Nanda, Santosh; Havert, Michael B.; Calderon, Gloria M.; Thomson, Michael; Liang, T. Jake] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Jacobson, Christian; Kastner, Daniel] NIAMS, Genet & Genom Branch, NIH, Bethesda, MD USA; [Nanda, Santosh; Havert, Michael B.] FDA, CBER, Bethesda, MD USA; [Thomson, Michael] GlaxoSmithKline, Virol Dept, Res Triangle Pk, NC USA; [Jacobson, Christian] Univ Waterloo, Dept Biol & Mech & Mechatron Engn, Waterloo, ON N2L 3G1, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); US Food & Drug Administration (FDA); GlaxoSmithKline; University of Waterloo	Nanda, S (corresponding author), NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA.	JakeL@intra.niddk.nih.gov			Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH.	Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Choudhury JA, 2003, MOL BIOL CELL, V14, P1334, DOI 10.1091/mbc.E02-07-0378; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cucchiarini M, 2000, CELL IMMUNOL, V203, P111, DOI 10.1006/cimm.2000.1683; Damdinsuren B, 2005, INT J ONCOL, V26, P319; Dasu MRK, 2004, GENE, V327, P51, DOI 10.1016/j.gene.2003.11.015; Diepolder HM, 1996, J MOL MED-JMM, V74, P583, DOI 10.1007/s001090050062; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Fernandez J, 2004, J VIROL, V78, P9782, DOI 10.1128/JVI.78.18.9782-9789.2004; Fujimoto S, 2007, INT IMMUNOL, V19, P1175, DOI 10.1093/intimm/dxm085; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Kaplan DE, 2007, GASTROENTEROLOGY, V132, P654, DOI 10.1053/j.gastro.2006.11.044; Khan J, 1998, CANCER RES, V58, P5009; Khan J, 1999, BBA-REV CANCER, V1423, pM17, DOI 10.1016/S0304-419X(99)00004-9; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Major ME, 2004, HEPATOLOGY, V39, P1709, DOI 10.1002/hep.20239; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Neumann-Haefelin C, 2005, J CLIN VIROL, V32, P75, DOI 10.1016/j.jcv.2004.05.008; Ollila J, 1998, BIOCHEM BIOPH RES CO, V249, P475, DOI 10.1006/bbrc.1998.9176; Rahman F, 2004, HEPATOLOGY, V40, P87, DOI 10.1002/hep.20253; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Smyk-Pearson S, 2008, J VIROL, V82, P1827, DOI 10.1128/JVI.01581-07; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thomson M, 2001, GASTROENTEROLOGY, V121, P1226, DOI 10.1053/gast.2001.28669; Thomson M, 2003, J VIROL, V77, P862, DOI 10.1128/JVI.77.2.862-870.2003; Tsunedomi R, 2006, INT J ONCOL, V29, P1445	38	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3442	10.1371/journal.pone.0003442	http://dx.doi.org/10.1371/journal.pone.0003442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927617	Green Submitted, gold, Green Published			2022-12-25	WOS:000265122400012
J	Chandrasekharan, B; Bala, V; Kolachala, VL; Vijay-Kumar, M; Jones, D; Gewirtz, AT; Sitaraman, SV; Srinivasan, S				Chandrasekharan, Bindu; Bala, Vanitha; Kolachala, Vasantha L.; Vijay-Kumar, Matam; Jones, Dean; Gewirtz, Andrew T.; Sitaraman, Shanthi V.; Srinivasan, Shanthi			Targeted Deletion of Neuropeptide Y (NPY) Modulates Experimental Colitis	PLOS ONE			English	Article								Background: Neurogenic inflammation plays a major role in the pathogenesis of inflammatory bowel disease (IBD). We examined the role of neuropeptide Y (NPY) and neuronal nitric oxide synthase (nNOS) in modulating colitis. Methods: Colitis was induced by administration of dextran sodium sulphate (3% DSS) or streptomycin pre-treated Salmonella typhimurium (S.T.) in wild type (WT) and NPY (NPY-/-) knockout mice. Colitis was assessed by clinical score, histological score and myeloperoxidase activity. NPY and nNOS expression was assessed by immunostaining. Oxidative stress was assessed by measuring catalase activity, glutathione and nitrite levels. Colonic motility was assessed by isometric muscle recording in WT and DSS-treated mice. Results: DSS/S. T. induced an increase in enteric neuronal NPY and nNOS expression in WT mice. WT mice were more susceptible to inflammation compared to NPY-/- as indicated by higher clinical & histological scores, and myeloperoxidase (MPO) activity (p<0.01). DSS-WT mice had increased nitrite, decreased glutathione (GSH) levels and increased catalase activity indicating more oxidative stress. The lower histological scores, MPO and chemokine KC in S.T.-treated nNOS(-/-) and NPY-/-/nNOS(-/-) mice supported the finding that loss of NPY-induced nNOS attenuated inflammation. The inflammation resulted in chronic impairment of colonic motility in DSS-WT mice. NPY -treated rat enteric neurons in vitro exhibited increased nitrite and TNF-alpha production. Conclusions: NPY mediated increase in nNOS is a determinant of oxidative stress and subsequent inflammation. Our study highlights the role of neuronal NPY and nNOS as mediators of inflammatory processes in IBD.	[Chandrasekharan, Bindu; Bala, Vanitha; Kolachala, Vasantha L.; Sitaraman, Shanthi V.; Srinivasan, Shanthi] Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA; [Vijay-Kumar, Matam; Gewirtz, Andrew T.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Jones, Dean] Emory Univ, Div Pulmonary Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Chandrasekharan, B (corresponding author), Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA.	ssrini2@emory.edu	Srinivasan, Shanthi/A-6133-2013; chandrasekharan, bindu/AAU-5479-2021; Chandrasekharan, Bindu/CAA-0476-2022	Chandrasekharan, Bindu/0000-0003-2943-3902	CCFA; NIH [KO8 DK067045, RO3 DK078552, DK06411]; Digestive Diseases Research Center [DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK078552, R24DK064399, K08DK067045] Funding Source: NIH RePORTER	CCFA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by CCFA Research Fellowship Awards (B. Chandrasekharan & M. Vijay Kumar), NIH grants KO8 DK067045 and RO3 DK078552 (S.Srinivasan) and DK06411 (S.V. Sitaraman), Digestive Diseases Research Center grant (DK064399).	Anitha M, 2006, J CLIN INVEST, V116, P344, DOI 10.1172/JCI26295; Anitha M, 2006, GASTROENTEROLOGY, V131, P1164, DOI 10.1053/j.gastro.2006.07.019; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bedoui S, 2002, J NEUROIMMUNOL, V132, P25, DOI 10.1016/S0165-5728(02)00278-3; BERGMEYER HU, 1955, BIOCHEM Z, V327, P255; Collins SM, 1996, GASTROENTEROLOGY, V111, P1683, DOI 10.1016/S0016-5085(96)70034-3; COOPER HS, 1993, LAB INVEST, V69, P238; di Mola FF, 2000, GUT, V46, P670, DOI 10.1136/gut.46.5.670; Dimitrijevic M, 2005, REGUL PEPTIDES, V124, P163, DOI 10.1016/j.regpep.2004.07.012; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; HAFSTROM I, 1993, ACTA PHYSIOL SCAND, V148, P341, DOI 10.1111/j.1748-1716.1993.tb09565.x; HOGABOAM CM, 1995, AM J PHYSIOL-GASTR L, V268, pG673, DOI 10.1152/ajpgi.1995.268.4.G673; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Levite M, 2001, ANN ONCOL, V12, pS19, DOI 10.1093/annonc/12.suppl_2.S19; Li Q, 2003, MOL BRAIN RES, V114, P46, DOI 10.1016/S0169-328X(03)00131-1; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; LUNDBERG JM, 1990, ANN NY ACAD SCI, V611, P166; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; MANTYH CR, 1988, P NATL ACAD SCI USA, V85, P3235, DOI 10.1073/pnas.85.9.3235; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Okajima K, 2006, CURR MED CHEM, V13, P2241, DOI 10.2174/092986706777935131; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Rachmilewitz D, 1998, AM J GASTROENTEROL, V93, P409, DOI 10.1016/S0002-9270(98)00009-4; RACHMILEWITZ D, 1995, GUT, V37, P247, DOI 10.1136/gut.37.2.247; Sang Q, 1998, ANAT REC, V251, P185; Song F, 1999, J IMMUNOL, V162, P2275; Takahashi T, 1997, GASTROENTEROLOGY, V113, P1535, DOI 10.1053/gast.1997.v113.pm9352855; Tomobuchi M, 2001, CLIN EXP PHARMACOL P, V28, P13, DOI 10.1046/j.1440-1681.2001.03396.x; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142; Villarroya H, 1997, J NEUROSCI RES, V49, P592, DOI 10.1002/(SICI)1097-4547(19970901)49:5<592::AID-JNR9>3.0.CO;2-6; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Woolf CJ, 1996, J NEUROSCI, V16, P2716; Yamaguchi T, 2001, HEPATO-GASTROENTEROL, V48, P118	36	54	56	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3304	10.1371/journal.pone.0003304	http://dx.doi.org/10.1371/journal.pone.0003304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18836554	gold, Green Published, Green Submitted			2022-12-25	WOS:000264797200009
J	Yang, BX; Zhao, D; Verkman, AS				Yang, Baoxue; Zhao, Dan; Verkman, A. S.			Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation	FASEB JOURNAL			English	Article						AQP2; water transport; water channel; transgenic mouse; NDI; polyuria	WATER CHANNEL AQUAPORIN-2; MICE LACKING; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; TARGETING HSP90; COLLECTING DUCT; GENE; TRAFFICKING; AQP2; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN	Mutations in aquaporin-2 (AQP2) that interfere with its cellular processing can produce autosomal recessive nephrogenic diabetes insipidus (NDI). Prior gene knock-in of the human NDI-causing AQP2 mutation T126M produced mutant mice that died by age 7 days. Here, we used a novel "conditional gene knock-in" strategy to generate adult, AQP2-T126M mutant mice. Mice separately heterozygous for floxed wild-type AQP2 and AQP2-T126M were bred to produce hemizygous mice, which following excision of the wild-type AQP2 gene by tamoxifen-induced Cre-recombinase gave AQP2(T126M/-) mice. AQP2(T126M/-) mice were polyuric (9-14 ml urine/day) compared to AQP2(+/+) mice (1.6 ml/day) and had reduced urine osmolality (400 vs. 1800 mosmol). Kidneys of AQP2(T126M/-) mice expressed core-glycosylated AQP2-T126M protein in an endoplasmic reticulum pattern. Screening of candidate protein folding "correctors" in AQP2-T126M-transfected kidney cells showed increased AQP2-T126M plasma membrane expression with the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG). 17-AAG increased urine osmolality in AQP2(T126M/-) mice by > 300 mosmol but had no effect in AQP2(-/-) mice. Kidneys of 17-AAG-treated AQP2(T126M/-) mice showed partial rescue of defective AQP2-T126M cellular processing. Our results establish an adult mouse model of NDI and demonstrate partial restoration of urinary concentration function by a compound currently in clinical trials for other indications. - Yang, B., Zhao, D., Verkman, A. S. Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock- in mouse model of aquaporin-2 mutation. FASEB J. 23, 503-512 (2009)	[Yang, Baoxue] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yang, BX (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, 1246 Hlth Sci E Tower,Box 0521, San Francisco, CA 94143 USA.	baoxue.yang@ucsf.edu			U.S. National Institute of Health (NIH) [DK35124, HL59198, EY13574, EB00415, DK72517, HL73856, DK66194]; Research Development Program; Cystic Fibrosis Foundation; American Heart Association [0365027Y]; Polycystic Kidney Disease Foundation [147a2r]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059198, R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, R01DK035124, R21DK066194, R37DK035124] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Development Program; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); American Heart Association(American Heart Association); Polycystic Kidney Disease Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Liman Qian for mouse breeding and genotype analysis. This work was supported by U.S. National Institute of Health (NIH) grants DK35124, HL59198, EY13574, EB00415, DK72517, and HL73856, and Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation (to A.S.V.), NIH grant DK66194, American Heart Association grant 0365027Y and Polycystic Kidney Disease Foundation grant 147a2r (to B.Y.).	Bichet DG, 2006, SEMIN NEPHROL, V26, P224, DOI 10.1016/j.semnephrol.2006.02.004; Boccalandro C, 2004, J AM SOC NEPHROL, V15, P1223, DOI 10.1097/01.ASN.0000125248.85135.43; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Buck TM, 2004, AM J PHYSIOL-CELL PH, V287, pC1292, DOI 10.1152/ajpcell.00561.2003; Carroll P, 2006, GENET MED, V8, P443, DOI 10.1097/01.gim.0000223554.46981.7a; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Deen PMT, 1997, J AM SOC NEPHROL, V8, P1493; DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920; Deen PMT, 1998, CURR OPIN NEPHROL HY, V7, P37; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Drysdale MJ, 2006, CURR OPIN DRUG DISC, V9, P483; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Fujiwara TM, 2005, J AM SOC NEPHROL, V16, P2836, DOI 10.1681/ASN.2005040371; Goji K, 1998, J CLIN ENDOCR METAB, V83, P3205, DOI 10.1210/jc.83.9.3205; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Hasler U, 2000, J BIOL CHEM, V275, P29011, DOI 10.1074/jbc.M002867200; Jiang CW, 1998, AM J PHYSIOL-CELL PH, V275, pC171, DOI 10.1152/ajpcell.1998.275.1.C171; Kamsteeg EJ, 2000, EXP NEPHROL, V8, P326; Klein JD, 2004, J AM SOC NEPHROL, V15, P1161, DOI 10.1097/01.ASN.0000125617.19799.72; Knoers NVAM, 2001, PEDIATR NEPHROL, V16, P1146, DOI 10.1007/s004670100051; Lloyd DJ, 2005, PLOS GENET, V1, P171, DOI 10.1371/journal.pgen.0010020; Lorenz JN, 2002, J BIOL CHEM, V277, P37871, DOI 10.1074/jbc.M205627200; Lu M, 2002, J BIOL CHEM, V277, P37881, DOI 10.1074/jbc.M206644200; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Marr N, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027355.41663.14; McDill BW, 2006, P NATL ACAD SCI USA, V103, P6952, DOI 10.1073/pnas.0602087103; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Mulders SM, 1997, J AM SOC NEPHROL, V8, P242; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Noda Y, 2005, BIOL CELL, V97, P885; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; SHI P, 2007, J PHYSL RENAL PHYSL, V292, pF1334; Sohara E, 2006, P NATL ACAD SCI USA, V103, P14217, DOI 10.1073/pnas.0602331103; Solit DB, 2007, CLIN CANCER RES, V13, P1775, DOI 10.1158/1078-0432.CCR-06-1863; Stravopodis DJ, 2007, CURR MED CHEM, V14, P3122, DOI 10.2174/092986707782793925; Sydor JR, 2006, P NATL ACAD SCI USA, V103, P17408, DOI 10.1073/pnas.0608372103; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Tamarappoo BK, 1999, J BIOL CHEM, V274, P34825, DOI 10.1074/jbc.274.49.34825; Verkman AS, 2008, SEMIN NEPHROL, V28, P217, DOI 10.1016/j.semnephrol.2008.03.004; Yang BX, 2006, AM J PHYSIOL-RENAL, V291, pF465, DOI 10.1152/ajprenal.00494.2005; Yang BX, 2001, J BIOL CHEM, V276, P2775, DOI 10.1074/jbc.M008216200; Yun J, 2000, J CLIN INVEST, V106, P1361, DOI 10.1172/JCI9154	48	35	37	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2009	23	2					503	512		10.1096/fj.08-118422	http://dx.doi.org/10.1096/fj.08-118422			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18854434	Green Published			2022-12-25	WOS:000262892900022
J	Pickering, MT; Stadler, BM; Kowalik, TF				Pickering, M. T.; Stadler, B. M.; Kowalik, T. F.			miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression	ONCOGENE			English	Article						checkpoint; DNA damage; E2F1; miRNA	DOUBLE-STRAND BREAKS; E2F1 TRANSCRIPTION FACTOR; GEL-ELECTROPHORESIS; DNA; APOPTOSIS; PHOSPHORYLATION; EXPRESSION; MICRORNAS; ONCOGENE; CANCERS	The stringent regulation of cell cycle progression helps to maintain genetic stability in cells. MicroRNAs (miRNAs) are critical regulators of gene expression in diverse cellular pathways, including developmental patterning, hematopoietic differentiation and antiviral defense. Here, we show that two c-Myc-regulated miRNAs, miR-17 and miR-20a, govern the transition through G1 in normal diploid human cells. Inhibition of these miRNAs leads to a G1 checkpoint due to an accumulation of DNA double-strand breaks, resulting from premature temporal accumulation of the E2F1 transcription factor. Surprisingly, gross changes in E2F1 levels were not required to initiate the DNA damage response and checkpoint, as these responses could occur with a less than twofold change in E2F1 protein levels. Instead, our findings indicate that the precise timing of E2F1 expression dictates S-phase entry and that accurate timing of E2F1 accumulation requires converging signals from the Rb/E2F pathway and the c-Myc-regulated miR-17 and miR-20a miRNAs to circumvent a G1 checkpoint arising from the untimely accumulation of E2F1. These data provide a mechanistic view of miRNA-based regulation of E2F1 in the context of the emerging model that miRNAs coordinate the timing of cell cycle progression.	[Pickering, M. T.; Stadler, B. M.; Kowalik, T. F.] Univ Massachusetts, Dept Mol Genet & Microbiol, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Kowalik, TF (corresponding author), Univ Massachusetts, Dept Mol Genet & Microbiol, Sch Med, 55 Lake Ave N, Worcester, MA 01605 USA.	timothy.kowalik@umassmed.edu		Pickering, Mary/0000-0002-0515-7248	Dimes Foundation [6-FY06-344]; NIH [AI0766189, 5 P30 DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	Dimes Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in parts by research grants from the March of Dimes Foundation (6-FY06-344) and the NIH (AI0766189 and 5 P30 DK32520). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Frame FM, 2006, ONCOGENE, V25, P3258, DOI 10.1038/sj.onc.1209352; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hong SL, 2008, CELL CYCLE, V7, P391, DOI 10.4161/cc.7.3.5286; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Lomazzi M, 2002, NAT GENET, V31, P190, DOI 10.1038/ng891; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OLIVE PL, 1991, CANCER RES, V51, P4671; OLIVE PL, 1992, EXP CELL RES, V198, P259, DOI 10.1016/0014-4827(92)90378-L; PERSSON H, 1985, MOL CELL BIOL, V5, P2903, DOI 10.1128/MCB.5.11.2903; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Powers JT, 2004, MOL CANCER RES, V2, P203; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711	29	132	139	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					140	145		10.1038/onc.2008.372	http://dx.doi.org/10.1038/onc.2008.372			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18836483	Green Accepted			2022-12-25	WOS:000262294100014
J	Bond, S; Forgac, M				Bond, Sarah; Forgac, Michael			The Ras/cAMP/Protein Kinase A Pathway Regulates Glucose-dependent Assembly of the Vacuolar (H+)-ATPase in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-SCALE ANALYSIS; H+-ATPASE; V-ATPASE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; GENE-EXPRESSION; PROTON PUMPS; SUBUNIT-G; ACTIVATION; RAS	Vacuolar (H+)-ATPases (V-ATPases) are ubiquitous, ATP-driven proton pumps that acidify organelles or the extracellular space. A rapid and effective mechanism for regulating V-ATPase activity involves reversible dissociation of the two functional domains of the pump, V-1 and V-0. This process is best characterized in yeast, where V-ATPases are reversibly disassembled in response to glucose depletion. To identify regulators that control this process in vivo, a genetic screen was performed in yeast to search for mutants that cannot disassemble their V-ATPases when grown in the absence of glucose. This screen identified IRA1 (inhibitory regulator of the Ras/cAMP pathway 1) and IRA2 as essential genes for regulating V-ATPase dissociation in vivo. IRA1 and IRA2 encode GTPase-activating proteins that negatively regulate Ras in nutrient-poor conditions. Downregulation of Ras lowers cAMP levels by reducing adenylate cyclase activity. Decreased cAMP levels in turn lead to reduced activity of protein kinase A (PKA). Our results show that targeted deletion of IRA2 results in defective disassembly of the V-ATPase in response to glucose depletion, and reexpression of the gene rescues this phenotype. Glucose-dependent dissociation is also blocked in strains expressing the dominant active RAS2(val19) allele or in strains deficient for the regulatory subunit of PKA, both of which lead to constitutively active PKA. These results reveal a role for PKA in controlling glucose-dependent V-ATPase assembly in yeast.	[Bond, Sarah; Forgac, Michael] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM 34478, T32DK007542, DK34928]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928, T32DK007542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 34478 (to M. F.) and predoctoral fellowship support from National Institutes of Health Grant T32DK007542. E. coli strains were provided by National Institutes of Health Grant DK34928. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARAI H, 1987, BIOCHEMISTRY-US, V26, P6632, DOI 10.1021/bi00395a011; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bles N, 2007, J IMMUNOL, V179, P3550, DOI 10.4049/jimmunol.179.6.3550; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; Dames P, 2006, P NATL ACAD SCI USA, V103, P3926, DOI 10.1073/pnas.0600011103; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Henry JP, 1998, NEUROCHEM INT, V32, P227, DOI 10.1016/S0197-0186(97)00092-2; HINTON A, 2007, PFLUGERS AR IN PRESS; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Howard SC, 2001, GENETICS, V159, P77; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; MORRIS RC, 1968, J CLIN INVEST, V47, P1389, DOI 10.1172/JCI105830; NANDA A, 1992, J BIOL CHEM, V267, P22740; ORCI L, 1994, J CELL BIOL, V126, P1149, DOI 10.1083/jcb.126.5.1149; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Qi J, 2007, J BIOL CHEM, V282, P24743, DOI 10.1074/jbc.M700663200; Rein J, 2008, AM J PHYSIOL-CELL PH, V294, pC56, DOI 10.1152/ajpcell.00041.2007; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; RossMacdonald P, 1997, P NATL ACAD SCI USA, V94, P190, DOI 10.1073/pnas.94.1.190; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; SCHLESINGER PH, 1994, MINER ELECTROL METAB, V20, P31; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; SIKORSKI RS, 1989, GENETICS, V122, P19; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; SUPEK F, 1994, J BIOL CHEM, V269, P24102; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TANAKA K, 1989, MOL CELL BIOL, V9, P757, DOI 10.1128/MCB.9.2.757; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; VOSS M, 2008, CELL TISSUE IN PRESS; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wilkin F, 2001, J IMMUNOL, V166, P7172, DOI 10.4049/jimmunol.166.12.7172; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200	59	64	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36513	36521		10.1074/jbc.M805232200	http://dx.doi.org/10.1074/jbc.M805232200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18936098	Green Published, hybrid			2022-12-25	WOS:000261840500049
J	Hansen, SB; Wang, HL; Taylor, P; Sine, SM				Hansen, Scott B.; Wang, Hai-Long; Taylor, Palmer; Sine, Steven M.			An Ion Selectivity Filter in the Extracellular Domain of Cys-loop Receptors Reveals Determinants for Ion Conductance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACH-BINDING PROTEIN; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CHANNEL; MECHANISMS; INTERFACES	Neurotransmitter binding to Cys-loop receptors promotes a prodigious transmembrane flux of several million ions/s, but to date, structural determinants of ion flux have been identified flanking the membrane-spanning region. Using x-ray crystallography, sequence analysis, and single-channel recording, we identified a novel determinant of ion conductance near the point of entry of permeant ions. Co-crystallization of acetylcholine-binding protein with sulfate anions revealed coordination of SO42- with a ring of lysines at a position equivalent to 24 A above the lipid membrane in homologous Cys-loop receptors. Analysis of multiple sequence alignments revealed that residues equivalent to the ring of lysines are negatively charged in cation-selective receptors but are positively charged in anion-selective receptors. Charge reversal of side chains at homologous positions in the nicotinic receptor from the motor end plate decreases unitary conductance up to 80%. Selectivity filters stemming from transmembrane alpha-helices have similar pore diameters and compositions of amino acids. These findings establish that when the channel opens under a physiological electrochemical gradient, permeant ions are initially stabilized within the extracellular vestibule of Cys-loop receptors, and this stabilization is a major determinant of ion conductance.	[Hansen, Scott B.; Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; [Wang, Hai-Long; Sine, Steven M.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA	University of California System; University of California San Diego; Mayo Clinic; Mayo Clinic	Taylor, P (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu; sine@mayo.edu			United States Public Health Service [R37-GM18360/UO1-DA019372, R37-NS031744]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA019372] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by United States Public Health Service Grants R37-GM18360/UO1-DA019372 (to P. T.) and R37-NS031744 (to S. M. S). Beamline 8.2.2 is supported by the Howard Hughes Medical Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kehoe J, 1998, J NEUROSCI, V18, P8198; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LEWIS CA, 1983, P NATL ACAD SCI-BIOL, V80, P6110, DOI 10.1073/pnas.80.19.6110; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	30	50	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36066	36070		10.1074/jbc.C800194200	http://dx.doi.org/10.1074/jbc.C800194200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940802	Green Published, hybrid			2022-12-25	WOS:000261840500002
J	Barr, RK; Lynn, HE; Moretti, PAB; Khew-Goodall, Y; Pitson, SM				Barr, Renae K.; Lynn, Helen E.; Moretti, Paul A. B.; Khew-Goodall, Yeesim; Pitson, Stuart M.			Deactivation of Sphingosine Kinase 1 by Protein Phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CELL-TRANSFORMATION; PLASMA-MEMBRANE; DEPENDENT TRANSLOCATION; REGULATORY SUBUNIT; TUMOR-ANTIGEN; BINDING SITE; FTY720; PP2A; ACTIVATION; CANCER	Sphingosine kinase 1 (SK1) is an important regulator of cellular signaling that has been implicated in a broad range of cellular processes. Cell exposure to a wide array of growth factors, cytokines, and other cell agonists can result in a rapid and transient increase in SK activity via an activating phosphorylation. We have previously identified extracellular signal-regulated kinases 1 and 2 (ERK1/2) as the kinases responsible for the phosphorylation of human SK1 at Ser(225), but the corresponding phosphatase targeting this phosphorylation has remained undefined. Here, we provide data to support a role for protein phosphatase 2A (PP2A) in the deactivation of SK1 through dephosphorylation of phospho-Ser(225). The catalytic subunit of PP2A (PP2Ac) was found to interact with SK1 using both GST-pulldown and coimmunoprecipitation analyses. Coexpression of PP2Ac with SK1 resulted in reduced Ser(225) phosphorylation of SK1 in human embryonic kidney (HEK293) cells. In vitro phosphatase assays showed that PP2Ac dephosphorylated both recombinant SK1 and a phosphopeptide based on the phospho-Ser225 region of SK1. Finally, both basal and tumor necrosis factor-alpha-stimulated cellular SK1 activity were regulated by molecular manipulation of PP2Ac activity. Thus, PP2A appears to function as an endogenous regulator of SK1 phosphorylation.	[Barr, Renae K.; Lynn, Helen E.; Moretti, Paul A. B.; Khew-Goodall, Yeesim; Pitson, Stuart M.] Univ Adelaide, Div Human Immunol, Inst Med & Vet Sci, Hanson Inst, Adelaide, SA 5005, Australia; [Khew-Goodall, Yeesim; Pitson, Stuart M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Hanson Institute; Institute Medical & Veterinary Science Australia; University of Adelaide; University of Adelaide	Pitson, SM (corresponding author), Inst Med & Vet Sci, Div Human Immunol, Frome Rd, Adelaide, SA 5000, Australia.	stuart.pitson@imvs.sa.gov.au	Pitson, Stuart/B-9342-2009	Pitson, Stuart/0000-0002-9527-2740; Barr, Renae/0000-0003-1601-7299	Fay Fuller Foundation; Cancer Council of South Australia; National Health and Medical Research Council of Australia; Peter Doherty Postdoctoral Research Fellowship [430909]; Senior Research Fellowship [508098]; Project Grant [453512]	Fay Fuller Foundation; Cancer Council of South Australia(Cancer Council South Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Peter Doherty Postdoctoral Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Senior Research Fellowship; Project Grant(Wellcome Trust)	This work was supported by the Fay Fuller Foundation, a Senior Research Fellowship from the Cancer Council of South Australia (to Y.K.-G.), and the National Health and Medical Research Council of Australia through a Peter Doherty Postdoctoral Research Fellowship 430909 (to R.K.B.), a Senior Research Fellowship 508098 (to S.M.P.), and Project Grant 453512. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; French KJ, 2003, CANCER RES, V63, P5962; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hu MCT, 1998, J BIOL CHEM, V273, P33561, DOI 10.1074/jbc.273.50.33561; Imai A, 2006, J Obstet Gynaecol, V26, P37; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Leclercq TM, 2006, IUBMB LIFE, V58, P467, DOI 10.1080/15216540600871126; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; MAYERJAEKEL RE, 1994, J CELL SCI, V107, P2609; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Ogris E, 1999, J VIROL, V73, P7390, DOI 10.1128/JVI.73.9.7390-7398.1999; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Ricciarelli R, 1998, ARCH BIOCHEM BIOPHYS, V355, P197, DOI 10.1006/abbi.1998.0732; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; SCHONTHAL AH, 1998, FRONT BIOSCI, V3, P1262; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Spiegel S, 2002, LEUKEMIA, V16, P1596, DOI 10.1038/sj.leu.2402611; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Sugiyama M, 2003, AM J OBSTET GYNECOL, V189, P1666, DOI 10.1016/S0002-9378(03)00907-4; Sugiyama M, 2003, ONCOL REP, V10, P1885; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; TUNG HYL, 1985, EUR J BIOCHEM, V149, P305, DOI 10.1111/j.1432-1033.1985.tb08927.x; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Zhou GS, 2004, J BIOL CHEM, V279, P49551, DOI 10.1074/jbc.M410317200; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200	54	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34994	35002		10.1074/jbc.M804658200	http://dx.doi.org/10.1074/jbc.M804658200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18852266	hybrid, Green Published			2022-12-25	WOS:000261469100056
J	Laneve, P; Gioia, U; Ragno, R; Altieri, F; Di Franco, C; Santini, T; Arceci, M; Bozzoni, I; Caffarelli, E				Laneve, Pietro; Gioia, Ubaldo; Ragno, Rino; Altieri, Fabio; Di Franco, Carmen; Santini, Tiziana; Arceci, Massimo; Bozzoni, Irene; Caffarelli, Elisa			The Tumor Marker Human Placental Protein 11 Is an Endoribonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNA; DIAGNOSTIC-SIGNIFICANCE; IN-VITRO; XENDOU; PURIFICATION; CLEAVAGE; CLONING; SERVER; PP11; SP1	Human PP11 ( placental protein 11) was previously described as a serine protease specifically expressed in the syncytiotrophoblast and in numerous tumor tissues. Several PP11-like proteins were annotated in distantly related organisms, such as worms and mammals, suggesting their involvement in evolutionarily conserved processes. Based on sequence similarity, human PP11 was included in a protein family whose characterized members are XendoU, a Xenopus laevis endoribonuclease involved in small nucleolar RNA processing, and Nsp15, an endoribonuclease essential for coronavirus replication. Here we show that the bacterially expressed human PP11 displays RNA binding capability and cleaves single stranded RNA in a Mn2+-dependent manner at uridylates, to produce molecules with 2', 3'-cyclic phosphate ends. These features, together with structural and mutagenesis analyses, which identified the potential active site residues, reveal striking parallels to the amphibian XendoU and assign a ribonuclease function to PP11. This newly discovered enzymatic activity places PP11-like proteins in a completely new perspective.	[Laneve, Pietro; Arceci, Massimo; Bozzoni, Irene; Caffarelli, Elisa] Univ Roma La Sapienza, CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy; [Gioia, Ubaldo; Di Franco, Carmen; Santini, Tiziana; Bozzoni, Irene] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Ragno, Rino] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farm, I-00185 Rome, Italy; [Altieri, Fabio] Univ Roma La Sapienza, Dipartimento Biochim, I-00185 Rome, Italy; [Bozzoni, Irene] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Caffarelli, E (corresponding author), Univ Roma La Sapienza, CNR, Ist Biol & Patol Mol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	elisa.caffarelli@uniroma1.it	Ragno, Rino/I-1286-2013; Gioia, Ubaldo/GZL-7436-2022; laneve, pietro/ABD-1633-2020; Gioia, Ubaldo/O-1660-2014; Altieri, Fabio/D-2790-2009; laneve, pietro/M-3386-2014	Ragno, Rino/0000-0001-5399-975X; Gioia, Ubaldo/0000-0002-4993-5283; Gioia, Ubaldo/0000-0002-4993-5283; Altieri, Fabio/0000-0002-6546-2738; laneve, pietro/0000-0002-8865-4038; bozzoni, irene/0000-0002-3485-8537; Santini, Tiziana/0000-0002-7181-7267	6th Framework Programme of the European Commission [LSHG-CT-2006037900]; PRIN and Centro di Eccellenza BEMM; Associazione Italiana Ricerca sul Cancro ( AIRC); AIRC-Rome Oncogenomic Center	6th Framework Programme of the European Commission(European Commission); PRIN and Centro di Eccellenza BEMM; Associazione Italiana Ricerca sul Cancro ( AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC-Rome Oncogenomic Center(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by grants from the 6th Framework Programme of the European Commission ( SIROCCO Project, LSHG-CT-2006037900), the ESF project " NuRNASu", PRIN and Centro di Eccellenza BEMM, Associazione Italiana Ricerca sul Cancro ( AIRC) and AIRC-Rome Oncogenomic Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bhardwaj K, 2006, J MOL BIOL, V361, P243, DOI 10.1016/j.jmb.2006.06.021; BOHN H, 1980, ARCH GYNECOL, V229, P293, DOI 10.1007/BF02108580; BOHN H, 1981, ONCODEV BIOL MED, V2, P141; CAFFARELLI E, 1994, MOL CELL BIOL, V14, P2966, DOI 10.1128/MCB.14.5.2966; Filippini D, 2001, BIOCHEM BIOPH RES CO, V288, P16, DOI 10.1006/bbrc.2001.5720; Gioia U, 2005, J BIOL CHEM, V280, P18996, DOI 10.1074/jbc.M501160200; GRUNDMANN U, 1990, DNA CELL BIOL, V9, P243, DOI 10.1089/dna.1990.9.243; Gupta AK, 2004, CLIN CHEM, V50, P2187, DOI 10.1373/clinchem.2004.040196; Huppertz B, 1998, HISTOCHEM CELL BIOL, V110, P495, DOI 10.1007/s004180050311; INABA N, 1982, ONCODEV BIOL MED, V3, P379; INABA N, 1980, KLIN WOCHENSCHR, V58, P789, DOI 10.1007/BF01478287; INABA N, 1981, ARCH GYNECOL, V231, P87, DOI 10.1007/BF02110028; INABA N, 1980, ARCH GYNECOL, V230, P109, DOI 10.1007/BF02108266; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; KOI H, 2000, BIOONE ONLINE J, V64, P1001; KRISCH K, 1966, BIOCHIM BIOPHYS ACTA, V122, P265, DOI 10.1016/0926-6593(66)90067-1; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; PAN T, 1992, BIOCHEMISTRY-US, V31, P3887, DOI 10.1021/bi00131a001; Pinard R, 1999, BIOCHEMISTRY-US, V38, P16035, DOI 10.1021/bi992024s; Renzi F, 2006, ACTA CRYSTALLOGR F, V62, P298, DOI 10.1107/S1744309106006373; Renzi F, 2006, P NATL ACAD SCI USA, V103, P12365, DOI 10.1073/pnas.0602426103; Roberts SA, 2007, J BIOL CHEM, V282, P10605, DOI 10.1074/jbc.M611125200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	29	37	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34712	34719		10.1074/jbc.M805759200	http://dx.doi.org/10.1074/jbc.M805759200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936097	Green Published, hybrid			2022-12-25	WOS:000261469100027
J	Li, F; ten Dam, GB; Murugan, S; Yamada, S; Hashiguchi, T; Mizumoto, S; Oguri, K; Okayama, M; van Kuppevelt, TH; Sugahara, K				Li, Fuchuan; ten Dam, Gerdy B.; Murugan, Sengottuvelan; Yamada, Shuhei; Hashiguchi, Taishi; Mizumoto, Shuji; Oguri, Kayoko; Okayama, Minoru; van Kuppevelt, Toin H.; Sugahara, Kazuyuki			Involvement of Highly Sulfated Chondroitin Sulfate in the Metastasis of the Lewis Lung Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX-VIRUS INFECTIVITY; HUMAN-MELANOMA CELLS; HEPARAN-SULFATE; P-SELECTIN; SYNDECAN-1 EXPRESSION; DERMATAN SULFATE; ANTIBODY GD3G7; FIBRIN MATRIX; CANCER CELLS; TUMOR-CELLS	The altered expression of cell surface chondroitin sulfate ( CS) and dermatan sulfate (DS) in cancer cells has been demonstrated to play a key role in malignant transformation and tumor metastasis. However, the functional highly sulfated structures in CS/DS chains and their involvement in the process have not been well documented. In the present study, a structural analysis of CS/DS from two mouse Lewis lung carcinoma (3LL)-derived cell lines with different metastatic potentials revealed a higher proportion of Delta(4,5)HexUA-GalNAc(4,6-O-disulfate) generated from E-units (GlcUA-GalNAc(4,6-O-disulfate)) in highly metastatic LM66-H11 cells than in low metastatic P29 cells, although much less CS/DS is expressed by LM66-H11 than P29 cells. This key finding prompted us to study the role of CS-E-like structures in experimental lung metastasis. The metastasis of LM66-H11 cells to lungs was effectively inhibited by enzymatic removal of tumor cell surface CS or by preadministration of CS-E rich in E-units in a dose-dependent manner. In addition, immunocytochemical analysis showed that LM66-H11 rather than P29 cells expressed more strongly the CS-E epitope, which was specifically recognized by the phage display antibody GD3G7. More importantly, this antibody and a CS-E decasaccharide fraction, the minimal structure recognized by GD3G7, strongly inhibited the metastasis of LM66-H11 cells probably by modifying the proliferative and invading behavior of the metastatic tumor cells. These results suggest that the E-unit-containing epitopes are involved in the metastatic process and a potential target for the diagnosis and treatment of malignant tumors.	[Sugahara, Kazuyuki] Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut,Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Li, Fuchuan; Yamada, Shuhei; Sugahara, Kazuyuki] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6588558, Japan; [Oguri, Kayoko] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi 4600001, Japan; [Okayama, Minoru] Kyoto Sangyo Univ, Fac Engn, Dept Biotechnol, Kyoto 6038555, Japan; [ten Dam, Gerdy B.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Hokkaido University; Kobe Pharmaceutical University; Nagoya Medical Center; Kyoto Sangyo University; Radboud University Nijmegen	Sugahara, K (corresponding author), Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut,Kita Ku, Nishi 11,Kita 21, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp	van Kuppevelt, A.H.M.S.M./L-4463-2015; Mizumoto, Shuji/F-8313-2018; Murugan, Sengottuvelan/G-9153-2012	Mizumoto, Shuji/0000-0002-4641-1505; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); New Energy and Industrial Technology Development Organization; Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Human Frontier Science Program [RGP62/2004, RGP18/2005]; Dutch Cancer Society Grant [2008-4058]; Scientific Research on Priority Areas [17046028]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Human Frontier Science Program(Human Frontier Science ProgramCore Research for Evolutional Science and Technology (CREST)); Dutch Cancer Society Grant(KWF Kankerbestrijding); Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid 16390026 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), funds from the New Energy and Industrial Technology Development Organization (to K. S.) and the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Human Frontier Science Program Grants RGP62/2004 (to T. H. V. K.) and RGP18/2005 (to K. S.), Dutch Cancer Society Grant 2008-4058 (to G. T. D.), the "Academic Frontier" Project for Private Universities matching funds subsidy (to M. O.), and in part by Grant-in Aid for Scientific Research on Priority Areas 17046028 (to K. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; Day RM, 1999, VIRCHOWS ARCH, V434, P121, DOI 10.1007/s004280050315; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Denholm EM, 2001, EUR J PHARMACOL, V416, P213, DOI 10.1016/S0014-2999(01)00884-6; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gallagher JT, 1989, CURR OPIN CELL BIOL, V1, P1201, DOI 10.1016/S0955-0674(89)80072-9; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; Iida J, 1998, J BIOL CHEM, V273, P5955, DOI 10.1074/jbc.273.10.5955; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; INKI P, 1994, BRIT J CANCER, V70, P319, DOI 10.1038/bjc.1994.300; ITANO N, 1993, J BIOCHEM, V114, P862, DOI 10.1093/oxfordjournals.jbchem.a124269; Ito Y, 2007, ACTA HISTOCHEM CYTOC, V40, P53, DOI 10.1267/ahc.07004; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kumar-Singh S, 1998, J PATHOL, V186, P300, DOI 10.1002/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q; KURE S, 1987, JPN J CANCER RES, V78, P1238; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Ludwig RJ, 2004, CANCER RES, V64, P2743, DOI 10.1158/0008-5472.CAN-03-1054; Lv HZ, 2007, ONCOLOGY-BASEL, V72, P347, DOI 10.1159/000113145; LYNCH SA, 1991, CANCER METAST REV, V10, P141, DOI 10.1007/BF00049411; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Matsumoto A, 1997, INT J CANCER, V74, P482, DOI 10.1002/(SICI)1097-0215(19971021)74:5<482::AID-IJC2>3.0.CO;2-#; MOCZAR M, 1993, CLIN EXP METASTAS, V11, P462, DOI 10.1007/BF00054937; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Munesue S, 2002, BIOCHEM J, V363, P201, DOI 10.1042/0264-6021:3630201; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; Nackaerts K, 1997, INT J CANCER, V74, P335, DOI 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.3.CO;2-4; NAKANISHI H, 1992, BIOCHEM J, V288, P215, DOI 10.1042/bj2880215; Nikitovic D, 2008, INT J BIOCHEM CELL B, V40, P72, DOI 10.1016/j.biocel.2007.06.019; Pluschke G, 1996, P NATL ACAD SCI USA, V93, P9710, DOI 10.1073/pnas.93.18.9710; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; REDINI F, 1986, BIOCHIM BIOPHYS ACTA, V883, P98, DOI 10.1016/0304-4165(86)90140-6; ROBINSON J, 1984, J CELL BIOL, V98, P946, DOI 10.1083/jcb.98.3.946; Safaiyan F, 1998, EUR J BIOCHEM, V252, P576, DOI 10.1046/j.1432-1327.1998.2520576.x; SAITO H, 1968, J BIOL CHEM, V243, P1536; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; STAMATOGLOU SC, 1983, J CELL BIOL, V96, P1820, DOI 10.1083/jcb.96.6.1820; Stanley MJ, 1999, AM J CLIN PATHOL, V112, P377; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Timar J, 2002, SEMIN CANCER BIOL, V12, P173, DOI 10.1016/S1044-579X(02)00021-4; TIMAR J, 1992, AM J PATHOL, V141, P467; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Yoshitomi Y, 2004, CANCER LETT, V207, P165, DOI 10.1016/j.canlet.2003.11.037	61	85	90	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34294	34304		10.1074/jbc.M806015200	http://dx.doi.org/10.1074/jbc.M806015200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18930920	Green Published, hybrid			2022-12-25	WOS:000261277700057
J	Lin, HL; Kumanovics, A; Nelson, JM; Warner, DE; Ward, DM; Kaplan, J				Lin, Huilan; Kumanovics, Attila; Nelson, Jenifer M.; Warner, David E.; Ward, Diane McVey; Kaplan, Jerry			Single Amino Acid Change in the Yeast Vacuolar Metal Transporters Zrc1 and Cot1 Alters Their Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; COPPER DETOXIFICATION; CATION-TRANSPORT; GENE-EXPRESSION; PLASMA-MEMBRANE; ZINC STORAGE; IRON STORAGE; H+-ATPASE; METABOLISM; RESISTANCE	Iron is an essential nutrient but in excess may damage cells by generating reactive oxygen species due to Fenton reaction or by substituting for other transition metals in essential proteins. The budding yeast Saccharomyces cerevisiae detoxifies cytosolic iron by storage in the vacuole. Deletion of CCC1, which encodes the vacuolar iron importer, results in high iron sensitivity due to increased cytosolic iron. We selected mutants that permitted Delta ccc1 cells to grow under high iron conditions by UV mutagenesis. We identified a mutation (N44I) in the vacuolar zinc transporter ZRC1 that changed the substrate specificity of the transporter from zinc to iron. COT1, a vacuolar zinc and cobalt transporter, is a homologue of ZRC1 and both are members of the cation diffusion facilitator family. Mutation of the homologous amino acid (N45I) in COT1 results in an increased ability to transport iron and decreased ability to transport cobalt. These mutations are within the second hydrophobic domain of the transporters and show the essential nature of this domain in the specificity of metal transport.	[Lin, Huilan; Kumanovics, Attila; Nelson, Jenifer M.; Warner, David E.; Ward, Diane McVey; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu	Lin, Huilan/B-7671-2013		National Institutes of Health [DK30534, NCI-CCSG P30CA 42014]; NCI; NIDDK Center of Excellence [5P30KD72437]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, T32DK007115, R37DK030534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30534 ( to J. K.), support for use of the Core Facilities was provided through NCI, National Institutes of Health Grant NCI-CCSG P30CA 42014 and NIDDK Center of Excellence Award 5P30KD72437. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; CALVIN NM, 1988, J BACTERIOL, V170, P2796, DOI 10.1128/jb.170.6.2796-2801.1988; CONKLIN DS, 1994, MOL GEN GENET, V244, P303, DOI 10.1007/BF00285458; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DIX DR, 1994, J BIOL CHEM, V269, P26092; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lapinskas PJ, 1996, MOL MICROBIOL, V21, P519, DOI 10.1111/j.1365-2958.1996.tb02561.x; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lu JMY, 1998, P NATL ACAD SCI USA, V95, P9025, DOI 10.1073/pnas.95.15.9025; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; MacDiarmid CW, 2003, J BIOL CHEM, V278, P15065, DOI 10.1074/jbc.M300568200; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Moore DD, 1995, GLOB MOB SURV; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Tuttle MS, 2003, J BIOL CHEM, V278, P1273, DOI 10.1074/jbc.M209631200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x	36	22	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33865	33873		10.1074/jbc.M804377200	http://dx.doi.org/10.1074/jbc.M804377200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18930916	Green Published, hybrid			2022-12-25	WOS:000261277700011
J	Wang, YL; Faiola, F; Xu, MY; Pan, SQ; Martinez, E				Wang, Yuan-Liang; Faiola, Francesco; Xu, Muyu; Pan, Songqin; Martinez, Ernest			Human ATAC Is a GCN5/PCAF-containing Acetylase Complex with a Novel NC2-like Histone Fold Module That Interacts with the TATA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASE ACTIVITY; TRANSCRIPTION FACTOR; GCN5; DISTINCT; PCAF; SAGA; METHYLTRANSFERASE; IDENTIFICATION; ONCOPROTEIN; COACTIVATOR	Eukaryotic GCN5 acetyltransferases influence diverse biological processes by acetylating histones and non-histone proteins and regulating chromatin and gene-specific transcription as part of multiprotein complexes. In lower eukaryotes and invertebrates, these complexes include the yeast ADA complex that is still incompletely understood; the SAGA (Spt-Ada-Gcn5 acetylase) complexes from yeast to Drosophila that are mostly coactivators; and the ATAC (Ada Two-A containing) complex, only known in Drosophila and still poorly characterized. In contrast, vertebrate organisms, express two paralogous GCN5-like acetyltransferases (GCN5 and PCAF), which have been found so far only in SAGA-type complexes referred to hereafter as the STAGA (SPT3-TAF9-GCN5/PCAF acetylase) complexes. We now report the purification and characterization of vertebrate (human) ATAC-type complexes and identify novel components of STAGA. We show that human ATAC complexes incorporate in addition to GCN5 or PCAF (GCN5/PCAF), other epigenetic coregulators (ADA2-A, ADA3, STAF36, and WDR5), cofactors of chromatin assembly/remodeling and DNA replication machineries (POLE3/CHRAC17 and POLE4), the stress- and TGF beta-activated protein kinase (TAK1/MAP3K7) and MAP3-kinase regulator (MBIP), additional cofactors of unknown function, and a novel YEATS2-NC2 beta histone fold module that interacts with the TATA-binding protein (TBP) and negatively regulates transcription when recruited to a promoter. We further identify the p38 kinase-interacting protein (p38IP/FAM48A) as a novel component of STAGA with distant similarity to yeast Spt20. These results suggest that vertebrate ATAC-type and STAGA-type complexes link specific extracellular signals to modification of chromatin structure and regulation of the basal transcription machinery.	[Wang, Yuan-Liang; Faiola, Francesco; Xu, Muyu; Martinez, Ernest] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Pan, Songqin] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Pan, Songqin] Univ Calif Riverside, Inst Integrat Genome Biol, WM Keck Prote Lab, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Martinez, E (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	ernest.martinez@ucr.edu	Lv, Yuanjie/AER-0767-2022; Faiola, Francesco/Q-4218-2018; xu, muyu/R-3044-2017	Faiola, Francesco/0000-0002-3512-8253; xu, muyu/0000-0002-0921-3665	National Institutes of Health [CA100464]; National Science Foundation [MCB-0448488]; NATIONAL CANCER INSTITUTE [R01CA100464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100464. This work was also supported by Career Grant MCB-0448488 from the National Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Barlev NA, 2003, MOL CELL BIOL, V23, P6944, DOI 10.1128/MCB.23.19.6944-6957.2003; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Carre C, 2008, EMBO REP, V9, P187, DOI 10.1038/sj.embor.7401141; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Fukuyama K, 2000, J BIOL CHEM, V275, P21247, DOI 10.1074/jbc.M001488200; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Hardy S, 2002, J BIOL CHEM, V277, P32875, DOI 10.1074/jbc.M205860200; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; INOSTROZA JA, 1992, CELL, V70, P477; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Menon Suchithra, 2008, BMC Biochemistry, V9, P1, DOI 10.1186/1471-2091-9-1; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	44	152	153	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33808	33815		10.1074/jbc.M806936200	http://dx.doi.org/10.1074/jbc.M806936200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18838386	hybrid, Green Published			2022-12-25	WOS:000261277700004
J	McKenzie, S; Sakamoto, S; Kyprianou, N				McKenzie, S.; Sakamoto, S.; Kyprianou, N.			Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT	ONCOGENE			English	Article						hypoxia; maspin; prostate cancer; apoptosis; tumor suppression; angiogenesis	INDUCIBLE FACTOR-I; TUMOR-SUPPRESSOR; UP-REGULATION; HUMAN BREAST; EXPRESSION; ADHESION; VEGF; CONTRIBUTES; PROGRESSION; METASTASIS	Hypoxia has been previously linked to the development of both benign prostatic hyperplasia and prostate cancer. This study investigated the effect of maspin, an extracellular matrix (ECM) tumor suppressor, on the apoptotic response of prostate cancer cells to hypoxia. Gene expression pro. ling of human benign and malignant prostate epithelial cells after exposure to hypoxia or normoxia revealed dramatic changes in ECM regulators. Maspin was found to be overexpressed in response to hypoxia in prostate cancer cells, but not in benign prostate cells. To dissect the contribution of maspin to tumor cell responses within a hypoxic microenvironment, we used maspin-overexpressing DU-145 human prostate cancer cells. Exposure to hypoxic conditions (1% O-2) led to a significant increase in apoptosis in the DU-145 maspin cells, compared to DU-145 neo-transfectants without a significant effect on cell migration. This enhanced sensitivity to hypoxia-induced apoptosis leads to a significant suppression of tumor growth and tumor vascularity in vivo by targeting Akt and focal adhesion kinase activation. Our findings implicate maspin in prostate cancer cell response to hypoxia via recruitment of intracellular signaling partners. This study may have significance in the identification of maspin-driven therapeutic targeting in advanced metastatic prostate cancer.	[McKenzie, S.; Sakamoto, S.; Kyprianou, N.] Univ Kentucky, Div Urol, Dept Surg, Lucille P Markey Canc Ctr,Coll Med, Lexington, KY 40536 USA; [McKenzie, S.; Sakamoto, S.; Kyprianou, N.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [McKenzie, S.; Sakamoto, S.; Kyprianou, N.] Univ Kentucky, Dept Pathol, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky	Kyprianou, N (corresponding author), Univ Kentucky, Div Urol, Dept Surg, Lucille P Markey Canc Ctr,Coll Med, MS 283,800 Rose St, Lexington, KY 40536 USA.	nkypr2@uky.edu			National Institutes of Health, NIH [CA107575-01]; NATIONAL CANCER INSTITUTE [R01CA107575] Funding Source: NIH RePORTER	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health, NIH CA107575-01 (NK). We thank Menglei Zhu for expert assistance with the preparation of the figures and Lorie Howard for help with the paper submission.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Amir S, 2005, CANCER BIOL THER, V4, P400; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Corley KM, 2005, J CELL BIOCHEM, V96, P971, DOI 10.1002/jcb.20559; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Denk AE, 2007, PIGM CELL RES, V20, P112, DOI 10.1111/j.1600-0749.2007.00363.x; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; Garrison JB, 2007, CANCER RES, V67, P11344, DOI 10.1158/0008-5472.CAN-07-1662; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kyprianou N, 2000, HISTOL HISTOPATHOL, V15, P1211, DOI 10.14670/HH-15.1211; Lee BL, 2008, CARCINOGENESIS, V29, P44, DOI 10.1093/carcin/bgm232; Lee SM, 2006, CANCER LETT, V242, P231, DOI 10.1016/j.canlet.2005.11.001; Liu JY, 2004, CANCER RES, V64, P1703, DOI 10.1158/0008-5472.CAN-03-2568; McKenzie S, 2006, J CELL BIOCHEM, V97, P18, DOI 10.1002/jcb.20634; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Rofstad EK, 2005, CANCER RES, V65, P2387, DOI 10.1158/0008-5472.CAN-04-3039; Schaefer JS, 2003, CURR MOL MED, V3, P653, DOI 10.2174/1566524033479519; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Tahmatzopoulos A, 2005, ONCOGENE, V24, P5375, DOI 10.1038/sj.onc.1208684; Welsh SJ, 2003, CURR CANCER DRUG TAR, V3, P391, DOI 10.2174/1568009033481732; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	32	25	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	57					7171	7179		10.1038/onc.2008.321	http://dx.doi.org/10.1038/onc.2008.321			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	379GG	18931702	Green Accepted			2022-12-25	WOS:000261384100004
J	Lee, JN; Zhang, XY; Feramisco, JD; Gong, Y; Ye, J				Lee, Joon No; Zhang, Xiangyu; Feramisco, Jamison D.; Gong, Yi; Ye, Jin			Unsaturated Fatty Acids Inhibit Proteasomal Degradation of Insig-1 at a Postubiquitination Step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL-REGULATED UBIQUITINATION; CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEIN-1C; BOUND TRANSCRIPTION FACTOR; ER-ASSOCIATED DEGRADATION; ACYL-COA SYNTHETASE; MEMBRANE-PROTEIN; CELLS; CHOLESTEROL; REDUCTASE	Proteasomes mediate the regulated degradation of Insig-1, a membrane protein of the endoplasmic reticulum (ER) that plays a crucial role in lipid metabolism. We showed previously that sterols inhibit this degradation by blocking ubiquitination of Insig-1. Here we show that unsaturated fatty acids stabilize Insig-1 without affecting its ubiquitination. Instead unsaturated fatty acids inhibit extraction of ubiquitinated Insig-1 from membranes, a process known to be mediated by valosin-containing protein and necessary for ER-associated degradation. Valosin-containing protein is recruited to Insig-1 through the action of another protein, Ubxd8. Unsaturated fatty acids block the binding between Ubxd8 and Insig-1, thereby abrogating the membrane extraction of Insig-1. Unsaturated fatty acid-mediated stabilization of Insig-1 enhances the ability of sterols to inhibit proteolytic activation of SREBP-1, which activates transcription of genes involved in fatty acid synthesis. The current study provides a molecular mechanism for regulation of proteasome-mediated ER protein degradation at a postubiquitination step.	[Lee, Joon No; Zhang, Xiangyu; Feramisco, Jamison D.; Gong, Yi; Ye, Jin] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Ye, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	jin.ye@utsouthwestern.edu	Gong, Yi/AAQ-7515-2020		National Institutes of Health [HL-20948]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-20948. This work was also supported by the Perot Family Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Dobrzyn A, 2005, PROSTAG LEUKOTR ESS, V73, P35, DOI 10.1016/j.plefa.2005.04.011; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Imai Y, 2002, BIOCHEM BIOPH RES CO, V297, P1282, DOI 10.1016/S0006-291X(02)02380-X; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee JN, 2006, P NATL ACAD SCI USA, V103, P4958, DOI 10.1073/pnas.0600422103; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; TOMODA H, 1991, J BIOL CHEM, V266, P4214; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	51	69	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33772	33783		10.1074/jbc.M806108200	http://dx.doi.org/10.1074/jbc.M806108200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18835813	Green Published, hybrid			2022-12-25	WOS:000261183700083
J	Patel, A; Dharmarajan, V; Cosgrove, MS				Patel, Anamika; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.			Structure of WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 LYSINE-4; METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; MOLECULAR RECOGNITION; MLL; METHYLATION; EXPRESSION; MICE	The mixed lineage leukemia protein-1 (MLL1) catalyzes histone H3 lysine 4 methylation and is regulated by interaction with WDR5 (WD-repeat protein-5), RbBP5 (retinoblastoma-binding protein-5), and the Ash2L (absent, small, homeotic discs-2-like) oncoprotein. In the accompanying investigation, we describe the identification of a conserved arginine containing motif, called the "Win" or WDR5 interaction motif, that is essential for the assembly and H3K4 dimethylation activity of the MLL1 core complex. Here we present a 1.7-angstrom crystal structure of WDR5 bound to a peptide derived from the MLL1 Win motif. Our results show that Arg-3765 of MLL1 is bound in the same arginine binding pocket on WDR5 that was previously suggested to bind histone H3. Thermodynamic binding experiments show that the MLL1 Win peptide is preferentially recognized by WDR5. These results are consistent with a model in which WDR5 recognizes Arg-3765 of MLL1, which is essential for the assembly and enzymatic activity of the MLL1 core complex.	[Patel, Anamika; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Cosgrove, MS (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA.	mscosgro@syr.edu			March of Dimes Birth Defects Foundation [5-FY06-585]; Syracuse University; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); Syracuse University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Research Grant 5-FY06-585 from the March of Dimes Birth Defects Foundation (to M. S. C.) and by funds from Syracuse University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	23	121	128	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32158	32161		10.1074/jbc.C800164200	http://dx.doi.org/10.1074/jbc.C800164200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18829459	hybrid			2022-12-25	WOS:000260893700002
J	Welch, TR; Blystone, LW				Welch, Thomas R.; Blystone, Lisa W.			Immune Complex Glomerulonephritis Following Bone Marrow Transplantation in C3 Deficient Mice	PLOS ONE			English	Article							TUBULAR EPITHELIAL-CELLS; MEDIATES STIMULATION; GENE-EXPRESSION; ACTIVATION; COMPONENT; C4	Background: The role of circulating complement in host defense and immune disease is well established. Although a number of cells and tissues are capable of synthesizing complement components locally, the importance of such local synthesis in immune disease has been difficult to establish. Methodology/Principal Findings: We used bone marrow transplantation (BMT) between C3 knockout (C3KO) and wild type (WT) mice to construct animals that were discordant for systemic (hepatic) and local (monocytic) C3 synthetic capacity. An immune complex glomerulonephritis (GN) was then induced using intraperitoneal injections of horse spleen apoferritin (HSA) with a lipopolysaccharide (LPS) adjuvant. All HSA/LPS animals developed a proliferative GN with glomerular infiltration by monocytes. By sensitive ELISA, monocyte C3 synthesis could be detected in C3KO animals transplanted with WT bone marrow cells. Despite this, there were no significant differences among groups of mice in measures of clinical (proteinuria, renal function) or histologic (glomerular cellularity, crescents) disease severity. Conclusions/Significance: In this model of GN, local synthesis of C3 by infiltrating cells does not appear to be of pathologic importance.	[Welch, Thomas R.; Blystone, Lisa W.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Welch, TR (corresponding author), SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA.	welcht@upstate.edu		Welch, Thomas/0000-0002-5893-4020				BROOIMANS RA, 1991, J CLIN INVEST, V88, P379, DOI 10.1172/JCI115314; Drouin SM, 1996, MOL IMMUNOL, V33, P1025, DOI 10.1016/S0161-5890(96)00071-5; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; Jose MD, 2003, TRANSPLANTATION, V76, P1015, DOI 10.1097/01.TP.0000083507.67995.13; LAUFER J, 1995, IMMUNOLOGY, V84, P207; Li K, 2004, J AM SOC NEPHROL, V15, P2414, DOI 10.1097/01.ASN.0000135974.06478.7B; PASSWELL J, 1988, J CLIN INVEST, V82, P1676, DOI 10.1172/JCI113780; Peng Q, 2008, BLOOD, V111, P2452, DOI 10.1182/blood-2007-06-095018; Reis ES, 2008, MOL IMMUNOL, V45, P1952, DOI 10.1016/j.molimm.2007.10.031; SEELEN MAJ, 1993, KIDNEY INT, V44, P50, DOI 10.1038/ki.1993.212; Sund S, 2004, CLIN NEPHROL, V62, P121; Thurman JM, 2007, J IMMUNOL, V178, P1819, DOI 10.4049/jimmunol.178.3.1819; Verschoor A, 2001, J IMMUNOL, V167, P2446, DOI 10.4049/jimmunol.167.5.2446; Welch TR, 2005, CLIN IMMUNOL, V115, P80, DOI 10.1016/j.clim.2004.10.008; WELCH TR, 1993, J CLIN INVEST, V92, P1451, DOI 10.1172/JCI116722; Welch TR, 2002, CLIN EXP IMMUNOL, V130, P43, DOI 10.1046/j.1365-2249.2002.01957.x; Welch TR, 2001, NEPHRON, V88, P199, DOI 10.1159/000045990; Welch TR, 2000, PEDIATR RES, V48, P200, DOI 10.1203/00006450-200008000-00013; WITTE DP, 1991, AM J PATHOL, V139, P717	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3334	10.1371/journal.pone.0003334	http://dx.doi.org/10.1371/journal.pone.0003334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836527	Green Published, Green Submitted, gold			2022-12-25	WOS:000265113500003
J	Wang, HB; Xie, HR; Dey, SK				Wang, Haibin; Xie, Huirong; Dey, Sudhansu K.			Loss of Cannabinoid Receptor CB1 Induces Preterm Birth	PLOS ONE			English	Article								Background: Preterm birth accounting approximate 10% of pregnancies in women is a tremendous social, clinical and economic burden. However, its underlying causes remain largely unknown. Emerging evidence suggests that endocannabinoid signaling via cannabinoid receptor CB1 play critical roles in multiple early pregnancy events in both animals and humans. Since our previous studies demonstrated that loss of CB1 defers the normal implantation window in mice, we surmised that CB1 deficiency would influence parturition events. Methods and Findings: Exploiting mouse models with targeted deletion of Cnr1, Cnr2 and Ptgs1 encoding CB1, CB2 and cyclooxygenase-1, respectively, we examined consequences of CB1 or CB2 silencing on the onset of parturition. We observed that genetic or pharmacological inactivation of CB1, but not CB2, induced preterm labor in mice. Radioimmunoassay analysis of circulating levels of ovarian steroid hormones revealed that premature birth resulting from CB1 inactivation is correlated with altered progesterone/ estrogen ratios prior to parturition. More strikingly, the phenotypic defects of prolonged pregnancy length and parturition failure in mice missing Ptgs1 were corrected by introducing CB1 deficiency into Ptgs1 null mice. In addition, loss of CB1 resulted in aberrant secretions of corticotrophin-releasing hormone and corticosterone during late gestation. The pathophysiological significance of this altered corticotrophin-releasing hormone-driven endocrine activity in the absence of CB1 was evident from our subsequent findings that a selective corticotrophin-releasing hormone antagonist was able to restore the normal parturition timing in Cnr1 deficient mice. In contrast, wild-type females receiving excessive levels of corticosterone induced preterm birth. Conclusions: CB1 deficiency altering normal progesterone and estrogen levels induces preterm birth in mice. This defect is independent of prostaglandins produced by cyclooxygenase-1. Moreover, CB1 inactivation resulted in aberrant corticotrophin-releasing hormone and corticosterone activities prior to parturition, suggesting that CB1 regulates labor by interacting with the corticotrophin-releasing hormone-driven endocrine axis.	[Wang, Haibin; Xie, Huirong; Dey, Sudhansu K.] Vanderbilt Univ, Med Ctr, Dept Pediat, Cell & Dev Biol, & Pharmacol, Nashville, TN USA	Vanderbilt University	Wang, HB (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sk.dey@cchmc.org			US National Institutes of Health NIH [DA06668, HD12304, CA77839, HD050315]; National Institute on Drug Abuse NIDA [MERIT Awards]; National Institute of Child Health and Human Development NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD050315, R37HD012304, R01HD012304] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006668, R37DA006668] Funding Source: NIH RePORTER	US National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Child Health and Human Development NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in parts by US National Institutes of Health (NIH) Grants DA06668, HD12304 & CA77839 to SKD, and HD050315 to HW. SKD is recipient of Method to Extend Research in Time (MERIT) Awards from the National Institute on Drug Abuse (NIDA) and the National Institute of Child Health and Human Development (NICHD).	Bayatti N, 2005, ENDOCRINOLOGY, V146, P1205, DOI 10.1210/en.2004-1154; Calogero AE, 1996, ENDOCRINOLOGY, V137, P4161, DOI 10.1210/en.137.10.4161; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Comings DE, 1997, MOL PSYCHIATR, V2, P161, DOI 10.1038/sj.mp.4000247; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2007, ENDOCRINOLOGY, V148, P1574, DOI 10.1210/en.2005-1649; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; DAS SK, 1994, DEVELOPMENT, V120, P1071; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Dennedy MC, 2004, AM J OBSTET GYNECOL, V190, P2, DOI 10.1016/j.ajog.2003.07.013; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dey SK, 2005, NATURE, V435, P34, DOI 10.1038/435034a; FernandezRuiz J, 1997, BIOCHEM PHARMACOL, V53, P1919; FIELD E, 1986, J PHARMACOL EXP THER, V238, P1034; Fride E, 2003, EUR J PHARMACOL, V461, P27, DOI 10.1016/S0014-2999(03)01295-0; Fride E, 2002, NEUROREPORT, V13, P1833, DOI 10.1097/00001756-200210280-00001; Gadzicki D, 1999, MOL CELL PROBE, V13, P321, DOI 10.1006/mcpr.1999.0249; Gammon CM, 2005, ENDOCRINOLOGY, V146, P4491, DOI 10.1210/en.2004-1672; Gross GA, 1998, P NATL ACAD SCI USA, V95, P11875, DOI 10.1073/pnas.95.20.11875; Guo Y, 2005, J BIOL CHEM, V280, P23429, DOI 10.1074/jbc.C500168200; Habayeb OMH, 2004, J CLIN ENDOCR METAB, V89, P5482, DOI 10.1210/jc.2004-0681; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Karalis K, 1996, NAT MED, V2, P556, DOI 10.1038/nm0596-556; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Linzer DIH, 1999, MOL ENDOCRINOL, V13, P837, DOI 10.1210/me.13.6.837; Maccarrone M, 2000, LANCET, V355, P1326, DOI 10.1016/S0140-6736(00)02115-2; Maccarrone M, 2002, VITAM HORM, V65, P225, DOI 10.1016/S0083-6729(02)65066-6; MASTORAKOS G, 1993, J CLIN INVEST, V92, P961, DOI 10.1172/JCI116672; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Mesiano S, 2007, SEMIN CELL DEV BIOL, V18, P321, DOI 10.1016/j.semcdb.2007.05.003; Mitchell MD, 2008, AM J PHYSIOL-ENDOC M, V294, pE352, DOI 10.1152/ajpendo.00495.2007; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; PARIA BC, 1995, P NATL ACAD SCI USA, V92, P9460, DOI 10.1073/pnas.92.21.9460; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; ROUZER CA, 2006, BIOCH J; Schmid PC, 1997, P NATL ACAD SCI USA, V94, P4188, DOI 10.1073/pnas.94.8.4188; Scorticati C, 2004, P NATL ACAD SCI USA, V101, P11891, DOI 10.1073/pnas.0404366101; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Song H, 2002, DEVELOPMENT, V129, P2879; STEGER RW, 1981, FERTIL STERIL, V35, P567; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Taylor AH, 2007, HUM REPROD UPDATE, V13, P501, DOI 10.1093/humupd/dmm018; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; Wang J, 1999, BIOL REPROD, V60, P839, DOI 10.1095/biolreprod60.4.839; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	58	48	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3320	10.1371/journal.pone.0003320	http://dx.doi.org/10.1371/journal.pone.0003320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833324	Green Submitted, Green Published, gold			2022-12-25	WOS:000264797400002
J	Mathew, A; O'Bryan, J; Marshall, W; Kotwal, GJ; Terajima, M; Green, S; Rothman, AL; Ennis, FA				Mathew, Anuja; O'Bryan, Joel; Marshall, William; Kotwal, Girish J.; Terajima, Masanori; Green, Sharone; Rothman, Alan L.; Ennis, Francis A.			Robust Intrapulmonary CD8 T Cell Responses and Protection with an Attenuated N1L Deleted Vaccinia Virus	PLOS ONE			English	Article								Background: Vaccinia viruses have been used as a model for viral disease and as a protective live vaccine. Methodology and Principal Findings: We investigated the immunogenicity of an attenuated strain of vaccinia virus engineered to inactivate the N1L gene (vGK5). Using the intranasal route, this recombinant virus was 2 logs less virulent compared to the wildtype VACV-WR. Infection by the intranasal, intraperitoneal, and tail scarification routes resulted in the robust induction of cytolytic virus-specific CD8 T cells in the spleens and the lungs. VACV- specific antibodies were also detected in the sera of mice infected 3-5 months prior with the attenuated vGK5 virus. Finally, mice immunized with vGK5 were significantly protected when challenged with a lethal dose of VACV-WR. Conclusions: These results indicate that the attenuated vGK5 virus protects against subsequent infection and suggest that the N1L protein limits the strength of the early antiviral CD8 T cell response following respiratory infection.	[Mathew, Anuja; O'Bryan, Joel; Terajima, Masanori; Green, Sharone; Rothman, Alan L.; Ennis, Francis A.] Univ Massachusetts, Ctr Infect Dis & Vaccine Res, Sch Med, Worcester, MA 01605 USA; [Marshall, William; Kotwal, Girish J.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mathew, A (corresponding author), Univ Massachusetts, Ctr Infect Dis & Vaccine Res, Sch Med, Worcester, MA 01605 USA.	anuja.mathew@umassmed.edu	Mathew, Anuja/V-6711-2019	Mathew, Anuja/0000-0002-6752-009X; Rothman, Alan/0000-0002-4064-6848	National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01-AI-25490, U19 AI057319, R01 AI070940, R21AI069167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070940, N01AI025490, R21AI069167, U19AI057319] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Contract No. N01-AI-25490 and grant U19 AI057319 to FAE and R01 AI070940 and R21AI069167 to WLM.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; ANDREW ME, 1989, IMMUNOL CELL BIOL, V67, P331, DOI 10.1038/icb.1989.48; Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Billings B, 2004, ANN NY ACAD SCI, V1030, P297, DOI 10.1196/annals.1329.037; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; de Moissac D, 1999, J BIOL CHEM, V274, P29505, DOI 10.1074/jbc.274.41.29505; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Gurt I, 2006, ANTIVIR RES, V69, P158, DOI 10.1016/j.antiviral.2005.11.006; Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KOTWAL GJ, 1989, VIROLOGY, V171, P579, DOI 10.1016/0042-6822(89)90627-2; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Mathew A, 2005, J IMMUNOL, V174, P2212, DOI 10.4049/jimmunol.174.4.2212; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Parker LC, 2005, J LEUKOCYTE BIOL, V77, P886, DOI 10.1189/jlb.1104636; Phelps A, 2005, VACCINE, V23, P3500, DOI 10.1016/j.vaccine.2005.02.005; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Reading PC, 2003, J EXP MED, V197, P1269, DOI 10.1084/jem.20022201; REED JC, 1987, SCIENCE, V236, P1295, DOI 10.1126/science.3495884; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rosenthal SR, 2001, EMERG INFECT DIS, V7, P920, DOI 10.3201/eid0706.010602; Smee DF, 2001, ANTIVIR CHEM CHEMOTH, V12, P71, DOI 10.1177/095632020101200105; Smee DF, 2001, ANTIVIR RES, V52, P55, DOI 10.1016/S0166-3542(01)00159-0; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; WILLIAMSON JD, 1990, J GEN VIROL, V71, P2761, DOI 10.1099/0022-1317-71-11-2761; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Zhang ZN, 2005, ANN NY ACAD SCI, V1056, P69, DOI 10.1196/annals.1352.005	38	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3323	10.1371/journal.pone.0003323	http://dx.doi.org/10.1371/journal.pone.0003323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830408	gold, Green Published, Green Submitted			2022-12-25	WOS:000264797300011
J	Meyer, DH; Bailis, AM				Meyer, Damon H.; Bailis, Adam M.			Telomerase Deficiency Affects the Formation of Chromosomal Translocations by Homologous Recombination in Saccharomyces cerevisiae	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-REPAIR; MITOTIC RECOMBINATION; REVERSE-TRANSCRIPTASE; MULTIPLE PATHWAYS; HUMAN FIBROBLASTS; YEAST TELOMERASE; DYSFUNCTION; CELLS; RAD52	Telomerase is a ribonucleoprotein complex required for the replication and protection of telomeric DNA in eukaryotes. Cells lacking telomerase undergo a progressive loss of telomeric DNA that results in loss of viability and a concomitant increase in genome instability. We have used budding yeast to investigate the relationship between telomerase deficiency and the generation of chromosomal translocations, a common characteristic of cancer cells. Telomerase deficiency increased the rate of formation of spontaneous translocations by homologous recombination involving telomere proximal sequences during crisis. However, telomerase deficiency also decreased the frequency of translocation formation following multiple HO-endonuclease catalyzed DNA double-strand breaks at telomere proximal or distal sequences before, during and after crisis. This decrease correlated with a sequestration of the central homologous recombination factor, Rad52, to telomeres determined by chromatin immuno-precipitation. This suggests that telomerase deficiency results in the sequestration of Rad52 to telomeres, limiting the capacity of the cell to repair double-strand breaks throughout the genome. Increased spontaneous translocation formation in telomerase-deficient yeast cells undergoing crisis is consistent with the increased incidence of cancer in elderly humans, as the majority of our cells lack telomerase. Decreased translocation formation by recombinational repair of double-strand breaks in telomerase-deficient yeast suggests that the reemergence of telomerase expression observed in many human tumors may further stimulate genome rearrangement. Thus, telomerase may exert a substantial effect on global genome stability, which may bear significantly on the appearance and progression of cancer in humans.	[Meyer, Damon H.; Bailis, Adam M.] Beckman Res Inst City Hope, Div Mol Biol, Duarte, CA USA; [Meyer, Damon H.] City of Hope, Grad Sch Biol Sci, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope	Meyer, DH (corresponding author), Beckman Res Inst City Hope, Div Mol Biol, Duarte, CA USA.	abailis@coh.org		Bailis, Adam/0000-0001-5628-0468	National Institutes of Health [GM057484]; Department of Defense Breast Cancer Research [W81XWH0410407]; Beckman Institute of the City of Hope; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); Beckman Institute of the City of Hope; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health Grant (GM057484 to AMB), Department of Defense Breast Cancer Research Program Grant (W81XWH0410407 to DHM), institutional funds from Beckman Institute of the City of Hope	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Beliveau A, 2007, P NATL ACAD SCI USA, V104, P4431, DOI 10.1073/pnas.0700260104; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Cheung ALM, 2008, FRONT BIOSCI-LANDMRK, V13, P2075, DOI 10.2741/2825; Cooper DM, 1998, MAMM GENOME, V9, P355, DOI 10.1007/s003359900769; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; DuBois ML, 2002, GENETICS, V161, P995; FASULLO MT, 1988, MOL CELL BIOL, V8, P4370, DOI 10.1128/MCB.8.10.4370; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Flint J, 1996, HUM MOL GENET, V5, P1163, DOI 10.1093/hmg/5.8.1163; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Hackett JA, 2003, MOL CELL BIOL, V23, P8450, DOI 10.1128/MCB.23.23.8450-8461.2003; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heacock ML, 2007, NUCLEIC ACIDS RES, V35, P6490, DOI 10.1093/nar/gkm472; HEALY KC, 1995, ONCOL RES, V7, P121; HUANG CH, 1981, BIOCHEMISTRY-US, V20, P233, DOI 10.1021/bi00505a001; Iadonato S P, 1996, Methods Mol Biol, V54, P75; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Knight W., 2006, CONFIDENCE INTERVALS; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Le S, 1999, GENETICS, V152, P143; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LESLIE M, 2005, SCI AGING KNOWLEDGE, pNF41; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; MANIATIS T, 1989, MOL CLONING LAB MANU, V2; Manthey GM, 2002, MOL CELL BIOL, V22, P5347, DOI 10.1128/MCB.22.15.5347-5356.2002; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; Meeker AK, 2004, CURR OPIN ONCOL, V16, P32, DOI 10.1097/00001622-200401000-00007; Meyer DH, 2007, GENETICS, V175, P1533, DOI 10.1534/genetics.106.068130; MEYER DH, 2008, MOL MICROBI IN PRESS; Mieczkowski PA, 2003, P NATL ACAD SCI USA, V100, P10854, DOI 10.1073/pnas.1934561100; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Murnane JP, 2004, BIOESSAYS, V26, P1164, DOI 10.1002/bies.20125; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; ONNO M, 1992, ONCOGENE, V7, P2519; Pannunzio NR, 2008, DNA REPAIR, V7, P788, DOI 10.1016/j.dnarep.2008.02.003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Perera SA, 2008, CARCINOGENESIS, V29, P747, DOI 10.1093/carcin/bgn050; RENAN MJ, 1993, MOL CARCINOGEN, V7, P139; RESNICK MA, 1979, NUCLEIC ACIDS RES, V6, P3145, DOI 10.1093/nar/6.9.3145; Riha K, 2006, ANNU REV GENET, V40, P237, DOI 10.1146/annurev.genet.39.110304.095755; Rizki A, 2001, NATURE, V411, P713, DOI 10.1038/35079641; RONNE H, 1988, P NATL ACAD SCI USA, V85, P2696, DOI 10.1073/pnas.85.8.2696; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SCHILD D, 1983, CLONING YEAST RECOMB; Sharma GG, 2003, ONCOGENE, V22, P131, DOI 10.1038/sj.onc.1206063; SHAY JW, 1993, EXP CELL RES, V209, P45, DOI 10.1006/excr.1993.1283; Sherman F., 1986, METHODS YEAST GENETI; Shin KH, 2004, CLIN CANCER RES, V10, P2551, DOI 10.1158/1078-0432.CCR-0669-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Singer MS, 1998, GENETICS, V150, P613; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; SUNG P, 1993, J BIOL CHEM, V268, P26391; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; THOMAS BJ, 1989, GENETICS, V123, P725; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Wu Y, 2006, J BIOL CHEM, V281, P40001, DOI 10.1074/jbc.M608071200; ZWELLING LA, 1981, BIOCHEMISTRY-US, V20, P6553, DOI 10.1021/bi00526a006	82	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3318	10.1371/journal.pone.0003318	http://dx.doi.org/10.1371/journal.pone.0003318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830407	Green Submitted, Green Published, gold			2022-12-25	WOS:000264797300008
J	Tran, TA; de Herve, MGD; Hendel-Chavez, H; Dembele, B; Le Nevot, E; Abbed, K; Pallier, C; Goujard, C; Gasnault, J; Delfraissy, JF; Balazuc, AM; Taoufik, Y				Tran, Tu-Anh; de Herve, Marie-Ghislaine de Goer; Hendel-Chavez, Houria; Dembele, Bamory; Le Nevot, Emilie; Abbed, Karim; Pallier, Coralie; Goujard, Cecile; Gasnault, Jacques; Delfraissy, Jean-Francois; Balazuc, Anne-Marie; Taoufik, Yassine			Resting Regulatory CD4 T Cells: A Site of HIV Persistence in Patients on Long-Term Effective Antiretroviral Therapy	PLOS ONE			English	Article								Background: In HIV-infected patients on long-term HAART, virus persistence in resting long-lived CD4 T cells is a major barrier to curing the infection. Cell quiescence, by favouring HIV latency, reduces the risk of recognition and cell destruction by cytotoxic lymphocytes. Several cell-activation-based approaches have been proposed to disrupt cell quiescence and then virus latency, but these approaches have not eradicated the virus. CD4(+)CD25(+) regulatory T cells (Tregs) are a CD4(+) T-cell subset with particular activation properties. We investigated the role of these cells in virus persistence in patients on long-term HAART. Methodology/Principal Findings: We found evidence of infection of resting Tregs (HLADR(-)CD69(-)CD25(hi)FoxP3(+)CD4(+) T cells) purified from patients on prolonged HAART. HIV DNA harbouring cells appear more abundant in the Treg subset than in non-Tregs. The half-life of the Treg reservoir was estimated at 20 months. Since Tregs from patients on prolonged HAART showed hyporesponsiveness to cell activation and inhibition of HIV-specific cytotoxic T lymphocyte-related functions upon activation, therapeutics targeting cell quiescence to induce virus expression may not be appropriate for purging the Treg reservoir. Conclusions: Our results identify Tregs as a particular compartment within the latent reservoir that may require a specific approach for its purging.	[Tran, Tu-Anh; de Herve, Marie-Ghislaine de Goer; Dembele, Bamory; Goujard, Cecile; Gasnault, Jacques; Delfraissy, Jean-Francois; Taoufik, Yassine] Univ Paris 11, INSERM, U802, Le Kremlin Bicetre, France; [Hendel-Chavez, Houria; Le Nevot, Emilie; Abbed, Karim; Taoufik, Yassine] AP HP, Hop Bicetre, Unite Immunol Biol, Le Kremlin Bicetre, France; [Goujard, Cecile; Gasnault, Jacques; Delfraissy, Jean-Francois] AP HP, Hop Bicetre, Serv Med Interne, Le Kremlin Bicetre, France; [Pallier, Coralie] AP HP, Hop Bicetre, Lab Virol, Le Kremlin Bicetre, France; [Balazuc, Anne-Marie] Inst Pasteur, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tran, TA (corresponding author), Univ Paris 11, INSERM, U802, Le Kremlin Bicetre, France.	yacine.taoufik@bct.aphp.fr		DEMBELE, Bamory/0000-0002-6165-9090; TRAN, Tu-Anh/0000-0001-6587-1876	INSERM; ANRS; SIDACTION; Universite Paris 11	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANRS(ANRSFrench National Research Agency (ANR)); SIDACTION; Universite Paris 11	The work was supported by grants from INSERM, ANRS, SIDACTION and Universite Paris 11.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Camara NOS, 2003, EUR J IMMUNOL, V33, P3473, DOI 10.1002/eji.200323966; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Demoustier A, 2002, AIDS, V16, P1749, DOI 10.1097/00002030-200209060-00006; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; GEERAERT L, 2007, ANN REV MED; Grant C, 2006, PLOS PATHOG, V2, P303, DOI 10.1371/journal.ppat.0020033; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Lambotte O, 2002, AIDS, V16, P2151, DOI 10.1097/00002030-200211080-00007; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Ramratnam B, 2004, JAIDS-J ACQ IMM DEF, V35, P33, DOI 10.1097/00126334-200401010-00004; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; von Boehmer H, 2003, J EXP MED, V198, P845, DOI 10.1084/jem.20031358; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yang QE, 2004, MED SCI MONITOR, V10, pRA155; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	51	67	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3305	10.1371/journal.pone.0003305	http://dx.doi.org/10.1371/journal.pone.0003305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827929	Green Submitted, Green Published, gold			2022-12-25	WOS:000264797200010
J	Bolego, C; Buccellati, C; Prada, A; Gaion, RM; Folco, G; Sala, A				Bolego, Chiara; Buccellati, Carola; Prada, Alberto; Gaion, Rosa Maria; Folco, Giancarlo; Sala, Angelo			Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone	FASEB JOURNAL			English	Article						selective cyclooxygenase inhibitors; prostaglandin; isoprostanes; COX-2 heterodimers; 12-HpETE	PROSTAGLANDIN-H SYNTHASE; ANTIINFLAMMATORY DRUGS; PHOSPHOLIPASE A(2); ARACHIDONIC-ACID; UP-REGULATION; SHEAR-STRESS; CYCLOOXYGENASE-2; EXPRESSION; PLATELETS; AND-2	We aimed at evaluating the relative contribution of cyclooxygenase (COX) -1 and COX-2 to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance. Selective inhibitors of either COX-1 (SC560 and FR122047) or COX-2 (SC236) concentration dependently (1-300 nM) reduced basal and interleukin (IL) -1 beta-induced prostacyclin production in human umbilical vein endothelial cells by 70% or more; compound selectivity was confirmed using a whole-blood assay (IC50 COX-1/COX-2: 13 nM/930 nM for SC-560; 9 mu M/457 nM for SC-236). The observed concomitant formation of isoprostane appeared to be associated with COX enzyme activity, while formation of COX-1/COX-2 heterodimers was detected by immunoprecipitation. In the presence of arachidonic acid and 12-hydroperoxy-eicosatetraenoic acid, either exogenous or provided by platelet activation, or after glutathione depletion, COX-1 inhibition but not COX-2 inhibition concentration dependently decreased prostacyclin production. Both isoforms appear to contribute to basal prostacyclin production by endothelial cells, with COX-2 providing the hydroperoxide tone required for COX-1 activity. Conversely, in the case of intracellular glutathione depletion or enhanced availability of arachidonic acid and hydroperoxides, selective COX-2 inhibition did not significantly affect the production of endothelial prostacyclin. These findings contribute to a better understanding of the effects of cyclooxygenase inhibitors on prostacyclin production.-Bolego, C., Buccellati, C., Prada, A., Gaion, R. M., Folco, G., Sala, A. Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone. FASEB J. 23, 605-612 (2009)	[Bolego, Chiara; Buccellati, Carola; Folco, Giancarlo; Sala, Angelo] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; [Gaion, Rosa Maria] Univ Padua, Dept Pharmacol & Anesthesiol, Padua, Italy; [Prada, Alberto] Rho Hosp, Rho, Italy	University of Milan; University of Padua	Sala, A (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	angelo.sala@unimi.it	Sala, Angelo/H-5478-2019	Sala, Angelo/0000-0001-9290-0257	European Community [LSHM-CT-2004-005033]; Italian Ministry of Instruction University and Research	European Community(European Commission); Italian Ministry of Instruction University and Research(Ministry of Education, Universities and Research (MIUR))	We thank Dr. A. Zanini for the assistance in collecting the umbilical cords and Dr. G. Simonutti for confocal microscopy analysis. The study was supported by grants from the European Community (LSHM-CT-2004-005033 to G. F. and A. S.) and from the Italian Ministry of Instruction, University and Research (FIRST to G. F. and A. S., and PRIN to A. S.).	Bolego C, 2006, BIOCHEM BIOPH RES CO, V339, P188, DOI 10.1016/j.bbrc.2005.11.017; Camacho M, 1998, CIRC RES, V83, P353, DOI 10.1161/01.RES.83.4.353; Camacho M, 2000, THROMB RES, V99, P155, DOI 10.1016/S0049-3848(00)00241-3; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Chen W, 1999, J BIOL CHEM, V274, P20301, DOI 10.1074/jbc.274.29.20301; Coffey MJ, 2004, CIRC RES, V94, P1598, DOI 10.1161/01.RES.0000132281.78948.65; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; Flavahan NA, 2007, TRENDS PHARMACOL SCI, V28, P106, DOI 10.1016/j.tips.2007.01.003; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; HABIB A, 1993, J BIOL CHEM, V268, P23448; HABIB A, 1995, THROMB HAEMOSTASIS, V74, P770; James MJ, 2001, INFLAMM RES, V50, P249, DOI 10.1007/s000110050750; Karim S, 1996, J BIOL CHEM, V271, P12042, DOI 10.1074/jbc.271.20.12042; Kokura S, 1999, CIRC RES, V84, P516, DOI 10.1161/01.RES.84.5.516; Kulmacz RJ, 1998, FEBS LETT, V430, P154, DOI 10.1016/S0014-5793(98)00657-7; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Mitchell JA, 2006, FASEB J, V20, P2468, DOI 10.1096/fj.06-6615com; NUGTEREN DH, 1975, BIOCHIM BIOPHYS ACTA, V380, P299, DOI 10.1016/0005-2760(75)90016-8; Ochi T, 2000, EUR J PHARMACOL, V391, P49, DOI 10.1016/S0014-2999(00)00051-0; Okahara K, 1998, ARTERIOSCL THROM VAS, V18, P1922, DOI 10.1161/01.ATV.18.12.1922; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; Pepicelli O, 2005, J NEUROCHEM, V93, P1561, DOI 10.1111/j.1471-4159.2005.03150.x; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Radi ZA, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/85091; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Shitashige M, 1998, BBA-LIPID LIPID MET, V1389, P57, DOI 10.1016/S0005-2760(97)00129-X; SIEGEL MI, 1980, P NATL ACAD SCI-BIOL, V77, P308, DOI 10.1073/pnas.77.1.308; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Swinney DC, 1997, J BIOL CHEM, V272, P12393, DOI 10.1074/jbc.272.19.12393; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Warner TD, 2006, FASEB J, V20, P542, DOI 10.1096/fj.05-4434fje; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412; Zidar N, 2007, CARDIOVASC PATHOL, V16, P300, DOI 10.1016/j.carpath.2007.02.005	39	24	24	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					605	612		10.1096/fj.08-106591	http://dx.doi.org/10.1096/fj.08-106591			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18838483				2022-12-25	WOS:000262892900031
J	Raafat, A; Lawson, S; Bargo, S; Klauzinska, M; Strizzi, L; Goldhar, AS; Buono, K; Salomon, D; Vonderhaar, BK; Callahan, R				Raafat, A.; Lawson, S.; Bargo, S.; Klauzinska, M.; Strizzi, L.; Goldhar, A. S.; Buono, K.; Salomon, D.; Vonderhaar, B. K.; Callahan, R.			Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis	ONCOGENE			English	Article						RBP-J; Int3; tumorigenesis	TRUNCATED INT3 GENE; NEOPLASTIC TRANSFORMATION; CELL-DIFFERENTIATION; NOTCH; ACTIVATION; TUMOR; EXPRESSION; SUPPRESSOR; EPITHELIUM; MICE	Transgenic mice expressing the Notch 4 intracellular domain (ICD) (Int3) in the mammary gland have two phenotypes: arrest of mammary alveolar/lobular development and mammary tumorigenesis. Notch4 signaling is mediated primarily through the interaction of Int3 with the transcription repressor/activator Rbpj. We have conditionally ablated the Rbpj gene in the mammary glands of mice expressing whey acidic protein (Wap)-Int3. Interestingly, Rbpj knockout mice (Wap-Cre(+)/Rbpj(-/-)/Wap-Int3) have normal mammary gland development, suggesting that the effect of endogenous Notch signaling on mammary gland development is complete by day 15 of pregnancy. RBP-J heterozygous (Wap-Cre(+)/Rbpj(-/-)/Wap-Int3) and Rbpj control (Rbpj(flox/flox)/Wap-Int3) mice are phenotypically the same as Wap-Int3 mice with respect to mammary gland development and tumorigenesis. In addition, the Wap-Cre(+)/Rbpj(-/-)/Wap-Int3- knockout mice also developed mammary tumors at a frequency similar to Rbpj heterozygous and Wap-Int3 control mice but with a slightly longer latency. Thus, the effect on mammary gland development is dependent on the interaction of the Notch ICD with the transcription repressor/activator Rbpj, and Notch-induced mammary tumor development is independent of this interaction.	[Raafat, A.; Lawson, S.; Bargo, S.; Klauzinska, M.; Strizzi, L.; Goldhar, A. S.; Salomon, D.; Vonderhaar, B. K.; Callahan, R.] NCI, Mammary Biol & Tumorigenesis Lab, NIH, Bethesda, MD 20892 USA; [Buono, K.] NIDDKD, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Callahan, R (corresponding author), NCI, Mammary Biol & Tumorigenesis Lab, NIH, 37 Convent Dr,Bldg 37,Room 1118A, Bethesda, MD 20892 USA.	rc54d@nih.gov			NIH; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008226, ZIABC005148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Rbpj<SUP>flox/flox</SUP> mice were kindly provided by Dr Tasuku Honjo, Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, and the WAP-Cre mice were kindly provided by Dr Lothar Hennighausen, Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Bashyam MD, 2002, CANCER, V94, P1821, DOI 10.1002/cncr.10362; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Dumont E, 2000, ONCOGENE, V19, P556, DOI 10.1038/sj.onc.1203352; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Furriols M, 2000, DEV BIOL, V227, P520, DOI 10.1006/dbio.2000.9923; GALLAHAN D, 1987, J VIROL, V61, P66, DOI 10.1128/JVI.61.1.66-74.1987; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; Gallahan D, 1996, CANCER RES, V56, P1775; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Imatani A, 2000, ONCOGENE, V19, P223, DOI 10.1038/sj.onc.1203295; Jeffries S, 2000, MOL CELL BIOL, V20, P3928, DOI 10.1128/MCB.20.11.3928-3941.2000; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; KORDON EC, 1995, J VIROL, V69, P8066, DOI 10.1128/JVI.69.12.8066-8069.1995; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Levy OA, 2002, DEV NEUROSCI-BASEL, V24, P79, DOI 10.1159/000064948; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Raafat A, 2007, ONCOGENE, V26, P662, DOI 10.1038/sj.onc.1209823; Raafat A, 2004, ONCOGENE, V23, P9401, DOI 10.1038/sj.onc.1208187; ROBBINS J, 1992, J VIROL, V66, P2594, DOI 10.1128/JVI.66.4.2594-2599.1992; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; SMITH GH, 1995, CELL GROWTH DIFFER, V6, P563; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Yoder BJ, 2007, BREAST J, V13, P172, DOI 10.1111/j.1524-4741.2007.00393.x; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	32	46	46	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					219	230		10.1038/onc.2008.379	http://dx.doi.org/10.1038/onc.2008.379			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18836481	Green Accepted			2022-12-25	WOS:000262501100006
J	Funkelstein, L; Toneff, T; Mosier, C; Hwang, SR; Beuschlein, F; Lichtenauer, UD; Reinheckel, T; Peters, C; Hook, V				Funkelstein, Lydiane; Toneff, Thomas; Mosier, Charles; Hwang, Shin-Rong; Beuschlein, Felix; Lichtenauer, Urs D.; Reinheckel, Thomas; Peters, Christoph; Hook, Vivian			Major Role of Cathepsin L for Producing the Peptide Hormones ACTH, beta-Endorphin, and alpha-MSH, Illustrated by Protease Gene Knockout and Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY VESICLES; PROHORMONE CONVERTASE-2; STIMULATED SECRETION; NUCLEOTIDE-SEQUENCE; CYSTEINE PROTEASES; PITUITARY-CELLS; PROOPIOMELANOCORTIN; BIOSYNTHESIS; ASPARTYL; BRAINS	The pituitary hormones adrenocorticotropic hormone (ACTH), beta-endorphin, and alpha-melanocyte stimulating hormone (alpha-MSH) are synthesized by proteolytic processing of their common proopiomelanocortin (POMC) precursor. Key findings from this study show that cathepsin L functions as a major proteolytic enzyme for the production of POMC-derived peptide hormones in secretory vesicles. Specifically, cathepsin L knockout mice showed major decreases in ACTH, beta-endorphin, and alpha-MSH that were reduced to 23, 18, and 7% of wild-type controls (100%) in pituitary. These decreased peptide levels were accompanied by increased levels of POMC consistent with proteolysis of POMC by cathepsin L. Immunofluorescence microscopy showed colocalization of cathepsin L with beta-endorphin and alpha-MSH in the intermediate pituitary and with ACTH in the anterior pituitary. In contrast, cathepsin L was only partially colocalized with the lysosomal marker Lamp-1 in pituitary, consistent with its extralysosomal function in secretory vesicles. Expression of cathepsin L in pituitary AtT-20 cells resulted in increased ACTH and beta-endorphin in the regulated secretory pathway. Furthermore, treatment of AtT-20 cells with CLIK-148, a specific inhibitor of cathepsin L, resulted in reduced production of ACTH and accumulation of POMC. These findings demonstrate a prominent role for cathepsin L in the production of ACTH, beta-endorphin, and alpha-MSH peptide hormones in the regulated secretory pathway.	[Funkelstein, Lydiane; Toneff, Thomas; Mosier, Charles; Hwang, Shin-Rong; Hook, Vivian] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Sch Med, Dept Med Neurosci, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Beuschlein, Felix; Lichtenauer, Urs D.; Reinheckel, Thomas; Peters, Christoph] Univ Freiburg, Inst Mol Med & Zellforsch, Freiburg, Germany; [Beuschlein, Felix] Univ Munich, Univ Hosp Innenstadt, Med Clin, Munich, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Freiburg; University of Munich	Hook, V (corresponding author), Univ Calif San Diego, Sch Pharm, 9500 Gilman Dr MC 0744, La Jolla, CA 92093 USA.	vhook@ucsd.edu	Lichtenauer, Urs/AFU-2746-2022; Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Beuschlein, Felix/0000-0001-7826-3984	National Institutes of Health [ROI MH 077305, ROI DA 04271, ROI NS 24553]; Deutsche Forschungsgemeinschaft; Landesstiftung Baden-Wuerttemberg; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024553, P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesstiftung Baden-Wuerttemberg; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants ROI MH 077305; ROI DA 04271, and ROI NS 24553 (to V.H.). This work was also supported by grants from the Deutsche Forschungsgemeinschaft (to T.R. and C.P.) and from the Landesstiftung Baden-Wuerttemberg (to F.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adan RAH, 2003, ANN NY ACAD SCI, V994, P267, DOI 10.1111/j.1749-6632.2003.tb03189.x; Allen RG, 2001, J NEUROSCI, V21, P5864, DOI 10.1523/JNEUROSCI.21-16-05864.2001; AZARYAN AV, 1994, FEBS LETT, V341, P197, DOI 10.1016/0014-5793(94)80456-7; AZARYAN AV, 1995, J BIOL CHEM, V270, P8201, DOI 10.1074/jbc.270.14.8201; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BOILEAU G, 1983, NUCLEIC ACIDS RES, V11, P8063, DOI 10.1093/nar/11.22.8063; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; DALAYEUN JF, 1993, BIOMED PHARMACOTHER, V47, P311, DOI 10.1016/0753-3322(93)90080-5; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FROHMAN LA, 1981, ENDOCRINOL METAB, P293; GAINER H, 1984, FEBS LETT, V175, P135, DOI 10.1016/0014-5793(84)80586-4; Hartwig A C, 1991, Anesth Prog, V38, P75; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; HOOK VYH, 1982, P NATL ACAD SCI-BIOL, V79, P6220, DOI 10.1073/pnas.79.20.6220; HOOK VYH, 1982, BIOCHEM BIOPH RES CO, V106, P1364, DOI 10.1016/0006-291X(82)91264-5; Hwang SR, 2007, J BIOL CHEM, V282, P9556, DOI 10.1074/jbc.M605510200; Hwang SR, 2007, J NEUROCHEM, V100, P1340, DOI 10.1111/j.1471-4159.2006.04325.x; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; Laurent V, 2004, ENDOCRINOLOGY, V145, P519, DOI 10.1210/en.2003-0829; Lechan RM, 2006, PEPTIDES, V27, P310, DOI 10.1016/j.peptides.2005.01.033; LOH YP, 1982, P NATL ACAD SCI-BIOL, V79, P108, DOI 10.1073/pnas.79.1.108; Miller R, 2003, J NEUROCHEM, V86, P556, DOI 10.1046/j.1471-4159.2003.01856.x; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; NORRIS DO, 1997, VERTEBRATE ENDOCRINO, P106; Pan H, 2005, BIOCHEMISTRY-US, V44, P4939, DOI 10.1021/bi047852m; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Sei C, 2003, PEPTIDES, V24, P717, DOI 10.1016/S0196-9781(03)00126-8; Sei C, 2002, PEPTIDES, V23, P1409, DOI 10.1016/S0196-9781(02)00079-7; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	35	55	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35652	35659		10.1074/jbc.M709010200	http://dx.doi.org/10.1074/jbc.M709010200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18849346	hybrid, Green Published			2022-12-25	WOS:000261687900039
J	Salter, MD; Nienhaus, K; Nienhaus, GU; Dewilde, S; Moens, L; Pesce, A; Nardini, M; Bolognesi, M; Olson, JS				Salter, Mallory D.; Nienhaus, Karin; Nienhaus, G. Ulrich; Dewilde, Sylvia; Moens, Luc; Pesce, Alessandra; Nardini, Marco; Bolognesi, Martino; Olson, John S.			The Apolar Channel in Cerebratulus lacteus Hemoglobin Is the Route for O-2 Entry and Exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND DOCKING SITES; X-RAY; STRUCTURAL DYNAMICS; TRUNCATED HEMOGLOBINS; NEMERTEAN WORM; HEME-PROTEINS; MYOGLOBIN; BINDING; MIGRATION; PATHWAYS	The major pathway for O-2 binding to mammalian myoglobins (Mb) and hemoglobins (Hb) involves transient upward movement of the distal histidine (His-64(E7)), allowing ligand capture in the distal pocket. The mini-globin from Cerebratulus lacteus (CerHb) appears to have an alternative pathway between the E and H helices that is made accessible by loss of the N-terminal A helix. To test this pathway, we examined the effects of changing the size of the E7 gate and closing the end of the apolar channel in CerHb by site-directed mutagenesis. Increasing the size of Gln-44(E7) from Ala to Trp causes variation of association (k'(O2)) and dissociation (k(O2)) rate coefficients, but the changes are not systematic. More significantly, the fractions (F-gem approximate to 0.05-0.19) and rates (k(gem) approximate to 50-100 mu s(-1)) of geminate CO recombination in the Gln-44(E7) mutants are all similar. In contrast, blocking the entrance to the apolar channel by increasing the size of Ala-55(E18) to Phe and Trp causes the following: 1) both k'(O2) and k(O2) to decrease roughly 4-fold; 2) F-gem for CO to increase from similar to 0.05 to 0.45; and 3) k(gem) to decrease from similar to 80 to similar to 9 mu s(-1), as ligands become trapped in the channel. Crystal structures and low temperature Fourier-transform infrared spectra of Phe-55 and Trp-55 CerHb confirm that the aromatic side chains block the channel entrance, with little effect on the distal pocket. These results provide unambiguous experimental proof that diatomic ligands can enter and exit a globin through an interior channel in preference to the more direct E7 pathway.	[Salter, Mallory D.; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Salter, Mallory D.; Olson, John S.] Rice Univ, WM Keck Ctr Computat Biol, Houston, TX 77005 USA; [Nienhaus, Karin; Nienhaus, G. Ulrich] Univ Ulm, Inst Biophys, D-89081 Ulm, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Dewilde, Sylvia; Moens, Luc] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Pesce, Alessandra] Univ Genoa, Dept Phys, CNISM, I-16146 Genoa, Italy; [Pesce, Alessandra] Univ Genoa, Ctr Excellence Biomed Res, I-16146 Genoa, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, INFM, CNR, Dept Biomol Sci & Biotechnol, I-20131 Milan, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, CIMAINA, I-20131 Milan, Italy	Rice University; Rice University; Ulm University; University of Illinois System; University of Illinois Urbana-Champaign; University of Antwerp; University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Milan; University of Milan	Olson, JS (corresponding author), 6100 Main St,MS-140, Houston, TX 77005 USA.	olson@rice.edu	Nardini, Marco/B-7842-2017; Nienhaus, Gerd Ulrich/G-8698-2012; Bolognesi, Martino/B-7924-2017; Pesce, Alessandra/A-3660-2015	Nardini, Marco/0000-0002-3718-2165; Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Bolognesi, Martino/0000-0002-9253-5170; Olson, John/0000-0002-0760-5403	National Institutes of Health [GM 35649, HL 47020]; Robert A. Welch Foundation [C-612]; Houston Area Molecular Biophysics Training Grant [GM80820]; Deutsche Forschungsgemeinschaft [Ni 291/3]; Italian Ministry of University and Scientific Research [RBLA03B3KC_005]; University of Milano; Fund for Scientific Research Flanders Project [G.0331.04N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080820, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Houston Area Molecular Biophysics Training Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Milano; Fund for Scientific Research Flanders Project(FWO); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant National Institutes of Health Grants GM 35649 and HL 47020. This work was also supported by Robert A. Welch Foundation Grant C-612 (to J.S.O.), Predoctoral Training Fellowship from the Houston Area Molecular Biophysics Training Grant GM80820 (to M. D. S.), Deutsche Forschungsgemeinschaft Grant Ni 291/3 and the "Fonds der Chemischen Industrie," grants from the Italian Ministry of University and Scientific Research (FIRB Project "Biologia Strutturale" RBLA03B3KC_005) and from the University of Milano (to M. B.), and Fund for Scientific Research Flanders Project " Hypoxia and Nerve Globins" Grant G.0331.04N) (to L. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aranda R, 2006, ACTA CRYSTALLOGR D, V62, P776, DOI 10.1107/S0907444906017318; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERENDZEN J, 1990, P NATL ACAD SCI USA, V87, P1, DOI 10.1073/pnas.87.1.1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Bidon-Chanal A, 2006, PROTEINS, V64, P457, DOI 10.1002/prot.21004; BOLOGNESI M, 1982, J MOL BIOL, V158, P305, DOI 10.1016/0022-2836(82)90435-1; Bourgeois D, 2006, P NATL ACAD SCI USA, V103, P4924, DOI 10.1073/pnas.0508880103; Cao WX, 2004, BIOCHEMISTRY-US, V43, P7017, DOI 10.1021/bi0497291; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Crespo A, 2005, J AM CHEM SOC, V127, P4433, DOI 10.1021/ja0450004; Deng PC, 2007, GENE, V398, P208, DOI 10.1016/j.gene.2007.01.037; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 2004, P CCP4 STUDY WEEKEND, P114; Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298; Geuens E, 2004, IUBMB LIFE, V56, P653, DOI 10.1080/15216540500037471; GIBSON QH, 1993, J BIOL CHEM, V268, P16993; Goldberg DE, 1999, CHEM REV, V99, P3371, DOI 10.1021/cr970152l; Huang SC, 1996, J BIOL CHEM, V271, P958, DOI 10.1074/jbc.271.2.958; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; JOHNSON K, 1993, THESIS RICE U HOUSTO; JOHNSON KA, 1989, J MOL BIOL, V207, P459, DOI 10.1016/0022-2836(89)90269-6; KENDREW JC, 1963, SCIENCE, V139, P1259, DOI 10.1126/science.139.3561.1259; LAI HH, 1995, PROTEINS, V22, P322, DOI 10.1002/prot.340220404; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGM, 2003, MOSFLM USER GUIDE MO; Lim Manho, 2005, V305, P243; Milani M, 2005, J INORG BIOCHEM, V99, P97, DOI 10.1016/j.jinorgbio.2004.10.035; Milani M, 2003, IUBMB LIFE, V55, P623, DOI 10.1080/15216540310001628708; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; MOURANT JR, 1993, BIOPHYS J, V65, P1496, DOI 10.1016/S0006-3495(93)81218-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nienhaus K, 2005, BIOCHEMISTRY-US, V44, P5095, DOI 10.1021/bi047513t; Nienhaus K, 2005, J AM CHEM SOC, V127, P40, DOI 10.1021/ja0466917; Nienhaus K, 2003, J BIOL CHEM, V278, P42532, DOI 10.1074/jbc.M306888200; Nienhaus K, 2003, BIOCHEMISTRY-US, V42, P9633, DOI 10.1021/bi034787s; Nienhaus K, 2008, METHOD ENZYMOL, V437, P347, DOI 10.1016/S0076-6879(07)37018-3; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Olson J S, 1981, Methods Enzymol, V76, P631; Olson JS, 2008, SMALLEST BIOMOLECULES: DIATOMICS AND THEIR INTERACTIONS WITH HEME PROTEINS, P3, DOI 10.1016/B978-044452839-1.50002-4; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Olson JS, 2003, METH MOLEC MED, V82, P65; PERUTZ MF, 1964, NATURE, V203, P687, DOI 10.1038/203687a0; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pesce A, 2004, J BIOL CHEM, V279, P33662, DOI 10.1074/jbc.M403597200; Pesce A, 2002, STRUCTURE, V10, P725, DOI 10.1016/S0969-2126(02)00763-3; Pesce A, 2001, ACTA CRYSTALLOGR D, V57, P1897, DOI 10.1107/S0907444901015815; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Schmidt M, 2005, P NATL ACAD SCI USA, V102, P11704, DOI 10.1073/pnas.0504932102; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; SCHWEERS RL, 2003, THESIS RICE U; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SMITH RD, 1999, THESIS RICE U HOUSTO; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vandergon TL, 1998, J BIOL CHEM, V273, P16998, DOI 10.1074/jbc.273.27.16998; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123	63	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35689	35702		10.1074/jbc.M805727200	http://dx.doi.org/10.1074/jbc.M805727200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18840607	Green Published, hybrid			2022-12-25	WOS:000261687900043
J	Dickey, DM; Burnett, JC; Potter, LR				Dickey, Deborah M.; Burnett, John C., Jr.; Potter, Lincoln R.			Novel Bifunctional Natriuretic Peptides as Potential Therapeutics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGESTIVE-HEART-FAILURE; RECEPTOR-A; ATRIAL; NESIRITIDE; RISK	Synthetic atrial natriuretic peptide (carperitide) and B-type natriuretic peptide (BNP; nesiritide) are used to treat congestive heart failure. However, despite beneficial cardiac unloading properties, reductions in renal perfusion pressures limit their clinical effectiveness. Recently, CD-NP, a chimeric peptide composed of C-type natriuretic peptide (CNP) fused to the C-terminal tail of Dendroaspis natriuretic peptide (DNP), was shown to be more glomerular filtration rate-enhancing than BNP in dogs. However, the molecular basis for the increased responsiveness was not determined. Here, we show that the DNP tail has a striking effect on CNP, converting it from a non-agonist to a partial agonist of natriuretic peptide receptor (NPR)-A while maintaining the ability to activate NPR-B. This effect is specific for human receptors because CD-NP was only a slightly better activator of rat NPR-A due to the promiscuous nature of CNP in this species. Interesting, the DNP tail alone had no effect on any NPR even though it is effective in vivo. To further increase the potency of CD-NP for NPR-A, we converted two different triplet sequences within the CNP ring to their corresponding residues in BNP. Both variants demonstrated increased affinity and full agonist activity for NPR-A, whereas one was as potent as any NPR-A activator known. In contrast to a previous report, we found that DNP binds the natriuretic peptide clearance receptor (NPR-C). However, none of the chimeric peptides bound NPR-C with significantly higher affinity than endogenous ligands. We suggest that bifunctional chimeric peptides represent a new generation of natriuretic peptide therapeutics.	[Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Potter, Lincoln R.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA; [Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Med, Div Cardiovasc Dis,Cardiorenal Res Lab, Rochester, MN 55905 USA; [Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Physiol, Div Cardiovasc Dis,Cardiorenal Res Lab, Rochester, MN 55905 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; Mayo Clinic	Potter, LR (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	potter@umn.edu			Medica; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066397] Funding Source: NIH RePORTER	Medica; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Minnesota-Mayo Partnership grant (to L.R.P. and J.C.B.) from Medica. CD-NP has been licensed by the Mayo Clinic to Nile Therapeutics, and J.C.B. is Chair of its Scientific Advisory Board. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Bryan PM, 2007, AM J PHYSIOL-RENAL, V292, pF1636, DOI 10.1152/ajprenal.00418.2006; Chen HH, 2002, J AM COLL CARDIOL, V40, P1186, DOI 10.1016/S0735-1097(02)02127-7; CUNNINGHAM BC, 1994, EMBO J, V13, P2508, DOI 10.1002/j.1460-2075.1994.tb06540.x; CURRIE MG, 1984, SCIENCE, V223, P67, DOI 10.1126/science.6419347; Dickey DM, 2007, ENDOCRINOLOGY, V148, P3518, DOI 10.1210/en.2007-0081; Johns DG, 2007, BIOCHEM BIOPH RES CO, V358, P145, DOI 10.1016/j.bbrc.2007.04.079; Langenickel TH, 2006, P NATL ACAD SCI USA, V103, P4735, DOI 10.1073/pnas.0510019103; Lisy O, 2001, HYPERTENSION, V37, P1089, DOI 10.1161/01.HYP.37.4.1089; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; MISONO KS, 1984, BIOCHEM BIOPH RES CO, V123, P444, DOI 10.1016/0006-291X(84)90250-X; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rose RA, 2008, J PHYSIOL-LONDON, V586, P353, DOI 10.1113/jphysiol.2007.144253; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; SCARBOROUGH RM, 1986, J BIOL CHEM, V261, P2960; SCHOENFELD JR, 1995, MOL PHARMACOL, V47, P172; Singh G, 2006, CIRC RES, V99, P183, DOI 10.1161/01.RES.0000232322.06633.d3; Socki T, 2005, J AM COLL CARDIOL, V45, P608, DOI 10.1016/j.jacc.2004.10.067; WEI CM, 1993, AM J PHYSIOL, V264, pH71, DOI 10.1152/ajpheart.1993.264.1.H71; WEI CM, 1993, J CLIN INVEST, V92, P2048, DOI 10.1172/JCI116800	22	67	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35003	35009		10.1074/jbc.M804538200	http://dx.doi.org/10.1074/jbc.M804538200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940797	Green Published, hybrid			2022-12-25	WOS:000261469100057
J	Gorbikova, EA; Wikstrom, M; Verkhovsky, MI				Gorbikova, Elena A.; Wikstrom, Marten; Verkhovsky, Michael I.			The Protonation State of the Cross-linked Tyrosine during the Catalytic Cycle of Cytochrome c Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATR-FTIR SPECTROSCOPY; P-M INTERMEDIATE; PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; OXYGEN ACTIVATION; ESCHERICHIA-COLI; SUBUNIT-I; REDUCTION; TIME; RESOLUTION	Cytochrome c oxidase is the terminal complex of the respiratory chain in mitochondria and some aerobic bacteria and is responsible for most of the O-2 consumption in biology. The key reaction in the catalysis of O-2 reduction is O-O bond scission that requires four electrons and a proton. In our recent work (Gorbikova, E. A., Belevich, I., Wikstrom, M., and Verkhovsky, M. I. ( 2008) Proc. Natl. Acad. Sci. U. S. A. 105, 10733-10737), it was shown that the cross-linked Tyr-280 ( Paracoccus denitrificans numbering) provides the proton for O-O bond cleavage. The deprotonated Tyr-280 must be reprotonated later on in the catalytic cycle to serve as a proton donor for the next oxygen reduction event. To find the reaction step at which the crosslinked Tyr-280 becomes reprotonated, all further steps of the catalytic cycle after O-O bond cleavage were followed by infrared spectroscopy. We found that complete reprotonation of the tyrosine is linked to the formation of the one-electron reduced state coupled to reduction of the Cu-B site.	[Gorbikova, Elena A.; Wikstrom, Marten; Verkhovsky, Michael I.] Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, FI-00014 Helsinki, Finland	University of Helsinki	Verkhovsky, MI (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, POB 65,Viikinkaari 1, FI-00014 Helsinki, Finland.	michael.verkhovsky@helsinki.fi		Wikstrom, Marten/0000-0002-7527-4415; Gorbikova, Elena/0000-0002-6078-6012	Biocentrum Helsinki,; Sigrid Juselius Foundation; Academy of Finland; ISB Graduate School	Biocentrum Helsinki,; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); ISB Graduate School	This work was supported by grants from the Biocentrum Helsinki, the Sigrid Juselius Foundation, and the Academy of Finland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the ISB Graduate School.	Adelroth P, 1997, BIOCHEMISTRY-US, V36, P13824, DOI 10.1021/bi9629079; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Behr J, 1998, BIOCHEMISTRY-US, V37, P7400, DOI 10.1021/bi9731697; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; CHANCE B, 1975, P NATL ACAD SCI USA, V72, P1635, DOI 10.1073/pnas.72.4.1635; GARCIAHORSMAN JA, 1995, BIOCHEMISTRY-US, V34, P4428, DOI 10.1021/bi00013a035; Gerwert K, 1999, BIOL CHEM, V380, P931, DOI 10.1515/BC.1999.115; Gorbikova EA, 2006, BIOCHEMISTRY-US, V45, P5641, DOI 10.1021/bi060257v; Gorbikova EA, 2008, P NATL ACAD SCI USA, V105, P10733, DOI 10.1073/pnas.0802512105; Gorbikova EA, 2007, BIOCHEMISTRY-US, V46, P13141, DOI 10.1021/bi701614w; Gorbikova EA, 2007, BIOCHEMISTRY-US, V46, P4177, DOI 10.1021/bi602523a; HAN SW, 1990, NATURE, V348, P89, DOI 10.1038/348089a0; Hellwig P, 1996, FEBS LETT, V385, P53, DOI 10.1016/0014-5793(96)00342-0; Hellwig P, 1998, BIOCHEMISTRY-US, V37, P7390, DOI 10.1021/bi9725576; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P1685, DOI 10.1021/bi982282+; Iwaki M, 2004, BIOCHEMISTRY-US, V43, P14370, DOI 10.1021/bi048545j; Iwaki M, 2006, BIOCHEMISTRY-US, V45, P10873, DOI 10.1021/bi061114b; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jasaitis A, 1999, BIOCHEMISTRY-US, V38, P2697, DOI 10.1021/bi982275l; Kitagawa T, 2000, J INORG BIOCHEM, V82, P9, DOI 10.1016/S0162-0134(00)00155-0; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Lubben M, 1999, BIOCHEMISTRY-US, V38, P2048, DOI 10.1021/bi981859k; McCauley KM, 2000, J AM CHEM SOC, V122, P2403, DOI 10.1021/ja993774s; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; MOODY AJ, 1991, FEBS LETT, V293, P101, DOI 10.1016/0014-5793(91)81161-Z; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; MORGAN JE, 1995, BIOCHEMISTRY-US, V34, P15633, DOI 10.1021/bi00048a005; OGURA T, 1990, J BIOL CHEM, V265, P14721; OLIVEBERG M, 1989, BIOCHIM BIOPHYS ACTA, V977, P322, DOI 10.1016/S0005-2728(89)80087-8; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Pfitzner U, 2000, BIOCHEMISTRY-US, V39, P6756, DOI 10.1021/bi992235x; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; PROVENCHER SW, 1983, PROGR SCI COMPUTING, V2, P304; Ribacka C, 2005, BIOCHEMISTRY-US, V44, P16502, DOI 10.1021/bi0511336; Rich PR, 2002, BIOCHEMISTRY-US, V41, P967, DOI 10.1021/bi0109717; Riistama S, 1999, BIOCHEMISTRY-US, V38, P10670, DOI 10.1021/bi990885v; Siletsky S, 1999, BIOCHEMISTRY-US, V38, P4853, DOI 10.1021/bi982614a; Smirnova IA, 1999, BIOCHEMISTRY-US, V38, P6826, DOI 10.1021/bi982865j; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; VERKHOVSKY MI, 1994, BIOCHEMISTRY-US, V33, P3079, DOI 10.1021/bi00176a042; Verkhovsky MI, 1996, P NATL ACAD SCI USA, V93, P12235, DOI 10.1073/pnas.93.22.12235; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; WILSON DF, 1976, ARCH BIOCHEM BIOPHYS, V175, P160, DOI 10.1016/0003-9861(76)90495-1; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	46	48	48	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34907	34912		10.1074/jbc.M803511200	http://dx.doi.org/10.1074/jbc.M803511200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18931371	Green Published, hybrid			2022-12-25	WOS:000261469100047
J	Shimojo, M				Shimojo, Masahito			Huntingtin Regulates RE1-silencing Transcription Factor/Neuron-restrictive Silencer Factor (REST/NRSF) Nuclear Trafficking Indirectly through a Complex with REST/NRSF-interacting LIM Domain Protein (RILP) and Dynactin p150(Glued)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; EMBRYONIC LETHALITY; TARGET GENES; DISEASE; LOCALIZATION; REPRESSOR; NEURONS; MICE; REST; HAP1	Huntingtin has been reported to regulate the nuclear translocation of the transcriptional repressor RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF). The REST/NRSF-interacting LIM domain protein ( RILP) has also been shown to regulate REST/NRSF nuclear translocation. Therefore, we were prompted to address the question of how two distinct proteins could have the same function. We initially used a yeast two-hybrid screen to look for an interaction between huntingtin and RILP. This screen identified dynactin p150(Glued) as an interacting protein. Coimmunoprecipitation of proteins in vitro expressed in a reticulocyte lysate system showed an interaction between REST/NRSF and RILP as well as between RILP and dynactin p150Glued. Coimmunoprecipitation analysis further showed a complex containing RILP, dynactin p150Glued, and huntingtin. Huntingtin did not interact directly with either REST/NRSF or RILP, but did interact with dynactin p150(Glued). The N-terminal fragment of wild-type huntingtin did not affect the interaction between dynactin p150Glued and RILP; however, mutant huntingtin weakened this interaction. We further show that HAP1 (huntingtin-associated protein-(1) under bar) prevents this complex from translocating REST/NRSF to the nucleus. Thus, this study suggests that REST/NRSF, dynactin p150Glued, huntingtin, HAP1, and RILP form a complex involved in the translocation of REST/NRSF into the nucleus and that HAP1 controls REST/NRSF cellular localization in neurons.	Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Shimojo, M (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Biomed Biol Sci Res Bldg,741 Limestone St, Lexington, KY 40536 USA.	mshim1@uky.edu	Shimojo, Masahito/T-8086-2019	Shimojo, Masahito/0000-0003-1859-4444	National Institutes of Health [P20RR020171]; National Center for Research Resources; National Institute of Mental Health [K01MH067123]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH067123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR020171 from the National Center for Research Resources and Grant K01MH067123 from the National Institute of Mental Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BATES G, 2002, HUNTINGTONS DIS; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Harper PS, 1991, HUNTINGTONS DIS; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Lunyak VV, 2005, CELL, V121, P499, DOI 10.1016/j.cell.2005.05.003; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Rong J, 2007, J NEUROSCI RES, V85, P3025, DOI 10.1002/jnr.21326; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Shimojo M, 2006, J NEUROCHEM, V96, P1130, DOI 10.1111/j.1471-4159.2005.03608.x; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Shimojo M, 2003, MOL CELL BIOL, V23, P9025, DOI 10.1128/MCB.23.24.9025-9031.2003; Thompson LM, 2003, NAT GENET, V35, P13, DOI 10.1038/ng0903-13; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	25	73	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34880	34886		10.1074/jbc.M804183200	http://dx.doi.org/10.1074/jbc.M804183200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922795	hybrid, Green Published			2022-12-25	WOS:000261469100044
J	Jackson, NE; Wang, HW; Bryant, KJ; McNeil, HP; Husain, A; Liu, K; Tedla, N; Thomas, PS; King, GC; Hettiaratchi, A; Cairns, J; Hunt, JE				Jackson, Nicole E.; Wang, Hong-Wei; Bryant, Katherine J.; McNeil, H. Patrick; Husain, Ahsan; Liu, Ke; Tedla, Nicodemus; Thomas, Paul S.; King, Garry C.; Hettiaratchi, Anusha; Cairns, Jennifer; Hunt, John E.			Alternate mRNA Splicing in Multiple Human Tryptase Genes Is Predicted to Regulate Tetramer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; BETA-TRYPTASE; HUMAN LUNG; ALPHA; AIRWAY; INHIBITORS; RESPONSES; MOUSE; FORMS; PURIFICATION	Tryptases are serine proteases that are thought to be uniquely and proteolytically active as tetramers. Crystallographic studies reveal that the active tetramer is a flat ring structure composed of four monomers, with their active sites arranged around a narrow central pore. This model explains why many of the preferred substrates of tryptase are short peptides; however, it does not explain how tryptase cleaves large protein substrates such as fibronectin, although a number of studies have reported in vitro mechanisms for generating active monomers that could digest larger substrates. Here we suggest that alternate mRNA splicing of human tryptase genes generates active tryptase monomers (or dimers). We have identified a conserved pattern of alternate splicing in four tryptase alleles (alpha II, beta I, beta III, and delta I), representing three distinct tryptase gene loci. When compared with their full-length counterparts, the splice variants use an alternate acceptor site within exon 4. This results in the deletion of 27 nucleotides within the central coding sequence and 9 amino acids from the translated protein product. Although modeling suggests that the deletion can be easily accommodated by the enzymes structurally, it is predicted to alter the specificity by enlarging the S1' or S2' binding pocket and results in the complete loss of the "47 loop," reported to be critical for the formation of tetramers. Although active monomers can be generated in vitro using a range of artificial conditions, we suggest that alternate splicing is the in vivo mechanism used to generate active tryptase that can cleave large protein substrates.	[Hunt, John E.] Univ New S Wales, Ctr Infect & Inflammat Res, Dept Pathol, Sch Med Sci, Sydney, NSW 2052, Australia; [Bryant, Katherine J.; McNeil, H. Patrick] Univ New S Wales, S Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [King, Garry C.] Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2052, Australia; [Husain, Ahsan; Liu, Ke] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Alabama System; University of Alabama Birmingham	Hunt, JE (corresponding author), Univ New S Wales, Ctr Infect & Inflammat Res, Dept Pathol, Sch Med Sci, Sydney, NSW 2052, Australia.	j.hunt@unsw.edu.au	Husain, Ahsan/J-6861-2012; Bryant, Katherine/E-8574-2010	Husain, Ahsan/0000-0003-3426-3469; Bryant, Katherine/0000-0002-8686-623X; McNeil, Hugh Patrick/0000-0003-4336-2960	National Health and Medical Research Council of Australia; Australian Research Council Linkage Grant [LP0455637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079040] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Linkage Grant(Australian Research Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Health and Medical Research Council of Australia and Australian Research Council Linkage Grant LP0455637. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Buckley MG, 2001, CLIN EXP ALLERGY, V31, P1696, DOI 10.1046/j.1365-2222.2001.01213.x; Burgess LE, 1999, P NATL ACAD SCI USA, V96, P8348, DOI 10.1073/pnas.96.15.8348; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; CLARK JM, 1995, AM J RESP CRIT CARE, V152, P2076, DOI 10.1164/ajrccm.152.6.8520778; Cline MS, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P17; Gamba G, 2001, AM J PHYSIOL-RENAL, V281, pF781, DOI 10.1152/ajprenal.2001.281.5.F781; GotisGraham I, 1997, ARTHRITIS RHEUM, V40, P479, DOI 10.1002/art.1780400314; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Harvima RJ, 1999, ARCH DERMATOL RES, V291, P73, DOI 10.1007/s004030050386; He SH, 1997, J IMMUNOL, V159, P6216; He SH, 2001, EUR J PHARMACOL, V412, P223, DOI 10.1016/S0014-2999(01)00734-8; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; HOLGATE ST, 1986, J ALLERGY CLIN IMMUN, V77, P274, DOI 10.1016/S0091-6749(86)80104-X; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Krishna MT, 2001, J ALLERGY CLIN IMMUN, V107, P1039, DOI 10.1067/mai.2001.115631; Mirza H, 1997, BLOOD, V90, P3914, DOI 10.1182/blood.V90.10.3914; Nakao M, 2005, NUCLEIC ACIDS RES, V33, P2355, DOI 10.1093/nar/gki520; Niles AL, 1998, BIOTECHNOL APPL BIOC, V28, P125; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; PEARLMAN DA, 1995, AMBER VERSION 4 1; Peng Q, 2003, EUR J BIOCHEM, V270, P270, DOI 10.1046/j.1432-1033.2003.03385.x; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Rice KD, 1998, CURR PHARM DESIGN, V4, P381; Schwartz LB, 1995, J CLIN INVEST, V96, P2702, DOI 10.1172/JCI118337; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SEKIZAWA K, 1989, J CLIN INVEST, V83, P175, DOI 10.1172/JCI113855; Selwood T, 2002, BIOCHEMISTRY-US, V41, P3329, DOI 10.1021/bi015662v; Tremaine WJ, 2002, ALIMENT PHARM THERAP, V16, P407, DOI 10.1046/j.1365-2036.2002.01194.x; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Wang HW, 2002, J IMMUNOL, V169, P5145, DOI 10.4049/jimmunol.169.9.5145; Wong GW, 2001, J BIOL CHEM, V276, P49169, DOI 10.1074/jbc.M108677200; Wung JL, 1996, BIOTECHNIQUES, V21, P808	34	11	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34178	34187		10.1074/jbc.M807553200	http://dx.doi.org/10.1074/jbc.M807553200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854315	hybrid, Green Published			2022-12-25	WOS:000261277700046
J	Mishra, VK; Palgunachari, MN; Krishna, R; Glushka, J; Segrest, JP; Anantharamaiah, GM				Mishra, Vinod K.; Palgunachari, Mayakonda N.; Krishna, Rama; Glushka, John; Segrest, Jere P.; Anantharamaiah, G. M.			Effect of Leucine to Phenylalanine Substitution on the Nonpolar Face of a Class A Amphipathic Helical Peptide on Its Interaction with Lipid HIGH RESOLUTION SOLUTION NMR STUDIES OF 4F-DIMYRISTOYLPHOSPHATIDYLCHOLINE DISCOIDAL COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR CD36; I-MIMETIC PEPTIDES; NUCLEAR-MAGNETIC-RESONANCE; E-NULL MICE; OXIDIZED PHOSPHOLIPIDS; TRANSGENIC MICE; APOA-I; MEMBRANE INTERACTIONS; SECONDARY STRUCTURE	Model class A amphipathic helical peptides mimic several properties of apolipoprotein A-I (apoA-I), the major protein component of high density lipoproteins. Previously, we reported the NMR structures of Ac-18A-NH2 (renamed as 2F because of two phenylalanines), the base-line model class A amphipathic helical peptide in the presence of lipid (Mishra, V. K., Anantharamaiah, G. M., Segrest, J. P., Palgunachari, M. N., Chaddha, M., Simon Sham, S. W., and Krishna, N. R. ( 2006) J Biol. Chem. 281, 6511-6519). Substitution of two Leu residues on the nonpolar face (Leu3 and Leu(14)) with Phe residues produced the peptide 4F (so named because of four phenylalanines), which has been extensively studied for its anti-inflammatory and antiatherogenic properties. Like 2F, 4F also forms discoidal nascent high density lipoprotein-like particles with 1,2-dimyristoylsn-glycero-3-phosphocholine (DMPC). Since subtle structural changes in the peptide-lipid complexes have been shown to be responsible for their antiatherogenic properties, we undertook high resolution NMR studies to deduce detailed structure of 4F in 4F center dot DMPC discs. Like 2F, 4F adopts a well defined amphipathic alpha-helical structure in association with the lipid at a 1:1 peptide/lipid weight ratio. Nuclear Overhauser effect (NOE) spectroscopy revealed a number of intermolecular close contacts between the aromatic residues in the hydrophobic face of the helix and the lipid acyl chain protons. Similar to 2F, the pattern of observed peptide-lipid NOEs is consistent with a parallel orientation of the amphipathic alpha helix, with respect to the plane of the lipid bilayer, on the edge of the disc (the belt model). However, in contrast to 2F in 2F alpha DMPC, 4F in the 4F alpha DMPC complex is located closer to the lipid headgroup as evidenced by a number of NOEs between 4F and DMPC headgroup protons. These NOEs are absent in the 2F center dot DMPC complex. In addition, the conformation of the DMPC sn-3 chain in 4F center dot DMPC complex is different than in the 2F center dot DMPC complex as evidenced by the NOE between lipid 2.CH and beta CH2 protons in 4F center dot DMPC, but not in 2F center dot DMPC, complex. Based on the results of this study, we infer that the antiatherogenic properties of 4F may result from its preferential interaction with lipid headgroups.	[Mishra, Vinod K.; Palgunachari, Mayakonda N.; Segrest, Jere P.; Anantharamaiah, G. M.] Univ Alabama Birmingham, Med Ctr, Dept Med, Atherosclerosis Res Unit, Birmingham, AL 35294 USA; [Krishna, Rama; Segrest, Jere P.; Anantharamaiah, G. M.] Univ Alabama Birmingham, Med Ctr, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Krishna, Rama; Segrest, Jere P.; Anantharamaiah, G. M.] Univ Alabama Birmingham, Med Ctr, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Glushka, John] Univ Georgia, Complex Carbohydrate Res Ctr, SE Collaboratory Biomol NMR, Athens, GA 30602 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Georgia; University of Georgia	Mishra, VK (corresponding author), Univ Alabama Birmingham, Med Ctr, Dept Med, Atherosclerosis Res Unit, D806,1808 7th Ave S, Birmingham, AL 35294 USA.	vmishra@uab.edu	Mishra, Vinod/S-1151-2019	Mishra, Vinod/0000-0002-4527-1512	National Institutes of Health [RO1HL089328, PO1 HL34343, CA-13148, GM66340]; NCRR, National Institutes of Health [1S10RR021064-01A1]; NIGMS; Georgia Research Alliance; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343, R01HL089328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Georgia Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL089328, PO1 HL34343 (NHLBI) and CA-13148 (NCI). The 600-MHz CryoProbe was funded by 1S10RR021064-01A1 (NCRR, National Institutes of Health). This research benefited from activities at the SE Collaboratory for High-Field Biomolecular NMR, a research resource at the University of Georgia, funded by NIGMS, National Institutes of Health (NIG MSEC Grant GM66340) and the Georgia Research Alliance. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anantharamaiah GM, 2007, J LIPID RES, V48, P1915, DOI 10.1194/jlr.R700010-JLR200; ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; BASUS VJ, 1989, METHOD ENZYMOL, V177, P132; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; CHUNG BH, 1985, J BIOL CHEM, V260, P256; Datta G, 2004, J BIOL CHEM, V279, P26509, DOI 10.1074/jbc.M314276200; Datta G, 2001, J LIPID RES, V42, P1096; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Duverger N, 1996, ARTERIOSCL THROM VAS, V16, P1424, DOI 10.1161/01.ATV.16.12.1424; Epand RM, 2004, J BIOL CHEM, V279, P51404, DOI 10.1074/jbc.M408581200; Epand RM, 2004, BIOCHEMISTRY-US, V43, P5073, DOI 10.1021/bi049786u; Gibbs AC, 1998, NAT STRUCT BIOL, V5, P284, DOI 10.1038/nsb0498-284; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Gupta H, 2005, CIRC RES, V97, P236, DOI 10.1161/01.RES.0000176530.66400.48; Gurtovenko AA, 2004, BIOPHYS J, V86, P3461, DOI 10.1529/biophysj.103.038760; Handattu SP, 2007, J BIOL CHEM, V282, P1980, DOI 10.1074/jbc.M606231200; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Jackson SP, 2007, NAT MED, V13, P1015, DOI 10.1038/nm0907-1015; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; Kruger AL, 2005, CIRCULATION, V111, P3126, DOI 10.1161/CIRCULATIONAHA.104.517102; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li XM, 2007, BIOCHEMISTRY-US, V46, P5009, DOI 10.1021/bi700163y; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; LUNDKATZ S, 1995, BIOCHEMISTRY-US, V34, P9219, DOI 10.1021/bi00028a035; Mishra VK, 2006, J BIOL CHEM, V281, P6511, DOI 10.1074/jbc.M511475200; Mishra VK, 2001, PEPTIDES, V22, P567, DOI 10.1016/S0196-9781(01)00365-5; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1426, DOI 10.1161/01.ATV.0000167412.98221.1a; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Ou JS, 2003, CIRCULATION, V107, P2337, DOI 10.1161/01.CIR.0000070589.61860.A9; Ou ZJ, 2003, CIRCULATION, V107, P1520, DOI 10.1161/01.CIR.0000061949.17174.B6; Peterson SJ, 2008, J LIPID RES, V49, P1658, DOI 10.1194/jlr.M800046-JLR200; Peterson SJ, 2007, J PHARMACOL EXP THER, V322, P514, DOI 10.1124/jpet.107.119479; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; SCHULTZ JR, 1992, J BIOL CHEM, V267, P21630; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SEGREST JP, 1992, J LIPID RES, V33, P141; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Van Lenten BJ, 2004, CIRCULATION, V110, P3252, DOI 10.1161/01.CIR.0000147232.75456.B3; Van Lenten BJ, 2002, CIRCULATION, V106, P1127, DOI 10.1161/01.CIR.0000030182.35880.3E; Van Lenten BJ, 2008, J LIPID RES, V49, P2302, DOI 10.1194/jlr.M800075-JLR200; VENKATACHALAPATHI YV, 1993, PROTEINS, V15, P349, DOI 10.1002/prot.340150403; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC	56	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34393	34402		10.1074/jbc.M806384200	http://dx.doi.org/10.1074/jbc.M806384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845546	Green Published, hybrid			2022-12-25	WOS:000261277700067
J	Jenkins, JL; Shen, HH; Green, MR; Kielkopf, CL				Jenkins, Jermaine L.; Shen, Haihong; Green, Michael R.; Kielkopf, Clara L.			Solution Conformation and Thermodynamic Characteristics of RNA Binding by the Splicing Factor U2AF(65)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SMALL-ANGLE SCATTERING; PROTEIN-PROTEIN INTERACTIONS; AUXILIARY FACTOR U2AF(65); RAY SOLUTION SCATTERING; POLYPYRIMIDINE-TRACT; U2 SNRNP; DOMAIN-STRUCTURE; STRUCTURAL BASIS; SEX-LETHAL	The U2 auxiliary factor large subunit (U2AF(65)) is an essential pre-mRNA splicing factor for the initial stages of spliceosome assembly. Tandem RNA recognition motifs (RRM)s of U2AF(65) recognize polypyrimidine tract signals adjacent to 3' splice sites. Despite the central importance of U2AF(65) for splice site recognition, the relative arrangement of the U2AF(65) RRMs and the energetic forces driving polypyrimidine tract recognition remain unknown. Here, the solution conformation of the U2AF(65) RNA binding domain determined using small angle x-ray scattering reveals a bilobal shape without apparent inter-domain contacts. The proximity of the N and C termini within the inter-RRM configuration is sufficient to explain the action of U2AF(65) on spliceosome components located both 5' and 3' to its binding site. Isothermal titration calorimetry further demonstrates that an unusually large enthalpy-entropy compensation underlies U2AF(65) recognition of an optimal polyuridine tract. Qualitative similarities were observed between the pairwise distance distribution functions of the U2AF(65) RNA binding domain and those either previously observed for N-terminal RRMs of Py tract-binding protein that lack interdomain contacts or calculated from the high resolution coordinates of a U2AF(65) deletion variant bound to RNA. To further test this model, the shapes and RNA interactions of the wild-type U2AF(65) RNA binding domain were compared with those of U2AF(65) variants containing either Py tract-binding protein linker sequences or a deletion within the inter-RRM linker. Results of these studies suggest inter-RRM conformational plasticity as a possible means for U2AF(65) to universally identify diverse pre-mRNA splice sites.	[Jenkins, Jermaine L.; Kielkopf, Clara L.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Shen, Haihong; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Shen, Haihong; Green, Michael R.] Univ Massachusetts, Sch Med, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA	University of Rochester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kielkopf, CL (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	clara_kielkopf@urmc.rochester.edu		Jenkins, Jermaine/0000-0003-2548-3275	National Institutes of Health [R01 GM070503, R01 GM035490]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035490, R01GM070503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM070503 ( to C. L. K.) and R01 GM035490 ( to M. R. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Banerjee H, 2003, RNA, V9, P88, DOI 10.1261/rna.2131603; Banerjee H, 2004, RNA, V10, P240, DOI 10.1261/rna.5153204; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Crichlow GV, 2008, EMBO J, V27, P277, DOI 10.1038/sj.emboj.7601936; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Guiner A, 1955, SMALL ANGLE SCATTERI, P167; Itoh H, 2004, RNA, V10, P1005, DOI 10.1261/rna.5221604; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kent OA, 2003, J BIOL CHEM, V278, P50572, DOI 10.1074/jbc.M307976200; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858; MULLEN MP, 1991, GENE DEV, V5, P642, DOI 10.1101/gad.5.4.642; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Ohnishi S, 2006, J AM CHEM SOC, V128, P16338, DOI 10.1021/ja066008b; Petoukhov MV, 2006, STRUCTURE, V14, P1021, DOI 10.1016/j.str.2006.04.005; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Sickmier EA, 2006, ACTA CRYSTALLOGR F, V62, P457, DOI 10.1107/S1744309106012504; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Singh R, 2000, RNA, V6, P901, DOI 10.1017/S1355838200000376; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Zagrovic B, 2005, J MOL BIOL, V353, P232, DOI 10.1016/j.jmb.2005.08.053; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0	46	26	26	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33641	33649		10.1074/jbc.M806297200	http://dx.doi.org/10.1074/jbc.M806297200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18842594	Green Published, hybrid			2022-12-25	WOS:000261183700070
J	Wang, Y; Dow, EC; Liang, YY; Ramakrishnan, R; Liu, HB; Sung, TL; Lin, X; Rice, AP				Wang, Yan; Dow, Eugene C.; Liang, Yao-Yun; Ramakrishnan, Rajesh; Liu, Hongbing; Sung, Tzu-Ling; Lin, Xia; Rice, Andrew P.			Phosphatase PPM1A Regulates Phosphorylation of Thr-186 in the Cdk9 T-loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; CYCLIN-DEPENDENT KINASES; 2C PROTEIN PHOSPHATASES; ELONGATION-FACTOR-B; P-TEFB; 7SK SNRNA; GENE-EXPRESSION; TAK/P-TEFB; TRANSCRIPTION; INDUCTION	Cdk9 is the catalytic subunit of a general RNA polymerase II elongation factor known as positive transcription elongation factor b (P-TEFb). The kinase function of P-TEFb requires phosphorylation of Thr-186 in the T-loop of Cdk9 to allow substrates to access the catalytic core of the enzyme. To identify human phosphatases that dephosphorylate the T-loop of Cdk9, we used a Thr-186-phosphospecific antiserum to screen a phosphatase expression library. Overexpression of PPM1A and the related PPM1B greatly reduced Cdk9 T-loop phosphorylation in vivo. PPM1A and Cdk9 appear to associate in vivo as the proteins could be co-immunoprecipitated. The short hairpin RNA depletion of PPM1A resulted in an increase in Cdk9 T-loop phosphorylation. In phosphatase reactions in vitro, purified PPM1A could dephosphorylate Thr-186 both with and without the association of 7SK RNA, a small nuclear RNA that is bound to similar to 50% of total cellular P-TEFb. PPM1B only efficiently dephosphorylated Cdk9 Thr-186 in vitro when 7SK RNA was depleted from P-TEFb. Taken together, our data indicate that PPM1A and to some extent PPM1B are important negative regulators of P-TEFb function.	[Wang, Yan; Dow, Eugene C.; Ramakrishnan, Rajesh; Liu, Hongbing; Sung, Tzu-Ling; Rice, Andrew P.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Liang, Yao-Yun; Lin, Xia] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Rice, AP (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	arice@bcm.tmc.edu		Rice, Andrew/0000-0002-1237-4769	National Institutes of Health [AI35381, DK073932]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI035381, R01AI035381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI35381 (to A. P. R.) and DK073932 (to X. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Ghose R, 2001, J VIROL, V75, P11336, DOI 10.1128/JVI.75.23.11336-11343.2001; Gold MO, 1998, J VIROL, V72, P4448, DOI 10.1128/JVI.72.5.4448-4453.1998; Haaland RE, 2003, AIDS, V17, P2429, DOI 10.1097/00002030-200311210-00004; He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003; Herrmann CH, 2001, J CELL SCI, V114, P1491; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liou LY, 2006, J LEUKOCYTE BIOL, V79, P388, DOI 10.1189/jlb.0805429; Liou LY, 2002, J VIROL, V76, P10579, DOI 10.1128/JVI.76.21.10579-10587.2002; Markert A, 2008, EMBO REP, V9, P569, DOI 10.1038/embor.2008.72; Marshall RM, 2005, J IMMUNOL, V175, P6402, DOI 10.4049/jimmunol.175.10.6402; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rice AP, 2003, CURR HIV RES, V1, P395, DOI 10.2174/1570162033485159; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; Sung TL, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-66; Wang Y, 2006, VIROLOGY, V352, P485, DOI 10.1016/j.virol.2006.05.013; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yu WD, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-32	31	44	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33578	33584		10.1074/jbc.M807495200	http://dx.doi.org/10.1074/jbc.M807495200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829461	hybrid, Green Published			2022-12-25	WOS:000261183700063
J	Lutskiy, MI; Park, JY; Remold, SK; Remold-O'Donnell, E				Lutskiy, Maxim I.; Park, Jun Y.; Remold, Susanna K.; Remold-O'Donnell, Eileen			Evolution of Highly Polymorphic T Cell Populations in Siblings with the Wiskott-Aldrich Syndrome	PLOS ONE			English	Article								Population level evolutionary processes can occur within a single organism when the germ line contains a mutation that confers a cost at the level of the cell. Here we describe how multiple compensatory mutations arose through a within-individual evolutionary process in two brothers with the immune deficiency Wiskott-Aldrich Syndrome (WAS). As a result, both brothers have T lymphocyte populations that are highly polymorphic at the locus of the germ line defect, and no single allele achieves fixation. WASP, the gene product affected in this disease, is specific to white blood cells where it is responsible for regulating actin cytoskeleton dynamics in a wide range of cellular responses. The brothers inherited a rare allele predicted to result in truncated WASP lacking the carboxy-terminal VCA domains, the region that directly catalyzes actin filament generation. Although the brothers' T cell populations are highly polymorphic, all share a corrective effect relative to the inherited allele in that they restore the VCA domain. This indicates massive selection against the truncated germ line allele. No single somatic allele becomes fixed in the circulating T cell population of either brother, indicating that a regulated step in maturation of the affected cell lineage is severely compromised by the germ line allele. Based on the finding of multiple somatic mutations, the known maturation pathway for T-lineage cells and the known defects of T cells and precursor thymocytes in mice with truncated WASP, we hypothesize that the presence of truncated WASP (WASP Delta VCA) confers an extreme disadvantage in early developing thymocytes, above and beyond the known cost of absence of full-length WASP, and that the disadvantage likely occurs through dominant negative competition of WASP Delta VCA with N-WASP, a protein that otherwise partially compensates for WASP absence in developing thymocytes.	[Lutskiy, Maxim I.; Park, Jun Y.; Remold-O'Donnell, Eileen] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Lutskiy, Maxim I.; Remold-O'Donnell, Eileen] Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA; [Remold, Susanna K.] Univ Louisville, Dept Biol, Program Dis Evolution, Louisville, KY 40292 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Louisville	Lutskiy, MI (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	remold@cbrinstitute.org			National Institutes of Health [HL59561, AI39574, HL081407]; National Science Foundation [DEB-0452163]; Jeffrey Modell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561, R21HL081407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039574, R01AI039574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Jeffrey Modell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants HL59561, AI39574 and HL081407, National Science Foundation grant DEB-0452163, and the Jeffrey Modell Foundation.	Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Almeida ARM, 2005, SEMIN IMMUNOL, V17, P239, DOI 10.1016/j.smim.2005.02.002; Ariga T, 1998, BLOOD, V92, P699, DOI 10.1182/blood.V92.2.699; Ariga T, 2001, J IMMUNOL, V166, P5245, DOI 10.4049/jimmunol.166.8.5245; Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; Cavazzana-Calvo M, 2007, J CLIN INVEST, V117, P1456, DOI 10.1172/JCI30953; Chinen J, 2004, CURR OPIN ALLERGY CL, V4, P523, DOI 10.1097/00130832-200412000-00008; Cotta-de-Almeida V, 2007, P NATL ACAD SCI USA, V104, P15424, DOI 10.1073/pnas.0706881104; DAVIS BR, 2008, BLOOD; Du W, 2006, HUM MUTAT, V27, P370, DOI 10.1002/humu.20308; Dupre L, 2002, IMMUNITY, V17, P157, DOI 10.1016/S1074-7613(02)00360-6; Filipovich AH, 2001, BLOOD, V97, P1598, DOI 10.1182/blood.V97.6.1598; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Jones LN, 2002, BLOOD CELL MOL DIS, V28, P392, DOI 10.1006/bcmd.2002.0523; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KWAN SP, 1995, P NATL ACAD SCI USA, V92, P4706, DOI 10.1073/pnas.92.10.4706; Lutskiy MI, 2005, J IMMUNOL, V175, P1329, DOI 10.4049/jimmunol.175.2.1329; Lutskiy MI, 2005, BLOOD, V106, P2815, DOI 10.1182/blood-2004-12-4724; Lutskiy MI, 2002, BLOOD, V100, P2763, DOI 10.1182/blood-2002-02-0388; MOLINA IJ, 1993, J IMMUNOL, V151, P4383; Park JY, 2004, CLIN EXP IMMUNOL, V136, P104, DOI 10.1111/j.1365-2249.2004.02409.x; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; RemoldODonnell E, 1997, J IMMUNOL, V158, P4021; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scherbina A, 1999, J IMMUNOL, V163, P6314; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; STEWART DM, 2006, J CLIN IMMUNOL; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Takenawa T, 2001, J CELL SCI, V114, P1801; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936; Wada T, 2003, J CLIN INVEST, V111, P1389, DOI 10.1172/JCI200315485; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; WENGLER G, 1995, BLOOD, V85, P2471, DOI 10.1182/blood.V85.9.2471.bloodjournal8592471; WISKOTT A, 1937, MONATSSCHR KINDERH, V68, P212; Zhang JY, 2002, P NATL ACAD SCI USA, V99, P2240, DOI 10.1073/pnas.042686099; ZHU QL, 1995, BLOOD, V86, P3797, DOI 10.1182/blood.V86.10.3797.bloodjournal86103797	42	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3444	10.1371/journal.pone.0003444	http://dx.doi.org/10.1371/journal.pone.0003444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941616	Green Published, Green Submitted, gold			2022-12-25	WOS:000265125600006
J	Becerra, JX; Venable, DL				Becerra, Judith X.; Venable, D. Lawrence			Sources and Sinks of Diversification and Conservation Priorities for the Mexican Tropical Dry Forest	PLOS ONE			English	Article							EVOLUTIONARY; TRENDS	Elucidating the geographical history of diversification is critical for inferring where future diversification may occur and thus could be a valuable aid in determining conservation priorities. However, it has been difficult to recognize areas with a higher likelihood of promoting diversification. We reconstructed centres of origin of lineages and identified areas in the Mexican tropical dry forest that have been important centres of diversification (sources) and areas where species are maintained but where diversification is less likely to occur (diversity sinks). We used a molecular phylogeny of the genus Bursera, a dominant member of the forest, along with information on current species distributions. Results indicate that vast areas of the forest have historically functioned as diversity sinks, generating few or no extant Bursera lineages. Only a few areas have functioned as major engines of diversification. Long-term preservation of biodiversity may be promoted by incorporation of such knowledge in decision-making.	[Becerra, Judith X.] Univ Arizona, Dept Biosphere 2, Tucson, AZ 85721 USA; [Venable, D. Lawrence] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Becerra, JX (corresponding author), Univ Arizona, Dept Biosphere 2, Tucson, AZ 85721 USA.	becerra@ag.arizona.edu		Becerra, Judith/0000-0002-3749-9058	NSF [DEB 0212782, DEB-9815648]; Arnold and Mabel Beckman Foundation [Young Investigator Award]	NSF(National Science Foundation (NSF)); Arnold and Mabel Beckman Foundation	Funding for this work was provided by NSF grants DEB 0212782, DEB 0212782 to DLV and a NSF CAREER grant DEB-9815648 and a Young Investigator Award from the Arnold and Mabel Beckman Foundation to JXB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra JX, 2007, P NATL ACAD SCI USA, V104, P7483, DOI 10.1073/pnas.0608253104; Becerra JX, 2005, P NATL ACAD SCI USA, V102, P10919, DOI 10.1073/pnas.0409127102; Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Becerra JX, 1999, P NATL ACAD SCI USA, V96, P12626, DOI 10.1073/pnas.96.22.12626; Becerra JX, 1999, AM J BOT, V86, P1047, DOI 10.2307/2656622; Becerra JX, 2003, MOL PHYLOGENET EVOL, V26, P300, DOI 10.1016/S1055-7903(02)00256-7; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Brooks D. R., 2002, NATURE DIVERSITY EVO; Cowling RM, 2001, P NATL ACAD SCI USA, V98, P5452, DOI 10.1073/pnas.101093498; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; KOHLMANN B, 1984, METODOS CUANTITATIVO; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; LOPEZRAMOS E, 1985, GEOLOGIA MEXICO; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Moran-Zenteno D., 1994, GEOLOGY MEXICAN REPU; MURPHY RW, 1983, OCCAS PAP CALIF ACAD, V137, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nieto-Samaniego AF, 1999, GEOL SOC AM BULL, V111, P347, DOI 10.1130/0016-7606(1999)111<0347:VOCEAV>2.3.CO;2; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; RONQUIST F, 1996, DIVA VER 1 1 COMPUTE; Rzedowski J., 1978, VEGETACION MEXICO; Trejo I, 2002, BIODIVERS CONSERV, V11, P2063, DOI 10.1023/A:1020876316013	24	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3436	10.1371/journal.pone.0003436	http://dx.doi.org/10.1371/journal.pone.0003436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927613	gold, Green Published, Green Submitted			2022-12-25	WOS:000265122400008
J	Chien, KL; Su, TC; Jeng, JS; Hsu, HC; Chang, WT; Chen, MF; Lee, YT; Hu, FB				Chien, Kuo-Liong; Su, Ta-Chen; Jeng, Jiann-Shing; Hsu, Hsiu-Ching; Chang, Wei-Tien; Chen, Ming-Fong; Lee, Yuan-Teh; Hu, Frank B.			Carotid Artery Intima-Media Thickness, Carotid Plaque and Coronary Heart Disease and Stroke in Chinese	PLOS ONE			English	Article							OPERATING CHARACTERISTIC CURVES; WALL SHEAR-STRESS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTOR; ISCHEMIC-STROKE; ATHEROSCLEROSIS; EVENTS; ASSOCIATION; PROGRESSION	Background: Our aim was to prospectively investigate the association between carotid artery intima-media thickness (IMT) as well as carotid plaque and incidence of coronary heart disease (CHD) and stroke in Chinese, among whom data are limited. Methods and Findings: We conducted a community-based cohort study composed of 2190 participants free of cardiovascular disease at baseline in one community. During a median 10.5-year follow up, we documented 68 new cases of coronary heart disease and 94 cases of stroke. The multivariate relative risks (RRs) associated with a change of 1 standard deviation of maximal common carotid IMT were 1.38 (95% confidence interval [CI], 1.12-1.70) for CHD and 1.47 (95% CI, 1.28-1.69) for stroke. The corresponding RRs with internal carotid IMT were 1.47 (95% CI, 1.21-1.79) for CHD and 1.52 (95% CI, 1.31-1.76) for stroke. Carotid plaque measured by the degree of diameter stenosis was also significantly associated with increased risk of CHD (p for trend, 0.0001) and stroke (p for trend, 0.0001). However, these associations were largely attenuated when adjusting for IMT measurements. Conclusions: This prospective study indicates a significant association between carotid IMT and incidence of CHD and stroke in Chinese adults. These measurements may be useful for cardiovascular risk assessment and stratification in Chinese.	[Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan; [Chien, Kuo-Liong; Su, Ta-Chen; Hsu, Hsiu-Ching; Chen, Ming-Fong; Lee, Yuan-Teh] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chang, Wei-Tien] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA USA	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Chien, KL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan.	ytlee@ha.mc.ntu.edu.tw; fhu@hsph.harvard.edu	Chen, Ming/GVU-8412-2022	CHIEN, KUO-LIONG/0000-0003-4979-8351; CHANG, WEI-TIEN/0000-0002-1880-7932; SU, TA-CHEN/0000-0001-7523-7166; JENG, JIANN-SHING/0000-0002-1456-3686	National Science Council in Taiwan [97-2314-B-002 -130 -MY3, 96-2314-B-002-155-]; American Heart Association Established Investigator Award	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); American Heart Association Established Investigator Award(American Heart Association)	This study was supported partly by grants from the National Science Council in Taiwan (NSC 97-2314-B-002 -130 -MY3, NSC 96-2314-B-002-155- ). Dr. Frank Hu's research is partly supported by American Heart Association Established Investigator Award.	Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Brook RD, 2006, ARTERIOSCL THROM VAS, V26, P656, DOI 10.1161/01.ATV.0000200079.18690.60; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chien KL, 2005, EUR J CARDIOV PREV R, V12, P95, DOI 10.1097/00149831-200504000-00003; Chien KL, 2002, STROKE, V33, P39, DOI 10.1161/hs0102.101626; Chien KL, 1999, ATHEROSCLEROSIS, V143, P267, DOI 10.1016/S0021-9150(98)00298-6; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Foerch C, 2003, HYPERTENSION, V42, pE17, DOI 10.1161/01.HYP.0000103164.73172.30; Freedman BI, 2005, DIABETOLOGIA, V48, P2511, DOI 10.1007/s00125-005-0017-2; Gnasso A, 1997, STROKE, V28, P993, DOI 10.1161/01.STR.28.5.993; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hernandez SAR, 2003, HYPERTENSION, V42, P56, DOI 10.1161/01.HYP.0000077983.66161.6F; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hollander M, 2003, STROKE, V34, P2367, DOI 10.1161/01.STR.0000091393.32060.0E; Hosmer Jr DW, 1989, MULTIPLE LOGISTIC RE, P25; Irace C, 2004, STROKE, V35, P464, DOI 10.1161/01.STR.0000111597.34179.47; Jacobowitz GR, 2003, J VASC SURG, V38, P705, DOI 10.1016/S0741-5214(03)00730-4; Johnson HM, 2007, STROKE, V38, P900, DOI 10.1161/01.STR.0000258003.31194.0a; Kanadasi M, 2006, ANGIOLOGY, V57, P585, DOI 10.1177/0003319706293123; Kitamura A, 2004, STROKE, V35, P2788, DOI 10.1161/01.STR.0000147723.52033.9e; Lacroix P, 2006, VASC MED, V11, P93, DOI 10.1191/1358863x06vm677oa; Lee YT, 2001, SCI TOTAL ENVIRON, V280, P165, DOI 10.1016/S0048-9697(01)00823-3; Lee YT, 2000, J CLIN EPIDEMIOL, V53, P838, DOI 10.1016/S0895-4356(00)00198-0; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Murakami S, 2005, BIOMED PHARMACOTHER, V59, pS49, DOI 10.1016/S0753-3322(05)80010-1; Nichols WW, 1999, NEW ENGL J MED, V340, P1762; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prabhakaran S, 2006, STROKE, V37, P2696, DOI 10.1161/01.STR.0000244780.82190.a4; Prati P, 2006, CEREBROVASC DIS, V22, P416, DOI 10.1159/000094993; Pruissen DMO, 2007, STROKE, V38, P1371, DOI 10.1161/01.STR.0000260220.37016.88; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Rockman CB, 2004, J VASC SURG, V39, P44, DOI 10.1016/j.jvs.2003.07.008; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; RUBIN MR, 2006, ATHEROSCLEROSIS; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; SCHMID C, 1998, ENCY BIOSTATISTICS; Scuteri A, 2004, J AM COLL CARDIOL, V43, P187, DOI 10.1016/j.jacc.2003.08.035; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Su T, 1999, J MED ULTRASOUND, V7, P73; Su TC, 2006, INT J CLIN PRACT, V60, P134, DOI 10.1111/j.1742-1241.2006.00777.x; Su TC, 2001, STROKE, V32, P2265, DOI 10.1161/str.32.10.2265; SZETO CC, 2007, J AM SOC NEPHROL; TANG TY, 2007, CORRELATION CAROTID; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Touboul PJ, 2000, CIRCULATION, V102, P313; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; WIELAND H, 1983, J LIPID RES, V24, P904; Yamasaki Y, 2000, DIABETES CARE, V23, P1310, DOI 10.2337/diacare.23.9.1310; YATES JF, 1982, ORGAN BEHAV HUM PERF, V30, P132, DOI 10.1016/0030-5073(82)90237-9; Zhang Yi-na, 2005, Chinese Medical Sciences Journal, V20, P10	56	58	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3435	10.1371/journal.pone.0003435	http://dx.doi.org/10.1371/journal.pone.0003435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927612	Green Published, gold, Green Submitted			2022-12-25	WOS:000265122400007
J	Mai, TQL; Heiman, FLW; Hien, DN; Walter, T; Phuong, VMH; Cuong, DV; Hang, LKN; Ha, HN; Thai, QN; Trung, VN; Trang, DV; Bich, TN; Thinh, NB; Binh, GN; Liem, TN; San, TL; Phuc, HP; Hung, VP; Tung, N; Annette, F; Cam, VN; Ha, QD; Martin, C; Jeremy, F; Hien, TN; Menno, DD; Peter, H				Mai T. Q. Le; Heiman F. L. Wertheim; Hien D. Nguyen; Walter Taylor; Phuong V. M. Hoang; Cuong D. Vuong; Hang L. K. Nguyen; Ha H. Nguyen; Thai Q. Nguyen; Trung V. Nguyen; Trang D. Van; Bich T. Ngoc; Thinh N. Bui; Binh G. Nguyen; Liem T. Nguyen; San T. Luong; Phuc H. Phan; Hung V. Pham; Tung Nguyen; Annette Fox; Cam V. Nguyen; Ha Q. Do; Martin Crusat; Jeremy Farrar; Hien T. Nguyen; Menno D. de Jong; Peter Horby			Influenza A H5N1 Clade 2.3.4 Virus with a Different Antiviral Susceptibility Profile Replaced Clade 1 Virus in Humans in Northern Vietnam	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; RESISTANCE; INFECTION; EMERGENCE	Background: Prior to 2007, highly pathogenic avian influenza ( HPAI) H5N1 viruses isolated from poultry and humans in Vietnam were consistently reported to be clade 1 viruses, susceptible to oseltamivir but resistant to amantadine. Here we describe the re-emergence of human HPAI H5N1 virus infections in Vietnam in 2007 and the characteristics of the isolated viruses. Methods and Findings: Respiratory specimens from patients suspected to be infected with avian influenza in 2007 were screened by influenza and H5 subtype specific polymerase chain reaction. Isolated H5N1 strains were further characterized by genome sequencing and drug susceptibility testing. Eleven poultry outbreak isolates from 2007 were included in the sequence analysis. Eight patients, all of them from northern Vietnam, were diagnosed with H5N1 in 2007 and five of them died. Phylogenetic analysis of H5N1 viruses isolated from humans and poultry in 2007 showed that clade 2.3.4 H5N1 viruses replaced clade 1 viruses in northern Vietnam. Four human H5N1 strains had eight-fold reduced in-vitro susceptibility to oseltamivir as compared to clade 1 viruses. In two poultry isolates the I117V mutation was found in the neuraminidase gene, which is associated with reduced susceptibility to oseltamivir. No mutations in the M2 gene conferring amantadine resistance were found. Conclusion: In 2007, H5N1 clade 2.3.4 viruses replaced clade 1 viruses in northern Vietnam and were susceptible to amantadine but showed reduced susceptibility to oseltamivir. Combination antiviral therapy with oseltamivir and amantadine for human cases in Vietnam is recommended.	[Mai T. Q. Le; Phuong V. M. Hoang; Cuong D. Vuong; Hang L. K. Nguyen; Hien T. Nguyen] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Heiman F. L. Wertheim; Walter Taylor; Bich T. Ngoc; Annette Fox; Peter Horby] Univ Oxford, Clin Res Unit, Hanoi, Vietnam; [Hien D. Nguyen; Ha H. Nguyen; Thai Q. Nguyen; Trung V. Nguyen; Trang D. Van] Natl Inst Infect & Trop Dis, Hanoi, Vietnam; [Thinh N. Bui; Binh G. Nguyen] Bach Mai Hosp, Hanoi, Vietnam; [Liem T. Nguyen; San T. Luong; Phuc H. Phan; Hung V. Pham] Natl Hosp Pediat, Hanoi, Vietnam; [Tung Nguyen; Cam V. Nguyen] Natl Ctr Vet Diagnosis, Hanoi, Vietnam; [Ha Q. Do; Martin Crusat; Jeremy Farrar; Menno D. de Jong] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Heiman F. L. Wertheim; Walter Taylor; Annette Fox; Ha Q. Do; Martin Crusat; Jeremy Farrar; Menno D. de Jong; Peter Horby] John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford, England	National Institute of Hygiene & Epidemiology (NIHE); University of Oxford; University of Oxford; University of Oxford	Mai, TQL (corresponding author), Natl Inst Hyg & Epidemiol, Hanoi, Vietnam.	hwertheim@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Wertheim, Heiman/F-3338-2016	Farrar, Jeremy/0000-0002-2700-623X; Horby, Peter/0000-0002-9822-1586; Fox, Annette/0000-0002-0565-7146; Wertheim, Heiman/0000-0002-5003-5565; My, Robinson/0000-0002-3602-1060	Center for Disease Control, United States of America (NIHE - National Influenza Project); South East Asian Influenza Clinical Research Network (SEAICRN); Wellcome Trust	Center for Disease Control, United States of America (NIHE - National Influenza Project); South East Asian Influenza Clinical Research Network (SEAICRN); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Center for Disease Control, United States of America (NIHE - National Influenza Project) the South East Asian Influenza Clinical Research Network (SEAICRN), and the Wellcome Trust. The funding sources did not have a role in the design, data acquisition, analysis or writing of this report.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Buxton RC, 2000, ANAL BIOCHEM, V280, P291, DOI 10.1006/abio.2000.4517; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Gubareva LV, 2002, ANTIVIR RES, V53, P47, DOI 10.1016/S0166-3542(01)00192-9; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; WHO, CLIN MAN HUM INF AV	22	57	59	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3339	10.1371/journal.pone.0003339	http://dx.doi.org/10.1371/journal.pone.0003339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836532	Green Published, gold			2022-12-25	WOS:000265113500006
J	Yang, ZH; Yu, HJ; Pan, A; Du, JY; Ruan, YC; Ko, WH; Chan, HC; Zhou, WL				Yang, Zi-Huan; Yu, Hai-Jie; Pan, Ao; Du, Jian-Yang; Ruan, Ye-Chun; Ko, Wing-Hung; Chan, Hsiao-Chang; Zhou, Wen-Liang			Cellular Mechanisms Underlying the Laxative Effect of Flavonol Naringenin on Rat Constipation Model	PLOS ONE			English	Article								Background & Aims: Symptoms of constipation are extremely common, especially in the elderly. The present study aim to identify an efficacious treatment strategy for constipation by evaluating the secretion-promoting and laxative effect of a herbal compound, naringenin, on intestinal epithelial anion secretion and a rat constipation model, respectively. Methods/Principal Findings: In isolated rat colonic crypts, mucosal addition of naringenin (100 mM) elicited a concentration-dependent and sustained increase in the short-circuit current (I-SC), which could be inhibited in Cl- free solution or by bumetanide and DPC (diphenylamine-2-carboxylic acid), but not by DIDS (4, 4'-diisothiocyanatostilbene-2, 2'-disulfonic acid). Naringenin could increase intracellular cAMP content and PKA activity, consisted with that MDL-12330A (N-(Cis-2-phenyl-cyclopentyl) azacyclotridecan-2-imine-hydrochloride) pretreatment reduced the naringenin-induced ISC. In addition, significant inhibition of the naringenin-induced I-SC by quinidine indicated that basolateral K+ channels were involved in maintaining this cAMP-dependent Cl- secretion. Naringenin-evoked whole cell current which exhibited a linear I-V relationship and time-and voltage-independent characteristics was inhibited by DPC, indicating that the cAMP activated Cl- conductance most likely CFTR (cystic fibrosis transmembrane conductance regulator) was involved. In rat constipation model, administration of naringenin restored the level of fecal output, water content and mucus secretion compared to loperamide-administrated group. Conclusions: Taken together, our data suggest that naringenin could stimulate Cl- secretion in colonic epithelium via a signaling pathway involving cAMP and PKA, hence provide an osmotic force for subsequent colonic fluid secretion by which the laxative effect observed in the rat constipation model. Naringenin appears to be a novel alternative treatment strategy for constipation.	[Yang, Zi-Huan; Yu, Hai-Jie; Pan, Ao; Du, Jian-Yang; Ruan, Ye-Chun; Zhou, Wen-Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Ko, Wing-Hung; Chan, Hsiao-Chang] Chinese Univ Hong Kong, Dept Physiol, Fac Med, Sha Tin 100083, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong	Yang, ZH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	hsiaocchan@cuhk.edu.hk; lsszwl@mail.sysu.edu.cn	Chan, Hsiao Chang/E-1507-2016; Du, Jianyang/B-3883-2010; Ko, Hung/R-1802-2018; RUAN, Ye Chun/T-5919-2017; Ruan, Ye Chun/T-7531-2019	Ko, Hung/0000-0002-2041-402X; RUAN, Ye Chun/0000-0002-4266-6789; Ruan, Ye Chun/0000-0002-4266-6789	National Natural Science Foundation of China [30770817]; South China National Research Center for Integrated Biosciences [2006CB504002]; Sun Yat-sen University [2006CB504002]; National 973 project foundation [2006CB504002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); South China National Research Center for Integrated Biosciences; Sun Yat-sen University; National 973 project foundation(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (No. 30770817) and the South China National Research Center for Integrated Biosciences in Collaboration with Sun Yat-sen University and National 973 project foundation (No. 2006CB504002).	Altabas K, 2003, COLLEGIUM ANTROPOL, V27, P197; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; BARRETT KE, 1993, AM J PHYSIOL, V265, pC859; Boockfor FR, 1998, AM J PHYSIOL-CELL PH, V274, pC922, DOI 10.1152/ajpcell.1998.274.4.C922; Busti AJ, 2004, PHARMACOTHERAPY, V24, P526, DOI 10.1592/phco.24.5.526.33351; CLIFF WH, 1990, P NATL ACAD SCI USA, V87, P4956, DOI 10.1073/pnas.87.13.4956; Cuppoletti J, 2004, AM J PHYSIOL-CELL PH, V287, pC1173, DOI 10.1152/ajpcell.00528.2003; Del Castillo IC, 2005, AM J PHYSIOL-CELL PH, V289, pC1332, DOI 10.1152/ajpcell.00580.2004; deMedina FS, 1997, LIFE SCI, V61, P2049; EWE K, 1988, PHARMACOLOGY, V36, P73, DOI 10.1159/000138424; FORTE LR, 1992, AM J PHYSIOL, V263, pC607, DOI 10.1152/ajpcell.1992.263.3.C607; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; Grondahl ML, 1998, J MED MICROBIOL, V47, P151, DOI 10.1099/00222615-47-2-151; Hollman PCH, 1999, FREE RADICAL RES, V31, pS75, DOI 10.1080/10715769900301351; HUANG SJ, 1993, AM J PHYSIOL, V264, pC794, DOI 10.1152/ajpcell.1993.264.4.C794; HUGHES S, 1984, GUT, V25, P931, DOI 10.1136/gut.25.9.931; Illek B, 2000, AM J PHYSIOL-CELL PH, V279, pC1838, DOI 10.1152/ajpcell.2000.279.6.C1838; Johanson John F, 2007, MedGenMed, V9, P25; Kawaii S, 1999, J AGR FOOD CHEM, V47, P3565, DOI 10.1021/jf990153+; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Ko WH, 2002, AM J PHYSIOL-GASTR L, V282, pG508, DOI 10.1152/ajpgi.00291.2001; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; Middleton E, 2000, PHARMACOL REV, V52, P673; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Rivkin A, 2006, CLIN THER, V28, P2008, DOI 10.1016/j.clinthera.2006.12.013; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Shimotoyodome A, 2000, COMP BIOCHEM PHYS A, V126, P203, DOI 10.1016/S1095-6433(00)00194-X; Sohji Y, 1978, Nihon Yakurigaku Zasshi, V74, P155; Sonawane ND, 2007, GASTROENTEROLOGY, V132, P1234, DOI 10.1053/j.gastro.2007.02.018; TAKASAKI K, 1994, JPN J PHARMACOL, V65, P67, DOI 10.1254/jjp.65.67; Tenore A, 1996, J ENDOCRINOL, V151, P431, DOI 10.1677/joe.0.1510431; Yue GGL, 2004, J BIOL CHEM, V279, P39310, DOI 10.1074/jbc.M406787200; Zhang ZR, 2000, BIOPHYS J, V79, P298, DOI 10.1016/S0006-3495(00)76292-8	33	51	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3348	10.1371/journal.pone.0003348	http://dx.doi.org/10.1371/journal.pone.0003348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833323	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797400012
J	Loerch, PM; Lu, T; Dakin, KA; Vann, JM; Isaacs, A; Geula, C; Wang, J; Pan, Y; Gabuzda, DH; Li, C; Prolla, TA; Yankner, BA				Loerch, Patrick M.; Lu, Tao; Dakin, Kelly A.; Vann, James M.; Isaacs, Adrian; Geula, Chengiz; Wang, Jianbin; Pan, Ying; Gabuzda, Dana H.; Li, Cheng; Prolla, Tomas A.; Yankner, Bruce A.			Evolution of the Aging Brain Transcriptome and Synaptic Regulation	PLOS ONE			English	Article								Alzheimer's disease and other neurodegenerative disorders of aging are characterized by clinical and pathological features that are relatively specific to humans. To obtain greater insight into how brain aging has evolved, we compared age-related gene expression changes in the cortex of humans, rhesus macaques, and mice on a genome-wide scale. A small subset of gene expression changes are conserved in all three species, including robust age-dependent upregulation of the neuroprotective gene apolipoprotein D (APOD) and downregulation of the synaptic cAMP signaling gene calcium/calmodulin-dependent protein kinase IV (CAMK4). However, analysis of gene ontology and cell type localization shows that humans and rhesus macaques have diverged from mice due to a dramatic increase in age-dependent repression of neuronal genes. Many of these age-regulated neuronal genes are associated with synaptic function. Notably, genes associated with GABA-ergic inhibitory function are robustly age-downregulated in humans but not in mice at the level of both mRNA and protein. Gene downregulation was not associated with overall neuronal or synaptic loss. Thus, repression of neuronal gene expression is a prominent and recently evolved feature of brain aging in humans and rhesus macaques that may alter neural networks and contribute to age-related cognitive changes.	[Loerch, Patrick M.; Lu, Tao; Dakin, Kelly A.; Isaacs, Adrian; Pan, Ying; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; [Geula, Chengiz] Northwestern Univ, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL USA; [Wang, Jianbin; Gabuzda, Dana H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Loerch, Patrick M.; Li, Cheng] Harvard Uni, Harvard Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat, Boston, MA USA	Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Loerch, PM (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	bruce_yankner@hms.harvard.edu			National Institute on Aging [AG26651, AG27040, AG27916]; Ellison Medical Foundation Senior Scholar award; NIH [T32GM074897]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027916, R01AG027040, R01AG026651] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation Senior Scholar award(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute on Aging (grant numbers AG26651, AG27040, AG27916), and an Ellison Medical Foundation Senior Scholar award to B.A.Y.. P.L. was supported by NIH training grant T32GM074897.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Backman L, 1997, J COGNITIVE NEUROSCI, V9, P378, DOI 10.1162/jocn.1997.9.3.378; Belloir B, 2001, J NEUROSCI RES, V64, P61, DOI 10.1002/jnr.1054; Bussiere T, 2003, NEUROSCIENCE, V117, P577, DOI 10.1016/S0306-4522(02)00942-9; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Ervin JF, 2007, J NEUROPATH EXP NEUR, V66, P1093, DOI 10.1097/nen.0b013e31815c196a; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Geula C, 2003, J COMP NEUROL, V455, P249, DOI 10.1002/cne.10475; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Kalman J, 2000, NEUROL RES, V22, P330; KINGSBURY AE, 1995, MOL BRAIN RES, V28, P318; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; Mohler H, 2007, J NEUROCHEM, V102, P1, DOI 10.1111/j.1471-4159.2007.04454.x; Peters A, 1998, CEREB CORTEX, V8, P671, DOI 10.1093/cercor/8.8.671; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; TIGGES J, 1988, AM J PRIMATOL, V15, P263, DOI 10.1002/ajp.1350150308; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walker DW, 2006, CURR BIOL, V16, P674, DOI 10.1016/j.cub.2006.01.057; Wang JB, 2006, J NEUROVIROL, V12, P472, DOI 10.1080/13550280601039659; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	37	219	223	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3329	10.1371/journal.pone.0003329	http://dx.doi.org/10.1371/journal.pone.0003329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830410	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797300013
J	Clark, ES; Brown, B; Whigham, AS; Kochaishvili, A; Yarbrough, WG; Weaver, AM				Clark, E. S.; Brown, B.; Whigham, A. S.; Kochaishvili, A.; Yarbrough, W. G.; Weaver, A. M.			Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon	ONCOGENE			English	Article						cortactin; secretion; tumor progression; HNSCC; head and neck cancer	SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-RECEPTOR; CLATHRIN-COATED PITS; BREAST-CANCER; EPITHELIAL-CELLS; POOR-PROGNOSIS; FACTOR-ALPHA; CYCLIN D1; HEPATOCELLULAR-CARCINOMA; ACTIN POLYMERIZATION	11q13 amplification is a late-stage event in several cancers that is often associated with poor prognosis. Among 11q13-amplified genes, the actin assembly protein cortactin/CTTN is considered a likely candidate for direct involvement in tumor progression because of its cell motility-enhancing functions. We modulated cortactin expression in head and neck squamous cell carcinoma (HNSCC) cell lines. Cortactin expression levels directly correlated with tumor size, vascularization and cell proliferation in an orthotopic HNSCC in vivo model. In contrast, under normal in vitro culture conditions, cortactin expression levels had no effect on cell proliferation. However, cell lines in which cortactin expression was reduced by knockdown (KD) grew poorly in vitro under harsh conditions of growth factor deprivation, anchorage independence and space constraint. In contrast, overexpression of cortactin enhanced in vitro growth under the same harsh conditions. Surprisingly, defects in growth factor-independent proliferation of cortactin-KD cells were rescued by coculture with cortactin-expressing cells. As the cocultured cells are separated by permeable filters, cortactin-expressing cells must secrete growth-supporting autocrine factors to rescue the cortactin-KD cells. Overall, cortactin expression modulates multiple cellular traits that may allow survival in a tumor environment, suggesting that the frequent overexpression of cortactin in tumors is not an epiphenomenon but rather promotes tumor aggressiveness.	[Weaver, A. M.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Brown, B.; Whigham, A. S.; Kochaishvili, A.; Yarbrough, W. G.] Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37232 USA; [Weaver, A. M.] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Weaver, AM (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 23rd Ave S Pierce,448 PRB, Nashville, TN 37232 USA.	alissa.weaver@vanderbilt.edu	Clark, Emily/GVR-7159-2022; Yarbrough, Wendell G/A-1969-2011; Whigham, Amy/AAT-7183-2020	Whigham, Amy/0000-0001-7648-1988	Robert J Kleberg Jr and Helen C Kleberg Foundation;  [1R21DE018244]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075126] Funding Source: NIH RePORTER	Robert J Kleberg Jr and Helen C Kleberg Foundation; ; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Julie Maier, Izu Iwueke and the IHC core for technical support; and Drs Ambra Pozzi and Vito Quaranta for advice. This work was supported by 1R21DE018244 to AMW. WGY, BB, ASW, and AK are partially supported through a grant from the Robert J Kleberg Jr and Helen C Kleberg Foundation. An endowment supporting the Barry Baker Laboratory for Head and Neck Oncology as well as the Robert J Kleberg Jr and Helen C Kleberg Foundation and an Ingram Professorship to WGY also provided support for this project.	AKERVALL JA, 1995, CANCER, V76, P853, DOI 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6; BATES SE, 1990, ENDOCRINOLOGY, V126, P596, DOI 10.1210/endo-126-1-596; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Chuma M, 2004, J HEPATOL, V41, P629, DOI 10.1016/j.jhep.2004.06.018; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; ETHIER SP, 1991, CELL GROWTH DIFFER, V2, P593; Ethier SP, 1996, MOL CARCINOGEN, V15, P134; Freier K, 2006, GENE CHROMOSOME CANC, V45, P118, DOI 10.1002/gcc.20270; Gabrilove JL, 2001, ONCOLOGIST, V6, P4; Gibcus JH, 2008, BRIT J CANCER, V98, P950, DOI 10.1038/sj.bjc.6604246; Gibcus JH, 2007, CLIN CANCER RES, V13, P6257, DOI 10.1158/1078-0432.CCR-07-1247; Greer RO, 2007, ORAL ONCOL, V43, P735, DOI 10.1016/j.oraloncology.2006.09.007; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hofman P, 2008, BRIT J CANCER, V98, P956, DOI 10.1038/sj.bjc.6604245; Hui R, 1998, ONCOGENE, V17, P1053, DOI 10.1038/sj.onc.1202023; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katsube T, 2004, ARCH BIOCHEM BIOPHYS, V427, P79, DOI 10.1016/j.abb.2004.04.015; Li YS, 2001, CANCER RES, V61, P6906; Luo ML, 2006, CANCER RES, V66, P11690, DOI 10.1158/0008-5472.CAN-06-1484; MARKOWITZ SD, 1990, J CLIN INVEST, V86, P356, DOI 10.1172/JCI114709; MEREDITH SD, 1995, ARCH OTOLARYNGOL, V121, P790; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Myllykangas S, 2007, SEMIN CANCER BIOL, V17, P42, DOI 10.1016/j.semcancer.2006.10.005; Ohoka Y, 1998, GENES CELLS, V3, P603, DOI 10.1046/j.1365-2443.1998.00216.x; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Rodrigo JP, 2000, CLIN CANCER RES, V6, P3177; SCHUURING E, 1995, GENE, V159, P83, DOI 10.1016/0378-1119(94)00562-7; SCHUURING E, 1992, ONCOGENE, V7, P355; Shores CG, 1998, LARYNGOSCOPE, V108, P1358, DOI 10.1097/00005537-199809000-00019; SOMERS KD, 1990, ONCOGENE, V5, P915; Takes RP, 1997, ARCH OTOLARYNGOL, V123, P412; Tsao MS, 1996, EXP CELL RES, V223, P268, DOI 10.1006/excr.1996.0081; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; van Rossum AGSH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-58; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; WEICHSELBAUM RR, 1986, P NATL ACAD SCI USA, V83, P2684, DOI 10.1073/pnas.83.8.2684; WILLIAMS ME, 1993, ARCH OTOLARYNGOL, V119, P1238; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yuan BZ, 2003, J MOL DIAGN, V5, P48, DOI 10.1016/S1525-1578(10)60451-5; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	50	68	68	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					431	444		10.1038/onc.2008.389	http://dx.doi.org/10.1038/onc.2008.389			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18931703	Green Accepted			2022-12-25	WOS:000262550300011
J	de Muga, SV; Timpson, P; Cubells, L; Evans, R; Hayes, TE; Rentero, C; Hegemann, A; Reverter, M; Leschner, J; Pol, A; Tebar, F; Daly, RJ; Enrich, C; Grewal, T				Vila de Muga, S.; Timpson, P.; Cubells, L.; Evans, R.; Hayes, T. E.; Rentero, C.; Hegemann, A.; Reverter, M.; Leschner, J.; Pol, A.; Tebar, F.; Daly, R. J.; Enrich, C.; Grewal, T.			Annexin A6 inhibits Ras signalling in breast cancer cells	ONCOGENE			English	Article						Annexin A6; p120GAP; Ras; EGF receptor; breast cancer	GTPASE-ACTIVATING PROTEIN; GROWTH-FACTOR RECEPTOR; COMPARATIVE GENOMIC HYBRIDIZATION; CARCINOMA-CELLS; H-RAS; INTERACTION NETWORK; MEMBRANE-BINDING; RAF-1 ACTIVATION; PLASMA-MEMBRANE; GENETIC SCREEN	Overexpression of epidermal growth factor receptor (EGFR) is associated with enhanced activation of wild-type (hyperactive) Ras in breast cancer. Little is known about the regulation of Ras inactivation and GTPase-activating proteins (GAPs), such as p120GAP, in cells with hyperactive Ras. Recently, we showed that in EGFR-over-expressing A431 cells, which lack endogenous Annexin A6 (AnxA6), ectopic expression of AnxA6 stimulates membrane recruitment of p120GAP to modulate Ras signalling. We now demonstrate that, AnxA6 is downregulated in a number of EGFR-overexpressing and estrogen receptor (ER)-negative breast cancer cells. In these cells, AnxA6 overexpression promotes Ca2+ - and EGF-inducible membrane targeting of p120GAP. In ER-negative MDA-MB-436 cells, overexpression of p120GAP, but not CAPRI or a p120GAP mutant lacking the AnxA6-binding domain inhibits Ras/MAPK activity. AnxA6 knockdown in MDA-MB-436 increases Ras activity and cell proliferation in anchorage-independent growth assays. Furthermore, AnxA6 co-immunoprecipitates with H-Ras in a Ca2+ - and EGF-inducible manner and fluorescence resonance energy transfer (FRET) microscopy confirmed that AnxA6 is in close proximity of active (G12V), but not inactive (S17N) H-Ras. Thus, association of AnxA6 with H-Ras-containing protein complexes may contribute to regulate p120GAP/Ras assembly in EGFR-overexpressing and ER-negative breast cancer cells.	[Evans, R.; Hayes, T. E.; Hegemann, A.; Leschner, J.; Grewal, T.] Univ Sydney, Fac Pharm A15, Sydney, NSW 2006, Australia; [Vila de Muga, S.; Cubells, L.; Rentero, C.; Reverter, M.; Tebar, F.; Enrich, C.] Univ Barcelona, Fac Med, Dept Cellular Biol, Barcelona 7, Spain; [Timpson, P.; Daly, R. J.] Garvan Inst Med Res, Sydney, NSW, Australia; [Pol, A.; Enrich, C.] Univ Barcelona, Fac Med, IDIBAPS, Barcelona 7, Spain	University of Sydney; University of Barcelona; Garvan Institute of Medical Research; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Grewal, T (corresponding author), Univ Sydney, Fac Pharm A15, Sydney, NSW 2006, Australia.	enrich@ub.edu; tgrewal@pharm.usyd.edu.au	Pol, Albert/M-1865-2014; Timpson, Paul/A-9429-2016; Daly, Roger J/C-8179-2009; timpson, paul/E-1618-2011; Rentero Alfonso, Carles/L-4430-2017; Tebar, Francesc/H-1498-2015	Pol, Albert/0000-0002-1750-1085; Rentero Alfonso, Carles/0000-0003-4684-0278; Tebar, Francesc/0000-0002-9522-9726; Enrich, Carlos/0000-0003-0382-2993; Timpson, Paul/0000-0002-5514-7080; Grewal, Thomas/0000-0002-7937-8887; Daly, Roger/0000-0002-5739-8027	Ministerio de Educacion y Ciencia, Spain [BFU2006-01151, V-2006-RET2008-0, PR-2006-0142]; National Health and Medical Research Council of Australia [510293, 510294]; National Heart Foundation of Australia [G06S2559]	Ministerio de Educacion y Ciencia, Spain(Spanish Government); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	We thank Dr Maria Calvo (SCT-UB) for her excellent assistance in confocal microscopy. This study was supported by grants to CE (BFU2006-01151, V-2006-RET2008-0 and fellowship PR-2006-0142 from Ministerio de Educacion y Ciencia, Spain) and TG (510293 and 510294 from the National Health and Medical Research Council of Australia and G06S2559 from the National Heart Foundation of Australia). SV is thankful to Ministerio de Educacion y Ciencia, Spain, (FPI mobility Program) for a short-term fellowship at the laboratory of TG (Sydney, Australia).	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Bernards A, 2005, GROWTH FACTORS, V23, P143, DOI 10.1080/08977190500130480; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Chetcuti A, 2001, CANCER RES, V61, P6331; Chow A, 1999, FEBS LETT, V460, P166, DOI 10.1016/S0014-5793(99)01336-8; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; COOPER JA, 1993, MOL CELL BIOL, V13, P1737, DOI 10.1128/MCB.13.3.1737; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Cullen PJ, 2006, CURR OPIN CELL BIOL, V18, P157, DOI 10.1016/j.ceb.2006.02.012; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; DAVIES AA, 1989, HUM GENET, V82, P234, DOI 10.1007/BF00291161; Davis AJ, 1996, J BIOL CHEM, V271, P24333, DOI 10.1074/jbc.271.40.24333; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; deFazio A, 2000, INT J CANCER, V87, P487, DOI 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.0.CO;2-J; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; EDWARDS HC, 1995, MOL CELL BIOCHEM, V149, P293, DOI 10.1007/BF01076591; Fleet A, 1999, BIOCHEM BIOPH RES CO, V260, P540, DOI 10.1006/bbrc.1999.0915; Fridman M, 2000, J BIOL CHEM, V275, P30363, DOI 10.1074/jbc.M003193200; GAWLER DJ, 1995, ONCOGENE, V10, P817; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2006, CURR SIGNAL TRANSD T, V1, P147, DOI 10.2174/157436206777012066; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; HUANG DCS, 1993, MOL CELL BIOL, V13, P2420, DOI 10.1128/MCB.13.4.2420; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Johannsdottir HK, 2006, INT J CANCER, V119, P1052, DOI 10.1002/ijc.21934; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; KRAUS MH, 1984, P NATL ACAD SCI-BIOL, V81, P5384, DOI 10.1073/pnas.81.17.5384; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Leighton X, 2004, CANCER LETT, V210, P239, DOI 10.1016/j.canlet.2004.01.018; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; Moreto J, 2008, CELL SIGNAL, V20, P1092, DOI 10.1016/j.cellsig.2008.01.022; MOSS SE, 1990, FEBS LETT, V261, P299, DOI 10.1016/0014-5793(90)80576-5; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; NORI M, 1991, MOL CELL BIOL, V11, P2812, DOI 10.1128/MCB.11.5.2812; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Pierga JY, 2007, BRIT J CANCER, V96, P341, DOI 10.1038/sj.bjc.6603483; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Pons M, 2001, FEBS LETT, V501, P69, DOI 10.1016/S0014-5793(01)02635-7; Pons M, 2001, EXP CELL RES, V269, P13, DOI 10.1006/excr.2001.5268; Rentero C, 2006, CELL SIGNAL, V18, P1006, DOI 10.1016/j.cellsig.2005.08.008; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sacks DB, 2006, BIOCHEM SOC T, V34, P833, DOI 10.1042/BST0340833; SMYTHE E, 1994, J CELL BIOL, V124, P301, DOI 10.1083/jcb.124.3.301; Strzelecka-Kiliszek A, 2008, J CELL BIOCHEM, V104, P418, DOI 10.1002/jcb.21632; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; THEOBALD J, 1994, BBA-MOL CELL RES, V1223, P383, DOI 10.1016/0167-4889(94)90099-X; THEOBALD J, 1995, BRIT J CANCER, V71, P786, DOI 10.1038/bjc.1995.152; Timpson P, 2007, CANCER RES, V67, P9304, DOI 10.1158/0008-5472.CAN-07-0798; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; Vishwanatha JK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-8; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197; Walker SA, 2003, FEBS LETT, V546, P6, DOI 10.1016/S0014-5793(03)00412-5; Wang Z, 2002, J BIOL CHEM, V277, P24022, DOI 10.1074/jbc.M201949200; Wang ZX, 1996, CELL GROWTH DIFFER, V7, P123; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033	67	55	56	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					363	377		10.1038/onc.2008.386	http://dx.doi.org/10.1038/onc.2008.386			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18850003				2022-12-25	WOS:000262550300005
J	Shanmugam, N; Reddy, MA; Natarajan, R				Shanmugam, Narkunaraja; Reddy, Marpadga A.; Natarajan, Rama			Distinct Roles of Heterogeneous Nuclear Ribonuclear Protein K and microRNA-16 in Cyclooxygenase-2 RNA Stability Induced by S100b, a Ligand of the Receptor for Advanced Glycation End Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; RIBONUCLEOPROTEIN-K; DIABETES COMPLICATIONS; 3'-UNTRANSLATED REGION; MOLECULAR-MECHANISMS; PROCESSING BODIES; BINDING PROTEINS; GENE-EXPRESSION; MONOCYTIC CELLS; OXIDANT STRESS	Advanced glycation end products play major roles in diabetic complications. They act via their receptor RAGE to induce inflammatory genes such as cyclooxygenase-2 (COX2). We examined the molecular mechanisms by which the RAGE ligand, S100b, induces COX-2 in monocytes. S100b significantly increased COX-2 mRNA accumulation in THP-1 monocytes at 2 h via mRNA stability. This was further confirmed by showing that S100b increased stability of luciferase-COX-2 3'-UTR mRNA. Chromatin immunoprecipitation and RNA immunoprecipitation revealed that S100b decreased occupancy of the DNA/RNA-binding protein, heterogeneous nuclear ribonuclear protein K (hnRNPK), at the COX-2 promoter but simultaneously increased its binding to the COX-2 3'-UTR. S100b treatment promoted the translocation of nuclear hnRNPK to cytoplasm, whereas a cytoplasmic translocation-deficient hnRNPK mutant inhibited S100b-induced COX-2 mRNA stability. Small interfering RNA-mediated specific knockdown of hnRNPK blocked S100b-induced COX-2 mRNA stability, whereas on the other hand, overexpression of hnRNPK increased S100b-induced COX-2 mRNA stability. S100b promoted the release of entrapped COX-2 mRNA from cytoplasmic processing bodies, sites of mRNA degradation. Furthermore, S100b significantly down-regulated the expression of a key microRNA, miR-16, which can destabilize COX-2 mRNA by binding to its 3'-UTR. MiR-16 inhibitor oligonucleotides increased, whereas, conversely, miR-16 mimic oligonucleotides decreased COX-2 mRNA stability in monocytes, further supporting the inhibitory effects of miR-16. Interestingly, hnRNPK knockdown increased miR-16 binding to COX-2 3'-UTR, indicating a cross-talk between them. These new results demonstrate that diabetic stimuli can efficiently stabilize inflammatory genes via opposing actions of key RNA-binding proteins and miRs.	[Natarajan, Rama] Beckman Res Inst City Hope, Dept Diabet, Div Diabet, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Natarajan, R (corresponding author), Beckman Res Inst City Hope, Dept Diabet, Div Diabet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	rnatarajan@coh.org		Reddy, Marpadga A/0000-0001-9259-7243	National Institutes of Health [R01 DK 065073]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 065073. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Bane TK, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf068; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chan JYH, 2008, INT J BIOCHEM CELL B, V40, P2078, DOI 10.1016/j.biocel.2008.02.005; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; Cosentino F, 2003, CIRCULATION, V107, P1017, DOI 10.1161/01.CIR.0000051367.92927.07; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Feliers D, 2007, AM J PHYSIOL-RENAL, V293, pF607, DOI 10.1152/ajprenal.00497.2006; Guha M, 2000, J BIOL CHEM, V275, P17728, DOI 10.1074/jbc.275.23.17728; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Lee SH, 2000, LIFE SCI, V68, P57, DOI 10.1016/S0024-3205(00)00920-6; McDaniel ML, 1996, P SOC EXP BIOL MED, V211, P24; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MOROHOSHI M, 1995, ANN NY ACAD SCI, V748, P562; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pontsler AV, 2002, J BIOL CHEM, V277, P13029, DOI 10.1074/jbc.M109546200; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Schonbeck U, 1999, AM J PATHOL, V155, P1281, DOI 10.1016/S0002-9440(10)65230-3; Shanmugam N, 2004, DIABETES, V53, P795, DOI 10.2337/diabetes.53.3.795; Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Shanmugam N, 2006, J BIOL CHEM, V281, P31212, DOI 10.1074/jbc.M602445200; Stains JP, 2005, BIOCHEM J, V385, P613, DOI 10.1042/BJ20040680; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Westwood ME, 1996, IMMUNOL LETT, V50, P17, DOI 10.1016/0165-2478(96)02496-0; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786	45	86	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36221	36233		10.1074/jbc.M806322200	http://dx.doi.org/10.1074/jbc.M806322200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18854308	hybrid, Green Published			2022-12-25	WOS:000261840500017
J	Baldwin, G; Novitskaya, V; Sadej, R; Pochec, E; Litynska, A; Hartmann, C; Williams, J; Ashman, L; Eble, JA; Berditchevski, F				Baldwin, Gouri; Novitskaya, Vera; Sadej, Rafal; Pochec, Ewa; Litynska, Anna; Hartmann, Christoph; Williams, Janelle; Ashman, Leonie; Eble, Johannes A.; Berditchevski, Fedor			Tetraspanin CD151 Regulates Glycosylation of alpha 3 beta 1 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; ALPHA(3)BETA(1) INTEGRIN; CELL-ADHESION; CORE FUCOSYLATION; LIGAND-BINDING; TM4SF PROTEIN; ASSOCIATION; SUPERFAMILY; COMPLEXES; HETERODIMERIZATION	The tetraspanin CD151 forms a stoichiometric complex with integrin alpha 3 beta 1 and regulates its endocytosis. We observed that down-regulation of CD151 in various epithelial cell lines changed glycosylation of alpha 3 beta 1. In contrast, glycosylation of other transmembrane proteins, including those associated with CD151 (e. g. alpha 6 beta 1, CD82, CD63, and emmprin/CD147) was not affected. The detailed analysis has shown that depletion of CD151 resulted in the reduction of Fuc alpha 1-2Gal and bisecting GlcNAc-beta(1 -> 4) linkage on N-glycans of the alpha 3 integrin subunit. The modulatory activity of CD151 toward alpha 3 beta 1 was specific, because stable knockdown of three other tetraspanins(i. e. CD9, CD63, and CD81) did not affect glycosylation of the integrin. Analysis of alpha 3 glycosylation in CD151-depleted breast cancer cells with reconstituted expression of various CD151 mutants has shown that a direct contact with integrin is required but not sufficient for the modulatory activity of the tetraspanin toward alpha 3 beta 1. We also found that glycosylation of CD151 is also critical; Asn1593Gln mutation in the large extracellular loop did not affect interactions of CD151 with other tetraspanins or alpha 3 beta 1 but negated its modulatory function. Changes in the glycosylation pattern of alpha 3 beta 1 observed in CD151-depleted cells correlated with a dramatic decrease in cell migration toward laminin-332. Migration toward fibronectin or static adhesion of cells to extracellular matrix ligands was not affected. Importantly, reconstituted expression of the wild-type CD151 but not glycosylation-deficient mutant restored the migratory potential of the cells. These results demonstrate that CD151 plays an important role in post-translation modification of alpha 3 beta 1 integrin and strongly suggest that changes in integrin glycosylation are critical for the promigratory activity of this tetraspanin.	[Baldwin, Gouri; Novitskaya, Vera; Sadej, Rafal; Berditchevski, Fedor] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Williams, Janelle; Ashman, Leonie] Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia; [Hartmann, Christoph; Eble, Johannes A.] Frankfurt Univ Hosp, Ctr Mol Med Dept, D-60590 Frankfurt, Germany; [Pochec, Ewa; Litynska, Anna] Jagiellonian Univ, Dept Glycoconjugate Biochem, PL-30060 Krakow, Poland	Cancer Research UK; University of Birmingham; University of Newcastle; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Jagiellonian University	Berditchevski, F (corresponding author), Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England.	f.berditchevski@bham.ac.uk	ASHMAN, LEONIE/G-7631-2013	ASHMAN, LEONIE/0000-0003-3559-3611; Sadej, Rafal/0000-0003-2583-7299	Cancer Research UK [C1322/A5705]; Deutsche Forschungsgemeinschaft [EXC147/1]	Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Cancer Research UK Grant C1322/A5705 ( to F. B.) and Deutsche Forschungsgemeinschaft Grant EXC147/1 (to J. A. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIYAMA SK, 1989, J BIOL CHEM, V264, P18011; ASHMAN LK, 1997, LEUKOCYTE TYPING 6 W; Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; BERDITCHEVSKI F, 1995, J BIOL CHEM, V270, P17784, DOI 10.1074/jbc.270.30.17784; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; CHAMMAS R, 1993, P NATL ACAD SCI USA, V90, P1795, DOI 10.1073/pnas.90.5.1795; Charrin S, 2003, BIOCHEM BIOPH RES CO, V304, P107, DOI 10.1016/S0006-291X(03)00545-X; DAHMS NM, 1986, J BIOL CHEM, V261, P3186; de Melker AA, 1999, BIOESSAYS, V21, P499, DOI 10.1002/(SICI)1521-1878(199906)21:6<499::AID-BIES6>3.0.CO;2-D; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Hakomori S, 2002, FEBS LETT, V531, P88, DOI 10.1016/S0014-5793(02)03479-8; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HEMLER ME, 1984, J IMMUNOL, V132, P3011; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Jee BK, 2007, BIOCHEM BIOPH RES CO, V359, P703, DOI 10.1016/j.bbrc.2007.05.159; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; KONIG R, 1988, J BIOL CHEM, V263, P9502; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Lau LM, 2004, BLOOD, V104, P2368, DOI 10.1182/blood-2003-12-4430; LE NF, 2006, MOL CELL PROTEOMICS, V5, P845; Lehmann M, 1996, J CELL BIOCHEM, V61, P266, DOI 10.1002/(SICI)1097-4644(19960501)61:2<266::AID-JCB10>3.0.CO;2-K; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Litynska A, 2000, ACTA BIOCHIM POL, V47, P427; Litynska A, 2002, ACTA BIOCHIM POL, V49, P491; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Ono M, 1999, CANCER RES, V59, P2335; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; OZ OK, 1989, INT J CANCER, V44, P343, DOI 10.1002/ijc.2910440226; Pochec E, 2006, EUR J CELL BIOL, V85, P47, DOI 10.1016/j.ejcb.2005.08.010; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Sasai K, 2003, J BIOL CHEM, V278, P25295, DOI 10.1074/jbc.M301913200; Sawada S, 2003, J BIOL CHEM, V278, P26323, DOI 10.1074/jbc.C300210200; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; SHEN LJ, 1995, J EXP MED, V181, P1773, DOI 10.1084/jem.181.5.1773; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Sincock PM, 1999, J CELL SCI, V112, P833; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Tachibana I, 1997, J BIOL CHEM, V272, P29181, DOI 10.1074/jbc.272.46.29181; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Vagin O, 2004, J BIOL CHEM, V279, P39026, DOI 10.1074/jbc.M405453200; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200; Xu JG, 2003, J BIOL CHEM, V278, P10770, DOI 10.1074/jbc.M207968200; Yamada M, 2008, FEBS J, V275, P3335, DOI 10.1111/j.1742-4658.2008.06481.x; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; ZHENG MZ, 1992, BIOCHEM BIOPH RES CO, V186, P1397, DOI 10.1016/S0006-291X(05)81561-X	76	50	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35445	35454		10.1074/jbc.M806394200	http://dx.doi.org/10.1074/jbc.M806394200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18852263	hybrid, Green Published			2022-12-25	WOS:000261687900016
J	Korkmaz, B; Kuhl, A; Bayat, B; Santoso, S; Jenne, DE				Korkmaz, Brice; Kuhl, Angelika; Bayat, Behnaz; Santoso, Sentot; Jenne, Dieter E.			A Hydrophobic Patch on Proteinase 3, the Target of Autoantibodies in Wegener Granulomatosis, Mediates Membrane Binding via NB1 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL ELASTASE; CATHEPSIN-G; POLYMORPHONUCLEAR NEUTROPHILS; PLASMA-MEMBRANE; ANTIGEN; SURFACE; CD177; AUTOANTIGEN; SITE; ANCA	Proteinase 3 (PR3), the target antigen of antineutrophil cytoplasm autoantibodies, which are found in patients with Wegener granulomatosis, is a neutrophil serine protease localized within cytoplasmic granules. Recently, the human neutrophil antigen NB1 was identified as a specific neutrophil cell surface receptor of PR3. We hypothesized that the unique hydrophobic cluster of PR3 that is not present on human neutrophil elastase and cathepsin G and presumably is also missing in other human PR3 homologs accounts for its binding to the NB1 receptor expressed on the cellular surface of NB1 cells. Instead of generating and testing various artificial human PR3 mutants, we cloned and expressed the very closely related gibbon (Hylobates pileatus) PR3 homolog, which did not bind to the human NB1 receptor. Moreover, a human-gibbon hybrid constructed from the N- and C-terminal half of the human and gibbon PR3, respectively, also did not interact with human NB1. The C-terminal half of gibbon PR3 differs only by 9 residues from human PR3, among which four closely spaced hydrophobic residues are substituted in a nonconservative manner (F166L, W218R, G219A, and L223H). The NB1-bound PR3 was active and was cleared from the surface by alpha-1-protease inhibitor. Conformational distortion of the hydrophobic 217-225 loop by alpha-1-protease inhibitor most likely triggers rapid solubilization.	[Korkmaz, Brice; Kuhl, Angelika; Jenne, Dieter E.] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Planegg Martinsried, Germany; [Bayat, Behnaz; Santoso, Sentot] Univ Giessen, Inst Clin Immunol & Transfus Med, D-35385 Giessen, Germany	Max Planck Society; Justus Liebig University Giessen	Jenne, DE (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Planegg Martinsried, Germany.	djenne@neuro.mpg.de	Jenne, Dieter Erich/AAP-1414-2020	KORKMAZ, BRICE/0000-0002-5159-8706	Deutsche Forschungsgemeinschaft [571]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 571) and the Bundesministerium fur Bildung und Forschung (Forschergruppe der Klinischen Infektiologie). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdel-Salam B, 2004, KIDNEY INT, V66, P1009, DOI 10.1111/j.1523-1755.2004.00849.x; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Campbell EJ, 2007, J BIOL CHEM, V282, P14645, DOI 10.1074/jbc.M608346200; David A, 2005, EXP CELL RES, V308, P156, DOI 10.1016/j.yexcr.2005.03.034; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Fridlich R, 2006, J CELL BIOCHEM, V99, P117, DOI 10.1002/jcb.20901; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; Goldmann WH, 1999, EUR J BIOCHEM, V261, P155, DOI 10.1046/j.1432-1327.1999.00259.x; Hajjar E, 2008, PROTEINS, V71, P1655, DOI 10.1002/prot.21853; Hopfner KP, 1998, P NATL ACAD SCI USA, V95, P9813, DOI 10.1073/pnas.95.17.9813; Jenne DE, 2006, CLIN NEPHROL, V66, P153; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kissel K, 2001, EUR J IMMUNOL, V31, P1301, DOI 10.1002/1521-4141(200105)31:5<1301::AID-IMMU1301>3.0.CO;2-J; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; Rarok AA, 2003, J LEUKOCYTE BIOL, V74, P3, DOI 10.1189/jlb.1202611; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Specks U, 2007, J BIOCHEM, V141, P101, DOI 10.1093/jb/mvm008; Stronach D., 2004, SILK ROAD, V2, P9; Stroncek DF, 2007, CURR OPIN HEMATOL, V14, P688, DOI 10.1097/MOH.0b013e3282efed9e; van der Geld YM, 2001, J LEUKOCYTE BIOL, V69, P177; von Vietinghoff S, 2005, CLIN NEPHROL, V64, P453; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496	29	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35976	35982		10.1074/jbc.M806754200	http://dx.doi.org/10.1074/jbc.M806754200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18854317	hybrid			2022-12-25	WOS:000261687900072
J	Macauley, MS; Bubb, AK; Martinez-Fleites, C; Davies, GJ; Vocadlo, DJ				Macauley, Matthew S.; Bubb, Abigail K.; Martinez-Fleites, Carlos; Davies, Gideon J.; Vocadlo, David J.			Elevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; SEQUENCE-BASED CLASSIFICATION; SUBSTRATE-ASSISTED CATALYSIS; STRUCTURAL INSIGHTS; NAG-THIAZOLINE; GLYCOSYLATION; MECHANISM; GLUCOSE; TRANSFERASE; PROTEINS	The O-GlcNAc post-translational modification is considered to act as a sensor of nutrient flux through the hexosamine biosynthetic pathway. A cornerstone of this hypothesis is that global elevation of protein O-GlcNAc levels, typically induced with the non-selective O-GlcNAcase inhibitor PUGNAc (O-(2-acetamido-2-deoxy-D-glycopyranosylidene) amino-N-phenylcarbamate), causes insulin resistance in adipocytes. Here we address the potential link between elevated O- GlcNAc and insulin resistance by using a potent and selective inhibitor of O- GlcNAcase (NButGT (1,2-dideoxy-2'-propyl-alpha-D-glucopyranoso-[2,1-D]-Delta 2'-thiazoline), 1200-fold selectivity). A comparison of the structures of a bacterial homologue of O-GlcNAcase in complex with PUGNAc or NButGT reveals that these inhibitors bind to the same region of the active site, underscoring the competitive nature of their inhibition of O- GlcNAcase and the molecular basis of selectivity. Treating 3T3-L1 adipocytes with NButGT induces rapid increases in global O- GlcNAc levels, but strikingly, NButGT treatment does not replicate the insulin desensitizing effects of the non-selective O- GlcNAcase inhibitor PUGNAc. Consistent with these observations, NButGT also does not recapitulate the impaired insulin-mediated phosphorylation of Akt that is induced by treatment with PUGNAc. Collectively, these results suggest that increases in global levels of O-GlcNAc-modified proteins of cultured adipocytes do not, on their own, cause insulin resistance.	[Macauley, Matthew S.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Bubb, Abigail K.; Martinez-Fleites, Carlos; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England	Simon Fraser University; University of York - UK	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Martinez Fleites, Carlos/F-8526-2010; Davies, Gideon J/A-9042-2011; Vocadlo, David J/E-5508-2014	Davies, Gideon J/0000-0002-7343-776X; Vocadlo, David J/0000-0001-6897-5558	Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council of Canada; Biotechnology and Biological Sciences Research Council; BBSRC [BB/F007124/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007124/1] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council of Canada (to D. J. V.) and the Biotechnology and Biological Sciences Research Council (to G. J. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hawkins M, 1997, J BIOL CHEM, V272, P4889, DOI 10.1074/jbc.272.8.4889; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Matthews JA, 2007, MOL CELL BIOCHEM, V298, P109, DOI 10.1007/s11010-006-9358-5; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOJIRI H, 1991, J BIOL CHEM, V266, P4531; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; Sale EM, 2008, CELL MOL LIFE SCI, V65, P113, DOI 10.1007/s00018-007-7274-9; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Stubbs KA, 2006, ORG BIOMOL CHEM, V4, P839, DOI 10.1039/b516273d; TRAXINGER RR, 1991, J BIOL CHEM, V266, P10148; VANECHTEN G, 1993, J BIOL CHEM, V268, P5341; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; WILLIAMS D, 1980, J BIOL CHEM, V255, P1253; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	51	98	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34687	34695		10.1074/jbc.M804525200	http://dx.doi.org/10.1074/jbc.M804525200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842583	Green Published, hybrid			2022-12-25	WOS:000261469100024
J	Boudko, SP; Engel, J; Bachinger, HP				Boudko, Sergei P.; Engel, Juergen; Baechinger, Hans Peter			Trimerization and Triple Helix Stabilization of the Collagen XIX NC2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL; PROTEIN; MODEL; CHAIN; SUPERFAMILY; TRANSITIONS; SUBDOMAINS; MEMBRANE; TRIMERS; REQUIRE	The mechanisms of chain selection and assembly of fibril-associated collagens with interrupted triple helices (FACITs) must differ from that of fibrillar collagens, since they lack the characteristic C-propeptide. We analyzed two carboxyl-terminal noncollagenous domains, NC2 and NC1, of collagen XIX as potential trimerization units and found that NC2 forms a stable trimer and substantially stabilizes a collagen triple helix attached to either end. In contrast, the NC1 domain requires formation of an adjacent collagen triple helix to form interchain disulfide bridges. The NC2 domain of collagen XIX and probably of other FACITs is responsible for chain selection and trimerization.	[Boudko, Sergei P.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Boudko, Sergei P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Oregon Health & Science University; University of Basel	Bachinger, HP (corresponding author), 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Boudko, Sergei/0000-0003-3856-4859	Shriners Hospital for Children	Shriners Hospital for Children	This work was supported by a grant from Shriners Hospital for Children. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bachmann A, 2005, P NATL ACAD SCI USA, V102, P13897, DOI 10.1073/pnas.0505141102; Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918; Boudko SP, 2007, J MOL BIOL, V366, P1538, DOI 10.1016/j.jmb.2006.12.046; Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Deng YQ, 2006, STRUCTURE, V14, P889, DOI 10.1016/j.str.2006.03.007; Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8; Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; INOGUCHI K, 1995, J BIOCHEM-TOKYO, V117, P137, DOI 10.1093/oxfordjournals.jbchem.a124700; Jaalinoja J, 2008, BIOCHEM J, V409, P545, DOI 10.1042/BJ20070984; Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Liu J, 2006, BIOCHEMISTRY-US, V45, P15224, DOI 10.1021/bi061914m; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MAZZORANA M, 1993, J BIOL CHEM, V268, P3029; MAZZORANA M, 1995, MATRIX BIOL, V14, P583, DOI 10.1016/S0945-053X(05)80007-1; Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Myers JC, 2003, J BIOL CHEM, V278, P32047, DOI 10.1074/jbc.M304629200; MYERS JC, 1993, GENE, V123, P211, DOI 10.1016/0378-1119(93)90126-N; MYERS JC, 1994, J BIOL CHEM, V269, P18549; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Sumiyoshi H, 2004, J CELL BIOL, V166, P591, DOI 10.1083/jcb.200402054; YOSHIOKA H, 1992, GENOMICS, V13, P884, DOI 10.1016/0888-7543(92)90176-S	28	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34345	34351		10.1074/jbc.M806352200	http://dx.doi.org/10.1074/jbc.M806352200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845531	Green Published, hybrid			2022-12-25	WOS:000261277700062
J	Abbott, KL; Matthews, RT; Pierce, M				Abbott, Karen L.; Matthews, Russell T.; Pierce, Michael			Receptor Tyrosine Phosphatase beta(RPTP beta) Activity and Signaling Are Attenuated by Glycosylation and Subsequent Cell Surface Galectin-1 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; MONOCLONAL-ANTIBODY HNK-1; MYELIN-ASSOCIATED GLYCOPROTEIN; EXPRESSION LEVELS; NERVOUS-SYSTEM; O-GLYCANS; N-GLYCANS; GNT-VB; ADHESION; BRAIN	O-Mannosyl-linked glycosylation is abundant within the central nervous system, yet very few glycoproteins with this glycan modification have been identified. Congenital diseases with significant neurological defects arise from inactivating mutations found within the glycosyltransferases that act early in the O-mannosyl glycosylation pathway. The N-acetylglucosaminyltransferase known as GnT-Vb or -IX is highly expressed in brain and branches O-mannosyl-linked glycans. Our results using SH-SY5Y neuroblastoma cells indicate that GnT-Vb activity promotes the addition of the O-mannosyl-linked HNK-1 modification found on the developmentally regulated and neuron-specific receptor protein-tyrosine phosphatase beta (RPTP beta). These changes in glycosylation accompany decreased cell-cell adhesion and increased rates of migration on laminin. In addition, we show that expression of GnT-Vb promotes its dimerization and inhibits RPTP beta intrinsic phosphatase activity, resulting in higher levels of phosphorylated beta-catenin, suggesting a mechanism by which GnT-Vb glycosylation couples to changes in cell adhesion. GnT-Vb-mediated glycosylation of RPTP beta promotes galectin-1 binding and RPTP beta levels of retention on the cell surface. N-Acetyllactosamine, but not sucrose, treatment of cells results in decreased RPTP retention, showing that galectin-1 binding contributes to the increased retention after GnT-Vb expression. These results place GnT-Vb as a regulator of RPTP beta signaling that influences cell-cell and cell-matrix interactions in the developing nervous system.	[Abbott, Karen L.; Pierce, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem, Athens, GA 30602 USA; [Matthews, Russell T.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Matthews, Russell T.] SUNY Upstate Med Sch, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	University System of Georgia; University of Georgia; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Abbott, KL (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem, 315 Riverbend Rd, Athens, GA 30602 USA.	kabbott@uga.edu			National Institutes of Health [RO1 CA64462]; Canary Fund/American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA064462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canary Fund/American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA64462 (NCI). This work was also supported by a Canary Fund/American Cancer Society Postdoctoral Fellowship (to K. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott KL, 2006, EXP CELL RES, V312, P2837, DOI 10.1016/j.yexcr.2006.05.022; ABO T, 1981, J IMMUNOL, V127, P1024; Allen HJ, 1998, GLYCOCONJUGATE J, V15, P691, DOI 10.1023/A:1006988515346; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Breen KC, 1998, MOL NEUROBIOL, V16, P163, DOI 10.1007/BF02740643; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; BURGER D, 1990, J NEUROCHEM, V54, P1569, DOI 10.1111/j.1471-4159.1990.tb01206.x; CAILLAUD JM, 1984, CANCER RES, V44, P4432; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; Dino MR, 2006, NEUROSCIENCE, V142, P1055, DOI 10.1016/j.neuroscience.2006.07.054; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; FINNE J, 1979, J BIOL CHEM, V254, P295; Fouillit M, 2000, GLYCOBIOLOGY, V10, P413, DOI 10.1093/glycob/10.4.413; GRUMET M, 1982, NATURE, V295, P693, DOI 10.1038/295693a0; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Hall H, 1997, EUR J BIOCHEM, V246, P233, DOI 10.1111/j.1432-1033.1997.t01-1-00233.x; Hall H, 1997, J NEUROCHEM, V68, P544; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; ILYAS AA, 1984, BIOCHEM BIOPH RES CO, V122, P1206, DOI 10.1016/0006-291X(84)91220-8; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Johnson G, 2001, INT J DEV NEUROSCI, V19, P439, DOI 10.1016/S0736-5748(01)00024-7; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; KIANG WL, 1981, J BIOL CHEM, V256, P529; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lander C, 1997, J NEUROSCI, V17, P1928; Lander C, 1998, J NEUROSCI, V18, P174; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; LIPINSKI M, 1983, J EXP MED, V158, P1775, DOI 10.1084/jem.158.5.1775; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; McGraw J, 2005, PAIN, V114, P7, DOI 10.1016/j.pain.2004.10.009; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ong E, 2002, J BIOL CHEM, V277, P18182, DOI 10.1074/jbc.M201312200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PEDRAZA L, 1995, J NEUROSCI RES, V40, P716, DOI 10.1002/jnr.490400603; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V362, P5, DOI 10.1016/j.bbrc.2007.06.050; RATHJEN FG, 1984, EMBO J, V3, P1; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; Sakaguchi M, 2007, CELL MOL LIFE SCI, V64, P1254, DOI 10.1007/s00018-007-6476-5; Schmidt JT, 1998, J NEUROBIOL, V37, P659, DOI 10.1002/(SICI)1097-4695(199812)37:4<659::AID-NEU13>3.0.CO;2-3; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHULLERPETROVIC S, 1983, NATURE, V306, P179, DOI 10.1038/306179a0; SCHWARTING GA, 1987, DEV BIOL, V120, P65, DOI 10.1016/0012-1606(87)90104-7; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Walzel H, 1999, IMMUNOL LETT, V67, P193, DOI 10.1016/S0165-2478(99)00012-7; WERNECKE H, 1985, J NEUROIMMUNOL, V9, P115, DOI 10.1016/S0165-5728(85)80012-6; Woodworth A, 2004, J BIOL CHEM, V279, P10413, DOI 10.1074/jbc.M312466200; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yuen CT, 1997, J BIOL CHEM, V272, P8924; Zhang WL, 2002, BIOCHEM J, V361, P153, DOI 10.1042/0264-6021:3610153	62	63	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33026	33035		10.1074/jbc.M803646200	http://dx.doi.org/10.1074/jbc.M803646200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838383	Green Published, hybrid			2022-12-25	WOS:000261183700002
J	Mattei, C; Wen, PJ; Nguyen-Huu, TD; Alvarez, M; Benoit, E; Bourdelais, AJ; Lewis, RJ; Baden, DG; Molgo, J; Meunier, FA				Mattei, Cesar; Wen, Peter J.; Nguyen-Huu, Truong D.; Alvarez, Martha; Benoit, Evelyne; Bourdelais, Andrea J.; Lewis, Richard J.; Baden, Daniel G.; Molgo, Jordi; Meunier, Frederic A.			Brevenal Inhibits Pacific Ciguatoxin-1B-Induced Neurosecretion from Bovine Chromaffin Cells	PLOS ONE			English	Article								Ciguatoxins and brevetoxins are neurotoxic cyclic polyether compounds produced by dinoflagellates, which are responsible for ciguatera and neurotoxic shellfish poisoning (NSP) respectively. Recently, brevenal, a natural compound was found to specifically inhibit brevetoxin action and to have a beneficial effect in NSP. Considering that brevetoxin and ciguatoxin specifically activate voltage-sensitive Na(+) channels through the same binding site, brevenal has therefore a good potential for the treatment of ciguatera. Pacific ciguatoxin-1B (P-CTX-1B) activates voltage-sensitive Na(+) channels and promotes an increase in neurotransmitter release believed to underpin the symptoms associated with ciguatera. However, the mechanism through which slow Na(+) influx promotes neurosecretion is not fully understood. In the present study, we used chromaffin cells as a model to reconstitute the sequence of events culminating in ciguatoxin-evoked neurosecretion. We show that P-CTX-1B induces a tetrodotoxin-sensitive rise in intracellular Na(+), closely followed by an increase in cytosolic Ca(2+) responsible for promoting SNARE-dependent catecholamine secretion. Our results reveal that brevenal and beta-naphtoyl-brevetoxin prevent P-CTX-1B secretagogue activity without affecting nicotine or barium-induced catecholamine secretion. Brevenal is therefore a potent inhibitor of ciguatoxin-induced neurotoxic effect and a potential treatment for ciguatera.	[Mattei, Cesar; Benoit, Evelyne; Molgo, Jordi] CNRS, Inst Neurobiol Alfred Fessard, Lab Neurobiol Cellulaire Mol, Gif Sur Yvette, France; [Wen, Peter J.; Nguyen-Huu, Truong D.; Alvarez, Martha; Meunier, Frederic A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Wen, Peter J.; Nguyen-Huu, Truong D.; Alvarez, Martha; Meunier, Frederic A.] Queensland Brain Inst, Brisbane, Qld, Australia; [Alvarez, Martha] Tecnol Monterrey, Photon & Math Opt Grp, Monterrey, Mexico; [Bourdelais, Andrea J.; Baden, Daniel G.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC USA; [Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Queensland; University of Queensland; Tecnologico de Monterrey; University of North Carolina; University of North Carolina Wilmington; University of Queensland	Mattei, C (corresponding author), Delegat Gen Armement, Bagneux, France.	Jordi.Molgo@nbcm.cnrs-gif.fr; f.meunier@uq.edu.au	Lewis, Richard J/E-8674-2013; Mattei, Cesar/K-5286-2015; Lewis, Richard/T-8763-2019; Meunier, Frederic A/C-8161-2009	Lewis, Richard J/0000-0003-3470-923X; Mattei, Cesar/0000-0002-2214-2611; Lewis, Richard/0000-0003-3470-923X; Meunier, Frederic A/0000-0001-6400-1107; BENOIT, Evelyne/0000-0001-5501-0888	National Health and Medical Research Council; DGA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES010594] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); DGA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the National Health and Medical Research Council (to F.A.M.), and C.M. was supported by a fellowship from DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WM, 2005, AM J RESP CRIT CARE, V171, P26, DOI 10.1164/rccm.200406-735OC; Achaibar Kira C, 2007, Pract Neurol, V7, P316, DOI 10.1136/jnnp.2007.129049; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Benoit E, 1996, NEUROSCIENCE, V71, P1121, DOI 10.1016/0306-4522(95)00506-4; BIDARD JN, 1984, J BIOL CHEM, V259, P8353; Bourdelais AJ, 2005, J NAT PROD, V68, P2, DOI 10.1021/np049797o; Bourdelais AJ, 2004, CELL MOL NEUROBIOL, V24, P553, DOI 10.1023/B:CEMN.0000023629.81595.09; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; CHEEK TR, 1990, FEBS LETT, V266, P91, DOI 10.1016/0014-5793(90)81514-O; CHEEK TR, 1993, J BIOL CHEM, V268, P27076; Dechraoui MYB, 2006, TOXICON, V48, P702, DOI 10.1016/j.toxicon.2006.07.032; GAWLEY RE, 1995, CHEM BIOL, V2, P533, DOI 10.1016/1074-5521(95)90187-6; Hidalgo J, 2002, BRIT J PHARMACOL, V137, P1055, DOI 10.1038/sj.bjp.0704980; Hogg RC, 1998, NEUROSCI LETT, V252, P103, DOI 10.1016/S0304-3940(98)00575-8; Isbister GK, 2005, LANCET NEUROL, V4, P219, DOI 10.1016/S1474-4422(05)70041-7; LAWRENCE GW, 1994, EUR J BIOCHEM, V222, P325, DOI 10.1111/j.1432-1033.1994.tb18871.x; Legrand AM, 1989, J APPL PHYCOL, V1, P183, DOI 10.1007/BF00003882; LePage KT, 2007, J PHARMACOL EXP THER, V323, P174, DOI 10.1124/jpet.107.124271; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; Li WI, 2001, P NATL ACAD SCI USA, V98, P7599, DOI 10.1073/pnas.121085898; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; LOPEZ MG, 1995, J PHYSIOL-LONDON, V482, P15, DOI 10.1113/jphysiol.1995.sp020496; MARXEN P, 1991, N-S ARCH PHARMACOL, V344, P387; Mattei C, 1999, BRAIN RES, V847, P50, DOI 10.1016/S0006-8993(99)02032-6; Mattei C, 1997, NEUROSCI LETT, V234, P75, DOI 10.1016/S0304-3940(97)00665-4; Mattei Cesar, 1999, Journal de la Societe de Biologie, V193, P329; Meunier FA, 2000, J CELL SCI, V113, P1119; Meunier FA, 1997, NEUROSCIENCE, V78, P883, DOI 10.1016/S0306-4522(96)00568-4; Michelliza S, 2007, CHEMBIOCHEM, V8, P2233, DOI 10.1002/cbic.200700317; MOLGO J, 1990, BRIT J PHARMACOL, V99, P695, DOI 10.1111/j.1476-5381.1990.tb12991.x; MOLGO J, 1993, NEUROSCI LETT, V160, P65, DOI 10.1016/0304-3940(93)9000-4; MOLGO J, 1993, NEUROSCI LETT, V158, P147, DOI 10.1016/0304-3940(93)90250-O; MURATA M, 1990, J AM CHEM SOC, V112, P4380, DOI 10.1021/ja00167a040; OSULLIVAN AJ, 1989, EMBO J, V8, P401, DOI 10.1002/j.1460-2075.1989.tb03391.x; Pearn J, 2001, J NEUROL NEUROSUR PS, V70, P4, DOI 10.1136/jnnp.70.1.4; POLI MA, 1986, MOL PHARMACOL, V30, P129; Shone CC, 1995, CURR TOP MICROBIOL, V195, P143; Soma S, 2006, J PHARMACOL SCI, V102, P88, DOI 10.1254/jphs.FPJ06006X; Strachan LC, 1999, J PHARMACOL EXP THER, V288, P379; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; WADA A, 1992, J PHARMACOL EXP THER, V263, P1347; Zerbes M, 2001, CELL CALCIUM, V29, P49, DOI 10.1054/ceca.2000.0160	45	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3448	10.1371/journal.pone.0003448	http://dx.doi.org/10.1371/journal.pone.0003448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941627	gold, Green Published			2022-12-25	WOS:000265125600008
J	Vollmers, C; Panda, S; DiTacchio, L				Vollmers, Christopher; Panda, Satchidananda; DiTacchio, Luciano			A High-Throughput Assay for siRNA-Based Circadian Screens in Human U2OS Cells	PLOS ONE			English	Article							GENE-EXPRESSION; CLOCK; REVEALS; CRYPTOCHROME; RHYTHMS; MOUSE; FBXL3	The advent of siRNA-based screens has revolutionized the efficiency by which functional components of biological processes are identified. A notable exception has been the field of mammalian circadian rhythms. Here, we outline a medium-to high-throughput siRNA-based approach that, in combination with real-time bioluminescence measurement of a circadian reporter gene, can be utilized to elucidate the effects of gene knockdown across several days in human cells.	[Vollmers, Christopher; Panda, Satchidananda; DiTacchio, Luciano] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Vollmers, Christopher] Heidelberg Univ Biochem Ctr BZH, Heidelberg, Germany	Salk Institute; Ruprecht Karls University Heidelberg	Vollmers, C (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ldeharo@salk.edu	DiTacchio, Luciano/D-6341-2011; Panda, Satchidananda/J-6891-2012	DiTacchio, Luciano/0000-0001-9570-7348; 	Pew Scholars Program in Biomedical Sciences; Dana Foundation; Whitehall Foundation; NIH [EY016807]; NRSA [1F32GM082083-01]; NATIONAL EYE INSTITUTE [R01EY016807] Funding Source: NIH RePORTER	Pew Scholars Program in Biomedical Sciences; Dana Foundation; Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Pew Scholars Program in Biomedical Sciences, Dana Foundation, Whitehall Foundation and NIH grants EY016807 (to S.P.), and by NRSA 1F32GM082083-01 (to L.D.)	Antoch MP, 2008, CELL CYCLE, V7, P1197, DOI 10.4161/cc.7.9.5886; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Isojima Y, 2003, J BIOCHEM, V134, P777, DOI 10.1093/jb/mvg219; Kondratov RV, 2007, COLD SPRING HARB SYM, V72, P477, DOI 10.1101/sqb.2007.72.050; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Metlaine A, 2005, IND HEALTH, V43, P11, DOI 10.2486/indhealth.43.11; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Sahar S, 2007, CELL CYCLE, V6, P1329, DOI 10.4161/cc.6.11.4295; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Straume M, 2004, METHOD ENZYMOL, V383, P149; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang JH, 2005, J BIOMOL SCREEN, V10, P695, DOI 10.1177/1087057105279149; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	31	32	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3457	10.1371/journal.pone.0003457	http://dx.doi.org/10.1371/journal.pone.0003457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941634	gold, Green Published, Green Submitted			2022-12-25	WOS:000265125600015
J	Hall, MD; Bussiere, LF; Brooks, R				Hall, Matthew D.; Bussiere, Luc F.; Brooks, Robert			The Effect of Diet Quality and Wing Morph on Male and Female Reproductive Investment in a Nuptial Feeding Ground Cricket	PLOS ONE			English	Article							REQUENA-VERTICALIS ORTHOPTERA; MALE BUSH-CRICKETS; SEXUAL SELECTION; TRADE-OFFS; PARENTAL INVESTMENT; FIELD CRICKETS; GRYLLUS-FIRMUS; MATE CHOICE; LIFE-SPAN; EVOLUTION	A common approach in the study of life-history trade-off evolution is to manipulate the nutrient content of diets during the life of an individual in order observe how the acquisition of resources influences the relationship between reproduction, lifespan and other life-history parameters such as dispersal. Here, we manipulate the quality of diet that replicate laboratory populations received as a thorough test of how diet quality influences the life-history trade-offs associated with reproductive investment in a nuptial feeding Australian ground cricket (Pteronemobius sp.). In this species, both males and females make significant contributions to the production of offspring, as males provide a nuptial gift by allowing females to chew on a modified tibial spur during copulation and feed directing on their haemolymph. Individuals also have two distinct wing morphs, a short-winged flightless morph and a long-winged morph that has the ability to disperse. By manipulating the quality of diet over seven generations, we found that the reproductive investment of males and females were affected differently by the diet quality treatment and wing morph of the individual. We discuss the broader implications of these findings including the differences in how males and females balance current and future reproductive effort in nuptial feeding insects, the changing nature of sexual selection when diets vary, and how the life-history trade-offs associated with the ability to disperse are expected to differ among populations.	[Hall, Matthew D.; Brooks, Robert] Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Bussiere, Luc F.] Univ Stirling, Sch Biol & Environm Sci, Stirling FK9 4LA, Scotland	University of New South Wales Sydney; University of Stirling	Hall, MD (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	m.hall@student.unsw.edu.au	Hall, Matthew D/A-2006-2009; Bussiere, Luc/T-2134-2018; Brooks, Robert/A-1251-2008	Hall, Matthew D/0000-0002-4738-203X; Bussiere, Luc/0000-0001-8937-8381; Brooks, Robert/0000-0001-6926-0781	UNSW; Australian Research Council; NSERC	UNSW; Australian Research Council(Australian Research Council); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from UNSW and the Australian Research Council, an Australian Postgraduate Award to MH, and NSERC fellowship to LFB and an ARC Fellowship to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Bonduriansky R, 2007, AM NAT, V169, P9, DOI 10.1086/510214; Brown WD, 1996, EVOLUTION, V50, P2400, DOI [10.2307/2410708, 10.1111/j.1558-5646.1996.tb03627.x]; Bussiere LF, 2005, BEHAV ECOL, V16, P223, DOI 10.1093/beheco/arh156; Chenoweth SF, 2005, AM NAT, V165, P281, DOI 10.1086/427271; Crnokrak P, 1998, ANIM BEHAV, V56, P433, DOI 10.1006/anbe.1998.0741; Crnokrak P, 2000, J EVOLUTION BIOL, V13, P396, DOI 10.1046/j.1420-9101.2000.00188.x; CUMMING JM, 1994, CAN ENTOMOL, V126, P907, DOI 10.4039/Ent126907-3; De Luca PA, 1998, BEHAVIOUR, V135, P777, DOI 10.1163/156853998792640422; DUSSOURD DE, 1991, P NATL ACAD SCI USA, V88, P9224, DOI 10.1073/pnas.88.20.9224; Fedorka KM, 2002, FLA ENTOMOL, V85, P317, DOI 10.1653/0015-4040(2002)085[0317:TSFIGC]2.0.CO;2; Fedorka KM, 2002, EVOLUTION, V56, P590, DOI 10.1111/j.0014-3820.2002.tb01369.x; Fedorka KM, 2002, ANIM BEHAV, V64, P361, DOI 10.1006/anbe.2002.3052; Glazier DS, 1999, EVOL ECOL, V13, P539, DOI 10.1023/A:1006793600600; GWYNNE DT, 1993, ECOLOGY, V74, P1406, DOI 10.2307/1940070; GWYNNE DT, 1990, NATURE, V346, P172, DOI 10.1038/346172a0; GWYNNE DT, 1990, AM NAT, V136, P474, DOI 10.1086/285108; GWYNNE DT, 1982, ANIM BEHAV, V30, P734, DOI 10.1016/S0003-3472(82)80145-0; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; HOULE D, 1991, EVOLUTION, V45, P630, DOI 10.1111/j.1558-5646.1991.tb04334.x; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kokko H, 2001, ECOL LETT, V4, P159, DOI 10.1046/j.1461-0248.2001.00212.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lynch M., 1998, GENETICS ANAL QUANTI; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Mappes J, 1996, P ROY SOC B-BIOL SCI, V263, P785, DOI 10.1098/rspb.1996.0117; MAYS D L, 1971, Florida Entomologist, V54, P113, DOI 10.2307/3493557; Post E, 1999, P NATL ACAD SCI USA, V96, P4467, DOI 10.1073/pnas.96.8.4467; Raubenheimer D, 2005, P ROY SOC B-BIOL SCI, V272, P2429, DOI 10.1098/rspb.2005.3271; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; ROFF DA, 1986, EVOLUTION, V40, P1009, DOI 10.1111/j.1558-5646.1986.tb00568.x; ROFF DA, 1991, AM ZOOL, V31, P243; ROFF DA, 1984, OECOLOGIA, V63, P30, DOI 10.1007/BF00379781; ROFF DA, 1994, AM NAT, V144, P772, DOI 10.1086/285706; Roff DA, 2003, J EVOLUTION BIOL, V16, P744, DOI 10.1046/j.1420-9101.2003.00570.x; Roff DA, 2002, EVOLUTION, V56, P84, DOI 10.1111/j.0014-3820.2002.tb00851.x; Roff Derek A., 1992; Simmons LW, 2006, P ROY SOC B-BIOL SCI, V273, P465, DOI 10.1098/rspb.2005.3309; SIMMONS LW, 1993, BEHAV ECOL SOCIOBIOL, V32, P135, DOI 10.1007/BF00164046; SIMMONS LW, 1992, BEHAV ECOL SOCIOBIOL, V31, P57, DOI 10.1007/BF00167816; SIMMONS LW, 1992, NATURE, V358, P61, DOI 10.1038/358061a0; SIMMONS LW, 1993, P ROY SOC B-BIOL SCI, V252, P1, DOI 10.1098/rspb.1993.0038; SIMMONS LW, 1994, J EVOLUTION BIOL, V7, P189, DOI 10.1046/j.1420-9101.1994.7020189.x; Simpson SJ, 2007, J GERONTOL A-BIOL, V62, P707, DOI 10.1093/gerona/62.7.707; Sokal RR, 1995, BIOMETRY; Stearns S.C., 1992, pi; Trivers R., 1972, SEXUAL SELECTION DES, P139; Tu MP, 2003, AGING CELL, V2, P327, DOI 10.1046/j.1474-9728.2003.00064.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; WEDELL N, 1994, BEHAV ECOL, V5, P418, DOI 10.1093/beheco/5.4.418; Zera AJ, 2000, J INSECT PHYSIOL, V46, P1207, DOI 10.1016/S0022-1910(00)00041-X; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	59	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3437	10.1371/journal.pone.0003437	http://dx.doi.org/10.1371/journal.pone.0003437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927614	Green Published, gold			2022-12-25	WOS:000265122400009
J	Shoham, DA; Durazo-Arvizu, R; Kramer, H; Luke, A; Vupputuri, S; Kshirsagar, A; Cooper, RS				Shoham, David A.; Durazo-Arvizu, Ramon; Kramer, Holly; Luke, Amy; Vupputuri, Suma; Kshirsagar, Abhijit; Cooper, Richard S.			Sugary Soda Consumption and Albuminuria: Results from the National Health and Nutrition Examination Survey, 1999-2004	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; FRUCTOSE; RISK; HYPERTENSION; PREVALENCE; POPULATION; OBESITY	Background: End-stage renal disease rates rose following widespread introduction of high fructose corn syrup in the American diet, supporting speculation that fructose harms the kidney. Sugar-sweetened soda is a primary source of fructose. We therefore hypothesized that sugary soda consumption was associated with albuminuria, a sensitive marker for kidney disease. Methodology/Principal Findings: Design was a cross-sectional analysis. Data were drawn from the National Health and Nutrition Examination Survey (NHANES), 1999-2004. The setting was a representative United States population sample. Participants included adults 20 years and older with no history of diabetes mellitus (n = 12,601); after exclusions for missing outcome and covariate information (n = 3,243), the analysis dataset consisted of 9,358 subjects. Exposure was consumption of two or more sugary soft drinks, based on 24-hour dietary recall. The main outcome measure was Albuminuria, defined by albumin to creatinine ratio cutpoints of >17 mg/g (males) and >25 mg/g (females). Logistic regression adjusted for confounders (diet soda, age, race-ethnicity, gender, poverty). Interactions between age, race-ethnicity, gender, and overweight-obesity were explored. Further analysis adjusted for potential mediators: energy intake, basal metabolic rate, obesity, hypertension, lipids, serum uric acid, smoking, energy expenditure, and glycohemoglobin. Alternative soda intake definitions and cola consumption were employed. Results: Weighted albuminuria prevalence was 11%, and 17% consumed 2+ sugary soft drinks/day. The confounder-adjusted odds ratio for sugary soda was 1.40 (95% confidence interval: 1.13, 1.74). Associations were modified by gender (p = 0.008) and overweight-obesity (p = 0.014). Among women, the OR was 1.86 (95% CI: 1.37, 2.53); the OR among males was not significant. In the group with body mass under 25 kg/m(2), OR = 2.15 (95% confidence interval: 1.42, 3.25). Adjustment for potential mediators and use of alternative definitions of albuminuria and soda consumption did not appreciably change results. Diet sodas were not associated with albuminuria. Conclusions: Findings suggest that sugary soda consumption may be associated with kidney damage, although moderate consumption of 1 or fewer sodas does not appear to be harmful. Additional studies are needed to assess whether HFCS itself, overall excess intake of sugar, or unmeasured lifestyle and confounding factors are responsible.	[Shoham, David A.; Durazo-Arvizu, Ramon; Kramer, Holly; Luke, Amy; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL USA; [Kramer, Holly] Loyola Univ, Dept Med, Div Nephrol, New Orleans, LA 70118 USA; [Vupputuri, Suma; Kshirsagar, Abhijit] Univ N Carolina, UNC Kidney Ctr, Chapel Hill, NC USA; [Vupputuri, Suma] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Vupputuri, Suma] Kaiser Permanente, Ctr Hlth Res, Atlanta, GA USA	Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Kaiser Permanente	Shoham, DA (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL USA.	dshoham@lumc.edu		Kramer, Holly/0000-0002-6374-837X				BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Bourdieu P., 1984, DISTINCTION SOCIAL C; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CHOI HK, 2008, SOFT DRINKS FRUCTOSE; Coresh J, 2004, CURR OPIN NEPHROL HY, V13, P73, DOI 10.1097/00041552-200401000-00011; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Gersch MS, 2007, AM J PHYSIOL-RENAL, V293, pF1256, DOI 10.1152/ajprenal.00181.2007; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hebert JR, 1997, AM J EPIDEMIOL, V146, P1046, DOI 10.1093/oxfordjournals.aje.a009233; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kaufman Jay S, 2004, Epidemiol Perspect Innov, V1, P4, DOI 10.1186/1742-5573-1-4; KLESGES RC, 1995, J CONSULT CLIN PSYCH, V63, P438; Kramer H, 2005, HYPERTENSION, V46, P38, DOI 10.1161/01.HYP.0000171189.48911.18; Kramer H, 2005, AM J KIDNEY DIS, V46, P587, DOI 10.1053/j.ajkd.2005.06.007; Kroke A, 1999, AM J CLIN NUTR, V70, P439; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; LUTSEY PL, 2008, DIETARY INTAKE DEV M; Martins D, 2006, AM J KIDNEY DIS, V47, P965, DOI 10.1053/j.ajkd.2006.02.179; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; National Kidney Foundation, 2002, K DOQI CLIN PRACT GU; *NCHS, 2006, AN REP GUID NAT HLTH; Neilson EG, 2007, J AM SOC NEPHROL, V18, P2619, DOI 10.1681/ASN.2007070750; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Pollan Michael, 2006, OMNIVORES DILEMMA NA; Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529; PORT FK, 1992, AM J KIDNEY DIS, V20, P3; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Rothman K. J., 2002, Epidemiology: an introduction; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Saldana TM, 2007, EPIDEMIOLOGY, V18, P501, DOI 10.1097/EDE.0b013e3180646338; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; Shoham DA, 2007, AM J KIDNEY DIS, V49, P217, DOI 10.1053/j.ajkd.2006.11.031; STIRPE F, 1970, LANCET, V2, P1310; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Taylor EN, 2008, KIDNEY INT, V73, P207, DOI 10.1038/sj.ki.5002588; *USDA, 2007, FOOD AV; *USRDS, 2007, ANN DAT REP ATL CHR; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; Wang ZQ, 2006, INT J EPIDEMIOL, V35, P1331, DOI 10.1093/ije/dyl115; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Yuyun MF, 2004, AM J EPIDEMIOL, V159, P284, DOI 10.1093/aje/kwh037	54	79	83	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3431	10.1371/journal.pone.0003431	http://dx.doi.org/10.1371/journal.pone.0003431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927611	Green Published, Green Submitted, gold			2022-12-25	WOS:000265122400006
J	Dace, DS; Khan, AA; Kelly, J; Apte, RS				Dace, Dru S.; Khan, Aslam A.; Kelly, Jennifer; Apte, Rajendra S.			Interleukin-10 Promotes Pathological Angiogenesis by Regulating Macrophage Response to Hypoxia during Development	PLOS ONE			English	Article								Aberrant angiogenesis in the eye is the most common cause of blindness. The current study examined the role of interleukin-10 (IL-10) in ischemia-induced pathological angiogenesis called neovascularization during postnatal development. IL-10 deficiency resulted in significantly reduced pathological retinal angiogenesis. In contrast to the choroicapillaris where IL-10 interferes with macrophage influx, IL-10 did not prevent anti-angiogenic macrophages from migrating to the retina in response to hypoxia. Instead, IL-10 promoted retinal angiogenesis by altering macrophage angiogenic function, as macrophages from wild-type mice demonstrated increased vascular endothelial growth factor (VEGF) and nitric oxide (NO) compared to IL-10 deficient macrophages. IL-10 appears to directly affect macrophage responsiveness to hypoxia, as macrophages responded to hypoxia with increased levels of IL-10 and STAT3 phosphorylation as opposed to IL-10 deficient macrophages. Also, IL-10 deficient macrophages inhibited the proliferation of vascular endothelial cells in response to hypoxia while wild-type macrophages failed to do so. These findings suggest that hypoxia guides macrophage behavior to a pro-angiogenic phenotype via IL-10 activated pathways.	[Dace, Dru S.; Khan, Aslam A.; Kelly, Jennifer; Apte, Rajendra S.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Apte, Rajendra S.] Washington Univ, Sch Med, Dev Biol Program, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Dace, DS (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	apte@vision.wustl.edu			NIH [K08EY016139]; Carl Marshall Reeves and Mildred Almen Reeves Foundation Inc. Award; RPB Career Development Award; American Federation for Aging; Knights Templar Eye Foundation, Inc.; International Retina Research Foundation Alston Callahan Scholar Award; NATIONAL EYE INSTITUTE [K08EY016139] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl Marshall Reeves and Mildred Almen Reeves Foundation Inc. Award; RPB Career Development Award; American Federation for Aging; Knights Templar Eye Foundation, Inc.; International Retina Research Foundation Alston Callahan Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH Grant K08EY016139 (R.S.A.), Carl Marshall Reeves and Mildred Almen Reeves Foundation Inc. Award (R.S.A.), RPB Career Development Award (R.S.A.), American Federation for Aging Research Grant (R.S.A.), The Knights Templar Eye Foundation, Inc. (D.S.D.) and the International Retina Research Foundation Alston Callahan Scholar Award (D.S.D)	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Ando A, 2002, J CELL PHYSIOL, V191, P116, DOI 10.1002/jcp.10083; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Arfken CL, 1998, DIABETES CARE, V21, P792, DOI 10.2337/diacare.21.5.792; BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; Canataroglu H, 2005, OCUL IMMUNOL INFLAMM, V13, P375, DOI 10.1080/09273940490518900; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Davies M, 2006, MOL VIS, V12, P467; ESSER P, 1993, BRIT J OPHTHALMOL, V77, P731, DOI 10.1136/bjo.77.11.731; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Jacobs F, 1998, CLIN EXP IMMUNOL, V113, P59, DOI 10.1046/j.1365-2249.1998.00637.x; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mechoulam H, 2005, INVEST OPHTH VIS SCI, V46, P4409, DOI 10.1167/iovs.05-0632; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Naug HL, 2000, CLIN EXP OPHTHALMOL, V28, P48, DOI 10.1046/j.1442-9071.2000.00226.x; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Prasad Anita G, 2007, Compr Ophthalmol Update, V8, P259; Qiao H, 2007, J LEUKOCYTE BIOL, V81, P1012, DOI 10.1189/jlb.0506342; Sennlaub F, 2001, J CLIN INVEST, V107, P717, DOI 10.1172/JCI10874; Shen JK, 2007, INVEST OPHTH VIS SCI, V48, P4335, DOI 10.1167/iovs.07-0113; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Silvestre JS, 2000, CIRC RES, V87, P448; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tsurumi Y, 1997, NAT MED, V3, P879, DOI 10.1038/nm0897-879; White JR, 2004, GENOMICS, V83, P1, DOI 10.1016/S0888-7543(03)00215-5; Yoshida A, 1999, HISTOL HISTOPATHOL, V14, P1287, DOI 10.14670/HH-14.1287; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117	41	111	113	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3381	10.1371/journal.pone.0003381	http://dx.doi.org/10.1371/journal.pone.0003381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852882	Green Published, Green Submitted, gold			2022-12-25	WOS:000265121600006
J	Ludewig, F; Huser, A; Fromm, H; Beauclair, L; Bouche, N				Ludewig, Frank; Hueser, Anke; Fromm, Hillel; Beauclair, Linda; Bouche, Nicolas			Mutants of GABA Transaminase (POP2) Suppress the Severe Phenotype of succinic semialdehyde dehydrogenase (ssadh) Mutants in Arabidopsis	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; QUORUM-SENSING SIGNAL; THERMOLUMINESCENCE; METABOLISM; SHUNT; GENE; ACCUMULATION; EXPRESSION; PLANTS	Background: The gamma-aminubutyrate (GABA) shunt bypasses two steps of the tricarboxylic acid cycle, and is present in both prokaryotes and eukaryotes. In plants, the pathway is composed of the calcium/calmodulin-regulated cytosolic enzyme glutamate decarboxylase (GAD), the mitochondrial enzymes GABA transaminase (GABA-T; POP2) and succinic semialdehyde dehydrogenase (SSADH). We have previously shown that compromising the function of the GABA-shunt, by disrupting the SSADH gene of Arabidopsis, causes enhanced accumulation of reactive oxygen intermediates (ROIs) and cell death in response to light and heat stress. However, to date, genetic investigations of the relationships between enzymes of the GABA shunt have not been reported. Principal Findings: To elucidate the role of succinic semialdehyde (SSA), gamma-hydroxybutyrate (GHB) and GABA in the accumulation of ROIs, we combined two genetic approaches to suppress the severe phenotype of ssadh mutants. Analysis of double pop2 ssadh mutants revealed that pop2 is epistatic to ssadh. Moreover, we isolated EMS-generated mutants suppressing the phenotype of ssadh revealing two new pop2 alleles. By measuring thermoluminescence at high temperature, the peroxide contents of ssadh and pop2 mutants were evaluated, showing that only ssadh plants accumulate peroxides. In addition, pop2 ssadh seedlings are more sensitive to exogenous SSA or GHB relative to wild type, because GHB and/or SSA accumulate in these plants. Significance: We conclude that the lack of supply of succinate and NADH to the TCA cycle is not responsible for the oxidative stress and growth retardations of ssadh mutants. Rather, we suggest that the accumulation of SSA, GHB, or both, produced downstream of the GABA-T transamination step, is toxic to the plants, resulting in high ROI levels and impaired development.	[Ludewig, Frank; Hueser, Anke] Univ Cologne, Inst Bot, D-5000 Cologne, Germany; [Fromm, Hillel] Tel Aviv Univ, Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Beauclair, Linda; Bouche, Nicolas] INRA, Inst Jean Pierre Bourgin, Stat Genet Ameliorat Plantes, UR254, Versailles, France	University of Cologne; Tel Aviv University; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Ludewig, F (corresponding author), Univ Cologne, Inst Bot, Gyrhofstr 15, D-5000 Cologne, Germany.	bouche@versailles.inra.fr	FROMM, HILLEL/AAF-6783-2019	FROMM, HILLEL/0000-0003-1977-1211; Bouche, Nicolas/0000-0002-3800-2613	German-Israel Foundation [I-933-239.12/2006]; The German Science Foundation [LU1199/2-1]	German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); The German Science Foundation	This work was supported in part by grants from the German-Israel Foundation (I-933-239.12/2006) to H.F. and F.L., and from The German Science Foundation (LU1199/2-1) to F.L.	Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Bouche N, 2004, PLANT MOL BIOL, V55, P315, DOI 10.1007/s11103-004-0650-z; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bouche N, 2003, TRENDS CELL BIOL, V13, P607, DOI 10.1016/j.tcb.2003.10.001; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Breitkreuz KE, 2003, J BIOL CHEM, V278, P41552, DOI 10.1074/jbc.M305717200; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; Coleman ST, 2001, J BIOL CHEM, V276, P244, DOI 10.1074/jbc.M007103200; Dingledine R, 1999, PHARMACOL REV, V51, P7; DUCRUET JM, 1992, PHOTOSYNTH RES, V33, P15, DOI 10.1007/BF00032979; Ducruet JM, 2003, J EXP BOT, V54, P2419, DOI 10.1093/jxb/erg268; Fait A, 2005, FEBS LETT, V579, P415, DOI 10.1016/j.febslet.2004.12.004; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; GIBSON KM, 2006, DIS NEUROTRANSMISSIO, P199; Gupta M, 2003, ANN NEUROL, V54, pS81, DOI 10.1002/ana.10625; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Hogema BM, 2001, NAT GENET, V29, P212, DOI 10.1038/ng727; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Lacombe B, 2001, SCIENCE, V292, P1486, DOI 10.1126/science.292.5521.1486b; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Li J, 2006, PLANT CELL, V18, P340, DOI 10.1105/tpc.105.037713; METZER E, 1990, J BACTERIOL, V172, P3250, DOI 10.1128/jb.172.6.3250-3256.1990; Meyer A, 2006, J BIOL CHEM, V281, P7197, DOI 10.1074/jbc.M510766200; Mirabella R, 2008, PLANT J, V53, P197, DOI 10.1111/j.1365-313X.2007.03323.x; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Pearl PL, 2004, CURR OPIN NEUROL, V17, P107, DOI 10.1097/00019052-200404000-00005; Sauer SW, 2007, NEUROCHEM INT, V50, P653, DOI 10.1016/j.neuint.2006.12.009; SCHREIBER U, 1977, PLANTA, V136, P233, DOI 10.1007/BF00385990; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Snedden WA, 1999, PLANT RESPONSES ENV; Storici P, 1999, BIOCHEMISTRY-US, V38, P8628, DOI 10.1021/bi990478j; Studart-Guimaraes C, 2007, PLANT PHYSIOL, V145, P626, DOI 10.1104/pp.107.103101; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; TILLAKARATNE NJK, 1995, COMP BIOCHEM PHYS A, V112, P247, DOI 10.1016/0300-9629(95)00099-2; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; VAVILIN DV, 1991, BIOL MEMBRANY, V8, P58; Vavilin DV, 1998, PHOTOCHEM PHOTOBIOL, V68, P191, DOI 10.1111/j.1751-1097.1998.tb02488.x; Wang C, 2006, MOL MICROBIOL, V62, P45, DOI 10.1111/j.1365-2958.2006.05351.x; Yu GH, 2006, CHEM BIOL, V13, P723, DOI 10.1016/j.chembiol.2006.05.007	39	68	77	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3383	10.1371/journal.pone.0003383	http://dx.doi.org/10.1371/journal.pone.0003383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846220	Green Published, gold, Green Submitted			2022-12-25	WOS:000265114500010
J	Ord, RL; Tami, A; Sutherland, CJ				Ord, Rosalynn L.; Tami, Adriana; Sutherland, Colin J.			ama1 Genes of Sympatric Plasmodium vivax and P. falciparum from Venezuela Differ Significantly in Genetic Diversity and Recombination Frequency	PLOS ONE			English	Article								Background: We present the first population genetic analysis of homologous loci from two sympatric human malaria parasite populations sharing the same human hosts, using full-length sequences of ama1 genes from Plasmodium vivax and P. falciparum collected in the Venezuelan Amazon. Methodology/Principal Findings: Significant differences between the two species were found in genetic diversity at the ama1 locus, with 18 distinct haplotypes identified among the 73 Pvama1 sequences obtained, compared to 6 unique haplotypes from 30 Pfama1 sequences, giving overall diversity estimates of h = 0.9091, and h = 0.538 respectively. Levels of recombination were also found to differ between the species, with P. falciparum exhibiting very little recombination across the 1.77kb sequence. In contrast, analysis of patterns of nucleotide substitutions provided evidence that polymorphisms in the ama1 gene of both species are maintained by balancing selection, particularly in domain I. The two distinct population structures observed are unlikely to result from different selective forces acting upon the two species, which share both human and mosquito hosts in this setting. Rather, the highly structured P. falciparum population appears to be the result of a population bottleneck, while the much less structured P. vivax population is likely to be derived from an ancient pool of diversity, as reflected in a larger estimate of effective population size for this species. Greatly reduced mosquito transmission in 1997, due to low rainfall prior to the second survey, was associated with far fewer P. falciparum infections, but an increase in P. vivax infections, probably due to hypnozoite activation. Conclusions/Significance: The relevance of these findings to putative competitive interactions between these two important human pathogen species is discussed. These results highlight the need for future control interventions to employ strategies targeting each of the parasite species present in endemic areas.	[Ord, Rosalynn L.; Tami, Adriana; Sutherland, Colin J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Ord, RL (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	colin.sutherland@lshtm.ac.uk	Sutherland, Colin/AAN-3939-2020	Sutherland, Colin/0000-0003-1592-6407; Tami, Adriana/0000-0002-1918-9144	UK Health Protection Agency	UK Health Protection Agency	This study was not externally funded. CJS is supported by the UK Health Protection Agency.	Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Bruce MC, 2002, CURR OPIN MICROBIOL, V5, P431, DOI 10.1016/S1369-5274(02)00348-X; CHENG Q, 1994, MOL BIOCHEM PARASIT, V65, P183, DOI 10.1016/0166-6851(94)90127-9; Craig AA, 1996, J INFECT DIS, V174, P373, DOI 10.1093/infdis/174.2.373; Cui LW, 2003, AM J TROP MED HYG, V68, P613, DOI 10.4269/ajtmh.2003.68.613; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Franks S, 2003, INFECT IMMUN, V71, P3485, DOI 10.1128/IAI.71.6.3485-3495.2003; FU YX, 1993, GENETICS, V133, P693; Grynberg P, 2007, CLIN MICROBIOL INFEC, V13, P1089, DOI 10.1111/j.1469-0691.2007.01815.x; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Gunasekera AM, 2007, MOL BIOL EVOL, V24, P939, DOI 10.1093/molbev/msm013; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Kirchgatter K, 1998, J INFECT DIS, V177, P511, DOI 10.1086/517389; LEWONTIN RC, 1964, GENETICS, V49, P49; Maguire JD, 2002, LANCET, V360, P58, DOI 10.1016/S0140-6736(02)09336-4; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Maitland K, 1997, PARASITOL TODAY, V13, P227, DOI 10.1016/S0169-4758(97)01061-2; Mason Daniel Philippe, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P57; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Mueller I, 2002, AM J TROP MED HYG, V67, P459, DOI 10.4269/ajtmh.2002.67.459; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Ord R, 2005, MOL BIOCHEM PARASIT, V144, P86, DOI 10.1016/j.molbiopara.2005.08.005; ORD RL, 2008, GENETIC DIVERSITY PL; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2001, GENETICS, V158, P1505; Rajesh V, 2007, EXP PARASITOL, V116, P252, DOI 10.1016/j.exppara.2007.01.006; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Smith T, 2001, AM J TROP MED HYG, V64, P262, DOI 10.4269/ajtmh.2001.64.262; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; TAJIMA F, 1989, GENETICS, V123, P585; Tami A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-7; Tami A, 2002, PARASITOLOGY, V124, P569, DOI 10.1017/S0031182002001713; Tan-Ariya Peerapan, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P784	46	48	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3366	10.1371/journal.pone.0003366	http://dx.doi.org/10.1371/journal.pone.0003366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846221	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000265114500006
J	Lim, KY; Soltis, DE; Soltis, PS; Tate, J; Matyasek, R; Srubarova, H; Kovarik, A; Pires, JC; Xiong, ZY; Leitch, AR				Lim, K. Yoong; Soltis, Douglas E.; Soltis, Pamela S.; Tate, Jennifer; Matyasek, Roman; Srubarova, Hana; Kovarik, Ales; Pires, J. Chris; Xiong, Zhiyong; Leitch, Andrew R.			Rapid Chromosome Evolution in Recently Formed Polyploids in Tragopogon (Asteraceae)	PLOS ONE			English	Article								Background: Polyploidy, frequently termed "whole genome duplication'', is a major force in the evolution of many eukaryotes. Indeed, most angiosperm species have undergone at least one round of polyploidy in their evolutionary history. Despite enormous progress in our understanding of many aspects of polyploidy, we essentially have no information about the role of chromosome divergence in the establishment of young polyploid populations. Here we investigate synthetic lines and natural populations of two recently and recurrently formed allotetraploids Tragopogon mirus and T. miscellus (formed within the past 80 years) to assess the role of aberrant meiosis in generating chromosomal/genomic diversity. That diversity is likely important in the formation, establishment and survival of polyploid populations and species. Methodology/Principal Findings: Applications of fluorescence in situ hybridisation (FISH) to natural populations of T. mirus and T. miscellus suggest that chromosomal rearrangements and other chromosomal changes are common in both allotetraploids. We detected extensive chromosomal polymorphism between individuals and populations, including (i) plants monosomic and trisomic for particular chromosomes (perhaps indicating compensatory trisomy), (ii) intergenomic translocations and (iii) variable sizes and expression patterns of individual ribosomal DNA (rDNA) loci. We even observed karyotypic variation among sibling plants. Significantly, translocations, chromosome loss, and meiotic irregularities, including quadrivalent formation, were observed in synthetic (S(0) and S(1) generations) polyploid lines. Our results not only provide a mechanism for chromosomal variation in natural populations, but also indicate that chromosomal changes occur rapidly following polyploidisation. Conclusions/Significance: These data shed new light on previous analyses of genome and transcriptome structures in de novo and establishing polyploid species. Crucially our results highlight the necessity of studying karyotypes in young (< 150 years old) polyploid species and synthetic polyploids that resemble natural species. The data also provide insight into the mechanisms that perturb inheritance patterns of genetic markers in synthetic polyploids and populations of young natural polyploid species.	[Lim, K. Yoong; Leitch, Andrew R.] Univ London, Queen Mary Coll, Sch Biol & Chem Sci, London, England; [Soltis, Douglas E.] Univ Florida, Genet Inst, Dept Bot, Gainesville, FL 32611 USA; [Soltis, Pamela S.] Univ Florida, Genet Inst, Florida Mus Nat Hist, Gainesville, FL 32611 USA; [Tate, Jennifer] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; [Matyasek, Roman; Srubarova, Hana; Kovarik, Ales] Acad Sci Czech Republic, Inst Biophys, Brno, Czech Republic; [Pires, J. Chris; Xiong, Zhiyong] Univ Missouri, Life Sci Ctr, Div Biol Sci, Columbia, MO 65211 USA	University of London; Queen Mary University London; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Massey University; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Missouri System; University of Missouri Columbia	Lim, KY (corresponding author), Univ London, Queen Mary Coll, Sch Biol & Chem Sci, London, England.	a.r.leitch@qmul.ac.uk	Pires, J. Chris/O-5122-2014; Soltis, Douglas/L-5957-2015; Leitch, Andrew R/J-6385-2014; Soltis, Pamela S/L-5184-2015; Xiong, Zhiyong/AAO-8735-2021; Kovarik, Ales/H-1952-2014; Soltis, Pamela S/GNH-5557-2022; Auer Malinská, Hana/AAI-3707-2021	Pires, J. Chris/0000-0001-9682-2639; Leitch, Andrew R/0000-0001-8574-302X; Xiong, Zhiyong/0000-0003-1894-7588; Soltis, Pamela S/0000-0001-9310-8659; Auer Malinská, Hana/0000-0001-7150-4044; Matyasek, Roman/0000-0001-8982-2358; Kovarik, Ales/0000-0003-2896-0698; Tate, Jennifer A./0000-0001-5138-2115	NERC; Grant Agency of the Czech Republic [521/07/0116]; USA National Science Foundation [MCB-0346437, DEB-0608268, DBI 0638536, DBI 0501712]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); USA National Science Foundation(National Science Foundation (NSF))	The authors thank NERC, Grant Agency of the Czech Republic (521/07/0116), and the USA National Science Foundation (grants MCB-0346437, DEB-0608268, DBI 0638536 and DBI 0501712) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2007, MOL ECOL, V16, P1023, DOI 10.1111/j.1365-294X.2007.03169.x; Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Ainouche ML, 2004, BIOL J LINN SOC, V82, P475, DOI 10.1111/j.1095-8312.2004.00334.x; AVERY AG, 1959, GENUS DATURA; BLAKESLEE AF, 1927, GENETICS DATURA, P117; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Buggs RJA, 2008, CASTANEA, V73, P74, DOI 10.2179/0008-7475(2008)73[74:DPDBPG]2.0.CO;2; BURK LG, 1973, J HERED, V64, P348, DOI 10.1093/oxfordjournals.jhered.a108438; Cook LM, 1998, MOL ECOL, V7, P1293, DOI 10.1046/j.1365-294x.1998.00453.x; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Fulnecek J, 2002, HEREDITY, V88, P19, DOI 10.1038/sj/hdy/6800001; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; GOODSPEED TH, 1954, GENUS NICOTIANA; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; JACKSON RC, 1973, EVOLUTION, V27, P243, DOI 10.1111/j.1558-5646.1973.tb00669.x; Kovarik A, 1996, THEOR APPL GENET, V92, P1108, DOI 10.1007/BF00224057; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Kovarik A, 2008, ANN BOT-LONDON, V101, P815, DOI 10.1093/aob/mcn019; KUSH GS, 1967, GENETICS, V56, P297; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; LEITCH AR, 2001, PLANT CELL BIOL PRAC, P267; Lim KY, 2004, BIOL J LINN SOC, V82, P599, DOI 10.1111/j.1095-8312.2004.00344.x; Liu Z, 2007, J INTEGR PLANT BIOL, V49, P1080, DOI 10.1111/j.1672-9072.2007.00462.x; Markova M, 2007, CHROMOSOME RES, V15, P1051, DOI 10.1007/s10577-007-1180-8; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; Mavrodiev EV, 2005, INT J PLANT SCI, V166, P117, DOI 10.1086/425206; Mavrodiev EV, 2007, INT J PLANT SCI, V168, P889, DOI 10.1086/518258; Nicolas SD, 2007, GENETICS, V175, P487, DOI 10.1534/genetics.106.062968; NOVAK SJ, 1991, AM J BOT, V78, P1586, DOI 10.2307/2444984; OWNBEY M, 1953, AM J BOT, V40, P788, DOI 10.2307/2438276; OWNBEY M, 1950, AM J BOT, V37, P487, DOI 10.2307/2438023; OWNBEY MARION, 1954, RHODORA, V56, P7; Pires JC, 2004, AM J BOT, V91, P1022, DOI 10.3732/ajb.91.7.1022; RILEY RALPH, 1960, HEREDITY, V15, P407, DOI 10.1038/hdy.1960.106; ROOSE ML, 1976, EVOLUTION, V30, P818, DOI 10.1111/j.1558-5646.1976.tb00963.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAINI RS, 1981, J HERED, V72, P354, DOI 10.1093/oxfordjournals.jhered.a109523; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; SEARS ER, 1953, AM NAT, V87, P245, DOI 10.1086/281780; SEARS ER, 1954, MO EXP STA RES B, V572, P1; Singh R.J., 2002, PLANT CYTOGENETICS; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; SOLTIS DE, 1989, AM J BOT, V76, P1119, DOI 10.2307/2444824; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P8089, DOI 10.1073/pnas.92.18.8089; Soltis DE, 2008, SYST BOT, V33, P7, DOI 10.1600/036364408783887401; SOLTIS PS, 1991, SYST BOT, V16, P407, DOI 10.2307/2419333; SOLTIS PS, 1995, AM J BOT, V82, P1329, DOI 10.2307/2446255; Tate JA, 2006, GENETICS, V173, P1599, DOI 10.1534/genetics.106.057646; Telgmann-Rauber A, 2007, MOL GENET GENOMICS, V278, P221, DOI 10.1007/s00438-007-0235-z; Urbanska KM, 1997, PLANT SYST EVOL, V204, P233, DOI 10.1007/BF00989208	51	131	134	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3353	10.1371/journal.pone.0003353	http://dx.doi.org/10.1371/journal.pone.0003353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18843372	Green Published, Green Submitted, gold			2022-12-25	WOS:000265114100002
J	Brunet, S; Dumont, J; Lee, KW; Kinoshita, K; Hikal, P; Gruss, OJ; Maro, B; Verlhac, MH				Brunet, Stephane; Dumont, Julien; Lee, Karen W.; Kinoshita, Kazuhisa; Hikal, Pascale; Gruss, Oliver J.; Maro, Bernard; Verlhac, Marie-Helene			Meiotic Regulation of TPX2 Protein Levels Governs Cell Cycle Progression in Mouse Oocytes	PLOS ONE			English	Article								Formation of female gametes requires acentriolar spindle assembly during meiosis. Mitotic spindles organize from centrosomes and via local activation of the RanGTPase on chromosomes. Vertebrate oocytes present a RanGTP gradient centred on chromatin at all stages of meiotic maturation. However, this gradient is dispensable for assembly of the first meiotic spindle. To understand this meiosis I peculiarity, we studied TPX2, a Ran target, in mouse oocytes. Strikingly, TPX2 activity is controlled at the protein level through its accumulation from meiosis I to II. By RNAi depletion and live imaging, we show that TPX2 is required for spindle assembly via two distinct functions. It controls microtubule assembly and spindle pole integrity via the phosphorylation of TACC3, a regulator of MTOCs activity. We show that meiotic spindle formation in vivo depends on the regulation of at least a target of Ran, TPX2, rather than on the regulation of the RanGTP gradient itself.	[Brunet, Stephane; Dumont, Julien; Lee, Karen W.; Hikal, Pascale; Maro, Bernard; Verlhac, Marie-Helene] Univ Paris 06, CNRS, UMR7622, Paris, France; [Kinoshita, Kazuhisa] RIKEN, Chromosome Dynam Lab, Wako, Saitama, Japan; [Gruss, Oliver J.] Zent Mol Biol Univ Heidelberg ZMBH, Heidelberg, Germany; [Maro, Bernard] Ramat Univ, Tel Aviv Univ, Dept Cell & Dev Biol, Tel Aviv, Israel	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; RIKEN; Ruprecht Karls University Heidelberg; Tel Aviv University	Brunet, S (corresponding author), Univ Paris 06, CNRS, UMR7622, Bat C,5E,9 Quai St Bernard, Paris, France.	marie-helene.verlhac@upmc.fr	Maro, Bernard/AAL-2220-2020; BRUNET, Stéphane/O-6953-2018; Brunet, Stephane/L-2604-2017; Holt, Janet E/B-2415-2013; Dumont, Julien/G-6624-2013; Lee, Karen/GVT-9602-2022	BRUNET, Stéphane/0000-0003-1990-1477; Brunet, Stephane/0000-0003-1990-1477; Kinoshita, Kazuhisa/0000-0002-0882-4296; VERLHAC, Marie-Helene/0000-0001-8377-9010	Association pour la Recherche sur le Cancer [ARC3877]; Agence Nationale pour la Recherche [ANRNT05-1-43120]; INSERM; KAKENHI [19770173]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale pour la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Association pour la Recherche sur le Cancer (ARC3877 to M.H.V.) and from the Agence Nationale pour la Recherche (ANRNT05-1-43120 to M.H.V.). S.B. is a recipient of INSERM. J.D. is a recipient of an Association pour la Recherche sur le Cancer doctoral fellowship. K.W.L. is supported by the Agence Nationale pour la Recherche (ANRNT05-1-43120). K.K. is supported by KAKENHI (19770173).	Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Brittle AL, 2005, CURR BIOL, V15, pR880, DOI 10.1016/j.cub.2005.10.022; Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Eichenlaub-Ritter U, 1989, Prog Clin Biol Res, V318, P259; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Polanski Z, 1998, DEVELOPMENT, V125, P4989; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640; SARDON T, 2008, EMBO J; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Terret ME, 2003, DEVELOPMENT, V130, P5169, DOI 10.1242/dev.00731; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zheng YX, 2004, ANNU REV CELL DEV BI, V20, P867, DOI 10.1146/annurev.cellbio.20.012103.094648	37	79	82	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3338	10.1371/journal.pone.0003338	http://dx.doi.org/10.1371/journal.pone.0003338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833336	Green Published, gold, Green Submitted			2022-12-25	WOS:000264797400008
J	Porter, JC; Hall, A				Porter, Joanna C.; Hall, Alan			Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium	FASEB JOURNAL			English	Article						transepithelial migration; lymphocytes; LFA-1; lung; Neuronal Wiskott-Aldrich syndrome protein; coxsackie-adenovirus receptor	INTERCELLULAR-ADHESION MOLECULE-1; OBSTRUCTIVE PULMONARY-DISEASE; LYMPHOCYTE MIGRATION; ENDOTHELIAL ICAM-1; PERIPHERAL-TISSUES; TIGHT JUNCTIONS; CC CHEMOKINES; LUNG; NEUTROPHILS; RECEPTOR	Egression of inflammatory cells from the lung interstitium into the airway lumen is critical for the resolution of inflammation, but the underlying mechanisms of this egression are unclear. Here, we use an in vitro system, in which human T cells migrate across a bronchial epithelial monolayer, to investigate the molecules involved. We show that although inhibition of T-cell LFA-1 blocks egression by 75 +/- 5.6% (P < 0.0001), inhibition of the FA-1-ligand ICAM-1 on the epithelium only inhibits by 52.7 +/- 0.06% (P = 0.0001). We, therefore, looked for other epithelial ligands for LFA-1 and demonstrate that ICAM-2, but not ICAM-3, is expressed on the bronchial epithelium. Blocking ICAM-2 inhibits egression by 50.95 +/- 10.79% (P = 0.04), and blocking both ICAM-1 and ICAM-2 inhibits egression by 69.6 +/- 5.2% (P < 0.0001). Inhibition of LFA-1/ICAM-1 and ICAM-2 interactions on the basolateral epithelium does not prevent egressing T cells from adhering, polarizing, or moving over the basal epithelium, but it does prevent their recognition of the interepithelial junctions. In conclusion, we show that egression of T cells involves three distinct sequential steps: adhesion, junctional recognition, and diapedesis; we further demonstrate that ICAM-2 is expressed on the bronchial epithelium and, together with ICAM-1, has an essential function in the clearance of T cells from the lung. - Porter, J.C., Hall, A. Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium. FASEB J. 23, 492-502 (2009)	[Porter, Joanna C.] Univ Coll London Hosp, Univ Coll London Hosp NHS Trust, Dept Resp Med, London NW1 2BU, England; [Porter, Joanna C.] UCL, MRC, Mol Cell Biol Lab, London, England; [Hall, Alan] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Memorial Sloan Kettering Cancer Center	Porter, JC (corresponding author), Univ Coll London Hosp, Univ Coll London Hosp NHS Trust, Dept Resp Med, Euston Rd, London NW1 2BU, England.	joanna.porter@ucl.ac.uk	Porter, Joanna/C-7162-2009	Porter, Joanna/0000-0002-7307-169X	CRUK; Wellcome Trust Advanced Clinical Fellowship	CRUK(Cancer Research UK); Wellcome Trust Advanced Clinical Fellowship(Wellcome Trust)	We thank Nancy Hogg (Cancer Research UK, London, UK) and Dieter Gruenert (California Pacific Medical Center, San Francisco, CA, USA) for generously providing reagents and Martin Raff for careful reading of the manuscript. This work was supported by CRUK and a Wellcome Trust Advanced Clinical Fellowship to J.C.P.	Adamson P, 1999, J IMMUNOL, V162, P2964; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; BURNS AR, 1994, J IMMUNOL, V153, P3189; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Etienne S, 1998, J IMMUNOL, V161, P5755; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gerwin N, 1999, IMMUNITY, V10, P9, DOI 10.1016/S1074-7613(00)80002-3; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Hikono H, 2006, IMMUNOL REV, V211, P119, DOI 10.1111/j.0105-2896.2006.00385.x; Li ZW, 2005, ENVIRON HEALTH PERSP, V113, P1747, DOI 10.1289/ehp.7947; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Miller LA, 1998, AM J RESP CELL MOL, V19, P892, DOI 10.1165/ajrcmb.19.6.3245mrev; Parkos CA, 1996, MOL MED, V2, P489, DOI 10.1007/BF03401908; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; PORTER JCM, 1998, IMMUNOLOGY, P246; Porter JC, 2008, J IMMUNOL, V180, P1866, DOI 10.4049/jimmunol.180.3.1866; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Taguchi M, 1998, J EXP MED, V187, P1927, DOI 10.1084/jem.187.12.1927; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Zen K, 2003, CURR OPIN CELL BIOL, V15, P557, DOI 10.1016/S0955-0674(03)00103-0; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036; Zhu J, 1999, EUR RESPIR J, V13, P1318, DOI 10.1183/09031936.99.13613299	37	38	42	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2009	23	2					492	502		10.1096/fj.08-115899	http://dx.doi.org/10.1096/fj.08-115899			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18842965	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000262892900021
J	Song, GJ; Li, Y; Cheng, CY; Zhao, Y; Gao, A; Zhang, RG; Joachimiak, A; Shaw, N; Liu, ZJ				Song, Gaojie; Li, Yang; Cheng, Chongyun; Zhao, Yu; Gao, Ang; Zhang, Rongguang; Joachimiak, Andrzej; Shaw, Neil; Liu, Zhi-Jie			Structural insight into acute intermittent porphyria	FASEB JOURNAL			English	Article						human porphobilinogen deaminase; X-ray structure; heme biosynthesis; porphobilinogen hinge	HUMAN PHENYLALANINE-HYDROXYLASE; UROPORPHYRINOGEN-I SYNTHETASE; PORPHOBILINOGEN DEAMINASE; ESCHERICHIA-COLI; HEME-BIOSYNTHESIS; PURIFICATION; PHENYLKETONURIA; GENE; SITE; REVEALS	Acute intermittent porphyria (AIP), an inherited disease of heme biosynthesis, is one of the most common types of porphyria. Reduced activity of the enzyme porphobilinogen deaminase (PBGD), which catalyzes the sequential condensation of 4 molecules of porphobilinogen to yield preuroporphyrinogen, has been linked to the symptoms of AIP. We have determined the 3-dimensional structure of human PBGD at 2.2 angstrom resolution. Analysis of the structure revealed a dipyrromethane cofactor molecule covalently linked to C261, sitting in a positively charged cleft region. In addition to the critical catalytic D99, a number of other residues are seen hydrogen bonded to the cofactor and play a role in catalysis. Sequential entry of 4 pyrrole molecules into the active site is accomplished by movement of the domains around the hinges. H120P mutation resulted in an inactive enzyme, supporting the role of H120 as a hinge residue. Interestingly, some of the mutations of the human PBGD documented in patients suffering from AIP are located far away from the active site. The structure provides insights into the mechanism of action of PBGD at the molecular level and could aid the development of potential drugs for the up-regulation of PBGD activity in AIP. - Song, G., Li, Y., Cheng, C., Zhao, Y., Gao, A., Zhang, R., Joachimiak, A., Shaw, N., Liu, Z.-J. Structural insight into acute intermittent porphyria. FASEB J. 23, 396-404 (2009)	[Song, Gaojie; Li, Yang; Cheng, Chongyun; Zhao, Yu; Gao, Ang; Shaw, Neil; Liu, Zhi-Jie] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, 15 Datun Lu, Beijing 100101, Peoples R China; [Zhang, Rongguang; Joachimiak, Andrzej] Argonne Natl Lab, Adv Photon Source, Struct Biol Ctr, Argonne, IL 60439 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; United States Department of Energy (DOE); Argonne National Laboratory	Shaw, N (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, 15 Datun Lu, Beijing 100101, Peoples R China.	neilshaw@moon.ibp.ac.cn; zjliu@ibp.ac.cn	Li, Yang/G-3685-2011; Li, Yang/M-1246-2013; Liu, Zhi-Jie/A-3946-2012	Liu, Zhi-Jie/0000-0001-7279-2893; Shaw, Neil/0000-0003-2722-9967	National Natural Science Foundation of China [20572063, 30670427]; Ministry of Science and Technology of China [2006AA02A316, 2006CB910901]; CAS-KIST [07CF09]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAS-KIST; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was funded by the National Natural Science Foundation of China (grants 20572063 and 30670427), the Ministry of Science and Technology of China (grants 2006AA02A316 and 2006CB910901), a CAS-KIST collaboration grant, and a CAS research grant (07CF09). Crystallographic data were collected at the Structural Biology Center's 19-ID beamline at the Advanced Photon Source, Argonne National Laboratory. The use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. Atomic coordinates for the structure of human PBGD have been deposited in the Protein Data Bank (PDB code 3ECR).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSON BF, 1990, NATURE, V344, P784, DOI 10.1038/344784a0; ANDERSON KE, 2001, METABOLIC MOL BASES, P2991; ANDERSON PM, 1980, J BIOL CHEM, V255, P1993; Brons-Poulsen J, 2005, SCAND J CLIN LAB INV, V65, P93, DOI 10.1080/00365510410003075; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Gamez A, 2007, MOL GENET METAB, V91, P325, DOI 10.1016/j.ymgme.2007.04.015; GARCIA SRC, 1991, Z NATURFORSCH C, V46, P1017; Grandchamp B, 1998, SEMIN LIVER DIS, V18, P17, DOI 10.1055/s-2007-1007136; GRANDCHAMP B, 1987, EUR J BIOCHEM, V162, P105, DOI 10.1111/j.1432-1033.1987.tb10548.x; Granick S, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P33; Hrdinka M, 2006, PHYSIOL RES, V55, pS119, DOI 10.33549/physiolres.930000.55.S2.119; JONES RM, 1994, BIOCHEM J, V299, P895, DOI 10.1042/bj2990895; JORDAN PM, 1988, BIOCHEM J, V254, P427, DOI 10.1042/bj2540427; JORDAN PM, 1973, J BIOL CHEM, V248, P1019; JORDAN PM, 2003, BIOCHEM SOC T, V31, P731; JORDAN PM, 1996, NEW COMPREHENSIVE BI, P1; JORDAN PMS, 1996, BIOCHEM J, V316, P373; KAPPAS A, 1995, METABOLIC MOL BASES, P2116; Kauppinen R, 2005, LANCET, V365, P241; KAUPPINEN R, 1992, MEDICINE, V71, P1; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; LOUIE GV, 1992, NATURE, V359, P33, DOI 10.1038/359033a0; Matalon R, 2005, MOL GENET METAB, V86, pS17, DOI 10.1016/j.ymgme.2005.06.024; MAZZETTI MB, 1988, BIOCHIM BIOPHYS ACTA, V957, P97, DOI 10.1016/0167-4838(88)90161-6; MEYER UA, 1978, METABOLIC BASIS INHE, P1166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Puy H, 1997, AM J HUM GENET, V60, P1373, DOI 10.1086/515455; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; STRAND LJ, 1972, J CLIN INVEST, V51, P2530, DOI 10.1172/JCI107068; WARREN MJ, 1988, BIOCHEMISTRY-US, V27, P9020, DOI 10.1021/bi00425a021; Woodard SI, 2000, ARCH BIOCHEM BIOPHYS, V384, P375, DOI 10.1006/abbi.2000.2069; WOODARD SI, 1995, ARCH BIOCHEM BIOPHYS, V316, P110, DOI 10.1006/abbi.1995.1016; WOODCOCK SC, 1994, BIOCHEMISTRY-US, V33, P2688, DOI 10.1021/bi00175a043	39	42	43	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					396	404		10.1096/fj.08-115469	http://dx.doi.org/10.1096/fj.08-115469			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18936296				2022-12-25	WOS:000262892900011
J	Chen, GY; Sakuma, K; Kannagi, R				Chen, Guo-Yun; Sakuma, Keiichiro; Kannagi, Reiji			Significance of NF-kappa B/GATA Axis in Tumor Necrosis Factor-alpha-induced Expression of 6-Sulfated Cell Recognition Glycans in Human T-lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-SELECTIN LIGANDS; SIALYL-LEWIS-X; GATA TRANSCRIPTION FACTORS; HIGH ENDOTHELIAL VENULES; FUCOSYL-TRANSFERASE-VII; DENDRITIC CELLS; TNF-ALPHA; REGULATES EXPRESSION; ADHESION MOLECULE-1; HUMAN MONOCYTES	Sulfated glycans play critical roles in various cell recognition events among leukocytes. The 6-sulfated lactosamine glycans in particular have been widely noted for their importance because they are involved in cell recognition events mediated by cell-adhesion molecules such as selectins and sialic acid-recognizing molecules such as siglecs and also in the activation of CD44 in binding to extracellular matrix hyaluronate. A pro-inflammatory cytokine, tumor necrosis factor-alpha, induces expression of 6-sulfated glycans on human leukocytes. Here we report that the transcription of the GlcNAc6ST-1 gene, the gene encoding a sulfotransferase for 6-sulfated glycan synthesis, is induced in human T-lymphoid cells through tandem NF-kappa B and GATA motifs in its 5'-regulatory region. Results of our reporter assays, immunoprecipitation, and chromatin immunoprecipitation analyses indicated that GATA-3 and/or GATA-2, but not GATA-1, associates with NF-kappa B in a transcription factor complex on the 5'-regulatory region of the gene and acts synergistically with NF-kappa B in triggering GlcNAc6ST-1 transcription. Recently, a skin-homing subset of helper memory T cells exhibiting the Th2 marker CCR4 was shown to specifically express 6-sulfated glycans. The transactivation mechanism described here suggested that GlcNAc6ST-1 transcription is coordinated with the NF-kappa B/GATA-3 axis, which is known to figure heavily in Th2 cell differentiation. In line with this, in vitro differentiation of human T cells to Th2 cells was found to significantly induce GlcNAc6ST-1 transcription and 6-sulfated glycan expression.	[Kannagi, Reiji] Aichi Canc Ctr, Res Inst, Dept Mol Pathol, Chikusa Ku, Nagoya, Aichi 4648681, Japan	Aichi Cancer Center	Kannagi, R (corresponding author), Aichi Canc Ctr, Res Inst, Dept Mol Pathol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	kannagi-gi@umin.ac.jp	Chen, Guo-yun/C-2436-2011; Sakuma, Keiichiro/AAW-4733-2021; Kannagi, Reiji/Q-6459-2018	Kannagi, Reiji/0000-0003-4202-2921	Ministry of Education, Science, Sports and Culture, Japan [19590298, 17015051]; Ministry of Health and Welfare, Japan; Nagono Medical Foundation; Mitsubishi Pharma Research Foundation; National Institute of Biomedical Innovation	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Nagono Medical Foundation; Mitsubishi Pharma Research Foundation; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports and Culture, Japan (19590298 and on priority areas 17015051), grants-in-aid for the Third-Term Comprehensive Ten-year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan, a grant from the Nagono Medical Foundation, a grant from Mitsubishi Pharma Research Foundation, and a grant for the Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baumeister SHC, 2007, BLOOD, V110, P3078, DOI 10.1182/blood-2006-12-062984; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Boothby M, 2001, NAT IMMUNOL, V2, P471, DOI 10.1038/88652; Brown KL, 2001, J IMMUNOL, V167, P5367, DOI 10.4049/jimmunol.167.9.5367; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; Farrar JD, 2002, J CLIN INVEST, V109, P431, DOI 10.1172/JCI200215093; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; Hiraiwa N, 2003, BLOOD, V101, P3615, DOI 10.1182/blood-2002-07-2301; Kannagi R, 2002, CURR OPIN STRUC BIOL, V12, P599, DOI 10.1016/S0959-440X(02)00365-2; KANNAGI R, 2008, GLYCOCONJ J IN PRESS; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; Kimura N, 2007, J BIOL CHEM, V282, P32200, DOI 10.1074/jbc.M702341200; La Ferla K, 2002, FASEB J, V16, P1811, DOI 10.1096/fj.02-0168fje; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; MANIATIS T, 1989, MOL CLONING LAB MANU, P187; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Ohmori K, 2000, BIOCHEM BIOPH RES CO, V278, P90, DOI 10.1006/bbrc.2000.3768; Ohmori K, 2006, BLOOD, V107, P3197, DOI 10.1182/blood-2005-05-2185; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Tjew SL, 2005, GLYCOBIOLOGY, V15, p7C, DOI 10.1093/glycob/cwi050; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Uchimura K, 1998, J BIOCHEM-TOKYO, V124, P670, DOI 10.1093/oxfordjournals.jbchem.a022164; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; Uchimura K, 2006, TRENDS IMMUNOL, V27, P559, DOI 10.1016/j.it.2006.10.007; Umetani M, 2001, ARTERIOSCL THROM VAS, V21, P917, DOI 10.1161/01.ATV.21.6.917	39	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34563	34570		10.1074/jbc.M804271200	http://dx.doi.org/10.1074/jbc.M804271200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18849568	Green Published, hybrid			2022-12-25	WOS:000261469100010
J	Choi, E; Han, C; Park, I; Lee, B; Jin, S; Choi, H; Kim, DH; Park, ZY; Eddy, EM; Cho, C				Choi, Eunyoung; Han, Cecil; Park, Inju; Lee, Boyeon; Jin, Sora; Choi, Heejin; Kim, Do Han; Park, Zee Yong; Eddy, Edward M.; Cho, Chunghee			A Novel Germ Cell-specific Protein, SHIP1, Forms a Complex with Chromatin Remodeling Activity during Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-DEACETYLASES; MOUSE SPERMATOGENESIS; VALPROIC ACID; CO-REPRESSOR; SANT DOMAIN; N-COR; MEIOSIS; HSP70-2; GENES; IDENTIFICATION	To determine the mechanisms of spermatogenesis, it is essential to identify and characterize germ cell-specific genes. Here we describe a protein encoded by a novel germ cell-specific gene, Mm. 290718/ZFP541, identified from the mouse spermatocyte UniGene library. Theprotein contains specific motifs and domains potentially involved in DNA binding and chromatin reorganization. An antibody against Mm. 290718/ZFP541 revealed the existence of the protein in testicular spermatogenic cells (159 kDa) but not testicular and mature sperm. Immunostaining analysis of cells at various stages of spermatogenesis consistently showed that the protein is present in spermatocytes and round spermatids only. Transfection assays and immunofluorescence studies indicate that the protein is localized specifically in the nucleus. Proteomic analyses performed to explore the functional characteristics of Mm. 290718/ZFP541 showed that the protein forms a unique complex. Other major components of the complex included histone deacetylase 1 (HDAC1) and heat-shock protein A2. Disappearance of Mm. 290718/ZFP541 was highly correlated with hyperacetylation in spermatids during spermatogenesis, and specific domains of the protein were involved in the regulation of interactions and nuclear localization of HDAC1. Furthermore, we found that premature hyperacetylation, induced by an HDAC inhibitor, is associated with an alteration in the integrity of Mm. 290718/ZFP541 in spermatogenic cells. Our results collectively suggest that the Mm. 290718/ZFP541 complex is implicated in chromatin remodeling during spermatogenesis, and we provide further information on the previously unknown molecular mechanism. Consequently, we re-designate Mm. 290718/ZFP541 as "SHIP1" representing spermatogenic cell HDAC-interacting protein 1.	[Choi, Eunyoung; Han, Cecil; Park, Inju; Lee, Boyeon; Jin, Sora; Choi, Heejin; Kim, Do Han; Park, Zee Yong; Cho, Chunghee] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Choi, Eunyoung; Han, Cecil; Park, Inju; Lee, Boyeon; Jin, Sora; Choi, Heejin; Kim, Do Han; Park, Zee Yong; Cho, Chunghee] Gwangju Inst Sci & Technol, Res Ctr Biomol Nanotechnol, Kwangju 500712, South Korea; [Eddy, Edward M.] NIEHS, Gamete Biol Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cho, C (corresponding author), Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea.	choch@gist.ac.kr		Park, Inju/0000-0002-8850-5032	National Institutes of Health [ZO1 ES070077]; Korea Science and Engineering Foundation [RO1-2007-000-20116]; Korean Systems Biology Research Grant [M10503010001-06N0301-00110]; GIST Systems Biology Infrastructure Establishment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070076, Z01ES070076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Systems Biology Research Grant; GIST Systems Biology Infrastructure Establishment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ZO1 ES070077 ( Project 1, Intramural Research Program, NIEHS). This work was also supported by the Korea Science and Engineering Foundation Grant RO1-2007-000-20116, Korean Systems Biology Research Grant M10503010001-06N0301-00110, and GIST Systems Biology Infrastructure Establishment grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Caron C, 2005, PROG MOLEC, V38, P65; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Cho C, 2003, BIOL REPROD, V69, P211, DOI 10.1095/biolreprod.102.015115; Choi E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-256; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Hong S, 2005, J BIOL CHEM, V280, P7685, DOI 10.1074/jbc.M412444200; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Li W, 2007, ASIAN J ANDROL, V9, P345, DOI 10.1111/j.1745-7262.2007.00245.x; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; PHELPS BM, 1990, J CELL BIOL, V111, P1839, DOI 10.1083/jcb.111.5.1839; ROSARIO MO, 1992, DEV BIOL, V150, P1, DOI 10.1016/0012-1606(92)90002-X; Rousseaux S, 2008, REPROD BIOMED ONLINE, V16, P492, DOI 10.1016/S1472-6483(10)60456-7; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Solari F, 1999, DEVELOPMENT, V126, P2483; Wang L, 2008, EMBO REP, V9, P555, DOI 10.1038/embor.2008.67; Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371; Zhu DH, 1997, DEVELOPMENT, V124, P3007	36	35	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35283	35294		10.1074/jbc.M805590200	http://dx.doi.org/10.1074/jbc.M805590200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18849567	Green Published, hybrid			2022-12-25	WOS:000261469100084
J	Lu, YF; Tian, C; Danialou, G; Gilbert, R; Petrof, BJ; Karpati, G; Nalbantoglu, J				Lu, Yifan; Tian, Chai; Danialou, Gawiyou; Gilbert, Renald; Petrof, Basil J.; Karpati, George; Nalbantoglu, Josephine			Targeting Artificial Transcription Factors to the Utrophin A Promoter EFFECTS ON DYSTROPHIC PATHOLOGY AND MUSCLE FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MDX MOUSE MUSCLE; THERAPEUTIC UP-REGULATION; GENE-EXPRESSION; MUSCULAR-DYSTROPHY; PROTEIN; ACTIVATION; DUCHENNE; PHENOTYPE; GABP; HEREGULIN	Duchenne muscular dystrophy is caused by a genetic defect in the dystrophin gene. The absence of dystrophin results in muscle fiber necrosis and regeneration, leading to progressive muscle fiber loss. Utrophin is a close analogue of dystrophin. A substantial, ectopic expression of utrophin in the extrasynaptic sarcolemma of dystrophin-deficient muscle fibers can prevent deleterious effects of dystrophin deficiency. An alternative approach for the extrasynaptic up-regulation of utrophin involves the augmentation of utrophin transcription via the endogenous utrophin A promoter using custom-designed transcriptional activator proteins with zinc finger (ZFP) motifs. We tested a panel of custom-designed ZFP for their ability to activate the utrophin A promoter. Expression of one such ZFP efficiently increased, in a time-dependent manner, utrophin transcript and protein levels both in vitro and in vivo. In dystrophic mouse (mdx) muscles, administration of adenoviral vectors expressing this ZFP led to significant enhancement of muscle function with decreased necrosis, restoration of the dystrophin-associated proteins, and improved resistance to eccentric contractions. These studies provide evidence that specifically designed ZFPs can act as strong transcriptional activators of the utrophin A promoter. These may thus serve as attractive therapeutic agents for dystrophin deficiency states such as Duchenne muscular dystrophy.	[Lu, Yifan; Tian, Chai; Karpati, George; Nalbantoglu, Josephine] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Lu, Yifan; Tian, Chai; Karpati, George; Nalbantoglu, Josephine] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Danialou, Gawiyou; Petrof, Basil J.] McGill Univ, Div Resp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Danialou, Gawiyou; Petrof, Basil J.] McGill Univ, Meakins Christie Labs, Montreal, PQ H3A 1A1, Canada; [Gilbert, Renald] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	McGill University; McGill University; McGill University; McGill University; National Research Council Canada	Nalbantoglu, J (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	Josephine.nalbantoglu@mcgill.ca			United States Muscular Dystrophy Association; Canadian Institutes of Health Research [MOP-5366]	United States Muscular Dystrophy Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the United States Muscular Dystrophy Association and the Canadian Institutes of Health Research ( Grant MOP-5366). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angus LM, 2005, AM J PHYSIOL-CELL PH, V289, pC908, DOI 10.1152/ajpcell.00196.2005; Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Beerli RR, 2000, J BIOL CHEM, V275, P32617, DOI 10.1074/jbc.M005108200; Briguet A, 2003, NEUROMUSCULAR DISORD, V13, P143, DOI 10.1016/S0960-8966(02)00217-1; Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; CLERK A, 1993, HISTOCHEM J, V25, P554; Corbi N, 2000, GENE THER, V7, P1076, DOI 10.1038/sj.gt.3301204; DelloRusso C, 2002, P NATL ACAD SCI USA, V99, P12979, DOI 10.1073/pnas.202300099; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Deol JR, 2007, MOL THER, V15, P1767, DOI 10.1038/sj.mt.6300260; Disatnik MH, 1998, J NEUROL SCI, V161, P77, DOI 10.1016/S0022-510X(98)00258-5; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Dudley RWR, 2004, HUM GENE THER, V15, P145, DOI 10.1089/104303404772679959; Galvagni F, 2002, J BIOL CHEM, V277, P19106, DOI 10.1074/jbc.M109642200; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Gilbert R, 2003, HUM MOL GENET, V12, P1287, DOI 10.1093/hmg/ddg141; Gilbert R, 2002, MOL THER, V6, P501, DOI 10.1006/mthe.2002.0689; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Gyrd-Hansen M, 2002, J NEUROL SCI, V197, P27, DOI 10.1016/S0022-510X(02)00038-2; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Jasmin BJ, 2002, J PHYSIOL-PARIS, V96, P31, DOI 10.1016/S0928-4257(01)00078-X; Karpati G, 1997, NAT MED, V3, P22, DOI 10.1038/nm0197-22; KARPATI G, 1993, J NEUROPATH EXP NEUR, V52, P119, DOI 10.1097/00005072-199303000-00004; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liu Q, 2002, J BIOL CHEM, V277, P3850, DOI 10.1074/jbc.M110669200; Mattei E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000774; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Nguyen T M, 1991, J Cell Biol, V115, P1695, DOI 10.1083/jcb.115.6.1695; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Perkins KJ, 2001, NUCLEIC ACIDS RES, V29, P4843, DOI 10.1093/nar/29.23.4843; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795; Rybakova IN, 2002, MOL BIOL CELL, V13, P1512, DOI 10.1091/mbc.01-09-0446; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; SCHOFIELD J, 1993, DEV DYNAM, V198, P254, DOI 10.1002/aja.1001980403; Tan SY, 2003, P NATL ACAD SCI USA, V100, P11997, DOI 10.1073/pnas.2035056100; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Taylor J, 1997, NEUROPATH APPL NEURO, V23, P399; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Wakefield PM, 2000, GENE THER, V7, P201, DOI 10.1038/sj.gt.3301066; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200	54	19	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34720	34727		10.1074/jbc.M804518200	http://dx.doi.org/10.1074/jbc.M804518200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945675	hybrid, Green Published			2022-12-25	WOS:000261469100028
J	Nunez, LR; Jesch, SA; Gaspar, ML; Almaguer, C; Villa-Garcia, M; Ruiz-Noriega, M; Patton-Vogt, J; Henry, SA				Nunez, Lilia R.; Jesch, Stephen A.; Gaspar, Maria L.; Almaguer, Claudia; Villa-Garcia, Manuel; Ruiz-Noriega, Monica; Patton-Vogt, Jana; Henry, Susan A.			Cell Wall Integrity MAPK Pathway Is Essential for Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; YEAST SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM STRESS; NEUROPATHY TARGET ESTERASE; GENOME-WIDE ANALYSIS; PHOSPHOLIPID BIOSYNTHESIS; SIGNALING PATHWAYS; GENE-EXPRESSION; CRYPTOCOCCUS-NEOFORMANS; TRANSMEMBRANE PROTEIN	The highly conserved yeast cell wall integrity mitogen-activated protein kinase pathway regulates cellular responses to cell wall and membrane stress. We report that this pathway is activated and essential for viability under growth conditions that alter both the abundance and pattern of synthesis and turnover of membrane phospholipids, particularly phosphatidylinositol and phosphatidylcholine. Mutants defective in this pathway exhibit a choline-sensitive inositol auxotrophy, yet fully derepress INO1 and other Opi1p-regulated genes when grown in the absence of inositol. Under these growth conditions, Mpk1p is transiently activated by phosphorylation and stimulates the transcription of known targets of Mpk1p signaling, including genes regulated by the Rlm1p transcription factor. mpk1 Delta cells also exhibit severe defects in lipid metabolism, including an abnormal accumulation of phosphatidylcholine, diacylglycerol, triacylglycerol, and free sterols, as well as aberrant turnover of phosphatidylcholine. Overexpression of the NTE1 phospholipase B gene suppresses the choline-sensitive inositol auxotrophy of mpk1 Delta cells, whereas overexpression of other phospholipase genes has no effect on this phenotype. These results indicate that an intact cell wall integrity pathway is required for maintaining proper lipid homeostasis in yeast, especially when cells are grown in the absence of inositol.	[Nunez, Lilia R.; Jesch, Stephen A.; Gaspar, Maria L.; Villa-Garcia, Manuel; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Almaguer, Claudia; Patton-Vogt, Jana] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Ruiz-Noriega, Monica] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Cornell University; Duquesne University; Carnegie Mellon University	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 260 Roberts Hall, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014		National Institutes of Health [GM019629, GM59817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019629, R01GM019629, R01GM059817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM019629 (to S. A. H.) and GM59817 (to J. P.-V.). This study is taken in part from the Ph.D. thesis of L. R. N., published under the name Lilia Nunez-Rodriguez (Cornell University, 2006). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alic N, 2003, J BIOL CHEM, V278, P41849, DOI 10.1074/jbc.M307760200; Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; ANTONSSON B, 1994, J BIOL CHEM, V269, P16821; ATKINSON KD, 1977, J BACTERIOL, V132, P806, DOI 10.1128/JB.132.3.806-817.1977; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Buehrer BM, 1997, MOL CELL BIOL, V17, P6517, DOI 10.1128/MCB.17.11.6517; Burnett WV, 1997, BIOTECHNIQUES, V22, P668, DOI 10.2144/97224st01; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang HJ, 2002, GENETICS, V162, P29; Chen R, 2007, MOL CELL BIOCHEM, V302, P179, DOI 10.1007/s11010-007-9439-0; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COOK SJ, 1989, BIOCHEM J, V263, P581, DOI 10.1042/bj2630581; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Dubois E, 2000, FEBS LETT, V486, P300, DOI 10.1016/S0014-5793(00)02318-8; ERREDE B, 1995, MOL REPROD DEV, V42, P477, DOI 10.1002/mrd.1080420416; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GREENBERG ML, 1982, GENETICS, V100, P19; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HANSON BA, 1982, J BACTERIOL, V151, P334, DOI 10.1128/JB.151.1.334-342.1982; HANSON BA, 1980, J BACTERIOL, V142, P79, DOI 10.1128/JB.142.1.79-89.1980; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; LEE KS, 1994, J BIOL CHEM, V269, P19725; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; LEVIN DE, 1994, CELL MOL BIOL RES, V40, P229; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P3987, DOI 10.1093/nar/19.14.3987; Mattison CP, 1999, MOL CELL BIOL, V19, P7651; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; MORI K, 1993, CELL, V74, P743; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; NISHIZUKA Y, 1984, SCIENCE, V225, P1365, DOI 10.1126/science.6147898; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NUNEZ L, 2006, THESIS CORNELL U ITH; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; RUIZNORIEGA M, 2000, THESIS CARNEGIE MELL; Schmitz HP, 2001, J MOL BIOL, V311, P1, DOI 10.1006/jmbi.2001.4848; Seidman C. E., 2003, CURRENT PROTOCOLS MO; Serrano R, 2006, J BIOL CHEM, V281, P39785, DOI 10.1074/jbc.M604497200; Staleva L, 2004, MOL BIOL CELL, V15, P5574, DOI 10.1091/mbc.E04-02-0142; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WATANABE M, 1994, J BIOL CHEM, V269, P16829; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; WHITE MJ, 1991, J BIOL CHEM, V266, P863; Xie ZH, 2001, MOL BIOL CELL, V12, P1117, DOI 10.1091/mbc.12.4.1117; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200	85	33	34	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34204	34217		10.1074/jbc.M806391200	http://dx.doi.org/10.1074/jbc.M806391200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18842580	Green Published, hybrid			2022-12-25	WOS:000261277700049
J	Malka, Y; Hornakova, T; Royer, Y; Knoops, L; Renauld, JC; Constantinescu, SN; Henis, YI				Malka, Yaniv; Hornakova, Tekla; Royer, Yohan; Knoops, Laurent; Renauld, Jean-Christophe; Constantinescu, Stefan N.; Henis, Yoav I.			Ligand-independent Homomeric and Heteromeric Complexes between Interleukin-2 or-9 Receptor Subunits and the gamma Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA RECEPTORS; TYROSINE KINASE JAK2; ERYTHROPOIETIN RECEPTOR; SIGNAL-TRANSDUCTION; CYTOKINE RECEPTOR; POLYCYTHEMIA-VERA; GROWTH-FACTOR; CYTOPLASMIC DOMAINS; CELL-GROWTH; T-CELLS	Signaling via interleukin-2 (IL-2) and interleukin-9 receptors (IL-2R and IL-9R) involves heteromeric interactions between specific interleukin receptor subunits, which bind Janus kinase 1 (JAK1) and the JAK3 binding common gamma chain (gamma(c)). The potential existence and roles of homomeric and heteromeric complexes before ligand binding and their modulation by ligand and JAK3 are unclear. Using computerized antibody-mediated immunofluorescence co-patching of epitope-tagged receptors at the surface of live cells, we demonstrate that IL-2R beta, IL-9R alpha, and gamma(c) each display a significant fraction of ligand-independent homomeric complexes (24-28% co-patching), whereas control co-patching levels with unrelated receptors are very low (7%). Heteromeric complex formation of IL2-R beta or IL-9R alpha with gamma(c) is also observed in the absence of ligand (15-30%). Ligand binding increases this hetero-oligomerization 2-fold but does not affect homo-oligomerization. Co-expression of IL-2R alpha does not affect the hetero-oligomerization of IL-2R beta and gamma(c). Recruitment of gamma(c) into heterocomplexes is partly at the expense of its homo-oligomerization, suggesting that a functional role of the latter may be to keep the receptors inactive in the absence of ligand. At the same time, the preformed complexes between gamma(c) and IL-2R beta or IL-9R alpha promote signaling by the JAK3 A572V mutant without ligand, supporting a pathophysiological role for the constitutive oligomerization in triggering ligand-independent activation of JAK3 (and perhaps other JAK mutants) mutants identified in several human cancers.	[Hornakova, Tekla; Royer, Yohan; Knoops, Laurent; Renauld, Jean-Christophe; Constantinescu, Stefan N.] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Hornakova, Tekla; Royer, Yohan; Knoops, Laurent; Renauld, Jean-Christophe; Constantinescu, Stefan N.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Malka, Yaniv; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Tel Aviv University	Constantinescu, SN (corresponding author), Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium.	stefan.constantinescu@bru.licr.org	Constantinescu, Stefan N/E-5277-2012; Renauld, Jean-Christophe/B-7268-2012	Henis, Yoav/0000-0002-1408-3877; Renauld, Jean-Christophe/0000-0003-1736-2131	Israeli Ministry of Health Chief Scientist's Office; Fonds National de la Recherche Scientifique (Belgium); Salus Sanguinis Foundation; Action de Recherche Concertee MEXP31C1(University Catholique de Louvain); Fondation Contre le Cancer (Brussels); PAI Program BCHM61B5 (Belgium); Atlantic Philantropies, New York	Israeli Ministry of Health Chief Scientist's Office; Fonds National de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Salus Sanguinis Foundation; Action de Recherche Concertee MEXP31C1(University Catholique de Louvain); Fondation Contre le Cancer (Brussels); PAI Program BCHM61B5 (Belgium); Atlantic Philantropies, New York	This research was supported in part by a grant from the Israeli Ministry of Health Chief Scientist's Office (to Y. I. H.). This work was also supported by the Fonds National de la Recherche Scientifique (Belgium), the Salus Sanguinis Foundation, the Action de Recherche Concertee MEXP31C1(University Catholique de Louvain), the Fondation Contre le Cancer (Brussels), PAI Program BCHM61B5 (Belgium), and the Atlantic Philantropies, New York (to S. N. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Constantinescu SN, 1999, EMBO J, V18, P3334, DOI 10.1093/emboj/18.12.3334; Constantinescu SN, 2003, J BIOL CHEM, V278, P43755, DOI 10.1074/jbc.M302974200; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demoulin JB, 1998, CYTOKINES CELL MOL T, V4, P243; DISANTO JP, 1994, EUR J IMMUNOL, V24, P3014, DOI 10.1002/eji.1830241214; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Gerland K, 2000, MOL CELL ENDOCRINOL, V168, P1, DOI 10.1016/S0303-7207(00)00314-2; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; Hofmann SR, 2004, MOL CELL BIOL, V24, P5039, DOI 10.1128/MCB.24.11.5039-5049.2004; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Keren T, 2001, J BIOL CHEM, V276, P28356, DOI 10.1074/jbc.M102235200; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; RENAULD J-C, 1990, Cytokine, V2, P9, DOI 10.1016/1043-4666(90)90037-T; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Sabath DF, 1999, BLOOD, V94, P365, DOI 10.1182/blood.V94.1.365.413a46_365_367; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9	57	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33569	33577		10.1074/jbc.M803125200	http://dx.doi.org/10.1074/jbc.M803125200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829468	hybrid, Green Published			2022-12-25	WOS:000261183700062
J	Chickarmane, V; Peterson, C				Chickarmane, Vijay; Peterson, Carsten			A Computational Model for Understanding Stem Cell, Trophectoderm and Endoderm Lineage Determination	PLOS ONE			English	Article							SELF-RENEWAL; PLURIPOTENCY; DIFFERENTIATION; FIBROBLASTS; EXPRESSION; OCT-4	Background: Recent studies have associated the transcription factors, Oct4, Sox2 and Nanog as parts of a self-regulating network which is responsible for maintaining embryonic stem cell properties: self renewal and pluripotency. In addition, mutual antagonism between two of these and other master regulators have been shown to regulate lineage determination. In particular, an excess of Cdx2 over Oct4 determines the trophectoderm lineage whereas an excess of Gata-6 over Nanog determines differentiation into the endoderm lineage. Also, under/over-expression studies of the master regulator Oct4 have revealed that some self-renewal/pluripotency as well as differentiation genes are expressed in a biphasic manner with respect to the concentration of Oct4. Methodology/Principal Findings: We construct a dynamical model of a minimalistic network, extracted from ChIP-on-chip and microarray data as well as literature studies. The model is based upon differential equations and makes two plausible assumptions; activation of Gata-6 by Oct4 and repression of Nanog by an Oct4-Gata-6 heterodimer. With these assumptions, the results of simulations successfully describe the biphasic behavior as well as lineage commitment. The model also predicts that reprogramming the network from a differentiated state, in particular the endoderm state, into a stem cell state, is best achieved by over-expressing Nanog, rather than by suppression of differentiation genes such as Gata-6. Conclusions: The computational model provides a mechanistic understanding of how different lineages arise from the dynamics of the underlying regulatory network. It provides a framework to explore strategies of reprogramming a cell from a differentiated state to a stem cell state through directed perturbations. Such an approach is highly relevant to regenerative medicine since it allows for a rapid search over the host of possibilities for reprogramming to a stem cell state.	[Chickarmane, Vijay] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Peterson, Carsten] Lund Univ, Dept Theoretical Phys, S-22100 Lund, Sweden; [Peterson, Carsten] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therapy, S-22100 Lund, Sweden	California Institute of Technology; Lund University; Lund University	Chickarmane, V (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	carsten@thep.lu.se			Swedish Foundation for Strategic Research; National Science Foundation-FIBR Award [EF-0330786]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Science Foundation-FIBR Award	This research was in part supported by the Swedish Foundation for Strategic Research through a Senior Individual Grant and the National Science Foundation-FIBR Award EF-0330786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Johnson BV, 2006, CURR OPIN GENET DEV, V16, P447, DOI 10.1016/j.gde.2006.08.012; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mullen EM, 2007, PPAR RES, V2007, DOI 10.1155/2007/61563; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	101	104	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3478	10.1371/journal.pone.0003478	http://dx.doi.org/10.1371/journal.pone.0003478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941526	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000265126100009
J	Ghosh, AK; Kanda, T; Steele, R; Ray, RB				Ghosh, Asish K.; Kanda, Tatsuo; Steele, Robert; Ray, Ratna B.			Knockdown of MBP-1 in Human Foreskin Fibroblasts Induces p53-p21 Dependent Senescence	PLOS ONE			English	Article							CELLULAR SENESCENCE; FUNCTIONAL DOMAINS; ONCOGENIC RAS; P53; INHIBITION; CLONING; GROWTH; CELLS; PML	MBP-1 acts as a general transcriptional repressor. Overexpression of MBP-1 induces cell death in a number of cancer cells and regresses tumor growth. However, the function of endogenous MBP-1 in normal cell growth regulation remains unknown. To unravel the role of endogenous MBP-1, we knocked down MBP-1 expression in primary human foreskin fibroblasts (HFF) by RNA interference. Knockdown of MBP-1 in HFF (HFF-MBPsi-4) resulted in an induction of premature senescence, displayed flattened cell morphology, and increased senescence-associated beta-galactosidase activity. FACS analysis of HFF-MBPsi-4 revealed accumulation of a high number of cells in the G1-phase. A significant upregulation of cyclin D1 and reduction of cyclin A was detected in HFF-MBPsi-4 as compared to control HFF. Senescent fibroblasts exhibited enhanced expression of phosphorylated and acetylated p53, and cyclin-dependent kinase inhibitor, p21. Further analysis suggested that promyolocytic leukemia protein (PML) bodies are dramatically increased in HFF-MBPsi-4. Together, these results demonstrated that knockdown of endogenous MBP-1 is involved in cellular senescence of HFF through p53-p21 pathway.	[Ghosh, Asish K.; Kanda, Tatsuo; Steele, Robert; Ray, Ratna B.] St Louis Univ, Dept Pathol, St Louis, MO USA; [Ray, Ratna B.] St Louis Univ, Canc Ctr, St Louis, MO USA	Saint Louis University; Saint Louis University	Ghosh, AK (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	rayrb@slu.edu		Kanda, Tatsuo/0000-0002-1654-5385	National Institutes of Health [CA52977]; Saint Louis University [Seed]; NATIONAL CANCER INSTITUTE [R01CA052977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by PHS grant CA52977 from the National Institutes of Health and Seed Grant from Saint Louis University.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2000, GENE DEV, V14, P2015; Ghosh AK, 2005, CANCER RES, V65, P718; Ghosh AK, 1999, MOL CELL BIOL, V19, P2880; Ghosh AK, 2002, ONCOGENE, V21, P2775, DOI 10.1038/sj.onc.1205384; Ghosh AK, 2006, J BIOL CHEM, V281, P23652, DOI 10.1074/jbc.M602930200; Ghosh AK, 2006, CANCER RES, V66, P11907, DOI 10.1158/0008-5472.CAN-06-2754; GIALLONGO A, 1986, P NATL ACAD SCI USA, V83, P6741, DOI 10.1073/pnas.83.18.6741; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; RAY R, 1991, MOL CELL BIOL, V11, P2154, DOI 10.1128/MCB.11.4.2154; Roninson IB, 2003, CANCER RES, V63, P2705; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200	28	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3384	10.1371/journal.pone.0003384	http://dx.doi.org/10.1371/journal.pone.0003384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852884	Green Published, gold			2022-12-25	WOS:000265121600008
J	Lavigne, JP; Nicolas-Chanoine, MH; Bourg, G; Moreau, J; Sotto, A				Lavigne, Jean-Philippe; Nicolas-Chanoine, Marie-Helene; Bourg, Gisele; Moreau, Jerome; Sotto, Albert			Virulent Synergistic Effect between Enterococcus faecalis and Escherichia coli Assayed by Using the Caenorhabditis elegans Model	PLOS ONE			English	Article								Background: The role of enterococci in the pathogenesis of polymicrobial infections is still debated. The purpose of this study was to evaluate the effect of virulent enterococci in the presence or absence of Escherichia coli strains in the in vivo Caenorhabditis elegans model. Principal Findings: This study demonstrated that there was a synergistic effect on virulence when an association of enterococci and E. coli (LT50 = 1.6 days +/- 0.1 according to the tested strains and death of nematodes in 4 days +/- 0.5) was tested in comparison with enterococci alone (LT50 = 4.6 days +/- 0.1 and death in 10.4 days +/- 0.6) or E. coli alone (LT50 = 2.1 +/- 0.9 and deaths 6.6 +/- 0.6) (p < 0.001). In addition, there was a relation between the virulence of E. faecalis strains alone and the virulence potential of the association with E. coli strains. Finally, in the presence of avirulent E. coli strains, enterococci have no effect (LT50 = 4.3 +/- 0.5 and deaths in 10.8 +/- 0.8), independently of the level of their own virulence, demonstrating that the 'enterococci effect' only occurred in the presence of virulent E. coli strains. Conclusion: This study allows a better understanding of a bacterial cooperation. Moreover, it could help to optimize the antibiotic regimen during polymicrobial infections.	[Lavigne, Jean-Philippe; Bourg, Gisele; Sotto, Albert] Univ Montpellier 1, INSERM, ESPRI 26, UFR Med, Nimes, France; [Lavigne, Jean-Philippe] CHU Caremeau, Lab Bacteriol, Virol, Parasitol, Nimes, France; [Nicolas-Chanoine, Marie-Helene] Hop AP HP Beaujon, Serv Microbiol, Clichy, France; [Nicolas-Chanoine, Marie-Helene] Univ Paris 07, U773, Inst Natl Sante Rech Med, F-75221 Paris, France; [Moreau, Jerome] Univ Bourgogne, Equipe Ecol Evolut UMR 5561 Biogeosci, F-21004 Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Bourgogne	Lavigne, JP (corresponding author), Univ Montpellier 1, INSERM, ESPRI 26, UFR Med, Nimes, France.	albert.sotto@chu-nimes.fr	moreau, jerome/A-3496-2013; Sotto, Albert/AFJ-9023-2022; Lavigne, Jean-Philippe/E-1756-2014	Lavigne, Jean-Philippe/0000-0002-9484-0304; Sotto, Albert/0000-0002-6463-9386	INSERM; Universite de Montpellier 1; Ville de Nimes; La Region Languedoc Roussillon	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Montpellier 1; Ville de Nimes; La Region Languedoc Roussillon(Region Occitanie)	INSERM Espri 26 is supported by INSERM, Universite de Montpellier 1, La Ville de Nimes and La Region Languedoc Roussillon. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blot S, 2005, DRUGS, V65, P1611, DOI 10.2165/00003495-200565120-00002; Chatterjee Indranil, 2007, Crit Care Resusc, V9, P69; COQUE TM, 1995, J INFECT DIS, V171, P1223, DOI 10.1093/infdis/171.5.1223; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; Diard M, 2007, MICROBES INFECT, V9, P214, DOI 10.1016/j.micinf.2006.11.009; DUNNY GM, 1979, PLASMID, V2, P454, DOI 10.1016/0147-619X(79)90029-5; Dupont H, 1998, INFECT IMMUN, V66, P2570, DOI 10.1128/IAI.66.6.2570-2575.1998; DUPONT H, 2007, DIAGN MICROBIOL INFE, V60, P247; Dupont H, 2007, INT J INFECT DIS, V11, pS1, DOI 10.1016/S1201-9712(07)60001-0; Franz CMAP, 2001, APPL ENVIRON MICROB, V67, P4385, DOI 10.1128/AEM.67.9.4385-4389.2001; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Harbarth S, 2004, EUR J CLIN MICROBIOL, V23, P73, DOI 10.1007/s10096-003-1078-0; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lavigne JP, 2006, CLIN MICROBIOL INFEC, V12, P1199, DOI 10.1111/j.1469-0691.2006.01536.x; Lavigne JP, 2005, PATHOL BIOL, V53, P539, DOI 10.1016/j.patbio.2005.06.005; Maadani A, 2007, INFECT IMMUN, V75, P2634, DOI 10.1128/IAI.01372-06; MONTRAVERS P, 1994, J INFECT DIS, V169, P821, DOI 10.1093/infdis/169.4.821; Montravers P, 1997, INFECT IMMUN, V65, P144, DOI 10.1128/IAI.65.1.144-149.1997; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Neeleman C, 2004, J CLIN MICROBIOL, V42, P4355, DOI 10.1128/JCM.42.9.4355-4357.2004; NICHOLS RL, 1992, CLIN INFECT DIS, V15, P72, DOI 10.1093/clinids/15.1.72; ONDERDONK AB, 1976, INFECT IMMUN, V13, P22, DOI 10.1128/IAI.13.1.22-26.1976; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Vergis EN, 2002, CLIN INFECT DIS, V35, P570, DOI 10.1086/341977	30	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3370	10.1371/journal.pone.0003370	http://dx.doi.org/10.1371/journal.pone.0003370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18843374	gold, Green Published, Green Submitted			2022-12-25	WOS:000265114100008
J	Ding, M; King, RS; Berry, EC; Wang, Y; Hardin, J; Chisholm, AD				Ding, Mei; King, Ryan S.; Berry, Emily C.; Wang, Ying; Hardin, Jeff; Chisholm, Andrew D.			The Cell Signaling Adaptor Protein EPS-8 Is Essential for C-elegans Epidermal Elongation and Interacts with the Ankyrin Repeat Protein VAB-19	PLOS ONE			English	Article								Background: The epidermal cells of the C. elegans embryo undergo coordinated cell shape changes that result in the morphogenetic process of elongation. The cytoskeletal ankyrin repeat protein VAB-19 is required for cell shape changes and localizes to cell-matrix attachment structures. The molecular functions of VAB-19 in this process are obscure, as no previous interactors for VAB-19 have been described. Methodology/Principal Findings: In screens for VAB-19 binding proteins we identified the signaling adaptor EPS-8. Within C. elegans epidermal cells, EPS-8 and VAB-19 colocalize at cell-matrix attachment structures. The central domain of EPS-8 is necessary and sufficient for its interaction with VAB-19. eps-8 null mutants, like vab-19 mutants, are defective in epidermal elongation and in epidermal-muscle attachment. The eps-8 locus encodes two isoforms, EPS-8A and EPS-8B, that appear to act redundantly in epidermal elongation. The function of EPS-8 in epidermal development involves its N-terminal PTB and central domains, and is independent of its C-terminal SH3 and actin-binding domains. VAB-19 appears to act earlier in the biogenesis of attachment structures and may recruit EPS-8 to these structures. Conclusions/Significance: EPS-8 and VAB-19 define a novel pathway acting at cell-matrix attachments to regulate epithelial cell shape. This is the first report of a role for EPS-8 proteins in cell-matrix attachments. The existence of EPS-8B-like isoforms in Drosophila suggests this function of EPS-8 proteins could be conserved among other organisms.	[Ding, Mei; Wang, Ying; Chisholm, Andrew D.] Univ Calif Santa Cruz, Dept Mol, Cellular & Dev Biol, Santa Cruz, CA 95064 USA; [King, Ryan S.; Hardin, Jeff] Univ Wisconsin, Dept Zool, Cellular & Mol Biol Grad Program, Madison, WI 53706 USA; [Berry, Emily C.; Chisholm, Andrew D.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Hardin, Jeff] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of California System; University of California Santa Cruz; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison	Ding, M (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.	chisholm@ucsd.edu		Chisholm, Andrew/0000-0001-5091-0537	NIH [T32 GM07215, R01 GM54657]; National Science Foundation [IOB 0518081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM054657] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Predoctoral Training Grant in Molecular Biosciences T32 GM07215 (R.K.), National Science Foundation Grant IOB 0518081 (to J.H.) and NIH R01 GM54657 (A.D.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; BRENNER S, 1974, GENETICS, V77, P71; CASTAGNINO P, 1995, ONCOGENE, V10, P723; Chisholm AD., EPIDERMAL MORPHOGENE, DOI [10.1895/wormbook.1.35.1, DOI 10.1895/WORMBOOK.1.35.1]; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; KARLSSON T, 1995, ONCOGENE, V10, P1475; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; Matoskova B, 1996, ONCOGENE, V12, P2679; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Mei D, 2004, EXP CELL RES, V301, P84, DOI 10.1016/j.yexcr.2004.08.017; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Piekny AJ, 2003, DEVELOPMENT, V130, P5695, DOI 10.1242/dev.00807; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Stetak A, 2006, EMBO J, V25, P2347, DOI 10.1038/sj.emboj.7601137; Tocchetti A, 2003, GENOMICS, V81, P234, DOI 10.1016/S0888-7543(03)00002-8; Wissmann A, 1999, DEV BIOL, V209, P111, DOI 10.1006/dbio.1999.9242; Woo WM, 2004, DEV BIOL, V267, P216, DOI 10.1016/j.ydbio.2003.11.007; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017	36	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3346	10.1371/journal.pone.0003346	http://dx.doi.org/10.1371/journal.pone.0003346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833327	Green Published, Green Submitted, gold			2022-12-25	WOS:000264797400011
J	Chen, ZH; Kim, HP; Sciurba, FC; Lee, SJ; Feghali-Bostwick, C; Stolz, DB; Dhir, R; Landreneau, RJ; Schuchert, MJ; Yousem, SA; Nakahira, K; Pilewski, JM; Lee, JS; Zhang, Y; Ryter, SW; Choi, AMK				Chen, Zhi-Hua; Kim, Hong Pyo; Sciurba, Frank C.; Lee, Seon-Jin; Feghali-Bostwick, Carol; Stolz, Donna B.; Dhir, Rajiv; Landreneau, Rodney J.; Schuchert, Mathew J.; Yousem, Samuel A.; Nakahira, Kiichi; Pilewski, Joseph M.; Lee, Janet S.; Zhang, Yingze; Ryter, Stefan W.; Choi, Augustine M. K.			Egr-1 Regulates Autophagy in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article								Background: Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by abnormal cellular responses to cigarette smoke, resulting in tissue destruction and airflow limitation. Autophagy is a degradative process involving lysosomal turnover of cellular components, though its role in human diseases remains unclear. Methodology and Principal Findings: Increased autophagy was observed in lung tissue from COPD patients, as indicated by electron microscopic analysis, as well as by increased activation of autophagic proteins (microtubule-associated protein-1 light chain-3B, LC3B, Atg4, Atg5/12, Atg7). Cigarette smoke extract (CSE) is an established model for studying the effects of cigarette smoke exposure in vitro. In human pulmonary epithelial cells, exposure to CSE or histone deacetylase (HDAC) inhibitor rapidly induced autophagy. CSE decreased HDAC activity, resulting in increased binding of early growth response-1 (Egr-1) and E2F factors to the autophagy gene LC3B promoter, and increased LC3B expression. Knockdown of E2F-4 or Egr-1 inhibited CSE-induced LC3B expression. Knockdown of Egr-1 also inhibited the expression of Atg4B, a critical factor for LC3B conversion. Inhibition of autophagy by LC3B-knockdown protected epithelial cells from CSE-induced apoptosis. Egr-1(-/-) mice, which displayed basal airspace enlargement, resisted cigarette-smoke induced autophagy, apoptosis, and emphysema. Conclusions: We demonstrate a critical role for Egr-1 in promoting autophagy and apoptosis in response to cigarette smoke exposure in vitro and in vivo. The induction of autophagy at early stages of COPD progression suggests novel therapeutic targets for the treatment of cigarette smoke induced lung injury.	[Chen, Zhi-Hua; Kim, Hong Pyo; Sciurba, Frank C.; Lee, Seon-Jin; Feghali-Bostwick, Carol; Nakahira, Kiichi; Pilewski, Joseph M.; Lee, Janet S.; Zhang, Yingze; Ryter, Stefan W.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15260 USA; [Chen, Zhi-Hua; Kim, Hong Pyo; Lee, Seon-Jin; Nakahira, Kiichi; Ryter, Stefan W.; Choi, Augustine M. K.] Harvard Univ, Harvard Med Sch, Brigham & Womens Hosp, Cambridge, MA 02138 USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Ctr Biol Imag, Pittsburgh, PA 15260 USA; [Dhir, Rajiv; Yousem, Samuel A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Landreneau, Rodney J.; Schuchert, Mathew J.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, ZH (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15260 USA.	amchoi@rics.bwh.harvard.edu	Pilewski, Joseph/AAF-5149-2021; Lee, Seon-Jin/AAJ-8258-2020; Sciurba, Frank/AAZ-9339-2021	Lee, Janet/0000-0002-6812-6043	NIH [R01-HL60234, R01-HL55330, R01-HL079904, P01-HL70807, P50HL084948]; American Heart Association [0335035N, 0525552U]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079904, P50HL084948, P01HL070807, R01HL060234, R01HL055330] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01-HL60234, R01-HL55330, R01-HL079904, and P01-HL70807 awarded to A. M. K. Choi, awards from the American Heart Association to S. W. Ryter (AHA #0335035N), and H.P. Kim (AHA #0525552U), and NIH grant 1 P50HL084948 to F. C. Sciurba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; DUNHILL MS, 1962, THORAX, V17, P320; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; *GOLD, 2001, NIH PUBL, V2701; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P713, DOI 10.1513/pats.200605-104SF; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Landesberg LJ, 2001, AM J PHYSIOL-LUNG C, V281, pL1138, DOI 10.1152/ajplung.2001.281.5.L1138; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lu Z, 2006, ONCOGENE, V25, P230, DOI 10.1038/sj.onc.1209025; Mayer AS, 2001, RESP PHYSIOL, V128, P3, DOI 10.1016/S0034-5687(01)00258-4; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Wang IM, 2008, AM J RESP CRIT CARE, V177, P402, DOI 10.1164/rccm.200703-390OC; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yan SF, 2000, J CLIN INVEST, V105, P553, DOI 10.1172/JCI9513; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	46	330	349	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3316	10.1371/journal.pone.0003316	http://dx.doi.org/10.1371/journal.pone.0003316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830406	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000264797300007
